data_2ldu_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ldu _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.2 t . . . . . 0 CA--C 1.549 0.906 0 CA-C-O 118.983 -0.532 . . . . 72.230000000000004 109.805 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.84 147.37 85.21 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 122.418 2.078 . . . . 72.549999999999997 110.894 171.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.29 -33.24 41.23 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.441 1.096 . . . . 73.349999999999994 113.36 -172.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.447 ' HB3' ' HH ' ' A' ' 78' ' ' TYR . 61.7 t80 -54.75 -52.76 61.55 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.681 0.792 . . . . 75.040000000000006 112.272 174.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 95.7 mt -77.26 -29.48 53.93 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 120.992 0.425 . . . . 74.430000000000007 109.912 -171.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.4 m -58.76 -48.4 81.34 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 114.351 -1.295 . . . . 74.329999999999998 111.395 173.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.486 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -69.28 -47.4 64.67 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.951 -0.568 . . . . 73.230000000000004 110.731 176.13 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.485 ' O ' HG23 ' A' ' 28' ' ' VAL . 58.9 tp -56.77 -54.76 42.6 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.597 1.159 . . . . 74.430000000000007 113.485 -174.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 89.5 t90 -56.34 -45.84 80.23 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.374 0.67 . . . . 74.409999999999997 111.13 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.1 m -69.26 -28.46 66.33 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.616 0.766 . . . . 75.219999999999999 111.663 177.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.453 ' HG ' HG23 ' A' ' 37' ' ' ILE . 49.6 tp -67.21 -46.2 74.58 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.932 1.293 . . . . 74.010000000000005 110.931 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 24' ' ' LEU . 23.6 t -63.53 -37.98 81.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-N 115.129 -0.941 . . . . 73.439999999999998 110.732 175.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.2 m -74.5 -19.97 60.16 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.841 0.856 . . . . 74.150000000000006 111.565 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -74.87 132.54 77.33 Favored Pre-proline 0 CA--C 1.556 1.173 0 C-N-CA 123.773 0.829 . . . . 64.209999999999994 110.988 -172.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.32 -28.19 12.66 Favored 'Trans proline' 0 C--N 1.384 2.44 0 C-N-CA 123.036 2.491 . . . . 74.209999999999994 114.235 -176.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -69.48 -43.39 73.29 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.244 0.618 . . . . 73.019999999999996 110.061 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.0 p -96.01 -1.25 49.31 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.733 -0.667 . . . . 70.329999999999998 111.325 -175.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -56.02 -30.83 62.45 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.645 1.178 . . . . 62.409999999999997 111.657 177.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.75 -36.31 78.61 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.237 -0.892 . . . . 74.239999999999995 112.152 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.8 mt -111.06 -6.0 14.7 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.166 0.587 . . . . 64.420000000000002 111.899 -176.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.453 HG23 ' HG ' ' A' ' 27' ' ' LEU . 18.8 tt -159.42 112.75 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 121.564 0.697 . . . . 74.109999999999999 110.504 175.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.525 ' SG ' ' HE2' ' A' ' 49' ' ' PHE . 24.5 p -139.9 145.41 37.95 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.174 0.59 . . . . 75.230000000000004 110.524 -174.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 18.8 p-90 -75.83 149.6 37.84 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.835 0.854 . . . . 71.120000000000005 111.513 -176.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.1 m -72.21 154.24 92.19 Favored Pre-proline 0 CA--C 1.556 1.192 0 C-N-CA 123.848 0.859 . . . . 64.030000000000001 109.262 174.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -43.21 -42.83 10.11 Favored 'Trans proline' 0 C--N 1.386 2.531 0 C-N-CA 124.432 3.421 . . . . 64.040000000000006 114.677 -176.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.2 m -67.52 -40.19 85.1 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.192 0.597 . . . . 71.409999999999997 111.37 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.11 11.82 55.8 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-N 115.901 -0.591 . . . . 61.439999999999998 112.793 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.405 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 28.0 p-10 -91.63 -4.76 54.87 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.26 1.024 . . . . 62.350000000000001 111.276 -175.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.6 p -155.31 170.93 20.73 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 123.937 0.895 . . . . 63.340000000000003 109.744 -174.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 50.7 p90 -142.12 149.23 39.55 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.07 0.548 . . . . 72.540000000000006 110.299 178.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -107.84 147.16 31.28 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.225 1.01 . . . . 73.510000000000005 108.398 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.604 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 60.2 t -123.3 131.31 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.018 -1.104 . . . . 72.409999999999997 108.018 176.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.525 ' HE2' ' SG ' ' A' ' 38' ' ' CYS . 79.3 m-85 -118.73 146.71 44.54 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 124.148 0.979 . . . . 73.409999999999997 109.4 -177.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 52.68 70.98 0.51 Allowed 'General case' 0 CA--C 1.548 0.898 0 O-C-N 124.693 1.246 . . . . 74.409999999999997 111.088 -178.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -46.79 -41.45 15.42 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 124.391 1.076 . . . . 73.109999999999999 112.955 -177.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.48 -46.58 76.18 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 115.646 -0.706 . . . . 75.409999999999997 112.822 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -72.69 -45.82 56.86 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.009 0.524 . . . . 74.319999999999993 110.822 -176.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.41 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 65.7 t80 -53.66 -49.15 68.57 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.778 1.231 . . . . 74.510000000000005 110.729 173.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 66' ' ' ASN . . . -64.44 -33.79 76.69 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 112.409 0.522 . . . . 71.230000000000004 112.409 178.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -69.41 -50.4 46.26 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.455 1.102 . . . . 74.299999999999997 112.167 -177.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.493 ' HG3' HG23 ' A' ' 58' ' ' VAL . 3.3 pt-20 -105.69 -43.97 4.78 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 113.098 0.777 . . . . 74.209999999999994 113.098 -174.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.493 HG23 ' HG3' ' A' ' 57' ' ' GLU . 94.5 t -76.78 -45.48 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 122.751 0.421 . . . . 74.129999999999995 111.017 -166.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 32.3 mt -61.8 -51.14 78.06 Favored Pre-proline 0 CA--C 1.557 1.225 0 CA-C-O 117.764 -1.113 . . . . 71.109999999999999 112.073 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.507 ' HG3' ' ND2' ' A' ' 66' ' ' ASN . 60.2 Cg_endo -70.21 -9.58 26.27 Favored 'Trans proline' 0 C--N 1.384 2.406 0 CA-C-N 122.291 1.854 . . . . 62.130000000000003 113.719 176.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -79.35 -53.49 6.87 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.284 0.633 . . . . 72.439999999999998 110.965 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -91.69 -46.82 7.71 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.075 0.55 . . . . 73.439999999999998 111.176 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -99.12 -177.29 3.57 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 108.254 -1.017 . . . . 73.530000000000001 108.254 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -113.16 37.52 3.13 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 119.112 0.869 . . . . 73.230000000000004 111.721 -172.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -157.05 158.33 36.28 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.91 0.484 . . . . 74.219999999999999 110.271 -174.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.507 ' ND2' ' HG3' ' A' ' 60' ' ' PRO . 10.4 m120 -105.31 -16.21 14.82 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 122.515 0.326 . . . . 65.329999999999998 110.671 177.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -75.86 124.72 27.78 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.842 0.457 . . . . 71.219999999999999 110.995 -175.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 12.7 tpt -75.1 -33.97 61.69 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.82 0.848 . . . . 75.109999999999999 111.779 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.07 -33.52 70.89 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.26 0.624 . . . . 60.149999999999999 111.68 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.43 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 48.2 t -64.7 -44.92 88.71 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.459 1.104 . . . . 73.450000000000003 111.223 175.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -60.64 -51.77 67.99 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.197 0.999 . . . . 73.510000000000005 110.709 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.6 t -61.32 -39.64 83.37 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 CA-C-N 115.0 -1.0 . . . . 74.319999999999993 111.342 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -60.69 -41.34 94.95 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.766 0.826 . . . . 74.239999999999995 112.096 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.43 ' HG2' ' O ' ' A' ' 70' ' ' SER . 13.8 mm100 -58.98 -47.41 85.24 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 123.943 0.777 . . . . 73.230000000000004 109.616 176.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.426 ' HB3' ' HB2' ' A' ' 80' ' ' PHE . 77.5 mt -61.65 -38.47 87.85 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.274 1.03 . . . . 72.5 112.172 -178.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -60.55 -35.65 76.55 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 122.557 0.343 . . . . 73.120000000000005 111.864 173.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 63.7 mtm -76.57 -23.56 53.54 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.039 0.536 . . . . 74.420000000000002 111.3 175.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.447 ' HH ' ' HB3' ' A' ' 20' ' ' PHE . 40.7 m-85 -85.9 -7.0 58.98 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.405 0.682 . . . . 72.129999999999995 111.602 175.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.93 10.2 66.96 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-O 119.569 -0.573 . . . . 64.239999999999995 114.27 175.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.426 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 24.0 m-85 -73.25 144.41 46.71 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 117.723 0.761 . . . . 75.409999999999997 109.506 178.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 57.5 ttt-85 -110.8 131.72 54.81 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.693 -0.484 . . . . 73.219999999999999 109.693 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.582 ' HE3' ' HA ' ' A' ' 99' ' ' THR . 18.6 tptm -74.48 127.43 33.04 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.735 0.814 . . . . 74.040000000000006 109.721 173.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 95.5 t -132.37 118.38 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 107.034 -1.469 . . . . 63.520000000000003 107.034 176.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.467 ' HB ' ' HE2' ' A' ' 82' ' ' LYS . 6.5 p -104.93 116.16 48.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 108.845 -0.798 . . . . 75.120000000000005 108.845 -177.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 . . . . . 0 N--CA 1.486 1.334 0 O-C-N 122.212 -0.305 . . . . 72.430000000000007 111.761 -177.454 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 . . . . . 0 C--O 1.242 0.674 0 CA-C-O 120.955 0.407 . . . . 75.439999999999998 110.253 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.87 142.02 28.13 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.028 -1.101 . . . . 72.109999999999999 108.028 170.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 20.3 t70 -106.7 105.13 15.02 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 106.891 -1.522 . . . . 64.200000000000003 106.891 166.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.604 ' HB ' ' HB ' ' A' ' 48' ' ' VAL . 31.6 m -112.79 91.24 3.58 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.118 0.567 . . . . 63.119999999999997 110.376 -171.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 46' ' ' PHE . 39.6 tt0 -98.32 114.68 27.07 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.9 0.48 . . . . 65.129999999999995 109.73 -175.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -98.68 120.24 38.78 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 109.199 -0.667 . . . . 74.209999999999994 109.199 171.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -108.22 144.24 35.93 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.171 0.988 . . . . 72.430000000000007 110.382 -175.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -160.08 132.27 4.29 Favored Pre-proline 0 N--CA 1.479 0.992 0 CA-C-O 119.193 -0.432 . . . . 74.409999999999997 110.206 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.41 -24.83 42.46 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 122.94 2.427 . . . . 74.310000000000002 113.616 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.487 ' HB2' HG12 ' A' ' 117' ' ' ILE . 13.2 m -95.1 8.49 42.81 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.738 0.415 . . . . 75.120000000000005 111.015 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 44' ' ' ASN . 74.5 t80 -111.43 100.43 9.02 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 107.816 -1.179 . . . . 73.430000000000007 107.816 175.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 110' ' ' GLN . 96.3 mt -120.58 154.09 35.87 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.196 0.598 . . . . 75.25 109.658 173.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -71.21 -22.56 62.0 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.111 0.964 . . . . 75.129999999999995 112.575 -170.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.61 27.19 6.65 Favored Glycine 0 N--CA 1.468 0.831 0 N-CA-C 112.268 -0.333 . . . . 73.019999999999996 112.268 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.526 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 14.5 mm100 -135.17 78.2 1.72 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.339 0.656 . . . . 72.400000000000006 110.182 -175.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -29.38 69.58 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.148 -0.933 . . . . 72.150000000000006 112.034 174.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 6.8 pm0 -76.28 -11.09 59.85 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.161 0.584 . . . . 74.319999999999993 111.693 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.0 mt -91.19 -12.78 34.36 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.658 0.383 . . . . 70.310000000000002 110.981 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 64.8 mt -69.1 -27.69 65.82 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.047 0.539 . . . . 71.510000000000005 110.631 175.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -89.72 0.9 56.69 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.612 0.765 . . . . 75.349999999999994 112.132 173.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -90.86 -17.36 26.65 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.282 -0.636 . . . . 74.439999999999998 109.282 161.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.487 HG12 ' HB2' ' A' ' 105' ' ' CYS . 32.7 mt -87.22 104.89 14.62 Favored 'Isoleucine or valine' 0 C--N 1.357 0.9 0 N-CA-C 106.64 -1.615 . . . . 75.230000000000004 106.64 173.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.472 ' HE2' ' HA ' ' A' ' 118' ' ' LYS . 11.0 mmpt? -112.47 155.81 23.63 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.953 -0.388 . . . . 73.319999999999993 109.953 -174.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 . . . . . 0 N--CA 1.477 0.893 0 C-N-CA 123.792 0.837 . . . . 73.319999999999993 109.152 179.51 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.402 HG12 ' HG1' ' A' ' 22' ' ' THR . 84.1 t . . . . . 0 CA--C 1.547 0.863 0 CA-C-O 119.381 -0.342 . . . . 74.030000000000001 110.212 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -53.0 140.35 59.46 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 123.44 2.76 . . . . 70.140000000000001 111.593 175.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.49 -40.4 65.33 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.635 0.774 . . . . 72.239999999999995 112.235 -178.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -52.33 -49.84 63.46 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.05 0.94 . . . . 71.25 112.307 171.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 90.4 mt -81.65 -25.1 35.88 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.887 0.475 . . . . 72.040000000000006 110.684 -170.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.402 ' HG1' HG12 ' A' ' 17' ' ' VAL . 73.5 m -64.74 -53.36 48.38 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 124.183 0.993 . . . . 71.409999999999997 110.657 174.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.533 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -69.34 -39.94 77.86 Favored 'General case' 0 C--N 1.345 0.396 0 CA-C-N 115.457 -0.792 . . . . 74.140000000000001 110.848 -179.395 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.406 ' O ' HG22 ' A' ' 28' ' ' VAL . 54.4 tp -60.49 -48.44 81.77 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.594 0.758 . . . . 73.400000000000006 111.733 176.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.595 ' HE1' ' HA ' ' A' ' 108' ' ' ARG . 56.3 t90 -59.04 -47.72 84.21 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.99 0.516 . . . . 73.010000000000005 111.13 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.9 m -59.4 -40.79 87.78 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.044 0.938 . . . . 75.239999999999995 110.886 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 22.1 tp -62.92 -52.92 61.17 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.752 1.621 . . . . 74.219999999999999 112.355 -178.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.412 HG11 ' HB3' ' A' ' 39' ' ' TRP . 93.6 t -60.84 -32.2 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 C-N-CA 124.227 1.011 . . . . 71.099999999999994 111.053 179.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.2 m -90.16 -5.84 56.02 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.271 1.028 . . . . 74.5 112.292 -176.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.409 ' HB3' ' OG1' ' A' ' 33' ' ' THR . 14.9 t70 -86.42 127.16 62.06 Favored Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 123.095 0.558 . . . . 72.209999999999994 111.192 -174.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.8 -32.39 77.81 Favored 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 123.782 2.988 . . . . 74.430000000000007 114.526 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -72.11 -39.94 68.51 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 122.901 0.481 . . . . 75.030000000000001 110.262 -178.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.409 ' OG1' ' HB3' ' A' ' 30' ' ' ASP . 29.8 p -98.14 0.46 46.03 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.736 -0.666 . . . . 64.439999999999998 111.445 -176.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -55.04 -31.21 60.92 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.603 1.161 . . . . 73.510000000000005 111.074 173.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.84 -39.94 86.85 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.065 0.946 . . . . 74.430000000000007 112.801 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 48.4 mt -103.54 -13.49 16.55 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.863 0.465 . . . . 75.239999999999995 111.96 -178.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.6 tt -159.81 122.27 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 121.061 0.458 . . . . 71.150000000000006 110.042 177.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 26.6 p -139.52 148.7 42.99 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 122.86 0.464 . . . . 72.430000000000007 111.245 -173.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.412 ' HB3' HG11 ' A' ' 28' ' ' VAL . 20.5 p-90 -77.85 148.99 34.41 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.418 0.687 . . . . 73.120000000000005 109.977 175.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.9 m -81.87 144.51 51.87 Favored Pre-proline 0 CA--C 1.551 1.008 0 N-CA-C 108.618 -0.882 . . . . 74.150000000000006 108.618 174.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.35 -22.15 15.27 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 123.883 3.055 . . . . 74.450000000000003 115.219 -173.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.3 m -78.06 -37.79 45.91 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.01 0.524 . . . . 45.549999999999997 111.073 176.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.9 4.14 51.62 Favored Glycine 0 C--N 1.351 1.416 0 N-CA-C 114.875 0.71 . . . . 63.310000000000002 114.875 167.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 6.6 p30 -106.5 2.08 25.95 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.804 0.842 . . . . 74.319999999999993 111.672 -175.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 81.0 p -148.01 158.09 43.87 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 109.016 -0.735 . . . . 75.510000000000005 109.016 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -142.57 152.67 42.81 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.8 0.44 . . . . 75.430000000000007 110.139 176.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -108.53 141.89 39.77 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.762 0.825 . . . . 75.519999999999996 109.336 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.437 HG13 ' HE1' ' A' ' 68' ' ' MET . 53.0 t -118.48 134.11 63.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 107.499 -1.297 . . . . 75.409999999999997 107.499 177.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 93.3 m-85 -123.45 147.21 47.38 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.853 0.861 . . . . 73.340000000000003 110.088 -172.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 48.11 63.32 2.09 Favored 'General case' 0 C--N 1.352 0.714 0 O-C-N 125.33 1.644 . . . . 74.349999999999994 111.356 175.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.524 ' HG2' ' HE3' ' A' ' 68' ' ' MET . 99.2 mt-30 -54.56 -29.14 50.29 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.309 1.044 . . . . 73.549999999999997 113.3 -171.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -63.42 -45.51 94.77 Favored Glycine 0 CA--C 1.531 1.069 0 O-C-N 123.36 0.413 . . . . 63.229999999999997 112.322 172.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -74.04 -45.71 47.89 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.81 0.844 . . . . 74.200000000000003 110.574 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.409 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 80.1 t80 -55.28 -52.6 62.91 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.752 1.621 . . . . 73.319999999999993 111.2 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.493 ' HB1' ' HB2' ' A' ' 68' ' ' MET . . . -66.92 -25.95 66.62 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.159 0.429 . . . . 73.25 112.159 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.8 -49.99 18.79 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.756 0.822 . . . . 75.209999999999994 112.25 -177.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.497 ' HG3' HG22 ' A' ' 58' ' ' VAL . 6.1 pt-20 -105.19 -42.63 5.23 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 112.746 0.647 . . . . 72.25 112.746 -175.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.497 HG22 ' HG3' ' A' ' 57' ' ' GLU . 74.2 t -76.77 -43.98 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 C-N-CA 123.109 0.564 . . . . 70.329999999999998 111.877 -167.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.467 ' HG ' ' HA ' ' A' ' 55' ' ' ALA . 38.8 mt -60.85 -54.76 51.33 Favored Pre-proline 0 CA--C 1.564 1.481 0 CA-C-O 118.272 -0.871 . . . . 73.099999999999994 112.082 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.488 ' HG3' ' ND2' ' A' ' 66' ' ' ASN . 30.9 Cg_endo -65.87 -12.23 34.37 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 121.925 1.75 . . . . 74.140000000000001 113.621 178.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -77.96 -62.53 1.64 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.113 0.965 . . . . 74.439999999999998 111.259 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.481 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 43.0 m-85 -78.77 -51.02 10.36 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.304 0.573 . . . . 72.239999999999995 110.676 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -89.36 -166.61 1.64 Allowed 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 107.53 -1.285 . . . . 74.099999999999994 107.53 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.59 43.57 3.11 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 119.531 1.059 . . . . 74.0 110.465 -178.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -163.61 162.64 24.4 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.06 -0.973 . . . . 71.439999999999998 108.854 -175.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.488 ' ND2' ' HG3' ' A' ' 60' ' ' PRO . 10.2 m120 -105.9 -148.95 0.42 Allowed 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 106.713 -1.588 . . . . 71.200000000000003 106.713 174.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 68.88 105.36 0.05 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.734 0.813 . . . . 73.409999999999997 111.644 169.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.524 ' HE3' ' HG2' ' A' ' 51' ' ' GLN . 13.8 tpt -70.39 -28.2 64.91 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.604 -0.725 . . . . 71.310000000000002 110.869 -175.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.15 -39.4 75.16 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.197 0.599 . . . . 73.349999999999994 111.32 176.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.8 t -65.88 -43.66 87.65 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.304 1.041 . . . . 75.430000000000007 111.388 177.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -65.13 -52.95 52.17 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.123 0.969 . . . . 73.530000000000001 111.161 -177.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.411 ' HA ' HD11 ' A' ' 75' ' ' LEU . 59.6 t -63.33 -34.4 66.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 CA-C-N 115.58 -0.736 . . . . 74.109999999999999 110.884 178.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -55.84 -42.31 75.59 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.26 0.624 . . . . 75.310000000000002 111.113 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -62.94 -47.31 83.76 Favored 'General case' 0 C--N 1.347 0.462 0 O-C-N 124.018 0.823 . . . . 72.219999999999999 110.105 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.411 HD11 ' HA ' ' A' ' 72' ' ' VAL . 77.3 mt -60.54 -44.62 95.91 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.222 1.009 . . . . 74.310000000000002 111.968 -177.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.4 HD22 HG13 ' A' ' 72' ' ' VAL . 66.9 m-80 -55.61 -41.04 72.88 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.979 0.512 . . . . 75.120000000000005 111.432 175.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 67.2 mtm -72.12 -36.9 69.55 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 116.221 -0.445 . . . . 74.120000000000005 110.708 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -77.34 -7.71 56.48 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.181 0.592 . . . . 74.120000000000005 111.251 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.91 14.4 56.47 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-O 119.631 -0.538 . . . . 74.010000000000005 114.419 174.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -76.39 134.91 39.5 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 109.117 -0.698 . . . . 72.349999999999994 109.117 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -99.28 123.26 43.41 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.881 -0.785 . . . . 74.420000000000002 108.881 -175.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.503 ' HE3' HG22 ' A' ' 99' ' ' THR . 1.3 tmtp? -72.16 116.83 13.05 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.277 -1.009 . . . . 75.150000000000006 108.277 174.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.556 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 61.7 t -107.24 122.09 60.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.911 0 N-CA-C 108.276 -1.009 . . . . 70.400000000000006 108.276 177.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.5 t -82.06 119.77 32.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 124.336 1.054 . . . . 75.439999999999998 109.669 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 108.782 -0.821 . . . . 74.040000000000006 108.782 174.878 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 . . . . . 0 C--O 1.242 0.682 0 CA-C-O 121.542 0.687 . . . . 73.420000000000002 110.39 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.456 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 22.0 m-20 -90.43 133.25 35.15 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.799 -0.815 . . . . 72.209999999999994 108.799 164.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -131.37 104.23 6.89 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 106.057 -1.831 . . . . 71.430000000000007 106.057 165.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.503 HG22 ' HE3' ' A' ' 82' ' ' LYS . 32.6 m -126.99 111.38 14.01 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.675 -0.693 . . . . 63.219999999999999 109.281 -173.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.556 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 41.5 tt0 -100.55 112.02 24.34 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 110.1 -0.333 . . . . 73.540000000000006 110.1 -173.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -97.45 122.53 40.6 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 109.032 -0.729 . . . . 71.129999999999995 109.032 174.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -120.98 145.56 47.61 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.552 0.741 . . . . 64.329999999999998 110.382 -176.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 -156.8 131.98 5.46 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 108.354 -0.98 . . . . 75.409999999999997 108.354 174.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -64.45 -20.81 66.38 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.986 2.457 . . . . 71.540000000000006 113.651 -175.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.463 ' HB2' HG12 ' A' ' 117' ' ' ILE . 18.5 m -98.4 7.12 46.62 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.324 0.65 . . . . 71.310000000000002 111.496 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.461 ' O ' ' HA ' ' A' ' 44' ' ' ASN . 62.3 t80 -108.09 100.87 10.16 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 107.721 -1.215 . . . . 75.150000000000006 107.721 175.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.565 ' HB2' ' HB3' ' A' ' 110' ' ' GLN . 96.0 mt -125.17 146.21 49.6 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.351 0.66 . . . . 72.310000000000002 109.321 173.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.595 ' HA ' ' HE1' ' A' ' 25' ' ' TRP . 31.4 ttt180 -83.11 102.11 11.61 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 109.397 -0.594 . . . . 74.010000000000005 109.397 176.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 123.99 -38.84 2.31 Favored Glycine 0 C--N 1.337 0.624 0 N-CA-C 110.349 -1.1 . . . . 72.450000000000003 110.349 -177.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.565 ' HB3' ' HB2' ' A' ' 107' ' ' LEU . 2.6 tp-100 -88.87 56.39 3.71 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.741 0.816 . . . . 70.230000000000004 109.012 176.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -62.87 -18.28 62.74 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.346 1.059 . . . . 73.329999999999998 112.514 -178.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -65.28 -20.91 66.63 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.558 0.743 . . . . 75.439999999999998 112.942 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.9 mt -91.89 -10.32 40.03 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.159 0.583 . . . . 71.430000000000007 111.693 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 74.5 mt -67.28 -35.41 79.42 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 121.394 0.616 . . . . 73.540000000000006 110.764 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -77.93 -4.93 49.36 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.498 -0.774 . . . . 64.450000000000003 111.99 176.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -103.17 -2.02 28.03 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.568 0.747 . . . . 72.150000000000006 110.014 173.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.463 HG12 ' HB2' ' A' ' 105' ' ' CYS . 60.0 mt -81.48 115.53 24.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.91 0 N-CA-C 107.053 -1.462 . . . . 72.510000000000005 107.053 168.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -105.68 136.55 45.07 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.756 -0.461 . . . . 74.040000000000006 109.756 -171.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 . . . . . 0 N--CA 1.478 0.943 0 C-N-CA 123.115 0.566 . . . . 74.430000000000007 110.402 172.631 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 CA--C 1.548 0.866 0 N-CA-C 108.81 -0.811 . . . . 65.519999999999996 108.81 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.516 ' HD2' HD12 ' A' ' 21' ' ' LEU . 32.4 Cg_exo -60.3 147.86 92.22 Favored 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.509 2.139 . . . . 74.420000000000002 111.682 173.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.63 -40.3 62.63 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.715 0.806 . . . . 70.439999999999998 111.508 176.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.533 ' HB3' ' HH ' ' A' ' 78' ' ' TYR . 45.8 t80 -53.72 -46.92 70.94 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.208 1.003 . . . . 73.0 111.705 174.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.516 HD12 ' HD2' ' A' ' 18' ' ' PRO . 28.9 mt -76.72 -37.35 56.21 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 112.468 0.544 . . . . 73.450000000000003 112.468 -173.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.8 t -69.87 -36.89 75.85 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 117.83 0.286 . . . . 75.540000000000006 110.699 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -75.73 -36.42 59.95 Favored 'General case' 0 C--N 1.358 0.964 0 C-N-CA 123.039 0.536 . . . . 71.530000000000001 110.392 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.2 tp -60.32 -44.6 95.31 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.307 0.643 . . . . 71.109999999999999 111.027 172.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 87.0 t90 -61.04 -44.85 96.78 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.714 0.806 . . . . 74.540000000000006 110.807 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 87.3 m -60.01 -38.99 84.25 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.213 1.005 . . . . 72.329999999999998 110.755 175.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.429 ' HG ' HD13 ' A' ' 37' ' ' ILE . 29.2 tp -67.41 -46.15 74.05 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.162 1.385 . . . . 72.340000000000003 111.726 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.5 t -62.4 -34.34 63.98 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 125.259 1.424 . . . . 75.129999999999995 111.343 175.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.8 t -90.01 -5.09 57.01 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.007 0.923 . . . . 71.340000000000003 111.871 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -82.15 119.73 75.66 Favored Pre-proline 0 N--CA 1.48 1.07 0 C-N-CA 123.361 0.664 . . . . 64.430000000000007 111.004 -174.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -71.28 -20.52 27.89 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.428 2.085 . . . . 74.519999999999996 113.075 176.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -66.44 -40.82 89.69 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.61 0.364 . . . . 53.450000000000003 110.198 176.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.8 p -99.64 4.36 45.63 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.321 0.648 . . . . 74.519999999999996 111.276 -175.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -53.49 -29.0 33.89 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 125.365 1.466 . . . . 74.040000000000006 112.791 -178.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.32 -37.01 85.6 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.74 0.816 . . . . 44.140000000000001 112.542 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.7 mt -114.6 -11.58 12.36 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 112.512 0.56 . . . . 72.409999999999997 112.512 -176.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.429 HD13 ' HG ' ' A' ' 27' ' ' LEU . 14.8 tt -160.96 130.12 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-O 121.108 0.48 . . . . 75.129999999999995 110.207 175.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.3 p -153.68 164.19 38.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.483 -0.78 . . . . 73.319999999999993 109.908 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 30.6 p-90 -66.12 148.07 52.38 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 123.942 0.776 . . . . 73.140000000000001 110.579 172.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.8 m -75.13 153.46 86.42 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 123.354 0.662 . . . . 71.140000000000001 110.835 171.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -60.83 -27.54 84.96 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.278 1.985 . . . . 61.329999999999998 111.375 170.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.6 m -59.25 -32.07 69.66 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.852 1.261 . . . . 64.340000000000003 111.956 172.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.42 -14.58 11.68 Favored Glycine 0 C--N 1.348 1.196 0 N-CA-C 115.122 0.809 . . . . 70.329999999999998 115.122 177.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 7.5 p30 -103.51 20.66 17.48 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.142 0.977 . . . . 72.319999999999993 110.64 -176.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.2 p -166.3 173.37 10.13 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.779 0.831 . . . . 64.349999999999994 109.833 -172.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 49.1 p90 -147.16 144.03 28.67 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.754 0.422 . . . . 72.510000000000005 110.607 176.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -100.52 148.46 24.76 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.812 0.845 . . . . 72.200000000000003 109.882 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.618 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 96.7 t -129.81 141.12 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.702 1.201 . . . . 75.109999999999999 107.959 176.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -124.03 147.5 47.78 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.697 0.799 . . . . 73.409999999999997 109.21 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 48.14 69.73 0.51 Allowed 'General case' 0 C--N 1.353 0.724 0 O-C-N 124.936 1.397 . . . . 72.409999999999997 111.293 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.436 ' HB3' ' HG2' ' A' ' 68' ' ' MET . 52.0 mt-30 -51.26 -30.93 19.28 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.637 1.175 . . . . 73.530000000000001 113.12 -174.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.86 -45.81 49.41 Favored Glycine 0 CA--C 1.534 1.233 0 O-C-N 123.382 0.426 . . . . 71.5 112.658 176.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -70.19 -42.26 72.64 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.591 0.757 . . . . 71.439999999999998 110.249 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -54.67 -48.35 72.48 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.5 1.52 . . . . 73.310000000000002 110.756 172.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.512 ' HB2' ' HB2' ' A' ' 68' ' ' MET . . . -64.8 -33.87 77.02 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 116.08 -0.509 . . . . 65.439999999999998 111.814 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -67.22 -47.4 70.95 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.497 1.119 . . . . 70.239999999999995 112.741 -178.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.463 ' HG3' HG22 ' A' ' 58' ' ' VAL . 9.7 pt-20 -112.32 -36.92 5.15 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 114.533 1.308 . . . . 72.420000000000002 114.533 -173.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.463 HG22 ' HG3' ' A' ' 57' ' ' GLU . 71.2 t -81.91 -42.91 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.467 0.707 . . . . 65.450000000000003 111.552 -169.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 47.9 mt -66.66 -44.52 54.51 Favored Pre-proline 0 CA--C 1.555 1.171 0 CA-C-O 117.928 -1.034 . . . . 75.400000000000006 112.718 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.404 ' HG3' ' ND2' ' A' ' 66' ' ' ASN . 29.0 Cg_endo -65.49 -15.3 49.03 Favored 'Trans proline' 0 C--N 1.383 2.343 0 CA-C-N 121.813 1.683 . . . . 71.049999999999997 113.647 171.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -74.16 -59.7 2.61 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.482 0.313 . . . . 72.519999999999996 110.843 176.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.421 ' CD1' HD11 ' A' ' 27' ' ' LEU . 47.7 m-85 -91.19 -14.91 30.19 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 113.107 0.78 . . . . 74.439999999999998 113.107 -175.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -133.11 -174.36 3.46 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 108.878 -0.786 . . . . 72.120000000000005 108.878 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -119.67 46.56 1.9 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.207 0.603 . . . . 74.120000000000005 109.533 -176.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 18.7 p80 -158.74 161.68 37.05 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.724 0.809 . . . . 75.340000000000003 109.603 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.435 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 9.4 m120 -118.1 2.25 12.02 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.613 0.765 . . . . 75.349999999999994 110.161 176.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -83.16 115.23 21.83 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.225 0.61 . . . . 72.099999999999994 110.669 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.512 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 12.1 tpt -66.81 -40.02 87.91 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.686 0.794 . . . . 74.310000000000002 110.556 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.63 -34.83 74.85 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.45 0.7 . . . . 72.349999999999994 112.03 -177.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.2 t -66.26 -42.85 87.94 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.81 0.844 . . . . 64.420000000000002 111.499 176.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -60.33 -49.6 76.96 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.4 1.08 . . . . 73.510000000000005 110.364 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 69.1 t -64.21 -36.56 77.4 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 124.225 1.01 . . . . 73.120000000000005 110.845 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -60.07 -41.54 92.62 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.609 0.763 . . . . 74.340000000000003 111.073 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -63.25 -45.7 90.34 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.929 -0.578 . . . . 72.340000000000003 110.767 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 80' ' ' PHE . 94.1 mt -62.82 -38.31 90.25 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.814 0.846 . . . . 74.219999999999999 111.708 -177.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -62.75 -32.69 73.88 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.806 0.442 . . . . 73.430000000000007 111.954 173.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 47.0 mtm -69.26 -35.15 75.8 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 110.436 -0.209 . . . . 73.430000000000007 110.436 173.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.533 ' HH ' ' HB3' ' A' ' 20' ' ' PHE . 57.2 m-85 -75.85 -18.59 59.38 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.252 0.621 . . . . 74.239999999999995 111.593 178.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.82 26.67 23.92 Favored Glycine 0 C--N 1.345 1.077 0 CA-C-O 119.709 -0.495 . . . . 73.519999999999996 113.997 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.454 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . 64.5 m-85 -78.72 133.01 37.18 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.856 -0.794 . . . . 74.209999999999994 108.856 171.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -102.12 127.61 48.96 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.267 0.627 . . . . 72.310000000000002 109.318 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.679 ' HE2' ' HB ' ' A' ' 84' ' ' VAL . 1.3 tmtp? -76.18 124.81 28.04 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.057 -1.09 . . . . 74.420000000000002 108.057 176.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.0 t -128.63 115.5 37.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 106.644 -1.613 . . . . 73.200000000000003 106.644 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.679 ' HB ' ' HE2' ' A' ' 82' ' ' LYS . 9.2 p -102.86 114.79 43.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 CA-C-O 121.487 0.661 . . . . 72.019999999999996 109.502 -174.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 . . . . . 0 N--CA 1.482 1.162 0 CA-C-N 115.868 -0.605 . . . . 75.25 110.858 -179.987 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 . . . . . 0 N--CA 1.483 1.198 0 N-CA-C 110.232 -0.284 . . . . 71.430000000000007 110.232 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -104.52 124.31 49.05 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.973 -0.751 . . . . 73.540000000000006 108.973 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.468 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 15.9 t70 -88.88 107.58 19.07 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.639 -1.245 . . . . 73.129999999999995 107.639 173.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.618 ' HB ' ' HB ' ' A' ' 48' ' ' VAL . 11.6 m -102.99 98.02 8.04 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 123.527 0.731 . . . . 75.409999999999997 110.017 -177.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 46' ' ' PHE . 38.6 tt0 -100.37 113.64 26.54 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.781 -0.822 . . . . 70.519999999999996 108.781 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.454 ' HB3' ' HB3' ' A' ' 80' ' ' PHE . 73.4 m-85 -96.33 120.32 36.41 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.549 -0.908 . . . . 75.530000000000001 108.549 173.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -110.13 146.71 35.0 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.8 0.84 . . . . 74.109999999999999 110.548 -174.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 23.9 t-80 -163.35 130.06 2.42 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 123.659 0.783 . . . . 74.420000000000002 108.901 172.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -64.89 -23.43 62.04 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.844 2.363 . . . . 72.310000000000002 112.957 -176.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 56.9 m -95.12 3.87 54.28 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.269 0.628 . . . . 63.020000000000003 111.328 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 44' ' ' ASN . 62.8 t80 -103.46 100.45 10.31 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 106.862 -1.533 . . . . 74.430000000000007 106.862 173.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.575 ' HB2' ' HB2' ' A' ' 110' ' ' GLN . 70.2 mt -113.48 134.66 54.55 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 109.354 -0.61 . . . . 74.109999999999999 109.354 173.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.0 ppt_? -62.96 -17.77 62.41 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.424 1.09 . . . . 73.049999999999997 112.636 -176.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -101.16 -42.6 2.37 Favored Glycine 0 C--N 1.346 1.096 0 N-CA-C 111.768 -0.533 . . . . 73.200000000000003 111.768 173.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.575 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 2.5 mp0 -91.36 84.06 5.54 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.451 0.7 . . . . 74.430000000000007 111.2 -172.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.9 -18.89 62.0 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.331 1.052 . . . . 71.209999999999994 112.827 177.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . 0.478 ' O ' ' HG2' ' A' ' 115' ' ' GLU . 4.8 pm0 -73.71 -14.52 61.16 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 111.637 0.236 . . . . 74.310000000000002 111.637 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 70.8 mt -84.16 -7.54 59.33 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.656 0.382 . . . . 74.239999999999995 111.792 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 51.0 mt -71.05 -21.62 62.23 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.055 0.542 . . . . 73.230000000000004 112.008 178.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 112' ' ' GLN . 16.9 pt-20 -80.18 -5.74 56.59 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 111.878 0.325 . . . . 75.239999999999995 111.878 174.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -90.9 -16.75 27.62 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.777 -0.823 . . . . 72.030000000000001 108.777 169.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.6 mt -90.87 73.46 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.886 0 N-CA-C 107.704 -1.221 . . . . 75.040000000000006 107.704 175.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.18 161.29 31.09 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.56 0.695 . . . . 73.120000000000005 110.945 169.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 . . . . . 0 C--O 1.239 0.514 0 N-CA-C 108.273 -1.01 . . . . 72.439999999999998 108.273 173.828 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 47.1 t . . . . . 0 CA--C 1.546 0.8 0 CA-C-O 119.237 -0.411 . . . . 73.530000000000001 110.09 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.412 ' HD2' HD12 ' A' ' 21' ' ' LEU . 49.9 Cg_exo -56.72 141.49 91.86 Favored 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.775 2.317 . . . . 71.450000000000003 111.148 173.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.92 -36.63 65.44 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.072 0.949 . . . . 55.210000000000001 113.022 -173.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -51.85 -43.94 63.42 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.035 0.534 . . . . 75.510000000000005 112.084 173.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.412 HD12 ' HD2' ' A' ' 18' ' ' PRO . 98.2 mt -84.29 -29.81 26.11 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.409 0.684 . . . . 74.530000000000001 110.4 -173.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.6 m -61.17 -39.64 90.9 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.273 1.029 . . . . 65.409999999999997 110.607 173.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.56 ' HA ' ' HE2' ' A' ' 23' ' ' LYS . 10.7 mmpt? -79.97 -47.79 14.41 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.715 -0.675 . . . . 72.109999999999999 110.473 177.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.474 ' O ' HG22 ' A' ' 28' ' ' VAL . 55.3 tp -56.47 -50.28 72.19 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.107 0.963 . . . . 74.5 112.502 -176.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 84.7 t90 -58.35 -47.78 82.69 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.791 0.436 . . . . 75.200000000000003 111.014 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.8 m -68.8 -22.6 64.25 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 115.684 -0.689 . . . . 71.430000000000007 111.42 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.407 HD13 ' CD1' ' A' ' 62' ' ' TYR . 31.0 tp -74.4 -44.31 52.56 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.393 1.077 . . . . 74.549999999999997 110.723 175.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.474 HG22 ' O ' ' A' ' 24' ' ' LEU . 60.0 t -61.92 -32.68 54.94 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 CA-C-O 121.685 0.755 . . . . 65.219999999999999 110.258 173.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.4 t -88.72 0.18 56.71 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 114.636 -1.165 . . . . 73.219999999999999 112.023 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -81.61 122.72 80.85 Favored Pre-proline 0 N--CA 1.479 1.02 0 O-C-N 121.919 -0.488 . . . . 71.530000000000001 111.448 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -73.62 -6.21 18.35 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 123.159 2.573 . . . . 64.409999999999997 113.822 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -86.35 -37.65 18.24 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.85 0.46 . . . . 73.120000000000005 110.987 174.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 41.6 p -104.34 8.61 35.94 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.772 0.429 . . . . 72.319999999999993 110.824 -175.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -59.51 -32.39 70.25 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.459 1.104 . . . . 61.450000000000003 111.896 -175.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.34 -32.35 73.24 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.637 0.775 . . . . 73.099999999999994 111.958 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 64.4 mt -102.82 -12.14 17.8 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.457 0.303 . . . . 73.430000000000007 111.219 -177.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.5 tt -159.89 122.83 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 123.053 0.541 . . . . 73.140000000000001 110.454 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 28.2 p -142.1 149.55 40.01 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.601 0.36 . . . . 70.239999999999995 110.567 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 22.7 p-90 -72.6 154.23 40.87 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.611 0.765 . . . . 73.519999999999996 111.148 177.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.6 m -81.41 141.0 48.71 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 109.121 -0.696 . . . . 61.049999999999997 109.121 169.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -50.36 -22.91 9.34 Favored 'Trans proline' 0 C--N 1.368 1.602 0 C-N-CA 123.373 2.715 . . . . 73.019999999999996 115.05 176.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 64.0 m -70.65 -30.27 66.85 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.999 0.52 . . . . 71.150000000000006 111.618 175.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.99 65.87 2.18 Favored Glycine 0 C--N 1.342 0.88 0 CA-C-N 116.308 -0.406 . . . . 50.149999999999999 112.474 177.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 26.8 p30 -168.52 -17.06 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.981 0.913 . . . . 74.120000000000005 111.725 -171.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.2 p -141.51 162.27 35.89 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 123.927 0.891 . . . . 72.510000000000005 108.701 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -140.19 146.38 38.65 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.572 0.225 . . . . 75.310000000000002 110.535 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -103.32 141.32 36.13 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.234 1.014 . . . . 74.049999999999997 109.536 -176.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.1 t -123.54 132.99 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.693 0.797 . . . . 75.439999999999998 108.983 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -122.75 151.96 41.09 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.549 1.14 . . . . 73.409999999999997 110.5 -174.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 53.62 60.82 3.43 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 124.584 1.178 . . . . 75.209999999999994 110.77 174.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -46.0 -37.31 6.44 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.006 1.322 . . . . 73.099999999999994 114.2 -170.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.51 -44.92 49.08 Favored Glycine 0 C--N 1.342 0.868 0 O-C-N 123.559 0.537 . . . . 44.509999999999998 112.844 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -72.83 -42.91 63.31 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.112 0.565 . . . . 73.430000000000007 110.111 -177.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -55.32 -52.62 62.89 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.188 1.395 . . . . 74.349999999999994 110.899 175.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.405 ' HA ' ' HG ' ' A' ' 59' ' ' LEU . . . -61.36 -31.82 71.71 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 116.298 -0.41 . . . . 64.340000000000003 111.676 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -70.49 -50.92 32.91 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.252 1.021 . . . . 75.409999999999997 112.421 -177.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.514 ' HG3' HG22 ' A' ' 58' ' ' VAL . 9.7 pt-20 -104.43 -39.24 6.5 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 112.855 0.687 . . . . 72.109999999999999 112.855 -173.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.514 HG22 ' HG3' ' A' ' 57' ' ' GLU . 96.5 t -80.94 -41.78 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.362 0.665 . . . . 62.109999999999999 112.016 -167.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.405 ' HG ' ' HA ' ' A' ' 55' ' ' ALA . 53.2 mt -64.15 -48.95 75.93 Favored Pre-proline 0 CA--C 1.565 1.528 0 CA-C-O 118.209 -0.9 . . . . 75.230000000000004 112.324 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.3 -8.49 23.52 Favored 'Trans proline' 0 C--N 1.387 2.598 0 CA-C-N 121.981 1.743 . . . . 74.25 113.281 175.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -73.63 -61.77 1.72 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.297 1.039 . . . . 72.319999999999993 110.391 174.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.541 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 25.5 m-85 -89.03 -38.59 14.29 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 112.005 0.372 . . . . 75.239999999999995 112.005 -177.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -102.81 -164.61 1.1 Allowed 'General case' 0 C--O 1.243 0.729 0 N-CA-C 107.566 -1.272 . . . . 75.540000000000006 107.566 176.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 31.5 mmtm -135.54 68.05 1.47 Allowed 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 121.856 0.836 . . . . 71.519999999999996 109.903 175.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -169.77 160.62 8.77 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 113.781 -1.554 . . . . 75.140000000000001 107.786 173.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -118.01 -5.79 10.97 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.74 0.416 . . . . 72.310000000000002 110.503 175.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -71.84 117.54 13.56 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 123.82 0.848 . . . . 73.319999999999993 110.47 176.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 11.7 ttm -70.89 -30.57 66.97 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.656 0.383 . . . . 71.25 111.034 176.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.67 -36.39 71.84 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.607 0.363 . . . . 73.319999999999993 111.241 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.42 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 40.2 t -63.94 -46.91 82.62 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.982 0.913 . . . . 73.040000000000006 111.633 172.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -63.18 -52.91 60.46 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.612 0.765 . . . . 75.439999999999998 111.052 -176.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.407 ' HA ' HD12 ' A' ' 75' ' ' LEU . 84.4 t -59.14 -40.66 81.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 124.088 0.955 . . . . 64.340000000000003 111.254 177.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.3 ttt-85 -56.82 -43.9 81.46 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.147 0.579 . . . . 74.310000000000002 111.559 177.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 70' ' ' SER . 16.7 mm100 -58.9 -49.83 76.32 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 124.024 0.828 . . . . 75.040000000000006 109.937 177.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.42 ' HB3' ' HB2' ' A' ' 80' ' ' PHE . 65.2 mt -58.35 -44.27 88.7 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.305 1.042 . . . . 73.319999999999993 112.086 -177.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -56.9 -39.55 74.63 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.504 0.722 . . . . 73.5 111.924 175.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 73.9 mtm -72.94 -35.03 66.9 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.051 0.54 . . . . 74.439999999999998 111.06 176.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 55.3 m-85 -85.26 2.92 41.84 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.093 0.557 . . . . 72.409999999999997 111.22 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.42 15.91 79.03 Favored Glycine 0 C--N 1.342 0.916 0 N-CA-C 114.652 0.621 . . . . 63.420000000000002 114.652 170.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.42 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 73.3 m-85 -73.74 129.42 37.9 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.273 0.559 . . . . 74.209999999999994 110.096 176.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -99.52 121.78 41.66 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.013 -0.994 . . . . 75.329999999999998 109.021 -175.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -81.45 126.75 32.03 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.588 1.155 . . . . 74.239999999999995 109.723 -175.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 85.8 t -128.97 119.72 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 108.17 -1.048 . . . . 72.109999999999999 108.17 175.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 p -99.68 126.0 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 108.415 -0.957 . . . . 71.420000000000002 108.415 -178.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 . . . . . 0 N--CA 1.479 1.006 0 C-N-CA 122.573 0.349 . . . . 73.030000000000001 110.62 -177.513 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 . . . . . 0 CA--C 1.551 0.981 0 N-CA-C 108.906 -0.776 . . . . 74.299999999999997 108.906 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -45.18 107.98 0.11 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.636 1.174 . . . . 62.43 112.958 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -91.37 122.2 33.77 Favored 'General case' 0 C--O 1.249 1.045 0 CA-C-N 114.867 -1.06 . . . . 62.299999999999997 108.191 177.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 57.8 m -129.27 117.23 20.36 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.894 -0.78 . . . . 75.420000000000002 108.894 -178.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -104.73 112.17 25.17 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.322 -0.992 . . . . 75.430000000000007 108.322 -175.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -96.93 123.88 40.76 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.824 -1.176 . . . . 74.510000000000005 107.824 175.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -122.65 145.75 48.08 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 122.985 0.514 . . . . 70.230000000000004 110.697 -173.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -156.53 132.31 5.74 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 108.66 -0.867 . . . . 73.409999999999997 108.66 176.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.74 -29.95 77.73 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.669 2.246 . . . . 73.329999999999998 113.195 -174.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 59.1 m -89.4 -2.78 58.53 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.641 0.376 . . . . 73.319999999999993 111.421 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' A' ' 44' ' ' ASN . 64.8 t80 -102.19 99.45 9.57 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 106.881 -1.525 . . . . 75.299999999999997 106.881 175.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.422 HD11 ' HG2' ' A' ' 110' ' ' GLN . 76.6 mt -120.79 164.7 16.2 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.95 0.405 . . . . 75.219999999999999 110.673 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -81.58 122.74 27.97 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.593 -0.73 . . . . 74.219999999999999 109.489 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 63.56 57.65 14.0 Favored Glycine 0 C--N 1.344 0.985 0 O-C-N 124.15 0.906 . . . . 64.129999999999995 111.974 -176.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.422 ' HG2' HD11 ' A' ' 107' ' ' LEU . 5.9 tp60 -156.18 63.64 0.56 Allowed 'General case' 0 CA--C 1.548 0.897 0 CA-C-O 121.919 0.866 . . . . 74.510000000000005 109.535 -172.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -52.35 -46.24 66.02 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 113.746 -1.57 . . . . 65.099999999999994 111.446 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 14.1 pm0 -65.74 -19.55 65.94 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.579 -1.191 . . . . 72.340000000000003 112.839 -174.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 27.9 mt -96.41 -20.11 18.69 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 119.181 0.901 . . . . 74.329999999999998 111.712 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 80.9 mt -63.95 -32.6 74.19 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-O 121.156 0.503 . . . . 73.129999999999995 110.376 175.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -79.35 -5.42 54.52 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 115.547 -0.751 . . . . 64.519999999999996 112.594 175.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -90.25 2.78 55.09 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 110.096 -0.335 . . . . 74.109999999999999 110.096 172.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 45.1 mt -96.98 128.01 48.61 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 N-CA-C 109.009 -0.737 . . . . 73.400000000000006 109.009 174.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.458 ' HE3' ' HA ' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -112.1 150.73 30.33 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.425 0.69 . . . . 74.140000000000001 110.031 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 . . . . . 0 N--CA 1.484 1.235 0 C-N-CA 124.151 0.98 . . . . 73.349999999999994 110.374 170.736 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.9 t . . . . . 0 CA--C 1.541 0.604 0 N-CA-C 108.982 -0.747 . . . . 74.420000000000002 108.982 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.486 ' HD2' HD13 ' A' ' 21' ' ' LEU . 21.4 Cg_exo -65.69 145.24 80.89 Favored 'Trans proline' 0 C--N 1.365 1.439 0 C-N-CA 122.417 2.078 . . . . 75.030000000000001 110.341 170.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.41 -39.82 23.82 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.149 1.38 . . . . 73.030000000000001 112.499 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -54.1 -45.43 71.84 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.96 0.904 . . . . 73.140000000000001 112.833 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.486 HD13 ' HD2' ' A' ' 18' ' ' PRO . 98.4 mt -83.36 -29.23 28.4 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.056 0.543 . . . . 74.239999999999995 109.948 -171.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.7 m -59.72 -50.59 73.23 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 124.548 1.155 . . . . 74.219999999999999 111.023 170.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.468 ' HE2' ' HA ' ' A' ' 23' ' ' LYS . 11.2 mmpt? -68.49 -43.25 77.28 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.876 -0.602 . . . . 71.510000000000005 110.045 178.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.454 ' O ' HG21 ' A' ' 28' ' ' VAL . 55.5 tp -55.26 -54.03 48.56 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 124.601 1.161 . . . . 75.340000000000003 112.214 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 14.1 t-105 -64.07 -46.08 85.92 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 122.629 0.372 . . . . 72.299999999999997 111.722 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.6 m -60.61 -25.01 65.93 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.306 0.574 . . . . 74.129999999999995 110.775 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.434 ' HG ' HD13 ' A' ' 37' ' ' ILE . 29.9 tp -80.47 -45.57 17.33 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 124.87 1.268 . . . . 74.329999999999998 111.94 177.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.454 HG21 ' O ' ' A' ' 24' ' ' LEU . 76.6 t -56.61 -39.97 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 C-N-CA 124.089 0.956 . . . . 71.25 111.513 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.5 t -89.36 -5.54 57.4 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 114.453 -1.249 . . . . 74.0 112.132 -175.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -74.35 122.28 87.17 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 122.68 0.392 . . . . 75.540000000000006 111.307 -175.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.4 -23.11 44.53 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 122.851 2.367 . . . . 75.310000000000002 112.944 176.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -73.8 -34.41 64.61 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.185 0.594 . . . . 73.010000000000005 111.514 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 53.5 p -110.99 11.82 22.14 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.043 0.537 . . . . 75.019999999999996 110.533 -177.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -54.95 -38.23 67.46 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.924 1.289 . . . . 74.319999999999993 111.788 -177.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.82 -29.47 69.95 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.692 -0.686 . . . . 63.399999999999999 112.178 -177.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.53 ' HA ' ' HB2' ' A' ' 49' ' ' PHE . 68.9 mt -106.41 -9.88 16.54 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.628 0.371 . . . . 72.549999999999997 111.657 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.434 HD13 ' HG ' ' A' ' 27' ' ' LEU . 16.7 tt -161.45 125.86 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.327 0.651 . . . . 74.530000000000001 110.501 172.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 22.1 p -149.02 157.41 43.39 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.934 0.397 . . . . 74.010000000000005 110.566 177.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 14.7 p-90 -71.38 152.85 42.78 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.731 1.212 . . . . 74.439999999999998 110.409 177.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.2 p -74.28 153.39 88.19 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 123.271 0.628 . . . . 75.129999999999995 110.346 172.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.8 -26.34 60.11 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.7 2.267 . . . . 73.420000000000002 111.925 176.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 66.9 p -75.05 -26.96 59.81 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.303 1.041 . . . . 72.030000000000001 110.15 172.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.97 3.3 84.34 Favored Glycine 0 C--N 1.356 1.692 0 CA-C-N 115.658 -0.701 . . . . 71.120000000000005 113.468 176.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -86.19 -5.91 59.1 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.689 0.796 . . . . 72.310000000000002 112.022 -173.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 65.1 p -159.3 179.09 9.29 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.793 0.837 . . . . 65.230000000000004 110.046 -174.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -140.18 148.21 41.26 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.781 -0.451 . . . . 64.209999999999994 109.781 172.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -110.84 143.49 41.34 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.009 0.924 . . . . 74.439999999999998 109.018 -177.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 67.3 t -123.48 120.96 61.48 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 C-N-CA 124.385 1.074 . . . . 62.450000000000003 108.631 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.53 ' HB2' ' HA ' ' A' ' 36' ' ' LEU . 90.1 m-85 -100.58 146.38 27.2 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 124.058 0.943 . . . . 72.430000000000007 109.87 -178.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.423 ' HB2' HD22 ' A' ' 36' ' ' LEU . 6.9 m-20 49.95 67.94 0.83 Allowed 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.799 1.312 . . . . 73.549999999999997 111.674 176.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.471 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 14.7 mm-40 -49.52 -34.86 18.42 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.002 0.921 . . . . 71.409999999999997 113.377 -175.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.09 -49.83 44.34 Favored Glycine 0 CA--C 1.536 1.365 0 CA-C-O 119.818 -0.434 . . . . 74.120000000000005 112.441 175.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -69.5 -45.64 68.44 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.299 0.639 . . . . 75.400000000000006 110.542 -176.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.483 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 65.1 t80 -52.24 -51.59 57.47 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.553 1.541 . . . . 75.310000000000002 111.05 173.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.511 ' HA ' ' HG ' ' A' ' 59' ' ' LEU . . . -61.36 -36.56 80.53 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.916 0.389 . . . . 74.439999999999998 111.537 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.87 -52.89 31.35 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.513 1.125 . . . . 72.340000000000003 113.154 -174.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.516 ' HG3' HG23 ' A' ' 58' ' ' VAL . 6.7 pt-20 -106.62 -33.85 7.52 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 113.602 0.964 . . . . 73.549999999999997 113.602 -173.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.516 HG23 ' HG3' ' A' ' 57' ' ' GLU . 90.4 t -83.03 -40.29 16.21 Favored 'Isoleucine or valine' 0 C--O 1.251 1.169 0 C-N-CA 123.404 0.681 . . . . 55.240000000000002 111.488 -169.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.511 ' HG ' ' HA ' ' A' ' 55' ' ' ALA . 54.0 mt -64.0 -50.46 69.36 Favored Pre-proline 0 CA--C 1.556 1.202 0 CA-C-O 118.242 -0.885 . . . . 75.25 111.81 177.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -67.42 -13.34 38.91 Favored 'Trans proline' 0 C--N 1.381 2.288 0 CA-C-N 121.975 1.741 . . . . 75.329999999999998 113.001 176.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -70.68 -54.69 10.9 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.01 0.524 . . . . 75.010000000000005 110.536 172.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.401 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 31.5 m-85 -89.87 -52.68 4.86 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.137 0.494 . . . . 74.019999999999996 111.984 -178.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -87.71 -171.79 3.59 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.274 -0.875 . . . . 72.109999999999999 108.828 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -123.05 45.15 2.48 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.668 0.746 . . . . 75.400000000000006 109.749 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -161.16 165.5 29.39 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.636 1.174 . . . . 75.150000000000006 108.377 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -122.3 -8.15 8.69 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.52 0.328 . . . . 73.099999999999994 110.579 174.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -61.1 115.88 4.11 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.152 0.981 . . . . 74.409999999999997 110.605 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.471 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 3.2 tpt -61.71 -49.87 74.73 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.203 1.401 . . . . 74.450000000000003 111.725 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.17 -35.31 71.39 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.866 0.867 . . . . 72.299999999999997 111.843 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.423 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 34.7 t -64.99 -42.98 94.02 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.731 0.813 . . . . 71.310000000000002 111.489 177.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -64.58 -50.25 67.96 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.827 0.851 . . . . 65.120000000000005 110.65 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.497 ' HA ' HD11 ' A' ' 75' ' ' LEU . 59.1 t -62.9 -38.45 81.94 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-N 115.417 -0.81 . . . . 72.340000000000003 111.128 178.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.403 ' O ' ' HG3' ' A' ' 77' ' ' MET . 39.4 ttm180 -58.67 -43.33 89.86 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.023 0.529 . . . . 73.299999999999997 110.858 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.462 ' HA ' ' HE3' ' A' ' 77' ' ' MET . 34.3 mm-40 -59.34 -50.01 75.6 Favored 'General case' 0 C--N 1.358 0.963 0 O-C-N 124.034 0.834 . . . . 75.019999999999996 109.872 177.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.497 HD11 ' HA ' ' A' ' 72' ' ' VAL . 30.6 mt -56.47 -48.32 77.35 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.109 0.964 . . . . 75.310000000000002 111.921 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -62.58 -30.09 71.07 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 122.754 0.422 . . . . 74.150000000000006 112.049 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.462 ' HE3' ' HA ' ' A' ' 74' ' ' GLN . 47.9 mtm -69.47 -40.42 77.11 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 109.931 -0.396 . . . . 75.5 109.931 173.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -81.74 -2.65 51.4 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.997 0.519 . . . . 70.519999999999996 111.214 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.66 20.28 44.77 Favored Glycine 0 C--N 1.349 1.279 0 N-CA-C 114.882 0.713 . . . . 71.239999999999995 114.882 172.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.497 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 83.9 m-85 -82.3 134.85 35.28 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.069 0.935 . . . . 74.219999999999999 109.506 177.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 38.3 ttm180 -101.44 126.74 48.27 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.086 0.554 . . . . 73.239999999999995 109.802 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.468 ' HE3' HG22 ' A' ' 84' ' ' VAL . 2.7 tmtm? -68.95 114.93 7.7 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 106.879 -1.526 . . . . 74.120000000000005 106.879 171.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.519 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 89.3 t -114.2 125.41 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 107.884 -1.154 . . . . 73.109999999999999 107.884 176.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.468 HG22 ' HE3' ' A' ' 82' ' ' LYS . 40.8 t -88.94 131.56 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.638 0.775 . . . . 73.420000000000002 109.315 -177.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 . . . . . 0 N--CA 1.484 1.233 0 N-CA-C 108.214 -1.032 . . . . 72.209999999999994 108.214 169.671 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 . . . . . 0 N--CA 1.47 0.554 0 CA-C-O 121.406 0.622 . . . . 72.219999999999999 110.976 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -91.27 148.4 22.37 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.463 -0.939 . . . . 74.129999999999995 108.463 156.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -113.4 106.1 14.18 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 105.355 -2.091 . . . . 72.310000000000002 105.355 156.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 32.3 m -115.05 107.36 15.25 Favored 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 123.823 0.702 . . . . 75.0 109.793 -170.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.519 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 41.7 tt0 -96.99 111.17 23.51 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.376 -1.342 . . . . 73.549999999999997 107.376 -177.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.433 ' HB3' ' HB3' ' A' ' 80' ' ' PHE . 71.4 m-85 -96.0 119.93 35.37 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.066 -1.087 . . . . 73.239999999999995 108.066 175.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -117.3 139.16 51.18 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.863 0.865 . . . . 75.219999999999999 109.287 -174.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.475 ' HB3' ' HB3' ' A' ' 106' ' ' PHE . 55.9 t-80 -152.66 135.08 9.0 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 123.466 0.706 . . . . 75.329999999999998 109.423 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -59.64 -42.85 43.33 Favored 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 122.863 2.376 . . . . 74.230000000000004 112.476 -174.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 37.0 m -92.19 16.66 10.96 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.996 0.518 . . . . 72.150000000000006 111.084 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.475 ' HB3' ' HB3' ' A' ' 103' ' ' HIS . 35.9 t80 -124.33 104.18 8.64 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.167 -1.049 . . . . 74.530000000000001 108.167 171.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.481 HD13 ' HG3' ' A' ' 110' ' ' GLN . 38.3 mt -120.46 173.65 7.03 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 107.128 -1.434 . . . . 75.319999999999993 107.128 167.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -63.28 -68.91 0.3 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.39 0.676 . . . . 73.019999999999996 110.942 -172.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -87.71 37.55 3.23 Favored Glycine 0 C--N 1.351 1.365 0 C-N-CA 122.77 0.224 . . . . 72.230000000000004 112.98 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.481 ' HG3' HD13 ' A' ' 107' ' ' LEU . 15.8 mm100 -126.43 53.08 1.67 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.92 0.888 . . . . 75.109999999999999 108.944 -177.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.412 ' HA ' ' HG ' ' A' ' 114' ' ' LEU . 10.6 pt-20 -60.14 -30.65 69.44 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 114.942 -1.026 . . . . 73.140000000000001 111.815 175.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.4 pm0 -63.39 -22.55 66.95 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.363 0.665 . . . . 75.239999999999995 111.838 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.437 ' O ' HG13 ' A' ' 117' ' ' ILE . 80.7 mt -90.82 -9.19 47.35 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.253 0.621 . . . . 74.129999999999995 112.152 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.412 ' HG ' ' HA ' ' A' ' 111' ' ' GLU . 91.5 mt -61.06 -38.57 86.65 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.202 0.525 . . . . 74.219999999999999 110.818 175.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -79.94 -11.11 59.82 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.365 -0.834 . . . . 74.319999999999993 112.051 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -87.55 -10.68 50.95 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.54 0.736 . . . . 74.409999999999997 109.682 173.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 113' ' ' LEU . 58.9 mt -86.23 135.18 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 108.845 -0.798 . . . . 63.509999999999998 108.845 175.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -122.92 150.33 43.08 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.728 0.811 . . . . 74.099999999999994 109.748 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 . . . . . 0 CA--C 1.543 0.696 0 N-CA-C 108.483 -0.932 . . . . 73.120000000000005 108.483 172.587 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.3 t . . . . . 0 CA--C 1.552 1.045 0 CA-C-O 118.884 -0.579 . . . . 73.409999999999997 109.805 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.89 163.2 39.99 Favored 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 122.65 2.233 . . . . 74.209999999999994 112.19 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.64 -49.12 57.65 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.08 0.952 . . . . 73.040000000000006 112.636 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -52.33 -47.51 66.0 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.444 0.698 . . . . 71.109999999999999 112.612 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 89.2 mt -79.64 -35.32 39.55 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.374 0.27 . . . . 45.109999999999999 110.955 -172.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.5 t -71.95 -18.76 61.98 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 111.72 0.267 . . . . 72.519999999999996 111.72 177.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.6 mmpt? -83.74 -40.99 18.14 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.767 -0.457 . . . . 74.0 109.767 168.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.8 tp -61.0 -50.61 72.66 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.003 0.921 . . . . 74.540000000000006 113.352 -176.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.434 ' HB3' HD11 ' A' ' 114' ' ' LEU . 5.1 p-90 -62.37 -37.43 85.69 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 118.628 0.649 . . . . 73.329999999999998 110.842 -177.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 41.3 m -63.83 -43.44 96.17 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 124.268 1.027 . . . . 73.140000000000001 110.898 175.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.4 tp -61.6 -49.56 76.1 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.624 1.57 . . . . 75.209999999999994 111.711 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.7 t -59.81 -33.62 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 C-N-CA 124.634 1.174 . . . . 74.109999999999999 111.536 176.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.9 t -94.85 -6.95 41.62 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.423 0.689 . . . . 75.120000000000005 112.09 -175.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -83.01 132.43 50.84 Favored Pre-proline 0 N--CA 1.486 1.355 0 CA-C-N 118.079 0.4 . . . . 61.43 111.837 -173.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -70.13 -23.82 28.67 Favored 'Trans proline' 0 C--N 1.388 2.652 0 C-N-CA 123.154 2.569 . . . . 72.310000000000002 114.209 -176.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -76.4 -32.33 58.47 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.008 0.523 . . . . 71.140000000000001 111.079 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.7 p -105.88 1.35 26.69 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.122 0.569 . . . . 74.230000000000004 111.61 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -57.31 -33.23 67.48 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.099 1.36 . . . . 72.439999999999998 112.56 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.97 -35.55 81.05 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.631 0.772 . . . . 65.319999999999993 113.027 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.519 HD22 ' HB2' ' A' ' 50' ' ' ASP . 80.9 mt -106.91 -11.05 15.8 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.063 0.545 . . . . 73.349999999999994 111.464 -175.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.2 tt -160.66 127.0 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 122.659 0.384 . . . . 74.129999999999995 110.631 174.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.1 p -158.92 161.29 36.75 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.032 0.533 . . . . 63.149999999999999 110.136 177.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 25.8 p-90 -71.12 147.3 48.55 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.028 -0.987 . . . . 73.540000000000006 110.455 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.4 m -70.96 153.54 94.66 Favored Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 124.016 0.926 . . . . 74.420000000000002 109.743 175.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -45.81 -44.63 17.96 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 123.613 2.875 . . . . 74.219999999999999 114.899 -175.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.7 m -75.22 -27.22 59.46 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.31 0.644 . . . . 72.230000000000004 111.584 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.82 18.44 61.48 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 116.562 -0.29 . . . . 73.540000000000006 113.606 175.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -80.85 -17.71 49.8 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.701 0.8 . . . . 71.319999999999993 111.326 175.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.0 p -158.28 -173.91 4.55 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.783 0.433 . . . . 71.450000000000003 110.806 -170.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -141.02 151.9 44.45 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.103 0.561 . . . . 73.540000000000006 110.179 176.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 55.5 m-70 -108.86 156.29 19.83 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.826 0.851 . . . . 73.129999999999995 109.647 176.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 84.7 t -130.51 123.16 54.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 124.442 1.097 . . . . 75.319999999999993 108.151 176.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -106.93 148.17 28.94 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.805 0.842 . . . . 64.329999999999998 109.686 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.519 ' HB2' HD22 ' A' ' 36' ' ' LEU . 7.9 m-20 54.23 55.54 8.05 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 124.714 1.258 . . . . 73.239999999999995 110.826 171.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.432 ' HA ' ' HB3' ' A' ' 54' ' ' PHE . 45.8 mt-30 -57.35 -22.77 44.59 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.759 -1.11 . . . . 73.329999999999998 113.158 -169.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.11 -47.83 56.95 Favored Glycine 0 C--N 1.348 1.23 0 N-CA-C 111.816 -0.513 . . . . 75.010000000000005 111.816 172.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -71.17 -45.39 63.55 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.836 0.855 . . . . 75.200000000000003 110.044 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.457 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 57.0 t80 -49.16 -50.8 36.03 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.591 1.556 . . . . 72.540000000000006 111.403 171.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.65 -36.89 84.29 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.357 -0.383 . . . . 60.100000000000001 111.69 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -69.06 -45.01 71.44 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.994 0.918 . . . . 73.549999999999997 112.896 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -114.78 -33.02 5.62 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 114.43 1.27 . . . . 73.340000000000003 114.43 -172.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.457 ' HB ' ' O ' ' A' ' 54' ' ' PHE . 77.2 t -81.95 -44.46 19.98 Favored 'Isoleucine or valine' 0 C--O 1.25 1.117 0 C-N-CA 122.787 0.435 . . . . 75.019999999999996 111.29 -172.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 46.1 mt -64.07 -46.83 80.45 Favored Pre-proline 0 CA--C 1.564 1.511 0 CA-C-O 118.081 -0.961 . . . . 72.319999999999993 112.77 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.58 -15.38 47.48 Favored 'Trans proline' 0 C--N 1.388 2.653 0 CA-C-N 121.999 1.75 . . . . 74.150000000000006 113.454 174.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -75.49 -54.52 6.89 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.177 0.591 . . . . 71.519999999999996 110.646 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -90.19 -40.07 12.42 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 112.112 0.412 . . . . 72.329999999999998 112.112 -177.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -106.4 -176.28 3.03 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.758 0.823 . . . . 71.540000000000006 108.808 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -119.42 48.83 1.44 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.522 -0.918 . . . . 72.450000000000003 108.522 -176.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -164.12 159.9 20.89 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.73 1.212 . . . . 70.25 108.265 176.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -112.32 -21.08 11.59 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.395 0.678 . . . . 64.209999999999994 109.253 176.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -61.02 119.55 8.52 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.198 0.999 . . . . 72.219999999999999 111.09 -176.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 12.9 tpt -73.46 -32.93 64.62 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.649 0.78 . . . . 73.439999999999998 111.25 -176.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.88 -34.26 69.59 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.05 0.54 . . . . 72.519999999999996 111.577 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.1 t -64.85 -42.35 94.98 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.334 1.054 . . . . 75.129999999999995 111.672 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -68.47 -51.16 46.53 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.948 0.899 . . . . 74.439999999999998 110.995 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.0 t -62.12 -37.15 77.74 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 C-N-CA 123.734 0.814 . . . . 74.400000000000006 111.194 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -53.94 -50.13 67.15 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.925 0.89 . . . . 72.400000000000006 111.117 175.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -56.97 -51.5 68.94 Favored 'General case' 0 C--N 1.35 0.614 0 O-C-N 124.556 1.16 . . . . 74.109999999999999 110.547 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.1 mt -62.23 -44.36 96.73 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.912 0.885 . . . . 71.400000000000006 112.03 -176.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -59.11 -38.61 79.98 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.293 0.637 . . . . 72.409999999999997 111.437 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 50.7 mtm -69.61 -33.21 72.36 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.842 0.457 . . . . 73.510000000000005 110.676 175.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -82.1 7.2 14.05 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 122.95 0.5 . . . . 72.310000000000002 111.299 178.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.96 20.44 67.82 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-O 119.948 -0.362 . . . . 72.439999999999998 113.447 172.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.522 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . 44.8 m-85 -82.82 137.89 34.15 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.978 -0.749 . . . . 75.299999999999997 108.978 175.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -101.46 125.24 48.07 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.022 -0.732 . . . . 75.040000000000006 109.022 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.59 115.58 8.13 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 107.965 -1.124 . . . . 74.219999999999999 107.965 173.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.7 t -131.27 113.86 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.219 -1.03 . . . . 73.420000000000002 108.219 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.5 p -96.11 126.45 48.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 108.443 -0.947 . . . . 63.340000000000003 108.443 -176.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 69.1 m-70 . . . . . 0 N--CA 1.485 1.315 0 C-N-CA 122.396 0.279 . . . . 74.219999999999999 110.767 -175.998 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 . . . . . 0 CA--C 1.544 0.73 0 CA-C-O 122.506 1.146 . . . . 72.329999999999998 108.302 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -35.26 101.17 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 111.888 -2.414 . . . . 43.240000000000002 113.877 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -99.14 115.83 29.96 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.332 -1.359 . . . . 73.519999999999996 107.332 175.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 91.2 m -125.77 119.8 28.9 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.265 -0.643 . . . . 54.140000000000001 109.265 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -104.13 117.45 34.3 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.375 -1.343 . . . . 73.430000000000007 107.375 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.522 ' HB3' ' HB3' ' A' ' 80' ' ' PHE . 97.6 m-85 -97.35 119.57 36.12 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 107.514 -1.291 . . . . 75.219999999999999 107.514 173.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 80' ' ' PHE . 10.2 pt20 -109.36 148.28 31.34 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.527 0.731 . . . . 72.109999999999999 110.151 -173.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -158.93 131.43 4.38 Favored Pre-proline 0 CA--C 1.547 0.846 0 CA-C-O 118.835 -0.603 . . . . 71.530000000000001 109.643 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -62.85 -26.55 74.67 Favored 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 123.152 2.568 . . . . 75.310000000000002 113.707 -176.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.4 m -102.33 22.26 13.67 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.119 0.567 . . . . 75.140000000000001 111.109 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -119.74 108.27 14.21 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.02 -1.104 . . . . 74.25 108.02 170.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 91.4 mt -116.82 111.13 19.29 Favored 'General case' 0 C--O 1.212 -0.875 0 CA-C-O 118.32 -0.847 . . . . 74.040000000000006 108.889 170.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 40.7 -80.96 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 126.0 1.72 . . . . 73.099999999999994 115.263 165.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.23 30.03 2.66 Favored Glycine 0 C--N 1.356 1.649 0 C-N-CA 123.351 0.501 . . . . 63.340000000000003 112.887 -176.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.502 HE21 ' N ' ' A' ' 110' ' ' GLN . 0.0 OUTLIER -89.33 87.07 6.97 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 107.79 -1.189 . . . . 75.5 107.79 176.281 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.35 -25.79 67.75 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.122 -0.944 . . . . 71.310000000000002 112.335 -176.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 16.5 pm0 -69.12 -21.51 64.03 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.716 0.406 . . . . 74.209999999999994 111.536 177.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 82.2 mt -89.63 -13.09 37.85 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.234 0.614 . . . . 73.120000000000005 111.2 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.434 HD11 ' HB3' ' A' ' 25' ' ' TRP . 91.9 mt -64.61 -35.61 81.56 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.943 0.497 . . . . 75.510000000000005 111.065 175.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -80.9 -1.67 44.38 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 111.719 0.266 . . . . 73.230000000000004 111.719 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.483 HD21 ' N ' ' A' ' 116' ' ' ASN . 0.6 OUTLIER -88.14 -24.75 23.27 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 108.95 -0.759 . . . . 74.109999999999999 108.95 170.504 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 57.9 mt -79.77 105.05 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.918 0.887 . . . . 74.299999999999997 108.868 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.551 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 10.8 mmpt? -107.39 139.53 41.74 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 120.86 0.362 . . . . 75.129999999999995 110.175 -170.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 . . . . . 0 N--CA 1.473 0.72 0 CA-C-N 115.307 -0.861 . . . . 74.329999999999998 110.821 -178.248 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.5 t . . . . . 0 C--O 1.242 0.688 0 N-CA-C 107.026 -1.472 . . . . 73.329999999999998 107.026 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.432 ' HD2' HD12 ' A' ' 21' ' ' LEU . 33.5 Cg_exo -58.15 146.32 88.75 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.479 2.12 . . . . 71.040000000000006 110.669 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.28 -34.29 45.91 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 123.711 0.632 . . . . 74.120000000000005 110.62 176.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -51.36 -52.39 46.08 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.911 0.885 . . . . 73.25 112.234 171.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.432 HD12 ' HD2' ' A' ' 18' ' ' PRO . 83.1 mt -80.86 -30.34 35.64 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.005 0.431 . . . . 71.319999999999993 110.065 -171.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.1 m -59.88 -51.66 68.75 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.856 1.262 . . . . 71.109999999999999 110.631 173.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.544 ' HB3' ' HB3' ' A' ' 62' ' ' TYR . 9.6 mmpt? -65.98 -45.38 81.88 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 115.548 -0.751 . . . . 75.329999999999998 110.144 177.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.416 ' O ' HG23 ' A' ' 28' ' ' VAL . 57.4 tp -56.29 -48.14 77.24 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.038 0.935 . . . . 74.530000000000001 111.595 -178.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 41.8 t90 -55.85 -46.3 78.25 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.05 0.94 . . . . 73.010000000000005 111.353 178.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 35.0 m -71.18 -25.48 62.56 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.469 1.108 . . . . 74.400000000000006 112.118 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.498 ' HG ' HD12 ' A' ' 37' ' ' ILE . 30.3 tp -78.01 -43.98 27.91 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.162 0.985 . . . . 73.530000000000001 110.793 -176.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 24' ' ' LEU . 74.3 t -57.96 -26.83 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.352 0 C-N-CA 125.042 1.337 . . . . 75.349999999999994 111.612 173.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 78.6 p -101.4 0.91 37.78 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.531 0.732 . . . . 75.230000000000004 112.631 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -81.45 120.15 77.42 Favored Pre-proline 0 N--CA 1.483 1.193 0 C-N-CA 122.946 0.498 . . . . 74.030000000000001 110.993 -172.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -71.77 -11.05 27.37 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 122.845 2.363 . . . . 73.209999999999994 113.165 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -74.16 -36.2 64.07 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 122.591 0.356 . . . . 75.140000000000001 110.225 173.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 70.5 p -117.79 13.18 14.07 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.6 0.76 . . . . 74.120000000000005 111.631 -173.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -62.19 -30.22 70.92 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.175 0.59 . . . . 64.299999999999997 112.123 -171.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.67 -20.19 58.62 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.847 0.684 . . . . 75.239999999999995 112.847 178.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 59.4 mt -105.67 -16.77 14.6 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.007 0.523 . . . . 75.409999999999997 110.718 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.498 HD12 ' HG ' ' A' ' 27' ' ' LEU . 17.5 tt -160.28 121.7 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.21 0.604 . . . . 73.439999999999998 110.715 175.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 48.6 t -154.93 154.93 33.38 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.287 0.635 . . . . 75.209999999999994 109.67 177.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 29.2 p-90 -74.45 152.82 39.39 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.643 0.777 . . . . 71.349999999999994 111.007 -174.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.3 m -79.31 142.11 58.29 Favored Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 108.487 -0.931 . . . . 71.049999999999997 108.487 172.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.99 -26.52 49.9 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 123.212 2.608 . . . . 74.340000000000003 114.152 -176.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.6 m -74.71 -27.45 60.39 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.914 0.486 . . . . 73.530000000000001 111.42 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 107' ' ' LEU . . . 94.48 -5.55 70.62 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-O 119.391 -0.671 . . . . 73.510000000000005 114.018 175.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.461 ' HA ' HD21 ' A' ' 107' ' ' LEU . 2.8 m-20 -78.94 -16.21 57.27 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.816 0.846 . . . . 71.049999999999997 111.955 -170.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 43.5 p -156.57 179.97 8.75 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.347 0.594 . . . . 73.109999999999999 110.965 -173.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -138.81 151.98 47.49 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.044 -0.98 . . . . 61.32 109.344 171.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -107.37 139.22 42.19 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.738 0.815 . . . . 75.109999999999999 109.136 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.497 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 71.2 t -118.2 127.5 75.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 107.324 -1.361 . . . . 74.409999999999997 107.324 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -113.64 146.29 39.99 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.177 -0.675 . . . . 75.310000000000002 109.177 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 53.64 68.76 0.79 Allowed 'General case' 0 N--CA 1.476 0.859 0 O-C-N 124.851 1.344 . . . . 71.129999999999995 110.8 176.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.588 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 47.0 mt-30 -53.28 -26.92 20.13 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.491 0.717 . . . . 74.109999999999999 112.63 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -64.82 -53.06 36.77 Favored Glycine 0 C--N 1.349 1.281 0 O-C-N 123.252 0.345 . . . . 62.109999999999999 112.289 172.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -69.8 -42.12 74.16 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.192 0.597 . . . . 71.239999999999995 110.754 -176.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.431 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 60.2 t80 -56.65 -50.16 72.89 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.49 1.516 . . . . 75.129999999999995 110.806 176.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.42 ' HB1' ' O ' ' A' ' 66' ' ' ASN . . . -62.4 -31.99 72.75 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 112.213 0.449 . . . . 73.319999999999993 112.213 177.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -70.6 -49.28 49.39 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.073 0.949 . . . . 73.519999999999996 112.778 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.54 ' HG3' HG21 ' A' ' 58' ' ' VAL . 4.4 pt-20 -108.48 -37.48 5.95 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 113.569 0.952 . . . . 75.450000000000003 113.569 -172.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.54 HG21 ' HG3' ' A' ' 57' ' ' GLU . 98.6 t -81.99 -45.86 19.91 Favored 'Isoleucine or valine' 0 C--O 1.249 1.07 0 C-N-CA 123.315 0.646 . . . . 75.239999999999995 111.565 -166.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.411 HD13 ' HE2' ' A' ' 68' ' ' MET . 50.1 mt -62.08 -48.97 87.03 Favored Pre-proline 0 CA--C 1.558 1.257 0 CA-C-O 117.79 -1.1 . . . . 72.140000000000001 112.705 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.539 ' HG3' ' ND2' ' A' ' 66' ' ' ASN . 52.6 Cg_endo -67.69 -15.23 44.06 Favored 'Trans proline' 0 C--N 1.388 2.611 0 C-N-CA 122.134 1.889 . . . . 73.140000000000001 113.186 176.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -74.05 -64.99 0.9 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.176 0.59 . . . . 73.209999999999994 110.824 178.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.544 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 29.8 m-85 -81.61 -46.51 14.29 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.209 0.528 . . . . 74.120000000000005 111.474 -176.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -98.57 -171.22 2.08 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 106.608 -1.627 . . . . 75.319999999999993 106.608 177.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -129.47 64.99 1.48 Allowed 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 119.428 1.013 . . . . 72.129999999999995 109.859 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -166.09 162.86 18.04 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 114.295 -1.32 . . . . 75.510000000000005 108.813 174.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.539 ' ND2' ' HG3' ' A' ' 60' ' ' PRO . 11.1 m120 -114.2 -5.85 13.02 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 122.682 0.393 . . . . 73.409999999999997 110.304 175.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -75.29 112.5 11.65 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 122.963 0.505 . . . . 74.319999999999993 110.66 -175.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.588 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 3.5 tpt -56.49 -48.64 76.72 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.281 1.432 . . . . 75.040000000000006 111.631 178.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.96 -30.07 67.64 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.414 -0.812 . . . . 75.120000000000005 112.597 -177.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.3 t -68.52 -41.35 80.07 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.643 0.777 . . . . 75.030000000000001 111.271 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -61.95 -49.24 76.89 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.832 0.853 . . . . 70.450000000000003 109.93 177.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 52.7 t -65.15 -35.4 75.32 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 CA-C-N 114.688 -1.142 . . . . 72.150000000000006 111.508 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -60.86 -42.49 97.98 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.67 0.788 . . . . 74.409999999999997 110.971 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.5 ' HA ' ' HE3' ' A' ' 77' ' ' MET . 32.1 mm-40 -64.85 -45.29 86.72 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.82 -0.627 . . . . 73.129999999999995 110.426 178.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.435 ' HB3' ' HB2' ' A' ' 80' ' ' PHE . 83.1 mt -63.59 -34.19 77.27 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.271 0.629 . . . . 74.319999999999993 111.847 -178.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -56.15 -40.03 73.21 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.212 0.605 . . . . 71.430000000000007 111.184 171.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.5 ' HE3' ' HA ' ' A' ' 74' ' ' GLN . 39.9 mtm -76.91 -23.91 52.49 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.278 0.631 . . . . 71.340000000000003 111.28 178.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -86.1 -8.61 57.76 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.06 0.544 . . . . 73.049999999999997 111.006 174.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.05 21.04 54.02 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 114.406 0.522 . . . . 75.019999999999996 114.406 173.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.435 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 17.7 m-85 -82.31 144.97 30.22 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 108.954 -0.758 . . . . 63.109999999999999 108.954 176.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -102.29 129.6 48.76 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.868 0.467 . . . . 75.5 110.24 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.584 ' HE3' HG22 ' A' ' 84' ' ' VAL . 52.8 tptt -68.71 118.65 11.97 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.426 1.09 . . . . 74.25 108.779 169.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 58.8 t -123.4 116.82 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 108.667 -0.864 . . . . 75.319999999999993 108.667 176.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.584 HG22 ' HE3' ' A' ' 82' ' ' LYS . 34.4 t -97.98 101.88 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.746 0.818 . . . . 74.030000000000001 109.318 -174.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 . . . . . 0 N--CA 1.484 1.236 0 O-C-N 122.341 -0.224 . . . . 70.310000000000002 110.656 179.649 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 . . . . . 0 CA--C 1.55 0.957 0 CA-C-O 121.143 0.497 . . . . 75.439999999999998 110.087 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -36.76 105.38 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 125.413 1.485 . . . . 71.540000000000006 112.56 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -90.33 112.77 24.47 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 107.608 -1.256 . . . . 65.319999999999993 107.608 -177.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.504 HG21 ' HD2' ' A' ' 82' ' ' LYS . 76.6 m -118.06 107.12 13.62 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.894 -1.048 . . . . 73.329999999999998 109.256 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.543 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 41.9 tt0 -96.23 109.63 22.07 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.596 -1.261 . . . . 65.409999999999997 107.596 177.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -95.03 118.68 32.26 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 107.125 -1.435 . . . . 74.200000000000003 107.125 172.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -123.37 149.29 45.13 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.861 0.864 . . . . 63.549999999999997 109.87 -174.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -156.74 133.14 6.13 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 109.276 -0.638 . . . . 73.150000000000006 109.276 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.21 -27.2 56.48 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 122.928 2.419 . . . . 74.519999999999996 113.044 -174.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.407 ' O ' ' HB3' ' A' ' 113' ' ' LEU . 59.2 m -105.86 37.38 2.26 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.644 0.778 . . . . 75.310000000000002 109.511 175.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -133.9 106.9 7.52 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.055 -1.091 . . . . 70.310000000000002 108.055 170.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.571 ' HB2' ' HB3' ' A' ' 110' ' ' GLN . 68.0 mt -128.2 149.63 50.37 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 108.514 -0.921 . . . . 74.400000000000006 108.514 172.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -63.02 -59.14 5.21 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.486 0.714 . . . . 74.540000000000006 111.659 -175.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -88.95 50.57 3.71 Favored Glycine 0 C--N 1.342 0.877 0 N-CA-C 111.87 -0.492 . . . . 75.519999999999996 111.87 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.571 ' HB3' ' HB2' ' A' ' 107' ' ' LEU . 4.1 tp60 -165.19 53.0 0.11 Allowed 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 108.691 -0.855 . . . . 74.239999999999995 108.691 -172.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -62.64 -18.4 62.22 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.024 0.93 . . . . 54.25 112.966 -176.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.0 pm0 -68.26 -6.58 24.55 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 122.957 0.503 . . . . 72.030000000000001 112.145 176.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.407 ' HB3' ' O ' ' A' ' 105' ' ' CYS . 63.4 mt -86.28 -23.7 26.22 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 122.751 0.42 . . . . 70.299999999999997 111.473 174.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.19 -37.98 89.35 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.274 0.63 . . . . 64.099999999999994 111.35 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -72.21 -13.49 61.55 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 114.895 -1.048 . . . . 72.430000000000007 112.267 177.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -93.9 -11.62 30.64 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.327 0.651 . . . . 75.230000000000004 110.865 173.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 35.8 mt -87.41 91.99 3.67 Favored 'Isoleucine or valine' 0 C--N 1.353 0.745 0 N-CA-C 107.134 -1.432 . . . . 72.010000000000005 107.134 176.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.43 ' HE2' ' HA ' ' A' ' 118' ' ' LYS . 11.1 mmpt? -87.48 144.48 26.7 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.219 -0.66 . . . . 74.310000000000002 109.219 -178.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 8.6 ptm85 . . . . . 0 N--CA 1.473 0.687 0 N-CA-C 109.572 -0.529 . . . . 74.319999999999993 109.572 178.562 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.5 t . . . . . 0 CA--C 1.55 0.952 0 CA-C-O 119.714 -0.184 . . . . 72.510000000000005 110.649 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -61.81 139.0 77.79 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 122.734 2.289 . . . . 74.549999999999997 111.8 170.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.416 ' HA ' HG23 ' A' ' 22' ' ' THR . . . -56.58 -38.47 72.02 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.592 0.757 . . . . 73.420000000000002 112.392 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -51.33 -46.85 62.78 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.587 0.755 . . . . 75.129999999999995 111.626 173.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.439 ' HB3' HD21 ' A' ' 114' ' ' LEU . 77.8 mt -79.69 -34.73 39.99 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.122 0.569 . . . . 75.140000000000001 112.498 -172.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.416 HG23 ' HA ' ' A' ' 19' ' ' ALA . 14.3 t -71.38 -34.89 70.81 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 118.041 0.382 . . . . 73.310000000000002 111.146 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.2 mtpt -81.06 -32.7 33.91 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 119.532 -0.271 . . . . 64.030000000000001 110.875 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.4 tp -63.55 -39.58 94.77 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.091 0.556 . . . . 75.129999999999995 110.497 170.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 64.7 t-105 -57.44 -52.67 64.44 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.871 0.868 . . . . 72.430000000000007 110.666 174.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 38.6 m -59.84 -40.74 89.56 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 124.238 0.961 . . . . 72.219999999999999 110.721 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.477 ' HG ' HD12 ' A' ' 37' ' ' ILE . 26.9 tp -59.64 -52.26 66.28 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.196 1.398 . . . . 73.540000000000006 112.304 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 96.9 t -62.01 -33.14 56.8 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 C-N-CA 123.855 0.862 . . . . 75.150000000000006 111.164 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.9 t -94.04 -1.71 54.05 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 123.911 0.884 . . . . 53.450000000000003 112.069 -174.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.4 ' HB3' ' OG1' ' A' ' 33' ' ' THR . 17.1 t70 -89.0 130.54 44.21 Favored Pre-proline 0 N--CA 1.49 1.555 0 C-N-CA 123.29 0.636 . . . . 75.409999999999997 111.467 -174.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -73.32 -21.82 19.54 Favored 'Trans proline' 0 C--N 1.39 2.716 0 C-N-CA 123.271 2.647 . . . . 73.5 114.369 -174.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -78.45 -36.33 45.57 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.316 0.646 . . . . 74.409999999999997 110.455 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.4 ' OG1' ' HB3' ' A' ' 30' ' ' ASP . 21.5 p -92.01 -0.96 57.48 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.227 0.611 . . . . 75.209999999999994 111.28 -176.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.69 -29.17 58.92 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.88 1.272 . . . . 73.209999999999994 112.107 -179.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.26 -36.98 79.03 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.934 0.894 . . . . 64.5 113.22 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.6 mt -114.16 -6.38 13.05 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.918 0.487 . . . . 73.510000000000005 112.134 -176.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.477 HD12 ' HG ' ' A' ' 27' ' ' LEU . 16.6 tt -160.11 125.71 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-O 120.943 0.401 . . . . 74.439999999999998 110.878 175.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 21.5 p -146.2 145.3 30.39 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.218 0.607 . . . . 63.450000000000003 110.255 -176.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 10.2 p-90 -69.25 152.19 45.36 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 118.028 0.376 . . . . 73.420000000000002 110.844 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 61.2 p -71.98 150.0 92.53 Favored Pre-proline 0 CA--C 1.552 1.048 0 N-CA-C 109.446 -0.575 . . . . 61.439999999999998 109.446 172.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -51.59 -24.27 16.82 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.564 2.176 . . . . 75.329999999999998 113.67 171.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 59.8 m -69.99 -52.26 25.74 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.241 0.616 . . . . 74.219999999999999 109.765 169.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.16 5.58 65.63 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.277 -0.874 . . . . 32.32 112.969 -177.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -87.92 -2.25 58.49 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.861 0.864 . . . . 72.040000000000006 110.022 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.7 p -163.59 170.57 17.0 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.375 1.07 . . . . 71.239999999999995 109.494 -169.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -142.07 143.46 33.1 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.465 0.306 . . . . 72.019999999999996 111.075 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 -97.77 140.27 32.4 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.173 0.989 . . . . 75.140000000000001 109.487 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.5 t -123.95 132.7 70.95 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 C-N-CA 124.387 1.075 . . . . 71.109999999999999 108.308 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 79.3 m-85 -115.82 146.86 41.61 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.39 1.076 . . . . 72.450000000000003 109.756 -177.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 49.77 72.59 0.31 Allowed 'General case' 0 N--CA 1.479 1.007 0 O-C-N 124.727 1.267 . . . . 70.219999999999999 111.378 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.416 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 16.3 mm-40 -51.09 -35.96 37.83 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.808 0.843 . . . . 73.420000000000002 112.717 -176.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.37 -47.38 71.16 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-N 115.809 -0.632 . . . . 63.549999999999997 112.885 177.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 -69.54 -44.33 71.19 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.187 0.595 . . . . 62.009999999999998 110.63 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.401 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 71.1 t80 -55.34 -49.26 72.68 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.376 1.47 . . . . 74.040000000000006 110.975 176.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.29 -35.93 78.68 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 116.432 -0.349 . . . . 71.340000000000003 111.932 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -70.11 -47.08 63.31 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 124.263 1.025 . . . . 74.439999999999998 113.078 -175.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.493 ' HG3' HG22 ' A' ' 58' ' ' VAL . 7.1 pt-20 -107.01 -37.38 6.34 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 113.912 1.079 . . . . 74.25 113.912 -174.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.493 HG22 ' HG3' ' A' ' 57' ' ' GLU . 98.4 t -81.0 -43.7 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 122.754 0.421 . . . . 75.540000000000006 111.512 -168.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.5 mt -67.03 -43.86 48.17 Favored Pre-proline 0 CA--C 1.556 1.21 0 CA-C-O 117.979 -1.01 . . . . 71.329999999999998 112.833 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.98 -14.36 43.37 Favored 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 121.894 1.729 . . . . 74.239999999999995 113.625 173.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -79.01 -57.76 3.58 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.384 0.674 . . . . 75.439999999999998 111.04 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.407 ' CE1' HD11 ' A' ' 27' ' ' LEU . 57.3 m-85 -86.57 -26.8 24.3 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 112.258 0.466 . . . . 74.430000000000007 112.258 -176.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -124.38 -178.45 4.11 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.063 0.945 . . . . 71.019999999999996 108.747 -176.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.66 37.67 2.85 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 122.917 0.487 . . . . 73.519999999999996 109.994 -172.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -160.84 160.7 31.41 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.92 0.888 . . . . 73.540000000000006 108.902 -176.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -109.69 -25.45 10.39 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 108.996 -0.742 . . . . 73.209999999999994 108.996 176.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -57.68 118.37 5.19 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.334 1.054 . . . . 62.509999999999998 111.655 -176.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.416 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 11.6 ttm -72.15 -31.57 66.08 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.1 -0.955 . . . . 74.209999999999994 111.709 -178.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.29 -37.36 69.74 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.076 0.55 . . . . 44.329999999999998 111.644 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.403 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 37.2 t -66.41 -44.96 81.52 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.214 1.005 . . . . 70.200000000000003 111.323 176.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -64.19 -52.91 56.62 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.531 1.132 . . . . 64.219999999999999 111.196 -176.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 68.0 t -65.8 -31.35 53.35 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 CA-C-N 115.515 -0.766 . . . . 73.239999999999995 111.251 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -60.28 -39.77 88.03 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 122.785 0.434 . . . . 75.549999999999997 111.227 173.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.403 ' HG2' ' O ' ' A' ' 70' ' ' SER . 21.7 mm-40 -65.09 -46.25 81.86 Favored 'General case' 0 C--N 1.355 0.809 0 O-C-N 123.646 0.591 . . . . 75.049999999999997 109.905 177.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.49 ' HB3' ' HB2' ' A' ' 80' ' ' PHE . 96.9 mt -57.4 -45.25 84.75 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 123.81 0.844 . . . . 74.230000000000004 111.285 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -55.57 -42.5 74.82 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.595 0.758 . . . . 74.510000000000005 111.933 176.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 59.3 mtm -73.6 -27.61 61.38 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 116.041 -0.527 . . . . 71.129999999999995 111.491 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -85.28 -6.97 59.22 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.569 0.348 . . . . 71.040000000000006 111.207 177.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.65 17.71 59.62 Favored Glycine 0 C--N 1.352 1.469 0 CA-C-O 119.794 -0.448 . . . . 63.119999999999997 113.927 175.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.49 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 38.7 m-85 -78.2 137.34 38.09 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 108.332 -0.988 . . . . 73.019999999999996 108.332 173.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 13.6 ttm180 -107.93 130.79 55.01 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.306 0.642 . . . . 73.430000000000007 109.545 -175.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -65.78 125.45 25.36 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.038 0.935 . . . . 75.200000000000003 109.369 174.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.536 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 51.7 t -116.0 113.54 43.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 107.835 -1.172 . . . . 73.219999999999999 107.835 176.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 71.1 t -86.46 140.15 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 123.762 0.825 . . . . 74.329999999999998 110.898 -177.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 32.5 m80 . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 108.066 -1.087 . . . . 74.519999999999996 108.066 172.029 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 . . . . . 0 C--O 1.24 0.553 0 CA-C-O 121.516 0.674 . . . . 75.510000000000005 111.381 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 18.0 m-20 -80.84 134.15 35.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.337 -1.302 . . . . 74.209999999999994 108.554 170.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -115.1 105.27 12.74 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 107.644 -1.243 . . . . 74.430000000000007 107.644 169.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 93.3 m -124.7 153.23 42.65 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.478 1.111 . . . . 70.340000000000003 109.637 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.536 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 37.8 tt0 -130.9 153.55 49.02 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.548 -0.908 . . . . 72.040000000000006 108.548 162.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -124.46 120.31 31.66 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 107.277 -1.379 . . . . 74.329999999999998 107.277 169.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -110.32 144.56 38.87 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.552 0.741 . . . . 74.409999999999997 110.242 -174.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.458 ' HB3' ' HB3' ' A' ' 106' ' ' PHE . 64.8 t-80 -149.46 130.81 7.3 Favored Pre-proline 0 CA--C 1.55 0.969 0 CA-C-O 119.351 -0.357 . . . . 72.040000000000006 110.423 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.25 -40.83 30.28 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 123.299 2.666 . . . . 74.409999999999997 113.667 -175.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.413 ' HB2' ' HE1' ' A' ' 103' ' ' HIS . 34.2 m -97.13 22.96 7.85 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.275 0.63 . . . . 73.299999999999997 111.096 -177.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.458 ' HB3' ' HB3' ' A' ' 103' ' ' HIS . 89.1 t80 -117.37 99.05 6.75 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 106.706 -1.59 . . . . 72.439999999999998 106.706 173.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 63.1 mt -119.31 139.36 52.07 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.137 -1.06 . . . . 72.530000000000001 108.137 177.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -68.89 132.27 46.47 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.508 0.723 . . . . 73.319999999999993 110.125 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.48 1.6 90.49 Favored Glycine 0 C--N 1.344 0.983 0 O-C-N 123.555 0.534 . . . . 65.140000000000001 113.052 -173.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -122.84 53.46 1.28 Allowed 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 108.144 -1.058 . . . . 62.530000000000001 108.144 -175.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.55 -26.1 65.09 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.236 1.414 . . . . 73.319999999999993 114.102 -177.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 7.9 pm0 -71.01 -8.19 51.6 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 112.204 0.446 . . . . 65.319999999999993 112.204 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.485 ' O ' HG13 ' A' ' 117' ' ' ILE . 24.6 mt -83.1 -14.22 54.11 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 118.771 -0.633 . . . . 73.230000000000004 111.485 173.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.439 HD21 ' HB3' ' A' ' 21' ' ' LEU . 96.4 mt -63.17 -35.3 79.86 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 118.295 0.498 . . . . 72.430000000000007 110.857 175.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -80.15 -1.59 40.96 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.962 -0.563 . . . . 62.210000000000001 112.148 175.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -103.61 -13.71 16.43 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.586 0.754 . . . . 75.209999999999994 110.528 168.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 113' ' ' LEU . 63.9 mt -85.74 109.74 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 106.879 -1.526 . . . . 73.230000000000004 106.879 173.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -109.21 170.39 8.08 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.807 -0.812 . . . . 71.129999999999995 108.807 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 24.6 ptt85 . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 108.155 -1.054 . . . . 73.329999999999998 108.155 168.993 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.4 t . . . . . 0 CA--C 1.551 0.983 0 CA-C-O 119.127 -0.463 . . . . 74.109999999999999 111.802 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -58.94 152.37 58.6 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 123.155 2.57 . . . . 74.420000000000002 112.314 174.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.72 -45.78 70.59 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.971 0.908 . . . . 74.019999999999996 112.1 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -54.85 -44.44 73.99 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 122.981 0.512 . . . . 73.310000000000002 112.009 176.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.2 mt -80.52 -31.09 37.16 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 112.393 0.516 . . . . 72.420000000000002 112.393 -171.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.1 t -70.99 -33.39 70.37 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.656 -0.498 . . . . 72.200000000000003 109.656 175.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -69.87 -42.41 73.52 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 122.915 0.486 . . . . 74.129999999999995 110.536 172.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.61 -43.67 93.68 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.8 0.84 . . . . 72.310000000000002 111.419 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 13.5 t-105 -64.58 -51.9 60.37 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-O 119.611 -0.233 . . . . 74.420000000000002 110.81 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 32.1 m -61.3 -20.69 63.2 Favored 'General case' 0 CA--C 1.554 1.133 0 CA-C-O 121.299 0.571 . . . . 74.140000000000001 110.883 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.0 tp -76.77 -54.77 6.18 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.597 1.159 . . . . 75.409999999999997 111.408 174.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 82.5 t -62.16 -36.22 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.749 0.819 . . . . 72.129999999999995 111.389 -177.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.5 p -78.15 -25.4 47.3 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.538 0.735 . . . . 74.140000000000001 112.305 -176.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -70.84 123.12 88.69 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 123.24 0.616 . . . . 75.319999999999993 111.563 -171.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.28 -13.51 33.45 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 122.975 2.45 . . . . 71.450000000000003 113.479 -177.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -87.12 -22.39 25.4 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.723 0.809 . . . . 74.25 110.987 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.414 HG21 ' HE1' ' A' ' 62' ' ' TYR . 24.7 p -110.6 1.25 17.95 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.158 0.583 . . . . 74.430000000000007 111.685 175.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -54.12 -36.95 63.81 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.486 1.114 . . . . 70.420000000000002 112.271 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.1 -33.17 75.39 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.526 -0.761 . . . . 74.129999999999995 112.256 -176.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.463 HD21 ' HB2' ' A' ' 50' ' ' ASP . 59.7 mt -103.48 -11.0 18.09 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.548 0.339 . . . . 71.230000000000004 111.36 -177.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.5 tt -162.15 128.43 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 122.971 0.508 . . . . 70.030000000000001 110.326 172.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 17.3 p -153.92 157.6 39.46 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.23 0.612 . . . . 71.209999999999994 110.057 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 41.4 p-90 -73.63 149.22 42.18 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.993 0.517 . . . . 74.230000000000004 110.097 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.5 m -70.24 143.51 91.1 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 123.879 0.872 . . . . 75.510000000000005 110.098 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -55.59 -32.49 83.36 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.813 2.342 . . . . 75.0 113.517 175.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.9 m -69.61 -19.68 63.64 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.217 0.607 . . . . 73.310000000000002 111.698 173.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.69 6.4 71.71 Favored Glycine 0 C--N 1.344 0.996 0 N-CA-C 115.617 1.007 . . . . 44.439999999999998 115.617 171.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -88.07 -5.66 58.36 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 118.109 0.955 . . . . 74.209999999999994 112.265 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.2 p -163.44 -171.66 2.65 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.162 0.585 . . . . 70.319999999999993 110.736 -170.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -145.03 148.81 34.13 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.404 0.682 . . . . 73.510000000000005 110.973 175.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 21.6 m-70 -99.52 150.79 21.86 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.588 1.155 . . . . 71.400000000000006 110.173 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.0 t -123.67 123.03 66.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 107.939 -1.134 . . . . 74.040000000000006 107.939 172.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -105.68 147.41 28.54 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.273 1.029 . . . . 72.400000000000006 110.034 -178.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.463 ' HB2' HD21 ' A' ' 36' ' ' LEU . 8.6 m-20 48.79 59.83 4.13 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 124.925 1.39 . . . . 63.219999999999999 111.196 172.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.501 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 75.7 mt-30 -54.65 -26.16 31.41 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.78 1.03 . . . . 71.25 113.78 -169.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.94 -50.08 37.33 Favored Glycine 0 C--N 1.35 1.348 0 O-C-N 123.198 0.311 . . . . 75.209999999999994 112.654 173.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -68.06 -40.13 82.84 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.452 0.701 . . . . 74.439999999999998 110.249 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.478 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 44.4 t80 -57.99 -48.14 80.91 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.113 1.365 . . . . 73.439999999999998 110.534 176.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.27 -36.67 80.66 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.196 -0.456 . . . . 71.209999999999994 111.486 177.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -68.47 -53.99 19.83 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.252 1.021 . . . . 73.129999999999995 112.985 -176.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.536 ' HG3' HG21 ' A' ' 58' ' ' VAL . 6.3 pt-20 -100.45 -38.07 8.56 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 112.893 0.701 . . . . 61.420000000000002 112.893 -173.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.536 HG21 ' HG3' ' A' ' 57' ' ' GLU . 77.6 t -81.92 -44.46 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.045 0.538 . . . . 73.340000000000003 112.144 -167.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 49.3 mt -63.52 -45.17 83.24 Favored Pre-proline 0 CA--C 1.56 1.36 0 CA-C-O 117.797 -1.097 . . . . 73.209999999999994 112.684 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.09 -16.52 44.89 Favored 'Trans proline' 0 C--N 1.386 2.538 0 CA-C-N 122.037 1.763 . . . . 75.510000000000005 113.312 173.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -73.13 -47.62 42.57 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.453 0.701 . . . . 73.200000000000003 111.073 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.414 ' HE1' HG21 ' A' ' 33' ' ' THR . 53.8 m-85 -96.12 -48.1 5.8 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 122.853 0.461 . . . . 74.430000000000007 111.903 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -99.08 -171.27 2.06 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.85 0.86 . . . . 75.049999999999997 109.117 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -118.89 44.72 2.24 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.361 0.601 . . . . 73.310000000000002 110.551 -176.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -164.04 164.51 22.99 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.333 -0.849 . . . . 74.299999999999997 109.557 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -121.91 -11.8 8.48 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.588 0.755 . . . . 75.310000000000002 110.278 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -66.93 117.39 8.95 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.035 0.934 . . . . 74.299999999999997 109.75 174.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.501 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 24.0 ttt -87.72 -18.68 28.94 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.558 0.343 . . . . 74.099999999999994 110.917 -176.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.5 -37.49 67.92 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.862 0.465 . . . . 74.510000000000005 110.22 172.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.479 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 44.0 t -66.44 -46.22 77.21 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.911 1.284 . . . . 71.200000000000003 111.343 175.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -61.75 -51.28 68.98 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.889 0.876 . . . . 74.010000000000005 110.478 -175.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.35 -40.85 90.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 123.914 0.885 . . . . 74.219999999999999 110.772 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -56.58 -39.91 74.33 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.257 1.023 . . . . 73.319999999999993 111.073 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.54 ' HA ' ' HE3' ' A' ' 77' ' ' MET . 25.8 mm-40 -63.38 -45.91 88.92 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 123.653 0.596 . . . . 72.409999999999997 109.822 176.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 64.4 mt -61.16 -37.43 82.87 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.729 0.811 . . . . 74.200000000000003 111.5 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -58.55 -38.54 78.03 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.509 0.724 . . . . 73.310000000000002 111.371 172.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.54 ' HE3' ' HA ' ' A' ' 74' ' ' GLN . 34.1 mtm -70.86 -34.07 71.26 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.189 -0.459 . . . . 72.420000000000002 110.493 177.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 119' ' ' ARG . 44.4 m-85 -81.21 -9.62 59.75 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.595 0.758 . . . . 71.430000000000007 111.59 -178.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.96 22.69 59.01 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 114.268 0.467 . . . . 61.0 114.268 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -79.49 137.17 37.11 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 108.443 -0.947 . . . . 74.519999999999996 108.443 171.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -102.81 127.14 50.1 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.153 0.581 . . . . 74.5 110.595 -170.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.3 tptt -65.05 115.88 5.89 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.865 1.266 . . . . 74.510000000000005 109.707 173.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.47 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 59.5 t -123.29 120.28 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 108.731 -0.84 . . . . 71.129999999999995 108.731 175.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 37.5 t -90.77 121.47 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.069 0.948 . . . . 70.420000000000002 109.384 -176.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 . . . . . 0 N--CA 1.489 1.502 0 C-N-CA 122.619 0.368 . . . . 62.229999999999997 110.696 179.216 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 . . . . . 0 N--CA 1.474 0.726 0 CA-C-O 120.925 0.393 . . . . 73.299999999999997 110.205 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -97.52 113.39 25.08 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 107.166 -1.42 . . . . 74.349999999999994 107.166 175.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -100.65 122.13 42.79 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 107.262 -1.384 . . . . 72.150000000000006 107.262 174.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 77.3 m -123.34 128.49 49.98 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.13 -0.693 . . . . 64.140000000000001 109.13 176.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.47 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 35.2 tt0 -101.55 111.0 23.1 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 106.799 -1.556 . . . . 75.430000000000007 106.799 172.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -94.05 119.88 33.53 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.445 -1.317 . . . . 65.450000000000003 107.445 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -121.69 142.12 50.48 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.788 -0.642 . . . . 75.420000000000002 110.796 -174.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 45.5 t-80 -147.26 130.28 8.0 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 107.665 -1.235 . . . . 74.239999999999995 107.665 175.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -63.01 -20.9 72.69 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.816 2.344 . . . . 73.329999999999998 113.846 -172.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.476 ' SG ' ' HB3' ' A' ' 113' ' ' LEU . 36.7 t -101.64 35.36 2.33 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.306 0.642 . . . . 73.129999999999995 110.099 175.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -137.48 109.01 6.94 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.931 0.892 . . . . 74.340000000000003 108.848 172.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 85.0 mt -118.14 104.86 11.23 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 118.969 -0.539 . . . . 72.310000000000002 109.933 174.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 52.14 -79.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 125.669 1.588 . . . . 75.109999999999999 112.688 176.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -141.57 42.13 1.18 Allowed Glycine 0 C--N 1.348 1.243 0 CA-C-N 115.827 -0.624 . . . . 62.409999999999997 111.923 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -82.1 74.19 9.09 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 106.677 -1.601 . . . . 75.200000000000003 106.677 173.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -62.0 -31.14 71.49 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.143 -1.39 . . . . 75.129999999999995 112.695 -171.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 17.5 pm0 -69.2 -16.89 63.72 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 122.502 0.321 . . . . 75.120000000000005 111.586 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.476 ' HB3' ' SG ' ' A' ' 105' ' ' CYS . 40.7 mt -87.24 -14.6 40.58 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.329 0.252 . . . . 74.439999999999998 111.462 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.86 -33.82 76.56 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.976 0.51 . . . . 73.230000000000004 111.661 177.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -73.74 -5.88 43.47 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.2 0.444 . . . . 55.25 112.2 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -101.56 -6.68 23.56 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.8 0.84 . . . . 72.340000000000003 109.594 175.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 44.2 mt -90.77 111.95 24.35 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 N-CA-C 107.226 -1.398 . . . . 74.129999999999995 107.226 174.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.42 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 11.4 mmpt? -101.25 136.69 40.68 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.347 0.659 . . . . 75.519999999999996 111.115 -167.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 78' ' ' TYR . 15.7 ptt180 . . . . . 0 N--CA 1.497 1.875 0 C-N-CA 123.546 0.738 . . . . 75.040000000000006 112.867 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 52.6 t . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 118.94 -0.553 . . . . 61.219999999999999 110.606 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -64.43 155.91 63.35 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 122.702 2.268 . . . . 74.310000000000002 111.44 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.24 -44.81 61.81 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.057 0.943 . . . . 64.530000000000001 112.232 -175.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -53.19 -46.33 68.94 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.17 0.588 . . . . 72.239999999999995 112.338 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 68.9 mt -80.26 -33.6 37.73 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 112.452 0.538 . . . . 73.239999999999995 112.452 -173.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.475 HG23 ' HZ3' ' A' ' 23' ' ' LYS . 9.9 t -71.67 -34.83 70.04 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 117.723 0.238 . . . . 75.299999999999997 110.415 176.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.518 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -70.44 -43.87 69.01 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 122.817 0.447 . . . . 74.310000000000002 110.078 174.018 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.439 ' O ' HG23 ' A' ' 28' ' ' VAL . 68.6 tp -54.28 -56.51 17.74 Favored 'General case' 0 C--O 1.214 -0.784 0 O-C-N 124.312 1.007 . . . . 73.439999999999998 111.546 177.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.465 ' HZ2' ' H ' ' A' ' 109' ' ' GLY . 23.0 t90 -58.11 -45.46 87.24 Favored 'General case' 0 CA--C 1.552 1.026 0 O-C-N 123.52 0.512 . . . . 74.120000000000005 110.908 -176.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.6 m -64.82 -30.75 71.77 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.704 0.802 . . . . 73.030000000000001 111.536 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.437 ' HG ' HG22 ' A' ' 37' ' ' ILE . 37.3 tp -74.05 -45.15 51.3 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.45 1.1 . . . . 72.439999999999998 111.26 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 24' ' ' LEU . 71.4 t -61.76 -32.04 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 C-N-CA 124.092 0.957 . . . . 72.010000000000005 110.321 173.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.6 t -93.64 5.15 52.56 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.359 1.064 . . . . 73.310000000000002 111.988 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -85.83 121.5 73.1 Favored Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 123.056 0.542 . . . . 73.430000000000007 110.436 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.46 -14.05 27.78 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.765 2.31 . . . . 74.439999999999998 113.54 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -78.96 -33.47 45.17 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.368 0.667 . . . . 73.329999999999998 111.23 177.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 67.4 p -111.62 9.53 21.09 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.812 -0.631 . . . . 74.420000000000002 110.683 -176.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -56.79 -34.62 67.82 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.338 1.455 . . . . 72.120000000000005 112.305 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.33 -34.01 76.76 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.503 -0.771 . . . . 74.140000000000001 111.71 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.405 HD23 ' HB2' ' A' ' 50' ' ' ASP . 87.9 mt -104.75 -13.57 15.85 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.227 0.611 . . . . 75.030000000000001 111.397 -174.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.437 HG22 ' HG ' ' A' ' 27' ' ' LEU . 20.1 tt -161.2 119.69 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 C-N-CA 123.005 0.522 . . . . 74.340000000000003 110.246 175.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 16.7 p -150.04 150.23 31.46 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.367 0.667 . . . . 75.25 109.768 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.438 ' HE3' ' HA2' ' A' ' 43' ' ' GLY . 8.2 p-90 -89.98 153.74 20.36 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.006 0.431 . . . . 75.430000000000007 109.891 178.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.8 m -82.43 155.24 69.11 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 114.823 -1.08 . . . . 72.219999999999999 109.316 -175.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.18 -16.53 13.03 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 122.884 2.389 . . . . 74.010000000000005 114.135 173.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.6 m -71.14 -36.42 72.08 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.073 0.949 . . . . 64.129999999999995 111.399 174.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.438 ' HA2' ' HE3' ' A' ' 39' ' ' TRP . . . 82.16 1.49 90.37 Favored Glycine 0 C--N 1.345 1.067 0 CA-C-N 115.744 -0.662 . . . . 74.340000000000003 114.66 176.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -103.08 -3.23 26.2 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.259 0.624 . . . . 63.340000000000003 111.09 -175.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.8 p -154.68 163.25 40.52 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.405 0.682 . . . . 51.109999999999999 110.599 -170.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -142.13 152.26 43.05 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.88 0.472 . . . . 74.549999999999997 110.446 174.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -109.16 148.68 30.52 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.776 0.83 . . . . 72.329999999999998 109.235 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 82.7 t -123.73 131.83 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 108.223 -1.029 . . . . 71.450000000000003 108.223 177.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.53 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 94.0 m-85 -115.41 147.19 40.84 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.864 0.866 . . . . 72.439999999999998 110.217 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.405 ' HB2' HD23 ' A' ' 36' ' ' LEU . 17.6 m-20 51.43 67.56 0.93 Allowed 'General case' 0 N--CA 1.481 1.113 0 O-C-N 124.647 1.217 . . . . 75.349999999999994 111.823 173.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -53.77 -31.34 48.32 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 114.516 1.302 . . . . 74.409999999999997 114.516 -172.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.4 -43.92 43.9 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 112.058 -0.417 . . . . 71.519999999999996 112.058 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.424 ' NE2' ' HD3' ' A' ' 56' ' ' LYS . 20.3 tp60 -72.29 -32.67 66.8 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.67 1.188 . . . . 72.420000000000002 110.968 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.472 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 53.6 t80 -69.71 -50.73 40.81 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.848 1.259 . . . . 75.340000000000003 109.762 178.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 66' ' ' ASN . . . -62.17 -32.14 72.73 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.628 -0.715 . . . . 74.5 112.135 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.424 ' HD3' ' NE2' ' A' ' 53' ' ' GLN . 31.5 tttm -62.38 -53.67 51.59 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.046 1.339 . . . . 74.299999999999997 113.45 -176.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -122.11 -22.11 5.74 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 114.033 1.123 . . . . 73.430000000000007 114.033 -170.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.472 ' HB ' ' O ' ' A' ' 54' ' ' PHE . 85.7 t -86.44 -45.03 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.16 0.584 . . . . 72.25 110.824 -175.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 26.3 mt -62.88 -48.83 84.38 Favored Pre-proline 0 CA--C 1.559 1.305 0 CA-C-O 118.507 -0.759 . . . . 75.099999999999994 112.55 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.431 ' HG3' ' ND2' ' A' ' 66' ' ' ASN . 55.6 Cg_endo -67.56 -13.18 38.2 Favored 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 121.926 1.75 . . . . 64.109999999999999 113.239 175.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -73.28 -54.07 9.31 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.262 0.625 . . . . 73.409999999999997 110.675 176.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.468 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 35.5 m-85 -92.84 -43.71 8.85 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 112.194 0.442 . . . . 74.099999999999994 112.194 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -98.77 -176.99 3.51 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.488 0.715 . . . . 72.409999999999997 109.335 -178.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.55 39.68 2.58 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.312 0.577 . . . . 72.510000000000005 111.132 -174.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -161.23 162.12 31.06 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.881 0.873 . . . . 65.129999999999995 109.875 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.488 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 7.3 m120 -106.8 -26.22 11.37 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 108.618 -0.882 . . . . 74.120000000000005 108.618 173.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -61.03 115.31 3.64 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.114 0.965 . . . . 74.340000000000003 111.52 -177.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.422 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 24.9 ttt -83.13 -20.11 35.43 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 116.195 -0.457 . . . . 75.120000000000005 111.296 -177.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.93 -36.2 72.16 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.356 0.262 . . . . 72.450000000000003 110.525 172.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.491 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 37.2 t -63.32 -51.69 64.96 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.085 0.954 . . . . 74.140000000000001 110.727 172.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -58.08 -54.9 41.7 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.166 0.986 . . . . 71.239999999999995 111.342 -174.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.1 -37.75 80.65 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 CA-C-N 115.506 -0.77 . . . . 71.329999999999998 111.033 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 58.2 ttt-85 -59.44 -43.9 93.02 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 117.894 0.316 . . . . 75.439999999999998 111.396 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 70' ' ' SER . 10.0 mm100 -62.0 -44.26 97.1 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.535 0.522 . . . . 74.420000000000002 109.627 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.1 mt -59.32 -41.16 88.44 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 123.946 0.779 . . . . 75.430000000000007 111.567 176.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -61.25 -37.59 83.66 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.589 0.756 . . . . 73.420000000000002 111.181 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.402 ' HE1' ' HA ' ' A' ' 74' ' ' GLN . 41.9 mtm -68.83 -31.87 71.15 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 122.757 0.423 . . . . 75.120000000000005 110.565 173.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -81.78 -4.01 55.29 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.963 0.905 . . . . 71.540000000000006 111.137 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.65 15.09 74.23 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-O 119.527 -0.596 . . . . 71.230000000000004 114.353 175.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -72.91 131.91 42.81 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 117.683 0.741 . . . . 75.109999999999999 109.222 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -99.42 121.77 41.6 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 109.144 -0.687 . . . . 73.349999999999994 109.144 -174.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.529 ' HE2' HG22 ' A' ' 84' ' ' VAL . 1.2 tmtp? -79.21 127.66 32.33 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.802 1.241 . . . . 73.019999999999996 108.063 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 61.7 t -123.75 129.17 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.166 0.986 . . . . 74.140000000000001 108.631 178.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.529 HG22 ' HE2' ' A' ' 82' ' ' LYS . 30.6 t -92.25 134.0 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 108.279 -1.008 . . . . 73.040000000000006 108.279 178.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 46.6 m-70 . . . . . 0 N--CA 1.483 1.221 0 C-N-CA 122.774 0.43 . . . . 74.319999999999993 111.099 175.449 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 . . . . . 0 N--CA 1.471 0.6 0 CA-C-O 121.24 0.543 . . . . 71.319999999999993 110.735 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.53 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 3.6 m-20 -81.08 119.4 23.5 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.53 -0.915 . . . . 75.230000000000004 108.53 -175.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -115.87 107.34 14.88 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 108.349 -0.982 . . . . 53.32 108.349 170.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.45 HG21 ' HG2' ' A' ' 82' ' ' LYS . 46.7 m -124.23 114.76 20.04 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 114.538 -1.21 . . . . 75.319999999999993 109.382 -172.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.539 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 32.0 tt0 -101.18 114.34 28.2 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 109.008 -0.738 . . . . 74.439999999999998 109.008 -176.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -96.95 119.95 36.38 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.109 -1.071 . . . . 75.450000000000003 108.109 171.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -123.02 141.61 51.77 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.239 0.615 . . . . 74.230000000000004 110.093 -177.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -158.68 132.52 4.99 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 109.16 -0.681 . . . . 72.439999999999998 109.16 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -65.2 -22.48 60.99 Favored 'Trans proline' 0 C--N 1.384 2.433 0 C-N-CA 123.054 2.503 . . . . 74.430000000000007 114.131 -173.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.536 ' HB2' HG12 ' A' ' 117' ' ' ILE . 13.6 m -92.39 -1.52 56.96 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.695 0.398 . . . . 74.099999999999994 111.839 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -104.72 98.37 8.12 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 107.132 -1.432 . . . . 75.0 107.132 175.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.429 ' HB2' ' HB2' ' A' ' 110' ' ' GLN . 67.1 mt -125.45 166.44 16.61 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 121.663 0.744 . . . . 75.129999999999995 111.918 -177.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -58.0 115.91 3.17 Favored 'General case' 0 CA--C 1.556 1.209 0 CA-C-N 113.883 -1.508 . . . . 73.120000000000005 111.673 170.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.465 ' H ' ' HZ2' ' A' ' 25' ' ' TRP . . . 70.21 7.0 59.17 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 115.041 0.776 . . . . 62.43 115.041 174.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.429 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 16.4 mm100 -100.67 65.41 1.15 Allowed 'General case' 0 C--O 1.242 0.67 0 CA-C-O 121.466 0.65 . . . . 60.509999999999998 110.296 -175.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -57.29 -36.07 70.6 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 114.895 -1.048 . . . . 71.0 111.482 173.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 19.2 pm0 -68.45 -16.59 63.96 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.204 0.601 . . . . 74.030000000000001 111.93 -176.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 79.9 mt -96.49 -19.68 18.95 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.335 0.654 . . . . 71.510000000000005 111.555 176.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.1 mt -67.03 -37.42 84.08 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.069 0.547 . . . . 75.219999999999999 110.682 178.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -69.23 -13.85 62.63 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.647 -0.706 . . . . 61.530000000000001 112.278 175.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -97.36 4.75 50.62 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.115 0.566 . . . . 72.420000000000002 110.369 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.536 HG12 ' HB2' ' A' ' 105' ' ' CYS . 44.9 mt -89.68 119.2 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 108.049 -1.093 . . . . 74.010000000000005 108.049 173.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -95.58 132.43 40.73 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.83 0.852 . . . . 63.310000000000002 111.411 -165.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 . . . . . 0 N--CA 1.486 1.366 0 C-N-CA 124.099 0.96 . . . . 74.030000000000001 111.386 173.92 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.42 HG11 ' HB2' ' A' ' 114' ' ' LEU . 54.9 t . . . . . 0 CA--C 1.556 1.197 0 CA-C-O 118.971 -0.538 . . . . 75.450000000000003 110.927 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -55.76 146.81 64.44 Favored 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 123.149 2.566 . . . . 74.150000000000006 112.733 176.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.56 -43.76 62.49 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 124.198 0.936 . . . . 71.120000000000005 111.674 177.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -50.05 -51.41 42.62 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.358 1.063 . . . . 73.219999999999999 112.307 174.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 98.1 mt -80.5 -34.43 35.74 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.474 0.484 . . . . 73.409999999999997 112.103 -169.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.6 t -69.89 -34.36 73.43 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 122.286 0.234 . . . . 73.219999999999999 110.992 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -44.76 75.42 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 109.749 -0.463 . . . . 75.239999999999995 109.749 171.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.2 tp -60.01 -40.37 89.01 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.012 0.925 . . . . 75.150000000000006 111.686 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.469 ' HB2' HD11 ' A' ' 114' ' ' LEU . 91.0 t90 -54.9 -56.2 22.22 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.412 1.085 . . . . 74.019999999999996 111.56 177.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.6 m -60.66 -38.32 84.48 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.895 -1.048 . . . . 73.549999999999997 110.604 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.469 ' HG ' HD13 ' A' ' 37' ' ' ILE . 34.3 tp -64.9 -52.0 58.87 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.351 1.46 . . . . 74.409999999999997 113.057 -174.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.7 t -57.19 -33.43 43.16 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 C-N-CA 124.015 0.926 . . . . 74.049999999999997 112.047 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.5 t -96.92 -3.19 42.28 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.825 0.85 . . . . 71.030000000000001 112.125 -177.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -76.93 128.97 80.12 Favored Pre-proline 0 N--CA 1.483 1.198 0 C-N-CA 123.419 0.688 . . . . 71.319999999999993 111.61 -170.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.37 -24.44 57.45 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 123.125 2.55 . . . . 75.040000000000006 113.5 -177.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -78.46 -29.34 46.82 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.618 0.367 . . . . 64.209999999999994 110.87 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.1 p -115.6 -5.35 12.19 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.369 0.877 . . . . 73.120000000000005 113.369 -172.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.49 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 2.8 p-10 -64.69 -21.4 66.73 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 118.664 0.666 . . . . 75.129999999999995 112.452 -172.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.29 -33.68 76.04 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.758 0.423 . . . . 72.439999999999998 111.337 174.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.56 HD23 ' HB2' ' A' ' 50' ' ' ASP . 43.3 mt -107.09 -12.92 15.3 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.565 0.746 . . . . 71.230000000000004 111.587 -175.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.49 ' O ' ' HA ' ' A' ' 34' ' ' ASP . 15.0 tt -156.77 108.81 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 CA-C-O 121.325 0.583 . . . . 74.230000000000004 110.495 175.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 23.5 p -133.62 145.96 50.48 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.678 0.391 . . . . 73.420000000000002 111.284 -172.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 18.4 p-90 -72.58 148.98 44.39 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.226 1.011 . . . . 74.030000000000001 111.194 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 25.3 p -70.94 153.1 94.89 Favored Pre-proline 0 CA--C 1.554 1.129 0 C-N-CA 123.19 0.596 . . . . 70.510000000000005 110.088 173.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -46.63 -31.9 10.96 Favored 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 123.333 2.688 . . . . 74.540000000000006 113.191 171.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.9 t -71.31 -60.47 2.21 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.514 -0.767 . . . . 70.540000000000006 109.517 170.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 103.53 19.45 12.26 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-N 115.513 -0.767 . . . . 71.099999999999994 113.706 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -101.64 6.6 42.07 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.58 0.752 . . . . 72.200000000000003 110.491 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.6 p -160.13 164.32 33.07 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 123.984 0.914 . . . . 63.439999999999998 109.431 -173.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.479 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 54.1 p90 -142.38 144.4 33.13 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.54 0.336 . . . . 74.430000000000007 111.176 178.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.463 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 59.3 m-70 -97.27 149.43 22.06 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.317 1.047 . . . . 74.439999999999998 108.813 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 98' ' ' ASP . 62.8 t -126.82 114.69 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.813 -0.81 . . . . 74.140000000000001 108.813 178.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -111.04 149.34 30.88 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.367 1.067 . . . . 73.140000000000001 110.227 -176.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.56 ' HB2' HD23 ' A' ' 36' ' ' LEU . 3.9 m-20 52.72 55.03 9.6 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 124.561 1.163 . . . . 74.530000000000001 110.061 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.532 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 78.3 mt-30 -55.3 -25.21 32.87 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 114.326 1.232 . . . . 64.439999999999998 114.326 -169.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.75 -44.56 56.33 Favored Glycine 0 CA--C 1.533 1.206 0 N-CA-C 111.923 -0.471 . . . . 72.219999999999999 111.923 173.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -70.5 -45.06 66.36 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.78 0.832 . . . . 74.310000000000002 109.853 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.442 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 69.2 t80 -48.44 -52.85 20.16 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.384 1.474 . . . . 74.319999999999993 111.689 173.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.42 ' HB3' ' HB2' ' A' ' 68' ' ' MET . . . -62.61 -33.3 74.73 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 116.336 -0.393 . . . . 72.439999999999998 111.693 178.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.1 tmtm? -73.38 -41.88 62.84 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 124.208 1.003 . . . . 70.209999999999994 113.244 -176.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.544 ' HG3' HG23 ' A' ' 58' ' ' VAL . 4.1 pt-20 -111.15 -39.63 4.69 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 113.583 0.957 . . . . 73.450000000000003 113.583 -172.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.544 HG23 ' HG3' ' A' ' 57' ' ' GLU . 66.3 t -80.28 -46.76 21.66 Favored 'Isoleucine or valine' 0 C--O 1.248 0.987 0 C-N-CA 123.725 0.81 . . . . 71.420000000000002 111.351 -168.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 54.9 mt -67.19 -41.7 35.73 Favored Pre-proline 0 CA--C 1.557 1.22 0 CA-C-O 118.326 -0.845 . . . . 74.319999999999993 112.757 -176.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.53 -17.58 53.34 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 121.941 1.761 . . . . 72.450000000000003 114.011 170.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -72.6 -57.88 3.79 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 117.858 0.299 . . . . 71.420000000000002 110.629 176.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -86.26 -40.26 15.71 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 112.14 0.422 . . . . 74.140000000000001 112.14 -175.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -106.98 -178.17 3.57 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.749 -0.834 . . . . 74.040000000000006 108.749 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -119.17 54.58 0.97 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 122.436 1.113 . . . . 74.019999999999996 109.557 -176.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -170.7 171.7 6.1 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.673 1.589 . . . . 73.310000000000002 107.81 178.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -117.95 -24.48 7.07 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 122.29 -0.257 . . . . 72.239999999999995 111.071 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -63.53 125.93 25.84 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.345 0.658 . . . . 74.099999999999994 112.054 -173.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.532 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 25.3 ttt -86.68 -29.63 22.33 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.388 0.675 . . . . 74.5 111.646 -176.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.37 -34.45 70.7 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 122.799 0.439 . . . . 72.5 111.36 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.443 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 44.1 t -66.74 -45.31 79.05 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.275 1.03 . . . . 70.329999999999998 110.789 173.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -63.14 -46.86 85.25 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.442 1.097 . . . . 75.209999999999994 110.565 -176.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 80.5 t -60.99 -45.31 98.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.23 1.012 . . . . 73.439999999999998 110.947 174.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -62.52 -32.6 73.56 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.781 0.432 . . . . 73.340000000000003 111.318 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 70' ' ' SER . 29.1 mm-40 -62.94 -51.71 65.84 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 109.903 -0.406 . . . . 74.299999999999997 109.903 172.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.9 mt -58.92 -38.0 77.95 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.859 0.864 . . . . 73.109999999999999 111.779 -177.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -59.13 -43.74 91.99 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.484 0.713 . . . . 73.120000000000005 111.075 175.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.419 ' HE3' ' HA ' ' A' ' 74' ' ' GLN . 43.6 mtm -67.29 -35.48 79.55 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.73 -0.668 . . . . 71.140000000000001 110.366 175.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -80.1 8.73 6.6 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 123.525 0.73 . . . . 64.150000000000006 110.917 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.29 4.82 87.8 Favored Glycine 0 C--N 1.351 1.41 0 N-CA-C 114.511 0.564 . . . . 62.329999999999998 114.511 169.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.552 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . 39.8 m-85 -74.09 141.27 45.67 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 108.939 -0.763 . . . . 74.120000000000005 108.939 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.486 ' HB3' ' HG2' ' A' ' 102' ' ' GLN . 32.7 ttm180 -101.6 129.07 47.63 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.774 0.43 . . . . 72.439999999999998 110.101 -173.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -71.92 111.54 7.26 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.897 1.279 . . . . 74.519999999999996 109.855 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.2 t -126.19 136.26 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 107.72 -1.215 . . . . 65.109999999999999 107.72 172.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 96.3 t -119.28 139.46 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.355 0.662 . . . . 74.140000000000001 109.322 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 71.9 m80 . . . . . 0 N--CA 1.48 1.06 0 C-N-CA 122.841 0.456 . . . . 74.540000000000006 110.704 -178.378 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 . . . . . 0 N--CA 1.471 0.597 0 N-CA-C 109.832 -0.432 . . . . 75.010000000000005 109.832 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -40.43 123.13 1.73 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.056 0.943 . . . . 75.519999999999996 111.118 171.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.441 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 22.0 t70 -112.3 134.88 53.59 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.386 -0.598 . . . . 73.129999999999995 109.386 178.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 73.9 m -133.9 128.53 34.75 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.049 -0.723 . . . . 71.219999999999999 109.049 166.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 46' ' ' PHE . 33.7 tt0 -104.46 117.09 33.32 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.02 -1.104 . . . . 74.430000000000007 108.02 170.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.552 ' HB3' ' HB3' ' A' ' 80' ' ' PHE . 97.7 m-85 -95.85 120.01 35.36 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.668 -1.234 . . . . 75.129999999999995 107.668 173.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.486 ' HG2' ' HB3' ' A' ' 81' ' ' ARG . 13.3 pt20 -115.74 136.45 53.05 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 123.182 0.593 . . . . 73.230000000000004 110.06 -174.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -156.43 128.73 4.07 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 123.021 0.529 . . . . 72.510000000000005 109.764 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.36 -39.74 44.68 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 123.089 2.526 . . . . 64.329999999999998 112.647 -174.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.486 ' HB2' HG12 ' A' ' 117' ' ' ILE . 3.4 m -81.66 -4.18 55.49 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.313 0.645 . . . . 75.510000000000005 110.754 -175.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -99.07 106.9 19.17 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 108.04 -1.096 . . . . 74.329999999999998 108.04 176.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.548 ' HB2' ' HB3' ' A' ' 110' ' ' GLN . 74.4 mt -117.1 141.59 48.07 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.733 -0.84 . . . . 71.510000000000005 108.733 169.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -60.32 -30.5 69.54 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 124.414 1.071 . . . . 72.530000000000001 112.69 -170.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -130.03 39.42 1.82 Allowed Glycine 0 C--N 1.345 1.032 0 N-CA-C 111.697 -0.561 . . . . 73.040000000000006 111.697 -178.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.548 ' HB3' ' HB2' ' A' ' 107' ' ' LEU . 3.0 tp-100 -141.58 74.09 1.44 Allowed 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.338 -0.986 . . . . 72.209999999999994 108.338 178.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -65.31 -22.78 66.87 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 114.895 -1.048 . . . . 74.209999999999994 112.795 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -71.45 -16.97 62.4 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.874 0.47 . . . . 75.239999999999995 112.258 -178.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.7 mt -93.49 -7.13 45.24 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 112.071 0.397 . . . . 73.409999999999997 112.071 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.469 HD11 ' HB2' ' A' ' 25' ' ' TRP . 66.4 mt -71.07 -27.63 63.76 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.612 0.365 . . . . 61.340000000000003 111.368 177.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -76.29 -3.69 38.0 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 112.097 0.406 . . . . 73.150000000000006 112.097 176.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -101.43 -6.96 23.33 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.945 0.898 . . . . 71.519999999999996 109.893 174.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.486 HG12 ' HB2' ' A' ' 105' ' ' CYS . 54.4 mt -87.55 117.33 31.3 Favored 'Isoleucine or valine' 0 C--N 1.354 0.79 0 N-CA-C 107.684 -1.228 . . . . 71.219999999999999 107.684 173.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -106.58 140.26 39.74 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 109.347 -0.612 . . . . 71.129999999999995 109.347 -174.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 . . . . . 0 N--CA 1.482 1.172 0 CA-C-O 121.682 0.753 . . . . 65.129999999999995 111.286 174.611 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 57.2 t . . . . . 0 CA--C 1.548 0.897 0 CA-C-O 118.632 -0.699 . . . . 72.040000000000006 109.136 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -50.26 133.63 36.45 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.886 2.391 . . . . 61.409999999999997 111.868 168.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.42 -38.41 59.03 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.62 1.168 . . . . 64.530000000000001 112.031 -178.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -52.14 -49.22 64.16 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 124.166 0.916 . . . . 73.150000000000006 111.638 174.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.462 HD12 ' HB ' ' A' ' 117' ' ' ILE . 95.2 mt -77.41 -43.14 33.62 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.259 0.624 . . . . 73.319999999999993 112.026 -170.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.0 t -64.35 -41.33 96.81 Favored 'General case' 0 CA--C 1.551 1.017 0 O-C-N 123.22 0.325 . . . . 74.25 110.71 -178.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -77.38 -27.1 52.41 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.9 0.48 . . . . 75.109999999999999 111.114 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.47 ' O ' HG22 ' A' ' 28' ' ' VAL . 60.7 tp -59.16 -50.35 74.39 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.566 0.541 . . . . 75.329999999999998 111.078 172.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.423 ' HH2' ' HG3' ' A' ' 108' ' ' ARG . 34.7 t-105 -63.52 -40.7 97.73 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-N 117.777 0.262 . . . . 74.310000000000002 111.405 177.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.6 m -57.34 -37.08 72.01 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-O 121.579 0.704 . . . . 64.329999999999998 110.402 176.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.414 HD12 ' CD1' ' A' ' 62' ' ' TYR . 35.3 tp -70.58 -45.46 65.35 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.358 1.463 . . . . 74.430000000000007 112.31 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 24' ' ' LEU . 91.8 t -62.02 -35.34 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 123.437 0.695 . . . . 75.420000000000002 111.066 177.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.6 t -90.22 -0.09 57.45 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.944 0.898 . . . . 71.420000000000002 111.809 -177.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -84.36 127.11 67.49 Favored Pre-proline 0 N--CA 1.483 1.191 0 C-N-CA 123.036 0.534 . . . . 60.020000000000003 110.47 -178.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.67 -20.62 17.5 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.743 2.295 . . . . 72.239999999999995 113.306 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -81.54 -22.82 37.61 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.128 0.571 . . . . 65.209999999999994 111.42 -176.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.7 p -111.88 6.73 19.73 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.353 0.661 . . . . 64.239999999999995 112.258 177.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.422 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 0.6 OUTLIER -59.51 -29.75 68.09 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.041 0.537 . . . . 63.43 111.914 -174.357 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.69 -28.66 70.09 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.825 0.85 . . . . 73.340000000000003 112.181 -177.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.462 HD21 ' HB2' ' A' ' 50' ' ' ASP . 87.9 mt -116.21 -9.96 11.53 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.245 0.618 . . . . 75.120000000000005 111.702 -177.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 34' ' ' ASP . 17.3 tt -160.43 118.91 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 121.312 0.577 . . . . 74.420000000000002 110.837 171.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.4 p -148.69 151.78 35.51 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.568 0.747 . . . . 72.0 109.502 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 7.7 p-90 -70.13 152.46 44.28 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.29 0.636 . . . . 75.239999999999995 110.213 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.5 m -71.71 154.3 93.05 Favored Pre-proline 0 CA--C 1.561 1.389 0 C-N-CA 123.818 0.847 . . . . 74.129999999999995 110.097 173.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -40.08 -46.67 4.03 Favored 'Trans proline' 0 C--N 1.389 2.663 0 C-N-CA 124.403 3.402 . . . . 75.519999999999996 114.994 -175.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 30.5 t -80.21 -41.27 25.52 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 122.697 0.399 . . . . 72.540000000000006 110.331 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.82 28.21 7.96 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-N 116.04 -0.527 . . . . 71.230000000000004 113.186 176.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -82.54 -10.69 58.88 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.582 0.753 . . . . 73.310000000000002 110.776 174.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.417 ' HB3' ' HB3' ' A' ' 102' ' ' GLN . 68.2 p -155.72 -176.79 6.13 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 123.741 0.816 . . . . 74.310000000000002 110.135 -177.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -141.95 145.97 35.11 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.376 0.671 . . . . 74.239999999999995 110.191 175.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 54.1 m-70 -97.64 147.66 24.09 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.059 0.944 . . . . 74.150000000000006 108.844 176.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 95.1 t -125.08 123.11 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.689 1.196 . . . . 73.230000000000004 108.095 175.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.451 ' HB2' ' HA ' ' A' ' 36' ' ' LEU . 97.0 m-85 -110.35 147.34 34.13 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.675 0.79 . . . . 72.129999999999995 110.867 -177.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.462 ' HB2' HD21 ' A' ' 36' ' ' LEU . 6.4 m-20 50.52 68.32 0.79 Allowed 'General case' 0 CA--C 1.541 0.62 0 O-C-N 124.922 1.389 . . . . 71.230000000000004 111.812 174.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -47.81 -32.81 6.48 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.729 1.211 . . . . 75.219999999999999 114.036 -173.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.4 -44.86 50.23 Favored Glycine 0 CA--C 1.531 1.07 0 O-C-N 123.397 0.435 . . . . 65.310000000000002 112.706 176.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -74.04 -44.92 52.61 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.554 0.741 . . . . 72.219999999999999 110.182 -176.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.419 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 69.1 t80 -49.56 -50.93 40.26 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.482 1.513 . . . . 74.219999999999999 111.209 169.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 66' ' ' ASN . . . -62.09 -35.52 78.92 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 116.196 -0.456 . . . . 54.399999999999999 111.872 178.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.439 ' HZ3' ' HB3' ' A' ' 57' ' ' GLU . 11.4 tmtt? -68.33 -46.82 69.15 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.27 1.028 . . . . 74.540000000000006 112.642 -175.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.47 ' HG3' HG22 ' A' ' 58' ' ' VAL . 11.9 pt-20 -115.16 -34.84 4.88 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 114.175 1.176 . . . . 72.299999999999997 114.175 -171.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.47 HG22 ' HG3' ' A' ' 57' ' ' GLU . 92.2 t -82.23 -42.27 18.62 Favored 'Isoleucine or valine' 0 C--O 1.247 0.929 0 C-N-CA 123.24 0.616 . . . . 74.420000000000002 110.987 -169.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 43.4 mt -66.02 -48.77 59.74 Favored Pre-proline 0 CA--C 1.558 1.272 0 CA-C-O 117.915 -1.041 . . . . 73.150000000000006 112.363 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -67.63 -13.95 40.49 Favored 'Trans proline' 0 C--N 1.384 2.432 0 CA-C-N 121.934 1.726 . . . . 63.43 113.046 175.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -72.64 -59.03 2.92 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.102 0.561 . . . . 74.200000000000003 110.119 176.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.414 ' CD1' HD12 ' A' ' 27' ' ' LEU . 37.2 m-85 -89.73 -47.99 7.56 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 112.405 0.521 . . . . 75.409999999999997 112.405 -179.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -93.82 -177.92 4.51 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 108.498 -0.927 . . . . 73.349999999999994 108.498 -178.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -116.93 43.79 2.2 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.778 -0.576 . . . . 75.150000000000006 110.159 -173.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 26.9 p80 -165.3 164.0 19.94 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.384 1.074 . . . . 73.409999999999997 108.832 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' A' ' 55' ' ' ALA . 1.5 m-20 -117.38 -12.71 10.42 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.007 0.523 . . . . 71.120000000000005 110.39 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -71.13 122.03 19.38 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.524 0.729 . . . . 72.129999999999995 109.738 178.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.424 ' HB2' ' HB1' ' A' ' 55' ' ' ALA . 22.8 ttt -90.92 -18.66 24.36 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.665 0.386 . . . . 75.019999999999996 111.472 -175.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.06 -37.61 72.07 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.848 0.459 . . . . 55.109999999999999 110.705 173.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.7 t -65.02 -44.04 90.48 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.446 1.098 . . . . 71.409999999999997 110.863 174.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -64.49 -53.24 51.26 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.351 1.06 . . . . 73.319999999999993 111.005 -175.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 66.7 t -63.05 -40.78 90.36 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 123.639 0.776 . . . . 75.120000000000005 111.317 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 -57.96 -38.64 76.37 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.13 0.572 . . . . 75.349999999999994 111.563 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -60.9 -49.67 76.51 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 123.789 0.681 . . . . 74.409999999999997 110.574 175.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 78.3 mt -61.22 -40.5 94.22 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.794 0.838 . . . . 75.340000000000003 111.618 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -57.75 -42.43 83.97 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.954 0.902 . . . . 74.409999999999997 111.454 175.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 70.8 mtm -74.59 -31.02 61.91 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.569 -0.741 . . . . 73.219999999999999 110.96 177.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -82.54 7.02 15.64 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.764 0.825 . . . . 62.25 110.857 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.1 10.37 82.8 Favored Glycine 0 C--N 1.347 1.181 0 N-CA-C 115.026 0.77 . . . . 61.340000000000003 115.026 168.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -71.98 138.49 48.03 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 117.638 0.719 . . . . 73.319999999999993 110.763 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 35.4 ttm-85 -100.45 122.53 43.33 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.927 -0.768 . . . . 74.120000000000005 108.927 -177.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.512 ' HE3' HG21 ' A' ' 99' ' ' THR . 1.3 tmtp? -78.92 123.24 27.07 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.777 1.231 . . . . 71.510000000000005 108.898 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 89.7 t -133.4 117.06 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.639 1.176 . . . . 74.239999999999995 108.058 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.6 p -102.92 126.21 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 109.118 -0.697 . . . . 72.239999999999995 109.118 -176.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 . . . . . 0 N--CA 1.488 1.454 0 C-N-CA 123.254 0.622 . . . . 74.030000000000001 110.626 -174.697 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 . . . . . 0 C--O 1.246 0.88 0 N-CA-C 107.849 -1.167 . . . . 74.140000000000001 107.849 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 5.1 m-20 -80.82 142.99 33.14 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.798 -0.815 . . . . 73.230000000000004 108.798 -179.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -135.67 122.67 21.39 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.343 -0.984 . . . . 75.450000000000003 108.343 167.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.512 HG21 ' HE3' ' A' ' 82' ' ' LYS . 24.1 m -136.9 114.08 10.72 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 109.236 -0.653 . . . . 74.340000000000003 109.236 177.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -103.91 111.88 24.61 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.857 -0.794 . . . . 74.349999999999994 108.857 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -97.26 129.29 44.59 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 109.072 -0.714 . . . . 73.310000000000002 109.072 175.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 19.3 pt20 -123.71 150.06 44.78 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.907 0.883 . . . . 72.120000000000005 109.533 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -156.68 135.55 7.8 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 108.357 -0.979 . . . . 71.319999999999993 108.357 175.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -59.82 -31.16 93.52 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.744 2.296 . . . . 75.030000000000001 112.823 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.492 ' HB2' HG12 ' A' ' 117' ' ' ILE . 5.2 m -92.1 7.75 40.98 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 122.953 0.501 . . . . 51.530000000000001 111.415 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -123.79 101.45 7.28 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 108.297 -1.001 . . . . 75.420000000000002 108.297 174.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 52.8 mt -126.27 174.17 8.75 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.49 0.716 . . . . 72.109999999999999 109.359 173.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.423 ' HG3' ' HH2' ' A' ' 25' ' ' TRP . 71.5 ttt180 -76.35 109.27 9.92 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.696 1.198 . . . . 72.519999999999996 110.84 -177.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.18 35.44 30.22 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 111.578 -0.609 . . . . 63.240000000000002 111.578 -177.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -132.88 42.67 3.05 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.205 -1.035 . . . . 74.129999999999995 108.205 -171.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.61 ' HA ' ' HG ' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -67.51 -21.18 65.5 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 114.134 -1.393 . . . . 72.549999999999997 112.531 -176.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.6 pm0 -72.16 -13.3 61.52 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.943 0.497 . . . . 65.420000000000002 111.713 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.404 ' HA ' HD21 ' A' ' 116' ' ' ASN . 31.9 mt -94.34 -7.4 41.86 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 112.236 0.458 . . . . 72.040000000000006 112.236 173.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.61 ' HG ' ' HA ' ' A' ' 111' ' ' GLU . 44.7 mt -72.12 -27.8 62.86 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 118.006 0.367 . . . . 74.140000000000001 111.63 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -65.34 -19.25 65.87 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.16 0.584 . . . . 73.019999999999996 111.466 173.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.404 HD21 ' HA ' ' A' ' 113' ' ' LEU . 36.3 m-80 -93.77 -10.85 32.81 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.327 0.651 . . . . 75.209999999999994 110.209 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.492 HG12 ' HB2' ' A' ' 105' ' ' CYS . 43.2 mt -84.86 124.83 40.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 108.051 -1.092 . . . . 73.409999999999997 108.051 177.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -126.75 145.98 50.4 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.429 0.691 . . . . 74.400000000000006 109.711 -173.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 . . . . . 0 N--CA 1.474 0.742 0 CA-C-N 115.395 -0.82 . . . . 73.299999999999997 109.236 169.626 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 70.7 t . . . . . 0 CA--C 1.554 1.131 0 CA-C-O 119.28 -0.391 . . . . 72.540000000000006 111.246 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -59.15 139.4 90.25 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 122.937 2.425 . . . . 72.129999999999995 112.039 173.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.7 -39.76 71.47 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.22 1.008 . . . . 52.439999999999998 112.294 -178.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -53.79 -45.86 70.85 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.109 0.564 . . . . 73.530000000000001 111.293 174.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 79.9 mt -76.32 -34.75 59.01 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 119.051 -0.5 . . . . 74.209999999999994 112.31 -172.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.6 t -71.13 -35.25 71.66 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 118.069 0.395 . . . . 73.319999999999993 110.369 177.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.522 ' HA ' ' HE2' ' A' ' 23' ' ' LYS . 8.3 mmpt? -70.63 -42.35 71.02 Favored 'General case' 0 C--N 1.353 0.751 0 C-N-CA 122.813 0.445 . . . . 74.310000000000002 110.678 176.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.407 ' O ' HG22 ' A' ' 28' ' ' VAL . 67.4 tp -59.94 -49.2 78.61 Favored 'General case' 0 N--CA 1.478 0.962 0 O-C-N 124.183 0.927 . . . . 71.219999999999999 111.172 175.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 90.8 t90 -53.99 -51.04 65.19 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.806 1.243 . . . . 75.400000000000006 111.182 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 64.2 m -64.92 -36.45 84.4 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.144 0.978 . . . . 74.25 111.512 177.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 32.2 tp -62.97 -51.04 68.4 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.673 1.189 . . . . 73.239999999999995 111.646 -178.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 24' ' ' LEU . 87.6 t -58.85 -35.69 57.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 124.609 1.164 . . . . 70.209999999999994 111.198 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 83.2 p -92.36 1.94 56.94 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.308 -0.86 . . . . 73.209999999999994 112.534 -174.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -89.98 134.2 32.27 Favored Pre-proline 0 CA--C 1.557 1.245 0 C-N-CA 123.035 0.534 . . . . 74.099999999999994 111.581 -174.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.78 -33.86 26.07 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 123.228 2.618 . . . . 73.129999999999995 114.236 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -70.54 -35.95 73.4 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.114 0.566 . . . . 65.540000000000006 110.916 -176.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.0 p -98.98 -0.02 42.96 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.776 -0.647 . . . . 71.109999999999999 111.208 -177.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -55.42 -32.4 62.67 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.54 1.136 . . . . 62.32 112.337 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.9 -36.52 83.65 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.455 0.702 . . . . 64.319999999999993 112.15 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.421 HD22 ' HB2' ' A' ' 50' ' ' ASP . 85.0 mt -109.07 -8.24 15.21 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.204 0.602 . . . . 74.25 111.48 -175.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.6 tt -160.56 118.3 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.037 0.535 . . . . 75.329999999999998 110.457 174.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 12.7 p -137.41 146.74 44.78 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.525 0.73 . . . . 75.109999999999999 109.75 -176.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 25.2 p-90 -71.24 147.37 48.29 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.013 0.525 . . . . 74.519999999999996 110.888 177.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.1 m -79.74 151.21 73.75 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 108.902 -0.777 . . . . 73.409999999999997 108.902 173.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.83 -19.59 55.17 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.674 2.249 . . . . 74.030000000000001 113.618 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 64.0 m -66.61 -35.64 80.67 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.146 0.578 . . . . 75.099999999999994 111.112 172.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.04 -2.69 74.3 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 115.784 -0.643 . . . . 64.25 113.877 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.445 ' N ' HD21 ' A' ' 44' ' ' ASN . 0.7 OUTLIER -97.55 3.26 50.63 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.116 0.966 . . . . 73.010000000000005 110.022 -179.617 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.3 p -158.03 169.56 24.28 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 123.806 0.842 . . . . 75.409999999999997 110.397 -170.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -150.33 153.38 35.98 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.909 0.884 . . . . 74.109999999999999 110.233 176.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -101.8 144.46 30.44 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.945 0.898 . . . . 74.409999999999997 109.277 176.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 97.8 t -122.75 120.86 61.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 124.928 1.291 . . . . 74.439999999999998 107.612 177.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 91.1 m-85 -106.01 146.84 29.57 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 123.905 0.882 . . . . 75.299999999999997 109.854 -176.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.421 ' HB2' HD22 ' A' ' 36' ' ' LEU . 15.4 m-20 52.36 65.24 1.56 Allowed 'General case' 0 C--N 1.353 0.73 0 O-C-N 124.911 1.382 . . . . 75.230000000000004 111.613 171.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.405 ' HB3' ' HG2' ' A' ' 68' ' ' MET . 85.2 mt-30 -52.72 -28.54 22.47 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 113.096 0.776 . . . . 73.299999999999997 113.096 -173.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -67.84 -48.34 55.61 Favored Glycine 0 C--N 1.344 0.997 0 O-C-N 123.343 0.402 . . . . 63.32 112.155 176.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -73.18 -45.53 55.93 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.31 0.644 . . . . 74.450000000000003 110.278 -178.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -54.04 -51.17 64.9 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.638 1.575 . . . . 71.439999999999998 111.574 176.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.514 ' HB1' ' HB2' ' A' ' 68' ' ' MET . . . -67.41 -29.73 69.3 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.307 0.484 . . . . 75.049999999999997 112.307 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -72.06 -43.21 65.25 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.971 0.909 . . . . 73.019999999999996 111.97 -177.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.524 ' HG3' HG22 ' A' ' 58' ' ' VAL . 7.0 pt-20 -109.02 -45.73 3.73 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 113.182 0.808 . . . . 75.209999999999994 113.182 -176.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.524 HG22 ' HG3' ' A' ' 57' ' ' GLU . 95.8 t -77.03 -42.3 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.42 0.688 . . . . 72.230000000000004 111.674 -167.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.2 mt -64.75 -49.49 69.16 Favored Pre-proline 0 CA--C 1.557 1.219 0 CA-C-O 117.946 -1.026 . . . . 72.200000000000003 112.384 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.93 -7.27 21.03 Favored 'Trans proline' 0 C--N 1.388 2.619 0 CA-C-N 121.743 1.658 . . . . 70.200000000000003 112.846 174.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -79.95 -66.63 0.85 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.112 0.565 . . . . 74.140000000000001 110.81 174.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -79.0 -40.15 32.26 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.257 0.623 . . . . 74.340000000000003 111.53 -176.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -105.06 -169.89 1.67 Allowed 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 108.138 -1.06 . . . . 62.240000000000002 108.138 178.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -126.32 45.26 2.69 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.513 0.673 . . . . 74.530000000000001 110.337 -174.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -159.16 161.78 36.29 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 115.109 -0.951 . . . . 74.219999999999999 108.973 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 55' ' ' ALA . 1.6 m-20 -114.16 -19.8 11.19 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.568 0.347 . . . . 73.230000000000004 111.598 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -71.31 114.15 9.09 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.414 0.286 . . . . 74.129999999999995 111.062 -173.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.514 ' HB2' ' HB1' ' A' ' 55' ' ' ALA . 13.9 tpt -65.82 -37.55 86.54 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.255 1.022 . . . . 75.420000000000002 111.353 -177.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.17 -35.03 72.84 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.148 0.579 . . . . 73.209999999999994 111.168 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.478 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 45.1 t -68.44 -38.73 81.42 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.588 0.755 . . . . 73.030000000000001 111.004 176.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -65.29 -50.91 63.92 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.117 0.967 . . . . 74.439999999999998 110.627 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.5 t -63.41 -36.36 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.444 0.698 . . . . 71.150000000000006 110.059 177.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.9 ttp180 -57.46 -41.54 80.77 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.987 0.915 . . . . 75.340000000000003 110.605 175.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.535 ' HA ' ' HE2' ' A' ' 77' ' ' MET . 26.3 mm-40 -61.89 -47.34 85.44 Favored 'General case' 0 C--N 1.357 0.912 0 N-CA-C 109.644 -0.502 . . . . 73.040000000000006 109.644 177.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.416 ' HB3' ' HB2' ' A' ' 80' ' ' PHE . 89.6 mt -61.91 -38.26 87.73 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.618 0.767 . . . . 75.099999999999994 111.106 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -58.55 -39.87 81.46 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.95 0.9 . . . . 75.5 110.537 174.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.535 ' HE2' ' HA ' ' A' ' 74' ' ' GLN . 48.6 mtm -66.21 -41.7 89.77 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.715 0.406 . . . . 72.239999999999995 110.351 174.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -80.97 2.84 25.16 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.61 0.764 . . . . 75.140000000000001 111.614 -174.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.62 19.76 61.25 Favored Glycine 0 C--N 1.346 1.094 0 N-CA-C 114.761 0.664 . . . . 73.319999999999993 114.761 171.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.416 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 42.0 m-85 -78.15 145.4 35.69 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.123 -0.695 . . . . 74.510000000000005 109.123 176.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -99.46 123.43 43.73 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.682 0.793 . . . . 74.230000000000004 109.035 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -75.62 110.7 10.24 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.031 1.332 . . . . 75.129999999999995 109.278 177.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.6 t -123.19 132.65 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 108.407 -0.96 . . . . 64.030000000000001 108.407 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 85.6 t -125.83 121.37 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.121 0.968 . . . . 74.530000000000001 108.57 175.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 . . . . . 0 N--CA 1.481 1.087 0 C-N-CA 123.122 0.569 . . . . 75.349999999999994 111.343 -177.476 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 . . . . . 0 N--CA 1.469 0.484 0 N-CA-C 108.513 -0.921 . . . . 70.329999999999998 108.513 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 4.1 m-20 -84.31 141.41 30.94 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.612 -0.514 . . . . 71.540000000000006 109.612 175.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -140.9 106.87 5.16 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.957 -1.127 . . . . 74.150000000000006 107.957 169.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 77.4 m -122.57 117.25 25.43 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.377 0.671 . . . . 63.439999999999998 110.486 -178.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -99.46 106.27 18.29 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.842 -0.799 . . . . 74.430000000000007 108.842 -177.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -95.14 122.09 37.45 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.919 -0.771 . . . . 73.450000000000003 108.919 176.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -122.63 144.35 49.18 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.939 0.896 . . . . 73.409999999999997 110.803 -174.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -159.06 131.24 4.25 Favored Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 123.741 0.816 . . . . 74.200000000000003 109.757 176.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.35 -31.49 62.41 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 123.156 2.57 . . . . 54.219999999999999 114.118 -174.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 82.0 m -94.0 8.42 41.46 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 122.384 0.274 . . . . 73.129999999999995 111.438 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -109.02 100.38 9.58 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.823 -1.177 . . . . 74.219999999999999 107.823 173.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.419 ' HB2' ' HB2' ' A' ' 110' ' ' GLN . 80.0 mt -118.35 132.41 56.27 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.306 0.642 . . . . 71.329999999999998 109.501 175.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -66.97 114.26 5.63 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 107.895 -1.15 . . . . 73.120000000000005 107.895 174.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 106.89 -12.86 41.64 Favored Glycine 0 N--CA 1.472 1.04 0 CA-C-O 119.944 -0.365 . . . . 74.430000000000007 113.083 -177.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.419 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 15.6 mm-40 -107.98 79.44 1.27 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 117.374 0.587 . . . . 74.439999999999998 110.305 176.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -59.44 -32.96 70.7 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.307 1.043 . . . . 73.349999999999994 112.563 175.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.9 pm0 -67.32 -26.12 66.35 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.433 0.693 . . . . 72.140000000000001 112.255 -177.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 76.8 mt -86.39 -6.76 58.86 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 122.122 -0.362 . . . . 74.010000000000005 111.571 -175.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 75.8 mt -65.37 -33.84 76.92 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.087 0.555 . . . . 73.299999999999997 111.135 175.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -82.44 -1.54 50.49 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.509 0.324 . . . . 74.239999999999995 111.78 176.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.466 HD21 ' N ' ' A' ' 116' ' ' ASN . 0.7 OUTLIER -92.4 -15.22 27.52 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.457 0.703 . . . . 73.430000000000007 109.407 172.451 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 55.2 mt -82.0 114.27 22.64 Favored 'Isoleucine or valine' 0 C--N 1.355 0.812 0 N-CA-C 108.269 -1.011 . . . . 72.530000000000001 108.269 176.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -103.48 137.43 41.57 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.1 -0.704 . . . . 75.239999999999995 109.1 -176.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 14.3 ptt-85 . . . . . 0 N--CA 1.474 0.751 0 C-N-CA 122.626 0.37 . . . . 74.140000000000001 110.911 176.119 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 66.2 t . . . . . 0 CA--C 1.537 0.455 0 N-CA-C 107.894 -1.15 . . . . 71.040000000000006 107.894 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.511 ' HD2' HD13 ' A' ' 21' ' ' LEU . 50.8 Cg_exo -55.88 142.3 84.44 Favored 'Trans proline' 0 C--N 1.368 1.588 0 C-N-CA 122.346 2.031 . . . . 53.009999999999998 111.856 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.92 -36.93 40.98 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.185 0.928 . . . . 63.109999999999999 111.081 175.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.433 ' HB3' ' HH ' ' A' ' 78' ' ' TYR . 47.4 t80 -55.41 -47.36 76.02 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.901 0.88 . . . . 74.129999999999995 112.028 174.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.511 HD13 ' HD2' ' A' ' 18' ' ' PRO . 55.7 mt -77.88 -35.31 50.97 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.682 0.393 . . . . 74.25 111.932 -172.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.4 t -72.11 -36.03 69.34 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 117.48 0.127 . . . . 75.430000000000007 110.962 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.571 ' HB3' ' HB3' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -69.01 -42.49 76.37 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 122.733 0.413 . . . . 74.200000000000003 109.964 173.672 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.425 ' O ' HG21 ' A' ' 28' ' ' VAL . 63.6 tp -59.46 -40.12 85.84 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.976 0.911 . . . . 63.020000000000003 111.251 176.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 70.6 t-105 -60.97 -53.37 58.14 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 123.275 0.63 . . . . 72.340000000000003 111.452 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.4 m -60.89 -28.85 69.2 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 115.01 -0.995 . . . . 70.400000000000006 110.638 178.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.403 HD11 HG12 ' A' ' 58' ' ' VAL . 30.0 tp -72.78 -50.04 26.89 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.291 1.436 . . . . 72.430000000000007 112.445 -178.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.425 HG21 ' O ' ' A' ' 24' ' ' LEU . 99.3 t -60.18 -29.87 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 123.672 0.789 . . . . 75.219999999999999 111.482 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.6 t -100.56 3.19 42.54 Favored 'General case' 0 CA--C 1.563 1.477 0 C-N-CA 124.062 0.945 . . . . 65.329999999999998 112.313 -176.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -85.38 134.01 41.26 Favored Pre-proline 0 N--CA 1.498 1.969 0 C-N-CA 123.942 0.897 . . . . 73.109999999999999 112.09 -176.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -77.92 -10.41 16.76 Favored 'Trans proline' 0 C--N 1.384 2.425 0 C-N-CA 123.233 2.622 . . . . 62.509999999999998 114.362 -175.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -87.67 -26.02 23.21 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 118.122 0.419 . . . . 63.0 110.446 174.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.6 p -117.07 -1.94 11.8 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.32 0.859 . . . . 74.430000000000007 113.32 -173.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.419 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 9.3 p-10 -62.06 -28.37 69.55 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 118.261 0.482 . . . . 73.549999999999997 111.904 -177.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.7 -25.77 67.46 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.597 0.759 . . . . 74.430000000000007 113.011 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.8 mt -116.0 -5.57 11.98 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.076 0.551 . . . . 75.450000000000003 112.045 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 34' ' ' ASP . 17.7 tt -160.19 115.25 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-O 121.381 0.61 . . . . 74.340000000000003 110.924 173.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 29.7 p -150.45 156.82 42.2 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.982 -0.747 . . . . 64.530000000000001 108.982 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 32.5 p-90 -74.96 152.41 38.79 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.711 0.804 . . . . 74.109999999999999 109.896 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.0 m -76.85 148.47 79.15 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 123.589 0.755 . . . . 72.0 110.401 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.82 -33.36 13.92 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 123.625 2.883 . . . . 75.5 116.102 178.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.1 m -76.83 -32.05 57.32 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.825 0.45 . . . . 64.340000000000003 110.511 175.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.17 -0.31 66.3 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-O 119.593 -0.559 . . . . 71.340000000000003 114.257 171.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -87.91 -1.69 58.14 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.129 0.571 . . . . 70.519999999999996 111.251 -174.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 54.1 p -153.8 177.6 10.82 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.893 0.877 . . . . 71.510000000000005 110.434 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -141.64 149.64 40.92 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.245 0.618 . . . . 74.549999999999997 109.73 170.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -101.43 157.54 16.73 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.273 0.629 . . . . 73.310000000000002 109.371 177.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 98' ' ' ASP . 95.1 t -128.49 124.18 61.28 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 C-N-CA 124.8 1.24 . . . . 75.420000000000002 107.781 173.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -107.84 149.75 27.87 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.54 0.736 . . . . 74.340000000000003 109.891 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.0 t0 44.34 65.69 1.0 Allowed 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 125.486 1.514 . . . . 73.319999999999993 110.878 177.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.633 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 29.4 mt-30 -58.42 -21.04 49.46 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.364 0.876 . . . . 72.439999999999998 113.364 -172.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.54 -46.45 47.7 Favored Glycine 0 C--N 1.346 1.091 0 N-CA-C 112.275 -0.33 . . . . 61.030000000000001 112.275 173.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -69.81 -44.51 69.87 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.523 -0.547 . . . . 74.420000000000002 109.523 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.529 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 54.6 t80 -52.54 -50.96 61.85 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.265 1.426 . . . . 71.120000000000005 111.297 175.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 66' ' ' ASN . . . -59.64 -37.35 78.43 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 121.106 0.479 . . . . 74.349999999999994 111.584 177.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -71.01 -49.26 47.07 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.594 1.158 . . . . 74.140000000000001 113.173 -175.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.488 ' HG3' HG23 ' A' ' 58' ' ' VAL . 6.5 pt-20 -105.81 -36.41 7.04 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 113.429 0.9 . . . . 64.340000000000003 113.429 -172.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.529 ' HB ' ' O ' ' A' ' 54' ' ' PHE . 55.2 t -81.67 -43.82 20.05 Favored 'Isoleucine or valine' 0 C--O 1.251 1.161 0 C-N-CA 123.728 0.811 . . . . 71.030000000000001 111.611 -168.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 55.3 mt -67.2 -44.01 46.9 Favored Pre-proline 0 CA--C 1.553 1.072 0 CA-C-O 118.158 -0.925 . . . . 70.310000000000002 112.639 -178.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -70.6 -10.16 27.31 Favored 'Trans proline' 0 C--N 1.377 2.051 0 CA-C-N 121.833 1.69 . . . . 74.319999999999993 113.527 171.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -75.86 -49.41 18.03 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.275 0.63 . . . . 74.209999999999994 110.693 176.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.571 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 64.9 m-85 -102.34 -34.87 9.03 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 113.752 1.019 . . . . 74.150000000000006 113.752 -178.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -109.84 -177.58 3.31 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 108.904 -0.776 . . . . 63.219999999999999 108.904 -175.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.491 ' HZ2' ' HB3' ' A' ' 64' ' ' LYS . 3.3 mmmp? -111.5 38.07 2.71 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.004 0.522 . . . . 74.420000000000002 110.951 -175.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -158.15 167.29 30.23 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.312 0.645 . . . . 75.439999999999998 109.684 -177.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.418 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 1.9 m-20 -121.33 -7.45 9.27 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.284 0.634 . . . . 74.519999999999996 110.768 176.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -78.7 120.19 23.01 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.119 0.568 . . . . 63.130000000000003 109.995 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.633 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 25.5 ttt -84.3 -18.72 35.39 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 116.79 -0.186 . . . . 75.230000000000004 111.267 -176.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -54.76 -38.74 67.57 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 122.971 0.508 . . . . 70.540000000000006 110.956 174.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.451 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 48.2 t -68.19 -44.67 75.32 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.034 -0.985 . . . . 62.009999999999998 111.188 174.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -59.44 -50.13 75.14 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.218 1.007 . . . . 71.109999999999999 110.46 -175.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.2 t -62.12 -45.91 97.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 114.932 -1.031 . . . . 74.299999999999997 111.119 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 54.2 ttt85 -58.33 -36.67 73.76 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 122.973 0.509 . . . . 74.25 111.516 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 70' ' ' SER . 31.3 mm-40 -61.67 -50.62 71.77 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 123.552 0.532 . . . . 72.349999999999994 109.701 176.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 98.1 mt -62.24 -33.55 74.8 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.628 0.771 . . . . 72.209999999999994 112.015 -177.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -56.9 -45.98 82.26 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 122.981 0.512 . . . . 71.209999999999994 110.866 170.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.444 ' HB3' ' O ' ' A' ' 119' ' ' ARG . 45.0 mtm -69.11 -28.84 66.84 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.294 0.638 . . . . 64.319999999999993 111.138 178.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.433 ' HH ' ' HB3' ' A' ' 20' ' ' PHE . 53.2 m-85 -82.39 2.37 32.8 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.4 0.68 . . . . 71.239999999999995 110.975 175.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.71 1.86 79.73 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-O 119.201 -0.777 . . . . 73.349999999999994 114.405 171.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -72.04 142.45 49.28 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 117.752 0.776 . . . . 73.040000000000006 109.079 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -100.44 131.31 46.43 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.579 -0.526 . . . . 75.25 109.579 -176.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.548 ' HE3' HG22 ' A' ' 84' ' ' VAL . 50.2 tptt -69.59 108.2 3.74 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.417 1.487 . . . . 75.019999999999996 109.328 173.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.489 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 42.5 t -112.98 111.26 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 108.008 -1.108 . . . . 71.430000000000007 108.008 178.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.548 HG22 ' HE3' ' A' ' 82' ' ' LYS . 11.1 t -93.01 101.22 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.854 0.862 . . . . 72.200000000000003 109.004 -172.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 109.324 -0.621 . . . . 72.329999999999998 109.324 178.1 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 . . . . . 0 CA--C 1.554 1.11 0 CA-C-O 121.214 0.53 . . . . 75.099999999999994 110.417 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.515 ' HB2' ' H ' ' A' ' 51' ' ' GLN . 5.8 m-20 -41.41 109.56 0.13 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.007 1.323 . . . . 71.200000000000003 112.142 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.538 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 25.7 t70 -120.74 115.83 24.06 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.307 0.643 . . . . 64.230000000000004 109.882 -178.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.409 HG23 ' HD2' ' A' ' 82' ' ' LYS . 58.4 m -118.43 131.41 56.28 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 123.673 0.789 . . . . 74.420000000000002 109.209 172.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.489 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 42.0 tt0 -105.26 113.52 27.16 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.536 -1.283 . . . . 71.150000000000006 107.536 172.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -96.41 118.86 33.8 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.098 -1.075 . . . . 75.349999999999994 108.098 174.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -115.48 140.54 49.06 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.561 0.744 . . . . 75.319999999999993 110.539 -175.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -158.55 134.07 5.9 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 123.264 0.626 . . . . 74.510000000000005 109.346 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -65.07 -28.42 57.06 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.826 2.351 . . . . 75.430000000000007 112.953 -176.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 33.5 m -96.1 20.37 10.31 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.896 0.479 . . . . 74.209999999999994 110.579 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -127.07 101.13 6.4 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 107.598 -1.26 . . . . 74.519999999999996 107.598 169.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.439 ' HB2' ' HB2' ' A' ' 110' ' ' GLN . 68.8 mt -108.31 170.41 8.03 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 109.323 -0.621 . . . . 72.25 109.323 174.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.77 -31.48 72.67 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 113.972 1.101 . . . . 73.120000000000005 113.972 -168.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -139.51 18.9 3.02 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-O 120.342 -0.143 . . . . 60.119999999999997 113.289 -175.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.439 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 17.4 mp0 -107.79 79.16 1.25 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.363 0.665 . . . . 63.149999999999999 110.041 -176.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -67.98 -27.7 66.8 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.364 1.066 . . . . 73.5 113.437 -177.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -71.28 -5.87 35.52 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.343 0.657 . . . . 64.099999999999994 111.866 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 72.7 mt -89.33 -6.65 56.51 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 122.972 0.509 . . . . 75.150000000000006 111.748 175.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 94.5 mt -68.23 -32.57 72.86 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 122.825 0.45 . . . . 55.329999999999998 111.231 176.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -74.12 -16.53 61.01 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.1 0.56 . . . . 74.230000000000004 111.109 175.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.461 ' N ' HD21 ' A' ' 116' ' ' ASN . 0.7 OUTLIER -79.95 -18.67 49.82 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.12 -0.696 . . . . 75.519999999999996 109.12 177.567 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 27.5 mt -98.51 122.27 50.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.667 0 C-N-CA 124.196 0.999 . . . . 74.409999999999997 108.677 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -113.07 153.47 28.11 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 108.98 -0.748 . . . . 74.140000000000001 108.98 176.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.444 ' O ' ' HB3' ' A' ' 77' ' ' MET . 13.3 ptp180 . . . . . 0 N--CA 1.483 1.209 0 CA-C-O 121.038 0.446 . . . . 74.120000000000005 110.029 175.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 74.0 t . . . . . 0 CA--C 1.554 1.101 0 CA-C-O 119.361 -0.352 . . . . 65.420000000000002 110.906 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.495 ' HD2' HD13 ' A' ' 21' ' ' LEU . 87.7 Cg_exo -52.77 143.46 47.55 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 123.537 2.825 . . . . 71.540000000000006 113.328 172.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.36 -40.29 64.84 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.373 1.069 . . . . 73.439999999999998 111.944 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -54.64 -48.94 71.66 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.177 0.591 . . . . 73.209999999999994 111.425 173.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.495 HD13 ' HD2' ' A' ' 18' ' ' PRO . 85.1 mt -75.36 -34.28 61.14 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 111.876 0.324 . . . . 72.010000000000005 111.876 -170.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.0 t -68.59 -38.83 80.96 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 117.579 0.172 . . . . 65.319999999999993 110.935 175.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.494 ' HE3' ' HA ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -67.22 -42.09 84.64 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 122.412 0.285 . . . . 70.230000000000004 110.659 175.291 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.9 tp -58.32 -52.41 65.7 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.018 0.927 . . . . 75.310000000000002 111.822 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 84.3 t90 -56.62 -47.87 78.74 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.777 0.831 . . . . 74.510000000000005 111.107 -178.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 36.2 m -61.23 -37.03 81.6 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.998 -1.001 . . . . 73.109999999999999 111.159 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.4 ' HG ' HD12 ' A' ' 37' ' ' ILE . 41.2 tp -68.49 -44.75 74.06 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.414 1.085 . . . . 70.129999999999995 111.757 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.5 t -63.53 -42.26 95.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.1 0.96 . . . . 74.450000000000003 110.67 177.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.1 t -80.74 0.12 36.0 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-N 115.254 -0.884 . . . . 75.340000000000003 111.639 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -86.41 125.62 67.06 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.707 0.803 . . . . 73.439999999999998 110.639 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -82.84 -10.29 10.58 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.919 2.413 . . . . 75.230000000000004 114.177 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -82.49 -30.42 29.89 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.136 0.575 . . . . 70.519999999999996 111.455 -178.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 50.7 p -100.4 7.8 44.03 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.837 0.455 . . . . 73.219999999999999 110.659 -177.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.413 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 7.0 p-10 -58.3 -22.94 54.77 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.934 1.294 . . . . 74.219999999999999 112.897 -175.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.21 -38.22 82.65 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.803 0.841 . . . . 72.209999999999994 112.264 177.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 57.0 mt -117.66 -10.38 10.57 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.94 0.496 . . . . 74.549999999999997 111.954 -178.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 34' ' ' ASP . 17.1 tt -158.64 122.42 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-O 121.365 0.602 . . . . 74.219999999999999 111.913 175.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 53.8 t -152.39 158.95 43.41 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.666 0.786 . . . . 63.539999999999999 109.761 176.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 13.2 p-90 -70.82 153.23 42.93 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.669 0.788 . . . . 74.420000000000002 110.877 176.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.8 m -73.2 154.61 90.37 Favored Pre-proline 0 CA--C 1.553 1.077 0 CA-C-O 118.058 -0.972 . . . . 74.340000000000003 109.182 170.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -42.92 -31.34 2.18 Favored 'Trans proline' 0 C--N 1.388 2.617 0 C-N-CA 124.091 3.194 . . . . 64.209999999999994 115.821 -175.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 79.6 p -76.25 -49.51 16.87 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.972 0.509 . . . . 61.340000000000003 110.923 175.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.8 13.49 23.66 Favored Glycine 0 C--N 1.352 1.443 0 CA-C-N 115.606 -0.724 . . . . 52.340000000000003 113.557 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -94.5 -11.08 30.33 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.046 0.538 . . . . 64.019999999999996 111.137 -175.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.6 p -147.2 170.15 17.85 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.24 1.016 . . . . 74.349999999999994 109.146 -176.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -144.15 155.43 43.92 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.86 0.464 . . . . 70.430000000000007 110.798 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.408 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 52.6 m-70 -112.11 150.04 31.29 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.202 1.001 . . . . 63.039999999999999 109.32 -176.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.453 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 84.5 t -126.42 139.01 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 108.452 -0.944 . . . . 73.329999999999998 108.452 176.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -125.48 146.3 49.7 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.552 0.741 . . . . 73.019999999999996 109.061 176.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.4 t70 45.34 76.69 0.09 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.709 1.603 . . . . 70.219999999999999 112.019 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.622 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 53.3 mt-30 -51.05 -29.64 13.39 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.306 1.042 . . . . 70.329999999999998 113.023 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.99 -49.53 40.69 Favored Glycine 0 C--N 1.348 1.234 0 O-C-N 123.308 0.38 . . . . 72.120000000000005 112.835 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -75.16 -40.97 59.09 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.396 0.679 . . . . 72.030000000000001 110.222 -176.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -56.81 -48.84 77.05 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.282 1.433 . . . . 74.120000000000005 110.779 175.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.415 ' HA ' ' HG ' ' A' ' 59' ' ' LEU . . . -65.97 -28.84 69.2 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.19 0.441 . . . . 62.340000000000003 112.19 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -72.38 -46.35 55.71 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.797 0.839 . . . . 74.030000000000001 112.107 -177.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.515 ' HG3' HG23 ' A' ' 58' ' ' VAL . 7.1 pt-20 -110.11 -40.4 4.73 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 113.542 0.941 . . . . 75.099999999999994 113.542 -173.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.515 HG23 ' HG3' ' A' ' 57' ' ' GLU . 73.9 t -80.05 -43.24 22.39 Favored 'Isoleucine or valine' 0 C--O 1.252 1.189 0 C-N-CA 123.064 0.545 . . . . 75.329999999999998 111.51 -168.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.486 HD13 ' HE1' ' A' ' 68' ' ' MET . 35.1 mt -63.06 -50.9 74.13 Favored Pre-proline 0 CA--C 1.558 1.28 0 CA-C-O 117.993 -1.003 . . . . 74.510000000000005 112.445 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.86 -12.91 36.92 Favored 'Trans proline' 0 C--N 1.389 2.695 0 C-N-CA 121.884 1.723 . . . . 75.140000000000001 113.138 177.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -74.43 -60.64 2.18 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 122.941 0.497 . . . . 73.010000000000005 110.306 177.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -85.34 -55.9 3.79 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 116.312 -0.403 . . . . 74.209999999999994 110.852 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -86.37 179.75 6.82 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 109.32 -0.622 . . . . 74.420000000000002 109.32 -176.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -113.07 38.97 2.67 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 121.526 0.679 . . . . 73.319999999999993 110.044 -171.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -162.6 163.95 26.95 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.936 -1.029 . . . . 74.420000000000002 109.301 -176.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -114.06 -7.89 13.06 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.173 0.589 . . . . 73.310000000000002 110.015 175.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -68.79 109.06 3.67 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.598 0.759 . . . . 72.200000000000003 111.0 -177.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.622 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 1.1 tpt -56.32 -39.76 73.29 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.498 1.119 . . . . 73.230000000000004 110.362 170.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.55 -41.54 66.56 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 124.548 1.155 . . . . 75.120000000000005 112.077 176.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.4 t -67.69 -41.39 83.71 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.631 0.772 . . . . 75.019999999999996 111.662 177.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -65.83 -52.37 51.1 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.465 0.706 . . . . 74.340000000000003 110.665 -176.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 95.4 t -61.11 -42.11 91.95 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-N 115.19 -0.914 . . . . 72.549999999999997 110.93 176.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -55.8 -46.9 77.92 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.564 0.746 . . . . 75.120000000000005 111.175 176.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -55.99 -55.57 31.13 Favored 'General case' 0 C--N 1.349 0.573 0 O-C-N 124.254 0.971 . . . . 72.439999999999998 110.417 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.4 mt -61.21 -42.41 98.54 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 124.15 0.906 . . . . 75.120000000000005 112.018 -175.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -59.19 -39.98 84.27 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.312 0.645 . . . . 74.150000000000006 111.368 175.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 57.2 mtm -73.86 -31.22 63.06 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.385 0.274 . . . . 72.409999999999997 110.795 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -79.38 3.51 18.12 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.71 0.804 . . . . 74.430000000000007 111.668 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.08 14.06 79.92 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-O 119.428 -0.651 . . . . 73.439999999999998 113.921 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -74.26 138.85 43.89 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 109.275 -0.639 . . . . 74.129999999999995 109.275 175.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -100.81 124.14 46.02 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.337 -0.616 . . . . 74.230000000000004 109.337 178.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.553 ' HE2' ' HB ' ' A' ' 84' ' ' VAL . 1.3 tmtp? -78.64 131.04 36.53 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.268 1.027 . . . . 74.530000000000001 108.934 177.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.2 t -129.97 122.66 54.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 107.472 -1.307 . . . . 74.430000000000007 107.472 175.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.553 ' HB ' ' HE2' ' A' ' 82' ' ' LYS . 6.5 p -99.14 124.87 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 109.226 -0.657 . . . . 74.219999999999999 109.226 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 . . . . . 0 N--CA 1.478 0.96 0 C-N-CA 123.069 0.548 . . . . 75.040000000000006 109.994 -177.703 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 . . . . . 0 CA--C 1.54 0.574 0 CA-C-O 122.182 0.992 . . . . 73.400000000000006 108.584 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -44.26 128.64 6.17 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 113.73 -1.577 . . . . 73.310000000000002 111.16 175.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -96.65 108.0 20.54 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.764 -0.828 . . . . 75.329999999999998 108.764 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.453 ' HB ' ' HB ' ' A' ' 48' ' ' VAL . 3.8 m -100.26 95.14 6.59 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 108.206 -1.035 . . . . 55.25 108.206 174.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -91.35 141.52 28.68 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.153 -1.054 . . . . 72.25 108.153 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -124.75 125.5 44.16 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.24 -1.022 . . . . 65.420000000000002 108.24 173.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -116.87 149.43 40.09 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.317 0.647 . . . . 73.340000000000003 110.083 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -162.96 127.92 2.07 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 108.936 -0.764 . . . . 72.099999999999994 108.936 174.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.3 -31.14 81.86 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 122.726 2.284 . . . . 73.329999999999998 113.355 -174.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 36.2 m -88.84 3.07 52.45 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 122.735 0.414 . . . . 73.209999999999994 111.466 -178.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -101.02 99.63 10.11 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.216 -1.401 . . . . 71.150000000000006 107.216 172.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 110' ' ' GLN . 87.5 mt -119.92 129.67 54.45 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.244 0.618 . . . . 72.319999999999993 109.349 176.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -72.05 93.18 1.37 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 107.641 -1.244 . . . . 74.25 107.641 174.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 145.45 -55.55 0.54 Allowed Glycine 0 C--N 1.33 0.213 0 N-CA-C 109.193 -1.563 . . . . 73.109999999999999 109.193 -173.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.523 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 2.6 mp0 -88.46 76.07 8.31 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.602 0.761 . . . . 75.420000000000002 110.181 176.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.68 -17.48 60.67 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.231 0.612 . . . . 55.549999999999997 112.036 175.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 19.3 pm0 -69.55 -21.72 63.61 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 111.494 0.183 . . . . 73.430000000000007 111.494 175.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.0 mt -80.04 -5.93 56.71 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.775 0.43 . . . . 73.530000000000001 112.125 -177.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 68.8 mt -69.97 -23.16 63.13 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.246 0.618 . . . . 71.200000000000003 111.944 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -81.13 -2.11 47.1 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 112.378 0.511 . . . . 72.120000000000005 112.378 176.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -90.32 -12.99 36.13 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 109.066 -0.716 . . . . 75.340000000000003 109.066 170.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 18.7 mt -93.19 121.3 43.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 107.79 -1.189 . . . . 75.329999999999998 107.79 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.81 168.57 18.49 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.067 0.46 . . . . 75.400000000000006 111.062 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 . . . . . 0 N--CA 1.468 0.471 0 C-N-CA 123.999 0.919 . . . . 75.109999999999999 109.668 -172.526 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 70.8 t . . . . . 0 CA--C 1.544 0.748 0 CA-C-O 118.804 -0.617 . . . . 73.510000000000005 110.37 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.36 145.74 34.97 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.897 2.398 . . . . 64.319999999999993 111.863 174.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.99 -40.73 67.2 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.751 0.82 . . . . 75.209999999999994 111.968 -176.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.412 ' HA ' ' HE1' ' A' ' 63' ' ' PHE . 54.1 t80 -53.25 -49.43 66.89 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.74 0.816 . . . . 75.349999999999994 111.851 173.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 92.5 mt -77.72 -31.07 52.06 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.007 0.523 . . . . 61.109999999999999 112.303 -170.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.5 t -76.02 -34.23 59.69 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 117.586 0.176 . . . . 75.420000000000002 110.973 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.15 -39.66 71.81 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.611 0.364 . . . . 71.549999999999997 110.035 174.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.466 ' O ' HG21 ' A' ' 28' ' ' VAL . 53.4 tp -61.85 -43.41 98.9 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 124.152 0.908 . . . . 72.319999999999993 110.801 174.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.486 ' CE3' HD11 ' A' ' 114' ' ' LEU . 70.9 t-105 -56.66 -47.7 79.21 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.234 1.013 . . . . 73.540000000000006 110.947 177.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.3 m -63.36 -42.66 98.9 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.03 -0.987 . . . . 71.239999999999995 110.949 174.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.8 tp -62.21 -53.24 58.07 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.386 1.474 . . . . 71.409999999999997 112.528 -172.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.466 HG21 ' O ' ' A' ' 24' ' ' LEU . 24.8 t -58.76 -33.85 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 C-N-CA 123.095 0.558 . . . . 74.030000000000001 111.41 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.0 t -87.11 -16.08 36.56 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.087 0.955 . . . . 65.409999999999997 111.647 -176.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -76.12 127.05 85.91 Favored Pre-proline 0 N--CA 1.481 1.089 0 C-N-CA 122.76 0.424 . . . . 64.25 111.115 -172.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.13 -30.64 46.56 Favored 'Trans proline' 0 C--N 1.385 2.467 0 C-N-CA 123.195 2.597 . . . . 73.310000000000002 114.543 -175.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -65.06 -38.32 90.44 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.438 0.637 . . . . 71.5 110.594 178.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.4 p -101.34 -2.02 32.01 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.922 -1.035 . . . . 74.319999999999993 111.542 -175.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -57.9 -35.97 71.78 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.513 1.125 . . . . 71.239999999999995 111.391 -178.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.43 -38.78 66.69 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.368 -0.833 . . . . 62.240000000000002 111.783 178.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.419 ' HA ' ' HB2' ' A' ' 49' ' ' PHE . 79.4 mt -98.24 -25.6 14.82 Favored 'General case' 0 C--O 1.213 -0.819 0 C-N-CA 123.08 0.552 . . . . 72.329999999999998 111.072 -178.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 47' ' ' HIS . 19.8 tt -149.48 116.04 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 O-C-N 121.251 -0.905 . . . . 72.120000000000005 111.231 -176.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 9.0 p -142.86 150.38 39.79 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.611 0.764 . . . . 74.219999999999999 110.62 -171.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -70.12 150.21 46.78 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.537 0.735 . . . . 72.5 110.307 176.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 56.3 p -71.66 155.93 91.83 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 122.995 0.518 . . . . 72.209999999999994 109.616 167.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -52.93 -29.47 43.95 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.612 2.208 . . . . 75.25 112.763 173.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.7 m -76.11 -38.02 57.39 Favored 'General case' 0 C--N 1.352 0.709 0 C-N-CA 123.088 0.555 . . . . 73.310000000000002 110.906 175.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.602 ' HA3' ' HD2' ' A' ' 108' ' ' ARG . . . 78.95 20.83 69.55 Favored Glycine 0 C--N 1.344 1.009 0 O-C-N 123.358 0.411 . . . . 71.030000000000001 113.24 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -95.24 -17.43 21.71 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.823 0.849 . . . . 75.299999999999997 109.988 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.6 p -142.48 168.84 18.79 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 123.806 0.842 . . . . 74.120000000000005 109.72 -174.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -143.05 147.22 34.7 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.79 0.436 . . . . 71.230000000000004 110.404 175.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.412 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 13.9 m-70 -104.15 142.55 34.29 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.154 0.982 . . . . 65.310000000000002 109.343 -178.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.2 t -124.18 125.78 71.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 108.06 -1.089 . . . . 62.450000000000003 108.06 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.462 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 79.9 m-85 -108.8 145.16 35.65 Favored 'General case' 0 C--O 1.247 0.941 0 C-N-CA 124.662 1.185 . . . . 75.430000000000007 109.067 -174.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 47.78 76.42 0.11 Allowed 'General case' 0 CA--C 1.542 0.669 0 O-C-N 124.561 1.163 . . . . 73.340000000000003 112.365 173.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.519 ' HG2' ' HB2' ' A' ' 97' ' ' ASP . 5.2 mm-40 -52.78 -29.49 27.72 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.735 -0.666 . . . . 75.510000000000005 112.173 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.99 -50.95 49.16 Favored Glycine 0 C--N 1.345 1.049 0 O-C-N 123.492 0.495 . . . . 62.509999999999998 112.894 174.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -70.14 -46.51 64.58 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.647 0.379 . . . . 73.120000000000005 110.62 -177.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.442 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 61.1 t80 -53.68 -50.88 64.87 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.169 1.388 . . . . 74.040000000000006 111.132 176.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.528 ' HB3' ' HB2' ' A' ' 68' ' ' MET . . . -59.48 -35.27 73.8 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.849 0.685 . . . . 74.310000000000002 112.849 177.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.56 -47.07 51.14 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.069 0.948 . . . . 75.129999999999995 112.406 -176.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.493 ' HG3' HG23 ' A' ' 58' ' ' VAL . 6.5 pt-20 -102.36 -43.03 5.8 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 112.664 0.616 . . . . 74.25 112.664 -173.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.493 HG23 ' HG3' ' A' ' 57' ' ' GLU . 55.8 t -79.33 -47.2 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.386 0.674 . . . . 73.319999999999993 111.418 -168.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.2 mt -65.36 -46.65 70.76 Favored Pre-proline 0 CA--C 1.561 1.39 0 N-CA-C 113.239 0.829 . . . . 74.299999999999997 113.239 -174.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.37 -16.0 49.93 Favored 'Trans proline' 0 C--N 1.387 2.584 0 CA-C-N 121.901 1.715 . . . . 74.109999999999999 113.031 173.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -79.67 -62.32 1.72 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 123.999 0.92 . . . . 73.049999999999997 111.584 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -84.97 -24.33 28.35 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 122.974 0.509 . . . . 74.519999999999996 111.642 -176.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.412 ' HE1' ' HA ' ' A' ' 20' ' ' PHE . 41.0 m-85 -122.65 -169.24 1.87 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.223 -1.028 . . . . 71.310000000000002 108.223 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -127.64 45.14 2.79 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.867 0.842 . . . . 71.129999999999995 110.334 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -154.51 156.12 36.1 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.649 1.18 . . . . 74.120000000000005 107.965 176.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.517 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 1.6 m-20 -108.43 -16.08 14.31 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 109.723 -0.473 . . . . 74.400000000000006 109.723 176.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -66.52 115.3 6.25 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.346 0.658 . . . . 52.310000000000002 110.994 -176.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.528 ' HB2' ' HB3' ' A' ' 55' ' ' ALA . 12.1 tpt -73.26 -33.78 65.46 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.781 0.832 . . . . 75.299999999999997 111.29 -177.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.3 -35.64 65.31 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.097 0.559 . . . . 75.400000000000006 111.282 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.519 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 44.1 t -66.13 -46.59 77.0 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.171 0.988 . . . . 72.019999999999996 110.944 176.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -62.26 -53.26 57.78 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.011 0.924 . . . . 73.120000000000005 110.682 -176.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.5 t -62.78 -37.63 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 115.449 -0.796 . . . . 71.239999999999995 111.087 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -59.88 -38.02 81.02 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.312 0.645 . . . . 74.340000000000003 111.347 177.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 70' ' ' SER . 81.1 mm-40 -60.19 -48.28 82.4 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 109.346 -0.612 . . . . 74.340000000000003 109.346 176.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.427 ' HA ' ' HB2' ' A' ' 78' ' ' TYR . 93.6 mt -63.77 -36.36 83.61 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.063 0.945 . . . . 74.099999999999994 111.498 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -60.29 -42.46 95.54 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.388 0.675 . . . . 72.140000000000001 110.972 173.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 72.1 mtm -76.14 -21.32 56.71 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.723 -0.671 . . . . 74.340000000000003 110.677 176.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.427 ' HB2' ' HA ' ' A' ' 75' ' ' LEU . 26.6 m-85 -83.04 -4.09 57.97 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.572 0.749 . . . . 71.329999999999998 111.414 173.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.62 17.7 77.04 Favored Glycine 0 C--N 1.347 1.17 0 N-CA-C 114.433 0.533 . . . . 73.340000000000003 114.433 174.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -66.59 154.36 40.66 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.427 0.691 . . . . 73.230000000000004 110.436 177.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -99.73 122.55 42.89 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.564 0.746 . . . . 74.25 109.199 -178.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.562 ' HE2' ' HB ' ' A' ' 84' ' ' VAL . 21.0 tptm -77.08 123.76 26.84 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.841 1.256 . . . . 73.409999999999997 109.557 177.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.469 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 47.5 t -126.21 109.29 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 N-CA-C 108.103 -1.073 . . . . 75.420000000000002 108.103 170.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.562 ' HB ' ' HE2' ' A' ' 82' ' ' LYS . 5.1 p -90.45 123.9 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.445 0.698 . . . . 74.219999999999999 109.599 -179.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 . . . . . 0 N--CA 1.481 1.101 0 C-N-CA 123.063 0.545 . . . . 75.519999999999996 111.713 -176.201 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 . . . . . 0 N--CA 1.47 0.526 0 N-CA-C 109.467 -0.568 . . . . 74.010000000000005 109.467 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.519 ' HB2' ' HG2' ' A' ' 51' ' ' GLN . 5.9 m-20 -103.53 145.02 30.64 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.77 -0.826 . . . . 72.329999999999998 108.77 165.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -129.64 112.54 13.78 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.466 -1.309 . . . . 75.319999999999993 107.466 168.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 41.2 m -123.32 118.71 28.15 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.167 0.987 . . . . 74.049999999999997 109.623 -175.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.469 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 41.2 tt0 -102.18 110.85 22.92 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.155 0.982 . . . . 74.409999999999997 108.628 -179.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -97.67 132.76 43.02 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.801 -0.815 . . . . 74.040000000000006 108.801 173.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -139.02 145.99 40.32 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.772 0.829 . . . . 65.120000000000005 109.305 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -149.3 136.88 11.29 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 109.025 -0.731 . . . . 75.450000000000003 109.025 -177.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -59.02 -34.82 99.23 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 122.692 2.261 . . . . 73.409999999999997 112.725 -177.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 15.7 m -89.63 14.32 11.93 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.223 0.609 . . . . 45.530000000000001 111.007 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -122.67 98.82 6.09 Favored 'General case' 0 C--O 1.245 0.838 0 N-CA-C 107.799 -1.185 . . . . 74.129999999999995 107.799 174.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 91.5 mt -131.4 151.78 51.23 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.386 1.075 . . . . 74.530000000000001 109.426 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.602 ' HD2' ' HA3' ' A' ' 43' ' ' GLY . 16.1 ptm180 -63.17 112.39 2.64 Favored 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 124.194 0.998 . . . . 72.439999999999998 111.484 -178.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.96 -8.22 63.12 Favored Glycine 0 N--CA 1.472 1.08 0 CA-C-N 116.388 -0.369 . . . . 71.310000000000002 113.585 -178.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.481 ' N ' HE21 ' A' ' 110' ' ' GLN . 0.0 OUTLIER -102.75 71.73 1.18 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 117.641 0.721 . . . . 74.200000000000003 111.034 -177.662 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.482 ' HA ' ' HG ' ' A' ' 114' ' ' LEU . 9.4 pt-20 -70.29 -26.06 63.63 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.658 -0.701 . . . . 74.329999999999998 111.679 170.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.4 pm0 -65.05 -15.15 62.03 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.708 0.803 . . . . 72.019999999999996 112.193 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 79.9 mt -95.14 -17.88 21.42 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.147 0.579 . . . . 73.200000000000003 111.764 176.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.486 HD11 ' CE3' ' A' ' 25' ' ' TRP . 80.4 mt -67.87 -37.72 82.16 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.246 0.619 . . . . 73.239999999999995 110.992 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -64.12 -14.51 55.35 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.246 -0.888 . . . . 71.340000000000003 112.429 174.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -101.2 -2.4 31.39 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.6 0.76 . . . . 75.230000000000004 110.682 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 37.0 mt -92.81 113.33 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 106.995 -1.483 . . . . 74.299999999999997 106.995 173.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.448 ' HE2' ' HA ' ' A' ' 118' ' ' LYS . 9.8 mmpt? -115.77 145.05 43.14 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.04 0.536 . . . . 75.120000000000005 111.254 -169.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 30.6 ptt85 . . . . . 0 N--CA 1.478 0.959 0 N-CA-C 108.247 -1.02 . . . . 72.409999999999997 108.247 168.608 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.4 t . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 119.386 -0.34 . . . . 73.099999999999994 110.677 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.28 141.84 94.23 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.618 2.212 . . . . 75.310000000000002 111.123 174.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.47 -40.5 62.39 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.814 0.845 . . . . 75.319999999999993 111.36 176.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -50.45 -47.78 56.71 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 124.248 0.967 . . . . 75.549999999999997 112.961 173.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 90.3 mt -83.68 -26.19 30.05 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.816 0.447 . . . . 72.219999999999999 110.402 -170.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.7 m -66.11 -45.22 81.93 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 124.154 0.982 . . . . 71.340000000000003 110.983 171.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.444 ' HA ' ' HE2' ' A' ' 23' ' ' LYS . 10.6 mmpt? -67.18 -44.72 78.95 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.726 0.41 . . . . 74.310000000000002 110.153 176.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.5 tp -56.11 -53.23 59.59 Favored 'General case' 0 C--N 1.356 0.876 0 O-C-N 124.483 1.114 . . . . 74.150000000000006 111.47 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.527 ' HH2' ' HG3' ' A' ' 108' ' ' ARG . 8.3 t-105 -59.37 -49.26 78.52 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 122.942 0.497 . . . . 74.530000000000001 111.832 -178.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.5 m -62.1 -28.05 69.35 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 122.805 0.442 . . . . 70.439999999999998 111.291 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.462 ' HG ' HD12 ' A' ' 37' ' ' ILE . 24.0 tp -74.37 -44.45 52.15 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.203 1.001 . . . . 74.5 111.793 176.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.2 t -61.87 -36.74 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.881 0.872 . . . . 72.040000000000006 110.401 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 88.4 p -90.34 10.8 23.51 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.842 0.857 . . . . 75.420000000000002 111.736 -177.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -90.86 116.42 66.38 Favored Pre-proline 0 CA--C 1.56 1.36 0 C-N-CA 123.052 0.541 . . . . 72.049999999999997 110.675 175.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.69 -7.81 16.76 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 123.256 2.637 . . . . 74.25 113.156 177.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -85.55 -25.72 26.59 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.689 0.795 . . . . 75.019999999999996 111.509 177.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 40.9 p -106.32 9.34 31.97 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.84 0.456 . . . . 75.120000000000005 111.122 178.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -57.85 -30.39 65.75 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 113.381 0.882 . . . . 72.140000000000001 113.381 -170.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -69.06 -24.08 64.12 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.574 0.583 . . . . 65.430000000000007 112.574 -176.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.468 HD22 ' HB2' ' A' ' 50' ' ' ASP . 77.4 mt -115.13 -18.17 11.23 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.2 0.6 . . . . 64.109999999999999 111.056 -178.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.462 HD12 ' HG ' ' A' ' 27' ' ' LEU . 14.9 tt -160.94 123.86 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.234 0.613 . . . . 75.099999999999994 110.231 171.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 23.2 p -150.55 161.69 42.07 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.159 0.584 . . . . 72.319999999999993 110.433 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 38.4 p-90 -73.33 147.27 44.58 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 124.048 0.842 . . . . 75.120000000000005 109.47 172.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.2 m -75.64 149.62 83.69 Favored Pre-proline 0 CA--C 1.548 0.9 0 N-CA-C 108.348 -0.982 . . . . 71.219999999999999 108.348 171.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.77 -28.43 23.05 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 123.101 2.534 . . . . 75.150000000000006 114.25 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.0 m -73.71 -24.8 59.97 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.309 0.644 . . . . 63.409999999999997 111.946 177.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.24 0.84 90.13 Favored Glycine 0 C--N 1.342 0.889 0 C-N-CA 123.129 0.395 . . . . 41.119999999999997 113.649 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -82.27 -25.4 34.07 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.727 0.811 . . . . 72.439999999999998 111.036 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.9 p -146.96 178.99 7.91 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.358 0.663 . . . . 74.120000000000005 110.311 -169.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.406 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 42.1 p90 -146.63 143.85 29.09 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.711 0.404 . . . . 70.340000000000003 110.985 178.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -103.33 151.71 22.41 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.23 0.612 . . . . 74.099999999999994 109.464 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 98' ' ' ASP . 95.5 t -124.23 132.13 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.363 1.065 . . . . 71.329999999999998 108.349 176.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -116.07 148.77 39.89 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.835 0.854 . . . . 71.25 109.604 178.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.468 ' HB2' HD22 ' A' ' 36' ' ' LEU . 20.8 m-20 53.16 63.44 2.23 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 124.692 1.245 . . . . 74.230000000000004 111.259 170.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -50.12 -33.35 18.48 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.181 0.993 . . . . 74.430000000000007 113.33 -172.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.64 -43.99 90.76 Favored Glycine 0 CA--C 1.533 1.196 0 O-C-N 123.412 0.445 . . . . 65.409999999999997 112.441 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -74.11 -45.48 48.78 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.392 0.677 . . . . 71.340000000000003 110.059 -178.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.442 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 39.1 t80 -50.51 -52.27 39.93 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.28 1.432 . . . . 75.209999999999994 111.494 174.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.2 -36.32 81.57 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.657 -0.701 . . . . 74.540000000000006 111.577 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -66.81 -46.92 73.65 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.85 0.86 . . . . 74.549999999999997 112.85 -175.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.493 ' HG3' HG22 ' A' ' 58' ' ' VAL . 11.1 pt-20 -113.07 -33.9 5.88 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 114.292 1.219 . . . . 74.420000000000002 114.292 -171.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.493 HG22 ' HG3' ' A' ' 57' ' ' GLU . 91.9 t -82.83 -45.03 19.24 Favored 'Isoleucine or valine' 0 C--O 1.253 1.286 0 C-N-CA 123.71 0.804 . . . . 64.129999999999995 111.938 -170.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.6 mt -64.59 -46.55 77.03 Favored Pre-proline 0 CA--C 1.557 1.231 0 CA-C-O 118.095 -0.955 . . . . 75.329999999999998 112.766 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.432 ' HG3' ' ND2' ' A' ' 66' ' ' ASN . 41.7 Cg_endo -67.2 -15.21 45.64 Favored 'Trans proline' 0 C--N 1.381 2.262 0 CA-C-N 121.954 1.733 . . . . 73.109999999999999 113.105 174.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -73.14 -50.6 21.8 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.58 0.752 . . . . 75.010000000000005 110.489 176.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.422 ' CD1' HD13 ' A' ' 27' ' ' LEU . 37.0 m-85 -92.76 -51.88 4.88 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 112.594 0.59 . . . . 74.299999999999997 112.594 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -90.87 -172.03 3.22 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.885 -0.783 . . . . 65.140000000000001 108.885 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -118.47 40.66 3.16 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 121.313 0.578 . . . . 65.420000000000002 110.397 -174.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -162.25 164.66 27.53 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.193 -0.912 . . . . 72.109999999999999 109.246 -177.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.432 ' ND2' ' HG3' ' A' ' 60' ' ' PRO . 13.1 m120 -106.24 -33.98 7.63 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.356 0.663 . . . . 72.420000000000002 109.864 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -62.97 127.09 29.62 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.31 0.644 . . . . 72.140000000000001 112.522 -173.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 25.7 ttt -88.16 -23.69 23.55 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.97 0.508 . . . . 75.340000000000003 111.365 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.42 -38.37 77.28 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 121.424 0.63 . . . . 74.040000000000006 111.211 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.411 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 22.8 t -68.89 -40.39 79.21 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.593 1.157 . . . . 74.340000000000003 111.087 176.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -62.39 -48.32 80.25 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.456 1.103 . . . . 74.230000000000004 110.899 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 83.4 t -65.24 -39.46 85.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 123.786 0.834 . . . . 73.340000000000003 111.102 177.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 70.0 ttt-85 -54.24 -43.71 71.14 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.195 0.598 . . . . 71.109999999999999 110.952 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.511 ' HA ' ' HE1' ' A' ' 77' ' ' MET . 10.2 mm100 -62.15 -45.77 91.96 Favored 'General case' 0 C--N 1.349 0.549 0 O-C-N 123.959 0.787 . . . . 63.119999999999997 110.352 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 43.1 mt -59.77 -36.92 77.66 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.662 0.785 . . . . 75.420000000000002 111.439 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -61.0 -40.68 94.48 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.839 0.456 . . . . 74.340000000000003 111.182 173.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.511 ' HE1' ' HA ' ' A' ' 74' ' ' GLN . 31.9 mtm -69.71 -35.6 75.19 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.563 0.345 . . . . 72.129999999999995 110.597 178.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -81.57 4.44 21.41 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.695 0.798 . . . . 74.420000000000002 111.019 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.89 24.96 75.87 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-O 119.459 -0.634 . . . . 74.219999999999999 114.538 170.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -73.03 148.89 43.7 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 117.271 0.535 . . . . 72.340000000000003 109.805 173.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.85 121.01 40.66 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.566 -0.901 . . . . 63.219999999999999 108.566 177.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.656 ' HE2' ' HB ' ' A' ' 84' ' ' VAL . 1.2 tmtp? -82.73 126.27 32.19 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.756 -1.202 . . . . 73.340000000000003 107.756 176.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 88.2 t -129.37 111.18 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 107.698 -1.223 . . . . 73.420000000000002 107.698 177.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.656 ' HB ' ' HE2' ' A' ' 82' ' ' LYS . 10.2 p -98.99 125.86 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 108.717 -0.846 . . . . 74.549999999999997 108.717 -177.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 . . . . . 0 N--CA 1.478 0.973 0 C-N-CA 122.839 0.455 . . . . 72.5 110.755 -176.897 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 . . . . . 0 CA--C 1.55 0.968 0 N-CA-C 109.519 -0.548 . . . . 75.510000000000005 109.519 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -39.95 107.21 0.07 Allowed 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.036 0.934 . . . . 72.349999999999994 112.796 175.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.447 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 12.8 t70 -97.21 113.3 24.89 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 107.718 -1.216 . . . . 74.230000000000004 107.718 174.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.467 HG22 ' HE3' ' A' ' 82' ' ' LYS . 87.1 m -122.49 112.08 17.6 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.89 0.876 . . . . 74.310000000000002 109.483 -176.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 46' ' ' PHE . 41.4 tt0 -105.0 114.17 28.21 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.898 0.879 . . . . 74.340000000000003 108.853 -178.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -95.97 121.4 37.68 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.023 -1.103 . . . . 75.409999999999997 108.023 174.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -125.75 143.7 50.94 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.531 0.733 . . . . 73.329999999999998 109.685 -176.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.2 t-80 -158.92 133.31 5.3 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 108.568 -0.901 . . . . 73.140000000000001 108.568 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -64.19 -21.39 67.54 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.617 2.211 . . . . 74.430000000000007 113.556 -175.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.409 ' HB2' HG12 ' A' ' 117' ' ' ILE . 12.0 m -96.36 6.24 49.19 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.969 0.507 . . . . 72.129999999999995 111.128 178.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -114.32 100.03 8.03 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 106.974 -1.491 . . . . 75.299999999999997 106.974 171.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.4 mt -129.38 158.95 37.71 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.707 -0.849 . . . . 74.420000000000002 108.707 175.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.527 ' HG3' ' HH2' ' A' ' 25' ' ' TRP . 35.8 ttp180 -73.62 126.38 30.15 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 123.394 0.677 . . . . 74.019999999999996 110.71 -178.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.57 28.86 72.92 Favored Glycine 0 C--N 1.346 1.134 0 O-C-N 123.872 0.732 . . . . 63.439999999999998 112.198 -177.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -136.96 37.94 2.57 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 122.633 1.206 . . . . 75.319999999999993 108.122 -175.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.92 -10.61 58.13 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 113.533 -1.667 . . . . 74.310000000000002 113.393 -173.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 21.0 pm0 -64.85 -18.31 65.03 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.719 0.408 . . . . 74.430000000000007 111.437 172.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.3 mt -90.52 -6.88 54.23 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.272 0.629 . . . . 72.140000000000001 111.837 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 96.6 mt -66.76 -33.71 76.23 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 118.041 0.382 . . . . 73.019999999999996 111.003 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -73.72 -12.78 60.83 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 120.882 0.372 . . . . 71.25 111.49 174.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -94.97 -14.45 24.39 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.569 0.747 . . . . 74.239999999999995 109.355 177.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.409 HG12 ' HB2' ' A' ' 105' ' ' CYS . 45.2 mt -83.93 75.46 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.069 0 N-CA-C 107.344 -1.354 . . . . 74.430000000000007 107.344 169.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.13 147.28 51.63 Favored 'General case' 0 CA--C 1.558 1.284 0 CA-C-N 115.322 -0.853 . . . . 72.510000000000005 113.296 173.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 . . . . . 0 N--CA 1.486 1.338 0 CA-C-N 114.712 -1.131 . . . . 75.409999999999997 109.536 174.881 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.4 t . . . . . 0 CA--C 1.557 1.215 0 CA-C-O 119.001 -0.523 . . . . 63.450000000000003 110.815 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.473 ' HD2' HD13 ' A' ' 21' ' ' LEU . 53.0 Cg_exo -56.61 155.93 24.46 Favored 'Trans proline' 0 C--N 1.382 2.299 0 C-N-CA 123.253 2.635 . . . . 74.450000000000003 112.495 178.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.82 -43.74 66.2 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.638 0.775 . . . . 74.109999999999999 111.283 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -53.37 -47.01 69.82 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.531 0.733 . . . . 73.519999999999996 112.151 175.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.473 HD13 ' HD2' ' A' ' 18' ' ' PRO . 72.9 mt -81.76 -27.64 33.68 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.31 0.485 . . . . 73.430000000000007 112.31 -171.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.1 t -76.07 -32.17 59.15 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 118.285 0.493 . . . . 75.510000000000005 111.045 174.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.462 ' HA ' ' HE2' ' A' ' 23' ' ' LYS . 10.2 mmpt? -71.33 -38.92 71.65 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.502 -0.555 . . . . 75.310000000000002 109.502 173.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.5 tp -61.44 -44.49 97.03 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 123.919 0.762 . . . . 75.400000000000006 110.797 172.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -53.51 -56.08 20.02 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.071 0.948 . . . . 72.140000000000001 111.233 177.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.1 m -56.5 -47.39 79.38 Favored 'General case' 0 C--O 1.214 -0.786 0 O-C-N 124.574 1.171 . . . . 73.420000000000002 110.402 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.7 tp -54.79 -53.11 59.45 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.605 1.562 . . . . 75.340000000000003 113.133 -174.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 65.6 t -66.82 -28.14 42.11 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 C-N-CA 123.821 0.848 . . . . 74.439999999999998 111.104 178.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.3 t -94.05 -7.21 43.28 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.314 1.046 . . . . 74.129999999999995 112.263 -177.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -89.68 128.73 49.41 Favored Pre-proline 0 N--CA 1.484 1.234 0 C-N-CA 123.515 0.726 . . . . 74.150000000000006 111.614 -171.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -77.5 -11.05 17.31 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 122.859 2.373 . . . . 75.439999999999998 114.232 -178.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -81.3 -28.75 34.49 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 118.422 0.555 . . . . 73.209999999999994 110.862 175.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 40.0 p -114.51 4.0 15.08 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 112.435 0.532 . . . . 71.040000000000006 112.435 -177.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.507 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 1.5 p-10 -65.44 -24.82 67.28 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 112.3 0.481 . . . . 73.030000000000001 112.3 -174.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -68.05 -26.57 65.93 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.265 0.626 . . . . 61.439999999999998 112.448 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.458 HD22 ' HB2' ' A' ' 50' ' ' ASP . 66.4 mt -106.57 -13.89 15.19 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.02 0.528 . . . . 73.129999999999995 111.517 178.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 34' ' ' ASP . 16.4 tt -161.25 124.67 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-O 120.844 0.354 . . . . 72.319999999999993 111.26 174.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 28.0 p -148.92 161.12 42.52 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.933 -0.766 . . . . 62.539999999999999 108.933 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 38.7 p-90 -82.47 148.54 28.09 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 108.965 -0.754 . . . . 60.130000000000003 108.965 176.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.9 m -75.54 151.31 85.04 Favored Pre-proline 0 CA--C 1.546 0.793 0 CA-C-N 115.176 -0.92 . . . . 74.239999999999995 110.084 -176.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -46.67 -39.64 23.51 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 123.468 2.779 . . . . 72.329999999999998 115.451 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 26.3 p -80.88 -9.8 59.79 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 112.086 0.402 . . . . 63.219999999999999 112.086 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.92 -0.08 83.76 Favored Glycine 0 C--N 1.351 1.403 0 N-CA-C 115.962 1.145 . . . . 64.409999999999997 115.962 163.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -94.44 -2.15 52.37 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.962 0.905 . . . . 71.319999999999993 111.705 -175.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 80.9 p -148.59 174.8 11.76 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.908 0.883 . . . . 60.32 110.163 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -145.66 153.97 41.6 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.226 0.61 . . . . 75.230000000000004 110.084 170.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -112.92 149.32 33.36 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.114 0.966 . . . . 74.519999999999996 110.065 -178.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 98' ' ' ASP . 76.3 t -123.35 105.84 16.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 124.787 1.235 . . . . 70.129999999999995 107.987 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -91.18 145.18 24.88 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 124.041 0.936 . . . . 62.549999999999997 110.669 -177.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.458 ' HB2' HD22 ' A' ' 36' ' ' LEU . 3.2 m-20 53.0 57.46 6.31 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 124.579 1.175 . . . . 71.340000000000003 111.61 173.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -55.33 -26.31 40.03 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 114.332 1.234 . . . . 72.530000000000001 114.332 -169.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.38 -47.88 40.77 Favored Glycine 0 CA--C 1.531 1.093 0 N-CA-C 111.838 -0.505 . . . . 60.310000000000002 111.838 174.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -69.17 -44.3 72.51 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.394 0.678 . . . . 71.310000000000002 109.477 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -52.74 -51.37 60.79 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.318 1.447 . . . . 74.450000000000003 111.331 175.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.411 ' HB1' ' HB2' ' A' ' 68' ' ' MET . . . -64.57 -34.88 79.28 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.51 -0.314 . . . . 73.530000000000001 111.778 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -66.1 -46.77 76.47 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.457 1.103 . . . . 74.209999999999994 112.377 -176.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.538 ' HG3' HG23 ' A' ' 58' ' ' VAL . 6.9 pt-20 -109.76 -39.26 5.16 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 113.766 1.024 . . . . 61.340000000000003 113.766 -173.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.538 HG23 ' HG3' ' A' ' 57' ' ' GLU . 84.9 t -82.5 -38.23 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.253 0.621 . . . . 74.329999999999998 111.615 -168.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 51.1 mt -69.97 -43.47 19.88 Favored Pre-proline 0 CA--C 1.565 1.519 0 CA-C-O 118.073 -0.965 . . . . 74.150000000000006 112.94 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -71.06 -10.57 27.72 Favored 'Trans proline' 0 C--N 1.385 2.497 0 CA-C-N 122.058 1.771 . . . . 74.400000000000006 113.155 171.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -78.91 -52.68 7.95 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.151 0.981 . . . . 74.329999999999998 110.964 176.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.443 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 49.3 m-85 -87.43 -24.45 24.17 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 122.892 0.477 . . . . 63.439999999999998 112.155 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -126.29 -150.09 0.43 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 107.35 -1.352 . . . . 74.299999999999997 107.35 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -142.88 55.54 1.39 Allowed 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.99 0.9 . . . . 73.230000000000004 109.615 172.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 32.7 p80 -154.51 148.3 25.48 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 114.845 -1.071 . . . . 71.530000000000001 108.825 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -110.98 0.18 16.92 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.263 0.625 . . . . 72.519999999999996 109.685 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -74.73 117.24 16.34 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.112 0.965 . . . . 74.530000000000001 110.088 176.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.411 ' HB2' ' HB1' ' A' ' 55' ' ' ALA . 13.6 tpt -75.56 -35.83 60.56 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.085 0.554 . . . . 73.209999999999994 110.77 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.89 -32.6 67.88 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.228 0.611 . . . . 63.439999999999998 111.61 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.451 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 44.7 t -59.25 -52.07 67.26 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.991 0.917 . . . . 71.319999999999993 111.068 173.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -64.96 -51.59 60.95 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.119 0.967 . . . . 74.420000000000002 110.894 -174.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.0 t -58.18 -46.46 88.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 124.024 0.93 . . . . 74.219999999999999 111.629 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.9 ttt85 -57.63 -41.2 80.89 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 123.671 0.607 . . . . 73.019999999999996 111.784 -178.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 70' ' ' SER . 13.3 mm100 -60.93 -48.12 83.28 Favored 'General case' 0 C--N 1.351 0.666 0 O-C-N 123.706 0.629 . . . . 75.349999999999994 109.829 -178.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.4 mt -64.98 -42.62 94.39 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.842 0.714 . . . . 74.510000000000005 111.129 -178.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.77 -37.91 80.36 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.243 0.617 . . . . 74.219999999999999 111.329 177.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 59.9 mtm -71.01 -32.55 69.37 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.627 0.371 . . . . 73.299999999999997 110.428 174.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -73.15 -2.2 20.59 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.476 0.71 . . . . 75.430000000000007 111.426 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.13 12.94 64.87 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-O 119.633 -0.537 . . . . 72.120000000000005 113.62 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -74.93 147.55 40.83 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.178 -1.045 . . . . 73.540000000000006 108.178 174.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.443 ' HB3' ' HG3' ' A' ' 102' ' ' GLN . 34.9 ttm-85 -98.88 122.03 41.6 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.723 -0.843 . . . . 74.530000000000001 108.723 -174.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -79.95 113.65 18.27 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.096 1.358 . . . . 75.040000000000006 108.846 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.408 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 39.4 t -123.86 125.56 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 108.905 -0.776 . . . . 73.409999999999997 108.905 178.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 68.9 t -106.21 110.08 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 108.127 -1.064 . . . . 75.209999999999994 108.127 178.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 . . . . . 0 N--CA 1.478 0.944 0 C-N-CA 122.826 0.45 . . . . 71.25 111.652 -173.71 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 . . . . . 0 N--CA 1.479 1.004 0 CA-C-O 120.886 0.374 . . . . 75.299999999999997 110.426 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -103.38 118.7 37.36 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.802 -0.814 . . . . 73.109999999999999 108.802 169.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.409 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 22.5 t70 -122.94 122.95 39.81 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.979 0.912 . . . . 65.519999999999996 109.773 177.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 50.1 m -120.06 127.55 52.68 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.741 0.816 . . . . 75.230000000000004 109.834 175.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.408 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 39.0 tt0 -100.52 117.54 34.88 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.407 -0.96 . . . . 75.530000000000001 108.407 173.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -98.19 118.93 35.92 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.357 -0.979 . . . . 73.209999999999994 108.357 169.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.443 ' HG3' ' HB3' ' A' ' 81' ' ' ARG . 16.6 pt20 -121.5 137.58 54.66 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.618 0.767 . . . . 73.329999999999998 109.292 178.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 106' ' ' PHE . 65.0 t-80 -148.33 129.24 7.0 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-O 118.95 -0.548 . . . . 74.510000000000005 110.353 -171.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -65.16 -38.86 25.72 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 123.14 2.56 . . . . 73.319999999999993 113.437 -173.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.445 ' HB2' ' HE1' ' A' ' 103' ' ' HIS . 35.4 m -93.54 28.93 2.12 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.926 0.49 . . . . 70.209999999999994 110.458 178.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.561 ' HB3' ' HB3' ' A' ' 103' ' ' HIS . 67.4 t80 -133.57 113.28 12.26 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.862 -0.792 . . . . 74.299999999999997 108.862 174.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.599 ' HB2' ' HB2' ' A' ' 110' ' ' GLN . 50.0 mt -117.51 157.48 26.23 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 108.706 -0.85 . . . . 72.109999999999999 108.706 173.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.38 -26.95 65.54 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.459 1.103 . . . . 75.340000000000003 112.974 -171.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.19 37.83 2.02 Favored Glycine 0 N--CA 1.471 0.973 0 N-CA-C 112.252 -0.339 . . . . 62.420000000000002 112.252 -177.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.599 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -131.24 71.8 1.48 Allowed 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 121.515 0.674 . . . . 74.319999999999993 109.673 -178.35 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -63.27 -30.36 71.51 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.345 1.058 . . . . 72.140000000000001 113.145 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 19.8 pm0 -66.28 -15.77 63.49 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.748 0.419 . . . . 75.430000000000007 111.639 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.515 ' O ' HG13 ' A' ' 117' ' ' ILE . 49.3 mt -87.03 -21.45 26.09 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 118.953 -0.546 . . . . 75.349999999999994 111.374 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 96.8 mt -57.4 -41.1 79.64 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 123.395 0.678 . . . . 73.019999999999996 111.33 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -76.93 -7.83 56.27 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 115.448 -0.796 . . . . 71.209999999999994 112.581 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -101.15 -9.19 21.56 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.705 0.802 . . . . 74.430000000000007 109.857 172.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.515 HG13 ' O ' ' A' ' 113' ' ' LEU . 72.7 mt -81.13 108.96 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 107.265 -1.383 . . . . 73.120000000000005 107.265 173.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.464 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 11.2 mmpt? -108.67 144.09 36.88 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.997 -0.742 . . . . 74.400000000000006 108.997 -172.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 31.0 ptt-85 . . . . . 0 N--CA 1.471 0.581 0 O-C-N 123.655 0.597 . . . . 73.450000000000003 110.788 179.349 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.6 t . . . . . 0 CA--C 1.553 1.083 0 N-CA-C 107.75 -1.204 . . . . 71.030000000000001 107.75 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -52.9 135.78 58.72 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 123.013 2.475 . . . . 74.239999999999995 112.621 177.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.96 -42.42 68.9 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.31 1.044 . . . . 74.340000000000003 112.335 -178.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -57.66 -40.75 80.05 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.252 0.621 . . . . 73.219999999999999 111.653 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 66.0 mt -78.04 -34.06 50.69 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 112.25 0.463 . . . . 73.209999999999994 112.25 -174.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.1 t -74.45 -37.22 63.32 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 119.688 -0.196 . . . . 74.040000000000006 110.885 178.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.479 ' HA ' ' HE2' ' A' ' 23' ' ' LYS . 8.5 mmpt? -70.79 -37.06 73.29 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 122.793 0.437 . . . . 74.310000000000002 110.102 175.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.9 tp -58.5 -53.59 56.63 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 123.808 0.843 . . . . 75.340000000000003 111.453 173.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 24.1 t-105 -61.68 -41.74 97.98 Favored 'General case' 0 CA--C 1.549 0.921 0 O-C-N 123.027 0.204 . . . . 75.340000000000003 111.182 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.442 ' O ' ' HB2' ' A' ' 30' ' ' ASP . 90.7 m -59.38 -36.52 75.95 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 122.897 0.479 . . . . 74.420000000000002 110.762 174.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.415 ' HG ' HG23 ' A' ' 37' ' ' ILE . 50.5 tp -70.78 -51.02 29.64 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.633 1.173 . . . . 72.040000000000006 111.939 -178.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 96.4 t -60.58 -33.86 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.69 1.196 . . . . 73.340000000000003 111.2 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.6 t -86.91 -24.44 24.82 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.855 0.862 . . . . 73.420000000000002 111.684 -176.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 26' ' ' THR . 8.7 t70 -69.3 128.62 92.34 Favored Pre-proline 0 N--CA 1.488 1.467 0 C-N-CA 122.856 0.462 . . . . 74.140000000000001 111.828 -168.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.32 -1.89 11.29 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 123.175 2.583 . . . . 75.219999999999999 114.507 -176.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -87.15 -34.28 19.12 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 118.305 0.502 . . . . 72.140000000000001 111.0 172.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.0 p -112.27 1.57 16.19 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.742 0.817 . . . . 75.219999999999999 112.398 -171.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.425 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 8.9 p-10 -61.18 -25.15 66.83 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.951 0.901 . . . . 62.240000000000002 111.923 -178.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.26 -33.64 75.94 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.957 0.903 . . . . 75.109999999999999 112.496 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.434 HD23 ' HB2' ' A' ' 50' ' ' ASP . 69.3 mt -108.14 -13.35 14.94 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.221 0.608 . . . . 72.439999999999998 112.001 -178.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 34' ' ' ASP . 19.8 tt -157.39 117.67 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-O 121.266 0.555 . . . . 73.120000000000005 110.507 177.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 29.0 p -144.73 153.01 41.24 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.212 0.605 . . . . 74.129999999999995 109.803 -178.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 35.5 p-90 -82.21 153.15 26.09 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.922 -0.581 . . . . 73.409999999999997 109.738 178.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.6 m -82.49 156.91 68.21 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 108.726 -0.842 . . . . 71.040000000000006 108.726 -178.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -61.23 -12.29 22.8 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.449 2.1 . . . . 52.020000000000003 113.297 178.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 77.2 p -74.44 -36.87 63.41 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.824 0.85 . . . . 74.430000000000007 110.656 171.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.93 -8.12 77.46 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 115.504 -0.771 . . . . 63.32 113.415 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.565 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 0.4 OUTLIER -101.2 12.59 37.27 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.181 0.992 . . . . 72.420000000000002 111.37 -172.246 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.4 p -163.77 151.86 13.12 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.888 0.875 . . . . 75.150000000000006 109.538 -175.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -138.99 147.25 41.92 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.946 0.498 . . . . 73.140000000000001 109.871 177.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -101.99 144.69 30.28 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.478 0.711 . . . . 65.329999999999998 109.556 -176.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 95.8 t -121.66 115.61 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 107.504 -1.295 . . . . 73.150000000000006 107.504 177.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.486 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 25.4 m-85 -114.51 149.14 36.85 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.661 1.185 . . . . 71.310000000000002 110.743 -172.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.434 ' HB2' HD23 ' A' ' 36' ' ' LEU . 5.4 m-20 52.36 53.2 12.75 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 125.021 1.45 . . . . 50.119999999999997 110.51 176.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.709 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 55.5 mt-30 -53.39 -25.85 17.2 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 114.853 -1.067 . . . . 71.439999999999998 113.576 -170.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.45 -50.42 55.47 Favored Glycine 0 CA--C 1.534 1.266 0 N-CA-C 112.205 -0.358 . . . . 72.340000000000003 112.205 174.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -73.72 -33.49 64.38 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.143 0.977 . . . . 74.409999999999997 110.608 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -66.03 -54.54 24.59 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.345 1.058 . . . . 74.420000000000002 110.582 -178.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.6 -26.04 67.66 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 116.108 -0.496 . . . . 72.140000000000001 111.724 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.1 tttm -64.01 -55.58 21.3 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.816 1.246 . . . . 72.319999999999993 113.064 178.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.492 ' HG3' HG23 ' A' ' 58' ' ' VAL . 2.1 pt-20 -112.02 -33.65 6.2 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 113.259 0.836 . . . . 73.409999999999997 113.259 -170.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.492 HG23 ' HG3' ' A' ' 57' ' ' GLU . 61.8 t -85.22 -43.23 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.305 0.642 . . . . 75.299999999999997 111.328 -168.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.443 HD13 ' HE2' ' A' ' 68' ' ' MET . 17.6 mt -62.57 -51.64 71.13 Favored Pre-proline 0 CA--C 1.558 1.272 0 CA-C-O 118.312 -0.851 . . . . 73.129999999999995 112.429 178.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.3 -7.48 21.32 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 121.726 1.617 . . . . 74.030000000000001 112.783 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -80.11 -60.97 2.13 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.09 0.956 . . . . 74.430000000000007 110.771 175.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -83.73 -32.17 25.64 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 122.755 0.422 . . . . 73.099999999999994 112.052 -176.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -112.11 -175.95 2.81 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.82 -0.807 . . . . 71.230000000000004 108.82 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.95 28.8 8.1 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.392 0.677 . . . . 73.120000000000005 111.295 -174.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 26.1 p80 -157.42 155.95 31.37 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.155 0.582 . . . . 72.109999999999999 109.82 -172.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 38.8 p30 -117.74 -7.5 10.99 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.394 0.677 . . . . 71.530000000000001 111.668 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -72.94 121.55 20.25 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.861 -0.422 . . . . 72.530000000000001 109.861 -178.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.709 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 2.4 tpt -59.48 -45.52 91.44 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.186 0.994 . . . . 74.209999999999994 111.227 178.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.73 -34.68 74.77 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.574 -0.739 . . . . 74.25 112.087 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.4 t -63.2 -40.92 98.86 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.252 0.621 . . . . 71.030000000000001 111.35 175.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -64.13 -53.08 55.24 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.134 0.974 . . . . 73.400000000000006 110.861 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.1 t -61.16 -39.49 82.63 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 CA-C-N 115.079 -0.964 . . . . 75.340000000000003 111.394 -179.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -57.78 -48.91 78.35 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.617 0.767 . . . . 74.299999999999997 111.235 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -58.13 -43.16 87.14 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 124.437 1.086 . . . . 74.530000000000001 110.641 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.7 mt -65.18 -41.53 94.52 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.219 0.608 . . . . 72.200000000000003 111.672 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -60.34 -35.88 76.69 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 122.584 0.354 . . . . 65.420000000000002 111.185 172.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.471 ' O ' ' HA ' ' A' ' 119' ' ' ARG . 48.2 mtp -65.63 -39.68 91.71 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.149 0.58 . . . . 71.019999999999996 110.126 175.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -81.53 -1.33 45.8 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.081 0.552 . . . . 71.299999999999997 111.518 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.03 22.15 57.95 Favored Glycine 0 C--N 1.35 1.331 0 N-CA-C 114.399 0.52 . . . . 60.200000000000003 114.399 174.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.545 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . 34.2 m-85 -78.82 130.56 35.84 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.343 -0.984 . . . . 74.319999999999993 108.343 173.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -100.93 129.61 46.81 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.208 0.603 . . . . 74.120000000000005 109.649 -171.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -71.54 122.55 20.67 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.514 1.126 . . . . 75.129999999999995 110.905 -178.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 90.6 t -132.3 127.4 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 107.488 -1.301 . . . . 71.420000000000002 107.488 172.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.59 131.97 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 109.122 -0.696 . . . . 74.450000000000003 109.122 177.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 29.6 m-70 . . . . . 0 N--CA 1.479 0.979 0 C-N-CA 123.054 0.542 . . . . 65.349999999999994 110.207 -178.054 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 . . . . . 0 C--O 1.244 0.811 0 CA-C-O 120.865 0.364 . . . . 73.340000000000003 110.184 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.486 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 2.5 m-20 -80.73 147.22 30.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.614 -0.721 . . . . 73.25 109.765 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -134.78 117.93 16.5 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.864 0.866 . . . . 65.430000000000007 109.345 172.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 86.3 m -135.06 109.0 8.12 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.595 0.758 . . . . 72.209999999999994 109.125 178.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -99.15 119.7 38.28 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.786 -0.82 . . . . 64.420000000000002 108.786 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.545 ' HB3' ' HB3' ' A' ' 80' ' ' PHE . 92.9 m-85 -99.62 120.31 39.47 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.556 -0.905 . . . . 75.340000000000003 108.556 173.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -109.99 144.59 38.31 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.368 0.667 . . . . 75.150000000000006 110.027 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -153.34 127.06 4.33 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 109.149 -0.686 . . . . 75.340000000000003 109.149 177.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.8 -34.86 59.8 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 123.021 2.481 . . . . 73.439999999999998 112.957 -177.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 36.1 m -93.19 26.29 2.94 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 121.234 0.54 . . . . 75.329999999999998 110.833 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.565 ' O ' ' HA ' ' A' ' 44' ' ' ASN . 85.8 t80 -124.9 110.36 14.16 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 107.092 -1.448 . . . . 73.299999999999997 107.092 172.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.614 ' HB2' ' HB3' ' A' ' 110' ' ' GLN . 85.2 mt -131.48 174.49 10.04 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 108.849 -0.797 . . . . 65.230000000000004 108.849 170.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -63.09 -75.7 0.07 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.527 0.731 . . . . 74.310000000000002 111.513 -178.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -80.25 -10.9 84.9 Favored Glycine 0 C--N 1.349 1.271 0 O-C-N 123.195 0.31 . . . . 74.329999999999998 113.157 -177.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.614 ' HB3' ' HB2' ' A' ' 107' ' ' LEU . 5.3 tp-100 -90.99 40.55 1.03 Allowed 'General case' 0 CA--C 1.556 1.178 0 CA-C-O 121.531 0.682 . . . . 72.219999999999999 109.323 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -69.63 -12.53 61.72 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.088 0.955 . . . . 65.420000000000002 112.687 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.3 pm0 -64.45 -10.11 23.03 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.197 0.599 . . . . 75.239999999999995 112.174 169.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.46 ' O ' HG13 ' A' ' 117' ' ' ILE . 53.0 mt -91.18 -4.58 55.96 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.172 0.589 . . . . 75.409999999999997 111.961 175.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 90.2 mt -66.03 -34.56 78.36 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 118.536 0.607 . . . . 74.439999999999998 111.162 176.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -75.25 -17.25 60.36 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.515 0.726 . . . . 75.430000000000007 111.415 172.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -90.86 -9.86 44.78 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.413 0.685 . . . . 71.230000000000004 110.034 176.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 113' ' ' LEU . 59.3 mt -84.26 121.7 36.95 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 N-CA-C 107.294 -1.373 . . . . 73.310000000000002 107.294 170.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.505 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 10.8 mmpt? -111.14 151.79 27.74 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.225 0.61 . . . . 75.430000000000007 109.837 -178.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 77' ' ' MET . 43.3 ptt85 . . . . . 0 N--CA 1.475 0.799 0 CA-C-N 115.053 -0.976 . . . . 75.25 109.563 170.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.8 t . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 118.989 -0.529 . . . . 74.230000000000004 110.25 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -52.28 148.48 25.22 Favored 'Trans proline' 0 C--N 1.386 2.526 0 C-N-CA 123.718 2.945 . . . . 75.219999999999999 113.172 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.77 -42.42 64.98 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.833 0.853 . . . . 75.310000000000002 111.771 176.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -52.71 -49.9 64.44 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.617 0.767 . . . . 73.109999999999999 112.081 174.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 82.5 mt -80.61 -30.81 36.78 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.187 0.44 . . . . 74.530000000000001 112.187 -169.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.8 t -72.15 -36.54 69.36 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 118.009 0.368 . . . . 73.530000000000001 111.026 175.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.473 ' HA ' ' HE2' ' A' ' 23' ' ' LYS . 9.0 mmpt? -73.52 -36.49 65.72 Favored 'General case' 0 C--N 1.359 0.981 0 C-N-CA 122.869 0.468 . . . . 51.240000000000002 110.324 176.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.0 tp -62.76 -49.34 75.38 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 124.049 0.843 . . . . 74.430000000000007 110.99 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.459 ' HH2' ' HG2' ' A' ' 108' ' ' ARG . 12.0 t-105 -60.47 -43.62 96.73 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 122.36 0.264 . . . . 73.340000000000003 111.209 178.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.4 m -54.42 -51.19 65.7 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 122.631 0.373 . . . . 74.0 110.436 172.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.427 ' HG ' HD13 ' A' ' 37' ' ' ILE . 37.1 tp -57.19 -53.39 58.68 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.116 1.767 . . . . 73.109999999999999 113.201 -175.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.7 t -61.47 -35.45 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.659 1.184 . . . . 70.549999999999997 111.785 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.2 t -93.32 -6.52 47.2 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.778 -0.646 . . . . 72.439999999999998 111.351 -176.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -83.42 129.83 58.79 Favored Pre-proline 0 CA--C 1.552 1.055 0 C-N-CA 123.004 0.521 . . . . 74.329999999999998 111.18 -172.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -80.88 -9.63 13.06 Favored 'Trans proline' 0 C--N 1.382 2.328 0 C-N-CA 122.863 2.375 . . . . 71.040000000000006 114.027 -176.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -80.53 -27.42 37.63 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 118.49 0.586 . . . . 74.239999999999995 110.589 175.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.8 p -105.59 10.02 33.15 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.537 0.735 . . . . 74.430000000000007 112.486 -179.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -56.83 -32.27 65.59 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.151 0.981 . . . . 73.340000000000003 112.476 -175.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.08 -38.24 90.39 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.835 0.854 . . . . 75.310000000000002 112.968 -176.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.448 ' HA ' ' HB2' ' A' ' 49' ' ' PHE . 77.9 mt -110.97 -8.5 14.47 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 122.687 0.395 . . . . 64.530000000000001 111.837 -175.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.427 HD13 ' HG ' ' A' ' 27' ' ' LEU . 18.6 tt -162.42 134.36 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 122.62 0.368 . . . . 75.310000000000002 111.163 173.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.3 p -161.96 156.6 22.55 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.15 0.58 . . . . 75.040000000000006 109.879 173.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 14.8 p-90 -77.03 150.31 35.8 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.335 0.654 . . . . 71.409999999999997 110.504 -177.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.2 m -75.54 147.11 81.57 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 108.579 -0.897 . . . . 75.219999999999999 108.579 176.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.49 -12.89 12.01 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.615 2.21 . . . . 71.109999999999999 113.639 176.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.0 m -65.76 -43.95 87.31 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.664 1.186 . . . . 73.450000000000003 110.728 169.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.46 -10.98 69.07 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 114.934 -1.03 . . . . 71.420000000000002 114.147 177.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -101.84 6.43 41.53 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.456 1.102 . . . . 74.340000000000003 111.605 -171.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.2 p -157.36 161.75 39.05 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.121 0.969 . . . . 65.420000000000002 109.657 -171.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.436 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 45.9 p90 -146.61 146.52 30.45 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.66 0.384 . . . . 74.099999999999994 110.731 177.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -103.28 143.55 32.51 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.575 0.75 . . . . 75.519999999999996 109.632 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.0 t -123.14 121.98 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 107.569 -1.271 . . . . 75.310000000000002 107.569 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.549 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 90.6 m-85 -105.14 144.71 31.55 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 123.572 0.749 . . . . 71.230000000000004 109.759 -177.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 42.98 73.02 0.15 Allowed 'General case' 0 N--CA 1.476 0.851 0 O-C-N 125.254 1.596 . . . . 64.340000000000003 112.608 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -53.72 -26.9 25.2 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.499 1.119 . . . . 71.129999999999995 113.498 -175.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.31 -48.12 47.51 Favored Glycine 0 C--N 1.35 1.35 0 O-C-N 123.014 0.196 . . . . 64.030000000000001 112.69 173.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -71.62 -37.13 70.95 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.018 0.927 . . . . 74.239999999999995 110.663 -178.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.478 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 59.8 t80 -61.96 -48.93 78.17 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.224 1.41 . . . . 75.099999999999994 110.135 176.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.446 ' HB1' ' HB2' ' A' ' 68' ' ' MET . . . -62.45 -33.0 73.96 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 116.06 -0.518 . . . . 73.450000000000003 111.6 178.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.1 tttm -67.74 -55.52 12.82 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.611 1.165 . . . . 72.319999999999993 113.398 -177.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -106.78 -33.38 7.6 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 113.138 0.792 . . . . 70.099999999999994 113.138 -170.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.478 ' HB ' ' O ' ' A' ' 54' ' ' PHE . 94.4 t -82.78 -49.94 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 122.923 0.489 . . . . 73.439999999999998 111.605 -171.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.2 mt -61.48 -47.76 92.42 Favored Pre-proline 0 CA--C 1.561 1.369 0 CA-C-O 118.048 -0.977 . . . . 73.099999999999994 113.042 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -66.62 -16.62 51.2 Favored 'Trans proline' 0 C--N 1.391 2.783 0 CA-C-N 121.964 1.737 . . . . 74.409999999999997 113.073 177.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -77.03 -53.97 7.14 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.384 0.674 . . . . 75.109999999999999 111.253 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -87.29 -46.71 9.45 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.241 0.617 . . . . 73.420000000000002 111.686 -177.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -100.33 -179.9 4.26 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.383 -0.826 . . . . 73.0 108.785 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -112.64 40.03 2.36 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 121.634 0.73 . . . . 73.409999999999997 109.654 -174.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 32.2 p80 -157.66 161.5 38.6 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 114.949 -1.023 . . . . 75.340000000000003 109.01 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -112.95 -11.01 13.47 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.217 0.607 . . . . 43.25 110.128 177.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -73.39 120.53 19.13 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.439 0.696 . . . . 73.040000000000006 111.262 -176.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.446 ' HB2' ' HB1' ' A' ' 55' ' ' ALA . 12.2 tpt -69.9 -36.63 75.55 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.702 0.801 . . . . 74.219999999999999 111.303 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.65 -30.92 67.68 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 123.724 0.64 . . . . 74.230000000000004 111.962 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.1 t -65.54 -47.35 76.16 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.39 1.076 . . . . 74.519999999999996 110.841 174.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -63.74 -52.92 58.28 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.511 1.125 . . . . 75.420000000000002 110.471 -176.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.7 t -62.94 -40.89 90.67 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 CA-C-N 115.25 -0.886 . . . . 62.229999999999997 111.055 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -57.7 -40.97 80.74 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 123.272 0.629 . . . . 73.329999999999998 111.407 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -57.57 -51.0 71.25 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 124.187 0.929 . . . . 73.439999999999998 110.07 176.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 68.2 mt -63.56 -38.14 89.98 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.923 0.889 . . . . 73.25 111.714 -177.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 -57.27 -44.6 84.11 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 122.803 0.441 . . . . 74.219999999999999 110.851 172.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 71.0 mtm -73.79 -25.17 59.99 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.905 -0.589 . . . . 73.439999999999998 111.499 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -86.54 1.58 51.13 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.35 0.66 . . . . 72.150000000000006 111.065 173.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.63 13.39 81.6 Favored Glycine 0 C--N 1.344 1.017 0 N-CA-C 115.068 0.787 . . . . 64.349999999999994 115.068 171.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -69.3 144.87 53.44 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 117.877 0.838 . . . . 74.439999999999998 109.248 177.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -101.18 122.54 43.82 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.414 -0.587 . . . . 75.310000000000002 109.414 -177.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.485 ' HE2' ' HB ' ' A' ' 84' ' ' VAL . 22.9 tptm -68.32 113.22 5.73 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.018 1.327 . . . . 74.109999999999999 109.743 172.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 90.3 t -125.58 106.61 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 107.711 -1.218 . . . . 73.549999999999997 107.711 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.485 ' HB ' ' HE2' ' A' ' 82' ' ' LYS . 3.5 p -107.7 123.11 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 108.442 -0.947 . . . . 73.019999999999996 108.442 -172.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 . . . . . 0 N--CA 1.482 1.137 0 C-N-CA 123.164 0.586 . . . . 75.349999999999994 111.725 -169.766 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 . . . . . 0 CA--C 1.542 0.645 0 CA-C-O 121.789 0.804 . . . . 75.129999999999995 111.917 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.549 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 52.4 m-20 -86.58 124.51 32.96 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.24 -1.022 . . . . 65.049999999999997 108.24 171.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -123.2 107.52 11.8 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 107.897 -1.149 . . . . 74.010000000000005 107.897 167.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 55.0 m -122.11 108.73 13.68 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.589 1.156 . . . . 70.25 109.579 -173.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 46' ' ' PHE . 38.7 tt0 -101.49 115.36 30.34 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.82 -0.807 . . . . 71.519999999999996 108.82 -179.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -96.63 120.03 36.2 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.181 -1.044 . . . . 74.430000000000007 108.181 171.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -118.3 145.48 45.04 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.714 -0.847 . . . . 75.340000000000003 108.714 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.437 ' HB3' ' HB3' ' A' ' 106' ' ' PHE . 42.6 t-80 -155.78 133.17 6.53 Favored Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 109.318 -0.623 . . . . 74.25 109.318 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -63.96 -35.53 54.46 Favored 'Trans proline' 0 C--N 1.384 2.447 0 C-N-CA 122.855 2.37 . . . . 71.430000000000007 112.268 -175.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 3.4 m -87.0 3.88 44.12 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.435 0.694 . . . . 73.400000000000006 111.002 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.437 ' HB3' ' HB3' ' A' ' 103' ' ' HIS . 88.9 t80 -111.84 103.28 11.53 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 107.911 -1.144 . . . . 74.200000000000003 107.911 175.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.412 HD13 ' HG2' ' A' ' 110' ' ' GLN . 28.3 mt -119.43 167.97 11.42 Favored 'General case' 0 C--O 1.246 0.881 0 N-CA-C 107.236 -1.394 . . . . 73.200000000000003 107.236 170.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . 0.459 ' HG2' ' HH2' ' A' ' 25' ' ' TRP . 30.3 ttp85 -60.63 -79.86 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.154 0.582 . . . . 75.310000000000002 110.903 -173.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -85.46 60.17 4.74 Favored Glycine 0 C--N 1.347 1.14 0 N-CA-C 111.624 -0.59 . . . . 63.420000000000002 111.624 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.412 ' HG2' HD13 ' A' ' 107' ' ' LEU . 2.8 tp-100 -150.93 35.44 0.6 Allowed 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 108.872 -0.788 . . . . 72.219999999999999 108.872 -170.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -64.16 -20.19 65.83 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.607 1.163 . . . . 61.210000000000001 113.154 -175.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.07 -8.18 53.13 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 112.022 0.379 . . . . 73.310000000000002 112.022 177.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.424 ' O ' HG13 ' A' ' 117' ' ' ILE . 17.7 mt -88.3 -16.61 32.64 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.368 0.667 . . . . 73.310000000000002 111.494 173.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 96.8 mt -61.61 -36.41 80.66 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.274 0.559 . . . . 64.420000000000002 111.212 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -72.77 -15.78 61.65 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 115.57 -0.741 . . . . 74.030000000000001 112.342 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -97.14 -7.68 31.95 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.706 0.802 . . . . 64.129999999999995 110.257 178.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 113' ' ' LEU . 64.2 mt -88.65 130.52 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 107.573 -1.269 . . . . 73.109999999999999 107.573 173.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -105.71 141.1 37.72 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.25 0.62 . . . . 74.400000000000006 109.992 -171.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 . . . . . 0 N--CA 1.48 1.031 0 O-C-N 124.209 0.943 . . . . 74.140000000000001 110.327 170.213 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.9 mmt . . . . . 0 N--CA 1.476 0.871 0 N-CA-C 109.549 -0.538 . . . . 71.340000000000003 109.549 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.26 96.01 0.98 Allowed Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.263 -0.88 . . . . 61.0 112.399 -177.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 -91.75 -36.07 13.78 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.617 -0.883 . . . . 74.120000000000005 108.617 168.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -70.35 103.23 2.35 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.859 0.864 . . . . 74.120000000000005 109.213 174.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.1 m-70 -116.68 154.25 30.9 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 124.003 0.921 . . . . 73.230000000000004 109.732 177.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -71.83 147.51 47.13 Favored 'General case' 0 C--O 1.241 0.627 0 O-C-N 124.054 0.846 . . . . 74.519999999999996 111.311 -177.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 11.2 t60 65.29 70.83 0.45 Allowed 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.707 1.203 . . . . 72.549999999999997 110.793 175.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -86.24 97.06 10.16 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 108.079 -1.082 . . . . 74.400000000000006 108.079 172.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 52.4 p -69.3 -69.68 0.32 Allowed 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 115.479 -0.782 . . . . 74.5 111.077 -172.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -133.7 28.47 3.92 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.344 1.058 . . . . 72.209999999999994 108.409 175.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 77.8 mtp -78.47 165.63 23.54 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.494 -1.23 . . . . 73.010000000000005 111.646 -175.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.12 137.36 14.82 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 114.904 -1.043 . . . . 55.020000000000003 108.396 171.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 171.99 -78.57 0.09 OUTLIER Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.217 -0.753 . . . . 64.030000000000001 111.217 -177.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -83.63 79.26 2.83 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 123.047 2.498 . . . . 74.329999999999998 112.254 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 96.9 p 47.8 55.22 8.81 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.701 1.2 . . . . 51.130000000000003 112.896 173.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.73 17.88 0.85 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.509 0.724 . . . . 74.420000000000002 111.281 178.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.2 t -69.57 129.09 91.76 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 123.879 0.872 . . . . 72.230000000000004 109.805 175.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.84 147.37 85.21 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 122.418 2.078 . . . . 72.549999999999997 110.894 171.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.29 -33.24 41.23 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.441 1.096 . . . . 73.349999999999994 113.36 -172.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.447 ' HB3' ' HH ' ' A' ' 78' ' ' TYR . 61.7 t80 -54.75 -52.76 61.55 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.681 0.792 . . . . 75.040000000000006 112.272 174.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 95.7 mt -77.26 -29.48 53.93 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 120.992 0.425 . . . . 74.430000000000007 109.912 -171.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.4 m -58.76 -48.4 81.34 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 114.351 -1.295 . . . . 74.329999999999998 111.395 173.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.486 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -69.28 -47.4 64.67 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.951 -0.568 . . . . 73.230000000000004 110.731 176.13 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.485 ' O ' HG23 ' A' ' 28' ' ' VAL . 58.9 tp -56.77 -54.76 42.6 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.597 1.159 . . . . 74.430000000000007 113.485 -174.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 89.5 t90 -56.34 -45.84 80.23 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.374 0.67 . . . . 74.409999999999997 111.13 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.1 m -69.26 -28.46 66.33 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.616 0.766 . . . . 75.219999999999999 111.663 177.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.453 ' HG ' HG23 ' A' ' 37' ' ' ILE . 49.6 tp -67.21 -46.2 74.58 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.932 1.293 . . . . 74.010000000000005 110.931 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 24' ' ' LEU . 23.6 t -63.53 -37.98 81.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-N 115.129 -0.941 . . . . 73.439999999999998 110.732 175.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.2 m -74.5 -19.97 60.16 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.841 0.856 . . . . 74.150000000000006 111.565 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -74.87 132.54 77.33 Favored Pre-proline 0 CA--C 1.556 1.173 0 C-N-CA 123.773 0.829 . . . . 64.209999999999994 110.988 -172.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.32 -28.19 12.66 Favored 'Trans proline' 0 C--N 1.384 2.44 0 C-N-CA 123.036 2.491 . . . . 74.209999999999994 114.235 -176.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -69.48 -43.39 73.29 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.244 0.618 . . . . 73.019999999999996 110.061 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.0 p -96.01 -1.25 49.31 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.733 -0.667 . . . . 70.329999999999998 111.325 -175.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -56.02 -30.83 62.45 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.645 1.178 . . . . 62.409999999999997 111.657 177.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.75 -36.31 78.61 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.237 -0.892 . . . . 74.239999999999995 112.152 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.8 mt -111.06 -6.0 14.7 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.166 0.587 . . . . 64.420000000000002 111.899 -176.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.453 HG23 ' HG ' ' A' ' 27' ' ' LEU . 18.8 tt -159.42 112.75 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 121.564 0.697 . . . . 74.109999999999999 110.504 175.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.525 ' SG ' ' HE2' ' A' ' 49' ' ' PHE . 24.5 p -139.9 145.41 37.95 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.174 0.59 . . . . 75.230000000000004 110.524 -174.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 18.8 p-90 -75.83 149.6 37.84 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.835 0.854 . . . . 71.120000000000005 111.513 -176.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.1 m -72.21 154.24 92.19 Favored Pre-proline 0 CA--C 1.556 1.192 0 C-N-CA 123.848 0.859 . . . . 64.030000000000001 109.262 174.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -43.21 -42.83 10.11 Favored 'Trans proline' 0 C--N 1.386 2.531 0 C-N-CA 124.432 3.421 . . . . 64.040000000000006 114.677 -176.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.2 m -67.52 -40.19 85.1 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.192 0.597 . . . . 71.409999999999997 111.37 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.11 11.82 55.8 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-N 115.901 -0.591 . . . . 61.439999999999998 112.793 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.405 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 28.0 p-10 -91.63 -4.76 54.87 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.26 1.024 . . . . 62.350000000000001 111.276 -175.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.6 p -155.31 170.93 20.73 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 123.937 0.895 . . . . 63.340000000000003 109.744 -174.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 50.7 p90 -142.12 149.23 39.55 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.07 0.548 . . . . 72.540000000000006 110.299 178.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -107.84 147.16 31.28 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.225 1.01 . . . . 73.510000000000005 108.398 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.604 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 60.2 t -123.3 131.31 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.018 -1.104 . . . . 72.409999999999997 108.018 176.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.525 ' HE2' ' SG ' ' A' ' 38' ' ' CYS . 79.3 m-85 -118.73 146.71 44.54 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 124.148 0.979 . . . . 73.409999999999997 109.4 -177.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 52.68 70.98 0.51 Allowed 'General case' 0 CA--C 1.548 0.898 0 O-C-N 124.693 1.246 . . . . 74.409999999999997 111.088 -178.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -46.79 -41.45 15.42 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 124.391 1.076 . . . . 73.109999999999999 112.955 -177.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.48 -46.58 76.18 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 115.646 -0.706 . . . . 75.409999999999997 112.822 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -72.69 -45.82 56.86 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.009 0.524 . . . . 74.319999999999993 110.822 -176.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.41 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 65.7 t80 -53.66 -49.15 68.57 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.778 1.231 . . . . 74.510000000000005 110.729 173.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 66' ' ' ASN . . . -64.44 -33.79 76.69 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 112.409 0.522 . . . . 71.230000000000004 112.409 178.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -69.41 -50.4 46.26 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.455 1.102 . . . . 74.299999999999997 112.167 -177.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.493 ' HG3' HG23 ' A' ' 58' ' ' VAL . 3.3 pt-20 -105.69 -43.97 4.78 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 113.098 0.777 . . . . 74.209999999999994 113.098 -174.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.493 HG23 ' HG3' ' A' ' 57' ' ' GLU . 94.5 t -76.78 -45.48 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 122.751 0.421 . . . . 74.129999999999995 111.017 -166.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 32.3 mt -61.8 -51.14 78.06 Favored Pre-proline 0 CA--C 1.557 1.225 0 CA-C-O 117.764 -1.113 . . . . 71.109999999999999 112.073 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.507 ' HG3' ' ND2' ' A' ' 66' ' ' ASN . 60.2 Cg_endo -70.21 -9.58 26.27 Favored 'Trans proline' 0 C--N 1.384 2.406 0 CA-C-N 122.291 1.854 . . . . 62.130000000000003 113.719 176.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -79.35 -53.49 6.87 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.284 0.633 . . . . 72.439999999999998 110.965 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -91.69 -46.82 7.71 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.075 0.55 . . . . 73.439999999999998 111.176 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -99.12 -177.29 3.57 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 108.254 -1.017 . . . . 73.530000000000001 108.254 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -113.16 37.52 3.13 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 119.112 0.869 . . . . 73.230000000000004 111.721 -172.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -157.05 158.33 36.28 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.91 0.484 . . . . 74.219999999999999 110.271 -174.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.507 ' ND2' ' HG3' ' A' ' 60' ' ' PRO . 10.4 m120 -105.31 -16.21 14.82 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 122.515 0.326 . . . . 65.329999999999998 110.671 177.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -75.86 124.72 27.78 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.842 0.457 . . . . 71.219999999999999 110.995 -175.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 12.7 tpt -75.1 -33.97 61.69 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.82 0.848 . . . . 75.109999999999999 111.779 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.07 -33.52 70.89 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.26 0.624 . . . . 60.149999999999999 111.68 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.43 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 48.2 t -64.7 -44.92 88.71 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.459 1.104 . . . . 73.450000000000003 111.223 175.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -60.64 -51.77 67.99 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.197 0.999 . . . . 73.510000000000005 110.709 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.6 t -61.32 -39.64 83.37 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 CA-C-N 115.0 -1.0 . . . . 74.319999999999993 111.342 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -60.69 -41.34 94.95 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.766 0.826 . . . . 74.239999999999995 112.096 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.43 ' HG2' ' O ' ' A' ' 70' ' ' SER . 13.8 mm100 -58.98 -47.41 85.24 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 123.943 0.777 . . . . 73.230000000000004 109.616 176.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.426 ' HB3' ' HB2' ' A' ' 80' ' ' PHE . 77.5 mt -61.65 -38.47 87.85 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.274 1.03 . . . . 72.5 112.172 -178.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -60.55 -35.65 76.55 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 122.557 0.343 . . . . 73.120000000000005 111.864 173.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 63.7 mtm -76.57 -23.56 53.54 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.039 0.536 . . . . 74.420000000000002 111.3 175.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.447 ' HH ' ' HB3' ' A' ' 20' ' ' PHE . 40.7 m-85 -85.9 -7.0 58.98 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.405 0.682 . . . . 72.129999999999995 111.602 175.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.93 10.2 66.96 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-O 119.569 -0.573 . . . . 64.239999999999995 114.27 175.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.426 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 24.0 m-85 -73.25 144.41 46.71 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 117.723 0.761 . . . . 75.409999999999997 109.506 178.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 57.5 ttt-85 -110.8 131.72 54.81 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.693 -0.484 . . . . 73.219999999999999 109.693 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.582 ' HE3' ' HA ' ' A' ' 99' ' ' THR . 18.6 tptm -74.48 127.43 33.04 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.735 0.814 . . . . 74.040000000000006 109.721 173.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 95.5 t -132.37 118.38 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 107.034 -1.469 . . . . 63.520000000000003 107.034 176.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.467 ' HB ' ' HE2' ' A' ' 82' ' ' LYS . 6.5 p -104.93 116.16 48.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 108.845 -0.798 . . . . 75.120000000000005 108.845 -177.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -91.02 -10.88 40.6 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 122.212 -0.305 . . . . 72.430000000000007 111.761 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 35.0 mm -89.54 116.17 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 108.594 -0.891 . . . . 75.219999999999999 108.594 168.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -75.97 88.69 2.94 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 109.102 -0.703 . . . . 75.329999999999998 109.102 176.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -72.27 110.94 7.05 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 114.843 -1.071 . . . . 74.319999999999993 111.213 -169.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -177.6 -141.34 4.08 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-N 115.87 -0.604 . . . . 55.340000000000003 112.208 177.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.56 59.18 4.63 Favored Glycine 0 C--N 1.344 1.001 0 N-CA-C 112.0 -0.44 . . . . 74.340000000000003 112.0 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 85.2 mt -123.69 157.57 33.59 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.185 0.994 . . . . 74.120000000000005 110.242 -177.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.9 p -83.22 7.57 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.489 0 C-N-CA 123.932 0.893 . . . . 71.430000000000007 110.867 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -57.53 156.91 15.01 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 125.44 1.496 . . . . 74.120000000000005 112.302 175.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -56.67 153.84 34.16 Favored 'Trans proline' 0 C--N 1.394 2.924 0 C-N-CA 122.985 2.457 . . . . 63.140000000000001 113.301 -174.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -82.45 27.44 0.51 Allowed 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.238 1.015 . . . . 74.030000000000001 112.629 -169.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -125.93 162.25 25.64 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.05 0.94 . . . . 75.439999999999998 110.253 -176.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.87 142.02 28.13 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.028 -1.101 . . . . 72.109999999999999 108.028 170.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.415 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 20.3 t70 -106.7 105.13 15.02 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 106.891 -1.522 . . . . 64.200000000000003 106.891 166.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.604 ' HB ' ' HB ' ' A' ' 48' ' ' VAL . 31.6 m -112.79 91.24 3.58 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.118 0.567 . . . . 63.119999999999997 110.376 -171.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.489 ' HA ' ' O ' ' A' ' 46' ' ' PHE . 39.6 tt0 -98.32 114.68 27.07 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.9 0.48 . . . . 65.129999999999995 109.73 -175.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -98.68 120.24 38.78 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 109.199 -0.667 . . . . 74.209999999999994 109.199 171.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -108.22 144.24 35.93 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.171 0.988 . . . . 72.430000000000007 110.382 -175.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -160.08 132.27 4.29 Favored Pre-proline 0 N--CA 1.479 0.992 0 CA-C-O 119.193 -0.432 . . . . 74.409999999999997 110.206 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.41 -24.83 42.46 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 122.94 2.427 . . . . 74.310000000000002 113.616 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.487 ' HB2' HG12 ' A' ' 117' ' ' ILE . 13.2 m -95.1 8.49 42.81 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.738 0.415 . . . . 75.120000000000005 111.015 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.405 ' O ' ' HA ' ' A' ' 44' ' ' ASN . 74.5 t80 -111.43 100.43 9.02 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 107.816 -1.179 . . . . 73.430000000000007 107.816 175.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 110' ' ' GLN . 96.3 mt -120.58 154.09 35.87 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.196 0.598 . . . . 75.25 109.658 173.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -71.21 -22.56 62.0 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.111 0.964 . . . . 75.129999999999995 112.575 -170.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.61 27.19 6.65 Favored Glycine 0 N--CA 1.468 0.831 0 N-CA-C 112.268 -0.333 . . . . 73.019999999999996 112.268 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.526 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 14.5 mm100 -135.17 78.2 1.72 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.339 0.656 . . . . 72.400000000000006 110.182 -175.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -29.38 69.58 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.148 -0.933 . . . . 72.150000000000006 112.034 174.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 6.8 pm0 -76.28 -11.09 59.85 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.161 0.584 . . . . 74.319999999999993 111.693 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.0 mt -91.19 -12.78 34.36 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.658 0.383 . . . . 70.310000000000002 110.981 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 64.8 mt -69.1 -27.69 65.82 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.047 0.539 . . . . 71.510000000000005 110.631 175.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -89.72 0.9 56.69 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.612 0.765 . . . . 75.349999999999994 112.132 173.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -90.86 -17.36 26.65 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.282 -0.636 . . . . 74.439999999999998 109.282 161.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.487 HG12 ' HB2' ' A' ' 105' ' ' CYS . 32.7 mt -87.22 104.89 14.62 Favored 'Isoleucine or valine' 0 C--N 1.357 0.9 0 N-CA-C 106.64 -1.615 . . . . 75.230000000000004 106.64 173.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.472 ' HE2' ' HA ' ' A' ' 118' ' ' LYS . 11.0 mmpt? -112.47 155.81 23.63 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.953 -0.388 . . . . 73.319999999999993 109.953 -174.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -107.14 -53.29 2.64 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.792 0.837 . . . . 73.319999999999993 109.152 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt 179.87 149.11 0.31 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.904 0.881 . . . . 64.420000000000002 110.867 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.0 p -85.96 -16.26 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 C-N-CA 123.466 0.706 . . . . 75.200000000000003 110.498 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 33.7 p -76.21 -8.49 57.16 Favored 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 123.736 0.814 . . . . 65.140000000000001 112.25 177.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 33.1 t -131.62 -152.87 0.52 Allowed 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 106.939 -1.504 . . . . 73.540000000000006 106.939 169.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.5 p -59.24 131.98 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 109.068 -0.715 . . . . 72.420000000000002 109.068 165.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 31.8 p . . . . . 0 C--O 1.254 1.316 0 CA-C-O 118.68 -0.676 . . . . 72.519999999999996 111.236 -174.828 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.422 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.312 0 N-CA-C 110.019 -0.363 . . . . 74.219999999999999 110.019 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 130.26 45.6 0.16 Allowed Glycine 0 C--N 1.343 0.96 0 CA-C-N 116.317 -0.401 . . . . 73.510000000000005 112.253 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -72.18 140.32 48.7 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.53 0.732 . . . . 75.439999999999998 110.298 176.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 67.59 73.85 0.31 Allowed 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.983 1.313 . . . . 73.420000000000002 111.783 173.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -145.46 -172.83 3.96 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.427 1.491 . . . . 75.120000000000005 108.52 175.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -113.65 82.62 1.71 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 122.1 0.953 . . . . 73.120000000000005 110.614 174.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.3 t-80 -100.37 129.0 46.3 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 106.902 -1.518 . . . . 73.409999999999997 106.902 168.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 34.0 p-80 -61.18 143.44 55.54 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 123.249 0.343 . . . . 74.430000000000007 110.736 -175.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.8 t -75.26 162.66 28.25 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 122.795 0.438 . . . . 71.120000000000005 110.58 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -75.25 161.5 29.27 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.904 -0.589 . . . . 73.099999999999994 111.157 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 35.2 mmt -80.57 -161.0 0.34 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.897 0.879 . . . . 75.109999999999999 111.562 -173.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.22 81.44 0.35 Allowed 'General case' 0 C--N 1.355 0.831 0 C-N-CA 123.563 0.745 . . . . 72.349999999999994 110.162 173.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -152.15 -67.06 0.01 OUTLIER Glycine 0 N--CA 1.466 0.664 0 N-CA-C 109.325 -1.51 . . . . 41.509999999999998 109.325 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -68.96 134.54 29.94 Favored 'Trans proline' 0 C--N 1.363 1.326 0 C-N-CA 122.559 2.172 . . . . 50.119999999999997 108.333 156.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.457 ' HB3' HG21 ' A' ' 17' ' ' VAL . 73.5 m -61.73 130.69 47.01 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.234 0.54 . . . . 64.230000000000004 112.35 -172.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.466 ' N ' HD21 ' A' ' 16' ' ' ASN . 0.8 OUTLIER -88.23 24.63 1.82 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.599 1.16 . . . . 63.43 110.276 -176.376 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.457 HG21 ' HB3' ' A' ' 15' ' ' SER . 84.1 t -61.27 129.83 91.13 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 124.267 1.027 . . . . 74.030000000000001 110.212 178.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -53.0 140.35 59.46 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 123.44 2.76 . . . . 70.140000000000001 111.593 175.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.49 -40.4 65.33 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.635 0.774 . . . . 72.239999999999995 112.235 -178.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -52.33 -49.84 63.46 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.05 0.94 . . . . 71.25 112.307 171.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 90.4 mt -81.65 -25.1 35.88 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.887 0.475 . . . . 72.040000000000006 110.684 -170.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.402 ' HG1' HG12 ' A' ' 17' ' ' VAL . 73.5 m -64.74 -53.36 48.38 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 124.183 0.993 . . . . 71.409999999999997 110.657 174.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.533 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -69.34 -39.94 77.86 Favored 'General case' 0 C--N 1.345 0.396 0 CA-C-N 115.457 -0.792 . . . . 74.140000000000001 110.848 -179.395 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.406 ' O ' HG22 ' A' ' 28' ' ' VAL . 54.4 tp -60.49 -48.44 81.77 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.594 0.758 . . . . 73.400000000000006 111.733 176.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.595 ' HE1' ' HA ' ' A' ' 108' ' ' ARG . 56.3 t90 -59.04 -47.72 84.21 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.99 0.516 . . . . 73.010000000000005 111.13 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.9 m -59.4 -40.79 87.78 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.044 0.938 . . . . 75.239999999999995 110.886 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 22.1 tp -62.92 -52.92 61.17 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.752 1.621 . . . . 74.219999999999999 112.355 -178.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.412 HG11 ' HB3' ' A' ' 39' ' ' TRP . 93.6 t -60.84 -32.2 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 C-N-CA 124.227 1.011 . . . . 71.099999999999994 111.053 179.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.2 m -90.16 -5.84 56.02 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.271 1.028 . . . . 74.5 112.292 -176.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.409 ' HB3' ' OG1' ' A' ' 33' ' ' THR . 14.9 t70 -86.42 127.16 62.06 Favored Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 123.095 0.558 . . . . 72.209999999999994 111.192 -174.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.8 -32.39 77.81 Favored 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 123.782 2.988 . . . . 74.430000000000007 114.526 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -72.11 -39.94 68.51 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 122.901 0.481 . . . . 75.030000000000001 110.262 -178.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.409 ' OG1' ' HB3' ' A' ' 30' ' ' ASP . 29.8 p -98.14 0.46 46.03 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.736 -0.666 . . . . 64.439999999999998 111.445 -176.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -55.04 -31.21 60.92 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.603 1.161 . . . . 73.510000000000005 111.074 173.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.84 -39.94 86.85 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.065 0.946 . . . . 74.430000000000007 112.801 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 48.4 mt -103.54 -13.49 16.55 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.863 0.465 . . . . 75.239999999999995 111.96 -178.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.6 tt -159.81 122.27 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 121.061 0.458 . . . . 71.150000000000006 110.042 177.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 26.6 p -139.52 148.7 42.99 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 122.86 0.464 . . . . 72.430000000000007 111.245 -173.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.412 ' HB3' HG11 ' A' ' 28' ' ' VAL . 20.5 p-90 -77.85 148.99 34.41 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.418 0.687 . . . . 73.120000000000005 109.977 175.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.9 m -81.87 144.51 51.87 Favored Pre-proline 0 CA--C 1.551 1.008 0 N-CA-C 108.618 -0.882 . . . . 74.150000000000006 108.618 174.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.35 -22.15 15.27 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 123.883 3.055 . . . . 74.450000000000003 115.219 -173.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.3 m -78.06 -37.79 45.91 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.01 0.524 . . . . 45.549999999999997 111.073 176.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.9 4.14 51.62 Favored Glycine 0 C--N 1.351 1.416 0 N-CA-C 114.875 0.71 . . . . 63.310000000000002 114.875 167.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 6.6 p30 -106.5 2.08 25.95 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.804 0.842 . . . . 74.319999999999993 111.672 -175.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 81.0 p -148.01 158.09 43.87 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 109.016 -0.735 . . . . 75.510000000000005 109.016 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -142.57 152.67 42.81 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.8 0.44 . . . . 75.430000000000007 110.139 176.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -108.53 141.89 39.77 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.762 0.825 . . . . 75.519999999999996 109.336 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.437 HG13 ' HE1' ' A' ' 68' ' ' MET . 53.0 t -118.48 134.11 63.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 107.499 -1.297 . . . . 75.409999999999997 107.499 177.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 93.3 m-85 -123.45 147.21 47.38 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.853 0.861 . . . . 73.340000000000003 110.088 -172.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 48.11 63.32 2.09 Favored 'General case' 0 C--N 1.352 0.714 0 O-C-N 125.33 1.644 . . . . 74.349999999999994 111.356 175.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.524 ' HG2' ' HE3' ' A' ' 68' ' ' MET . 99.2 mt-30 -54.56 -29.14 50.29 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.309 1.044 . . . . 73.549999999999997 113.3 -171.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -63.42 -45.51 94.77 Favored Glycine 0 CA--C 1.531 1.069 0 O-C-N 123.36 0.413 . . . . 63.229999999999997 112.322 172.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -74.04 -45.71 47.89 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.81 0.844 . . . . 74.200000000000003 110.574 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.409 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 80.1 t80 -55.28 -52.6 62.91 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.752 1.621 . . . . 73.319999999999993 111.2 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.493 ' HB1' ' HB2' ' A' ' 68' ' ' MET . . . -66.92 -25.95 66.62 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.159 0.429 . . . . 73.25 112.159 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.8 -49.99 18.79 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.756 0.822 . . . . 75.209999999999994 112.25 -177.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.497 ' HG3' HG22 ' A' ' 58' ' ' VAL . 6.1 pt-20 -105.19 -42.63 5.23 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 112.746 0.647 . . . . 72.25 112.746 -175.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.497 HG22 ' HG3' ' A' ' 57' ' ' GLU . 74.2 t -76.77 -43.98 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 C-N-CA 123.109 0.564 . . . . 70.329999999999998 111.877 -167.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.467 ' HG ' ' HA ' ' A' ' 55' ' ' ALA . 38.8 mt -60.85 -54.76 51.33 Favored Pre-proline 0 CA--C 1.564 1.481 0 CA-C-O 118.272 -0.871 . . . . 73.099999999999994 112.082 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.488 ' HG3' ' ND2' ' A' ' 66' ' ' ASN . 30.9 Cg_endo -65.87 -12.23 34.37 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 121.925 1.75 . . . . 74.140000000000001 113.621 178.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -77.96 -62.53 1.64 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.113 0.965 . . . . 74.439999999999998 111.259 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.481 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 43.0 m-85 -78.77 -51.02 10.36 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.304 0.573 . . . . 72.239999999999995 110.676 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -89.36 -166.61 1.64 Allowed 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 107.53 -1.285 . . . . 74.099999999999994 107.53 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.59 43.57 3.11 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 119.531 1.059 . . . . 74.0 110.465 -178.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -163.61 162.64 24.4 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.06 -0.973 . . . . 71.439999999999998 108.854 -175.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.488 ' ND2' ' HG3' ' A' ' 60' ' ' PRO . 10.2 m120 -105.9 -148.95 0.42 Allowed 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 106.713 -1.588 . . . . 71.200000000000003 106.713 174.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 68.88 105.36 0.05 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.734 0.813 . . . . 73.409999999999997 111.644 169.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.524 ' HE3' ' HG2' ' A' ' 51' ' ' GLN . 13.8 tpt -70.39 -28.2 64.91 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.604 -0.725 . . . . 71.310000000000002 110.869 -175.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.15 -39.4 75.16 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.197 0.599 . . . . 73.349999999999994 111.32 176.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.8 t -65.88 -43.66 87.65 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.304 1.041 . . . . 75.430000000000007 111.388 177.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -65.13 -52.95 52.17 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.123 0.969 . . . . 73.530000000000001 111.161 -177.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.411 ' HA ' HD11 ' A' ' 75' ' ' LEU . 59.6 t -63.33 -34.4 66.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 CA-C-N 115.58 -0.736 . . . . 74.109999999999999 110.884 178.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -55.84 -42.31 75.59 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.26 0.624 . . . . 75.310000000000002 111.113 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -62.94 -47.31 83.76 Favored 'General case' 0 C--N 1.347 0.462 0 O-C-N 124.018 0.823 . . . . 72.219999999999999 110.105 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.411 HD11 ' HA ' ' A' ' 72' ' ' VAL . 77.3 mt -60.54 -44.62 95.91 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.222 1.009 . . . . 74.310000000000002 111.968 -177.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.4 HD22 HG13 ' A' ' 72' ' ' VAL . 66.9 m-80 -55.61 -41.04 72.88 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.979 0.512 . . . . 75.120000000000005 111.432 175.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 67.2 mtm -72.12 -36.9 69.55 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 116.221 -0.445 . . . . 74.120000000000005 110.708 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -77.34 -7.71 56.48 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.181 0.592 . . . . 74.120000000000005 111.251 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.91 14.4 56.47 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-O 119.631 -0.538 . . . . 74.010000000000005 114.419 174.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -76.39 134.91 39.5 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 109.117 -0.698 . . . . 72.349999999999994 109.117 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -99.28 123.26 43.41 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.881 -0.785 . . . . 74.420000000000002 108.881 -175.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.503 ' HE3' HG22 ' A' ' 99' ' ' THR . 1.3 tmtp? -72.16 116.83 13.05 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.277 -1.009 . . . . 75.150000000000006 108.277 174.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.556 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 61.7 t -107.24 122.09 60.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.911 0 N-CA-C 108.276 -1.009 . . . . 70.400000000000006 108.276 177.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.5 t -82.06 119.77 32.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 124.336 1.054 . . . . 75.439999999999998 109.669 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -112.58 -49.66 2.94 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.782 -0.821 . . . . 74.040000000000006 108.782 174.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.425 HG12 ' HB3' ' A' ' 98' ' ' ASP . 50.2 mm -78.19 94.59 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 108.366 -0.976 . . . . 75.209999999999994 108.366 172.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.406 ' HB2' HD12 ' A' ' 91' ' ' LEU . 41.1 mt-10 -88.27 112.96 23.4 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 114.356 -1.293 . . . . 70.319999999999993 109.455 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -76.18 152.66 36.59 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.544 0.738 . . . . 72.409999999999997 110.513 177.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 148.57 -120.8 1.24 Allowed Glycine 0 C--N 1.338 0.69 0 N-CA-C 110.346 -1.102 . . . . 71.0 110.346 -177.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -98.01 -0.62 58.64 Favored Glycine 0 C--N 1.343 0.917 0 CA-C-O 119.987 -0.341 . . . . 74.219999999999999 112.873 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.406 HD12 ' HB2' ' A' ' 87' ' ' GLU . 59.2 mt -75.56 143.03 42.63 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.236 0.614 . . . . 74.420000000000002 111.417 -175.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 28.0 m -100.21 16.22 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.165 0.986 . . . . 75.239999999999995 111.023 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -62.19 142.34 95.76 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 109.516 -0.55 . . . . 74.329999999999998 109.516 172.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -49.82 144.88 19.55 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 124.071 3.18 . . . . 72.129999999999995 113.964 -163.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -79.7 10.41 4.06 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 114.534 -1.212 . . . . 75.209999999999994 112.231 -169.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -73.3 170.44 15.02 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.67 -0.695 . . . . 73.420000000000002 110.39 171.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.456 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 22.0 m-20 -90.43 133.25 35.15 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.799 -0.815 . . . . 72.209999999999994 108.799 164.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.425 ' HB3' HG12 ' A' ' 86' ' ' ILE . 9.1 t70 -131.37 104.23 6.89 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 106.057 -1.831 . . . . 71.430000000000007 106.057 165.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.503 HG22 ' HE3' ' A' ' 82' ' ' LYS . 32.6 m -126.99 111.38 14.01 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.675 -0.693 . . . . 63.219999999999999 109.281 -173.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.556 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 41.5 tt0 -100.55 112.02 24.34 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 110.1 -0.333 . . . . 73.540000000000006 110.1 -173.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -97.45 122.53 40.6 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 109.032 -0.729 . . . . 71.129999999999995 109.032 174.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -120.98 145.56 47.61 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.552 0.741 . . . . 64.329999999999998 110.382 -176.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 -156.8 131.98 5.46 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 108.354 -0.98 . . . . 75.409999999999997 108.354 174.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -64.45 -20.81 66.38 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.986 2.457 . . . . 71.540000000000006 113.651 -175.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.463 ' HB2' HG12 ' A' ' 117' ' ' ILE . 18.5 m -98.4 7.12 46.62 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.324 0.65 . . . . 71.310000000000002 111.496 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.461 ' O ' ' HA ' ' A' ' 44' ' ' ASN . 62.3 t80 -108.09 100.87 10.16 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 107.721 -1.215 . . . . 75.150000000000006 107.721 175.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.565 ' HB2' ' HB3' ' A' ' 110' ' ' GLN . 96.0 mt -125.17 146.21 49.6 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.351 0.66 . . . . 72.310000000000002 109.321 173.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.595 ' HA ' ' HE1' ' A' ' 25' ' ' TRP . 31.4 ttt180 -83.11 102.11 11.61 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 109.397 -0.594 . . . . 74.010000000000005 109.397 176.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 123.99 -38.84 2.31 Favored Glycine 0 C--N 1.337 0.624 0 N-CA-C 110.349 -1.1 . . . . 72.450000000000003 110.349 -177.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.565 ' HB3' ' HB2' ' A' ' 107' ' ' LEU . 2.6 tp-100 -88.87 56.39 3.71 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.741 0.816 . . . . 70.230000000000004 109.012 176.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -62.87 -18.28 62.74 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.346 1.059 . . . . 73.329999999999998 112.514 -178.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -65.28 -20.91 66.63 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.558 0.743 . . . . 75.439999999999998 112.942 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.9 mt -91.89 -10.32 40.03 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.159 0.583 . . . . 71.430000000000007 111.693 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 74.5 mt -67.28 -35.41 79.42 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 121.394 0.616 . . . . 73.540000000000006 110.764 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -77.93 -4.93 49.36 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.498 -0.774 . . . . 64.450000000000003 111.99 176.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -103.17 -2.02 28.03 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.568 0.747 . . . . 72.150000000000006 110.014 173.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.463 HG12 ' HB2' ' A' ' 105' ' ' CYS . 60.0 mt -81.48 115.53 24.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.91 0 N-CA-C 107.053 -1.462 . . . . 72.510000000000005 107.053 168.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -105.68 136.55 45.07 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.756 -0.461 . . . . 74.040000000000006 109.756 -171.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -90.15 -21.74 22.07 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.115 0.566 . . . . 74.430000000000007 110.402 172.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -129.71 151.79 49.92 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.098 0.959 . . . . 73.430000000000007 108.864 176.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.1 p -70.73 -23.11 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 123.431 0.692 . . . . 75.299999999999997 110.648 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 48.9 p -82.69 178.55 8.14 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.554 0.742 . . . . 74.120000000000005 110.858 173.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 27.4 t -69.86 116.32 10.11 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.566 0.746 . . . . 71.310000000000002 110.446 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.7 p -156.33 155.48 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.118 0 C-N-CA 123.131 0.573 . . . . 70.219999999999999 110.614 -173.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 21.7 m . . . . . 0 C--O 1.251 1.132 0 N-CA-C 107.457 -1.312 . . . . 73.420000000000002 107.457 170.51 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.2 mtt . . . . . 0 N--CA 1.486 1.367 0 N-CA-C 110.108 -0.33 . . . . 72.340000000000003 110.108 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 146.79 113.42 0.78 Allowed Glycine 0 C--N 1.348 1.247 0 N-CA-C 111.481 -0.648 . . . . 71.340000000000003 111.481 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -120.82 5.42 10.48 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.322 0.649 . . . . 63.539999999999999 110.07 177.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 52.3 m-70 -123.82 169.11 11.89 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.275 1.03 . . . . 74.540000000000006 110.076 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -152.1 120.24 6.28 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 109.131 -0.692 . . . . 75.319999999999993 109.131 171.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -83.29 142.96 30.72 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 109.27 -0.641 . . . . 74.140000000000001 109.27 175.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -153.62 154.26 33.87 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.012 -0.54 . . . . 73.439999999999998 110.008 -169.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 47.7 m80 -73.19 92.84 1.78 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.671 -0.695 . . . . 72.209999999999994 109.43 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.1 t -96.24 113.44 25.04 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.544 0.738 . . . . 62.039999999999999 110.61 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 17.5 p-80 -156.17 134.05 11.16 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.21 1.004 . . . . 75.120000000000005 108.733 173.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.0 ppp? -83.3 171.85 13.15 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.931 0.492 . . . . 74.430000000000007 109.771 173.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.59 61.46 5.72 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.159 0.584 . . . . 74.219999999999999 112.358 -174.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.45 -97.1 0.81 Allowed Glycine 0 C--N 1.344 1.009 0 N-CA-C 109.777 -1.329 . . . . 44.539999999999999 109.777 168.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -91.97 101.91 0.21 Allowed 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 122.581 2.187 . . . . 64.409999999999997 109.842 166.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 58.7 m -59.77 144.61 47.86 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.134 -0.484 . . . . 71.319999999999993 111.656 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.478 ' HB2' ' HB2' ' A' ' 115' ' ' GLU . 20.0 m-80 -84.34 21.75 1.37 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.171 0.989 . . . . 72.319999999999993 111.875 -170.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.1 t -67.77 118.18 55.25 Favored Pre-proline 0 CA--C 1.548 0.866 0 N-CA-C 108.81 -0.811 . . . . 65.519999999999996 108.81 173.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.516 ' HD2' HD12 ' A' ' 21' ' ' LEU . 32.4 Cg_exo -60.3 147.86 92.22 Favored 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.509 2.139 . . . . 74.420000000000002 111.682 173.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.63 -40.3 62.63 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.715 0.806 . . . . 70.439999999999998 111.508 176.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.533 ' HB3' ' HH ' ' A' ' 78' ' ' TYR . 45.8 t80 -53.72 -46.92 70.94 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.208 1.003 . . . . 73.0 111.705 174.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.516 HD12 ' HD2' ' A' ' 18' ' ' PRO . 28.9 mt -76.72 -37.35 56.21 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 112.468 0.544 . . . . 73.450000000000003 112.468 -173.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.8 t -69.87 -36.89 75.85 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 117.83 0.286 . . . . 75.540000000000006 110.699 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -75.73 -36.42 59.95 Favored 'General case' 0 C--N 1.358 0.964 0 C-N-CA 123.039 0.536 . . . . 71.530000000000001 110.392 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.2 tp -60.32 -44.6 95.31 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.307 0.643 . . . . 71.109999999999999 111.027 172.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 87.0 t90 -61.04 -44.85 96.78 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.714 0.806 . . . . 74.540000000000006 110.807 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 87.3 m -60.01 -38.99 84.25 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.213 1.005 . . . . 72.329999999999998 110.755 175.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.429 ' HG ' HD13 ' A' ' 37' ' ' ILE . 29.2 tp -67.41 -46.15 74.05 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.162 1.385 . . . . 72.340000000000003 111.726 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.5 t -62.4 -34.34 63.98 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 125.259 1.424 . . . . 75.129999999999995 111.343 175.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.8 t -90.01 -5.09 57.01 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.007 0.923 . . . . 71.340000000000003 111.871 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -82.15 119.73 75.66 Favored Pre-proline 0 N--CA 1.48 1.07 0 C-N-CA 123.361 0.664 . . . . 64.430000000000007 111.004 -174.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -71.28 -20.52 27.89 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.428 2.085 . . . . 74.519999999999996 113.075 176.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -66.44 -40.82 89.69 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.61 0.364 . . . . 53.450000000000003 110.198 176.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.8 p -99.64 4.36 45.63 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.321 0.648 . . . . 74.519999999999996 111.276 -175.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -53.49 -29.0 33.89 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 125.365 1.466 . . . . 74.040000000000006 112.791 -178.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.32 -37.01 85.6 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.74 0.816 . . . . 44.140000000000001 112.542 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.7 mt -114.6 -11.58 12.36 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 112.512 0.56 . . . . 72.409999999999997 112.512 -176.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.429 HD13 ' HG ' ' A' ' 27' ' ' LEU . 14.8 tt -160.96 130.12 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-O 121.108 0.48 . . . . 75.129999999999995 110.207 175.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.3 p -153.68 164.19 38.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.483 -0.78 . . . . 73.319999999999993 109.908 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 30.6 p-90 -66.12 148.07 52.38 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 123.942 0.776 . . . . 73.140000000000001 110.579 172.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.8 m -75.13 153.46 86.42 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 123.354 0.662 . . . . 71.140000000000001 110.835 171.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -60.83 -27.54 84.96 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.278 1.985 . . . . 61.329999999999998 111.375 170.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.6 m -59.25 -32.07 69.66 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.852 1.261 . . . . 64.340000000000003 111.956 172.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.42 -14.58 11.68 Favored Glycine 0 C--N 1.348 1.196 0 N-CA-C 115.122 0.809 . . . . 70.329999999999998 115.122 177.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 7.5 p30 -103.51 20.66 17.48 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.142 0.977 . . . . 72.319999999999993 110.64 -176.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.2 p -166.3 173.37 10.13 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.779 0.831 . . . . 64.349999999999994 109.833 -172.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 49.1 p90 -147.16 144.03 28.67 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.754 0.422 . . . . 72.510000000000005 110.607 176.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -100.52 148.46 24.76 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.812 0.845 . . . . 72.200000000000003 109.882 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.618 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 96.7 t -129.81 141.12 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.702 1.201 . . . . 75.109999999999999 107.959 176.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -124.03 147.5 47.78 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.697 0.799 . . . . 73.409999999999997 109.21 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 48.14 69.73 0.51 Allowed 'General case' 0 C--N 1.353 0.724 0 O-C-N 124.936 1.397 . . . . 72.409999999999997 111.293 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.436 ' HB3' ' HG2' ' A' ' 68' ' ' MET . 52.0 mt-30 -51.26 -30.93 19.28 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.637 1.175 . . . . 73.530000000000001 113.12 -174.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.86 -45.81 49.41 Favored Glycine 0 CA--C 1.534 1.233 0 O-C-N 123.382 0.426 . . . . 71.5 112.658 176.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -70.19 -42.26 72.64 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.591 0.757 . . . . 71.439999999999998 110.249 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -54.67 -48.35 72.48 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.5 1.52 . . . . 73.310000000000002 110.756 172.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.512 ' HB2' ' HB2' ' A' ' 68' ' ' MET . . . -64.8 -33.87 77.02 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 116.08 -0.509 . . . . 65.439999999999998 111.814 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -67.22 -47.4 70.95 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.497 1.119 . . . . 70.239999999999995 112.741 -178.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.463 ' HG3' HG22 ' A' ' 58' ' ' VAL . 9.7 pt-20 -112.32 -36.92 5.15 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 114.533 1.308 . . . . 72.420000000000002 114.533 -173.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.463 HG22 ' HG3' ' A' ' 57' ' ' GLU . 71.2 t -81.91 -42.91 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.467 0.707 . . . . 65.450000000000003 111.552 -169.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 47.9 mt -66.66 -44.52 54.51 Favored Pre-proline 0 CA--C 1.555 1.171 0 CA-C-O 117.928 -1.034 . . . . 75.400000000000006 112.718 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.404 ' HG3' ' ND2' ' A' ' 66' ' ' ASN . 29.0 Cg_endo -65.49 -15.3 49.03 Favored 'Trans proline' 0 C--N 1.383 2.343 0 CA-C-N 121.813 1.683 . . . . 71.049999999999997 113.647 171.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -74.16 -59.7 2.61 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.482 0.313 . . . . 72.519999999999996 110.843 176.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.421 ' CD1' HD11 ' A' ' 27' ' ' LEU . 47.7 m-85 -91.19 -14.91 30.19 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 113.107 0.78 . . . . 74.439999999999998 113.107 -175.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -133.11 -174.36 3.46 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 108.878 -0.786 . . . . 72.120000000000005 108.878 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -119.67 46.56 1.9 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.207 0.603 . . . . 74.120000000000005 109.533 -176.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 18.7 p80 -158.74 161.68 37.05 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.724 0.809 . . . . 75.340000000000003 109.603 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.435 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 9.4 m120 -118.1 2.25 12.02 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.613 0.765 . . . . 75.349999999999994 110.161 176.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -83.16 115.23 21.83 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.225 0.61 . . . . 72.099999999999994 110.669 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.512 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 12.1 tpt -66.81 -40.02 87.91 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.686 0.794 . . . . 74.310000000000002 110.556 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.63 -34.83 74.85 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.45 0.7 . . . . 72.349999999999994 112.03 -177.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.2 t -66.26 -42.85 87.94 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.81 0.844 . . . . 64.420000000000002 111.499 176.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -60.33 -49.6 76.96 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.4 1.08 . . . . 73.510000000000005 110.364 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 69.1 t -64.21 -36.56 77.4 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 124.225 1.01 . . . . 73.120000000000005 110.845 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -60.07 -41.54 92.62 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.609 0.763 . . . . 74.340000000000003 111.073 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -63.25 -45.7 90.34 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.929 -0.578 . . . . 72.340000000000003 110.767 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.406 ' HB3' ' HB2' ' A' ' 80' ' ' PHE . 94.1 mt -62.82 -38.31 90.25 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.814 0.846 . . . . 74.219999999999999 111.708 -177.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -62.75 -32.69 73.88 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.806 0.442 . . . . 73.430000000000007 111.954 173.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 47.0 mtm -69.26 -35.15 75.8 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 110.436 -0.209 . . . . 73.430000000000007 110.436 173.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.533 ' HH ' ' HB3' ' A' ' 20' ' ' PHE . 57.2 m-85 -75.85 -18.59 59.38 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.252 0.621 . . . . 74.239999999999995 111.593 178.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.82 26.67 23.92 Favored Glycine 0 C--N 1.345 1.077 0 CA-C-O 119.709 -0.495 . . . . 73.519999999999996 113.997 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.454 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . 64.5 m-85 -78.72 133.01 37.18 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.856 -0.794 . . . . 74.209999999999994 108.856 171.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -102.12 127.61 48.96 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.267 0.627 . . . . 72.310000000000002 109.318 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.679 ' HE2' ' HB ' ' A' ' 84' ' ' VAL . 1.3 tmtp? -76.18 124.81 28.04 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.057 -1.09 . . . . 74.420000000000002 108.057 176.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.0 t -128.63 115.5 37.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 106.644 -1.613 . . . . 73.200000000000003 106.644 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.679 ' HB ' ' HE2' ' A' ' 82' ' ' LYS . 9.2 p -102.86 114.79 43.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 CA-C-O 121.487 0.661 . . . . 72.019999999999996 109.502 -174.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -87.37 3.99 44.79 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.868 -0.605 . . . . 75.25 110.858 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 48.9 mm -109.43 153.16 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.733 1.213 . . . . 74.450000000000003 108.734 169.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.409 ' HB3' HD13 ' A' ' 91' ' ' LEU . 28.7 tt0 -134.52 131.86 38.48 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 109.809 -0.441 . . . . 64.120000000000005 109.809 171.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -86.03 16.95 3.8 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.72 1.208 . . . . 75.230000000000004 111.472 -175.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -76.8 -2.33 76.13 Favored Glycine 0 C--N 1.358 1.763 0 C-N-CA 123.066 0.365 . . . . 55.020000000000003 113.843 175.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 91.48 57.88 1.5 Allowed Glycine 0 C--N 1.35 1.359 0 N-CA-C 111.624 -0.59 . . . . 64.040000000000006 111.624 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.409 HD13 ' HB3' ' A' ' 87' ' ' GLU . 81.3 mt -107.94 -175.55 2.81 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.685 0.794 . . . . 75.030000000000001 110.392 -177.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.4 p -64.79 -17.1 20.97 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.309 0 C-N-CA 124.268 1.027 . . . . 75.530000000000001 110.991 171.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -65.11 130.89 94.98 Favored Pre-proline 0 CA--C 1.553 1.071 0 C-N-CA 124.032 0.933 . . . . 74.329999999999998 110.41 174.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -63.85 162.89 26.92 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 123.505 2.804 . . . . 63.020000000000003 112.989 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -69.05 -20.64 64.12 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.686 0.795 . . . . 75.120000000000005 112.544 -173.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -63.68 156.2 27.64 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.15 0.58 . . . . 71.430000000000007 110.232 174.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -104.52 124.31 49.05 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.973 -0.751 . . . . 73.540000000000006 108.973 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.468 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 15.9 t70 -88.88 107.58 19.07 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.639 -1.245 . . . . 73.129999999999995 107.639 173.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.618 ' HB ' ' HB ' ' A' ' 48' ' ' VAL . 11.6 m -102.99 98.02 8.04 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 123.527 0.731 . . . . 75.409999999999997 110.017 -177.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 46' ' ' PHE . 38.6 tt0 -100.37 113.64 26.54 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.781 -0.822 . . . . 70.519999999999996 108.781 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.454 ' HB3' ' HB3' ' A' ' 80' ' ' PHE . 73.4 m-85 -96.33 120.32 36.41 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.549 -0.908 . . . . 75.530000000000001 108.549 173.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -110.13 146.71 35.0 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.8 0.84 . . . . 74.109999999999999 110.548 -174.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 23.9 t-80 -163.35 130.06 2.42 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 123.659 0.783 . . . . 74.420000000000002 108.901 172.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -64.89 -23.43 62.04 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.844 2.363 . . . . 72.310000000000002 112.957 -176.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 56.9 m -95.12 3.87 54.28 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.269 0.628 . . . . 63.020000000000003 111.328 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 44' ' ' ASN . 62.8 t80 -103.46 100.45 10.31 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 106.862 -1.533 . . . . 74.430000000000007 106.862 173.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.575 ' HB2' ' HB2' ' A' ' 110' ' ' GLN . 70.2 mt -113.48 134.66 54.55 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 109.354 -0.61 . . . . 74.109999999999999 109.354 173.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.0 ppt_? -62.96 -17.77 62.41 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.424 1.09 . . . . 73.049999999999997 112.636 -176.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -101.16 -42.6 2.37 Favored Glycine 0 C--N 1.346 1.096 0 N-CA-C 111.768 -0.533 . . . . 73.200000000000003 111.768 173.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.575 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 2.5 mp0 -91.36 84.06 5.54 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.451 0.7 . . . . 74.430000000000007 111.2 -172.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.9 -18.89 62.0 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.331 1.052 . . . . 71.209999999999994 112.827 177.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.478 ' O ' ' HG2' ' A' ' 115' ' ' GLU . 4.8 pm0 -73.71 -14.52 61.16 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 111.637 0.236 . . . . 74.310000000000002 111.637 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 70.8 mt -84.16 -7.54 59.33 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.656 0.382 . . . . 74.239999999999995 111.792 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 51.0 mt -71.05 -21.62 62.23 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.055 0.542 . . . . 73.230000000000004 112.008 178.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 16' ' ' ASN . 16.9 pt-20 -80.18 -5.74 56.59 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 111.878 0.325 . . . . 75.239999999999995 111.878 174.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -90.9 -16.75 27.62 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.777 -0.823 . . . . 72.030000000000001 108.777 169.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.6 mt -90.87 73.46 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.886 0 N-CA-C 107.704 -1.221 . . . . 75.040000000000006 107.704 175.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.18 161.29 31.09 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.56 0.695 . . . . 73.120000000000005 110.945 169.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -109.75 -55.85 2.39 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.273 -1.01 . . . . 72.439999999999998 108.273 173.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.594 ' HD3' HG22 ' A' ' 124' ' ' VAL . 49.1 mtpt -146.12 164.1 33.24 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.248 1.019 . . . . 75.329999999999998 108.983 -177.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 28.0 m -88.66 -19.53 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-N 116.026 -0.534 . . . . 72.099999999999994 110.137 174.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 29.9 p -79.25 166.18 22.44 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 124.407 1.083 . . . . 75.209999999999994 110.728 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.2 m -74.11 93.87 2.34 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.731 0.812 . . . . 72.319999999999993 111.072 -173.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.594 HG22 ' HD3' ' A' ' 120' ' ' LYS . 41.1 t -119.77 135.13 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 108.267 -1.012 . . . . 73.25 108.267 176.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 27.8 p . . . . . 0 CA--C 1.551 0.984 0 C-N-CA 123.905 0.882 . . . . 70.209999999999994 109.163 -176.323 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 108.96 -0.756 . . . . 75.340000000000003 108.96 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.16 133.21 2.68 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 111.991 -0.443 . . . . 72.430000000000007 111.991 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 40.8 t-80 -101.91 15.63 28.42 Favored 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 108.857 -0.794 . . . . 70.540000000000006 108.857 171.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -65.16 129.4 39.59 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 124.822 1.249 . . . . 74.329999999999998 110.683 -176.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -119.98 150.96 39.69 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.118 0.567 . . . . 74.319999999999993 109.51 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -152.38 105.06 2.99 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.381 -0.97 . . . . 75.549999999999997 108.381 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -136.5 145.2 44.84 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.023 0.929 . . . . 75.209999999999994 109.185 175.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -140.29 82.53 1.86 Allowed 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.876 -1.157 . . . . 74.409999999999997 107.876 173.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.0 m -65.04 116.39 6.41 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.361 -0.836 . . . . 75.150000000000006 110.494 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -148.16 141.26 24.97 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.324 -0.991 . . . . 75.430000000000007 108.324 176.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 9.9 tpt -157.09 98.92 1.77 Allowed 'General case' 0 C--O 1.239 0.527 0 N-CA-C 109.0 -0.741 . . . . 73.049999999999997 109.0 -178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.34 87.91 0.12 Allowed 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.576 0.75 . . . . 72.409999999999997 109.215 174.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.35 123.53 6.86 Favored Glycine 0 C--N 1.343 0.963 0 CA-C-O 118.867 -0.963 . . . . 71.430000000000007 112.085 -175.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -72.48 75.62 2.45 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.433 2.089 . . . . 64.310000000000002 109.915 173.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.0 m -63.77 161.39 15.34 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.014 -0.994 . . . . 75.209999999999994 112.051 -172.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -87.02 29.3 0.83 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.914 0.885 . . . . 75.439999999999998 110.945 -172.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 47.1 t -70.05 130.2 90.03 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.278 1.031 . . . . 73.530000000000001 110.09 -174.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.412 ' HD2' HD12 ' A' ' 21' ' ' LEU . 49.9 Cg_exo -56.72 141.49 91.86 Favored 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.775 2.317 . . . . 71.450000000000003 111.148 173.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.92 -36.63 65.44 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.072 0.949 . . . . 55.210000000000001 113.022 -173.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -51.85 -43.94 63.42 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.035 0.534 . . . . 75.510000000000005 112.084 173.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.412 HD12 ' HD2' ' A' ' 18' ' ' PRO . 98.2 mt -84.29 -29.81 26.11 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.409 0.684 . . . . 74.530000000000001 110.4 -173.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.6 m -61.17 -39.64 90.9 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.273 1.029 . . . . 65.409999999999997 110.607 173.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.56 ' HA ' ' HE2' ' A' ' 23' ' ' LYS . 10.7 mmpt? -79.97 -47.79 14.41 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.715 -0.675 . . . . 72.109999999999999 110.473 177.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.474 ' O ' HG22 ' A' ' 28' ' ' VAL . 55.3 tp -56.47 -50.28 72.19 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.107 0.963 . . . . 74.5 112.502 -176.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 84.7 t90 -58.35 -47.78 82.69 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.791 0.436 . . . . 75.200000000000003 111.014 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.8 m -68.8 -22.6 64.25 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 115.684 -0.689 . . . . 71.430000000000007 111.42 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.407 HD13 ' CD1' ' A' ' 62' ' ' TYR . 31.0 tp -74.4 -44.31 52.56 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.393 1.077 . . . . 74.549999999999997 110.723 175.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.474 HG22 ' O ' ' A' ' 24' ' ' LEU . 60.0 t -61.92 -32.68 54.94 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 CA-C-O 121.685 0.755 . . . . 65.219999999999999 110.258 173.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.4 t -88.72 0.18 56.71 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 114.636 -1.165 . . . . 73.219999999999999 112.023 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -81.61 122.72 80.85 Favored Pre-proline 0 N--CA 1.479 1.02 0 O-C-N 121.919 -0.488 . . . . 71.530000000000001 111.448 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -73.62 -6.21 18.35 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 123.159 2.573 . . . . 64.409999999999997 113.822 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -86.35 -37.65 18.24 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.85 0.46 . . . . 73.120000000000005 110.987 174.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 41.6 p -104.34 8.61 35.94 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.772 0.429 . . . . 72.319999999999993 110.824 -175.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -59.51 -32.39 70.25 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.459 1.104 . . . . 61.450000000000003 111.896 -175.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.34 -32.35 73.24 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.637 0.775 . . . . 73.099999999999994 111.958 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 64.4 mt -102.82 -12.14 17.8 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.457 0.303 . . . . 73.430000000000007 111.219 -177.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.5 tt -159.89 122.83 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 123.053 0.541 . . . . 73.140000000000001 110.454 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 28.2 p -142.1 149.55 40.01 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.601 0.36 . . . . 70.239999999999995 110.567 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 22.7 p-90 -72.6 154.23 40.87 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.611 0.765 . . . . 73.519999999999996 111.148 177.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.6 m -81.41 141.0 48.71 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 109.121 -0.696 . . . . 61.049999999999997 109.121 169.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -50.36 -22.91 9.34 Favored 'Trans proline' 0 C--N 1.368 1.602 0 C-N-CA 123.373 2.715 . . . . 73.019999999999996 115.05 176.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 64.0 m -70.65 -30.27 66.85 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.999 0.52 . . . . 71.150000000000006 111.618 175.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.99 65.87 2.18 Favored Glycine 0 C--N 1.342 0.88 0 CA-C-N 116.308 -0.406 . . . . 50.149999999999999 112.474 177.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 26.8 p30 -168.52 -17.06 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.981 0.913 . . . . 74.120000000000005 111.725 -171.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.2 p -141.51 162.27 35.89 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 123.927 0.891 . . . . 72.510000000000005 108.701 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -140.19 146.38 38.65 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.572 0.225 . . . . 75.310000000000002 110.535 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -103.32 141.32 36.13 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.234 1.014 . . . . 74.049999999999997 109.536 -176.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.1 t -123.54 132.99 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.693 0.797 . . . . 75.439999999999998 108.983 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -122.75 151.96 41.09 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.549 1.14 . . . . 73.409999999999997 110.5 -174.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 53.62 60.82 3.43 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 124.584 1.178 . . . . 75.209999999999994 110.77 174.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -46.0 -37.31 6.44 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.006 1.322 . . . . 73.099999999999994 114.2 -170.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.51 -44.92 49.08 Favored Glycine 0 C--N 1.342 0.868 0 O-C-N 123.559 0.537 . . . . 44.509999999999998 112.844 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -72.83 -42.91 63.31 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.112 0.565 . . . . 73.430000000000007 110.111 -177.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -55.32 -52.62 62.89 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.188 1.395 . . . . 74.349999999999994 110.899 175.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.405 ' HA ' ' HG ' ' A' ' 59' ' ' LEU . . . -61.36 -31.82 71.71 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 116.298 -0.41 . . . . 64.340000000000003 111.676 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -70.49 -50.92 32.91 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.252 1.021 . . . . 75.409999999999997 112.421 -177.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.514 ' HG3' HG22 ' A' ' 58' ' ' VAL . 9.7 pt-20 -104.43 -39.24 6.5 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 112.855 0.687 . . . . 72.109999999999999 112.855 -173.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.514 HG22 ' HG3' ' A' ' 57' ' ' GLU . 96.5 t -80.94 -41.78 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.362 0.665 . . . . 62.109999999999999 112.016 -167.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.405 ' HG ' ' HA ' ' A' ' 55' ' ' ALA . 53.2 mt -64.15 -48.95 75.93 Favored Pre-proline 0 CA--C 1.565 1.528 0 CA-C-O 118.209 -0.9 . . . . 75.230000000000004 112.324 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.3 -8.49 23.52 Favored 'Trans proline' 0 C--N 1.387 2.598 0 CA-C-N 121.981 1.743 . . . . 74.25 113.281 175.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -73.63 -61.77 1.72 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.297 1.039 . . . . 72.319999999999993 110.391 174.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.541 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 25.5 m-85 -89.03 -38.59 14.29 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 112.005 0.372 . . . . 75.239999999999995 112.005 -177.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -102.81 -164.61 1.1 Allowed 'General case' 0 C--O 1.243 0.729 0 N-CA-C 107.566 -1.272 . . . . 75.540000000000006 107.566 176.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 31.5 mmtm -135.54 68.05 1.47 Allowed 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 121.856 0.836 . . . . 71.519999999999996 109.903 175.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -169.77 160.62 8.77 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 113.781 -1.554 . . . . 75.140000000000001 107.786 173.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -118.01 -5.79 10.97 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.74 0.416 . . . . 72.310000000000002 110.503 175.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -71.84 117.54 13.56 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 123.82 0.848 . . . . 73.319999999999993 110.47 176.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 11.7 ttm -70.89 -30.57 66.97 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.656 0.383 . . . . 71.25 111.034 176.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.67 -36.39 71.84 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.607 0.363 . . . . 73.319999999999993 111.241 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.42 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 40.2 t -63.94 -46.91 82.62 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.982 0.913 . . . . 73.040000000000006 111.633 172.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -63.18 -52.91 60.46 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.612 0.765 . . . . 75.439999999999998 111.052 -176.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.407 ' HA ' HD12 ' A' ' 75' ' ' LEU . 84.4 t -59.14 -40.66 81.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 124.088 0.955 . . . . 64.340000000000003 111.254 177.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.3 ttt-85 -56.82 -43.9 81.46 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.147 0.579 . . . . 74.310000000000002 111.559 177.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 70' ' ' SER . 16.7 mm100 -58.9 -49.83 76.32 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 124.024 0.828 . . . . 75.040000000000006 109.937 177.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.42 ' HB3' ' HB2' ' A' ' 80' ' ' PHE . 65.2 mt -58.35 -44.27 88.7 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.305 1.042 . . . . 73.319999999999993 112.086 -177.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -56.9 -39.55 74.63 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.504 0.722 . . . . 73.5 111.924 175.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 73.9 mtm -72.94 -35.03 66.9 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.051 0.54 . . . . 74.439999999999998 111.06 176.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 55.3 m-85 -85.26 2.92 41.84 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.093 0.557 . . . . 72.409999999999997 111.22 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.42 15.91 79.03 Favored Glycine 0 C--N 1.342 0.916 0 N-CA-C 114.652 0.621 . . . . 63.420000000000002 114.652 170.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.42 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 73.3 m-85 -73.74 129.42 37.9 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.273 0.559 . . . . 74.209999999999994 110.096 176.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -99.52 121.78 41.66 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.013 -0.994 . . . . 75.329999999999998 109.021 -175.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -81.45 126.75 32.03 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.588 1.155 . . . . 74.239999999999995 109.723 -175.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 85.8 t -128.97 119.72 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 108.17 -1.048 . . . . 72.109999999999999 108.17 175.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.5 p -99.68 126.0 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 108.415 -0.957 . . . . 71.420000000000002 108.415 -178.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -101.36 -23.52 14.36 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.573 0.349 . . . . 73.030000000000001 110.62 -177.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.54 HG12 ' HB3' ' A' ' 98' ' ' ASP . 29.4 mm -95.26 103.46 14.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 CA-C-O 121.04 0.448 . . . . 74.040000000000006 109.976 176.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -69.6 118.79 12.92 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 107.58 -1.267 . . . . 72.109999999999999 107.58 168.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -58.27 107.2 0.46 Allowed 'General case' 0 N--CA 1.477 0.924 0 O-C-N 124.529 1.143 . . . . 74.030000000000001 111.476 -168.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.61 172.12 29.66 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 114.193 -1.367 . . . . 64.349999999999994 111.747 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -83.12 57.29 5.07 Favored Glycine 0 N--CA 1.47 0.909 0 C-N-CA 123.401 0.524 . . . . 72.040000000000006 112.751 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 77.5 mt -84.02 -170.93 3.33 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.811 0.844 . . . . 73.019999999999996 110.88 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.5 p -81.08 42.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 123.255 1.502 . . . . 73.340000000000003 110.207 174.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.517 ' HB3' HD13 ' A' ' 86' ' ' ILE . 68.1 mttm -134.63 162.34 58.29 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 126.734 2.014 . . . . 74.310000000000002 106.959 -175.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.401 ' HB2' ' HG2' ' A' ' 96' ' ' ARG . 73.6 Cg_endo -70.33 137.39 33.69 Favored 'Trans proline' 0 C--N 1.372 1.775 0 CA-C-N 120.47 1.204 . . . . 74.519999999999996 109.615 167.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -74.73 -16.52 60.73 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 122.859 0.464 . . . . 75.519999999999996 111.11 -176.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.401 ' HG2' ' HB2' ' A' ' 94' ' ' PRO . 10.4 ptp180 -72.31 106.39 4.45 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 108.906 -0.776 . . . . 74.299999999999997 108.906 175.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -45.18 107.98 0.11 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.636 1.174 . . . . 62.43 112.958 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.54 ' HB3' HG12 ' A' ' 86' ' ' ILE . 15.5 t70 -91.37 122.2 33.77 Favored 'General case' 0 C--O 1.249 1.045 0 CA-C-N 114.867 -1.06 . . . . 62.299999999999997 108.191 177.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 57.8 m -129.27 117.23 20.36 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.894 -0.78 . . . . 75.420000000000002 108.894 -178.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -104.73 112.17 25.17 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.322 -0.992 . . . . 75.430000000000007 108.322 -175.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -96.93 123.88 40.76 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.824 -1.176 . . . . 74.510000000000005 107.824 175.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -122.65 145.75 48.08 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 122.985 0.514 . . . . 70.230000000000004 110.697 -173.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -156.53 132.31 5.74 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 108.66 -0.867 . . . . 73.409999999999997 108.66 176.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.74 -29.95 77.73 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.669 2.246 . . . . 73.329999999999998 113.195 -174.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 59.1 m -89.4 -2.78 58.53 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.641 0.376 . . . . 73.319999999999993 111.421 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' A' ' 44' ' ' ASN . 64.8 t80 -102.19 99.45 9.57 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 106.881 -1.525 . . . . 75.299999999999997 106.881 175.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.422 HD11 ' HG2' ' A' ' 110' ' ' GLN . 76.6 mt -120.79 164.7 16.2 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.95 0.405 . . . . 75.219999999999999 110.673 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -81.58 122.74 27.97 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.593 -0.73 . . . . 74.219999999999999 109.489 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 63.56 57.65 14.0 Favored Glycine 0 C--N 1.344 0.985 0 O-C-N 124.15 0.906 . . . . 64.129999999999995 111.974 -176.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.422 ' HG2' HD11 ' A' ' 107' ' ' LEU . 5.9 tp60 -156.18 63.64 0.56 Allowed 'General case' 0 CA--C 1.548 0.897 0 CA-C-O 121.919 0.866 . . . . 74.510000000000005 109.535 -172.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -52.35 -46.24 66.02 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 113.746 -1.57 . . . . 65.099999999999994 111.446 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 14.1 pm0 -65.74 -19.55 65.94 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.579 -1.191 . . . . 72.340000000000003 112.839 -174.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 27.9 mt -96.41 -20.11 18.69 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 119.181 0.901 . . . . 74.329999999999998 111.712 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 80.9 mt -63.95 -32.6 74.19 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-O 121.156 0.503 . . . . 73.129999999999995 110.376 175.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -79.35 -5.42 54.52 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 115.547 -0.751 . . . . 64.519999999999996 112.594 175.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -90.25 2.78 55.09 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 110.096 -0.335 . . . . 74.109999999999999 110.096 172.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 45.1 mt -96.98 128.01 48.61 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 N-CA-C 109.009 -0.737 . . . . 73.400000000000006 109.009 174.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.458 ' HE3' ' HA ' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -112.1 150.73 30.33 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.425 0.69 . . . . 74.140000000000001 110.031 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -82.92 33.63 0.44 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.151 0.98 . . . . 73.349999999999994 110.374 170.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -129.45 159.32 36.63 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.516 1.127 . . . . 75.439999999999998 109.156 -175.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.6 m -70.54 0.06 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 N-CA-C 113.539 0.94 . . . . 74.540000000000006 113.539 -173.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.9 t -64.2 -32.49 74.08 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 109.797 -0.446 . . . . 75.340000000000003 109.797 167.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 32.2 t -97.51 97.39 9.04 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 107.518 -1.29 . . . . 73.120000000000005 107.518 169.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 30.8 m -85.31 160.29 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.445 0.698 . . . . 74.209999999999994 111.996 -172.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 CA--C 1.553 1.085 0 C-N-CA 124.451 1.101 . . . . 54.210000000000001 109.034 172.996 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.486 1.374 0 N-CA-C 108.957 -0.757 . . . . 74.209999999999994 108.957 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -99.22 74.98 0.51 Allowed Glycine 0 C--N 1.346 1.084 0 O-C-N 123.291 0.37 . . . . 73.239999999999995 113.586 -173.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -125.92 9.64 7.55 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 117.296 0.548 . . . . 72.109999999999999 111.506 176.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 57.6 t60 -98.07 88.03 4.11 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.319 -0.993 . . . . 74.109999999999999 108.319 172.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -137.57 152.57 49.55 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.878 0.871 . . . . 73.219999999999999 109.573 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 48.1 p-80 -149.54 144.48 26.28 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.589 0.756 . . . . 73.439999999999998 109.339 172.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -113.16 146.38 39.34 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 124.474 1.11 . . . . 75.230000000000004 108.284 175.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 65.4 m-70 -67.05 90.63 0.19 Allowed 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 109.774 -0.454 . . . . 60.399999999999999 109.774 173.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.8 m -85.85 61.79 7.06 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.96 0.904 . . . . 74.310000000000002 109.356 175.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -88.1 114.39 24.67 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.253 -0.431 . . . . 75.230000000000004 111.369 -172.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 93.4 mmm -84.99 151.28 24.31 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.745 -0.661 . . . . 71.329999999999998 109.489 169.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -161.36 178.43 9.19 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 124.197 0.999 . . . . 72.420000000000002 109.83 -175.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -135.83 68.92 0.52 Allowed Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.415 -0.674 . . . . 74.25 111.415 175.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -87.46 137.3 4.18 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.312 2.008 . . . . 72.239999999999995 112.378 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.44 ' HB3' HG21 ' A' ' 17' ' ' VAL . 42.8 m -79.06 147.34 32.84 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.785 -0.643 . . . . 74.030000000000001 110.264 170.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -93.91 22.72 5.42 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.032 -0.986 . . . . 73.25 110.381 -175.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.44 HG21 ' HB3' ' A' ' 15' ' ' SER . 22.9 t -70.52 125.61 92.04 Favored Pre-proline 0 C--N 1.352 0.693 0 N-CA-C 108.982 -0.747 . . . . 74.420000000000002 108.982 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.486 ' HD2' HD13 ' A' ' 21' ' ' LEU . 21.4 Cg_exo -65.69 145.24 80.89 Favored 'Trans proline' 0 C--N 1.365 1.439 0 C-N-CA 122.417 2.078 . . . . 75.030000000000001 110.341 170.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.41 -39.82 23.82 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.149 1.38 . . . . 73.030000000000001 112.499 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -54.1 -45.43 71.84 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.96 0.904 . . . . 73.140000000000001 112.833 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.486 HD13 ' HD2' ' A' ' 18' ' ' PRO . 98.4 mt -83.36 -29.23 28.4 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.056 0.543 . . . . 74.239999999999995 109.948 -171.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.7 m -59.72 -50.59 73.23 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 124.548 1.155 . . . . 74.219999999999999 111.023 170.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.468 ' HE2' ' HA ' ' A' ' 23' ' ' LYS . 11.2 mmpt? -68.49 -43.25 77.28 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.876 -0.602 . . . . 71.510000000000005 110.045 178.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.454 ' O ' HG21 ' A' ' 28' ' ' VAL . 55.5 tp -55.26 -54.03 48.56 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 124.601 1.161 . . . . 75.340000000000003 112.214 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 14.1 t-105 -64.07 -46.08 85.92 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 122.629 0.372 . . . . 72.299999999999997 111.722 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.6 m -60.61 -25.01 65.93 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.306 0.574 . . . . 74.129999999999995 110.775 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.434 ' HG ' HD13 ' A' ' 37' ' ' ILE . 29.9 tp -80.47 -45.57 17.33 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 124.87 1.268 . . . . 74.329999999999998 111.94 177.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.454 HG21 ' O ' ' A' ' 24' ' ' LEU . 76.6 t -56.61 -39.97 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 C-N-CA 124.089 0.956 . . . . 71.25 111.513 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.5 t -89.36 -5.54 57.4 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 114.453 -1.249 . . . . 74.0 112.132 -175.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -74.35 122.28 87.17 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 122.68 0.392 . . . . 75.540000000000006 111.307 -175.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.4 -23.11 44.53 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 122.851 2.367 . . . . 75.310000000000002 112.944 176.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -73.8 -34.41 64.61 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.185 0.594 . . . . 73.010000000000005 111.514 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 53.5 p -110.99 11.82 22.14 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.043 0.537 . . . . 75.019999999999996 110.533 -177.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -54.95 -38.23 67.46 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.924 1.289 . . . . 74.319999999999993 111.788 -177.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.82 -29.47 69.95 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.692 -0.686 . . . . 63.399999999999999 112.178 -177.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.53 ' HA ' ' HB2' ' A' ' 49' ' ' PHE . 68.9 mt -106.41 -9.88 16.54 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.628 0.371 . . . . 72.549999999999997 111.657 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.434 HD13 ' HG ' ' A' ' 27' ' ' LEU . 16.7 tt -161.45 125.86 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.327 0.651 . . . . 74.530000000000001 110.501 172.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 22.1 p -149.02 157.41 43.39 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.934 0.397 . . . . 74.010000000000005 110.566 177.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 14.7 p-90 -71.38 152.85 42.78 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.731 1.212 . . . . 74.439999999999998 110.409 177.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.2 p -74.28 153.39 88.19 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 123.271 0.628 . . . . 75.129999999999995 110.346 172.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.8 -26.34 60.11 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.7 2.267 . . . . 73.420000000000002 111.925 176.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 66.9 p -75.05 -26.96 59.81 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.303 1.041 . . . . 72.030000000000001 110.15 172.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.97 3.3 84.34 Favored Glycine 0 C--N 1.356 1.692 0 CA-C-N 115.658 -0.701 . . . . 71.120000000000005 113.468 176.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -86.19 -5.91 59.1 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.689 0.796 . . . . 72.310000000000002 112.022 -173.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 65.1 p -159.3 179.09 9.29 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.793 0.837 . . . . 65.230000000000004 110.046 -174.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -140.18 148.21 41.26 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.781 -0.451 . . . . 64.209999999999994 109.781 172.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -110.84 143.49 41.34 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.009 0.924 . . . . 74.439999999999998 109.018 -177.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 67.3 t -123.48 120.96 61.48 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 C-N-CA 124.385 1.074 . . . . 62.450000000000003 108.631 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.53 ' HB2' ' HA ' ' A' ' 36' ' ' LEU . 90.1 m-85 -100.58 146.38 27.2 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 124.058 0.943 . . . . 72.430000000000007 109.87 -178.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.423 ' HB2' HD22 ' A' ' 36' ' ' LEU . 6.9 m-20 49.95 67.94 0.83 Allowed 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.799 1.312 . . . . 73.549999999999997 111.674 176.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.471 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 14.7 mm-40 -49.52 -34.86 18.42 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.002 0.921 . . . . 71.409999999999997 113.377 -175.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.09 -49.83 44.34 Favored Glycine 0 CA--C 1.536 1.365 0 CA-C-O 119.818 -0.434 . . . . 74.120000000000005 112.441 175.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -69.5 -45.64 68.44 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.299 0.639 . . . . 75.400000000000006 110.542 -176.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.483 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 65.1 t80 -52.24 -51.59 57.47 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.553 1.541 . . . . 75.310000000000002 111.05 173.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.511 ' HA ' ' HG ' ' A' ' 59' ' ' LEU . . . -61.36 -36.56 80.53 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.916 0.389 . . . . 74.439999999999998 111.537 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.87 -52.89 31.35 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.513 1.125 . . . . 72.340000000000003 113.154 -174.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.516 ' HG3' HG23 ' A' ' 58' ' ' VAL . 6.7 pt-20 -106.62 -33.85 7.52 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 113.602 0.964 . . . . 73.549999999999997 113.602 -173.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.516 HG23 ' HG3' ' A' ' 57' ' ' GLU . 90.4 t -83.03 -40.29 16.21 Favored 'Isoleucine or valine' 0 C--O 1.251 1.169 0 C-N-CA 123.404 0.681 . . . . 55.240000000000002 111.488 -169.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.511 ' HG ' ' HA ' ' A' ' 55' ' ' ALA . 54.0 mt -64.0 -50.46 69.36 Favored Pre-proline 0 CA--C 1.556 1.202 0 CA-C-O 118.242 -0.885 . . . . 75.25 111.81 177.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -67.42 -13.34 38.91 Favored 'Trans proline' 0 C--N 1.381 2.288 0 CA-C-N 121.975 1.741 . . . . 75.329999999999998 113.001 176.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -70.68 -54.69 10.9 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.01 0.524 . . . . 75.010000000000005 110.536 172.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.401 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 31.5 m-85 -89.87 -52.68 4.86 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.137 0.494 . . . . 74.019999999999996 111.984 -178.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -87.71 -171.79 3.59 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.274 -0.875 . . . . 72.109999999999999 108.828 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -123.05 45.15 2.48 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.668 0.746 . . . . 75.400000000000006 109.749 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -161.16 165.5 29.39 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.636 1.174 . . . . 75.150000000000006 108.377 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -122.3 -8.15 8.69 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.52 0.328 . . . . 73.099999999999994 110.579 174.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -61.1 115.88 4.11 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.152 0.981 . . . . 74.409999999999997 110.605 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.471 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 3.2 tpt -61.71 -49.87 74.73 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.203 1.401 . . . . 74.450000000000003 111.725 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.17 -35.31 71.39 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.866 0.867 . . . . 72.299999999999997 111.843 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.423 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 34.7 t -64.99 -42.98 94.02 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.731 0.813 . . . . 71.310000000000002 111.489 177.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -64.58 -50.25 67.96 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.827 0.851 . . . . 65.120000000000005 110.65 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.497 ' HA ' HD11 ' A' ' 75' ' ' LEU . 59.1 t -62.9 -38.45 81.94 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-N 115.417 -0.81 . . . . 72.340000000000003 111.128 178.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.403 ' O ' ' HG3' ' A' ' 77' ' ' MET . 39.4 ttm180 -58.67 -43.33 89.86 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.023 0.529 . . . . 73.299999999999997 110.858 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.462 ' HA ' ' HE3' ' A' ' 77' ' ' MET . 34.3 mm-40 -59.34 -50.01 75.6 Favored 'General case' 0 C--N 1.358 0.963 0 O-C-N 124.034 0.834 . . . . 75.019999999999996 109.872 177.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.497 HD11 ' HA ' ' A' ' 72' ' ' VAL . 30.6 mt -56.47 -48.32 77.35 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.109 0.964 . . . . 75.310000000000002 111.921 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -62.58 -30.09 71.07 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 122.754 0.422 . . . . 74.150000000000006 112.049 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.462 ' HE3' ' HA ' ' A' ' 74' ' ' GLN . 47.9 mtm -69.47 -40.42 77.11 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 109.931 -0.396 . . . . 75.5 109.931 173.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -81.74 -2.65 51.4 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.997 0.519 . . . . 70.519999999999996 111.214 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.66 20.28 44.77 Favored Glycine 0 C--N 1.349 1.279 0 N-CA-C 114.882 0.713 . . . . 71.239999999999995 114.882 172.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.497 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 83.9 m-85 -82.3 134.85 35.28 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.069 0.935 . . . . 74.219999999999999 109.506 177.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 38.3 ttm180 -101.44 126.74 48.27 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.086 0.554 . . . . 73.239999999999995 109.802 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.468 ' HE3' HG22 ' A' ' 84' ' ' VAL . 2.7 tmtm? -68.95 114.93 7.7 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 106.879 -1.526 . . . . 74.120000000000005 106.879 171.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.519 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 89.3 t -114.2 125.41 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 107.884 -1.154 . . . . 73.109999999999999 107.884 176.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.468 HG22 ' HE3' ' A' ' 82' ' ' LYS . 40.8 t -88.94 131.56 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.638 0.775 . . . . 73.420000000000002 109.315 -177.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 -125.4 -45.95 1.79 Allowed 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 108.214 -1.032 . . . . 72.209999999999994 108.214 169.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.44 HG21 ' HG2' ' A' ' 94' ' ' PRO . 36.6 mm -97.19 131.88 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 108.823 -0.806 . . . . 73.25 108.823 167.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -108.17 150.82 26.74 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 125.12 1.368 . . . . 74.420000000000002 109.482 -171.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -127.42 91.67 3.35 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.288 0.635 . . . . 73.230000000000004 109.693 173.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.79 23.33 1.8 Allowed Glycine 0 N--CA 1.47 0.961 0 CA-C-N 115.946 -0.57 . . . . 72.420000000000002 112.246 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 83.0 20.02 61.87 Favored Glycine 0 C--N 1.343 0.934 0 O-C-N 123.044 -0.092 . . . . 73.530000000000001 112.884 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 78.5 mt -82.65 -177.42 6.71 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.588 1.155 . . . . 74.329999999999998 111.141 -177.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.0 p -88.19 74.49 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 CA-C-O 123.161 1.458 . . . . 73.030000000000001 108.578 168.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -133.28 165.79 34.08 Favored Pre-proline 0 N--CA 1.477 0.92 0 CA-C-N 113.593 -1.64 . . . . 73.109999999999999 108.349 176.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.44 ' HG2' HG21 ' A' ' 86' ' ' ILE . 35.2 Cg_endo -65.99 156.43 64.55 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 121.552 1.501 . . . . 72.239999999999995 111.283 164.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -76.29 -4.49 42.34 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.829 0.851 . . . . 73.230000000000004 112.139 -173.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.7 ptt180 -82.64 168.49 17.24 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.226 1.01 . . . . 72.219999999999999 110.976 174.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -91.27 148.4 22.37 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.463 -0.939 . . . . 74.129999999999995 108.463 156.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -113.4 106.1 14.18 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 105.355 -2.091 . . . . 72.310000000000002 105.355 156.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 32.3 m -115.05 107.36 15.25 Favored 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 123.823 0.702 . . . . 75.0 109.793 -170.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.519 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 41.7 tt0 -96.99 111.17 23.51 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.376 -1.342 . . . . 73.549999999999997 107.376 -177.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.433 ' HB3' ' HB3' ' A' ' 80' ' ' PHE . 71.4 m-85 -96.0 119.93 35.37 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.066 -1.087 . . . . 73.239999999999995 108.066 175.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -117.3 139.16 51.18 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.863 0.865 . . . . 75.219999999999999 109.287 -174.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.475 ' HB3' ' HB3' ' A' ' 106' ' ' PHE . 55.9 t-80 -152.66 135.08 9.0 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 123.466 0.706 . . . . 75.329999999999998 109.423 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -59.64 -42.85 43.33 Favored 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 122.863 2.376 . . . . 74.230000000000004 112.476 -174.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 37.0 m -92.19 16.66 10.96 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.996 0.518 . . . . 72.150000000000006 111.084 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.475 ' HB3' ' HB3' ' A' ' 103' ' ' HIS . 35.9 t80 -124.33 104.18 8.64 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.167 -1.049 . . . . 74.530000000000001 108.167 171.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.481 HD13 ' HG3' ' A' ' 110' ' ' GLN . 38.3 mt -120.46 173.65 7.03 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 107.128 -1.434 . . . . 75.319999999999993 107.128 167.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -63.28 -68.91 0.3 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.39 0.676 . . . . 73.019999999999996 110.942 -172.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -87.71 37.55 3.23 Favored Glycine 0 C--N 1.351 1.365 0 C-N-CA 122.77 0.224 . . . . 72.230000000000004 112.98 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.481 ' HG3' HD13 ' A' ' 107' ' ' LEU . 15.8 mm100 -126.43 53.08 1.67 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.92 0.888 . . . . 75.109999999999999 108.944 -177.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.412 ' HA ' ' HG ' ' A' ' 114' ' ' LEU . 10.6 pt-20 -60.14 -30.65 69.44 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 114.942 -1.026 . . . . 73.140000000000001 111.815 175.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.4 pm0 -63.39 -22.55 66.95 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.363 0.665 . . . . 75.239999999999995 111.838 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.437 ' O ' HG13 ' A' ' 117' ' ' ILE . 80.7 mt -90.82 -9.19 47.35 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.253 0.621 . . . . 74.129999999999995 112.152 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.412 ' HG ' ' HA ' ' A' ' 111' ' ' GLU . 91.5 mt -61.06 -38.57 86.65 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.202 0.525 . . . . 74.219999999999999 110.818 175.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -79.94 -11.11 59.82 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.365 -0.834 . . . . 74.319999999999993 112.051 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -87.55 -10.68 50.95 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.54 0.736 . . . . 74.409999999999997 109.682 173.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 113' ' ' LEU . 58.9 mt -86.23 135.18 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 108.845 -0.798 . . . . 63.509999999999998 108.845 175.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -122.92 150.33 43.08 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.728 0.811 . . . . 74.099999999999994 109.748 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -85.15 -41.65 15.48 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 108.483 -0.932 . . . . 73.120000000000005 108.483 172.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -155.83 -170.09 3.3 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 126.153 1.781 . . . . 75.319999999999993 108.012 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.1 p -66.85 -33.66 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 N-CA-C 108.827 -0.805 . . . . 75.010000000000005 108.827 167.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 5.9 m -91.77 102.21 14.81 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.986 0.914 . . . . 63.509999999999998 109.104 171.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.8 m -130.89 95.74 3.9 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.67 0.788 . . . . 74.519999999999996 109.225 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 59.0 t -75.11 98.89 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 109.34 -0.615 . . . . 61.350000000000001 109.34 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 C--O 1.254 1.295 0 N-CA-C 108.494 -0.928 . . . . 74.310000000000002 108.494 176.983 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.402 ' SD ' ' N ' ' A' ' 1' ' ' MET . 3.8 mpp? . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 109.532 -0.544 . . . . 74.010000000000005 109.532 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -136.78 94.65 0.23 Allowed Glycine 0 C--N 1.35 1.341 0 N-CA-C 110.793 -0.923 . . . . 62.020000000000003 110.793 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -121.37 128.85 52.65 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.477 0.711 . . . . 72.099999999999994 110.329 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 34.3 m-70 -127.11 128.7 46.63 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.053 0.941 . . . . 73.019999999999996 109.066 175.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -140.54 116.88 10.67 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.748 0.819 . . . . 71.019999999999996 109.981 -175.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.3 p-80 -72.28 113.38 9.24 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-O 121.0 0.428 . . . . 73.010000000000005 110.129 174.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -129.66 144.76 51.43 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.66 0.784 . . . . 74.319999999999993 109.645 176.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 51.5 t60 -138.29 96.32 3.16 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.203 -0.665 . . . . 75.549999999999997 109.203 176.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.2 p -75.94 100.35 4.82 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.206 0.602 . . . . 71.450000000000003 110.553 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 38.0 t60 -66.56 103.63 1.1 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.688 0.795 . . . . 73.239999999999995 110.536 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 55.0 ttm -78.5 118.42 20.62 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.46 0.704 . . . . 71.299999999999997 109.889 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.57 97.69 0.81 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.591 0.756 . . . . 74.299999999999997 110.326 177.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -97.39 -131.47 7.06 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 119.382 -0.677 . . . . 71.25 113.388 -172.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -99.41 175.6 0.37 Allowed 'Trans proline' 0 C--N 1.371 1.744 0 C-N-CA 123.311 2.674 . . . . 72.439999999999998 114.962 -175.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.4 t -85.35 131.2 34.44 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 107.284 -1.376 . . . . 73.319999999999993 107.284 166.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -90.78 18.42 6.53 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.001 0.52 . . . . 74.439999999999998 112.367 -167.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.3 t -71.69 116.52 48.72 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 124.065 0.946 . . . . 73.409999999999997 109.805 177.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.89 163.2 39.99 Favored 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 122.65 2.233 . . . . 74.209999999999994 112.19 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.64 -49.12 57.65 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.08 0.952 . . . . 73.040000000000006 112.636 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -52.33 -47.51 66.0 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.444 0.698 . . . . 71.109999999999999 112.612 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 89.2 mt -79.64 -35.32 39.55 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.374 0.27 . . . . 45.109999999999999 110.955 -172.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.5 t -71.95 -18.76 61.98 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 111.72 0.267 . . . . 72.519999999999996 111.72 177.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.6 mmpt? -83.74 -40.99 18.14 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.767 -0.457 . . . . 74.0 109.767 168.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.8 tp -61.0 -50.61 72.66 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.003 0.921 . . . . 74.540000000000006 113.352 -176.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.434 ' HB3' HD11 ' A' ' 114' ' ' LEU . 5.1 p-90 -62.37 -37.43 85.69 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 118.628 0.649 . . . . 73.329999999999998 110.842 -177.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 41.3 m -63.83 -43.44 96.17 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 124.268 1.027 . . . . 73.140000000000001 110.898 175.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.4 tp -61.6 -49.56 76.1 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.624 1.57 . . . . 75.209999999999994 111.711 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.7 t -59.81 -33.62 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 C-N-CA 124.634 1.174 . . . . 74.109999999999999 111.536 176.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.9 t -94.85 -6.95 41.62 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.423 0.689 . . . . 75.120000000000005 112.09 -175.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -83.01 132.43 50.84 Favored Pre-proline 0 N--CA 1.486 1.355 0 CA-C-N 118.079 0.4 . . . . 61.43 111.837 -173.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -70.13 -23.82 28.67 Favored 'Trans proline' 0 C--N 1.388 2.652 0 C-N-CA 123.154 2.569 . . . . 72.310000000000002 114.209 -176.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -76.4 -32.33 58.47 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.008 0.523 . . . . 71.140000000000001 111.079 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.7 p -105.88 1.35 26.69 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.122 0.569 . . . . 74.230000000000004 111.61 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -57.31 -33.23 67.48 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.099 1.36 . . . . 72.439999999999998 112.56 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.97 -35.55 81.05 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.631 0.772 . . . . 65.319999999999993 113.027 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.519 HD22 ' HB2' ' A' ' 50' ' ' ASP . 80.9 mt -106.91 -11.05 15.8 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.063 0.545 . . . . 73.349999999999994 111.464 -175.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.2 tt -160.66 127.0 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 122.659 0.384 . . . . 74.129999999999995 110.631 174.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.1 p -158.92 161.29 36.75 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.032 0.533 . . . . 63.149999999999999 110.136 177.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 25.8 p-90 -71.12 147.3 48.55 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.028 -0.987 . . . . 73.540000000000006 110.455 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.4 m -70.96 153.54 94.66 Favored Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 124.016 0.926 . . . . 74.420000000000002 109.743 175.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -45.81 -44.63 17.96 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 123.613 2.875 . . . . 74.219999999999999 114.899 -175.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.7 m -75.22 -27.22 59.46 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.31 0.644 . . . . 72.230000000000004 111.584 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.82 18.44 61.48 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 116.562 -0.29 . . . . 73.540000000000006 113.606 175.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -80.85 -17.71 49.8 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.701 0.8 . . . . 71.319999999999993 111.326 175.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.0 p -158.28 -173.91 4.55 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.783 0.433 . . . . 71.450000000000003 110.806 -170.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -141.02 151.9 44.45 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.103 0.561 . . . . 73.540000000000006 110.179 176.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 55.5 m-70 -108.86 156.29 19.83 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.826 0.851 . . . . 73.129999999999995 109.647 176.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 84.7 t -130.51 123.16 54.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 124.442 1.097 . . . . 75.319999999999993 108.151 176.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -106.93 148.17 28.94 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.805 0.842 . . . . 64.329999999999998 109.686 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.519 ' HB2' HD22 ' A' ' 36' ' ' LEU . 7.9 m-20 54.23 55.54 8.05 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 124.714 1.258 . . . . 73.239999999999995 110.826 171.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.432 ' HA ' ' HB3' ' A' ' 54' ' ' PHE . 45.8 mt-30 -57.35 -22.77 44.59 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.759 -1.11 . . . . 73.329999999999998 113.158 -169.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.11 -47.83 56.95 Favored Glycine 0 C--N 1.348 1.23 0 N-CA-C 111.816 -0.513 . . . . 75.010000000000005 111.816 172.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -71.17 -45.39 63.55 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.836 0.855 . . . . 75.200000000000003 110.044 -179.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.457 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 57.0 t80 -49.16 -50.8 36.03 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.591 1.556 . . . . 72.540000000000006 111.403 171.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.65 -36.89 84.29 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.357 -0.383 . . . . 60.100000000000001 111.69 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -69.06 -45.01 71.44 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.994 0.918 . . . . 73.549999999999997 112.896 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -114.78 -33.02 5.62 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 114.43 1.27 . . . . 73.340000000000003 114.43 -172.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.457 ' HB ' ' O ' ' A' ' 54' ' ' PHE . 77.2 t -81.95 -44.46 19.98 Favored 'Isoleucine or valine' 0 C--O 1.25 1.117 0 C-N-CA 122.787 0.435 . . . . 75.019999999999996 111.29 -172.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 46.1 mt -64.07 -46.83 80.45 Favored Pre-proline 0 CA--C 1.564 1.511 0 CA-C-O 118.081 -0.961 . . . . 72.319999999999993 112.77 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.58 -15.38 47.48 Favored 'Trans proline' 0 C--N 1.388 2.653 0 CA-C-N 121.999 1.75 . . . . 74.150000000000006 113.454 174.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -75.49 -54.52 6.89 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.177 0.591 . . . . 71.519999999999996 110.646 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -90.19 -40.07 12.42 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 112.112 0.412 . . . . 72.329999999999998 112.112 -177.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -106.4 -176.28 3.03 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.758 0.823 . . . . 71.540000000000006 108.808 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -119.42 48.83 1.44 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.522 -0.918 . . . . 72.450000000000003 108.522 -176.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -164.12 159.9 20.89 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.73 1.212 . . . . 70.25 108.265 176.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -112.32 -21.08 11.59 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.395 0.678 . . . . 64.209999999999994 109.253 176.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -61.02 119.55 8.52 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.198 0.999 . . . . 72.219999999999999 111.09 -176.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 12.9 tpt -73.46 -32.93 64.62 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.649 0.78 . . . . 73.439999999999998 111.25 -176.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.88 -34.26 69.59 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.05 0.54 . . . . 72.519999999999996 111.577 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.1 t -64.85 -42.35 94.98 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.334 1.054 . . . . 75.129999999999995 111.672 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -68.47 -51.16 46.53 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.948 0.899 . . . . 74.439999999999998 110.995 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.0 t -62.12 -37.15 77.74 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 C-N-CA 123.734 0.814 . . . . 74.400000000000006 111.194 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -53.94 -50.13 67.15 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.925 0.89 . . . . 72.400000000000006 111.117 175.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -56.97 -51.5 68.94 Favored 'General case' 0 C--N 1.35 0.614 0 O-C-N 124.556 1.16 . . . . 74.109999999999999 110.547 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.1 mt -62.23 -44.36 96.73 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.912 0.885 . . . . 71.400000000000006 112.03 -176.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -59.11 -38.61 79.98 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.293 0.637 . . . . 72.409999999999997 111.437 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 50.7 mtm -69.61 -33.21 72.36 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.842 0.457 . . . . 73.510000000000005 110.676 175.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -82.1 7.2 14.05 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 122.95 0.5 . . . . 72.310000000000002 111.299 178.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.96 20.44 67.82 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-O 119.948 -0.362 . . . . 72.439999999999998 113.447 172.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.522 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . 44.8 m-85 -82.82 137.89 34.15 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.978 -0.749 . . . . 75.299999999999997 108.978 175.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -101.46 125.24 48.07 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.022 -0.732 . . . . 75.040000000000006 109.022 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.59 115.58 8.13 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 107.965 -1.124 . . . . 74.219999999999999 107.965 173.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.7 t -131.27 113.86 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.219 -1.03 . . . . 73.420000000000002 108.219 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.5 p -96.11 126.45 48.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 108.443 -0.947 . . . . 63.340000000000003 108.443 -176.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 69.1 m-70 -105.13 -42.56 5.26 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.396 0.279 . . . . 74.219999999999999 110.767 -175.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.416 HG21 ' NE2' ' A' ' 88' ' ' GLN . 34.0 mm -74.54 109.88 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 108.25 -1.019 . . . . 74.519999999999996 108.25 169.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.722 ' HB3' ' HZ3' ' A' ' 93' ' ' LYS . 8.9 tm-20 -55.66 133.75 50.81 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.753 1.221 . . . . 73.340000000000003 110.869 179.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.416 ' NE2' HG21 ' A' ' 86' ' ' ILE . 35.5 mm-40 -116.83 6.17 13.12 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.188 0.995 . . . . 71.010000000000005 112.257 -171.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -70.5 -58.57 5.84 Favored Glycine 0 C--N 1.347 1.151 0 O-C-N 123.092 0.245 . . . . 73.040000000000006 112.813 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 162.93 74.64 0.02 OUTLIER Glycine 0 C--N 1.347 1.172 0 C-N-CA 121.533 -0.365 . . . . 61.229999999999997 113.415 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.416 ' HB2' ' HZ1' ' A' ' 93' ' ' LYS . 75.7 mt -112.34 174.39 5.91 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.156 0.582 . . . . 74.319999999999993 110.019 169.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.4 p -59.14 -33.78 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 124.565 1.146 . . . . 74.299999999999997 112.903 -174.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.722 ' HZ3' ' HB3' ' A' ' 87' ' ' GLU . 24.0 pttm -63.28 152.45 84.74 Favored Pre-proline 0 N--CA 1.479 1.025 0 C-N-CA 123.733 0.813 . . . . 74.209999999999994 111.16 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.36 140.22 69.12 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.031 1.821 . . . . 73.099999999999994 110.358 172.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -86.93 51.47 2.25 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.286 0.634 . . . . 74.329999999999998 110.461 -176.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -72.6 86.22 1.19 Allowed 'General case' 0 C--N 1.354 0.776 0 CA-C-O 122.506 1.146 . . . . 72.329999999999998 108.302 175.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -35.26 101.17 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 111.888 -2.414 . . . . 43.240000000000002 113.877 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -99.14 115.83 29.96 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.332 -1.359 . . . . 73.519999999999996 107.332 175.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 91.2 m -125.77 119.8 28.9 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.265 -0.643 . . . . 54.140000000000001 109.265 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -104.13 117.45 34.3 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.375 -1.343 . . . . 73.430000000000007 107.375 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.522 ' HB3' ' HB3' ' A' ' 80' ' ' PHE . 97.6 m-85 -97.35 119.57 36.12 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 107.514 -1.291 . . . . 75.219999999999999 107.514 173.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 80' ' ' PHE . 10.2 pt20 -109.36 148.28 31.34 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.527 0.731 . . . . 72.109999999999999 110.151 -173.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -158.93 131.43 4.38 Favored Pre-proline 0 CA--C 1.547 0.846 0 CA-C-O 118.835 -0.603 . . . . 71.530000000000001 109.643 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -62.85 -26.55 74.67 Favored 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 123.152 2.568 . . . . 75.310000000000002 113.707 -176.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.4 m -102.33 22.26 13.67 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.119 0.567 . . . . 75.140000000000001 111.109 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -119.74 108.27 14.21 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.02 -1.104 . . . . 74.25 108.02 170.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 91.4 mt -116.82 111.13 19.29 Favored 'General case' 0 C--O 1.212 -0.875 0 CA-C-O 118.32 -0.847 . . . . 74.040000000000006 108.889 170.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 40.7 -80.96 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 126.0 1.72 . . . . 73.099999999999994 115.263 165.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.23 30.03 2.66 Favored Glycine 0 C--N 1.356 1.649 0 C-N-CA 123.351 0.501 . . . . 63.340000000000003 112.887 -176.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.502 HE21 ' N ' ' A' ' 110' ' ' GLN . 0.0 OUTLIER -89.33 87.07 6.97 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 107.79 -1.189 . . . . 75.5 107.79 176.281 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.35 -25.79 67.75 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.122 -0.944 . . . . 71.310000000000002 112.335 -176.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 16.5 pm0 -69.12 -21.51 64.03 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.716 0.406 . . . . 74.209999999999994 111.536 177.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 82.2 mt -89.63 -13.09 37.85 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.234 0.614 . . . . 73.120000000000005 111.2 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.434 HD11 ' HB3' ' A' ' 25' ' ' TRP . 91.9 mt -64.61 -35.61 81.56 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.943 0.497 . . . . 75.510000000000005 111.065 175.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -80.9 -1.67 44.38 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 111.719 0.266 . . . . 73.230000000000004 111.719 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.483 HD21 ' N ' ' A' ' 116' ' ' ASN . 0.6 OUTLIER -88.14 -24.75 23.27 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 108.95 -0.759 . . . . 74.109999999999999 108.95 170.504 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 57.9 mt -79.77 105.05 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.918 0.887 . . . . 74.299999999999997 108.868 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.551 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 10.8 mmpt? -107.39 139.53 41.74 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 120.86 0.362 . . . . 75.129999999999995 110.175 -170.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.454 ' HG3' ' HG3' ' A' ' 120' ' ' LYS . 16.1 ptm180 -79.43 -32.74 42.85 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.307 -0.861 . . . . 74.329999999999998 110.821 -178.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.454 ' HG3' ' HG3' ' A' ' 119' ' ' ARG . 54.8 mtpt -132.27 -176.36 4.05 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.902 0.881 . . . . 74.430000000000007 110.42 -175.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 57.5 t -77.9 -53.62 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 107.967 -1.123 . . . . 72.200000000000003 107.967 167.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 20.1 p -74.3 90.33 2.11 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 108.976 -0.75 . . . . 73.219999999999999 108.976 169.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 66.2 m -146.73 49.06 1.15 Allowed 'General case' 0 C--O 1.245 0.839 0 C-N-CA 123.986 0.915 . . . . 60.350000000000001 109.045 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 28.8 m -59.21 134.25 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 115.709 -0.678 . . . . 71.299999999999997 109.263 173.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 68.5 m . . . . . 0 C--O 1.253 1.252 0 O-C-N 124.491 1.119 . . . . 61.32 109.058 -159.758 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 111.131 0.049 . . . . 74.010000000000005 111.131 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 110.15 134.34 6.77 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 111.946 -0.461 . . . . 73.329999999999998 111.946 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.0 m170 -96.85 149.05 22.29 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.429 0.692 . . . . 74.040000000000006 110.085 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -78.97 121.43 24.9 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.144 -1.058 . . . . 64.150000000000006 108.144 167.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -71.05 -3.37 19.32 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.239 1.015 . . . . 74.310000000000002 112.492 -169.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 68.91 11.36 8.32 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.756 1.222 . . . . 75.200000000000003 112.631 171.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -89.89 111.57 22.66 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.43 0.633 . . . . 72.430000000000007 111.405 -173.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 -134.87 153.09 52.19 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.701 1.2 . . . . 73.230000000000004 107.926 167.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.0 t -65.6 117.91 8.74 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 122.735 0.414 . . . . 72.239999999999995 111.103 -174.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -116.93 140.17 49.78 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 108.439 -0.948 . . . . 73.310000000000002 108.439 175.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.1 ptm -151.47 -179.88 7.77 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 120.804 0.335 . . . . 75.310000000000002 111.713 -169.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.43 99.55 2.64 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.591 1.157 . . . . 75.150000000000006 107.974 176.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -167.95 -131.96 1.35 Allowed Glycine 0 C--N 1.347 1.18 0 CA-C-O 118.478 -1.179 . . . . 74.530000000000001 113.027 -173.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.2 115.12 2.22 Favored 'Trans proline' 0 C--N 1.388 2.637 0 C-N-CA 123.495 2.797 . . . . 73.530000000000001 112.583 -174.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 71.8 p 57.56 -82.17 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.876 1.671 . . . . 70.439999999999998 112.335 -173.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 61.98 68.39 0.69 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.704 1.202 . . . . 72.519999999999996 110.908 -175.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.5 t -81.17 115.71 58.0 Favored Pre-proline 0 C--O 1.242 0.688 0 N-CA-C 107.026 -1.472 . . . . 73.329999999999998 107.026 163.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.432 ' HD2' HD12 ' A' ' 21' ' ' LEU . 33.5 Cg_exo -58.15 146.32 88.75 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.479 2.12 . . . . 71.040000000000006 110.669 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.28 -34.29 45.91 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 123.711 0.632 . . . . 74.120000000000005 110.62 176.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -51.36 -52.39 46.08 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.911 0.885 . . . . 73.25 112.234 171.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.432 HD12 ' HD2' ' A' ' 18' ' ' PRO . 83.1 mt -80.86 -30.34 35.64 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.005 0.431 . . . . 71.319999999999993 110.065 -171.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.1 m -59.88 -51.66 68.75 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.856 1.262 . . . . 71.109999999999999 110.631 173.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.544 ' HB3' ' HB3' ' A' ' 62' ' ' TYR . 9.6 mmpt? -65.98 -45.38 81.88 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 115.548 -0.751 . . . . 75.329999999999998 110.144 177.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.416 ' O ' HG23 ' A' ' 28' ' ' VAL . 57.4 tp -56.29 -48.14 77.24 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.038 0.935 . . . . 74.530000000000001 111.595 -178.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 41.8 t90 -55.85 -46.3 78.25 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.05 0.94 . . . . 73.010000000000005 111.353 178.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 35.0 m -71.18 -25.48 62.56 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.469 1.108 . . . . 74.400000000000006 112.118 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.498 ' HG ' HD12 ' A' ' 37' ' ' ILE . 30.3 tp -78.01 -43.98 27.91 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.162 0.985 . . . . 73.530000000000001 110.793 -176.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 24' ' ' LEU . 74.3 t -57.96 -26.83 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.352 0 C-N-CA 125.042 1.337 . . . . 75.349999999999994 111.612 173.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 78.6 p -101.4 0.91 37.78 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.531 0.732 . . . . 75.230000000000004 112.631 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -81.45 120.15 77.42 Favored Pre-proline 0 N--CA 1.483 1.193 0 C-N-CA 122.946 0.498 . . . . 74.030000000000001 110.993 -172.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -71.77 -11.05 27.37 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 122.845 2.363 . . . . 73.209999999999994 113.165 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -74.16 -36.2 64.07 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 122.591 0.356 . . . . 75.140000000000001 110.225 173.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 70.5 p -117.79 13.18 14.07 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.6 0.76 . . . . 74.120000000000005 111.631 -173.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -62.19 -30.22 70.92 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.175 0.59 . . . . 64.299999999999997 112.123 -171.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.67 -20.19 58.62 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.847 0.684 . . . . 75.239999999999995 112.847 178.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 59.4 mt -105.67 -16.77 14.6 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.007 0.523 . . . . 75.409999999999997 110.718 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.498 HD12 ' HG ' ' A' ' 27' ' ' LEU . 17.5 tt -160.28 121.7 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.21 0.604 . . . . 73.439999999999998 110.715 175.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 48.6 t -154.93 154.93 33.38 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.287 0.635 . . . . 75.209999999999994 109.67 177.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 29.2 p-90 -74.45 152.82 39.39 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.643 0.777 . . . . 71.349999999999994 111.007 -174.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.3 m -79.31 142.11 58.29 Favored Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 108.487 -0.931 . . . . 71.049999999999997 108.487 172.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.99 -26.52 49.9 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 123.212 2.608 . . . . 74.340000000000003 114.152 -176.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.6 m -74.71 -27.45 60.39 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.914 0.486 . . . . 73.530000000000001 111.42 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 107' ' ' LEU . . . 94.48 -5.55 70.62 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-O 119.391 -0.671 . . . . 73.510000000000005 114.018 175.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.461 ' HA ' HD21 ' A' ' 107' ' ' LEU . 2.8 m-20 -78.94 -16.21 57.27 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.816 0.846 . . . . 71.049999999999997 111.955 -170.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 43.5 p -156.57 179.97 8.75 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.347 0.594 . . . . 73.109999999999999 110.965 -173.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -138.81 151.98 47.49 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.044 -0.98 . . . . 61.32 109.344 171.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -107.37 139.22 42.19 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.738 0.815 . . . . 75.109999999999999 109.136 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.497 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 71.2 t -118.2 127.5 75.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 107.324 -1.361 . . . . 74.409999999999997 107.324 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -113.64 146.29 39.99 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.177 -0.675 . . . . 75.310000000000002 109.177 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 53.64 68.76 0.79 Allowed 'General case' 0 N--CA 1.476 0.859 0 O-C-N 124.851 1.344 . . . . 71.129999999999995 110.8 176.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.588 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 47.0 mt-30 -53.28 -26.92 20.13 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.491 0.717 . . . . 74.109999999999999 112.63 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -64.82 -53.06 36.77 Favored Glycine 0 C--N 1.349 1.281 0 O-C-N 123.252 0.345 . . . . 62.109999999999999 112.289 172.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -69.8 -42.12 74.16 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.192 0.597 . . . . 71.239999999999995 110.754 -176.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.431 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 60.2 t80 -56.65 -50.16 72.89 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.49 1.516 . . . . 75.129999999999995 110.806 176.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.42 ' HB1' ' O ' ' A' ' 66' ' ' ASN . . . -62.4 -31.99 72.75 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 112.213 0.449 . . . . 73.319999999999993 112.213 177.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -70.6 -49.28 49.39 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.073 0.949 . . . . 73.519999999999996 112.778 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.54 ' HG3' HG21 ' A' ' 58' ' ' VAL . 4.4 pt-20 -108.48 -37.48 5.95 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 113.569 0.952 . . . . 75.450000000000003 113.569 -172.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.54 HG21 ' HG3' ' A' ' 57' ' ' GLU . 98.6 t -81.99 -45.86 19.91 Favored 'Isoleucine or valine' 0 C--O 1.249 1.07 0 C-N-CA 123.315 0.646 . . . . 75.239999999999995 111.565 -166.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.411 HD13 ' HE2' ' A' ' 68' ' ' MET . 50.1 mt -62.08 -48.97 87.03 Favored Pre-proline 0 CA--C 1.558 1.257 0 CA-C-O 117.79 -1.1 . . . . 72.140000000000001 112.705 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.539 ' HG3' ' ND2' ' A' ' 66' ' ' ASN . 52.6 Cg_endo -67.69 -15.23 44.06 Favored 'Trans proline' 0 C--N 1.388 2.611 0 C-N-CA 122.134 1.889 . . . . 73.140000000000001 113.186 176.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -74.05 -64.99 0.9 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.176 0.59 . . . . 73.209999999999994 110.824 178.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.544 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 29.8 m-85 -81.61 -46.51 14.29 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.209 0.528 . . . . 74.120000000000005 111.474 -176.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -98.57 -171.22 2.08 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 106.608 -1.627 . . . . 75.319999999999993 106.608 177.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -129.47 64.99 1.48 Allowed 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 119.428 1.013 . . . . 72.129999999999995 109.859 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -166.09 162.86 18.04 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 114.295 -1.32 . . . . 75.510000000000005 108.813 174.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.539 ' ND2' ' HG3' ' A' ' 60' ' ' PRO . 11.1 m120 -114.2 -5.85 13.02 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 122.682 0.393 . . . . 73.409999999999997 110.304 175.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -75.29 112.5 11.65 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 122.963 0.505 . . . . 74.319999999999993 110.66 -175.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.588 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 3.5 tpt -56.49 -48.64 76.72 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.281 1.432 . . . . 75.040000000000006 111.631 178.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.96 -30.07 67.64 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.414 -0.812 . . . . 75.120000000000005 112.597 -177.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.3 t -68.52 -41.35 80.07 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.643 0.777 . . . . 75.030000000000001 111.271 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -61.95 -49.24 76.89 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.832 0.853 . . . . 70.450000000000003 109.93 177.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 52.7 t -65.15 -35.4 75.32 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 CA-C-N 114.688 -1.142 . . . . 72.150000000000006 111.508 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -60.86 -42.49 97.98 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.67 0.788 . . . . 74.409999999999997 110.971 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.5 ' HA ' ' HE3' ' A' ' 77' ' ' MET . 32.1 mm-40 -64.85 -45.29 86.72 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.82 -0.627 . . . . 73.129999999999995 110.426 178.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.435 ' HB3' ' HB2' ' A' ' 80' ' ' PHE . 83.1 mt -63.59 -34.19 77.27 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.271 0.629 . . . . 74.319999999999993 111.847 -178.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -56.15 -40.03 73.21 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.212 0.605 . . . . 71.430000000000007 111.184 171.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.5 ' HE3' ' HA ' ' A' ' 74' ' ' GLN . 39.9 mtm -76.91 -23.91 52.49 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.278 0.631 . . . . 71.340000000000003 111.28 178.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -86.1 -8.61 57.76 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.06 0.544 . . . . 73.049999999999997 111.006 174.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.05 21.04 54.02 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 114.406 0.522 . . . . 75.019999999999996 114.406 173.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.435 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 17.7 m-85 -82.31 144.97 30.22 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 108.954 -0.758 . . . . 63.109999999999999 108.954 176.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -102.29 129.6 48.76 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.868 0.467 . . . . 75.5 110.24 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.584 ' HE3' HG22 ' A' ' 84' ' ' VAL . 52.8 tptt -68.71 118.65 11.97 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.426 1.09 . . . . 74.25 108.779 169.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.543 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 58.8 t -123.4 116.82 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 108.667 -0.864 . . . . 75.319999999999993 108.667 176.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.584 HG22 ' HE3' ' A' ' 82' ' ' LYS . 34.4 t -97.98 101.88 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.746 0.818 . . . . 74.030000000000001 109.318 -174.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -86.03 -36.76 19.53 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 122.341 -0.224 . . . . 70.310000000000002 110.656 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 47.2 mm -78.77 82.04 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 107.629 -1.248 . . . . 74.219999999999999 107.629 166.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -64.54 126.84 29.14 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 113.976 -1.466 . . . . 73.030000000000001 108.815 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -60.62 113.13 2.29 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.601 0.761 . . . . 64.430000000000007 111.743 -168.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.01 167.11 21.96 Favored Glycine 0 C--O 1.244 0.742 0 CA-C-N 114.009 -1.45 . . . . 63.399999999999999 110.688 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -73.73 78.04 0.91 Allowed Glycine 0 CA--C 1.526 0.771 0 C-N-CA 122.932 0.301 . . . . 74.420000000000002 112.829 177.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 80.3 mt -93.07 164.02 13.42 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.053 0.941 . . . . 72.010000000000005 110.166 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.5 p -75.73 -21.82 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 CA-C-O 121.356 0.598 . . . . 74.010000000000005 109.446 171.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -61.63 137.62 94.99 Favored Pre-proline 0 CA--C 1.552 1.028 0 CA-C-N 115.029 -0.987 . . . . 74.129999999999995 109.759 169.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -68.2 155.67 68.57 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 122.825 2.35 . . . . 73.439999999999998 113.14 -172.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -78.42 0.53 25.39 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.582 1.153 . . . . 71.049999999999997 112.849 -170.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -64.81 86.95 0.05 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.13 0.572 . . . . 75.439999999999998 110.087 173.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -36.76 105.38 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 125.413 1.485 . . . . 71.540000000000006 112.56 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -90.33 112.77 24.47 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 107.608 -1.256 . . . . 65.319999999999993 107.608 -177.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.504 HG21 ' HD2' ' A' ' 82' ' ' LYS . 76.6 m -118.06 107.12 13.62 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.894 -1.048 . . . . 73.329999999999998 109.256 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.543 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 41.9 tt0 -96.23 109.63 22.07 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.596 -1.261 . . . . 65.409999999999997 107.596 177.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -95.03 118.68 32.26 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 107.125 -1.435 . . . . 74.200000000000003 107.125 172.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -123.37 149.29 45.13 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.861 0.864 . . . . 63.549999999999997 109.87 -174.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -156.74 133.14 6.13 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 109.276 -0.638 . . . . 73.150000000000006 109.276 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.21 -27.2 56.48 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 122.928 2.419 . . . . 74.519999999999996 113.044 -174.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.407 ' O ' ' HB3' ' A' ' 113' ' ' LEU . 59.2 m -105.86 37.38 2.26 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.644 0.778 . . . . 75.310000000000002 109.511 175.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -133.9 106.9 7.52 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.055 -1.091 . . . . 70.310000000000002 108.055 170.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.571 ' HB2' ' HB3' ' A' ' 110' ' ' GLN . 68.0 mt -128.2 149.63 50.37 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 108.514 -0.921 . . . . 74.400000000000006 108.514 172.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -63.02 -59.14 5.21 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.486 0.714 . . . . 74.540000000000006 111.659 -175.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -88.95 50.57 3.71 Favored Glycine 0 C--N 1.342 0.877 0 N-CA-C 111.87 -0.492 . . . . 75.519999999999996 111.87 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.571 ' HB3' ' HB2' ' A' ' 107' ' ' LEU . 4.1 tp60 -165.19 53.0 0.11 Allowed 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 108.691 -0.855 . . . . 74.239999999999995 108.691 -172.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -62.64 -18.4 62.22 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.024 0.93 . . . . 54.25 112.966 -176.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.0 pm0 -68.26 -6.58 24.55 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 122.957 0.503 . . . . 72.030000000000001 112.145 176.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.407 ' HB3' ' O ' ' A' ' 105' ' ' CYS . 63.4 mt -86.28 -23.7 26.22 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 122.751 0.42 . . . . 70.299999999999997 111.473 174.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.19 -37.98 89.35 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.274 0.63 . . . . 64.099999999999994 111.35 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -72.21 -13.49 61.55 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 114.895 -1.048 . . . . 72.430000000000007 112.267 177.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -93.9 -11.62 30.64 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.327 0.651 . . . . 75.230000000000004 110.865 173.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 35.8 mt -87.41 91.99 3.67 Favored 'Isoleucine or valine' 0 C--N 1.353 0.745 0 N-CA-C 107.134 -1.432 . . . . 72.010000000000005 107.134 176.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.43 ' HE2' ' HA ' ' A' ' 118' ' ' LYS . 11.1 mmpt? -87.48 144.48 26.7 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.219 -0.66 . . . . 74.310000000000002 109.219 -178.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 8.6 ptm85 -86.24 -69.7 0.65 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.572 -0.529 . . . . 74.319999999999993 109.572 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -149.77 -166.41 2.54 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.464 1.106 . . . . 74.510000000000005 108.871 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.0 p -50.71 -41.76 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 C-N-CA 124.186 0.995 . . . . 75.510000000000005 112.13 -177.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 5.6 t -105.43 134.13 49.05 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.971 0.909 . . . . 74.340000000000003 109.661 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 41.9 t -96.33 101.51 13.16 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.649 -0.871 . . . . 73.099999999999994 108.649 173.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.1 p -153.44 97.72 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 124.136 0.974 . . . . 75.230000000000004 109.284 -178.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 31.1 t . . . . . 0 C--O 1.247 0.951 0 N-CA-C 107.01 -1.478 . . . . 75.540000000000006 107.01 178.094 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 mmt . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 108.409 -0.96 . . . . 75.129999999999995 108.409 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -172.67 -127.46 0.97 Allowed Glycine 0 C--N 1.337 0.634 0 CA-C-N 115.3 -0.864 . . . . 73.319999999999993 111.601 -175.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.2 p80 43.54 43.32 4.53 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 125.787 1.635 . . . . 74.409999999999997 111.647 -174.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -132.25 114.1 14.04 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.713 1.205 . . . . 75.519999999999996 108.736 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -79.86 141.49 36.11 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 108.646 -0.872 . . . . 75.329999999999998 108.646 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -64.0 100.86 0.34 Allowed 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.089 0.555 . . . . 73.409999999999997 111.239 -177.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -103.57 110.92 23.16 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.389 0.676 . . . . 73.25 110.951 177.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 -95.41 26.81 3.64 Favored 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 108.922 -0.77 . . . . 74.349999999999994 108.922 164.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.0 m -62.76 151.72 37.84 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 125.154 1.381 . . . . 74.25 111.482 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -146.62 135.14 22.02 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.41 0.684 . . . . 74.409999999999997 110.03 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.1 mmt -83.85 -178.69 7.08 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.857 0.863 . . . . 73.299999999999997 110.352 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -123.04 108.12 12.55 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.346 0.658 . . . . 73.439999999999998 109.462 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 130.21 173.23 13.33 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-N 116.181 -0.463 . . . . 64.129999999999995 112.547 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -89.0 171.28 4.77 Favored 'Trans proline' 0 C--N 1.367 1.522 0 C-N-CA 123.181 2.588 . . . . 74.310000000000002 112.511 173.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 95.3 p 53.21 43.8 31.06 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 125.279 1.432 . . . . 75.129999999999995 112.908 172.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -91.41 28.12 1.78 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.877 -0.601 . . . . 72.329999999999998 110.155 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.5 t -73.84 123.49 89.36 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 123.893 0.877 . . . . 72.510000000000005 110.649 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -61.81 139.0 77.79 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 122.734 2.289 . . . . 74.549999999999997 111.8 170.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.416 ' HA ' HG23 ' A' ' 22' ' ' THR . . . -56.58 -38.47 72.02 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.592 0.757 . . . . 73.420000000000002 112.392 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -51.33 -46.85 62.78 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.587 0.755 . . . . 75.129999999999995 111.626 173.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.439 ' HB3' HD21 ' A' ' 114' ' ' LEU . 77.8 mt -79.69 -34.73 39.99 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.122 0.569 . . . . 75.140000000000001 112.498 -172.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.416 HG23 ' HA ' ' A' ' 19' ' ' ALA . 14.3 t -71.38 -34.89 70.81 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 118.041 0.382 . . . . 73.310000000000002 111.146 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.2 mtpt -81.06 -32.7 33.91 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 119.532 -0.271 . . . . 64.030000000000001 110.875 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.4 tp -63.55 -39.58 94.77 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.091 0.556 . . . . 75.129999999999995 110.497 170.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 64.7 t-105 -57.44 -52.67 64.44 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.871 0.868 . . . . 72.430000000000007 110.666 174.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 38.6 m -59.84 -40.74 89.56 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 124.238 0.961 . . . . 72.219999999999999 110.721 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.477 ' HG ' HD12 ' A' ' 37' ' ' ILE . 26.9 tp -59.64 -52.26 66.28 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.196 1.398 . . . . 73.540000000000006 112.304 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 96.9 t -62.01 -33.14 56.8 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 C-N-CA 123.855 0.862 . . . . 75.150000000000006 111.164 177.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.9 t -94.04 -1.71 54.05 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 123.911 0.884 . . . . 53.450000000000003 112.069 -174.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.4 ' HB3' ' OG1' ' A' ' 33' ' ' THR . 17.1 t70 -89.0 130.54 44.21 Favored Pre-proline 0 N--CA 1.49 1.555 0 C-N-CA 123.29 0.636 . . . . 75.409999999999997 111.467 -174.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -73.32 -21.82 19.54 Favored 'Trans proline' 0 C--N 1.39 2.716 0 C-N-CA 123.271 2.647 . . . . 73.5 114.369 -174.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -78.45 -36.33 45.57 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.316 0.646 . . . . 74.409999999999997 110.455 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.4 ' OG1' ' HB3' ' A' ' 30' ' ' ASP . 21.5 p -92.01 -0.96 57.48 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.227 0.611 . . . . 75.209999999999994 111.28 -176.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.69 -29.17 58.92 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.88 1.272 . . . . 73.209999999999994 112.107 -179.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.26 -36.98 79.03 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.934 0.894 . . . . 64.5 113.22 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.6 mt -114.16 -6.38 13.05 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.918 0.487 . . . . 73.510000000000005 112.134 -176.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.477 HD12 ' HG ' ' A' ' 27' ' ' LEU . 16.6 tt -160.11 125.71 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-O 120.943 0.401 . . . . 74.439999999999998 110.878 175.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 21.5 p -146.2 145.3 30.39 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.218 0.607 . . . . 63.450000000000003 110.255 -176.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 10.2 p-90 -69.25 152.19 45.36 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 118.028 0.376 . . . . 73.420000000000002 110.844 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 61.2 p -71.98 150.0 92.53 Favored Pre-proline 0 CA--C 1.552 1.048 0 N-CA-C 109.446 -0.575 . . . . 61.439999999999998 109.446 172.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -51.59 -24.27 16.82 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.564 2.176 . . . . 75.329999999999998 113.67 171.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 59.8 m -69.99 -52.26 25.74 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.241 0.616 . . . . 74.219999999999999 109.765 169.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.16 5.58 65.63 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.277 -0.874 . . . . 32.32 112.969 -177.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -87.92 -2.25 58.49 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.861 0.864 . . . . 72.040000000000006 110.022 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.7 p -163.59 170.57 17.0 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.375 1.07 . . . . 71.239999999999995 109.494 -169.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -142.07 143.46 33.1 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.465 0.306 . . . . 72.019999999999996 111.075 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 -97.77 140.27 32.4 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.173 0.989 . . . . 75.140000000000001 109.487 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.5 t -123.95 132.7 70.95 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 C-N-CA 124.387 1.075 . . . . 71.109999999999999 108.308 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 79.3 m-85 -115.82 146.86 41.61 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.39 1.076 . . . . 72.450000000000003 109.756 -177.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 49.77 72.59 0.31 Allowed 'General case' 0 N--CA 1.479 1.007 0 O-C-N 124.727 1.267 . . . . 70.219999999999999 111.378 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.416 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 16.3 mm-40 -51.09 -35.96 37.83 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.808 0.843 . . . . 73.420000000000002 112.717 -176.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.37 -47.38 71.16 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-N 115.809 -0.632 . . . . 63.549999999999997 112.885 177.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 -69.54 -44.33 71.19 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.187 0.595 . . . . 62.009999999999998 110.63 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.401 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 71.1 t80 -55.34 -49.26 72.68 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.376 1.47 . . . . 74.040000000000006 110.975 176.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.29 -35.93 78.68 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 116.432 -0.349 . . . . 71.340000000000003 111.932 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -70.11 -47.08 63.31 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 124.263 1.025 . . . . 74.439999999999998 113.078 -175.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.493 ' HG3' HG22 ' A' ' 58' ' ' VAL . 7.1 pt-20 -107.01 -37.38 6.34 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 113.912 1.079 . . . . 74.25 113.912 -174.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.493 HG22 ' HG3' ' A' ' 57' ' ' GLU . 98.4 t -81.0 -43.7 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 122.754 0.421 . . . . 75.540000000000006 111.512 -168.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.5 mt -67.03 -43.86 48.17 Favored Pre-proline 0 CA--C 1.556 1.21 0 CA-C-O 117.979 -1.01 . . . . 71.329999999999998 112.833 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.98 -14.36 43.37 Favored 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 121.894 1.729 . . . . 74.239999999999995 113.625 173.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -79.01 -57.76 3.58 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.384 0.674 . . . . 75.439999999999998 111.04 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.407 ' CE1' HD11 ' A' ' 27' ' ' LEU . 57.3 m-85 -86.57 -26.8 24.3 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 112.258 0.466 . . . . 74.430000000000007 112.258 -176.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -124.38 -178.45 4.11 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.063 0.945 . . . . 71.019999999999996 108.747 -176.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.66 37.67 2.85 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 122.917 0.487 . . . . 73.519999999999996 109.994 -172.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -160.84 160.7 31.41 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.92 0.888 . . . . 73.540000000000006 108.902 -176.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -109.69 -25.45 10.39 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 108.996 -0.742 . . . . 73.209999999999994 108.996 176.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -57.68 118.37 5.19 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.334 1.054 . . . . 62.509999999999998 111.655 -176.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.416 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 11.6 ttm -72.15 -31.57 66.08 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.1 -0.955 . . . . 74.209999999999994 111.709 -178.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.29 -37.36 69.74 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.076 0.55 . . . . 44.329999999999998 111.644 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.403 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 37.2 t -66.41 -44.96 81.52 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.214 1.005 . . . . 70.200000000000003 111.323 176.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -64.19 -52.91 56.62 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.531 1.132 . . . . 64.219999999999999 111.196 -176.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 68.0 t -65.8 -31.35 53.35 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 CA-C-N 115.515 -0.766 . . . . 73.239999999999995 111.251 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -60.28 -39.77 88.03 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 122.785 0.434 . . . . 75.549999999999997 111.227 173.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.403 ' HG2' ' O ' ' A' ' 70' ' ' SER . 21.7 mm-40 -65.09 -46.25 81.86 Favored 'General case' 0 C--N 1.355 0.809 0 O-C-N 123.646 0.591 . . . . 75.049999999999997 109.905 177.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.49 ' HB3' ' HB2' ' A' ' 80' ' ' PHE . 96.9 mt -57.4 -45.25 84.75 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 123.81 0.844 . . . . 74.230000000000004 111.285 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -55.57 -42.5 74.82 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.595 0.758 . . . . 74.510000000000005 111.933 176.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 59.3 mtm -73.6 -27.61 61.38 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 116.041 -0.527 . . . . 71.129999999999995 111.491 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -85.28 -6.97 59.22 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.569 0.348 . . . . 71.040000000000006 111.207 177.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.65 17.71 59.62 Favored Glycine 0 C--N 1.352 1.469 0 CA-C-O 119.794 -0.448 . . . . 63.119999999999997 113.927 175.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.49 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 38.7 m-85 -78.2 137.34 38.09 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 108.332 -0.988 . . . . 73.019999999999996 108.332 173.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 13.6 ttm180 -107.93 130.79 55.01 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.306 0.642 . . . . 73.430000000000007 109.545 -175.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -65.78 125.45 25.36 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.038 0.935 . . . . 75.200000000000003 109.369 174.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.536 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 51.7 t -116.0 113.54 43.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 107.835 -1.172 . . . . 73.219999999999999 107.835 176.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 71.1 t -86.46 140.15 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 123.762 0.825 . . . . 74.329999999999998 110.898 -177.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -131.01 -61.28 0.94 Allowed 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 108.066 -1.087 . . . . 74.519999999999996 108.066 172.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.665 HG22 ' HB3' ' A' ' 93' ' ' LYS . 41.3 mm -120.49 123.33 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 115.307 -0.86 . . . . 74.200000000000003 110.047 -177.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -124.98 119.88 29.99 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.39 1.076 . . . . 74.25 108.336 170.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -87.42 10.72 16.6 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.233 0.613 . . . . 71.209999999999994 112.554 -174.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -75.49 78.68 1.13 Allowed Glycine 0 C--N 1.352 1.446 0 N-CA-C 113.591 0.196 . . . . 63.420000000000002 113.591 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 80.1 5.26 89.7 Favored Glycine 0 C--N 1.351 1.395 0 C-N-CA 123.018 0.342 . . . . 74.140000000000001 113.597 177.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 55.5 mt -103.12 158.75 16.09 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.89 0.876 . . . . 72.120000000000005 110.481 -174.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.5 p -81.95 75.77 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 CA-C-O 123.203 1.478 . . . . 72.329999999999998 109.252 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.665 ' HB3' HG22 ' A' ' 86' ' ' ILE . 73.1 mmtt -132.26 161.69 61.41 Favored Pre-proline 0 N--CA 1.482 1.137 0 CA-C-N 113.617 -1.628 . . . . 74.310000000000002 109.925 -173.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.82 172.96 6.28 Favored 'Trans proline' 0 C--N 1.386 2.519 0 C-N-CA 122.422 2.081 . . . . 71.329999999999998 113.319 174.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -34.85 79.22 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.108 -0.951 . . . . 74.420000000000002 111.291 -178.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -86.21 152.59 22.69 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.516 0.674 . . . . 75.510000000000005 111.381 -172.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 18.0 m-20 -80.84 134.15 35.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.337 -1.302 . . . . 74.209999999999994 108.554 170.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -115.1 105.27 12.74 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 107.644 -1.243 . . . . 74.430000000000007 107.644 169.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 93.3 m -124.7 153.23 42.65 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.478 1.111 . . . . 70.340000000000003 109.637 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.536 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 37.8 tt0 -130.9 153.55 49.02 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.548 -0.908 . . . . 72.040000000000006 108.548 162.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -124.46 120.31 31.66 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 107.277 -1.379 . . . . 74.329999999999998 107.277 169.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -110.32 144.56 38.87 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.552 0.741 . . . . 74.409999999999997 110.242 -174.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.458 ' HB3' ' HB3' ' A' ' 106' ' ' PHE . 64.8 t-80 -149.46 130.81 7.3 Favored Pre-proline 0 CA--C 1.55 0.969 0 CA-C-O 119.351 -0.357 . . . . 72.040000000000006 110.423 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.25 -40.83 30.28 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 123.299 2.666 . . . . 74.409999999999997 113.667 -175.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.413 ' HB2' ' HE1' ' A' ' 103' ' ' HIS . 34.2 m -97.13 22.96 7.85 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.275 0.63 . . . . 73.299999999999997 111.096 -177.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.458 ' HB3' ' HB3' ' A' ' 103' ' ' HIS . 89.1 t80 -117.37 99.05 6.75 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 106.706 -1.59 . . . . 72.439999999999998 106.706 173.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 63.1 mt -119.31 139.36 52.07 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.137 -1.06 . . . . 72.530000000000001 108.137 177.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -68.89 132.27 46.47 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.508 0.723 . . . . 73.319999999999993 110.125 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.48 1.6 90.49 Favored Glycine 0 C--N 1.344 0.983 0 O-C-N 123.555 0.534 . . . . 65.140000000000001 113.052 -173.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -122.84 53.46 1.28 Allowed 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 108.144 -1.058 . . . . 62.530000000000001 108.144 -175.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.55 -26.1 65.09 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.236 1.414 . . . . 73.319999999999993 114.102 -177.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 7.9 pm0 -71.01 -8.19 51.6 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 112.204 0.446 . . . . 65.319999999999993 112.204 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.485 ' O ' HG13 ' A' ' 117' ' ' ILE . 24.6 mt -83.1 -14.22 54.11 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 118.771 -0.633 . . . . 73.230000000000004 111.485 173.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.439 HD21 ' HB3' ' A' ' 21' ' ' LEU . 96.4 mt -63.17 -35.3 79.86 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 118.295 0.498 . . . . 72.430000000000007 110.857 175.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -80.15 -1.59 40.96 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.962 -0.563 . . . . 62.210000000000001 112.148 175.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -103.61 -13.71 16.43 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.586 0.754 . . . . 75.209999999999994 110.528 168.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 113' ' ' LEU . 63.9 mt -85.74 109.74 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 106.879 -1.526 . . . . 73.230000000000004 106.879 173.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -109.21 170.39 8.08 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.807 -0.812 . . . . 71.129999999999995 108.807 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 24.6 ptt85 -119.86 -40.65 2.72 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.155 -1.054 . . . . 73.329999999999998 108.155 168.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -137.15 179.23 6.51 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.519 1.128 . . . . 71.230000000000004 109.476 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 86.5 t -80.59 -37.23 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 N-CA-C 109.055 -0.72 . . . . 74.439999999999998 109.055 166.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 10.0 t -94.34 52.91 1.63 Allowed 'General case' 0 CA--C 1.559 1.308 0 CA-C-O 122.49 1.138 . . . . 74.439999999999998 110.64 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 36.7 m -86.39 92.99 9.0 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 115.196 -0.911 . . . . 75.439999999999998 108.969 175.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.9 m -109.15 16.63 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 124.096 0.958 . . . . 71.299999999999997 112.258 -173.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.479 1.015 0 C-N-CA 123.716 0.807 . . . . 73.519999999999996 109.018 176.026 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.484 1.228 0 CA-C-O 120.893 0.378 . . . . 74.150000000000006 110.74 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -149.31 30.88 1.17 Allowed Glycine 0 N--CA 1.469 0.879 0 CA-C-N 115.669 -0.696 . . . . 74.540000000000006 111.467 175.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -97.6 138.02 35.64 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.23 1.012 . . . . 71.129999999999995 109.52 -174.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -62.98 112.72 2.71 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.79 0.836 . . . . 75.25 111.324 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -97.86 -87.37 0.33 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.482 0.713 . . . . 74.140000000000001 109.868 175.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -166.41 164.58 17.36 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.434 0.693 . . . . 75.140000000000001 110.011 -176.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -89.36 171.47 9.73 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.419 0.628 . . . . 73.150000000000006 111.905 -177.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -123.25 52.09 1.41 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.825 1.25 . . . . 72.010000000000005 107.764 170.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.3 t -64.96 110.64 2.52 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 114.495 -1.23 . . . . 74.040000000000006 112.844 -167.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 29.5 p80 -152.15 131.45 12.83 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.87 0.868 . . . . 65.409999999999997 108.878 167.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -83.4 143.71 30.12 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.045 0.538 . . . . 71.409999999999997 110.881 -174.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -119.86 105.97 11.62 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.623 0.769 . . . . 62.039999999999999 109.505 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -154.98 109.11 0.39 Allowed Glycine 0 C--N 1.346 1.134 0 CA-C-O 118.929 -0.928 . . . . 62.229999999999997 112.024 -177.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -77.65 153.35 30.06 Favored 'Trans proline' 0 C--N 1.375 1.967 0 C-N-CA 122.906 2.404 . . . . 75.219999999999999 112.112 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.1 t -82.32 131.84 35.22 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 108.814 -0.81 . . . . 74.439999999999998 108.814 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -81.27 18.1 1.18 Allowed 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.329 1.052 . . . . 74.019999999999996 112.702 -172.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.4 t -57.83 130.67 82.53 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 124.356 1.062 . . . . 74.109999999999999 111.802 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -58.94 152.37 58.6 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 123.155 2.57 . . . . 74.420000000000002 112.314 174.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.72 -45.78 70.59 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.971 0.908 . . . . 74.019999999999996 112.1 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -54.85 -44.44 73.99 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 122.981 0.512 . . . . 73.310000000000002 112.009 176.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.2 mt -80.52 -31.09 37.16 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 112.393 0.516 . . . . 72.420000000000002 112.393 -171.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.1 t -70.99 -33.39 70.37 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.656 -0.498 . . . . 72.200000000000003 109.656 175.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -69.87 -42.41 73.52 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 122.915 0.486 . . . . 74.129999999999995 110.536 172.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.61 -43.67 93.68 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.8 0.84 . . . . 72.310000000000002 111.419 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 13.5 t-105 -64.58 -51.9 60.37 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-O 119.611 -0.233 . . . . 74.420000000000002 110.81 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 32.1 m -61.3 -20.69 63.2 Favored 'General case' 0 CA--C 1.554 1.133 0 CA-C-O 121.299 0.571 . . . . 74.140000000000001 110.883 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.0 tp -76.77 -54.77 6.18 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.597 1.159 . . . . 75.409999999999997 111.408 174.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 82.5 t -62.16 -36.22 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.749 0.819 . . . . 72.129999999999995 111.389 -177.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.5 p -78.15 -25.4 47.3 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.538 0.735 . . . . 74.140000000000001 112.305 -176.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -70.84 123.12 88.69 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 123.24 0.616 . . . . 75.319999999999993 111.563 -171.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.28 -13.51 33.45 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 122.975 2.45 . . . . 71.450000000000003 113.479 -177.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -87.12 -22.39 25.4 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.723 0.809 . . . . 74.25 110.987 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.414 HG21 ' HE1' ' A' ' 62' ' ' TYR . 24.7 p -110.6 1.25 17.95 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.158 0.583 . . . . 74.430000000000007 111.685 175.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -54.12 -36.95 63.81 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.486 1.114 . . . . 70.420000000000002 112.271 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.1 -33.17 75.39 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.526 -0.761 . . . . 74.129999999999995 112.256 -176.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.463 HD21 ' HB2' ' A' ' 50' ' ' ASP . 59.7 mt -103.48 -11.0 18.09 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.548 0.339 . . . . 71.230000000000004 111.36 -177.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.5 tt -162.15 128.43 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 122.971 0.508 . . . . 70.030000000000001 110.326 172.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 17.3 p -153.92 157.6 39.46 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.23 0.612 . . . . 71.209999999999994 110.057 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 41.4 p-90 -73.63 149.22 42.18 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.993 0.517 . . . . 74.230000000000004 110.097 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.5 m -70.24 143.51 91.1 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 123.879 0.872 . . . . 75.510000000000005 110.098 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -55.59 -32.49 83.36 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.813 2.342 . . . . 75.0 113.517 175.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.9 m -69.61 -19.68 63.64 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.217 0.607 . . . . 73.310000000000002 111.698 173.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.69 6.4 71.71 Favored Glycine 0 C--N 1.344 0.996 0 N-CA-C 115.617 1.007 . . . . 44.439999999999998 115.617 171.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -88.07 -5.66 58.36 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 118.109 0.955 . . . . 74.209999999999994 112.265 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.2 p -163.44 -171.66 2.65 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.162 0.585 . . . . 70.319999999999993 110.736 -170.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -145.03 148.81 34.13 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.404 0.682 . . . . 73.510000000000005 110.973 175.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 21.6 m-70 -99.52 150.79 21.86 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.588 1.155 . . . . 71.400000000000006 110.173 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.0 t -123.67 123.03 66.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 107.939 -1.134 . . . . 74.040000000000006 107.939 172.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -105.68 147.41 28.54 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.273 1.029 . . . . 72.400000000000006 110.034 -178.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.463 ' HB2' HD21 ' A' ' 36' ' ' LEU . 8.6 m-20 48.79 59.83 4.13 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 124.925 1.39 . . . . 63.219999999999999 111.196 172.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.501 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 75.7 mt-30 -54.65 -26.16 31.41 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.78 1.03 . . . . 71.25 113.78 -169.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.94 -50.08 37.33 Favored Glycine 0 C--N 1.35 1.348 0 O-C-N 123.198 0.311 . . . . 75.209999999999994 112.654 173.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -68.06 -40.13 82.84 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.452 0.701 . . . . 74.439999999999998 110.249 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.478 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 44.4 t80 -57.99 -48.14 80.91 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.113 1.365 . . . . 73.439999999999998 110.534 176.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.27 -36.67 80.66 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.196 -0.456 . . . . 71.209999999999994 111.486 177.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -68.47 -53.99 19.83 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.252 1.021 . . . . 73.129999999999995 112.985 -176.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.536 ' HG3' HG21 ' A' ' 58' ' ' VAL . 6.3 pt-20 -100.45 -38.07 8.56 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 112.893 0.701 . . . . 61.420000000000002 112.893 -173.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.536 HG21 ' HG3' ' A' ' 57' ' ' GLU . 77.6 t -81.92 -44.46 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.045 0.538 . . . . 73.340000000000003 112.144 -167.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 49.3 mt -63.52 -45.17 83.24 Favored Pre-proline 0 CA--C 1.56 1.36 0 CA-C-O 117.797 -1.097 . . . . 73.209999999999994 112.684 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.09 -16.52 44.89 Favored 'Trans proline' 0 C--N 1.386 2.538 0 CA-C-N 122.037 1.763 . . . . 75.510000000000005 113.312 173.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -73.13 -47.62 42.57 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.453 0.701 . . . . 73.200000000000003 111.073 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.414 ' HE1' HG21 ' A' ' 33' ' ' THR . 53.8 m-85 -96.12 -48.1 5.8 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 122.853 0.461 . . . . 74.430000000000007 111.903 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -99.08 -171.27 2.06 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.85 0.86 . . . . 75.049999999999997 109.117 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -118.89 44.72 2.24 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.361 0.601 . . . . 73.310000000000002 110.551 -176.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -164.04 164.51 22.99 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.333 -0.849 . . . . 74.299999999999997 109.557 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -121.91 -11.8 8.48 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.588 0.755 . . . . 75.310000000000002 110.278 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -66.93 117.39 8.95 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.035 0.934 . . . . 74.299999999999997 109.75 174.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.501 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 24.0 ttt -87.72 -18.68 28.94 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.558 0.343 . . . . 74.099999999999994 110.917 -176.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.5 -37.49 67.92 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.862 0.465 . . . . 74.510000000000005 110.22 172.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.479 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 44.0 t -66.44 -46.22 77.21 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.911 1.284 . . . . 71.200000000000003 111.343 175.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -61.75 -51.28 68.98 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.889 0.876 . . . . 74.010000000000005 110.478 -175.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.35 -40.85 90.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 123.914 0.885 . . . . 74.219999999999999 110.772 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -56.58 -39.91 74.33 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.257 1.023 . . . . 73.319999999999993 111.073 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.54 ' HA ' ' HE3' ' A' ' 77' ' ' MET . 25.8 mm-40 -63.38 -45.91 88.92 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 123.653 0.596 . . . . 72.409999999999997 109.822 176.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 64.4 mt -61.16 -37.43 82.87 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.729 0.811 . . . . 74.200000000000003 111.5 -178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -58.55 -38.54 78.03 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.509 0.724 . . . . 73.310000000000002 111.371 172.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.54 ' HE3' ' HA ' ' A' ' 74' ' ' GLN . 34.1 mtm -70.86 -34.07 71.26 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.189 -0.459 . . . . 72.420000000000002 110.493 177.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 119' ' ' ARG . 44.4 m-85 -81.21 -9.62 59.75 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.595 0.758 . . . . 71.430000000000007 111.59 -178.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.96 22.69 59.01 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 114.268 0.467 . . . . 61.0 114.268 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -79.49 137.17 37.11 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 108.443 -0.947 . . . . 74.519999999999996 108.443 171.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -102.81 127.14 50.1 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.153 0.581 . . . . 74.5 110.595 -170.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.3 tptt -65.05 115.88 5.89 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.865 1.266 . . . . 74.510000000000005 109.707 173.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.47 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 59.5 t -123.29 120.28 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 108.731 -0.84 . . . . 71.129999999999995 108.731 175.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 37.5 t -90.77 121.47 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.069 0.948 . . . . 70.420000000000002 109.384 -176.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 -107.84 -46.78 3.72 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 122.619 0.368 . . . . 62.229999999999997 110.696 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.7 mm -69.48 115.57 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 108.274 -1.01 . . . . 75.340000000000003 108.274 168.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -67.47 117.91 10.07 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.692 0.797 . . . . 72.519999999999996 110.014 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -69.75 94.53 0.81 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.924 0.89 . . . . 74.010000000000005 110.749 -174.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.84 163.57 30.21 Favored Glycine 0 C--O 1.242 0.6 0 CA-C-N 114.539 -1.21 . . . . 62.549999999999997 111.358 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.54 83.85 0.36 Allowed Glycine 0 C--N 1.339 0.73 0 O-C-N 123.79 0.347 . . . . 72.049999999999997 112.293 176.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.406 ' HB2' ' HG2' ' A' ' 93' ' ' LYS . 88.7 mt -117.01 170.39 8.68 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.338 1.055 . . . . 74.349999999999994 109.802 -178.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.6 p -70.25 -23.4 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.234 0.613 . . . . 75.430000000000007 111.094 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.406 ' HG2' ' HB2' ' A' ' 91' ' ' LEU . 16.4 ptmt -70.61 158.06 88.71 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 124.042 0.937 . . . . 74.040000000000006 110.19 178.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -58.5 141.59 97.4 Favored 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 122.566 2.177 . . . . 75.010000000000005 112.639 -174.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -81.86 2.45 30.31 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.296 1.038 . . . . 74.319999999999993 111.371 -177.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -59.06 153.37 17.98 Favored 'General case' 0 C--N 1.36 1.026 0 C-N-CA 123.556 0.742 . . . . 73.299999999999997 110.205 173.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -97.52 113.39 25.08 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 107.166 -1.42 . . . . 74.349999999999994 107.166 175.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -100.65 122.13 42.79 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 107.262 -1.384 . . . . 72.150000000000006 107.262 174.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 77.3 m -123.34 128.49 49.98 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.13 -0.693 . . . . 64.140000000000001 109.13 176.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.47 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 35.2 tt0 -101.55 111.0 23.1 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 106.799 -1.556 . . . . 75.430000000000007 106.799 172.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -94.05 119.88 33.53 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.445 -1.317 . . . . 65.450000000000003 107.445 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -121.69 142.12 50.48 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.788 -0.642 . . . . 75.420000000000002 110.796 -174.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 45.5 t-80 -147.26 130.28 8.0 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 107.665 -1.235 . . . . 74.239999999999995 107.665 175.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -63.01 -20.9 72.69 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.816 2.344 . . . . 73.329999999999998 113.846 -172.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.476 ' SG ' ' HB3' ' A' ' 113' ' ' LEU . 36.7 t -101.64 35.36 2.33 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.306 0.642 . . . . 73.129999999999995 110.099 175.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -137.48 109.01 6.94 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.931 0.892 . . . . 74.340000000000003 108.848 172.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 85.0 mt -118.14 104.86 11.23 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 118.969 -0.539 . . . . 72.310000000000002 109.933 174.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 52.14 -79.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 125.669 1.588 . . . . 75.109999999999999 112.688 176.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -141.57 42.13 1.18 Allowed Glycine 0 C--N 1.348 1.243 0 CA-C-N 115.827 -0.624 . . . . 62.409999999999997 111.923 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -82.1 74.19 9.09 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 106.677 -1.601 . . . . 75.200000000000003 106.677 173.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -62.0 -31.14 71.49 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.143 -1.39 . . . . 75.129999999999995 112.695 -171.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 17.5 pm0 -69.2 -16.89 63.72 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 122.502 0.321 . . . . 75.120000000000005 111.586 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.476 ' HB3' ' SG ' ' A' ' 105' ' ' CYS . 40.7 mt -87.24 -14.6 40.58 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.329 0.252 . . . . 74.439999999999998 111.462 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.86 -33.82 76.56 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.976 0.51 . . . . 73.230000000000004 111.661 177.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -73.74 -5.88 43.47 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.2 0.444 . . . . 55.25 112.2 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -101.56 -6.68 23.56 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.8 0.84 . . . . 72.340000000000003 109.594 175.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 44.2 mt -90.77 111.95 24.35 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 N-CA-C 107.226 -1.398 . . . . 74.129999999999995 107.226 174.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.42 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 11.4 mmpt? -101.25 136.69 40.68 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.347 0.659 . . . . 75.519999999999996 111.115 -167.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 78' ' ' TYR . 15.7 ptt180 -83.07 19.64 1.38 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 123.546 0.738 . . . . 75.040000000000006 112.867 178.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -103.68 132.61 49.78 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.55 -1.278 . . . . 74.319999999999993 107.55 164.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.1 p -80.6 78.27 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 CA-C-O 123.074 1.416 . . . . 61.240000000000002 109.579 -172.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 10.1 t -77.67 57.24 1.59 Allowed 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 113.299 -1.773 . . . . 73.299999999999997 110.816 177.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.4 t -162.69 142.8 9.48 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-N 115.374 -0.83 . . . . 74.319999999999993 108.995 -177.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 16.4 m -70.9 96.69 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 CA-C-O 121.561 0.696 . . . . 74.409999999999997 110.366 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 C--O 1.248 0.994 0 C-N-CA 123.807 0.843 . . . . 61.420000000000002 109.492 -175.105 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.6 mmm . . . . . 0 N--CA 1.476 0.873 0 N-CA-C 109.396 -0.594 . . . . 75.109999999999999 109.396 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.92 126.3 0.91 Allowed Glycine 0 C--N 1.333 0.372 0 N-CA-C 110.048 -1.221 . . . . 72.310000000000002 110.048 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -144.73 106.34 4.26 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-N 117.496 0.648 . . . . 75.019999999999996 109.87 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 47.5 t60 -64.93 125.14 23.93 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 123.926 0.89 . . . . 75.010000000000005 109.141 174.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -64.31 104.49 0.77 Allowed 'General case' 0 N--CA 1.475 0.791 0 O-C-N 124.258 0.974 . . . . 64.0 109.569 176.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -92.8 145.18 24.6 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.041 -0.981 . . . . 62.299999999999997 110.209 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -118.24 127.16 53.46 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.824 -0.806 . . . . 75.299999999999997 108.824 175.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -85.65 101.78 13.03 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.052 -1.092 . . . . 74.530000000000001 108.052 171.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.0 p -79.95 65.05 4.98 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.904 0.859 . . . . 75.140000000000001 109.531 175.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -76.92 137.23 38.97 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.496 -1.229 . . . . 74.239999999999995 109.977 -175.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 21.6 ptm -145.9 171.27 15.07 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.513 1.125 . . . . 75.019999999999996 109.22 -178.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.15 172.62 13.16 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.003 0.921 . . . . 74.030000000000001 108.553 172.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -121.32 72.93 0.36 Allowed Glycine 0 N--CA 1.468 0.811 0 CA-C-O 119.528 -0.596 . . . . 72.239999999999995 112.352 176.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -88.46 12.15 2.88 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 122.475 2.117 . . . . 73.310000000000002 110.871 172.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.413 ' OG ' HG22 ' A' ' 17' ' ' VAL . 20.3 t -86.66 162.53 17.87 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 124.743 1.217 . . . . 74.530000000000001 109.676 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -85.78 7.06 25.19 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.171 0.588 . . . . 72.420000000000002 111.366 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.413 HG22 ' OG ' ' A' ' 15' ' ' SER . 52.6 t -57.49 119.63 34.06 Favored Pre-proline 0 N--CA 1.48 1.065 0 C-N-CA 124.434 1.094 . . . . 61.219999999999999 110.606 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -64.43 155.91 63.35 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 122.702 2.268 . . . . 74.310000000000002 111.44 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.24 -44.81 61.81 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.057 0.943 . . . . 64.530000000000001 112.232 -175.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -53.19 -46.33 68.94 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.17 0.588 . . . . 72.239999999999995 112.338 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 68.9 mt -80.26 -33.6 37.73 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 112.452 0.538 . . . . 73.239999999999995 112.452 -173.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.475 HG23 ' HZ3' ' A' ' 23' ' ' LYS . 9.9 t -71.67 -34.83 70.04 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 117.723 0.238 . . . . 75.299999999999997 110.415 176.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.518 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -70.44 -43.87 69.01 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 122.817 0.447 . . . . 74.310000000000002 110.078 174.018 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.439 ' O ' HG23 ' A' ' 28' ' ' VAL . 68.6 tp -54.28 -56.51 17.74 Favored 'General case' 0 C--O 1.214 -0.784 0 O-C-N 124.312 1.007 . . . . 73.439999999999998 111.546 177.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.465 ' HZ2' ' H ' ' A' ' 109' ' ' GLY . 23.0 t90 -58.11 -45.46 87.24 Favored 'General case' 0 CA--C 1.552 1.026 0 O-C-N 123.52 0.512 . . . . 74.120000000000005 110.908 -176.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.6 m -64.82 -30.75 71.77 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.704 0.802 . . . . 73.030000000000001 111.536 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.437 ' HG ' HG22 ' A' ' 37' ' ' ILE . 37.3 tp -74.05 -45.15 51.3 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.45 1.1 . . . . 72.439999999999998 111.26 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 24' ' ' LEU . 71.4 t -61.76 -32.04 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 C-N-CA 124.092 0.957 . . . . 72.010000000000005 110.321 173.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.6 t -93.64 5.15 52.56 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.359 1.064 . . . . 73.310000000000002 111.988 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -85.83 121.5 73.1 Favored Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 123.056 0.542 . . . . 73.430000000000007 110.436 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.46 -14.05 27.78 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.765 2.31 . . . . 74.439999999999998 113.54 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -78.96 -33.47 45.17 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.368 0.667 . . . . 73.329999999999998 111.23 177.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 67.4 p -111.62 9.53 21.09 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.812 -0.631 . . . . 74.420000000000002 110.683 -176.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -56.79 -34.62 67.82 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.338 1.455 . . . . 72.120000000000005 112.305 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.33 -34.01 76.76 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.503 -0.771 . . . . 74.140000000000001 111.71 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.405 HD23 ' HB2' ' A' ' 50' ' ' ASP . 87.9 mt -104.75 -13.57 15.85 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.227 0.611 . . . . 75.030000000000001 111.397 -174.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.437 HG22 ' HG ' ' A' ' 27' ' ' LEU . 20.1 tt -161.2 119.69 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 C-N-CA 123.005 0.522 . . . . 74.340000000000003 110.246 175.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 16.7 p -150.04 150.23 31.46 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.367 0.667 . . . . 75.25 109.768 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.438 ' HE3' ' HA2' ' A' ' 43' ' ' GLY . 8.2 p-90 -89.98 153.74 20.36 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.006 0.431 . . . . 75.430000000000007 109.891 178.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.8 m -82.43 155.24 69.11 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 114.823 -1.08 . . . . 72.219999999999999 109.316 -175.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.18 -16.53 13.03 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 122.884 2.389 . . . . 74.010000000000005 114.135 173.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.6 m -71.14 -36.42 72.08 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.073 0.949 . . . . 64.129999999999995 111.399 174.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.438 ' HA2' ' HE3' ' A' ' 39' ' ' TRP . . . 82.16 1.49 90.37 Favored Glycine 0 C--N 1.345 1.067 0 CA-C-N 115.744 -0.662 . . . . 74.340000000000003 114.66 176.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -103.08 -3.23 26.2 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.259 0.624 . . . . 63.340000000000003 111.09 -175.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.8 p -154.68 163.25 40.52 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.405 0.682 . . . . 51.109999999999999 110.599 -170.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -142.13 152.26 43.05 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.88 0.472 . . . . 74.549999999999997 110.446 174.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -109.16 148.68 30.52 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.776 0.83 . . . . 72.329999999999998 109.235 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 82.7 t -123.73 131.83 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 108.223 -1.029 . . . . 71.450000000000003 108.223 177.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.53 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 94.0 m-85 -115.41 147.19 40.84 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.864 0.866 . . . . 72.439999999999998 110.217 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.405 ' HB2' HD23 ' A' ' 36' ' ' LEU . 17.6 m-20 51.43 67.56 0.93 Allowed 'General case' 0 N--CA 1.481 1.113 0 O-C-N 124.647 1.217 . . . . 75.349999999999994 111.823 173.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -53.77 -31.34 48.32 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 114.516 1.302 . . . . 74.409999999999997 114.516 -172.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.4 -43.92 43.9 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 112.058 -0.417 . . . . 71.519999999999996 112.058 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.424 ' NE2' ' HD3' ' A' ' 56' ' ' LYS . 20.3 tp60 -72.29 -32.67 66.8 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.67 1.188 . . . . 72.420000000000002 110.968 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.472 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 53.6 t80 -69.71 -50.73 40.81 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.848 1.259 . . . . 75.340000000000003 109.762 178.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 66' ' ' ASN . . . -62.17 -32.14 72.73 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.628 -0.715 . . . . 74.5 112.135 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.424 ' HD3' ' NE2' ' A' ' 53' ' ' GLN . 31.5 tttm -62.38 -53.67 51.59 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.046 1.339 . . . . 74.299999999999997 113.45 -176.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -122.11 -22.11 5.74 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 114.033 1.123 . . . . 73.430000000000007 114.033 -170.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.472 ' HB ' ' O ' ' A' ' 54' ' ' PHE . 85.7 t -86.44 -45.03 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.16 0.584 . . . . 72.25 110.824 -175.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 26.3 mt -62.88 -48.83 84.38 Favored Pre-proline 0 CA--C 1.559 1.305 0 CA-C-O 118.507 -0.759 . . . . 75.099999999999994 112.55 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.431 ' HG3' ' ND2' ' A' ' 66' ' ' ASN . 55.6 Cg_endo -67.56 -13.18 38.2 Favored 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 121.926 1.75 . . . . 64.109999999999999 113.239 175.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -73.28 -54.07 9.31 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.262 0.625 . . . . 73.409999999999997 110.675 176.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.468 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 35.5 m-85 -92.84 -43.71 8.85 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 112.194 0.442 . . . . 74.099999999999994 112.194 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -98.77 -176.99 3.51 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.488 0.715 . . . . 72.409999999999997 109.335 -178.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.55 39.68 2.58 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.312 0.577 . . . . 72.510000000000005 111.132 -174.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -161.23 162.12 31.06 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.881 0.873 . . . . 65.129999999999995 109.875 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.488 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 7.3 m120 -106.8 -26.22 11.37 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 108.618 -0.882 . . . . 74.120000000000005 108.618 173.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -61.03 115.31 3.64 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.114 0.965 . . . . 74.340000000000003 111.52 -177.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.422 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 24.9 ttt -83.13 -20.11 35.43 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 116.195 -0.457 . . . . 75.120000000000005 111.296 -177.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.93 -36.2 72.16 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.356 0.262 . . . . 72.450000000000003 110.525 172.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.491 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 37.2 t -63.32 -51.69 64.96 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.085 0.954 . . . . 74.140000000000001 110.727 172.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -58.08 -54.9 41.7 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.166 0.986 . . . . 71.239999999999995 111.342 -174.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.1 -37.75 80.65 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 CA-C-N 115.506 -0.77 . . . . 71.329999999999998 111.033 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 58.2 ttt-85 -59.44 -43.9 93.02 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 117.894 0.316 . . . . 75.439999999999998 111.396 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 70' ' ' SER . 10.0 mm100 -62.0 -44.26 97.1 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.535 0.522 . . . . 74.420000000000002 109.627 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.1 mt -59.32 -41.16 88.44 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 123.946 0.779 . . . . 75.430000000000007 111.567 176.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -61.25 -37.59 83.66 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.589 0.756 . . . . 73.420000000000002 111.181 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.402 ' HE1' ' HA ' ' A' ' 74' ' ' GLN . 41.9 mtm -68.83 -31.87 71.15 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 122.757 0.423 . . . . 75.120000000000005 110.565 173.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -81.78 -4.01 55.29 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.963 0.905 . . . . 71.540000000000006 111.137 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.65 15.09 74.23 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-O 119.527 -0.596 . . . . 71.230000000000004 114.353 175.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -72.91 131.91 42.81 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 117.683 0.741 . . . . 75.109999999999999 109.222 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -99.42 121.77 41.6 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 109.144 -0.687 . . . . 73.349999999999994 109.144 -174.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.529 ' HE2' HG22 ' A' ' 84' ' ' VAL . 1.2 tmtp? -79.21 127.66 32.33 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.802 1.241 . . . . 73.019999999999996 108.063 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 61.7 t -123.75 129.17 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.166 0.986 . . . . 74.140000000000001 108.631 178.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.529 HG22 ' HE2' ' A' ' 82' ' ' LYS . 30.6 t -92.25 134.0 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 108.279 -1.008 . . . . 73.040000000000006 108.279 178.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 46.6 m-70 -118.21 -0.26 11.59 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 122.774 0.43 . . . . 74.319999999999993 111.099 175.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 48.1 mm -108.98 100.23 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.73 0.812 . . . . 74.0 109.294 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -82.1 168.02 18.17 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.231 0.612 . . . . 74.420000000000002 110.707 175.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -107.39 123.42 48.35 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.845 0.858 . . . . 75.409999999999997 109.02 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.96 -69.97 0.12 Allowed Glycine 0 C--N 1.341 0.846 0 N-CA-C 111.658 -0.577 . . . . 62.009999999999998 111.658 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 173.71 76.39 0.05 OUTLIER Glycine 0 C--N 1.337 0.605 0 N-CA-C 110.719 -0.952 . . . . 72.040000000000006 110.719 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.52 HD11 ' HD3' ' A' ' 93' ' ' LYS . 71.0 mt -87.1 156.1 19.86 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.614 0.765 . . . . 75.140000000000001 110.929 -177.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.5 p -87.32 -14.6 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 123.98 0.912 . . . . 72.209999999999994 108.953 165.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.52 ' HD3' HD11 ' A' ' 91' ' ' LEU . 24.8 mtpp -65.78 158.83 73.13 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 125.578 1.551 . . . . 74.549999999999997 110.619 177.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.48 141.22 45.76 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 121.612 1.541 . . . . 70.420000000000002 110.76 171.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -80.8 3.66 21.7 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.497 0.719 . . . . 74.329999999999998 112.126 -174.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -63.79 169.69 3.93 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.653 0.781 . . . . 71.319999999999993 110.735 173.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.53 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 3.6 m-20 -81.08 119.4 23.5 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.53 -0.915 . . . . 75.230000000000004 108.53 -175.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -115.87 107.34 14.88 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 108.349 -0.982 . . . . 53.32 108.349 170.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.45 HG21 ' HG2' ' A' ' 82' ' ' LYS . 46.7 m -124.23 114.76 20.04 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 114.538 -1.21 . . . . 75.319999999999993 109.382 -172.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.539 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 32.0 tt0 -101.18 114.34 28.2 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 109.008 -0.738 . . . . 74.439999999999998 109.008 -176.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -96.95 119.95 36.38 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.109 -1.071 . . . . 75.450000000000003 108.109 171.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -123.02 141.61 51.77 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.239 0.615 . . . . 74.230000000000004 110.093 -177.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -158.68 132.52 4.99 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 109.16 -0.681 . . . . 72.439999999999998 109.16 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -65.2 -22.48 60.99 Favored 'Trans proline' 0 C--N 1.384 2.433 0 C-N-CA 123.054 2.503 . . . . 74.430000000000007 114.131 -173.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.536 ' HB2' HG12 ' A' ' 117' ' ' ILE . 13.6 m -92.39 -1.52 56.96 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.695 0.398 . . . . 74.099999999999994 111.839 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -104.72 98.37 8.12 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 107.132 -1.432 . . . . 75.0 107.132 175.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.429 ' HB2' ' HB2' ' A' ' 110' ' ' GLN . 67.1 mt -125.45 166.44 16.61 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 121.663 0.744 . . . . 75.129999999999995 111.918 -177.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -58.0 115.91 3.17 Favored 'General case' 0 CA--C 1.556 1.209 0 CA-C-N 113.883 -1.508 . . . . 73.120000000000005 111.673 170.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.465 ' H ' ' HZ2' ' A' ' 25' ' ' TRP . . . 70.21 7.0 59.17 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 115.041 0.776 . . . . 62.43 115.041 174.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.429 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 16.4 mm100 -100.67 65.41 1.15 Allowed 'General case' 0 C--O 1.242 0.67 0 CA-C-O 121.466 0.65 . . . . 60.509999999999998 110.296 -175.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -57.29 -36.07 70.6 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 114.895 -1.048 . . . . 71.0 111.482 173.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 19.2 pm0 -68.45 -16.59 63.96 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.204 0.601 . . . . 74.030000000000001 111.93 -176.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 79.9 mt -96.49 -19.68 18.95 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.335 0.654 . . . . 71.510000000000005 111.555 176.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.1 mt -67.03 -37.42 84.08 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.069 0.547 . . . . 75.219999999999999 110.682 178.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -69.23 -13.85 62.63 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.647 -0.706 . . . . 61.530000000000001 112.278 175.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -97.36 4.75 50.62 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.115 0.566 . . . . 72.420000000000002 110.369 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.536 HG12 ' HB2' ' A' ' 105' ' ' CYS . 44.9 mt -89.68 119.2 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 108.049 -1.093 . . . . 74.010000000000005 108.049 173.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -95.58 132.43 40.73 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.83 0.852 . . . . 63.310000000000002 111.411 -165.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -109.03 -8.63 15.16 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.099 0.96 . . . . 74.030000000000001 111.386 173.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -98.8 167.97 10.42 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.241 0.616 . . . . 74.400000000000006 110.578 175.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . 0.27 9.2 p 39.79 69.4 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 126.24 1.816 . . . . 71.129999999999995 112.46 -172.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 15.3 t -166.42 -158.64 0.33 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 113.742 -1.572 . . . . 74.129999999999995 107.858 -172.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 78.4 p -72.56 73.24 1.03 Allowed 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 123.206 0.603 . . . . 73.230000000000004 111.22 176.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 17.5 t -89.28 67.24 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 107.808 -1.182 . . . . 73.230000000000004 107.808 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 72.0 m . . . . . 0 C--O 1.247 0.956 0 N-CA-C 107.354 -1.35 . . . . 62.340000000000003 107.354 178.8 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.485 1.287 0 N-CA-C 109.713 -0.477 . . . . 64.019999999999996 109.713 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 69.33 -103.48 1.1 Allowed Glycine 0 C--N 1.353 1.494 0 O-C-N 123.428 0.455 . . . . 75.120000000000005 112.115 -177.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.1 p80 -162.06 141.1 9.49 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.559 0.744 . . . . 60.399999999999999 109.847 173.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -155.3 81.15 1.05 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.388 -0.597 . . . . 74.129999999999995 109.388 176.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -130.23 83.91 2.16 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 107.431 -1.322 . . . . 73.209999999999994 107.431 177.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -107.99 128.87 55.03 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.585 0.754 . . . . 74.430000000000007 110.754 -178.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -146.97 162.32 38.99 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.741 1.216 . . . . 75.019999999999996 109.353 173.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -169.44 146.26 3.39 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.823 0.849 . . . . 65.420000000000002 109.667 174.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.8 m -77.31 96.75 4.67 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 123.659 0.6 . . . . 74.420000000000002 110.705 -173.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -74.11 123.25 24.07 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.289 -0.869 . . . . 73.409999999999997 109.805 -178.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -135.05 158.19 44.99 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.124 0.57 . . . . 72.129999999999995 110.922 -173.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.75 97.67 2.64 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.059 0.944 . . . . 64.340000000000003 108.835 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.99 148.57 44.77 Favored Glycine 0 C--N 1.353 1.5 0 CA-C-O 119.283 -0.732 . . . . 73.239999999999995 113.239 -175.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -79.62 175.85 10.18 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.969 2.446 . . . . 72.439999999999998 112.58 177.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.1 t -113.83 179.69 3.89 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.431 0.692 . . . . 73.109999999999999 109.491 177.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -66.09 -14.66 62.14 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 122.796 0.438 . . . . 75.340000000000003 111.541 178.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.42 HG11 ' HB2' ' A' ' 114' ' ' LEU . 54.9 t -57.12 117.69 19.55 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 124.846 1.258 . . . . 75.450000000000003 110.927 176.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -55.76 146.81 64.44 Favored 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 123.149 2.566 . . . . 74.150000000000006 112.733 176.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.56 -43.76 62.49 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 124.198 0.936 . . . . 71.120000000000005 111.674 177.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -50.05 -51.41 42.62 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.358 1.063 . . . . 73.219999999999999 112.307 174.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 98.1 mt -80.5 -34.43 35.74 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.474 0.484 . . . . 73.409999999999997 112.103 -169.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.6 t -69.89 -34.36 73.43 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 122.286 0.234 . . . . 73.219999999999999 110.992 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.11 -44.76 75.42 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 109.749 -0.463 . . . . 75.239999999999995 109.749 171.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.2 tp -60.01 -40.37 89.01 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.012 0.925 . . . . 75.150000000000006 111.686 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.469 ' HB2' HD11 ' A' ' 114' ' ' LEU . 91.0 t90 -54.9 -56.2 22.22 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.412 1.085 . . . . 74.019999999999996 111.56 177.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.6 m -60.66 -38.32 84.48 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.895 -1.048 . . . . 73.549999999999997 110.604 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.469 ' HG ' HD13 ' A' ' 37' ' ' ILE . 34.3 tp -64.9 -52.0 58.87 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.351 1.46 . . . . 74.409999999999997 113.057 -174.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.7 t -57.19 -33.43 43.16 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 C-N-CA 124.015 0.926 . . . . 74.049999999999997 112.047 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.5 t -96.92 -3.19 42.28 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.825 0.85 . . . . 71.030000000000001 112.125 -177.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -76.93 128.97 80.12 Favored Pre-proline 0 N--CA 1.483 1.198 0 C-N-CA 123.419 0.688 . . . . 71.319999999999993 111.61 -170.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.37 -24.44 57.45 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 123.125 2.55 . . . . 75.040000000000006 113.5 -177.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -78.46 -29.34 46.82 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.618 0.367 . . . . 64.209999999999994 110.87 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.1 p -115.6 -5.35 12.19 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.369 0.877 . . . . 73.120000000000005 113.369 -172.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.49 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 2.8 p-10 -64.69 -21.4 66.73 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 118.664 0.666 . . . . 75.129999999999995 112.452 -172.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.29 -33.68 76.04 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.758 0.423 . . . . 72.439999999999998 111.337 174.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.56 HD23 ' HB2' ' A' ' 50' ' ' ASP . 43.3 mt -107.09 -12.92 15.3 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.565 0.746 . . . . 71.230000000000004 111.587 -175.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.49 ' O ' ' HA ' ' A' ' 34' ' ' ASP . 15.0 tt -156.77 108.81 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 CA-C-O 121.325 0.583 . . . . 74.230000000000004 110.495 175.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 23.5 p -133.62 145.96 50.48 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.678 0.391 . . . . 73.420000000000002 111.284 -172.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 18.4 p-90 -72.58 148.98 44.39 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.226 1.011 . . . . 74.030000000000001 111.194 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 25.3 p -70.94 153.1 94.89 Favored Pre-proline 0 CA--C 1.554 1.129 0 C-N-CA 123.19 0.596 . . . . 70.510000000000005 110.088 173.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -46.63 -31.9 10.96 Favored 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 123.333 2.688 . . . . 74.540000000000006 113.191 171.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.9 t -71.31 -60.47 2.21 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.514 -0.767 . . . . 70.540000000000006 109.517 170.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 103.53 19.45 12.26 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-N 115.513 -0.767 . . . . 71.099999999999994 113.706 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -101.64 6.6 42.07 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.58 0.752 . . . . 72.200000000000003 110.491 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.6 p -160.13 164.32 33.07 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 123.984 0.914 . . . . 63.439999999999998 109.431 -173.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.479 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 54.1 p90 -142.38 144.4 33.13 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.54 0.336 . . . . 74.430000000000007 111.176 178.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.463 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 59.3 m-70 -97.27 149.43 22.06 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.317 1.047 . . . . 74.439999999999998 108.813 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 98' ' ' ASP . 62.8 t -126.82 114.69 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.813 -0.81 . . . . 74.140000000000001 108.813 178.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -111.04 149.34 30.88 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.367 1.067 . . . . 73.140000000000001 110.227 -176.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.56 ' HB2' HD23 ' A' ' 36' ' ' LEU . 3.9 m-20 52.72 55.03 9.6 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 124.561 1.163 . . . . 74.530000000000001 110.061 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.532 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 78.3 mt-30 -55.3 -25.21 32.87 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 114.326 1.232 . . . . 64.439999999999998 114.326 -169.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.75 -44.56 56.33 Favored Glycine 0 CA--C 1.533 1.206 0 N-CA-C 111.923 -0.471 . . . . 72.219999999999999 111.923 173.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -70.5 -45.06 66.36 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.78 0.832 . . . . 74.310000000000002 109.853 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.442 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 69.2 t80 -48.44 -52.85 20.16 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.384 1.474 . . . . 74.319999999999993 111.689 173.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.42 ' HB3' ' HB2' ' A' ' 68' ' ' MET . . . -62.61 -33.3 74.73 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 116.336 -0.393 . . . . 72.439999999999998 111.693 178.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.1 tmtm? -73.38 -41.88 62.84 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 124.208 1.003 . . . . 70.209999999999994 113.244 -176.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.544 ' HG3' HG23 ' A' ' 58' ' ' VAL . 4.1 pt-20 -111.15 -39.63 4.69 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 113.583 0.957 . . . . 73.450000000000003 113.583 -172.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.544 HG23 ' HG3' ' A' ' 57' ' ' GLU . 66.3 t -80.28 -46.76 21.66 Favored 'Isoleucine or valine' 0 C--O 1.248 0.987 0 C-N-CA 123.725 0.81 . . . . 71.420000000000002 111.351 -168.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 54.9 mt -67.19 -41.7 35.73 Favored Pre-proline 0 CA--C 1.557 1.22 0 CA-C-O 118.326 -0.845 . . . . 74.319999999999993 112.757 -176.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.53 -17.58 53.34 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 121.941 1.761 . . . . 72.450000000000003 114.011 170.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -72.6 -57.88 3.79 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 117.858 0.299 . . . . 71.420000000000002 110.629 176.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -86.26 -40.26 15.71 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 112.14 0.422 . . . . 74.140000000000001 112.14 -175.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -106.98 -178.17 3.57 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.749 -0.834 . . . . 74.040000000000006 108.749 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -119.17 54.58 0.97 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 122.436 1.113 . . . . 74.019999999999996 109.557 -176.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -170.7 171.7 6.1 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.673 1.589 . . . . 73.310000000000002 107.81 178.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -117.95 -24.48 7.07 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 122.29 -0.257 . . . . 72.239999999999995 111.071 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -63.53 125.93 25.84 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.345 0.658 . . . . 74.099999999999994 112.054 -173.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.532 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 25.3 ttt -86.68 -29.63 22.33 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.388 0.675 . . . . 74.5 111.646 -176.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.37 -34.45 70.7 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 122.799 0.439 . . . . 72.5 111.36 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.443 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 44.1 t -66.74 -45.31 79.05 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.275 1.03 . . . . 70.329999999999998 110.789 173.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -63.14 -46.86 85.25 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.442 1.097 . . . . 75.209999999999994 110.565 -176.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 80.5 t -60.99 -45.31 98.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.23 1.012 . . . . 73.439999999999998 110.947 174.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -62.52 -32.6 73.56 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.781 0.432 . . . . 73.340000000000003 111.318 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 70' ' ' SER . 29.1 mm-40 -62.94 -51.71 65.84 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 109.903 -0.406 . . . . 74.299999999999997 109.903 172.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.9 mt -58.92 -38.0 77.95 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.859 0.864 . . . . 73.109999999999999 111.779 -177.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -59.13 -43.74 91.99 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.484 0.713 . . . . 73.120000000000005 111.075 175.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.419 ' HE3' ' HA ' ' A' ' 74' ' ' GLN . 43.6 mtm -67.29 -35.48 79.55 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.73 -0.668 . . . . 71.140000000000001 110.366 175.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -80.1 8.73 6.6 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 123.525 0.73 . . . . 64.150000000000006 110.917 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.29 4.82 87.8 Favored Glycine 0 C--N 1.351 1.41 0 N-CA-C 114.511 0.564 . . . . 62.329999999999998 114.511 169.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.552 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . 39.8 m-85 -74.09 141.27 45.67 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 108.939 -0.763 . . . . 74.120000000000005 108.939 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.486 ' HB3' ' HG2' ' A' ' 102' ' ' GLN . 32.7 ttm180 -101.6 129.07 47.63 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.774 0.43 . . . . 72.439999999999998 110.101 -173.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -71.92 111.54 7.26 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.897 1.279 . . . . 74.519999999999996 109.855 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.2 t -126.19 136.26 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 107.72 -1.215 . . . . 65.109999999999999 107.72 172.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 96.3 t -119.28 139.46 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.355 0.662 . . . . 74.140000000000001 109.322 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -117.01 -44.53 2.8 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.841 0.456 . . . . 74.540000000000006 110.704 -178.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.558 ' HA ' ' HE2' ' A' ' 93' ' ' LYS . 23.1 mm -67.35 132.94 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 110.168 -0.308 . . . . 74.019999999999996 110.168 173.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -114.09 130.8 56.56 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.285 1.034 . . . . 72.510000000000005 108.676 -177.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -96.34 141.12 30.04 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.642 0.377 . . . . 71.430000000000007 111.168 -174.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 139.77 -151.0 21.79 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 110.455 -1.058 . . . . 72.530000000000001 110.455 -177.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -94.73 62.26 1.64 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.6 -0.6 . . . . 61.530000000000001 111.6 175.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 96.5 mt -119.47 150.8 39.63 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.779 0.832 . . . . 65.340000000000003 109.913 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.37 71.67 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.105 0 CA-C-O 122.863 1.316 . . . . 73.430000000000007 110.912 -172.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.558 ' HE2' ' HA ' ' A' ' 86' ' ' ILE . 17.9 ptmt -166.22 156.98 11.38 Favored Pre-proline 0 CA--C 1.553 1.088 0 CA-C-N 114.168 -1.378 . . . . 73.200000000000003 108.13 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.555 ' HB2' ' HG2' ' A' ' 96' ' ' ARG . 35.1 Cg_endo -61.29 158.89 33.28 Favored 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 122.457 2.105 . . . . 74.150000000000006 113.209 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -95.62 4.06 53.44 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.093 -0.958 . . . . 75.430000000000007 111.647 -174.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.555 ' HG2' ' HB2' ' A' ' 94' ' ' PRO . 5.3 ptp180 -71.76 100.58 2.39 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.198 0.599 . . . . 75.010000000000005 109.832 174.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -40.43 123.13 1.73 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.056 0.943 . . . . 75.519999999999996 111.118 171.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.441 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 22.0 t70 -112.3 134.88 53.59 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.386 -0.598 . . . . 73.129999999999995 109.386 178.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 73.9 m -133.9 128.53 34.75 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.049 -0.723 . . . . 71.219999999999999 109.049 166.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 46' ' ' PHE . 33.7 tt0 -104.46 117.09 33.32 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.02 -1.104 . . . . 74.430000000000007 108.02 170.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.552 ' HB3' ' HB3' ' A' ' 80' ' ' PHE . 97.7 m-85 -95.85 120.01 35.36 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.668 -1.234 . . . . 75.129999999999995 107.668 173.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.486 ' HG2' ' HB3' ' A' ' 81' ' ' ARG . 13.3 pt20 -115.74 136.45 53.05 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 123.182 0.593 . . . . 73.230000000000004 110.06 -174.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -156.43 128.73 4.07 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 123.021 0.529 . . . . 72.510000000000005 109.764 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.36 -39.74 44.68 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 123.089 2.526 . . . . 64.329999999999998 112.647 -174.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.486 ' HB2' HG12 ' A' ' 117' ' ' ILE . 3.4 m -81.66 -4.18 55.49 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.313 0.645 . . . . 75.510000000000005 110.754 -175.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -99.07 106.9 19.17 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 108.04 -1.096 . . . . 74.329999999999998 108.04 176.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.548 ' HB2' ' HB3' ' A' ' 110' ' ' GLN . 74.4 mt -117.1 141.59 48.07 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.733 -0.84 . . . . 71.510000000000005 108.733 169.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -60.32 -30.5 69.54 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 124.414 1.071 . . . . 72.530000000000001 112.69 -170.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -130.03 39.42 1.82 Allowed Glycine 0 C--N 1.345 1.032 0 N-CA-C 111.697 -0.561 . . . . 73.040000000000006 111.697 -178.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.548 ' HB3' ' HB2' ' A' ' 107' ' ' LEU . 3.0 tp-100 -141.58 74.09 1.44 Allowed 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.338 -0.986 . . . . 72.209999999999994 108.338 178.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -65.31 -22.78 66.87 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 114.895 -1.048 . . . . 74.209999999999994 112.795 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -71.45 -16.97 62.4 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.874 0.47 . . . . 75.239999999999995 112.258 -178.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.7 mt -93.49 -7.13 45.24 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 112.071 0.397 . . . . 73.409999999999997 112.071 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.469 HD11 ' HB2' ' A' ' 25' ' ' TRP . 66.4 mt -71.07 -27.63 63.76 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.612 0.365 . . . . 61.340000000000003 111.368 177.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -76.29 -3.69 38.0 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 112.097 0.406 . . . . 73.150000000000006 112.097 176.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -101.43 -6.96 23.33 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.945 0.898 . . . . 71.519999999999996 109.893 174.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.486 HG12 ' HB2' ' A' ' 105' ' ' CYS . 54.4 mt -87.55 117.33 31.3 Favored 'Isoleucine or valine' 0 C--N 1.354 0.79 0 N-CA-C 107.684 -1.228 . . . . 71.219999999999999 107.684 173.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -106.58 140.26 39.74 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 109.347 -0.612 . . . . 71.129999999999995 109.347 -174.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -85.86 36.92 0.68 Allowed 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 121.682 0.753 . . . . 65.129999999999995 111.286 174.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -132.65 138.88 47.48 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 107.216 -1.401 . . . . 74.430000000000007 107.216 175.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.2 p -149.94 92.39 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 122.097 0.951 . . . . 74.310000000000002 109.269 -170.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.2 t -62.48 91.96 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 114.24 -1.345 . . . . 73.010000000000005 110.432 176.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 67.5 m -72.98 91.7 1.58 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.353 -0.839 . . . . 62.109999999999999 110.581 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.7 p -64.37 109.21 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 C-N-CA 124.234 1.014 . . . . 73.319999999999993 110.329 177.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.6 m . . . . . 0 C--O 1.254 1.32 0 C-N-CA 123.983 0.913 . . . . 71.010000000000005 109.813 -170.941 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptm . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 110.135 -0.321 . . . . 75.409999999999997 110.135 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.5 -28.68 3.03 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 115.823 1.089 . . . . 74.299999999999997 115.823 169.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -72.89 -22.14 60.8 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 117.426 0.613 . . . . 74.409999999999997 111.939 -172.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -86.18 31.69 0.64 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.468 0.707 . . . . 75.420000000000002 111.083 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -52.31 -35.73 51.4 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.746 1.618 . . . . 74.0 112.035 -173.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -128.27 80.44 1.96 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.498 1.119 . . . . 70.099999999999994 109.012 168.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 53.4 t60 -126.97 101.46 6.57 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 124.262 1.025 . . . . 75.450000000000003 108.444 171.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 68.4 t60 -74.51 92.29 2.35 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 109.233 -0.654 . . . . 71.099999999999994 109.233 173.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.3 t -88.05 -89.69 0.13 Allowed 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 106.421 -1.696 . . . . 75.510000000000005 106.421 167.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 27.0 m80 -157.07 143.41 18.07 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.545 1.138 . . . . 75.340000000000003 108.863 170.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 81.2 mtp -84.09 151.47 24.91 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 108.948 -0.76 . . . . 74.200000000000003 108.948 171.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.68 108.37 0.83 Allowed 'General case' 0 CA--C 1.545 0.751 0 O-C-N 124.173 0.92 . . . . 72.0 111.482 -177.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -164.75 63.77 0.23 Allowed Glycine 0 CA--C 1.533 1.211 0 N-CA-C 111.038 -0.825 . . . . 72.420000000000002 111.038 177.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -81.9 -1.0 10.65 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 123.04 2.494 . . . . 71.439999999999998 113.556 -173.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.4 p 53.25 -86.66 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 125.697 1.599 . . . . 64.340000000000003 112.172 -173.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.23 39.41 7.45 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.202 1.001 . . . . 71.430000000000007 110.248 -177.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 57.2 t -65.94 126.42 91.78 Favored Pre-proline 0 CA--C 1.548 0.897 0 CA-C-N 114.665 -1.152 . . . . 72.040000000000006 109.136 170.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -50.26 133.63 36.45 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.886 2.391 . . . . 61.409999999999997 111.868 168.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.42 -38.41 59.03 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.62 1.168 . . . . 64.530000000000001 112.031 -178.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -52.14 -49.22 64.16 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 124.166 0.916 . . . . 73.150000000000006 111.638 174.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.462 HD12 ' HB ' ' A' ' 117' ' ' ILE . 95.2 mt -77.41 -43.14 33.62 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.259 0.624 . . . . 73.319999999999993 112.026 -170.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.0 t -64.35 -41.33 96.81 Favored 'General case' 0 CA--C 1.551 1.017 0 O-C-N 123.22 0.325 . . . . 74.25 110.71 -178.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -77.38 -27.1 52.41 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.9 0.48 . . . . 75.109999999999999 111.114 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.47 ' O ' HG22 ' A' ' 28' ' ' VAL . 60.7 tp -59.16 -50.35 74.39 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.566 0.541 . . . . 75.329999999999998 111.078 172.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.423 ' HH2' ' HG3' ' A' ' 108' ' ' ARG . 34.7 t-105 -63.52 -40.7 97.73 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-N 117.777 0.262 . . . . 74.310000000000002 111.405 177.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.6 m -57.34 -37.08 72.01 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-O 121.579 0.704 . . . . 64.329999999999998 110.402 176.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.414 HD12 ' CD1' ' A' ' 62' ' ' TYR . 35.3 tp -70.58 -45.46 65.35 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.358 1.463 . . . . 74.430000000000007 112.31 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 24' ' ' LEU . 91.8 t -62.02 -35.34 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 123.437 0.695 . . . . 75.420000000000002 111.066 177.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.6 t -90.22 -0.09 57.45 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.944 0.898 . . . . 71.420000000000002 111.809 -177.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -84.36 127.11 67.49 Favored Pre-proline 0 N--CA 1.483 1.191 0 C-N-CA 123.036 0.534 . . . . 60.020000000000003 110.47 -178.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.67 -20.62 17.5 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.743 2.295 . . . . 72.239999999999995 113.306 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -81.54 -22.82 37.61 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.128 0.571 . . . . 65.209999999999994 111.42 -176.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.7 p -111.88 6.73 19.73 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.353 0.661 . . . . 64.239999999999995 112.258 177.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.422 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 0.6 OUTLIER -59.51 -29.75 68.09 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.041 0.537 . . . . 63.43 111.914 -174.357 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.69 -28.66 70.09 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.825 0.85 . . . . 73.340000000000003 112.181 -177.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.462 HD21 ' HB2' ' A' ' 50' ' ' ASP . 87.9 mt -116.21 -9.96 11.53 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.245 0.618 . . . . 75.120000000000005 111.702 -177.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 34' ' ' ASP . 17.3 tt -160.43 118.91 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 121.312 0.577 . . . . 74.420000000000002 110.837 171.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.4 p -148.69 151.78 35.51 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.568 0.747 . . . . 72.0 109.502 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 7.7 p-90 -70.13 152.46 44.28 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.29 0.636 . . . . 75.239999999999995 110.213 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.5 m -71.71 154.3 93.05 Favored Pre-proline 0 CA--C 1.561 1.389 0 C-N-CA 123.818 0.847 . . . . 74.129999999999995 110.097 173.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -40.08 -46.67 4.03 Favored 'Trans proline' 0 C--N 1.389 2.663 0 C-N-CA 124.403 3.402 . . . . 75.519999999999996 114.994 -175.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 30.5 t -80.21 -41.27 25.52 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 122.697 0.399 . . . . 72.540000000000006 110.331 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.82 28.21 7.96 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-N 116.04 -0.527 . . . . 71.230000000000004 113.186 176.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -82.54 -10.69 58.88 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.582 0.753 . . . . 73.310000000000002 110.776 174.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.417 ' HB3' ' HB3' ' A' ' 102' ' ' GLN . 68.2 p -155.72 -176.79 6.13 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 123.741 0.816 . . . . 74.310000000000002 110.135 -177.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -141.95 145.97 35.11 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.376 0.671 . . . . 74.239999999999995 110.191 175.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 54.1 m-70 -97.64 147.66 24.09 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.059 0.944 . . . . 74.150000000000006 108.844 176.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 95.1 t -125.08 123.11 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.689 1.196 . . . . 73.230000000000004 108.095 175.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.451 ' HB2' ' HA ' ' A' ' 36' ' ' LEU . 97.0 m-85 -110.35 147.34 34.13 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.675 0.79 . . . . 72.129999999999995 110.867 -177.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.462 ' HB2' HD21 ' A' ' 36' ' ' LEU . 6.4 m-20 50.52 68.32 0.79 Allowed 'General case' 0 CA--C 1.541 0.62 0 O-C-N 124.922 1.389 . . . . 71.230000000000004 111.812 174.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -47.81 -32.81 6.48 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.729 1.211 . . . . 75.219999999999999 114.036 -173.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.4 -44.86 50.23 Favored Glycine 0 CA--C 1.531 1.07 0 O-C-N 123.397 0.435 . . . . 65.310000000000002 112.706 176.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -74.04 -44.92 52.61 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.554 0.741 . . . . 72.219999999999999 110.182 -176.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.419 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 69.1 t80 -49.56 -50.93 40.26 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.482 1.513 . . . . 74.219999999999999 111.209 169.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 66' ' ' ASN . . . -62.09 -35.52 78.92 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 116.196 -0.456 . . . . 54.399999999999999 111.872 178.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.439 ' HZ3' ' HB3' ' A' ' 57' ' ' GLU . 11.4 tmtt? -68.33 -46.82 69.15 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.27 1.028 . . . . 74.540000000000006 112.642 -175.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.47 ' HG3' HG22 ' A' ' 58' ' ' VAL . 11.9 pt-20 -115.16 -34.84 4.88 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 114.175 1.176 . . . . 72.299999999999997 114.175 -171.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.47 HG22 ' HG3' ' A' ' 57' ' ' GLU . 92.2 t -82.23 -42.27 18.62 Favored 'Isoleucine or valine' 0 C--O 1.247 0.929 0 C-N-CA 123.24 0.616 . . . . 74.420000000000002 110.987 -169.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 43.4 mt -66.02 -48.77 59.74 Favored Pre-proline 0 CA--C 1.558 1.272 0 CA-C-O 117.915 -1.041 . . . . 73.150000000000006 112.363 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -67.63 -13.95 40.49 Favored 'Trans proline' 0 C--N 1.384 2.432 0 CA-C-N 121.934 1.726 . . . . 63.43 113.046 175.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -72.64 -59.03 2.92 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.102 0.561 . . . . 74.200000000000003 110.119 176.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.414 ' CD1' HD12 ' A' ' 27' ' ' LEU . 37.2 m-85 -89.73 -47.99 7.56 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 112.405 0.521 . . . . 75.409999999999997 112.405 -179.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -93.82 -177.92 4.51 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 108.498 -0.927 . . . . 73.349999999999994 108.498 -178.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -116.93 43.79 2.2 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.778 -0.576 . . . . 75.150000000000006 110.159 -173.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 26.9 p80 -165.3 164.0 19.94 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.384 1.074 . . . . 73.409999999999997 108.832 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' A' ' 55' ' ' ALA . 1.5 m-20 -117.38 -12.71 10.42 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.007 0.523 . . . . 71.120000000000005 110.39 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -71.13 122.03 19.38 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.524 0.729 . . . . 72.129999999999995 109.738 178.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.424 ' HB2' ' HB1' ' A' ' 55' ' ' ALA . 22.8 ttt -90.92 -18.66 24.36 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.665 0.386 . . . . 75.019999999999996 111.472 -175.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.06 -37.61 72.07 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.848 0.459 . . . . 55.109999999999999 110.705 173.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.7 t -65.02 -44.04 90.48 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.446 1.098 . . . . 71.409999999999997 110.863 174.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -64.49 -53.24 51.26 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.351 1.06 . . . . 73.319999999999993 111.005 -175.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 66.7 t -63.05 -40.78 90.36 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 123.639 0.776 . . . . 75.120000000000005 111.317 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 -57.96 -38.64 76.37 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.13 0.572 . . . . 75.349999999999994 111.563 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -60.9 -49.67 76.51 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 123.789 0.681 . . . . 74.409999999999997 110.574 175.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 78.3 mt -61.22 -40.5 94.22 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.794 0.838 . . . . 75.340000000000003 111.618 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -57.75 -42.43 83.97 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.954 0.902 . . . . 74.409999999999997 111.454 175.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 70.8 mtm -74.59 -31.02 61.91 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.569 -0.741 . . . . 73.219999999999999 110.96 177.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -82.54 7.02 15.64 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.764 0.825 . . . . 62.25 110.857 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.1 10.37 82.8 Favored Glycine 0 C--N 1.347 1.181 0 N-CA-C 115.026 0.77 . . . . 61.340000000000003 115.026 168.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -71.98 138.49 48.03 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 117.638 0.719 . . . . 73.319999999999993 110.763 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 35.4 ttm-85 -100.45 122.53 43.33 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.927 -0.768 . . . . 74.120000000000005 108.927 -177.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.512 ' HE3' HG21 ' A' ' 99' ' ' THR . 1.3 tmtp? -78.92 123.24 27.07 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.777 1.231 . . . . 71.510000000000005 108.898 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 89.7 t -133.4 117.06 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.639 1.176 . . . . 74.239999999999995 108.058 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.6 p -102.92 126.21 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 109.118 -0.697 . . . . 72.239999999999995 109.118 -176.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -100.63 -37.25 8.84 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.254 0.622 . . . . 74.030000000000001 110.626 -174.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.573 HG21 ' HB3' ' A' ' 93' ' ' LYS . 45.6 mm -74.81 86.86 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 107.327 -1.36 . . . . 73.120000000000005 107.327 166.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.553 ' HB2' ' HE3' ' A' ' 93' ' ' LYS . 32.4 mt-10 -61.68 101.33 0.18 Allowed 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.026 -0.988 . . . . 74.340000000000003 110.653 -174.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -66.41 128.87 37.84 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 114.579 -1.191 . . . . 74.329999999999998 112.145 -169.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.36 -148.0 13.73 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-N 115.207 -0.906 . . . . 44.409999999999997 111.416 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -99.03 25.12 29.48 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 112.008 -0.437 . . . . 72.319999999999993 112.008 175.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 81.2 mt -77.69 173.95 11.5 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.99 0.916 . . . . 74.409999999999997 110.761 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.7 p -76.82 9.0 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.569 0 C-N-CA 123.849 0.86 . . . . 64.420000000000002 112.058 -178.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.573 ' HB3' HG21 ' A' ' 86' ' ' ILE . 74.4 mmtt -58.02 150.74 48.94 Favored Pre-proline 0 N--CA 1.483 1.193 0 C-N-CA 124.301 1.041 . . . . 72.430000000000007 110.923 173.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.422 ' HD2' HD11 ' A' ' 86' ' ' ILE . 73.5 Cg_endo -72.13 146.87 47.23 Favored 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 122.293 1.995 . . . . 74.209999999999994 110.003 169.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -84.64 68.58 10.42 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 122.584 1.183 . . . . 62.509999999999998 110.677 -177.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -134.85 157.13 47.59 Favored 'General case' 0 C--O 1.246 0.88 0 CA-C-N 114.187 -1.369 . . . . 74.140000000000001 107.849 167.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 5.1 m-20 -80.82 142.99 33.14 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.798 -0.815 . . . . 73.230000000000004 108.798 -179.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -135.67 122.67 21.39 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.343 -0.984 . . . . 75.450000000000003 108.343 167.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.512 HG21 ' HE3' ' A' ' 82' ' ' LYS . 24.1 m -136.9 114.08 10.72 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 109.236 -0.653 . . . . 74.340000000000003 109.236 177.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -103.91 111.88 24.61 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.857 -0.794 . . . . 74.349999999999994 108.857 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -97.26 129.29 44.59 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 109.072 -0.714 . . . . 73.310000000000002 109.072 175.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 19.3 pt20 -123.71 150.06 44.78 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.907 0.883 . . . . 72.120000000000005 109.533 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -156.68 135.55 7.8 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 108.357 -0.979 . . . . 71.319999999999993 108.357 175.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -59.82 -31.16 93.52 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.744 2.296 . . . . 75.030000000000001 112.823 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.492 ' HB2' HG12 ' A' ' 117' ' ' ILE . 5.2 m -92.1 7.75 40.98 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 122.953 0.501 . . . . 51.530000000000001 111.415 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -123.79 101.45 7.28 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 108.297 -1.001 . . . . 75.420000000000002 108.297 174.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 52.8 mt -126.27 174.17 8.75 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.49 0.716 . . . . 72.109999999999999 109.359 173.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.423 ' HG3' ' HH2' ' A' ' 25' ' ' TRP . 71.5 ttt180 -76.35 109.27 9.92 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.696 1.198 . . . . 72.519999999999996 110.84 -177.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.18 35.44 30.22 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 111.578 -0.609 . . . . 63.240000000000002 111.578 -177.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -132.88 42.67 3.05 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.205 -1.035 . . . . 74.129999999999995 108.205 -171.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.61 ' HA ' ' HG ' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -67.51 -21.18 65.5 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 114.134 -1.393 . . . . 72.549999999999997 112.531 -176.966 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.6 pm0 -72.16 -13.3 61.52 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.943 0.497 . . . . 65.420000000000002 111.713 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.404 ' HA ' HD21 ' A' ' 116' ' ' ASN . 31.9 mt -94.34 -7.4 41.86 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 112.236 0.458 . . . . 72.040000000000006 112.236 173.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.61 ' HG ' ' HA ' ' A' ' 111' ' ' GLU . 44.7 mt -72.12 -27.8 62.86 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 118.006 0.367 . . . . 74.140000000000001 111.63 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -65.34 -19.25 65.87 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.16 0.584 . . . . 73.019999999999996 111.466 173.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.404 HD21 ' HA ' ' A' ' 113' ' ' LEU . 36.3 m-80 -93.77 -10.85 32.81 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.327 0.651 . . . . 75.209999999999994 110.209 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.492 HG12 ' HB2' ' A' ' 105' ' ' CYS . 43.2 mt -84.86 124.83 40.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 108.051 -1.092 . . . . 73.409999999999997 108.051 177.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.435 ' HD2' ' HB2' ' A' ' 123' ' ' SER . 74.4 mmtt -126.75 145.98 50.4 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.429 0.691 . . . . 74.400000000000006 109.711 -173.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -92.68 -16.49 25.46 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.395 -0.82 . . . . 73.299999999999997 109.236 169.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.419 ' HE2' ' HB3' ' A' ' 120' ' ' LYS . 11.2 ptpt -179.22 -171.31 0.2 Allowed 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 127.218 2.207 . . . . 73.340000000000003 108.078 170.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.0 t -56.76 -47.95 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-N 118.466 0.575 . . . . 75.239999999999995 110.327 178.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.5 t -79.46 96.23 6.02 Favored 'General case' 0 CA--C 1.557 1.218 0 CA-C-O 121.443 0.64 . . . . 74.120000000000005 109.714 172.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.435 ' HB2' ' HD2' ' A' ' 118' ' ' LYS . 54.7 m -144.24 77.91 1.56 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.683 0.793 . . . . 75.540000000000006 109.956 176.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 40.4 t -125.3 153.15 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.329 1.452 . . . . 72.120000000000005 107.447 176.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 CA--C 1.556 1.181 0 C-N-CA 123.353 0.661 . . . . 73.510000000000005 110.54 177.72 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.9 ptp . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 121.356 0.598 . . . . 74.540000000000006 110.375 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.78 49.16 44.55 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 115.914 -0.584 . . . . 71.239999999999995 112.062 -176.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.2 t60 -80.87 98.78 8.0 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.544 0.737 . . . . 75.109999999999999 109.012 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -73.23 129.17 37.45 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.142 -0.688 . . . . 72.129999999999995 109.142 176.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 35.2 m-70 -92.49 144.2 25.59 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.814 0.846 . . . . 61.509999999999998 109.5 -178.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -69.94 117.81 12.0 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.755 0.822 . . . . 74.010000000000005 109.675 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -76.59 87.68 3.28 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-O 121.915 0.864 . . . . 55.130000000000003 111.277 -175.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -96.41 2.72 52.89 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.786 0.834 . . . . 74.140000000000001 110.163 174.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.6 p -77.7 85.27 4.02 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.659 1.184 . . . . 71.230000000000004 111.033 -177.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -82.54 -34.89 27.69 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.635 -0.711 . . . . 71.540000000000006 109.82 175.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 65.0 mtm 69.8 -67.13 0.24 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 125.889 1.676 . . . . 75.329999999999998 111.38 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.02 159.3 1.83 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.529 1.132 . . . . 72.230000000000004 112.295 176.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -155.48 -171.76 22.37 Favored Glycine 0 C--O 1.242 0.654 0 CA-C-N 115.981 -0.554 . . . . 75.450000000000003 113.134 -177.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.01 178.43 5.35 Favored 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 123.454 2.77 . . . . 73.310000000000002 112.361 176.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 44.3 t -60.43 154.97 19.26 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.618 0.767 . . . . 72.540000000000006 110.609 176.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.408 ' HB2' ' HB2' ' A' ' 115' ' ' GLU . 36.3 m-80 -93.62 -1.1 55.78 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.745 0.418 . . . . 74.409999999999997 111.446 -176.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 70.7 t -57.05 117.03 15.33 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 124.204 1.002 . . . . 72.540000000000006 111.246 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -59.15 139.4 90.25 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 122.937 2.425 . . . . 72.129999999999995 112.039 173.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.7 -39.76 71.47 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.22 1.008 . . . . 52.439999999999998 112.294 -178.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -53.79 -45.86 70.85 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.109 0.564 . . . . 73.530000000000001 111.293 174.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 79.9 mt -76.32 -34.75 59.01 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 119.051 -0.5 . . . . 74.209999999999994 112.31 -172.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.6 t -71.13 -35.25 71.66 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 118.069 0.395 . . . . 73.319999999999993 110.369 177.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.522 ' HA ' ' HE2' ' A' ' 23' ' ' LYS . 8.3 mmpt? -70.63 -42.35 71.02 Favored 'General case' 0 C--N 1.353 0.751 0 C-N-CA 122.813 0.445 . . . . 74.310000000000002 110.678 176.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.407 ' O ' HG22 ' A' ' 28' ' ' VAL . 67.4 tp -59.94 -49.2 78.61 Favored 'General case' 0 N--CA 1.478 0.962 0 O-C-N 124.183 0.927 . . . . 71.219999999999999 111.172 175.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 90.8 t90 -53.99 -51.04 65.19 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.806 1.243 . . . . 75.400000000000006 111.182 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 64.2 m -64.92 -36.45 84.4 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.144 0.978 . . . . 74.25 111.512 177.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 32.2 tp -62.97 -51.04 68.4 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.673 1.189 . . . . 73.239999999999995 111.646 -178.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 24' ' ' LEU . 87.6 t -58.85 -35.69 57.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 124.609 1.164 . . . . 70.209999999999994 111.198 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 83.2 p -92.36 1.94 56.94 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.308 -0.86 . . . . 73.209999999999994 112.534 -174.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -89.98 134.2 32.27 Favored Pre-proline 0 CA--C 1.557 1.245 0 C-N-CA 123.035 0.534 . . . . 74.099999999999994 111.581 -174.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.78 -33.86 26.07 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 123.228 2.618 . . . . 73.129999999999995 114.236 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -70.54 -35.95 73.4 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.114 0.566 . . . . 65.540000000000006 110.916 -176.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.0 p -98.98 -0.02 42.96 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.776 -0.647 . . . . 71.109999999999999 111.208 -177.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -55.42 -32.4 62.67 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.54 1.136 . . . . 62.32 112.337 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.9 -36.52 83.65 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.455 0.702 . . . . 64.319999999999993 112.15 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.421 HD22 ' HB2' ' A' ' 50' ' ' ASP . 85.0 mt -109.07 -8.24 15.21 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.204 0.602 . . . . 74.25 111.48 -175.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.6 tt -160.56 118.3 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.037 0.535 . . . . 75.329999999999998 110.457 174.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 12.7 p -137.41 146.74 44.78 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.525 0.73 . . . . 75.109999999999999 109.75 -176.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 25.2 p-90 -71.24 147.37 48.29 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.013 0.525 . . . . 74.519999999999996 110.888 177.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.1 m -79.74 151.21 73.75 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 108.902 -0.777 . . . . 73.409999999999997 108.902 173.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.83 -19.59 55.17 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.674 2.249 . . . . 74.030000000000001 113.618 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 64.0 m -66.61 -35.64 80.67 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.146 0.578 . . . . 75.099999999999994 111.112 172.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.04 -2.69 74.3 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 115.784 -0.643 . . . . 64.25 113.877 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.445 ' N ' HD21 ' A' ' 44' ' ' ASN . 0.7 OUTLIER -97.55 3.26 50.63 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.116 0.966 . . . . 73.010000000000005 110.022 -179.617 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.3 p -158.03 169.56 24.28 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 123.806 0.842 . . . . 75.409999999999997 110.397 -170.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -150.33 153.38 35.98 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.909 0.884 . . . . 74.109999999999999 110.233 176.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -101.8 144.46 30.44 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.945 0.898 . . . . 74.409999999999997 109.277 176.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 97.8 t -122.75 120.86 61.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 124.928 1.291 . . . . 74.439999999999998 107.612 177.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 91.1 m-85 -106.01 146.84 29.57 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 123.905 0.882 . . . . 75.299999999999997 109.854 -176.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.421 ' HB2' HD22 ' A' ' 36' ' ' LEU . 15.4 m-20 52.36 65.24 1.56 Allowed 'General case' 0 C--N 1.353 0.73 0 O-C-N 124.911 1.382 . . . . 75.230000000000004 111.613 171.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.405 ' HB3' ' HG2' ' A' ' 68' ' ' MET . 85.2 mt-30 -52.72 -28.54 22.47 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 113.096 0.776 . . . . 73.299999999999997 113.096 -173.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -67.84 -48.34 55.61 Favored Glycine 0 C--N 1.344 0.997 0 O-C-N 123.343 0.402 . . . . 63.32 112.155 176.142 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -73.18 -45.53 55.93 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.31 0.644 . . . . 74.450000000000003 110.278 -178.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -54.04 -51.17 64.9 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.638 1.575 . . . . 71.439999999999998 111.574 176.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.514 ' HB1' ' HB2' ' A' ' 68' ' ' MET . . . -67.41 -29.73 69.3 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.307 0.484 . . . . 75.049999999999997 112.307 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -72.06 -43.21 65.25 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.971 0.909 . . . . 73.019999999999996 111.97 -177.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.524 ' HG3' HG22 ' A' ' 58' ' ' VAL . 7.0 pt-20 -109.02 -45.73 3.73 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 113.182 0.808 . . . . 75.209999999999994 113.182 -176.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.524 HG22 ' HG3' ' A' ' 57' ' ' GLU . 95.8 t -77.03 -42.3 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.42 0.688 . . . . 72.230000000000004 111.674 -167.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.2 mt -64.75 -49.49 69.16 Favored Pre-proline 0 CA--C 1.557 1.219 0 CA-C-O 117.946 -1.026 . . . . 72.200000000000003 112.384 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.93 -7.27 21.03 Favored 'Trans proline' 0 C--N 1.388 2.619 0 CA-C-N 121.743 1.658 . . . . 70.200000000000003 112.846 174.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -79.95 -66.63 0.85 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.112 0.565 . . . . 74.140000000000001 110.81 174.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -79.0 -40.15 32.26 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.257 0.623 . . . . 74.340000000000003 111.53 -176.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -105.06 -169.89 1.67 Allowed 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 108.138 -1.06 . . . . 62.240000000000002 108.138 178.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -126.32 45.26 2.69 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.513 0.673 . . . . 74.530000000000001 110.337 -174.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -159.16 161.78 36.29 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 115.109 -0.951 . . . . 74.219999999999999 108.973 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 55' ' ' ALA . 1.6 m-20 -114.16 -19.8 11.19 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.568 0.347 . . . . 73.230000000000004 111.598 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -71.31 114.15 9.09 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.414 0.286 . . . . 74.129999999999995 111.062 -173.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.514 ' HB2' ' HB1' ' A' ' 55' ' ' ALA . 13.9 tpt -65.82 -37.55 86.54 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.255 1.022 . . . . 75.420000000000002 111.353 -177.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.17 -35.03 72.84 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.148 0.579 . . . . 73.209999999999994 111.168 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.478 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 45.1 t -68.44 -38.73 81.42 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.588 0.755 . . . . 73.030000000000001 111.004 176.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -65.29 -50.91 63.92 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.117 0.967 . . . . 74.439999999999998 110.627 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.5 t -63.41 -36.36 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.444 0.698 . . . . 71.150000000000006 110.059 177.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.9 ttp180 -57.46 -41.54 80.77 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.987 0.915 . . . . 75.340000000000003 110.605 175.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.535 ' HA ' ' HE2' ' A' ' 77' ' ' MET . 26.3 mm-40 -61.89 -47.34 85.44 Favored 'General case' 0 C--N 1.357 0.912 0 N-CA-C 109.644 -0.502 . . . . 73.040000000000006 109.644 177.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.416 ' HB3' ' HB2' ' A' ' 80' ' ' PHE . 89.6 mt -61.91 -38.26 87.73 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.618 0.767 . . . . 75.099999999999994 111.106 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -58.55 -39.87 81.46 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.95 0.9 . . . . 75.5 110.537 174.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.535 ' HE2' ' HA ' ' A' ' 74' ' ' GLN . 48.6 mtm -66.21 -41.7 89.77 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.715 0.406 . . . . 72.239999999999995 110.351 174.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -80.97 2.84 25.16 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.61 0.764 . . . . 75.140000000000001 111.614 -174.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.62 19.76 61.25 Favored Glycine 0 C--N 1.346 1.094 0 N-CA-C 114.761 0.664 . . . . 73.319999999999993 114.761 171.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.416 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 42.0 m-85 -78.15 145.4 35.69 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.123 -0.695 . . . . 74.510000000000005 109.123 176.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -99.46 123.43 43.73 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.682 0.793 . . . . 74.230000000000004 109.035 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -75.62 110.7 10.24 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.031 1.332 . . . . 75.129999999999995 109.278 177.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.6 t -123.19 132.65 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 108.407 -0.96 . . . . 64.030000000000001 108.407 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 85.6 t -125.83 121.37 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.121 0.968 . . . . 74.530000000000001 108.57 175.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -94.97 -15.88 23.2 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.122 0.569 . . . . 75.349999999999994 111.343 -177.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.458 HG12 ' HB3' ' A' ' 98' ' ' ASP . 41.7 mm -69.84 109.71 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 122.918 0.487 . . . . 74.040000000000006 110.231 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -125.28 99.15 5.94 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.175 0.99 . . . . 74.540000000000006 108.56 172.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -80.82 93.6 6.28 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.891 0.876 . . . . 72.540000000000006 109.379 -177.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -153.38 -25.14 0.04 OUTLIER Glycine 0 C--N 1.346 1.136 0 CA-C-N 115.623 -0.717 . . . . 74.409999999999997 113.282 -175.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 162.89 20.53 0.02 OUTLIER Glycine 0 N--CA 1.475 1.247 0 CA-C-N 117.074 0.437 . . . . 71.540000000000006 113.712 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 76.1 mt -99.87 153.12 19.41 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.995 0.918 . . . . 75.299999999999997 110.189 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.82 69.38 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.172 0 CA-C-O 122.93 1.348 . . . . 74.319999999999993 109.672 176.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.438 ' HE3' HD12 ' A' ' 86' ' ' ILE . 25.1 mtpp -124.87 144.06 45.69 Favored Pre-proline 0 C--O 1.244 0.768 0 CA-C-N 114.378 -1.283 . . . . 72.019999999999996 108.466 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.74 148.28 71.18 Favored 'Trans proline' 0 C--N 1.372 1.798 0 C-N-CA 122.629 2.219 . . . . 74.450000000000003 111.504 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -83.17 65.98 8.49 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 122.411 1.101 . . . . 73.519999999999996 110.503 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -135.07 -178.47 5.11 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.474 -1.239 . . . . 70.329999999999998 108.513 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 4.1 m-20 -84.31 141.41 30.94 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.612 -0.514 . . . . 71.540000000000006 109.612 175.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.458 ' HB3' HG12 ' A' ' 86' ' ' ILE . 22.5 t70 -140.9 106.87 5.16 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.957 -1.127 . . . . 74.150000000000006 107.957 169.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 77.4 m -122.57 117.25 25.43 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.377 0.671 . . . . 63.439999999999998 110.486 -178.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -99.46 106.27 18.29 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.842 -0.799 . . . . 74.430000000000007 108.842 -177.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -95.14 122.09 37.45 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.919 -0.771 . . . . 73.450000000000003 108.919 176.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -122.63 144.35 49.18 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.939 0.896 . . . . 73.409999999999997 110.803 -174.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -159.06 131.24 4.25 Favored Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 123.741 0.816 . . . . 74.200000000000003 109.757 176.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.35 -31.49 62.41 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 123.156 2.57 . . . . 54.219999999999999 114.118 -174.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 82.0 m -94.0 8.42 41.46 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 122.384 0.274 . . . . 73.129999999999995 111.438 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -109.02 100.38 9.58 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.823 -1.177 . . . . 74.219999999999999 107.823 173.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.419 ' HB2' ' HB2' ' A' ' 110' ' ' GLN . 80.0 mt -118.35 132.41 56.27 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.306 0.642 . . . . 71.329999999999998 109.501 175.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -66.97 114.26 5.63 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 107.895 -1.15 . . . . 73.120000000000005 107.895 174.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 106.89 -12.86 41.64 Favored Glycine 0 N--CA 1.472 1.04 0 CA-C-O 119.944 -0.365 . . . . 74.430000000000007 113.083 -177.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.419 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 15.6 mm-40 -107.98 79.44 1.27 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 117.374 0.587 . . . . 74.439999999999998 110.305 176.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -59.44 -32.96 70.7 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.307 1.043 . . . . 73.349999999999994 112.563 175.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.9 pm0 -67.32 -26.12 66.35 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.433 0.693 . . . . 72.140000000000001 112.255 -177.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 76.8 mt -86.39 -6.76 58.86 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 122.122 -0.362 . . . . 74.010000000000005 111.571 -175.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 75.8 mt -65.37 -33.84 76.92 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.087 0.555 . . . . 73.299999999999997 111.135 175.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.408 ' HB2' ' HB2' ' A' ' 16' ' ' ASN . 12.0 pt-20 -82.44 -1.54 50.49 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.509 0.324 . . . . 74.239999999999995 111.78 176.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.466 HD21 ' N ' ' A' ' 116' ' ' ASN . 0.7 OUTLIER -92.4 -15.22 27.52 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.457 0.703 . . . . 73.430000000000007 109.407 172.451 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 55.2 mt -82.0 114.27 22.64 Favored 'Isoleucine or valine' 0 C--N 1.355 0.812 0 N-CA-C 108.269 -1.011 . . . . 72.530000000000001 108.269 176.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -103.48 137.43 41.57 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.1 -0.704 . . . . 75.239999999999995 109.1 -176.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 14.3 ptt-85 -99.16 -61.55 1.35 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.626 0.37 . . . . 74.140000000000001 110.911 176.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -157.17 178.08 10.75 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.253 1.421 . . . . 75.140000000000001 109.045 -169.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.9 p -64.04 -30.68 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 122.745 0.418 . . . . 74.299999999999997 110.106 172.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.4 p -72.76 79.78 1.12 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.074 0.95 . . . . 75.510000000000005 110.029 175.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.5 t -173.44 -176.7 1.35 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.719 1.208 . . . . 62.140000000000001 108.459 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.5 p -64.4 104.17 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.342 0 C-N-CA 123.35 0.66 . . . . 64.140000000000001 110.363 174.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 14.9 t . . . . . 0 C--O 1.253 1.272 0 N-CA-C 108.496 -0.928 . . . . 72.409999999999997 108.496 -175.736 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.3 mtp . . . . . 0 N--CA 1.486 1.373 0 N-CA-C 109.892 -0.41 . . . . 74.129999999999995 109.892 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.87 -147.18 47.73 Favored Glycine 0 C--N 1.352 1.46 0 O-C-N 123.739 0.649 . . . . 73.310000000000002 112.123 -176.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.3 m80 -131.08 128.57 40.48 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 107.882 -1.155 . . . . 72.019999999999996 107.882 173.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -63.14 114.16 3.58 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 123.651 0.594 . . . . 74.209999999999994 110.13 -178.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.4 m170 -76.61 131.22 38.77 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 115.631 -0.713 . . . . 75.430000000000007 111.016 -173.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -148.52 138.78 22.52 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.025 0.93 . . . . 71.019999999999996 109.716 -175.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 63.47 83.59 0.16 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.463 1.105 . . . . 75.230000000000004 111.442 171.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -91.42 104.58 17.08 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.469 0.708 . . . . 65.349999999999994 109.095 173.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.6 t -83.32 90.28 7.12 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.126 0.489 . . . . 73.519999999999996 110.326 -177.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -105.16 -7.65 18.91 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.697 0.799 . . . . 72.129999999999995 110.107 172.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 27.6 ttt -68.78 94.7 0.62 Allowed 'General case' 0 C--N 1.354 0.804 0 CA-C-O 121.193 0.521 . . . . 75.209999999999994 109.611 175.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -88.31 40.37 0.95 Allowed 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.355 -0.839 . . . . 71.049999999999997 110.677 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.37 -66.96 2.11 Favored Glycine 0 C--N 1.353 1.477 0 N-CA-C 110.292 -1.123 . . . . 62.240000000000002 110.292 172.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.39 112.67 2.78 Favored 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 122.183 1.922 . . . . 74.129999999999995 109.167 160.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 55.5 p -58.17 -57.46 12.77 Favored 'General case' 0 C--O 1.246 0.875 0 C-N-CA 123.344 0.658 . . . . 71.319999999999993 111.048 -175.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.408 ' N ' HD21 ' A' ' 16' ' ' ASN . 0.8 OUTLIER 59.52 50.78 7.09 Favored 'General case' 0 C--N 1.354 0.788 0 CA-C-N 114.297 -1.32 . . . . 75.040000000000006 109.674 178.196 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 66.2 t -67.38 110.17 4.83 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 114.491 -1.231 . . . . 71.040000000000006 107.894 169.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.511 ' HD2' HD13 ' A' ' 21' ' ' LEU . 50.8 Cg_exo -55.88 142.3 84.44 Favored 'Trans proline' 0 C--N 1.368 1.588 0 C-N-CA 122.346 2.031 . . . . 53.009999999999998 111.856 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.92 -36.93 40.98 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.185 0.928 . . . . 63.109999999999999 111.081 175.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.433 ' HB3' ' HH ' ' A' ' 78' ' ' TYR . 47.4 t80 -55.41 -47.36 76.02 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.901 0.88 . . . . 74.129999999999995 112.028 174.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.511 HD13 ' HD2' ' A' ' 18' ' ' PRO . 55.7 mt -77.88 -35.31 50.97 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.682 0.393 . . . . 74.25 111.932 -172.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.4 t -72.11 -36.03 69.34 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 117.48 0.127 . . . . 75.430000000000007 110.962 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.571 ' HB3' ' HB3' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -69.01 -42.49 76.37 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 122.733 0.413 . . . . 74.200000000000003 109.964 173.672 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.425 ' O ' HG21 ' A' ' 28' ' ' VAL . 63.6 tp -59.46 -40.12 85.84 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.976 0.911 . . . . 63.020000000000003 111.251 176.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 70.6 t-105 -60.97 -53.37 58.14 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 123.275 0.63 . . . . 72.340000000000003 111.452 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.4 m -60.89 -28.85 69.2 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 115.01 -0.995 . . . . 70.400000000000006 110.638 178.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.403 HD11 HG12 ' A' ' 58' ' ' VAL . 30.0 tp -72.78 -50.04 26.89 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.291 1.436 . . . . 72.430000000000007 112.445 -178.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.425 HG21 ' O ' ' A' ' 24' ' ' LEU . 99.3 t -60.18 -29.87 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 123.672 0.789 . . . . 75.219999999999999 111.482 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.6 t -100.56 3.19 42.54 Favored 'General case' 0 CA--C 1.563 1.477 0 C-N-CA 124.062 0.945 . . . . 65.329999999999998 112.313 -176.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -85.38 134.01 41.26 Favored Pre-proline 0 N--CA 1.498 1.969 0 C-N-CA 123.942 0.897 . . . . 73.109999999999999 112.09 -176.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -77.92 -10.41 16.76 Favored 'Trans proline' 0 C--N 1.384 2.425 0 C-N-CA 123.233 2.622 . . . . 62.509999999999998 114.362 -175.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -87.67 -26.02 23.21 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 118.122 0.419 . . . . 63.0 110.446 174.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.6 p -117.07 -1.94 11.8 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.32 0.859 . . . . 74.430000000000007 113.32 -173.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.419 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 9.3 p-10 -62.06 -28.37 69.55 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 118.261 0.482 . . . . 73.549999999999997 111.904 -177.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.7 -25.77 67.46 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.597 0.759 . . . . 74.430000000000007 113.011 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.8 mt -116.0 -5.57 11.98 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.076 0.551 . . . . 75.450000000000003 112.045 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 34' ' ' ASP . 17.7 tt -160.19 115.25 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-O 121.381 0.61 . . . . 74.340000000000003 110.924 173.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 29.7 p -150.45 156.82 42.2 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.982 -0.747 . . . . 64.530000000000001 108.982 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 32.5 p-90 -74.96 152.41 38.79 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.711 0.804 . . . . 74.109999999999999 109.896 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.0 m -76.85 148.47 79.15 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 123.589 0.755 . . . . 72.0 110.401 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.82 -33.36 13.92 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 123.625 2.883 . . . . 75.5 116.102 178.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.1 m -76.83 -32.05 57.32 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.825 0.45 . . . . 64.340000000000003 110.511 175.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.17 -0.31 66.3 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-O 119.593 -0.559 . . . . 71.340000000000003 114.257 171.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -87.91 -1.69 58.14 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.129 0.571 . . . . 70.519999999999996 111.251 -174.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 54.1 p -153.8 177.6 10.82 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.893 0.877 . . . . 71.510000000000005 110.434 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -141.64 149.64 40.92 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.245 0.618 . . . . 74.549999999999997 109.73 170.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -101.43 157.54 16.73 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.273 0.629 . . . . 73.310000000000002 109.371 177.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.538 ' O ' ' HA ' ' A' ' 98' ' ' ASP . 95.1 t -128.49 124.18 61.28 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 C-N-CA 124.8 1.24 . . . . 75.420000000000002 107.781 173.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -107.84 149.75 27.87 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.54 0.736 . . . . 74.340000000000003 109.891 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.0 t0 44.34 65.69 1.0 Allowed 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 125.486 1.514 . . . . 73.319999999999993 110.878 177.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.633 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 29.4 mt-30 -58.42 -21.04 49.46 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.364 0.876 . . . . 72.439999999999998 113.364 -172.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.54 -46.45 47.7 Favored Glycine 0 C--N 1.346 1.091 0 N-CA-C 112.275 -0.33 . . . . 61.030000000000001 112.275 173.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -69.81 -44.51 69.87 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.523 -0.547 . . . . 74.420000000000002 109.523 177.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.529 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 54.6 t80 -52.54 -50.96 61.85 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.265 1.426 . . . . 71.120000000000005 111.297 175.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 66' ' ' ASN . . . -59.64 -37.35 78.43 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 121.106 0.479 . . . . 74.349999999999994 111.584 177.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -71.01 -49.26 47.07 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.594 1.158 . . . . 74.140000000000001 113.173 -175.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.488 ' HG3' HG23 ' A' ' 58' ' ' VAL . 6.5 pt-20 -105.81 -36.41 7.04 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 113.429 0.9 . . . . 64.340000000000003 113.429 -172.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.529 ' HB ' ' O ' ' A' ' 54' ' ' PHE . 55.2 t -81.67 -43.82 20.05 Favored 'Isoleucine or valine' 0 C--O 1.251 1.161 0 C-N-CA 123.728 0.811 . . . . 71.030000000000001 111.611 -168.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 55.3 mt -67.2 -44.01 46.9 Favored Pre-proline 0 CA--C 1.553 1.072 0 CA-C-O 118.158 -0.925 . . . . 70.310000000000002 112.639 -178.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -70.6 -10.16 27.31 Favored 'Trans proline' 0 C--N 1.377 2.051 0 CA-C-N 121.833 1.69 . . . . 74.319999999999993 113.527 171.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -75.86 -49.41 18.03 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.275 0.63 . . . . 74.209999999999994 110.693 176.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.571 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 64.9 m-85 -102.34 -34.87 9.03 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 113.752 1.019 . . . . 74.150000000000006 113.752 -178.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -109.84 -177.58 3.31 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 108.904 -0.776 . . . . 63.219999999999999 108.904 -175.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.491 ' HZ2' ' HB3' ' A' ' 64' ' ' LYS . 3.3 mmmp? -111.5 38.07 2.71 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.004 0.522 . . . . 74.420000000000002 110.951 -175.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -158.15 167.29 30.23 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.312 0.645 . . . . 75.439999999999998 109.684 -177.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.418 ' O ' ' HB3' ' A' ' 55' ' ' ALA . 1.9 m-20 -121.33 -7.45 9.27 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.284 0.634 . . . . 74.519999999999996 110.768 176.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -78.7 120.19 23.01 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.119 0.568 . . . . 63.130000000000003 109.995 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.633 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 25.5 ttt -84.3 -18.72 35.39 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 116.79 -0.186 . . . . 75.230000000000004 111.267 -176.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -54.76 -38.74 67.57 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 122.971 0.508 . . . . 70.540000000000006 110.956 174.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.451 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 48.2 t -68.19 -44.67 75.32 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.034 -0.985 . . . . 62.009999999999998 111.188 174.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -59.44 -50.13 75.14 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.218 1.007 . . . . 71.109999999999999 110.46 -175.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.2 t -62.12 -45.91 97.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 114.932 -1.031 . . . . 74.299999999999997 111.119 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 54.2 ttt85 -58.33 -36.67 73.76 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 122.973 0.509 . . . . 74.25 111.516 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 70' ' ' SER . 31.3 mm-40 -61.67 -50.62 71.77 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 123.552 0.532 . . . . 72.349999999999994 109.701 176.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 98.1 mt -62.24 -33.55 74.8 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.628 0.771 . . . . 72.209999999999994 112.015 -177.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -56.9 -45.98 82.26 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 122.981 0.512 . . . . 71.209999999999994 110.866 170.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.444 ' HB3' ' O ' ' A' ' 119' ' ' ARG . 45.0 mtm -69.11 -28.84 66.84 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.294 0.638 . . . . 64.319999999999993 111.138 178.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.433 ' HH ' ' HB3' ' A' ' 20' ' ' PHE . 53.2 m-85 -82.39 2.37 32.8 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.4 0.68 . . . . 71.239999999999995 110.975 175.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.71 1.86 79.73 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-O 119.201 -0.777 . . . . 73.349999999999994 114.405 171.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -72.04 142.45 49.28 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 117.752 0.776 . . . . 73.040000000000006 109.079 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -100.44 131.31 46.43 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.579 -0.526 . . . . 75.25 109.579 -176.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.548 ' HE3' HG22 ' A' ' 84' ' ' VAL . 50.2 tptt -69.59 108.2 3.74 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.417 1.487 . . . . 75.019999999999996 109.328 173.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.489 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 42.5 t -112.98 111.26 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 108.008 -1.108 . . . . 71.430000000000007 108.008 178.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.548 HG22 ' HE3' ' A' ' 82' ' ' LYS . 11.1 t -93.01 101.22 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.854 0.862 . . . . 72.200000000000003 109.004 -172.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -90.88 -62.93 1.34 Allowed 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.324 -0.621 . . . . 72.329999999999998 109.324 178.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 28.4 mm -75.67 101.46 2.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 107.422 -1.325 . . . . 63.219999999999999 107.422 166.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -86.63 127.02 34.9 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 114.833 -1.076 . . . . 73.109999999999999 108.225 175.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -79.96 117.66 21.0 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.022 0.439 . . . . 75.219999999999999 111.616 -177.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.18 -163.85 32.22 Favored Glycine 0 C--N 1.337 0.585 0 CA-C-N 114.857 -1.065 . . . . 72.319999999999993 111.523 175.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -84.6 57.41 5.02 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.003 -0.839 . . . . 72.340000000000003 111.003 174.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 47.5 mt -104.28 -179.17 3.87 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.072 0.949 . . . . 74.200000000000003 110.707 -173.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.1 p -79.1 -28.93 13.74 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 C-N-CA 123.639 0.776 . . . . 75.409999999999997 109.794 173.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -63.23 132.17 95.01 Favored Pre-proline 0 N--CA 1.48 1.065 0 C-N-CA 124.011 0.924 . . . . 75.420000000000002 110.422 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.53 153.42 70.0 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.724 2.283 . . . . 72.340000000000003 110.781 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -74.61 8.38 2.38 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.556 0.947 . . . . 71.319999999999993 113.556 -168.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -65.29 87.21 0.07 Allowed 'General case' 0 CA--C 1.554 1.11 0 CA-C-O 121.214 0.53 . . . . 75.099999999999994 110.417 176.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.515 ' HB2' ' H ' ' A' ' 51' ' ' GLN . 5.8 m-20 -41.41 109.56 0.13 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.007 1.323 . . . . 71.200000000000003 112.142 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.538 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 25.7 t70 -120.74 115.83 24.06 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.307 0.643 . . . . 64.230000000000004 109.882 -178.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.409 HG23 ' HD2' ' A' ' 82' ' ' LYS . 58.4 m -118.43 131.41 56.28 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 123.673 0.789 . . . . 74.420000000000002 109.209 172.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.489 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 42.0 tt0 -105.26 113.52 27.16 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.536 -1.283 . . . . 71.150000000000006 107.536 172.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -96.41 118.86 33.8 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.098 -1.075 . . . . 75.349999999999994 108.098 174.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -115.48 140.54 49.06 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.561 0.744 . . . . 75.319999999999993 110.539 -175.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -158.55 134.07 5.9 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 123.264 0.626 . . . . 74.510000000000005 109.346 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -65.07 -28.42 57.06 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.826 2.351 . . . . 75.430000000000007 112.953 -176.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 33.5 m -96.1 20.37 10.31 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.896 0.479 . . . . 74.209999999999994 110.579 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -127.07 101.13 6.4 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 107.598 -1.26 . . . . 74.519999999999996 107.598 169.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.439 ' HB2' ' HB2' ' A' ' 110' ' ' GLN . 68.8 mt -108.31 170.41 8.03 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 109.323 -0.621 . . . . 72.25 109.323 174.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.77 -31.48 72.67 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 113.972 1.101 . . . . 73.120000000000005 113.972 -168.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -139.51 18.9 3.02 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-O 120.342 -0.143 . . . . 60.119999999999997 113.289 -175.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.439 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 17.4 mp0 -107.79 79.16 1.25 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.363 0.665 . . . . 63.149999999999999 110.041 -176.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -67.98 -27.7 66.8 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.364 1.066 . . . . 73.5 113.437 -177.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -71.28 -5.87 35.52 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.343 0.657 . . . . 64.099999999999994 111.866 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 72.7 mt -89.33 -6.65 56.51 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 122.972 0.509 . . . . 75.150000000000006 111.748 175.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 94.5 mt -68.23 -32.57 72.86 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 122.825 0.45 . . . . 55.329999999999998 111.231 176.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -74.12 -16.53 61.01 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.1 0.56 . . . . 74.230000000000004 111.109 175.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.461 ' N ' HD21 ' A' ' 116' ' ' ASN . 0.7 OUTLIER -79.95 -18.67 49.82 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.12 -0.696 . . . . 75.519999999999996 109.12 177.567 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 27.5 mt -98.51 122.27 50.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.667 0 C-N-CA 124.196 0.999 . . . . 74.409999999999997 108.677 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -113.07 153.47 28.11 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 108.98 -0.748 . . . . 74.140000000000001 108.98 176.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.444 ' O ' ' HB3' ' A' ' 77' ' ' MET . 13.3 ptp180 -76.99 -35.37 57.21 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 121.038 0.446 . . . . 74.120000000000005 110.029 175.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -174.35 140.55 0.66 Allowed 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.583 1.153 . . . . 74.540000000000006 108.796 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.6 p -98.58 -27.99 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 CA-C-N 115.204 -0.907 . . . . 75.109999999999999 109.635 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.5 t -95.08 156.9 16.12 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.41 -0.959 . . . . 74.140000000000001 108.41 167.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 32.9 t 61.68 24.12 14.29 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.875 0.87 . . . . 65.540000000000006 110.918 -176.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 5.1 p -75.43 105.65 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.467 0.707 . . . . 75.019999999999996 110.516 -176.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 30.8 p . . . . . 0 CA--C 1.558 1.282 0 CA-C-N 115.548 -0.751 . . . . 73.120000000000005 109.916 177.872 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 120.737 0.304 . . . . 74.310000000000002 110.897 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 91.47 29.18 12.61 Favored Glycine 0 C--N 1.344 0.972 0 CA-C-N 115.936 -0.575 . . . . 73.25 112.893 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -76.06 79.06 2.91 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 108.386 -0.968 . . . . 75.200000000000003 108.386 171.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -148.39 161.14 42.18 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.9 1.68 . . . . 64.129999999999995 107.23 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -74.58 83.98 2.05 Favored 'General case' 0 CA--C 1.558 1.27 0 CA-C-O 122.518 1.151 . . . . 75.319999999999993 111.396 -174.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -129.25 20.01 5.81 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.703 -1.135 . . . . 64.329999999999998 109.225 173.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 60.0 t60 -73.12 81.36 1.27 Allowed 'General case' 0 C--N 1.356 0.871 0 CA-C-O 122.104 0.954 . . . . 73.450000000000003 109.544 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 47.7 m80 -135.59 83.86 2.05 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 105.447 -2.057 . . . . 72.239999999999995 105.447 175.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.7 m -62.35 96.98 0.08 Allowed 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.88 -1.055 . . . . 71.310000000000002 111.577 -169.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 38.7 m170 -114.39 -47.34 2.93 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.113 0.965 . . . . 72.209999999999994 110.215 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 52.0 mtm -105.01 148.73 26.43 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.41 1.084 . . . . 74.540000000000006 109.55 -177.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.09 128.8 37.19 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.944 0.898 . . . . 61.310000000000002 111.814 -175.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 146.28 -82.03 0.2 Allowed Glycine 0 C--N 1.341 0.853 0 N-CA-C 110.83 -0.908 . . . . 73.099999999999994 110.83 -174.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.49 113.78 3.73 Favored 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 122.519 2.146 . . . . 70.239999999999995 111.441 176.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 34.9 t -71.75 158.4 36.19 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.89 0.476 . . . . 72.5 109.765 174.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -81.67 -1.54 47.16 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.089 0.555 . . . . 75.450000000000003 110.989 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 74.0 t -58.15 120.06 40.17 Favored Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 124.599 1.16 . . . . 65.420000000000002 110.906 175.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.495 ' HD2' HD13 ' A' ' 21' ' ' LEU . 87.7 Cg_exo -52.77 143.46 47.55 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 123.537 2.825 . . . . 71.540000000000006 113.328 172.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.36 -40.29 64.84 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.373 1.069 . . . . 73.439999999999998 111.944 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -54.64 -48.94 71.66 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.177 0.591 . . . . 73.209999999999994 111.425 173.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.495 HD13 ' HD2' ' A' ' 18' ' ' PRO . 85.1 mt -75.36 -34.28 61.14 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 111.876 0.324 . . . . 72.010000000000005 111.876 -170.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.0 t -68.59 -38.83 80.96 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 117.579 0.172 . . . . 65.319999999999993 110.935 175.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.494 ' HE3' ' HA ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -67.22 -42.09 84.64 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 122.412 0.285 . . . . 70.230000000000004 110.659 175.291 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.9 tp -58.32 -52.41 65.7 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.018 0.927 . . . . 75.310000000000002 111.822 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 84.3 t90 -56.62 -47.87 78.74 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.777 0.831 . . . . 74.510000000000005 111.107 -178.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 36.2 m -61.23 -37.03 81.6 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.998 -1.001 . . . . 73.109999999999999 111.159 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.4 ' HG ' HD12 ' A' ' 37' ' ' ILE . 41.2 tp -68.49 -44.75 74.06 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.414 1.085 . . . . 70.129999999999995 111.757 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.5 t -63.53 -42.26 95.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.1 0.96 . . . . 74.450000000000003 110.67 177.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.1 t -80.74 0.12 36.0 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-N 115.254 -0.884 . . . . 75.340000000000003 111.639 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -86.41 125.62 67.06 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.707 0.803 . . . . 73.439999999999998 110.639 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -82.84 -10.29 10.58 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.919 2.413 . . . . 75.230000000000004 114.177 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -82.49 -30.42 29.89 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.136 0.575 . . . . 70.519999999999996 111.455 -178.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 50.7 p -100.4 7.8 44.03 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.837 0.455 . . . . 73.219999999999999 110.659 -177.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.413 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 7.0 p-10 -58.3 -22.94 54.77 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.934 1.294 . . . . 74.219999999999999 112.897 -175.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.21 -38.22 82.65 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.803 0.841 . . . . 72.209999999999994 112.264 177.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 57.0 mt -117.66 -10.38 10.57 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.94 0.496 . . . . 74.549999999999997 111.954 -178.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 34' ' ' ASP . 17.1 tt -158.64 122.42 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-O 121.365 0.602 . . . . 74.219999999999999 111.913 175.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 53.8 t -152.39 158.95 43.41 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.666 0.786 . . . . 63.539999999999999 109.761 176.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 13.2 p-90 -70.82 153.23 42.93 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.669 0.788 . . . . 74.420000000000002 110.877 176.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.8 m -73.2 154.61 90.37 Favored Pre-proline 0 CA--C 1.553 1.077 0 CA-C-O 118.058 -0.972 . . . . 74.340000000000003 109.182 170.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -42.92 -31.34 2.18 Favored 'Trans proline' 0 C--N 1.388 2.617 0 C-N-CA 124.091 3.194 . . . . 64.209999999999994 115.821 -175.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 79.6 p -76.25 -49.51 16.87 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.972 0.509 . . . . 61.340000000000003 110.923 175.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.8 13.49 23.66 Favored Glycine 0 C--N 1.352 1.443 0 CA-C-N 115.606 -0.724 . . . . 52.340000000000003 113.557 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -94.5 -11.08 30.33 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.046 0.538 . . . . 64.019999999999996 111.137 -175.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.6 p -147.2 170.15 17.85 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.24 1.016 . . . . 74.349999999999994 109.146 -176.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -144.15 155.43 43.92 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.86 0.464 . . . . 70.430000000000007 110.798 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.408 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 52.6 m-70 -112.11 150.04 31.29 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.202 1.001 . . . . 63.039999999999999 109.32 -176.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.453 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 84.5 t -126.42 139.01 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 108.452 -0.944 . . . . 73.329999999999998 108.452 176.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -125.48 146.3 49.7 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.552 0.741 . . . . 73.019999999999996 109.061 176.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.4 t70 45.34 76.69 0.09 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.709 1.603 . . . . 70.219999999999999 112.019 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.622 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 53.3 mt-30 -51.05 -29.64 13.39 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.306 1.042 . . . . 70.329999999999998 113.023 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.99 -49.53 40.69 Favored Glycine 0 C--N 1.348 1.234 0 O-C-N 123.308 0.38 . . . . 72.120000000000005 112.835 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -75.16 -40.97 59.09 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.396 0.679 . . . . 72.030000000000001 110.222 -176.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -56.81 -48.84 77.05 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.282 1.433 . . . . 74.120000000000005 110.779 175.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.415 ' HA ' ' HG ' ' A' ' 59' ' ' LEU . . . -65.97 -28.84 69.2 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.19 0.441 . . . . 62.340000000000003 112.19 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -72.38 -46.35 55.71 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.797 0.839 . . . . 74.030000000000001 112.107 -177.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.515 ' HG3' HG23 ' A' ' 58' ' ' VAL . 7.1 pt-20 -110.11 -40.4 4.73 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 113.542 0.941 . . . . 75.099999999999994 113.542 -173.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.515 HG23 ' HG3' ' A' ' 57' ' ' GLU . 73.9 t -80.05 -43.24 22.39 Favored 'Isoleucine or valine' 0 C--O 1.252 1.189 0 C-N-CA 123.064 0.545 . . . . 75.329999999999998 111.51 -168.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.486 HD13 ' HE1' ' A' ' 68' ' ' MET . 35.1 mt -63.06 -50.9 74.13 Favored Pre-proline 0 CA--C 1.558 1.28 0 CA-C-O 117.993 -1.003 . . . . 74.510000000000005 112.445 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.86 -12.91 36.92 Favored 'Trans proline' 0 C--N 1.389 2.695 0 C-N-CA 121.884 1.723 . . . . 75.140000000000001 113.138 177.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -74.43 -60.64 2.18 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 122.941 0.497 . . . . 73.010000000000005 110.306 177.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -85.34 -55.9 3.79 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 116.312 -0.403 . . . . 74.209999999999994 110.852 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -86.37 179.75 6.82 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 109.32 -0.622 . . . . 74.420000000000002 109.32 -176.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -113.07 38.97 2.67 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 121.526 0.679 . . . . 73.319999999999993 110.044 -171.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -162.6 163.95 26.95 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.936 -1.029 . . . . 74.420000000000002 109.301 -176.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -114.06 -7.89 13.06 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.173 0.589 . . . . 73.310000000000002 110.015 175.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -68.79 109.06 3.67 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.598 0.759 . . . . 72.200000000000003 111.0 -177.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.622 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 1.1 tpt -56.32 -39.76 73.29 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.498 1.119 . . . . 73.230000000000004 110.362 170.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.55 -41.54 66.56 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 124.548 1.155 . . . . 75.120000000000005 112.077 176.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.4 t -67.69 -41.39 83.71 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.631 0.772 . . . . 75.019999999999996 111.662 177.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -65.83 -52.37 51.1 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.465 0.706 . . . . 74.340000000000003 110.665 -176.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 95.4 t -61.11 -42.11 91.95 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-N 115.19 -0.914 . . . . 72.549999999999997 110.93 176.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -55.8 -46.9 77.92 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.564 0.746 . . . . 75.120000000000005 111.175 176.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -55.99 -55.57 31.13 Favored 'General case' 0 C--N 1.349 0.573 0 O-C-N 124.254 0.971 . . . . 72.439999999999998 110.417 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.4 mt -61.21 -42.41 98.54 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 124.15 0.906 . . . . 75.120000000000005 112.018 -175.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -59.19 -39.98 84.27 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.312 0.645 . . . . 74.150000000000006 111.368 175.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 57.2 mtm -73.86 -31.22 63.06 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.385 0.274 . . . . 72.409999999999997 110.795 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -79.38 3.51 18.12 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.71 0.804 . . . . 74.430000000000007 111.668 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.08 14.06 79.92 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-O 119.428 -0.651 . . . . 73.439999999999998 113.921 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -74.26 138.85 43.89 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 109.275 -0.639 . . . . 74.129999999999995 109.275 175.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -100.81 124.14 46.02 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.337 -0.616 . . . . 74.230000000000004 109.337 178.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.553 ' HE2' ' HB ' ' A' ' 84' ' ' VAL . 1.3 tmtp? -78.64 131.04 36.53 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.268 1.027 . . . . 74.530000000000001 108.934 177.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.2 t -129.97 122.66 54.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 107.472 -1.307 . . . . 74.430000000000007 107.472 175.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.553 ' HB ' ' HE2' ' A' ' 82' ' ' LYS . 6.5 p -99.14 124.87 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 109.226 -0.657 . . . . 74.219999999999999 109.226 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -99.24 -48.35 4.85 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.069 0.548 . . . . 75.040000000000006 109.994 -177.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.579 HG23 ' HB3' ' A' ' 93' ' ' LYS . 47.3 mm -89.04 98.96 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 109.693 -0.484 . . . . 74.299999999999997 109.693 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -79.57 123.67 27.81 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.294 -0.866 . . . . 72.519999999999996 109.737 177.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.55 HE22 ' HA ' ' A' ' 95' ' ' GLU . 16.9 mm100 -101.33 160.33 14.51 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.222 1.009 . . . . 73.209999999999994 111.706 -173.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 141.57 -80.37 0.26 Allowed Glycine 0 C--N 1.349 1.264 0 CA-C-N 115.201 -0.908 . . . . 63.310000000000002 111.378 176.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -147.66 22.78 1.49 Allowed Glycine 0 C--N 1.343 0.921 0 C-N-CA 122.879 0.275 . . . . 72.439999999999998 112.709 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 78.2 mt -89.75 170.95 9.99 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.743 0.817 . . . . 74.439999999999998 110.636 178.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.9 p -82.98 -3.2 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.457 0 C-N-CA 122.864 0.466 . . . . 73.400000000000006 111.549 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.579 ' HB3' HG23 ' A' ' 86' ' ' ILE . 45.7 mmtm -54.86 146.76 35.66 Favored Pre-proline 0 N--CA 1.491 1.607 0 C-N-CA 123.898 0.879 . . . . 74.420000000000002 110.929 171.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -62.77 158.18 43.79 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 122.928 2.418 . . . . 75.030000000000001 111.629 178.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.55 ' HA ' HE22 ' A' ' 88' ' ' GLN . 11.4 pt-20 -85.75 58.87 5.29 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 122.403 1.097 . . . . 64.109999999999999 111.428 -177.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -155.83 83.49 1.02 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 114.261 -1.336 . . . . 73.400000000000006 108.584 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -44.26 128.64 6.17 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 113.73 -1.577 . . . . 73.310000000000002 111.16 175.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -96.65 108.0 20.54 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.764 -0.828 . . . . 75.329999999999998 108.764 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.453 ' HB ' ' HB ' ' A' ' 48' ' ' VAL . 3.8 m -100.26 95.14 6.59 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 108.206 -1.035 . . . . 55.25 108.206 174.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -91.35 141.52 28.68 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.153 -1.054 . . . . 72.25 108.153 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -124.75 125.5 44.16 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.24 -1.022 . . . . 65.420000000000002 108.24 173.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -116.87 149.43 40.09 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.317 0.647 . . . . 73.340000000000003 110.083 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -162.96 127.92 2.07 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 108.936 -0.764 . . . . 72.099999999999994 108.936 174.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.3 -31.14 81.86 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 122.726 2.284 . . . . 73.329999999999998 113.355 -174.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 36.2 m -88.84 3.07 52.45 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 122.735 0.414 . . . . 73.209999999999994 111.466 -178.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -101.02 99.63 10.11 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.216 -1.401 . . . . 71.150000000000006 107.216 172.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 110' ' ' GLN . 87.5 mt -119.92 129.67 54.45 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.244 0.618 . . . . 72.319999999999993 109.349 176.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -72.05 93.18 1.37 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 107.641 -1.244 . . . . 74.25 107.641 174.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 145.45 -55.55 0.54 Allowed Glycine 0 C--N 1.33 0.213 0 N-CA-C 109.193 -1.563 . . . . 73.109999999999999 109.193 -173.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.523 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 2.6 mp0 -88.46 76.07 8.31 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.602 0.761 . . . . 75.420000000000002 110.181 176.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.68 -17.48 60.67 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.231 0.612 . . . . 55.549999999999997 112.036 175.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 19.3 pm0 -69.55 -21.72 63.61 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 111.494 0.183 . . . . 73.430000000000007 111.494 175.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.0 mt -80.04 -5.93 56.71 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.775 0.43 . . . . 73.530000000000001 112.125 -177.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 68.8 mt -69.97 -23.16 63.13 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.246 0.618 . . . . 71.200000000000003 111.944 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -81.13 -2.11 47.1 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 112.378 0.511 . . . . 72.120000000000005 112.378 176.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -90.32 -12.99 36.13 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 109.066 -0.716 . . . . 75.340000000000003 109.066 170.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 18.7 mt -93.19 121.3 43.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 107.79 -1.189 . . . . 75.329999999999998 107.79 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.81 168.57 18.49 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.067 0.46 . . . . 75.400000000000006 111.062 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.529 HH21 ' HA ' ' A' ' 123' ' ' SER . 28.1 ptt180 -133.72 -46.68 0.8 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.999 0.919 . . . . 75.109999999999999 109.668 -172.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.468 ' N ' ' HG3' ' A' ' 119' ' ' ARG . 31.2 mmmt -140.65 -156.3 0.66 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.879 1.672 . . . . 75.239999999999995 106.902 -172.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.6 m -107.89 7.02 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 122.144 -0.347 . . . . 73.25 110.565 167.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.6 t -116.2 146.52 42.25 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.644 0.778 . . . . 74.319999999999993 111.084 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.529 ' HA ' HH21 ' A' ' 119' ' ' ARG . 35.7 t -162.38 68.37 0.25 Allowed 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 107.501 -1.296 . . . . 70.5 107.501 175.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 30.5 m -108.86 -164.9 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 124.385 1.074 . . . . 75.340000000000003 110.882 -172.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.1 p . . . . . 0 CA--C 1.557 1.235 0 C-N-CA 123.725 0.81 . . . . 73.329999999999998 111.124 177.242 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.9 ttm . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 109.003 -0.739 . . . . 73.150000000000006 109.003 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.07 124.49 9.1 Favored Glycine 0 C--N 1.347 1.183 0 N-CA-C 111.307 -0.717 . . . . 61.030000000000001 111.307 175.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -76.8 -28.06 55.47 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.144 0.578 . . . . 74.140000000000001 110.255 173.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 40.1 m-70 71.66 119.35 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.161 1.384 . . . . 75.530000000000001 111.864 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -98.38 43.41 1.06 Allowed 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 107.657 -1.238 . . . . 71.519999999999996 107.657 163.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -64.55 104.75 0.84 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.43 0.692 . . . . 72.0 109.39 -176.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -130.31 124.63 32.79 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.366 1.066 . . . . 75.340000000000003 109.439 -176.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -71.91 -38.53 69.9 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.494 0.718 . . . . 73.439999999999998 109.986 173.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.8 m 62.21 17.46 9.27 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.316 1.046 . . . . 70.519999999999996 113.126 176.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -89.81 -17.08 28.83 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.025 0.53 . . . . 74.5 111.716 -177.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 56.7 mtt -74.8 153.96 38.52 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.855 0.462 . . . . 73.109999999999999 110.368 175.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.5 14.86 1.13 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.317 0.647 . . . . 61.310000000000002 112.441 -177.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -109.01 84.22 0.36 Allowed Glycine 0 C--N 1.343 0.953 0 CA-C-O 119.053 -0.859 . . . . 72.219999999999999 111.083 168.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -88.72 -158.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 123.012 2.475 . . . . 72.310000000000002 111.793 -178.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 73.5 m -67.19 160.21 27.38 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 122.872 0.469 . . . . 63.109999999999999 110.356 170.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -84.57 40.55 0.8 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.528 1.131 . . . . 72.209999999999994 110.771 -174.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 70.8 t -68.19 122.58 84.71 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 123.982 0.913 . . . . 73.510000000000005 110.37 -174.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.36 145.74 34.97 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.897 2.398 . . . . 64.319999999999993 111.863 174.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.99 -40.73 67.2 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.751 0.82 . . . . 75.209999999999994 111.968 -176.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.412 ' HA ' ' HE1' ' A' ' 63' ' ' PHE . 54.1 t80 -53.25 -49.43 66.89 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.74 0.816 . . . . 75.349999999999994 111.851 173.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 92.5 mt -77.72 -31.07 52.06 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.007 0.523 . . . . 61.109999999999999 112.303 -170.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.5 t -76.02 -34.23 59.69 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 117.586 0.176 . . . . 75.420000000000002 110.973 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.15 -39.66 71.81 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.611 0.364 . . . . 71.549999999999997 110.035 174.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.466 ' O ' HG21 ' A' ' 28' ' ' VAL . 53.4 tp -61.85 -43.41 98.9 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 124.152 0.908 . . . . 72.319999999999993 110.801 174.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.486 ' CE3' HD11 ' A' ' 114' ' ' LEU . 70.9 t-105 -56.66 -47.7 79.21 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.234 1.013 . . . . 73.540000000000006 110.947 177.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.3 m -63.36 -42.66 98.9 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.03 -0.987 . . . . 71.239999999999995 110.949 174.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.8 tp -62.21 -53.24 58.07 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.386 1.474 . . . . 71.409999999999997 112.528 -172.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.466 HG21 ' O ' ' A' ' 24' ' ' LEU . 24.8 t -58.76 -33.85 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 C-N-CA 123.095 0.558 . . . . 74.030000000000001 111.41 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.0 t -87.11 -16.08 36.56 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.087 0.955 . . . . 65.409999999999997 111.647 -176.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -76.12 127.05 85.91 Favored Pre-proline 0 N--CA 1.481 1.089 0 C-N-CA 122.76 0.424 . . . . 64.25 111.115 -172.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.13 -30.64 46.56 Favored 'Trans proline' 0 C--N 1.385 2.467 0 C-N-CA 123.195 2.597 . . . . 73.310000000000002 114.543 -175.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -65.06 -38.32 90.44 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.438 0.637 . . . . 71.5 110.594 178.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.4 p -101.34 -2.02 32.01 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.922 -1.035 . . . . 74.319999999999993 111.542 -175.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -57.9 -35.97 71.78 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.513 1.125 . . . . 71.239999999999995 111.391 -178.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.43 -38.78 66.69 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.368 -0.833 . . . . 62.240000000000002 111.783 178.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.419 ' HA ' ' HB2' ' A' ' 49' ' ' PHE . 79.4 mt -98.24 -25.6 14.82 Favored 'General case' 0 C--O 1.213 -0.819 0 C-N-CA 123.08 0.552 . . . . 72.329999999999998 111.072 -178.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.412 ' HA ' ' O ' ' A' ' 47' ' ' HIS . 19.8 tt -149.48 116.04 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 O-C-N 121.251 -0.905 . . . . 72.120000000000005 111.231 -176.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 9.0 p -142.86 150.38 39.79 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.611 0.764 . . . . 74.219999999999999 110.62 -171.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -70.12 150.21 46.78 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.537 0.735 . . . . 72.5 110.307 176.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 56.3 p -71.66 155.93 91.83 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 122.995 0.518 . . . . 72.209999999999994 109.616 167.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -52.93 -29.47 43.95 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.612 2.208 . . . . 75.25 112.763 173.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.7 m -76.11 -38.02 57.39 Favored 'General case' 0 C--N 1.352 0.709 0 C-N-CA 123.088 0.555 . . . . 73.310000000000002 110.906 175.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.602 ' HA3' ' HD2' ' A' ' 108' ' ' ARG . . . 78.95 20.83 69.55 Favored Glycine 0 C--N 1.344 1.009 0 O-C-N 123.358 0.411 . . . . 71.030000000000001 113.24 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -95.24 -17.43 21.71 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.823 0.849 . . . . 75.299999999999997 109.988 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.6 p -142.48 168.84 18.79 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 123.806 0.842 . . . . 74.120000000000005 109.72 -174.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -143.05 147.22 34.7 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.79 0.436 . . . . 71.230000000000004 110.404 175.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.412 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 13.9 m-70 -104.15 142.55 34.29 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.154 0.982 . . . . 65.310000000000002 109.343 -178.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.2 t -124.18 125.78 71.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 108.06 -1.089 . . . . 62.450000000000003 108.06 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.462 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 79.9 m-85 -108.8 145.16 35.65 Favored 'General case' 0 C--O 1.247 0.941 0 C-N-CA 124.662 1.185 . . . . 75.430000000000007 109.067 -174.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 47.78 76.42 0.11 Allowed 'General case' 0 CA--C 1.542 0.669 0 O-C-N 124.561 1.163 . . . . 73.340000000000003 112.365 173.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.519 ' HG2' ' HB2' ' A' ' 97' ' ' ASP . 5.2 mm-40 -52.78 -29.49 27.72 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.735 -0.666 . . . . 75.510000000000005 112.173 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.99 -50.95 49.16 Favored Glycine 0 C--N 1.345 1.049 0 O-C-N 123.492 0.495 . . . . 62.509999999999998 112.894 174.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -70.14 -46.51 64.58 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.647 0.379 . . . . 73.120000000000005 110.62 -177.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.442 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 61.1 t80 -53.68 -50.88 64.87 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.169 1.388 . . . . 74.040000000000006 111.132 176.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.528 ' HB3' ' HB2' ' A' ' 68' ' ' MET . . . -59.48 -35.27 73.8 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.849 0.685 . . . . 74.310000000000002 112.849 177.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.56 -47.07 51.14 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.069 0.948 . . . . 75.129999999999995 112.406 -176.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.493 ' HG3' HG23 ' A' ' 58' ' ' VAL . 6.5 pt-20 -102.36 -43.03 5.8 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 112.664 0.616 . . . . 74.25 112.664 -173.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.493 HG23 ' HG3' ' A' ' 57' ' ' GLU . 55.8 t -79.33 -47.2 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.386 0.674 . . . . 73.319999999999993 111.418 -168.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.2 mt -65.36 -46.65 70.76 Favored Pre-proline 0 CA--C 1.561 1.39 0 N-CA-C 113.239 0.829 . . . . 74.299999999999997 113.239 -174.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.37 -16.0 49.93 Favored 'Trans proline' 0 C--N 1.387 2.584 0 CA-C-N 121.901 1.715 . . . . 74.109999999999999 113.031 173.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -79.67 -62.32 1.72 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 123.999 0.92 . . . . 73.049999999999997 111.584 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -84.97 -24.33 28.35 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 122.974 0.509 . . . . 74.519999999999996 111.642 -176.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.412 ' HE1' ' HA ' ' A' ' 20' ' ' PHE . 41.0 m-85 -122.65 -169.24 1.87 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.223 -1.028 . . . . 71.310000000000002 108.223 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -127.64 45.14 2.79 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.867 0.842 . . . . 71.129999999999995 110.334 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -154.51 156.12 36.1 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.649 1.18 . . . . 74.120000000000005 107.965 176.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.517 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 1.6 m-20 -108.43 -16.08 14.31 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 109.723 -0.473 . . . . 74.400000000000006 109.723 176.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -66.52 115.3 6.25 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.346 0.658 . . . . 52.310000000000002 110.994 -176.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.528 ' HB2' ' HB3' ' A' ' 55' ' ' ALA . 12.1 tpt -73.26 -33.78 65.46 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.781 0.832 . . . . 75.299999999999997 111.29 -177.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.3 -35.64 65.31 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.097 0.559 . . . . 75.400000000000006 111.282 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.519 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 44.1 t -66.13 -46.59 77.0 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.171 0.988 . . . . 72.019999999999996 110.944 176.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -62.26 -53.26 57.78 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.011 0.924 . . . . 73.120000000000005 110.682 -176.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.5 t -62.78 -37.63 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 115.449 -0.796 . . . . 71.239999999999995 111.087 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -59.88 -38.02 81.02 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.312 0.645 . . . . 74.340000000000003 111.347 177.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 70' ' ' SER . 81.1 mm-40 -60.19 -48.28 82.4 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 109.346 -0.612 . . . . 74.340000000000003 109.346 176.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.427 ' HA ' ' HB2' ' A' ' 78' ' ' TYR . 93.6 mt -63.77 -36.36 83.61 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.063 0.945 . . . . 74.099999999999994 111.498 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -60.29 -42.46 95.54 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.388 0.675 . . . . 72.140000000000001 110.972 173.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 72.1 mtm -76.14 -21.32 56.71 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.723 -0.671 . . . . 74.340000000000003 110.677 176.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.427 ' HB2' ' HA ' ' A' ' 75' ' ' LEU . 26.6 m-85 -83.04 -4.09 57.97 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.572 0.749 . . . . 71.329999999999998 111.414 173.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.62 17.7 77.04 Favored Glycine 0 C--N 1.347 1.17 0 N-CA-C 114.433 0.533 . . . . 73.340000000000003 114.433 174.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -66.59 154.36 40.66 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.427 0.691 . . . . 73.230000000000004 110.436 177.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -99.73 122.55 42.89 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.564 0.746 . . . . 74.25 109.199 -178.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.562 ' HE2' ' HB ' ' A' ' 84' ' ' VAL . 21.0 tptm -77.08 123.76 26.84 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.841 1.256 . . . . 73.409999999999997 109.557 177.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.469 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 47.5 t -126.21 109.29 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 N-CA-C 108.103 -1.073 . . . . 75.420000000000002 108.103 170.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.562 ' HB ' ' HE2' ' A' ' 82' ' ' LYS . 5.1 p -90.45 123.9 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.445 0.698 . . . . 74.219999999999999 109.599 -179.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -108.45 -23.25 11.95 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.063 0.545 . . . . 75.519999999999996 111.713 -176.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 21.3 mm -121.24 101.13 9.95 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 N-CA-C 109.686 -0.487 . . . . 72.319999999999993 109.686 175.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -79.03 124.83 28.65 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.306 -0.627 . . . . 71.25 109.306 171.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -70.88 126.08 28.6 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.435 0.694 . . . . 73.099999999999994 111.9 -174.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 153.51 -163.81 30.86 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-N 115.378 -0.828 . . . . 72.019999999999996 112.713 177.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -81.93 71.78 2.9 Favored Glycine 0 N--CA 1.468 0.794 0 CA-C-N 114.979 -0.611 . . . . 72.129999999999995 112.531 -174.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.496 HD12 ' HZ1' ' A' ' 93' ' ' LYS . 96.1 mt -124.35 -176.16 3.44 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.317 1.047 . . . . 74.219999999999999 110.026 -176.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.0 p -83.4 30.15 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-O 122.17 0.986 . . . . 73.239999999999995 110.934 -178.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.655 ' HZ3' ' HB2' ' A' ' 93' ' ' LYS . 9.1 mtmp? -134.08 146.26 59.08 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 124.715 1.206 . . . . 74.319999999999993 108.98 -174.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.459 ' HG2' ' HG2' ' A' ' 96' ' ' ARG . 58.0 Cg_endo -70.16 175.83 7.91 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 122.199 1.933 . . . . 74.439999999999998 111.523 170.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -80.66 13.41 2.58 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 112.688 0.625 . . . . 63.450000000000003 112.688 -177.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.459 ' HG2' ' HG2' ' A' ' 94' ' ' PRO . 21.4 ptt180 -64.92 154.24 38.02 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.258 0.623 . . . . 74.010000000000005 109.467 169.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.519 ' HB2' ' HG2' ' A' ' 51' ' ' GLN . 5.9 m-20 -103.53 145.02 30.64 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.77 -0.826 . . . . 72.329999999999998 108.77 165.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -129.64 112.54 13.78 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.466 -1.309 . . . . 75.319999999999993 107.466 168.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 41.2 m -123.32 118.71 28.15 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.167 0.987 . . . . 74.049999999999997 109.623 -175.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.469 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 41.2 tt0 -102.18 110.85 22.92 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.155 0.982 . . . . 74.409999999999997 108.628 -179.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -97.67 132.76 43.02 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.801 -0.815 . . . . 74.040000000000006 108.801 173.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 27.0 pt20 -139.02 145.99 40.32 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.772 0.829 . . . . 65.120000000000005 109.305 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -149.3 136.88 11.29 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 109.025 -0.731 . . . . 75.450000000000003 109.025 -177.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -59.02 -34.82 99.23 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 122.692 2.261 . . . . 73.409999999999997 112.725 -177.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 15.7 m -89.63 14.32 11.93 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.223 0.609 . . . . 45.530000000000001 111.007 179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -122.67 98.82 6.09 Favored 'General case' 0 C--O 1.245 0.838 0 N-CA-C 107.799 -1.185 . . . . 74.129999999999995 107.799 174.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 91.5 mt -131.4 151.78 51.23 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.386 1.075 . . . . 74.530000000000001 109.426 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.602 ' HD2' ' HA3' ' A' ' 43' ' ' GLY . 16.1 ptm180 -63.17 112.39 2.64 Favored 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 124.194 0.998 . . . . 72.439999999999998 111.484 -178.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.96 -8.22 63.12 Favored Glycine 0 N--CA 1.472 1.08 0 CA-C-N 116.388 -0.369 . . . . 71.310000000000002 113.585 -178.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.481 ' N ' HE21 ' A' ' 110' ' ' GLN . 0.0 OUTLIER -102.75 71.73 1.18 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 117.641 0.721 . . . . 74.200000000000003 111.034 -177.662 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.482 ' HA ' ' HG ' ' A' ' 114' ' ' LEU . 9.4 pt-20 -70.29 -26.06 63.63 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.658 -0.701 . . . . 74.329999999999998 111.679 170.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.4 pm0 -65.05 -15.15 62.03 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.708 0.803 . . . . 72.019999999999996 112.193 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 79.9 mt -95.14 -17.88 21.42 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.147 0.579 . . . . 73.200000000000003 111.764 176.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.486 HD11 ' CE3' ' A' ' 25' ' ' TRP . 80.4 mt -67.87 -37.72 82.16 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.246 0.619 . . . . 73.239999999999995 110.992 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -64.12 -14.51 55.35 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.246 -0.888 . . . . 71.340000000000003 112.429 174.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -101.2 -2.4 31.39 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.6 0.76 . . . . 75.230000000000004 110.682 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 37.0 mt -92.81 113.33 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 106.995 -1.483 . . . . 74.299999999999997 106.995 173.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.448 ' HE2' ' HA ' ' A' ' 118' ' ' LYS . 9.8 mmpt? -115.77 145.05 43.14 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.04 0.536 . . . . 75.120000000000005 111.254 -169.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 30.6 ptt85 -110.95 11.5 22.22 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 108.247 -1.02 . . . . 72.409999999999997 108.247 168.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -107.97 155.09 20.72 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.389 1.476 . . . . 72.400000000000006 109.017 177.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 6.5 m 51.79 24.52 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 C-N-CA 126.35 1.86 . . . . 74.329999999999998 113.767 173.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.1 t -125.87 -33.54 2.7 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.509 0.559 . . . . 75.230000000000004 112.509 -171.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 48.2 p -163.57 -169.71 2.01 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.976 0.51 . . . . 73.120000000000005 111.062 -173.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 99.7 t -79.32 133.0 30.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 123.038 0.535 . . . . 73.030000000000001 110.491 178.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 24.1 m . . . . . 0 C--O 1.249 1.059 0 C-N-CA 124.443 1.097 . . . . 74.120000000000005 108.342 175.258 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.3 mmm . . . . . 0 N--CA 1.474 0.758 0 N-CA-C 110.243 -0.28 . . . . 74.420000000000002 110.243 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -102.5 51.48 0.87 Allowed Glycine 0 C--N 1.352 1.453 0 N-CA-C 114.317 0.487 . . . . 61.119999999999997 114.317 -169.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -157.59 86.58 0.93 Allowed 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 121.602 0.715 . . . . 75.239999999999995 110.129 172.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -118.05 91.33 3.54 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.391 1.076 . . . . 53.520000000000003 108.916 178.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.4 m-70 -91.92 101.84 14.41 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.491 -0.777 . . . . 71.310000000000002 109.181 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -67.24 97.42 0.54 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.659 -0.7 . . . . 73.340000000000003 109.139 173.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -70.06 92.52 0.74 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.859 -0.61 . . . . 62.340000000000003 109.384 175.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -81.21 85.04 6.43 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 107.653 -1.24 . . . . 73.310000000000002 107.653 168.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.3 m -89.01 164.01 15.27 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 114.562 -1.199 . . . . 65.239999999999995 109.959 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 -73.49 91.31 1.79 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 108.463 -0.94 . . . . 62.32 108.463 170.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 63.8 mtm -80.94 61.12 4.42 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.414 1.085 . . . . 71.140000000000001 110.323 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.33 154.57 7.21 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.761 1.624 . . . . 73.230000000000004 108.023 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.28 -86.13 0.48 Allowed Glycine 0 N--CA 1.469 0.884 0 N-CA-C 110.954 -0.858 . . . . 64.340000000000003 110.954 -176.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -76.77 38.4 0.63 Allowed 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 123.141 2.561 . . . . 73.439999999999998 111.707 166.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.416 ' OG ' HG21 ' A' ' 17' ' ' VAL . 40.0 t -76.38 152.66 36.22 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.645 0.778 . . . . 73.040000000000006 111.348 -172.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -108.5 15.69 23.64 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.65 -0.704 . . . . 75.140000000000001 111.22 -174.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.416 HG21 ' OG ' ' A' ' 15' ' ' SER . 91.4 t -60.93 129.12 90.02 Favored Pre-proline 0 N--CA 1.482 1.14 0 CA-C-O 119.386 -0.34 . . . . 73.099999999999994 110.677 -177.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.28 141.84 94.23 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.618 2.212 . . . . 75.310000000000002 111.123 174.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.47 -40.5 62.39 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.814 0.845 . . . . 75.319999999999993 111.36 176.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -50.45 -47.78 56.71 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 124.248 0.967 . . . . 75.549999999999997 112.961 173.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 90.3 mt -83.68 -26.19 30.05 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.816 0.447 . . . . 72.219999999999999 110.402 -170.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.7 m -66.11 -45.22 81.93 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 124.154 0.982 . . . . 71.340000000000003 110.983 171.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.444 ' HA ' ' HE2' ' A' ' 23' ' ' LYS . 10.6 mmpt? -67.18 -44.72 78.95 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.726 0.41 . . . . 74.310000000000002 110.153 176.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.5 tp -56.11 -53.23 59.59 Favored 'General case' 0 C--N 1.356 0.876 0 O-C-N 124.483 1.114 . . . . 74.150000000000006 111.47 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.527 ' HH2' ' HG3' ' A' ' 108' ' ' ARG . 8.3 t-105 -59.37 -49.26 78.52 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 122.942 0.497 . . . . 74.530000000000001 111.832 -178.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.5 m -62.1 -28.05 69.35 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 122.805 0.442 . . . . 70.439999999999998 111.291 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.462 ' HG ' HD12 ' A' ' 37' ' ' ILE . 24.0 tp -74.37 -44.45 52.15 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.203 1.001 . . . . 74.5 111.793 176.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.2 t -61.87 -36.74 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.881 0.872 . . . . 72.040000000000006 110.401 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 88.4 p -90.34 10.8 23.51 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.842 0.857 . . . . 75.420000000000002 111.736 -177.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -90.86 116.42 66.38 Favored Pre-proline 0 CA--C 1.56 1.36 0 C-N-CA 123.052 0.541 . . . . 72.049999999999997 110.675 175.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.69 -7.81 16.76 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 123.256 2.637 . . . . 74.25 113.156 177.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -85.55 -25.72 26.59 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.689 0.795 . . . . 75.019999999999996 111.509 177.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 40.9 p -106.32 9.34 31.97 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.84 0.456 . . . . 75.120000000000005 111.122 178.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -57.85 -30.39 65.75 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 113.381 0.882 . . . . 72.140000000000001 113.381 -170.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -69.06 -24.08 64.12 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.574 0.583 . . . . 65.430000000000007 112.574 -176.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.468 HD22 ' HB2' ' A' ' 50' ' ' ASP . 77.4 mt -115.13 -18.17 11.23 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.2 0.6 . . . . 64.109999999999999 111.056 -178.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.462 HD12 ' HG ' ' A' ' 27' ' ' LEU . 14.9 tt -160.94 123.86 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.234 0.613 . . . . 75.099999999999994 110.231 171.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 23.2 p -150.55 161.69 42.07 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.159 0.584 . . . . 72.319999999999993 110.433 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 38.4 p-90 -73.33 147.27 44.58 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 124.048 0.842 . . . . 75.120000000000005 109.47 172.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.2 m -75.64 149.62 83.69 Favored Pre-proline 0 CA--C 1.548 0.9 0 N-CA-C 108.348 -0.982 . . . . 71.219999999999999 108.348 171.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.77 -28.43 23.05 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 123.101 2.534 . . . . 75.150000000000006 114.25 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.0 m -73.71 -24.8 59.97 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.309 0.644 . . . . 63.409999999999997 111.946 177.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.24 0.84 90.13 Favored Glycine 0 C--N 1.342 0.889 0 C-N-CA 123.129 0.395 . . . . 41.119999999999997 113.649 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -82.27 -25.4 34.07 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.727 0.811 . . . . 72.439999999999998 111.036 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.9 p -146.96 178.99 7.91 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.358 0.663 . . . . 74.120000000000005 110.311 -169.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.406 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 42.1 p90 -146.63 143.85 29.09 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.711 0.404 . . . . 70.340000000000003 110.985 178.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -103.33 151.71 22.41 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.23 0.612 . . . . 74.099999999999994 109.464 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 98' ' ' ASP . 95.5 t -124.23 132.13 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.363 1.065 . . . . 71.329999999999998 108.349 176.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -116.07 148.77 39.89 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.835 0.854 . . . . 71.25 109.604 178.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.468 ' HB2' HD22 ' A' ' 36' ' ' LEU . 20.8 m-20 53.16 63.44 2.23 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 124.692 1.245 . . . . 74.230000000000004 111.259 170.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -50.12 -33.35 18.48 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.181 0.993 . . . . 74.430000000000007 113.33 -172.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.64 -43.99 90.76 Favored Glycine 0 CA--C 1.533 1.196 0 O-C-N 123.412 0.445 . . . . 65.409999999999997 112.441 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -74.11 -45.48 48.78 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.392 0.677 . . . . 71.340000000000003 110.059 -178.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.442 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 39.1 t80 -50.51 -52.27 39.93 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.28 1.432 . . . . 75.209999999999994 111.494 174.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.2 -36.32 81.57 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.657 -0.701 . . . . 74.540000000000006 111.577 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -66.81 -46.92 73.65 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.85 0.86 . . . . 74.549999999999997 112.85 -175.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.493 ' HG3' HG22 ' A' ' 58' ' ' VAL . 11.1 pt-20 -113.07 -33.9 5.88 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 114.292 1.219 . . . . 74.420000000000002 114.292 -171.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.493 HG22 ' HG3' ' A' ' 57' ' ' GLU . 91.9 t -82.83 -45.03 19.24 Favored 'Isoleucine or valine' 0 C--O 1.253 1.286 0 C-N-CA 123.71 0.804 . . . . 64.129999999999995 111.938 -170.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.6 mt -64.59 -46.55 77.03 Favored Pre-proline 0 CA--C 1.557 1.231 0 CA-C-O 118.095 -0.955 . . . . 75.329999999999998 112.766 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.432 ' HG3' ' ND2' ' A' ' 66' ' ' ASN . 41.7 Cg_endo -67.2 -15.21 45.64 Favored 'Trans proline' 0 C--N 1.381 2.262 0 CA-C-N 121.954 1.733 . . . . 73.109999999999999 113.105 174.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -73.14 -50.6 21.8 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.58 0.752 . . . . 75.010000000000005 110.489 176.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.422 ' CD1' HD13 ' A' ' 27' ' ' LEU . 37.0 m-85 -92.76 -51.88 4.88 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 112.594 0.59 . . . . 74.299999999999997 112.594 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -90.87 -172.03 3.22 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.885 -0.783 . . . . 65.140000000000001 108.885 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -118.47 40.66 3.16 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 121.313 0.578 . . . . 65.420000000000002 110.397 -174.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -162.25 164.66 27.53 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.193 -0.912 . . . . 72.109999999999999 109.246 -177.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.432 ' ND2' ' HG3' ' A' ' 60' ' ' PRO . 13.1 m120 -106.24 -33.98 7.63 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.356 0.663 . . . . 72.420000000000002 109.864 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -62.97 127.09 29.62 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.31 0.644 . . . . 72.140000000000001 112.522 -173.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 25.7 ttt -88.16 -23.69 23.55 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.97 0.508 . . . . 75.340000000000003 111.365 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.42 -38.37 77.28 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 121.424 0.63 . . . . 74.040000000000006 111.211 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.411 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 22.8 t -68.89 -40.39 79.21 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.593 1.157 . . . . 74.340000000000003 111.087 176.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -62.39 -48.32 80.25 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.456 1.103 . . . . 74.230000000000004 110.899 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 83.4 t -65.24 -39.46 85.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 123.786 0.834 . . . . 73.340000000000003 111.102 177.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 70.0 ttt-85 -54.24 -43.71 71.14 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.195 0.598 . . . . 71.109999999999999 110.952 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.511 ' HA ' ' HE1' ' A' ' 77' ' ' MET . 10.2 mm100 -62.15 -45.77 91.96 Favored 'General case' 0 C--N 1.349 0.549 0 O-C-N 123.959 0.787 . . . . 63.119999999999997 110.352 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 43.1 mt -59.77 -36.92 77.66 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.662 0.785 . . . . 75.420000000000002 111.439 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -61.0 -40.68 94.48 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.839 0.456 . . . . 74.340000000000003 111.182 173.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.511 ' HE1' ' HA ' ' A' ' 74' ' ' GLN . 31.9 mtm -69.71 -35.6 75.19 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.563 0.345 . . . . 72.129999999999995 110.597 178.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -81.57 4.44 21.41 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.695 0.798 . . . . 74.420000000000002 111.019 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.89 24.96 75.87 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-O 119.459 -0.634 . . . . 74.219999999999999 114.538 170.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -73.03 148.89 43.7 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 117.271 0.535 . . . . 72.340000000000003 109.805 173.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.85 121.01 40.66 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.566 -0.901 . . . . 63.219999999999999 108.566 177.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.656 ' HE2' ' HB ' ' A' ' 84' ' ' VAL . 1.2 tmtp? -82.73 126.27 32.19 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.756 -1.202 . . . . 73.340000000000003 107.756 176.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 88.2 t -129.37 111.18 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 107.698 -1.223 . . . . 73.420000000000002 107.698 177.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.656 ' HB ' ' HE2' ' A' ' 82' ' ' LYS . 10.2 p -98.99 125.86 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 108.717 -0.846 . . . . 74.549999999999997 108.717 -177.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -97.72 -25.67 15.0 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.839 0.455 . . . . 72.5 110.755 -176.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.404 HD13 ' HD2' ' A' ' 93' ' ' LYS . 45.4 mm -94.04 98.54 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 108.927 -0.768 . . . . 73.409999999999997 108.927 174.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -79.35 132.12 36.33 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.944 -1.026 . . . . 63.420000000000002 110.582 -178.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -64.58 96.86 0.18 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.629 0.772 . . . . 74.25 110.867 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.01 174.18 46.75 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.066 -0.97 . . . . 65.310000000000002 112.736 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -83.37 61.32 4.78 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 114.639 -0.78 . . . . 73.450000000000003 111.851 175.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 76.4 mt -106.45 176.77 5.06 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.412 1.085 . . . . 74.310000000000002 110.134 -174.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.8 p -76.64 -3.15 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.516 0 CA-C-O 121.433 0.635 . . . . 75.329999999999998 110.509 174.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.404 ' HD2' HD13 ' A' ' 86' ' ' ILE . 47.3 mmtm -68.13 127.89 93.27 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 123.673 0.789 . . . . 71.450000000000003 110.202 170.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.18 136.84 20.57 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.35 2.033 . . . . 73.129999999999995 110.446 173.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -71.75 6.67 1.85 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 114.277 1.214 . . . . 75.299999999999997 114.277 -163.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -67.11 96.66 0.47 Allowed 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 109.519 -0.548 . . . . 75.510000000000005 109.519 168.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -39.95 107.21 0.07 Allowed 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.036 0.934 . . . . 72.349999999999994 112.796 175.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.447 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 12.8 t70 -97.21 113.3 24.89 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 107.718 -1.216 . . . . 74.230000000000004 107.718 174.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.467 HG22 ' HE3' ' A' ' 82' ' ' LYS . 87.1 m -122.49 112.08 17.6 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.89 0.876 . . . . 74.310000000000002 109.483 -176.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 46' ' ' PHE . 41.4 tt0 -105.0 114.17 28.21 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.898 0.879 . . . . 74.340000000000003 108.853 -178.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -95.97 121.4 37.68 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.023 -1.103 . . . . 75.409999999999997 108.023 174.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -125.75 143.7 50.94 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.531 0.733 . . . . 73.329999999999998 109.685 -176.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.2 t-80 -158.92 133.31 5.3 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 108.568 -0.901 . . . . 73.140000000000001 108.568 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -64.19 -21.39 67.54 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.617 2.211 . . . . 74.430000000000007 113.556 -175.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.409 ' HB2' HG12 ' A' ' 117' ' ' ILE . 12.0 m -96.36 6.24 49.19 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.969 0.507 . . . . 72.129999999999995 111.128 178.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -114.32 100.03 8.03 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 106.974 -1.491 . . . . 75.299999999999997 106.974 171.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 49.4 mt -129.38 158.95 37.71 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.707 -0.849 . . . . 74.420000000000002 108.707 175.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.527 ' HG3' ' HH2' ' A' ' 25' ' ' TRP . 35.8 ttp180 -73.62 126.38 30.15 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 123.394 0.677 . . . . 74.019999999999996 110.71 -178.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.57 28.86 72.92 Favored Glycine 0 C--N 1.346 1.134 0 O-C-N 123.872 0.732 . . . . 63.439999999999998 112.198 -177.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -136.96 37.94 2.57 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 122.633 1.206 . . . . 75.319999999999993 108.122 -175.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.92 -10.61 58.13 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 113.533 -1.667 . . . . 74.310000000000002 113.393 -173.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 21.0 pm0 -64.85 -18.31 65.03 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.719 0.408 . . . . 74.430000000000007 111.437 172.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.3 mt -90.52 -6.88 54.23 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.272 0.629 . . . . 72.140000000000001 111.837 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 96.6 mt -66.76 -33.71 76.23 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 118.041 0.382 . . . . 73.019999999999996 111.003 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -73.72 -12.78 60.83 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 120.882 0.372 . . . . 71.25 111.49 174.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -94.97 -14.45 24.39 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.569 0.747 . . . . 74.239999999999995 109.355 177.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.409 HG12 ' HB2' ' A' ' 105' ' ' CYS . 45.2 mt -83.93 75.46 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.069 0 N-CA-C 107.344 -1.354 . . . . 74.430000000000007 107.344 169.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.424 ' HD2' ' O ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -69.13 147.28 51.63 Favored 'General case' 0 CA--C 1.558 1.284 0 CA-C-N 115.322 -0.853 . . . . 72.510000000000005 113.296 173.644 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -86.01 -27.66 24.68 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 114.712 -1.131 . . . . 75.409999999999997 109.536 174.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.424 ' O ' ' HD2' ' A' ' 118' ' ' LYS . 31.5 mmmt -103.48 171.84 7.14 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.204 1.402 . . . . 71.219999999999999 109.69 175.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.5 p -95.27 33.26 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-O 122.627 1.203 . . . . 70.140000000000001 109.633 175.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 4.7 t -62.33 101.8 0.26 Allowed 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 114.279 -1.328 . . . . 75.530000000000001 110.904 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.2 p -174.88 153.0 1.62 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.972 1.309 . . . . 72.209999999999994 108.488 -174.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.6 m -63.97 137.28 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 122.785 0.434 . . . . 74.340000000000003 111.81 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 26.7 m . . . . . 0 CA--C 1.554 1.12 0 C-N-CA 123.301 0.64 . . . . 72.549999999999997 109.98 -177.895 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.1 ttm . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 120.763 0.316 . . . . 71.310000000000002 110.279 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -99.44 153.5 19.65 Favored Glycine 0 C--N 1.349 1.273 0 N-CA-C 111.047 -0.821 . . . . 71.010000000000005 111.047 173.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -70.41 86.23 0.61 Allowed 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.103 -0.702 . . . . 65.420000000000002 109.103 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.38 121.66 21.74 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.155 0.582 . . . . 71.329999999999998 111.22 -175.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 64.5 t60 -157.2 112.05 2.75 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.421 0.688 . . . . 63.299999999999997 109.589 177.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 46.6 p-80 -146.54 155.34 42.43 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.642 0.777 . . . . 75.420000000000002 110.13 176.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -133.77 148.43 51.38 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.105 0.962 . . . . 71.219999999999999 109.025 172.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 24.1 p80 -132.56 116.6 16.92 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.288 -1.004 . . . . 74.519999999999996 108.288 171.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.0 t -118.98 125.17 48.77 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.164 0.985 . . . . 75.450000000000003 110.579 -170.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -81.74 90.11 6.34 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 109.182 -0.673 . . . . 74.420000000000002 109.182 170.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 38.7 mtt -99.43 123.38 43.65 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.145 0.578 . . . . 73.200000000000003 109.481 173.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -108.78 113.73 26.92 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.053 0.941 . . . . 64.219999999999999 108.897 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.6 132.63 38.01 Favored Glycine 0 C--N 1.348 1.202 0 CA-C-O 118.11 -1.383 . . . . 72.299999999999997 111.491 175.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -56.82 92.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 123.185 2.59 . . . . 73.239999999999995 112.181 -177.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 77.5 p -71.7 128.42 35.73 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.694 0.798 . . . . 74.219999999999999 109.061 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.539 ' N ' HD21 ' A' ' 16' ' ' ASN . 0.7 OUTLIER -83.45 -6.71 59.54 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.278 0.631 . . . . 72.239999999999995 111.423 -171.297 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.4 t -50.37 114.8 4.82 Favored Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 124.348 1.059 . . . . 63.450000000000003 110.815 176.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.473 ' HD2' HD13 ' A' ' 21' ' ' LEU . 53.0 Cg_exo -56.61 155.93 24.46 Favored 'Trans proline' 0 C--N 1.382 2.299 0 C-N-CA 123.253 2.635 . . . . 74.450000000000003 112.495 178.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.82 -43.74 66.2 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.638 0.775 . . . . 74.109999999999999 111.283 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -53.37 -47.01 69.82 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.531 0.733 . . . . 73.519999999999996 112.151 175.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.473 HD13 ' HD2' ' A' ' 18' ' ' PRO . 72.9 mt -81.76 -27.64 33.68 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.31 0.485 . . . . 73.430000000000007 112.31 -171.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.1 t -76.07 -32.17 59.15 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 118.285 0.493 . . . . 75.510000000000005 111.045 174.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.462 ' HA ' ' HE2' ' A' ' 23' ' ' LYS . 10.2 mmpt? -71.33 -38.92 71.65 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.502 -0.555 . . . . 75.310000000000002 109.502 173.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.5 tp -61.44 -44.49 97.03 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 123.919 0.762 . . . . 75.400000000000006 110.797 172.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -53.51 -56.08 20.02 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.071 0.948 . . . . 72.140000000000001 111.233 177.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.1 m -56.5 -47.39 79.38 Favored 'General case' 0 C--O 1.214 -0.786 0 O-C-N 124.574 1.171 . . . . 73.420000000000002 110.402 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.7 tp -54.79 -53.11 59.45 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.605 1.562 . . . . 75.340000000000003 113.133 -174.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 65.6 t -66.82 -28.14 42.11 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 C-N-CA 123.821 0.848 . . . . 74.439999999999998 111.104 178.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.3 t -94.05 -7.21 43.28 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.314 1.046 . . . . 74.129999999999995 112.263 -177.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -89.68 128.73 49.41 Favored Pre-proline 0 N--CA 1.484 1.234 0 C-N-CA 123.515 0.726 . . . . 74.150000000000006 111.614 -171.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -77.5 -11.05 17.31 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 122.859 2.373 . . . . 75.439999999999998 114.232 -178.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -81.3 -28.75 34.49 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 118.422 0.555 . . . . 73.209999999999994 110.862 175.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 40.0 p -114.51 4.0 15.08 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 112.435 0.532 . . . . 71.040000000000006 112.435 -177.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.507 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 1.5 p-10 -65.44 -24.82 67.28 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 112.3 0.481 . . . . 73.030000000000001 112.3 -174.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -68.05 -26.57 65.93 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.265 0.626 . . . . 61.439999999999998 112.448 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.458 HD22 ' HB2' ' A' ' 50' ' ' ASP . 66.4 mt -106.57 -13.89 15.19 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.02 0.528 . . . . 73.129999999999995 111.517 178.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 34' ' ' ASP . 16.4 tt -161.25 124.67 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-O 120.844 0.354 . . . . 72.319999999999993 111.26 174.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 28.0 p -148.92 161.12 42.52 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.933 -0.766 . . . . 62.539999999999999 108.933 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 38.7 p-90 -82.47 148.54 28.09 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 108.965 -0.754 . . . . 60.130000000000003 108.965 176.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.9 m -75.54 151.31 85.04 Favored Pre-proline 0 CA--C 1.546 0.793 0 CA-C-N 115.176 -0.92 . . . . 74.239999999999995 110.084 -176.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -46.67 -39.64 23.51 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 123.468 2.779 . . . . 72.329999999999998 115.451 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 26.3 p -80.88 -9.8 59.79 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 112.086 0.402 . . . . 63.219999999999999 112.086 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.92 -0.08 83.76 Favored Glycine 0 C--N 1.351 1.403 0 N-CA-C 115.962 1.145 . . . . 64.409999999999997 115.962 163.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -94.44 -2.15 52.37 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.962 0.905 . . . . 71.319999999999993 111.705 -175.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 80.9 p -148.59 174.8 11.76 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.908 0.883 . . . . 60.32 110.163 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -145.66 153.97 41.6 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.226 0.61 . . . . 75.230000000000004 110.084 170.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -112.92 149.32 33.36 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.114 0.966 . . . . 74.519999999999996 110.065 -178.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 98' ' ' ASP . 76.3 t -123.35 105.84 16.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 124.787 1.235 . . . . 70.129999999999995 107.987 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -91.18 145.18 24.88 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 124.041 0.936 . . . . 62.549999999999997 110.669 -177.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.458 ' HB2' HD22 ' A' ' 36' ' ' LEU . 3.2 m-20 53.0 57.46 6.31 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 124.579 1.175 . . . . 71.340000000000003 111.61 173.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -55.33 -26.31 40.03 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 114.332 1.234 . . . . 72.530000000000001 114.332 -169.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.38 -47.88 40.77 Favored Glycine 0 CA--C 1.531 1.093 0 N-CA-C 111.838 -0.505 . . . . 60.310000000000002 111.838 174.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -69.17 -44.3 72.51 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.394 0.678 . . . . 71.310000000000002 109.477 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -52.74 -51.37 60.79 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.318 1.447 . . . . 74.450000000000003 111.331 175.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.411 ' HB1' ' HB2' ' A' ' 68' ' ' MET . . . -64.57 -34.88 79.28 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.51 -0.314 . . . . 73.530000000000001 111.778 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -66.1 -46.77 76.47 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.457 1.103 . . . . 74.209999999999994 112.377 -176.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.538 ' HG3' HG23 ' A' ' 58' ' ' VAL . 6.9 pt-20 -109.76 -39.26 5.16 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 113.766 1.024 . . . . 61.340000000000003 113.766 -173.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.538 HG23 ' HG3' ' A' ' 57' ' ' GLU . 84.9 t -82.5 -38.23 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.253 0.621 . . . . 74.329999999999998 111.615 -168.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 51.1 mt -69.97 -43.47 19.88 Favored Pre-proline 0 CA--C 1.565 1.519 0 CA-C-O 118.073 -0.965 . . . . 74.150000000000006 112.94 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -71.06 -10.57 27.72 Favored 'Trans proline' 0 C--N 1.385 2.497 0 CA-C-N 122.058 1.771 . . . . 74.400000000000006 113.155 171.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -78.91 -52.68 7.95 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.151 0.981 . . . . 74.329999999999998 110.964 176.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.443 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 49.3 m-85 -87.43 -24.45 24.17 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 122.892 0.477 . . . . 63.439999999999998 112.155 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -126.29 -150.09 0.43 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 107.35 -1.352 . . . . 74.299999999999997 107.35 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -142.88 55.54 1.39 Allowed 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.99 0.9 . . . . 73.230000000000004 109.615 172.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 32.7 p80 -154.51 148.3 25.48 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 114.845 -1.071 . . . . 71.530000000000001 108.825 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -110.98 0.18 16.92 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.263 0.625 . . . . 72.519999999999996 109.685 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -74.73 117.24 16.34 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.112 0.965 . . . . 74.530000000000001 110.088 176.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.411 ' HB2' ' HB1' ' A' ' 55' ' ' ALA . 13.6 tpt -75.56 -35.83 60.56 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.085 0.554 . . . . 73.209999999999994 110.77 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.89 -32.6 67.88 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.228 0.611 . . . . 63.439999999999998 111.61 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.451 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 44.7 t -59.25 -52.07 67.26 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.991 0.917 . . . . 71.319999999999993 111.068 173.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -64.96 -51.59 60.95 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.119 0.967 . . . . 74.420000000000002 110.894 -174.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.0 t -58.18 -46.46 88.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 124.024 0.93 . . . . 74.219999999999999 111.629 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.9 ttt85 -57.63 -41.2 80.89 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 123.671 0.607 . . . . 73.019999999999996 111.784 -178.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.451 ' HG2' ' O ' ' A' ' 70' ' ' SER . 13.3 mm100 -60.93 -48.12 83.28 Favored 'General case' 0 C--N 1.351 0.666 0 O-C-N 123.706 0.629 . . . . 75.349999999999994 109.829 -178.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.4 mt -64.98 -42.62 94.39 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.842 0.714 . . . . 74.510000000000005 111.129 -178.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.77 -37.91 80.36 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.243 0.617 . . . . 74.219999999999999 111.329 177.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 59.9 mtm -71.01 -32.55 69.37 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.627 0.371 . . . . 73.299999999999997 110.428 174.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -73.15 -2.2 20.59 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.476 0.71 . . . . 75.430000000000007 111.426 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.13 12.94 64.87 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-O 119.633 -0.537 . . . . 72.120000000000005 113.62 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -74.93 147.55 40.83 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.178 -1.045 . . . . 73.540000000000006 108.178 174.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.443 ' HB3' ' HG3' ' A' ' 102' ' ' GLN . 34.9 ttm-85 -98.88 122.03 41.6 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.723 -0.843 . . . . 74.530000000000001 108.723 -174.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -79.95 113.65 18.27 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.096 1.358 . . . . 75.040000000000006 108.846 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.408 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 39.4 t -123.86 125.56 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 108.905 -0.776 . . . . 73.409999999999997 108.905 178.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 68.9 t -106.21 110.08 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 108.127 -1.064 . . . . 75.209999999999994 108.127 178.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -88.33 -46.88 8.83 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.826 0.45 . . . . 71.25 111.652 -173.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.544 ' HA ' ' HD3' ' A' ' 93' ' ' LYS . 33.0 mm -80.1 90.51 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 121.604 0.716 . . . . 74.329999999999998 109.855 -175.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -67.04 87.96 0.15 Allowed 'General case' 0 C--O 1.245 0.839 0 CA-C-N 114.274 -1.33 . . . . 71.150000000000006 109.844 171.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -80.22 93.23 5.83 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.465 -0.789 . . . . 74.519999999999996 109.476 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -155.9 17.71 0.47 Allowed Glycine 0 C--N 1.34 0.799 0 CA-C-N 115.297 -0.865 . . . . 64.219999999999999 112.238 178.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.24 26.96 16.92 Favored Glycine 0 C--N 1.347 1.16 0 C-N-CA 122.91 0.29 . . . . 63.43 113.031 -178.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 59.5 mt -93.56 172.03 8.52 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.556 0.742 . . . . 71.510000000000005 110.204 172.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.8 p -77.73 72.41 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-O 122.744 1.259 . . . . 75.120000000000005 110.394 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.544 ' HD3' ' HA ' ' A' ' 86' ' ' ILE . 62.2 mttp -143.9 151.2 52.19 Favored Pre-proline 0 CA--C 1.557 1.235 0 C-N-CA 125.29 1.436 . . . . 72.519999999999996 109.783 -178.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.76 156.7 64.73 Favored 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 123.157 2.571 . . . . 60.109999999999999 112.749 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -82.59 61.9 5.95 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.316 0.646 . . . . 72.450000000000003 111.112 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -137.46 165.87 25.21 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.091 0.557 . . . . 75.299999999999997 110.426 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -103.38 118.7 37.36 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.802 -0.814 . . . . 73.109999999999999 108.802 169.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.486 ' HB3' HG12 ' A' ' 86' ' ' ILE . 22.5 t70 -122.94 122.95 39.81 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.979 0.912 . . . . 65.519999999999996 109.773 177.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 50.1 m -120.06 127.55 52.68 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.741 0.816 . . . . 75.230000000000004 109.834 175.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.408 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 39.0 tt0 -100.52 117.54 34.88 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.407 -0.96 . . . . 75.530000000000001 108.407 173.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -98.19 118.93 35.92 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.357 -0.979 . . . . 73.209999999999994 108.357 169.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.443 ' HG3' ' HB3' ' A' ' 81' ' ' ARG . 16.6 pt20 -121.5 137.58 54.66 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.618 0.767 . . . . 73.329999999999998 109.292 178.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 106' ' ' PHE . 65.0 t-80 -148.33 129.24 7.0 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-O 118.95 -0.548 . . . . 74.510000000000005 110.353 -171.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -65.16 -38.86 25.72 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 123.14 2.56 . . . . 73.319999999999993 113.437 -173.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.445 ' HB2' ' HE1' ' A' ' 103' ' ' HIS . 35.4 m -93.54 28.93 2.12 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.926 0.49 . . . . 70.209999999999994 110.458 178.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.561 ' HB3' ' HB3' ' A' ' 103' ' ' HIS . 67.4 t80 -133.57 113.28 12.26 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.862 -0.792 . . . . 74.299999999999997 108.862 174.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.599 ' HB2' ' HB2' ' A' ' 110' ' ' GLN . 50.0 mt -117.51 157.48 26.23 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 108.706 -0.85 . . . . 72.109999999999999 108.706 173.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.38 -26.95 65.54 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.459 1.103 . . . . 75.340000000000003 112.974 -171.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.19 37.83 2.02 Favored Glycine 0 N--CA 1.471 0.973 0 N-CA-C 112.252 -0.339 . . . . 62.420000000000002 112.252 -177.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.599 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -131.24 71.8 1.48 Allowed 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 121.515 0.674 . . . . 74.319999999999993 109.673 -178.35 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -63.27 -30.36 71.51 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.345 1.058 . . . . 72.140000000000001 113.145 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 19.8 pm0 -66.28 -15.77 63.49 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.748 0.419 . . . . 75.430000000000007 111.639 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.515 ' O ' HG13 ' A' ' 117' ' ' ILE . 49.3 mt -87.03 -21.45 26.09 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 118.953 -0.546 . . . . 75.349999999999994 111.374 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 96.8 mt -57.4 -41.1 79.64 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 123.395 0.678 . . . . 73.019999999999996 111.33 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -76.93 -7.83 56.27 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 115.448 -0.796 . . . . 71.209999999999994 112.581 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -101.15 -9.19 21.56 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.705 0.802 . . . . 74.430000000000007 109.857 172.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.515 HG13 ' O ' ' A' ' 113' ' ' LEU . 72.7 mt -81.13 108.96 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 107.265 -1.383 . . . . 73.120000000000005 107.265 173.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.464 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 11.2 mmpt? -108.67 144.09 36.88 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.997 -0.742 . . . . 74.400000000000006 108.997 -172.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 31.0 ptt-85 -96.94 2.38 51.55 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.655 0.597 . . . . 73.450000000000003 110.788 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -100.98 176.34 5.3 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.692 0.797 . . . . 71.349999999999994 110.442 177.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 29.6 m -87.5 68.95 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-O 123.18 1.467 . . . . 72.150000000000006 111.09 -174.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.0 t -77.38 -168.88 1.24 Allowed 'General case' 0 CA--C 1.559 1.318 0 CA-C-N 113.806 -1.543 . . . . 65.209999999999994 109.782 171.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 17.4 p -74.75 73.07 2.05 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 121.726 0.774 . . . . 74.439999999999998 111.275 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 16.5 m -139.48 157.4 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 125.308 1.443 . . . . 75.25 108.704 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 62.2 m . . . . . 0 C--O 1.254 1.296 0 N-CA-C 108.759 -0.83 . . . . 72.310000000000002 108.759 175.736 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 121.041 0.448 . . . . 74.329999999999998 110.786 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 155.11 128.66 1.17 Allowed Glycine 0 C--N 1.344 0.98 0 N-CA-C 110.284 -1.127 . . . . 74.430000000000007 110.284 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -92.73 165.36 12.99 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.974 0.51 . . . . 75.120000000000005 109.765 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -61.48 95.1 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.003 0.921 . . . . 73.439999999999998 111.106 -173.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.2 m170 -104.79 153.82 20.82 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.783 0.833 . . . . 74.349999999999994 109.32 173.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.2 m80 68.38 10.96 8.17 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 125.106 1.363 . . . . 74.299999999999997 112.283 175.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -75.1 119.55 19.4 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 109.785 -0.45 . . . . 71.540000000000006 109.785 -177.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -145.96 176.11 9.94 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.531 0.732 . . . . 61.450000000000003 109.803 -178.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.9 m -137.13 126.81 25.39 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.79 0.836 . . . . 75.5 108.86 175.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -59.24 -63.98 1.11 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.285 0.634 . . . . 74.109999999999999 110.315 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.489 ' HG3' ' O ' ' A' ' 14' ' ' PRO . 0.0 OUTLIER 177.61 149.86 0.18 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.085 1.354 . . . . 75.430000000000007 108.998 174.116 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -129.73 40.42 3.58 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.012 0.925 . . . . 74.040000000000006 108.543 177.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 176.29 -71.55 0.08 OUTLIER Glycine 0 C--N 1.348 1.219 0 CA-C-N 115.055 -0.975 . . . . 74.129999999999995 112.351 -177.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.489 ' O ' ' HG3' ' A' ' 11' ' ' MET . 34.3 Cg_exo -61.56 88.4 0.1 OUTLIER 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 123.413 2.742 . . . . 74.239999999999995 112.875 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 42.6 t -68.57 131.92 46.05 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.519 0.728 . . . . 74.540000000000006 111.189 -177.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.92 -3.7 57.32 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.433 0.693 . . . . 73.540000000000006 111.92 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.6 t -70.17 118.95 68.71 Favored Pre-proline 0 CA--C 1.553 1.083 0 N-CA-C 107.75 -1.204 . . . . 71.030000000000001 107.75 166.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -52.9 135.78 58.72 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 123.013 2.475 . . . . 74.239999999999995 112.621 177.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.96 -42.42 68.9 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.31 1.044 . . . . 74.340000000000003 112.335 -178.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -57.66 -40.75 80.05 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.252 0.621 . . . . 73.219999999999999 111.653 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 66.0 mt -78.04 -34.06 50.69 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 112.25 0.463 . . . . 73.209999999999994 112.25 -174.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.1 t -74.45 -37.22 63.32 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 119.688 -0.196 . . . . 74.040000000000006 110.885 178.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.479 ' HA ' ' HE2' ' A' ' 23' ' ' LYS . 8.5 mmpt? -70.79 -37.06 73.29 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 122.793 0.437 . . . . 74.310000000000002 110.102 175.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.9 tp -58.5 -53.59 56.63 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 123.808 0.843 . . . . 75.340000000000003 111.453 173.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 24.1 t-105 -61.68 -41.74 97.98 Favored 'General case' 0 CA--C 1.549 0.921 0 O-C-N 123.027 0.204 . . . . 75.340000000000003 111.182 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.442 ' O ' ' HB2' ' A' ' 30' ' ' ASP . 90.7 m -59.38 -36.52 75.95 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 122.897 0.479 . . . . 74.420000000000002 110.762 174.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.415 ' HG ' HG23 ' A' ' 37' ' ' ILE . 50.5 tp -70.78 -51.02 29.64 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.633 1.173 . . . . 72.040000000000006 111.939 -178.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 96.4 t -60.58 -33.86 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.69 1.196 . . . . 73.340000000000003 111.2 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.6 t -86.91 -24.44 24.82 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.855 0.862 . . . . 73.420000000000002 111.684 -176.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 26' ' ' THR . 8.7 t70 -69.3 128.62 92.34 Favored Pre-proline 0 N--CA 1.488 1.467 0 C-N-CA 122.856 0.462 . . . . 74.140000000000001 111.828 -168.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.32 -1.89 11.29 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 123.175 2.583 . . . . 75.219999999999999 114.507 -176.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -87.15 -34.28 19.12 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 118.305 0.502 . . . . 72.140000000000001 111.0 172.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.0 p -112.27 1.57 16.19 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.742 0.817 . . . . 75.219999999999999 112.398 -171.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.425 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 8.9 p-10 -61.18 -25.15 66.83 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.951 0.901 . . . . 62.240000000000002 111.923 -178.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.26 -33.64 75.94 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.957 0.903 . . . . 75.109999999999999 112.496 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.434 HD23 ' HB2' ' A' ' 50' ' ' ASP . 69.3 mt -108.14 -13.35 14.94 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.221 0.608 . . . . 72.439999999999998 112.001 -178.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 34' ' ' ASP . 19.8 tt -157.39 117.67 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-O 121.266 0.555 . . . . 73.120000000000005 110.507 177.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 29.0 p -144.73 153.01 41.24 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.212 0.605 . . . . 74.129999999999995 109.803 -178.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 35.5 p-90 -82.21 153.15 26.09 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.922 -0.581 . . . . 73.409999999999997 109.738 178.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.6 m -82.49 156.91 68.21 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 108.726 -0.842 . . . . 71.040000000000006 108.726 -178.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -61.23 -12.29 22.8 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.449 2.1 . . . . 52.020000000000003 113.297 178.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 77.2 p -74.44 -36.87 63.41 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.824 0.85 . . . . 74.430000000000007 110.656 171.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.93 -8.12 77.46 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 115.504 -0.771 . . . . 63.32 113.415 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.565 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 0.4 OUTLIER -101.2 12.59 37.27 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.181 0.992 . . . . 72.420000000000002 111.37 -172.246 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.4 p -163.77 151.86 13.12 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.888 0.875 . . . . 75.150000000000006 109.538 -175.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -138.99 147.25 41.92 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.946 0.498 . . . . 73.140000000000001 109.871 177.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -101.99 144.69 30.28 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.478 0.711 . . . . 65.329999999999998 109.556 -176.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 95.8 t -121.66 115.61 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 107.504 -1.295 . . . . 73.150000000000006 107.504 177.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.486 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 25.4 m-85 -114.51 149.14 36.85 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.661 1.185 . . . . 71.310000000000002 110.743 -172.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.434 ' HB2' HD23 ' A' ' 36' ' ' LEU . 5.4 m-20 52.36 53.2 12.75 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 125.021 1.45 . . . . 50.119999999999997 110.51 176.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.709 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 55.5 mt-30 -53.39 -25.85 17.2 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 114.853 -1.067 . . . . 71.439999999999998 113.576 -170.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.45 -50.42 55.47 Favored Glycine 0 CA--C 1.534 1.266 0 N-CA-C 112.205 -0.358 . . . . 72.340000000000003 112.205 174.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -73.72 -33.49 64.38 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.143 0.977 . . . . 74.409999999999997 110.608 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -66.03 -54.54 24.59 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.345 1.058 . . . . 74.420000000000002 110.582 -178.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.6 -26.04 67.66 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 116.108 -0.496 . . . . 72.140000000000001 111.724 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.1 tttm -64.01 -55.58 21.3 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.816 1.246 . . . . 72.319999999999993 113.064 178.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.492 ' HG3' HG23 ' A' ' 58' ' ' VAL . 2.1 pt-20 -112.02 -33.65 6.2 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 113.259 0.836 . . . . 73.409999999999997 113.259 -170.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.492 HG23 ' HG3' ' A' ' 57' ' ' GLU . 61.8 t -85.22 -43.23 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.305 0.642 . . . . 75.299999999999997 111.328 -168.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.443 HD13 ' HE2' ' A' ' 68' ' ' MET . 17.6 mt -62.57 -51.64 71.13 Favored Pre-proline 0 CA--C 1.558 1.272 0 CA-C-O 118.312 -0.851 . . . . 73.129999999999995 112.429 178.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.3 -7.48 21.32 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 121.726 1.617 . . . . 74.030000000000001 112.783 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -80.11 -60.97 2.13 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.09 0.956 . . . . 74.430000000000007 110.771 175.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -83.73 -32.17 25.64 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 122.755 0.422 . . . . 73.099999999999994 112.052 -176.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -112.11 -175.95 2.81 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.82 -0.807 . . . . 71.230000000000004 108.82 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.95 28.8 8.1 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.392 0.677 . . . . 73.120000000000005 111.295 -174.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 26.1 p80 -157.42 155.95 31.37 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.155 0.582 . . . . 72.109999999999999 109.82 -172.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 38.8 p30 -117.74 -7.5 10.99 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.394 0.677 . . . . 71.530000000000001 111.668 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -72.94 121.55 20.25 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.861 -0.422 . . . . 72.530000000000001 109.861 -178.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.709 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 2.4 tpt -59.48 -45.52 91.44 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.186 0.994 . . . . 74.209999999999994 111.227 178.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.73 -34.68 74.77 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.574 -0.739 . . . . 74.25 112.087 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.4 t -63.2 -40.92 98.86 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.252 0.621 . . . . 71.030000000000001 111.35 175.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -64.13 -53.08 55.24 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.134 0.974 . . . . 73.400000000000006 110.861 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.1 t -61.16 -39.49 82.63 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 CA-C-N 115.079 -0.964 . . . . 75.340000000000003 111.394 -179.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -57.78 -48.91 78.35 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.617 0.767 . . . . 74.299999999999997 111.235 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -58.13 -43.16 87.14 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 124.437 1.086 . . . . 74.530000000000001 110.641 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.7 mt -65.18 -41.53 94.52 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.219 0.608 . . . . 72.200000000000003 111.672 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -60.34 -35.88 76.69 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 122.584 0.354 . . . . 65.420000000000002 111.185 172.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.471 ' O ' ' HA ' ' A' ' 119' ' ' ARG . 48.2 mtp -65.63 -39.68 91.71 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.149 0.58 . . . . 71.019999999999996 110.126 175.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -81.53 -1.33 45.8 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.081 0.552 . . . . 71.299999999999997 111.518 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.03 22.15 57.95 Favored Glycine 0 C--N 1.35 1.331 0 N-CA-C 114.399 0.52 . . . . 60.200000000000003 114.399 174.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.545 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . 34.2 m-85 -78.82 130.56 35.84 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.343 -0.984 . . . . 74.319999999999993 108.343 173.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -100.93 129.61 46.81 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.208 0.603 . . . . 74.120000000000005 109.649 -171.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -71.54 122.55 20.67 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.514 1.126 . . . . 75.129999999999995 110.905 -178.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 90.6 t -132.3 127.4 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 107.488 -1.301 . . . . 71.420000000000002 107.488 172.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.59 131.97 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 109.122 -0.696 . . . . 74.450000000000003 109.122 177.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 29.6 m-70 -102.49 -33.29 9.57 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.054 0.542 . . . . 65.349999999999994 110.207 -178.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 30.8 mm -74.11 87.83 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 108.736 -0.838 . . . . 75.109999999999999 108.736 169.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -81.09 125.01 29.69 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 114.644 -1.162 . . . . 73.129999999999995 111.613 -175.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.663 HE22 ' HB2' ' A' ' 93' ' ' LYS . 80.9 mm-40 -117.49 75.6 1.0 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.344 0.657 . . . . 73.299999999999997 110.176 177.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -88.66 -69.03 1.27 Allowed Glycine 0 N--CA 1.47 0.902 0 N-CA-C 110.227 -1.149 . . . . 61.329999999999998 110.227 170.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -135.12 17.92 4.04 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 123.946 0.784 . . . . 71.019999999999996 111.241 171.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 68.9 mt -91.12 169.76 10.58 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.431 1.093 . . . . 73.0 110.643 -175.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.5 p -101.68 -67.01 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 CA-C-O 118.985 -0.531 . . . . 73.219999999999999 109.796 175.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.663 ' HB2' HE22 ' A' ' 88' ' ' GLN . 64.0 mttm 58.98 165.83 0.08 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 C-N-CA 124.733 1.213 . . . . 75.109999999999999 113.224 -178.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -61.73 145.28 97.47 Favored 'Trans proline' 0 C--N 1.385 2.481 0 C-N-CA 122.153 1.902 . . . . 65.140000000000001 110.764 170.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.57 -14.78 61.7 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.326 0.65 . . . . 72.120000000000005 112.56 -170.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -59.96 142.82 53.1 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 123.525 0.73 . . . . 73.340000000000003 110.184 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.486 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 2.5 m-20 -80.73 147.22 30.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.614 -0.721 . . . . 73.25 109.765 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -134.78 117.93 16.5 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.864 0.866 . . . . 65.430000000000007 109.345 172.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 86.3 m -135.06 109.0 8.12 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.595 0.758 . . . . 72.209999999999994 109.125 178.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -99.15 119.7 38.28 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.786 -0.82 . . . . 64.420000000000002 108.786 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.545 ' HB3' ' HB3' ' A' ' 80' ' ' PHE . 92.9 m-85 -99.62 120.31 39.47 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.556 -0.905 . . . . 75.340000000000003 108.556 173.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -109.99 144.59 38.31 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.368 0.667 . . . . 75.150000000000006 110.027 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -153.34 127.06 4.33 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 109.149 -0.686 . . . . 75.340000000000003 109.149 177.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.8 -34.86 59.8 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 123.021 2.481 . . . . 73.439999999999998 112.957 -177.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 36.1 m -93.19 26.29 2.94 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 121.234 0.54 . . . . 75.329999999999998 110.833 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.565 ' O ' ' HA ' ' A' ' 44' ' ' ASN . 85.8 t80 -124.9 110.36 14.16 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 107.092 -1.448 . . . . 73.299999999999997 107.092 172.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.614 ' HB2' ' HB3' ' A' ' 110' ' ' GLN . 85.2 mt -131.48 174.49 10.04 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 108.849 -0.797 . . . . 65.230000000000004 108.849 170.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -63.09 -75.7 0.07 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.527 0.731 . . . . 74.310000000000002 111.513 -178.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -80.25 -10.9 84.9 Favored Glycine 0 C--N 1.349 1.271 0 O-C-N 123.195 0.31 . . . . 74.329999999999998 113.157 -177.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.614 ' HB3' ' HB2' ' A' ' 107' ' ' LEU . 5.3 tp-100 -90.99 40.55 1.03 Allowed 'General case' 0 CA--C 1.556 1.178 0 CA-C-O 121.531 0.682 . . . . 72.219999999999999 109.323 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -69.63 -12.53 61.72 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.088 0.955 . . . . 65.420000000000002 112.687 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.3 pm0 -64.45 -10.11 23.03 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.197 0.599 . . . . 75.239999999999995 112.174 169.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.46 ' O ' HG13 ' A' ' 117' ' ' ILE . 53.0 mt -91.18 -4.58 55.96 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.172 0.589 . . . . 75.409999999999997 111.961 175.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 90.2 mt -66.03 -34.56 78.36 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 118.536 0.607 . . . . 74.439999999999998 111.162 176.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -75.25 -17.25 60.36 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.515 0.726 . . . . 75.430000000000007 111.415 172.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -90.86 -9.86 44.78 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.413 0.685 . . . . 71.230000000000004 110.034 176.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 113' ' ' LEU . 59.3 mt -84.26 121.7 36.95 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 N-CA-C 107.294 -1.373 . . . . 73.310000000000002 107.294 170.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.505 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 10.8 mmpt? -111.14 151.79 27.74 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.225 0.61 . . . . 75.430000000000007 109.837 -178.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 77' ' ' MET . 43.3 ptt85 -107.98 -179.46 3.9 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.053 -0.976 . . . . 75.25 109.563 170.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -73.66 165.53 24.92 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 116.051 -0.522 . . . . 75.450000000000003 109.985 169.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 22.3 t 63.44 65.52 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.242 1.017 . . . . 74.030000000000001 109.075 -171.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.3 t -156.5 148.78 23.32 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.815 -1.084 . . . . 75.129999999999995 108.981 178.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 66.2 p -168.09 144.02 3.85 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.046 0.539 . . . . 62.539999999999999 110.278 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.3 p -75.25 92.41 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 N-CA-C 108.84 -0.8 . . . . 74.310000000000002 108.84 170.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 39.3 m . . . . . 0 CA--C 1.557 1.246 0 C-N-CA 124.707 1.203 . . . . 71.319999999999993 109.989 -171.615 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 N--CA 1.482 1.133 0 N-CA-C 110.18 -0.304 . . . . 72.010000000000005 110.18 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -131.7 53.53 0.8 Allowed Glycine 0 C--N 1.355 1.588 0 N-CA-C 112.364 -0.294 . . . . 74.219999999999999 112.364 -170.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -131.65 42.88 3.13 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.685 0.794 . . . . 71.510000000000005 109.069 171.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 26.2 m170 -62.65 129.95 42.85 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.086 -0.961 . . . . 62.439999999999998 110.789 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -106.05 46.09 0.94 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.354 0.662 . . . . 73.120000000000005 110.218 -177.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -78.62 80.85 4.97 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 107.99 -1.115 . . . . 65.239999999999995 107.99 168.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 -138.44 87.61 2.24 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.622 -1.172 . . . . 74.439999999999998 108.672 -169.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.1 p80 55.18 115.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 126.895 2.078 . . . . 74.319999999999993 113.692 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.7 p -143.6 159.11 43.03 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.138 0.975 . . . . 73.120000000000005 109.823 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 54.2 m80 59.45 30.77 20.49 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.384 1.073 . . . . 74.150000000000006 111.816 176.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 70.8 mtp -60.43 108.18 0.78 Allowed 'General case' 0 C--N 1.352 0.676 0 C-N-CA 123.975 0.91 . . . . 73.140000000000001 108.982 175.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.79 157.74 35.87 Favored 'General case' 0 C--O 1.24 0.553 0 O-C-N 123.51 0.506 . . . . 74.209999999999994 110.792 -177.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.26 95.07 1.06 Allowed Glycine 0 C--N 1.336 0.576 0 CA-C-O 119.183 -0.787 . . . . 74.140000000000001 111.441 175.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.03 113.91 3.41 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 121.847 1.698 . . . . 72.219999999999999 110.353 174.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.8 t -76.8 -176.78 4.01 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.346 0.659 . . . . 72.540000000000006 110.339 -176.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.42 ' HB2' ' HB2' ' A' ' 115' ' ' GLU . 25.0 m-80 -65.83 -10.62 39.56 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.306 0.642 . . . . 71.319999999999993 111.866 178.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.8 t -57.55 115.24 10.22 Favored Pre-proline 0 N--CA 1.482 1.168 0 C-N-CA 123.878 0.871 . . . . 74.230000000000004 110.25 176.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -52.28 148.48 25.22 Favored 'Trans proline' 0 C--N 1.386 2.526 0 C-N-CA 123.718 2.945 . . . . 75.219999999999999 113.172 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.77 -42.42 64.98 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.833 0.853 . . . . 75.310000000000002 111.771 176.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -52.71 -49.9 64.44 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.617 0.767 . . . . 73.109999999999999 112.081 174.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 82.5 mt -80.61 -30.81 36.78 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.187 0.44 . . . . 74.530000000000001 112.187 -169.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.8 t -72.15 -36.54 69.36 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 118.009 0.368 . . . . 73.530000000000001 111.026 175.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.473 ' HA ' ' HE2' ' A' ' 23' ' ' LYS . 9.0 mmpt? -73.52 -36.49 65.72 Favored 'General case' 0 C--N 1.359 0.981 0 C-N-CA 122.869 0.468 . . . . 51.240000000000002 110.324 176.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.0 tp -62.76 -49.34 75.38 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 124.049 0.843 . . . . 74.430000000000007 110.99 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.459 ' HH2' ' HG2' ' A' ' 108' ' ' ARG . 12.0 t-105 -60.47 -43.62 96.73 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 122.36 0.264 . . . . 73.340000000000003 111.209 178.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.4 m -54.42 -51.19 65.7 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 122.631 0.373 . . . . 74.0 110.436 172.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.427 ' HG ' HD13 ' A' ' 37' ' ' ILE . 37.1 tp -57.19 -53.39 58.68 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.116 1.767 . . . . 73.109999999999999 113.201 -175.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.7 t -61.47 -35.45 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.659 1.184 . . . . 70.549999999999997 111.785 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.2 t -93.32 -6.52 47.2 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.778 -0.646 . . . . 72.439999999999998 111.351 -176.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -83.42 129.83 58.79 Favored Pre-proline 0 CA--C 1.552 1.055 0 C-N-CA 123.004 0.521 . . . . 74.329999999999998 111.18 -172.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -80.88 -9.63 13.06 Favored 'Trans proline' 0 C--N 1.382 2.328 0 C-N-CA 122.863 2.375 . . . . 71.040000000000006 114.027 -176.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -80.53 -27.42 37.63 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 118.49 0.586 . . . . 74.239999999999995 110.589 175.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.8 p -105.59 10.02 33.15 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.537 0.735 . . . . 74.430000000000007 112.486 -179.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -56.83 -32.27 65.59 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.151 0.981 . . . . 73.340000000000003 112.476 -175.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.08 -38.24 90.39 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.835 0.854 . . . . 75.310000000000002 112.968 -176.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.448 ' HA ' ' HB2' ' A' ' 49' ' ' PHE . 77.9 mt -110.97 -8.5 14.47 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 122.687 0.395 . . . . 64.530000000000001 111.837 -175.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.427 HD13 ' HG ' ' A' ' 27' ' ' LEU . 18.6 tt -162.42 134.36 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 122.62 0.368 . . . . 75.310000000000002 111.163 173.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.3 p -161.96 156.6 22.55 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.15 0.58 . . . . 75.040000000000006 109.879 173.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 14.8 p-90 -77.03 150.31 35.8 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.335 0.654 . . . . 71.409999999999997 110.504 -177.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.2 m -75.54 147.11 81.57 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 108.579 -0.897 . . . . 75.219999999999999 108.579 176.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.49 -12.89 12.01 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.615 2.21 . . . . 71.109999999999999 113.639 176.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.0 m -65.76 -43.95 87.31 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.664 1.186 . . . . 73.450000000000003 110.728 169.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.46 -10.98 69.07 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 114.934 -1.03 . . . . 71.420000000000002 114.147 177.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -101.84 6.43 41.53 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.456 1.102 . . . . 74.340000000000003 111.605 -171.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.2 p -157.36 161.75 39.05 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.121 0.969 . . . . 65.420000000000002 109.657 -171.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.436 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 45.9 p90 -146.61 146.52 30.45 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.66 0.384 . . . . 74.099999999999994 110.731 177.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -103.28 143.55 32.51 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.575 0.75 . . . . 75.519999999999996 109.632 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.0 t -123.14 121.98 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 107.569 -1.271 . . . . 75.310000000000002 107.569 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.549 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 90.6 m-85 -105.14 144.71 31.55 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 123.572 0.749 . . . . 71.230000000000004 109.759 -177.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 42.98 73.02 0.15 Allowed 'General case' 0 N--CA 1.476 0.851 0 O-C-N 125.254 1.596 . . . . 64.340000000000003 112.608 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -53.72 -26.9 25.2 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.499 1.119 . . . . 71.129999999999995 113.498 -175.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.31 -48.12 47.51 Favored Glycine 0 C--N 1.35 1.35 0 O-C-N 123.014 0.196 . . . . 64.030000000000001 112.69 173.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -71.62 -37.13 70.95 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.018 0.927 . . . . 74.239999999999995 110.663 -178.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.478 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 59.8 t80 -61.96 -48.93 78.17 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.224 1.41 . . . . 75.099999999999994 110.135 176.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.446 ' HB1' ' HB2' ' A' ' 68' ' ' MET . . . -62.45 -33.0 73.96 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 116.06 -0.518 . . . . 73.450000000000003 111.6 178.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.1 tttm -67.74 -55.52 12.82 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.611 1.165 . . . . 72.319999999999993 113.398 -177.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -106.78 -33.38 7.6 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 113.138 0.792 . . . . 70.099999999999994 113.138 -170.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.478 ' HB ' ' O ' ' A' ' 54' ' ' PHE . 94.4 t -82.78 -49.94 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 122.923 0.489 . . . . 73.439999999999998 111.605 -171.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.2 mt -61.48 -47.76 92.42 Favored Pre-proline 0 CA--C 1.561 1.369 0 CA-C-O 118.048 -0.977 . . . . 73.099999999999994 113.042 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -66.62 -16.62 51.2 Favored 'Trans proline' 0 C--N 1.391 2.783 0 CA-C-N 121.964 1.737 . . . . 74.409999999999997 113.073 177.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -77.03 -53.97 7.14 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.384 0.674 . . . . 75.109999999999999 111.253 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -87.29 -46.71 9.45 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.241 0.617 . . . . 73.420000000000002 111.686 -177.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -100.33 -179.9 4.26 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.383 -0.826 . . . . 73.0 108.785 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -112.64 40.03 2.36 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 121.634 0.73 . . . . 73.409999999999997 109.654 -174.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 32.2 p80 -157.66 161.5 38.6 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 114.949 -1.023 . . . . 75.340000000000003 109.01 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -112.95 -11.01 13.47 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.217 0.607 . . . . 43.25 110.128 177.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -73.39 120.53 19.13 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.439 0.696 . . . . 73.040000000000006 111.262 -176.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.446 ' HB2' ' HB1' ' A' ' 55' ' ' ALA . 12.2 tpt -69.9 -36.63 75.55 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.702 0.801 . . . . 74.219999999999999 111.303 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.65 -30.92 67.68 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 123.724 0.64 . . . . 74.230000000000004 111.962 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.1 t -65.54 -47.35 76.16 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.39 1.076 . . . . 74.519999999999996 110.841 174.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -63.74 -52.92 58.28 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.511 1.125 . . . . 75.420000000000002 110.471 -176.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.7 t -62.94 -40.89 90.67 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 CA-C-N 115.25 -0.886 . . . . 62.229999999999997 111.055 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -57.7 -40.97 80.74 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 123.272 0.629 . . . . 73.329999999999998 111.407 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -57.57 -51.0 71.25 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 124.187 0.929 . . . . 73.439999999999998 110.07 176.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 68.2 mt -63.56 -38.14 89.98 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.923 0.889 . . . . 73.25 111.714 -177.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 -57.27 -44.6 84.11 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 122.803 0.441 . . . . 74.219999999999999 110.851 172.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 71.0 mtm -73.79 -25.17 59.99 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.905 -0.589 . . . . 73.439999999999998 111.499 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -86.54 1.58 51.13 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.35 0.66 . . . . 72.150000000000006 111.065 173.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.63 13.39 81.6 Favored Glycine 0 C--N 1.344 1.017 0 N-CA-C 115.068 0.787 . . . . 64.349999999999994 115.068 171.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -69.3 144.87 53.44 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 117.877 0.838 . . . . 74.439999999999998 109.248 177.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -101.18 122.54 43.82 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.414 -0.587 . . . . 75.310000000000002 109.414 -177.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.485 ' HE2' ' HB ' ' A' ' 84' ' ' VAL . 22.9 tptm -68.32 113.22 5.73 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.018 1.327 . . . . 74.109999999999999 109.743 172.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 90.3 t -125.58 106.61 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 107.711 -1.218 . . . . 73.549999999999997 107.711 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.485 ' HB ' ' HE2' ' A' ' 82' ' ' LYS . 3.5 p -107.7 123.11 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 108.442 -0.947 . . . . 73.019999999999996 108.442 -172.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -95.7 -26.05 15.86 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.164 0.586 . . . . 75.349999999999994 111.725 -169.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 47.1 mm -90.47 107.85 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.134 0.574 . . . . 73.209999999999994 110.242 -178.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -90.02 100.89 13.62 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.836 0.854 . . . . 73.230000000000004 109.476 169.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -71.99 94.88 1.52 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.521 0.728 . . . . 73.209999999999994 109.121 176.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -160.23 -127.87 0.93 Allowed Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.106 -0.798 . . . . 73.129999999999995 111.106 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -98.24 51.61 1.26 Allowed Glycine 0 C--N 1.343 0.97 0 CA-C-N 116.893 0.347 . . . . 74.340000000000003 112.503 178.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 89.2 mt -120.86 168.44 11.45 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.963 0.905 . . . . 74.420000000000002 110.949 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.3 p -112.06 79.64 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 CA-C-O 122.97 1.366 . . . . 75.120000000000005 109.263 175.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -140.2 161.24 56.48 Favored Pre-proline 0 N--CA 1.48 1.054 0 CA-C-N 113.817 -1.538 . . . . 72.420000000000002 107.756 175.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -66.21 133.52 33.23 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 121.358 1.372 . . . . 72.230000000000004 109.707 174.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -81.12 4.95 18.24 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.933 0.893 . . . . 65.140000000000001 112.257 -170.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -57.54 171.15 0.47 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.214 1.006 . . . . 75.129999999999995 111.917 171.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.549 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 52.4 m-20 -86.58 124.51 32.96 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.24 -1.022 . . . . 65.049999999999997 108.24 171.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -123.2 107.52 11.8 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 107.897 -1.149 . . . . 74.010000000000005 107.897 167.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 55.0 m -122.11 108.73 13.68 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.589 1.156 . . . . 70.25 109.579 -173.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.436 ' HA ' ' O ' ' A' ' 46' ' ' PHE . 38.7 tt0 -101.49 115.36 30.34 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.82 -0.807 . . . . 71.519999999999996 108.82 -179.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -96.63 120.03 36.2 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.181 -1.044 . . . . 74.430000000000007 108.181 171.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -118.3 145.48 45.04 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.714 -0.847 . . . . 75.340000000000003 108.714 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.437 ' HB3' ' HB3' ' A' ' 106' ' ' PHE . 42.6 t-80 -155.78 133.17 6.53 Favored Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 109.318 -0.623 . . . . 74.25 109.318 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -63.96 -35.53 54.46 Favored 'Trans proline' 0 C--N 1.384 2.447 0 C-N-CA 122.855 2.37 . . . . 71.430000000000007 112.268 -175.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 3.4 m -87.0 3.88 44.12 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.435 0.694 . . . . 73.400000000000006 111.002 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.437 ' HB3' ' HB3' ' A' ' 103' ' ' HIS . 88.9 t80 -111.84 103.28 11.53 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 107.911 -1.144 . . . . 74.200000000000003 107.911 175.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.412 HD13 ' HG2' ' A' ' 110' ' ' GLN . 28.3 mt -119.43 167.97 11.42 Favored 'General case' 0 C--O 1.246 0.881 0 N-CA-C 107.236 -1.394 . . . . 73.200000000000003 107.236 170.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.459 ' HG2' ' HH2' ' A' ' 25' ' ' TRP . 30.3 ttp85 -60.63 -79.86 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.154 0.582 . . . . 75.310000000000002 110.903 -173.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -85.46 60.17 4.74 Favored Glycine 0 C--N 1.347 1.14 0 N-CA-C 111.624 -0.59 . . . . 63.420000000000002 111.624 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.412 ' HG2' HD13 ' A' ' 107' ' ' LEU . 2.8 tp-100 -150.93 35.44 0.6 Allowed 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 108.872 -0.788 . . . . 72.219999999999999 108.872 -170.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -64.16 -20.19 65.83 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.607 1.163 . . . . 61.210000000000001 113.154 -175.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.07 -8.18 53.13 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 112.022 0.379 . . . . 73.310000000000002 112.022 177.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.424 ' O ' HG13 ' A' ' 117' ' ' ILE . 17.7 mt -88.3 -16.61 32.64 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.368 0.667 . . . . 73.310000000000002 111.494 173.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 96.8 mt -61.61 -36.41 80.66 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.274 0.559 . . . . 64.420000000000002 111.212 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 16' ' ' ASN . 12.6 pt-20 -72.77 -15.78 61.65 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 115.57 -0.741 . . . . 74.030000000000001 112.342 177.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -97.14 -7.68 31.95 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.706 0.802 . . . . 64.129999999999995 110.257 178.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 113' ' ' LEU . 64.2 mt -88.65 130.52 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 107.573 -1.269 . . . . 73.109999999999999 107.573 173.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -105.71 141.1 37.72 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.25 0.62 . . . . 74.400000000000006 109.992 -171.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -92.2 7.04 44.39 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 124.209 0.943 . . . . 74.140000000000001 110.327 170.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -102.58 -168.75 1.57 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.078 0.951 . . . . 72.129999999999995 110.695 -173.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.2 p -60.55 -22.89 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.373 0 C-N-CA 124.417 1.087 . . . . 63.119999999999997 113.775 -168.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 38.6 p -82.13 73.23 9.17 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 121.515 0.674 . . . . 73.010000000000005 110.27 174.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 34.0 t -170.45 172.71 5.91 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 114.606 -1.179 . . . . 75.430000000000007 109.228 -174.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 7.4 p -165.53 134.13 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 C-N-CA 124.056 0.942 . . . . 74.540000000000006 109.749 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 CA--C 1.556 1.178 0 N-CA-C 108.443 -0.947 . . . . 72.430000000000007 108.443 177.199 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.2 t . . . . . 0 CA--C 1.549 0.906 0 CA-C-O 118.983 -0.532 . . . . 71.43 109.805 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.84 147.37 85.21 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 122.418 2.078 . . . . 72.55 110.894 171.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.29 -33.24 41.23 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.441 1.096 . . . . 73.35 113.36 -172.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -54.75 -52.76 61.55 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.681 0.792 . . . . 72.15 112.272 174.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 95.7 mt -77.26 -29.48 53.93 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 120.992 0.425 . . . . 74.43 109.912 -171.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.4 m -58.76 -48.4 81.34 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 114.351 -1.295 . . . . 74.33 111.395 173.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.475 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -69.28 -47.4 64.67 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.951 -0.568 . . . . 73.23 110.731 176.13 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.5 ' O ' HG23 ' A' ' 28' ' ' VAL . 58.9 tp -56.77 -54.76 42.6 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.597 1.159 . . . . 74.43 113.485 -174.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 89.5 t90 -56.34 -45.84 80.23 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.374 0.67 . . . . 74.41 111.13 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.1 m -69.26 -28.46 66.33 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.616 0.766 . . . . 75.22 111.663 177.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.506 ' HG ' HG21 ' A' ' 37' ' ' ILE . 49.6 tp -67.21 -46.2 74.58 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.932 1.293 . . . . 74.01 110.931 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 24' ' ' LEU . 23.6 t -63.53 -37.98 81.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-N 115.129 -0.941 . . . . 73.44 110.732 175.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.2 m -74.5 -19.97 60.16 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.841 0.856 . . . . 74.15 111.565 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -74.87 132.54 77.33 Favored Pre-proline 0 CA--C 1.556 1.173 0 C-N-CA 123.773 0.829 . . . . 64.21 110.988 -172.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.32 -28.19 12.66 Favored 'Trans proline' 0 C--N 1.384 2.44 0 C-N-CA 123.036 2.491 . . . . 74.21 114.235 -176.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -69.48 -43.39 73.29 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.244 0.618 . . . . 63.24 110.061 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.0 p -96.01 -1.25 49.31 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.733 -0.667 . . . . 70.33 111.325 -175.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -56.02 -30.83 62.45 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.645 1.178 . . . . 62.41 111.657 177.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.75 -36.31 78.61 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.237 -0.892 . . . . 74.24 112.152 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.8 mt -111.06 -6.0 14.7 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.166 0.587 . . . . 64.42 111.899 -176.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.506 HG21 ' HG ' ' A' ' 27' ' ' LEU . 18.8 tt -159.42 112.75 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 121.564 0.697 . . . . 74.11 110.504 175.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.527 ' SG ' ' HE2' ' A' ' 49' ' ' PHE . 24.5 p -139.9 145.41 37.95 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.174 0.59 . . . . 75.23 110.524 -174.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 18.8 p-90 -75.83 149.6 37.84 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.835 0.854 . . . . 71.12 111.513 -176.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.1 m -72.21 154.24 92.19 Favored Pre-proline 0 CA--C 1.556 1.192 0 C-N-CA 123.848 0.859 . . . . 62.22 109.262 174.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -43.21 -42.83 10.11 Favored 'Trans proline' 0 C--N 1.386 2.531 0 C-N-CA 124.432 3.421 . . . . 63.32 114.677 -176.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.2 m -67.52 -40.19 85.1 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.192 0.597 . . . . 71.21 111.37 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.11 11.82 55.8 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-N 115.901 -0.591 . . . . 44.41 112.793 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.409 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 28.0 p-10 -91.63 -4.76 54.87 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.26 1.024 . . . . 62.35 111.276 -175.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.6 p -155.31 170.93 20.73 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 123.937 0.895 . . . . 52.32 109.744 -174.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 50.7 p90 -142.12 149.23 39.55 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.07 0.548 . . . . 72.33 110.299 178.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -107.84 147.16 31.28 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.225 1.01 . . . . 65.45 108.398 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.624 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 60.2 t -123.3 131.31 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.018 -1.104 . . . . 72.41 108.018 176.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.527 ' HE2' ' SG ' ' A' ' 38' ' ' CYS . 79.3 m-85 -118.73 146.71 44.54 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 124.148 0.979 . . . . 72.14 109.4 -177.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 52.68 70.98 0.51 Allowed 'General case' 0 CA--C 1.548 0.898 0 O-C-N 124.693 1.246 . . . . 74.41 111.088 -178.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -46.79 -41.45 15.42 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 124.391 1.076 . . . . 73.11 112.955 -177.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.48 -46.58 76.18 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 115.646 -0.706 . . . . 75.41 112.822 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -72.69 -45.82 56.86 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.009 0.524 . . . . 74.32 110.822 -176.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.4 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 65.7 t80 -53.66 -49.15 68.57 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.778 1.231 . . . . 74.51 110.729 173.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.496 ' HB1' ' O ' ' A' ' 66' ' ' ASN . . . -64.44 -33.79 76.69 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 112.409 0.522 . . . . 71.23 112.409 178.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -69.41 -50.4 46.26 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.455 1.102 . . . . 71.34 112.167 -177.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.509 ' HG3' HG23 ' A' ' 58' ' ' VAL . 3.3 pt-20 -105.69 -43.97 4.78 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 113.098 0.777 . . . . 74.21 113.098 -174.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.509 HG23 ' HG3' ' A' ' 57' ' ' GLU . 94.5 t -76.78 -45.48 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 122.751 0.421 . . . . 74.13 111.017 -166.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 32.3 mt -61.8 -51.14 78.06 Favored Pre-proline 0 CA--C 1.557 1.225 0 CA-C-O 117.764 -1.113 . . . . 55.31 112.073 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.21 -9.58 26.27 Favored 'Trans proline' 0 C--N 1.384 2.406 0 CA-C-N 122.291 1.854 . . . . 62.13 113.719 176.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -79.35 -53.49 6.87 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.284 0.633 . . . . 72.3 110.965 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -91.69 -46.82 7.71 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.075 0.55 . . . . 73.44 111.176 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -99.12 -177.29 3.57 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 108.254 -1.017 . . . . 65.13 108.254 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -113.16 37.52 3.13 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 119.112 0.869 . . . . 72.41 111.721 -172.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -157.05 158.33 36.28 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.91 0.484 . . . . 74.22 110.271 -174.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.496 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 9.0 m-80 -105.31 -16.21 14.82 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 122.515 0.326 . . . . 63.31 110.671 177.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -75.86 124.72 27.78 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.842 0.457 . . . . 40.1 110.995 -175.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 12.7 tpt -75.1 -33.97 61.69 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.82 0.848 . . . . 75.11 111.779 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.07 -33.52 70.89 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.26 0.624 . . . . 60.15 111.68 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.44 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 48.2 t -64.7 -44.92 88.71 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.459 1.104 . . . . 73.45 111.223 175.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -60.64 -51.77 67.99 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.197 0.999 . . . . 73.51 110.709 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.6 t -61.32 -39.64 83.37 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 CA-C-N 115.0 -1.0 . . . . 40.34 111.342 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -60.69 -41.34 94.95 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.766 0.826 . . . . 71.44 112.096 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' A' ' 70' ' ' SER . 13.8 mm100 -58.98 -47.41 85.24 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 123.943 0.777 . . . . 54.2 109.616 176.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 80' ' ' PHE . 77.5 mt -61.65 -38.47 87.85 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.274 1.03 . . . . 72.5 112.172 -178.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -60.55 -35.65 76.55 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 122.557 0.343 . . . . 60.12 111.864 173.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 63.7 mtm -76.57 -23.56 53.54 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.039 0.536 . . . . 73.0 111.3 175.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -85.9 -7.0 58.98 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.405 0.682 . . . . 64.21 111.602 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.93 10.2 66.96 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-O 119.569 -0.573 . . . . 62.45 114.27 175.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.429 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 24.0 m-85 -73.25 144.41 46.71 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 117.723 0.761 . . . . 71.33 109.506 178.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 57.5 ttt-85 -110.8 131.72 54.81 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.693 -0.484 . . . . 54.53 109.693 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.574 ' HE3' ' HA ' ' A' ' 99' ' ' THR . 18.6 tptm -74.48 127.43 33.04 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.735 0.814 . . . . 45.01 109.721 173.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 95.5 t -132.37 118.38 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 107.034 -1.469 . . . . 63.52 107.034 176.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.483 ' HB ' ' HE2' ' A' ' 82' ' ' LYS . 6.5 p -104.93 116.16 48.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 108.845 -0.798 . . . . 75.12 108.845 -177.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 . . . . . 0 N--CA 1.486 1.334 0 O-C-N 122.212 -0.305 . . . . 63.14 111.761 -177.454 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 . . . . . 0 C--O 1.242 0.674 0 CA-C-O 120.955 0.407 . . . . 75.44 110.253 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.87 142.02 28.13 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.028 -1.101 . . . . 72.11 108.028 170.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.421 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 20.3 t70 -106.7 105.13 15.02 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 106.891 -1.522 . . . . 54.21 106.891 166.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.624 ' HB ' ' HB ' ' A' ' 48' ' ' VAL . 31.6 m -112.79 91.24 3.58 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.118 0.567 . . . . 62.25 110.376 -171.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 46' ' ' PHE . 39.6 tt0 -98.32 114.68 27.07 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.9 0.48 . . . . 65.13 109.73 -175.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -98.68 120.24 38.78 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 109.199 -0.667 . . . . 74.21 109.199 171.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -108.22 144.24 35.93 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.171 0.988 . . . . 71.42 110.382 -175.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -160.08 132.27 4.29 Favored Pre-proline 0 N--CA 1.479 0.992 0 CA-C-O 119.193 -0.432 . . . . 74.41 110.206 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.41 -24.83 42.46 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 122.94 2.427 . . . . 72.41 113.616 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.513 ' HB2' HG12 ' A' ' 117' ' ' ILE . 13.2 m -95.1 8.49 42.81 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.738 0.415 . . . . 72.01 111.015 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 44' ' ' ASN . 74.5 t80 -111.43 100.43 9.02 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 107.816 -1.179 . . . . 73.43 107.816 175.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 110' ' ' GLN . 96.3 mt -120.58 154.09 35.87 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.196 0.598 . . . . 61.23 109.658 173.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -71.21 -22.56 62.0 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.111 0.964 . . . . 75.13 112.575 -170.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.61 27.19 6.65 Favored Glycine 0 N--CA 1.468 0.831 0 N-CA-C 112.268 -0.333 . . . . 53.22 112.268 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.525 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 26.8 mm-40 -135.17 78.2 1.72 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.339 0.656 . . . . 65.02 110.182 -175.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -29.38 69.58 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.148 -0.933 . . . . 72.15 112.034 174.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 6.8 pm0 -76.28 -11.09 59.85 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.161 0.584 . . . . 62.14 111.693 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.0 mt -91.19 -12.78 34.36 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.658 0.383 . . . . 70.31 110.981 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 64.8 mt -69.1 -27.69 65.82 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.047 0.539 . . . . 64.13 110.631 175.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -89.72 0.9 56.69 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.612 0.765 . . . . 71.54 112.132 173.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -90.86 -17.36 26.65 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.282 -0.636 . . . . 43.23 109.282 161.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.513 HG12 ' HB2' ' A' ' 105' ' ' CYS . 32.7 mt -87.22 104.89 14.62 Favored 'Isoleucine or valine' 0 C--N 1.357 0.9 0 N-CA-C 106.64 -1.615 . . . . 65.31 106.64 173.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.481 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 11.0 mmpt? -112.47 155.81 23.63 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.953 -0.388 . . . . 51.31 109.953 -174.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 . . . . . 0 N--CA 1.477 0.893 0 C-N-CA 123.792 0.837 . . . . 71.31 109.152 179.51 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 84.1 t . . . . . 0 CA--C 1.547 0.863 0 CA-C-O 119.381 -0.342 . . . . 74.03 110.212 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -53.0 140.35 59.46 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 123.44 2.76 . . . . 70.14 111.593 175.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.49 -40.4 65.33 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.635 0.774 . . . . 64.43 112.235 -178.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -52.33 -49.84 63.46 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.05 0.94 . . . . 61.35 112.307 171.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 90.4 mt -81.65 -25.1 35.88 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.887 0.475 . . . . 72.04 110.684 -170.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.5 m -64.74 -53.36 48.38 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 124.183 0.993 . . . . 51.12 110.657 174.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.525 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -69.34 -39.94 77.86 Favored 'General case' 0 C--N 1.345 0.396 0 CA-C-N 115.457 -0.792 . . . . 74.14 110.848 -179.395 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.443 ' O ' HG23 ' A' ' 28' ' ' VAL . 54.4 tp -60.49 -48.44 81.77 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.594 0.758 . . . . 72.04 111.733 176.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.606 ' HE1' ' HA ' ' A' ' 108' ' ' ARG . 56.3 t90 -59.04 -47.72 84.21 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.99 0.516 . . . . 73.01 111.13 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.9 m -59.4 -40.79 87.78 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.044 0.938 . . . . 74.23 110.886 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 22.1 tp -62.92 -52.92 61.17 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.752 1.621 . . . . 54.43 112.355 -178.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 24' ' ' LEU . 93.6 t -60.84 -32.2 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 C-N-CA 124.227 1.011 . . . . 71.1 111.053 179.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.2 m -90.16 -5.84 56.02 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.271 1.028 . . . . 64.44 112.292 -176.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.409 ' HB3' ' OG1' ' A' ' 33' ' ' THR . 14.9 t70 -86.42 127.16 62.06 Favored Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 123.095 0.558 . . . . 72.21 111.192 -174.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.8 -32.39 77.81 Favored 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 123.782 2.988 . . . . 74.32 114.526 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -72.11 -39.94 68.51 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 122.901 0.481 . . . . 75.03 110.262 -178.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.409 ' OG1' ' HB3' ' A' ' 30' ' ' ASP . 29.8 p -98.14 0.46 46.03 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.736 -0.666 . . . . 61.43 111.445 -176.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -55.04 -31.21 60.92 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.603 1.161 . . . . 73.13 111.074 173.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.84 -39.94 86.85 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.065 0.946 . . . . 72.11 112.801 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 48.4 mt -103.54 -13.49 16.55 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.863 0.465 . . . . 75.24 111.96 -178.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.6 tt -159.81 122.27 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 121.061 0.458 . . . . 71.15 110.042 177.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 26.6 p -139.52 148.7 42.99 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 122.86 0.464 . . . . 71.13 111.245 -173.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.42 ' HB3' HG12 ' A' ' 28' ' ' VAL . 20.5 p-90 -77.85 148.99 34.41 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.418 0.687 . . . . 73.12 109.977 175.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.9 m -81.87 144.51 51.87 Favored Pre-proline 0 CA--C 1.551 1.008 0 N-CA-C 108.618 -0.882 . . . . 71.21 108.618 174.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.35 -22.15 15.27 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 123.883 3.055 . . . . 74.45 115.219 -173.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.3 m -78.06 -37.79 45.91 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.01 0.524 . . . . 45.55 111.073 176.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.9 4.14 51.62 Favored Glycine 0 C--N 1.351 1.416 0 N-CA-C 114.875 0.71 . . . . 62.33 114.875 167.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 6.6 p30 -106.5 2.08 25.95 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.804 0.842 . . . . 74.32 111.672 -175.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 81.0 p -148.01 158.09 43.87 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 109.016 -0.735 . . . . 53.42 109.016 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -142.57 152.67 42.81 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.8 0.44 . . . . 74.31 110.139 176.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -108.53 141.89 39.77 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.762 0.825 . . . . 75.52 109.336 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.0 t -118.48 134.11 63.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 107.499 -1.297 . . . . 64.15 107.499 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.452 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 93.3 m-85 -123.45 147.21 47.38 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.853 0.861 . . . . 72.12 110.088 -172.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 48.11 63.32 2.09 Favored 'General case' 0 C--N 1.352 0.714 0 O-C-N 125.33 1.644 . . . . 74.35 111.356 175.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.521 ' HG2' ' HE2' ' A' ' 68' ' ' MET . 99.2 mt-30 -54.56 -29.14 50.29 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.309 1.044 . . . . 65.15 113.3 -171.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -63.42 -45.51 94.77 Favored Glycine 0 CA--C 1.531 1.069 0 O-C-N 123.36 0.413 . . . . 24.41 112.322 172.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -74.04 -45.71 47.89 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.81 0.844 . . . . 73.02 110.574 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.408 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 80.1 t80 -55.28 -52.6 62.91 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.752 1.621 . . . . 71.31 111.2 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.503 ' HB2' ' HB2' ' A' ' 68' ' ' MET . . . -66.92 -25.95 66.62 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.159 0.429 . . . . 73.25 112.159 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.8 -49.99 18.79 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.756 0.822 . . . . 75.21 112.25 -177.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.524 ' HG3' HG23 ' A' ' 58' ' ' VAL . 6.1 pt-20 -105.19 -42.63 5.23 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 112.746 0.647 . . . . 72.25 112.746 -175.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.524 HG23 ' HG3' ' A' ' 57' ' ' GLU . 74.2 t -76.77 -43.98 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 C-N-CA 123.109 0.564 . . . . 61.3 111.877 -167.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.468 ' HG ' ' HA ' ' A' ' 55' ' ' ALA . 38.8 mt -60.85 -54.76 51.33 Favored Pre-proline 0 CA--C 1.564 1.481 0 CA-C-O 118.272 -0.871 . . . . 71.05 112.082 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -65.87 -12.23 34.37 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 121.925 1.75 . . . . 74.12 113.621 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -77.96 -62.53 1.64 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.113 0.965 . . . . 71.13 111.259 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.493 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 43.0 m-85 -78.77 -51.02 10.36 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.304 0.573 . . . . 72.24 110.676 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -89.36 -166.61 1.64 Allowed 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 107.53 -1.285 . . . . 74.1 107.53 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.59 43.57 3.11 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 119.531 1.059 . . . . 74.0 110.465 -178.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -163.61 162.64 24.4 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.06 -0.973 . . . . 71.44 108.854 -175.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -105.9 -148.95 0.42 Allowed 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 106.713 -1.588 . . . . 71.2 106.713 174.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 68.88 105.36 0.05 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.734 0.813 . . . . 73.41 111.644 169.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.521 ' HE2' ' HG2' ' A' ' 51' ' ' GLN . 13.8 tpt -70.39 -28.2 64.91 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.604 -0.725 . . . . 64.24 110.869 -175.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.15 -39.4 75.16 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.197 0.599 . . . . 62.31 111.32 176.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.8 t -65.88 -43.66 87.65 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.304 1.041 . . . . 75.43 111.388 177.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -65.13 -52.95 52.17 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.123 0.969 . . . . 71.43 111.161 -177.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.416 ' HA ' HD12 ' A' ' 75' ' ' LEU . 59.6 t -63.33 -34.4 66.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 CA-C-N 115.58 -0.736 . . . . 74.11 110.884 178.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -55.84 -42.31 75.59 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.26 0.624 . . . . 71.05 111.113 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -62.94 -47.31 83.76 Favored 'General case' 0 C--N 1.347 0.462 0 O-C-N 124.018 0.823 . . . . 62.14 110.105 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 72' ' ' VAL . 77.3 mt -60.54 -44.62 95.91 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.222 1.009 . . . . 74.31 111.968 -177.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -55.61 -41.04 72.88 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.979 0.512 . . . . 75.12 111.432 175.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 67.2 mtm -72.12 -36.9 69.55 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 116.221 -0.445 . . . . 74.12 110.708 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -77.34 -7.71 56.48 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.181 0.592 . . . . 61.04 111.251 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.91 14.4 56.47 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-O 119.631 -0.538 . . . . 74.01 114.419 174.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -76.39 134.91 39.5 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 109.117 -0.698 . . . . 72.35 109.117 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -99.28 123.26 43.41 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.881 -0.785 . . . . 52.1 108.881 -175.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.525 ' HE3' HG23 ' A' ' 99' ' ' THR . 1.3 tmtp? -72.16 116.83 13.05 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.277 -1.009 . . . . 52.54 108.277 174.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.561 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 61.7 t -107.24 122.09 60.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.911 0 N-CA-C 108.276 -1.009 . . . . 64.04 108.276 177.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.5 t -82.06 119.77 32.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 124.336 1.054 . . . . 62.43 109.669 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 108.782 -0.821 . . . . 74.04 108.782 174.878 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 . . . . . 0 C--O 1.242 0.682 0 CA-C-O 121.542 0.687 . . . . 73.42 110.39 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 22.0 m-20 -90.43 133.25 35.15 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.799 -0.815 . . . . 72.21 108.799 164.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -131.37 104.23 6.89 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 106.057 -1.831 . . . . 71.43 106.057 165.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.525 HG23 ' HE3' ' A' ' 82' ' ' LYS . 32.6 m -126.99 111.38 14.01 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.675 -0.693 . . . . 53.22 109.281 -173.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.561 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 41.5 tt0 -100.55 112.02 24.34 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 110.1 -0.333 . . . . 72.45 110.1 -173.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -97.45 122.53 40.6 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 109.032 -0.729 . . . . 71.13 109.032 174.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -120.98 145.56 47.61 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.552 0.741 . . . . 63.42 110.382 -176.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 -156.8 131.98 5.46 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 108.354 -0.98 . . . . 75.41 108.354 174.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -64.45 -20.81 66.38 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.986 2.457 . . . . 62.14 113.651 -175.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.495 ' HB2' HG12 ' A' ' 117' ' ' ILE . 18.5 m -98.4 7.12 46.62 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.324 0.65 . . . . 64.05 111.496 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 44' ' ' ASN . 62.3 t80 -108.09 100.87 10.16 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 107.721 -1.215 . . . . 70.23 107.721 175.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.594 ' HB2' ' HB3' ' A' ' 110' ' ' GLN . 96.0 mt -125.17 146.21 49.6 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.351 0.66 . . . . 71.11 109.321 173.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.606 ' HA ' ' HE1' ' A' ' 25' ' ' TRP . 31.4 ttt180 -83.11 102.11 11.61 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 109.397 -0.594 . . . . 63.13 109.397 176.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 123.99 -38.84 2.31 Favored Glycine 0 C--N 1.337 0.624 0 N-CA-C 110.349 -1.1 . . . . 72.45 110.349 -177.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.594 ' HB3' ' HB2' ' A' ' 107' ' ' LEU . 2.6 tp-100 -88.87 56.39 3.71 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.741 0.816 . . . . 70.23 109.012 176.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -62.87 -18.28 62.74 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.346 1.059 . . . . 73.33 112.514 -178.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -65.28 -20.91 66.63 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.558 0.743 . . . . 75.44 112.942 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.9 mt -91.89 -10.32 40.03 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.159 0.583 . . . . 71.43 111.693 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 74.5 mt -67.28 -35.41 79.42 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 121.394 0.616 . . . . 63.41 110.764 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -77.93 -4.93 49.36 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.498 -0.774 . . . . 64.45 111.99 176.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -103.17 -2.02 28.03 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.568 0.747 . . . . 64.33 110.014 173.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.495 HG12 ' HB2' ' A' ' 105' ' ' CYS . 60.0 mt -81.48 115.53 24.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.91 0 N-CA-C 107.053 -1.462 . . . . 72.51 107.053 168.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -105.68 136.55 45.07 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.756 -0.461 . . . . 74.04 109.756 -171.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 . . . . . 0 N--CA 1.478 0.943 0 C-N-CA 123.115 0.566 . . . . 74.43 110.402 172.631 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 CA--C 1.548 0.866 0 N-CA-C 108.81 -0.811 . . . . 65.25 108.81 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.529 ' HD2' HD12 ' A' ' 21' ' ' LEU . 32.4 Cg_exo -60.3 147.86 92.22 Favored 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.509 2.139 . . . . 74.25 111.682 173.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.63 -40.3 62.63 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.715 0.806 . . . . 44.31 111.508 176.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -53.72 -46.92 70.94 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.208 1.003 . . . . 52.43 111.705 174.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.529 HD12 ' HD2' ' A' ' 18' ' ' PRO . 28.9 mt -76.72 -37.35 56.21 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 112.468 0.544 . . . . 73.45 112.468 -173.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.8 t -69.87 -36.89 75.85 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 117.83 0.286 . . . . 75.54 110.699 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -75.73 -36.42 59.95 Favored 'General case' 0 C--N 1.358 0.964 0 C-N-CA 123.039 0.536 . . . . 34.23 110.392 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.2 tp -60.32 -44.6 95.31 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.307 0.643 . . . . 71.11 111.027 172.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 87.0 t90 -61.04 -44.85 96.78 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.714 0.806 . . . . 71.45 110.807 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 87.3 m -60.01 -38.99 84.25 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.213 1.005 . . . . 71.24 110.755 175.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.453 HD13 ' CD1' ' A' ' 62' ' ' TYR . 29.2 tp -67.41 -46.15 74.05 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.162 1.385 . . . . 55.04 111.726 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.5 t -62.4 -34.34 63.98 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 125.259 1.424 . . . . 72.34 111.343 175.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.8 t -90.01 -5.09 57.01 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.007 0.923 . . . . 71.34 111.871 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -82.15 119.73 75.66 Favored Pre-proline 0 N--CA 1.48 1.07 0 C-N-CA 123.361 0.664 . . . . 64.43 111.004 -174.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.42 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 68.2 Cg_endo -71.28 -20.52 27.89 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.428 2.085 . . . . 74.52 113.075 176.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -66.44 -40.82 89.69 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.61 0.364 . . . . 53.45 110.198 176.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.8 p -99.64 4.36 45.63 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.321 0.648 . . . . 64.22 111.276 -175.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.42 ' HB2' ' HA ' ' A' ' 31' ' ' PRO . 24.1 t70 -53.49 -29.0 33.89 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 125.365 1.466 . . . . 54.55 112.791 -178.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.32 -37.01 85.6 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.74 0.816 . . . . 42.31 112.542 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.7 mt -114.6 -11.58 12.36 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 112.512 0.56 . . . . 72.15 112.512 -176.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.429 HD13 ' HG ' ' A' ' 27' ' ' LEU . 14.8 tt -160.96 130.12 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-O 121.108 0.48 . . . . 73.34 110.207 175.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.3 p -153.68 164.19 38.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.483 -0.78 . . . . 72.51 109.908 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 30.6 p-90 -66.12 148.07 52.38 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 123.942 0.776 . . . . 71.14 110.579 172.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.8 m -75.13 153.46 86.42 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 123.354 0.662 . . . . 65.11 110.835 171.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -60.83 -27.54 84.96 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.278 1.985 . . . . 40.22 111.375 170.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.6 m -59.25 -32.07 69.66 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.852 1.261 . . . . 64.34 111.956 172.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.42 -14.58 11.68 Favored Glycine 0 C--N 1.348 1.196 0 N-CA-C 115.122 0.809 . . . . 43.44 115.122 177.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 2.5 p-10 -103.51 20.66 17.48 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.142 0.977 . . . . 72.32 110.64 -176.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.2 p -166.3 173.37 10.13 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.779 0.831 . . . . 64.35 109.833 -172.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 49.1 p90 -147.16 144.03 28.67 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.754 0.422 . . . . 62.42 110.607 176.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -100.52 148.46 24.76 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.812 0.845 . . . . 72.2 109.882 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.643 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 96.7 t -129.81 141.12 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.702 1.201 . . . . 75.11 107.959 176.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -124.03 147.5 47.78 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.697 0.799 . . . . 73.41 109.21 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 48.14 69.73 0.51 Allowed 'General case' 0 C--N 1.353 0.724 0 O-C-N 124.936 1.397 . . . . 63.42 111.293 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.445 ' HB3' ' HG2' ' A' ' 68' ' ' MET . 48.3 mt-30 -51.26 -30.93 19.28 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.637 1.175 . . . . 73.53 113.12 -174.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.86 -45.81 49.41 Favored Glycine 0 CA--C 1.534 1.233 0 O-C-N 123.382 0.426 . . . . 60.44 112.658 176.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -70.19 -42.26 72.64 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.591 0.757 . . . . 71.44 110.249 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -54.67 -48.35 72.48 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.5 1.52 . . . . 73.31 110.756 172.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.545 ' HB2' ' HB2' ' A' ' 68' ' ' MET . . . -64.8 -33.87 77.02 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 116.08 -0.509 . . . . 53.22 111.814 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -67.22 -47.4 70.95 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.497 1.119 . . . . 61.52 112.741 -178.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.449 ' HG3' HG23 ' A' ' 58' ' ' VAL . 9.7 pt-20 -112.32 -36.92 5.15 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 114.533 1.308 . . . . 72.11 114.533 -173.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.449 HG23 ' HG3' ' A' ' 57' ' ' GLU . 71.2 t -81.91 -42.91 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.467 0.707 . . . . 65.45 111.552 -169.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 47.9 mt -66.66 -44.52 54.51 Favored Pre-proline 0 CA--C 1.555 1.171 0 CA-C-O 117.928 -1.034 . . . . 75.4 112.718 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -65.49 -15.3 49.03 Favored 'Trans proline' 0 C--N 1.383 2.343 0 CA-C-N 121.813 1.683 . . . . 64.1 113.647 171.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -74.16 -59.7 2.61 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.482 0.313 . . . . 61.21 110.843 176.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.453 ' CD1' HD13 ' A' ' 27' ' ' LEU . 47.7 m-85 -91.19 -14.91 30.19 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 113.107 0.78 . . . . 74.44 113.107 -175.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -133.11 -174.36 3.46 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 108.878 -0.786 . . . . 72.12 108.878 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -119.67 46.56 1.9 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.207 0.603 . . . . 74.12 109.533 -176.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 55.8 p-80 -158.74 161.68 37.05 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.724 0.809 . . . . 75.34 109.603 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.488 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 8.1 m-80 -118.1 2.25 12.02 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.613 0.765 . . . . 75.35 110.161 176.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -83.16 115.23 21.83 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.225 0.61 . . . . 72.1 110.669 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.545 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 12.1 tpt -66.81 -40.02 87.91 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.686 0.794 . . . . 62.04 110.556 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.63 -34.83 74.85 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.45 0.7 . . . . 72.35 112.03 -177.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.2 t -66.26 -42.85 87.94 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.81 0.844 . . . . 64.42 111.499 176.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -60.33 -49.6 76.96 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.4 1.08 . . . . 73.51 110.364 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 69.1 t -64.21 -36.56 77.4 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 124.225 1.01 . . . . 70.21 110.845 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -60.07 -41.54 92.62 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.609 0.763 . . . . 73.34 111.073 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -63.25 -45.7 90.34 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.929 -0.578 . . . . 70.03 110.767 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 80' ' ' PHE . 94.1 mt -62.82 -38.31 90.25 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.814 0.846 . . . . 70.24 111.708 -177.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -62.75 -32.69 73.88 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.806 0.442 . . . . 73.43 111.954 173.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 47.0 mtm -69.26 -35.15 75.8 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 110.436 -0.209 . . . . 73.42 110.436 173.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -75.85 -18.59 59.38 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.252 0.621 . . . . 74.24 111.593 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.82 26.67 23.92 Favored Glycine 0 C--N 1.345 1.077 0 CA-C-O 119.709 -0.495 . . . . 61.13 113.997 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.44 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . 64.5 m-85 -78.72 133.01 37.18 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.856 -0.794 . . . . 74.21 108.856 171.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -102.12 127.61 48.96 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.267 0.627 . . . . 55.31 109.318 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.693 ' HE2' ' HB ' ' A' ' 84' ' ' VAL . 1.3 tmtp? -76.18 124.81 28.04 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.057 -1.09 . . . . 74.42 108.057 176.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.0 t -128.63 115.5 37.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 106.644 -1.613 . . . . 73.2 106.644 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.693 ' HB ' ' HE2' ' A' ' 82' ' ' LYS . 9.2 p -102.86 114.79 43.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 CA-C-O 121.487 0.661 . . . . 71.2 109.502 -174.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 . . . . . 0 N--CA 1.482 1.162 0 CA-C-N 115.868 -0.605 . . . . 75.25 110.858 -179.987 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 . . . . . 0 N--CA 1.483 1.198 0 N-CA-C 110.232 -0.284 . . . . 71.43 110.232 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -104.52 124.31 49.05 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.973 -0.751 . . . . 73.2 108.973 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.47 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 15.9 t70 -88.88 107.58 19.07 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.639 -1.245 . . . . 73.13 107.639 173.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.643 ' HB ' ' HB ' ' A' ' 48' ' ' VAL . 11.6 m -102.99 98.02 8.04 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 123.527 0.731 . . . . 75.41 110.017 -177.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 46' ' ' PHE . 38.6 tt0 -100.37 113.64 26.54 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.781 -0.822 . . . . 70.52 108.781 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.44 ' HB3' ' HB3' ' A' ' 80' ' ' PHE . 73.4 m-85 -96.33 120.32 36.41 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.549 -0.908 . . . . 62.2 108.549 173.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -110.13 146.71 35.0 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.8 0.84 . . . . 72.0 110.548 -174.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 23.9 t-80 -163.35 130.06 2.42 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 123.659 0.783 . . . . 74.42 108.901 172.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -64.89 -23.43 62.04 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.844 2.363 . . . . 55.3 112.957 -176.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 56.9 m -95.12 3.87 54.28 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.269 0.628 . . . . 61.33 111.328 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.439 ' O ' ' HA ' ' A' ' 44' ' ' ASN . 62.8 t80 -103.46 100.45 10.31 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 106.862 -1.533 . . . . 74.43 106.862 173.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.602 ' HB2' ' HB2' ' A' ' 110' ' ' GLN . 70.2 mt -113.48 134.66 54.55 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 109.354 -0.61 . . . . 71.14 109.354 173.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.0 ppt_? -62.96 -17.77 62.41 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.424 1.09 . . . . 72.33 112.636 -176.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -101.16 -42.6 2.37 Favored Glycine 0 C--N 1.346 1.096 0 N-CA-C 111.768 -0.533 . . . . 73.2 111.768 173.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.602 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 1.8 mp0 -91.36 84.06 5.54 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.451 0.7 . . . . 73.53 111.2 -172.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.9 -18.89 62.0 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.331 1.052 . . . . 63.35 112.827 177.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLN . . . . . 0.488 ' O ' ' HG2' ' A' ' 115' ' ' GLU . 4.8 pm0 -73.71 -14.52 61.16 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 111.637 0.236 . . . . 74.31 111.637 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 70.8 mt -84.16 -7.54 59.33 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.656 0.382 . . . . 74.24 111.792 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 51.0 mt -71.05 -21.62 62.23 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.055 0.542 . . . . 65.44 112.008 178.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 112' ' ' GLN . 16.9 pt-20 -80.18 -5.74 56.59 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 111.878 0.325 . . . . 75.24 111.878 174.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -90.9 -16.75 27.62 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.777 -0.823 . . . . 72.03 108.777 169.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.6 mt -90.87 73.46 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.886 0 N-CA-C 107.704 -1.221 . . . . 72.32 107.704 175.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.18 161.29 31.09 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.56 0.695 . . . . 73.11 110.945 169.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 . . . . . 0 C--O 1.239 0.514 0 N-CA-C 108.273 -1.01 . . . . 72.44 108.273 173.828 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 47.1 t . . . . . 0 CA--C 1.546 0.8 0 CA-C-O 119.237 -0.411 . . . . 61.22 110.09 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.404 ' HD2' HD12 ' A' ' 21' ' ' LEU . 49.9 Cg_exo -56.72 141.49 91.86 Favored 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.775 2.317 . . . . 71.45 111.148 173.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.92 -36.63 65.44 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.072 0.949 . . . . 55.21 113.022 -173.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -51.85 -43.94 63.42 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.035 0.534 . . . . 75.51 112.084 173.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.404 HD12 ' HD2' ' A' ' 18' ' ' PRO . 98.2 mt -84.29 -29.81 26.11 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.409 0.684 . . . . 71.3 110.4 -173.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.6 m -61.17 -39.64 90.9 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.273 1.029 . . . . 51.23 110.607 173.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.558 ' HE2' ' HA ' ' A' ' 23' ' ' LYS . 10.7 mmpt? -79.97 -47.79 14.41 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.715 -0.675 . . . . 64.14 110.473 177.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.5 ' O ' HG23 ' A' ' 28' ' ' VAL . 55.3 tp -56.47 -50.28 72.19 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.107 0.963 . . . . 73.53 112.502 -176.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.467 ' HZ2' ' H ' ' A' ' 109' ' ' GLY . 84.7 t90 -58.35 -47.78 82.69 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.791 0.436 . . . . 75.2 111.014 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.8 m -68.8 -22.6 64.25 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 115.684 -0.689 . . . . 71.43 111.42 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.489 HD11 HG13 ' A' ' 58' ' ' VAL . 31.0 tp -74.4 -44.31 52.56 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.393 1.077 . . . . 74.55 110.723 175.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 24' ' ' LEU . 60.0 t -61.92 -32.68 54.94 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 CA-C-O 121.685 0.755 . . . . 65.22 110.258 173.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.4 t -88.72 0.18 56.71 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 114.636 -1.165 . . . . 73.22 112.023 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -81.61 122.72 80.85 Favored Pre-proline 0 N--CA 1.479 1.02 0 O-C-N 121.919 -0.488 . . . . 71.53 111.448 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -73.62 -6.21 18.35 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 123.159 2.573 . . . . 64.41 113.822 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -86.35 -37.65 18.24 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.85 0.46 . . . . 72.51 110.987 174.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 41.6 p -104.34 8.61 35.94 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.772 0.429 . . . . 70.41 110.824 -175.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -59.51 -32.39 70.25 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.459 1.104 . . . . 61.45 111.896 -175.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.34 -32.35 73.24 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.637 0.775 . . . . 73.1 111.958 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 64.4 mt -102.82 -12.14 17.8 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.457 0.303 . . . . 73.43 111.219 -177.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.5 tt -159.89 122.83 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 123.053 0.541 . . . . 60.2 110.454 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 28.2 p -142.1 149.55 40.01 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.601 0.36 . . . . 63.43 110.567 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 22.7 p-90 -72.6 154.23 40.87 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.611 0.765 . . . . 73.52 111.148 177.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.6 m -81.41 141.0 48.71 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 109.121 -0.696 . . . . 61.05 109.121 169.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -50.36 -22.91 9.34 Favored 'Trans proline' 0 C--N 1.368 1.602 0 C-N-CA 123.373 2.715 . . . . 73.02 115.05 176.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 64.0 m -70.65 -30.27 66.85 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.999 0.52 . . . . 71.15 111.618 175.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.99 65.87 2.18 Favored Glycine 0 C--N 1.342 0.88 0 CA-C-N 116.308 -0.406 . . . . 50.15 112.474 177.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.413 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 26.8 p30 -168.52 -17.06 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.981 0.913 . . . . 54.24 111.725 -171.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.2 p -141.51 162.27 35.89 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 123.927 0.891 . . . . 71.43 108.701 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -140.19 146.38 38.65 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.572 0.225 . . . . 75.31 110.535 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -103.32 141.32 36.13 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.234 1.014 . . . . 63.14 109.536 -176.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.1 t -123.54 132.99 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.693 0.797 . . . . 75.44 108.983 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -122.75 151.96 41.09 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.549 1.14 . . . . 73.21 110.5 -174.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 53.62 60.82 3.43 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 124.584 1.178 . . . . 64.42 110.77 174.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -46.0 -37.31 6.44 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.006 1.322 . . . . 54.13 114.2 -170.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.51 -44.92 49.08 Favored Glycine 0 C--N 1.342 0.868 0 O-C-N 123.559 0.537 . . . . 44.23 112.844 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -72.83 -42.91 63.31 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.112 0.565 . . . . 73.43 110.111 -177.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -55.32 -52.62 62.89 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.188 1.395 . . . . 64.24 110.899 175.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.36 -31.82 71.71 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 116.298 -0.41 . . . . 52.24 111.676 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -70.49 -50.92 32.91 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.252 1.021 . . . . 74.02 112.421 -177.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.541 ' HG3' HG23 ' A' ' 58' ' ' VAL . 9.7 pt-20 -104.43 -39.24 6.5 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 112.855 0.687 . . . . 72.11 112.855 -173.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.541 HG23 ' HG3' ' A' ' 57' ' ' GLU . 96.5 t -80.94 -41.78 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.362 0.665 . . . . 62.11 112.016 -167.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 53.2 mt -64.15 -48.95 75.93 Favored Pre-proline 0 CA--C 1.565 1.528 0 CA-C-O 118.209 -0.9 . . . . 52.22 112.324 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.3 -8.49 23.52 Favored 'Trans proline' 0 C--N 1.387 2.598 0 CA-C-N 121.981 1.743 . . . . 74.25 113.281 175.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -73.63 -61.77 1.72 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.297 1.039 . . . . 72.32 110.391 174.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.541 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 25.5 m-85 -89.03 -38.59 14.29 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 112.005 0.372 . . . . 74.14 112.005 -177.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -102.81 -164.61 1.1 Allowed 'General case' 0 C--O 1.243 0.729 0 N-CA-C 107.566 -1.272 . . . . 75.33 107.566 176.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 64' ' ' LYS . 31.5 mmtm -135.54 68.05 1.47 Allowed 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 121.856 0.836 . . . . 54.15 109.903 175.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -169.77 160.62 8.77 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 113.781 -1.554 . . . . 72.13 107.786 173.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -118.01 -5.79 10.97 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.74 0.416 . . . . 72.31 110.503 175.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -71.84 117.54 13.56 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 123.82 0.848 . . . . 73.32 110.47 176.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 11.7 ttm -70.89 -30.57 66.97 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.656 0.383 . . . . 71.25 111.034 176.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.67 -36.39 71.84 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.607 0.363 . . . . 64.13 111.241 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.429 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 40.2 t -63.94 -46.91 82.62 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.982 0.913 . . . . 73.04 111.633 172.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -63.18 -52.91 60.46 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.612 0.765 . . . . 75.44 111.052 -176.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.41 ' HA ' HD12 ' A' ' 75' ' ' LEU . 84.4 t -59.14 -40.66 81.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 124.088 0.955 . . . . 64.34 111.254 177.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.3 ttt-85 -56.82 -43.9 81.46 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.147 0.579 . . . . 73.35 111.559 177.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 70' ' ' SER . 16.7 mm100 -58.9 -49.83 76.32 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 124.024 0.828 . . . . 73.41 109.937 177.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.433 ' HB3' ' HB2' ' A' ' 80' ' ' PHE . 65.2 mt -58.35 -44.27 88.7 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.305 1.042 . . . . 73.2 112.086 -177.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -56.9 -39.55 74.63 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.504 0.722 . . . . 73.5 111.924 175.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 73.9 mtm -72.94 -35.03 66.9 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.051 0.54 . . . . 73.31 111.06 176.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.425 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 55.3 m-85 -85.26 2.92 41.84 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.093 0.557 . . . . 72.41 111.22 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.42 15.91 79.03 Favored Glycine 0 C--N 1.342 0.916 0 N-CA-C 114.652 0.621 . . . . 63.42 114.652 170.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.433 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 73.3 m-85 -73.74 129.42 37.9 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.273 0.559 . . . . 73.24 110.096 176.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -99.52 121.78 41.66 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.013 -0.994 . . . . 71.01 109.021 -175.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.424 ' HE3' HG23 ' A' ' 99' ' ' THR . 1.6 tmtp? -81.45 126.75 32.03 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.588 1.155 . . . . 53.41 109.723 -175.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 85.8 t -128.97 119.72 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 108.17 -1.048 . . . . 72.11 108.17 175.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.421 ' HB ' ' HE2' ' A' ' 82' ' ' LYS . 7.5 p -99.68 126.0 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 108.415 -0.957 . . . . 71.1 108.415 -178.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 . . . . . 0 N--CA 1.479 1.006 0 C-N-CA 122.573 0.349 . . . . 73.03 110.62 -177.513 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 . . . . . 0 CA--C 1.551 0.981 0 N-CA-C 108.906 -0.776 . . . . 63.11 108.906 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -45.18 107.98 0.11 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.636 1.174 . . . . 62.43 112.958 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -91.37 122.2 33.77 Favored 'General case' 0 C--O 1.249 1.045 0 CA-C-N 114.867 -1.06 . . . . 41.31 108.191 177.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.424 HG23 ' HE3' ' A' ' 82' ' ' LYS . 57.8 m -129.27 117.23 20.36 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.894 -0.78 . . . . 75.42 108.894 -178.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -104.73 112.17 25.17 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.322 -0.992 . . . . 75.43 108.322 -175.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -96.93 123.88 40.76 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.824 -1.176 . . . . 71.2 107.824 175.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -122.65 145.75 48.08 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 122.985 0.514 . . . . 70.23 110.697 -173.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 66.2 t60 -156.53 132.31 5.74 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 108.66 -0.867 . . . . 73.41 108.66 176.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.74 -29.95 77.73 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.669 2.246 . . . . 73.33 113.195 -174.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 59.1 m -89.4 -2.78 58.53 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.641 0.376 . . . . 73.32 111.421 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 44' ' ' ASN . 64.8 t80 -102.19 99.45 9.57 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 106.881 -1.525 . . . . 75.3 106.881 175.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.421 HD12 ' HG2' ' A' ' 110' ' ' GLN . 76.6 mt -120.79 164.7 16.2 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.95 0.405 . . . . 73.25 110.673 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -81.58 122.74 27.97 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.593 -0.73 . . . . 73.31 109.489 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.467 ' H ' ' HZ2' ' A' ' 25' ' ' TRP . . . 63.56 57.65 14.0 Favored Glycine 0 C--N 1.344 0.985 0 O-C-N 124.15 0.906 . . . . 64.13 111.974 -176.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.421 ' HG2' HD12 ' A' ' 107' ' ' LEU . 5.9 tp60 -156.18 63.64 0.56 Allowed 'General case' 0 CA--C 1.548 0.897 0 CA-C-O 121.919 0.866 . . . . 74.51 109.535 -172.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -52.35 -46.24 66.02 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 113.746 -1.57 . . . . 65.1 111.446 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 14.1 pm0 -65.74 -19.55 65.94 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.579 -1.191 . . . . 72.34 112.839 -174.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 27.9 mt -96.41 -20.11 18.69 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 119.181 0.901 . . . . 74.33 111.712 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 80.9 mt -63.95 -32.6 74.19 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-O 121.156 0.503 . . . . 63.41 110.376 175.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -79.35 -5.42 54.52 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 115.547 -0.751 . . . . 64.52 112.594 175.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -90.25 2.78 55.09 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 110.096 -0.335 . . . . 74.11 110.096 172.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 45.1 mt -96.98 128.01 48.61 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 N-CA-C 109.009 -0.737 . . . . 71.33 109.009 174.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.456 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -112.1 150.73 30.33 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.425 0.69 . . . . 65.45 110.031 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 . . . . . 0 N--CA 1.484 1.235 0 C-N-CA 124.151 0.98 . . . . 73.35 110.374 170.736 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.9 t . . . . . 0 CA--C 1.541 0.604 0 N-CA-C 108.982 -0.747 . . . . 74.42 108.982 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 21' ' ' LEU . 21.4 Cg_exo -65.69 145.24 80.89 Favored 'Trans proline' 0 C--N 1.365 1.439 0 C-N-CA 122.417 2.078 . . . . 75.03 110.341 170.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.41 -39.82 23.82 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.149 1.38 . . . . 64.41 112.499 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -54.1 -45.43 71.84 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.96 0.904 . . . . 73.14 112.833 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 18' ' ' PRO . 98.4 mt -83.36 -29.23 28.4 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.056 0.543 . . . . 74.24 109.948 -171.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.7 m -59.72 -50.59 73.23 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 124.548 1.155 . . . . 61.24 111.023 170.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.486 ' HE2' ' HA ' ' A' ' 23' ' ' LYS . 11.2 mmpt? -68.49 -43.25 77.28 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.876 -0.602 . . . . 61.12 110.045 178.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.468 ' O ' HG23 ' A' ' 28' ' ' VAL . 55.5 tp -55.26 -54.03 48.56 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 124.601 1.161 . . . . 70.32 112.214 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 14.1 t-105 -64.07 -46.08 85.92 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 122.629 0.372 . . . . 72.3 111.722 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.6 m -60.61 -25.01 65.93 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.306 0.574 . . . . 74.13 110.775 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.48 HD11 ' CG1' ' A' ' 58' ' ' VAL . 29.9 tp -80.47 -45.57 17.33 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 124.87 1.268 . . . . 62.04 111.94 177.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 24' ' ' LEU . 76.6 t -56.61 -39.97 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 C-N-CA 124.089 0.956 . . . . 42.32 111.513 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.5 t -89.36 -5.54 57.4 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 114.453 -1.249 . . . . 74.0 112.132 -175.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -74.35 122.28 87.17 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 122.68 0.392 . . . . 74.22 111.307 -175.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.4 -23.11 44.53 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 122.851 2.367 . . . . 73.11 112.944 176.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -73.8 -34.41 64.61 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.185 0.594 . . . . 73.01 111.514 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 53.5 p -110.99 11.82 22.14 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.043 0.537 . . . . 75.02 110.533 -177.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -54.95 -38.23 67.46 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.924 1.289 . . . . 72.13 111.788 -177.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.82 -29.47 69.95 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.692 -0.686 . . . . 63.4 112.178 -177.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.533 ' HA ' ' HB2' ' A' ' 49' ' ' PHE . 68.9 mt -106.41 -9.88 16.54 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.628 0.371 . . . . 72.55 111.657 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.474 HD13 ' HG ' ' A' ' 27' ' ' LEU . 16.7 tt -161.45 125.86 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.327 0.651 . . . . 74.53 110.501 172.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 22.1 p -149.02 157.41 43.39 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.934 0.397 . . . . 74.01 110.566 177.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 14.7 p-90 -71.38 152.85 42.78 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.731 1.212 . . . . 74.44 110.409 177.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.2 p -74.28 153.39 88.19 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 123.271 0.628 . . . . 75.13 110.346 172.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.8 -26.34 60.11 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.7 2.267 . . . . 65.04 111.925 176.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 66.9 p -75.05 -26.96 59.81 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.303 1.041 . . . . 72.03 110.15 172.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.97 3.3 84.34 Favored Glycine 0 C--N 1.356 1.692 0 CA-C-N 115.658 -0.701 . . . . 64.42 113.468 176.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -86.19 -5.91 59.1 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.689 0.796 . . . . 65.14 112.022 -173.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 65.1 p -159.3 179.09 9.29 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.793 0.837 . . . . 64.53 110.046 -174.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -140.18 148.21 41.26 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.781 -0.451 . . . . 64.21 109.781 172.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -110.84 143.49 41.34 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.009 0.924 . . . . 74.44 109.018 -177.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 67.3 t -123.48 120.96 61.48 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 C-N-CA 124.385 1.074 . . . . 62.32 108.631 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.533 ' HB2' ' HA ' ' A' ' 36' ' ' LEU . 90.1 m-85 -100.58 146.38 27.2 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 124.058 0.943 . . . . 72.43 109.87 -178.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.428 ' H ' ' HB2' ' A' ' 96' ' ' ARG . 6.9 m-20 49.95 67.94 0.83 Allowed 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.799 1.312 . . . . 73.55 111.674 176.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.474 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 14.7 mm-40 -49.52 -34.86 18.42 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.002 0.921 . . . . 71.13 113.377 -175.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.09 -49.83 44.34 Favored Glycine 0 CA--C 1.536 1.365 0 CA-C-O 119.818 -0.434 . . . . 74.12 112.441 175.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -69.5 -45.64 68.44 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.299 0.639 . . . . 75.4 110.542 -176.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.479 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 65.1 t80 -52.24 -51.59 57.47 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.553 1.541 . . . . 72.25 111.05 173.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.507 ' HA ' ' HG ' ' A' ' 59' ' ' LEU . . . -61.36 -36.56 80.53 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.916 0.389 . . . . 74.44 111.537 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.87 -52.89 31.35 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.513 1.125 . . . . 72.34 113.154 -174.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.518 ' HG3' HG23 ' A' ' 58' ' ' VAL . 6.7 pt-20 -106.62 -33.85 7.52 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 113.602 0.964 . . . . 73.2 113.602 -173.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.518 HG23 ' HG3' ' A' ' 57' ' ' GLU . 90.4 t -83.03 -40.29 16.21 Favored 'Isoleucine or valine' 0 C--O 1.251 1.169 0 C-N-CA 123.404 0.681 . . . . 55.24 111.488 -169.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.507 ' HG ' ' HA ' ' A' ' 55' ' ' ALA . 54.0 mt -64.0 -50.46 69.36 Favored Pre-proline 0 CA--C 1.556 1.202 0 CA-C-O 118.242 -0.885 . . . . 75.25 111.81 177.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -67.42 -13.34 38.91 Favored 'Trans proline' 0 C--N 1.381 2.288 0 CA-C-N 121.975 1.741 . . . . 74.54 113.001 176.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -70.68 -54.69 10.9 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.01 0.524 . . . . 72.24 110.536 172.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.414 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 31.5 m-85 -89.87 -52.68 4.86 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.137 0.494 . . . . 74.02 111.984 -178.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -87.71 -171.79 3.59 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.274 -0.875 . . . . 53.44 108.828 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -123.05 45.15 2.48 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.668 0.746 . . . . 74.32 109.749 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -161.16 165.5 29.39 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.636 1.174 . . . . 64.43 108.377 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -122.3 -8.15 8.69 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.52 0.328 . . . . 73.1 110.579 174.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -61.1 115.88 4.11 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.152 0.981 . . . . 74.41 110.605 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.474 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 3.2 tpt -61.71 -49.87 74.73 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.203 1.401 . . . . 71.23 111.725 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.17 -35.31 71.39 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.866 0.867 . . . . 72.3 111.843 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.431 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 34.7 t -64.99 -42.98 94.02 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.731 0.813 . . . . 64.42 111.489 177.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -64.58 -50.25 67.96 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.827 0.851 . . . . 53.23 110.65 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.497 ' HA ' HD12 ' A' ' 75' ' ' LEU . 59.1 t -62.9 -38.45 81.94 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-N 115.417 -0.81 . . . . 64.21 111.128 178.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.411 ' O ' ' HG3' ' A' ' 77' ' ' MET . 39.4 ttm180 -58.67 -43.33 89.86 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.023 0.529 . . . . 71.41 110.858 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.491 ' HA ' ' HE2' ' A' ' 77' ' ' MET . 34.3 mm-40 -59.34 -50.01 75.6 Favored 'General case' 0 C--N 1.358 0.963 0 O-C-N 124.034 0.834 . . . . 75.02 109.872 177.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.501 ' HB3' ' HB2' ' A' ' 80' ' ' PHE . 30.6 mt -56.47 -48.32 77.35 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.109 0.964 . . . . 75.31 111.921 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -62.58 -30.09 71.07 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 122.754 0.422 . . . . 71.22 112.049 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.491 ' HE2' ' HA ' ' A' ' 74' ' ' GLN . 47.9 mtm -69.47 -40.42 77.11 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 109.931 -0.396 . . . . 75.5 109.931 173.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -81.74 -2.65 51.4 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.997 0.519 . . . . 70.52 111.214 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.66 20.28 44.77 Favored Glycine 0 C--N 1.349 1.279 0 N-CA-C 114.882 0.713 . . . . 71.24 114.882 172.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.501 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 83.9 m-85 -82.3 134.85 35.28 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.069 0.935 . . . . 74.22 109.506 177.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 38.3 ttm180 -101.44 126.74 48.27 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.086 0.554 . . . . 71.03 109.802 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.517 ' HE3' HG22 ' A' ' 84' ' ' VAL . 2.7 tmtm? -68.95 114.93 7.7 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 106.879 -1.526 . . . . 64.12 106.879 171.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.522 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 89.3 t -114.2 125.41 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 107.884 -1.154 . . . . 73.11 107.884 176.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.517 HG22 ' HE3' ' A' ' 82' ' ' LYS . 40.8 t -88.94 131.56 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.638 0.775 . . . . 73.42 109.315 -177.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 . . . . . 0 N--CA 1.484 1.233 0 N-CA-C 108.214 -1.032 . . . . 71.32 108.214 169.671 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.428 ' HB2' ' H ' ' A' ' 50' ' ' ASP . 17.7 ptt180 . . . . . 0 N--CA 1.47 0.554 0 CA-C-O 121.406 0.622 . . . . 51.32 110.976 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -91.27 148.4 22.37 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.463 -0.939 . . . . 61.43 108.463 156.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -113.4 106.1 14.18 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 105.355 -2.091 . . . . 72.31 105.355 156.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 32.3 m -115.05 107.36 15.25 Favored 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 123.823 0.702 . . . . 75.0 109.793 -170.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.522 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 41.7 tt0 -96.99 111.17 23.51 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.376 -1.342 . . . . 73.55 107.376 -177.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.419 ' HB3' ' HB3' ' A' ' 80' ' ' PHE . 71.4 m-85 -96.0 119.93 35.37 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.066 -1.087 . . . . 71.14 108.066 175.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -117.3 139.16 51.18 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.863 0.865 . . . . 75.22 109.287 -174.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 106' ' ' PHE . 77.3 t60 -152.66 135.08 9.0 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 123.466 0.706 . . . . 75.33 109.423 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -59.64 -42.85 43.33 Favored 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 122.863 2.376 . . . . 74.23 112.476 -174.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 37.0 m -92.19 16.66 10.96 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.996 0.518 . . . . 60.33 111.084 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.491 ' HB3' ' HB3' ' A' ' 103' ' ' HIS . 35.9 t80 -124.33 104.18 8.64 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.167 -1.049 . . . . 74.53 108.167 171.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.493 HD12 ' HG3' ' A' ' 110' ' ' GLN . 38.3 mt -120.46 173.65 7.03 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 107.128 -1.434 . . . . 60.2 107.128 167.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -63.28 -68.91 0.3 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.39 0.676 . . . . 73.02 110.942 -172.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -87.71 37.55 3.23 Favored Glycine 0 C--N 1.351 1.365 0 C-N-CA 122.77 0.224 . . . . 72.23 112.98 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.493 ' HG3' HD12 ' A' ' 107' ' ' LEU . 15.8 mm100 -126.43 53.08 1.67 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.92 0.888 . . . . 75.11 108.944 -177.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.418 ' HA ' ' HG ' ' A' ' 114' ' ' LEU . 10.6 pt-20 -60.14 -30.65 69.44 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 114.942 -1.026 . . . . 73.14 111.815 175.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.4 pm0 -63.39 -22.55 66.95 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.363 0.665 . . . . 54.52 111.838 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.443 ' O ' HG13 ' A' ' 117' ' ' ILE . 80.7 mt -90.82 -9.19 47.35 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.253 0.621 . . . . 72.2 112.152 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.418 ' HG ' ' HA ' ' A' ' 111' ' ' GLU . 91.5 mt -61.06 -38.57 86.65 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.202 0.525 . . . . 74.22 110.818 175.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -79.94 -11.11 59.82 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.365 -0.834 . . . . 52.25 112.051 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -87.55 -10.68 50.95 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.54 0.736 . . . . 71.23 109.682 173.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 113' ' ' LEU . 58.9 mt -86.23 135.18 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 108.845 -0.798 . . . . 55.12 108.845 175.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -122.92 150.33 43.08 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.728 0.811 . . . . 74.1 109.748 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 . . . . . 0 CA--C 1.543 0.696 0 N-CA-C 108.483 -0.932 . . . . 73.12 108.483 172.587 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.3 t . . . . . 0 CA--C 1.552 1.045 0 CA-C-O 118.884 -0.579 . . . . 73.41 109.805 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.89 163.2 39.99 Favored 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 122.65 2.233 . . . . 61.42 112.19 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.64 -49.12 57.65 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.08 0.952 . . . . 51.41 112.636 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -52.33 -47.51 66.0 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.444 0.698 . . . . 71.11 112.612 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 89.2 mt -79.64 -35.32 39.55 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.374 0.27 . . . . 41.03 110.955 -172.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.5 t -71.95 -18.76 61.98 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 111.72 0.267 . . . . 72.52 111.72 177.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.6 mmpt? -83.74 -40.99 18.14 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.767 -0.457 . . . . 73.13 109.767 168.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.8 tp -61.0 -50.61 72.66 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.003 0.921 . . . . 74.54 113.352 -176.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.469 ' HB3' HD11 ' A' ' 114' ' ' LEU . 5.1 p-90 -62.37 -37.43 85.69 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 118.628 0.649 . . . . 73.33 110.842 -177.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 41.3 m -63.83 -43.44 96.17 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 124.268 1.027 . . . . 55.32 110.898 175.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.409 HD11 ' CG1' ' A' ' 58' ' ' VAL . 27.4 tp -61.6 -49.56 76.1 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.624 1.57 . . . . 74.52 111.711 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.7 t -59.81 -33.62 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 C-N-CA 124.634 1.174 . . . . 74.11 111.536 176.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.9 t -94.85 -6.95 41.62 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.423 0.689 . . . . 55.33 112.09 -175.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -83.01 132.43 50.84 Favored Pre-proline 0 N--CA 1.486 1.355 0 CA-C-N 118.079 0.4 . . . . 61.43 111.837 -173.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -70.13 -23.82 28.67 Favored 'Trans proline' 0 C--N 1.388 2.652 0 C-N-CA 123.154 2.569 . . . . 72.31 114.209 -176.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -76.4 -32.33 58.47 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.008 0.523 . . . . 71.14 111.079 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.7 p -105.88 1.35 26.69 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.122 0.569 . . . . 74.23 111.61 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -57.31 -33.23 67.48 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.099 1.36 . . . . 72.44 112.56 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.97 -35.55 81.05 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.631 0.772 . . . . 65.32 113.027 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.528 HD22 ' HB2' ' A' ' 50' ' ' ASP . 80.9 mt -106.91 -11.05 15.8 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.063 0.545 . . . . 73.35 111.464 -175.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.2 tt -160.66 127.0 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 122.659 0.384 . . . . 74.13 110.631 174.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.1 p -158.92 161.29 36.75 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.032 0.533 . . . . 63.15 110.136 177.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 25.8 p-90 -71.12 147.3 48.55 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.028 -0.987 . . . . 73.54 110.455 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.4 m -70.96 153.54 94.66 Favored Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 124.016 0.926 . . . . 74.2 109.743 175.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -45.81 -44.63 17.96 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 123.613 2.875 . . . . 74.22 114.899 -175.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.7 m -75.22 -27.22 59.46 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.31 0.644 . . . . 60.14 111.584 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.82 18.44 61.48 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 116.562 -0.29 . . . . 55.12 113.606 175.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -80.85 -17.71 49.8 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.701 0.8 . . . . 71.32 111.326 175.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.0 p -158.28 -173.91 4.55 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.783 0.433 . . . . 71.45 110.806 -170.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -141.02 151.9 44.45 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.103 0.561 . . . . 73.54 110.179 176.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 55.5 m-70 -108.86 156.29 19.83 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.826 0.851 . . . . 72.01 109.647 176.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 84.7 t -130.51 123.16 54.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 124.442 1.097 . . . . 75.32 108.151 176.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -106.93 148.17 28.94 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.805 0.842 . . . . 64.33 109.686 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.528 ' HB2' HD22 ' A' ' 36' ' ' LEU . 7.9 m-20 54.23 55.54 8.05 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 124.714 1.258 . . . . 73.24 110.826 171.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.458 ' HA ' ' HB3' ' A' ' 54' ' ' PHE . 45.8 mt-30 -57.35 -22.77 44.59 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.759 -1.11 . . . . 70.33 113.158 -169.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.11 -47.83 56.95 Favored Glycine 0 C--N 1.348 1.23 0 N-CA-C 111.816 -0.513 . . . . 73.33 111.816 172.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.407 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 56.3 tp60 -71.17 -45.39 63.55 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.836 0.855 . . . . 75.2 110.044 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.458 ' HB3' ' HA ' ' A' ' 51' ' ' GLN . 57.0 t80 -49.16 -50.8 36.03 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.591 1.556 . . . . 72.54 111.403 171.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.65 -36.89 84.29 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.357 -0.383 . . . . 60.1 111.69 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -69.06 -45.01 71.44 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.994 0.918 . . . . 73.55 112.896 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 53' ' ' GLN . 11.1 pt-20 -114.78 -33.02 5.62 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 114.43 1.27 . . . . 73.34 114.43 -172.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.447 ' HB ' ' O ' ' A' ' 54' ' ' PHE . 77.2 t -81.95 -44.46 19.98 Favored 'Isoleucine or valine' 0 C--O 1.25 1.117 0 C-N-CA 122.787 0.435 . . . . 75.02 111.29 -172.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 46.1 mt -64.07 -46.83 80.45 Favored Pre-proline 0 CA--C 1.564 1.511 0 CA-C-O 118.081 -0.961 . . . . 72.32 112.77 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.58 -15.38 47.48 Favored 'Trans proline' 0 C--N 1.388 2.653 0 CA-C-N 121.999 1.75 . . . . 71.35 113.454 174.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -75.49 -54.52 6.89 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.177 0.591 . . . . 71.52 110.646 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -90.19 -40.07 12.42 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 112.112 0.412 . . . . 72.14 112.112 -177.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -106.4 -176.28 3.03 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.758 0.823 . . . . 61.04 108.808 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -119.42 48.83 1.44 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.522 -0.918 . . . . 72.45 108.522 -176.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -164.12 159.9 20.89 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.73 1.212 . . . . 62.03 108.265 176.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -112.32 -21.08 11.59 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.395 0.678 . . . . 55.33 109.253 176.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -61.02 119.55 8.52 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.198 0.999 . . . . 50.11 111.09 -176.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 12.9 tpt -73.46 -32.93 64.62 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.649 0.78 . . . . 73.44 111.25 -176.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.88 -34.26 69.59 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.05 0.54 . . . . 72.52 111.577 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.1 t -64.85 -42.35 94.98 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.334 1.054 . . . . 74.02 111.672 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -68.47 -51.16 46.53 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.948 0.899 . . . . 74.44 110.995 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.0 t -62.12 -37.15 77.74 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 C-N-CA 123.734 0.814 . . . . 74.4 111.194 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -53.94 -50.13 67.15 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.925 0.89 . . . . 62.44 111.117 175.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -56.97 -51.5 68.94 Favored 'General case' 0 C--N 1.35 0.614 0 O-C-N 124.556 1.16 . . . . 62.34 110.547 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.1 mt -62.23 -44.36 96.73 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.912 0.885 . . . . 70.0 112.03 -176.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -59.11 -38.61 79.98 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.293 0.637 . . . . 72.41 111.437 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 50.7 mtm -69.61 -33.21 72.36 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.842 0.457 . . . . 73.51 110.676 175.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -82.1 7.2 14.05 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 122.95 0.5 . . . . 72.31 111.299 178.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.96 20.44 67.82 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-O 119.948 -0.362 . . . . 72.23 113.447 172.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.523 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . 44.8 m-85 -82.82 137.89 34.15 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.978 -0.749 . . . . 72.45 108.978 175.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -101.46 125.24 48.07 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.022 -0.732 . . . . 75.04 109.022 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.59 115.58 8.13 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 107.965 -1.124 . . . . 74.12 107.965 173.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.7 t -131.27 113.86 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.219 -1.03 . . . . 73.42 108.219 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.5 p -96.11 126.45 48.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 108.443 -0.947 . . . . 63.34 108.443 -176.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 69.1 m-70 . . . . . 0 N--CA 1.485 1.315 0 C-N-CA 122.396 0.279 . . . . 64.21 110.767 -175.998 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 . . . . . 0 CA--C 1.544 0.73 0 CA-C-O 122.506 1.146 . . . . 63.33 108.302 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -35.26 101.17 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 111.888 -2.414 . . . . 43.24 113.877 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -99.14 115.83 29.96 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.332 -1.359 . . . . 71.52 107.332 175.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 91.2 m -125.77 119.8 28.9 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.265 -0.643 . . . . 52.12 109.265 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -104.13 117.45 34.3 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.375 -1.343 . . . . 54.21 107.375 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.523 ' HB3' ' HB3' ' A' ' 80' ' ' PHE . 97.6 m-85 -97.35 119.57 36.12 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 107.514 -1.291 . . . . 73.51 107.514 173.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 80' ' ' PHE . 10.2 pt20 -109.36 148.28 31.34 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.527 0.731 . . . . 72.11 110.151 -173.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -158.93 131.43 4.38 Favored Pre-proline 0 CA--C 1.547 0.846 0 CA-C-O 118.835 -0.603 . . . . 51.32 109.643 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -62.85 -26.55 74.67 Favored 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 123.152 2.568 . . . . 75.31 113.707 -176.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.4 m -102.33 22.26 13.67 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.119 0.567 . . . . 75.14 111.109 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -119.74 108.27 14.21 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.02 -1.104 . . . . 73.44 108.02 170.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 91.4 mt -116.82 111.13 19.29 Favored 'General case' 0 C--O 1.212 -0.875 0 CA-C-O 118.32 -0.847 . . . . 72.52 108.889 170.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 40.7 -80.96 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 126.0 1.72 . . . . 73.1 115.263 165.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.23 30.03 2.66 Favored Glycine 0 C--N 1.356 1.649 0 C-N-CA 123.351 0.501 . . . . 63.13 112.887 -176.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 8.3 mp0 -89.33 87.07 6.97 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 107.79 -1.189 . . . . 75.24 107.79 176.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.35 -25.79 67.75 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.122 -0.944 . . . . 61.4 112.335 -176.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 16.5 pm0 -69.12 -21.51 64.03 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.716 0.406 . . . . 74.21 111.536 177.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 82.2 mt -89.63 -13.09 37.85 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.234 0.614 . . . . 54.12 111.2 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.469 HD11 ' HB3' ' A' ' 25' ' ' TRP . 91.9 mt -64.61 -35.61 81.56 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.943 0.497 . . . . 63.55 111.065 175.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -80.9 -1.67 44.38 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 111.719 0.266 . . . . 54.1 111.719 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -88.14 -24.75 23.27 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 108.95 -0.759 . . . . 73.54 108.95 170.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 57.9 mt -79.77 105.05 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.918 0.887 . . . . 74.3 108.868 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.556 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 10.8 mmpt? -107.39 139.53 41.74 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 120.86 0.362 . . . . 75.13 110.175 -170.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 . . . . . 0 N--CA 1.473 0.72 0 CA-C-N 115.307 -0.861 . . . . 74.33 110.821 -178.248 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.5 t . . . . . 0 C--O 1.242 0.688 0 N-CA-C 107.026 -1.472 . . . . 72.13 107.026 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.459 ' HD2' HD12 ' A' ' 21' ' ' LEU . 33.5 Cg_exo -58.15 146.32 88.75 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.479 2.12 . . . . 71.04 110.669 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.28 -34.29 45.91 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 123.711 0.632 . . . . 62.3 110.62 176.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -51.36 -52.39 46.08 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.911 0.885 . . . . 72.14 112.234 171.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.459 HD12 ' HD2' ' A' ' 18' ' ' PRO . 83.1 mt -80.86 -30.34 35.64 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.005 0.431 . . . . 71.23 110.065 -171.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.1 m -59.88 -51.66 68.75 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.856 1.262 . . . . 62.3 110.631 173.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.539 ' HB3' ' HB3' ' A' ' 62' ' ' TYR . 9.6 mmpt? -65.98 -45.38 81.88 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 115.548 -0.751 . . . . 75.33 110.144 177.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.459 ' O ' HG23 ' A' ' 28' ' ' VAL . 57.4 tp -56.29 -48.14 77.24 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.038 0.935 . . . . 74.53 111.595 -178.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 41.8 t90 -55.85 -46.3 78.25 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.05 0.94 . . . . 72.44 111.353 178.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 35.0 m -71.18 -25.48 62.56 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.469 1.108 . . . . 74.11 112.118 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.538 HD11 HG13 ' A' ' 58' ' ' VAL . 30.3 tp -78.01 -43.98 27.91 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.162 0.985 . . . . 73.53 110.793 -176.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 24' ' ' LEU . 74.3 t -57.96 -26.83 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.352 0 C-N-CA 125.042 1.337 . . . . 74.33 111.612 173.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 78.6 p -101.4 0.91 37.78 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.531 0.732 . . . . 75.23 112.631 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -81.45 120.15 77.42 Favored Pre-proline 0 N--CA 1.483 1.193 0 C-N-CA 122.946 0.498 . . . . 74.03 110.993 -172.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -71.77 -11.05 27.37 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 122.845 2.363 . . . . 71.42 113.165 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -74.16 -36.2 64.07 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 122.591 0.356 . . . . 75.14 110.225 173.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 70.5 p -117.79 13.18 14.07 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.6 0.76 . . . . 72.23 111.631 -173.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -62.19 -30.22 70.92 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.175 0.59 . . . . 60.12 112.123 -171.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.67 -20.19 58.62 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.847 0.684 . . . . 73.23 112.847 178.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 59.4 mt -105.67 -16.77 14.6 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.007 0.523 . . . . 75.41 110.718 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.513 HD13 ' HG ' ' A' ' 27' ' ' LEU . 17.5 tt -160.28 121.7 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.21 0.604 . . . . 73.44 110.715 175.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 48.6 t -154.93 154.93 33.38 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.287 0.635 . . . . 75.21 109.67 177.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 29.2 p-90 -74.45 152.82 39.39 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.643 0.777 . . . . 71.35 111.007 -174.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.3 m -79.31 142.11 58.29 Favored Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 108.487 -0.931 . . . . 64.13 108.487 172.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.99 -26.52 49.9 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 123.212 2.608 . . . . 71.02 114.152 -176.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.6 m -74.71 -27.45 60.39 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.914 0.486 . . . . 54.41 111.42 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 107' ' ' LEU . . . 94.48 -5.55 70.62 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-O 119.391 -0.671 . . . . 73.51 114.018 175.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.468 ' HA ' HD23 ' A' ' 107' ' ' LEU . 2.8 m-20 -78.94 -16.21 57.27 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.816 0.846 . . . . 61.43 111.955 -170.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 43.5 p -156.57 179.97 8.75 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.347 0.594 . . . . 71.04 110.965 -173.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -138.81 151.98 47.49 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.044 -0.98 . . . . 53.52 109.344 171.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -107.37 139.22 42.19 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.738 0.815 . . . . 75.11 109.136 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.517 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 71.2 t -118.2 127.5 75.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 107.324 -1.361 . . . . 74.34 107.324 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -113.64 146.29 39.99 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.177 -0.675 . . . . 75.31 109.177 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 53.64 68.76 0.79 Allowed 'General case' 0 N--CA 1.476 0.859 0 O-C-N 124.851 1.344 . . . . 71.11 110.8 176.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.578 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 47.0 mt-30 -53.28 -26.92 20.13 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.491 0.717 . . . . 71.1 112.63 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -64.82 -53.06 36.77 Favored Glycine 0 C--N 1.349 1.281 0 O-C-N 123.252 0.345 . . . . 61.21 112.289 172.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -69.8 -42.12 74.16 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.192 0.597 . . . . 71.24 110.754 -176.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.437 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 60.2 t80 -56.65 -50.16 72.89 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.49 1.516 . . . . 75.13 110.806 176.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.445 ' HB1' ' O ' ' A' ' 66' ' ' ASN . . . -62.4 -31.99 72.75 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 112.213 0.449 . . . . 51.51 112.213 177.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -70.6 -49.28 49.39 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.073 0.949 . . . . 64.45 112.778 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.573 ' HG3' HG23 ' A' ' 58' ' ' VAL . 4.4 pt-20 -108.48 -37.48 5.95 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 113.569 0.952 . . . . 62.12 113.569 -172.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.573 HG23 ' HG3' ' A' ' 57' ' ' GLU . 98.6 t -81.99 -45.86 19.91 Favored 'Isoleucine or valine' 0 C--O 1.249 1.07 0 C-N-CA 123.315 0.646 . . . . 75.24 111.565 -166.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.1 mt -62.08 -48.97 87.03 Favored Pre-proline 0 CA--C 1.558 1.257 0 CA-C-O 117.79 -1.1 . . . . 72.14 112.705 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -67.69 -15.23 44.06 Favored 'Trans proline' 0 C--N 1.388 2.611 0 C-N-CA 122.134 1.889 . . . . 73.14 113.186 176.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -74.05 -64.99 0.9 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.176 0.59 . . . . 63.34 110.824 178.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.539 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 29.8 m-85 -81.61 -46.51 14.29 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.209 0.528 . . . . 74.12 111.474 -176.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -98.57 -171.22 2.08 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 106.608 -1.627 . . . . 74.44 106.608 177.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -129.47 64.99 1.48 Allowed 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 119.428 1.013 . . . . 72.13 109.859 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -166.09 162.86 18.04 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 114.295 -1.32 . . . . 75.51 108.813 174.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.445 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 8.6 m-80 -114.2 -5.85 13.02 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 122.682 0.393 . . . . 72.33 110.304 175.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -75.29 112.5 11.65 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 122.963 0.505 . . . . 74.32 110.66 -175.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.578 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 3.5 tpt -56.49 -48.64 76.72 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.281 1.432 . . . . 44.25 111.631 178.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.96 -30.07 67.64 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.414 -0.812 . . . . 75.12 112.597 -177.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.3 t -68.52 -41.35 80.07 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.643 0.777 . . . . 75.03 111.271 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -61.95 -49.24 76.89 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.832 0.853 . . . . 65.24 109.93 177.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 52.7 t -65.15 -35.4 75.32 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 CA-C-N 114.688 -1.142 . . . . 72.15 111.508 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -60.86 -42.49 97.98 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.67 0.788 . . . . 73.52 110.971 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.507 ' HA ' ' HE2' ' A' ' 77' ' ' MET . 32.1 mm-40 -64.85 -45.29 86.72 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.82 -0.627 . . . . 63.31 110.426 178.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.442 ' HB3' ' HB2' ' A' ' 80' ' ' PHE . 83.1 mt -63.59 -34.19 77.27 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.271 0.629 . . . . 71.31 111.847 -178.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -56.15 -40.03 73.21 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.212 0.605 . . . . 71.43 111.184 171.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.507 ' HE2' ' HA ' ' A' ' 74' ' ' GLN . 39.9 mtm -76.91 -23.91 52.49 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.278 0.631 . . . . 63.22 111.28 178.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -86.1 -8.61 57.76 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.06 0.544 . . . . 72.22 111.006 174.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.05 21.04 54.02 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 114.406 0.522 . . . . 40.01 114.406 173.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.442 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 17.7 m-85 -82.31 144.97 30.22 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 108.954 -0.758 . . . . 61.31 108.954 176.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -102.29 129.6 48.76 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.868 0.467 . . . . 75.5 110.24 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.631 ' HE3' HG22 ' A' ' 84' ' ' VAL . 52.8 tptt -68.71 118.65 11.97 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.426 1.09 . . . . 74.22 108.779 169.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.548 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 58.8 t -123.4 116.82 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 108.667 -0.864 . . . . 73.24 108.667 176.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.631 HG22 ' HE3' ' A' ' 82' ' ' LYS . 34.4 t -97.98 101.88 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.746 0.818 . . . . 74.03 109.318 -174.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 . . . . . 0 N--CA 1.484 1.236 0 O-C-N 122.341 -0.224 . . . . 70.31 110.656 179.649 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 . . . . . 0 CA--C 1.55 0.957 0 CA-C-O 121.143 0.497 . . . . 74.4 110.087 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -36.76 105.38 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 125.413 1.485 . . . . 54.11 112.56 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -90.33 112.77 24.47 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 107.608 -1.256 . . . . 65.32 107.608 -177.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.53 HG23 ' HD2' ' A' ' 82' ' ' LYS . 76.6 m -118.06 107.12 13.62 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.894 -1.048 . . . . 70.41 109.256 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.548 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 41.9 tt0 -96.23 109.63 22.07 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.596 -1.261 . . . . 65.41 107.596 177.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -95.03 118.68 32.26 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 107.125 -1.435 . . . . 74.2 107.125 172.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -123.37 149.29 45.13 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.861 0.864 . . . . 63.55 109.87 -174.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -156.74 133.14 6.13 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 109.276 -0.638 . . . . 73.15 109.276 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.21 -27.2 56.48 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 122.928 2.419 . . . . 74.52 113.044 -174.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 113' ' ' LEU . 59.2 m -105.86 37.38 2.26 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.644 0.778 . . . . 62.32 109.511 175.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -133.9 106.9 7.52 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.055 -1.091 . . . . 70.31 108.055 170.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.596 ' HB2' ' HB3' ' A' ' 110' ' ' GLN . 68.0 mt -128.2 149.63 50.37 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 108.514 -0.921 . . . . 63.12 108.514 172.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -63.02 -59.14 5.21 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.486 0.714 . . . . 74.35 111.659 -175.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -88.95 50.57 3.71 Favored Glycine 0 C--N 1.342 0.877 0 N-CA-C 111.87 -0.492 . . . . 53.04 111.87 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.596 ' HB3' ' HB2' ' A' ' 107' ' ' LEU . 4.1 tp60 -165.19 53.0 0.11 Allowed 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 108.691 -0.855 . . . . 73.52 108.691 -172.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -62.64 -18.4 62.22 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.024 0.93 . . . . 44.2 112.966 -176.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.0 pm0 -68.26 -6.58 24.55 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 122.957 0.503 . . . . 72.03 112.145 176.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.414 ' HB3' ' O ' ' A' ' 105' ' ' CYS . 63.4 mt -86.28 -23.7 26.22 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 122.751 0.42 . . . . 70.3 111.473 174.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.19 -37.98 89.35 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.274 0.63 . . . . 64.1 111.35 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -72.21 -13.49 61.55 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 114.895 -1.048 . . . . 72.43 112.267 177.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -93.9 -11.62 30.64 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.327 0.651 . . . . 75.23 110.865 173.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 35.8 mt -87.41 91.99 3.67 Favored 'Isoleucine or valine' 0 C--N 1.353 0.745 0 N-CA-C 107.134 -1.432 . . . . 72.01 107.134 176.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.443 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 11.1 mmpt? -87.48 144.48 26.7 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.219 -0.66 . . . . 72.32 109.219 -178.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 8.6 ptm85 . . . . . 0 N--CA 1.473 0.687 0 N-CA-C 109.572 -0.529 . . . . 73.44 109.572 178.562 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.5 t . . . . . 0 CA--C 1.55 0.952 0 CA-C-O 119.714 -0.184 . . . . 64.33 110.649 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -61.81 139.0 77.79 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 122.734 2.289 . . . . 74.55 111.8 170.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.453 ' HA ' HG22 ' A' ' 22' ' ' THR . . . -56.58 -38.47 72.02 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.592 0.757 . . . . 73.31 112.392 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -51.33 -46.85 62.78 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.587 0.755 . . . . 75.13 111.626 173.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.449 ' HB3' HD22 ' A' ' 114' ' ' LEU . 77.8 mt -79.69 -34.73 39.99 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.122 0.569 . . . . 71.05 112.498 -172.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.453 HG22 ' HA ' ' A' ' 19' ' ' ALA . 14.3 t -71.38 -34.89 70.81 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 118.041 0.382 . . . . 73.31 111.146 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.2 mtpt -81.06 -32.7 33.91 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 119.532 -0.271 . . . . 63.24 110.875 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.426 ' O ' HG23 ' A' ' 28' ' ' VAL . 57.4 tp -63.55 -39.58 94.77 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.091 0.556 . . . . 75.13 110.497 170.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 64.7 t-105 -57.44 -52.67 64.44 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.871 0.868 . . . . 65.42 110.666 174.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 38.6 m -59.84 -40.74 89.56 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 124.238 0.961 . . . . 72.22 110.721 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.483 ' HG ' HD13 ' A' ' 37' ' ' ILE . 26.9 tp -59.64 -52.26 66.28 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.196 1.398 . . . . 72.44 112.304 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 24' ' ' LEU . 96.9 t -62.01 -33.14 56.8 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 C-N-CA 123.855 0.862 . . . . 75.15 111.164 177.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.9 t -94.04 -1.71 54.05 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 123.911 0.884 . . . . 51.34 112.069 -174.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -89.0 130.54 44.21 Favored Pre-proline 0 N--CA 1.49 1.555 0 C-N-CA 123.29 0.636 . . . . 75.41 111.467 -174.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -73.32 -21.82 19.54 Favored 'Trans proline' 0 C--N 1.39 2.716 0 C-N-CA 123.271 2.647 . . . . 71.33 114.369 -174.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -78.45 -36.33 45.57 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.316 0.646 . . . . 74.41 110.455 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.5 p -92.01 -0.96 57.48 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.227 0.611 . . . . 61.34 111.28 -176.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.69 -29.17 58.92 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.88 1.272 . . . . 73.21 112.107 -179.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.26 -36.98 79.03 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.934 0.894 . . . . 64.5 113.22 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.6 mt -114.16 -6.38 13.05 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.918 0.487 . . . . 63.12 112.134 -176.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.483 HD13 ' HG ' ' A' ' 27' ' ' LEU . 16.6 tt -160.11 125.71 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-O 120.943 0.401 . . . . 74.44 110.878 175.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 21.5 p -146.2 145.3 30.39 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.218 0.607 . . . . 63.45 110.255 -176.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 10.2 p-90 -69.25 152.19 45.36 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 118.028 0.376 . . . . 71.11 110.844 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 61.2 p -71.98 150.0 92.53 Favored Pre-proline 0 CA--C 1.552 1.048 0 N-CA-C 109.446 -0.575 . . . . 55.43 109.446 172.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -51.59 -24.27 16.82 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.564 2.176 . . . . 73.34 113.67 171.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 59.8 m -69.99 -52.26 25.74 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.241 0.616 . . . . 64.02 109.765 169.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.16 5.58 65.63 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.277 -0.874 . . . . 32.32 112.969 -177.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -87.92 -2.25 58.49 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.861 0.864 . . . . 72.04 110.022 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.7 p -163.59 170.57 17.0 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.375 1.07 . . . . 71.24 109.494 -169.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -142.07 143.46 33.1 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.465 0.306 . . . . 50.3 111.075 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 -97.77 140.27 32.4 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.173 0.989 . . . . 64.42 109.487 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.5 t -123.95 132.7 70.95 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 C-N-CA 124.387 1.075 . . . . 61.23 108.308 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.416 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 79.3 m-85 -115.82 146.86 41.61 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.39 1.076 . . . . 72.45 109.756 -177.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 49.77 72.59 0.31 Allowed 'General case' 0 N--CA 1.479 1.007 0 O-C-N 124.727 1.267 . . . . 63.1 111.378 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.416 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 16.3 mm-40 -51.09 -35.96 37.83 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.808 0.843 . . . . 72.31 112.717 -176.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.37 -47.38 71.16 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-N 115.809 -0.632 . . . . 52.12 112.885 177.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 -69.54 -44.33 71.19 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.187 0.595 . . . . 62.01 110.63 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -55.34 -49.26 72.68 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.376 1.47 . . . . 74.04 110.975 176.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.29 -35.93 78.68 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 116.432 -0.349 . . . . 71.34 111.932 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -70.11 -47.08 63.31 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 124.263 1.025 . . . . 72.24 113.078 -175.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.487 ' HG3' HG23 ' A' ' 58' ' ' VAL . 7.1 pt-20 -107.01 -37.38 6.34 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 113.912 1.079 . . . . 74.25 113.912 -174.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.487 HG23 ' HG3' ' A' ' 57' ' ' GLU . 98.4 t -81.0 -43.7 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 122.754 0.421 . . . . 75.54 111.512 -168.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.5 mt -67.03 -43.86 48.17 Favored Pre-proline 0 CA--C 1.556 1.21 0 CA-C-O 117.979 -1.01 . . . . 71.33 112.833 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.98 -14.36 43.37 Favored 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 121.894 1.729 . . . . 73.43 113.625 173.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -79.01 -57.76 3.58 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.384 0.674 . . . . 70.33 111.04 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.437 ' CE1' HD13 ' A' ' 27' ' ' LEU . 57.3 m-85 -86.57 -26.8 24.3 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 112.258 0.466 . . . . 74.43 112.258 -176.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -124.38 -178.45 4.11 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.063 0.945 . . . . 50.52 108.747 -176.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.66 37.67 2.85 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 122.917 0.487 . . . . 72.4 109.994 -172.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -160.84 160.7 31.41 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.92 0.888 . . . . 73.54 108.902 -176.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -109.69 -25.45 10.39 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 108.996 -0.742 . . . . 73.21 108.996 176.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -57.68 118.37 5.19 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.334 1.054 . . . . 55.42 111.655 -176.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.416 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 11.6 ttm -72.15 -31.57 66.08 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.1 -0.955 . . . . 73.44 111.709 -178.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.29 -37.36 69.74 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.076 0.55 . . . . 44.33 111.644 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.404 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 37.2 t -66.41 -44.96 81.52 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.214 1.005 . . . . 64.31 111.323 176.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -64.19 -52.91 56.62 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.531 1.132 . . . . 64.03 111.196 -176.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 68.0 t -65.8 -31.35 53.35 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 CA-C-N 115.515 -0.766 . . . . 64.15 111.251 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -60.28 -39.77 88.03 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 122.785 0.434 . . . . 73.44 111.227 173.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 70' ' ' SER . 21.7 mm-40 -65.09 -46.25 81.86 Favored 'General case' 0 C--N 1.355 0.809 0 O-C-N 123.646 0.591 . . . . 75.05 109.905 177.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 80' ' ' PHE . 96.9 mt -57.4 -45.25 84.75 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 123.81 0.844 . . . . 61.15 111.285 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -55.57 -42.5 74.82 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.595 0.758 . . . . 74.51 111.933 176.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 59.3 mtm -73.6 -27.61 61.38 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 116.041 -0.527 . . . . 71.13 111.491 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -85.28 -6.97 59.22 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.569 0.348 . . . . 71.04 111.207 177.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.65 17.71 59.62 Favored Glycine 0 C--N 1.352 1.469 0 CA-C-O 119.794 -0.448 . . . . 32.31 113.927 175.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.502 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 38.7 m-85 -78.2 137.34 38.09 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 108.332 -0.988 . . . . 73.02 108.332 173.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 13.6 ttm180 -107.93 130.79 55.01 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.306 0.642 . . . . 73.43 109.545 -175.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -65.78 125.45 25.36 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.038 0.935 . . . . 73.12 109.369 174.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 51.7 t -116.0 113.54 43.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 107.835 -1.172 . . . . 73.22 107.835 176.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 71.1 t -86.46 140.15 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 123.762 0.825 . . . . 73.23 110.898 -177.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 32.5 m80 . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 108.066 -1.087 . . . . 74.52 108.066 172.029 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 . . . . . 0 C--O 1.24 0.553 0 CA-C-O 121.516 0.674 . . . . 72.43 111.381 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.416 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 18.0 m-20 -80.84 134.15 35.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.337 -1.302 . . . . 74.21 108.554 170.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -115.1 105.27 12.74 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 107.644 -1.243 . . . . 71.24 107.644 169.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 93.3 m -124.7 153.23 42.65 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.478 1.111 . . . . 64.41 109.637 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.546 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 37.8 tt0 -130.9 153.55 49.02 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.548 -0.908 . . . . 72.04 108.548 162.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -124.46 120.31 31.66 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 107.277 -1.379 . . . . 74.33 107.277 169.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -110.32 144.56 38.87 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.552 0.741 . . . . 74.41 110.242 -174.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.463 ' HB3' ' HB3' ' A' ' 106' ' ' PHE . 64.8 t-80 -149.46 130.81 7.3 Favored Pre-proline 0 CA--C 1.55 0.969 0 CA-C-O 119.351 -0.357 . . . . 64.0 110.423 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.25 -40.83 30.28 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 123.299 2.666 . . . . 74.41 113.667 -175.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.416 ' HB2' ' HE1' ' A' ' 103' ' ' HIS . 34.2 m -97.13 22.96 7.85 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.275 0.63 . . . . 73.3 111.096 -177.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.463 ' HB3' ' HB3' ' A' ' 103' ' ' HIS . 89.1 t80 -117.37 99.05 6.75 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 106.706 -1.59 . . . . 72.44 106.706 173.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 63.1 mt -119.31 139.36 52.07 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.137 -1.06 . . . . 63.34 108.137 177.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -68.89 132.27 46.47 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.508 0.723 . . . . 73.31 110.125 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.48 1.6 90.49 Favored Glycine 0 C--N 1.344 0.983 0 O-C-N 123.555 0.534 . . . . 43.14 113.052 -173.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -122.84 53.46 1.28 Allowed 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 108.144 -1.058 . . . . 62.53 108.144 -175.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.55 -26.1 65.09 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.236 1.414 . . . . 73.32 114.102 -177.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 7.9 pm0 -71.01 -8.19 51.6 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 112.204 0.446 . . . . 65.32 112.204 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.491 ' O ' HG13 ' A' ' 117' ' ' ILE . 24.6 mt -83.1 -14.22 54.11 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 118.771 -0.633 . . . . 73.23 111.485 173.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.449 HD22 ' HB3' ' A' ' 21' ' ' LEU . 96.4 mt -63.17 -35.3 79.86 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 118.295 0.498 . . . . 72.15 110.857 175.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -80.15 -1.59 40.96 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.962 -0.563 . . . . 60.51 112.148 175.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -103.61 -13.71 16.43 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.586 0.754 . . . . 75.21 110.528 168.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 113' ' ' LEU . 63.9 mt -85.74 109.74 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 106.879 -1.526 . . . . 72.1 106.879 173.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -109.21 170.39 8.08 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.807 -0.812 . . . . 70.4 108.807 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 24.6 ptt85 . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 108.155 -1.054 . . . . 55.51 108.155 168.993 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.4 t . . . . . 0 CA--C 1.551 0.983 0 CA-C-O 119.127 -0.463 . . . . 73.51 111.802 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -58.94 152.37 58.6 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 123.155 2.57 . . . . 74.42 112.314 174.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.72 -45.78 70.59 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.971 0.908 . . . . 71.41 112.1 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -54.85 -44.44 73.99 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 122.981 0.512 . . . . 73.31 112.009 176.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.2 mt -80.52 -31.09 37.16 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 112.393 0.516 . . . . 61.55 112.393 -171.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.1 t -70.99 -33.39 70.37 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.656 -0.498 . . . . 72.2 109.656 175.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -69.87 -42.41 73.52 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 122.915 0.486 . . . . 65.23 110.536 172.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.61 -43.67 93.68 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.8 0.84 . . . . 54.23 111.419 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 13.5 t-105 -64.58 -51.9 60.37 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-O 119.611 -0.233 . . . . 74.42 110.81 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 32.1 m -61.3 -20.69 63.2 Favored 'General case' 0 CA--C 1.554 1.133 0 CA-C-O 121.299 0.571 . . . . 73.1 110.883 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.0 tp -76.77 -54.77 6.18 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.597 1.159 . . . . 75.41 111.408 174.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 82.5 t -62.16 -36.22 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.749 0.819 . . . . 72.13 111.389 -177.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.5 p -78.15 -25.4 47.3 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.538 0.735 . . . . 74.14 112.305 -176.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -70.84 123.12 88.69 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 123.24 0.616 . . . . 63.34 111.563 -171.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.28 -13.51 33.45 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 122.975 2.45 . . . . 61.13 113.479 -177.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -87.12 -22.39 25.4 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.723 0.809 . . . . 74.25 110.987 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.451 HG21 ' HE1' ' A' ' 62' ' ' TYR . 24.7 p -110.6 1.25 17.95 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.158 0.583 . . . . 74.43 111.685 175.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -54.12 -36.95 63.81 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.486 1.114 . . . . 70.42 112.271 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.1 -33.17 75.39 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.526 -0.761 . . . . 72.12 112.256 -176.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.462 HD22 ' HB2' ' A' ' 50' ' ' ASP . 59.7 mt -103.48 -11.0 18.09 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.548 0.339 . . . . 55.43 111.36 -177.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.5 tt -162.15 128.43 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 122.971 0.508 . . . . 70.03 110.326 172.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 17.3 p -153.92 157.6 39.46 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.23 0.612 . . . . 71.21 110.057 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 41.4 p-90 -73.63 149.22 42.18 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.993 0.517 . . . . 74.23 110.097 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.5 m -70.24 143.51 91.1 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 123.879 0.872 . . . . 75.51 110.098 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -55.59 -32.49 83.36 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.813 2.342 . . . . 75.0 113.517 175.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.9 m -69.61 -19.68 63.64 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.217 0.607 . . . . 73.31 111.698 173.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.69 6.4 71.71 Favored Glycine 0 C--N 1.344 0.996 0 N-CA-C 115.617 1.007 . . . . 41.24 115.617 171.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -88.07 -5.66 58.36 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 118.109 0.955 . . . . 74.21 112.265 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.2 p -163.44 -171.66 2.65 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.162 0.585 . . . . 64.42 110.736 -170.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -145.03 148.81 34.13 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.404 0.682 . . . . 73.51 110.973 175.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 21.6 m-70 -99.52 150.79 21.86 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.588 1.155 . . . . 71.4 110.173 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.0 t -123.67 123.03 66.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 107.939 -1.134 . . . . 61.33 107.939 172.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -105.68 147.41 28.54 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.273 1.029 . . . . 64.42 110.034 -178.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.462 ' HB2' HD22 ' A' ' 36' ' ' LEU . 8.6 m-20 48.79 59.83 4.13 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 124.925 1.39 . . . . 63.22 111.196 172.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.496 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 23.6 mt-30 -54.65 -26.16 31.41 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.78 1.03 . . . . 71.25 113.78 -169.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.94 -50.08 37.33 Favored Glycine 0 C--N 1.35 1.348 0 O-C-N 123.198 0.311 . . . . 75.21 112.654 173.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -68.06 -40.13 82.84 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.452 0.701 . . . . 70.43 110.249 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.476 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 44.4 t80 -57.99 -48.14 80.91 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.113 1.365 . . . . 73.44 110.534 176.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.435 ' HB2' ' HB2' ' A' ' 68' ' ' MET . . . -61.27 -36.67 80.66 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.196 -0.456 . . . . 71.21 111.486 177.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -68.47 -53.99 19.83 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.252 1.021 . . . . 73.13 112.985 -176.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.559 ' HG3' HG23 ' A' ' 58' ' ' VAL . 6.3 pt-20 -100.45 -38.07 8.56 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 112.893 0.701 . . . . 61.42 112.893 -173.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.559 HG23 ' HG3' ' A' ' 57' ' ' GLU . 77.6 t -81.92 -44.46 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.045 0.538 . . . . 71.24 112.144 -167.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 49.3 mt -63.52 -45.17 83.24 Favored Pre-proline 0 CA--C 1.56 1.36 0 CA-C-O 117.797 -1.097 . . . . 73.21 112.684 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.09 -16.52 44.89 Favored 'Trans proline' 0 C--N 1.386 2.538 0 CA-C-N 122.037 1.763 . . . . 75.51 113.312 173.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -73.13 -47.62 42.57 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.453 0.701 . . . . 73.2 111.073 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.451 ' HE1' HG21 ' A' ' 33' ' ' THR . 53.8 m-85 -96.12 -48.1 5.8 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 122.853 0.461 . . . . 65.13 111.903 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -99.08 -171.27 2.06 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.85 0.86 . . . . 75.05 109.117 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -118.89 44.72 2.24 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.361 0.601 . . . . 72.23 110.551 -176.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -164.04 164.51 22.99 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.333 -0.849 . . . . 74.3 109.557 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -121.91 -11.8 8.48 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.588 0.755 . . . . 75.31 110.278 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -66.93 117.39 8.95 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.035 0.934 . . . . 74.3 109.75 174.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.496 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 24.0 ttt -87.72 -18.68 28.94 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.558 0.343 . . . . 73.35 110.917 -176.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.5 -37.49 67.92 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.862 0.465 . . . . 74.51 110.22 172.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.485 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 44.0 t -66.44 -46.22 77.21 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.911 1.284 . . . . 63.02 111.343 175.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -61.75 -51.28 68.98 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.889 0.876 . . . . 74.01 110.478 -175.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.35 -40.85 90.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 123.914 0.885 . . . . 61.43 110.772 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -56.58 -39.91 74.33 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.257 1.023 . . . . 73.32 111.073 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 70' ' ' SER . 25.8 mm-40 -63.38 -45.91 88.92 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 123.653 0.596 . . . . 72.24 109.822 176.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 80' ' ' PHE . 64.4 mt -61.16 -37.43 82.87 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.729 0.811 . . . . 71.34 111.5 -178.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -58.55 -38.54 78.03 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.509 0.724 . . . . 52.42 111.371 172.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 34.1 mtm -70.86 -34.07 71.26 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.189 -0.459 . . . . 72.42 110.493 177.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.454 ' CZ ' ' HB3' ' A' ' 119' ' ' ARG . 44.4 m-85 -81.21 -9.62 59.75 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.595 0.758 . . . . 71.43 111.59 -178.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.96 22.69 59.01 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 114.268 0.467 . . . . 61.0 114.268 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.4 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 72.1 m-85 -79.49 137.17 37.11 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 108.443 -0.947 . . . . 61.31 108.443 171.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -102.81 127.14 50.1 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.153 0.581 . . . . 74.5 110.595 -170.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.402 ' HD2' HG23 ' A' ' 99' ' ' THR . 41.3 tptt -65.05 115.88 5.89 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.865 1.266 . . . . 74.51 109.707 173.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 59.5 t -123.29 120.28 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 108.731 -0.84 . . . . 71.13 108.731 175.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 37.5 t -90.77 121.47 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.069 0.948 . . . . 65.11 109.384 -176.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 . . . . . 0 N--CA 1.489 1.502 0 C-N-CA 122.619 0.368 . . . . 62.23 110.696 179.216 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 . . . . . 0 N--CA 1.474 0.726 0 CA-C-O 120.925 0.393 . . . . 61.31 110.205 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -97.52 113.39 25.08 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 107.166 -1.42 . . . . 61.24 107.166 175.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -100.65 122.13 42.79 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 107.262 -1.384 . . . . 72.15 107.262 174.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.402 HG23 ' HD2' ' A' ' 82' ' ' LYS . 77.3 m -123.34 128.49 49.98 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.13 -0.693 . . . . 50.5 109.13 176.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.476 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 35.2 tt0 -101.55 111.0 23.1 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 106.799 -1.556 . . . . 75.43 106.799 172.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -94.05 119.88 33.53 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.445 -1.317 . . . . 65.12 107.445 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -121.69 142.12 50.48 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.788 -0.642 . . . . 75.42 110.796 -174.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 45.5 t-80 -147.26 130.28 8.0 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 107.665 -1.235 . . . . 74.24 107.665 175.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -63.01 -20.9 72.69 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.816 2.344 . . . . 62.51 113.846 -172.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.472 ' SG ' ' HB3' ' A' ' 113' ' ' LEU . 36.7 t -101.64 35.36 2.33 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.306 0.642 . . . . 70.15 110.099 175.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -137.48 109.01 6.94 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.931 0.892 . . . . 74.34 108.848 172.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 85.0 mt -118.14 104.86 11.23 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 118.969 -0.539 . . . . 62.31 109.933 174.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 52.14 -79.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 125.669 1.588 . . . . 75.11 112.688 176.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -141.57 42.13 1.18 Allowed Glycine 0 C--N 1.348 1.243 0 CA-C-N 115.827 -0.624 . . . . 32.43 111.923 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -82.1 74.19 9.09 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 106.677 -1.601 . . . . 70.52 106.677 173.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -62.0 -31.14 71.49 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.143 -1.39 . . . . 75.13 112.695 -171.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 17.5 pm0 -69.2 -16.89 63.72 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 122.502 0.321 . . . . 72.12 111.586 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.472 ' HB3' ' SG ' ' A' ' 105' ' ' CYS . 40.7 mt -87.24 -14.6 40.58 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.329 0.252 . . . . 73.43 111.462 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.407 HD23 HD12 ' A' ' 117' ' ' ILE . 96.5 mt -63.86 -33.82 76.56 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.976 0.51 . . . . 73.23 111.661 177.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -73.74 -5.88 43.47 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.2 0.444 . . . . 54.34 112.2 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -101.56 -6.68 23.56 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.8 0.84 . . . . 71.54 109.594 175.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.407 HD12 HD23 ' A' ' 114' ' ' LEU . 44.2 mt -90.77 111.95 24.35 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 N-CA-C 107.226 -1.398 . . . . 73.02 107.226 174.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.421 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 11.4 mmpt? -101.25 136.69 40.68 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.347 0.659 . . . . 75.52 111.115 -167.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 78' ' ' TYR . 15.7 ptt180 . . . . . 0 N--CA 1.497 1.875 0 C-N-CA 123.546 0.738 . . . . 73.14 112.867 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 52.6 t . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 118.94 -0.553 . . . . 54.24 110.606 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -64.43 155.91 63.35 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 122.702 2.268 . . . . 74.31 111.44 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.24 -44.81 61.81 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.057 0.943 . . . . 64.53 112.232 -175.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -53.19 -46.33 68.94 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.17 0.588 . . . . 62.53 112.338 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 68.9 mt -80.26 -33.6 37.73 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 112.452 0.538 . . . . 63.14 112.452 -173.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.9 t -71.67 -34.83 70.04 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 117.723 0.238 . . . . 64.41 110.415 176.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.512 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -70.44 -43.87 69.01 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 122.817 0.447 . . . . 74.31 110.078 174.018 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.474 ' O ' HG23 ' A' ' 28' ' ' VAL . 68.6 tp -54.28 -56.51 17.74 Favored 'General case' 0 C--O 1.214 -0.784 0 O-C-N 124.312 1.007 . . . . 73.44 111.546 177.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.518 ' HZ2' ' H ' ' A' ' 109' ' ' GLY . 23.0 t90 -58.11 -45.46 87.24 Favored 'General case' 0 CA--C 1.552 1.026 0 O-C-N 123.52 0.512 . . . . 74.12 110.908 -176.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.6 m -64.82 -30.75 71.77 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.704 0.802 . . . . 73.03 111.536 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.542 HD11 ' CG1' ' A' ' 58' ' ' VAL . 37.3 tp -74.05 -45.15 51.3 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.45 1.1 . . . . 72.44 111.26 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 24' ' ' LEU . 71.4 t -61.76 -32.04 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 C-N-CA 124.092 0.957 . . . . 62.22 110.321 173.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.6 t -93.64 5.15 52.56 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.359 1.064 . . . . 73.31 111.988 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -85.83 121.5 73.1 Favored Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 123.056 0.542 . . . . 61.13 110.436 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.46 -14.05 27.78 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.765 2.31 . . . . 74.44 113.54 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -78.96 -33.47 45.17 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.368 0.667 . . . . 73.33 111.23 177.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 67.4 p -111.62 9.53 21.09 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.812 -0.631 . . . . 74.42 110.683 -176.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -56.79 -34.62 67.82 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.338 1.455 . . . . 61.22 112.305 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.33 -34.01 76.76 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.503 -0.771 . . . . 74.14 111.71 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.418 HD22 ' HB2' ' A' ' 50' ' ' ASP . 87.9 mt -104.75 -13.57 15.85 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.227 0.611 . . . . 74.44 111.397 -174.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.48 HG21 ' HG ' ' A' ' 27' ' ' LEU . 20.1 tt -161.2 119.69 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 C-N-CA 123.005 0.522 . . . . 74.34 110.246 175.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 16.7 p -150.04 150.23 31.46 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.367 0.667 . . . . 75.25 109.768 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.441 ' HE3' ' HA2' ' A' ' 43' ' ' GLY . 8.2 p-90 -89.98 153.74 20.36 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.006 0.431 . . . . 75.43 109.891 178.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.8 m -82.43 155.24 69.11 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 114.823 -1.08 . . . . 72.22 109.316 -175.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.18 -16.53 13.03 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 122.884 2.389 . . . . 74.01 114.135 173.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.6 m -71.14 -36.42 72.08 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.073 0.949 . . . . 64.13 111.399 174.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.441 ' HA2' ' HE3' ' A' ' 39' ' ' TRP . . . 82.16 1.49 90.37 Favored Glycine 0 C--N 1.345 1.067 0 CA-C-N 115.744 -0.662 . . . . 72.42 114.66 176.056 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -103.08 -3.23 26.2 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.259 0.624 . . . . 54.4 111.09 -175.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.8 p -154.68 163.25 40.52 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.405 0.682 . . . . 51.11 110.599 -170.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -142.13 152.26 43.05 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.88 0.472 . . . . 74.54 110.446 174.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -109.16 148.68 30.52 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.776 0.83 . . . . 62.43 109.235 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 82.7 t -123.73 131.83 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 108.223 -1.029 . . . . 71.11 108.223 177.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 94.0 m-85 -115.41 147.19 40.84 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.864 0.866 . . . . 62.5 110.217 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.418 ' HB2' HD22 ' A' ' 36' ' ' LEU . 17.6 m-20 51.43 67.56 0.93 Allowed 'General case' 0 N--CA 1.481 1.113 0 O-C-N 124.647 1.217 . . . . 75.35 111.823 173.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -53.77 -31.34 48.32 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 114.516 1.302 . . . . 74.41 114.516 -172.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.4 -43.92 43.9 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 112.058 -0.417 . . . . 71.52 112.058 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -72.29 -32.67 66.8 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.67 1.188 . . . . 61.45 110.968 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.462 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 53.6 t80 -69.71 -50.73 40.81 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.848 1.259 . . . . 75.34 109.762 178.052 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.496 ' HB1' ' O ' ' A' ' 66' ' ' ASN . . . -62.17 -32.14 72.73 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.628 -0.715 . . . . 74.5 112.135 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.5 tttm -62.38 -53.67 51.59 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.046 1.339 . . . . 71.22 113.45 -176.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -122.11 -22.11 5.74 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 114.033 1.123 . . . . 73.43 114.033 -170.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.542 ' CG1' HD11 ' A' ' 27' ' ' LEU . 85.7 t -86.44 -45.03 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.16 0.584 . . . . 72.25 110.824 -175.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 26.3 mt -62.88 -48.83 84.38 Favored Pre-proline 0 CA--C 1.559 1.305 0 CA-C-O 118.507 -0.759 . . . . 73.44 112.55 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.56 -13.18 38.2 Favored 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 121.926 1.75 . . . . 64.11 113.239 175.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -73.28 -54.07 9.31 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.262 0.625 . . . . 73.41 110.675 176.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.5 ' CD1' HD13 ' A' ' 27' ' ' LEU . 35.5 m-85 -92.84 -43.71 8.85 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 112.194 0.442 . . . . 74.1 112.194 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -98.77 -176.99 3.51 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.488 0.715 . . . . 72.33 109.335 -178.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.55 39.68 2.58 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.312 0.577 . . . . 72.51 111.132 -174.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -161.23 162.12 31.06 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.881 0.873 . . . . 53.33 109.875 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.496 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 5.7 m-80 -106.8 -26.22 11.37 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 108.618 -0.882 . . . . 53.13 108.618 173.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -61.03 115.31 3.64 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.114 0.965 . . . . 64.22 111.52 -177.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.476 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 24.9 ttt -83.13 -20.11 35.43 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 116.195 -0.457 . . . . 75.12 111.296 -177.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.93 -36.2 72.16 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.356 0.262 . . . . 72.45 110.525 172.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.492 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 37.2 t -63.32 -51.69 64.96 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.085 0.954 . . . . 45.11 110.727 172.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -58.08 -54.9 41.7 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.166 0.986 . . . . 71.24 111.342 -174.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.1 -37.75 80.65 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 CA-C-N 115.506 -0.77 . . . . 71.33 111.033 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 58.2 ttt-85 -59.44 -43.9 93.02 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 117.894 0.316 . . . . 75.44 111.396 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 70' ' ' SER . 10.0 mm100 -62.0 -44.26 97.1 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.535 0.522 . . . . 74.42 109.627 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.1 mt -59.32 -41.16 88.44 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 123.946 0.779 . . . . 73.53 111.567 176.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -61.25 -37.59 83.66 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.589 0.756 . . . . 73.42 111.181 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 41.9 mtm -68.83 -31.87 71.15 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 122.757 0.423 . . . . 75.12 110.565 173.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -81.78 -4.01 55.29 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.963 0.905 . . . . 71.54 111.137 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.65 15.09 74.23 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-O 119.527 -0.596 . . . . 71.23 114.353 175.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -72.91 131.91 42.81 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 117.683 0.741 . . . . 75.11 109.222 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -99.42 121.77 41.6 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 109.144 -0.687 . . . . 54.14 109.144 -174.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.554 ' HE2' HG22 ' A' ' 84' ' ' VAL . 1.2 tmtp? -79.21 127.66 32.33 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.802 1.241 . . . . 73.02 108.063 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 61.7 t -123.75 129.17 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.166 0.986 . . . . 74.14 108.631 178.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.554 HG22 ' HE2' ' A' ' 82' ' ' LYS . 30.6 t -92.25 134.0 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 108.279 -1.008 . . . . 73.04 108.279 178.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 46.6 m-70 . . . . . 0 N--CA 1.483 1.221 0 C-N-CA 122.774 0.43 . . . . 74.32 111.099 175.449 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 . . . . . 0 N--CA 1.471 0.6 0 CA-C-O 121.24 0.543 . . . . 71.15 110.735 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.534 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 3.6 m-20 -81.08 119.4 23.5 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.53 -0.915 . . . . 75.23 108.53 -175.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -115.87 107.34 14.88 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 108.349 -0.982 . . . . 53.32 108.349 170.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.456 HG23 ' HG2' ' A' ' 82' ' ' LYS . 46.7 m -124.23 114.76 20.04 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 114.538 -1.21 . . . . 75.32 109.382 -172.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.544 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 32.0 tt0 -101.18 114.34 28.2 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 109.008 -0.738 . . . . 71.33 109.008 -176.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -96.95 119.95 36.38 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.109 -1.071 . . . . 75.45 108.109 171.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -123.02 141.61 51.77 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.239 0.615 . . . . 73.51 110.093 -177.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -158.68 132.52 4.99 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 109.16 -0.681 . . . . 72.44 109.16 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -65.2 -22.48 60.99 Favored 'Trans proline' 0 C--N 1.384 2.433 0 C-N-CA 123.054 2.503 . . . . 65.24 114.131 -173.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.548 ' HB2' HG12 ' A' ' 117' ' ' ILE . 13.6 m -92.39 -1.52 56.96 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.695 0.398 . . . . 65.02 111.839 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -104.72 98.37 8.12 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 107.132 -1.432 . . . . 75.0 107.132 175.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 110' ' ' GLN . 67.1 mt -125.45 166.44 16.61 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 121.663 0.744 . . . . 64.03 111.918 -177.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -58.0 115.91 3.17 Favored 'General case' 0 CA--C 1.556 1.209 0 CA-C-N 113.883 -1.508 . . . . 71.12 111.673 170.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.518 ' H ' ' HZ2' ' A' ' 25' ' ' TRP . . . 70.21 7.0 59.17 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 115.041 0.776 . . . . 50.32 115.041 174.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.428 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 16.4 mm100 -100.67 65.41 1.15 Allowed 'General case' 0 C--O 1.242 0.67 0 CA-C-O 121.466 0.65 . . . . 54.33 110.296 -175.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -57.29 -36.07 70.6 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 114.895 -1.048 . . . . 71.0 111.482 173.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 19.2 pm0 -68.45 -16.59 63.96 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.204 0.601 . . . . 74.03 111.93 -176.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 79.9 mt -96.49 -19.68 18.95 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.335 0.654 . . . . 71.51 111.555 176.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.1 mt -67.03 -37.42 84.08 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.069 0.547 . . . . 73.24 110.682 178.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -69.23 -13.85 62.63 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.647 -0.706 . . . . 61.53 112.278 175.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -97.36 4.75 50.62 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.115 0.566 . . . . 71.42 110.369 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.548 HG12 ' HB2' ' A' ' 105' ' ' CYS . 44.9 mt -89.68 119.2 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 108.049 -1.093 . . . . 74.01 108.049 173.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -95.58 132.43 40.73 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.83 0.852 . . . . 62.52 111.411 -165.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 . . . . . 0 N--CA 1.486 1.366 0 C-N-CA 124.099 0.96 . . . . 73.5 111.386 173.92 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.443 HG13 ' HB2' ' A' ' 114' ' ' LEU . 54.9 t . . . . . 0 CA--C 1.556 1.197 0 CA-C-O 118.971 -0.538 . . . . 75.45 110.927 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -55.76 146.81 64.44 Favored 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 123.149 2.566 . . . . 61.1 112.733 176.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.56 -43.76 62.49 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 124.198 0.936 . . . . 71.12 111.674 177.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.418 ' HA ' ' HE1' ' A' ' 63' ' ' PHE . 86.9 t80 -50.05 -51.41 42.62 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.358 1.063 . . . . 73.22 112.307 174.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 98.1 mt -80.5 -34.43 35.74 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.474 0.484 . . . . 73.41 112.103 -169.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.6 t -69.89 -34.36 73.43 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 122.286 0.234 . . . . 64.34 110.992 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.411 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -68.11 -44.76 75.42 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 109.749 -0.463 . . . . 73.32 109.749 171.174 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.2 tp -60.01 -40.37 89.01 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.012 0.925 . . . . 72.54 111.686 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.473 ' HB2' HD11 ' A' ' 114' ' ' LEU . 91.0 t90 -54.9 -56.2 22.22 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.412 1.085 . . . . 74.02 111.56 177.034 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.6 m -60.66 -38.32 84.48 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.895 -1.048 . . . . 73.55 110.604 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.494 HD11 ' CG1' ' A' ' 58' ' ' VAL . 34.3 tp -64.9 -52.0 58.87 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.351 1.46 . . . . 74.41 113.057 -174.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.7 t -57.19 -33.43 43.16 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 C-N-CA 124.015 0.926 . . . . 71.4 112.047 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.5 t -96.92 -3.19 42.28 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.825 0.85 . . . . 60.12 112.125 -177.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.401 ' HB3' ' OG1' ' A' ' 33' ' ' THR . 37.2 t70 -76.93 128.97 80.12 Favored Pre-proline 0 N--CA 1.483 1.198 0 C-N-CA 123.419 0.688 . . . . 71.32 111.61 -170.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.37 -24.44 57.45 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 123.125 2.55 . . . . 75.04 113.5 -177.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -78.46 -29.34 46.82 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.618 0.367 . . . . 64.21 110.87 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.401 ' OG1' ' HB3' ' A' ' 30' ' ' ASP . 68.1 p -115.6 -5.35 12.19 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.369 0.877 . . . . 73.12 113.369 -172.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.492 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 2.8 p-10 -64.69 -21.4 66.73 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 118.664 0.666 . . . . 75.13 112.452 -172.509 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.29 -33.68 76.04 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.758 0.423 . . . . 72.44 111.337 174.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.591 HD22 ' HB2' ' A' ' 50' ' ' ASP . 43.3 mt -107.09 -12.92 15.3 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.565 0.746 . . . . 63.41 111.587 -175.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 34' ' ' ASP . 15.0 tt -156.77 108.81 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 CA-C-O 121.325 0.583 . . . . 74.23 110.495 175.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.437 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 23.5 p -133.62 145.96 50.48 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.678 0.391 . . . . 73.42 111.284 -172.134 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 18.4 p-90 -72.58 148.98 44.39 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.226 1.011 . . . . 74.03 111.194 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 25.3 p -70.94 153.1 94.89 Favored Pre-proline 0 CA--C 1.554 1.129 0 C-N-CA 123.19 0.596 . . . . 70.51 110.088 173.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -46.63 -31.9 10.96 Favored 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 123.333 2.688 . . . . 65.04 113.191 171.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.9 t -71.31 -60.47 2.21 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.514 -0.767 . . . . 70.54 109.517 170.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 103.53 19.45 12.26 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-N 115.513 -0.767 . . . . 65.53 113.706 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -101.64 6.6 42.07 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.58 0.752 . . . . 72.2 110.491 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.6 p -160.13 164.32 33.07 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 123.984 0.914 . . . . 53.2 109.431 -173.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 54.1 p90 -142.38 144.4 33.13 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.54 0.336 . . . . 74.43 111.176 178.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.47 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 59.3 m-70 -97.27 149.43 22.06 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.317 1.047 . . . . 74.33 108.813 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 98' ' ' ASP . 62.8 t -126.82 114.69 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.813 -0.81 . . . . 73.35 108.813 178.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -111.04 149.34 30.88 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.367 1.067 . . . . 73.14 110.227 -176.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.591 ' HB2' HD22 ' A' ' 36' ' ' LEU . 3.9 m-20 52.72 55.03 9.6 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 124.561 1.163 . . . . 71.44 110.061 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.534 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 78.3 mt-30 -55.3 -25.21 32.87 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 114.326 1.232 . . . . 52.21 114.326 -169.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.75 -44.56 56.33 Favored Glycine 0 CA--C 1.533 1.206 0 N-CA-C 111.923 -0.471 . . . . 65.34 111.923 173.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -70.5 -45.06 66.36 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.78 0.832 . . . . 74.31 109.853 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.434 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 69.2 t80 -48.44 -52.85 20.16 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.384 1.474 . . . . 74.32 111.689 173.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.488 ' HB2' ' HB2' ' A' ' 68' ' ' MET . . . -62.61 -33.3 74.73 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 116.336 -0.393 . . . . 44.33 111.693 178.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.1 tmtm? -73.38 -41.88 62.84 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 124.208 1.003 . . . . 54.53 113.244 -176.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.561 ' HG3' HG23 ' A' ' 58' ' ' VAL . 4.1 pt-20 -111.15 -39.63 4.69 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 113.583 0.957 . . . . 70.04 113.583 -172.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.561 HG23 ' HG3' ' A' ' 57' ' ' GLU . 66.3 t -80.28 -46.76 21.66 Favored 'Isoleucine or valine' 0 C--O 1.248 0.987 0 C-N-CA 123.725 0.81 . . . . 71.34 111.351 -168.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 54.9 mt -67.19 -41.7 35.73 Favored Pre-proline 0 CA--C 1.557 1.22 0 CA-C-O 118.326 -0.845 . . . . 74.32 112.757 -176.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.53 -17.58 53.34 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 121.941 1.761 . . . . 45.11 114.011 170.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -72.6 -57.88 3.79 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 117.858 0.299 . . . . 71.31 110.629 176.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.459 ' CD1' HD13 ' A' ' 27' ' ' LEU . 37.5 m-85 -86.26 -40.26 15.71 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 112.14 0.422 . . . . 74.14 112.14 -175.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.418 ' HE1' ' HA ' ' A' ' 20' ' ' PHE . 48.8 m-85 -106.98 -178.17 3.57 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.749 -0.834 . . . . 74.04 108.749 -178.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -119.17 54.58 0.97 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 122.436 1.113 . . . . 74.02 109.557 -176.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -170.7 171.7 6.1 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.673 1.589 . . . . 73.31 107.81 178.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -117.95 -24.48 7.07 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 122.29 -0.257 . . . . 65.22 111.071 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -63.53 125.93 25.84 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.345 0.658 . . . . 74.1 112.054 -173.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.534 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 25.3 ttt -86.68 -29.63 22.33 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.388 0.675 . . . . 70.13 111.646 -176.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.37 -34.45 70.7 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 122.799 0.439 . . . . 43.34 111.36 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.448 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 44.1 t -66.74 -45.31 79.05 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.275 1.03 . . . . 70.33 110.789 173.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -63.14 -46.86 85.25 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.442 1.097 . . . . 75.21 110.565 -176.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 80.5 t -60.99 -45.31 98.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.23 1.012 . . . . 63.22 110.947 174.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -62.52 -32.6 73.56 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.781 0.432 . . . . 73.34 111.318 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.461 ' HA ' ' HE2' ' A' ' 77' ' ' MET . 29.1 mm-40 -62.94 -51.71 65.84 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 109.903 -0.406 . . . . 74.3 109.903 172.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.9 mt -58.92 -38.0 77.95 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.859 0.864 . . . . 72.11 111.779 -177.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -59.13 -43.74 91.99 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.484 0.713 . . . . 73.12 111.075 175.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.461 ' HE2' ' HA ' ' A' ' 74' ' ' GLN . 43.6 mtm -67.29 -35.48 79.55 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.73 -0.668 . . . . 71.14 110.366 175.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -80.1 8.73 6.6 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 123.525 0.73 . . . . 63.15 110.917 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.29 4.82 87.8 Favored Glycine 0 C--N 1.351 1.41 0 N-CA-C 114.511 0.564 . . . . 51.51 114.511 169.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.55 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . 39.8 m-85 -74.09 141.27 45.67 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 108.939 -0.763 . . . . 74.12 108.939 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.499 ' HB3' ' HG2' ' A' ' 102' ' ' GLN . 32.7 ttm180 -101.6 129.07 47.63 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.774 0.43 . . . . 72.44 110.101 -173.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -71.92 111.54 7.26 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.897 1.279 . . . . 63.42 109.855 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.2 t -126.19 136.26 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 107.72 -1.215 . . . . 65.11 107.72 172.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 96.3 t -119.28 139.46 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.355 0.662 . . . . 74.14 109.322 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 71.9 m80 . . . . . 0 N--CA 1.48 1.06 0 C-N-CA 122.841 0.456 . . . . 74.54 110.704 -178.378 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.446 ' HB2' ' H ' ' A' ' 50' ' ' ASP . 5.3 ptp180 . . . . . 0 N--CA 1.471 0.597 0 N-CA-C 109.832 -0.432 . . . . 74.21 109.832 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -40.43 123.13 1.73 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.056 0.943 . . . . 74.11 111.118 171.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 22.0 t70 -112.3 134.88 53.59 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.386 -0.598 . . . . 73.13 109.386 178.062 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 73.9 m -133.9 128.53 34.75 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.049 -0.723 . . . . 64.02 109.049 166.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 46' ' ' PHE . 33.7 tt0 -104.46 117.09 33.32 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.02 -1.104 . . . . 74.43 108.02 170.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.55 ' HB3' ' HB3' ' A' ' 80' ' ' PHE . 97.7 m-85 -95.85 120.01 35.36 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.668 -1.234 . . . . 75.13 107.668 173.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.499 ' HG2' ' HB3' ' A' ' 81' ' ' ARG . 13.3 pt20 -115.74 136.45 53.05 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 123.182 0.593 . . . . 73.23 110.06 -174.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 52.5 t60 -156.43 128.73 4.07 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 123.021 0.529 . . . . 72.51 109.764 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.36 -39.74 44.68 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 123.089 2.526 . . . . 64.33 112.647 -174.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.516 ' HB2' HG12 ' A' ' 117' ' ' ILE . 3.4 m -81.66 -4.18 55.49 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.313 0.645 . . . . 73.14 110.754 -175.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -99.07 106.9 19.17 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 108.04 -1.096 . . . . 74.33 108.04 176.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.568 ' HB2' ' HB3' ' A' ' 110' ' ' GLN . 74.4 mt -117.1 141.59 48.07 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.733 -0.84 . . . . 71.51 108.733 169.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -60.32 -30.5 69.54 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 124.414 1.071 . . . . 54.42 112.69 -170.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -130.03 39.42 1.82 Allowed Glycine 0 C--N 1.345 1.032 0 N-CA-C 111.697 -0.561 . . . . 73.04 111.697 -178.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.568 ' HB3' ' HB2' ' A' ' 107' ' ' LEU . 3.0 tp-100 -141.58 74.09 1.44 Allowed 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.338 -0.986 . . . . 70.1 108.338 178.114 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -65.31 -22.78 66.87 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 114.895 -1.048 . . . . 74.21 112.795 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -71.45 -16.97 62.4 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.874 0.47 . . . . 75.24 112.258 -178.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.7 mt -93.49 -7.13 45.24 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 112.071 0.397 . . . . 73.41 112.071 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.473 HD11 ' HB2' ' A' ' 25' ' ' TRP . 66.4 mt -71.07 -27.63 63.76 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.612 0.365 . . . . 61.34 111.368 177.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -76.29 -3.69 38.0 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 112.097 0.406 . . . . 73.15 112.097 176.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -101.43 -6.96 23.33 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.945 0.898 . . . . 61.24 109.893 174.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.516 HG12 ' HB2' ' A' ' 105' ' ' CYS . 54.4 mt -87.55 117.33 31.3 Favored 'Isoleucine or valine' 0 C--N 1.354 0.79 0 N-CA-C 107.684 -1.228 . . . . 62.23 107.684 173.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -106.58 140.26 39.74 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 109.347 -0.612 . . . . 63.33 109.347 -174.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 . . . . . 0 N--CA 1.482 1.172 0 CA-C-O 121.682 0.753 . . . . 55.42 111.286 174.611 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 57.2 t . . . . . 0 CA--C 1.548 0.897 0 CA-C-O 118.632 -0.699 . . . . 71.12 109.136 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -50.26 133.63 36.45 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.886 2.391 . . . . 61.41 111.868 168.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.42 -38.41 59.03 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.62 1.168 . . . . 45.15 112.031 -178.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -52.14 -49.22 64.16 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 124.166 0.916 . . . . 71.33 111.638 174.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.439 HD13 ' HB ' ' A' ' 117' ' ' ILE . 95.2 mt -77.41 -43.14 33.62 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.259 0.624 . . . . 73.32 112.026 -170.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.0 t -64.35 -41.33 96.81 Favored 'General case' 0 CA--C 1.551 1.017 0 O-C-N 123.22 0.325 . . . . 74.25 110.71 -178.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -77.38 -27.1 52.41 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.9 0.48 . . . . 75.11 111.114 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.485 ' O ' HG23 ' A' ' 28' ' ' VAL . 60.7 tp -59.16 -50.35 74.39 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.566 0.541 . . . . 75.33 111.078 172.055 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.424 ' HH2' ' HG3' ' A' ' 108' ' ' ARG . 34.7 t-105 -63.52 -40.7 97.73 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-N 117.777 0.262 . . . . 74.31 111.405 177.087 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.6 m -57.34 -37.08 72.01 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-O 121.579 0.704 . . . . 60.54 110.402 176.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.518 HD11 HG13 ' A' ' 58' ' ' VAL . 35.3 tp -70.58 -45.46 65.35 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.358 1.463 . . . . 65.21 112.31 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 24' ' ' LEU . 91.8 t -62.02 -35.34 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 123.437 0.695 . . . . 72.4 111.066 177.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.6 t -90.22 -0.09 57.45 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.944 0.898 . . . . 64.35 111.809 -177.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -84.36 127.11 67.49 Favored Pre-proline 0 N--CA 1.483 1.191 0 C-N-CA 123.036 0.534 . . . . 43.24 110.47 -178.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.67 -20.62 17.5 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.743 2.295 . . . . 41.44 113.306 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -81.54 -22.82 37.61 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.128 0.571 . . . . 64.05 111.42 -176.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.7 p -111.88 6.73 19.73 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.353 0.661 . . . . 62.51 112.258 177.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.423 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 0.6 OUTLIER -59.51 -29.75 68.09 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.041 0.537 . . . . 61.02 111.914 -174.357 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.69 -28.66 70.09 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.825 0.85 . . . . 72.32 112.181 -177.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.462 HD22 ' HB2' ' A' ' 50' ' ' ASP . 87.9 mt -116.21 -9.96 11.53 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.245 0.618 . . . . 75.12 111.702 -177.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 34' ' ' ASP . 17.3 tt -160.43 118.91 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 121.312 0.577 . . . . 74.42 110.837 171.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.4 p -148.69 151.78 35.51 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.568 0.747 . . . . 72.0 109.502 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 7.7 p-90 -70.13 152.46 44.28 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.29 0.636 . . . . 73.33 110.213 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.5 m -71.71 154.3 93.05 Favored Pre-proline 0 CA--C 1.561 1.389 0 C-N-CA 123.818 0.847 . . . . 74.13 110.097 173.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -40.08 -46.67 4.03 Favored 'Trans proline' 0 C--N 1.389 2.663 0 C-N-CA 124.403 3.402 . . . . 75.52 114.994 -175.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 30.5 t -80.21 -41.27 25.52 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 122.697 0.399 . . . . 72.54 110.331 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.82 28.21 7.96 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-N 116.04 -0.527 . . . . 71.23 113.186 176.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -82.54 -10.69 58.88 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.582 0.753 . . . . 73.31 110.776 174.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.457 ' HB3' ' HB3' ' A' ' 102' ' ' GLN . 68.2 p -155.72 -176.79 6.13 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 123.741 0.816 . . . . 74.31 110.135 -177.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -141.95 145.97 35.11 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.376 0.671 . . . . 72.11 110.191 175.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 54.1 m-70 -97.64 147.66 24.09 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.059 0.944 . . . . 63.11 108.844 176.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 95.1 t -125.08 123.11 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.689 1.196 . . . . 72.43 108.095 175.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.459 ' HB2' ' HA ' ' A' ' 36' ' ' LEU . 97.0 m-85 -110.35 147.34 34.13 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.675 0.79 . . . . 54.13 110.867 -177.13 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.462 ' HB2' HD22 ' A' ' 36' ' ' LEU . 6.4 m-20 50.52 68.32 0.79 Allowed 'General case' 0 CA--C 1.541 0.62 0 O-C-N 124.922 1.389 . . . . 71.23 111.812 174.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -47.81 -32.81 6.48 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.729 1.211 . . . . 75.22 114.036 -173.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.4 -44.86 50.23 Favored Glycine 0 CA--C 1.531 1.07 0 O-C-N 123.397 0.435 . . . . 65.31 112.706 176.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -74.04 -44.92 52.61 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.554 0.741 . . . . 72.22 110.182 -176.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.404 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 69.1 t80 -49.56 -50.93 40.26 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.482 1.513 . . . . 74.22 111.209 169.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.498 ' HB2' ' HB2' ' A' ' 68' ' ' MET . . . -62.09 -35.52 78.92 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 116.196 -0.456 . . . . 53.34 111.872 178.334 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -68.33 -46.82 69.15 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.27 1.028 . . . . 64.32 112.642 -175.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.452 ' HG3' HG23 ' A' ' 58' ' ' VAL . 11.9 pt-20 -115.16 -34.84 4.88 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 114.175 1.176 . . . . 72.3 114.175 -171.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.518 HG13 HD11 ' A' ' 27' ' ' LEU . 92.2 t -82.23 -42.27 18.62 Favored 'Isoleucine or valine' 0 C--O 1.247 0.929 0 C-N-CA 123.24 0.616 . . . . 70.4 110.987 -169.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 43.4 mt -66.02 -48.77 59.74 Favored Pre-proline 0 CA--C 1.558 1.272 0 CA-C-O 117.915 -1.041 . . . . 65.4 112.363 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -67.63 -13.95 40.49 Favored 'Trans proline' 0 C--N 1.384 2.432 0 CA-C-N 121.934 1.726 . . . . 45.31 113.046 175.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -72.64 -59.03 2.92 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.102 0.561 . . . . 74.2 110.119 176.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.475 ' CD1' HD13 ' A' ' 27' ' ' LEU . 37.2 m-85 -89.73 -47.99 7.56 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 112.405 0.521 . . . . 74.41 112.405 -179.056 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -93.82 -177.92 4.51 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 108.498 -0.927 . . . . 73.35 108.498 -178.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -116.93 43.79 2.2 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.778 -0.576 . . . . 74.11 110.159 -173.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 26.9 p80 -165.3 164.0 19.94 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.384 1.074 . . . . 73.41 108.832 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.477 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 1.5 m-20 -117.38 -12.71 10.42 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.007 0.523 . . . . 62.41 110.39 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -71.13 122.03 19.38 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.524 0.729 . . . . 72.13 109.738 178.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.498 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 22.8 ttt -90.92 -18.66 24.36 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.665 0.386 . . . . 75.02 111.472 -175.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.06 -37.61 72.07 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.848 0.459 . . . . 55.11 110.705 173.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.7 t -65.02 -44.04 90.48 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.446 1.098 . . . . 61.51 110.863 174.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -64.49 -53.24 51.26 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.351 1.06 . . . . 52.3 111.005 -175.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 66.7 t -63.05 -40.78 90.36 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 123.639 0.776 . . . . 75.12 111.317 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 -57.96 -38.64 76.37 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.13 0.572 . . . . 75.35 111.563 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -60.9 -49.67 76.51 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 123.789 0.681 . . . . 74.41 110.574 175.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 78.3 mt -61.22 -40.5 94.22 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.794 0.838 . . . . 75.34 111.618 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -57.75 -42.43 83.97 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.954 0.902 . . . . 74.23 111.454 175.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 70.8 mtm -74.59 -31.02 61.91 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.569 -0.741 . . . . 73.22 110.96 177.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -82.54 7.02 15.64 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.764 0.825 . . . . 62.25 110.857 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.1 10.37 82.8 Favored Glycine 0 C--N 1.347 1.181 0 N-CA-C 115.026 0.77 . . . . 61.34 115.026 168.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -71.98 138.49 48.03 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 117.638 0.719 . . . . 72.35 110.763 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 35.4 ttm-85 -100.45 122.53 43.33 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.927 -0.768 . . . . 74.12 108.927 -177.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.523 ' HE3' HG23 ' A' ' 99' ' ' THR . 1.3 tmtp? -78.92 123.24 27.07 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.777 1.231 . . . . 71.51 108.898 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 89.7 t -133.4 117.06 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.639 1.176 . . . . 74.24 108.058 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.6 p -102.92 126.21 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 109.118 -0.697 . . . . 54.15 109.118 -176.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 . . . . . 0 N--CA 1.488 1.454 0 C-N-CA 123.254 0.622 . . . . 74.03 110.626 -174.697 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 . . . . . 0 C--O 1.246 0.88 0 N-CA-C 107.849 -1.167 . . . . 74.14 107.849 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 5.1 m-20 -80.82 142.99 33.14 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.798 -0.815 . . . . 73.23 108.798 -179.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -135.67 122.67 21.39 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.343 -0.984 . . . . 75.45 108.343 167.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.523 HG23 ' HE3' ' A' ' 82' ' ' LYS . 24.1 m -136.9 114.08 10.72 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 109.236 -0.653 . . . . 51.44 109.236 177.289 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -103.91 111.88 24.61 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.857 -0.794 . . . . 65.41 108.857 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -97.26 129.29 44.59 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 109.072 -0.714 . . . . 63.23 109.072 175.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.457 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 19.3 pt20 -123.71 150.06 44.78 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.907 0.883 . . . . 72.12 109.533 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -156.68 135.55 7.8 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 108.357 -0.979 . . . . 71.32 108.357 175.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -59.82 -31.16 93.52 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.744 2.296 . . . . 75.03 112.823 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.503 ' HB2' HG12 ' A' ' 117' ' ' ILE . 5.2 m -92.1 7.75 40.98 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 122.953 0.501 . . . . 44.31 111.415 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -123.79 101.45 7.28 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 108.297 -1.001 . . . . 75.42 108.297 174.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 52.8 mt -126.27 174.17 8.75 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.49 0.716 . . . . 72.11 109.359 173.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.424 ' HG3' ' HH2' ' A' ' 25' ' ' TRP . 71.5 ttt180 -76.35 109.27 9.92 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.696 1.198 . . . . 72.52 110.84 -177.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.18 35.44 30.22 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 111.578 -0.609 . . . . 63.24 111.578 -177.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -132.88 42.67 3.05 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.205 -1.035 . . . . 64.33 108.205 -171.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.622 ' HA ' ' HG ' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -67.51 -21.18 65.5 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 114.134 -1.393 . . . . 72.55 112.531 -176.966 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.6 pm0 -72.16 -13.3 61.52 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.943 0.497 . . . . 65.42 111.713 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 31.9 mt -94.34 -7.4 41.86 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 112.236 0.458 . . . . 72.04 112.236 173.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.622 ' HG ' ' HA ' ' A' ' 111' ' ' GLU . 44.7 mt -72.12 -27.8 62.86 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 118.006 0.367 . . . . 74.14 111.63 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -65.34 -19.25 65.87 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.16 0.584 . . . . 73.02 111.466 173.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -93.77 -10.85 32.81 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.327 0.651 . . . . 75.21 110.209 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.503 HG12 ' HB2' ' A' ' 105' ' ' CYS . 43.2 mt -84.86 124.83 40.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 108.051 -1.092 . . . . 73.41 108.051 177.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -126.75 145.98 50.4 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.429 0.691 . . . . 74.4 109.711 -173.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 . . . . . 0 N--CA 1.474 0.742 0 CA-C-N 115.395 -0.82 . . . . 73.3 109.236 169.626 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 70.7 t . . . . . 0 CA--C 1.554 1.131 0 CA-C-O 119.28 -0.391 . . . . 71.14 111.246 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -59.15 139.4 90.25 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 122.937 2.425 . . . . 72.13 112.039 173.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.7 -39.76 71.47 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.22 1.008 . . . . 52.44 112.294 -178.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -53.79 -45.86 70.85 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.109 0.564 . . . . 73.53 111.293 174.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 79.9 mt -76.32 -34.75 59.01 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 119.051 -0.5 . . . . 74.21 112.31 -172.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.6 t -71.13 -35.25 71.66 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 118.069 0.395 . . . . 73.12 110.369 177.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.551 ' HE2' ' HA ' ' A' ' 23' ' ' LYS . 8.3 mmpt? -70.63 -42.35 71.02 Favored 'General case' 0 C--N 1.353 0.751 0 C-N-CA 122.813 0.445 . . . . 71.43 110.678 176.154 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 28' ' ' VAL . 67.4 tp -59.94 -49.2 78.61 Favored 'General case' 0 N--CA 1.478 0.962 0 O-C-N 124.183 0.927 . . . . 71.22 111.172 175.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 90.8 t90 -53.99 -51.04 65.19 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.806 1.243 . . . . 75.4 111.182 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 64.2 m -64.92 -36.45 84.4 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.144 0.978 . . . . 72.21 111.512 177.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.408 ' HG ' HD13 ' A' ' 37' ' ' ILE . 32.2 tp -62.97 -51.04 68.4 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.673 1.189 . . . . 72.13 111.646 -178.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 24' ' ' LEU . 87.6 t -58.85 -35.69 57.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 124.609 1.164 . . . . 45.02 111.198 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 83.2 p -92.36 1.94 56.94 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.308 -0.86 . . . . 73.21 112.534 -174.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -89.98 134.2 32.27 Favored Pre-proline 0 CA--C 1.557 1.245 0 C-N-CA 123.035 0.534 . . . . 74.1 111.581 -174.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.78 -33.86 26.07 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 123.228 2.618 . . . . 73.13 114.236 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -70.54 -35.95 73.4 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.114 0.566 . . . . 52.44 110.916 -176.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.0 p -98.98 -0.02 42.96 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.776 -0.647 . . . . 71.11 111.208 -177.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -55.42 -32.4 62.67 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.54 1.136 . . . . 41.21 112.337 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.9 -36.52 83.65 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.455 0.702 . . . . 64.32 112.15 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.425 HD22 ' HB2' ' A' ' 50' ' ' ASP . 85.0 mt -109.07 -8.24 15.21 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.204 0.602 . . . . 74.25 111.48 -175.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.408 HD13 ' HG ' ' A' ' 27' ' ' LEU . 18.6 tt -160.56 118.3 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.037 0.535 . . . . 75.33 110.457 174.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 12.7 p -137.41 146.74 44.78 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.525 0.73 . . . . 33.43 109.75 -176.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 25.2 p-90 -71.24 147.37 48.29 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.013 0.525 . . . . 74.52 110.888 177.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.1 m -79.74 151.21 73.75 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 108.902 -0.777 . . . . 53.32 108.902 173.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.83 -19.59 55.17 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.674 2.249 . . . . 65.51 113.618 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 64.0 m -66.61 -35.64 80.67 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.146 0.578 . . . . 42.25 111.112 172.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.04 -2.69 74.3 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 115.784 -0.643 . . . . 25.24 113.877 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -97.55 3.26 50.63 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.116 0.966 . . . . 54.24 110.022 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.3 p -158.03 169.56 24.28 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 123.806 0.842 . . . . 74.21 110.397 -170.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -150.33 153.38 35.98 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.909 0.884 . . . . 65.53 110.233 176.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -101.8 144.46 30.44 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.945 0.898 . . . . 71.25 109.277 176.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 97.8 t -122.75 120.86 61.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 124.928 1.291 . . . . 74.44 107.612 177.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 91.1 m-85 -106.01 146.84 29.57 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 123.905 0.882 . . . . 75.3 109.854 -176.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.425 ' HB2' HD22 ' A' ' 36' ' ' LEU . 15.4 m-20 52.36 65.24 1.56 Allowed 'General case' 0 C--N 1.353 0.73 0 O-C-N 124.911 1.382 . . . . 45.1 111.613 171.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.404 ' HB3' ' HG2' ' A' ' 68' ' ' MET . 22.2 mt-30 -52.72 -28.54 22.47 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 113.096 0.776 . . . . 73.3 113.096 -173.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -67.84 -48.34 55.61 Favored Glycine 0 C--N 1.344 0.997 0 O-C-N 123.343 0.402 . . . . 61.34 112.155 176.142 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -73.18 -45.53 55.93 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.31 0.644 . . . . 63.1 110.278 -178.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -54.04 -51.17 64.9 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.638 1.575 . . . . 71.44 111.574 176.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.532 ' HB2' ' HB2' ' A' ' 68' ' ' MET . . . -67.41 -29.73 69.3 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.307 0.484 . . . . 63.14 112.307 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -72.06 -43.21 65.25 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.971 0.909 . . . . 70.44 111.97 -177.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.553 ' HG3' HG23 ' A' ' 58' ' ' VAL . 7.0 pt-20 -109.02 -45.73 3.73 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 113.182 0.808 . . . . 75.21 113.182 -176.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.553 HG23 ' HG3' ' A' ' 57' ' ' GLU . 95.8 t -77.03 -42.3 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.42 0.688 . . . . 72.23 111.674 -167.077 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.2 mt -64.75 -49.49 69.16 Favored Pre-proline 0 CA--C 1.557 1.219 0 CA-C-O 117.946 -1.026 . . . . 61.45 112.384 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.93 -7.27 21.03 Favored 'Trans proline' 0 C--N 1.388 2.619 0 CA-C-N 121.743 1.658 . . . . 70.2 112.846 174.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -79.95 -66.63 0.85 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.112 0.565 . . . . 73.03 110.81 174.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -79.0 -40.15 32.26 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.257 0.623 . . . . 74.34 111.53 -176.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -105.06 -169.89 1.67 Allowed 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 108.138 -1.06 . . . . 61.11 108.138 178.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -126.32 45.26 2.69 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.513 0.673 . . . . 74.53 110.337 -174.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 -159.16 161.78 36.29 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 115.109 -0.951 . . . . 74.22 108.973 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.502 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 1.6 m-20 -114.16 -19.8 11.19 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.568 0.347 . . . . 63.32 111.598 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -71.31 114.15 9.09 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.414 0.286 . . . . 74.13 111.062 -173.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.532 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 13.9 tpt -65.82 -37.55 86.54 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.255 1.022 . . . . 75.42 111.353 -177.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.17 -35.03 72.84 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.148 0.579 . . . . 62.21 111.168 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.482 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 45.1 t -68.44 -38.73 81.42 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.588 0.755 . . . . 73.03 111.004 176.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -65.29 -50.91 63.92 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.117 0.967 . . . . 71.11 110.627 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.5 t -63.41 -36.36 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.444 0.698 . . . . 63.0 110.059 177.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.9 ttp180 -57.46 -41.54 80.77 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.987 0.915 . . . . 75.34 110.605 175.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.545 ' HA ' ' HE2' ' A' ' 77' ' ' MET . 26.3 mm-40 -61.89 -47.34 85.44 Favored 'General case' 0 C--N 1.357 0.912 0 N-CA-C 109.644 -0.502 . . . . 73.04 109.644 177.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.422 ' HB3' ' HB2' ' A' ' 80' ' ' PHE . 89.6 mt -61.91 -38.26 87.73 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.618 0.767 . . . . 75.1 111.106 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -58.55 -39.87 81.46 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.95 0.9 . . . . 75.5 110.537 174.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.545 ' HE2' ' HA ' ' A' ' 74' ' ' GLN . 48.6 mtm -66.21 -41.7 89.77 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.715 0.406 . . . . 51.43 110.351 174.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -80.97 2.84 25.16 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.61 0.764 . . . . 74.14 111.614 -174.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.62 19.76 61.25 Favored Glycine 0 C--N 1.346 1.094 0 N-CA-C 114.761 0.664 . . . . 62.13 114.761 171.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.422 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 42.0 m-85 -78.15 145.4 35.69 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.123 -0.695 . . . . 74.51 109.123 176.104 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -99.46 123.43 43.73 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.682 0.793 . . . . 70.44 109.035 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -75.62 110.7 10.24 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.031 1.332 . . . . 70.55 109.278 177.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.6 t -123.19 132.65 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 108.407 -0.96 . . . . 50.42 108.407 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 85.6 t -125.83 121.37 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.121 0.968 . . . . 74.0 108.57 175.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 . . . . . 0 N--CA 1.481 1.087 0 C-N-CA 123.122 0.569 . . . . 75.35 111.343 -177.476 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 . . . . . 0 N--CA 1.469 0.484 0 N-CA-C 108.513 -0.921 . . . . 64.34 108.513 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 4.1 m-20 -84.31 141.41 30.94 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.612 -0.514 . . . . 71.54 109.612 175.009 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -140.9 106.87 5.16 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.957 -1.127 . . . . 74.15 107.957 169.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 77.4 m -122.57 117.25 25.43 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.377 0.671 . . . . 53.04 110.486 -178.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -99.46 106.27 18.29 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.842 -0.799 . . . . 72.51 108.842 -177.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -95.14 122.09 37.45 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.919 -0.771 . . . . 73.45 108.919 176.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -122.63 144.35 49.18 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.939 0.896 . . . . 54.13 110.803 -174.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 65.1 t60 -159.06 131.24 4.25 Favored Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 123.741 0.816 . . . . 74.2 109.757 176.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.35 -31.49 62.41 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 123.156 2.57 . . . . 54.22 114.118 -174.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 82.0 m -94.0 8.42 41.46 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 122.384 0.274 . . . . 72.44 111.438 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -109.02 100.38 9.58 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.823 -1.177 . . . . 65.21 107.823 173.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.408 ' HB2' ' HB2' ' A' ' 110' ' ' GLN . 80.0 mt -118.35 132.41 56.27 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.306 0.642 . . . . 62.51 109.501 175.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -66.97 114.26 5.63 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 107.895 -1.15 . . . . 73.12 107.895 174.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 106.89 -12.86 41.64 Favored Glycine 0 N--CA 1.472 1.04 0 CA-C-O 119.944 -0.365 . . . . 64.45 113.083 -177.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.408 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 15.6 mm-40 -107.98 79.44 1.27 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 117.374 0.587 . . . . 73.41 110.305 176.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -59.44 -32.96 70.7 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.307 1.043 . . . . 73.2 112.563 175.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.9 pm0 -67.32 -26.12 66.35 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.433 0.693 . . . . 72.14 112.255 -177.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 76.8 mt -86.39 -6.76 58.86 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 122.122 -0.362 . . . . 72.42 111.571 -175.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 75.8 mt -65.37 -33.84 76.92 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.087 0.555 . . . . 71.24 111.135 175.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -82.44 -1.54 50.49 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.509 0.324 . . . . 74.24 111.78 176.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -92.4 -15.22 27.52 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.457 0.703 . . . . 73.1 109.407 172.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 55.2 mt -82.0 114.27 22.64 Favored 'Isoleucine or valine' 0 C--N 1.355 0.812 0 N-CA-C 108.269 -1.011 . . . . 72.53 108.269 176.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -103.48 137.43 41.57 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.1 -0.704 . . . . 75.21 109.1 -176.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 14.3 ptt-85 . . . . . 0 N--CA 1.474 0.751 0 C-N-CA 122.626 0.37 . . . . 65.5 110.911 176.119 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 66.2 t . . . . . 0 CA--C 1.537 0.455 0 N-CA-C 107.894 -1.15 . . . . 71.04 107.894 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.535 ' HD2' HD12 ' A' ' 21' ' ' LEU . 50.8 Cg_exo -55.88 142.3 84.44 Favored 'Trans proline' 0 C--N 1.368 1.588 0 C-N-CA 122.346 2.031 . . . . 53.01 111.856 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.92 -36.93 40.98 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.185 0.928 . . . . 45.43 111.081 175.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -55.41 -47.36 76.02 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.901 0.88 . . . . 74.13 112.028 174.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.535 HD12 ' HD2' ' A' ' 18' ' ' PRO . 55.7 mt -77.88 -35.31 50.97 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.682 0.393 . . . . 72.2 111.932 -172.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.4 t -72.11 -36.03 69.34 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 117.48 0.127 . . . . 75.43 110.962 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.573 ' HB3' ' HB3' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -69.01 -42.49 76.37 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 122.733 0.413 . . . . 72.42 109.964 173.672 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.46 ' O ' HG23 ' A' ' 28' ' ' VAL . 63.6 tp -59.46 -40.12 85.84 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.976 0.911 . . . . 63.02 111.251 176.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 70.6 t-105 -60.97 -53.37 58.14 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 123.275 0.63 . . . . 70.43 111.452 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.4 m -60.89 -28.85 69.2 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 115.01 -0.995 . . . . 50.4 110.638 178.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.553 HD11 HG13 ' A' ' 58' ' ' VAL . 30.0 tp -72.78 -50.04 26.89 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.291 1.436 . . . . 71.13 112.445 -178.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 24' ' ' LEU . 99.3 t -60.18 -29.87 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 123.672 0.789 . . . . 75.11 111.482 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.6 t -100.56 3.19 42.54 Favored 'General case' 0 CA--C 1.563 1.477 0 C-N-CA 124.062 0.945 . . . . 63.0 112.313 -176.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -85.38 134.01 41.26 Favored Pre-proline 0 N--CA 1.498 1.969 0 C-N-CA 123.942 0.897 . . . . 44.32 112.09 -176.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -77.92 -10.41 16.76 Favored 'Trans proline' 0 C--N 1.384 2.425 0 C-N-CA 123.233 2.622 . . . . 62.51 114.362 -175.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -87.67 -26.02 23.21 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 118.122 0.419 . . . . 63.0 110.446 174.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.6 p -117.07 -1.94 11.8 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.32 0.859 . . . . 74.43 113.32 -173.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.423 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 9.3 p-10 -62.06 -28.37 69.55 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 118.261 0.482 . . . . 73.55 111.904 -177.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.7 -25.77 67.46 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.597 0.759 . . . . 65.14 113.011 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.8 mt -116.0 -5.57 11.98 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.076 0.551 . . . . 75.21 112.045 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 34' ' ' ASP . 17.7 tt -160.19 115.25 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-O 121.381 0.61 . . . . 74.34 110.924 173.005 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 29.7 p -150.45 156.82 42.2 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.982 -0.747 . . . . 64.11 108.982 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 32.5 p-90 -74.96 152.41 38.79 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.711 0.804 . . . . 74.11 109.896 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.0 m -76.85 148.47 79.15 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 123.589 0.755 . . . . 61.52 110.401 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.82 -33.36 13.92 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 123.625 2.883 . . . . 74.42 116.102 178.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.1 m -76.83 -32.05 57.32 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.825 0.45 . . . . 64.34 110.511 175.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.17 -0.31 66.3 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-O 119.593 -0.559 . . . . 71.34 114.257 171.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 56.2 m-20 -87.91 -1.69 58.14 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.129 0.571 . . . . 70.52 111.251 -174.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 54.1 p -153.8 177.6 10.82 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.893 0.877 . . . . 71.51 110.434 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -141.64 149.64 40.92 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.245 0.618 . . . . 72.24 109.73 170.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -101.43 157.54 16.73 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.273 0.629 . . . . 73.21 109.371 177.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 98' ' ' ASP . 95.1 t -128.49 124.18 61.28 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 C-N-CA 124.8 1.24 . . . . 74.04 107.781 173.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -107.84 149.75 27.87 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.54 0.736 . . . . 74.34 109.891 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.0 t0 44.34 65.69 1.0 Allowed 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 125.486 1.514 . . . . 73.32 110.878 177.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.627 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 29.4 mt-30 -58.42 -21.04 49.46 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.364 0.876 . . . . 64.33 113.364 -172.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.54 -46.45 47.7 Favored Glycine 0 C--N 1.346 1.091 0 N-CA-C 112.275 -0.33 . . . . 44.2 112.275 173.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.405 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 58.2 tp60 -69.81 -44.51 69.87 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.523 -0.547 . . . . 72.44 109.523 177.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.526 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 54.6 t80 -52.54 -50.96 61.85 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.265 1.426 . . . . 71.12 111.297 175.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.445 ' HB1' ' O ' ' A' ' 66' ' ' ASN . . . -59.64 -37.35 78.43 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 121.106 0.479 . . . . 74.35 111.584 177.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -71.01 -49.26 47.07 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.594 1.158 . . . . 71.2 113.173 -175.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.503 ' HG3' HG23 ' A' ' 58' ' ' VAL . 6.5 pt-20 -105.81 -36.41 7.04 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 113.429 0.9 . . . . 64.34 113.429 -172.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.553 HG13 HD11 ' A' ' 27' ' ' LEU . 55.2 t -81.67 -43.82 20.05 Favored 'Isoleucine or valine' 0 C--O 1.251 1.161 0 C-N-CA 123.728 0.811 . . . . 62.35 111.611 -168.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 55.3 mt -67.2 -44.01 46.9 Favored Pre-proline 0 CA--C 1.553 1.072 0 CA-C-O 118.158 -0.925 . . . . 70.31 112.639 -178.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -70.6 -10.16 27.31 Favored 'Trans proline' 0 C--N 1.377 2.051 0 CA-C-N 121.833 1.69 . . . . 74.32 113.527 171.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -75.86 -49.41 18.03 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.275 0.63 . . . . 74.21 110.693 176.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.573 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 64.9 m-85 -102.34 -34.87 9.03 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 113.752 1.019 . . . . 74.15 113.752 -178.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -109.84 -177.58 3.31 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 108.904 -0.776 . . . . 63.22 108.904 -175.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -111.5 38.07 2.71 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.004 0.522 . . . . 70.25 110.951 -175.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -158.15 167.29 30.23 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.312 0.645 . . . . 75.44 109.684 -177.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.445 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 1.9 m-20 -121.33 -7.45 9.27 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.284 0.634 . . . . 74.52 110.768 176.083 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -78.7 120.19 23.01 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.119 0.568 . . . . 54.42 109.995 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.627 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 25.5 ttt -84.3 -18.72 35.39 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 116.79 -0.186 . . . . 71.21 111.267 -176.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -54.76 -38.74 67.57 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 122.971 0.508 . . . . 70.54 110.956 174.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.456 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 48.2 t -68.19 -44.67 75.32 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.034 -0.985 . . . . 53.33 111.188 174.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -59.44 -50.13 75.14 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.218 1.007 . . . . 64.13 110.46 -175.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.2 t -62.12 -45.91 97.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 114.932 -1.031 . . . . 63.34 111.119 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 54.2 ttt85 -58.33 -36.67 73.76 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 122.973 0.509 . . . . 71.42 111.516 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 70' ' ' SER . 31.3 mm-40 -61.67 -50.62 71.77 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 123.552 0.532 . . . . 71.23 109.701 176.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 98.1 mt -62.24 -33.55 74.8 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.628 0.771 . . . . 65.25 112.015 -177.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -56.9 -45.98 82.26 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 122.981 0.512 . . . . 71.21 110.866 170.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.455 ' HB3' ' O ' ' A' ' 119' ' ' ARG . 45.0 mtm -69.11 -28.84 66.84 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.294 0.638 . . . . 53.03 111.138 178.219 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -82.39 2.37 32.8 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.4 0.68 . . . . 71.24 110.975 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.71 1.86 79.73 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-O 119.201 -0.777 . . . . 73.35 114.405 171.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -72.04 142.45 49.28 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 117.752 0.776 . . . . 72.32 109.079 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -100.44 131.31 46.43 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.579 -0.526 . . . . 75.0 109.579 -176.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.573 ' HE3' HG22 ' A' ' 84' ' ' VAL . 50.2 tptt -69.59 108.2 3.74 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.417 1.487 . . . . 74.23 109.328 173.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.49 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 42.5 t -112.98 111.26 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 108.008 -1.108 . . . . 71.43 108.008 178.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.573 HG22 ' HE3' ' A' ' 82' ' ' LYS . 11.1 t -93.01 101.22 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.854 0.862 . . . . 63.11 109.004 -172.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 109.324 -0.621 . . . . 72.33 109.324 178.1 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 . . . . . 0 CA--C 1.554 1.11 0 CA-C-O 121.214 0.53 . . . . 75.1 110.417 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.571 ' HB2' ' H ' ' A' ' 51' ' ' GLN . 5.8 m-20 -41.41 109.56 0.13 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.007 1.323 . . . . 71.2 112.142 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.536 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 25.7 t70 -120.74 115.83 24.06 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.307 0.643 . . . . 63.51 109.882 -178.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.405 HG23 ' HD2' ' A' ' 82' ' ' LYS . 58.4 m -118.43 131.41 56.28 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 123.673 0.789 . . . . 74.42 109.209 172.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.49 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 42.0 tt0 -105.26 113.52 27.16 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.536 -1.283 . . . . 71.15 107.536 172.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -96.41 118.86 33.8 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.098 -1.075 . . . . 71.43 108.098 174.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -115.48 140.54 49.06 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.561 0.744 . . . . 43.13 110.539 -175.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -158.55 134.07 5.9 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 123.264 0.626 . . . . 62.45 109.346 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -65.07 -28.42 57.06 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.826 2.351 . . . . 75.43 112.953 -176.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 33.5 m -96.1 20.37 10.31 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.896 0.479 . . . . 74.21 110.579 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -127.07 101.13 6.4 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 107.598 -1.26 . . . . 74.34 107.598 169.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 110' ' ' GLN . 68.8 mt -108.31 170.41 8.03 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 109.323 -0.621 . . . . 71.43 109.323 174.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.77 -31.48 72.67 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 113.972 1.101 . . . . 73.12 113.972 -168.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -139.51 18.9 3.02 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-O 120.342 -0.143 . . . . 60.12 113.289 -175.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 17.4 mp0 -107.79 79.16 1.25 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.363 0.665 . . . . 62.33 110.041 -176.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -67.98 -27.7 66.8 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.364 1.066 . . . . 73.5 113.437 -177.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -71.28 -5.87 35.52 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.343 0.657 . . . . 53.52 111.866 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 72.7 mt -89.33 -6.65 56.51 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 122.972 0.509 . . . . 62.44 111.748 175.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 94.5 mt -68.23 -32.57 72.86 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 122.825 0.45 . . . . 51.43 111.231 176.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -74.12 -16.53 61.01 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.1 0.56 . . . . 72.13 111.109 175.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -79.95 -18.67 49.82 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.12 -0.696 . . . . 71.33 109.12 177.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 27.5 mt -98.51 122.27 50.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.667 0 C-N-CA 124.196 0.999 . . . . 74.41 108.677 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -113.07 153.47 28.11 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 108.98 -0.748 . . . . 70.43 108.98 176.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.455 ' O ' ' HB3' ' A' ' 77' ' ' MET . 13.3 ptp180 . . . . . 0 N--CA 1.483 1.209 0 CA-C-O 121.038 0.446 . . . . 64.42 110.029 175.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 74.0 t . . . . . 0 CA--C 1.554 1.101 0 CA-C-O 119.361 -0.352 . . . . 65.42 110.906 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.499 ' HD2' HD12 ' A' ' 21' ' ' LEU . 87.7 Cg_exo -52.77 143.46 47.55 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 123.537 2.825 . . . . 71.54 113.328 172.183 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.36 -40.29 64.84 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.373 1.069 . . . . 73.44 111.944 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -54.64 -48.94 71.66 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.177 0.591 . . . . 73.21 111.425 173.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.499 HD12 ' HD2' ' A' ' 18' ' ' PRO . 85.1 mt -75.36 -34.28 61.14 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 111.876 0.324 . . . . 70.34 111.876 -170.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.0 t -68.59 -38.83 80.96 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 117.579 0.172 . . . . 65.32 110.935 175.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.491 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -67.22 -42.09 84.64 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 122.412 0.285 . . . . 70.02 110.659 175.291 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.9 tp -58.32 -52.41 65.7 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.018 0.927 . . . . 75.31 111.822 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 84.3 t90 -56.62 -47.87 78.74 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.777 0.831 . . . . 71.53 111.107 -178.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 36.2 m -61.23 -37.03 81.6 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.998 -1.001 . . . . 73.11 111.159 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.2 tp -68.49 -44.75 74.06 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.414 1.085 . . . . 70.13 111.757 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.5 t -63.53 -42.26 95.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.1 0.96 . . . . 50.33 110.67 177.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.1 t -80.74 0.12 36.0 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-N 115.254 -0.884 . . . . 54.44 111.639 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -86.41 125.62 67.06 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.707 0.803 . . . . 63.13 110.639 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -82.84 -10.29 10.58 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.919 2.413 . . . . 60.31 114.177 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -82.49 -30.42 29.89 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.136 0.575 . . . . 64.1 111.455 -178.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 50.7 p -100.4 7.8 44.03 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.837 0.455 . . . . 61.23 110.659 -177.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.425 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 7.0 p-10 -58.3 -22.94 54.77 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.934 1.294 . . . . 74.22 112.897 -175.034 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.21 -38.22 82.65 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.803 0.841 . . . . 72.21 112.264 177.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 57.0 mt -117.66 -10.38 10.57 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.94 0.496 . . . . 74.55 111.954 -178.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 34' ' ' ASP . 17.1 tt -158.64 122.42 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-O 121.365 0.602 . . . . 74.22 111.913 175.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 53.8 t -152.39 158.95 43.41 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.666 0.786 . . . . 43.22 109.761 176.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 13.2 p-90 -70.82 153.23 42.93 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.669 0.788 . . . . 74.42 110.877 176.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.8 m -73.2 154.61 90.37 Favored Pre-proline 0 CA--C 1.553 1.077 0 CA-C-O 118.058 -0.972 . . . . 54.44 109.182 170.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -42.92 -31.34 2.18 Favored 'Trans proline' 0 C--N 1.388 2.617 0 C-N-CA 124.091 3.194 . . . . 64.21 115.821 -175.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 79.6 p -76.25 -49.51 16.87 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.972 0.509 . . . . 54.32 110.923 175.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.8 13.49 23.66 Favored Glycine 0 C--N 1.352 1.443 0 CA-C-N 115.606 -0.724 . . . . 52.34 113.557 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -94.5 -11.08 30.33 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.046 0.538 . . . . 64.02 111.137 -175.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.6 p -147.2 170.15 17.85 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.24 1.016 . . . . 71.24 109.146 -176.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -144.15 155.43 43.92 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.86 0.464 . . . . 70.43 110.798 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.402 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 52.6 m-70 -112.11 150.04 31.29 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.202 1.001 . . . . 62.44 109.32 -176.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.463 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 84.5 t -126.42 139.01 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 108.452 -0.944 . . . . 64.11 108.452 176.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -125.48 146.3 49.7 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.552 0.741 . . . . 73.02 109.061 176.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.4 t70 45.34 76.69 0.09 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.709 1.603 . . . . 70.22 112.019 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.606 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 53.3 mt-30 -51.05 -29.64 13.39 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.306 1.042 . . . . 64.31 113.023 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.99 -49.53 40.69 Favored Glycine 0 C--N 1.348 1.234 0 O-C-N 123.308 0.38 . . . . 64.51 112.835 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -75.16 -40.97 59.09 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.396 0.679 . . . . 61.02 110.222 -176.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -56.81 -48.84 77.05 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.282 1.433 . . . . 74.12 110.779 175.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' A' ' 66' ' ' ASN . . . -65.97 -28.84 69.2 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.19 0.441 . . . . 62.34 112.19 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -72.38 -46.35 55.71 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.797 0.839 . . . . 72.21 112.107 -177.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.523 ' HG3' HG23 ' A' ' 58' ' ' VAL . 7.1 pt-20 -110.11 -40.4 4.73 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 113.542 0.941 . . . . 75.1 113.542 -173.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.523 HG23 ' HG3' ' A' ' 57' ' ' GLU . 73.9 t -80.05 -43.24 22.39 Favored 'Isoleucine or valine' 0 C--O 1.252 1.189 0 C-N-CA 123.064 0.545 . . . . 71.45 111.51 -168.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.408 ' HG ' ' HA ' ' A' ' 55' ' ' ALA . 35.1 mt -63.06 -50.9 74.13 Favored Pre-proline 0 CA--C 1.558 1.28 0 CA-C-O 117.993 -1.003 . . . . 60.24 112.445 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.86 -12.91 36.92 Favored 'Trans proline' 0 C--N 1.389 2.695 0 C-N-CA 121.884 1.723 . . . . 75.14 113.138 177.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -74.43 -60.64 2.18 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 122.941 0.497 . . . . 71.35 110.306 177.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -85.34 -55.9 3.79 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 116.312 -0.403 . . . . 74.21 110.852 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -86.37 179.75 6.82 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 109.32 -0.622 . . . . 74.42 109.32 -176.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -113.07 38.97 2.67 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 121.526 0.679 . . . . 65.43 110.044 -171.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -162.6 163.95 26.95 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.936 -1.029 . . . . 74.42 109.301 -176.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.425 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 1.6 m120 -114.06 -7.89 13.06 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.173 0.589 . . . . 73.31 110.015 175.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -68.79 109.06 3.67 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.598 0.759 . . . . 72.2 111.0 -177.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.606 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 1.1 tpt -56.32 -39.76 73.29 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.498 1.119 . . . . 73.23 110.362 170.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.55 -41.54 66.56 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 124.548 1.155 . . . . 74.13 112.077 176.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.4 t -67.69 -41.39 83.71 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.631 0.772 . . . . 75.02 111.662 177.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -65.83 -52.37 51.1 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.465 0.706 . . . . 74.34 110.665 -176.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 95.4 t -61.11 -42.11 91.95 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-N 115.19 -0.914 . . . . 72.55 110.93 176.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -55.8 -46.9 77.92 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.564 0.746 . . . . 74.21 111.175 176.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -55.99 -55.57 31.13 Favored 'General case' 0 C--N 1.349 0.573 0 O-C-N 124.254 0.971 . . . . 72.44 110.417 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.4 mt -61.21 -42.41 98.54 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 124.15 0.906 . . . . 63.33 112.018 -175.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -59.19 -39.98 84.27 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.312 0.645 . . . . 71.24 111.368 175.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 57.2 mtm -73.86 -31.22 63.06 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.385 0.274 . . . . 72.41 110.795 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -79.38 3.51 18.12 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.71 0.804 . . . . 74.43 111.668 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.08 14.06 79.92 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-O 119.428 -0.651 . . . . 73.32 113.921 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -74.26 138.85 43.89 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 109.275 -0.639 . . . . 74.13 109.275 175.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -100.81 124.14 46.02 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.337 -0.616 . . . . 74.23 109.337 178.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.58 ' HE2' ' HB ' ' A' ' 84' ' ' VAL . 1.3 tmtp? -78.64 131.04 36.53 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.268 1.027 . . . . 74.53 108.934 177.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.2 t -129.97 122.66 54.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 107.472 -1.307 . . . . 74.43 107.472 175.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.58 ' HB ' ' HE2' ' A' ' 82' ' ' LYS . 6.5 p -99.14 124.87 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 109.226 -0.657 . . . . 71.44 109.226 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 . . . . . 0 N--CA 1.478 0.96 0 C-N-CA 123.069 0.548 . . . . 72.33 109.994 -177.703 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 . . . . . 0 CA--C 1.54 0.574 0 CA-C-O 122.182 0.992 . . . . 64.01 108.584 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -44.26 128.64 6.17 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 113.73 -1.577 . . . . 40.43 111.16 175.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -96.65 108.0 20.54 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.764 -0.828 . . . . 75.33 108.764 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.463 ' HB ' ' HB ' ' A' ' 48' ' ' VAL . 3.8 m -100.26 95.14 6.59 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 108.206 -1.035 . . . . 51.51 108.206 174.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -91.35 141.52 28.68 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.153 -1.054 . . . . 72.25 108.153 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -124.75 125.5 44.16 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.24 -1.022 . . . . 65.42 108.24 173.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -116.87 149.43 40.09 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.317 0.647 . . . . 73.34 110.083 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 33.8 t60 -162.96 127.92 2.07 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 108.936 -0.764 . . . . 64.43 108.936 174.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.3 -31.14 81.86 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 122.726 2.284 . . . . 62.42 113.355 -174.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 36.2 m -88.84 3.07 52.45 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 122.735 0.414 . . . . 73.21 111.466 -178.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -101.02 99.63 10.11 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.216 -1.401 . . . . 65.34 107.216 172.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 110' ' ' GLN . 87.5 mt -119.92 129.67 54.45 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.244 0.618 . . . . 63.13 109.349 176.102 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -72.05 93.18 1.37 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 107.641 -1.244 . . . . 74.25 107.641 174.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 145.45 -55.55 0.54 Allowed Glycine 0 C--N 1.33 0.213 0 N-CA-C 109.193 -1.563 . . . . 52.21 109.193 -173.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.539 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 2.6 mp0 -88.46 76.07 8.31 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.602 0.761 . . . . 72.12 110.181 176.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.68 -17.48 60.67 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.231 0.612 . . . . 43.23 112.036 175.368 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 19.3 pm0 -69.55 -21.72 63.61 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 111.494 0.183 . . . . 72.51 111.494 175.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.0 mt -80.04 -5.93 56.71 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.775 0.43 . . . . 73.22 112.125 -177.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 68.8 mt -69.97 -23.16 63.13 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.246 0.618 . . . . 71.2 111.944 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -81.13 -2.11 47.1 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 112.378 0.511 . . . . 72.12 112.378 176.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -90.32 -12.99 36.13 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 109.066 -0.716 . . . . 75.34 109.066 170.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 18.7 mt -93.19 121.3 43.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 107.79 -1.189 . . . . 72.12 107.79 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.81 168.57 18.49 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.067 0.46 . . . . 75.4 111.062 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 . . . . . 0 N--CA 1.468 0.471 0 C-N-CA 123.999 0.919 . . . . 72.11 109.668 -172.526 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 70.8 t . . . . . 0 CA--C 1.544 0.748 0 CA-C-O 118.804 -0.617 . . . . 72.51 110.37 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.36 145.74 34.97 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.897 2.398 . . . . 64.14 111.863 174.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.99 -40.73 67.2 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.751 0.82 . . . . 75.21 111.968 -176.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.425 ' HA ' ' HE1' ' A' ' 63' ' ' PHE . 54.1 t80 -53.25 -49.43 66.89 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.74 0.816 . . . . 55.43 111.851 173.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 92.5 mt -77.72 -31.07 52.06 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.007 0.523 . . . . 60.34 112.303 -170.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.5 t -76.02 -34.23 59.69 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 117.586 0.176 . . . . 75.42 110.973 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.15 -39.66 71.81 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.611 0.364 . . . . 71.33 110.035 174.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.49 ' O ' HG23 ' A' ' 28' ' ' VAL . 53.4 tp -61.85 -43.41 98.9 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 124.152 0.908 . . . . 71.41 110.801 174.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.514 ' CE3' HD11 ' A' ' 114' ' ' LEU . 70.9 t-105 -56.66 -47.7 79.21 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.234 1.013 . . . . 71.2 110.947 177.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.3 m -63.36 -42.66 98.9 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.03 -0.987 . . . . 71.01 110.949 174.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.8 tp -62.21 -53.24 58.07 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.386 1.474 . . . . 71.41 112.528 -172.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 24' ' ' LEU . 24.8 t -58.76 -33.85 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 C-N-CA 123.095 0.558 . . . . 74.03 111.41 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.0 t -87.11 -16.08 36.56 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.087 0.955 . . . . 65.41 111.647 -176.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -76.12 127.05 85.91 Favored Pre-proline 0 N--CA 1.481 1.089 0 C-N-CA 122.76 0.424 . . . . 64.25 111.115 -172.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.13 -30.64 46.56 Favored 'Trans proline' 0 C--N 1.385 2.467 0 C-N-CA 123.195 2.597 . . . . 55.1 114.543 -175.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -65.06 -38.32 90.44 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.438 0.637 . . . . 71.5 110.594 178.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.4 p -101.34 -2.02 32.01 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.922 -1.035 . . . . 71.44 111.542 -175.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -57.9 -35.97 71.78 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.513 1.125 . . . . 71.24 111.391 -178.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.43 -38.78 66.69 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.368 -0.833 . . . . 62.24 111.783 178.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.419 ' HA ' ' HB2' ' A' ' 49' ' ' PHE . 79.4 mt -98.24 -25.6 14.82 Favored 'General case' 0 C--O 1.213 -0.819 0 C-N-CA 123.08 0.552 . . . . 63.51 111.072 -178.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 47' ' ' HIS . 19.8 tt -149.48 116.04 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 O-C-N 121.251 -0.905 . . . . 72.12 111.231 -176.129 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 9.0 p -142.86 150.38 39.79 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.611 0.764 . . . . 61.42 110.62 -171.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -70.12 150.21 46.78 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.537 0.735 . . . . 72.35 110.307 176.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 56.3 p -71.66 155.93 91.83 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 122.995 0.518 . . . . 70.12 109.616 167.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -52.93 -29.47 43.95 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.612 2.208 . . . . 75.25 112.763 173.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.7 m -76.11 -38.02 57.39 Favored 'General case' 0 C--N 1.352 0.709 0 C-N-CA 123.088 0.555 . . . . 73.31 110.906 175.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.606 ' HA3' ' HD2' ' A' ' 108' ' ' ARG . . . 78.95 20.83 69.55 Favored Glycine 0 C--N 1.344 1.009 0 O-C-N 123.358 0.411 . . . . 60.41 113.24 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -95.24 -17.43 21.71 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.823 0.849 . . . . 75.3 109.988 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.401 ' HB3' ' HB3' ' A' ' 102' ' ' GLN . 66.6 p -142.48 168.84 18.79 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 123.806 0.842 . . . . 72.15 109.72 -174.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.403 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 46.3 p90 -143.05 147.22 34.7 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.79 0.436 . . . . 64.21 110.404 175.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.417 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 13.9 m-70 -104.15 142.55 34.29 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.154 0.982 . . . . 25.22 109.343 -178.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.2 t -124.18 125.78 71.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 108.06 -1.089 . . . . 62.45 108.06 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 79.9 m-85 -108.8 145.16 35.65 Favored 'General case' 0 C--O 1.247 0.941 0 C-N-CA 124.662 1.185 . . . . 72.23 109.067 -174.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 47.78 76.42 0.11 Allowed 'General case' 0 CA--C 1.542 0.669 0 O-C-N 124.561 1.163 . . . . 73.34 112.365 173.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.542 ' HG2' ' HB2' ' A' ' 97' ' ' ASP . 5.2 mm-40 -52.78 -29.49 27.72 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.735 -0.666 . . . . 75.51 112.173 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.99 -50.95 49.16 Favored Glycine 0 C--N 1.345 1.049 0 O-C-N 123.492 0.495 . . . . 61.34 112.894 174.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.407 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 62.7 tp60 -70.14 -46.51 64.58 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.647 0.379 . . . . 60.35 110.62 -177.03 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.44 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 61.1 t80 -53.68 -50.88 64.87 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.169 1.388 . . . . 74.04 111.132 176.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.59 ' HB2' ' HB2' ' A' ' 68' ' ' MET . . . -59.48 -35.27 73.8 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.849 0.685 . . . . 74.31 112.849 177.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.56 -47.07 51.14 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.069 0.948 . . . . 61.2 112.406 -176.246 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.503 ' HG3' HG23 ' A' ' 58' ' ' VAL . 6.5 pt-20 -102.36 -43.03 5.8 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 112.664 0.616 . . . . 74.25 112.664 -173.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.503 HG23 ' HG3' ' A' ' 57' ' ' GLU . 55.8 t -79.33 -47.2 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.386 0.674 . . . . 54.42 111.418 -168.173 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.2 mt -65.36 -46.65 70.76 Favored Pre-proline 0 CA--C 1.561 1.39 0 N-CA-C 113.239 0.829 . . . . 63.52 113.239 -174.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.37 -16.0 49.93 Favored 'Trans proline' 0 C--N 1.387 2.584 0 CA-C-N 121.901 1.715 . . . . 74.11 113.031 173.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -79.67 -62.32 1.72 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 123.999 0.92 . . . . 72.44 111.584 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -84.97 -24.33 28.35 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 122.974 0.509 . . . . 74.52 111.642 -176.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.425 ' HE1' ' HA ' ' A' ' 20' ' ' PHE . 41.0 m-85 -122.65 -169.24 1.87 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.223 -1.028 . . . . 71.31 108.223 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -127.64 45.14 2.79 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.867 0.842 . . . . 71.11 110.334 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -154.51 156.12 36.1 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.649 1.18 . . . . 63.21 107.965 176.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.524 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 1.6 m-20 -108.43 -16.08 14.31 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 109.723 -0.473 . . . . 54.24 109.723 176.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -66.52 115.3 6.25 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.346 0.658 . . . . 52.31 110.994 -176.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.59 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 12.1 tpt -73.26 -33.78 65.46 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.781 0.832 . . . . 64.12 111.29 -177.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.3 -35.64 65.31 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.097 0.559 . . . . 74.4 111.282 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.529 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 44.1 t -66.13 -46.59 77.0 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.171 0.988 . . . . 72.02 110.944 176.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -62.26 -53.26 57.78 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.011 0.924 . . . . 70.42 110.682 -176.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.5 t -62.78 -37.63 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 115.449 -0.796 . . . . 71.24 111.087 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -59.88 -38.02 81.02 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.312 0.645 . . . . 74.34 111.347 177.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 70' ' ' SER . 81.1 mm-40 -60.19 -48.28 82.4 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 109.346 -0.612 . . . . 71.25 109.346 176.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.438 ' HA ' ' HB2' ' A' ' 78' ' ' TYR . 93.6 mt -63.77 -36.36 83.61 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.063 0.945 . . . . 74.1 111.498 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -60.29 -42.46 95.54 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.388 0.675 . . . . 62.11 110.972 173.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 72.1 mtm -76.14 -21.32 56.71 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.723 -0.671 . . . . 74.34 110.677 176.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.438 ' HB2' ' HA ' ' A' ' 75' ' ' LEU . 26.6 m-85 -83.04 -4.09 57.97 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.572 0.749 . . . . 71.33 111.414 173.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.62 17.7 77.04 Favored Glycine 0 C--N 1.347 1.17 0 N-CA-C 114.433 0.533 . . . . 24.01 114.433 174.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -66.59 154.36 40.66 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.427 0.691 . . . . 72.43 110.436 177.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -99.73 122.55 42.89 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.564 0.746 . . . . 73.3 109.199 -178.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.582 ' HE2' ' HB ' ' A' ' 84' ' ' VAL . 21.0 tptm -77.08 123.76 26.84 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.841 1.256 . . . . 73.41 109.557 177.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.463 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 47.5 t -126.21 109.29 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 N-CA-C 108.103 -1.073 . . . . 71.14 108.103 170.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.582 ' HB ' ' HE2' ' A' ' 82' ' ' LYS . 5.1 p -90.45 123.9 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.445 0.698 . . . . 74.22 109.599 -179.32 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 . . . . . 0 N--CA 1.481 1.101 0 C-N-CA 123.063 0.545 . . . . 74.22 111.713 -176.201 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 . . . . . 0 N--CA 1.47 0.526 0 N-CA-C 109.467 -0.568 . . . . 74.01 109.467 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.542 ' HB2' ' HG2' ' A' ' 51' ' ' GLN . 5.9 m-20 -103.53 145.02 30.64 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.77 -0.826 . . . . 64.43 108.77 165.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -129.64 112.54 13.78 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.466 -1.309 . . . . 75.32 107.466 168.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 41.2 m -123.32 118.71 28.15 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.167 0.987 . . . . 73.13 109.623 -175.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.463 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 41.2 tt0 -102.18 110.85 22.92 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.155 0.982 . . . . 74.41 108.628 -179.084 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -97.67 132.76 43.02 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.801 -0.815 . . . . 73.35 108.801 173.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.401 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 3.9 pt20 -139.02 145.99 40.32 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.772 0.829 . . . . 42.55 109.305 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -149.3 136.88 11.29 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 109.025 -0.731 . . . . 75.45 109.025 -177.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -59.02 -34.82 99.23 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 122.692 2.261 . . . . 73.41 112.725 -177.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.403 ' HB2' HG12 ' A' ' 117' ' ' ILE . 15.7 m -89.63 14.32 11.93 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.223 0.609 . . . . 45.53 111.007 179.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -122.67 98.82 6.09 Favored 'General case' 0 C--O 1.245 0.838 0 N-CA-C 107.799 -1.185 . . . . 74.13 107.799 174.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 91.5 mt -131.4 151.78 51.23 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.386 1.075 . . . . 71.0 109.426 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.606 ' HD2' ' HA3' ' A' ' 43' ' ' GLY . 16.1 ptm180 -63.17 112.39 2.64 Favored 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 124.194 0.998 . . . . 71.15 111.484 -178.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.96 -8.22 63.12 Favored Glycine 0 N--CA 1.472 1.08 0 CA-C-N 116.388 -0.369 . . . . 64.22 113.585 -178.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -102.75 71.73 1.18 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 117.641 0.721 . . . . 64.22 111.034 -177.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.473 ' HA ' ' HG ' ' A' ' 114' ' ' LEU . 9.4 pt-20 -70.29 -26.06 63.63 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.658 -0.701 . . . . 73.54 111.679 170.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.4 pm0 -65.05 -15.15 62.03 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.708 0.803 . . . . 72.02 112.193 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 79.9 mt -95.14 -17.88 21.42 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.147 0.579 . . . . 54.22 111.764 176.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.514 HD11 ' CE3' ' A' ' 25' ' ' TRP . 80.4 mt -67.87 -37.72 82.16 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.246 0.619 . . . . 63.53 110.992 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -64.12 -14.51 55.35 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.246 -0.888 . . . . 71.34 112.429 174.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -101.2 -2.4 31.39 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.6 0.76 . . . . 73.51 110.682 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.403 HG12 ' HB2' ' A' ' 105' ' ' CYS . 37.0 mt -92.81 113.33 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 106.995 -1.483 . . . . 74.3 106.995 173.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.446 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 9.8 mmpt? -115.77 145.05 43.14 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.04 0.536 . . . . 62.2 111.254 -169.007 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 30.6 ptt85 . . . . . 0 N--CA 1.478 0.959 0 N-CA-C 108.247 -1.02 . . . . 71.33 108.247 168.608 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.4 t . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 119.386 -0.34 . . . . 54.44 110.677 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.28 141.84 94.23 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.618 2.212 . . . . 71.54 111.123 174.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.47 -40.5 62.39 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.814 0.845 . . . . 74.21 111.36 176.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -50.45 -47.78 56.71 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 124.248 0.967 . . . . 75.55 112.961 173.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 90.3 mt -83.68 -26.19 30.05 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.816 0.447 . . . . 72.1 110.402 -170.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.7 m -66.11 -45.22 81.93 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 124.154 0.982 . . . . 60.24 110.983 171.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.464 ' HE2' ' HA ' ' A' ' 23' ' ' LYS . 10.6 mmpt? -67.18 -44.72 78.95 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.726 0.41 . . . . 72.3 110.153 176.149 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.5 tp -56.11 -53.23 59.59 Favored 'General case' 0 C--N 1.356 0.876 0 O-C-N 124.483 1.114 . . . . 72.15 111.47 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.528 ' HH2' ' HG3' ' A' ' 108' ' ' ARG . 8.3 t-105 -59.37 -49.26 78.52 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 122.942 0.497 . . . . 74.43 111.832 -178.31 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.5 m -62.1 -28.05 69.35 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 122.805 0.442 . . . . 70.44 111.291 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.474 HD13 ' CD1' ' A' ' 62' ' ' TYR . 24.0 tp -74.37 -44.45 52.15 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.203 1.001 . . . . 64.23 111.793 176.059 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.2 t -61.87 -36.74 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.881 0.872 . . . . 62.24 110.401 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 88.4 p -90.34 10.8 23.51 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.842 0.857 . . . . 73.41 111.736 -177.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -90.86 116.42 66.38 Favored Pre-proline 0 CA--C 1.56 1.36 0 C-N-CA 123.052 0.541 . . . . 44.32 110.675 175.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.69 -7.81 16.76 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 123.256 2.637 . . . . 72.55 113.156 177.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -85.55 -25.72 26.59 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.689 0.795 . . . . 75.02 111.509 177.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 40.9 p -106.32 9.34 31.97 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.84 0.456 . . . . 75.12 111.122 178.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -57.85 -30.39 65.75 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 113.381 0.882 . . . . 64.52 113.381 -170.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -69.06 -24.08 64.12 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.574 0.583 . . . . 65.43 112.574 -176.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.474 HD22 ' HB2' ' A' ' 50' ' ' ASP . 77.4 mt -115.13 -18.17 11.23 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.2 0.6 . . . . 64.11 111.056 -178.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.463 HD13 ' HG ' ' A' ' 27' ' ' LEU . 14.9 tt -160.94 123.86 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.234 0.613 . . . . 64.01 110.231 171.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 23.2 p -150.55 161.69 42.07 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.159 0.584 . . . . 40.41 110.433 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 38.4 p-90 -73.33 147.27 44.58 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 124.048 0.842 . . . . 75.03 109.47 172.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.2 m -75.64 149.62 83.69 Favored Pre-proline 0 CA--C 1.548 0.9 0 N-CA-C 108.348 -0.982 . . . . 71.22 108.348 171.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.77 -28.43 23.05 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 123.101 2.534 . . . . 75.15 114.25 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.0 m -73.71 -24.8 59.97 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.309 0.644 . . . . 50.54 111.946 177.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.24 0.84 90.13 Favored Glycine 0 C--N 1.342 0.889 0 C-N-CA 123.129 0.395 . . . . 34.22 113.649 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 -82.27 -25.4 34.07 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.727 0.811 . . . . 72.3 111.036 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.9 p -146.96 178.99 7.91 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.358 0.663 . . . . 74.12 110.311 -169.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 42.1 p90 -146.63 143.85 29.09 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.711 0.404 . . . . 70.34 110.985 178.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -103.33 151.71 22.41 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.23 0.612 . . . . 74.1 109.464 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 98' ' ' ASP . 95.5 t -124.23 132.13 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.363 1.065 . . . . 71.33 108.349 176.046 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -116.07 148.77 39.89 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.835 0.854 . . . . 71.22 109.604 178.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.474 ' HB2' HD22 ' A' ' 36' ' ' LEU . 20.8 m-20 53.16 63.44 2.23 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 124.692 1.245 . . . . 70.43 111.259 170.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -50.12 -33.35 18.48 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.181 0.993 . . . . 73.13 113.33 -172.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.64 -43.99 90.76 Favored Glycine 0 CA--C 1.533 1.196 0 O-C-N 123.412 0.445 . . . . 65.41 112.441 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -74.11 -45.48 48.78 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.392 0.677 . . . . 71.34 110.059 -178.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.436 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 39.1 t80 -50.51 -52.27 39.93 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.28 1.432 . . . . 75.21 111.494 174.131 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.463 ' HB2' ' HB2' ' A' ' 68' ' ' MET . . . -62.2 -36.32 81.57 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.657 -0.701 . . . . 60.04 111.577 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -66.81 -46.92 73.65 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.85 0.86 . . . . 63.33 112.85 -175.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.488 ' HG3' HG23 ' A' ' 58' ' ' VAL . 11.1 pt-20 -113.07 -33.9 5.88 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 114.292 1.219 . . . . 74.42 114.292 -171.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.488 HG23 ' HG3' ' A' ' 57' ' ' GLU . 91.9 t -82.83 -45.03 19.24 Favored 'Isoleucine or valine' 0 C--O 1.253 1.286 0 C-N-CA 123.71 0.804 . . . . 50.43 111.938 -170.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.6 mt -64.59 -46.55 77.03 Favored Pre-proline 0 CA--C 1.557 1.231 0 CA-C-O 118.095 -0.955 . . . . 63.34 112.766 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.2 -15.21 45.64 Favored 'Trans proline' 0 C--N 1.381 2.262 0 CA-C-N 121.954 1.733 . . . . 73.11 113.105 174.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -73.14 -50.6 21.8 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.58 0.752 . . . . 75.01 110.489 176.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.474 ' CD1' HD13 ' A' ' 27' ' ' LEU . 37.0 m-85 -92.76 -51.88 4.88 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 112.594 0.59 . . . . 74.3 112.594 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -90.87 -172.03 3.22 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.885 -0.783 . . . . 65.14 108.885 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -118.47 40.66 3.16 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 121.313 0.578 . . . . 65.42 110.397 -174.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -162.25 164.66 27.53 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.193 -0.912 . . . . 72.11 109.246 -177.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -106.24 -33.98 7.63 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.356 0.663 . . . . 72.25 109.864 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -62.97 127.09 29.62 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.31 0.644 . . . . 72.14 112.522 -173.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.463 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 25.7 ttt -88.16 -23.69 23.55 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.97 0.508 . . . . 75.34 111.365 -176.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.42 -38.37 77.28 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 121.424 0.63 . . . . 74.04 111.211 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.415 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 22.8 t -68.89 -40.39 79.21 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.593 1.157 . . . . 62.42 111.087 176.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -62.39 -48.32 80.25 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.456 1.103 . . . . 74.23 110.899 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 83.4 t -65.24 -39.46 85.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 123.786 0.834 . . . . 73.34 111.102 177.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 70.0 ttt-85 -54.24 -43.71 71.14 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.195 0.598 . . . . 71.11 110.952 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.519 ' HA ' ' HE2' ' A' ' 77' ' ' MET . 10.2 mm100 -62.15 -45.77 91.96 Favored 'General case' 0 C--N 1.349 0.549 0 O-C-N 123.959 0.787 . . . . 55.25 110.352 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 43.1 mt -59.77 -36.92 77.66 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.662 0.785 . . . . 75.42 111.439 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -61.0 -40.68 94.48 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.839 0.456 . . . . 64.12 111.182 173.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.519 ' HE2' ' HA ' ' A' ' 74' ' ' GLN . 31.9 mtm -69.71 -35.6 75.19 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.563 0.345 . . . . 60.41 110.597 178.084 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -81.57 4.44 21.41 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.695 0.798 . . . . 74.14 111.019 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.89 24.96 75.87 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-O 119.459 -0.634 . . . . 74.22 114.538 170.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -73.03 148.89 43.7 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 117.271 0.535 . . . . 72.34 109.805 173.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.85 121.01 40.66 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.566 -0.901 . . . . 62.4 108.566 177.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.678 ' HE2' ' HB ' ' A' ' 84' ' ' VAL . 1.2 tmtp? -82.73 126.27 32.19 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.756 -1.202 . . . . 61.13 107.756 176.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 88.2 t -129.37 111.18 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 107.698 -1.223 . . . . 73.11 107.698 177.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.678 ' HB ' ' HE2' ' A' ' 82' ' ' LYS . 10.2 p -98.99 125.86 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 108.717 -0.846 . . . . 74.55 108.717 -177.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 . . . . . 0 N--CA 1.478 0.973 0 C-N-CA 122.839 0.455 . . . . 72.5 110.755 -176.897 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 . . . . . 0 CA--C 1.55 0.968 0 N-CA-C 109.519 -0.548 . . . . 61.32 109.519 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -39.95 107.21 0.07 Allowed 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.036 0.934 . . . . 72.35 112.796 175.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.434 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 12.8 t70 -97.21 113.3 24.89 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 107.718 -1.216 . . . . 54.2 107.718 174.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.534 HG23 ' HE3' ' A' ' 82' ' ' LYS . 87.1 m -122.49 112.08 17.6 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.89 0.876 . . . . 61.03 109.483 -176.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 46' ' ' PHE . 41.4 tt0 -105.0 114.17 28.21 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.898 0.879 . . . . 74.34 108.853 -178.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -95.97 121.4 37.68 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.023 -1.103 . . . . 74.21 108.023 174.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -125.75 143.7 50.94 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.531 0.733 . . . . 70.23 109.685 -176.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.2 t-80 -158.92 133.31 5.3 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 108.568 -0.901 . . . . 73.14 108.568 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -64.19 -21.39 67.54 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.617 2.211 . . . . 74.43 113.556 -175.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.427 ' HB2' HG12 ' A' ' 117' ' ' ILE . 12.0 m -96.36 6.24 49.19 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.969 0.507 . . . . 72.01 111.128 178.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -114.32 100.03 8.03 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 106.974 -1.491 . . . . 74.34 106.974 171.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 110' ' ' GLN . 49.4 mt -129.38 158.95 37.71 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.707 -0.849 . . . . 74.42 108.707 175.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.528 ' HG3' ' HH2' ' A' ' 25' ' ' TRP . 35.8 ttp180 -73.62 126.38 30.15 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 123.394 0.677 . . . . 74.02 110.71 -178.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.57 28.86 72.92 Favored Glycine 0 C--N 1.346 1.134 0 O-C-N 123.872 0.732 . . . . 62.5 112.198 -177.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.403 ' HB3' ' HB2' ' A' ' 107' ' ' LEU . 6.3 tp60 -136.96 37.94 2.57 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 122.633 1.206 . . . . 75.32 108.122 -175.107 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.92 -10.61 58.13 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 113.533 -1.667 . . . . 71.24 113.393 -173.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 21.0 pm0 -64.85 -18.31 65.03 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.719 0.408 . . . . 71.42 111.437 172.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.3 mt -90.52 -6.88 54.23 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.272 0.629 . . . . 42.31 111.837 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 96.6 mt -66.76 -33.71 76.23 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 118.041 0.382 . . . . 72.25 111.003 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -73.72 -12.78 60.83 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 120.882 0.372 . . . . 70.45 111.49 174.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -94.97 -14.45 24.39 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.569 0.747 . . . . 74.24 109.355 177.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.427 HG12 ' HB2' ' A' ' 105' ' ' CYS . 45.2 mt -83.93 75.46 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.069 0 N-CA-C 107.344 -1.354 . . . . 73.33 107.344 169.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.13 147.28 51.63 Favored 'General case' 0 CA--C 1.558 1.284 0 CA-C-N 115.322 -0.853 . . . . 62.44 113.296 173.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 . . . . . 0 N--CA 1.486 1.338 0 CA-C-N 114.712 -1.131 . . . . 75.41 109.536 174.881 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.4 t . . . . . 0 CA--C 1.557 1.215 0 CA-C-O 119.001 -0.523 . . . . 63.41 110.815 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.48 ' HD2' HD12 ' A' ' 21' ' ' LEU . 53.0 Cg_exo -56.61 155.93 24.46 Favored 'Trans proline' 0 C--N 1.382 2.299 0 C-N-CA 123.253 2.635 . . . . 74.45 112.495 178.045 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.82 -43.74 66.2 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.638 0.775 . . . . 74.11 111.283 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -53.37 -47.01 69.82 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.531 0.733 . . . . 73.52 112.151 175.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.48 HD12 ' HD2' ' A' ' 18' ' ' PRO . 72.9 mt -81.76 -27.64 33.68 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.31 0.485 . . . . 73.43 112.31 -171.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.1 t -76.07 -32.17 59.15 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 118.285 0.493 . . . . 71.13 111.045 174.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.488 ' HE2' ' HA ' ' A' ' 23' ' ' LYS . 10.2 mmpt? -71.33 -38.92 71.65 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.502 -0.555 . . . . 52.13 109.502 173.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.5 tp -61.44 -44.49 97.03 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 123.919 0.762 . . . . 75.02 110.797 172.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -53.51 -56.08 20.02 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.071 0.948 . . . . 72.14 111.233 177.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.1 m -56.5 -47.39 79.38 Favored 'General case' 0 C--O 1.214 -0.786 0 O-C-N 124.574 1.171 . . . . 40.44 110.402 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.426 ' HG ' HG21 ' A' ' 37' ' ' ILE . 28.7 tp -54.79 -53.11 59.45 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.605 1.562 . . . . 73.34 113.133 -174.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 65.6 t -66.82 -28.14 42.11 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 C-N-CA 123.821 0.848 . . . . 74.44 111.104 178.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.3 t -94.05 -7.21 43.28 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.314 1.046 . . . . 71.24 112.263 -177.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -89.68 128.73 49.41 Favored Pre-proline 0 N--CA 1.484 1.234 0 C-N-CA 123.515 0.726 . . . . 74.15 111.614 -171.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -77.5 -11.05 17.31 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 122.859 2.373 . . . . 75.44 114.232 -178.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -81.3 -28.75 34.49 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 118.422 0.555 . . . . 73.21 110.862 175.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.422 HG21 ' HE1' ' A' ' 62' ' ' TYR . 40.0 p -114.51 4.0 15.08 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 112.435 0.532 . . . . 71.04 112.435 -177.265 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 1.5 p-10 -65.44 -24.82 67.28 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 112.3 0.481 . . . . 65.31 112.3 -174.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -68.05 -26.57 65.93 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.265 0.626 . . . . 61.44 112.448 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.455 HD22 ' HB2' ' A' ' 50' ' ' ASP . 66.4 mt -106.57 -13.89 15.19 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.02 0.528 . . . . 73.13 111.517 178.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.509 ' O ' ' HA ' ' A' ' 34' ' ' ASP . 16.4 tt -161.25 124.67 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-O 120.844 0.354 . . . . 64.14 111.26 174.148 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 28.0 p -148.92 161.12 42.52 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.933 -0.766 . . . . 62.54 108.933 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 38.7 p-90 -82.47 148.54 28.09 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 108.965 -0.754 . . . . 60.13 108.965 176.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.9 m -75.54 151.31 85.04 Favored Pre-proline 0 CA--C 1.546 0.793 0 CA-C-N 115.176 -0.92 . . . . 52.24 110.084 -176.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -46.67 -39.64 23.51 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 123.468 2.779 . . . . 72.33 115.451 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 26.3 p -80.88 -9.8 59.79 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 112.086 0.402 . . . . 61.35 112.086 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.92 -0.08 83.76 Favored Glycine 0 C--N 1.351 1.403 0 N-CA-C 115.962 1.145 . . . . 64.41 115.962 163.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -94.44 -2.15 52.37 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.962 0.905 . . . . 71.21 111.705 -175.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.409 ' HB3' ' HB3' ' A' ' 102' ' ' GLN . 80.9 p -148.59 174.8 11.76 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.908 0.883 . . . . 43.14 110.163 -179.136 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -145.66 153.97 41.6 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.226 0.61 . . . . 72.42 110.084 170.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -112.92 149.32 33.36 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.114 0.966 . . . . 63.35 110.065 -178.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 98' ' ' ASP . 76.3 t -123.35 105.84 16.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 124.787 1.235 . . . . 62.15 107.987 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -91.18 145.18 24.88 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 124.041 0.936 . . . . 55.14 110.669 -177.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.455 ' HB2' HD22 ' A' ' 36' ' ' LEU . 3.2 m-20 53.0 57.46 6.31 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 124.579 1.175 . . . . 71.34 111.61 173.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -55.33 -26.31 40.03 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 114.332 1.234 . . . . 72.15 114.332 -169.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.38 -47.88 40.77 Favored Glycine 0 CA--C 1.531 1.093 0 N-CA-C 111.838 -0.505 . . . . 60.31 111.838 174.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -69.17 -44.3 72.51 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.394 0.678 . . . . 71.31 109.477 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -52.74 -51.37 60.79 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.318 1.447 . . . . 74.45 111.331 175.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.414 ' HB2' ' HB2' ' A' ' 68' ' ' MET . . . -64.57 -34.88 79.28 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.51 -0.314 . . . . 61.43 111.778 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -66.1 -46.77 76.47 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.457 1.103 . . . . 74.03 112.377 -176.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.546 ' HG3' HG23 ' A' ' 58' ' ' VAL . 6.9 pt-20 -109.76 -39.26 5.16 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 113.766 1.024 . . . . 55.32 113.766 -173.322 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.546 HG23 ' HG3' ' A' ' 57' ' ' GLU . 84.9 t -82.5 -38.23 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.253 0.621 . . . . 62.14 111.615 -168.167 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 51.1 mt -69.97 -43.47 19.88 Favored Pre-proline 0 CA--C 1.565 1.519 0 CA-C-O 118.073 -0.965 . . . . 73.55 112.94 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -71.06 -10.57 27.72 Favored 'Trans proline' 0 C--N 1.385 2.497 0 CA-C-N 122.058 1.771 . . . . 42.32 113.155 171.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -78.91 -52.68 7.95 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.151 0.981 . . . . 74.33 110.964 176.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.436 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 49.3 m-85 -87.43 -24.45 24.17 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 122.892 0.477 . . . . 63.44 112.155 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -126.29 -150.09 0.43 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 107.35 -1.352 . . . . 74.24 107.35 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -142.88 55.54 1.39 Allowed 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.99 0.9 . . . . 73.23 109.615 172.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 32.7 p80 -154.51 148.3 25.48 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 114.845 -1.071 . . . . 65.1 108.825 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -110.98 0.18 16.92 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.263 0.625 . . . . 62.31 109.685 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -74.73 117.24 16.34 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.112 0.965 . . . . 74.53 110.088 176.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.414 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 13.6 tpt -75.56 -35.83 60.56 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.085 0.554 . . . . 73.21 110.77 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.89 -32.6 67.88 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.228 0.611 . . . . 63.43 111.61 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.46 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 44.7 t -59.25 -52.07 67.26 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.991 0.917 . . . . 71.32 111.068 173.022 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -64.96 -51.59 60.95 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.119 0.967 . . . . 74.42 110.894 -174.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.0 t -58.18 -46.46 88.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 124.024 0.93 . . . . 74.22 111.629 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.9 ttt85 -57.63 -41.2 80.89 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 123.671 0.607 . . . . 73.02 111.784 -178.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 70' ' ' SER . 13.3 mm100 -60.93 -48.12 83.28 Favored 'General case' 0 C--N 1.351 0.666 0 O-C-N 123.706 0.629 . . . . 74.22 109.829 -178.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.4 mt -64.98 -42.62 94.39 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.842 0.714 . . . . 60.4 111.129 -178.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -59.77 -37.91 80.36 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.243 0.617 . . . . 74.22 111.329 177.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 59.9 mtm -71.01 -32.55 69.37 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.627 0.371 . . . . 54.54 110.428 174.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -73.15 -2.2 20.59 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.476 0.71 . . . . 74.01 111.426 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.13 12.94 64.87 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-O 119.633 -0.537 . . . . 72.12 113.62 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -74.93 147.55 40.83 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.178 -1.045 . . . . 73.54 108.178 174.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.465 ' HB3' ' HG3' ' A' ' 102' ' ' GLN . 34.9 ttm-85 -98.88 122.03 41.6 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.723 -0.843 . . . . 74.53 108.723 -174.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -79.95 113.65 18.27 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.096 1.358 . . . . 63.14 108.846 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 39.4 t -123.86 125.56 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 108.905 -0.776 . . . . 52.21 108.905 178.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 68.9 t -106.21 110.08 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 108.127 -1.064 . . . . 75.21 108.127 178.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 . . . . . 0 N--CA 1.478 0.944 0 C-N-CA 122.826 0.45 . . . . 71.25 111.652 -173.71 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 . . . . . 0 N--CA 1.479 1.004 0 CA-C-O 120.886 0.374 . . . . 64.14 110.426 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -103.38 118.7 37.36 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.802 -0.814 . . . . 73.11 108.802 169.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.404 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 22.5 t70 -122.94 122.95 39.81 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.979 0.912 . . . . 64.13 109.773 177.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 50.1 m -120.06 127.55 52.68 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.741 0.816 . . . . 72.52 109.834 175.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.403 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 39.0 tt0 -100.52 117.54 34.88 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.407 -0.96 . . . . 75.53 108.407 173.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -98.19 118.93 35.92 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.357 -0.979 . . . . 73.21 108.357 169.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.465 ' HG3' ' HB3' ' A' ' 81' ' ' ARG . 2.6 pt20 -121.5 137.58 54.66 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.618 0.767 . . . . 73.33 109.292 178.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.574 ' HB3' ' HB3' ' A' ' 106' ' ' PHE . 65.0 t-80 -148.33 129.24 7.0 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-O 118.95 -0.548 . . . . 74.51 110.353 -171.224 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -65.16 -38.86 25.72 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 123.14 2.56 . . . . 61.33 113.437 -173.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.46 ' HB2' ' HE1' ' A' ' 103' ' ' HIS . 35.4 m -93.54 28.93 2.12 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.926 0.49 . . . . 61.23 110.458 178.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.574 ' HB3' ' HB3' ' A' ' 103' ' ' HIS . 67.4 t80 -133.57 113.28 12.26 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.862 -0.792 . . . . 64.23 108.862 174.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.63 ' HB2' ' HB2' ' A' ' 110' ' ' GLN . 50.0 mt -117.51 157.48 26.23 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 108.706 -0.85 . . . . 63.12 108.706 173.259 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.38 -26.95 65.54 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.459 1.103 . . . . 74.53 112.974 -171.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.19 37.83 2.02 Favored Glycine 0 N--CA 1.471 0.973 0 N-CA-C 112.252 -0.339 . . . . 62.42 112.252 -177.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.63 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -131.24 71.8 1.48 Allowed 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 121.515 0.674 . . . . 74.32 109.673 -178.35 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -63.27 -30.36 71.51 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.345 1.058 . . . . 61.34 113.145 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 19.8 pm0 -66.28 -15.77 63.49 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.748 0.419 . . . . 73.54 111.639 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.525 ' O ' HG13 ' A' ' 117' ' ' ILE . 49.3 mt -87.03 -21.45 26.09 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 118.953 -0.546 . . . . 75.35 111.374 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 96.8 mt -57.4 -41.1 79.64 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 123.395 0.678 . . . . 63.25 111.33 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -76.93 -7.83 56.27 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 115.448 -0.796 . . . . 71.21 112.581 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -101.15 -9.19 21.56 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.705 0.802 . . . . 74.43 109.857 172.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 113' ' ' LEU . 72.7 mt -81.13 108.96 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 107.265 -1.383 . . . . 72.53 107.265 173.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.478 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 11.2 mmpt? -108.67 144.09 36.88 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.997 -0.742 . . . . 74.4 108.997 -172.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 31.0 ptt-85 . . . . . 0 N--CA 1.471 0.581 0 O-C-N 123.655 0.597 . . . . 63.32 110.788 179.349 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.6 t . . . . . 0 CA--C 1.553 1.083 0 N-CA-C 107.75 -1.204 . . . . 71.03 107.75 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -52.9 135.78 58.72 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 123.013 2.475 . . . . 74.24 112.621 177.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.96 -42.42 68.9 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.31 1.044 . . . . 74.34 112.335 -178.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -57.66 -40.75 80.05 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.252 0.621 . . . . 73.22 111.653 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 66.0 mt -78.04 -34.06 50.69 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 112.25 0.463 . . . . 73.21 112.25 -174.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.1 t -74.45 -37.22 63.32 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 119.688 -0.196 . . . . 73.25 110.885 178.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.501 ' HE2' ' HA ' ' A' ' 23' ' ' LYS . 8.5 mmpt? -70.79 -37.06 73.29 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 122.793 0.437 . . . . 63.45 110.102 175.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.436 ' O ' HG23 ' A' ' 28' ' ' VAL . 59.9 tp -58.5 -53.59 56.63 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 123.808 0.843 . . . . 75.34 111.453 173.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 24.1 t-105 -61.68 -41.74 97.98 Favored 'General case' 0 CA--C 1.549 0.921 0 O-C-N 123.027 0.204 . . . . 75.34 111.182 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.453 ' O ' ' HB2' ' A' ' 30' ' ' ASP . 90.7 m -59.38 -36.52 75.95 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 122.897 0.479 . . . . 74.42 110.762 174.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.48 ' HG ' HG21 ' A' ' 37' ' ' ILE . 50.5 tp -70.78 -51.02 29.64 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.633 1.173 . . . . 65.41 111.939 -178.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 24' ' ' LEU . 96.4 t -60.58 -33.86 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.69 1.196 . . . . 65.43 111.2 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.6 t -86.91 -24.44 24.82 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.855 0.862 . . . . 73.42 111.684 -176.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 26' ' ' THR . 8.7 t70 -69.3 128.62 92.34 Favored Pre-proline 0 N--CA 1.488 1.467 0 C-N-CA 122.856 0.462 . . . . 74.14 111.828 -168.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.32 -1.89 11.29 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 123.175 2.583 . . . . 75.22 114.507 -176.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -87.15 -34.28 19.12 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 118.305 0.502 . . . . 61.54 111.0 172.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.0 p -112.27 1.57 16.19 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.742 0.817 . . . . 74.23 112.398 -171.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.432 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 8.9 p-10 -61.18 -25.15 66.83 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.951 0.901 . . . . 54.42 111.923 -178.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.26 -33.64 75.94 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.957 0.903 . . . . 75.11 112.496 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.438 HD22 ' HB2' ' A' ' 50' ' ' ASP . 69.3 mt -108.14 -13.35 14.94 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.221 0.608 . . . . 62.2 112.001 -178.073 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.48 HG21 ' HG ' ' A' ' 27' ' ' LEU . 19.8 tt -157.39 117.67 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-O 121.266 0.555 . . . . 64.21 110.507 177.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 29.0 p -144.73 153.01 41.24 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.212 0.605 . . . . 74.13 109.803 -178.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 35.5 p-90 -82.21 153.15 26.09 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.922 -0.581 . . . . 73.41 109.738 178.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.6 m -82.49 156.91 68.21 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 108.726 -0.842 . . . . 65.41 108.726 -178.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -61.23 -12.29 22.8 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.449 2.1 . . . . 35.04 113.297 178.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 77.2 p -74.44 -36.87 63.41 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.824 0.85 . . . . 74.43 110.656 171.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.93 -8.12 77.46 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 115.504 -0.771 . . . . 63.32 113.415 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.572 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 25.1 p30 -101.2 12.59 37.27 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.181 0.992 . . . . 50.03 111.37 -172.246 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.4 p -163.77 151.86 13.12 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.888 0.875 . . . . 63.05 109.538 -175.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -138.99 147.25 41.92 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.946 0.498 . . . . 71.44 109.871 177.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -101.99 144.69 30.28 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.478 0.711 . . . . 61.43 109.556 -176.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.408 HG12 ' HG2' ' A' ' 51' ' ' GLN . 95.8 t -121.66 115.61 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 107.504 -1.295 . . . . 71.1 107.504 177.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.483 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 25.4 m-85 -114.51 149.14 36.85 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.661 1.185 . . . . 71.31 110.743 -172.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.438 ' HB2' HD22 ' A' ' 36' ' ' LEU . 5.4 m-20 52.36 53.2 12.75 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 125.021 1.45 . . . . 50.12 110.51 176.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.706 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 55.5 mt-30 -53.39 -25.85 17.2 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 114.853 -1.067 . . . . 71.21 113.576 -170.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.45 -50.42 55.47 Favored Glycine 0 CA--C 1.534 1.266 0 N-CA-C 112.205 -0.358 . . . . 71.11 112.205 174.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -73.72 -33.49 64.38 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.143 0.977 . . . . 74.41 110.608 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.43 ' HB3' ' HA ' ' A' ' 51' ' ' GLN . 83.3 t80 -66.03 -54.54 24.59 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.345 1.058 . . . . 74.42 110.582 -178.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.6 -26.04 67.66 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 116.108 -0.496 . . . . 43.31 111.724 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.1 tttm -64.01 -55.58 21.3 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.816 1.246 . . . . 72.14 113.064 178.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.491 ' HG3' HG23 ' A' ' 58' ' ' VAL . 2.1 pt-20 -112.02 -33.65 6.2 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 113.259 0.836 . . . . 73.41 113.259 -170.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.491 HG23 ' HG3' ' A' ' 57' ' ' GLU . 61.8 t -85.22 -43.23 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.305 0.642 . . . . 75.3 111.328 -168.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 17.6 mt -62.57 -51.64 71.13 Favored Pre-proline 0 CA--C 1.558 1.272 0 CA-C-O 118.312 -0.851 . . . . 41.0 112.429 178.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.3 -7.48 21.32 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 121.726 1.617 . . . . 45.02 112.783 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -80.11 -60.97 2.13 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.09 0.956 . . . . 71.13 110.771 175.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -83.73 -32.17 25.64 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 122.755 0.422 . . . . 64.23 112.052 -176.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -112.11 -175.95 2.81 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.82 -0.807 . . . . 71.23 108.82 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.95 28.8 8.1 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.392 0.677 . . . . 73.12 111.295 -174.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 26.1 p80 -157.42 155.95 31.37 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.155 0.582 . . . . 65.41 109.82 -172.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 38.8 p30 -117.74 -7.5 10.99 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.394 0.677 . . . . 71.53 111.668 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -72.94 121.55 20.25 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.861 -0.422 . . . . 61.41 109.861 -178.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.706 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 2.4 tpt -59.48 -45.52 91.44 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.186 0.994 . . . . 74.21 111.227 178.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.73 -34.68 74.77 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.574 -0.739 . . . . 65.44 112.087 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.4 t -63.2 -40.92 98.86 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.252 0.621 . . . . 71.03 111.35 175.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -64.13 -53.08 55.24 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.134 0.974 . . . . 72.04 110.861 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.4 HG22 ' HZ ' ' A' ' 101' ' ' PHE . 58.1 t -61.16 -39.49 82.63 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 CA-C-N 115.079 -0.964 . . . . 75.34 111.394 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -57.78 -48.91 78.35 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.617 0.767 . . . . 74.3 111.235 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -58.13 -43.16 87.14 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 124.437 1.086 . . . . 72.41 110.641 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.7 mt -65.18 -41.53 94.52 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.219 0.608 . . . . 64.2 111.672 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -60.34 -35.88 76.69 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 122.584 0.354 . . . . 63.55 111.185 172.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.47 ' O ' ' HA ' ' A' ' 119' ' ' ARG . 48.2 mtp -65.63 -39.68 91.71 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.149 0.58 . . . . 64.33 110.126 175.252 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -81.53 -1.33 45.8 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.081 0.552 . . . . 64.03 111.518 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.03 22.15 57.95 Favored Glycine 0 C--N 1.35 1.331 0 N-CA-C 114.399 0.52 . . . . 60.2 114.399 174.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.553 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . 34.2 m-85 -78.82 130.56 35.84 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.343 -0.984 . . . . 51.23 108.343 173.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -100.93 129.61 46.81 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.208 0.603 . . . . 73.43 109.649 -171.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -71.54 122.55 20.67 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.514 1.126 . . . . 71.44 110.905 -178.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 90.6 t -132.3 127.4 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 107.488 -1.301 . . . . 71.42 107.488 172.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.59 131.97 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 109.122 -0.696 . . . . 55.15 109.122 177.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 29.6 m-70 . . . . . 0 N--CA 1.479 0.979 0 C-N-CA 123.054 0.542 . . . . 65.35 110.207 -178.054 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 . . . . . 0 C--O 1.244 0.811 0 CA-C-O 120.865 0.364 . . . . 71.24 110.184 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.483 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 2.5 m-20 -80.73 147.22 30.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.614 -0.721 . . . . 61.35 109.765 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -134.78 117.93 16.5 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.864 0.866 . . . . 55.14 109.345 172.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 86.3 m -135.06 109.0 8.12 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.595 0.758 . . . . 72.21 109.125 178.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -99.15 119.7 38.28 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.786 -0.82 . . . . 64.42 108.786 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.553 ' HB3' ' HB3' ' A' ' 80' ' ' PHE . 92.9 m-85 -99.62 120.31 39.47 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.556 -0.905 . . . . 72.11 108.556 173.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -109.99 144.59 38.31 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.368 0.667 . . . . 64.25 110.027 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 15.9 t60 -153.34 127.06 4.33 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 109.149 -0.686 . . . . 75.34 109.149 177.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.8 -34.86 59.8 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 123.021 2.481 . . . . 73.44 112.957 -177.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 36.1 m -93.19 26.29 2.94 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 121.234 0.54 . . . . 75.33 110.833 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.572 ' O ' ' HA ' ' A' ' 44' ' ' ASN . 85.8 t80 -124.9 110.36 14.16 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 107.092 -1.448 . . . . 73.3 107.092 172.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.647 ' HB2' ' HB3' ' A' ' 110' ' ' GLN . 85.2 mt -131.48 174.49 10.04 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 108.849 -0.797 . . . . 65.23 108.849 170.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -63.09 -75.7 0.07 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.527 0.731 . . . . 72.33 111.513 -178.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -80.25 -10.9 84.9 Favored Glycine 0 C--N 1.349 1.271 0 O-C-N 123.195 0.31 . . . . 74.33 113.157 -177.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.647 ' HB3' ' HB2' ' A' ' 107' ' ' LEU . 5.3 tp-100 -90.99 40.55 1.03 Allowed 'General case' 0 CA--C 1.556 1.178 0 CA-C-O 121.531 0.682 . . . . 70.43 109.323 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -69.63 -12.53 61.72 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.088 0.955 . . . . 65.42 112.687 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.3 pm0 -64.45 -10.11 23.03 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.197 0.599 . . . . 75.24 112.174 169.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.474 ' O ' HG13 ' A' ' 117' ' ' ILE . 53.0 mt -91.18 -4.58 55.96 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.172 0.589 . . . . 75.41 111.961 175.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 90.2 mt -66.03 -34.56 78.36 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 118.536 0.607 . . . . 62.31 111.162 176.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -75.25 -17.25 60.36 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.515 0.726 . . . . 52.31 111.415 172.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -90.86 -9.86 44.78 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.413 0.685 . . . . 71.23 110.034 176.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 113' ' ' LEU . 59.3 mt -84.26 121.7 36.95 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 N-CA-C 107.294 -1.373 . . . . 73.1 107.294 170.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.521 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 10.8 mmpt? -111.14 151.79 27.74 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.225 0.61 . . . . 64.11 109.837 -178.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 77' ' ' MET . 43.3 ptt85 . . . . . 0 N--CA 1.475 0.799 0 CA-C-N 115.053 -0.976 . . . . 75.25 109.563 170.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.8 t . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 118.989 -0.529 . . . . 43.3 110.25 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -52.28 148.48 25.22 Favored 'Trans proline' 0 C--N 1.386 2.526 0 C-N-CA 123.718 2.945 . . . . 75.22 113.172 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.77 -42.42 64.98 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.833 0.853 . . . . 75.31 111.771 176.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -52.71 -49.9 64.44 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.617 0.767 . . . . 73.1 112.081 174.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 82.5 mt -80.61 -30.81 36.78 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.187 0.44 . . . . 72.13 112.187 -169.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.8 t -72.15 -36.54 69.36 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 118.009 0.368 . . . . 61.32 111.026 175.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.498 ' HE2' ' HA ' ' A' ' 23' ' ' LYS . 9.0 mmpt? -73.52 -36.49 65.72 Favored 'General case' 0 C--N 1.359 0.981 0 C-N-CA 122.869 0.468 . . . . 33.23 110.324 176.078 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.0 tp -62.76 -49.34 75.38 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 124.049 0.843 . . . . 74.02 110.99 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.478 ' HH2' ' HG2' ' A' ' 108' ' ' ARG . 12.0 t-105 -60.47 -43.62 96.73 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 122.36 0.264 . . . . 61.13 111.209 178.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.4 m -54.42 -51.19 65.7 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 122.631 0.373 . . . . 74.0 110.436 172.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.45 ' HG ' HD13 ' A' ' 37' ' ' ILE . 37.1 tp -57.19 -53.39 58.68 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.116 1.767 . . . . 44.12 113.201 -175.623 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.7 t -61.47 -35.45 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.659 1.184 . . . . 63.05 111.785 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.2 t -93.32 -6.52 47.2 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.778 -0.646 . . . . 44.52 111.351 -176.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -83.42 129.83 58.79 Favored Pre-proline 0 CA--C 1.552 1.055 0 C-N-CA 123.004 0.521 . . . . 74.33 111.18 -172.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -80.88 -9.63 13.06 Favored 'Trans proline' 0 C--N 1.382 2.328 0 C-N-CA 122.863 2.375 . . . . 42.34 114.027 -176.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -80.53 -27.42 37.63 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 118.49 0.586 . . . . 74.24 110.589 175.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.8 p -105.59 10.02 33.15 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.537 0.735 . . . . 74.41 112.486 -179.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -56.83 -32.27 65.59 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.151 0.981 . . . . 61.04 112.476 -175.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.08 -38.24 90.39 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.835 0.854 . . . . 75.31 112.968 -176.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.446 ' HA ' ' HB2' ' A' ' 49' ' ' PHE . 77.9 mt -110.97 -8.5 14.47 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 122.687 0.395 . . . . 61.01 111.837 -175.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.45 HD13 ' HG ' ' A' ' 27' ' ' LEU . 18.6 tt -162.42 134.36 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 122.62 0.368 . . . . 74.42 111.163 173.052 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.3 p -161.96 156.6 22.55 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.15 0.58 . . . . 75.04 109.879 173.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 14.8 p-90 -77.03 150.31 35.8 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.335 0.654 . . . . 71.41 110.504 -177.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.2 m -75.54 147.11 81.57 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 108.579 -0.897 . . . . 75.22 108.579 176.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.49 -12.89 12.01 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.615 2.21 . . . . 62.44 113.639 176.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.0 m -65.76 -43.95 87.31 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.664 1.186 . . . . 55.15 110.728 169.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.46 -10.98 69.07 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 114.934 -1.03 . . . . 71.42 114.147 177.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -101.84 6.43 41.53 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.456 1.102 . . . . 74.34 111.605 -171.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.2 p -157.36 161.75 39.05 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.121 0.969 . . . . 65.42 109.657 -171.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.431 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 45.9 p90 -146.61 146.52 30.45 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.66 0.384 . . . . 72.13 110.731 177.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -103.28 143.55 32.51 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.575 0.75 . . . . 63.33 109.632 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.0 t -123.14 121.98 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 107.569 -1.271 . . . . 71.13 107.569 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.552 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 90.6 m-85 -105.14 144.71 31.55 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 123.572 0.749 . . . . 71.23 109.759 -177.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 42.98 73.02 0.15 Allowed 'General case' 0 N--CA 1.476 0.851 0 O-C-N 125.254 1.596 . . . . 64.34 112.608 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -53.72 -26.9 25.2 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.499 1.119 . . . . 71.13 113.498 -175.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.31 -48.12 47.51 Favored Glycine 0 C--N 1.35 1.35 0 O-C-N 123.014 0.196 . . . . 61.43 112.69 173.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.423 ' HG3' HD11 ' A' ' 36' ' ' LEU . 56.1 tp60 -71.62 -37.13 70.95 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.018 0.927 . . . . 74.24 110.663 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.468 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 59.8 t80 -61.96 -48.93 78.17 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.224 1.41 . . . . 75.1 110.135 176.235 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.466 ' HB2' ' HB2' ' A' ' 68' ' ' MET . . . -62.45 -33.0 73.96 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 116.06 -0.518 . . . . 73.45 111.6 178.024 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.1 tttm -67.74 -55.52 12.82 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.611 1.165 . . . . 71.44 113.398 -177.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -106.78 -33.38 7.6 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 113.138 0.792 . . . . 70.1 113.138 -170.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.468 ' HB ' ' O ' ' A' ' 54' ' ' PHE . 94.4 t -82.78 -49.94 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 122.923 0.489 . . . . 73.44 111.605 -171.156 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.2 mt -61.48 -47.76 92.42 Favored Pre-proline 0 CA--C 1.561 1.369 0 CA-C-O 118.048 -0.977 . . . . 61.05 113.042 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -66.62 -16.62 51.2 Favored 'Trans proline' 0 C--N 1.391 2.783 0 CA-C-N 121.964 1.737 . . . . 74.41 113.073 177.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -77.03 -53.97 7.14 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.384 0.674 . . . . 54.25 111.253 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -87.29 -46.71 9.45 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.241 0.617 . . . . 73.42 111.686 -177.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -100.33 -179.9 4.26 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.383 -0.826 . . . . 64.42 108.785 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -112.64 40.03 2.36 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 121.634 0.73 . . . . 64.45 109.654 -174.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 32.2 p80 -157.66 161.5 38.6 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 114.949 -1.023 . . . . 75.34 109.01 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.413 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 31.7 p30 -112.95 -11.01 13.47 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.217 0.607 . . . . 43.25 110.128 177.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -73.39 120.53 19.13 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.439 0.696 . . . . 73.04 111.262 -176.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.466 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 12.2 tpt -69.9 -36.63 75.55 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.702 0.801 . . . . 74.22 111.303 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.65 -30.92 67.68 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 123.724 0.64 . . . . 73.5 111.962 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.1 t -65.54 -47.35 76.16 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.39 1.076 . . . . 71.45 110.841 174.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -63.74 -52.92 58.28 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.511 1.125 . . . . 75.42 110.471 -176.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.7 t -62.94 -40.89 90.67 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 CA-C-N 115.25 -0.886 . . . . 62.23 111.055 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -57.7 -40.97 80.74 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 123.272 0.629 . . . . 73.33 111.407 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -57.57 -51.0 71.25 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 124.187 0.929 . . . . 73.44 110.07 176.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 68.2 mt -63.56 -38.14 89.98 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.923 0.889 . . . . 73.25 111.714 -177.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -57.27 -44.6 84.11 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 122.803 0.441 . . . . 71.22 110.851 172.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 71.0 mtm -73.79 -25.17 59.99 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.905 -0.589 . . . . 54.11 111.499 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -86.54 1.58 51.13 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.35 0.66 . . . . 62.52 111.065 173.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.63 13.39 81.6 Favored Glycine 0 C--N 1.344 1.017 0 N-CA-C 115.068 0.787 . . . . 53.25 115.068 171.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -69.3 144.87 53.44 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 117.877 0.838 . . . . 73.12 109.248 177.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -101.18 122.54 43.82 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.414 -0.587 . . . . 75.31 109.414 -177.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.502 ' HE2' ' HB ' ' A' ' 84' ' ' VAL . 22.9 tptm -68.32 113.22 5.73 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.018 1.327 . . . . 74.11 109.743 172.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 90.3 t -125.58 106.61 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 107.711 -1.218 . . . . 73.55 107.711 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.502 ' HB ' ' HE2' ' A' ' 82' ' ' LYS . 3.5 p -107.7 123.11 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 108.442 -0.947 . . . . 73.02 108.442 -172.155 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 . . . . . 0 N--CA 1.482 1.137 0 C-N-CA 123.164 0.586 . . . . 75.35 111.725 -169.766 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 . . . . . 0 CA--C 1.542 0.645 0 CA-C-O 121.789 0.804 . . . . 75.13 111.917 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.552 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 52.4 m-20 -86.58 124.51 32.96 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.24 -1.022 . . . . 64.53 108.24 171.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -123.2 107.52 11.8 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 107.897 -1.149 . . . . 74.01 107.897 167.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 55.0 m -122.11 108.73 13.68 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.589 1.156 . . . . 42.11 109.579 -173.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 46' ' ' PHE . 38.7 tt0 -101.49 115.36 30.34 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.82 -0.807 . . . . 71.05 108.82 -179.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -96.63 120.03 36.2 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.181 -1.044 . . . . 63.52 108.181 171.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -118.3 145.48 45.04 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.714 -0.847 . . . . 64.33 108.714 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.467 ' HB3' ' HB3' ' A' ' 106' ' ' PHE . 56.1 t60 -155.78 133.17 6.53 Favored Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 109.318 -0.623 . . . . 74.25 109.318 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -63.96 -35.53 54.46 Favored 'Trans proline' 0 C--N 1.384 2.447 0 C-N-CA 122.855 2.37 . . . . 54.21 112.268 -175.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 3.4 m -87.0 3.88 44.12 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.435 0.694 . . . . 73.4 111.002 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.467 ' HB3' ' HB3' ' A' ' 103' ' ' HIS . 88.9 t80 -111.84 103.28 11.53 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 107.911 -1.144 . . . . 74.2 107.911 175.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.413 HD12 ' HG2' ' A' ' 110' ' ' GLN . 28.3 mt -119.43 167.97 11.42 Favored 'General case' 0 C--O 1.246 0.881 0 N-CA-C 107.236 -1.394 . . . . 71.22 107.236 170.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ARG . . . . . 0.478 ' HG2' ' HH2' ' A' ' 25' ' ' TRP . 30.3 ttp85 -60.63 -79.86 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.154 0.582 . . . . 75.31 110.903 -173.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -85.46 60.17 4.74 Favored Glycine 0 C--N 1.347 1.14 0 N-CA-C 111.624 -0.59 . . . . 63.42 111.624 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.413 ' HG2' HD12 ' A' ' 107' ' ' LEU . 2.8 tp-100 -150.93 35.44 0.6 Allowed 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 108.872 -0.788 . . . . 72.22 108.872 -170.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -64.16 -20.19 65.83 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.607 1.163 . . . . 61.21 113.154 -175.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.07 -8.18 53.13 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 112.022 0.379 . . . . 73.31 112.022 177.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.435 ' O ' HG13 ' A' ' 117' ' ' ILE . 17.7 mt -88.3 -16.61 32.64 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.368 0.667 . . . . 71.52 111.494 173.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 96.8 mt -61.61 -36.41 80.66 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.274 0.559 . . . . 64.42 111.212 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -72.77 -15.78 61.65 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 115.57 -0.741 . . . . 74.03 112.342 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -97.14 -7.68 31.95 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.706 0.802 . . . . 64.13 110.257 178.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 113' ' ' LEU . 64.2 mt -88.65 130.52 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 107.573 -1.269 . . . . 71.11 107.573 173.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -105.71 141.1 37.72 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.25 0.62 . . . . 61.54 109.992 -171.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 . . . . . 0 N--CA 1.48 1.031 0 O-C-N 124.209 0.943 . . . . 74.14 110.327 170.213 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.9 mmt . . . . . 0 N--CA 1.476 0.871 0 N-CA-C 109.549 -0.538 . . . . 71.34 109.549 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.26 96.01 0.98 Allowed Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.263 -0.88 . . . . 61.0 112.399 -177.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 -91.75 -36.07 13.78 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.617 -0.883 . . . . 74.12 108.617 168.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -70.35 103.23 2.35 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.859 0.864 . . . . 74.12 109.213 174.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.1 m-70 -116.68 154.25 30.9 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 124.003 0.921 . . . . 71.4 109.732 177.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -71.83 147.51 47.13 Favored 'General case' 0 C--O 1.241 0.627 0 O-C-N 124.054 0.846 . . . . 74.52 111.311 -177.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 11.2 t60 65.29 70.83 0.45 Allowed 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.707 1.203 . . . . 71.53 110.793 175.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -86.24 97.06 10.16 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 108.079 -1.082 . . . . 74.4 108.079 172.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 52.4 p -69.3 -69.68 0.32 Allowed 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 115.479 -0.782 . . . . 74.5 111.077 -172.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -133.7 28.47 3.92 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.344 1.058 . . . . 72.21 108.409 175.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 77.8 mtp -78.47 165.63 23.54 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.494 -1.23 . . . . 73.01 111.646 -175.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.12 137.36 14.82 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 114.904 -1.043 . . . . 55.02 108.396 171.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 171.99 -78.57 0.09 OUTLIER Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.217 -0.753 . . . . 64.03 111.217 -177.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -83.63 79.26 2.83 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 123.047 2.498 . . . . 74.33 112.254 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 96.9 p 47.8 55.22 8.81 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.701 1.2 . . . . 45.41 112.896 173.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -79.73 17.88 0.85 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.509 0.724 . . . . 74.42 111.281 178.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.2 t -69.57 129.09 91.76 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 123.879 0.872 . . . . 71.43 109.805 175.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.84 147.37 85.21 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 122.418 2.078 . . . . 72.55 110.894 171.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.29 -33.24 41.23 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.441 1.096 . . . . 73.35 113.36 -172.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -54.75 -52.76 61.55 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.681 0.792 . . . . 72.15 112.272 174.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 95.7 mt -77.26 -29.48 53.93 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 120.992 0.425 . . . . 74.43 109.912 -171.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.4 m -58.76 -48.4 81.34 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 114.351 -1.295 . . . . 74.33 111.395 173.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.475 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -69.28 -47.4 64.67 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.951 -0.568 . . . . 73.23 110.731 176.13 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.5 ' O ' HG23 ' A' ' 28' ' ' VAL . 58.9 tp -56.77 -54.76 42.6 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.597 1.159 . . . . 74.43 113.485 -174.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 89.5 t90 -56.34 -45.84 80.23 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.374 0.67 . . . . 74.41 111.13 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.1 m -69.26 -28.46 66.33 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.616 0.766 . . . . 75.22 111.663 177.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.506 ' HG ' HG21 ' A' ' 37' ' ' ILE . 49.6 tp -67.21 -46.2 74.58 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.932 1.293 . . . . 74.01 110.931 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 24' ' ' LEU . 23.6 t -63.53 -37.98 81.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-N 115.129 -0.941 . . . . 73.44 110.732 175.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.2 m -74.5 -19.97 60.16 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.841 0.856 . . . . 74.15 111.565 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -74.87 132.54 77.33 Favored Pre-proline 0 CA--C 1.556 1.173 0 C-N-CA 123.773 0.829 . . . . 64.21 110.988 -172.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.32 -28.19 12.66 Favored 'Trans proline' 0 C--N 1.384 2.44 0 C-N-CA 123.036 2.491 . . . . 74.21 114.235 -176.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -69.48 -43.39 73.29 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.244 0.618 . . . . 63.24 110.061 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.0 p -96.01 -1.25 49.31 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.733 -0.667 . . . . 70.33 111.325 -175.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -56.02 -30.83 62.45 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.645 1.178 . . . . 62.41 111.657 177.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.75 -36.31 78.61 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.237 -0.892 . . . . 74.24 112.152 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.8 mt -111.06 -6.0 14.7 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.166 0.587 . . . . 64.42 111.899 -176.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.506 HG21 ' HG ' ' A' ' 27' ' ' LEU . 18.8 tt -159.42 112.75 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 121.564 0.697 . . . . 74.11 110.504 175.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.527 ' SG ' ' HE2' ' A' ' 49' ' ' PHE . 24.5 p -139.9 145.41 37.95 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.174 0.59 . . . . 75.23 110.524 -174.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 18.8 p-90 -75.83 149.6 37.84 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.835 0.854 . . . . 71.12 111.513 -176.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.1 m -72.21 154.24 92.19 Favored Pre-proline 0 CA--C 1.556 1.192 0 C-N-CA 123.848 0.859 . . . . 62.22 109.262 174.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -43.21 -42.83 10.11 Favored 'Trans proline' 0 C--N 1.386 2.531 0 C-N-CA 124.432 3.421 . . . . 63.32 114.677 -176.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.2 m -67.52 -40.19 85.1 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.192 0.597 . . . . 71.21 111.37 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.11 11.82 55.8 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-N 115.901 -0.591 . . . . 44.41 112.793 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.409 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 28.0 p-10 -91.63 -4.76 54.87 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.26 1.024 . . . . 62.35 111.276 -175.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.6 p -155.31 170.93 20.73 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 123.937 0.895 . . . . 52.32 109.744 -174.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 50.7 p90 -142.12 149.23 39.55 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.07 0.548 . . . . 72.33 110.299 178.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -107.84 147.16 31.28 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.225 1.01 . . . . 65.45 108.398 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.624 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 60.2 t -123.3 131.31 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.018 -1.104 . . . . 72.41 108.018 176.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.527 ' HE2' ' SG ' ' A' ' 38' ' ' CYS . 79.3 m-85 -118.73 146.71 44.54 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 124.148 0.979 . . . . 72.14 109.4 -177.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 52.68 70.98 0.51 Allowed 'General case' 0 CA--C 1.548 0.898 0 O-C-N 124.693 1.246 . . . . 74.41 111.088 -178.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -46.79 -41.45 15.42 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 124.391 1.076 . . . . 73.11 112.955 -177.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.48 -46.58 76.18 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 115.646 -0.706 . . . . 75.41 112.822 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -72.69 -45.82 56.86 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.009 0.524 . . . . 74.32 110.822 -176.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.4 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 65.7 t80 -53.66 -49.15 68.57 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.778 1.231 . . . . 74.51 110.729 173.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.496 ' HB1' ' O ' ' A' ' 66' ' ' ASN . . . -64.44 -33.79 76.69 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 112.409 0.522 . . . . 71.23 112.409 178.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -69.41 -50.4 46.26 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.455 1.102 . . . . 71.34 112.167 -177.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.509 ' HG3' HG23 ' A' ' 58' ' ' VAL . 3.3 pt-20 -105.69 -43.97 4.78 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 113.098 0.777 . . . . 74.21 113.098 -174.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.509 HG23 ' HG3' ' A' ' 57' ' ' GLU . 94.5 t -76.78 -45.48 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 122.751 0.421 . . . . 74.13 111.017 -166.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 32.3 mt -61.8 -51.14 78.06 Favored Pre-proline 0 CA--C 1.557 1.225 0 CA-C-O 117.764 -1.113 . . . . 55.31 112.073 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.21 -9.58 26.27 Favored 'Trans proline' 0 C--N 1.384 2.406 0 CA-C-N 122.291 1.854 . . . . 62.13 113.719 176.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -79.35 -53.49 6.87 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.284 0.633 . . . . 72.3 110.965 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -91.69 -46.82 7.71 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.075 0.55 . . . . 73.44 111.176 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -99.12 -177.29 3.57 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 108.254 -1.017 . . . . 65.13 108.254 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -113.16 37.52 3.13 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 119.112 0.869 . . . . 72.41 111.721 -172.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -157.05 158.33 36.28 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.91 0.484 . . . . 74.22 110.271 -174.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.496 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 9.0 m-80 -105.31 -16.21 14.82 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 122.515 0.326 . . . . 63.31 110.671 177.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -75.86 124.72 27.78 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.842 0.457 . . . . 40.1 110.995 -175.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 12.7 tpt -75.1 -33.97 61.69 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.82 0.848 . . . . 75.11 111.779 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.07 -33.52 70.89 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.26 0.624 . . . . 60.15 111.68 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.44 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 48.2 t -64.7 -44.92 88.71 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.459 1.104 . . . . 73.45 111.223 175.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -60.64 -51.77 67.99 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.197 0.999 . . . . 73.51 110.709 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.6 t -61.32 -39.64 83.37 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 CA-C-N 115.0 -1.0 . . . . 40.34 111.342 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -60.69 -41.34 94.95 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.766 0.826 . . . . 71.44 112.096 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' A' ' 70' ' ' SER . 13.8 mm100 -58.98 -47.41 85.24 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 123.943 0.777 . . . . 54.2 109.616 176.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 80' ' ' PHE . 77.5 mt -61.65 -38.47 87.85 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.274 1.03 . . . . 72.5 112.172 -178.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -60.55 -35.65 76.55 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 122.557 0.343 . . . . 60.12 111.864 173.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 63.7 mtm -76.57 -23.56 53.54 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.039 0.536 . . . . 73.0 111.3 175.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -85.9 -7.0 58.98 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.405 0.682 . . . . 64.21 111.602 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.93 10.2 66.96 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-O 119.569 -0.573 . . . . 62.45 114.27 175.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.429 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 24.0 m-85 -73.25 144.41 46.71 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 117.723 0.761 . . . . 71.33 109.506 178.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 57.5 ttt-85 -110.8 131.72 54.81 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.693 -0.484 . . . . 54.53 109.693 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.574 ' HE3' ' HA ' ' A' ' 99' ' ' THR . 18.6 tptm -74.48 127.43 33.04 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.735 0.814 . . . . 45.01 109.721 173.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 95.5 t -132.37 118.38 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 107.034 -1.469 . . . . 63.52 107.034 176.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.483 ' HB ' ' HE2' ' A' ' 82' ' ' LYS . 6.5 p -104.93 116.16 48.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 108.845 -0.798 . . . . 75.12 108.845 -177.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -91.02 -10.88 40.6 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 122.212 -0.305 . . . . 63.14 111.761 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 35.0 mm -89.54 116.17 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 108.594 -0.891 . . . . 73.3 108.594 168.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -75.97 88.69 2.94 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 109.102 -0.703 . . . . 71.2 109.102 176.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -72.27 110.94 7.05 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 114.843 -1.071 . . . . 65.23 111.213 -169.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -177.6 -141.34 4.08 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-N 115.87 -0.604 . . . . 44.22 112.208 177.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.56 59.18 4.63 Favored Glycine 0 C--N 1.344 1.001 0 N-CA-C 112.0 -0.44 . . . . 43.24 112.0 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 85.2 mt -123.69 157.57 33.59 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.185 0.994 . . . . 73.13 110.242 -177.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.9 p -83.22 7.57 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.489 0 C-N-CA 123.932 0.893 . . . . 71.43 110.867 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -57.53 156.91 15.01 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 125.44 1.496 . . . . 74.12 112.302 175.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -56.67 153.84 34.16 Favored 'Trans proline' 0 C--N 1.394 2.924 0 C-N-CA 122.985 2.457 . . . . 63.14 113.301 -174.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -82.45 27.44 0.51 Allowed 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.238 1.015 . . . . 74.03 112.629 -169.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -125.93 162.25 25.64 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.05 0.94 . . . . 75.44 110.253 -176.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.87 142.02 28.13 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.028 -1.101 . . . . 72.11 108.028 170.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.421 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 20.3 t70 -106.7 105.13 15.02 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 106.891 -1.522 . . . . 54.21 106.891 166.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.624 ' HB ' ' HB ' ' A' ' 48' ' ' VAL . 31.6 m -112.79 91.24 3.58 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.118 0.567 . . . . 62.25 110.376 -171.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 46' ' ' PHE . 39.6 tt0 -98.32 114.68 27.07 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.9 0.48 . . . . 65.13 109.73 -175.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -98.68 120.24 38.78 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 109.199 -0.667 . . . . 74.21 109.199 171.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -108.22 144.24 35.93 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.171 0.988 . . . . 71.42 110.382 -175.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -160.08 132.27 4.29 Favored Pre-proline 0 N--CA 1.479 0.992 0 CA-C-O 119.193 -0.432 . . . . 74.41 110.206 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.41 -24.83 42.46 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 122.94 2.427 . . . . 72.41 113.616 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.513 ' HB2' HG12 ' A' ' 117' ' ' ILE . 13.2 m -95.1 8.49 42.81 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.738 0.415 . . . . 72.01 111.015 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 44' ' ' ASN . 74.5 t80 -111.43 100.43 9.02 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 107.816 -1.179 . . . . 73.43 107.816 175.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 110' ' ' GLN . 96.3 mt -120.58 154.09 35.87 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.196 0.598 . . . . 61.23 109.658 173.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -71.21 -22.56 62.0 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.111 0.964 . . . . 75.13 112.575 -170.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.61 27.19 6.65 Favored Glycine 0 N--CA 1.468 0.831 0 N-CA-C 112.268 -0.333 . . . . 53.22 112.268 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.525 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 26.8 mm-40 -135.17 78.2 1.72 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.339 0.656 . . . . 65.02 110.182 -175.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -29.38 69.58 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.148 -0.933 . . . . 72.15 112.034 174.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 6.8 pm0 -76.28 -11.09 59.85 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.161 0.584 . . . . 62.14 111.693 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.0 mt -91.19 -12.78 34.36 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.658 0.383 . . . . 70.31 110.981 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 64.8 mt -69.1 -27.69 65.82 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.047 0.539 . . . . 64.13 110.631 175.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -89.72 0.9 56.69 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.612 0.765 . . . . 71.54 112.132 173.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -90.86 -17.36 26.65 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.282 -0.636 . . . . 43.23 109.282 161.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.513 HG12 ' HB2' ' A' ' 105' ' ' CYS . 32.7 mt -87.22 104.89 14.62 Favored 'Isoleucine or valine' 0 C--N 1.357 0.9 0 N-CA-C 106.64 -1.615 . . . . 65.31 106.64 173.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.481 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 11.0 mmpt? -112.47 155.81 23.63 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.953 -0.388 . . . . 51.31 109.953 -174.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -107.14 -53.29 2.64 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.792 0.837 . . . . 71.31 109.152 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt 179.87 149.11 0.31 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.904 0.881 . . . . 64.42 110.867 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.0 p -85.96 -16.26 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 C-N-CA 123.466 0.706 . . . . 75.2 110.498 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 33.7 p -76.21 -8.49 57.16 Favored 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 123.736 0.814 . . . . 64.14 112.25 177.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 33.1 t -131.62 -152.87 0.52 Allowed 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 106.939 -1.504 . . . . 73.54 106.939 169.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.5 p -59.24 131.98 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 109.068 -0.715 . . . . 72.42 109.068 165.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 31.8 p . . . . . 0 C--O 1.254 1.316 0 CA-C-O 118.68 -0.676 . . . . 44.23 111.236 -174.828 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.312 0 N-CA-C 110.019 -0.363 . . . . 63.31 110.019 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 130.26 45.6 0.16 Allowed Glycine 0 C--N 1.343 0.96 0 CA-C-N 116.317 -0.401 . . . . 72.44 112.253 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -72.18 140.32 48.7 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.53 0.732 . . . . 75.44 110.298 176.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 67.59 73.85 0.31 Allowed 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.983 1.313 . . . . 72.32 111.783 173.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -145.46 -172.83 3.96 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.427 1.491 . . . . 72.53 108.52 175.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -113.65 82.62 1.71 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 122.1 0.953 . . . . 73.12 110.614 174.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.3 t-80 -100.37 129.0 46.3 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 106.902 -1.518 . . . . 73.41 106.902 168.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 34.0 p-80 -61.18 143.44 55.54 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 123.249 0.343 . . . . 60.44 110.736 -175.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.8 t -75.26 162.66 28.25 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 122.795 0.438 . . . . 71.12 110.58 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -75.25 161.5 29.27 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.904 -0.589 . . . . 72.14 111.157 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 35.2 mmt -80.57 -161.0 0.34 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.897 0.879 . . . . 74.33 111.562 -173.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.22 81.44 0.35 Allowed 'General case' 0 C--N 1.355 0.831 0 C-N-CA 123.563 0.745 . . . . 72.35 110.162 173.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -152.15 -67.06 0.01 OUTLIER Glycine 0 N--CA 1.466 0.664 0 N-CA-C 109.325 -1.51 . . . . 41.44 109.325 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -68.96 134.54 29.94 Favored 'Trans proline' 0 C--N 1.363 1.326 0 C-N-CA 122.559 2.172 . . . . 45.13 108.333 156.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.482 ' HB3' HG23 ' A' ' 17' ' ' VAL . 73.5 m -61.73 130.69 47.01 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.234 0.54 . . . . 64.23 112.35 -172.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -88.23 24.63 1.82 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.599 1.16 . . . . 63.43 110.276 -176.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.482 HG23 ' HB3' ' A' ' 15' ' ' SER . 84.1 t -61.27 129.83 91.13 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 124.267 1.027 . . . . 74.03 110.212 178.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -53.0 140.35 59.46 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 123.44 2.76 . . . . 70.14 111.593 175.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.49 -40.4 65.33 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.635 0.774 . . . . 64.43 112.235 -178.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -52.33 -49.84 63.46 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.05 0.94 . . . . 61.35 112.307 171.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 90.4 mt -81.65 -25.1 35.88 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.887 0.475 . . . . 72.04 110.684 -170.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.5 m -64.74 -53.36 48.38 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 124.183 0.993 . . . . 51.12 110.657 174.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.525 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -69.34 -39.94 77.86 Favored 'General case' 0 C--N 1.345 0.396 0 CA-C-N 115.457 -0.792 . . . . 74.14 110.848 -179.395 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.443 ' O ' HG23 ' A' ' 28' ' ' VAL . 54.4 tp -60.49 -48.44 81.77 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.594 0.758 . . . . 72.04 111.733 176.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.606 ' HE1' ' HA ' ' A' ' 108' ' ' ARG . 56.3 t90 -59.04 -47.72 84.21 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.99 0.516 . . . . 73.01 111.13 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.9 m -59.4 -40.79 87.78 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.044 0.938 . . . . 74.23 110.886 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 22.1 tp -62.92 -52.92 61.17 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.752 1.621 . . . . 54.43 112.355 -178.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 24' ' ' LEU . 93.6 t -60.84 -32.2 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 C-N-CA 124.227 1.011 . . . . 71.1 111.053 179.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.2 m -90.16 -5.84 56.02 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.271 1.028 . . . . 64.44 112.292 -176.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.409 ' HB3' ' OG1' ' A' ' 33' ' ' THR . 14.9 t70 -86.42 127.16 62.06 Favored Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 123.095 0.558 . . . . 72.21 111.192 -174.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.8 -32.39 77.81 Favored 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 123.782 2.988 . . . . 74.32 114.526 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -72.11 -39.94 68.51 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 122.901 0.481 . . . . 75.03 110.262 -178.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.409 ' OG1' ' HB3' ' A' ' 30' ' ' ASP . 29.8 p -98.14 0.46 46.03 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.736 -0.666 . . . . 61.43 111.445 -176.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -55.04 -31.21 60.92 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.603 1.161 . . . . 73.13 111.074 173.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.84 -39.94 86.85 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.065 0.946 . . . . 72.11 112.801 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 48.4 mt -103.54 -13.49 16.55 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.863 0.465 . . . . 75.24 111.96 -178.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.6 tt -159.81 122.27 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 121.061 0.458 . . . . 71.15 110.042 177.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 26.6 p -139.52 148.7 42.99 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 122.86 0.464 . . . . 71.13 111.245 -173.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.42 ' HB3' HG12 ' A' ' 28' ' ' VAL . 20.5 p-90 -77.85 148.99 34.41 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.418 0.687 . . . . 73.12 109.977 175.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.9 m -81.87 144.51 51.87 Favored Pre-proline 0 CA--C 1.551 1.008 0 N-CA-C 108.618 -0.882 . . . . 71.21 108.618 174.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.35 -22.15 15.27 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 123.883 3.055 . . . . 74.45 115.219 -173.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.3 m -78.06 -37.79 45.91 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.01 0.524 . . . . 45.55 111.073 176.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.9 4.14 51.62 Favored Glycine 0 C--N 1.351 1.416 0 N-CA-C 114.875 0.71 . . . . 62.33 114.875 167.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 6.6 p30 -106.5 2.08 25.95 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.804 0.842 . . . . 74.32 111.672 -175.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 81.0 p -148.01 158.09 43.87 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 109.016 -0.735 . . . . 53.42 109.016 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -142.57 152.67 42.81 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.8 0.44 . . . . 74.31 110.139 176.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -108.53 141.89 39.77 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.762 0.825 . . . . 75.52 109.336 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.0 t -118.48 134.11 63.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 107.499 -1.297 . . . . 64.15 107.499 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.452 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 93.3 m-85 -123.45 147.21 47.38 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.853 0.861 . . . . 72.12 110.088 -172.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 48.11 63.32 2.09 Favored 'General case' 0 C--N 1.352 0.714 0 O-C-N 125.33 1.644 . . . . 74.35 111.356 175.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.521 ' HG2' ' HE2' ' A' ' 68' ' ' MET . 99.2 mt-30 -54.56 -29.14 50.29 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.309 1.044 . . . . 65.15 113.3 -171.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -63.42 -45.51 94.77 Favored Glycine 0 CA--C 1.531 1.069 0 O-C-N 123.36 0.413 . . . . 24.41 112.322 172.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -74.04 -45.71 47.89 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.81 0.844 . . . . 73.02 110.574 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.408 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 80.1 t80 -55.28 -52.6 62.91 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.752 1.621 . . . . 71.31 111.2 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.503 ' HB2' ' HB2' ' A' ' 68' ' ' MET . . . -66.92 -25.95 66.62 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.159 0.429 . . . . 73.25 112.159 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.8 -49.99 18.79 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.756 0.822 . . . . 75.21 112.25 -177.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.524 ' HG3' HG23 ' A' ' 58' ' ' VAL . 6.1 pt-20 -105.19 -42.63 5.23 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 112.746 0.647 . . . . 72.25 112.746 -175.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.524 HG23 ' HG3' ' A' ' 57' ' ' GLU . 74.2 t -76.77 -43.98 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 C-N-CA 123.109 0.564 . . . . 61.3 111.877 -167.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.468 ' HG ' ' HA ' ' A' ' 55' ' ' ALA . 38.8 mt -60.85 -54.76 51.33 Favored Pre-proline 0 CA--C 1.564 1.481 0 CA-C-O 118.272 -0.871 . . . . 71.05 112.082 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -65.87 -12.23 34.37 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 121.925 1.75 . . . . 74.12 113.621 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -77.96 -62.53 1.64 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.113 0.965 . . . . 71.13 111.259 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.493 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 43.0 m-85 -78.77 -51.02 10.36 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.304 0.573 . . . . 72.24 110.676 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -89.36 -166.61 1.64 Allowed 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 107.53 -1.285 . . . . 74.1 107.53 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.59 43.57 3.11 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 119.531 1.059 . . . . 74.0 110.465 -178.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -163.61 162.64 24.4 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.06 -0.973 . . . . 71.44 108.854 -175.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.7 m-80 -105.9 -148.95 0.42 Allowed 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 106.713 -1.588 . . . . 71.2 106.713 174.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 68.88 105.36 0.05 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.734 0.813 . . . . 73.41 111.644 169.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.521 ' HE2' ' HG2' ' A' ' 51' ' ' GLN . 13.8 tpt -70.39 -28.2 64.91 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.604 -0.725 . . . . 64.24 110.869 -175.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.15 -39.4 75.16 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.197 0.599 . . . . 62.31 111.32 176.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.8 t -65.88 -43.66 87.65 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.304 1.041 . . . . 75.43 111.388 177.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -65.13 -52.95 52.17 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.123 0.969 . . . . 71.43 111.161 -177.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.416 ' HA ' HD12 ' A' ' 75' ' ' LEU . 59.6 t -63.33 -34.4 66.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 CA-C-N 115.58 -0.736 . . . . 74.11 110.884 178.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -55.84 -42.31 75.59 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.26 0.624 . . . . 71.05 111.113 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -62.94 -47.31 83.76 Favored 'General case' 0 C--N 1.347 0.462 0 O-C-N 124.018 0.823 . . . . 62.14 110.105 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 72' ' ' VAL . 77.3 mt -60.54 -44.62 95.91 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.222 1.009 . . . . 74.31 111.968 -177.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -55.61 -41.04 72.88 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.979 0.512 . . . . 75.12 111.432 175.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 67.2 mtm -72.12 -36.9 69.55 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 116.221 -0.445 . . . . 74.12 110.708 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -77.34 -7.71 56.48 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.181 0.592 . . . . 61.04 111.251 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.91 14.4 56.47 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-O 119.631 -0.538 . . . . 74.01 114.419 174.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -76.39 134.91 39.5 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 109.117 -0.698 . . . . 72.35 109.117 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -99.28 123.26 43.41 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.881 -0.785 . . . . 52.1 108.881 -175.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.525 ' HE3' HG23 ' A' ' 99' ' ' THR . 1.3 tmtp? -72.16 116.83 13.05 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.277 -1.009 . . . . 52.54 108.277 174.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.561 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 61.7 t -107.24 122.09 60.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.911 0 N-CA-C 108.276 -1.009 . . . . 64.04 108.276 177.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.5 t -82.06 119.77 32.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 124.336 1.054 . . . . 62.43 109.669 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -112.58 -49.66 2.94 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.782 -0.821 . . . . 74.04 108.782 174.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.447 HG12 ' HB3' ' A' ' 98' ' ' ASP . 50.2 mm -78.19 94.59 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 108.366 -0.976 . . . . 75.21 108.366 172.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.425 ' HB2' HD12 ' A' ' 91' ' ' LEU . 41.1 mt-10 -88.27 112.96 23.4 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 114.356 -1.293 . . . . 60.12 109.455 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -76.18 152.66 36.59 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.544 0.738 . . . . 72.41 110.513 177.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 148.57 -120.8 1.24 Allowed Glycine 0 C--N 1.338 0.69 0 N-CA-C 110.346 -1.102 . . . . 54.02 110.346 -177.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -98.01 -0.62 58.64 Favored Glycine 0 C--N 1.343 0.917 0 CA-C-O 119.987 -0.341 . . . . 74.22 112.873 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.425 HD12 ' HB2' ' A' ' 87' ' ' GLU . 59.2 mt -75.56 143.03 42.63 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.236 0.614 . . . . 72.21 111.417 -175.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 28.0 m -100.21 16.22 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.165 0.986 . . . . 75.24 111.023 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -62.19 142.34 95.76 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 109.516 -0.55 . . . . 74.33 109.516 172.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -49.82 144.88 19.55 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 124.071 3.18 . . . . 72.13 113.964 -163.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -79.7 10.41 4.06 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 114.534 -1.212 . . . . 75.21 112.231 -169.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -73.3 170.44 15.02 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.67 -0.695 . . . . 73.42 110.39 171.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 22.0 m-20 -90.43 133.25 35.15 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.799 -0.815 . . . . 72.21 108.799 164.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.447 ' HB3' HG12 ' A' ' 86' ' ' ILE . 9.1 t70 -131.37 104.23 6.89 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 106.057 -1.831 . . . . 71.43 106.057 165.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.525 HG23 ' HE3' ' A' ' 82' ' ' LYS . 32.6 m -126.99 111.38 14.01 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.675 -0.693 . . . . 53.22 109.281 -173.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.561 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 41.5 tt0 -100.55 112.02 24.34 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 110.1 -0.333 . . . . 72.45 110.1 -173.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -97.45 122.53 40.6 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 109.032 -0.729 . . . . 71.13 109.032 174.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -120.98 145.56 47.61 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.552 0.741 . . . . 63.42 110.382 -176.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 -156.8 131.98 5.46 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 108.354 -0.98 . . . . 75.41 108.354 174.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -64.45 -20.81 66.38 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.986 2.457 . . . . 62.14 113.651 -175.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.495 ' HB2' HG12 ' A' ' 117' ' ' ILE . 18.5 m -98.4 7.12 46.62 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.324 0.65 . . . . 64.05 111.496 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 44' ' ' ASN . 62.3 t80 -108.09 100.87 10.16 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 107.721 -1.215 . . . . 70.23 107.721 175.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.594 ' HB2' ' HB3' ' A' ' 110' ' ' GLN . 96.0 mt -125.17 146.21 49.6 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.351 0.66 . . . . 71.11 109.321 173.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.606 ' HA ' ' HE1' ' A' ' 25' ' ' TRP . 31.4 ttt180 -83.11 102.11 11.61 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 109.397 -0.594 . . . . 63.13 109.397 176.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 123.99 -38.84 2.31 Favored Glycine 0 C--N 1.337 0.624 0 N-CA-C 110.349 -1.1 . . . . 72.45 110.349 -177.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.594 ' HB3' ' HB2' ' A' ' 107' ' ' LEU . 2.6 tp-100 -88.87 56.39 3.71 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.741 0.816 . . . . 70.23 109.012 176.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -62.87 -18.28 62.74 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.346 1.059 . . . . 73.33 112.514 -178.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -65.28 -20.91 66.63 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.558 0.743 . . . . 75.44 112.942 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.9 mt -91.89 -10.32 40.03 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.159 0.583 . . . . 71.43 111.693 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 74.5 mt -67.28 -35.41 79.42 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 121.394 0.616 . . . . 63.41 110.764 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -77.93 -4.93 49.36 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.498 -0.774 . . . . 64.45 111.99 176.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -103.17 -2.02 28.03 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.568 0.747 . . . . 64.33 110.014 173.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.495 HG12 ' HB2' ' A' ' 105' ' ' CYS . 60.0 mt -81.48 115.53 24.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.91 0 N-CA-C 107.053 -1.462 . . . . 72.51 107.053 168.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -105.68 136.55 45.07 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.756 -0.461 . . . . 74.04 109.756 -171.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -90.15 -21.74 22.07 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.115 0.566 . . . . 74.43 110.402 172.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -129.71 151.79 49.92 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.098 0.959 . . . . 71.23 108.864 176.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.1 p -70.73 -23.11 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 123.431 0.692 . . . . 72.2 110.648 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 48.9 p -82.69 178.55 8.14 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.554 0.742 . . . . 71.04 110.858 173.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 27.4 t -69.86 116.32 10.11 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.566 0.746 . . . . 62.1 110.446 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.7 p -156.33 155.48 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.118 0 C-N-CA 123.131 0.573 . . . . 70.22 110.614 -173.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 21.7 m . . . . . 0 C--O 1.251 1.132 0 N-CA-C 107.457 -1.312 . . . . 72.31 107.457 170.51 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.2 mtt . . . . . 0 N--CA 1.486 1.367 0 N-CA-C 110.108 -0.33 . . . . 63.44 110.108 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 146.79 113.42 0.78 Allowed Glycine 0 C--N 1.348 1.247 0 N-CA-C 111.481 -0.648 . . . . 71.34 111.481 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -120.82 5.42 10.48 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.322 0.649 . . . . 63.54 110.07 177.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 52.3 m-70 -123.82 169.11 11.89 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.275 1.03 . . . . 74.24 110.076 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -152.1 120.24 6.28 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 109.131 -0.692 . . . . 75.32 109.131 171.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -83.29 142.96 30.72 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 109.27 -0.641 . . . . 74.14 109.27 175.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -153.62 154.26 33.87 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.012 -0.54 . . . . 73.44 110.008 -169.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 47.7 m80 -73.19 92.84 1.78 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.671 -0.695 . . . . 72.21 109.43 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.1 t -96.24 113.44 25.04 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.544 0.738 . . . . 62.04 110.61 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -156.17 134.05 11.16 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.21 1.004 . . . . 75.12 108.733 173.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.0 ppp? -83.3 171.85 13.15 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.931 0.492 . . . . 74.43 109.771 173.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.59 61.46 5.72 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.159 0.584 . . . . 74.22 112.358 -174.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.45 -97.1 0.81 Allowed Glycine 0 C--N 1.344 1.009 0 N-CA-C 109.777 -1.329 . . . . 44.54 109.777 168.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -91.97 101.91 0.21 Allowed 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 122.581 2.187 . . . . 63.13 109.842 166.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 58.7 m -59.77 144.61 47.86 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.134 -0.484 . . . . 45.23 111.656 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.492 ' HB2' ' HB2' ' A' ' 115' ' ' GLU . 20.0 m-80 -84.34 21.75 1.37 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.171 0.989 . . . . 64.13 111.875 -170.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.1 t -67.77 118.18 55.25 Favored Pre-proline 0 CA--C 1.548 0.866 0 N-CA-C 108.81 -0.811 . . . . 65.25 108.81 173.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.529 ' HD2' HD12 ' A' ' 21' ' ' LEU . 32.4 Cg_exo -60.3 147.86 92.22 Favored 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.509 2.139 . . . . 74.25 111.682 173.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.63 -40.3 62.63 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.715 0.806 . . . . 44.31 111.508 176.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -53.72 -46.92 70.94 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.208 1.003 . . . . 52.43 111.705 174.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.529 HD12 ' HD2' ' A' ' 18' ' ' PRO . 28.9 mt -76.72 -37.35 56.21 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 112.468 0.544 . . . . 73.45 112.468 -173.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.8 t -69.87 -36.89 75.85 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 117.83 0.286 . . . . 75.54 110.699 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -75.73 -36.42 59.95 Favored 'General case' 0 C--N 1.358 0.964 0 C-N-CA 123.039 0.536 . . . . 34.23 110.392 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.2 tp -60.32 -44.6 95.31 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.307 0.643 . . . . 71.11 111.027 172.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 87.0 t90 -61.04 -44.85 96.78 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.714 0.806 . . . . 71.45 110.807 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 87.3 m -60.01 -38.99 84.25 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.213 1.005 . . . . 71.24 110.755 175.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.453 HD13 ' CD1' ' A' ' 62' ' ' TYR . 29.2 tp -67.41 -46.15 74.05 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.162 1.385 . . . . 55.04 111.726 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.5 t -62.4 -34.34 63.98 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 125.259 1.424 . . . . 72.34 111.343 175.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.8 t -90.01 -5.09 57.01 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.007 0.923 . . . . 71.34 111.871 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -82.15 119.73 75.66 Favored Pre-proline 0 N--CA 1.48 1.07 0 C-N-CA 123.361 0.664 . . . . 64.43 111.004 -174.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.42 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 68.2 Cg_endo -71.28 -20.52 27.89 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.428 2.085 . . . . 74.52 113.075 176.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -66.44 -40.82 89.69 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.61 0.364 . . . . 53.45 110.198 176.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.8 p -99.64 4.36 45.63 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.321 0.648 . . . . 64.22 111.276 -175.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.42 ' HB2' ' HA ' ' A' ' 31' ' ' PRO . 24.1 t70 -53.49 -29.0 33.89 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 125.365 1.466 . . . . 54.55 112.791 -178.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.32 -37.01 85.6 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.74 0.816 . . . . 42.31 112.542 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.7 mt -114.6 -11.58 12.36 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 112.512 0.56 . . . . 72.15 112.512 -176.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.429 HD13 ' HG ' ' A' ' 27' ' ' LEU . 14.8 tt -160.96 130.12 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-O 121.108 0.48 . . . . 73.34 110.207 175.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.3 p -153.68 164.19 38.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.483 -0.78 . . . . 72.51 109.908 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 30.6 p-90 -66.12 148.07 52.38 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 123.942 0.776 . . . . 71.14 110.579 172.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.8 m -75.13 153.46 86.42 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 123.354 0.662 . . . . 65.11 110.835 171.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -60.83 -27.54 84.96 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.278 1.985 . . . . 40.22 111.375 170.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.6 m -59.25 -32.07 69.66 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.852 1.261 . . . . 64.34 111.956 172.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.42 -14.58 11.68 Favored Glycine 0 C--N 1.348 1.196 0 N-CA-C 115.122 0.809 . . . . 43.44 115.122 177.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 2.5 p-10 -103.51 20.66 17.48 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.142 0.977 . . . . 72.32 110.64 -176.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.2 p -166.3 173.37 10.13 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.779 0.831 . . . . 64.35 109.833 -172.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 49.1 p90 -147.16 144.03 28.67 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.754 0.422 . . . . 62.42 110.607 176.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -100.52 148.46 24.76 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.812 0.845 . . . . 72.2 109.882 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.643 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 96.7 t -129.81 141.12 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.702 1.201 . . . . 75.11 107.959 176.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -124.03 147.5 47.78 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.697 0.799 . . . . 73.41 109.21 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 48.14 69.73 0.51 Allowed 'General case' 0 C--N 1.353 0.724 0 O-C-N 124.936 1.397 . . . . 63.42 111.293 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.445 ' HB3' ' HG2' ' A' ' 68' ' ' MET . 48.3 mt-30 -51.26 -30.93 19.28 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.637 1.175 . . . . 73.53 113.12 -174.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.86 -45.81 49.41 Favored Glycine 0 CA--C 1.534 1.233 0 O-C-N 123.382 0.426 . . . . 60.44 112.658 176.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -70.19 -42.26 72.64 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.591 0.757 . . . . 71.44 110.249 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -54.67 -48.35 72.48 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.5 1.52 . . . . 73.31 110.756 172.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.545 ' HB2' ' HB2' ' A' ' 68' ' ' MET . . . -64.8 -33.87 77.02 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 116.08 -0.509 . . . . 53.22 111.814 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -67.22 -47.4 70.95 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.497 1.119 . . . . 61.52 112.741 -178.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.449 ' HG3' HG23 ' A' ' 58' ' ' VAL . 9.7 pt-20 -112.32 -36.92 5.15 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 114.533 1.308 . . . . 72.11 114.533 -173.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.449 HG23 ' HG3' ' A' ' 57' ' ' GLU . 71.2 t -81.91 -42.91 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.467 0.707 . . . . 65.45 111.552 -169.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 47.9 mt -66.66 -44.52 54.51 Favored Pre-proline 0 CA--C 1.555 1.171 0 CA-C-O 117.928 -1.034 . . . . 75.4 112.718 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -65.49 -15.3 49.03 Favored 'Trans proline' 0 C--N 1.383 2.343 0 CA-C-N 121.813 1.683 . . . . 64.1 113.647 171.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -74.16 -59.7 2.61 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.482 0.313 . . . . 61.21 110.843 176.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.453 ' CD1' HD13 ' A' ' 27' ' ' LEU . 47.7 m-85 -91.19 -14.91 30.19 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 113.107 0.78 . . . . 74.44 113.107 -175.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -133.11 -174.36 3.46 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 108.878 -0.786 . . . . 72.12 108.878 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -119.67 46.56 1.9 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.207 0.603 . . . . 74.12 109.533 -176.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 55.8 p-80 -158.74 161.68 37.05 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.724 0.809 . . . . 75.34 109.603 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.488 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 8.1 m-80 -118.1 2.25 12.02 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.613 0.765 . . . . 75.35 110.161 176.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -83.16 115.23 21.83 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.225 0.61 . . . . 72.1 110.669 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.545 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 12.1 tpt -66.81 -40.02 87.91 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.686 0.794 . . . . 62.04 110.556 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.63 -34.83 74.85 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.45 0.7 . . . . 72.35 112.03 -177.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.2 t -66.26 -42.85 87.94 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.81 0.844 . . . . 64.42 111.499 176.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -60.33 -49.6 76.96 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.4 1.08 . . . . 73.51 110.364 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 69.1 t -64.21 -36.56 77.4 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 124.225 1.01 . . . . 70.21 110.845 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -60.07 -41.54 92.62 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.609 0.763 . . . . 73.34 111.073 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -63.25 -45.7 90.34 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.929 -0.578 . . . . 70.03 110.767 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 80' ' ' PHE . 94.1 mt -62.82 -38.31 90.25 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.814 0.846 . . . . 70.24 111.708 -177.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -62.75 -32.69 73.88 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.806 0.442 . . . . 73.43 111.954 173.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 47.0 mtm -69.26 -35.15 75.8 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 110.436 -0.209 . . . . 73.42 110.436 173.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -75.85 -18.59 59.38 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.252 0.621 . . . . 74.24 111.593 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.82 26.67 23.92 Favored Glycine 0 C--N 1.345 1.077 0 CA-C-O 119.709 -0.495 . . . . 61.13 113.997 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.44 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . 64.5 m-85 -78.72 133.01 37.18 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.856 -0.794 . . . . 74.21 108.856 171.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -102.12 127.61 48.96 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.267 0.627 . . . . 55.31 109.318 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.693 ' HE2' ' HB ' ' A' ' 84' ' ' VAL . 1.3 tmtp? -76.18 124.81 28.04 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.057 -1.09 . . . . 74.42 108.057 176.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.0 t -128.63 115.5 37.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 106.644 -1.613 . . . . 73.2 106.644 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.693 ' HB ' ' HE2' ' A' ' 82' ' ' LYS . 9.2 p -102.86 114.79 43.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 CA-C-O 121.487 0.661 . . . . 71.2 109.502 -174.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -87.37 3.99 44.79 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.868 -0.605 . . . . 75.25 110.858 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 48.9 mm -109.43 153.16 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.733 1.213 . . . . 74.45 108.734 169.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.434 ' HB3' HD12 ' A' ' 91' ' ' LEU . 28.7 tt0 -134.52 131.86 38.48 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 109.809 -0.441 . . . . 64.12 109.809 171.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -86.03 16.95 3.8 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.72 1.208 . . . . 75.23 111.472 -175.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -76.8 -2.33 76.13 Favored Glycine 0 C--N 1.358 1.763 0 C-N-CA 123.066 0.365 . . . . 55.02 113.843 175.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 91.48 57.88 1.5 Allowed Glycine 0 C--N 1.35 1.359 0 N-CA-C 111.624 -0.59 . . . . 64.04 111.624 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.434 HD12 ' HB3' ' A' ' 87' ' ' GLU . 81.3 mt -107.94 -175.55 2.81 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.685 0.794 . . . . 71.22 110.392 -177.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.4 p -64.79 -17.1 20.97 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.309 0 C-N-CA 124.268 1.027 . . . . 74.51 110.991 171.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -65.11 130.89 94.98 Favored Pre-proline 0 CA--C 1.553 1.071 0 C-N-CA 124.032 0.933 . . . . 74.33 110.41 174.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -63.85 162.89 26.92 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 123.505 2.804 . . . . 63.02 112.989 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -69.05 -20.64 64.12 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.686 0.795 . . . . 62.4 112.544 -173.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -63.68 156.2 27.64 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.15 0.58 . . . . 71.43 110.232 174.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -104.52 124.31 49.05 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.973 -0.751 . . . . 73.2 108.973 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.47 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 15.9 t70 -88.88 107.58 19.07 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.639 -1.245 . . . . 73.13 107.639 173.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.643 ' HB ' ' HB ' ' A' ' 48' ' ' VAL . 11.6 m -102.99 98.02 8.04 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 123.527 0.731 . . . . 75.41 110.017 -177.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 46' ' ' PHE . 38.6 tt0 -100.37 113.64 26.54 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.781 -0.822 . . . . 70.52 108.781 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.44 ' HB3' ' HB3' ' A' ' 80' ' ' PHE . 73.4 m-85 -96.33 120.32 36.41 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.549 -0.908 . . . . 62.2 108.549 173.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -110.13 146.71 35.0 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.8 0.84 . . . . 72.0 110.548 -174.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 23.9 t-80 -163.35 130.06 2.42 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 123.659 0.783 . . . . 74.42 108.901 172.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -64.89 -23.43 62.04 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.844 2.363 . . . . 55.3 112.957 -176.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 56.9 m -95.12 3.87 54.28 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.269 0.628 . . . . 61.33 111.328 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.439 ' O ' ' HA ' ' A' ' 44' ' ' ASN . 62.8 t80 -103.46 100.45 10.31 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 106.862 -1.533 . . . . 74.43 106.862 173.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.602 ' HB2' ' HB2' ' A' ' 110' ' ' GLN . 70.2 mt -113.48 134.66 54.55 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 109.354 -0.61 . . . . 71.14 109.354 173.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.0 ppt_? -62.96 -17.77 62.41 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.424 1.09 . . . . 72.33 112.636 -176.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -101.16 -42.6 2.37 Favored Glycine 0 C--N 1.346 1.096 0 N-CA-C 111.768 -0.533 . . . . 73.2 111.768 173.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.602 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 1.8 mp0 -91.36 84.06 5.54 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.451 0.7 . . . . 73.53 111.2 -172.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.9 -18.89 62.0 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.331 1.052 . . . . 63.35 112.827 177.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.488 ' O ' ' HG2' ' A' ' 115' ' ' GLU . 4.8 pm0 -73.71 -14.52 61.16 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 111.637 0.236 . . . . 74.31 111.637 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 70.8 mt -84.16 -7.54 59.33 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.656 0.382 . . . . 74.24 111.792 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 51.0 mt -71.05 -21.62 62.23 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.055 0.542 . . . . 65.44 112.008 178.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.492 ' HB2' ' HB2' ' A' ' 16' ' ' ASN . 16.9 pt-20 -80.18 -5.74 56.59 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 111.878 0.325 . . . . 75.24 111.878 174.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -90.9 -16.75 27.62 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.777 -0.823 . . . . 72.03 108.777 169.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.6 mt -90.87 73.46 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.886 0 N-CA-C 107.704 -1.221 . . . . 72.32 107.704 175.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.18 161.29 31.09 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.56 0.695 . . . . 73.11 110.945 169.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -109.75 -55.85 2.39 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.273 -1.01 . . . . 72.44 108.273 173.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.599 ' HD3' HG21 ' A' ' 124' ' ' VAL . 49.1 mtpt -146.12 164.1 33.24 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.248 1.019 . . . . 75.33 108.983 -177.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 28.0 m -88.66 -19.53 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-N 116.026 -0.534 . . . . 72.1 110.137 174.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 29.9 p -79.25 166.18 22.44 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 124.407 1.083 . . . . 64.4 110.728 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.2 m -74.11 93.87 2.34 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.731 0.812 . . . . 72.32 111.072 -173.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.599 HG21 ' HD3' ' A' ' 120' ' ' LYS . 41.1 t -119.77 135.13 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 108.267 -1.012 . . . . 71.5 108.267 176.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 27.8 p . . . . . 0 CA--C 1.551 0.984 0 C-N-CA 123.905 0.882 . . . . 65.12 109.163 -176.323 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 108.96 -0.756 . . . . 74.13 108.96 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.16 133.21 2.68 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 111.991 -0.443 . . . . 72.43 111.991 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 40.8 t-80 -101.91 15.63 28.42 Favored 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 108.857 -0.794 . . . . 70.54 108.857 171.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -65.16 129.4 39.59 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 124.822 1.249 . . . . 74.33 110.683 -176.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -119.98 150.96 39.69 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.118 0.567 . . . . 70.51 109.51 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -152.38 105.06 2.99 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.381 -0.97 . . . . 75.55 108.381 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -136.5 145.2 44.84 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.023 0.929 . . . . 75.21 109.185 175.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -140.29 82.53 1.86 Allowed 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.876 -1.157 . . . . 74.41 107.876 173.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.0 m -65.04 116.39 6.41 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.361 -0.836 . . . . 75.15 110.494 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -148.16 141.26 24.97 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.324 -0.991 . . . . 75.41 108.324 176.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 9.9 tpt -157.09 98.92 1.77 Allowed 'General case' 0 C--O 1.239 0.527 0 N-CA-C 109.0 -0.741 . . . . 42.31 109.0 -178.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.34 87.91 0.12 Allowed 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.576 0.75 . . . . 72.41 109.215 174.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.35 123.53 6.86 Favored Glycine 0 C--N 1.343 0.963 0 CA-C-O 118.867 -0.963 . . . . 71.43 112.085 -175.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -72.48 75.62 2.45 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.433 2.089 . . . . 54.23 109.915 173.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.0 m -63.77 161.39 15.34 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.014 -0.994 . . . . 73.44 112.051 -172.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -87.02 29.3 0.83 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.914 0.885 . . . . 74.54 110.945 -172.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 47.1 t -70.05 130.2 90.03 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.278 1.031 . . . . 61.22 110.09 -174.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.404 ' HD2' HD12 ' A' ' 21' ' ' LEU . 49.9 Cg_exo -56.72 141.49 91.86 Favored 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.775 2.317 . . . . 71.45 111.148 173.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.92 -36.63 65.44 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.072 0.949 . . . . 55.21 113.022 -173.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -51.85 -43.94 63.42 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.035 0.534 . . . . 75.51 112.084 173.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.404 HD12 ' HD2' ' A' ' 18' ' ' PRO . 98.2 mt -84.29 -29.81 26.11 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.409 0.684 . . . . 71.3 110.4 -173.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.6 m -61.17 -39.64 90.9 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.273 1.029 . . . . 51.23 110.607 173.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.558 ' HE2' ' HA ' ' A' ' 23' ' ' LYS . 10.7 mmpt? -79.97 -47.79 14.41 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.715 -0.675 . . . . 64.14 110.473 177.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.5 ' O ' HG23 ' A' ' 28' ' ' VAL . 55.3 tp -56.47 -50.28 72.19 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.107 0.963 . . . . 73.53 112.502 -176.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.467 ' HZ2' ' H ' ' A' ' 109' ' ' GLY . 84.7 t90 -58.35 -47.78 82.69 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.791 0.436 . . . . 75.2 111.014 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.8 m -68.8 -22.6 64.25 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 115.684 -0.689 . . . . 71.43 111.42 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.489 HD11 HG13 ' A' ' 58' ' ' VAL . 31.0 tp -74.4 -44.31 52.56 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.393 1.077 . . . . 74.55 110.723 175.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 24' ' ' LEU . 60.0 t -61.92 -32.68 54.94 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 CA-C-O 121.685 0.755 . . . . 65.22 110.258 173.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.4 t -88.72 0.18 56.71 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 114.636 -1.165 . . . . 73.22 112.023 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -81.61 122.72 80.85 Favored Pre-proline 0 N--CA 1.479 1.02 0 O-C-N 121.919 -0.488 . . . . 71.53 111.448 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -73.62 -6.21 18.35 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 123.159 2.573 . . . . 64.41 113.822 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -86.35 -37.65 18.24 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.85 0.46 . . . . 72.51 110.987 174.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 41.6 p -104.34 8.61 35.94 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.772 0.429 . . . . 70.41 110.824 -175.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -59.51 -32.39 70.25 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.459 1.104 . . . . 61.45 111.896 -175.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.34 -32.35 73.24 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.637 0.775 . . . . 73.1 111.958 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 64.4 mt -102.82 -12.14 17.8 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.457 0.303 . . . . 73.43 111.219 -177.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.5 tt -159.89 122.83 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 123.053 0.541 . . . . 60.2 110.454 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 28.2 p -142.1 149.55 40.01 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.601 0.36 . . . . 63.43 110.567 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 22.7 p-90 -72.6 154.23 40.87 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.611 0.765 . . . . 73.52 111.148 177.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.6 m -81.41 141.0 48.71 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 109.121 -0.696 . . . . 61.05 109.121 169.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -50.36 -22.91 9.34 Favored 'Trans proline' 0 C--N 1.368 1.602 0 C-N-CA 123.373 2.715 . . . . 73.02 115.05 176.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 64.0 m -70.65 -30.27 66.85 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.999 0.52 . . . . 71.15 111.618 175.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.99 65.87 2.18 Favored Glycine 0 C--N 1.342 0.88 0 CA-C-N 116.308 -0.406 . . . . 50.15 112.474 177.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.413 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 26.8 p30 -168.52 -17.06 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.981 0.913 . . . . 54.24 111.725 -171.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.2 p -141.51 162.27 35.89 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 123.927 0.891 . . . . 71.43 108.701 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -140.19 146.38 38.65 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.572 0.225 . . . . 75.31 110.535 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -103.32 141.32 36.13 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.234 1.014 . . . . 63.14 109.536 -176.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.1 t -123.54 132.99 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.693 0.797 . . . . 75.44 108.983 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -122.75 151.96 41.09 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.549 1.14 . . . . 73.21 110.5 -174.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 53.62 60.82 3.43 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 124.584 1.178 . . . . 64.42 110.77 174.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -46.0 -37.31 6.44 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.006 1.322 . . . . 54.13 114.2 -170.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.51 -44.92 49.08 Favored Glycine 0 C--N 1.342 0.868 0 O-C-N 123.559 0.537 . . . . 44.23 112.844 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -72.83 -42.91 63.31 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.112 0.565 . . . . 73.43 110.111 -177.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -55.32 -52.62 62.89 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.188 1.395 . . . . 64.24 110.899 175.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.36 -31.82 71.71 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 116.298 -0.41 . . . . 52.24 111.676 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -70.49 -50.92 32.91 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.252 1.021 . . . . 74.02 112.421 -177.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.541 ' HG3' HG23 ' A' ' 58' ' ' VAL . 9.7 pt-20 -104.43 -39.24 6.5 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 112.855 0.687 . . . . 72.11 112.855 -173.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.541 HG23 ' HG3' ' A' ' 57' ' ' GLU . 96.5 t -80.94 -41.78 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.362 0.665 . . . . 62.11 112.016 -167.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 53.2 mt -64.15 -48.95 75.93 Favored Pre-proline 0 CA--C 1.565 1.528 0 CA-C-O 118.209 -0.9 . . . . 52.22 112.324 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.3 -8.49 23.52 Favored 'Trans proline' 0 C--N 1.387 2.598 0 CA-C-N 121.981 1.743 . . . . 74.25 113.281 175.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -73.63 -61.77 1.72 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.297 1.039 . . . . 72.32 110.391 174.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.541 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 25.5 m-85 -89.03 -38.59 14.29 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 112.005 0.372 . . . . 74.14 112.005 -177.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -102.81 -164.61 1.1 Allowed 'General case' 0 C--O 1.243 0.729 0 N-CA-C 107.566 -1.272 . . . . 75.33 107.566 176.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.443 ' HD3' ' HA ' ' A' ' 64' ' ' LYS . 31.5 mmtm -135.54 68.05 1.47 Allowed 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 121.856 0.836 . . . . 54.15 109.903 175.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -169.77 160.62 8.77 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 113.781 -1.554 . . . . 72.13 107.786 173.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -118.01 -5.79 10.97 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.74 0.416 . . . . 72.31 110.503 175.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -71.84 117.54 13.56 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 123.82 0.848 . . . . 73.32 110.47 176.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 11.7 ttm -70.89 -30.57 66.97 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.656 0.383 . . . . 71.25 111.034 176.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.67 -36.39 71.84 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.607 0.363 . . . . 64.13 111.241 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.429 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 40.2 t -63.94 -46.91 82.62 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.982 0.913 . . . . 73.04 111.633 172.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -63.18 -52.91 60.46 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.612 0.765 . . . . 75.44 111.052 -176.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.41 ' HA ' HD12 ' A' ' 75' ' ' LEU . 84.4 t -59.14 -40.66 81.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 124.088 0.955 . . . . 64.34 111.254 177.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.3 ttt-85 -56.82 -43.9 81.46 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.147 0.579 . . . . 73.35 111.559 177.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 70' ' ' SER . 16.7 mm100 -58.9 -49.83 76.32 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 124.024 0.828 . . . . 73.41 109.937 177.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.433 ' HB3' ' HB2' ' A' ' 80' ' ' PHE . 65.2 mt -58.35 -44.27 88.7 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.305 1.042 . . . . 73.2 112.086 -177.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -56.9 -39.55 74.63 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.504 0.722 . . . . 73.5 111.924 175.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 73.9 mtm -72.94 -35.03 66.9 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.051 0.54 . . . . 73.31 111.06 176.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.425 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 55.3 m-85 -85.26 2.92 41.84 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.093 0.557 . . . . 72.41 111.22 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.42 15.91 79.03 Favored Glycine 0 C--N 1.342 0.916 0 N-CA-C 114.652 0.621 . . . . 63.42 114.652 170.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.433 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 73.3 m-85 -73.74 129.42 37.9 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.273 0.559 . . . . 73.24 110.096 176.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -99.52 121.78 41.66 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.013 -0.994 . . . . 71.01 109.021 -175.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.424 ' HE3' HG23 ' A' ' 99' ' ' THR . 1.6 tmtp? -81.45 126.75 32.03 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.588 1.155 . . . . 53.41 109.723 -175.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 85.8 t -128.97 119.72 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 108.17 -1.048 . . . . 72.11 108.17 175.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.421 ' HB ' ' HE2' ' A' ' 82' ' ' LYS . 7.5 p -99.68 126.0 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 108.415 -0.957 . . . . 71.1 108.415 -178.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -101.36 -23.52 14.36 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.573 0.349 . . . . 73.03 110.62 -177.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.566 HG12 ' HB3' ' A' ' 98' ' ' ASP . 29.4 mm -95.26 103.46 14.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 CA-C-O 121.04 0.448 . . . . 74.04 109.976 176.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -69.6 118.79 12.92 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 107.58 -1.267 . . . . 72.11 107.58 168.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -58.27 107.2 0.46 Allowed 'General case' 0 N--CA 1.477 0.924 0 O-C-N 124.529 1.143 . . . . 74.03 111.476 -168.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.61 172.12 29.66 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 114.193 -1.367 . . . . 33.52 111.747 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -83.12 57.29 5.07 Favored Glycine 0 N--CA 1.47 0.909 0 C-N-CA 123.401 0.524 . . . . 71.04 112.751 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 77.5 mt -84.02 -170.93 3.33 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.811 0.844 . . . . 62.42 110.88 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.5 p -81.08 42.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 123.255 1.502 . . . . 72.21 110.207 174.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.525 ' HB3' HD12 ' A' ' 86' ' ' ILE . 68.1 mttm -134.63 162.34 58.29 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 126.734 2.014 . . . . 70.43 106.959 -175.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.414 ' HB2' ' HG2' ' A' ' 96' ' ' ARG . 73.6 Cg_endo -70.33 137.39 33.69 Favored 'Trans proline' 0 C--N 1.372 1.775 0 CA-C-N 120.47 1.204 . . . . 74.52 109.615 167.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -74.73 -16.52 60.73 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 122.859 0.464 . . . . 75.14 111.11 -176.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.414 ' HG2' ' HB2' ' A' ' 94' ' ' PRO . 10.4 ptp180 -72.31 106.39 4.45 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 108.906 -0.776 . . . . 63.11 108.906 175.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -45.18 107.98 0.11 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.636 1.174 . . . . 62.43 112.958 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.566 ' HB3' HG12 ' A' ' 86' ' ' ILE . 15.5 t70 -91.37 122.2 33.77 Favored 'General case' 0 C--O 1.249 1.045 0 CA-C-N 114.867 -1.06 . . . . 41.31 108.191 177.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.424 HG23 ' HE3' ' A' ' 82' ' ' LYS . 57.8 m -129.27 117.23 20.36 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.894 -0.78 . . . . 75.42 108.894 -178.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -104.73 112.17 25.17 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.322 -0.992 . . . . 75.43 108.322 -175.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -96.93 123.88 40.76 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.824 -1.176 . . . . 71.2 107.824 175.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -122.65 145.75 48.08 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 122.985 0.514 . . . . 70.23 110.697 -173.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -156.53 132.31 5.74 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 108.66 -0.867 . . . . 73.41 108.66 176.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.74 -29.95 77.73 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.669 2.246 . . . . 73.33 113.195 -174.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 59.1 m -89.4 -2.78 58.53 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.641 0.376 . . . . 73.32 111.421 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 44' ' ' ASN . 64.8 t80 -102.19 99.45 9.57 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 106.881 -1.525 . . . . 75.3 106.881 175.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.421 HD12 ' HG2' ' A' ' 110' ' ' GLN . 76.6 mt -120.79 164.7 16.2 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.95 0.405 . . . . 73.25 110.673 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -81.58 122.74 27.97 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.593 -0.73 . . . . 73.31 109.489 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.467 ' H ' ' HZ2' ' A' ' 25' ' ' TRP . . . 63.56 57.65 14.0 Favored Glycine 0 C--N 1.344 0.985 0 O-C-N 124.15 0.906 . . . . 64.13 111.974 -176.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.421 ' HG2' HD12 ' A' ' 107' ' ' LEU . 5.9 tp60 -156.18 63.64 0.56 Allowed 'General case' 0 CA--C 1.548 0.897 0 CA-C-O 121.919 0.866 . . . . 74.51 109.535 -172.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -52.35 -46.24 66.02 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 113.746 -1.57 . . . . 65.1 111.446 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 14.1 pm0 -65.74 -19.55 65.94 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.579 -1.191 . . . . 72.34 112.839 -174.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 27.9 mt -96.41 -20.11 18.69 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 119.181 0.901 . . . . 74.33 111.712 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 80.9 mt -63.95 -32.6 74.19 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-O 121.156 0.503 . . . . 63.41 110.376 175.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -79.35 -5.42 54.52 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 115.547 -0.751 . . . . 64.52 112.594 175.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -90.25 2.78 55.09 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 110.096 -0.335 . . . . 74.11 110.096 172.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 45.1 mt -96.98 128.01 48.61 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 N-CA-C 109.009 -0.737 . . . . 71.33 109.009 174.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.456 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -112.1 150.73 30.33 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.425 0.69 . . . . 65.45 110.031 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -82.92 33.63 0.44 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.151 0.98 . . . . 73.35 110.374 170.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -129.45 159.32 36.63 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.516 1.127 . . . . 64.11 109.156 -175.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.6 m -70.54 0.06 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 N-CA-C 113.539 0.94 . . . . 73.45 113.539 -173.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.9 t -64.2 -32.49 74.08 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 109.797 -0.446 . . . . 75.34 109.797 167.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 32.2 t -97.51 97.39 9.04 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 107.518 -1.29 . . . . 73.12 107.518 169.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 30.8 m -85.31 160.29 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.445 0.698 . . . . 70.35 111.996 -172.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 CA--C 1.553 1.085 0 C-N-CA 124.451 1.101 . . . . 51.21 109.034 172.996 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.486 1.374 0 N-CA-C 108.957 -0.757 . . . . 73.51 108.957 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -99.22 74.98 0.51 Allowed Glycine 0 C--N 1.346 1.084 0 O-C-N 123.291 0.37 . . . . 72.1 113.586 -173.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -125.92 9.64 7.55 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 117.296 0.548 . . . . 72.11 111.506 176.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 57.6 t60 -98.07 88.03 4.11 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.319 -0.993 . . . . 74.11 108.319 172.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -137.57 152.57 49.55 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.878 0.871 . . . . 72.52 109.573 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 48.1 p-80 -149.54 144.48 26.28 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.589 0.756 . . . . 61.45 109.339 172.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -113.16 146.38 39.34 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 124.474 1.11 . . . . 75.23 108.284 175.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 65.4 m-70 -67.05 90.63 0.19 Allowed 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 109.774 -0.454 . . . . 60.4 109.774 173.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.8 m -85.85 61.79 7.06 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.96 0.904 . . . . 74.31 109.356 175.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -88.1 114.39 24.67 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.253 -0.431 . . . . 75.23 111.369 -172.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 93.4 mmm -84.99 151.28 24.31 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.745 -0.661 . . . . 71.33 109.489 169.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -161.36 178.43 9.19 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 124.197 0.999 . . . . 72.42 109.83 -175.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -135.83 68.92 0.52 Allowed Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.415 -0.674 . . . . 74.21 111.415 175.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -87.46 137.3 4.18 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.312 2.008 . . . . 65.43 112.378 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.483 ' HB3' HG23 ' A' ' 17' ' ' VAL . 42.8 m -79.06 147.34 32.84 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.785 -0.643 . . . . 74.03 110.264 170.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -93.91 22.72 5.42 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.032 -0.986 . . . . 65.12 110.381 -175.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.483 HG23 ' HB3' ' A' ' 15' ' ' SER . 22.9 t -70.52 125.61 92.04 Favored Pre-proline 0 C--N 1.352 0.693 0 N-CA-C 108.982 -0.747 . . . . 74.42 108.982 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 21' ' ' LEU . 21.4 Cg_exo -65.69 145.24 80.89 Favored 'Trans proline' 0 C--N 1.365 1.439 0 C-N-CA 122.417 2.078 . . . . 75.03 110.341 170.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.41 -39.82 23.82 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.149 1.38 . . . . 64.41 112.499 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -54.1 -45.43 71.84 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.96 0.904 . . . . 73.14 112.833 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 18' ' ' PRO . 98.4 mt -83.36 -29.23 28.4 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.056 0.543 . . . . 74.24 109.948 -171.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.7 m -59.72 -50.59 73.23 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 124.548 1.155 . . . . 61.24 111.023 170.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.486 ' HE2' ' HA ' ' A' ' 23' ' ' LYS . 11.2 mmpt? -68.49 -43.25 77.28 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.876 -0.602 . . . . 61.12 110.045 178.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.468 ' O ' HG23 ' A' ' 28' ' ' VAL . 55.5 tp -55.26 -54.03 48.56 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 124.601 1.161 . . . . 70.32 112.214 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 14.1 t-105 -64.07 -46.08 85.92 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 122.629 0.372 . . . . 72.3 111.722 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.6 m -60.61 -25.01 65.93 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.306 0.574 . . . . 74.13 110.775 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.48 HD11 ' CG1' ' A' ' 58' ' ' VAL . 29.9 tp -80.47 -45.57 17.33 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 124.87 1.268 . . . . 62.04 111.94 177.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 24' ' ' LEU . 76.6 t -56.61 -39.97 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 C-N-CA 124.089 0.956 . . . . 42.32 111.513 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.5 t -89.36 -5.54 57.4 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 114.453 -1.249 . . . . 74.0 112.132 -175.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -74.35 122.28 87.17 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 122.68 0.392 . . . . 74.22 111.307 -175.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.4 -23.11 44.53 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 122.851 2.367 . . . . 73.11 112.944 176.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -73.8 -34.41 64.61 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.185 0.594 . . . . 73.01 111.514 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 53.5 p -110.99 11.82 22.14 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.043 0.537 . . . . 75.02 110.533 -177.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -54.95 -38.23 67.46 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.924 1.289 . . . . 72.13 111.788 -177.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.82 -29.47 69.95 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.692 -0.686 . . . . 63.4 112.178 -177.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.533 ' HA ' ' HB2' ' A' ' 49' ' ' PHE . 68.9 mt -106.41 -9.88 16.54 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.628 0.371 . . . . 72.55 111.657 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.474 HD13 ' HG ' ' A' ' 27' ' ' LEU . 16.7 tt -161.45 125.86 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.327 0.651 . . . . 74.53 110.501 172.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 22.1 p -149.02 157.41 43.39 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.934 0.397 . . . . 74.01 110.566 177.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 14.7 p-90 -71.38 152.85 42.78 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.731 1.212 . . . . 74.44 110.409 177.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.2 p -74.28 153.39 88.19 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 123.271 0.628 . . . . 75.13 110.346 172.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.8 -26.34 60.11 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.7 2.267 . . . . 65.04 111.925 176.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 66.9 p -75.05 -26.96 59.81 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.303 1.041 . . . . 72.03 110.15 172.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.97 3.3 84.34 Favored Glycine 0 C--N 1.356 1.692 0 CA-C-N 115.658 -0.701 . . . . 64.42 113.468 176.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -86.19 -5.91 59.1 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.689 0.796 . . . . 65.14 112.022 -173.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 65.1 p -159.3 179.09 9.29 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.793 0.837 . . . . 64.53 110.046 -174.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -140.18 148.21 41.26 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.781 -0.451 . . . . 64.21 109.781 172.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -110.84 143.49 41.34 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.009 0.924 . . . . 74.44 109.018 -177.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 67.3 t -123.48 120.96 61.48 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 C-N-CA 124.385 1.074 . . . . 62.32 108.631 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.533 ' HB2' ' HA ' ' A' ' 36' ' ' LEU . 90.1 m-85 -100.58 146.38 27.2 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 124.058 0.943 . . . . 72.43 109.87 -178.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.428 ' H ' ' HB2' ' A' ' 96' ' ' ARG . 6.9 m-20 49.95 67.94 0.83 Allowed 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.799 1.312 . . . . 73.55 111.674 176.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.474 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 14.7 mm-40 -49.52 -34.86 18.42 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.002 0.921 . . . . 71.13 113.377 -175.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.09 -49.83 44.34 Favored Glycine 0 CA--C 1.536 1.365 0 CA-C-O 119.818 -0.434 . . . . 74.12 112.441 175.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -69.5 -45.64 68.44 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.299 0.639 . . . . 75.4 110.542 -176.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.479 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 65.1 t80 -52.24 -51.59 57.47 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.553 1.541 . . . . 72.25 111.05 173.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.507 ' HA ' ' HG ' ' A' ' 59' ' ' LEU . . . -61.36 -36.56 80.53 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.916 0.389 . . . . 74.44 111.537 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.87 -52.89 31.35 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.513 1.125 . . . . 72.34 113.154 -174.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.518 ' HG3' HG23 ' A' ' 58' ' ' VAL . 6.7 pt-20 -106.62 -33.85 7.52 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 113.602 0.964 . . . . 73.2 113.602 -173.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.518 HG23 ' HG3' ' A' ' 57' ' ' GLU . 90.4 t -83.03 -40.29 16.21 Favored 'Isoleucine or valine' 0 C--O 1.251 1.169 0 C-N-CA 123.404 0.681 . . . . 55.24 111.488 -169.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.507 ' HG ' ' HA ' ' A' ' 55' ' ' ALA . 54.0 mt -64.0 -50.46 69.36 Favored Pre-proline 0 CA--C 1.556 1.202 0 CA-C-O 118.242 -0.885 . . . . 75.25 111.81 177.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -67.42 -13.34 38.91 Favored 'Trans proline' 0 C--N 1.381 2.288 0 CA-C-N 121.975 1.741 . . . . 74.54 113.001 176.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -70.68 -54.69 10.9 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.01 0.524 . . . . 72.24 110.536 172.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.414 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 31.5 m-85 -89.87 -52.68 4.86 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.137 0.494 . . . . 74.02 111.984 -178.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -87.71 -171.79 3.59 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.274 -0.875 . . . . 53.44 108.828 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -123.05 45.15 2.48 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.668 0.746 . . . . 74.32 109.749 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -161.16 165.5 29.39 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.636 1.174 . . . . 64.43 108.377 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -122.3 -8.15 8.69 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.52 0.328 . . . . 73.1 110.579 174.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -61.1 115.88 4.11 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.152 0.981 . . . . 74.41 110.605 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.474 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 3.2 tpt -61.71 -49.87 74.73 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.203 1.401 . . . . 71.23 111.725 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.17 -35.31 71.39 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.866 0.867 . . . . 72.3 111.843 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.431 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 34.7 t -64.99 -42.98 94.02 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.731 0.813 . . . . 64.42 111.489 177.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -64.58 -50.25 67.96 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.827 0.851 . . . . 53.23 110.65 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.497 ' HA ' HD12 ' A' ' 75' ' ' LEU . 59.1 t -62.9 -38.45 81.94 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-N 115.417 -0.81 . . . . 64.21 111.128 178.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.411 ' O ' ' HG3' ' A' ' 77' ' ' MET . 39.4 ttm180 -58.67 -43.33 89.86 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.023 0.529 . . . . 71.41 110.858 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.491 ' HA ' ' HE2' ' A' ' 77' ' ' MET . 34.3 mm-40 -59.34 -50.01 75.6 Favored 'General case' 0 C--N 1.358 0.963 0 O-C-N 124.034 0.834 . . . . 75.02 109.872 177.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.501 ' HB3' ' HB2' ' A' ' 80' ' ' PHE . 30.6 mt -56.47 -48.32 77.35 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.109 0.964 . . . . 75.31 111.921 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -62.58 -30.09 71.07 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 122.754 0.422 . . . . 71.22 112.049 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.491 ' HE2' ' HA ' ' A' ' 74' ' ' GLN . 47.9 mtm -69.47 -40.42 77.11 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 109.931 -0.396 . . . . 75.5 109.931 173.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -81.74 -2.65 51.4 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.997 0.519 . . . . 70.52 111.214 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.66 20.28 44.77 Favored Glycine 0 C--N 1.349 1.279 0 N-CA-C 114.882 0.713 . . . . 71.24 114.882 172.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.501 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 83.9 m-85 -82.3 134.85 35.28 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.069 0.935 . . . . 74.22 109.506 177.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 38.3 ttm180 -101.44 126.74 48.27 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.086 0.554 . . . . 71.03 109.802 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.517 ' HE3' HG22 ' A' ' 84' ' ' VAL . 2.7 tmtm? -68.95 114.93 7.7 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 106.879 -1.526 . . . . 64.12 106.879 171.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.522 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 89.3 t -114.2 125.41 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 107.884 -1.154 . . . . 73.11 107.884 176.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.517 HG22 ' HE3' ' A' ' 82' ' ' LYS . 40.8 t -88.94 131.56 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.638 0.775 . . . . 73.42 109.315 -177.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 -125.4 -45.95 1.79 Allowed 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 108.214 -1.032 . . . . 71.32 108.214 169.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.419 HG21 ' HG2' ' A' ' 94' ' ' PRO . 36.6 mm -97.19 131.88 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 108.823 -0.806 . . . . 73.24 108.823 167.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -108.17 150.82 26.74 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 125.12 1.368 . . . . 74.42 109.482 -171.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -127.42 91.67 3.35 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.288 0.635 . . . . 73.2 109.693 173.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.79 23.33 1.8 Allowed Glycine 0 N--CA 1.47 0.961 0 CA-C-N 115.946 -0.57 . . . . 72.42 112.246 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 83.0 20.02 61.87 Favored Glycine 0 C--N 1.343 0.934 0 O-C-N 123.044 -0.092 . . . . 73.53 112.884 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 78.5 mt -82.65 -177.42 6.71 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.588 1.155 . . . . 74.33 111.141 -177.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.0 p -88.19 74.49 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 CA-C-O 123.161 1.458 . . . . 70.22 108.578 168.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -133.28 165.79 34.08 Favored Pre-proline 0 N--CA 1.477 0.92 0 CA-C-N 113.593 -1.64 . . . . 73.11 108.349 176.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.419 ' HG2' HG21 ' A' ' 86' ' ' ILE . 35.2 Cg_endo -65.99 156.43 64.55 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 121.552 1.501 . . . . 72.14 111.283 164.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -76.29 -4.49 42.34 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.829 0.851 . . . . 73.23 112.139 -173.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.428 ' HB2' ' H ' ' A' ' 50' ' ' ASP . 17.7 ptt180 -82.64 168.49 17.24 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.226 1.01 . . . . 51.32 110.976 174.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -91.27 148.4 22.37 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.463 -0.939 . . . . 61.43 108.463 156.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -113.4 106.1 14.18 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 105.355 -2.091 . . . . 72.31 105.355 156.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 32.3 m -115.05 107.36 15.25 Favored 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 123.823 0.702 . . . . 75.0 109.793 -170.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.522 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 41.7 tt0 -96.99 111.17 23.51 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.376 -1.342 . . . . 73.55 107.376 -177.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.419 ' HB3' ' HB3' ' A' ' 80' ' ' PHE . 71.4 m-85 -96.0 119.93 35.37 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.066 -1.087 . . . . 71.14 108.066 175.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -117.3 139.16 51.18 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.863 0.865 . . . . 75.22 109.287 -174.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 106' ' ' PHE . 77.3 t60 -152.66 135.08 9.0 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 123.466 0.706 . . . . 75.33 109.423 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -59.64 -42.85 43.33 Favored 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 122.863 2.376 . . . . 74.23 112.476 -174.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 37.0 m -92.19 16.66 10.96 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.996 0.518 . . . . 60.33 111.084 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.491 ' HB3' ' HB3' ' A' ' 103' ' ' HIS . 35.9 t80 -124.33 104.18 8.64 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.167 -1.049 . . . . 74.53 108.167 171.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.493 HD12 ' HG3' ' A' ' 110' ' ' GLN . 38.3 mt -120.46 173.65 7.03 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 107.128 -1.434 . . . . 60.2 107.128 167.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -63.28 -68.91 0.3 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.39 0.676 . . . . 73.02 110.942 -172.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -87.71 37.55 3.23 Favored Glycine 0 C--N 1.351 1.365 0 C-N-CA 122.77 0.224 . . . . 72.23 112.98 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.493 ' HG3' HD12 ' A' ' 107' ' ' LEU . 15.8 mm100 -126.43 53.08 1.67 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.92 0.888 . . . . 75.11 108.944 -177.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.418 ' HA ' ' HG ' ' A' ' 114' ' ' LEU . 10.6 pt-20 -60.14 -30.65 69.44 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 114.942 -1.026 . . . . 73.14 111.815 175.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.4 pm0 -63.39 -22.55 66.95 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.363 0.665 . . . . 54.52 111.838 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.443 ' O ' HG13 ' A' ' 117' ' ' ILE . 80.7 mt -90.82 -9.19 47.35 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.253 0.621 . . . . 72.2 112.152 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.418 ' HG ' ' HA ' ' A' ' 111' ' ' GLU . 91.5 mt -61.06 -38.57 86.65 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.202 0.525 . . . . 74.22 110.818 175.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -79.94 -11.11 59.82 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.365 -0.834 . . . . 52.25 112.051 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -87.55 -10.68 50.95 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.54 0.736 . . . . 71.23 109.682 173.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 113' ' ' LEU . 58.9 mt -86.23 135.18 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 108.845 -0.798 . . . . 55.12 108.845 175.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -122.92 150.33 43.08 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.728 0.811 . . . . 74.1 109.748 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -85.15 -41.65 15.48 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 108.483 -0.932 . . . . 73.12 108.483 172.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -155.83 -170.09 3.3 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 126.153 1.781 . . . . 75.01 108.012 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.1 p -66.85 -33.66 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 N-CA-C 108.827 -0.805 . . . . 74.41 108.827 167.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 5.9 m -91.77 102.21 14.81 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.986 0.914 . . . . 63.51 109.104 171.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.8 m -130.89 95.74 3.9 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.67 0.788 . . . . 74.52 109.225 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 59.0 t -75.11 98.89 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 109.34 -0.615 . . . . 55.11 109.34 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 C--O 1.254 1.295 0 N-CA-C 108.494 -0.928 . . . . 52.32 108.494 176.983 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 109.532 -0.544 . . . . 72.22 109.532 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -136.78 94.65 0.23 Allowed Glycine 0 C--N 1.35 1.341 0 N-CA-C 110.793 -0.923 . . . . 62.02 110.793 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -121.37 128.85 52.65 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.477 0.711 . . . . 72.1 110.329 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 34.3 m-70 -127.11 128.7 46.63 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.053 0.941 . . . . 73.02 109.066 175.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -140.54 116.88 10.67 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.748 0.819 . . . . 64.41 109.981 -175.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.3 p-80 -72.28 113.38 9.24 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-O 121.0 0.428 . . . . 70.25 110.129 174.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -129.66 144.76 51.43 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.66 0.784 . . . . 74.32 109.645 176.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 51.5 t60 -138.29 96.32 3.16 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.203 -0.665 . . . . 75.55 109.203 176.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.2 p -75.94 100.35 4.82 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.206 0.602 . . . . 70.13 110.553 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 38.0 t60 -66.56 103.63 1.1 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.688 0.795 . . . . 73.24 110.536 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 55.0 ttm -78.5 118.42 20.62 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.46 0.704 . . . . 62.4 109.889 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.57 97.69 0.81 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.591 0.756 . . . . 51.11 110.326 177.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -97.39 -131.47 7.06 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 119.382 -0.677 . . . . 71.25 113.388 -172.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -99.41 175.6 0.37 Allowed 'Trans proline' 0 C--N 1.371 1.744 0 C-N-CA 123.311 2.674 . . . . 63.5 114.962 -175.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.4 t -85.35 131.2 34.44 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 107.284 -1.376 . . . . 51.34 107.284 166.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -90.78 18.42 6.53 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.001 0.52 . . . . 74.44 112.367 -167.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.3 t -71.69 116.52 48.72 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 124.065 0.946 . . . . 73.41 109.805 177.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.89 163.2 39.99 Favored 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 122.65 2.233 . . . . 61.42 112.19 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.64 -49.12 57.65 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.08 0.952 . . . . 51.41 112.636 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -52.33 -47.51 66.0 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.444 0.698 . . . . 71.11 112.612 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 89.2 mt -79.64 -35.32 39.55 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.374 0.27 . . . . 41.03 110.955 -172.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.5 t -71.95 -18.76 61.98 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 111.72 0.267 . . . . 72.52 111.72 177.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.6 mmpt? -83.74 -40.99 18.14 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.767 -0.457 . . . . 73.13 109.767 168.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.8 tp -61.0 -50.61 72.66 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.003 0.921 . . . . 74.54 113.352 -176.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.469 ' HB3' HD11 ' A' ' 114' ' ' LEU . 5.1 p-90 -62.37 -37.43 85.69 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 118.628 0.649 . . . . 73.33 110.842 -177.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 41.3 m -63.83 -43.44 96.17 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 124.268 1.027 . . . . 55.32 110.898 175.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.409 HD11 ' CG1' ' A' ' 58' ' ' VAL . 27.4 tp -61.6 -49.56 76.1 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.624 1.57 . . . . 74.52 111.711 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.7 t -59.81 -33.62 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 C-N-CA 124.634 1.174 . . . . 74.11 111.536 176.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.9 t -94.85 -6.95 41.62 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.423 0.689 . . . . 55.33 112.09 -175.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -83.01 132.43 50.84 Favored Pre-proline 0 N--CA 1.486 1.355 0 CA-C-N 118.079 0.4 . . . . 61.43 111.837 -173.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -70.13 -23.82 28.67 Favored 'Trans proline' 0 C--N 1.388 2.652 0 C-N-CA 123.154 2.569 . . . . 72.31 114.209 -176.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -76.4 -32.33 58.47 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.008 0.523 . . . . 71.14 111.079 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.7 p -105.88 1.35 26.69 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.122 0.569 . . . . 74.23 111.61 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -57.31 -33.23 67.48 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.099 1.36 . . . . 72.44 112.56 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.97 -35.55 81.05 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.631 0.772 . . . . 65.32 113.027 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.528 HD22 ' HB2' ' A' ' 50' ' ' ASP . 80.9 mt -106.91 -11.05 15.8 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.063 0.545 . . . . 73.35 111.464 -175.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.2 tt -160.66 127.0 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 122.659 0.384 . . . . 74.13 110.631 174.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.1 p -158.92 161.29 36.75 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.032 0.533 . . . . 63.15 110.136 177.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 25.8 p-90 -71.12 147.3 48.55 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.028 -0.987 . . . . 73.54 110.455 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.4 m -70.96 153.54 94.66 Favored Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 124.016 0.926 . . . . 74.2 109.743 175.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -45.81 -44.63 17.96 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 123.613 2.875 . . . . 74.22 114.899 -175.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.7 m -75.22 -27.22 59.46 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.31 0.644 . . . . 60.14 111.584 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.82 18.44 61.48 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 116.562 -0.29 . . . . 55.12 113.606 175.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -80.85 -17.71 49.8 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.701 0.8 . . . . 71.32 111.326 175.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.0 p -158.28 -173.91 4.55 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.783 0.433 . . . . 71.45 110.806 -170.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -141.02 151.9 44.45 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.103 0.561 . . . . 73.54 110.179 176.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 55.5 m-70 -108.86 156.29 19.83 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.826 0.851 . . . . 72.01 109.647 176.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 84.7 t -130.51 123.16 54.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 124.442 1.097 . . . . 75.32 108.151 176.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -106.93 148.17 28.94 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.805 0.842 . . . . 64.33 109.686 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.528 ' HB2' HD22 ' A' ' 36' ' ' LEU . 7.9 m-20 54.23 55.54 8.05 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 124.714 1.258 . . . . 73.24 110.826 171.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.458 ' HA ' ' HB3' ' A' ' 54' ' ' PHE . 45.8 mt-30 -57.35 -22.77 44.59 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.759 -1.11 . . . . 70.33 113.158 -169.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.11 -47.83 56.95 Favored Glycine 0 C--N 1.348 1.23 0 N-CA-C 111.816 -0.513 . . . . 73.33 111.816 172.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.407 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 56.3 tp60 -71.17 -45.39 63.55 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.836 0.855 . . . . 75.2 110.044 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.458 ' HB3' ' HA ' ' A' ' 51' ' ' GLN . 57.0 t80 -49.16 -50.8 36.03 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.591 1.556 . . . . 72.54 111.403 171.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.65 -36.89 84.29 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.357 -0.383 . . . . 60.1 111.69 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -69.06 -45.01 71.44 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.994 0.918 . . . . 73.55 112.896 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 53' ' ' GLN . 11.1 pt-20 -114.78 -33.02 5.62 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 114.43 1.27 . . . . 73.34 114.43 -172.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.447 ' HB ' ' O ' ' A' ' 54' ' ' PHE . 77.2 t -81.95 -44.46 19.98 Favored 'Isoleucine or valine' 0 C--O 1.25 1.117 0 C-N-CA 122.787 0.435 . . . . 75.02 111.29 -172.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 46.1 mt -64.07 -46.83 80.45 Favored Pre-proline 0 CA--C 1.564 1.511 0 CA-C-O 118.081 -0.961 . . . . 72.32 112.77 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.58 -15.38 47.48 Favored 'Trans proline' 0 C--N 1.388 2.653 0 CA-C-N 121.999 1.75 . . . . 71.35 113.454 174.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -75.49 -54.52 6.89 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.177 0.591 . . . . 71.52 110.646 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -90.19 -40.07 12.42 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 112.112 0.412 . . . . 72.14 112.112 -177.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -106.4 -176.28 3.03 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.758 0.823 . . . . 61.04 108.808 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -119.42 48.83 1.44 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.522 -0.918 . . . . 72.45 108.522 -176.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -164.12 159.9 20.89 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.73 1.212 . . . . 62.03 108.265 176.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -112.32 -21.08 11.59 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.395 0.678 . . . . 55.33 109.253 176.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -61.02 119.55 8.52 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.198 0.999 . . . . 50.11 111.09 -176.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 12.9 tpt -73.46 -32.93 64.62 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.649 0.78 . . . . 73.44 111.25 -176.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.88 -34.26 69.59 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.05 0.54 . . . . 72.52 111.577 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.1 t -64.85 -42.35 94.98 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.334 1.054 . . . . 74.02 111.672 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -68.47 -51.16 46.53 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.948 0.899 . . . . 74.44 110.995 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.0 t -62.12 -37.15 77.74 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 C-N-CA 123.734 0.814 . . . . 74.4 111.194 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -53.94 -50.13 67.15 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.925 0.89 . . . . 62.44 111.117 175.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -56.97 -51.5 68.94 Favored 'General case' 0 C--N 1.35 0.614 0 O-C-N 124.556 1.16 . . . . 62.34 110.547 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.1 mt -62.23 -44.36 96.73 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.912 0.885 . . . . 70.0 112.03 -176.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -59.11 -38.61 79.98 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.293 0.637 . . . . 72.41 111.437 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 50.7 mtm -69.61 -33.21 72.36 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.842 0.457 . . . . 73.51 110.676 175.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -82.1 7.2 14.05 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 122.95 0.5 . . . . 72.31 111.299 178.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.96 20.44 67.82 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-O 119.948 -0.362 . . . . 72.23 113.447 172.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.523 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . 44.8 m-85 -82.82 137.89 34.15 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.978 -0.749 . . . . 72.45 108.978 175.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -101.46 125.24 48.07 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.022 -0.732 . . . . 75.04 109.022 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.59 115.58 8.13 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 107.965 -1.124 . . . . 74.12 107.965 173.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.7 t -131.27 113.86 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.219 -1.03 . . . . 73.42 108.219 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.5 p -96.11 126.45 48.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 108.443 -0.947 . . . . 63.34 108.443 -176.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 69.1 m-70 -105.13 -42.56 5.26 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.396 0.279 . . . . 64.21 110.767 -175.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 34.0 mm -74.54 109.88 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 108.25 -1.019 . . . . 72.23 108.25 169.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -55.66 133.75 50.81 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.753 1.221 . . . . 73.34 110.869 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -116.83 6.17 13.12 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.188 0.995 . . . . 62.14 112.257 -171.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -70.5 -58.57 5.84 Favored Glycine 0 C--N 1.347 1.151 0 O-C-N 123.092 0.245 . . . . 43.04 112.813 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 162.93 74.64 0.02 OUTLIER Glycine 0 C--N 1.347 1.172 0 C-N-CA 121.533 -0.365 . . . . 61.23 113.415 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 75.7 mt -112.34 174.39 5.91 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.156 0.582 . . . . 70.4 110.019 169.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.4 p -59.14 -33.78 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 124.565 1.146 . . . . 74.3 112.903 -174.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -63.28 152.45 84.74 Favored Pre-proline 0 N--CA 1.479 1.025 0 C-N-CA 123.733 0.813 . . . . 65.21 111.16 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.36 140.22 69.12 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.031 1.821 . . . . 73.1 110.358 172.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -86.93 51.47 2.25 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.286 0.634 . . . . 51.44 110.461 -176.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -72.6 86.22 1.19 Allowed 'General case' 0 C--N 1.354 0.776 0 CA-C-O 122.506 1.146 . . . . 63.33 108.302 175.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -35.26 101.17 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 111.888 -2.414 . . . . 43.24 113.877 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -99.14 115.83 29.96 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.332 -1.359 . . . . 71.52 107.332 175.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 91.2 m -125.77 119.8 28.9 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.265 -0.643 . . . . 52.12 109.265 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -104.13 117.45 34.3 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.375 -1.343 . . . . 54.21 107.375 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.523 ' HB3' ' HB3' ' A' ' 80' ' ' PHE . 97.6 m-85 -97.35 119.57 36.12 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 107.514 -1.291 . . . . 73.51 107.514 173.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 80' ' ' PHE . 10.2 pt20 -109.36 148.28 31.34 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.527 0.731 . . . . 72.11 110.151 -173.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -158.93 131.43 4.38 Favored Pre-proline 0 CA--C 1.547 0.846 0 CA-C-O 118.835 -0.603 . . . . 51.32 109.643 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -62.85 -26.55 74.67 Favored 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 123.152 2.568 . . . . 75.31 113.707 -176.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.4 m -102.33 22.26 13.67 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.119 0.567 . . . . 75.14 111.109 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -119.74 108.27 14.21 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.02 -1.104 . . . . 73.44 108.02 170.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 91.4 mt -116.82 111.13 19.29 Favored 'General case' 0 C--O 1.212 -0.875 0 CA-C-O 118.32 -0.847 . . . . 72.52 108.889 170.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 40.7 -80.96 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 126.0 1.72 . . . . 73.1 115.263 165.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.23 30.03 2.66 Favored Glycine 0 C--N 1.356 1.649 0 C-N-CA 123.351 0.501 . . . . 63.13 112.887 -176.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 8.3 mp0 -89.33 87.07 6.97 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 107.79 -1.189 . . . . 75.24 107.79 176.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.35 -25.79 67.75 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.122 -0.944 . . . . 61.4 112.335 -176.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 16.5 pm0 -69.12 -21.51 64.03 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.716 0.406 . . . . 74.21 111.536 177.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 82.2 mt -89.63 -13.09 37.85 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.234 0.614 . . . . 54.12 111.2 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.469 HD11 ' HB3' ' A' ' 25' ' ' TRP . 91.9 mt -64.61 -35.61 81.56 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.943 0.497 . . . . 63.55 111.065 175.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -80.9 -1.67 44.38 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 111.719 0.266 . . . . 54.1 111.719 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -88.14 -24.75 23.27 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 108.95 -0.759 . . . . 73.54 108.95 170.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 57.9 mt -79.77 105.05 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.918 0.887 . . . . 74.3 108.868 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.556 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 10.8 mmpt? -107.39 139.53 41.74 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 120.86 0.362 . . . . 75.13 110.175 -170.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.43 ' HG3' ' HG3' ' A' ' 120' ' ' LYS . 16.1 ptm180 -79.43 -32.74 42.85 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.307 -0.861 . . . . 74.33 110.821 -178.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.43 ' HG3' ' HG3' ' A' ' 119' ' ' ARG . 54.8 mtpt -132.27 -176.36 4.05 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.902 0.881 . . . . 74.43 110.42 -175.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 57.5 t -77.9 -53.62 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 107.967 -1.123 . . . . 71.42 107.967 167.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 20.1 p -74.3 90.33 2.11 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 108.976 -0.75 . . . . 73.22 108.976 169.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 66.2 m -146.73 49.06 1.15 Allowed 'General case' 0 C--O 1.245 0.839 0 C-N-CA 123.986 0.915 . . . . 60.35 109.045 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 28.8 m -59.21 134.25 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 115.709 -0.678 . . . . 61.31 109.263 173.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 68.5 m . . . . . 0 C--O 1.253 1.252 0 O-C-N 124.491 1.119 . . . . 61.32 109.058 -159.758 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 111.131 0.049 . . . . 74.01 111.131 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 110.15 134.34 6.77 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 111.946 -0.461 . . . . 73.33 111.946 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.0 m170 -96.85 149.05 22.29 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.429 0.692 . . . . 74.04 110.085 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -78.97 121.43 24.9 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.144 -1.058 . . . . 64.15 108.144 167.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -71.05 -3.37 19.32 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.239 1.015 . . . . 74.31 112.492 -169.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 68.91 11.36 8.32 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.756 1.222 . . . . 75.2 112.631 171.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -89.89 111.57 22.66 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.43 0.633 . . . . 72.43 111.405 -173.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 -134.87 153.09 52.19 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.701 1.2 . . . . 73.23 107.926 167.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.0 t -65.6 117.91 8.74 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 122.735 0.414 . . . . 72.24 111.103 -174.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -116.93 140.17 49.78 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 108.439 -0.948 . . . . 73.13 108.439 175.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.1 ptm -151.47 -179.88 7.77 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 120.804 0.335 . . . . 75.31 111.713 -169.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.43 99.55 2.64 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.591 1.157 . . . . 75.15 107.974 176.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -167.95 -131.96 1.35 Allowed Glycine 0 C--N 1.347 1.18 0 CA-C-O 118.478 -1.179 . . . . 71.2 113.027 -173.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.2 115.12 2.22 Favored 'Trans proline' 0 C--N 1.388 2.637 0 C-N-CA 123.495 2.797 . . . . 71.43 112.583 -174.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 71.8 p 57.56 -82.17 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.876 1.671 . . . . 61.54 112.335 -173.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 61.98 68.39 0.69 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.704 1.202 . . . . 71.13 110.908 -175.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.5 t -81.17 115.71 58.0 Favored Pre-proline 0 C--O 1.242 0.688 0 N-CA-C 107.026 -1.472 . . . . 72.13 107.026 163.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.459 ' HD2' HD12 ' A' ' 21' ' ' LEU . 33.5 Cg_exo -58.15 146.32 88.75 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.479 2.12 . . . . 71.04 110.669 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.28 -34.29 45.91 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 123.711 0.632 . . . . 62.3 110.62 176.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -51.36 -52.39 46.08 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.911 0.885 . . . . 72.14 112.234 171.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.459 HD12 ' HD2' ' A' ' 18' ' ' PRO . 83.1 mt -80.86 -30.34 35.64 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.005 0.431 . . . . 71.23 110.065 -171.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.1 m -59.88 -51.66 68.75 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.856 1.262 . . . . 62.3 110.631 173.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.539 ' HB3' ' HB3' ' A' ' 62' ' ' TYR . 9.6 mmpt? -65.98 -45.38 81.88 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 115.548 -0.751 . . . . 75.33 110.144 177.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.459 ' O ' HG23 ' A' ' 28' ' ' VAL . 57.4 tp -56.29 -48.14 77.24 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.038 0.935 . . . . 74.53 111.595 -178.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 41.8 t90 -55.85 -46.3 78.25 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.05 0.94 . . . . 72.44 111.353 178.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 35.0 m -71.18 -25.48 62.56 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.469 1.108 . . . . 74.11 112.118 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.538 HD11 HG13 ' A' ' 58' ' ' VAL . 30.3 tp -78.01 -43.98 27.91 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.162 0.985 . . . . 73.53 110.793 -176.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 24' ' ' LEU . 74.3 t -57.96 -26.83 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.352 0 C-N-CA 125.042 1.337 . . . . 74.33 111.612 173.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 78.6 p -101.4 0.91 37.78 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.531 0.732 . . . . 75.23 112.631 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -81.45 120.15 77.42 Favored Pre-proline 0 N--CA 1.483 1.193 0 C-N-CA 122.946 0.498 . . . . 74.03 110.993 -172.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -71.77 -11.05 27.37 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 122.845 2.363 . . . . 71.42 113.165 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -74.16 -36.2 64.07 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 122.591 0.356 . . . . 75.14 110.225 173.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 70.5 p -117.79 13.18 14.07 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.6 0.76 . . . . 72.23 111.631 -173.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -62.19 -30.22 70.92 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.175 0.59 . . . . 60.12 112.123 -171.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.67 -20.19 58.62 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.847 0.684 . . . . 73.23 112.847 178.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 59.4 mt -105.67 -16.77 14.6 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.007 0.523 . . . . 75.41 110.718 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.513 HD13 ' HG ' ' A' ' 27' ' ' LEU . 17.5 tt -160.28 121.7 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.21 0.604 . . . . 73.44 110.715 175.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 48.6 t -154.93 154.93 33.38 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.287 0.635 . . . . 75.21 109.67 177.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 29.2 p-90 -74.45 152.82 39.39 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.643 0.777 . . . . 71.35 111.007 -174.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.3 m -79.31 142.11 58.29 Favored Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 108.487 -0.931 . . . . 64.13 108.487 172.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.99 -26.52 49.9 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 123.212 2.608 . . . . 71.02 114.152 -176.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.6 m -74.71 -27.45 60.39 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.914 0.486 . . . . 54.41 111.42 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 107' ' ' LEU . . . 94.48 -5.55 70.62 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-O 119.391 -0.671 . . . . 73.51 114.018 175.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.468 ' HA ' HD23 ' A' ' 107' ' ' LEU . 2.8 m-20 -78.94 -16.21 57.27 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.816 0.846 . . . . 61.43 111.955 -170.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 43.5 p -156.57 179.97 8.75 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.347 0.594 . . . . 71.04 110.965 -173.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -138.81 151.98 47.49 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.044 -0.98 . . . . 53.52 109.344 171.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -107.37 139.22 42.19 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.738 0.815 . . . . 75.11 109.136 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.517 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 71.2 t -118.2 127.5 75.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 107.324 -1.361 . . . . 74.34 107.324 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -113.64 146.29 39.99 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.177 -0.675 . . . . 75.31 109.177 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 53.64 68.76 0.79 Allowed 'General case' 0 N--CA 1.476 0.859 0 O-C-N 124.851 1.344 . . . . 71.11 110.8 176.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.578 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 47.0 mt-30 -53.28 -26.92 20.13 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.491 0.717 . . . . 71.1 112.63 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -64.82 -53.06 36.77 Favored Glycine 0 C--N 1.349 1.281 0 O-C-N 123.252 0.345 . . . . 61.21 112.289 172.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -69.8 -42.12 74.16 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.192 0.597 . . . . 71.24 110.754 -176.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.437 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 60.2 t80 -56.65 -50.16 72.89 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.49 1.516 . . . . 75.13 110.806 176.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.445 ' HB1' ' O ' ' A' ' 66' ' ' ASN . . . -62.4 -31.99 72.75 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 112.213 0.449 . . . . 51.51 112.213 177.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -70.6 -49.28 49.39 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.073 0.949 . . . . 64.45 112.778 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.573 ' HG3' HG23 ' A' ' 58' ' ' VAL . 4.4 pt-20 -108.48 -37.48 5.95 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 113.569 0.952 . . . . 62.12 113.569 -172.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.573 HG23 ' HG3' ' A' ' 57' ' ' GLU . 98.6 t -81.99 -45.86 19.91 Favored 'Isoleucine or valine' 0 C--O 1.249 1.07 0 C-N-CA 123.315 0.646 . . . . 75.24 111.565 -166.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.1 mt -62.08 -48.97 87.03 Favored Pre-proline 0 CA--C 1.558 1.257 0 CA-C-O 117.79 -1.1 . . . . 72.14 112.705 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -67.69 -15.23 44.06 Favored 'Trans proline' 0 C--N 1.388 2.611 0 C-N-CA 122.134 1.889 . . . . 73.14 113.186 176.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -74.05 -64.99 0.9 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.176 0.59 . . . . 63.34 110.824 178.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.539 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 29.8 m-85 -81.61 -46.51 14.29 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.209 0.528 . . . . 74.12 111.474 -176.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -98.57 -171.22 2.08 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 106.608 -1.627 . . . . 74.44 106.608 177.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -129.47 64.99 1.48 Allowed 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 119.428 1.013 . . . . 72.13 109.859 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -166.09 162.86 18.04 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 114.295 -1.32 . . . . 75.51 108.813 174.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.445 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 8.6 m-80 -114.2 -5.85 13.02 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 122.682 0.393 . . . . 72.33 110.304 175.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -75.29 112.5 11.65 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 122.963 0.505 . . . . 74.32 110.66 -175.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.578 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 3.5 tpt -56.49 -48.64 76.72 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.281 1.432 . . . . 44.25 111.631 178.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.96 -30.07 67.64 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.414 -0.812 . . . . 75.12 112.597 -177.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.3 t -68.52 -41.35 80.07 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.643 0.777 . . . . 75.03 111.271 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -61.95 -49.24 76.89 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.832 0.853 . . . . 65.24 109.93 177.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 52.7 t -65.15 -35.4 75.32 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 CA-C-N 114.688 -1.142 . . . . 72.15 111.508 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -60.86 -42.49 97.98 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.67 0.788 . . . . 73.52 110.971 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.507 ' HA ' ' HE2' ' A' ' 77' ' ' MET . 32.1 mm-40 -64.85 -45.29 86.72 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.82 -0.627 . . . . 63.31 110.426 178.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.442 ' HB3' ' HB2' ' A' ' 80' ' ' PHE . 83.1 mt -63.59 -34.19 77.27 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.271 0.629 . . . . 71.31 111.847 -178.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -56.15 -40.03 73.21 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.212 0.605 . . . . 71.43 111.184 171.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.507 ' HE2' ' HA ' ' A' ' 74' ' ' GLN . 39.9 mtm -76.91 -23.91 52.49 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.278 0.631 . . . . 63.22 111.28 178.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -86.1 -8.61 57.76 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.06 0.544 . . . . 72.22 111.006 174.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.05 21.04 54.02 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 114.406 0.522 . . . . 40.01 114.406 173.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.442 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 17.7 m-85 -82.31 144.97 30.22 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 108.954 -0.758 . . . . 61.31 108.954 176.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -102.29 129.6 48.76 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.868 0.467 . . . . 75.5 110.24 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.631 ' HE3' HG22 ' A' ' 84' ' ' VAL . 52.8 tptt -68.71 118.65 11.97 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.426 1.09 . . . . 74.22 108.779 169.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.548 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 58.8 t -123.4 116.82 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 108.667 -0.864 . . . . 73.24 108.667 176.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.631 HG22 ' HE3' ' A' ' 82' ' ' LYS . 34.4 t -97.98 101.88 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.746 0.818 . . . . 74.03 109.318 -174.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -86.03 -36.76 19.53 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 122.341 -0.224 . . . . 70.31 110.656 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 47.2 mm -78.77 82.04 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 107.629 -1.248 . . . . 74.22 107.629 166.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -64.54 126.84 29.14 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 113.976 -1.466 . . . . 73.03 108.815 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -60.62 113.13 2.29 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.601 0.761 . . . . 64.43 111.743 -168.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.01 167.11 21.96 Favored Glycine 0 C--O 1.244 0.742 0 CA-C-N 114.009 -1.45 . . . . 63.4 110.688 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -73.73 78.04 0.91 Allowed Glycine 0 CA--C 1.526 0.771 0 C-N-CA 122.932 0.301 . . . . 74.42 112.829 177.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 80.3 mt -93.07 164.02 13.42 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.053 0.941 . . . . 72.01 110.166 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.5 p -75.73 -21.82 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 CA-C-O 121.356 0.598 . . . . 71.44 109.446 171.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -61.63 137.62 94.99 Favored Pre-proline 0 CA--C 1.552 1.028 0 CA-C-N 115.029 -0.987 . . . . 74.13 109.759 169.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -68.2 155.67 68.57 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 122.825 2.35 . . . . 73.02 113.14 -172.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -78.42 0.53 25.39 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.582 1.153 . . . . 51.13 112.849 -170.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -64.81 86.95 0.05 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.13 0.572 . . . . 74.4 110.087 173.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -36.76 105.38 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 125.413 1.485 . . . . 54.11 112.56 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -90.33 112.77 24.47 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 107.608 -1.256 . . . . 65.32 107.608 -177.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.53 HG23 ' HD2' ' A' ' 82' ' ' LYS . 76.6 m -118.06 107.12 13.62 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.894 -1.048 . . . . 70.41 109.256 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.548 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 41.9 tt0 -96.23 109.63 22.07 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.596 -1.261 . . . . 65.41 107.596 177.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -95.03 118.68 32.26 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 107.125 -1.435 . . . . 74.2 107.125 172.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -123.37 149.29 45.13 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.861 0.864 . . . . 63.55 109.87 -174.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -156.74 133.14 6.13 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 109.276 -0.638 . . . . 73.15 109.276 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.21 -27.2 56.48 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 122.928 2.419 . . . . 74.52 113.044 -174.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 113' ' ' LEU . 59.2 m -105.86 37.38 2.26 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.644 0.778 . . . . 62.32 109.511 175.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -133.9 106.9 7.52 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.055 -1.091 . . . . 70.31 108.055 170.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.596 ' HB2' ' HB3' ' A' ' 110' ' ' GLN . 68.0 mt -128.2 149.63 50.37 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 108.514 -0.921 . . . . 63.12 108.514 172.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -63.02 -59.14 5.21 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.486 0.714 . . . . 74.35 111.659 -175.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -88.95 50.57 3.71 Favored Glycine 0 C--N 1.342 0.877 0 N-CA-C 111.87 -0.492 . . . . 53.04 111.87 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.596 ' HB3' ' HB2' ' A' ' 107' ' ' LEU . 4.1 tp60 -165.19 53.0 0.11 Allowed 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 108.691 -0.855 . . . . 73.52 108.691 -172.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -62.64 -18.4 62.22 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.024 0.93 . . . . 44.2 112.966 -176.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.0 pm0 -68.26 -6.58 24.55 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 122.957 0.503 . . . . 72.03 112.145 176.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.414 ' HB3' ' O ' ' A' ' 105' ' ' CYS . 63.4 mt -86.28 -23.7 26.22 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 122.751 0.42 . . . . 70.3 111.473 174.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.19 -37.98 89.35 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.274 0.63 . . . . 64.1 111.35 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -72.21 -13.49 61.55 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 114.895 -1.048 . . . . 72.43 112.267 177.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 24.0 m120 -93.9 -11.62 30.64 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.327 0.651 . . . . 75.23 110.865 173.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 35.8 mt -87.41 91.99 3.67 Favored 'Isoleucine or valine' 0 C--N 1.353 0.745 0 N-CA-C 107.134 -1.432 . . . . 72.01 107.134 176.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.443 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 11.1 mmpt? -87.48 144.48 26.7 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.219 -0.66 . . . . 72.32 109.219 -178.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 8.6 ptm85 -86.24 -69.7 0.65 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.572 -0.529 . . . . 73.44 109.572 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -149.77 -166.41 2.54 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.464 1.106 . . . . 74.44 108.871 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.0 p -50.71 -41.76 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 C-N-CA 124.186 0.995 . . . . 75.51 112.13 -177.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 5.6 t -105.43 134.13 49.05 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.971 0.909 . . . . 62.31 109.661 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 41.9 t -96.33 101.51 13.16 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.649 -0.871 . . . . 63.24 108.649 173.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.1 p -153.44 97.72 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 124.136 0.974 . . . . 75.23 109.284 -178.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 31.1 t . . . . . 0 C--O 1.247 0.951 0 N-CA-C 107.01 -1.478 . . . . 75.54 107.01 178.094 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 mmt . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 108.409 -0.96 . . . . 72.42 108.409 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -172.67 -127.46 0.97 Allowed Glycine 0 C--N 1.337 0.634 0 CA-C-N 115.3 -0.864 . . . . 41.22 111.601 -175.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.2 p80 43.54 43.32 4.53 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 125.787 1.635 . . . . 74.41 111.647 -174.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -132.25 114.1 14.04 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.713 1.205 . . . . 73.04 108.736 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -79.86 141.49 36.11 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 108.646 -0.872 . . . . 61.25 108.646 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -64.0 100.86 0.34 Allowed 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.089 0.555 . . . . 73.41 111.239 -177.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -103.57 110.92 23.16 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.389 0.676 . . . . 73.25 110.951 177.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 -95.41 26.81 3.64 Favored 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 108.922 -0.77 . . . . 72.43 108.922 164.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.0 m -62.76 151.72 37.84 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 125.154 1.381 . . . . 74.25 111.482 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -146.62 135.14 22.02 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.41 0.684 . . . . 73.22 110.03 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.1 mmt -83.85 -178.69 7.08 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.857 0.863 . . . . 73.3 110.352 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -123.04 108.12 12.55 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.346 0.658 . . . . 63.11 109.462 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 130.21 173.23 13.33 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-N 116.181 -0.463 . . . . 64.13 112.547 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -89.0 171.28 4.77 Favored 'Trans proline' 0 C--N 1.367 1.522 0 C-N-CA 123.181 2.588 . . . . 74.31 112.511 173.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 95.3 p 53.21 43.8 31.06 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 125.279 1.432 . . . . 75.13 112.908 172.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -91.41 28.12 1.78 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.877 -0.601 . . . . 62.02 110.155 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.5 t -73.84 123.49 89.36 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 123.893 0.877 . . . . 64.33 110.649 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -61.81 139.0 77.79 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 122.734 2.289 . . . . 74.55 111.8 170.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.453 ' HA ' HG22 ' A' ' 22' ' ' THR . . . -56.58 -38.47 72.02 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.592 0.757 . . . . 73.31 112.392 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -51.33 -46.85 62.78 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.587 0.755 . . . . 75.13 111.626 173.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.449 ' HB3' HD22 ' A' ' 114' ' ' LEU . 77.8 mt -79.69 -34.73 39.99 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.122 0.569 . . . . 71.05 112.498 -172.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.453 HG22 ' HA ' ' A' ' 19' ' ' ALA . 14.3 t -71.38 -34.89 70.81 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 118.041 0.382 . . . . 73.31 111.146 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.2 mtpt -81.06 -32.7 33.91 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 119.532 -0.271 . . . . 63.24 110.875 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.426 ' O ' HG23 ' A' ' 28' ' ' VAL . 57.4 tp -63.55 -39.58 94.77 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.091 0.556 . . . . 75.13 110.497 170.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 64.7 t-105 -57.44 -52.67 64.44 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.871 0.868 . . . . 65.42 110.666 174.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 38.6 m -59.84 -40.74 89.56 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 124.238 0.961 . . . . 72.22 110.721 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.483 ' HG ' HD13 ' A' ' 37' ' ' ILE . 26.9 tp -59.64 -52.26 66.28 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.196 1.398 . . . . 72.44 112.304 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 24' ' ' LEU . 96.9 t -62.01 -33.14 56.8 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 C-N-CA 123.855 0.862 . . . . 75.15 111.164 177.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.9 t -94.04 -1.71 54.05 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 123.911 0.884 . . . . 51.34 112.069 -174.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -89.0 130.54 44.21 Favored Pre-proline 0 N--CA 1.49 1.555 0 C-N-CA 123.29 0.636 . . . . 75.41 111.467 -174.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -73.32 -21.82 19.54 Favored 'Trans proline' 0 C--N 1.39 2.716 0 C-N-CA 123.271 2.647 . . . . 71.33 114.369 -174.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -78.45 -36.33 45.57 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.316 0.646 . . . . 74.41 110.455 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.5 p -92.01 -0.96 57.48 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.227 0.611 . . . . 61.34 111.28 -176.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.69 -29.17 58.92 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.88 1.272 . . . . 73.21 112.107 -179.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.26 -36.98 79.03 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.934 0.894 . . . . 64.5 113.22 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.6 mt -114.16 -6.38 13.05 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.918 0.487 . . . . 63.12 112.134 -176.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.483 HD13 ' HG ' ' A' ' 27' ' ' LEU . 16.6 tt -160.11 125.71 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-O 120.943 0.401 . . . . 74.44 110.878 175.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 21.5 p -146.2 145.3 30.39 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.218 0.607 . . . . 63.45 110.255 -176.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 10.2 p-90 -69.25 152.19 45.36 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 118.028 0.376 . . . . 71.11 110.844 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 61.2 p -71.98 150.0 92.53 Favored Pre-proline 0 CA--C 1.552 1.048 0 N-CA-C 109.446 -0.575 . . . . 55.43 109.446 172.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -51.59 -24.27 16.82 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.564 2.176 . . . . 73.34 113.67 171.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 59.8 m -69.99 -52.26 25.74 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.241 0.616 . . . . 64.02 109.765 169.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.16 5.58 65.63 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.277 -0.874 . . . . 32.32 112.969 -177.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -87.92 -2.25 58.49 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.861 0.864 . . . . 72.04 110.022 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.7 p -163.59 170.57 17.0 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.375 1.07 . . . . 71.24 109.494 -169.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -142.07 143.46 33.1 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.465 0.306 . . . . 50.3 111.075 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 -97.77 140.27 32.4 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.173 0.989 . . . . 64.42 109.487 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.5 t -123.95 132.7 70.95 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 C-N-CA 124.387 1.075 . . . . 61.23 108.308 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.416 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 79.3 m-85 -115.82 146.86 41.61 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.39 1.076 . . . . 72.45 109.756 -177.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 49.77 72.59 0.31 Allowed 'General case' 0 N--CA 1.479 1.007 0 O-C-N 124.727 1.267 . . . . 63.1 111.378 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.416 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 16.3 mm-40 -51.09 -35.96 37.83 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.808 0.843 . . . . 72.31 112.717 -176.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.37 -47.38 71.16 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-N 115.809 -0.632 . . . . 52.12 112.885 177.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 -69.54 -44.33 71.19 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.187 0.595 . . . . 62.01 110.63 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -55.34 -49.26 72.68 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.376 1.47 . . . . 74.04 110.975 176.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.29 -35.93 78.68 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 116.432 -0.349 . . . . 71.34 111.932 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -70.11 -47.08 63.31 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 124.263 1.025 . . . . 72.24 113.078 -175.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.487 ' HG3' HG23 ' A' ' 58' ' ' VAL . 7.1 pt-20 -107.01 -37.38 6.34 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 113.912 1.079 . . . . 74.25 113.912 -174.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.487 HG23 ' HG3' ' A' ' 57' ' ' GLU . 98.4 t -81.0 -43.7 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 122.754 0.421 . . . . 75.54 111.512 -168.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.5 mt -67.03 -43.86 48.17 Favored Pre-proline 0 CA--C 1.556 1.21 0 CA-C-O 117.979 -1.01 . . . . 71.33 112.833 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.98 -14.36 43.37 Favored 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 121.894 1.729 . . . . 73.43 113.625 173.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -79.01 -57.76 3.58 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.384 0.674 . . . . 70.33 111.04 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.437 ' CE1' HD13 ' A' ' 27' ' ' LEU . 57.3 m-85 -86.57 -26.8 24.3 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 112.258 0.466 . . . . 74.43 112.258 -176.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -124.38 -178.45 4.11 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.063 0.945 . . . . 50.52 108.747 -176.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.66 37.67 2.85 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 122.917 0.487 . . . . 72.4 109.994 -172.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -160.84 160.7 31.41 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.92 0.888 . . . . 73.54 108.902 -176.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -109.69 -25.45 10.39 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 108.996 -0.742 . . . . 73.21 108.996 176.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -57.68 118.37 5.19 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.334 1.054 . . . . 55.42 111.655 -176.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.416 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 11.6 ttm -72.15 -31.57 66.08 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.1 -0.955 . . . . 73.44 111.709 -178.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.29 -37.36 69.74 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.076 0.55 . . . . 44.33 111.644 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.404 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 37.2 t -66.41 -44.96 81.52 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.214 1.005 . . . . 64.31 111.323 176.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -64.19 -52.91 56.62 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.531 1.132 . . . . 64.03 111.196 -176.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 68.0 t -65.8 -31.35 53.35 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 CA-C-N 115.515 -0.766 . . . . 64.15 111.251 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -60.28 -39.77 88.03 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 122.785 0.434 . . . . 73.44 111.227 173.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 70' ' ' SER . 21.7 mm-40 -65.09 -46.25 81.86 Favored 'General case' 0 C--N 1.355 0.809 0 O-C-N 123.646 0.591 . . . . 75.05 109.905 177.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 80' ' ' PHE . 96.9 mt -57.4 -45.25 84.75 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 123.81 0.844 . . . . 61.15 111.285 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -55.57 -42.5 74.82 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.595 0.758 . . . . 74.51 111.933 176.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 59.3 mtm -73.6 -27.61 61.38 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 116.041 -0.527 . . . . 71.13 111.491 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -85.28 -6.97 59.22 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.569 0.348 . . . . 71.04 111.207 177.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.65 17.71 59.62 Favored Glycine 0 C--N 1.352 1.469 0 CA-C-O 119.794 -0.448 . . . . 32.31 113.927 175.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.502 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 38.7 m-85 -78.2 137.34 38.09 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 108.332 -0.988 . . . . 73.02 108.332 173.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 13.6 ttm180 -107.93 130.79 55.01 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.306 0.642 . . . . 73.43 109.545 -175.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -65.78 125.45 25.36 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.038 0.935 . . . . 73.12 109.369 174.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 51.7 t -116.0 113.54 43.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 107.835 -1.172 . . . . 73.22 107.835 176.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 71.1 t -86.46 140.15 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 123.762 0.825 . . . . 73.23 110.898 -177.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -131.01 -61.28 0.94 Allowed 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 108.066 -1.087 . . . . 74.52 108.066 172.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.673 HG23 ' HB3' ' A' ' 93' ' ' LYS . 41.3 mm -120.49 123.33 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 115.307 -0.86 . . . . 74.2 110.047 -177.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -124.98 119.88 29.99 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.39 1.076 . . . . 74.25 108.336 170.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -87.42 10.72 16.6 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.233 0.613 . . . . 71.21 112.554 -174.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -75.49 78.68 1.13 Allowed Glycine 0 C--N 1.352 1.446 0 N-CA-C 113.591 0.196 . . . . 63.42 113.591 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 80.1 5.26 89.7 Favored Glycine 0 C--N 1.351 1.395 0 C-N-CA 123.018 0.342 . . . . 74.14 113.597 177.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 55.5 mt -103.12 158.75 16.09 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.89 0.876 . . . . 72.12 110.481 -174.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.5 p -81.95 75.77 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 CA-C-O 123.203 1.478 . . . . 72.33 109.252 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.673 ' HB3' HG23 ' A' ' 86' ' ' ILE . 73.1 mmtt -132.26 161.69 61.41 Favored Pre-proline 0 N--CA 1.482 1.137 0 CA-C-N 113.617 -1.628 . . . . 74.31 109.925 -173.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.82 172.96 6.28 Favored 'Trans proline' 0 C--N 1.386 2.519 0 C-N-CA 122.422 2.081 . . . . 71.33 113.319 174.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -34.85 79.22 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.108 -0.951 . . . . 74.42 111.291 -178.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -86.21 152.59 22.69 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.516 0.674 . . . . 72.43 111.381 -172.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.416 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 18.0 m-20 -80.84 134.15 35.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.337 -1.302 . . . . 74.21 108.554 170.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -115.1 105.27 12.74 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 107.644 -1.243 . . . . 71.24 107.644 169.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 93.3 m -124.7 153.23 42.65 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.478 1.111 . . . . 64.41 109.637 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.546 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 37.8 tt0 -130.9 153.55 49.02 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.548 -0.908 . . . . 72.04 108.548 162.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -124.46 120.31 31.66 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 107.277 -1.379 . . . . 74.33 107.277 169.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -110.32 144.56 38.87 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.552 0.741 . . . . 74.41 110.242 -174.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.463 ' HB3' ' HB3' ' A' ' 106' ' ' PHE . 64.8 t-80 -149.46 130.81 7.3 Favored Pre-proline 0 CA--C 1.55 0.969 0 CA-C-O 119.351 -0.357 . . . . 64.0 110.423 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.25 -40.83 30.28 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 123.299 2.666 . . . . 74.41 113.667 -175.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.416 ' HB2' ' HE1' ' A' ' 103' ' ' HIS . 34.2 m -97.13 22.96 7.85 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.275 0.63 . . . . 73.3 111.096 -177.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.463 ' HB3' ' HB3' ' A' ' 103' ' ' HIS . 89.1 t80 -117.37 99.05 6.75 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 106.706 -1.59 . . . . 72.44 106.706 173.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 63.1 mt -119.31 139.36 52.07 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.137 -1.06 . . . . 63.34 108.137 177.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -68.89 132.27 46.47 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.508 0.723 . . . . 73.31 110.125 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.48 1.6 90.49 Favored Glycine 0 C--N 1.344 0.983 0 O-C-N 123.555 0.534 . . . . 43.14 113.052 -173.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -122.84 53.46 1.28 Allowed 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 108.144 -1.058 . . . . 62.53 108.144 -175.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.55 -26.1 65.09 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.236 1.414 . . . . 73.32 114.102 -177.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 7.9 pm0 -71.01 -8.19 51.6 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 112.204 0.446 . . . . 65.32 112.204 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.491 ' O ' HG13 ' A' ' 117' ' ' ILE . 24.6 mt -83.1 -14.22 54.11 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 118.771 -0.633 . . . . 73.23 111.485 173.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.449 HD22 ' HB3' ' A' ' 21' ' ' LEU . 96.4 mt -63.17 -35.3 79.86 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 118.295 0.498 . . . . 72.15 110.857 175.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -80.15 -1.59 40.96 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.962 -0.563 . . . . 60.51 112.148 175.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -103.61 -13.71 16.43 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.586 0.754 . . . . 75.21 110.528 168.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 113' ' ' LEU . 63.9 mt -85.74 109.74 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 106.879 -1.526 . . . . 72.1 106.879 173.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -109.21 170.39 8.08 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.807 -0.812 . . . . 70.4 108.807 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 24.6 ptt85 -119.86 -40.65 2.72 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.155 -1.054 . . . . 55.51 108.155 168.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -137.15 179.23 6.51 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.519 1.128 . . . . 71.23 109.476 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 86.5 t -80.59 -37.23 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 N-CA-C 109.055 -0.72 . . . . 74.44 109.055 166.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 10.0 t -94.34 52.91 1.63 Allowed 'General case' 0 CA--C 1.559 1.308 0 CA-C-O 122.49 1.138 . . . . 70.25 110.64 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 36.7 m -86.39 92.99 9.0 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 115.196 -0.911 . . . . 75.44 108.969 175.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.9 m -109.15 16.63 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 124.096 0.958 . . . . 62.33 112.258 -173.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.479 1.015 0 C-N-CA 123.716 0.807 . . . . 44.13 109.018 176.026 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.484 1.228 0 CA-C-O 120.893 0.378 . . . . 74.15 110.74 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -149.31 30.88 1.17 Allowed Glycine 0 N--CA 1.469 0.879 0 CA-C-N 115.669 -0.696 . . . . 74.54 111.467 175.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -97.6 138.02 35.64 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.23 1.012 . . . . 71.13 109.52 -174.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -62.98 112.72 2.71 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.79 0.836 . . . . 52.33 111.324 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -97.86 -87.37 0.33 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.482 0.713 . . . . 72.53 109.868 175.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -166.41 164.58 17.36 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.434 0.693 . . . . 75.14 110.011 -176.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -89.36 171.47 9.73 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.419 0.628 . . . . 73.15 111.905 -177.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -123.25 52.09 1.41 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.825 1.25 . . . . 62.21 107.764 170.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.3 t -64.96 110.64 2.52 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 114.495 -1.23 . . . . 74.04 112.844 -167.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 29.5 p80 -152.15 131.45 12.83 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.87 0.868 . . . . 65.41 108.878 167.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -83.4 143.71 30.12 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.045 0.538 . . . . 53.23 110.881 -174.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -119.86 105.97 11.62 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.623 0.769 . . . . 62.04 109.505 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -154.98 109.11 0.39 Allowed Glycine 0 C--N 1.346 1.134 0 CA-C-O 118.929 -0.928 . . . . 61.52 112.024 -177.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -77.65 153.35 30.06 Favored 'Trans proline' 0 C--N 1.375 1.967 0 C-N-CA 122.906 2.404 . . . . 75.22 112.112 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.1 t -82.32 131.84 35.22 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 108.814 -0.81 . . . . 74.44 108.814 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -81.27 18.1 1.18 Allowed 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.329 1.052 . . . . 74.02 112.702 -172.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.4 t -57.83 130.67 82.53 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 124.356 1.062 . . . . 73.51 111.802 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -58.94 152.37 58.6 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 123.155 2.57 . . . . 74.42 112.314 174.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.72 -45.78 70.59 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.971 0.908 . . . . 71.41 112.1 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -54.85 -44.44 73.99 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 122.981 0.512 . . . . 73.31 112.009 176.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.2 mt -80.52 -31.09 37.16 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 112.393 0.516 . . . . 61.55 112.393 -171.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.1 t -70.99 -33.39 70.37 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.656 -0.498 . . . . 72.2 109.656 175.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -69.87 -42.41 73.52 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 122.915 0.486 . . . . 65.23 110.536 172.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.61 -43.67 93.68 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.8 0.84 . . . . 54.23 111.419 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 13.5 t-105 -64.58 -51.9 60.37 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-O 119.611 -0.233 . . . . 74.42 110.81 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 32.1 m -61.3 -20.69 63.2 Favored 'General case' 0 CA--C 1.554 1.133 0 CA-C-O 121.299 0.571 . . . . 73.1 110.883 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.0 tp -76.77 -54.77 6.18 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.597 1.159 . . . . 75.41 111.408 174.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 82.5 t -62.16 -36.22 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.749 0.819 . . . . 72.13 111.389 -177.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.5 p -78.15 -25.4 47.3 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.538 0.735 . . . . 74.14 112.305 -176.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -70.84 123.12 88.69 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 123.24 0.616 . . . . 63.34 111.563 -171.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.28 -13.51 33.45 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 122.975 2.45 . . . . 61.13 113.479 -177.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -87.12 -22.39 25.4 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.723 0.809 . . . . 74.25 110.987 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.451 HG21 ' HE1' ' A' ' 62' ' ' TYR . 24.7 p -110.6 1.25 17.95 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.158 0.583 . . . . 74.43 111.685 175.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -54.12 -36.95 63.81 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.486 1.114 . . . . 70.42 112.271 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.1 -33.17 75.39 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.526 -0.761 . . . . 72.12 112.256 -176.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.462 HD22 ' HB2' ' A' ' 50' ' ' ASP . 59.7 mt -103.48 -11.0 18.09 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.548 0.339 . . . . 55.43 111.36 -177.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.5 tt -162.15 128.43 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 122.971 0.508 . . . . 70.03 110.326 172.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 17.3 p -153.92 157.6 39.46 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.23 0.612 . . . . 71.21 110.057 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 41.4 p-90 -73.63 149.22 42.18 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.993 0.517 . . . . 74.23 110.097 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.5 m -70.24 143.51 91.1 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 123.879 0.872 . . . . 75.51 110.098 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -55.59 -32.49 83.36 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.813 2.342 . . . . 75.0 113.517 175.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.9 m -69.61 -19.68 63.64 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.217 0.607 . . . . 73.31 111.698 173.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.69 6.4 71.71 Favored Glycine 0 C--N 1.344 0.996 0 N-CA-C 115.617 1.007 . . . . 41.24 115.617 171.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -88.07 -5.66 58.36 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 118.109 0.955 . . . . 74.21 112.265 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.2 p -163.44 -171.66 2.65 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.162 0.585 . . . . 64.42 110.736 -170.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -145.03 148.81 34.13 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.404 0.682 . . . . 73.51 110.973 175.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 21.6 m-70 -99.52 150.79 21.86 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.588 1.155 . . . . 71.4 110.173 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.0 t -123.67 123.03 66.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 107.939 -1.134 . . . . 61.33 107.939 172.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -105.68 147.41 28.54 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.273 1.029 . . . . 64.42 110.034 -178.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.462 ' HB2' HD22 ' A' ' 36' ' ' LEU . 8.6 m-20 48.79 59.83 4.13 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 124.925 1.39 . . . . 63.22 111.196 172.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.496 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 23.6 mt-30 -54.65 -26.16 31.41 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.78 1.03 . . . . 71.25 113.78 -169.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.94 -50.08 37.33 Favored Glycine 0 C--N 1.35 1.348 0 O-C-N 123.198 0.311 . . . . 75.21 112.654 173.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -68.06 -40.13 82.84 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.452 0.701 . . . . 70.43 110.249 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.476 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 44.4 t80 -57.99 -48.14 80.91 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.113 1.365 . . . . 73.44 110.534 176.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.435 ' HB2' ' HB2' ' A' ' 68' ' ' MET . . . -61.27 -36.67 80.66 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.196 -0.456 . . . . 71.21 111.486 177.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -68.47 -53.99 19.83 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.252 1.021 . . . . 73.13 112.985 -176.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.559 ' HG3' HG23 ' A' ' 58' ' ' VAL . 6.3 pt-20 -100.45 -38.07 8.56 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 112.893 0.701 . . . . 61.42 112.893 -173.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.559 HG23 ' HG3' ' A' ' 57' ' ' GLU . 77.6 t -81.92 -44.46 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.045 0.538 . . . . 71.24 112.144 -167.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 49.3 mt -63.52 -45.17 83.24 Favored Pre-proline 0 CA--C 1.56 1.36 0 CA-C-O 117.797 -1.097 . . . . 73.21 112.684 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.09 -16.52 44.89 Favored 'Trans proline' 0 C--N 1.386 2.538 0 CA-C-N 122.037 1.763 . . . . 75.51 113.312 173.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -73.13 -47.62 42.57 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.453 0.701 . . . . 73.2 111.073 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.451 ' HE1' HG21 ' A' ' 33' ' ' THR . 53.8 m-85 -96.12 -48.1 5.8 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 122.853 0.461 . . . . 65.13 111.903 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -99.08 -171.27 2.06 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.85 0.86 . . . . 75.05 109.117 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -118.89 44.72 2.24 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.361 0.601 . . . . 72.23 110.551 -176.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -164.04 164.51 22.99 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.333 -0.849 . . . . 74.3 109.557 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -121.91 -11.8 8.48 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.588 0.755 . . . . 75.31 110.278 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -66.93 117.39 8.95 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.035 0.934 . . . . 74.3 109.75 174.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.496 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 24.0 ttt -87.72 -18.68 28.94 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.558 0.343 . . . . 73.35 110.917 -176.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.5 -37.49 67.92 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.862 0.465 . . . . 74.51 110.22 172.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.485 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 44.0 t -66.44 -46.22 77.21 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.911 1.284 . . . . 63.02 111.343 175.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -61.75 -51.28 68.98 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.889 0.876 . . . . 74.01 110.478 -175.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.35 -40.85 90.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 123.914 0.885 . . . . 61.43 110.772 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -56.58 -39.91 74.33 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.257 1.023 . . . . 73.32 111.073 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 70' ' ' SER . 25.8 mm-40 -63.38 -45.91 88.92 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 123.653 0.596 . . . . 72.24 109.822 176.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 80' ' ' PHE . 64.4 mt -61.16 -37.43 82.87 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.729 0.811 . . . . 71.34 111.5 -178.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -58.55 -38.54 78.03 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.509 0.724 . . . . 52.42 111.371 172.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 34.1 mtm -70.86 -34.07 71.26 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.189 -0.459 . . . . 72.42 110.493 177.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.454 ' CZ ' ' HB3' ' A' ' 119' ' ' ARG . 44.4 m-85 -81.21 -9.62 59.75 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.595 0.758 . . . . 71.43 111.59 -178.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.96 22.69 59.01 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 114.268 0.467 . . . . 61.0 114.268 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.4 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 72.1 m-85 -79.49 137.17 37.11 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 108.443 -0.947 . . . . 61.31 108.443 171.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -102.81 127.14 50.1 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.153 0.581 . . . . 74.5 110.595 -170.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.402 ' HD2' HG23 ' A' ' 99' ' ' THR . 41.3 tptt -65.05 115.88 5.89 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.865 1.266 . . . . 74.51 109.707 173.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 59.5 t -123.29 120.28 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 108.731 -0.84 . . . . 71.13 108.731 175.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 37.5 t -90.77 121.47 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.069 0.948 . . . . 65.11 109.384 -176.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 -107.84 -46.78 3.72 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 122.619 0.368 . . . . 62.23 110.696 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.7 mm -69.48 115.57 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 108.274 -1.01 . . . . 75.34 108.274 168.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -67.47 117.91 10.07 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.692 0.797 . . . . 72.52 110.014 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -69.75 94.53 0.81 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.924 0.89 . . . . 74.01 110.749 -174.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.84 163.57 30.21 Favored Glycine 0 C--O 1.242 0.6 0 CA-C-N 114.539 -1.21 . . . . 62.55 111.358 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.54 83.85 0.36 Allowed Glycine 0 C--N 1.339 0.73 0 O-C-N 123.79 0.347 . . . . 72.05 112.293 176.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.428 ' HB2' ' HG2' ' A' ' 93' ' ' LYS . 88.7 mt -117.01 170.39 8.68 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.338 1.055 . . . . 71.53 109.802 -178.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.6 p -70.25 -23.4 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.234 0.613 . . . . 75.43 111.094 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.428 ' HG2' ' HB2' ' A' ' 91' ' ' LEU . 16.4 ptmt -70.61 158.06 88.71 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 124.042 0.937 . . . . 60.1 110.19 178.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -58.5 141.59 97.4 Favored 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 122.566 2.177 . . . . 74.24 112.639 -174.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -81.86 2.45 30.31 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.296 1.038 . . . . 74.32 111.371 -177.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -59.06 153.37 17.98 Favored 'General case' 0 C--N 1.36 1.026 0 C-N-CA 123.556 0.742 . . . . 61.31 110.205 173.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -97.52 113.39 25.08 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 107.166 -1.42 . . . . 61.24 107.166 175.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -100.65 122.13 42.79 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 107.262 -1.384 . . . . 72.15 107.262 174.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.402 HG23 ' HD2' ' A' ' 82' ' ' LYS . 77.3 m -123.34 128.49 49.98 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.13 -0.693 . . . . 50.5 109.13 176.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.476 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 35.2 tt0 -101.55 111.0 23.1 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 106.799 -1.556 . . . . 75.43 106.799 172.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -94.05 119.88 33.53 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.445 -1.317 . . . . 65.12 107.445 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -121.69 142.12 50.48 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.788 -0.642 . . . . 75.42 110.796 -174.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 45.5 t-80 -147.26 130.28 8.0 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 107.665 -1.235 . . . . 74.24 107.665 175.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -63.01 -20.9 72.69 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.816 2.344 . . . . 62.51 113.846 -172.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.472 ' SG ' ' HB3' ' A' ' 113' ' ' LEU . 36.7 t -101.64 35.36 2.33 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.306 0.642 . . . . 70.15 110.099 175.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -137.48 109.01 6.94 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.931 0.892 . . . . 74.34 108.848 172.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 85.0 mt -118.14 104.86 11.23 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 118.969 -0.539 . . . . 62.31 109.933 174.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 52.14 -79.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 125.669 1.588 . . . . 75.11 112.688 176.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -141.57 42.13 1.18 Allowed Glycine 0 C--N 1.348 1.243 0 CA-C-N 115.827 -0.624 . . . . 32.43 111.923 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -82.1 74.19 9.09 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 106.677 -1.601 . . . . 70.52 106.677 173.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -62.0 -31.14 71.49 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.143 -1.39 . . . . 75.13 112.695 -171.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 17.5 pm0 -69.2 -16.89 63.72 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 122.502 0.321 . . . . 72.12 111.586 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.472 ' HB3' ' SG ' ' A' ' 105' ' ' CYS . 40.7 mt -87.24 -14.6 40.58 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.329 0.252 . . . . 73.43 111.462 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.407 HD23 HD12 ' A' ' 117' ' ' ILE . 96.5 mt -63.86 -33.82 76.56 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.976 0.51 . . . . 73.23 111.661 177.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -73.74 -5.88 43.47 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.2 0.444 . . . . 54.34 112.2 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -101.56 -6.68 23.56 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.8 0.84 . . . . 71.54 109.594 175.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.407 HD12 HD23 ' A' ' 114' ' ' LEU . 44.2 mt -90.77 111.95 24.35 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 N-CA-C 107.226 -1.398 . . . . 73.02 107.226 174.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.421 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 11.4 mmpt? -101.25 136.69 40.68 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.347 0.659 . . . . 75.52 111.115 -167.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 78' ' ' TYR . 15.7 ptt180 -83.07 19.64 1.38 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 123.546 0.738 . . . . 73.14 112.867 178.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -103.68 132.61 49.78 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.55 -1.278 . . . . 74.32 107.55 164.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.1 p -80.6 78.27 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 CA-C-O 123.074 1.416 . . . . 61.24 109.579 -172.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 10.1 t -77.67 57.24 1.59 Allowed 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 113.299 -1.773 . . . . 53.54 110.816 177.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.4 t -162.69 142.8 9.48 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-N 115.374 -0.83 . . . . 74.11 108.995 -177.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 16.4 m -70.9 96.69 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 CA-C-O 121.561 0.696 . . . . 71.55 110.366 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 C--O 1.248 0.994 0 C-N-CA 123.807 0.843 . . . . 52.15 109.492 -175.105 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.6 mmm . . . . . 0 N--CA 1.476 0.873 0 N-CA-C 109.396 -0.594 . . . . 74.04 109.396 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.92 126.3 0.91 Allowed Glycine 0 C--N 1.333 0.372 0 N-CA-C 110.048 -1.221 . . . . 65.23 110.048 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -144.73 106.34 4.26 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-N 117.496 0.648 . . . . 75.02 109.87 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 47.5 t60 -64.93 125.14 23.93 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 123.926 0.89 . . . . 75.01 109.141 174.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -64.31 104.49 0.77 Allowed 'General case' 0 N--CA 1.475 0.791 0 O-C-N 124.258 0.974 . . . . 64.0 109.569 176.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -92.8 145.18 24.6 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.041 -0.981 . . . . 52.24 110.209 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -118.24 127.16 53.46 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.824 -0.806 . . . . 73.13 108.824 175.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -85.65 101.78 13.03 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.052 -1.092 . . . . 74.53 108.052 171.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.0 p -79.95 65.05 4.98 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.904 0.859 . . . . 54.01 109.531 175.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -76.92 137.23 38.97 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.496 -1.229 . . . . 74.24 109.977 -175.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 21.6 ptm -145.9 171.27 15.07 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.513 1.125 . . . . 75.02 109.22 -178.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.15 172.62 13.16 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.003 0.921 . . . . 74.03 108.553 172.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -121.32 72.93 0.36 Allowed Glycine 0 N--CA 1.468 0.811 0 CA-C-O 119.528 -0.596 . . . . 72.24 112.352 176.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -88.46 12.15 2.88 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 122.475 2.117 . . . . 62.44 110.871 172.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.433 ' OG ' HG23 ' A' ' 17' ' ' VAL . 20.3 t -86.66 162.53 17.87 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 124.743 1.217 . . . . 74.53 109.676 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -85.78 7.06 25.19 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.171 0.588 . . . . 72.42 111.366 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.433 HG23 ' OG ' ' A' ' 15' ' ' SER . 52.6 t -57.49 119.63 34.06 Favored Pre-proline 0 N--CA 1.48 1.065 0 C-N-CA 124.434 1.094 . . . . 54.24 110.606 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -64.43 155.91 63.35 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 122.702 2.268 . . . . 74.31 111.44 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.24 -44.81 61.81 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.057 0.943 . . . . 64.53 112.232 -175.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -53.19 -46.33 68.94 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.17 0.588 . . . . 62.53 112.338 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 68.9 mt -80.26 -33.6 37.73 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 112.452 0.538 . . . . 63.14 112.452 -173.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.9 t -71.67 -34.83 70.04 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 117.723 0.238 . . . . 64.41 110.415 176.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.512 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -70.44 -43.87 69.01 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 122.817 0.447 . . . . 74.31 110.078 174.018 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.474 ' O ' HG23 ' A' ' 28' ' ' VAL . 68.6 tp -54.28 -56.51 17.74 Favored 'General case' 0 C--O 1.214 -0.784 0 O-C-N 124.312 1.007 . . . . 73.44 111.546 177.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.518 ' HZ2' ' H ' ' A' ' 109' ' ' GLY . 23.0 t90 -58.11 -45.46 87.24 Favored 'General case' 0 CA--C 1.552 1.026 0 O-C-N 123.52 0.512 . . . . 74.12 110.908 -176.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.6 m -64.82 -30.75 71.77 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.704 0.802 . . . . 73.03 111.536 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.542 HD11 ' CG1' ' A' ' 58' ' ' VAL . 37.3 tp -74.05 -45.15 51.3 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.45 1.1 . . . . 72.44 111.26 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 24' ' ' LEU . 71.4 t -61.76 -32.04 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 C-N-CA 124.092 0.957 . . . . 62.22 110.321 173.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.6 t -93.64 5.15 52.56 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.359 1.064 . . . . 73.31 111.988 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -85.83 121.5 73.1 Favored Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 123.056 0.542 . . . . 61.13 110.436 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.46 -14.05 27.78 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.765 2.31 . . . . 74.44 113.54 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -78.96 -33.47 45.17 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.368 0.667 . . . . 73.33 111.23 177.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 67.4 p -111.62 9.53 21.09 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.812 -0.631 . . . . 74.42 110.683 -176.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -56.79 -34.62 67.82 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.338 1.455 . . . . 61.22 112.305 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.33 -34.01 76.76 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.503 -0.771 . . . . 74.14 111.71 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.418 HD22 ' HB2' ' A' ' 50' ' ' ASP . 87.9 mt -104.75 -13.57 15.85 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.227 0.611 . . . . 74.44 111.397 -174.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.48 HG21 ' HG ' ' A' ' 27' ' ' LEU . 20.1 tt -161.2 119.69 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 C-N-CA 123.005 0.522 . . . . 74.34 110.246 175.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 16.7 p -150.04 150.23 31.46 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.367 0.667 . . . . 75.25 109.768 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.441 ' HE3' ' HA2' ' A' ' 43' ' ' GLY . 8.2 p-90 -89.98 153.74 20.36 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.006 0.431 . . . . 75.43 109.891 178.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.8 m -82.43 155.24 69.11 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 114.823 -1.08 . . . . 72.22 109.316 -175.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.18 -16.53 13.03 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 122.884 2.389 . . . . 74.01 114.135 173.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.6 m -71.14 -36.42 72.08 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.073 0.949 . . . . 64.13 111.399 174.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.441 ' HA2' ' HE3' ' A' ' 39' ' ' TRP . . . 82.16 1.49 90.37 Favored Glycine 0 C--N 1.345 1.067 0 CA-C-N 115.744 -0.662 . . . . 72.42 114.66 176.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -103.08 -3.23 26.2 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.259 0.624 . . . . 54.4 111.09 -175.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.8 p -154.68 163.25 40.52 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.405 0.682 . . . . 51.11 110.599 -170.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -142.13 152.26 43.05 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.88 0.472 . . . . 74.54 110.446 174.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -109.16 148.68 30.52 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.776 0.83 . . . . 62.43 109.235 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 82.7 t -123.73 131.83 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 108.223 -1.029 . . . . 71.11 108.223 177.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 94.0 m-85 -115.41 147.19 40.84 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.864 0.866 . . . . 62.5 110.217 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.418 ' HB2' HD22 ' A' ' 36' ' ' LEU . 17.6 m-20 51.43 67.56 0.93 Allowed 'General case' 0 N--CA 1.481 1.113 0 O-C-N 124.647 1.217 . . . . 75.35 111.823 173.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -53.77 -31.34 48.32 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 114.516 1.302 . . . . 74.41 114.516 -172.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.4 -43.92 43.9 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 112.058 -0.417 . . . . 71.52 112.058 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -72.29 -32.67 66.8 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.67 1.188 . . . . 61.45 110.968 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.462 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 53.6 t80 -69.71 -50.73 40.81 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.848 1.259 . . . . 75.34 109.762 178.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.496 ' HB1' ' O ' ' A' ' 66' ' ' ASN . . . -62.17 -32.14 72.73 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.628 -0.715 . . . . 74.5 112.135 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.5 tttm -62.38 -53.67 51.59 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.046 1.339 . . . . 71.22 113.45 -176.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -122.11 -22.11 5.74 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 114.033 1.123 . . . . 73.43 114.033 -170.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.542 ' CG1' HD11 ' A' ' 27' ' ' LEU . 85.7 t -86.44 -45.03 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.16 0.584 . . . . 72.25 110.824 -175.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 26.3 mt -62.88 -48.83 84.38 Favored Pre-proline 0 CA--C 1.559 1.305 0 CA-C-O 118.507 -0.759 . . . . 73.44 112.55 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.56 -13.18 38.2 Favored 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 121.926 1.75 . . . . 64.11 113.239 175.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -73.28 -54.07 9.31 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.262 0.625 . . . . 73.41 110.675 176.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.5 ' CD1' HD13 ' A' ' 27' ' ' LEU . 35.5 m-85 -92.84 -43.71 8.85 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 112.194 0.442 . . . . 74.1 112.194 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -98.77 -176.99 3.51 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.488 0.715 . . . . 72.33 109.335 -178.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.55 39.68 2.58 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.312 0.577 . . . . 72.51 111.132 -174.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -161.23 162.12 31.06 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.881 0.873 . . . . 53.33 109.875 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.496 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 5.7 m-80 -106.8 -26.22 11.37 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 108.618 -0.882 . . . . 53.13 108.618 173.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -61.03 115.31 3.64 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.114 0.965 . . . . 64.22 111.52 -177.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.476 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 24.9 ttt -83.13 -20.11 35.43 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 116.195 -0.457 . . . . 75.12 111.296 -177.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.93 -36.2 72.16 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.356 0.262 . . . . 72.45 110.525 172.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.492 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 37.2 t -63.32 -51.69 64.96 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.085 0.954 . . . . 45.11 110.727 172.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -58.08 -54.9 41.7 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.166 0.986 . . . . 71.24 111.342 -174.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.1 -37.75 80.65 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 CA-C-N 115.506 -0.77 . . . . 71.33 111.033 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 58.2 ttt-85 -59.44 -43.9 93.02 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 117.894 0.316 . . . . 75.44 111.396 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 70' ' ' SER . 10.0 mm100 -62.0 -44.26 97.1 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.535 0.522 . . . . 74.42 109.627 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.1 mt -59.32 -41.16 88.44 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 123.946 0.779 . . . . 73.53 111.567 176.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -61.25 -37.59 83.66 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.589 0.756 . . . . 73.42 111.181 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 41.9 mtm -68.83 -31.87 71.15 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 122.757 0.423 . . . . 75.12 110.565 173.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -81.78 -4.01 55.29 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.963 0.905 . . . . 71.54 111.137 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.65 15.09 74.23 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-O 119.527 -0.596 . . . . 71.23 114.353 175.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -72.91 131.91 42.81 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 117.683 0.741 . . . . 75.11 109.222 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -99.42 121.77 41.6 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 109.144 -0.687 . . . . 54.14 109.144 -174.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.554 ' HE2' HG22 ' A' ' 84' ' ' VAL . 1.2 tmtp? -79.21 127.66 32.33 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.802 1.241 . . . . 73.02 108.063 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 61.7 t -123.75 129.17 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.166 0.986 . . . . 74.14 108.631 178.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.554 HG22 ' HE2' ' A' ' 82' ' ' LYS . 30.6 t -92.25 134.0 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 108.279 -1.008 . . . . 73.04 108.279 178.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 46.6 m-70 -118.21 -0.26 11.59 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 122.774 0.43 . . . . 74.32 111.099 175.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 48.1 mm -108.98 100.23 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.73 0.812 . . . . 74.0 109.294 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -82.1 168.02 18.17 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.231 0.612 . . . . 73.22 110.707 175.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -107.39 123.42 48.35 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.845 0.858 . . . . 71.34 109.02 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.96 -69.97 0.12 Allowed Glycine 0 C--N 1.341 0.846 0 N-CA-C 111.658 -0.577 . . . . 61.32 111.658 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 173.71 76.39 0.05 OUTLIER Glycine 0 C--N 1.337 0.605 0 N-CA-C 110.719 -0.952 . . . . 71.03 110.719 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.524 HD13 ' HD3' ' A' ' 93' ' ' LYS . 71.0 mt -87.1 156.1 19.86 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.614 0.765 . . . . 70.45 110.929 -177.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.5 p -87.32 -14.6 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 123.98 0.912 . . . . 63.52 108.953 165.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.524 ' HD3' HD13 ' A' ' 91' ' ' LEU . 24.8 mtpp -65.78 158.83 73.13 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 125.578 1.551 . . . . 73.34 110.619 177.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.48 141.22 45.76 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 121.612 1.541 . . . . 70.42 110.76 171.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -80.8 3.66 21.7 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.497 0.719 . . . . 73.31 112.126 -174.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -63.79 169.69 3.93 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.653 0.781 . . . . 71.15 110.735 173.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.534 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 3.6 m-20 -81.08 119.4 23.5 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.53 -0.915 . . . . 75.23 108.53 -175.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -115.87 107.34 14.88 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 108.349 -0.982 . . . . 53.32 108.349 170.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.456 HG23 ' HG2' ' A' ' 82' ' ' LYS . 46.7 m -124.23 114.76 20.04 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 114.538 -1.21 . . . . 75.32 109.382 -172.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.544 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 32.0 tt0 -101.18 114.34 28.2 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 109.008 -0.738 . . . . 71.33 109.008 -176.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -96.95 119.95 36.38 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.109 -1.071 . . . . 75.45 108.109 171.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -123.02 141.61 51.77 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.239 0.615 . . . . 73.51 110.093 -177.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -158.68 132.52 4.99 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 109.16 -0.681 . . . . 72.44 109.16 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -65.2 -22.48 60.99 Favored 'Trans proline' 0 C--N 1.384 2.433 0 C-N-CA 123.054 2.503 . . . . 65.24 114.131 -173.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.548 ' HB2' HG12 ' A' ' 117' ' ' ILE . 13.6 m -92.39 -1.52 56.96 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.695 0.398 . . . . 65.02 111.839 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -104.72 98.37 8.12 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 107.132 -1.432 . . . . 75.0 107.132 175.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 110' ' ' GLN . 67.1 mt -125.45 166.44 16.61 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 121.663 0.744 . . . . 64.03 111.918 -177.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -58.0 115.91 3.17 Favored 'General case' 0 CA--C 1.556 1.209 0 CA-C-N 113.883 -1.508 . . . . 71.12 111.673 170.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.518 ' H ' ' HZ2' ' A' ' 25' ' ' TRP . . . 70.21 7.0 59.17 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 115.041 0.776 . . . . 50.32 115.041 174.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.428 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 16.4 mm100 -100.67 65.41 1.15 Allowed 'General case' 0 C--O 1.242 0.67 0 CA-C-O 121.466 0.65 . . . . 54.33 110.296 -175.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -57.29 -36.07 70.6 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 114.895 -1.048 . . . . 71.0 111.482 173.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 19.2 pm0 -68.45 -16.59 63.96 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.204 0.601 . . . . 74.03 111.93 -176.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 79.9 mt -96.49 -19.68 18.95 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.335 0.654 . . . . 71.51 111.555 176.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.1 mt -67.03 -37.42 84.08 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.069 0.547 . . . . 73.24 110.682 178.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -69.23 -13.85 62.63 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.647 -0.706 . . . . 61.53 112.278 175.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -97.36 4.75 50.62 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.115 0.566 . . . . 71.42 110.369 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.548 HG12 ' HB2' ' A' ' 105' ' ' CYS . 44.9 mt -89.68 119.2 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 108.049 -1.093 . . . . 74.01 108.049 173.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -95.58 132.43 40.73 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.83 0.852 . . . . 62.52 111.411 -165.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -109.03 -8.63 15.16 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.099 0.96 . . . . 73.5 111.386 173.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -98.8 167.97 10.42 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.241 0.616 . . . . 73.43 110.578 175.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . 0.27 9.2 p 39.79 69.4 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 126.24 1.816 . . . . 71.13 112.46 -172.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 15.3 t -166.42 -158.64 0.33 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 113.742 -1.572 . . . . 72.02 107.858 -172.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 78.4 p -72.56 73.24 1.03 Allowed 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 123.206 0.603 . . . . 61.31 111.22 176.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 17.5 t -89.28 67.24 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 107.808 -1.182 . . . . 63.14 107.808 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 72.0 m . . . . . 0 C--O 1.247 0.956 0 N-CA-C 107.354 -1.35 . . . . 62.34 107.354 178.8 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.485 1.287 0 N-CA-C 109.713 -0.477 . . . . 64.02 109.713 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 69.33 -103.48 1.1 Allowed Glycine 0 C--N 1.353 1.494 0 O-C-N 123.428 0.455 . . . . 74.15 112.115 -177.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.1 p80 -162.06 141.1 9.49 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.559 0.744 . . . . 60.4 109.847 173.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -155.3 81.15 1.05 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.388 -0.597 . . . . 74.13 109.388 176.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -130.23 83.91 2.16 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 107.431 -1.322 . . . . 73.21 107.431 177.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -107.99 128.87 55.03 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.585 0.754 . . . . 74.12 110.754 -178.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -146.97 162.32 38.99 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.741 1.216 . . . . 75.02 109.353 173.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -169.44 146.26 3.39 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.823 0.849 . . . . 52.24 109.667 174.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.8 m -77.31 96.75 4.67 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 123.659 0.6 . . . . 74.42 110.705 -173.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -74.11 123.25 24.07 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.289 -0.869 . . . . 71.55 109.805 -178.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -135.05 158.19 44.99 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.124 0.57 . . . . 72.13 110.922 -173.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.75 97.67 2.64 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.059 0.944 . . . . 62.32 108.835 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.99 148.57 44.77 Favored Glycine 0 C--N 1.353 1.5 0 CA-C-O 119.283 -0.732 . . . . 51.14 113.239 -175.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -79.62 175.85 10.18 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.969 2.446 . . . . 71.21 112.58 177.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.1 t -113.83 179.69 3.89 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.431 0.692 . . . . 53.21 109.491 177.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -66.09 -14.66 62.14 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 122.796 0.438 . . . . 73.2 111.541 178.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.443 HG13 ' HB2' ' A' ' 114' ' ' LEU . 54.9 t -57.12 117.69 19.55 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 124.846 1.258 . . . . 75.45 110.927 176.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -55.76 146.81 64.44 Favored 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 123.149 2.566 . . . . 61.1 112.733 176.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.56 -43.76 62.49 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 124.198 0.936 . . . . 71.12 111.674 177.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.418 ' HA ' ' HE1' ' A' ' 63' ' ' PHE . 86.9 t80 -50.05 -51.41 42.62 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.358 1.063 . . . . 73.22 112.307 174.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 98.1 mt -80.5 -34.43 35.74 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.474 0.484 . . . . 73.41 112.103 -169.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.6 t -69.89 -34.36 73.43 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 122.286 0.234 . . . . 64.34 110.992 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.411 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -68.11 -44.76 75.42 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 109.749 -0.463 . . . . 73.32 109.749 171.174 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.2 tp -60.01 -40.37 89.01 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.012 0.925 . . . . 72.54 111.686 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.473 ' HB2' HD11 ' A' ' 114' ' ' LEU . 91.0 t90 -54.9 -56.2 22.22 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.412 1.085 . . . . 74.02 111.56 177.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.6 m -60.66 -38.32 84.48 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.895 -1.048 . . . . 73.55 110.604 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.494 HD11 ' CG1' ' A' ' 58' ' ' VAL . 34.3 tp -64.9 -52.0 58.87 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.351 1.46 . . . . 74.41 113.057 -174.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.7 t -57.19 -33.43 43.16 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 C-N-CA 124.015 0.926 . . . . 71.4 112.047 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.5 t -96.92 -3.19 42.28 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.825 0.85 . . . . 60.12 112.125 -177.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.401 ' HB3' ' OG1' ' A' ' 33' ' ' THR . 37.2 t70 -76.93 128.97 80.12 Favored Pre-proline 0 N--CA 1.483 1.198 0 C-N-CA 123.419 0.688 . . . . 71.32 111.61 -170.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.37 -24.44 57.45 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 123.125 2.55 . . . . 75.04 113.5 -177.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -78.46 -29.34 46.82 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.618 0.367 . . . . 64.21 110.87 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.401 ' OG1' ' HB3' ' A' ' 30' ' ' ASP . 68.1 p -115.6 -5.35 12.19 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.369 0.877 . . . . 73.12 113.369 -172.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.492 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 2.8 p-10 -64.69 -21.4 66.73 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 118.664 0.666 . . . . 75.13 112.452 -172.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.29 -33.68 76.04 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.758 0.423 . . . . 72.44 111.337 174.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.591 HD22 ' HB2' ' A' ' 50' ' ' ASP . 43.3 mt -107.09 -12.92 15.3 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.565 0.746 . . . . 63.41 111.587 -175.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 34' ' ' ASP . 15.0 tt -156.77 108.81 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 CA-C-O 121.325 0.583 . . . . 74.23 110.495 175.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.437 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 23.5 p -133.62 145.96 50.48 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.678 0.391 . . . . 73.42 111.284 -172.134 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 18.4 p-90 -72.58 148.98 44.39 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.226 1.011 . . . . 74.03 111.194 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 25.3 p -70.94 153.1 94.89 Favored Pre-proline 0 CA--C 1.554 1.129 0 C-N-CA 123.19 0.596 . . . . 70.51 110.088 173.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -46.63 -31.9 10.96 Favored 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 123.333 2.688 . . . . 65.04 113.191 171.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.9 t -71.31 -60.47 2.21 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.514 -0.767 . . . . 70.54 109.517 170.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 103.53 19.45 12.26 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-N 115.513 -0.767 . . . . 65.53 113.706 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -101.64 6.6 42.07 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.58 0.752 . . . . 72.2 110.491 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.6 p -160.13 164.32 33.07 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 123.984 0.914 . . . . 53.2 109.431 -173.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 54.1 p90 -142.38 144.4 33.13 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.54 0.336 . . . . 74.43 111.176 178.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.47 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 59.3 m-70 -97.27 149.43 22.06 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.317 1.047 . . . . 74.33 108.813 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 98' ' ' ASP . 62.8 t -126.82 114.69 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.813 -0.81 . . . . 73.35 108.813 178.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -111.04 149.34 30.88 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.367 1.067 . . . . 73.14 110.227 -176.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.591 ' HB2' HD22 ' A' ' 36' ' ' LEU . 3.9 m-20 52.72 55.03 9.6 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 124.561 1.163 . . . . 71.44 110.061 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.534 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 78.3 mt-30 -55.3 -25.21 32.87 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 114.326 1.232 . . . . 52.21 114.326 -169.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.75 -44.56 56.33 Favored Glycine 0 CA--C 1.533 1.206 0 N-CA-C 111.923 -0.471 . . . . 65.34 111.923 173.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -70.5 -45.06 66.36 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.78 0.832 . . . . 74.31 109.853 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.434 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 69.2 t80 -48.44 -52.85 20.16 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.384 1.474 . . . . 74.32 111.689 173.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.488 ' HB2' ' HB2' ' A' ' 68' ' ' MET . . . -62.61 -33.3 74.73 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 116.336 -0.393 . . . . 44.33 111.693 178.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.1 tmtm? -73.38 -41.88 62.84 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 124.208 1.003 . . . . 54.53 113.244 -176.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.561 ' HG3' HG23 ' A' ' 58' ' ' VAL . 4.1 pt-20 -111.15 -39.63 4.69 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 113.583 0.957 . . . . 70.04 113.583 -172.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.561 HG23 ' HG3' ' A' ' 57' ' ' GLU . 66.3 t -80.28 -46.76 21.66 Favored 'Isoleucine or valine' 0 C--O 1.248 0.987 0 C-N-CA 123.725 0.81 . . . . 71.34 111.351 -168.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 54.9 mt -67.19 -41.7 35.73 Favored Pre-proline 0 CA--C 1.557 1.22 0 CA-C-O 118.326 -0.845 . . . . 74.32 112.757 -176.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.53 -17.58 53.34 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 121.941 1.761 . . . . 45.11 114.011 170.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -72.6 -57.88 3.79 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 117.858 0.299 . . . . 71.31 110.629 176.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.459 ' CD1' HD13 ' A' ' 27' ' ' LEU . 37.5 m-85 -86.26 -40.26 15.71 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 112.14 0.422 . . . . 74.14 112.14 -175.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.418 ' HE1' ' HA ' ' A' ' 20' ' ' PHE . 48.8 m-85 -106.98 -178.17 3.57 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.749 -0.834 . . . . 74.04 108.749 -178.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -119.17 54.58 0.97 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 122.436 1.113 . . . . 74.02 109.557 -176.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -170.7 171.7 6.1 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.673 1.589 . . . . 73.31 107.81 178.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -117.95 -24.48 7.07 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 122.29 -0.257 . . . . 65.22 111.071 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -63.53 125.93 25.84 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.345 0.658 . . . . 74.1 112.054 -173.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.534 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 25.3 ttt -86.68 -29.63 22.33 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.388 0.675 . . . . 70.13 111.646 -176.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.37 -34.45 70.7 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 122.799 0.439 . . . . 43.34 111.36 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.448 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 44.1 t -66.74 -45.31 79.05 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.275 1.03 . . . . 70.33 110.789 173.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -63.14 -46.86 85.25 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.442 1.097 . . . . 75.21 110.565 -176.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 80.5 t -60.99 -45.31 98.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.23 1.012 . . . . 63.22 110.947 174.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -62.52 -32.6 73.56 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.781 0.432 . . . . 73.34 111.318 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.461 ' HA ' ' HE2' ' A' ' 77' ' ' MET . 29.1 mm-40 -62.94 -51.71 65.84 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 109.903 -0.406 . . . . 74.3 109.903 172.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.9 mt -58.92 -38.0 77.95 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.859 0.864 . . . . 72.11 111.779 -177.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -59.13 -43.74 91.99 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.484 0.713 . . . . 73.12 111.075 175.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.461 ' HE2' ' HA ' ' A' ' 74' ' ' GLN . 43.6 mtm -67.29 -35.48 79.55 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.73 -0.668 . . . . 71.14 110.366 175.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -80.1 8.73 6.6 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 123.525 0.73 . . . . 63.15 110.917 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.29 4.82 87.8 Favored Glycine 0 C--N 1.351 1.41 0 N-CA-C 114.511 0.564 . . . . 51.51 114.511 169.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.55 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . 39.8 m-85 -74.09 141.27 45.67 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 108.939 -0.763 . . . . 74.12 108.939 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.499 ' HB3' ' HG2' ' A' ' 102' ' ' GLN . 32.7 ttm180 -101.6 129.07 47.63 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.774 0.43 . . . . 72.44 110.101 -173.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -71.92 111.54 7.26 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.897 1.279 . . . . 63.42 109.855 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.2 t -126.19 136.26 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 107.72 -1.215 . . . . 65.11 107.72 172.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 96.3 t -119.28 139.46 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.355 0.662 . . . . 74.14 109.322 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -117.01 -44.53 2.8 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.841 0.456 . . . . 74.54 110.704 -178.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.563 ' HA ' ' HE2' ' A' ' 93' ' ' LYS . 23.1 mm -67.35 132.94 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 110.168 -0.308 . . . . 62.52 110.168 173.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -114.09 130.8 56.56 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.285 1.034 . . . . 72.51 108.676 -177.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -96.34 141.12 30.04 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.642 0.377 . . . . 63.32 111.168 -174.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 139.77 -151.0 21.79 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 110.455 -1.058 . . . . 72.53 110.455 -177.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -94.73 62.26 1.64 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.6 -0.6 . . . . 41.34 111.6 175.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 96.5 mt -119.47 150.8 39.63 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.779 0.832 . . . . 62.0 109.913 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.37 71.67 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.105 0 CA-C-O 122.863 1.316 . . . . 44.54 110.912 -172.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.563 ' HE2' ' HA ' ' A' ' 86' ' ' ILE . 17.9 ptmt -166.22 156.98 11.38 Favored Pre-proline 0 CA--C 1.553 1.088 0 CA-C-N 114.168 -1.378 . . . . 73.11 108.13 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.569 ' HB2' ' HG2' ' A' ' 96' ' ' ARG . 35.1 Cg_endo -61.29 158.89 33.28 Favored 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 122.457 2.105 . . . . 60.22 113.209 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -95.62 4.06 53.44 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.093 -0.958 . . . . 73.24 111.647 -174.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.569 ' HG2' ' HB2' ' A' ' 94' ' ' PRO . 5.3 ptp180 -71.76 100.58 2.39 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.198 0.599 . . . . 74.21 109.832 174.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -40.43 123.13 1.73 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.056 0.943 . . . . 74.11 111.118 171.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 22.0 t70 -112.3 134.88 53.59 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.386 -0.598 . . . . 73.13 109.386 178.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 73.9 m -133.9 128.53 34.75 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.049 -0.723 . . . . 64.02 109.049 166.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 46' ' ' PHE . 33.7 tt0 -104.46 117.09 33.32 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.02 -1.104 . . . . 74.43 108.02 170.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.55 ' HB3' ' HB3' ' A' ' 80' ' ' PHE . 97.7 m-85 -95.85 120.01 35.36 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.668 -1.234 . . . . 75.13 107.668 173.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.499 ' HG2' ' HB3' ' A' ' 81' ' ' ARG . 13.3 pt20 -115.74 136.45 53.05 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 123.182 0.593 . . . . 73.23 110.06 -174.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 52.5 t60 -156.43 128.73 4.07 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 123.021 0.529 . . . . 72.51 109.764 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.36 -39.74 44.68 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 123.089 2.526 . . . . 64.33 112.647 -174.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.516 ' HB2' HG12 ' A' ' 117' ' ' ILE . 3.4 m -81.66 -4.18 55.49 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.313 0.645 . . . . 73.14 110.754 -175.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -99.07 106.9 19.17 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 108.04 -1.096 . . . . 74.33 108.04 176.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.568 ' HB2' ' HB3' ' A' ' 110' ' ' GLN . 74.4 mt -117.1 141.59 48.07 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.733 -0.84 . . . . 71.51 108.733 169.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -60.32 -30.5 69.54 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 124.414 1.071 . . . . 54.42 112.69 -170.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -130.03 39.42 1.82 Allowed Glycine 0 C--N 1.345 1.032 0 N-CA-C 111.697 -0.561 . . . . 73.04 111.697 -178.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.568 ' HB3' ' HB2' ' A' ' 107' ' ' LEU . 3.0 tp-100 -141.58 74.09 1.44 Allowed 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.338 -0.986 . . . . 70.1 108.338 178.114 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -65.31 -22.78 66.87 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 114.895 -1.048 . . . . 74.21 112.795 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -71.45 -16.97 62.4 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.874 0.47 . . . . 75.24 112.258 -178.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 53.7 mt -93.49 -7.13 45.24 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 112.071 0.397 . . . . 73.41 112.071 178.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.473 HD11 ' HB2' ' A' ' 25' ' ' TRP . 66.4 mt -71.07 -27.63 63.76 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.612 0.365 . . . . 61.34 111.368 177.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -76.29 -3.69 38.0 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 112.097 0.406 . . . . 73.15 112.097 176.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -101.43 -6.96 23.33 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.945 0.898 . . . . 61.24 109.893 174.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.516 HG12 ' HB2' ' A' ' 105' ' ' CYS . 54.4 mt -87.55 117.33 31.3 Favored 'Isoleucine or valine' 0 C--N 1.354 0.79 0 N-CA-C 107.684 -1.228 . . . . 62.23 107.684 173.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -106.58 140.26 39.74 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 109.347 -0.612 . . . . 63.33 109.347 -174.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -85.86 36.92 0.68 Allowed 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 121.682 0.753 . . . . 55.42 111.286 174.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -132.65 138.88 47.48 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 107.216 -1.401 . . . . 74.43 107.216 175.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.2 p -149.94 92.39 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 122.097 0.951 . . . . 74.31 109.269 -170.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.2 t -62.48 91.96 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 114.24 -1.345 . . . . 51.11 110.432 176.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 67.5 m -72.98 91.7 1.58 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.353 -0.839 . . . . 61.05 110.581 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.7 p -64.37 109.21 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 C-N-CA 124.234 1.014 . . . . 73.32 110.329 177.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.6 m . . . . . 0 C--O 1.254 1.32 0 C-N-CA 123.983 0.913 . . . . 64.51 109.813 -170.941 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptm . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 110.135 -0.321 . . . . 75.33 110.135 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.5 -28.68 3.03 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 115.823 1.089 . . . . 74.3 115.823 169.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -72.89 -22.14 60.8 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 117.426 0.613 . . . . 74.41 111.939 -172.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -86.18 31.69 0.64 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.468 0.707 . . . . 43.54 111.083 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -52.31 -35.73 51.4 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.746 1.618 . . . . 73.25 112.035 -173.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -128.27 80.44 1.96 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.498 1.119 . . . . 70.1 109.012 168.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -126.97 101.46 6.57 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 124.262 1.025 . . . . 61.45 108.444 171.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 68.4 t60 -74.51 92.29 2.35 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 109.233 -0.654 . . . . 63.51 109.233 173.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.3 t -88.05 -89.69 0.13 Allowed 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 106.421 -1.696 . . . . 75.51 106.421 167.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 27.0 m80 -157.07 143.41 18.07 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.545 1.138 . . . . 75.34 108.863 170.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 81.2 mtp -84.09 151.47 24.91 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 108.948 -0.76 . . . . 74.2 108.948 171.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.68 108.37 0.83 Allowed 'General case' 0 CA--C 1.545 0.751 0 O-C-N 124.173 0.92 . . . . 72.0 111.482 -177.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -164.75 63.77 0.23 Allowed Glycine 0 CA--C 1.533 1.211 0 N-CA-C 111.038 -0.825 . . . . 32.14 111.038 177.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -81.9 -1.0 10.65 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 123.04 2.494 . . . . 54.03 113.556 -173.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.4 p 53.25 -86.66 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 125.697 1.599 . . . . 64.34 112.172 -173.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.23 39.41 7.45 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.202 1.001 . . . . 61.35 110.248 -177.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 57.2 t -65.94 126.42 91.78 Favored Pre-proline 0 CA--C 1.548 0.897 0 CA-C-N 114.665 -1.152 . . . . 71.12 109.136 170.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -50.26 133.63 36.45 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.886 2.391 . . . . 61.41 111.868 168.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.42 -38.41 59.03 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.62 1.168 . . . . 45.15 112.031 -178.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -52.14 -49.22 64.16 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 124.166 0.916 . . . . 71.33 111.638 174.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.439 HD13 ' HB ' ' A' ' 117' ' ' ILE . 95.2 mt -77.41 -43.14 33.62 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.259 0.624 . . . . 73.32 112.026 -170.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.0 t -64.35 -41.33 96.81 Favored 'General case' 0 CA--C 1.551 1.017 0 O-C-N 123.22 0.325 . . . . 74.25 110.71 -178.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -77.38 -27.1 52.41 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.9 0.48 . . . . 75.11 111.114 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.485 ' O ' HG23 ' A' ' 28' ' ' VAL . 60.7 tp -59.16 -50.35 74.39 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.566 0.541 . . . . 75.33 111.078 172.055 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.424 ' HH2' ' HG3' ' A' ' 108' ' ' ARG . 34.7 t-105 -63.52 -40.7 97.73 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-N 117.777 0.262 . . . . 74.31 111.405 177.087 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.6 m -57.34 -37.08 72.01 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-O 121.579 0.704 . . . . 60.54 110.402 176.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.518 HD11 HG13 ' A' ' 58' ' ' VAL . 35.3 tp -70.58 -45.46 65.35 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.358 1.463 . . . . 65.21 112.31 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 24' ' ' LEU . 91.8 t -62.02 -35.34 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 123.437 0.695 . . . . 72.4 111.066 177.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.6 t -90.22 -0.09 57.45 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.944 0.898 . . . . 64.35 111.809 -177.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -84.36 127.11 67.49 Favored Pre-proline 0 N--CA 1.483 1.191 0 C-N-CA 123.036 0.534 . . . . 43.24 110.47 -178.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.67 -20.62 17.5 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.743 2.295 . . . . 41.44 113.306 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -81.54 -22.82 37.61 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.128 0.571 . . . . 64.05 111.42 -176.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.7 p -111.88 6.73 19.73 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.353 0.661 . . . . 62.51 112.258 177.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.423 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 0.6 OUTLIER -59.51 -29.75 68.09 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.041 0.537 . . . . 61.02 111.914 -174.357 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.69 -28.66 70.09 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.825 0.85 . . . . 72.32 112.181 -177.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.462 HD22 ' HB2' ' A' ' 50' ' ' ASP . 87.9 mt -116.21 -9.96 11.53 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.245 0.618 . . . . 75.12 111.702 -177.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 34' ' ' ASP . 17.3 tt -160.43 118.91 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 121.312 0.577 . . . . 74.42 110.837 171.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.4 p -148.69 151.78 35.51 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.568 0.747 . . . . 72.0 109.502 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 7.7 p-90 -70.13 152.46 44.28 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.29 0.636 . . . . 73.33 110.213 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.5 m -71.71 154.3 93.05 Favored Pre-proline 0 CA--C 1.561 1.389 0 C-N-CA 123.818 0.847 . . . . 74.13 110.097 173.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -40.08 -46.67 4.03 Favored 'Trans proline' 0 C--N 1.389 2.663 0 C-N-CA 124.403 3.402 . . . . 75.52 114.994 -175.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 30.5 t -80.21 -41.27 25.52 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 122.697 0.399 . . . . 72.54 110.331 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.82 28.21 7.96 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-N 116.04 -0.527 . . . . 71.23 113.186 176.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -82.54 -10.69 58.88 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.582 0.753 . . . . 73.31 110.776 174.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.457 ' HB3' ' HB3' ' A' ' 102' ' ' GLN . 68.2 p -155.72 -176.79 6.13 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 123.741 0.816 . . . . 74.31 110.135 -177.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -141.95 145.97 35.11 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.376 0.671 . . . . 72.11 110.191 175.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 54.1 m-70 -97.64 147.66 24.09 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.059 0.944 . . . . 63.11 108.844 176.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 95.1 t -125.08 123.11 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.689 1.196 . . . . 72.43 108.095 175.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.459 ' HB2' ' HA ' ' A' ' 36' ' ' LEU . 97.0 m-85 -110.35 147.34 34.13 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.675 0.79 . . . . 54.13 110.867 -177.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.462 ' HB2' HD22 ' A' ' 36' ' ' LEU . 6.4 m-20 50.52 68.32 0.79 Allowed 'General case' 0 CA--C 1.541 0.62 0 O-C-N 124.922 1.389 . . . . 71.23 111.812 174.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -47.81 -32.81 6.48 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.729 1.211 . . . . 75.22 114.036 -173.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.4 -44.86 50.23 Favored Glycine 0 CA--C 1.531 1.07 0 O-C-N 123.397 0.435 . . . . 65.31 112.706 176.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -74.04 -44.92 52.61 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.554 0.741 . . . . 72.22 110.182 -176.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.404 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 69.1 t80 -49.56 -50.93 40.26 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.482 1.513 . . . . 74.22 111.209 169.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.498 ' HB2' ' HB2' ' A' ' 68' ' ' MET . . . -62.09 -35.52 78.92 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 116.196 -0.456 . . . . 53.34 111.872 178.334 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -68.33 -46.82 69.15 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.27 1.028 . . . . 64.32 112.642 -175.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.452 ' HG3' HG23 ' A' ' 58' ' ' VAL . 11.9 pt-20 -115.16 -34.84 4.88 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 114.175 1.176 . . . . 72.3 114.175 -171.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.518 HG13 HD11 ' A' ' 27' ' ' LEU . 92.2 t -82.23 -42.27 18.62 Favored 'Isoleucine or valine' 0 C--O 1.247 0.929 0 C-N-CA 123.24 0.616 . . . . 70.4 110.987 -169.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 43.4 mt -66.02 -48.77 59.74 Favored Pre-proline 0 CA--C 1.558 1.272 0 CA-C-O 117.915 -1.041 . . . . 65.4 112.363 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -67.63 -13.95 40.49 Favored 'Trans proline' 0 C--N 1.384 2.432 0 CA-C-N 121.934 1.726 . . . . 45.31 113.046 175.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -72.64 -59.03 2.92 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.102 0.561 . . . . 74.2 110.119 176.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.475 ' CD1' HD13 ' A' ' 27' ' ' LEU . 37.2 m-85 -89.73 -47.99 7.56 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 112.405 0.521 . . . . 74.41 112.405 -179.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -93.82 -177.92 4.51 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 108.498 -0.927 . . . . 73.35 108.498 -178.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -116.93 43.79 2.2 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.778 -0.576 . . . . 74.11 110.159 -173.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 26.9 p80 -165.3 164.0 19.94 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.384 1.074 . . . . 73.41 108.832 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.477 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 1.5 m-20 -117.38 -12.71 10.42 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.007 0.523 . . . . 62.41 110.39 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -71.13 122.03 19.38 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.524 0.729 . . . . 72.13 109.738 178.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.498 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 22.8 ttt -90.92 -18.66 24.36 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.665 0.386 . . . . 75.02 111.472 -175.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.06 -37.61 72.07 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.848 0.459 . . . . 55.11 110.705 173.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.7 t -65.02 -44.04 90.48 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.446 1.098 . . . . 61.51 110.863 174.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -64.49 -53.24 51.26 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.351 1.06 . . . . 52.3 111.005 -175.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 66.7 t -63.05 -40.78 90.36 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 123.639 0.776 . . . . 75.12 111.317 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 -57.96 -38.64 76.37 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.13 0.572 . . . . 75.35 111.563 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -60.9 -49.67 76.51 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 123.789 0.681 . . . . 74.41 110.574 175.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 78.3 mt -61.22 -40.5 94.22 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.794 0.838 . . . . 75.34 111.618 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -57.75 -42.43 83.97 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.954 0.902 . . . . 74.23 111.454 175.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 70.8 mtm -74.59 -31.02 61.91 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.569 -0.741 . . . . 73.22 110.96 177.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -82.54 7.02 15.64 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.764 0.825 . . . . 62.25 110.857 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.1 10.37 82.8 Favored Glycine 0 C--N 1.347 1.181 0 N-CA-C 115.026 0.77 . . . . 61.34 115.026 168.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -71.98 138.49 48.03 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 117.638 0.719 . . . . 72.35 110.763 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 35.4 ttm-85 -100.45 122.53 43.33 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.927 -0.768 . . . . 74.12 108.927 -177.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.523 ' HE3' HG23 ' A' ' 99' ' ' THR . 1.3 tmtp? -78.92 123.24 27.07 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.777 1.231 . . . . 71.51 108.898 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 89.7 t -133.4 117.06 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.639 1.176 . . . . 74.24 108.058 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.6 p -102.92 126.21 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 109.118 -0.697 . . . . 54.15 109.118 -176.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -100.63 -37.25 8.84 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.254 0.622 . . . . 74.03 110.626 -174.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.577 HG23 ' HB3' ' A' ' 93' ' ' LYS . 45.6 mm -74.81 86.86 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 107.327 -1.36 . . . . 73.12 107.327 166.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.558 ' HB2' ' HE3' ' A' ' 93' ' ' LYS . 32.4 mt-10 -61.68 101.33 0.18 Allowed 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.026 -0.988 . . . . 74.34 110.653 -174.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -66.41 128.87 37.84 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 114.579 -1.191 . . . . 51.22 112.145 -169.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.36 -148.0 13.73 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-N 115.207 -0.906 . . . . 44.41 111.416 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -99.03 25.12 29.48 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 112.008 -0.437 . . . . 72.32 112.008 175.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 81.2 mt -77.69 173.95 11.5 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.99 0.916 . . . . 74.41 110.761 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.7 p -76.82 9.0 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.569 0 C-N-CA 123.849 0.86 . . . . 63.22 112.058 -178.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.577 ' HB3' HG23 ' A' ' 86' ' ' ILE . 74.4 mmtt -58.02 150.74 48.94 Favored Pre-proline 0 N--CA 1.483 1.193 0 C-N-CA 124.301 1.041 . . . . 72.43 110.923 173.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.419 ' HD2' HD12 ' A' ' 86' ' ' ILE . 73.5 Cg_endo -72.13 146.87 47.23 Favored 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 122.293 1.995 . . . . 54.41 110.003 169.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -84.64 68.58 10.42 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 122.584 1.183 . . . . 62.51 110.677 -177.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -134.85 157.13 47.59 Favored 'General case' 0 C--O 1.246 0.88 0 CA-C-N 114.187 -1.369 . . . . 74.14 107.849 167.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 5.1 m-20 -80.82 142.99 33.14 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.798 -0.815 . . . . 73.23 108.798 -179.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -135.67 122.67 21.39 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.343 -0.984 . . . . 75.45 108.343 167.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.523 HG23 ' HE3' ' A' ' 82' ' ' LYS . 24.1 m -136.9 114.08 10.72 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 109.236 -0.653 . . . . 51.44 109.236 177.289 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -103.91 111.88 24.61 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.857 -0.794 . . . . 65.41 108.857 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -97.26 129.29 44.59 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 109.072 -0.714 . . . . 63.23 109.072 175.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.457 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 19.3 pt20 -123.71 150.06 44.78 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.907 0.883 . . . . 72.12 109.533 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -156.68 135.55 7.8 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 108.357 -0.979 . . . . 71.32 108.357 175.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -59.82 -31.16 93.52 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.744 2.296 . . . . 75.03 112.823 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.503 ' HB2' HG12 ' A' ' 117' ' ' ILE . 5.2 m -92.1 7.75 40.98 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 122.953 0.501 . . . . 44.31 111.415 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -123.79 101.45 7.28 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 108.297 -1.001 . . . . 75.42 108.297 174.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 52.8 mt -126.27 174.17 8.75 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.49 0.716 . . . . 72.11 109.359 173.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.424 ' HG3' ' HH2' ' A' ' 25' ' ' TRP . 71.5 ttt180 -76.35 109.27 9.92 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.696 1.198 . . . . 72.52 110.84 -177.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.18 35.44 30.22 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 111.578 -0.609 . . . . 63.24 111.578 -177.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -132.88 42.67 3.05 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.205 -1.035 . . . . 64.33 108.205 -171.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.622 ' HA ' ' HG ' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -67.51 -21.18 65.5 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 114.134 -1.393 . . . . 72.55 112.531 -176.966 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.6 pm0 -72.16 -13.3 61.52 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.943 0.497 . . . . 65.42 111.713 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 31.9 mt -94.34 -7.4 41.86 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 112.236 0.458 . . . . 72.04 112.236 173.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.622 ' HG ' ' HA ' ' A' ' 111' ' ' GLU . 44.7 mt -72.12 -27.8 62.86 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 118.006 0.367 . . . . 74.14 111.63 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -65.34 -19.25 65.87 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.16 0.584 . . . . 73.02 111.466 173.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -93.77 -10.85 32.81 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.327 0.651 . . . . 75.21 110.209 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.503 HG12 ' HB2' ' A' ' 105' ' ' CYS . 43.2 mt -84.86 124.83 40.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 108.051 -1.092 . . . . 73.41 108.051 177.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.452 ' HD2' ' HB2' ' A' ' 123' ' ' SER . 74.4 mmtt -126.75 145.98 50.4 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.429 0.691 . . . . 74.4 109.711 -173.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -92.68 -16.49 25.46 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.395 -0.82 . . . . 73.3 109.236 169.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.422 ' HB3' ' HE2' ' A' ' 120' ' ' LYS . 11.2 ptpt -179.22 -171.31 0.2 Allowed 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 127.218 2.207 . . . . 73.31 108.078 170.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.0 t -56.76 -47.95 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-N 118.466 0.575 . . . . 74.4 110.327 178.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.5 t -79.46 96.23 6.02 Favored 'General case' 0 CA--C 1.557 1.218 0 CA-C-O 121.443 0.64 . . . . 54.34 109.714 172.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.452 ' HB2' ' HD2' ' A' ' 118' ' ' LYS . 54.7 m -144.24 77.91 1.56 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.683 0.793 . . . . 75.54 109.956 176.106 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 40.4 t -125.3 153.15 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.329 1.452 . . . . 72.12 107.447 176.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 CA--C 1.556 1.181 0 C-N-CA 123.353 0.661 . . . . 52.33 110.54 177.72 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.9 ptp . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 121.356 0.598 . . . . 74.54 110.375 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.78 49.16 44.55 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 115.914 -0.584 . . . . 71.24 112.062 -176.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.2 t60 -80.87 98.78 8.0 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.544 0.737 . . . . 75.11 109.012 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -73.23 129.17 37.45 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.142 -0.688 . . . . 62.0 109.142 176.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 35.2 m-70 -92.49 144.2 25.59 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.814 0.846 . . . . 61.51 109.5 -178.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -69.94 117.81 12.0 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.755 0.822 . . . . 53.42 109.675 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -76.59 87.68 3.28 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-O 121.915 0.864 . . . . 55.13 111.277 -175.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -96.41 2.72 52.89 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.786 0.834 . . . . 74.14 110.163 174.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.6 p -77.7 85.27 4.02 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.659 1.184 . . . . 71.23 111.033 -177.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -82.54 -34.89 27.69 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.635 -0.711 . . . . 71.54 109.82 175.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 65.0 mtm 69.8 -67.13 0.24 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 125.889 1.676 . . . . 65.34 111.38 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.02 159.3 1.83 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.529 1.132 . . . . 50.32 112.295 176.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -155.48 -171.76 22.37 Favored Glycine 0 C--O 1.242 0.654 0 CA-C-N 115.981 -0.554 . . . . 43.14 113.134 -177.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.01 178.43 5.35 Favored 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 123.454 2.77 . . . . 73.14 112.361 176.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 44.3 t -60.43 154.97 19.26 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.618 0.767 . . . . 72.54 110.609 176.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.428 ' HB2' ' HB2' ' A' ' 115' ' ' GLU . 36.3 m-80 -93.62 -1.1 55.78 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.745 0.418 . . . . 74.41 111.446 -176.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 70.7 t -57.05 117.03 15.33 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 124.204 1.002 . . . . 71.14 111.246 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -59.15 139.4 90.25 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 122.937 2.425 . . . . 72.13 112.039 173.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.7 -39.76 71.47 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.22 1.008 . . . . 52.44 112.294 -178.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -53.79 -45.86 70.85 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.109 0.564 . . . . 73.53 111.293 174.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 79.9 mt -76.32 -34.75 59.01 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 119.051 -0.5 . . . . 74.21 112.31 -172.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.6 t -71.13 -35.25 71.66 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 118.069 0.395 . . . . 73.12 110.369 177.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.551 ' HE2' ' HA ' ' A' ' 23' ' ' LYS . 8.3 mmpt? -70.63 -42.35 71.02 Favored 'General case' 0 C--N 1.353 0.751 0 C-N-CA 122.813 0.445 . . . . 71.43 110.678 176.154 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 28' ' ' VAL . 67.4 tp -59.94 -49.2 78.61 Favored 'General case' 0 N--CA 1.478 0.962 0 O-C-N 124.183 0.927 . . . . 71.22 111.172 175.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 90.8 t90 -53.99 -51.04 65.19 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.806 1.243 . . . . 75.4 111.182 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 64.2 m -64.92 -36.45 84.4 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.144 0.978 . . . . 72.21 111.512 177.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.408 ' HG ' HD13 ' A' ' 37' ' ' ILE . 32.2 tp -62.97 -51.04 68.4 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.673 1.189 . . . . 72.13 111.646 -178.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 24' ' ' LEU . 87.6 t -58.85 -35.69 57.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 124.609 1.164 . . . . 45.02 111.198 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 83.2 p -92.36 1.94 56.94 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.308 -0.86 . . . . 73.21 112.534 -174.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -89.98 134.2 32.27 Favored Pre-proline 0 CA--C 1.557 1.245 0 C-N-CA 123.035 0.534 . . . . 74.1 111.581 -174.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.78 -33.86 26.07 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 123.228 2.618 . . . . 73.13 114.236 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -70.54 -35.95 73.4 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.114 0.566 . . . . 52.44 110.916 -176.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.0 p -98.98 -0.02 42.96 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.776 -0.647 . . . . 71.11 111.208 -177.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -55.42 -32.4 62.67 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.54 1.136 . . . . 41.21 112.337 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.9 -36.52 83.65 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.455 0.702 . . . . 64.32 112.15 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.425 HD22 ' HB2' ' A' ' 50' ' ' ASP . 85.0 mt -109.07 -8.24 15.21 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.204 0.602 . . . . 74.25 111.48 -175.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.408 HD13 ' HG ' ' A' ' 27' ' ' LEU . 18.6 tt -160.56 118.3 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.037 0.535 . . . . 75.33 110.457 174.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 12.7 p -137.41 146.74 44.78 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.525 0.73 . . . . 33.43 109.75 -176.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 25.2 p-90 -71.24 147.37 48.29 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.013 0.525 . . . . 74.52 110.888 177.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.1 m -79.74 151.21 73.75 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 108.902 -0.777 . . . . 53.32 108.902 173.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.83 -19.59 55.17 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.674 2.249 . . . . 65.51 113.618 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 64.0 m -66.61 -35.64 80.67 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.146 0.578 . . . . 42.25 111.112 172.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.04 -2.69 74.3 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 115.784 -0.643 . . . . 25.24 113.877 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -97.55 3.26 50.63 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.116 0.966 . . . . 54.24 110.022 -179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.3 p -158.03 169.56 24.28 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 123.806 0.842 . . . . 74.21 110.397 -170.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -150.33 153.38 35.98 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.909 0.884 . . . . 65.53 110.233 176.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -101.8 144.46 30.44 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.945 0.898 . . . . 71.25 109.277 176.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 97.8 t -122.75 120.86 61.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 124.928 1.291 . . . . 74.44 107.612 177.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 91.1 m-85 -106.01 146.84 29.57 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 123.905 0.882 . . . . 75.3 109.854 -176.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.425 ' HB2' HD22 ' A' ' 36' ' ' LEU . 15.4 m-20 52.36 65.24 1.56 Allowed 'General case' 0 C--N 1.353 0.73 0 O-C-N 124.911 1.382 . . . . 45.1 111.613 171.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.404 ' HB3' ' HG2' ' A' ' 68' ' ' MET . 22.2 mt-30 -52.72 -28.54 22.47 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 113.096 0.776 . . . . 73.3 113.096 -173.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -67.84 -48.34 55.61 Favored Glycine 0 C--N 1.344 0.997 0 O-C-N 123.343 0.402 . . . . 61.34 112.155 176.142 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -73.18 -45.53 55.93 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.31 0.644 . . . . 63.1 110.278 -178.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -54.04 -51.17 64.9 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.638 1.575 . . . . 71.44 111.574 176.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.532 ' HB2' ' HB2' ' A' ' 68' ' ' MET . . . -67.41 -29.73 69.3 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.307 0.484 . . . . 63.14 112.307 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -72.06 -43.21 65.25 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.971 0.909 . . . . 70.44 111.97 -177.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.553 ' HG3' HG23 ' A' ' 58' ' ' VAL . 7.0 pt-20 -109.02 -45.73 3.73 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 113.182 0.808 . . . . 75.21 113.182 -176.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.553 HG23 ' HG3' ' A' ' 57' ' ' GLU . 95.8 t -77.03 -42.3 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.42 0.688 . . . . 72.23 111.674 -167.077 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.2 mt -64.75 -49.49 69.16 Favored Pre-proline 0 CA--C 1.557 1.219 0 CA-C-O 117.946 -1.026 . . . . 61.45 112.384 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.93 -7.27 21.03 Favored 'Trans proline' 0 C--N 1.388 2.619 0 CA-C-N 121.743 1.658 . . . . 70.2 112.846 174.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -79.95 -66.63 0.85 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.112 0.565 . . . . 73.03 110.81 174.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -79.0 -40.15 32.26 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.257 0.623 . . . . 74.34 111.53 -176.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -105.06 -169.89 1.67 Allowed 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 108.138 -1.06 . . . . 61.11 108.138 178.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -126.32 45.26 2.69 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.513 0.673 . . . . 74.53 110.337 -174.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 -159.16 161.78 36.29 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 115.109 -0.951 . . . . 74.22 108.973 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.502 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 1.6 m-20 -114.16 -19.8 11.19 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.568 0.347 . . . . 63.32 111.598 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -71.31 114.15 9.09 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.414 0.286 . . . . 74.13 111.062 -173.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.532 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 13.9 tpt -65.82 -37.55 86.54 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.255 1.022 . . . . 75.42 111.353 -177.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.17 -35.03 72.84 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.148 0.579 . . . . 62.21 111.168 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.482 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 45.1 t -68.44 -38.73 81.42 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.588 0.755 . . . . 73.03 111.004 176.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -65.29 -50.91 63.92 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.117 0.967 . . . . 71.11 110.627 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.5 t -63.41 -36.36 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.444 0.698 . . . . 63.0 110.059 177.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.9 ttp180 -57.46 -41.54 80.77 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.987 0.915 . . . . 75.34 110.605 175.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.545 ' HA ' ' HE2' ' A' ' 77' ' ' MET . 26.3 mm-40 -61.89 -47.34 85.44 Favored 'General case' 0 C--N 1.357 0.912 0 N-CA-C 109.644 -0.502 . . . . 73.04 109.644 177.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.422 ' HB3' ' HB2' ' A' ' 80' ' ' PHE . 89.6 mt -61.91 -38.26 87.73 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.618 0.767 . . . . 75.1 111.106 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -58.55 -39.87 81.46 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.95 0.9 . . . . 75.5 110.537 174.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.545 ' HE2' ' HA ' ' A' ' 74' ' ' GLN . 48.6 mtm -66.21 -41.7 89.77 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.715 0.406 . . . . 51.43 110.351 174.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -80.97 2.84 25.16 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.61 0.764 . . . . 74.14 111.614 -174.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.62 19.76 61.25 Favored Glycine 0 C--N 1.346 1.094 0 N-CA-C 114.761 0.664 . . . . 62.13 114.761 171.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.422 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 42.0 m-85 -78.15 145.4 35.69 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.123 -0.695 . . . . 74.51 109.123 176.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -99.46 123.43 43.73 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.682 0.793 . . . . 70.44 109.035 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -75.62 110.7 10.24 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.031 1.332 . . . . 70.55 109.278 177.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.6 t -123.19 132.65 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 108.407 -0.96 . . . . 50.42 108.407 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 85.6 t -125.83 121.37 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.121 0.968 . . . . 74.0 108.57 175.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -94.97 -15.88 23.2 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.122 0.569 . . . . 75.35 111.343 -177.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.462 HG12 ' HB3' ' A' ' 98' ' ' ASP . 41.7 mm -69.84 109.71 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 122.918 0.487 . . . . 74.04 110.231 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -125.28 99.15 5.94 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.175 0.99 . . . . 74.53 108.56 172.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -80.82 93.6 6.28 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.891 0.876 . . . . 72.54 109.379 -177.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -153.38 -25.14 0.04 OUTLIER Glycine 0 C--N 1.346 1.136 0 CA-C-N 115.623 -0.717 . . . . 74.41 113.282 -175.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 162.89 20.53 0.02 OUTLIER Glycine 0 N--CA 1.475 1.247 0 CA-C-N 117.074 0.437 . . . . 71.54 113.712 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 76.1 mt -99.87 153.12 19.41 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.995 0.918 . . . . 75.3 110.189 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.82 69.38 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.172 0 CA-C-O 122.93 1.348 . . . . 73.31 109.672 176.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.457 ' HE3' HD13 ' A' ' 86' ' ' ILE . 25.1 mtpp -124.87 144.06 45.69 Favored Pre-proline 0 C--O 1.244 0.768 0 CA-C-N 114.378 -1.283 . . . . 72.02 108.466 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.74 148.28 71.18 Favored 'Trans proline' 0 C--N 1.372 1.798 0 C-N-CA 122.629 2.219 . . . . 62.35 111.504 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -83.17 65.98 8.49 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 122.411 1.101 . . . . 73.52 110.503 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -135.07 -178.47 5.11 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.474 -1.239 . . . . 64.34 108.513 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 4.1 m-20 -84.31 141.41 30.94 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.612 -0.514 . . . . 71.54 109.612 175.009 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.462 ' HB3' HG12 ' A' ' 86' ' ' ILE . 22.5 t70 -140.9 106.87 5.16 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.957 -1.127 . . . . 74.15 107.957 169.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 77.4 m -122.57 117.25 25.43 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.377 0.671 . . . . 53.04 110.486 -178.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -99.46 106.27 18.29 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.842 -0.799 . . . . 72.51 108.842 -177.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -95.14 122.09 37.45 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.919 -0.771 . . . . 73.45 108.919 176.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -122.63 144.35 49.18 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.939 0.896 . . . . 54.13 110.803 -174.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 65.1 t60 -159.06 131.24 4.25 Favored Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 123.741 0.816 . . . . 74.2 109.757 176.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.35 -31.49 62.41 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 123.156 2.57 . . . . 54.22 114.118 -174.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 82.0 m -94.0 8.42 41.46 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 122.384 0.274 . . . . 72.44 111.438 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -109.02 100.38 9.58 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.823 -1.177 . . . . 65.21 107.823 173.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.408 ' HB2' ' HB2' ' A' ' 110' ' ' GLN . 80.0 mt -118.35 132.41 56.27 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.306 0.642 . . . . 62.51 109.501 175.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -66.97 114.26 5.63 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 107.895 -1.15 . . . . 73.12 107.895 174.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 106.89 -12.86 41.64 Favored Glycine 0 N--CA 1.472 1.04 0 CA-C-O 119.944 -0.365 . . . . 64.45 113.083 -177.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.408 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 15.6 mm-40 -107.98 79.44 1.27 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 117.374 0.587 . . . . 73.41 110.305 176.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -59.44 -32.96 70.7 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.307 1.043 . . . . 73.2 112.563 175.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.9 pm0 -67.32 -26.12 66.35 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.433 0.693 . . . . 72.14 112.255 -177.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 76.8 mt -86.39 -6.76 58.86 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 122.122 -0.362 . . . . 72.42 111.571 -175.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 75.8 mt -65.37 -33.84 76.92 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.087 0.555 . . . . 71.24 111.135 175.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 16' ' ' ASN . 12.0 pt-20 -82.44 -1.54 50.49 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.509 0.324 . . . . 74.24 111.78 176.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -92.4 -15.22 27.52 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.457 0.703 . . . . 73.1 109.407 172.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 55.2 mt -82.0 114.27 22.64 Favored 'Isoleucine or valine' 0 C--N 1.355 0.812 0 N-CA-C 108.269 -1.011 . . . . 72.53 108.269 176.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -103.48 137.43 41.57 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.1 -0.704 . . . . 75.21 109.1 -176.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 14.3 ptt-85 -99.16 -61.55 1.35 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.626 0.37 . . . . 65.5 110.911 176.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -157.17 178.08 10.75 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.253 1.421 . . . . 73.52 109.045 -169.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.9 p -64.04 -30.68 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 122.745 0.418 . . . . 70.21 110.106 172.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.4 p -72.76 79.78 1.12 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.074 0.95 . . . . 75.51 110.029 175.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.5 t -173.44 -176.7 1.35 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.719 1.208 . . . . 51.25 108.459 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.5 p -64.4 104.17 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.342 0 C-N-CA 123.35 0.66 . . . . 64.14 110.363 174.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 14.9 t . . . . . 0 C--O 1.253 1.272 0 N-CA-C 108.496 -0.928 . . . . 72.41 108.496 -175.736 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.3 mtp . . . . . 0 N--CA 1.486 1.373 0 N-CA-C 109.892 -0.41 . . . . 74.13 109.892 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.87 -147.18 47.73 Favored Glycine 0 C--N 1.352 1.46 0 O-C-N 123.739 0.649 . . . . 73.31 112.123 -176.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.3 m80 -131.08 128.57 40.48 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 107.882 -1.155 . . . . 72.02 107.882 173.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -63.14 114.16 3.58 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 123.651 0.594 . . . . 74.21 110.13 -178.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.4 m170 -76.61 131.22 38.77 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 115.631 -0.713 . . . . 75.43 111.016 -173.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -148.52 138.78 22.52 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.025 0.93 . . . . 71.02 109.716 -175.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 63.47 83.59 0.16 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.463 1.105 . . . . 75.23 111.442 171.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -91.42 104.58 17.08 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.469 0.708 . . . . 61.44 109.095 173.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.6 t -83.32 90.28 7.12 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.126 0.489 . . . . 73.52 110.326 -177.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -105.16 -7.65 18.91 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.697 0.799 . . . . 72.13 110.107 172.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 27.6 ttt -68.78 94.7 0.62 Allowed 'General case' 0 C--N 1.354 0.804 0 CA-C-O 121.193 0.521 . . . . 63.43 109.611 175.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -88.31 40.37 0.95 Allowed 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.355 -0.839 . . . . 71.05 110.677 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.37 -66.96 2.11 Favored Glycine 0 C--N 1.353 1.477 0 N-CA-C 110.292 -1.123 . . . . 61.22 110.292 172.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.39 112.67 2.78 Favored 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 122.183 1.922 . . . . 64.44 109.167 160.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 55.5 p -58.17 -57.46 12.77 Favored 'General case' 0 C--O 1.246 0.875 0 C-N-CA 123.344 0.658 . . . . 71.32 111.048 -175.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 59.52 50.78 7.09 Favored 'General case' 0 C--N 1.354 0.788 0 CA-C-N 114.297 -1.32 . . . . 65.34 109.674 178.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 66.2 t -67.38 110.17 4.83 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 114.491 -1.231 . . . . 71.04 107.894 169.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.535 ' HD2' HD12 ' A' ' 21' ' ' LEU . 50.8 Cg_exo -55.88 142.3 84.44 Favored 'Trans proline' 0 C--N 1.368 1.588 0 C-N-CA 122.346 2.031 . . . . 53.01 111.856 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.92 -36.93 40.98 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.185 0.928 . . . . 45.43 111.081 175.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -55.41 -47.36 76.02 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.901 0.88 . . . . 74.13 112.028 174.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.535 HD12 ' HD2' ' A' ' 18' ' ' PRO . 55.7 mt -77.88 -35.31 50.97 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.682 0.393 . . . . 72.2 111.932 -172.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.4 t -72.11 -36.03 69.34 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 117.48 0.127 . . . . 75.43 110.962 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.573 ' HB3' ' HB3' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -69.01 -42.49 76.37 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 122.733 0.413 . . . . 72.42 109.964 173.672 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.46 ' O ' HG23 ' A' ' 28' ' ' VAL . 63.6 tp -59.46 -40.12 85.84 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.976 0.911 . . . . 63.02 111.251 176.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 70.6 t-105 -60.97 -53.37 58.14 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 123.275 0.63 . . . . 70.43 111.452 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.4 m -60.89 -28.85 69.2 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 115.01 -0.995 . . . . 50.4 110.638 178.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.553 HD11 HG13 ' A' ' 58' ' ' VAL . 30.0 tp -72.78 -50.04 26.89 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.291 1.436 . . . . 71.13 112.445 -178.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 24' ' ' LEU . 99.3 t -60.18 -29.87 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 123.672 0.789 . . . . 75.11 111.482 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.6 t -100.56 3.19 42.54 Favored 'General case' 0 CA--C 1.563 1.477 0 C-N-CA 124.062 0.945 . . . . 63.0 112.313 -176.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -85.38 134.01 41.26 Favored Pre-proline 0 N--CA 1.498 1.969 0 C-N-CA 123.942 0.897 . . . . 44.32 112.09 -176.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -77.92 -10.41 16.76 Favored 'Trans proline' 0 C--N 1.384 2.425 0 C-N-CA 123.233 2.622 . . . . 62.51 114.362 -175.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -87.67 -26.02 23.21 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 118.122 0.419 . . . . 63.0 110.446 174.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.6 p -117.07 -1.94 11.8 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.32 0.859 . . . . 74.43 113.32 -173.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.423 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 9.3 p-10 -62.06 -28.37 69.55 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 118.261 0.482 . . . . 73.55 111.904 -177.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.7 -25.77 67.46 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.597 0.759 . . . . 65.14 113.011 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.8 mt -116.0 -5.57 11.98 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.076 0.551 . . . . 75.21 112.045 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 34' ' ' ASP . 17.7 tt -160.19 115.25 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-O 121.381 0.61 . . . . 74.34 110.924 173.005 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 29.7 p -150.45 156.82 42.2 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.982 -0.747 . . . . 64.11 108.982 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 32.5 p-90 -74.96 152.41 38.79 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.711 0.804 . . . . 74.11 109.896 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.0 m -76.85 148.47 79.15 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 123.589 0.755 . . . . 61.52 110.401 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.82 -33.36 13.92 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 123.625 2.883 . . . . 74.42 116.102 178.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.1 m -76.83 -32.05 57.32 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.825 0.45 . . . . 64.34 110.511 175.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.17 -0.31 66.3 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-O 119.593 -0.559 . . . . 71.34 114.257 171.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 56.2 m-20 -87.91 -1.69 58.14 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.129 0.571 . . . . 70.52 111.251 -174.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 54.1 p -153.8 177.6 10.82 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.893 0.877 . . . . 71.51 110.434 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -141.64 149.64 40.92 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.245 0.618 . . . . 72.24 109.73 170.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -101.43 157.54 16.73 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.273 0.629 . . . . 73.21 109.371 177.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 98' ' ' ASP . 95.1 t -128.49 124.18 61.28 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 C-N-CA 124.8 1.24 . . . . 74.04 107.781 173.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -107.84 149.75 27.87 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.54 0.736 . . . . 74.34 109.891 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.0 t0 44.34 65.69 1.0 Allowed 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 125.486 1.514 . . . . 73.32 110.878 177.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.627 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 29.4 mt-30 -58.42 -21.04 49.46 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.364 0.876 . . . . 64.33 113.364 -172.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.54 -46.45 47.7 Favored Glycine 0 C--N 1.346 1.091 0 N-CA-C 112.275 -0.33 . . . . 44.2 112.275 173.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.405 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 58.2 tp60 -69.81 -44.51 69.87 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.523 -0.547 . . . . 72.44 109.523 177.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.526 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 54.6 t80 -52.54 -50.96 61.85 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.265 1.426 . . . . 71.12 111.297 175.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.445 ' HB1' ' O ' ' A' ' 66' ' ' ASN . . . -59.64 -37.35 78.43 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 121.106 0.479 . . . . 74.35 111.584 177.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -71.01 -49.26 47.07 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.594 1.158 . . . . 71.2 113.173 -175.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.503 ' HG3' HG23 ' A' ' 58' ' ' VAL . 6.5 pt-20 -105.81 -36.41 7.04 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 113.429 0.9 . . . . 64.34 113.429 -172.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.553 HG13 HD11 ' A' ' 27' ' ' LEU . 55.2 t -81.67 -43.82 20.05 Favored 'Isoleucine or valine' 0 C--O 1.251 1.161 0 C-N-CA 123.728 0.811 . . . . 62.35 111.611 -168.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 55.3 mt -67.2 -44.01 46.9 Favored Pre-proline 0 CA--C 1.553 1.072 0 CA-C-O 118.158 -0.925 . . . . 70.31 112.639 -178.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -70.6 -10.16 27.31 Favored 'Trans proline' 0 C--N 1.377 2.051 0 CA-C-N 121.833 1.69 . . . . 74.32 113.527 171.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -75.86 -49.41 18.03 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.275 0.63 . . . . 74.21 110.693 176.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.573 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 64.9 m-85 -102.34 -34.87 9.03 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 113.752 1.019 . . . . 74.15 113.752 -178.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -109.84 -177.58 3.31 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 108.904 -0.776 . . . . 63.22 108.904 -175.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -111.5 38.07 2.71 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.004 0.522 . . . . 70.25 110.951 -175.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -158.15 167.29 30.23 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.312 0.645 . . . . 75.44 109.684 -177.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.445 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 1.9 m-20 -121.33 -7.45 9.27 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.284 0.634 . . . . 74.52 110.768 176.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -78.7 120.19 23.01 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.119 0.568 . . . . 54.42 109.995 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.627 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 25.5 ttt -84.3 -18.72 35.39 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 116.79 -0.186 . . . . 71.21 111.267 -176.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -54.76 -38.74 67.57 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 122.971 0.508 . . . . 70.54 110.956 174.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.456 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 48.2 t -68.19 -44.67 75.32 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.034 -0.985 . . . . 53.33 111.188 174.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -59.44 -50.13 75.14 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.218 1.007 . . . . 64.13 110.46 -175.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.2 t -62.12 -45.91 97.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 114.932 -1.031 . . . . 63.34 111.119 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 54.2 ttt85 -58.33 -36.67 73.76 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 122.973 0.509 . . . . 71.42 111.516 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 70' ' ' SER . 31.3 mm-40 -61.67 -50.62 71.77 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 123.552 0.532 . . . . 71.23 109.701 176.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 98.1 mt -62.24 -33.55 74.8 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.628 0.771 . . . . 65.25 112.015 -177.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -56.9 -45.98 82.26 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 122.981 0.512 . . . . 71.21 110.866 170.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.455 ' HB3' ' O ' ' A' ' 119' ' ' ARG . 45.0 mtm -69.11 -28.84 66.84 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.294 0.638 . . . . 53.03 111.138 178.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -82.39 2.37 32.8 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.4 0.68 . . . . 71.24 110.975 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.71 1.86 79.73 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-O 119.201 -0.777 . . . . 73.35 114.405 171.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -72.04 142.45 49.28 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 117.752 0.776 . . . . 72.32 109.079 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -100.44 131.31 46.43 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.579 -0.526 . . . . 75.0 109.579 -176.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.573 ' HE3' HG22 ' A' ' 84' ' ' VAL . 50.2 tptt -69.59 108.2 3.74 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.417 1.487 . . . . 74.23 109.328 173.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.49 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 42.5 t -112.98 111.26 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 108.008 -1.108 . . . . 71.43 108.008 178.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.573 HG22 ' HE3' ' A' ' 82' ' ' LYS . 11.1 t -93.01 101.22 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.854 0.862 . . . . 63.11 109.004 -172.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -90.88 -62.93 1.34 Allowed 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.324 -0.621 . . . . 72.33 109.324 178.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 28.4 mm -75.67 101.46 2.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 107.422 -1.325 . . . . 61.4 107.422 166.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -86.63 127.02 34.9 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 114.833 -1.076 . . . . 73.11 108.225 175.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -79.96 117.66 21.0 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.022 0.439 . . . . 64.14 111.616 -177.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.18 -163.85 32.22 Favored Glycine 0 C--N 1.337 0.585 0 CA-C-N 114.857 -1.065 . . . . 65.11 111.523 175.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -84.6 57.41 5.02 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.003 -0.839 . . . . 64.13 111.003 174.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 47.5 mt -104.28 -179.17 3.87 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.072 0.949 . . . . 74.2 110.707 -173.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.1 p -79.1 -28.93 13.74 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 C-N-CA 123.639 0.776 . . . . 75.41 109.794 173.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -63.23 132.17 95.01 Favored Pre-proline 0 N--CA 1.48 1.065 0 C-N-CA 124.011 0.924 . . . . 41.21 110.422 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.53 153.42 70.0 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.724 2.283 . . . . 72.34 110.781 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -74.61 8.38 2.38 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.556 0.947 . . . . 71.12 113.556 -168.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -65.29 87.21 0.07 Allowed 'General case' 0 CA--C 1.554 1.11 0 CA-C-O 121.214 0.53 . . . . 75.1 110.417 176.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.571 ' HB2' ' H ' ' A' ' 51' ' ' GLN . 5.8 m-20 -41.41 109.56 0.13 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.007 1.323 . . . . 71.2 112.142 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.536 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 25.7 t70 -120.74 115.83 24.06 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.307 0.643 . . . . 63.51 109.882 -178.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.405 HG23 ' HD2' ' A' ' 82' ' ' LYS . 58.4 m -118.43 131.41 56.28 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 123.673 0.789 . . . . 74.42 109.209 172.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.49 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 42.0 tt0 -105.26 113.52 27.16 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.536 -1.283 . . . . 71.15 107.536 172.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -96.41 118.86 33.8 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.098 -1.075 . . . . 71.43 108.098 174.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -115.48 140.54 49.06 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.561 0.744 . . . . 43.13 110.539 -175.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -158.55 134.07 5.9 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 123.264 0.626 . . . . 62.45 109.346 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -65.07 -28.42 57.06 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.826 2.351 . . . . 75.43 112.953 -176.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 33.5 m -96.1 20.37 10.31 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.896 0.479 . . . . 74.21 110.579 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -127.07 101.13 6.4 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 107.598 -1.26 . . . . 74.34 107.598 169.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 110' ' ' GLN . 68.8 mt -108.31 170.41 8.03 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 109.323 -0.621 . . . . 71.43 109.323 174.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.77 -31.48 72.67 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 113.972 1.101 . . . . 73.12 113.972 -168.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -139.51 18.9 3.02 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-O 120.342 -0.143 . . . . 60.12 113.289 -175.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 17.4 mp0 -107.79 79.16 1.25 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.363 0.665 . . . . 62.33 110.041 -176.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -67.98 -27.7 66.8 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.364 1.066 . . . . 73.5 113.437 -177.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -71.28 -5.87 35.52 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.343 0.657 . . . . 53.52 111.866 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 72.7 mt -89.33 -6.65 56.51 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 122.972 0.509 . . . . 62.44 111.748 175.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 94.5 mt -68.23 -32.57 72.86 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 122.825 0.45 . . . . 51.43 111.231 176.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -74.12 -16.53 61.01 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.1 0.56 . . . . 72.13 111.109 175.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -79.95 -18.67 49.82 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.12 -0.696 . . . . 71.33 109.12 177.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 27.5 mt -98.51 122.27 50.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.667 0 C-N-CA 124.196 0.999 . . . . 74.41 108.677 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -113.07 153.47 28.11 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 108.98 -0.748 . . . . 70.43 108.98 176.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.455 ' O ' ' HB3' ' A' ' 77' ' ' MET . 13.3 ptp180 -76.99 -35.37 57.21 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 121.038 0.446 . . . . 64.42 110.029 175.119 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -174.35 140.55 0.66 Allowed 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.583 1.153 . . . . 74.54 108.796 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.6 p -98.58 -27.99 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 CA-C-N 115.204 -0.907 . . . . 75.11 109.635 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.5 t -95.08 156.9 16.12 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.41 -0.959 . . . . 62.51 108.41 167.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 32.9 t 61.68 24.12 14.29 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.875 0.87 . . . . 65.54 110.918 -176.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 5.1 p -75.43 105.65 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.467 0.707 . . . . 75.02 110.516 -176.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 30.8 p . . . . . 0 CA--C 1.558 1.282 0 CA-C-N 115.548 -0.751 . . . . 73.12 109.916 177.872 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 120.737 0.304 . . . . 74.31 110.897 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 91.47 29.18 12.61 Favored Glycine 0 C--N 1.344 0.972 0 CA-C-N 115.936 -0.575 . . . . 73.25 112.893 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -76.06 79.06 2.91 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 108.386 -0.968 . . . . 75.2 108.386 171.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -148.39 161.14 42.18 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.9 1.68 . . . . 64.13 107.23 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -74.58 83.98 2.05 Favored 'General case' 0 CA--C 1.558 1.27 0 CA-C-O 122.518 1.151 . . . . 73.13 111.396 -174.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -129.25 20.01 5.81 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.703 -1.135 . . . . 55.42 109.225 173.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 60.0 t60 -73.12 81.36 1.27 Allowed 'General case' 0 C--N 1.356 0.871 0 CA-C-O 122.104 0.954 . . . . 73.45 109.544 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 47.7 m80 -135.59 83.86 2.05 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 105.447 -2.057 . . . . 61.45 105.447 175.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.7 m -62.35 96.98 0.08 Allowed 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.88 -1.055 . . . . 54.21 111.577 -169.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 38.7 m170 -114.39 -47.34 2.93 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.113 0.965 . . . . 72.21 110.215 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 52.0 mtm -105.01 148.73 26.43 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.41 1.084 . . . . 74.54 109.55 -177.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.09 128.8 37.19 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.944 0.898 . . . . 31.32 111.814 -175.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 146.28 -82.03 0.2 Allowed Glycine 0 C--N 1.341 0.853 0 N-CA-C 110.83 -0.908 . . . . 73.1 110.83 -174.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.49 113.78 3.73 Favored 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 122.519 2.146 . . . . 42.51 111.441 176.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 34.9 t -71.75 158.4 36.19 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.89 0.476 . . . . 72.5 109.765 174.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -81.67 -1.54 47.16 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.089 0.555 . . . . 75.45 110.989 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 74.0 t -58.15 120.06 40.17 Favored Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 124.599 1.16 . . . . 65.42 110.906 175.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.499 ' HD2' HD12 ' A' ' 21' ' ' LEU . 87.7 Cg_exo -52.77 143.46 47.55 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 123.537 2.825 . . . . 71.54 113.328 172.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.36 -40.29 64.84 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.373 1.069 . . . . 73.44 111.944 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -54.64 -48.94 71.66 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.177 0.591 . . . . 73.21 111.425 173.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.499 HD12 ' HD2' ' A' ' 18' ' ' PRO . 85.1 mt -75.36 -34.28 61.14 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 111.876 0.324 . . . . 70.34 111.876 -170.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.0 t -68.59 -38.83 80.96 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 117.579 0.172 . . . . 65.32 110.935 175.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.491 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -67.22 -42.09 84.64 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 122.412 0.285 . . . . 70.02 110.659 175.291 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.9 tp -58.32 -52.41 65.7 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.018 0.927 . . . . 75.31 111.822 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 84.3 t90 -56.62 -47.87 78.74 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.777 0.831 . . . . 71.53 111.107 -178.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 36.2 m -61.23 -37.03 81.6 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.998 -1.001 . . . . 73.11 111.159 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.2 tp -68.49 -44.75 74.06 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.414 1.085 . . . . 70.13 111.757 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.5 t -63.53 -42.26 95.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.1 0.96 . . . . 50.33 110.67 177.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.1 t -80.74 0.12 36.0 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-N 115.254 -0.884 . . . . 54.44 111.639 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -86.41 125.62 67.06 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.707 0.803 . . . . 63.13 110.639 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -82.84 -10.29 10.58 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.919 2.413 . . . . 60.31 114.177 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -82.49 -30.42 29.89 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.136 0.575 . . . . 64.1 111.455 -178.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 50.7 p -100.4 7.8 44.03 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.837 0.455 . . . . 61.23 110.659 -177.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.425 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 7.0 p-10 -58.3 -22.94 54.77 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.934 1.294 . . . . 74.22 112.897 -175.034 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.21 -38.22 82.65 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.803 0.841 . . . . 72.21 112.264 177.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 57.0 mt -117.66 -10.38 10.57 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.94 0.496 . . . . 74.55 111.954 -178.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 34' ' ' ASP . 17.1 tt -158.64 122.42 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-O 121.365 0.602 . . . . 74.22 111.913 175.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 53.8 t -152.39 158.95 43.41 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.666 0.786 . . . . 43.22 109.761 176.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 13.2 p-90 -70.82 153.23 42.93 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.669 0.788 . . . . 74.42 110.877 176.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.8 m -73.2 154.61 90.37 Favored Pre-proline 0 CA--C 1.553 1.077 0 CA-C-O 118.058 -0.972 . . . . 54.44 109.182 170.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -42.92 -31.34 2.18 Favored 'Trans proline' 0 C--N 1.388 2.617 0 C-N-CA 124.091 3.194 . . . . 64.21 115.821 -175.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 79.6 p -76.25 -49.51 16.87 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.972 0.509 . . . . 54.32 110.923 175.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.8 13.49 23.66 Favored Glycine 0 C--N 1.352 1.443 0 CA-C-N 115.606 -0.724 . . . . 52.34 113.557 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -94.5 -11.08 30.33 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.046 0.538 . . . . 64.02 111.137 -175.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.6 p -147.2 170.15 17.85 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.24 1.016 . . . . 71.24 109.146 -176.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -144.15 155.43 43.92 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.86 0.464 . . . . 70.43 110.798 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.402 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 52.6 m-70 -112.11 150.04 31.29 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.202 1.001 . . . . 62.44 109.32 -176.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.463 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 84.5 t -126.42 139.01 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 108.452 -0.944 . . . . 64.11 108.452 176.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -125.48 146.3 49.7 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.552 0.741 . . . . 73.02 109.061 176.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.4 t70 45.34 76.69 0.09 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.709 1.603 . . . . 70.22 112.019 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.606 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 53.3 mt-30 -51.05 -29.64 13.39 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.306 1.042 . . . . 64.31 113.023 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.99 -49.53 40.69 Favored Glycine 0 C--N 1.348 1.234 0 O-C-N 123.308 0.38 . . . . 64.51 112.835 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -75.16 -40.97 59.09 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.396 0.679 . . . . 61.02 110.222 -176.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -56.81 -48.84 77.05 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.282 1.433 . . . . 74.12 110.779 175.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' A' ' 66' ' ' ASN . . . -65.97 -28.84 69.2 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.19 0.441 . . . . 62.34 112.19 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -72.38 -46.35 55.71 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.797 0.839 . . . . 72.21 112.107 -177.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.523 ' HG3' HG23 ' A' ' 58' ' ' VAL . 7.1 pt-20 -110.11 -40.4 4.73 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 113.542 0.941 . . . . 75.1 113.542 -173.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.523 HG23 ' HG3' ' A' ' 57' ' ' GLU . 73.9 t -80.05 -43.24 22.39 Favored 'Isoleucine or valine' 0 C--O 1.252 1.189 0 C-N-CA 123.064 0.545 . . . . 71.45 111.51 -168.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.408 ' HG ' ' HA ' ' A' ' 55' ' ' ALA . 35.1 mt -63.06 -50.9 74.13 Favored Pre-proline 0 CA--C 1.558 1.28 0 CA-C-O 117.993 -1.003 . . . . 60.24 112.445 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.86 -12.91 36.92 Favored 'Trans proline' 0 C--N 1.389 2.695 0 C-N-CA 121.884 1.723 . . . . 75.14 113.138 177.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -74.43 -60.64 2.18 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 122.941 0.497 . . . . 71.35 110.306 177.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -85.34 -55.9 3.79 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 116.312 -0.403 . . . . 74.21 110.852 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -86.37 179.75 6.82 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 109.32 -0.622 . . . . 74.42 109.32 -176.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -113.07 38.97 2.67 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 121.526 0.679 . . . . 65.43 110.044 -171.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -162.6 163.95 26.95 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.936 -1.029 . . . . 74.42 109.301 -176.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.425 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 1.6 m120 -114.06 -7.89 13.06 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.173 0.589 . . . . 73.31 110.015 175.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -68.79 109.06 3.67 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.598 0.759 . . . . 72.2 111.0 -177.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.606 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 1.1 tpt -56.32 -39.76 73.29 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.498 1.119 . . . . 73.23 110.362 170.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.55 -41.54 66.56 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 124.548 1.155 . . . . 74.13 112.077 176.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.4 t -67.69 -41.39 83.71 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.631 0.772 . . . . 75.02 111.662 177.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -65.83 -52.37 51.1 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.465 0.706 . . . . 74.34 110.665 -176.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 95.4 t -61.11 -42.11 91.95 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-N 115.19 -0.914 . . . . 72.55 110.93 176.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -55.8 -46.9 77.92 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.564 0.746 . . . . 74.21 111.175 176.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -55.99 -55.57 31.13 Favored 'General case' 0 C--N 1.349 0.573 0 O-C-N 124.254 0.971 . . . . 72.44 110.417 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.4 mt -61.21 -42.41 98.54 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 124.15 0.906 . . . . 63.33 112.018 -175.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -59.19 -39.98 84.27 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.312 0.645 . . . . 71.24 111.368 175.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 57.2 mtm -73.86 -31.22 63.06 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.385 0.274 . . . . 72.41 110.795 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -79.38 3.51 18.12 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.71 0.804 . . . . 74.43 111.668 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.08 14.06 79.92 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-O 119.428 -0.651 . . . . 73.32 113.921 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -74.26 138.85 43.89 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 109.275 -0.639 . . . . 74.13 109.275 175.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -100.81 124.14 46.02 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.337 -0.616 . . . . 74.23 109.337 178.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.58 ' HE2' ' HB ' ' A' ' 84' ' ' VAL . 1.3 tmtp? -78.64 131.04 36.53 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.268 1.027 . . . . 74.53 108.934 177.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.2 t -129.97 122.66 54.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 107.472 -1.307 . . . . 74.43 107.472 175.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.58 ' HB ' ' HE2' ' A' ' 82' ' ' LYS . 6.5 p -99.14 124.87 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 109.226 -0.657 . . . . 71.44 109.226 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -99.24 -48.35 4.85 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.069 0.548 . . . . 72.33 109.994 -177.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.584 HG23 ' HB3' ' A' ' 93' ' ' LYS . 47.3 mm -89.04 98.96 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 109.693 -0.484 . . . . 74.3 109.693 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -79.57 123.67 27.81 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.294 -0.866 . . . . 54.45 109.737 177.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.405 HE21 HG22 ' A' ' 86' ' ' ILE . 37.6 mm-40 -101.33 160.33 14.51 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.222 1.009 . . . . 73.21 111.706 -173.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 141.57 -80.37 0.26 Allowed Glycine 0 C--N 1.349 1.264 0 CA-C-N 115.201 -0.908 . . . . 63.31 111.378 176.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -147.66 22.78 1.49 Allowed Glycine 0 C--N 1.343 0.921 0 C-N-CA 122.879 0.275 . . . . 45.4 112.709 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 78.2 mt -89.75 170.95 9.99 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.743 0.817 . . . . 74.44 110.636 178.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.9 p -82.98 -3.2 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.457 0 C-N-CA 122.864 0.466 . . . . 71.15 111.549 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.584 ' HB3' HG23 ' A' ' 86' ' ' ILE . 45.7 mmtm -54.86 146.76 35.66 Favored Pre-proline 0 N--CA 1.491 1.607 0 C-N-CA 123.898 0.879 . . . . 74.42 110.929 171.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -62.77 158.18 43.79 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 122.928 2.418 . . . . 75.03 111.629 178.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -85.75 58.87 5.29 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 122.403 1.097 . . . . 64.11 111.428 -177.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -155.83 83.49 1.02 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 114.261 -1.336 . . . . 64.01 108.584 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -44.26 128.64 6.17 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 113.73 -1.577 . . . . 40.43 111.16 175.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -96.65 108.0 20.54 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.764 -0.828 . . . . 75.33 108.764 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.463 ' HB ' ' HB ' ' A' ' 48' ' ' VAL . 3.8 m -100.26 95.14 6.59 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 108.206 -1.035 . . . . 51.51 108.206 174.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -91.35 141.52 28.68 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.153 -1.054 . . . . 72.25 108.153 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -124.75 125.5 44.16 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.24 -1.022 . . . . 65.42 108.24 173.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -116.87 149.43 40.09 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.317 0.647 . . . . 73.34 110.083 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 33.8 t60 -162.96 127.92 2.07 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 108.936 -0.764 . . . . 64.43 108.936 174.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.3 -31.14 81.86 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 122.726 2.284 . . . . 62.42 113.355 -174.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 36.2 m -88.84 3.07 52.45 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 122.735 0.414 . . . . 73.21 111.466 -178.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -101.02 99.63 10.11 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.216 -1.401 . . . . 65.34 107.216 172.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 110' ' ' GLN . 87.5 mt -119.92 129.67 54.45 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.244 0.618 . . . . 63.13 109.349 176.102 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -72.05 93.18 1.37 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 107.641 -1.244 . . . . 74.25 107.641 174.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 145.45 -55.55 0.54 Allowed Glycine 0 C--N 1.33 0.213 0 N-CA-C 109.193 -1.563 . . . . 52.21 109.193 -173.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.539 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 2.6 mp0 -88.46 76.07 8.31 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.602 0.761 . . . . 72.12 110.181 176.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.68 -17.48 60.67 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.231 0.612 . . . . 43.23 112.036 175.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 19.3 pm0 -69.55 -21.72 63.61 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 111.494 0.183 . . . . 72.51 111.494 175.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.0 mt -80.04 -5.93 56.71 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.775 0.43 . . . . 73.22 112.125 -177.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 68.8 mt -69.97 -23.16 63.13 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.246 0.618 . . . . 71.2 111.944 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -81.13 -2.11 47.1 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 112.378 0.511 . . . . 72.12 112.378 176.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -90.32 -12.99 36.13 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 109.066 -0.716 . . . . 75.34 109.066 170.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 18.7 mt -93.19 121.3 43.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 107.79 -1.189 . . . . 72.12 107.79 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.81 168.57 18.49 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.067 0.46 . . . . 75.4 111.062 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.508 HH21 ' HA ' ' A' ' 123' ' ' SER . 28.1 ptt180 -133.72 -46.68 0.8 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.999 0.919 . . . . 72.11 109.668 -172.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.471 ' N ' ' HG3' ' A' ' 119' ' ' ARG . 31.2 mmmt -140.65 -156.3 0.66 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.879 1.672 . . . . 71.53 106.902 -172.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.6 m -107.89 7.02 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 122.144 -0.347 . . . . 72.32 110.565 167.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.6 t -116.2 146.52 42.25 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.644 0.778 . . . . 53.43 111.084 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.508 ' HA ' HH21 ' A' ' 119' ' ' ARG . 35.7 t -162.38 68.37 0.25 Allowed 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 107.501 -1.296 . . . . 33.42 107.501 175.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 30.5 m -108.86 -164.9 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 124.385 1.074 . . . . 75.34 110.882 -172.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.1 p . . . . . 0 CA--C 1.557 1.235 0 C-N-CA 123.725 0.81 . . . . 73.33 111.124 177.242 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.9 ttm . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 109.003 -0.739 . . . . 71.13 109.003 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.07 124.49 9.1 Favored Glycine 0 C--N 1.347 1.183 0 N-CA-C 111.307 -0.717 . . . . 61.03 111.307 175.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -76.8 -28.06 55.47 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.144 0.578 . . . . 74.14 110.255 173.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 40.1 m-70 71.66 119.35 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.161 1.384 . . . . 63.51 111.864 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -98.38 43.41 1.06 Allowed 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 107.657 -1.238 . . . . 71.52 107.657 163.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -64.55 104.75 0.84 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.43 0.692 . . . . 62.2 109.39 -176.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -130.31 124.63 32.79 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.366 1.066 . . . . 64.23 109.439 -176.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -71.91 -38.53 69.9 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.494 0.718 . . . . 73.44 109.986 173.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.8 m 62.21 17.46 9.27 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.316 1.046 . . . . 70.52 113.126 176.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -89.81 -17.08 28.83 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.025 0.53 . . . . 74.5 111.716 -177.068 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 56.7 mtt -74.8 153.96 38.52 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.855 0.462 . . . . 73.11 110.368 175.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.5 14.86 1.13 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.317 0.647 . . . . 61.31 112.441 -177.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -109.01 84.22 0.36 Allowed Glycine 0 C--N 1.343 0.953 0 CA-C-O 119.053 -0.859 . . . . 72.22 111.083 168.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -88.72 -158.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 123.012 2.475 . . . . 72.31 111.793 -178.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 73.5 m -67.19 160.21 27.38 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 122.872 0.469 . . . . 63.11 110.356 170.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -84.57 40.55 0.8 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.528 1.131 . . . . 72.21 110.771 -174.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 70.8 t -68.19 122.58 84.71 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 123.982 0.913 . . . . 72.51 110.37 -174.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.36 145.74 34.97 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.897 2.398 . . . . 64.14 111.863 174.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.99 -40.73 67.2 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.751 0.82 . . . . 75.21 111.968 -176.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.425 ' HA ' ' HE1' ' A' ' 63' ' ' PHE . 54.1 t80 -53.25 -49.43 66.89 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.74 0.816 . . . . 55.43 111.851 173.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 92.5 mt -77.72 -31.07 52.06 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.007 0.523 . . . . 60.34 112.303 -170.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.5 t -76.02 -34.23 59.69 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 117.586 0.176 . . . . 75.42 110.973 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.15 -39.66 71.81 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.611 0.364 . . . . 71.33 110.035 174.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.49 ' O ' HG23 ' A' ' 28' ' ' VAL . 53.4 tp -61.85 -43.41 98.9 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 124.152 0.908 . . . . 71.41 110.801 174.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.514 ' CE3' HD11 ' A' ' 114' ' ' LEU . 70.9 t-105 -56.66 -47.7 79.21 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.234 1.013 . . . . 71.2 110.947 177.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.3 m -63.36 -42.66 98.9 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.03 -0.987 . . . . 71.01 110.949 174.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.8 tp -62.21 -53.24 58.07 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.386 1.474 . . . . 71.41 112.528 -172.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 24' ' ' LEU . 24.8 t -58.76 -33.85 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 C-N-CA 123.095 0.558 . . . . 74.03 111.41 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.0 t -87.11 -16.08 36.56 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.087 0.955 . . . . 65.41 111.647 -176.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -76.12 127.05 85.91 Favored Pre-proline 0 N--CA 1.481 1.089 0 C-N-CA 122.76 0.424 . . . . 64.25 111.115 -172.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.13 -30.64 46.56 Favored 'Trans proline' 0 C--N 1.385 2.467 0 C-N-CA 123.195 2.597 . . . . 55.1 114.543 -175.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -65.06 -38.32 90.44 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.438 0.637 . . . . 71.5 110.594 178.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.4 p -101.34 -2.02 32.01 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.922 -1.035 . . . . 71.44 111.542 -175.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -57.9 -35.97 71.78 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.513 1.125 . . . . 71.24 111.391 -178.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.43 -38.78 66.69 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.368 -0.833 . . . . 62.24 111.783 178.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.419 ' HA ' ' HB2' ' A' ' 49' ' ' PHE . 79.4 mt -98.24 -25.6 14.82 Favored 'General case' 0 C--O 1.213 -0.819 0 C-N-CA 123.08 0.552 . . . . 63.51 111.072 -178.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 47' ' ' HIS . 19.8 tt -149.48 116.04 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 O-C-N 121.251 -0.905 . . . . 72.12 111.231 -176.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 9.0 p -142.86 150.38 39.79 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.611 0.764 . . . . 61.42 110.62 -171.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -70.12 150.21 46.78 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.537 0.735 . . . . 72.35 110.307 176.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 56.3 p -71.66 155.93 91.83 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 122.995 0.518 . . . . 70.12 109.616 167.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -52.93 -29.47 43.95 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.612 2.208 . . . . 75.25 112.763 173.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.7 m -76.11 -38.02 57.39 Favored 'General case' 0 C--N 1.352 0.709 0 C-N-CA 123.088 0.555 . . . . 73.31 110.906 175.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.606 ' HA3' ' HD2' ' A' ' 108' ' ' ARG . . . 78.95 20.83 69.55 Favored Glycine 0 C--N 1.344 1.009 0 O-C-N 123.358 0.411 . . . . 60.41 113.24 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -95.24 -17.43 21.71 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.823 0.849 . . . . 75.3 109.988 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.401 ' HB3' ' HB3' ' A' ' 102' ' ' GLN . 66.6 p -142.48 168.84 18.79 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 123.806 0.842 . . . . 72.15 109.72 -174.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.403 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 46.3 p90 -143.05 147.22 34.7 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.79 0.436 . . . . 64.21 110.404 175.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.417 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 13.9 m-70 -104.15 142.55 34.29 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.154 0.982 . . . . 25.22 109.343 -178.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.2 t -124.18 125.78 71.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 108.06 -1.089 . . . . 62.45 108.06 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 79.9 m-85 -108.8 145.16 35.65 Favored 'General case' 0 C--O 1.247 0.941 0 C-N-CA 124.662 1.185 . . . . 72.23 109.067 -174.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 47.78 76.42 0.11 Allowed 'General case' 0 CA--C 1.542 0.669 0 O-C-N 124.561 1.163 . . . . 73.34 112.365 173.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.542 ' HG2' ' HB2' ' A' ' 97' ' ' ASP . 5.2 mm-40 -52.78 -29.49 27.72 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.735 -0.666 . . . . 75.51 112.173 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.99 -50.95 49.16 Favored Glycine 0 C--N 1.345 1.049 0 O-C-N 123.492 0.495 . . . . 61.34 112.894 174.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.407 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 62.7 tp60 -70.14 -46.51 64.58 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.647 0.379 . . . . 60.35 110.62 -177.03 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.44 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 61.1 t80 -53.68 -50.88 64.87 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.169 1.388 . . . . 74.04 111.132 176.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.59 ' HB2' ' HB2' ' A' ' 68' ' ' MET . . . -59.48 -35.27 73.8 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.849 0.685 . . . . 74.31 112.849 177.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.56 -47.07 51.14 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.069 0.948 . . . . 61.2 112.406 -176.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.503 ' HG3' HG23 ' A' ' 58' ' ' VAL . 6.5 pt-20 -102.36 -43.03 5.8 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 112.664 0.616 . . . . 74.25 112.664 -173.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.503 HG23 ' HG3' ' A' ' 57' ' ' GLU . 55.8 t -79.33 -47.2 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.386 0.674 . . . . 54.42 111.418 -168.173 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.2 mt -65.36 -46.65 70.76 Favored Pre-proline 0 CA--C 1.561 1.39 0 N-CA-C 113.239 0.829 . . . . 63.52 113.239 -174.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.37 -16.0 49.93 Favored 'Trans proline' 0 C--N 1.387 2.584 0 CA-C-N 121.901 1.715 . . . . 74.11 113.031 173.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -79.67 -62.32 1.72 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 123.999 0.92 . . . . 72.44 111.584 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -84.97 -24.33 28.35 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 122.974 0.509 . . . . 74.52 111.642 -176.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.425 ' HE1' ' HA ' ' A' ' 20' ' ' PHE . 41.0 m-85 -122.65 -169.24 1.87 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.223 -1.028 . . . . 71.31 108.223 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -127.64 45.14 2.79 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.867 0.842 . . . . 71.11 110.334 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -154.51 156.12 36.1 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.649 1.18 . . . . 63.21 107.965 176.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.524 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 1.6 m-20 -108.43 -16.08 14.31 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 109.723 -0.473 . . . . 54.24 109.723 176.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -66.52 115.3 6.25 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.346 0.658 . . . . 52.31 110.994 -176.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.59 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 12.1 tpt -73.26 -33.78 65.46 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.781 0.832 . . . . 64.12 111.29 -177.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.3 -35.64 65.31 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.097 0.559 . . . . 74.4 111.282 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.529 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 44.1 t -66.13 -46.59 77.0 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.171 0.988 . . . . 72.02 110.944 176.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -62.26 -53.26 57.78 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.011 0.924 . . . . 70.42 110.682 -176.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.5 t -62.78 -37.63 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 115.449 -0.796 . . . . 71.24 111.087 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -59.88 -38.02 81.02 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.312 0.645 . . . . 74.34 111.347 177.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 70' ' ' SER . 81.1 mm-40 -60.19 -48.28 82.4 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 109.346 -0.612 . . . . 71.25 109.346 176.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.438 ' HA ' ' HB2' ' A' ' 78' ' ' TYR . 93.6 mt -63.77 -36.36 83.61 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.063 0.945 . . . . 74.1 111.498 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -60.29 -42.46 95.54 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.388 0.675 . . . . 62.11 110.972 173.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 72.1 mtm -76.14 -21.32 56.71 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.723 -0.671 . . . . 74.34 110.677 176.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.438 ' HB2' ' HA ' ' A' ' 75' ' ' LEU . 26.6 m-85 -83.04 -4.09 57.97 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.572 0.749 . . . . 71.33 111.414 173.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.62 17.7 77.04 Favored Glycine 0 C--N 1.347 1.17 0 N-CA-C 114.433 0.533 . . . . 24.01 114.433 174.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -66.59 154.36 40.66 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.427 0.691 . . . . 72.43 110.436 177.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -99.73 122.55 42.89 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.564 0.746 . . . . 73.3 109.199 -178.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.582 ' HE2' ' HB ' ' A' ' 84' ' ' VAL . 21.0 tptm -77.08 123.76 26.84 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.841 1.256 . . . . 73.41 109.557 177.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.463 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 47.5 t -126.21 109.29 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 N-CA-C 108.103 -1.073 . . . . 71.14 108.103 170.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.582 ' HB ' ' HE2' ' A' ' 82' ' ' LYS . 5.1 p -90.45 123.9 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.445 0.698 . . . . 74.22 109.599 -179.32 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -108.45 -23.25 11.95 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.063 0.545 . . . . 74.22 111.713 -176.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 21.3 mm -121.24 101.13 9.95 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 N-CA-C 109.686 -0.487 . . . . 71.44 109.686 175.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -79.03 124.83 28.65 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.306 -0.627 . . . . 65.44 109.306 171.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -70.88 126.08 28.6 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.435 0.694 . . . . 73.1 111.9 -174.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 153.51 -163.81 30.86 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-N 115.378 -0.828 . . . . 72.02 112.713 177.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -81.93 71.78 2.9 Favored Glycine 0 N--CA 1.468 0.794 0 CA-C-N 114.979 -0.611 . . . . 72.13 112.531 -174.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 96.1 mt -124.35 -176.16 3.44 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.317 1.047 . . . . 71.35 110.026 -176.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.0 p -83.4 30.15 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-O 122.17 0.986 . . . . 72.1 110.934 -178.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.432 ' HB2' ' NZ ' ' A' ' 93' ' ' LYS . 9.1 mtmp? -134.08 146.26 59.08 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 124.715 1.206 . . . . 70.02 108.98 -174.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.447 ' HG2' ' HG2' ' A' ' 96' ' ' ARG . 58.0 Cg_endo -70.16 175.83 7.91 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 122.199 1.933 . . . . 74.44 111.523 170.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -80.66 13.41 2.58 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 112.688 0.625 . . . . 63.34 112.688 -177.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.447 ' HG2' ' HG2' ' A' ' 94' ' ' PRO . 21.4 ptt180 -64.92 154.24 38.02 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.258 0.623 . . . . 74.01 109.467 169.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.542 ' HB2' ' HG2' ' A' ' 51' ' ' GLN . 5.9 m-20 -103.53 145.02 30.64 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.77 -0.826 . . . . 64.43 108.77 165.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -129.64 112.54 13.78 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.466 -1.309 . . . . 75.32 107.466 168.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 41.2 m -123.32 118.71 28.15 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.167 0.987 . . . . 73.13 109.623 -175.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.463 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 41.2 tt0 -102.18 110.85 22.92 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.155 0.982 . . . . 74.41 108.628 -179.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -97.67 132.76 43.02 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.801 -0.815 . . . . 73.35 108.801 173.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.401 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 3.9 pt20 -139.02 145.99 40.32 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.772 0.829 . . . . 42.55 109.305 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -149.3 136.88 11.29 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 109.025 -0.731 . . . . 75.45 109.025 -177.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -59.02 -34.82 99.23 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 122.692 2.261 . . . . 73.41 112.725 -177.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.403 ' HB2' HG12 ' A' ' 117' ' ' ILE . 15.7 m -89.63 14.32 11.93 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.223 0.609 . . . . 45.53 111.007 179.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -122.67 98.82 6.09 Favored 'General case' 0 C--O 1.245 0.838 0 N-CA-C 107.799 -1.185 . . . . 74.13 107.799 174.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 91.5 mt -131.4 151.78 51.23 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.386 1.075 . . . . 71.0 109.426 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.606 ' HD2' ' HA3' ' A' ' 43' ' ' GLY . 16.1 ptm180 -63.17 112.39 2.64 Favored 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 124.194 0.998 . . . . 71.15 111.484 -178.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.96 -8.22 63.12 Favored Glycine 0 N--CA 1.472 1.08 0 CA-C-N 116.388 -0.369 . . . . 64.22 113.585 -178.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -102.75 71.73 1.18 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 117.641 0.721 . . . . 64.22 111.034 -177.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.473 ' HA ' ' HG ' ' A' ' 114' ' ' LEU . 9.4 pt-20 -70.29 -26.06 63.63 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.658 -0.701 . . . . 73.54 111.679 170.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.4 pm0 -65.05 -15.15 62.03 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.708 0.803 . . . . 72.02 112.193 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 79.9 mt -95.14 -17.88 21.42 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.147 0.579 . . . . 54.22 111.764 176.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.514 HD11 ' CE3' ' A' ' 25' ' ' TRP . 80.4 mt -67.87 -37.72 82.16 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.246 0.619 . . . . 63.53 110.992 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -64.12 -14.51 55.35 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.246 -0.888 . . . . 71.34 112.429 174.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -101.2 -2.4 31.39 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.6 0.76 . . . . 73.51 110.682 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.403 HG12 ' HB2' ' A' ' 105' ' ' CYS . 37.0 mt -92.81 113.33 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 106.995 -1.483 . . . . 74.3 106.995 173.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.446 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 9.8 mmpt? -115.77 145.05 43.14 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.04 0.536 . . . . 62.2 111.254 -169.007 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 30.6 ptt85 -110.95 11.5 22.22 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 108.247 -1.02 . . . . 71.33 108.247 168.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -107.97 155.09 20.72 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.389 1.476 . . . . 72.4 109.017 177.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 6.5 m 51.79 24.52 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 C-N-CA 126.35 1.86 . . . . 74.33 113.767 173.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.1 t -125.87 -33.54 2.7 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.509 0.559 . . . . 75.23 112.509 -171.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 48.2 p -163.57 -169.71 2.01 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.976 0.51 . . . . 73.12 111.062 -173.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 99.7 t -79.32 133.0 30.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 123.038 0.535 . . . . 71.11 110.491 178.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 24.1 m . . . . . 0 C--O 1.249 1.059 0 C-N-CA 124.443 1.097 . . . . 74.12 108.342 175.258 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.3 mmm . . . . . 0 N--CA 1.474 0.758 0 N-CA-C 110.243 -0.28 . . . . 74.01 110.243 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -102.5 51.48 0.87 Allowed Glycine 0 C--N 1.352 1.453 0 N-CA-C 114.317 0.487 . . . . 61.12 114.317 -169.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -157.59 86.58 0.93 Allowed 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 121.602 0.715 . . . . 75.24 110.129 172.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -118.05 91.33 3.54 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.391 1.076 . . . . 45.02 108.916 178.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.4 m-70 -91.92 101.84 14.41 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.491 -0.777 . . . . 71.31 109.181 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -67.24 97.42 0.54 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.659 -0.7 . . . . 72.44 109.139 173.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -70.06 92.52 0.74 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.859 -0.61 . . . . 61.43 109.384 175.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -81.21 85.04 6.43 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 107.653 -1.24 . . . . 73.31 107.653 168.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.3 m -89.01 164.01 15.27 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 114.562 -1.199 . . . . 65.24 109.959 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 -73.49 91.31 1.79 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 108.463 -0.94 . . . . 62.32 108.463 170.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 63.8 mtm -80.94 61.12 4.42 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.414 1.085 . . . . 71.14 110.323 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.33 154.57 7.21 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.761 1.624 . . . . 72.31 108.023 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.28 -86.13 0.48 Allowed Glycine 0 N--CA 1.469 0.884 0 N-CA-C 110.954 -0.858 . . . . 63.12 110.954 -176.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -76.77 38.4 0.63 Allowed 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 123.141 2.561 . . . . 73.44 111.707 166.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.435 ' OG ' HG23 ' A' ' 17' ' ' VAL . 40.0 t -76.38 152.66 36.22 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.645 0.778 . . . . 73.04 111.348 -172.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -108.5 15.69 23.64 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.65 -0.704 . . . . 75.14 111.22 -174.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.435 HG23 ' OG ' ' A' ' 15' ' ' SER . 91.4 t -60.93 129.12 90.02 Favored Pre-proline 0 N--CA 1.482 1.14 0 CA-C-O 119.386 -0.34 . . . . 54.44 110.677 -177.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.28 141.84 94.23 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.618 2.212 . . . . 71.54 111.123 174.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.47 -40.5 62.39 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.814 0.845 . . . . 74.21 111.36 176.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -50.45 -47.78 56.71 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 124.248 0.967 . . . . 75.55 112.961 173.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 90.3 mt -83.68 -26.19 30.05 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.816 0.447 . . . . 72.1 110.402 -170.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.7 m -66.11 -45.22 81.93 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 124.154 0.982 . . . . 60.24 110.983 171.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.464 ' HE2' ' HA ' ' A' ' 23' ' ' LYS . 10.6 mmpt? -67.18 -44.72 78.95 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.726 0.41 . . . . 72.3 110.153 176.149 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.5 tp -56.11 -53.23 59.59 Favored 'General case' 0 C--N 1.356 0.876 0 O-C-N 124.483 1.114 . . . . 72.15 111.47 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.528 ' HH2' ' HG3' ' A' ' 108' ' ' ARG . 8.3 t-105 -59.37 -49.26 78.52 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 122.942 0.497 . . . . 74.43 111.832 -178.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.5 m -62.1 -28.05 69.35 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 122.805 0.442 . . . . 70.44 111.291 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.474 HD13 ' CD1' ' A' ' 62' ' ' TYR . 24.0 tp -74.37 -44.45 52.15 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.203 1.001 . . . . 64.23 111.793 176.059 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.2 t -61.87 -36.74 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.881 0.872 . . . . 62.24 110.401 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 88.4 p -90.34 10.8 23.51 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.842 0.857 . . . . 73.41 111.736 -177.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -90.86 116.42 66.38 Favored Pre-proline 0 CA--C 1.56 1.36 0 C-N-CA 123.052 0.541 . . . . 44.32 110.675 175.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.69 -7.81 16.76 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 123.256 2.637 . . . . 72.55 113.156 177.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -85.55 -25.72 26.59 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.689 0.795 . . . . 75.02 111.509 177.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 40.9 p -106.32 9.34 31.97 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.84 0.456 . . . . 75.12 111.122 178.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -57.85 -30.39 65.75 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 113.381 0.882 . . . . 64.52 113.381 -170.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -69.06 -24.08 64.12 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.574 0.583 . . . . 65.43 112.574 -176.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.474 HD22 ' HB2' ' A' ' 50' ' ' ASP . 77.4 mt -115.13 -18.17 11.23 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.2 0.6 . . . . 64.11 111.056 -178.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.463 HD13 ' HG ' ' A' ' 27' ' ' LEU . 14.9 tt -160.94 123.86 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.234 0.613 . . . . 64.01 110.231 171.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 23.2 p -150.55 161.69 42.07 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.159 0.584 . . . . 40.41 110.433 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 38.4 p-90 -73.33 147.27 44.58 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 124.048 0.842 . . . . 75.03 109.47 172.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.2 m -75.64 149.62 83.69 Favored Pre-proline 0 CA--C 1.548 0.9 0 N-CA-C 108.348 -0.982 . . . . 71.22 108.348 171.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.77 -28.43 23.05 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 123.101 2.534 . . . . 75.15 114.25 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.0 m -73.71 -24.8 59.97 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.309 0.644 . . . . 50.54 111.946 177.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.24 0.84 90.13 Favored Glycine 0 C--N 1.342 0.889 0 C-N-CA 123.129 0.395 . . . . 34.22 113.649 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 55.9 m-20 -82.27 -25.4 34.07 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.727 0.811 . . . . 72.3 111.036 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.9 p -146.96 178.99 7.91 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.358 0.663 . . . . 74.12 110.311 -169.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 42.1 p90 -146.63 143.85 29.09 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.711 0.404 . . . . 70.34 110.985 178.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -103.33 151.71 22.41 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.23 0.612 . . . . 74.1 109.464 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 98' ' ' ASP . 95.5 t -124.23 132.13 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.363 1.065 . . . . 71.33 108.349 176.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -116.07 148.77 39.89 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.835 0.854 . . . . 71.22 109.604 178.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.474 ' HB2' HD22 ' A' ' 36' ' ' LEU . 20.8 m-20 53.16 63.44 2.23 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 124.692 1.245 . . . . 70.43 111.259 170.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -50.12 -33.35 18.48 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.181 0.993 . . . . 73.13 113.33 -172.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.64 -43.99 90.76 Favored Glycine 0 CA--C 1.533 1.196 0 O-C-N 123.412 0.445 . . . . 65.41 112.441 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -74.11 -45.48 48.78 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.392 0.677 . . . . 71.34 110.059 -178.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.436 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 39.1 t80 -50.51 -52.27 39.93 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.28 1.432 . . . . 75.21 111.494 174.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.463 ' HB2' ' HB2' ' A' ' 68' ' ' MET . . . -62.2 -36.32 81.57 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.657 -0.701 . . . . 60.04 111.577 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -66.81 -46.92 73.65 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.85 0.86 . . . . 63.33 112.85 -175.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.488 ' HG3' HG23 ' A' ' 58' ' ' VAL . 11.1 pt-20 -113.07 -33.9 5.88 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 114.292 1.219 . . . . 74.42 114.292 -171.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.488 HG23 ' HG3' ' A' ' 57' ' ' GLU . 91.9 t -82.83 -45.03 19.24 Favored 'Isoleucine or valine' 0 C--O 1.253 1.286 0 C-N-CA 123.71 0.804 . . . . 50.43 111.938 -170.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.6 mt -64.59 -46.55 77.03 Favored Pre-proline 0 CA--C 1.557 1.231 0 CA-C-O 118.095 -0.955 . . . . 63.34 112.766 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.2 -15.21 45.64 Favored 'Trans proline' 0 C--N 1.381 2.262 0 CA-C-N 121.954 1.733 . . . . 73.11 113.105 174.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -73.14 -50.6 21.8 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.58 0.752 . . . . 75.01 110.489 176.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.474 ' CD1' HD13 ' A' ' 27' ' ' LEU . 37.0 m-85 -92.76 -51.88 4.88 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 112.594 0.59 . . . . 74.3 112.594 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -90.87 -172.03 3.22 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.885 -0.783 . . . . 65.14 108.885 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -118.47 40.66 3.16 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 121.313 0.578 . . . . 65.42 110.397 -174.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -162.25 164.66 27.53 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.193 -0.912 . . . . 72.11 109.246 -177.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -106.24 -33.98 7.63 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.356 0.663 . . . . 72.25 109.864 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -62.97 127.09 29.62 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.31 0.644 . . . . 72.14 112.522 -173.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.463 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 25.7 ttt -88.16 -23.69 23.55 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.97 0.508 . . . . 75.34 111.365 -176.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.42 -38.37 77.28 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 121.424 0.63 . . . . 74.04 111.211 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.415 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 22.8 t -68.89 -40.39 79.21 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.593 1.157 . . . . 62.42 111.087 176.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -62.39 -48.32 80.25 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.456 1.103 . . . . 74.23 110.899 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 83.4 t -65.24 -39.46 85.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 123.786 0.834 . . . . 73.34 111.102 177.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 70.0 ttt-85 -54.24 -43.71 71.14 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.195 0.598 . . . . 71.11 110.952 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.519 ' HA ' ' HE2' ' A' ' 77' ' ' MET . 10.2 mm100 -62.15 -45.77 91.96 Favored 'General case' 0 C--N 1.349 0.549 0 O-C-N 123.959 0.787 . . . . 55.25 110.352 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 43.1 mt -59.77 -36.92 77.66 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.662 0.785 . . . . 75.42 111.439 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -61.0 -40.68 94.48 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.839 0.456 . . . . 64.12 111.182 173.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.519 ' HE2' ' HA ' ' A' ' 74' ' ' GLN . 31.9 mtm -69.71 -35.6 75.19 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.563 0.345 . . . . 60.41 110.597 178.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -81.57 4.44 21.41 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.695 0.798 . . . . 74.14 111.019 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.89 24.96 75.87 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-O 119.459 -0.634 . . . . 74.22 114.538 170.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -73.03 148.89 43.7 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 117.271 0.535 . . . . 72.34 109.805 173.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.85 121.01 40.66 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.566 -0.901 . . . . 62.4 108.566 177.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.678 ' HE2' ' HB ' ' A' ' 84' ' ' VAL . 1.2 tmtp? -82.73 126.27 32.19 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.756 -1.202 . . . . 61.13 107.756 176.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 88.2 t -129.37 111.18 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 107.698 -1.223 . . . . 73.11 107.698 177.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.678 ' HB ' ' HE2' ' A' ' 82' ' ' LYS . 10.2 p -98.99 125.86 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 108.717 -0.846 . . . . 74.55 108.717 -177.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -97.72 -25.67 15.0 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.839 0.455 . . . . 72.5 110.755 -176.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.416 HD13 ' HD2' ' A' ' 93' ' ' LYS . 45.4 mm -94.04 98.54 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 108.927 -0.768 . . . . 73.41 108.927 174.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -79.35 132.12 36.33 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.944 -1.026 . . . . 63.42 110.582 -178.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -64.58 96.86 0.18 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.629 0.772 . . . . 74.25 110.867 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.01 174.18 46.75 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.066 -0.97 . . . . 65.31 112.736 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -83.37 61.32 4.78 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 114.639 -0.78 . . . . 71.11 111.851 175.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 76.4 mt -106.45 176.77 5.06 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.412 1.085 . . . . 71.5 110.134 -174.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.8 p -76.64 -3.15 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.516 0 CA-C-O 121.433 0.635 . . . . 75.33 110.509 174.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.416 ' HD2' HD13 ' A' ' 86' ' ' ILE . 47.3 mmtm -68.13 127.89 93.27 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 123.673 0.789 . . . . 71.12 110.202 170.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.18 136.84 20.57 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.35 2.033 . . . . 55.33 110.446 173.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -71.75 6.67 1.85 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 114.277 1.214 . . . . 75.3 114.277 -163.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -67.11 96.66 0.47 Allowed 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 109.519 -0.548 . . . . 61.32 109.519 168.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -39.95 107.21 0.07 Allowed 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.036 0.934 . . . . 72.35 112.796 175.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.434 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 12.8 t70 -97.21 113.3 24.89 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 107.718 -1.216 . . . . 54.2 107.718 174.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.534 HG23 ' HE3' ' A' ' 82' ' ' LYS . 87.1 m -122.49 112.08 17.6 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.89 0.876 . . . . 61.03 109.483 -176.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 46' ' ' PHE . 41.4 tt0 -105.0 114.17 28.21 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.898 0.879 . . . . 74.34 108.853 -178.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -95.97 121.4 37.68 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.023 -1.103 . . . . 74.21 108.023 174.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -125.75 143.7 50.94 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.531 0.733 . . . . 70.23 109.685 -176.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.2 t-80 -158.92 133.31 5.3 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 108.568 -0.901 . . . . 73.14 108.568 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -64.19 -21.39 67.54 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.617 2.211 . . . . 74.43 113.556 -175.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.427 ' HB2' HG12 ' A' ' 117' ' ' ILE . 12.0 m -96.36 6.24 49.19 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.969 0.507 . . . . 72.01 111.128 178.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -114.32 100.03 8.03 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 106.974 -1.491 . . . . 74.34 106.974 171.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 110' ' ' GLN . 49.4 mt -129.38 158.95 37.71 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.707 -0.849 . . . . 74.42 108.707 175.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.528 ' HG3' ' HH2' ' A' ' 25' ' ' TRP . 35.8 ttp180 -73.62 126.38 30.15 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 123.394 0.677 . . . . 74.02 110.71 -178.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.57 28.86 72.92 Favored Glycine 0 C--N 1.346 1.134 0 O-C-N 123.872 0.732 . . . . 62.5 112.198 -177.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.403 ' HB3' ' HB2' ' A' ' 107' ' ' LEU . 6.3 tp60 -136.96 37.94 2.57 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 122.633 1.206 . . . . 75.32 108.122 -175.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.92 -10.61 58.13 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 113.533 -1.667 . . . . 71.24 113.393 -173.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 21.0 pm0 -64.85 -18.31 65.03 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.719 0.408 . . . . 71.42 111.437 172.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 67.3 mt -90.52 -6.88 54.23 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.272 0.629 . . . . 42.31 111.837 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 96.6 mt -66.76 -33.71 76.23 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 118.041 0.382 . . . . 72.25 111.003 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -73.72 -12.78 60.83 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 120.882 0.372 . . . . 70.45 111.49 174.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -94.97 -14.45 24.39 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.569 0.747 . . . . 74.24 109.355 177.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.427 HG12 ' HB2' ' A' ' 105' ' ' CYS . 45.2 mt -83.93 75.46 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.069 0 N-CA-C 107.344 -1.354 . . . . 73.33 107.344 169.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.435 ' HD2' ' O ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -69.13 147.28 51.63 Favored 'General case' 0 CA--C 1.558 1.284 0 CA-C-N 115.322 -0.853 . . . . 62.44 113.296 173.644 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -86.01 -27.66 24.68 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 114.712 -1.131 . . . . 75.41 109.536 174.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.435 ' O ' ' HD2' ' A' ' 118' ' ' LYS . 31.5 mmmt -103.48 171.84 7.14 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.204 1.402 . . . . 63.22 109.69 175.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.5 p -95.27 33.26 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-O 122.627 1.203 . . . . 65.54 109.633 175.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 4.7 t -62.33 101.8 0.26 Allowed 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 114.279 -1.328 . . . . 75.53 110.904 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.2 p -174.88 153.0 1.62 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.972 1.309 . . . . 72.01 108.488 -174.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.6 m -63.97 137.28 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 122.785 0.434 . . . . 72.42 111.81 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 26.7 m . . . . . 0 CA--C 1.554 1.12 0 C-N-CA 123.301 0.64 . . . . 72.55 109.98 -177.895 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.1 ttm . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 120.763 0.316 . . . . 64.2 110.279 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -99.44 153.5 19.65 Favored Glycine 0 C--N 1.349 1.273 0 N-CA-C 111.047 -0.821 . . . . 55.14 111.047 173.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -70.41 86.23 0.61 Allowed 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.103 -0.702 . . . . 65.42 109.103 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.38 121.66 21.74 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.155 0.582 . . . . 63.34 111.22 -175.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 64.5 t60 -157.2 112.05 2.75 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.421 0.688 . . . . 62.31 109.589 177.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 46.6 p-80 -146.54 155.34 42.43 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.642 0.777 . . . . 73.32 110.13 176.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -133.77 148.43 51.38 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.105 0.962 . . . . 71.22 109.025 172.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 24.1 p80 -132.56 116.6 16.92 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.288 -1.004 . . . . 74.52 108.288 171.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.0 t -118.98 125.17 48.77 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.164 0.985 . . . . 63.33 110.579 -170.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -81.74 90.11 6.34 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 109.182 -0.673 . . . . 64.04 109.182 170.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 38.7 mtt -99.43 123.38 43.65 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.145 0.578 . . . . 62.23 109.481 173.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -108.78 113.73 26.92 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.053 0.941 . . . . 51.51 108.897 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.6 132.63 38.01 Favored Glycine 0 C--N 1.348 1.202 0 CA-C-O 118.11 -1.383 . . . . 72.3 111.491 175.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -56.82 92.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 123.185 2.59 . . . . 65.43 112.181 -177.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 77.5 p -71.7 128.42 35.73 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.694 0.798 . . . . 74.22 109.061 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -83.45 -6.71 59.54 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.278 0.631 . . . . 72.21 111.423 -171.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.4 t -50.37 114.8 4.82 Favored Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 124.348 1.059 . . . . 63.41 110.815 176.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.48 ' HD2' HD12 ' A' ' 21' ' ' LEU . 53.0 Cg_exo -56.61 155.93 24.46 Favored 'Trans proline' 0 C--N 1.382 2.299 0 C-N-CA 123.253 2.635 . . . . 74.45 112.495 178.045 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.82 -43.74 66.2 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.638 0.775 . . . . 74.11 111.283 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -53.37 -47.01 69.82 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.531 0.733 . . . . 73.52 112.151 175.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.48 HD12 ' HD2' ' A' ' 18' ' ' PRO . 72.9 mt -81.76 -27.64 33.68 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.31 0.485 . . . . 73.43 112.31 -171.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.1 t -76.07 -32.17 59.15 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 118.285 0.493 . . . . 71.13 111.045 174.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.488 ' HE2' ' HA ' ' A' ' 23' ' ' LYS . 10.2 mmpt? -71.33 -38.92 71.65 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.502 -0.555 . . . . 52.13 109.502 173.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.5 tp -61.44 -44.49 97.03 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 123.919 0.762 . . . . 75.02 110.797 172.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -53.51 -56.08 20.02 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.071 0.948 . . . . 72.14 111.233 177.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.1 m -56.5 -47.39 79.38 Favored 'General case' 0 C--O 1.214 -0.786 0 O-C-N 124.574 1.171 . . . . 40.44 110.402 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.426 ' HG ' HG21 ' A' ' 37' ' ' ILE . 28.7 tp -54.79 -53.11 59.45 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.605 1.562 . . . . 73.34 113.133 -174.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 65.6 t -66.82 -28.14 42.11 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 C-N-CA 123.821 0.848 . . . . 74.44 111.104 178.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.3 t -94.05 -7.21 43.28 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.314 1.046 . . . . 71.24 112.263 -177.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -89.68 128.73 49.41 Favored Pre-proline 0 N--CA 1.484 1.234 0 C-N-CA 123.515 0.726 . . . . 74.15 111.614 -171.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -77.5 -11.05 17.31 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 122.859 2.373 . . . . 75.44 114.232 -178.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -81.3 -28.75 34.49 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 118.422 0.555 . . . . 73.21 110.862 175.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.422 HG21 ' HE1' ' A' ' 62' ' ' TYR . 40.0 p -114.51 4.0 15.08 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 112.435 0.532 . . . . 71.04 112.435 -177.265 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 1.5 p-10 -65.44 -24.82 67.28 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 112.3 0.481 . . . . 65.31 112.3 -174.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -68.05 -26.57 65.93 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.265 0.626 . . . . 61.44 112.448 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.455 HD22 ' HB2' ' A' ' 50' ' ' ASP . 66.4 mt -106.57 -13.89 15.19 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.02 0.528 . . . . 73.13 111.517 178.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.509 ' O ' ' HA ' ' A' ' 34' ' ' ASP . 16.4 tt -161.25 124.67 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-O 120.844 0.354 . . . . 64.14 111.26 174.148 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 28.0 p -148.92 161.12 42.52 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.933 -0.766 . . . . 62.54 108.933 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 38.7 p-90 -82.47 148.54 28.09 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 108.965 -0.754 . . . . 60.13 108.965 176.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.9 m -75.54 151.31 85.04 Favored Pre-proline 0 CA--C 1.546 0.793 0 CA-C-N 115.176 -0.92 . . . . 52.24 110.084 -176.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -46.67 -39.64 23.51 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 123.468 2.779 . . . . 72.33 115.451 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 26.3 p -80.88 -9.8 59.79 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 112.086 0.402 . . . . 61.35 112.086 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.92 -0.08 83.76 Favored Glycine 0 C--N 1.351 1.403 0 N-CA-C 115.962 1.145 . . . . 64.41 115.962 163.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -94.44 -2.15 52.37 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.962 0.905 . . . . 71.21 111.705 -175.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.409 ' HB3' ' HB3' ' A' ' 102' ' ' GLN . 80.9 p -148.59 174.8 11.76 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.908 0.883 . . . . 43.14 110.163 -179.136 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -145.66 153.97 41.6 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.226 0.61 . . . . 72.42 110.084 170.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -112.92 149.32 33.36 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.114 0.966 . . . . 63.35 110.065 -178.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 98' ' ' ASP . 76.3 t -123.35 105.84 16.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 124.787 1.235 . . . . 62.15 107.987 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -91.18 145.18 24.88 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 124.041 0.936 . . . . 55.14 110.669 -177.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.455 ' HB2' HD22 ' A' ' 36' ' ' LEU . 3.2 m-20 53.0 57.46 6.31 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 124.579 1.175 . . . . 71.34 111.61 173.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -55.33 -26.31 40.03 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 114.332 1.234 . . . . 72.15 114.332 -169.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.38 -47.88 40.77 Favored Glycine 0 CA--C 1.531 1.093 0 N-CA-C 111.838 -0.505 . . . . 60.31 111.838 174.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -69.17 -44.3 72.51 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.394 0.678 . . . . 71.31 109.477 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -52.74 -51.37 60.79 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.318 1.447 . . . . 74.45 111.331 175.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.414 ' HB2' ' HB2' ' A' ' 68' ' ' MET . . . -64.57 -34.88 79.28 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.51 -0.314 . . . . 61.43 111.778 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -66.1 -46.77 76.47 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.457 1.103 . . . . 74.03 112.377 -176.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.546 ' HG3' HG23 ' A' ' 58' ' ' VAL . 6.9 pt-20 -109.76 -39.26 5.16 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 113.766 1.024 . . . . 55.32 113.766 -173.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.546 HG23 ' HG3' ' A' ' 57' ' ' GLU . 84.9 t -82.5 -38.23 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.253 0.621 . . . . 62.14 111.615 -168.167 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 51.1 mt -69.97 -43.47 19.88 Favored Pre-proline 0 CA--C 1.565 1.519 0 CA-C-O 118.073 -0.965 . . . . 73.55 112.94 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -71.06 -10.57 27.72 Favored 'Trans proline' 0 C--N 1.385 2.497 0 CA-C-N 122.058 1.771 . . . . 42.32 113.155 171.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -78.91 -52.68 7.95 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.151 0.981 . . . . 74.33 110.964 176.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.436 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 49.3 m-85 -87.43 -24.45 24.17 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 122.892 0.477 . . . . 63.44 112.155 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -126.29 -150.09 0.43 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 107.35 -1.352 . . . . 74.24 107.35 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -142.88 55.54 1.39 Allowed 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.99 0.9 . . . . 73.23 109.615 172.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 32.7 p80 -154.51 148.3 25.48 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 114.845 -1.071 . . . . 65.1 108.825 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -110.98 0.18 16.92 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.263 0.625 . . . . 62.31 109.685 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -74.73 117.24 16.34 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.112 0.965 . . . . 74.53 110.088 176.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.414 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 13.6 tpt -75.56 -35.83 60.56 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.085 0.554 . . . . 73.21 110.77 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.89 -32.6 67.88 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.228 0.611 . . . . 63.43 111.61 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.46 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 44.7 t -59.25 -52.07 67.26 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.991 0.917 . . . . 71.32 111.068 173.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -64.96 -51.59 60.95 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.119 0.967 . . . . 74.42 110.894 -174.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.0 t -58.18 -46.46 88.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 124.024 0.93 . . . . 74.22 111.629 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.9 ttt85 -57.63 -41.2 80.89 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 123.671 0.607 . . . . 73.02 111.784 -178.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 70' ' ' SER . 13.3 mm100 -60.93 -48.12 83.28 Favored 'General case' 0 C--N 1.351 0.666 0 O-C-N 123.706 0.629 . . . . 74.22 109.829 -178.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.4 mt -64.98 -42.62 94.39 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.842 0.714 . . . . 60.4 111.129 -178.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -59.77 -37.91 80.36 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.243 0.617 . . . . 74.22 111.329 177.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 59.9 mtm -71.01 -32.55 69.37 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.627 0.371 . . . . 54.54 110.428 174.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -73.15 -2.2 20.59 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.476 0.71 . . . . 74.01 111.426 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.13 12.94 64.87 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-O 119.633 -0.537 . . . . 72.12 113.62 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -74.93 147.55 40.83 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.178 -1.045 . . . . 73.54 108.178 174.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.465 ' HB3' ' HG3' ' A' ' 102' ' ' GLN . 34.9 ttm-85 -98.88 122.03 41.6 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.723 -0.843 . . . . 74.53 108.723 -174.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -79.95 113.65 18.27 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.096 1.358 . . . . 63.14 108.846 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 39.4 t -123.86 125.56 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 108.905 -0.776 . . . . 52.21 108.905 178.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 68.9 t -106.21 110.08 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 108.127 -1.064 . . . . 75.21 108.127 178.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -88.33 -46.88 8.83 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.826 0.45 . . . . 71.25 111.652 -173.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.532 ' HA ' ' HD3' ' A' ' 93' ' ' LYS . 33.0 mm -80.1 90.51 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 121.604 0.716 . . . . 74.33 109.855 -175.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -67.04 87.96 0.15 Allowed 'General case' 0 C--O 1.245 0.839 0 CA-C-N 114.274 -1.33 . . . . 71.15 109.844 171.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -80.22 93.23 5.83 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.465 -0.789 . . . . 74.33 109.476 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -155.9 17.71 0.47 Allowed Glycine 0 C--N 1.34 0.799 0 CA-C-N 115.297 -0.865 . . . . 64.22 112.238 178.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.24 26.96 16.92 Favored Glycine 0 C--N 1.347 1.16 0 C-N-CA 122.91 0.29 . . . . 63.43 113.031 -178.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 59.5 mt -93.56 172.03 8.52 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.556 0.742 . . . . 71.51 110.204 172.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.8 p -77.73 72.41 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-O 122.744 1.259 . . . . 75.12 110.394 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.532 ' HD3' ' HA ' ' A' ' 86' ' ' ILE . 62.2 mttp -143.9 151.2 52.19 Favored Pre-proline 0 CA--C 1.557 1.235 0 C-N-CA 125.29 1.436 . . . . 72.52 109.783 -178.161 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.76 156.7 64.73 Favored 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 123.157 2.571 . . . . 60.11 112.749 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -82.59 61.9 5.95 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.316 0.646 . . . . 72.45 111.112 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -137.46 165.87 25.21 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.091 0.557 . . . . 64.14 110.426 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -103.38 118.7 37.36 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.802 -0.814 . . . . 73.11 108.802 169.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.504 ' HB3' HG12 ' A' ' 86' ' ' ILE . 22.5 t70 -122.94 122.95 39.81 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.979 0.912 . . . . 64.13 109.773 177.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 50.1 m -120.06 127.55 52.68 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.741 0.816 . . . . 72.52 109.834 175.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.403 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 39.0 tt0 -100.52 117.54 34.88 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.407 -0.96 . . . . 75.53 108.407 173.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -98.19 118.93 35.92 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.357 -0.979 . . . . 73.21 108.357 169.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.465 ' HG3' ' HB3' ' A' ' 81' ' ' ARG . 2.6 pt20 -121.5 137.58 54.66 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.618 0.767 . . . . 73.33 109.292 178.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.574 ' HB3' ' HB3' ' A' ' 106' ' ' PHE . 65.0 t-80 -148.33 129.24 7.0 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-O 118.95 -0.548 . . . . 74.51 110.353 -171.224 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -65.16 -38.86 25.72 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 123.14 2.56 . . . . 61.33 113.437 -173.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.46 ' HB2' ' HE1' ' A' ' 103' ' ' HIS . 35.4 m -93.54 28.93 2.12 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.926 0.49 . . . . 61.23 110.458 178.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.574 ' HB3' ' HB3' ' A' ' 103' ' ' HIS . 67.4 t80 -133.57 113.28 12.26 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.862 -0.792 . . . . 64.23 108.862 174.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.63 ' HB2' ' HB2' ' A' ' 110' ' ' GLN . 50.0 mt -117.51 157.48 26.23 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 108.706 -0.85 . . . . 63.12 108.706 173.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.38 -26.95 65.54 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.459 1.103 . . . . 74.53 112.974 -171.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.19 37.83 2.02 Favored Glycine 0 N--CA 1.471 0.973 0 N-CA-C 112.252 -0.339 . . . . 62.42 112.252 -177.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.63 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -131.24 71.8 1.48 Allowed 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 121.515 0.674 . . . . 74.32 109.673 -178.35 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -63.27 -30.36 71.51 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.345 1.058 . . . . 61.34 113.145 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 19.8 pm0 -66.28 -15.77 63.49 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.748 0.419 . . . . 73.54 111.639 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.525 ' O ' HG13 ' A' ' 117' ' ' ILE . 49.3 mt -87.03 -21.45 26.09 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 118.953 -0.546 . . . . 75.35 111.374 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 96.8 mt -57.4 -41.1 79.64 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 123.395 0.678 . . . . 63.25 111.33 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -76.93 -7.83 56.27 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 115.448 -0.796 . . . . 71.21 112.581 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -101.15 -9.19 21.56 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.705 0.802 . . . . 74.43 109.857 172.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 113' ' ' LEU . 72.7 mt -81.13 108.96 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 107.265 -1.383 . . . . 72.53 107.265 173.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.478 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 11.2 mmpt? -108.67 144.09 36.88 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.997 -0.742 . . . . 74.4 108.997 -172.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 31.0 ptt-85 -96.94 2.38 51.55 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.655 0.597 . . . . 63.32 110.788 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -100.98 176.34 5.3 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.692 0.797 . . . . 71.35 110.442 177.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 29.6 m -87.5 68.95 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-O 123.18 1.467 . . . . 64.12 111.09 -174.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.0 t -77.38 -168.88 1.24 Allowed 'General case' 0 CA--C 1.559 1.318 0 CA-C-N 113.806 -1.543 . . . . 64.31 109.782 171.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 17.4 p -74.75 73.07 2.05 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 121.726 0.774 . . . . 74.44 111.275 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 16.5 m -139.48 157.4 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 125.308 1.443 . . . . 72.25 108.704 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 62.2 m . . . . . 0 C--O 1.254 1.296 0 N-CA-C 108.759 -0.83 . . . . 72.31 108.759 175.736 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 121.041 0.448 . . . . 55.32 110.786 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 155.11 128.66 1.17 Allowed Glycine 0 C--N 1.344 0.98 0 N-CA-C 110.284 -1.127 . . . . 74.43 110.284 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -92.73 165.36 12.99 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.974 0.51 . . . . 75.12 109.765 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -61.48 95.1 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.003 0.921 . . . . 73.44 111.106 -173.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.2 m170 -104.79 153.82 20.82 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.783 0.833 . . . . 74.35 109.32 173.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.2 m80 68.38 10.96 8.17 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 125.106 1.363 . . . . 71.54 112.283 175.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -75.1 119.55 19.4 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 109.785 -0.45 . . . . 54.31 109.785 -177.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -145.96 176.11 9.94 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.531 0.732 . . . . 61.45 109.803 -178.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.9 m -137.13 126.81 25.39 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.79 0.836 . . . . 74.03 108.86 175.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -59.24 -63.98 1.11 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.285 0.634 . . . . 72.54 110.315 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.499 ' HG3' ' O ' ' A' ' 14' ' ' PRO . 0.0 OUTLIER 177.61 149.86 0.18 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.085 1.354 . . . . 72.42 108.998 174.116 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -129.73 40.42 3.58 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.012 0.925 . . . . 31.05 108.543 177.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 176.29 -71.55 0.08 OUTLIER Glycine 0 C--N 1.348 1.219 0 CA-C-N 115.055 -0.975 . . . . 74.13 112.351 -177.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.499 ' O ' ' HG3' ' A' ' 11' ' ' MET . 34.3 Cg_exo -61.56 88.4 0.1 OUTLIER 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 123.413 2.742 . . . . 74.24 112.875 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 42.6 t -68.57 131.92 46.05 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.519 0.728 . . . . 71.21 111.189 -177.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -82.92 -3.7 57.32 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.433 0.693 . . . . 54.53 111.92 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.6 t -70.17 118.95 68.71 Favored Pre-proline 0 CA--C 1.553 1.083 0 N-CA-C 107.75 -1.204 . . . . 71.03 107.75 166.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -52.9 135.78 58.72 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 123.013 2.475 . . . . 74.24 112.621 177.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.96 -42.42 68.9 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.31 1.044 . . . . 74.34 112.335 -178.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -57.66 -40.75 80.05 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.252 0.621 . . . . 73.22 111.653 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 66.0 mt -78.04 -34.06 50.69 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 112.25 0.463 . . . . 73.21 112.25 -174.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.1 t -74.45 -37.22 63.32 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 119.688 -0.196 . . . . 73.25 110.885 178.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.501 ' HE2' ' HA ' ' A' ' 23' ' ' LYS . 8.5 mmpt? -70.79 -37.06 73.29 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 122.793 0.437 . . . . 63.45 110.102 175.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.436 ' O ' HG23 ' A' ' 28' ' ' VAL . 59.9 tp -58.5 -53.59 56.63 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 123.808 0.843 . . . . 75.34 111.453 173.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 24.1 t-105 -61.68 -41.74 97.98 Favored 'General case' 0 CA--C 1.549 0.921 0 O-C-N 123.027 0.204 . . . . 75.34 111.182 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.453 ' O ' ' HB2' ' A' ' 30' ' ' ASP . 90.7 m -59.38 -36.52 75.95 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 122.897 0.479 . . . . 74.42 110.762 174.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.48 ' HG ' HG21 ' A' ' 37' ' ' ILE . 50.5 tp -70.78 -51.02 29.64 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.633 1.173 . . . . 65.41 111.939 -178.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 24' ' ' LEU . 96.4 t -60.58 -33.86 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.69 1.196 . . . . 65.43 111.2 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.6 t -86.91 -24.44 24.82 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.855 0.862 . . . . 73.42 111.684 -176.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 26' ' ' THR . 8.7 t70 -69.3 128.62 92.34 Favored Pre-proline 0 N--CA 1.488 1.467 0 C-N-CA 122.856 0.462 . . . . 74.14 111.828 -168.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.32 -1.89 11.29 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 123.175 2.583 . . . . 75.22 114.507 -176.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -87.15 -34.28 19.12 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 118.305 0.502 . . . . 61.54 111.0 172.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.0 p -112.27 1.57 16.19 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.742 0.817 . . . . 74.23 112.398 -171.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.432 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 8.9 p-10 -61.18 -25.15 66.83 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.951 0.901 . . . . 54.42 111.923 -178.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.26 -33.64 75.94 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.957 0.903 . . . . 75.11 112.496 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.438 HD22 ' HB2' ' A' ' 50' ' ' ASP . 69.3 mt -108.14 -13.35 14.94 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.221 0.608 . . . . 62.2 112.001 -178.073 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.48 HG21 ' HG ' ' A' ' 27' ' ' LEU . 19.8 tt -157.39 117.67 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-O 121.266 0.555 . . . . 64.21 110.507 177.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 29.0 p -144.73 153.01 41.24 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.212 0.605 . . . . 74.13 109.803 -178.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 35.5 p-90 -82.21 153.15 26.09 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.922 -0.581 . . . . 73.41 109.738 178.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.6 m -82.49 156.91 68.21 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 108.726 -0.842 . . . . 65.41 108.726 -178.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -61.23 -12.29 22.8 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.449 2.1 . . . . 35.04 113.297 178.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 77.2 p -74.44 -36.87 63.41 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.824 0.85 . . . . 74.43 110.656 171.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.93 -8.12 77.46 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 115.504 -0.771 . . . . 63.32 113.415 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.572 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 25.1 p30 -101.2 12.59 37.27 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.181 0.992 . . . . 50.03 111.37 -172.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.4 p -163.77 151.86 13.12 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.888 0.875 . . . . 63.05 109.538 -175.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -138.99 147.25 41.92 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.946 0.498 . . . . 71.44 109.871 177.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -101.99 144.69 30.28 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.478 0.711 . . . . 61.43 109.556 -176.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.408 HG12 ' HG2' ' A' ' 51' ' ' GLN . 95.8 t -121.66 115.61 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 107.504 -1.295 . . . . 71.1 107.504 177.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.483 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 25.4 m-85 -114.51 149.14 36.85 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.661 1.185 . . . . 71.31 110.743 -172.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.438 ' HB2' HD22 ' A' ' 36' ' ' LEU . 5.4 m-20 52.36 53.2 12.75 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 125.021 1.45 . . . . 50.12 110.51 176.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.706 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 55.5 mt-30 -53.39 -25.85 17.2 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 114.853 -1.067 . . . . 71.21 113.576 -170.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.45 -50.42 55.47 Favored Glycine 0 CA--C 1.534 1.266 0 N-CA-C 112.205 -0.358 . . . . 71.11 112.205 174.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -73.72 -33.49 64.38 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.143 0.977 . . . . 74.41 110.608 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.43 ' HB3' ' HA ' ' A' ' 51' ' ' GLN . 83.3 t80 -66.03 -54.54 24.59 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.345 1.058 . . . . 74.42 110.582 -178.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.6 -26.04 67.66 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 116.108 -0.496 . . . . 43.31 111.724 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.1 tttm -64.01 -55.58 21.3 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.816 1.246 . . . . 72.14 113.064 178.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.491 ' HG3' HG23 ' A' ' 58' ' ' VAL . 2.1 pt-20 -112.02 -33.65 6.2 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 113.259 0.836 . . . . 73.41 113.259 -170.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.491 HG23 ' HG3' ' A' ' 57' ' ' GLU . 61.8 t -85.22 -43.23 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.305 0.642 . . . . 75.3 111.328 -168.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 17.6 mt -62.57 -51.64 71.13 Favored Pre-proline 0 CA--C 1.558 1.272 0 CA-C-O 118.312 -0.851 . . . . 41.0 112.429 178.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.3 -7.48 21.32 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 121.726 1.617 . . . . 45.02 112.783 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -80.11 -60.97 2.13 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.09 0.956 . . . . 71.13 110.771 175.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -83.73 -32.17 25.64 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 122.755 0.422 . . . . 64.23 112.052 -176.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -112.11 -175.95 2.81 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.82 -0.807 . . . . 71.23 108.82 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.95 28.8 8.1 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.392 0.677 . . . . 73.12 111.295 -174.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 26.1 p80 -157.42 155.95 31.37 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.155 0.582 . . . . 65.41 109.82 -172.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 38.8 p30 -117.74 -7.5 10.99 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.394 0.677 . . . . 71.53 111.668 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -72.94 121.55 20.25 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.861 -0.422 . . . . 61.41 109.861 -178.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.706 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 2.4 tpt -59.48 -45.52 91.44 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.186 0.994 . . . . 74.21 111.227 178.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.73 -34.68 74.77 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.574 -0.739 . . . . 65.44 112.087 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.4 t -63.2 -40.92 98.86 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.252 0.621 . . . . 71.03 111.35 175.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -64.13 -53.08 55.24 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.134 0.974 . . . . 72.04 110.861 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.4 HG22 ' HZ ' ' A' ' 101' ' ' PHE . 58.1 t -61.16 -39.49 82.63 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 CA-C-N 115.079 -0.964 . . . . 75.34 111.394 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -57.78 -48.91 78.35 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.617 0.767 . . . . 74.3 111.235 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -58.13 -43.16 87.14 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 124.437 1.086 . . . . 72.41 110.641 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.7 mt -65.18 -41.53 94.52 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.219 0.608 . . . . 64.2 111.672 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -60.34 -35.88 76.69 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 122.584 0.354 . . . . 63.55 111.185 172.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.47 ' O ' ' HA ' ' A' ' 119' ' ' ARG . 48.2 mtp -65.63 -39.68 91.71 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.149 0.58 . . . . 64.33 110.126 175.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -81.53 -1.33 45.8 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.081 0.552 . . . . 64.03 111.518 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.03 22.15 57.95 Favored Glycine 0 C--N 1.35 1.331 0 N-CA-C 114.399 0.52 . . . . 60.2 114.399 174.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.553 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . 34.2 m-85 -78.82 130.56 35.84 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.343 -0.984 . . . . 51.23 108.343 173.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -100.93 129.61 46.81 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.208 0.603 . . . . 73.43 109.649 -171.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -71.54 122.55 20.67 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.514 1.126 . . . . 71.44 110.905 -178.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 90.6 t -132.3 127.4 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 107.488 -1.301 . . . . 71.42 107.488 172.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.59 131.97 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 109.122 -0.696 . . . . 55.15 109.122 177.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 29.6 m-70 -102.49 -33.29 9.57 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.054 0.542 . . . . 65.35 110.207 -178.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 30.8 mm -74.11 87.83 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 108.736 -0.838 . . . . 64.02 108.736 169.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.417 ' H ' ' HE3' ' A' ' 93' ' ' LYS . 46.3 mt-10 -81.09 125.01 29.69 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 114.644 -1.162 . . . . 73.13 111.613 -175.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -117.49 75.6 1.0 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.344 0.657 . . . . 73.3 110.176 177.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -88.66 -69.03 1.27 Allowed Glycine 0 N--CA 1.47 0.902 0 N-CA-C 110.227 -1.149 . . . . 61.33 110.227 170.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -135.12 17.92 4.04 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 123.946 0.784 . . . . 71.02 111.241 171.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 68.9 mt -91.12 169.76 10.58 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.431 1.093 . . . . 73.0 110.643 -175.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.452 HG13 ' H ' ' A' ' 93' ' ' LYS . 6.5 p -101.68 -67.01 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 CA-C-O 118.985 -0.531 . . . . 63.12 109.796 175.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.452 ' H ' HG13 ' A' ' 92' ' ' VAL . 64.0 mttm 58.98 165.83 0.08 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 C-N-CA 124.733 1.213 . . . . 61.42 113.224 -178.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -61.73 145.28 97.47 Favored 'Trans proline' 0 C--N 1.385 2.481 0 C-N-CA 122.153 1.902 . . . . 65.14 110.764 170.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.57 -14.78 61.7 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.326 0.65 . . . . 72.12 112.56 -170.213 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -59.96 142.82 53.1 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 123.525 0.73 . . . . 71.24 110.184 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.483 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 2.5 m-20 -80.73 147.22 30.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.614 -0.721 . . . . 61.35 109.765 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -134.78 117.93 16.5 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.864 0.866 . . . . 55.14 109.345 172.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 86.3 m -135.06 109.0 8.12 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.595 0.758 . . . . 72.21 109.125 178.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -99.15 119.7 38.28 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.786 -0.82 . . . . 64.42 108.786 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.553 ' HB3' ' HB3' ' A' ' 80' ' ' PHE . 92.9 m-85 -99.62 120.31 39.47 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.556 -0.905 . . . . 72.11 108.556 173.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -109.99 144.59 38.31 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.368 0.667 . . . . 64.25 110.027 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 15.9 t60 -153.34 127.06 4.33 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 109.149 -0.686 . . . . 75.34 109.149 177.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.8 -34.86 59.8 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 123.021 2.481 . . . . 73.44 112.957 -177.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 36.1 m -93.19 26.29 2.94 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 121.234 0.54 . . . . 75.33 110.833 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.572 ' O ' ' HA ' ' A' ' 44' ' ' ASN . 85.8 t80 -124.9 110.36 14.16 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 107.092 -1.448 . . . . 73.3 107.092 172.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.647 ' HB2' ' HB3' ' A' ' 110' ' ' GLN . 85.2 mt -131.48 174.49 10.04 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 108.849 -0.797 . . . . 65.23 108.849 170.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -63.09 -75.7 0.07 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.527 0.731 . . . . 72.33 111.513 -178.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -80.25 -10.9 84.9 Favored Glycine 0 C--N 1.349 1.271 0 O-C-N 123.195 0.31 . . . . 74.33 113.157 -177.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.647 ' HB3' ' HB2' ' A' ' 107' ' ' LEU . 5.3 tp-100 -90.99 40.55 1.03 Allowed 'General case' 0 CA--C 1.556 1.178 0 CA-C-O 121.531 0.682 . . . . 70.43 109.323 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -69.63 -12.53 61.72 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.088 0.955 . . . . 65.42 112.687 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.3 pm0 -64.45 -10.11 23.03 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.197 0.599 . . . . 75.24 112.174 169.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.474 ' O ' HG13 ' A' ' 117' ' ' ILE . 53.0 mt -91.18 -4.58 55.96 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.172 0.589 . . . . 75.41 111.961 175.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 90.2 mt -66.03 -34.56 78.36 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 118.536 0.607 . . . . 62.31 111.162 176.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -75.25 -17.25 60.36 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.515 0.726 . . . . 52.31 111.415 172.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -90.86 -9.86 44.78 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.413 0.685 . . . . 71.23 110.034 176.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 113' ' ' LEU . 59.3 mt -84.26 121.7 36.95 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 N-CA-C 107.294 -1.373 . . . . 73.1 107.294 170.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.521 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 10.8 mmpt? -111.14 151.79 27.74 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.225 0.61 . . . . 64.11 109.837 -178.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 77' ' ' MET . 43.3 ptt85 -107.98 -179.46 3.9 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.053 -0.976 . . . . 75.25 109.563 170.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -73.66 165.53 24.92 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 116.051 -0.522 . . . . 75.45 109.985 169.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 22.3 t 63.44 65.52 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.242 1.017 . . . . 64.31 109.075 -171.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.3 t -156.5 148.78 23.32 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.815 -1.084 . . . . 75.13 108.981 178.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 66.2 p -168.09 144.02 3.85 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.046 0.539 . . . . 62.54 110.278 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.3 p -75.25 92.41 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 N-CA-C 108.84 -0.8 . . . . 70.23 108.84 170.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 39.3 m . . . . . 0 CA--C 1.557 1.246 0 C-N-CA 124.707 1.203 . . . . 63.43 109.989 -171.615 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 N--CA 1.482 1.133 0 N-CA-C 110.18 -0.304 . . . . 63.33 110.18 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -131.7 53.53 0.8 Allowed Glycine 0 C--N 1.355 1.588 0 N-CA-C 112.364 -0.294 . . . . 52.31 112.364 -170.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -131.65 42.88 3.13 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.685 0.794 . . . . 44.12 109.069 171.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 26.2 m170 -62.65 129.95 42.85 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.086 -0.961 . . . . 62.44 110.789 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -106.05 46.09 0.94 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.354 0.662 . . . . 73.12 110.218 -177.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -78.62 80.85 4.97 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 107.99 -1.115 . . . . 65.24 107.99 168.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 -138.44 87.61 2.24 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.622 -1.172 . . . . 61.22 108.672 -169.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.1 p80 55.18 115.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 126.895 2.078 . . . . 74.32 113.692 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.7 p -143.6 159.11 43.03 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.138 0.975 . . . . 72.45 109.823 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 54.2 m80 59.45 30.77 20.49 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.384 1.073 . . . . 72.14 111.816 176.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 70.8 mtp -60.43 108.18 0.78 Allowed 'General case' 0 C--N 1.352 0.676 0 C-N-CA 123.975 0.91 . . . . 73.14 108.982 175.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.79 157.74 35.87 Favored 'General case' 0 C--O 1.24 0.553 0 O-C-N 123.51 0.506 . . . . 62.11 110.792 -177.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.26 95.07 1.06 Allowed Glycine 0 C--N 1.336 0.576 0 CA-C-O 119.183 -0.787 . . . . 64.14 111.441 175.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.03 113.91 3.41 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 121.847 1.698 . . . . 65.11 110.353 174.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.8 t -76.8 -176.78 4.01 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.346 0.659 . . . . 72.54 110.339 -176.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.434 ' HB2' ' HB2' ' A' ' 115' ' ' GLU . 25.0 m-80 -65.83 -10.62 39.56 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.306 0.642 . . . . 71.32 111.866 178.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.8 t -57.55 115.24 10.22 Favored Pre-proline 0 N--CA 1.482 1.168 0 C-N-CA 123.878 0.871 . . . . 43.3 110.25 176.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -52.28 148.48 25.22 Favored 'Trans proline' 0 C--N 1.386 2.526 0 C-N-CA 123.718 2.945 . . . . 75.22 113.172 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.77 -42.42 64.98 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.833 0.853 . . . . 75.31 111.771 176.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -52.71 -49.9 64.44 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.617 0.767 . . . . 73.1 112.081 174.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 82.5 mt -80.61 -30.81 36.78 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.187 0.44 . . . . 72.13 112.187 -169.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.8 t -72.15 -36.54 69.36 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 118.009 0.368 . . . . 61.32 111.026 175.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.498 ' HE2' ' HA ' ' A' ' 23' ' ' LYS . 9.0 mmpt? -73.52 -36.49 65.72 Favored 'General case' 0 C--N 1.359 0.981 0 C-N-CA 122.869 0.468 . . . . 33.23 110.324 176.078 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.0 tp -62.76 -49.34 75.38 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 124.049 0.843 . . . . 74.02 110.99 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.478 ' HH2' ' HG2' ' A' ' 108' ' ' ARG . 12.0 t-105 -60.47 -43.62 96.73 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 122.36 0.264 . . . . 61.13 111.209 178.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.4 m -54.42 -51.19 65.7 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 122.631 0.373 . . . . 74.0 110.436 172.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.45 ' HG ' HD13 ' A' ' 37' ' ' ILE . 37.1 tp -57.19 -53.39 58.68 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.116 1.767 . . . . 44.12 113.201 -175.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.7 t -61.47 -35.45 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.659 1.184 . . . . 63.05 111.785 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.2 t -93.32 -6.52 47.2 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.778 -0.646 . . . . 44.52 111.351 -176.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -83.42 129.83 58.79 Favored Pre-proline 0 CA--C 1.552 1.055 0 C-N-CA 123.004 0.521 . . . . 74.33 111.18 -172.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -80.88 -9.63 13.06 Favored 'Trans proline' 0 C--N 1.382 2.328 0 C-N-CA 122.863 2.375 . . . . 42.34 114.027 -176.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -80.53 -27.42 37.63 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 118.49 0.586 . . . . 74.24 110.589 175.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.8 p -105.59 10.02 33.15 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.537 0.735 . . . . 74.41 112.486 -179.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -56.83 -32.27 65.59 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.151 0.981 . . . . 61.04 112.476 -175.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.08 -38.24 90.39 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.835 0.854 . . . . 75.31 112.968 -176.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.446 ' HA ' ' HB2' ' A' ' 49' ' ' PHE . 77.9 mt -110.97 -8.5 14.47 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 122.687 0.395 . . . . 61.01 111.837 -175.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.45 HD13 ' HG ' ' A' ' 27' ' ' LEU . 18.6 tt -162.42 134.36 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 122.62 0.368 . . . . 74.42 111.163 173.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.3 p -161.96 156.6 22.55 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.15 0.58 . . . . 75.04 109.879 173.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 14.8 p-90 -77.03 150.31 35.8 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.335 0.654 . . . . 71.41 110.504 -177.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.2 m -75.54 147.11 81.57 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 108.579 -0.897 . . . . 75.22 108.579 176.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.49 -12.89 12.01 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.615 2.21 . . . . 62.44 113.639 176.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.0 m -65.76 -43.95 87.31 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.664 1.186 . . . . 55.15 110.728 169.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.46 -10.98 69.07 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 114.934 -1.03 . . . . 71.42 114.147 177.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -101.84 6.43 41.53 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.456 1.102 . . . . 74.34 111.605 -171.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.2 p -157.36 161.75 39.05 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.121 0.969 . . . . 65.42 109.657 -171.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.431 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 45.9 p90 -146.61 146.52 30.45 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.66 0.384 . . . . 72.13 110.731 177.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -103.28 143.55 32.51 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.575 0.75 . . . . 63.33 109.632 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.0 t -123.14 121.98 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 107.569 -1.271 . . . . 71.13 107.569 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.552 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 90.6 m-85 -105.14 144.71 31.55 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 123.572 0.749 . . . . 71.23 109.759 -177.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 42.98 73.02 0.15 Allowed 'General case' 0 N--CA 1.476 0.851 0 O-C-N 125.254 1.596 . . . . 64.34 112.608 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -53.72 -26.9 25.2 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.499 1.119 . . . . 71.13 113.498 -175.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.31 -48.12 47.51 Favored Glycine 0 C--N 1.35 1.35 0 O-C-N 123.014 0.196 . . . . 61.43 112.69 173.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.423 ' HG3' HD11 ' A' ' 36' ' ' LEU . 56.1 tp60 -71.62 -37.13 70.95 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.018 0.927 . . . . 74.24 110.663 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.468 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 59.8 t80 -61.96 -48.93 78.17 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.224 1.41 . . . . 75.1 110.135 176.235 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.466 ' HB2' ' HB2' ' A' ' 68' ' ' MET . . . -62.45 -33.0 73.96 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 116.06 -0.518 . . . . 73.45 111.6 178.024 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.1 tttm -67.74 -55.52 12.82 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.611 1.165 . . . . 71.44 113.398 -177.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -106.78 -33.38 7.6 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 113.138 0.792 . . . . 70.1 113.138 -170.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.468 ' HB ' ' O ' ' A' ' 54' ' ' PHE . 94.4 t -82.78 -49.94 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 122.923 0.489 . . . . 73.44 111.605 -171.156 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.2 mt -61.48 -47.76 92.42 Favored Pre-proline 0 CA--C 1.561 1.369 0 CA-C-O 118.048 -0.977 . . . . 61.05 113.042 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -66.62 -16.62 51.2 Favored 'Trans proline' 0 C--N 1.391 2.783 0 CA-C-N 121.964 1.737 . . . . 74.41 113.073 177.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -77.03 -53.97 7.14 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.384 0.674 . . . . 54.25 111.253 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -87.29 -46.71 9.45 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.241 0.617 . . . . 73.42 111.686 -177.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -100.33 -179.9 4.26 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.383 -0.826 . . . . 64.42 108.785 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -112.64 40.03 2.36 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 121.634 0.73 . . . . 64.45 109.654 -174.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 32.2 p80 -157.66 161.5 38.6 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 114.949 -1.023 . . . . 75.34 109.01 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.413 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 31.7 p30 -112.95 -11.01 13.47 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.217 0.607 . . . . 43.25 110.128 177.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -73.39 120.53 19.13 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.439 0.696 . . . . 73.04 111.262 -176.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.466 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 12.2 tpt -69.9 -36.63 75.55 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.702 0.801 . . . . 74.22 111.303 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.65 -30.92 67.68 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 123.724 0.64 . . . . 73.5 111.962 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.1 t -65.54 -47.35 76.16 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.39 1.076 . . . . 71.45 110.841 174.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -63.74 -52.92 58.28 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.511 1.125 . . . . 75.42 110.471 -176.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.7 t -62.94 -40.89 90.67 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 CA-C-N 115.25 -0.886 . . . . 62.23 111.055 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -57.7 -40.97 80.74 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 123.272 0.629 . . . . 73.33 111.407 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -57.57 -51.0 71.25 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 124.187 0.929 . . . . 73.44 110.07 176.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 68.2 mt -63.56 -38.14 89.98 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.923 0.889 . . . . 73.25 111.714 -177.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -57.27 -44.6 84.11 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 122.803 0.441 . . . . 71.22 110.851 172.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 71.0 mtm -73.79 -25.17 59.99 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.905 -0.589 . . . . 54.11 111.499 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -86.54 1.58 51.13 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.35 0.66 . . . . 62.52 111.065 173.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.63 13.39 81.6 Favored Glycine 0 C--N 1.344 1.017 0 N-CA-C 115.068 0.787 . . . . 53.25 115.068 171.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -69.3 144.87 53.44 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 117.877 0.838 . . . . 73.12 109.248 177.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -101.18 122.54 43.82 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.414 -0.587 . . . . 75.31 109.414 -177.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.502 ' HE2' ' HB ' ' A' ' 84' ' ' VAL . 22.9 tptm -68.32 113.22 5.73 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.018 1.327 . . . . 74.11 109.743 172.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 90.3 t -125.58 106.61 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 107.711 -1.218 . . . . 73.55 107.711 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.502 ' HB ' ' HE2' ' A' ' 82' ' ' LYS . 3.5 p -107.7 123.11 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 108.442 -0.947 . . . . 73.02 108.442 -172.155 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -95.7 -26.05 15.86 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.164 0.586 . . . . 75.35 111.725 -169.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.412 HG12 ' HB3' ' A' ' 98' ' ' ASP . 47.1 mm -90.47 107.85 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.134 0.574 . . . . 63.21 110.242 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -90.02 100.89 13.62 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.836 0.854 . . . . 73.23 109.476 169.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -71.99 94.88 1.52 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.521 0.728 . . . . 73.21 109.121 176.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -160.23 -127.87 0.93 Allowed Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.106 -0.798 . . . . 62.24 111.106 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -98.24 51.61 1.26 Allowed Glycine 0 C--N 1.343 0.97 0 CA-C-N 116.893 0.347 . . . . 63.35 112.503 178.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 89.2 mt -120.86 168.44 11.45 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.963 0.905 . . . . 61.34 110.949 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.3 p -112.06 79.64 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 CA-C-O 122.97 1.366 . . . . 72.13 109.263 175.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -140.2 161.24 56.48 Favored Pre-proline 0 N--CA 1.48 1.054 0 CA-C-N 113.817 -1.538 . . . . 72.42 107.756 175.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -66.21 133.52 33.23 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 121.358 1.372 . . . . 71.22 109.707 174.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -81.12 4.95 18.24 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.933 0.893 . . . . 64.11 112.257 -170.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -57.54 171.15 0.47 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.214 1.006 . . . . 75.13 111.917 171.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.552 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 52.4 m-20 -86.58 124.51 32.96 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.24 -1.022 . . . . 64.53 108.24 171.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.412 ' HB3' HG12 ' A' ' 86' ' ' ILE . 29.6 t70 -123.2 107.52 11.8 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 107.897 -1.149 . . . . 74.01 107.897 167.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 55.0 m -122.11 108.73 13.68 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.589 1.156 . . . . 42.11 109.579 -173.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 46' ' ' PHE . 38.7 tt0 -101.49 115.36 30.34 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.82 -0.807 . . . . 71.05 108.82 -179.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -96.63 120.03 36.2 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.181 -1.044 . . . . 63.52 108.181 171.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -118.3 145.48 45.04 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.714 -0.847 . . . . 64.33 108.714 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.467 ' HB3' ' HB3' ' A' ' 106' ' ' PHE . 56.1 t60 -155.78 133.17 6.53 Favored Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 109.318 -0.623 . . . . 74.25 109.318 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -63.96 -35.53 54.46 Favored 'Trans proline' 0 C--N 1.384 2.447 0 C-N-CA 122.855 2.37 . . . . 54.21 112.268 -175.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 3.4 m -87.0 3.88 44.12 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.435 0.694 . . . . 73.4 111.002 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.467 ' HB3' ' HB3' ' A' ' 103' ' ' HIS . 88.9 t80 -111.84 103.28 11.53 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 107.911 -1.144 . . . . 74.2 107.911 175.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.413 HD12 ' HG2' ' A' ' 110' ' ' GLN . 28.3 mt -119.43 167.97 11.42 Favored 'General case' 0 C--O 1.246 0.881 0 N-CA-C 107.236 -1.394 . . . . 71.22 107.236 170.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.478 ' HG2' ' HH2' ' A' ' 25' ' ' TRP . 30.3 ttp85 -60.63 -79.86 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.154 0.582 . . . . 75.31 110.903 -173.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -85.46 60.17 4.74 Favored Glycine 0 C--N 1.347 1.14 0 N-CA-C 111.624 -0.59 . . . . 63.42 111.624 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.413 ' HG2' HD12 ' A' ' 107' ' ' LEU . 2.8 tp-100 -150.93 35.44 0.6 Allowed 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 108.872 -0.788 . . . . 72.22 108.872 -170.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -64.16 -20.19 65.83 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.607 1.163 . . . . 61.21 113.154 -175.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.07 -8.18 53.13 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 112.022 0.379 . . . . 73.31 112.022 177.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.435 ' O ' HG13 ' A' ' 117' ' ' ILE . 17.7 mt -88.3 -16.61 32.64 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.368 0.667 . . . . 71.52 111.494 173.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 96.8 mt -61.61 -36.41 80.66 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.274 0.559 . . . . 64.42 111.212 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.434 ' HB2' ' HB2' ' A' ' 16' ' ' ASN . 12.6 pt-20 -72.77 -15.78 61.65 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 115.57 -0.741 . . . . 74.03 112.342 177.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -97.14 -7.68 31.95 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.706 0.802 . . . . 64.13 110.257 178.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 113' ' ' LEU . 64.2 mt -88.65 130.52 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 107.573 -1.269 . . . . 71.11 107.573 173.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -105.71 141.1 37.72 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.25 0.62 . . . . 61.54 109.992 -171.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -92.2 7.04 44.39 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 124.209 0.943 . . . . 74.14 110.327 170.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -102.58 -168.75 1.57 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.078 0.951 . . . . 72.13 110.695 -173.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.2 p -60.55 -22.89 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.373 0 C-N-CA 124.417 1.087 . . . . 63.12 113.775 -168.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 38.6 p -82.13 73.23 9.17 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 121.515 0.674 . . . . 73.01 110.27 174.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 34.0 t -170.45 172.71 5.91 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 114.606 -1.179 . . . . 75.43 109.228 -174.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 7.4 p -165.53 134.13 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 C-N-CA 124.056 0.942 . . . . 74.54 109.749 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 CA--C 1.556 1.178 0 N-CA-C 108.443 -0.947 . . . . 72.43 108.443 177.199 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.2 t . . . . . 0 CA--C 1.549 0.906 0 CA-C-O 118.983 -0.532 . . . . 71.43 109.805 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.84 147.37 85.21 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 122.418 2.078 . . . . 72.55 110.894 171.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.29 -33.24 41.23 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.441 1.096 . . . . 73.35 113.36 -172.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -54.75 -52.76 61.55 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.681 0.792 . . . . 72.15 112.272 174.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 95.7 mt -77.26 -29.48 53.93 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 120.992 0.425 . . . . 74.43 109.912 -171.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.4 m -58.76 -48.4 81.34 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 114.351 -1.295 . . . . 74.33 111.395 173.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.475 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -69.28 -47.4 64.67 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.951 -0.568 . . . . 73.23 110.731 176.13 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.5 ' O ' HG23 ' A' ' 28' ' ' VAL . 58.9 tp -56.77 -54.76 42.6 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.597 1.159 . . . . 74.43 113.485 -174.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 89.5 t90 -56.34 -45.84 80.23 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.374 0.67 . . . . 74.41 111.13 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.1 m -69.26 -28.46 66.33 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.616 0.766 . . . . 75.22 111.663 177.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.506 ' HG ' HG21 ' A' ' 37' ' ' ILE . 49.6 tp -67.21 -46.2 74.58 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.932 1.293 . . . . 74.01 110.931 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 24' ' ' LEU . 23.6 t -63.53 -37.98 81.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-N 115.129 -0.941 . . . . 73.44 110.732 175.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.2 m -74.5 -19.97 60.16 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.841 0.856 . . . . 74.15 111.565 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -74.87 132.54 77.33 Favored Pre-proline 0 CA--C 1.556 1.173 0 C-N-CA 123.773 0.829 . . . . 64.21 110.988 -172.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.32 -28.19 12.66 Favored 'Trans proline' 0 C--N 1.384 2.44 0 C-N-CA 123.036 2.491 . . . . 74.21 114.235 -176.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -69.48 -43.39 73.29 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.244 0.618 . . . . 63.24 110.061 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.0 p -96.01 -1.25 49.31 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.733 -0.667 . . . . 70.33 111.325 -175.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -56.02 -30.83 62.45 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.645 1.178 . . . . 62.41 111.657 177.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.75 -36.31 78.61 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.237 -0.892 . . . . 74.24 112.152 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.8 mt -111.06 -6.0 14.7 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.166 0.587 . . . . 64.42 111.899 -176.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.506 HG21 ' HG ' ' A' ' 27' ' ' LEU . 18.8 tt -159.42 112.75 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 121.564 0.697 . . . . 74.11 110.504 175.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.527 ' SG ' ' HE2' ' A' ' 49' ' ' PHE . 24.5 p -139.9 145.41 37.95 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.174 0.59 . . . . 75.23 110.524 -174.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 18.8 p-90 -75.83 149.6 37.84 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.835 0.854 . . . . 71.12 111.513 -176.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.1 m -72.21 154.24 92.19 Favored Pre-proline 0 CA--C 1.556 1.192 0 C-N-CA 123.848 0.859 . . . . 62.22 109.262 174.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -43.21 -42.83 10.11 Favored 'Trans proline' 0 C--N 1.386 2.531 0 C-N-CA 124.432 3.421 . . . . 63.32 114.677 -176.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.2 m -67.52 -40.19 85.1 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.192 0.597 . . . . 71.21 111.37 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.11 11.82 55.8 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-N 115.901 -0.591 . . . . 44.41 112.793 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.409 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 28.0 p-10 -91.63 -4.76 54.87 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.26 1.024 . . . . 62.35 111.276 -175.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.6 p -155.31 170.93 20.73 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 123.937 0.895 . . . . 52.32 109.744 -174.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 50.7 p90 -142.12 149.23 39.55 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.07 0.548 . . . . 72.33 110.299 178.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -107.84 147.16 31.28 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.225 1.01 . . . . 65.45 108.398 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.624 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 60.2 t -123.3 131.31 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.018 -1.104 . . . . 72.41 108.018 176.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.527 ' HE2' ' SG ' ' A' ' 38' ' ' CYS . 79.3 m-85 -118.73 146.71 44.54 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 124.148 0.979 . . . . 72.14 109.4 -177.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 52.68 70.98 0.51 Allowed 'General case' 0 CA--C 1.548 0.898 0 O-C-N 124.693 1.246 . . . . 74.41 111.088 -178.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -46.79 -41.45 15.42 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 124.391 1.076 . . . . 73.11 112.955 -177.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.48 -46.58 76.18 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 115.646 -0.706 . . . . 75.41 112.822 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -72.69 -45.82 56.86 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.009 0.524 . . . . 74.32 110.822 -176.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.4 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 65.7 t80 -53.66 -49.15 68.57 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.778 1.231 . . . . 74.51 110.729 173.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.496 ' HB1' ' O ' ' A' ' 66' ' ' ASN . . . -64.44 -33.79 76.69 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 112.409 0.522 . . . . 71.23 112.409 178.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -69.41 -50.4 46.26 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.455 1.102 . . . . 71.34 112.167 -177.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.509 ' HG3' HG23 ' A' ' 58' ' ' VAL . 3.3 pt-20 -105.69 -43.97 4.78 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 113.098 0.777 . . . . 74.21 113.098 -174.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.509 HG23 ' HG3' ' A' ' 57' ' ' GLU . 94.5 t -76.78 -45.48 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 122.751 0.421 . . . . 74.13 111.017 -166.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 32.3 mt -61.8 -51.14 78.06 Favored Pre-proline 0 CA--C 1.557 1.225 0 CA-C-O 117.764 -1.113 . . . . 55.31 112.073 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.5 ' HG3' ' ND2' ' A' ' 66' ' ' ASN . 60.2 Cg_endo -70.21 -9.58 26.27 Favored 'Trans proline' 0 C--N 1.384 2.406 0 CA-C-N 122.291 1.854 . . . . 62.13 113.719 176.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -79.35 -53.49 6.87 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.284 0.633 . . . . 72.3 110.965 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -91.69 -46.82 7.71 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.075 0.55 . . . . 73.44 111.176 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -99.12 -177.29 3.57 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 108.254 -1.017 . . . . 65.13 108.254 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -113.16 37.52 3.13 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 119.112 0.869 . . . . 72.41 111.721 -172.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -157.05 158.33 36.28 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.91 0.484 . . . . 74.22 110.271 -174.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.5 ' ND2' ' HG3' ' A' ' 60' ' ' PRO . 10.4 m120 -105.31 -16.21 14.82 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 122.515 0.326 . . . . 63.31 110.671 177.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -75.86 124.72 27.78 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.842 0.457 . . . . 40.1 110.995 -175.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 12.7 tpt -75.1 -33.97 61.69 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.82 0.848 . . . . 75.11 111.779 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.07 -33.52 70.89 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.26 0.624 . . . . 60.15 111.68 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.44 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 48.2 t -64.7 -44.92 88.71 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.459 1.104 . . . . 73.45 111.223 175.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -60.64 -51.77 67.99 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.197 0.999 . . . . 73.51 110.709 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.6 t -61.32 -39.64 83.37 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 CA-C-N 115.0 -1.0 . . . . 40.34 111.342 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -60.69 -41.34 94.95 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.766 0.826 . . . . 71.44 112.096 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' A' ' 70' ' ' SER . 13.8 mm100 -58.98 -47.41 85.24 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 123.943 0.777 . . . . 54.2 109.616 176.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 80' ' ' PHE . 77.5 mt -61.65 -38.47 87.85 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.274 1.03 . . . . 72.5 112.172 -178.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -60.55 -35.65 76.55 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 122.557 0.343 . . . . 60.12 111.864 173.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 63.7 mtm -76.57 -23.56 53.54 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.039 0.536 . . . . 73.0 111.3 175.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -85.9 -7.0 58.98 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.405 0.682 . . . . 64.21 111.602 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.93 10.2 66.96 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-O 119.569 -0.573 . . . . 62.45 114.27 175.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.429 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 24.0 m-85 -73.25 144.41 46.71 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 117.723 0.761 . . . . 71.33 109.506 178.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 57.5 ttt-85 -110.8 131.72 54.81 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.693 -0.484 . . . . 54.53 109.693 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.574 ' HE3' ' HA ' ' A' ' 99' ' ' THR . 18.6 tptm -74.48 127.43 33.04 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.735 0.814 . . . . 45.01 109.721 173.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 95.5 t -132.37 118.38 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 107.034 -1.469 . . . . 63.52 107.034 176.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.483 ' HB ' ' HE2' ' A' ' 82' ' ' LYS . 6.5 p -104.93 116.16 48.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 108.845 -0.798 . . . . 75.12 108.845 -177.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 . . . . . 0 N--CA 1.486 1.334 0 O-C-N 122.212 -0.305 . . . . 63.14 111.761 -177.454 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 . . . . . 0 C--O 1.242 0.674 0 CA-C-O 120.955 0.407 . . . . 75.44 110.253 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.87 142.02 28.13 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.028 -1.101 . . . . 72.11 108.028 170.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.421 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 20.3 t70 -106.7 105.13 15.02 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 106.891 -1.522 . . . . 54.21 106.891 166.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.624 ' HB ' ' HB ' ' A' ' 48' ' ' VAL . 31.6 m -112.79 91.24 3.58 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.118 0.567 . . . . 62.25 110.376 -171.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 46' ' ' PHE . 39.6 tt0 -98.32 114.68 27.07 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.9 0.48 . . . . 65.13 109.73 -175.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -98.68 120.24 38.78 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 109.199 -0.667 . . . . 74.21 109.199 171.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -108.22 144.24 35.93 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.171 0.988 . . . . 71.42 110.382 -175.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -160.08 132.27 4.29 Favored Pre-proline 0 N--CA 1.479 0.992 0 CA-C-O 119.193 -0.432 . . . . 74.41 110.206 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.41 -24.83 42.46 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 122.94 2.427 . . . . 72.41 113.616 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.513 ' HB2' HG12 ' A' ' 117' ' ' ILE . 13.2 m -95.1 8.49 42.81 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.738 0.415 . . . . 72.01 111.015 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 44' ' ' ASN . 74.5 t80 -111.43 100.43 9.02 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 107.816 -1.179 . . . . 73.43 107.816 175.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 110' ' ' GLN . 96.3 mt -120.58 154.09 35.87 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.196 0.598 . . . . 61.23 109.658 173.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -71.21 -22.56 62.0 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.111 0.964 . . . . 75.13 112.575 -170.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.61 27.19 6.65 Favored Glycine 0 N--CA 1.468 0.831 0 N-CA-C 112.268 -0.333 . . . . 53.22 112.268 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.525 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 14.5 mm100 -135.17 78.2 1.72 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.339 0.656 . . . . 65.02 110.182 -175.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -29.38 69.58 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.148 -0.933 . . . . 72.15 112.034 174.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 6.8 pm0 -76.28 -11.09 59.85 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.161 0.584 . . . . 62.14 111.693 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.445 ' HA ' HD22 ' A' ' 116' ' ' ASN . 53.0 mt -91.19 -12.78 34.36 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.658 0.383 . . . . 70.31 110.981 176.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 64.8 mt -69.1 -27.69 65.82 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.047 0.539 . . . . 64.13 110.631 175.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -89.72 0.9 56.69 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.612 0.765 . . . . 71.54 112.132 173.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.445 HD22 ' HA ' ' A' ' 113' ' ' LEU . 20.3 m-80 -90.86 -17.36 26.65 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.282 -0.636 . . . . 43.23 109.282 161.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.513 HG12 ' HB2' ' A' ' 105' ' ' CYS . 32.7 mt -87.22 104.89 14.62 Favored 'Isoleucine or valine' 0 C--N 1.357 0.9 0 N-CA-C 106.64 -1.615 . . . . 65.31 106.64 173.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.481 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 11.0 mmpt? -112.47 155.81 23.63 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.953 -0.388 . . . . 51.31 109.953 -174.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 . . . . . 0 N--CA 1.477 0.893 0 C-N-CA 123.792 0.837 . . . . 71.31 109.152 179.51 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 84.1 t . . . . . 0 CA--C 1.547 0.863 0 CA-C-O 119.381 -0.342 . . . . 74.03 110.212 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -53.0 140.35 59.46 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 123.44 2.76 . . . . 70.14 111.593 175.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.49 -40.4 65.33 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.635 0.774 . . . . 64.43 112.235 -178.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -52.33 -49.84 63.46 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.05 0.94 . . . . 61.35 112.307 171.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 90.4 mt -81.65 -25.1 35.88 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.887 0.475 . . . . 72.04 110.684 -170.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.5 m -64.74 -53.36 48.38 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 124.183 0.993 . . . . 51.12 110.657 174.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.525 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -69.34 -39.94 77.86 Favored 'General case' 0 C--N 1.345 0.396 0 CA-C-N 115.457 -0.792 . . . . 74.14 110.848 -179.395 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.443 ' O ' HG23 ' A' ' 28' ' ' VAL . 54.4 tp -60.49 -48.44 81.77 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.594 0.758 . . . . 72.04 111.733 176.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.606 ' HE1' ' HA ' ' A' ' 108' ' ' ARG . 56.3 t90 -59.04 -47.72 84.21 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.99 0.516 . . . . 73.01 111.13 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.9 m -59.4 -40.79 87.78 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.044 0.938 . . . . 74.23 110.886 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 22.1 tp -62.92 -52.92 61.17 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.752 1.621 . . . . 54.43 112.355 -178.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 24' ' ' LEU . 93.6 t -60.84 -32.2 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 C-N-CA 124.227 1.011 . . . . 71.1 111.053 179.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.2 m -90.16 -5.84 56.02 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.271 1.028 . . . . 64.44 112.292 -176.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.409 ' HB3' ' OG1' ' A' ' 33' ' ' THR . 14.9 t70 -86.42 127.16 62.06 Favored Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 123.095 0.558 . . . . 72.21 111.192 -174.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.8 -32.39 77.81 Favored 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 123.782 2.988 . . . . 74.32 114.526 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -72.11 -39.94 68.51 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 122.901 0.481 . . . . 75.03 110.262 -178.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.409 ' OG1' ' HB3' ' A' ' 30' ' ' ASP . 29.8 p -98.14 0.46 46.03 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.736 -0.666 . . . . 61.43 111.445 -176.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -55.04 -31.21 60.92 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.603 1.161 . . . . 73.13 111.074 173.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.84 -39.94 86.85 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.065 0.946 . . . . 72.11 112.801 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 48.4 mt -103.54 -13.49 16.55 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.863 0.465 . . . . 75.24 111.96 -178.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.6 tt -159.81 122.27 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 121.061 0.458 . . . . 71.15 110.042 177.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 26.6 p -139.52 148.7 42.99 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 122.86 0.464 . . . . 71.13 111.245 -173.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.42 ' HB3' HG12 ' A' ' 28' ' ' VAL . 20.5 p-90 -77.85 148.99 34.41 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.418 0.687 . . . . 73.12 109.977 175.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.9 m -81.87 144.51 51.87 Favored Pre-proline 0 CA--C 1.551 1.008 0 N-CA-C 108.618 -0.882 . . . . 71.21 108.618 174.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.35 -22.15 15.27 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 123.883 3.055 . . . . 74.45 115.219 -173.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.3 m -78.06 -37.79 45.91 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.01 0.524 . . . . 45.55 111.073 176.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.9 4.14 51.62 Favored Glycine 0 C--N 1.351 1.416 0 N-CA-C 114.875 0.71 . . . . 62.33 114.875 167.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 6.6 p30 -106.5 2.08 25.95 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.804 0.842 . . . . 74.32 111.672 -175.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 81.0 p -148.01 158.09 43.87 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 109.016 -0.735 . . . . 53.42 109.016 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -142.57 152.67 42.81 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.8 0.44 . . . . 74.31 110.139 176.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -108.53 141.89 39.77 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.762 0.825 . . . . 75.52 109.336 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.0 t -118.48 134.11 63.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 107.499 -1.297 . . . . 64.15 107.499 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.452 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 93.3 m-85 -123.45 147.21 47.38 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.853 0.861 . . . . 72.12 110.088 -172.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 48.11 63.32 2.09 Favored 'General case' 0 C--N 1.352 0.714 0 O-C-N 125.33 1.644 . . . . 74.35 111.356 175.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.521 ' HG2' ' HE2' ' A' ' 68' ' ' MET . 99.2 mt-30 -54.56 -29.14 50.29 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.309 1.044 . . . . 65.15 113.3 -171.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -63.42 -45.51 94.77 Favored Glycine 0 CA--C 1.531 1.069 0 O-C-N 123.36 0.413 . . . . 24.41 112.322 172.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -74.04 -45.71 47.89 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.81 0.844 . . . . 73.02 110.574 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.408 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 80.1 t80 -55.28 -52.6 62.91 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.752 1.621 . . . . 71.31 111.2 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.503 ' HB2' ' HB2' ' A' ' 68' ' ' MET . . . -66.92 -25.95 66.62 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.159 0.429 . . . . 73.25 112.159 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.8 -49.99 18.79 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.756 0.822 . . . . 75.21 112.25 -177.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.524 ' HG3' HG23 ' A' ' 58' ' ' VAL . 6.1 pt-20 -105.19 -42.63 5.23 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 112.746 0.647 . . . . 72.25 112.746 -175.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.524 HG23 ' HG3' ' A' ' 57' ' ' GLU . 74.2 t -76.77 -43.98 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 C-N-CA 123.109 0.564 . . . . 61.3 111.877 -167.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.468 ' HG ' ' HA ' ' A' ' 55' ' ' ALA . 38.8 mt -60.85 -54.76 51.33 Favored Pre-proline 0 CA--C 1.564 1.481 0 CA-C-O 118.272 -0.871 . . . . 71.05 112.082 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.481 ' HG3' ' ND2' ' A' ' 66' ' ' ASN . 30.9 Cg_endo -65.87 -12.23 34.37 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 121.925 1.75 . . . . 74.12 113.621 178.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -77.96 -62.53 1.64 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.113 0.965 . . . . 71.13 111.259 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.493 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 43.0 m-85 -78.77 -51.02 10.36 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.304 0.573 . . . . 72.24 110.676 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -89.36 -166.61 1.64 Allowed 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 107.53 -1.285 . . . . 74.1 107.53 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.59 43.57 3.11 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 119.531 1.059 . . . . 74.0 110.465 -178.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -163.61 162.64 24.4 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.06 -0.973 . . . . 71.44 108.854 -175.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.481 ' ND2' ' HG3' ' A' ' 60' ' ' PRO . 10.2 m120 -105.9 -148.95 0.42 Allowed 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 106.713 -1.588 . . . . 71.2 106.713 174.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 68.88 105.36 0.05 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.734 0.813 . . . . 73.41 111.644 169.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.521 ' HE2' ' HG2' ' A' ' 51' ' ' GLN . 13.8 tpt -70.39 -28.2 64.91 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.604 -0.725 . . . . 64.24 110.869 -175.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.15 -39.4 75.16 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.197 0.599 . . . . 62.31 111.32 176.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.8 t -65.88 -43.66 87.65 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.304 1.041 . . . . 75.43 111.388 177.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -65.13 -52.95 52.17 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.123 0.969 . . . . 71.43 111.161 -177.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.42 HG12 HD21 ' A' ' 76' ' ' ASN . 59.6 t -63.33 -34.4 66.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 CA-C-N 115.58 -0.736 . . . . 74.11 110.884 178.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -55.84 -42.31 75.59 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.26 0.624 . . . . 71.05 111.113 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -62.94 -47.31 83.76 Favored 'General case' 0 C--N 1.347 0.462 0 O-C-N 124.018 0.823 . . . . 62.14 110.105 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 72' ' ' VAL . 77.3 mt -60.54 -44.62 95.91 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.222 1.009 . . . . 74.31 111.968 -177.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.42 HD21 HG12 ' A' ' 72' ' ' VAL . 66.9 m-80 -55.61 -41.04 72.88 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.979 0.512 . . . . 75.12 111.432 175.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 67.2 mtm -72.12 -36.9 69.55 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 116.221 -0.445 . . . . 74.12 110.708 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -77.34 -7.71 56.48 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.181 0.592 . . . . 61.04 111.251 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.91 14.4 56.47 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-O 119.631 -0.538 . . . . 74.01 114.419 174.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -76.39 134.91 39.5 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 109.117 -0.698 . . . . 72.35 109.117 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.431 ' HD2' HE21 ' A' ' 102' ' ' GLN . 29.7 ttm180 -99.28 123.26 43.41 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.881 -0.785 . . . . 52.1 108.881 -175.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.525 ' HE3' HG23 ' A' ' 99' ' ' THR . 1.3 tmtp? -72.16 116.83 13.05 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.277 -1.009 . . . . 52.54 108.277 174.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.561 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 61.7 t -107.24 122.09 60.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.911 0 N-CA-C 108.276 -1.009 . . . . 64.04 108.276 177.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.5 t -82.06 119.77 32.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 124.336 1.054 . . . . 62.43 109.669 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 108.782 -0.821 . . . . 74.04 108.782 174.878 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 . . . . . 0 C--O 1.242 0.682 0 CA-C-O 121.542 0.687 . . . . 73.42 110.39 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 22.0 m-20 -90.43 133.25 35.15 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.799 -0.815 . . . . 72.21 108.799 164.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -131.37 104.23 6.89 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 106.057 -1.831 . . . . 71.43 106.057 165.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.525 HG23 ' HE3' ' A' ' 82' ' ' LYS . 32.6 m -126.99 111.38 14.01 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.675 -0.693 . . . . 53.22 109.281 -173.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.561 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 41.5 tt0 -100.55 112.02 24.34 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 110.1 -0.333 . . . . 72.45 110.1 -173.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -97.45 122.53 40.6 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 109.032 -0.729 . . . . 71.13 109.032 174.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.431 HE21 ' HD2' ' A' ' 81' ' ' ARG . 29.2 pt20 -120.98 145.56 47.61 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.552 0.741 . . . . 63.42 110.382 -176.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 -156.8 131.98 5.46 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 108.354 -0.98 . . . . 75.41 108.354 174.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -64.45 -20.81 66.38 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.986 2.457 . . . . 62.14 113.651 -175.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.495 ' HB2' HG12 ' A' ' 117' ' ' ILE . 18.5 m -98.4 7.12 46.62 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.324 0.65 . . . . 64.05 111.496 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 44' ' ' ASN . 62.3 t80 -108.09 100.87 10.16 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 107.721 -1.215 . . . . 70.23 107.721 175.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.594 ' HB2' ' HB3' ' A' ' 110' ' ' GLN . 96.0 mt -125.17 146.21 49.6 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.351 0.66 . . . . 71.11 109.321 173.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.606 ' HA ' ' HE1' ' A' ' 25' ' ' TRP . 31.4 ttt180 -83.11 102.11 11.61 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 109.397 -0.594 . . . . 63.13 109.397 176.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 123.99 -38.84 2.31 Favored Glycine 0 C--N 1.337 0.624 0 N-CA-C 110.349 -1.1 . . . . 72.45 110.349 -177.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.594 ' HB3' ' HB2' ' A' ' 107' ' ' LEU . 2.6 tp-100 -88.87 56.39 3.71 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.741 0.816 . . . . 70.23 109.012 176.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -62.87 -18.28 62.74 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.346 1.059 . . . . 73.33 112.514 -178.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -65.28 -20.91 66.63 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.558 0.743 . . . . 75.44 112.942 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.9 mt -91.89 -10.32 40.03 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.159 0.583 . . . . 71.43 111.693 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 74.5 mt -67.28 -35.41 79.42 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 121.394 0.616 . . . . 63.41 110.764 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -77.93 -4.93 49.36 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.498 -0.774 . . . . 64.45 111.99 176.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -103.17 -2.02 28.03 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.568 0.747 . . . . 64.33 110.014 173.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.495 HG12 ' HB2' ' A' ' 105' ' ' CYS . 60.0 mt -81.48 115.53 24.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.91 0 N-CA-C 107.053 -1.462 . . . . 72.51 107.053 168.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -105.68 136.55 45.07 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.756 -0.461 . . . . 74.04 109.756 -171.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 . . . . . 0 N--CA 1.478 0.943 0 C-N-CA 123.115 0.566 . . . . 74.43 110.402 172.631 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.1 t . . . . . 0 CA--C 1.548 0.866 0 N-CA-C 108.81 -0.811 . . . . 65.25 108.81 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.529 ' HD2' HD12 ' A' ' 21' ' ' LEU . 32.4 Cg_exo -60.3 147.86 92.22 Favored 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.509 2.139 . . . . 74.25 111.682 173.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.63 -40.3 62.63 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.715 0.806 . . . . 44.31 111.508 176.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -53.72 -46.92 70.94 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.208 1.003 . . . . 52.43 111.705 174.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.529 HD12 ' HD2' ' A' ' 18' ' ' PRO . 28.9 mt -76.72 -37.35 56.21 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 112.468 0.544 . . . . 73.45 112.468 -173.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.8 t -69.87 -36.89 75.85 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 117.83 0.286 . . . . 75.54 110.699 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -75.73 -36.42 59.95 Favored 'General case' 0 C--N 1.358 0.964 0 C-N-CA 123.039 0.536 . . . . 34.23 110.392 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.2 tp -60.32 -44.6 95.31 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.307 0.643 . . . . 71.11 111.027 172.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 87.0 t90 -61.04 -44.85 96.78 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.714 0.806 . . . . 71.45 110.807 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 87.3 m -60.01 -38.99 84.25 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.213 1.005 . . . . 71.24 110.755 175.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.453 HD13 ' CD1' ' A' ' 62' ' ' TYR . 29.2 tp -67.41 -46.15 74.05 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.162 1.385 . . . . 55.04 111.726 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.5 t -62.4 -34.34 63.98 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 125.259 1.424 . . . . 72.34 111.343 175.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.8 t -90.01 -5.09 57.01 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.007 0.923 . . . . 71.34 111.871 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -82.15 119.73 75.66 Favored Pre-proline 0 N--CA 1.48 1.07 0 C-N-CA 123.361 0.664 . . . . 64.43 111.004 -174.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.42 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 68.2 Cg_endo -71.28 -20.52 27.89 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.428 2.085 . . . . 74.52 113.075 176.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -66.44 -40.82 89.69 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.61 0.364 . . . . 53.45 110.198 176.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.8 p -99.64 4.36 45.63 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.321 0.648 . . . . 64.22 111.276 -175.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.42 ' HB2' ' HA ' ' A' ' 31' ' ' PRO . 24.1 t70 -53.49 -29.0 33.89 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 125.365 1.466 . . . . 54.55 112.791 -178.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.32 -37.01 85.6 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.74 0.816 . . . . 42.31 112.542 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.7 mt -114.6 -11.58 12.36 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 112.512 0.56 . . . . 72.15 112.512 -176.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.429 HD13 ' HG ' ' A' ' 27' ' ' LEU . 14.8 tt -160.96 130.12 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-O 121.108 0.48 . . . . 73.34 110.207 175.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.3 p -153.68 164.19 38.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.483 -0.78 . . . . 72.51 109.908 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 30.6 p-90 -66.12 148.07 52.38 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 123.942 0.776 . . . . 71.14 110.579 172.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.8 m -75.13 153.46 86.42 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 123.354 0.662 . . . . 65.11 110.835 171.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -60.83 -27.54 84.96 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.278 1.985 . . . . 40.22 111.375 170.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.6 m -59.25 -32.07 69.66 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.852 1.261 . . . . 64.34 111.956 172.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.42 -14.58 11.68 Favored Glycine 0 C--N 1.348 1.196 0 N-CA-C 115.122 0.809 . . . . 43.44 115.122 177.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 7.5 p30 -103.51 20.66 17.48 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.142 0.977 . . . . 72.32 110.64 -176.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.2 p -166.3 173.37 10.13 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.779 0.831 . . . . 64.35 109.833 -172.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 49.1 p90 -147.16 144.03 28.67 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.754 0.422 . . . . 62.42 110.607 176.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -100.52 148.46 24.76 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.812 0.845 . . . . 72.2 109.882 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.643 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 96.7 t -129.81 141.12 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.702 1.201 . . . . 75.11 107.959 176.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -124.03 147.5 47.78 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.697 0.799 . . . . 73.41 109.21 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 48.14 69.73 0.51 Allowed 'General case' 0 C--N 1.353 0.724 0 O-C-N 124.936 1.397 . . . . 63.42 111.293 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.445 ' HB3' ' HG2' ' A' ' 68' ' ' MET . 52.0 mt-30 -51.26 -30.93 19.28 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.637 1.175 . . . . 73.53 113.12 -174.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.86 -45.81 49.41 Favored Glycine 0 CA--C 1.534 1.233 0 O-C-N 123.382 0.426 . . . . 60.44 112.658 176.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -70.19 -42.26 72.64 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.591 0.757 . . . . 71.44 110.249 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -54.67 -48.35 72.48 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.5 1.52 . . . . 73.31 110.756 172.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.545 ' HB2' ' HB2' ' A' ' 68' ' ' MET . . . -64.8 -33.87 77.02 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 116.08 -0.509 . . . . 53.22 111.814 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -67.22 -47.4 70.95 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.497 1.119 . . . . 61.52 112.741 -178.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.449 ' HG3' HG23 ' A' ' 58' ' ' VAL . 9.7 pt-20 -112.32 -36.92 5.15 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 114.533 1.308 . . . . 72.11 114.533 -173.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.449 HG23 ' HG3' ' A' ' 57' ' ' GLU . 71.2 t -81.91 -42.91 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.467 0.707 . . . . 65.45 111.552 -169.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 47.9 mt -66.66 -44.52 54.51 Favored Pre-proline 0 CA--C 1.555 1.171 0 CA-C-O 117.928 -1.034 . . . . 75.4 112.718 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -65.49 -15.3 49.03 Favored 'Trans proline' 0 C--N 1.383 2.343 0 CA-C-N 121.813 1.683 . . . . 64.1 113.647 171.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -74.16 -59.7 2.61 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.482 0.313 . . . . 61.21 110.843 176.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.453 ' CD1' HD13 ' A' ' 27' ' ' LEU . 47.7 m-85 -91.19 -14.91 30.19 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 113.107 0.78 . . . . 74.44 113.107 -175.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -133.11 -174.36 3.46 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 108.878 -0.786 . . . . 72.12 108.878 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -119.67 46.56 1.9 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.207 0.603 . . . . 74.12 109.533 -176.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 18.7 p80 -158.74 161.68 37.05 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.724 0.809 . . . . 75.34 109.603 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.488 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 9.4 m120 -118.1 2.25 12.02 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.613 0.765 . . . . 75.35 110.161 176.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -83.16 115.23 21.83 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.225 0.61 . . . . 72.1 110.669 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.545 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 12.1 tpt -66.81 -40.02 87.91 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.686 0.794 . . . . 62.04 110.556 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.63 -34.83 74.85 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.45 0.7 . . . . 72.35 112.03 -177.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.2 t -66.26 -42.85 87.94 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.81 0.844 . . . . 64.42 111.499 176.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -60.33 -49.6 76.96 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.4 1.08 . . . . 73.51 110.364 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 69.1 t -64.21 -36.56 77.4 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 124.225 1.01 . . . . 70.21 110.845 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -60.07 -41.54 92.62 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.609 0.763 . . . . 73.34 111.073 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -63.25 -45.7 90.34 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.929 -0.578 . . . . 70.03 110.767 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 80' ' ' PHE . 94.1 mt -62.82 -38.31 90.25 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.814 0.846 . . . . 70.24 111.708 -177.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -62.75 -32.69 73.88 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.806 0.442 . . . . 73.43 111.954 173.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 47.0 mtm -69.26 -35.15 75.8 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 110.436 -0.209 . . . . 73.42 110.436 173.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -75.85 -18.59 59.38 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.252 0.621 . . . . 74.24 111.593 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.82 26.67 23.92 Favored Glycine 0 C--N 1.345 1.077 0 CA-C-O 119.709 -0.495 . . . . 61.13 113.997 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.44 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . 64.5 m-85 -78.72 133.01 37.18 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.856 -0.794 . . . . 74.21 108.856 171.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -102.12 127.61 48.96 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.267 0.627 . . . . 55.31 109.318 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.693 ' HE2' ' HB ' ' A' ' 84' ' ' VAL . 1.3 tmtp? -76.18 124.81 28.04 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.057 -1.09 . . . . 74.42 108.057 176.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.0 t -128.63 115.5 37.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 106.644 -1.613 . . . . 73.2 106.644 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.693 ' HB ' ' HE2' ' A' ' 82' ' ' LYS . 9.2 p -102.86 114.79 43.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 CA-C-O 121.487 0.661 . . . . 71.2 109.502 -174.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 . . . . . 0 N--CA 1.482 1.162 0 CA-C-N 115.868 -0.605 . . . . 75.25 110.858 -179.987 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 . . . . . 0 N--CA 1.483 1.198 0 N-CA-C 110.232 -0.284 . . . . 71.43 110.232 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -104.52 124.31 49.05 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.973 -0.751 . . . . 73.2 108.973 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.47 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 15.9 t70 -88.88 107.58 19.07 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.639 -1.245 . . . . 73.13 107.639 173.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.643 ' HB ' ' HB ' ' A' ' 48' ' ' VAL . 11.6 m -102.99 98.02 8.04 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 123.527 0.731 . . . . 75.41 110.017 -177.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 46' ' ' PHE . 38.6 tt0 -100.37 113.64 26.54 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.781 -0.822 . . . . 70.52 108.781 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.44 ' HB3' ' HB3' ' A' ' 80' ' ' PHE . 73.4 m-85 -96.33 120.32 36.41 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.549 -0.908 . . . . 62.2 108.549 173.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -110.13 146.71 35.0 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.8 0.84 . . . . 72.0 110.548 -174.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 23.9 t-80 -163.35 130.06 2.42 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 123.659 0.783 . . . . 74.42 108.901 172.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -64.89 -23.43 62.04 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.844 2.363 . . . . 55.3 112.957 -176.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 56.9 m -95.12 3.87 54.28 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.269 0.628 . . . . 61.33 111.328 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.439 ' O ' ' HA ' ' A' ' 44' ' ' ASN . 62.8 t80 -103.46 100.45 10.31 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 106.862 -1.533 . . . . 74.43 106.862 173.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.602 ' HB2' ' HB2' ' A' ' 110' ' ' GLN . 70.2 mt -113.48 134.66 54.55 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 109.354 -0.61 . . . . 71.14 109.354 173.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.0 ppt_? -62.96 -17.77 62.41 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.424 1.09 . . . . 72.33 112.636 -176.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -101.16 -42.6 2.37 Favored Glycine 0 C--N 1.346 1.096 0 N-CA-C 111.768 -0.533 . . . . 73.2 111.768 173.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.602 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 2.5 mp0 -91.36 84.06 5.54 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.451 0.7 . . . . 73.53 111.2 -172.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.9 -18.89 62.0 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.331 1.052 . . . . 63.35 112.827 177.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . 0.488 ' O ' ' HG2' ' A' ' 115' ' ' GLU . 4.8 pm0 -73.71 -14.52 61.16 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 111.637 0.236 . . . . 74.31 111.637 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.426 ' HA ' HD22 ' A' ' 116' ' ' ASN . 70.8 mt -84.16 -7.54 59.33 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.656 0.382 . . . . 74.24 111.792 178.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 51.0 mt -71.05 -21.62 62.23 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.055 0.542 . . . . 65.44 112.008 178.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 112' ' ' GLN . 16.9 pt-20 -80.18 -5.74 56.59 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 111.878 0.325 . . . . 75.24 111.878 174.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.426 HD22 ' HA ' ' A' ' 113' ' ' LEU . 28.3 m-80 -90.9 -16.75 27.62 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.777 -0.823 . . . . 72.03 108.777 169.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.6 mt -90.87 73.46 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.886 0 N-CA-C 107.704 -1.221 . . . . 72.32 107.704 175.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.18 161.29 31.09 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.56 0.695 . . . . 73.11 110.945 169.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 . . . . . 0 C--O 1.239 0.514 0 N-CA-C 108.273 -1.01 . . . . 72.44 108.273 173.828 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 47.1 t . . . . . 0 CA--C 1.546 0.8 0 CA-C-O 119.237 -0.411 . . . . 61.22 110.09 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.404 ' HD2' HD12 ' A' ' 21' ' ' LEU . 49.9 Cg_exo -56.72 141.49 91.86 Favored 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.775 2.317 . . . . 71.45 111.148 173.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.92 -36.63 65.44 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.072 0.949 . . . . 55.21 113.022 -173.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -51.85 -43.94 63.42 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.035 0.534 . . . . 75.51 112.084 173.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.404 HD12 ' HD2' ' A' ' 18' ' ' PRO . 98.2 mt -84.29 -29.81 26.11 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.409 0.684 . . . . 71.3 110.4 -173.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.6 m -61.17 -39.64 90.9 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.273 1.029 . . . . 51.23 110.607 173.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.558 ' HE2' ' HA ' ' A' ' 23' ' ' LYS . 10.7 mmpt? -79.97 -47.79 14.41 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.715 -0.675 . . . . 64.14 110.473 177.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.5 ' O ' HG23 ' A' ' 28' ' ' VAL . 55.3 tp -56.47 -50.28 72.19 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.107 0.963 . . . . 73.53 112.502 -176.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.467 ' HZ2' ' H ' ' A' ' 109' ' ' GLY . 84.7 t90 -58.35 -47.78 82.69 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.791 0.436 . . . . 75.2 111.014 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.8 m -68.8 -22.6 64.25 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 115.684 -0.689 . . . . 71.43 111.42 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.489 HD11 HG13 ' A' ' 58' ' ' VAL . 31.0 tp -74.4 -44.31 52.56 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.393 1.077 . . . . 74.55 110.723 175.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 24' ' ' LEU . 60.0 t -61.92 -32.68 54.94 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 CA-C-O 121.685 0.755 . . . . 65.22 110.258 173.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.4 t -88.72 0.18 56.71 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 114.636 -1.165 . . . . 73.22 112.023 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -81.61 122.72 80.85 Favored Pre-proline 0 N--CA 1.479 1.02 0 O-C-N 121.919 -0.488 . . . . 71.53 111.448 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -73.62 -6.21 18.35 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 123.159 2.573 . . . . 64.41 113.822 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -86.35 -37.65 18.24 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.85 0.46 . . . . 72.51 110.987 174.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 41.6 p -104.34 8.61 35.94 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.772 0.429 . . . . 70.41 110.824 -175.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -59.51 -32.39 70.25 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.459 1.104 . . . . 61.45 111.896 -175.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.34 -32.35 73.24 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.637 0.775 . . . . 73.1 111.958 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 64.4 mt -102.82 -12.14 17.8 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.457 0.303 . . . . 73.43 111.219 -177.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.5 tt -159.89 122.83 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 123.053 0.541 . . . . 60.2 110.454 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 28.2 p -142.1 149.55 40.01 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.601 0.36 . . . . 63.43 110.567 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 22.7 p-90 -72.6 154.23 40.87 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.611 0.765 . . . . 73.52 111.148 177.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.6 m -81.41 141.0 48.71 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 109.121 -0.696 . . . . 61.05 109.121 169.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -50.36 -22.91 9.34 Favored 'Trans proline' 0 C--N 1.368 1.602 0 C-N-CA 123.373 2.715 . . . . 73.02 115.05 176.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 64.0 m -70.65 -30.27 66.85 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.999 0.52 . . . . 71.15 111.618 175.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.99 65.87 2.18 Favored Glycine 0 C--N 1.342 0.88 0 CA-C-N 116.308 -0.406 . . . . 50.15 112.474 177.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.413 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 26.8 p30 -168.52 -17.06 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.981 0.913 . . . . 54.24 111.725 -171.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.2 p -141.51 162.27 35.89 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 123.927 0.891 . . . . 71.43 108.701 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -140.19 146.38 38.65 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.572 0.225 . . . . 75.31 110.535 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -103.32 141.32 36.13 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.234 1.014 . . . . 63.14 109.536 -176.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.1 t -123.54 132.99 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.693 0.797 . . . . 75.44 108.983 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -122.75 151.96 41.09 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.549 1.14 . . . . 73.21 110.5 -174.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 53.62 60.82 3.43 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 124.584 1.178 . . . . 64.42 110.77 174.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -46.0 -37.31 6.44 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.006 1.322 . . . . 54.13 114.2 -170.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.51 -44.92 49.08 Favored Glycine 0 C--N 1.342 0.868 0 O-C-N 123.559 0.537 . . . . 44.23 112.844 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -72.83 -42.91 63.31 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.112 0.565 . . . . 73.43 110.111 -177.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -55.32 -52.62 62.89 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.188 1.395 . . . . 64.24 110.899 175.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.36 -31.82 71.71 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 116.298 -0.41 . . . . 52.24 111.676 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -70.49 -50.92 32.91 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.252 1.021 . . . . 74.02 112.421 -177.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.541 ' HG3' HG23 ' A' ' 58' ' ' VAL . 9.7 pt-20 -104.43 -39.24 6.5 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 112.855 0.687 . . . . 72.11 112.855 -173.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.541 HG23 ' HG3' ' A' ' 57' ' ' GLU . 96.5 t -80.94 -41.78 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.362 0.665 . . . . 62.11 112.016 -167.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 53.2 mt -64.15 -48.95 75.93 Favored Pre-proline 0 CA--C 1.565 1.528 0 CA-C-O 118.209 -0.9 . . . . 52.22 112.324 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.3 -8.49 23.52 Favored 'Trans proline' 0 C--N 1.387 2.598 0 CA-C-N 121.981 1.743 . . . . 74.25 113.281 175.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -73.63 -61.77 1.72 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.297 1.039 . . . . 72.32 110.391 174.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.541 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 25.5 m-85 -89.03 -38.59 14.29 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 112.005 0.372 . . . . 74.14 112.005 -177.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -102.81 -164.61 1.1 Allowed 'General case' 0 C--O 1.243 0.729 0 N-CA-C 107.566 -1.272 . . . . 75.33 107.566 176.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 64' ' ' LYS . 31.5 mmtm -135.54 68.05 1.47 Allowed 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 121.856 0.836 . . . . 54.15 109.903 175.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -169.77 160.62 8.77 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 113.781 -1.554 . . . . 72.13 107.786 173.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -118.01 -5.79 10.97 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.74 0.416 . . . . 72.31 110.503 175.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -71.84 117.54 13.56 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 123.82 0.848 . . . . 73.32 110.47 176.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 11.7 ttm -70.89 -30.57 66.97 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.656 0.383 . . . . 71.25 111.034 176.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.67 -36.39 71.84 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.607 0.363 . . . . 64.13 111.241 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.429 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 40.2 t -63.94 -46.91 82.62 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.982 0.913 . . . . 73.04 111.633 172.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -63.18 -52.91 60.46 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.612 0.765 . . . . 75.44 111.052 -176.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.41 ' HA ' HD12 ' A' ' 75' ' ' LEU . 84.4 t -59.14 -40.66 81.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 124.088 0.955 . . . . 64.34 111.254 177.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.3 ttt-85 -56.82 -43.9 81.46 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.147 0.579 . . . . 73.35 111.559 177.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 70' ' ' SER . 16.7 mm100 -58.9 -49.83 76.32 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 124.024 0.828 . . . . 73.41 109.937 177.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.433 ' HB3' ' HB2' ' A' ' 80' ' ' PHE . 65.2 mt -58.35 -44.27 88.7 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.305 1.042 . . . . 73.2 112.086 -177.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -56.9 -39.55 74.63 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.504 0.722 . . . . 73.5 111.924 175.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 73.9 mtm -72.94 -35.03 66.9 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.051 0.54 . . . . 73.31 111.06 176.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.425 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 55.3 m-85 -85.26 2.92 41.84 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.093 0.557 . . . . 72.41 111.22 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.42 15.91 79.03 Favored Glycine 0 C--N 1.342 0.916 0 N-CA-C 114.652 0.621 . . . . 63.42 114.652 170.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.433 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 73.3 m-85 -73.74 129.42 37.9 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.273 0.559 . . . . 73.24 110.096 176.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -99.52 121.78 41.66 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.013 -0.994 . . . . 71.01 109.021 -175.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.424 ' HE3' HG23 ' A' ' 99' ' ' THR . 1.6 tmtp? -81.45 126.75 32.03 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.588 1.155 . . . . 53.41 109.723 -175.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 85.8 t -128.97 119.72 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 108.17 -1.048 . . . . 72.11 108.17 175.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.421 ' HB ' ' HE2' ' A' ' 82' ' ' LYS . 7.5 p -99.68 126.0 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 108.415 -0.957 . . . . 71.1 108.415 -178.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 . . . . . 0 N--CA 1.479 1.006 0 C-N-CA 122.573 0.349 . . . . 73.03 110.62 -177.513 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 . . . . . 0 CA--C 1.551 0.981 0 N-CA-C 108.906 -0.776 . . . . 63.11 108.906 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -45.18 107.98 0.11 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.636 1.174 . . . . 62.43 112.958 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -91.37 122.2 33.77 Favored 'General case' 0 C--O 1.249 1.045 0 CA-C-N 114.867 -1.06 . . . . 41.31 108.191 177.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.424 HG23 ' HE3' ' A' ' 82' ' ' LYS . 57.8 m -129.27 117.23 20.36 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.894 -0.78 . . . . 75.42 108.894 -178.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -104.73 112.17 25.17 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.322 -0.992 . . . . 75.43 108.322 -175.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -96.93 123.88 40.76 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.824 -1.176 . . . . 71.2 107.824 175.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -122.65 145.75 48.08 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 122.985 0.514 . . . . 70.23 110.697 -173.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -156.53 132.31 5.74 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 108.66 -0.867 . . . . 73.41 108.66 176.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.74 -29.95 77.73 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.669 2.246 . . . . 73.33 113.195 -174.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 59.1 m -89.4 -2.78 58.53 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.641 0.376 . . . . 73.32 111.421 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 44' ' ' ASN . 64.8 t80 -102.19 99.45 9.57 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 106.881 -1.525 . . . . 75.3 106.881 175.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.421 HD12 ' HG2' ' A' ' 110' ' ' GLN . 76.6 mt -120.79 164.7 16.2 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.95 0.405 . . . . 73.25 110.673 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -81.58 122.74 27.97 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.593 -0.73 . . . . 73.31 109.489 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.467 ' H ' ' HZ2' ' A' ' 25' ' ' TRP . . . 63.56 57.65 14.0 Favored Glycine 0 C--N 1.344 0.985 0 O-C-N 124.15 0.906 . . . . 64.13 111.974 -176.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.421 ' HG2' HD12 ' A' ' 107' ' ' LEU . 5.9 tp60 -156.18 63.64 0.56 Allowed 'General case' 0 CA--C 1.548 0.897 0 CA-C-O 121.919 0.866 . . . . 74.51 109.535 -172.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -52.35 -46.24 66.02 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 113.746 -1.57 . . . . 65.1 111.446 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 14.1 pm0 -65.74 -19.55 65.94 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.579 -1.191 . . . . 72.34 112.839 -174.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.41 ' HA ' HD22 ' A' ' 116' ' ' ASN . 27.9 mt -96.41 -20.11 18.69 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 119.181 0.901 . . . . 74.33 111.712 177.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 80.9 mt -63.95 -32.6 74.19 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-O 121.156 0.503 . . . . 63.41 110.376 175.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -79.35 -5.42 54.52 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 115.547 -0.751 . . . . 64.52 112.594 175.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.41 HD22 ' HA ' ' A' ' 113' ' ' LEU . 26.0 m-80 -90.25 2.78 55.09 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 110.096 -0.335 . . . . 74.11 110.096 172.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 45.1 mt -96.98 128.01 48.61 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 N-CA-C 109.009 -0.737 . . . . 71.33 109.009 174.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.456 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -112.1 150.73 30.33 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.425 0.69 . . . . 65.45 110.031 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 . . . . . 0 N--CA 1.484 1.235 0 C-N-CA 124.151 0.98 . . . . 73.35 110.374 170.736 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.9 t . . . . . 0 CA--C 1.541 0.604 0 N-CA-C 108.982 -0.747 . . . . 74.42 108.982 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 21' ' ' LEU . 21.4 Cg_exo -65.69 145.24 80.89 Favored 'Trans proline' 0 C--N 1.365 1.439 0 C-N-CA 122.417 2.078 . . . . 75.03 110.341 170.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.41 -39.82 23.82 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.149 1.38 . . . . 64.41 112.499 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -54.1 -45.43 71.84 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.96 0.904 . . . . 73.14 112.833 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 18' ' ' PRO . 98.4 mt -83.36 -29.23 28.4 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.056 0.543 . . . . 74.24 109.948 -171.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.7 m -59.72 -50.59 73.23 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 124.548 1.155 . . . . 61.24 111.023 170.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.486 ' HE2' ' HA ' ' A' ' 23' ' ' LYS . 11.2 mmpt? -68.49 -43.25 77.28 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.876 -0.602 . . . . 61.12 110.045 178.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.468 ' O ' HG23 ' A' ' 28' ' ' VAL . 55.5 tp -55.26 -54.03 48.56 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 124.601 1.161 . . . . 70.32 112.214 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 14.1 t-105 -64.07 -46.08 85.92 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 122.629 0.372 . . . . 72.3 111.722 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.6 m -60.61 -25.01 65.93 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.306 0.574 . . . . 74.13 110.775 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.48 HD11 ' CG1' ' A' ' 58' ' ' VAL . 29.9 tp -80.47 -45.57 17.33 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 124.87 1.268 . . . . 62.04 111.94 177.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 24' ' ' LEU . 76.6 t -56.61 -39.97 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 C-N-CA 124.089 0.956 . . . . 42.32 111.513 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.5 t -89.36 -5.54 57.4 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 114.453 -1.249 . . . . 74.0 112.132 -175.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -74.35 122.28 87.17 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 122.68 0.392 . . . . 74.22 111.307 -175.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.4 -23.11 44.53 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 122.851 2.367 . . . . 73.11 112.944 176.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -73.8 -34.41 64.61 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.185 0.594 . . . . 73.01 111.514 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 53.5 p -110.99 11.82 22.14 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.043 0.537 . . . . 75.02 110.533 -177.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -54.95 -38.23 67.46 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.924 1.289 . . . . 72.13 111.788 -177.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.82 -29.47 69.95 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.692 -0.686 . . . . 63.4 112.178 -177.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.533 ' HA ' ' HB2' ' A' ' 49' ' ' PHE . 68.9 mt -106.41 -9.88 16.54 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.628 0.371 . . . . 72.55 111.657 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.474 HD13 ' HG ' ' A' ' 27' ' ' LEU . 16.7 tt -161.45 125.86 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.327 0.651 . . . . 74.53 110.501 172.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 22.1 p -149.02 157.41 43.39 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.934 0.397 . . . . 74.01 110.566 177.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 14.7 p-90 -71.38 152.85 42.78 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.731 1.212 . . . . 74.44 110.409 177.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.2 p -74.28 153.39 88.19 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 123.271 0.628 . . . . 75.13 110.346 172.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.8 -26.34 60.11 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.7 2.267 . . . . 65.04 111.925 176.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 66.9 p -75.05 -26.96 59.81 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.303 1.041 . . . . 72.03 110.15 172.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.97 3.3 84.34 Favored Glycine 0 C--N 1.356 1.692 0 CA-C-N 115.658 -0.701 . . . . 64.42 113.468 176.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -86.19 -5.91 59.1 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.689 0.796 . . . . 65.14 112.022 -173.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 65.1 p -159.3 179.09 9.29 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.793 0.837 . . . . 64.53 110.046 -174.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -140.18 148.21 41.26 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.781 -0.451 . . . . 64.21 109.781 172.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -110.84 143.49 41.34 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.009 0.924 . . . . 74.44 109.018 -177.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 67.3 t -123.48 120.96 61.48 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 C-N-CA 124.385 1.074 . . . . 62.32 108.631 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.533 ' HB2' ' HA ' ' A' ' 36' ' ' LEU . 90.1 m-85 -100.58 146.38 27.2 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 124.058 0.943 . . . . 72.43 109.87 -178.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.428 ' H ' ' HB2' ' A' ' 96' ' ' ARG . 6.9 m-20 49.95 67.94 0.83 Allowed 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.799 1.312 . . . . 73.55 111.674 176.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.474 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 14.7 mm-40 -49.52 -34.86 18.42 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.002 0.921 . . . . 71.13 113.377 -175.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.09 -49.83 44.34 Favored Glycine 0 CA--C 1.536 1.365 0 CA-C-O 119.818 -0.434 . . . . 74.12 112.441 175.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -69.5 -45.64 68.44 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.299 0.639 . . . . 75.4 110.542 -176.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.479 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 65.1 t80 -52.24 -51.59 57.47 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.553 1.541 . . . . 72.25 111.05 173.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.507 ' HA ' ' HG ' ' A' ' 59' ' ' LEU . . . -61.36 -36.56 80.53 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.916 0.389 . . . . 74.44 111.537 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.87 -52.89 31.35 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.513 1.125 . . . . 72.34 113.154 -174.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.518 ' HG3' HG23 ' A' ' 58' ' ' VAL . 6.7 pt-20 -106.62 -33.85 7.52 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 113.602 0.964 . . . . 73.2 113.602 -173.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.518 HG23 ' HG3' ' A' ' 57' ' ' GLU . 90.4 t -83.03 -40.29 16.21 Favored 'Isoleucine or valine' 0 C--O 1.251 1.169 0 C-N-CA 123.404 0.681 . . . . 55.24 111.488 -169.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.507 ' HG ' ' HA ' ' A' ' 55' ' ' ALA . 54.0 mt -64.0 -50.46 69.36 Favored Pre-proline 0 CA--C 1.556 1.202 0 CA-C-O 118.242 -0.885 . . . . 75.25 111.81 177.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -67.42 -13.34 38.91 Favored 'Trans proline' 0 C--N 1.381 2.288 0 CA-C-N 121.975 1.741 . . . . 74.54 113.001 176.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -70.68 -54.69 10.9 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.01 0.524 . . . . 72.24 110.536 172.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.414 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 31.5 m-85 -89.87 -52.68 4.86 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.137 0.494 . . . . 74.02 111.984 -178.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -87.71 -171.79 3.59 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.274 -0.875 . . . . 53.44 108.828 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -123.05 45.15 2.48 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.668 0.746 . . . . 74.32 109.749 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -161.16 165.5 29.39 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.636 1.174 . . . . 64.43 108.377 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -122.3 -8.15 8.69 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.52 0.328 . . . . 73.1 110.579 174.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -61.1 115.88 4.11 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.152 0.981 . . . . 74.41 110.605 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.474 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 3.2 tpt -61.71 -49.87 74.73 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.203 1.401 . . . . 71.23 111.725 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.17 -35.31 71.39 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.866 0.867 . . . . 72.3 111.843 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.431 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 34.7 t -64.99 -42.98 94.02 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.731 0.813 . . . . 64.42 111.489 177.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -64.58 -50.25 67.96 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.827 0.851 . . . . 53.23 110.65 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.497 ' HA ' HD12 ' A' ' 75' ' ' LEU . 59.1 t -62.9 -38.45 81.94 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-N 115.417 -0.81 . . . . 64.21 111.128 178.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.411 ' O ' ' HG3' ' A' ' 77' ' ' MET . 39.4 ttm180 -58.67 -43.33 89.86 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.023 0.529 . . . . 71.41 110.858 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.491 ' HA ' ' HE2' ' A' ' 77' ' ' MET . 34.3 mm-40 -59.34 -50.01 75.6 Favored 'General case' 0 C--N 1.358 0.963 0 O-C-N 124.034 0.834 . . . . 75.02 109.872 177.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.501 ' HB3' ' HB2' ' A' ' 80' ' ' PHE . 30.6 mt -56.47 -48.32 77.35 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.109 0.964 . . . . 75.31 111.921 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -62.58 -30.09 71.07 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 122.754 0.422 . . . . 71.22 112.049 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.491 ' HE2' ' HA ' ' A' ' 74' ' ' GLN . 47.9 mtm -69.47 -40.42 77.11 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 109.931 -0.396 . . . . 75.5 109.931 173.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -81.74 -2.65 51.4 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.997 0.519 . . . . 70.52 111.214 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.66 20.28 44.77 Favored Glycine 0 C--N 1.349 1.279 0 N-CA-C 114.882 0.713 . . . . 71.24 114.882 172.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.501 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 83.9 m-85 -82.3 134.85 35.28 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.069 0.935 . . . . 74.22 109.506 177.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 38.3 ttm180 -101.44 126.74 48.27 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.086 0.554 . . . . 71.03 109.802 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.517 ' HE3' HG22 ' A' ' 84' ' ' VAL . 2.7 tmtm? -68.95 114.93 7.7 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 106.879 -1.526 . . . . 64.12 106.879 171.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.522 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 89.3 t -114.2 125.41 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 107.884 -1.154 . . . . 73.11 107.884 176.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.517 HG22 ' HE3' ' A' ' 82' ' ' LYS . 40.8 t -88.94 131.56 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.638 0.775 . . . . 73.42 109.315 -177.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 . . . . . 0 N--CA 1.484 1.233 0 N-CA-C 108.214 -1.032 . . . . 71.32 108.214 169.671 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.428 ' HB2' ' H ' ' A' ' 50' ' ' ASP . 17.7 ptt180 . . . . . 0 N--CA 1.47 0.554 0 CA-C-O 121.406 0.622 . . . . 51.32 110.976 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -91.27 148.4 22.37 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.463 -0.939 . . . . 61.43 108.463 156.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -113.4 106.1 14.18 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 105.355 -2.091 . . . . 72.31 105.355 156.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 32.3 m -115.05 107.36 15.25 Favored 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 123.823 0.702 . . . . 75.0 109.793 -170.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.522 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 41.7 tt0 -96.99 111.17 23.51 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.376 -1.342 . . . . 73.55 107.376 -177.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.419 ' HB3' ' HB3' ' A' ' 80' ' ' PHE . 71.4 m-85 -96.0 119.93 35.37 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.066 -1.087 . . . . 71.14 108.066 175.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -117.3 139.16 51.18 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.863 0.865 . . . . 75.22 109.287 -174.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 106' ' ' PHE . 55.9 t-80 -152.66 135.08 9.0 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 123.466 0.706 . . . . 75.33 109.423 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -59.64 -42.85 43.33 Favored 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 122.863 2.376 . . . . 74.23 112.476 -174.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 37.0 m -92.19 16.66 10.96 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.996 0.518 . . . . 60.33 111.084 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.491 ' HB3' ' HB3' ' A' ' 103' ' ' HIS . 35.9 t80 -124.33 104.18 8.64 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.167 -1.049 . . . . 74.53 108.167 171.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.493 HD12 ' HG3' ' A' ' 110' ' ' GLN . 38.3 mt -120.46 173.65 7.03 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 107.128 -1.434 . . . . 60.2 107.128 167.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -63.28 -68.91 0.3 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.39 0.676 . . . . 73.02 110.942 -172.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -87.71 37.55 3.23 Favored Glycine 0 C--N 1.351 1.365 0 C-N-CA 122.77 0.224 . . . . 72.23 112.98 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.493 ' HG3' HD12 ' A' ' 107' ' ' LEU . 15.8 mm100 -126.43 53.08 1.67 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.92 0.888 . . . . 75.11 108.944 -177.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.418 ' HA ' ' HG ' ' A' ' 114' ' ' LEU . 10.6 pt-20 -60.14 -30.65 69.44 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 114.942 -1.026 . . . . 73.14 111.815 175.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.4 pm0 -63.39 -22.55 66.95 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.363 0.665 . . . . 54.52 111.838 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.443 ' O ' HG13 ' A' ' 117' ' ' ILE . 80.7 mt -90.82 -9.19 47.35 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.253 0.621 . . . . 72.2 112.152 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.418 ' HG ' ' HA ' ' A' ' 111' ' ' GLU . 91.5 mt -61.06 -38.57 86.65 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.202 0.525 . . . . 74.22 110.818 175.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -79.94 -11.11 59.82 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.365 -0.834 . . . . 52.25 112.051 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.417 HD22 ' HA ' ' A' ' 113' ' ' LEU . 23.3 m-80 -87.55 -10.68 50.95 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.54 0.736 . . . . 71.23 109.682 173.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 113' ' ' LEU . 58.9 mt -86.23 135.18 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 108.845 -0.798 . . . . 55.12 108.845 175.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -122.92 150.33 43.08 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.728 0.811 . . . . 74.1 109.748 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 . . . . . 0 CA--C 1.543 0.696 0 N-CA-C 108.483 -0.932 . . . . 73.12 108.483 172.587 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.3 t . . . . . 0 CA--C 1.552 1.045 0 CA-C-O 118.884 -0.579 . . . . 73.41 109.805 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.89 163.2 39.99 Favored 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 122.65 2.233 . . . . 61.42 112.19 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.64 -49.12 57.65 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.08 0.952 . . . . 51.41 112.636 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -52.33 -47.51 66.0 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.444 0.698 . . . . 71.11 112.612 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 89.2 mt -79.64 -35.32 39.55 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.374 0.27 . . . . 41.03 110.955 -172.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.5 t -71.95 -18.76 61.98 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 111.72 0.267 . . . . 72.52 111.72 177.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.6 mmpt? -83.74 -40.99 18.14 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.767 -0.457 . . . . 73.13 109.767 168.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.8 tp -61.0 -50.61 72.66 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.003 0.921 . . . . 74.54 113.352 -176.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.469 ' HB3' HD11 ' A' ' 114' ' ' LEU . 5.1 p-90 -62.37 -37.43 85.69 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 118.628 0.649 . . . . 73.33 110.842 -177.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 41.3 m -63.83 -43.44 96.17 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 124.268 1.027 . . . . 55.32 110.898 175.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.409 HD11 ' CG1' ' A' ' 58' ' ' VAL . 27.4 tp -61.6 -49.56 76.1 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.624 1.57 . . . . 74.52 111.711 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.7 t -59.81 -33.62 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 C-N-CA 124.634 1.174 . . . . 74.11 111.536 176.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.9 t -94.85 -6.95 41.62 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.423 0.689 . . . . 55.33 112.09 -175.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -83.01 132.43 50.84 Favored Pre-proline 0 N--CA 1.486 1.355 0 CA-C-N 118.079 0.4 . . . . 61.43 111.837 -173.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -70.13 -23.82 28.67 Favored 'Trans proline' 0 C--N 1.388 2.652 0 C-N-CA 123.154 2.569 . . . . 72.31 114.209 -176.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -76.4 -32.33 58.47 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.008 0.523 . . . . 71.14 111.079 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.7 p -105.88 1.35 26.69 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.122 0.569 . . . . 74.23 111.61 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -57.31 -33.23 67.48 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.099 1.36 . . . . 72.44 112.56 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.97 -35.55 81.05 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.631 0.772 . . . . 65.32 113.027 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.528 HD22 ' HB2' ' A' ' 50' ' ' ASP . 80.9 mt -106.91 -11.05 15.8 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.063 0.545 . . . . 73.35 111.464 -175.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.2 tt -160.66 127.0 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 122.659 0.384 . . . . 74.13 110.631 174.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.1 p -158.92 161.29 36.75 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.032 0.533 . . . . 63.15 110.136 177.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 25.8 p-90 -71.12 147.3 48.55 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.028 -0.987 . . . . 73.54 110.455 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.4 m -70.96 153.54 94.66 Favored Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 124.016 0.926 . . . . 74.2 109.743 175.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -45.81 -44.63 17.96 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 123.613 2.875 . . . . 74.22 114.899 -175.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.7 m -75.22 -27.22 59.46 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.31 0.644 . . . . 60.14 111.584 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.82 18.44 61.48 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 116.562 -0.29 . . . . 55.12 113.606 175.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -80.85 -17.71 49.8 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.701 0.8 . . . . 71.32 111.326 175.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.0 p -158.28 -173.91 4.55 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.783 0.433 . . . . 71.45 110.806 -170.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -141.02 151.9 44.45 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.103 0.561 . . . . 73.54 110.179 176.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 55.5 m-70 -108.86 156.29 19.83 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.826 0.851 . . . . 72.01 109.647 176.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 84.7 t -130.51 123.16 54.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 124.442 1.097 . . . . 75.32 108.151 176.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -106.93 148.17 28.94 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.805 0.842 . . . . 64.33 109.686 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.528 ' HB2' HD22 ' A' ' 36' ' ' LEU . 7.9 m-20 54.23 55.54 8.05 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 124.714 1.258 . . . . 73.24 110.826 171.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.458 ' HA ' ' HB3' ' A' ' 54' ' ' PHE . 45.8 mt-30 -57.35 -22.77 44.59 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.759 -1.11 . . . . 70.33 113.158 -169.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.11 -47.83 56.95 Favored Glycine 0 C--N 1.348 1.23 0 N-CA-C 111.816 -0.513 . . . . 73.33 111.816 172.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.407 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 56.3 tp60 -71.17 -45.39 63.55 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.836 0.855 . . . . 75.2 110.044 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.458 ' HB3' ' HA ' ' A' ' 51' ' ' GLN . 57.0 t80 -49.16 -50.8 36.03 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.591 1.556 . . . . 72.54 111.403 171.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.65 -36.89 84.29 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.357 -0.383 . . . . 60.1 111.69 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -69.06 -45.01 71.44 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.994 0.918 . . . . 73.55 112.896 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 53' ' ' GLN . 11.1 pt-20 -114.78 -33.02 5.62 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 114.43 1.27 . . . . 73.34 114.43 -172.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.447 ' HB ' ' O ' ' A' ' 54' ' ' PHE . 77.2 t -81.95 -44.46 19.98 Favored 'Isoleucine or valine' 0 C--O 1.25 1.117 0 C-N-CA 122.787 0.435 . . . . 75.02 111.29 -172.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 46.1 mt -64.07 -46.83 80.45 Favored Pre-proline 0 CA--C 1.564 1.511 0 CA-C-O 118.081 -0.961 . . . . 72.32 112.77 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.58 -15.38 47.48 Favored 'Trans proline' 0 C--N 1.388 2.653 0 CA-C-N 121.999 1.75 . . . . 71.35 113.454 174.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -75.49 -54.52 6.89 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.177 0.591 . . . . 71.52 110.646 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -90.19 -40.07 12.42 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 112.112 0.412 . . . . 72.14 112.112 -177.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -106.4 -176.28 3.03 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.758 0.823 . . . . 61.04 108.808 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -119.42 48.83 1.44 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.522 -0.918 . . . . 72.45 108.522 -176.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -164.12 159.9 20.89 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.73 1.212 . . . . 62.03 108.265 176.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -112.32 -21.08 11.59 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.395 0.678 . . . . 55.33 109.253 176.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -61.02 119.55 8.52 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.198 0.999 . . . . 50.11 111.09 -176.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 12.9 tpt -73.46 -32.93 64.62 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.649 0.78 . . . . 73.44 111.25 -176.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.88 -34.26 69.59 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.05 0.54 . . . . 72.52 111.577 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.1 t -64.85 -42.35 94.98 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.334 1.054 . . . . 74.02 111.672 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -68.47 -51.16 46.53 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.948 0.899 . . . . 74.44 110.995 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.0 t -62.12 -37.15 77.74 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 C-N-CA 123.734 0.814 . . . . 74.4 111.194 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -53.94 -50.13 67.15 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.925 0.89 . . . . 62.44 111.117 175.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -56.97 -51.5 68.94 Favored 'General case' 0 C--N 1.35 0.614 0 O-C-N 124.556 1.16 . . . . 62.34 110.547 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.1 mt -62.23 -44.36 96.73 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.912 0.885 . . . . 70.0 112.03 -176.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -59.11 -38.61 79.98 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.293 0.637 . . . . 72.41 111.437 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 50.7 mtm -69.61 -33.21 72.36 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.842 0.457 . . . . 73.51 110.676 175.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -82.1 7.2 14.05 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 122.95 0.5 . . . . 72.31 111.299 178.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.96 20.44 67.82 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-O 119.948 -0.362 . . . . 72.23 113.447 172.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.523 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . 44.8 m-85 -82.82 137.89 34.15 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.978 -0.749 . . . . 72.45 108.978 175.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -101.46 125.24 48.07 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.022 -0.732 . . . . 75.04 109.022 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.59 115.58 8.13 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 107.965 -1.124 . . . . 74.12 107.965 173.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.7 t -131.27 113.86 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.219 -1.03 . . . . 73.42 108.219 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.5 p -96.11 126.45 48.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 108.443 -0.947 . . . . 63.34 108.443 -176.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 69.1 m-70 . . . . . 0 N--CA 1.485 1.315 0 C-N-CA 122.396 0.279 . . . . 64.21 110.767 -175.998 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 . . . . . 0 CA--C 1.544 0.73 0 CA-C-O 122.506 1.146 . . . . 63.33 108.302 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -35.26 101.17 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 111.888 -2.414 . . . . 43.24 113.877 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -99.14 115.83 29.96 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.332 -1.359 . . . . 71.52 107.332 175.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 91.2 m -125.77 119.8 28.9 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.265 -0.643 . . . . 52.12 109.265 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -104.13 117.45 34.3 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.375 -1.343 . . . . 54.21 107.375 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.523 ' HB3' ' HB3' ' A' ' 80' ' ' PHE . 97.6 m-85 -97.35 119.57 36.12 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 107.514 -1.291 . . . . 73.51 107.514 173.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 80' ' ' PHE . 10.2 pt20 -109.36 148.28 31.34 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.527 0.731 . . . . 72.11 110.151 -173.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -158.93 131.43 4.38 Favored Pre-proline 0 CA--C 1.547 0.846 0 CA-C-O 118.835 -0.603 . . . . 51.32 109.643 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -62.85 -26.55 74.67 Favored 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 123.152 2.568 . . . . 75.31 113.707 -176.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.4 m -102.33 22.26 13.67 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.119 0.567 . . . . 75.14 111.109 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -119.74 108.27 14.21 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.02 -1.104 . . . . 73.44 108.02 170.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 91.4 mt -116.82 111.13 19.29 Favored 'General case' 0 C--O 1.212 -0.875 0 CA-C-O 118.32 -0.847 . . . . 72.52 108.889 170.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 40.7 -80.96 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 126.0 1.72 . . . . 73.1 115.263 165.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.23 30.03 2.66 Favored Glycine 0 C--N 1.356 1.649 0 C-N-CA 123.351 0.501 . . . . 63.13 112.887 -176.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.55 ' N ' HE21 ' A' ' 110' ' ' GLN . 0.0 OUTLIER -89.33 87.07 6.97 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 107.79 -1.189 . . . . 75.24 107.79 176.281 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.35 -25.79 67.75 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.122 -0.944 . . . . 61.4 112.335 -176.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 16.5 pm0 -69.12 -21.51 64.03 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.716 0.406 . . . . 74.21 111.536 177.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 82.2 mt -89.63 -13.09 37.85 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.234 0.614 . . . . 54.12 111.2 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.469 HD11 ' HB3' ' A' ' 25' ' ' TRP . 91.9 mt -64.61 -35.61 81.56 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.943 0.497 . . . . 63.55 111.065 175.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -80.9 -1.67 44.38 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 111.719 0.266 . . . . 54.1 111.719 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.503 HD22 ' N ' ' A' ' 116' ' ' ASN . 0.6 OUTLIER -88.14 -24.75 23.27 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 108.95 -0.759 . . . . 73.54 108.95 170.504 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 57.9 mt -79.77 105.05 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.918 0.887 . . . . 74.3 108.868 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.556 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 10.8 mmpt? -107.39 139.53 41.74 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 120.86 0.362 . . . . 75.13 110.175 -170.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 16.1 ptm180 . . . . . 0 N--CA 1.473 0.72 0 CA-C-N 115.307 -0.861 . . . . 74.33 110.821 -178.248 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.5 t . . . . . 0 C--O 1.242 0.688 0 N-CA-C 107.026 -1.472 . . . . 72.13 107.026 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.459 ' HD2' HD12 ' A' ' 21' ' ' LEU . 33.5 Cg_exo -58.15 146.32 88.75 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.479 2.12 . . . . 71.04 110.669 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.28 -34.29 45.91 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 123.711 0.632 . . . . 62.3 110.62 176.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -51.36 -52.39 46.08 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.911 0.885 . . . . 72.14 112.234 171.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.459 HD12 ' HD2' ' A' ' 18' ' ' PRO . 83.1 mt -80.86 -30.34 35.64 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.005 0.431 . . . . 71.23 110.065 -171.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.1 m -59.88 -51.66 68.75 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.856 1.262 . . . . 62.3 110.631 173.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.539 ' HB3' ' HB3' ' A' ' 62' ' ' TYR . 9.6 mmpt? -65.98 -45.38 81.88 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 115.548 -0.751 . . . . 75.33 110.144 177.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.459 ' O ' HG23 ' A' ' 28' ' ' VAL . 57.4 tp -56.29 -48.14 77.24 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.038 0.935 . . . . 74.53 111.595 -178.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 41.8 t90 -55.85 -46.3 78.25 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.05 0.94 . . . . 72.44 111.353 178.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 35.0 m -71.18 -25.48 62.56 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.469 1.108 . . . . 74.11 112.118 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.538 HD11 HG13 ' A' ' 58' ' ' VAL . 30.3 tp -78.01 -43.98 27.91 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.162 0.985 . . . . 73.53 110.793 -176.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 24' ' ' LEU . 74.3 t -57.96 -26.83 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.352 0 C-N-CA 125.042 1.337 . . . . 74.33 111.612 173.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 78.6 p -101.4 0.91 37.78 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.531 0.732 . . . . 75.23 112.631 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -81.45 120.15 77.42 Favored Pre-proline 0 N--CA 1.483 1.193 0 C-N-CA 122.946 0.498 . . . . 74.03 110.993 -172.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -71.77 -11.05 27.37 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 122.845 2.363 . . . . 71.42 113.165 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -74.16 -36.2 64.07 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 122.591 0.356 . . . . 75.14 110.225 173.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 70.5 p -117.79 13.18 14.07 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.6 0.76 . . . . 72.23 111.631 -173.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -62.19 -30.22 70.92 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.175 0.59 . . . . 60.12 112.123 -171.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.67 -20.19 58.62 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.847 0.684 . . . . 73.23 112.847 178.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 59.4 mt -105.67 -16.77 14.6 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.007 0.523 . . . . 75.41 110.718 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.513 HD13 ' HG ' ' A' ' 27' ' ' LEU . 17.5 tt -160.28 121.7 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.21 0.604 . . . . 73.44 110.715 175.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 48.6 t -154.93 154.93 33.38 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.287 0.635 . . . . 75.21 109.67 177.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 29.2 p-90 -74.45 152.82 39.39 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.643 0.777 . . . . 71.35 111.007 -174.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.3 m -79.31 142.11 58.29 Favored Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 108.487 -0.931 . . . . 64.13 108.487 172.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.99 -26.52 49.9 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 123.212 2.608 . . . . 71.02 114.152 -176.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.6 m -74.71 -27.45 60.39 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.914 0.486 . . . . 54.41 111.42 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 107' ' ' LEU . . . 94.48 -5.55 70.62 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-O 119.391 -0.671 . . . . 73.51 114.018 175.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.468 ' HA ' HD23 ' A' ' 107' ' ' LEU . 2.8 m-20 -78.94 -16.21 57.27 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.816 0.846 . . . . 61.43 111.955 -170.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 43.5 p -156.57 179.97 8.75 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.347 0.594 . . . . 71.04 110.965 -173.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -138.81 151.98 47.49 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.044 -0.98 . . . . 53.52 109.344 171.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -107.37 139.22 42.19 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.738 0.815 . . . . 75.11 109.136 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.517 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 71.2 t -118.2 127.5 75.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 107.324 -1.361 . . . . 74.34 107.324 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -113.64 146.29 39.99 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.177 -0.675 . . . . 75.31 109.177 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 53.64 68.76 0.79 Allowed 'General case' 0 N--CA 1.476 0.859 0 O-C-N 124.851 1.344 . . . . 71.11 110.8 176.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.578 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 47.0 mt-30 -53.28 -26.92 20.13 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.491 0.717 . . . . 71.1 112.63 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -64.82 -53.06 36.77 Favored Glycine 0 C--N 1.349 1.281 0 O-C-N 123.252 0.345 . . . . 61.21 112.289 172.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -69.8 -42.12 74.16 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.192 0.597 . . . . 71.24 110.754 -176.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.437 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 60.2 t80 -56.65 -50.16 72.89 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.49 1.516 . . . . 75.13 110.806 176.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.445 ' HB1' ' O ' ' A' ' 66' ' ' ASN . . . -62.4 -31.99 72.75 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 112.213 0.449 . . . . 51.51 112.213 177.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -70.6 -49.28 49.39 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.073 0.949 . . . . 64.45 112.778 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.573 ' HG3' HG23 ' A' ' 58' ' ' VAL . 4.4 pt-20 -108.48 -37.48 5.95 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 113.569 0.952 . . . . 62.12 113.569 -172.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.573 HG23 ' HG3' ' A' ' 57' ' ' GLU . 98.6 t -81.99 -45.86 19.91 Favored 'Isoleucine or valine' 0 C--O 1.249 1.07 0 C-N-CA 123.315 0.646 . . . . 75.24 111.565 -166.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.1 mt -62.08 -48.97 87.03 Favored Pre-proline 0 CA--C 1.558 1.257 0 CA-C-O 117.79 -1.1 . . . . 72.14 112.705 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.521 ' HG3' ' ND2' ' A' ' 66' ' ' ASN . 52.6 Cg_endo -67.69 -15.23 44.06 Favored 'Trans proline' 0 C--N 1.388 2.611 0 C-N-CA 122.134 1.889 . . . . 73.14 113.186 176.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -74.05 -64.99 0.9 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.176 0.59 . . . . 63.34 110.824 178.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.539 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 29.8 m-85 -81.61 -46.51 14.29 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.209 0.528 . . . . 74.12 111.474 -176.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -98.57 -171.22 2.08 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 106.608 -1.627 . . . . 74.44 106.608 177.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -129.47 64.99 1.48 Allowed 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 119.428 1.013 . . . . 72.13 109.859 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -166.09 162.86 18.04 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 114.295 -1.32 . . . . 75.51 108.813 174.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.521 ' ND2' ' HG3' ' A' ' 60' ' ' PRO . 11.1 m120 -114.2 -5.85 13.02 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 122.682 0.393 . . . . 72.33 110.304 175.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -75.29 112.5 11.65 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 122.963 0.505 . . . . 74.32 110.66 -175.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.578 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 3.5 tpt -56.49 -48.64 76.72 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.281 1.432 . . . . 44.25 111.631 178.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.96 -30.07 67.64 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.414 -0.812 . . . . 75.12 112.597 -177.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.3 t -68.52 -41.35 80.07 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.643 0.777 . . . . 75.03 111.271 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -61.95 -49.24 76.89 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.832 0.853 . . . . 65.24 109.93 177.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 52.7 t -65.15 -35.4 75.32 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 CA-C-N 114.688 -1.142 . . . . 72.15 111.508 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -60.86 -42.49 97.98 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.67 0.788 . . . . 73.52 110.971 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.507 ' HA ' ' HE2' ' A' ' 77' ' ' MET . 32.1 mm-40 -64.85 -45.29 86.72 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.82 -0.627 . . . . 63.31 110.426 178.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.442 ' HB3' ' HB2' ' A' ' 80' ' ' PHE . 83.1 mt -63.59 -34.19 77.27 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.271 0.629 . . . . 71.31 111.847 -178.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -56.15 -40.03 73.21 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.212 0.605 . . . . 71.43 111.184 171.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.507 ' HE2' ' HA ' ' A' ' 74' ' ' GLN . 39.9 mtm -76.91 -23.91 52.49 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.278 0.631 . . . . 63.22 111.28 178.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -86.1 -8.61 57.76 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.06 0.544 . . . . 72.22 111.006 174.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.05 21.04 54.02 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 114.406 0.522 . . . . 40.01 114.406 173.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.442 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 17.7 m-85 -82.31 144.97 30.22 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 108.954 -0.758 . . . . 61.31 108.954 176.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -102.29 129.6 48.76 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.868 0.467 . . . . 75.5 110.24 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.631 ' HE3' HG22 ' A' ' 84' ' ' VAL . 52.8 tptt -68.71 118.65 11.97 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.426 1.09 . . . . 74.22 108.779 169.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.548 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 58.8 t -123.4 116.82 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 108.667 -0.864 . . . . 73.24 108.667 176.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.631 HG22 ' HE3' ' A' ' 82' ' ' LYS . 34.4 t -97.98 101.88 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.746 0.818 . . . . 74.03 109.318 -174.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 . . . . . 0 N--CA 1.484 1.236 0 O-C-N 122.341 -0.224 . . . . 70.31 110.656 179.649 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 . . . . . 0 CA--C 1.55 0.957 0 CA-C-O 121.143 0.497 . . . . 74.4 110.087 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -36.76 105.38 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 125.413 1.485 . . . . 54.11 112.56 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -90.33 112.77 24.47 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 107.608 -1.256 . . . . 65.32 107.608 -177.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.53 HG23 ' HD2' ' A' ' 82' ' ' LYS . 76.6 m -118.06 107.12 13.62 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.894 -1.048 . . . . 70.41 109.256 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.548 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 41.9 tt0 -96.23 109.63 22.07 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.596 -1.261 . . . . 65.41 107.596 177.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -95.03 118.68 32.26 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 107.125 -1.435 . . . . 74.2 107.125 172.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -123.37 149.29 45.13 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.861 0.864 . . . . 63.55 109.87 -174.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -156.74 133.14 6.13 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 109.276 -0.638 . . . . 73.15 109.276 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.21 -27.2 56.48 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 122.928 2.419 . . . . 74.52 113.044 -174.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 113' ' ' LEU . 59.2 m -105.86 37.38 2.26 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.644 0.778 . . . . 62.32 109.511 175.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -133.9 106.9 7.52 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.055 -1.091 . . . . 70.31 108.055 170.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.596 ' HB2' ' HB3' ' A' ' 110' ' ' GLN . 68.0 mt -128.2 149.63 50.37 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 108.514 -0.921 . . . . 63.12 108.514 172.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -63.02 -59.14 5.21 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.486 0.714 . . . . 74.35 111.659 -175.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -88.95 50.57 3.71 Favored Glycine 0 C--N 1.342 0.877 0 N-CA-C 111.87 -0.492 . . . . 53.04 111.87 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.596 ' HB3' ' HB2' ' A' ' 107' ' ' LEU . 4.1 tp60 -165.19 53.0 0.11 Allowed 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 108.691 -0.855 . . . . 73.52 108.691 -172.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -62.64 -18.4 62.22 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.024 0.93 . . . . 44.2 112.966 -176.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.0 pm0 -68.26 -6.58 24.55 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 122.957 0.503 . . . . 72.03 112.145 176.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.414 ' HB3' ' O ' ' A' ' 105' ' ' CYS . 63.4 mt -86.28 -23.7 26.22 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 122.751 0.42 . . . . 70.3 111.473 174.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.19 -37.98 89.35 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.274 0.63 . . . . 64.1 111.35 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -72.21 -13.49 61.55 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 114.895 -1.048 . . . . 72.43 112.267 177.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -93.9 -11.62 30.64 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.327 0.651 . . . . 75.23 110.865 173.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 35.8 mt -87.41 91.99 3.67 Favored 'Isoleucine or valine' 0 C--N 1.353 0.745 0 N-CA-C 107.134 -1.432 . . . . 72.01 107.134 176.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.443 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 11.1 mmpt? -87.48 144.48 26.7 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.219 -0.66 . . . . 72.32 109.219 -178.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 8.6 ptm85 . . . . . 0 N--CA 1.473 0.687 0 N-CA-C 109.572 -0.529 . . . . 73.44 109.572 178.562 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.5 t . . . . . 0 CA--C 1.55 0.952 0 CA-C-O 119.714 -0.184 . . . . 64.33 110.649 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -61.81 139.0 77.79 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 122.734 2.289 . . . . 74.55 111.8 170.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.453 ' HA ' HG22 ' A' ' 22' ' ' THR . . . -56.58 -38.47 72.02 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.592 0.757 . . . . 73.31 112.392 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -51.33 -46.85 62.78 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.587 0.755 . . . . 75.13 111.626 173.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.449 ' HB3' HD22 ' A' ' 114' ' ' LEU . 77.8 mt -79.69 -34.73 39.99 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.122 0.569 . . . . 71.05 112.498 -172.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.453 HG22 ' HA ' ' A' ' 19' ' ' ALA . 14.3 t -71.38 -34.89 70.81 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 118.041 0.382 . . . . 73.31 111.146 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.2 mtpt -81.06 -32.7 33.91 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 119.532 -0.271 . . . . 63.24 110.875 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.426 ' O ' HG23 ' A' ' 28' ' ' VAL . 57.4 tp -63.55 -39.58 94.77 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.091 0.556 . . . . 75.13 110.497 170.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 64.7 t-105 -57.44 -52.67 64.44 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.871 0.868 . . . . 65.42 110.666 174.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 38.6 m -59.84 -40.74 89.56 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 124.238 0.961 . . . . 72.22 110.721 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.483 ' HG ' HD13 ' A' ' 37' ' ' ILE . 26.9 tp -59.64 -52.26 66.28 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.196 1.398 . . . . 72.44 112.304 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 24' ' ' LEU . 96.9 t -62.01 -33.14 56.8 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 C-N-CA 123.855 0.862 . . . . 75.15 111.164 177.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.9 t -94.04 -1.71 54.05 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 123.911 0.884 . . . . 51.34 112.069 -174.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -89.0 130.54 44.21 Favored Pre-proline 0 N--CA 1.49 1.555 0 C-N-CA 123.29 0.636 . . . . 75.41 111.467 -174.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -73.32 -21.82 19.54 Favored 'Trans proline' 0 C--N 1.39 2.716 0 C-N-CA 123.271 2.647 . . . . 71.33 114.369 -174.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -78.45 -36.33 45.57 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.316 0.646 . . . . 74.41 110.455 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.5 p -92.01 -0.96 57.48 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.227 0.611 . . . . 61.34 111.28 -176.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.69 -29.17 58.92 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.88 1.272 . . . . 73.21 112.107 -179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.26 -36.98 79.03 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.934 0.894 . . . . 64.5 113.22 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.6 mt -114.16 -6.38 13.05 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.918 0.487 . . . . 63.12 112.134 -176.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.483 HD13 ' HG ' ' A' ' 27' ' ' LEU . 16.6 tt -160.11 125.71 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-O 120.943 0.401 . . . . 74.44 110.878 175.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 21.5 p -146.2 145.3 30.39 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.218 0.607 . . . . 63.45 110.255 -176.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 10.2 p-90 -69.25 152.19 45.36 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 118.028 0.376 . . . . 71.11 110.844 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 61.2 p -71.98 150.0 92.53 Favored Pre-proline 0 CA--C 1.552 1.048 0 N-CA-C 109.446 -0.575 . . . . 55.43 109.446 172.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -51.59 -24.27 16.82 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.564 2.176 . . . . 73.34 113.67 171.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 59.8 m -69.99 -52.26 25.74 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.241 0.616 . . . . 64.02 109.765 169.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.16 5.58 65.63 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.277 -0.874 . . . . 32.32 112.969 -177.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -87.92 -2.25 58.49 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.861 0.864 . . . . 72.04 110.022 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.7 p -163.59 170.57 17.0 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.375 1.07 . . . . 71.24 109.494 -169.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -142.07 143.46 33.1 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.465 0.306 . . . . 50.3 111.075 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 -97.77 140.27 32.4 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.173 0.989 . . . . 64.42 109.487 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.5 t -123.95 132.7 70.95 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 C-N-CA 124.387 1.075 . . . . 61.23 108.308 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.416 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 79.3 m-85 -115.82 146.86 41.61 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.39 1.076 . . . . 72.45 109.756 -177.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 49.77 72.59 0.31 Allowed 'General case' 0 N--CA 1.479 1.007 0 O-C-N 124.727 1.267 . . . . 63.1 111.378 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.416 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 16.3 mm-40 -51.09 -35.96 37.83 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.808 0.843 . . . . 72.31 112.717 -176.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.37 -47.38 71.16 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-N 115.809 -0.632 . . . . 52.12 112.885 177.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 -69.54 -44.33 71.19 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.187 0.595 . . . . 62.01 110.63 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -55.34 -49.26 72.68 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.376 1.47 . . . . 74.04 110.975 176.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.29 -35.93 78.68 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 116.432 -0.349 . . . . 71.34 111.932 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -70.11 -47.08 63.31 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 124.263 1.025 . . . . 72.24 113.078 -175.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.487 ' HG3' HG23 ' A' ' 58' ' ' VAL . 7.1 pt-20 -107.01 -37.38 6.34 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 113.912 1.079 . . . . 74.25 113.912 -174.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.487 HG23 ' HG3' ' A' ' 57' ' ' GLU . 98.4 t -81.0 -43.7 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 122.754 0.421 . . . . 75.54 111.512 -168.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.5 mt -67.03 -43.86 48.17 Favored Pre-proline 0 CA--C 1.556 1.21 0 CA-C-O 117.979 -1.01 . . . . 71.33 112.833 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.98 -14.36 43.37 Favored 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 121.894 1.729 . . . . 73.43 113.625 173.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -79.01 -57.76 3.58 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.384 0.674 . . . . 70.33 111.04 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.437 ' CE1' HD13 ' A' ' 27' ' ' LEU . 57.3 m-85 -86.57 -26.8 24.3 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 112.258 0.466 . . . . 74.43 112.258 -176.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -124.38 -178.45 4.11 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.063 0.945 . . . . 50.52 108.747 -176.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.66 37.67 2.85 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 122.917 0.487 . . . . 72.4 109.994 -172.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -160.84 160.7 31.41 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.92 0.888 . . . . 73.54 108.902 -176.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -109.69 -25.45 10.39 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 108.996 -0.742 . . . . 73.21 108.996 176.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -57.68 118.37 5.19 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.334 1.054 . . . . 55.42 111.655 -176.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.416 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 11.6 ttm -72.15 -31.57 66.08 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.1 -0.955 . . . . 73.44 111.709 -178.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.29 -37.36 69.74 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.076 0.55 . . . . 44.33 111.644 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.404 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 37.2 t -66.41 -44.96 81.52 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.214 1.005 . . . . 64.31 111.323 176.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -64.19 -52.91 56.62 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.531 1.132 . . . . 64.03 111.196 -176.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 68.0 t -65.8 -31.35 53.35 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 CA-C-N 115.515 -0.766 . . . . 64.15 111.251 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -60.28 -39.77 88.03 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 122.785 0.434 . . . . 73.44 111.227 173.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 70' ' ' SER . 21.7 mm-40 -65.09 -46.25 81.86 Favored 'General case' 0 C--N 1.355 0.809 0 O-C-N 123.646 0.591 . . . . 75.05 109.905 177.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 80' ' ' PHE . 96.9 mt -57.4 -45.25 84.75 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 123.81 0.844 . . . . 61.15 111.285 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -55.57 -42.5 74.82 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.595 0.758 . . . . 74.51 111.933 176.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 59.3 mtm -73.6 -27.61 61.38 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 116.041 -0.527 . . . . 71.13 111.491 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -85.28 -6.97 59.22 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.569 0.348 . . . . 71.04 111.207 177.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.65 17.71 59.62 Favored Glycine 0 C--N 1.352 1.469 0 CA-C-O 119.794 -0.448 . . . . 32.31 113.927 175.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.502 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 38.7 m-85 -78.2 137.34 38.09 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 108.332 -0.988 . . . . 73.02 108.332 173.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 13.6 ttm180 -107.93 130.79 55.01 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.306 0.642 . . . . 73.43 109.545 -175.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -65.78 125.45 25.36 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.038 0.935 . . . . 73.12 109.369 174.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 51.7 t -116.0 113.54 43.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 107.835 -1.172 . . . . 73.22 107.835 176.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 71.1 t -86.46 140.15 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 123.762 0.825 . . . . 73.23 110.898 -177.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 32.5 m80 . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 108.066 -1.087 . . . . 74.52 108.066 172.029 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 . . . . . 0 C--O 1.24 0.553 0 CA-C-O 121.516 0.674 . . . . 72.43 111.381 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.416 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 18.0 m-20 -80.84 134.15 35.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.337 -1.302 . . . . 74.21 108.554 170.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -115.1 105.27 12.74 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 107.644 -1.243 . . . . 71.24 107.644 169.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 93.3 m -124.7 153.23 42.65 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.478 1.111 . . . . 64.41 109.637 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.546 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 37.8 tt0 -130.9 153.55 49.02 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.548 -0.908 . . . . 72.04 108.548 162.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -124.46 120.31 31.66 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 107.277 -1.379 . . . . 74.33 107.277 169.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -110.32 144.56 38.87 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.552 0.741 . . . . 74.41 110.242 -174.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.463 ' HB3' ' HB3' ' A' ' 106' ' ' PHE . 64.8 t-80 -149.46 130.81 7.3 Favored Pre-proline 0 CA--C 1.55 0.969 0 CA-C-O 119.351 -0.357 . . . . 64.0 110.423 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.25 -40.83 30.28 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 123.299 2.666 . . . . 74.41 113.667 -175.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.416 ' HB2' ' HE1' ' A' ' 103' ' ' HIS . 34.2 m -97.13 22.96 7.85 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.275 0.63 . . . . 73.3 111.096 -177.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.463 ' HB3' ' HB3' ' A' ' 103' ' ' HIS . 89.1 t80 -117.37 99.05 6.75 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 106.706 -1.59 . . . . 72.44 106.706 173.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 63.1 mt -119.31 139.36 52.07 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.137 -1.06 . . . . 63.34 108.137 177.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -68.89 132.27 46.47 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.508 0.723 . . . . 73.31 110.125 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.48 1.6 90.49 Favored Glycine 0 C--N 1.344 0.983 0 O-C-N 123.555 0.534 . . . . 43.14 113.052 -173.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -122.84 53.46 1.28 Allowed 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 108.144 -1.058 . . . . 62.53 108.144 -175.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.55 -26.1 65.09 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.236 1.414 . . . . 73.32 114.102 -177.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 7.9 pm0 -71.01 -8.19 51.6 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 112.204 0.446 . . . . 65.32 112.204 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.491 ' O ' HG13 ' A' ' 117' ' ' ILE . 24.6 mt -83.1 -14.22 54.11 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 118.771 -0.633 . . . . 73.23 111.485 173.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.449 HD22 ' HB3' ' A' ' 21' ' ' LEU . 96.4 mt -63.17 -35.3 79.86 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 118.295 0.498 . . . . 72.15 110.857 175.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -80.15 -1.59 40.96 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.962 -0.563 . . . . 60.51 112.148 175.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -103.61 -13.71 16.43 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.586 0.754 . . . . 75.21 110.528 168.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 113' ' ' LEU . 63.9 mt -85.74 109.74 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 106.879 -1.526 . . . . 72.1 106.879 173.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -109.21 170.39 8.08 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.807 -0.812 . . . . 70.4 108.807 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 24.6 ptt85 . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 108.155 -1.054 . . . . 55.51 108.155 168.993 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.4 t . . . . . 0 CA--C 1.551 0.983 0 CA-C-O 119.127 -0.463 . . . . 73.51 111.802 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -58.94 152.37 58.6 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 123.155 2.57 . . . . 74.42 112.314 174.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.72 -45.78 70.59 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.971 0.908 . . . . 71.41 112.1 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -54.85 -44.44 73.99 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 122.981 0.512 . . . . 73.31 112.009 176.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.2 mt -80.52 -31.09 37.16 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 112.393 0.516 . . . . 61.55 112.393 -171.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.1 t -70.99 -33.39 70.37 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.656 -0.498 . . . . 72.2 109.656 175.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -69.87 -42.41 73.52 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 122.915 0.486 . . . . 65.23 110.536 172.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.61 -43.67 93.68 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.8 0.84 . . . . 54.23 111.419 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 13.5 t-105 -64.58 -51.9 60.37 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-O 119.611 -0.233 . . . . 74.42 110.81 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 32.1 m -61.3 -20.69 63.2 Favored 'General case' 0 CA--C 1.554 1.133 0 CA-C-O 121.299 0.571 . . . . 73.1 110.883 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.0 tp -76.77 -54.77 6.18 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.597 1.159 . . . . 75.41 111.408 174.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 82.5 t -62.16 -36.22 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.749 0.819 . . . . 72.13 111.389 -177.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.5 p -78.15 -25.4 47.3 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.538 0.735 . . . . 74.14 112.305 -176.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -70.84 123.12 88.69 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 123.24 0.616 . . . . 63.34 111.563 -171.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.28 -13.51 33.45 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 122.975 2.45 . . . . 61.13 113.479 -177.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -87.12 -22.39 25.4 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.723 0.809 . . . . 74.25 110.987 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.451 HG21 ' HE1' ' A' ' 62' ' ' TYR . 24.7 p -110.6 1.25 17.95 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.158 0.583 . . . . 74.43 111.685 175.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -54.12 -36.95 63.81 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.486 1.114 . . . . 70.42 112.271 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.1 -33.17 75.39 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.526 -0.761 . . . . 72.12 112.256 -176.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.462 HD22 ' HB2' ' A' ' 50' ' ' ASP . 59.7 mt -103.48 -11.0 18.09 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.548 0.339 . . . . 55.43 111.36 -177.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.5 tt -162.15 128.43 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 122.971 0.508 . . . . 70.03 110.326 172.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 17.3 p -153.92 157.6 39.46 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.23 0.612 . . . . 71.21 110.057 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 41.4 p-90 -73.63 149.22 42.18 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.993 0.517 . . . . 74.23 110.097 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.5 m -70.24 143.51 91.1 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 123.879 0.872 . . . . 75.51 110.098 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -55.59 -32.49 83.36 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.813 2.342 . . . . 75.0 113.517 175.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.9 m -69.61 -19.68 63.64 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.217 0.607 . . . . 73.31 111.698 173.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.69 6.4 71.71 Favored Glycine 0 C--N 1.344 0.996 0 N-CA-C 115.617 1.007 . . . . 41.24 115.617 171.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -88.07 -5.66 58.36 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 118.109 0.955 . . . . 74.21 112.265 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.2 p -163.44 -171.66 2.65 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.162 0.585 . . . . 64.42 110.736 -170.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -145.03 148.81 34.13 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.404 0.682 . . . . 73.51 110.973 175.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 21.6 m-70 -99.52 150.79 21.86 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.588 1.155 . . . . 71.4 110.173 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.0 t -123.67 123.03 66.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 107.939 -1.134 . . . . 61.33 107.939 172.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -105.68 147.41 28.54 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.273 1.029 . . . . 64.42 110.034 -178.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.462 ' HB2' HD22 ' A' ' 36' ' ' LEU . 8.6 m-20 48.79 59.83 4.13 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 124.925 1.39 . . . . 63.22 111.196 172.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.496 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 75.7 mt-30 -54.65 -26.16 31.41 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.78 1.03 . . . . 71.25 113.78 -169.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.94 -50.08 37.33 Favored Glycine 0 C--N 1.35 1.348 0 O-C-N 123.198 0.311 . . . . 75.21 112.654 173.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -68.06 -40.13 82.84 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.452 0.701 . . . . 70.43 110.249 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.476 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 44.4 t80 -57.99 -48.14 80.91 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.113 1.365 . . . . 73.44 110.534 176.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.435 ' HB2' ' HB2' ' A' ' 68' ' ' MET . . . -61.27 -36.67 80.66 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.196 -0.456 . . . . 71.21 111.486 177.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -68.47 -53.99 19.83 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.252 1.021 . . . . 73.13 112.985 -176.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.559 ' HG3' HG23 ' A' ' 58' ' ' VAL . 6.3 pt-20 -100.45 -38.07 8.56 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 112.893 0.701 . . . . 61.42 112.893 -173.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.559 HG23 ' HG3' ' A' ' 57' ' ' GLU . 77.6 t -81.92 -44.46 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.045 0.538 . . . . 71.24 112.144 -167.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 49.3 mt -63.52 -45.17 83.24 Favored Pre-proline 0 CA--C 1.56 1.36 0 CA-C-O 117.797 -1.097 . . . . 73.21 112.684 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.09 -16.52 44.89 Favored 'Trans proline' 0 C--N 1.386 2.538 0 CA-C-N 122.037 1.763 . . . . 75.51 113.312 173.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -73.13 -47.62 42.57 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.453 0.701 . . . . 73.2 111.073 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.451 ' HE1' HG21 ' A' ' 33' ' ' THR . 53.8 m-85 -96.12 -48.1 5.8 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 122.853 0.461 . . . . 65.13 111.903 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -99.08 -171.27 2.06 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.85 0.86 . . . . 75.05 109.117 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -118.89 44.72 2.24 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.361 0.601 . . . . 72.23 110.551 -176.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -164.04 164.51 22.99 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.333 -0.849 . . . . 74.3 109.557 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -121.91 -11.8 8.48 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.588 0.755 . . . . 75.31 110.278 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -66.93 117.39 8.95 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.035 0.934 . . . . 74.3 109.75 174.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.496 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 24.0 ttt -87.72 -18.68 28.94 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.558 0.343 . . . . 73.35 110.917 -176.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.5 -37.49 67.92 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.862 0.465 . . . . 74.51 110.22 172.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.485 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 44.0 t -66.44 -46.22 77.21 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.911 1.284 . . . . 63.02 111.343 175.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -61.75 -51.28 68.98 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.889 0.876 . . . . 74.01 110.478 -175.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.35 -40.85 90.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 123.914 0.885 . . . . 61.43 110.772 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -56.58 -39.91 74.33 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.257 1.023 . . . . 73.32 111.073 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 70' ' ' SER . 25.8 mm-40 -63.38 -45.91 88.92 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 123.653 0.596 . . . . 72.24 109.822 176.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 80' ' ' PHE . 64.4 mt -61.16 -37.43 82.87 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.729 0.811 . . . . 71.34 111.5 -178.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -58.55 -38.54 78.03 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.509 0.724 . . . . 52.42 111.371 172.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 34.1 mtm -70.86 -34.07 71.26 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.189 -0.459 . . . . 72.42 110.493 177.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.454 ' CZ ' ' HB3' ' A' ' 119' ' ' ARG . 44.4 m-85 -81.21 -9.62 59.75 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.595 0.758 . . . . 71.43 111.59 -178.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.96 22.69 59.01 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 114.268 0.467 . . . . 61.0 114.268 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.4 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 72.1 m-85 -79.49 137.17 37.11 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 108.443 -0.947 . . . . 61.31 108.443 171.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -102.81 127.14 50.1 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.153 0.581 . . . . 74.5 110.595 -170.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.402 ' HD2' HG23 ' A' ' 99' ' ' THR . 41.3 tptt -65.05 115.88 5.89 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.865 1.266 . . . . 74.51 109.707 173.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 59.5 t -123.29 120.28 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 108.731 -0.84 . . . . 71.13 108.731 175.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 37.5 t -90.77 121.47 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.069 0.948 . . . . 65.11 109.384 -176.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 . . . . . 0 N--CA 1.489 1.502 0 C-N-CA 122.619 0.368 . . . . 62.23 110.696 179.216 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 . . . . . 0 N--CA 1.474 0.726 0 CA-C-O 120.925 0.393 . . . . 61.31 110.205 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -97.52 113.39 25.08 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 107.166 -1.42 . . . . 61.24 107.166 175.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -100.65 122.13 42.79 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 107.262 -1.384 . . . . 72.15 107.262 174.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.402 HG23 ' HD2' ' A' ' 82' ' ' LYS . 77.3 m -123.34 128.49 49.98 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.13 -0.693 . . . . 50.5 109.13 176.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.476 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 35.2 tt0 -101.55 111.0 23.1 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 106.799 -1.556 . . . . 75.43 106.799 172.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -94.05 119.88 33.53 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.445 -1.317 . . . . 65.12 107.445 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -121.69 142.12 50.48 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.788 -0.642 . . . . 75.42 110.796 -174.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 45.5 t-80 -147.26 130.28 8.0 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 107.665 -1.235 . . . . 74.24 107.665 175.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -63.01 -20.9 72.69 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.816 2.344 . . . . 62.51 113.846 -172.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.472 ' SG ' ' HB3' ' A' ' 113' ' ' LEU . 36.7 t -101.64 35.36 2.33 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.306 0.642 . . . . 70.15 110.099 175.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -137.48 109.01 6.94 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.931 0.892 . . . . 74.34 108.848 172.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 85.0 mt -118.14 104.86 11.23 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 118.969 -0.539 . . . . 62.31 109.933 174.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 52.14 -79.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 125.669 1.588 . . . . 75.11 112.688 176.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -141.57 42.13 1.18 Allowed Glycine 0 C--N 1.348 1.243 0 CA-C-N 115.827 -0.624 . . . . 32.43 111.923 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -82.1 74.19 9.09 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 106.677 -1.601 . . . . 70.52 106.677 173.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -62.0 -31.14 71.49 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.143 -1.39 . . . . 75.13 112.695 -171.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 17.5 pm0 -69.2 -16.89 63.72 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 122.502 0.321 . . . . 72.12 111.586 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.472 ' HB3' ' SG ' ' A' ' 105' ' ' CYS . 40.7 mt -87.24 -14.6 40.58 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.329 0.252 . . . . 73.43 111.462 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.407 HD23 HD12 ' A' ' 117' ' ' ILE . 96.5 mt -63.86 -33.82 76.56 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.976 0.51 . . . . 73.23 111.661 177.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -73.74 -5.88 43.47 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.2 0.444 . . . . 54.34 112.2 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.434 HD22 ' HA ' ' A' ' 113' ' ' LEU . 23.2 m-80 -101.56 -6.68 23.56 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.8 0.84 . . . . 71.54 109.594 175.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.407 HD12 HD23 ' A' ' 114' ' ' LEU . 44.2 mt -90.77 111.95 24.35 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 N-CA-C 107.226 -1.398 . . . . 73.02 107.226 174.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.421 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 11.4 mmpt? -101.25 136.69 40.68 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.347 0.659 . . . . 75.52 111.115 -167.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 78' ' ' TYR . 15.7 ptt180 . . . . . 0 N--CA 1.497 1.875 0 C-N-CA 123.546 0.738 . . . . 73.14 112.867 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 52.6 t . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 118.94 -0.553 . . . . 54.24 110.606 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -64.43 155.91 63.35 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 122.702 2.268 . . . . 74.31 111.44 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.24 -44.81 61.81 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.057 0.943 . . . . 64.53 112.232 -175.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -53.19 -46.33 68.94 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.17 0.588 . . . . 62.53 112.338 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 68.9 mt -80.26 -33.6 37.73 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 112.452 0.538 . . . . 63.14 112.452 -173.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.9 t -71.67 -34.83 70.04 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 117.723 0.238 . . . . 64.41 110.415 176.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.512 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -70.44 -43.87 69.01 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 122.817 0.447 . . . . 74.31 110.078 174.018 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.474 ' O ' HG23 ' A' ' 28' ' ' VAL . 68.6 tp -54.28 -56.51 17.74 Favored 'General case' 0 C--O 1.214 -0.784 0 O-C-N 124.312 1.007 . . . . 73.44 111.546 177.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.518 ' HZ2' ' H ' ' A' ' 109' ' ' GLY . 23.0 t90 -58.11 -45.46 87.24 Favored 'General case' 0 CA--C 1.552 1.026 0 O-C-N 123.52 0.512 . . . . 74.12 110.908 -176.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.6 m -64.82 -30.75 71.77 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.704 0.802 . . . . 73.03 111.536 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.542 HD11 ' CG1' ' A' ' 58' ' ' VAL . 37.3 tp -74.05 -45.15 51.3 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.45 1.1 . . . . 72.44 111.26 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 24' ' ' LEU . 71.4 t -61.76 -32.04 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 C-N-CA 124.092 0.957 . . . . 62.22 110.321 173.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.6 t -93.64 5.15 52.56 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.359 1.064 . . . . 73.31 111.988 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -85.83 121.5 73.1 Favored Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 123.056 0.542 . . . . 61.13 110.436 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.46 -14.05 27.78 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.765 2.31 . . . . 74.44 113.54 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -78.96 -33.47 45.17 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.368 0.667 . . . . 73.33 111.23 177.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 67.4 p -111.62 9.53 21.09 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.812 -0.631 . . . . 74.42 110.683 -176.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -56.79 -34.62 67.82 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.338 1.455 . . . . 61.22 112.305 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.33 -34.01 76.76 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.503 -0.771 . . . . 74.14 111.71 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.418 HD22 ' HB2' ' A' ' 50' ' ' ASP . 87.9 mt -104.75 -13.57 15.85 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.227 0.611 . . . . 74.44 111.397 -174.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.48 HG21 ' HG ' ' A' ' 27' ' ' LEU . 20.1 tt -161.2 119.69 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 C-N-CA 123.005 0.522 . . . . 74.34 110.246 175.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 16.7 p -150.04 150.23 31.46 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.367 0.667 . . . . 75.25 109.768 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.441 ' HE3' ' HA2' ' A' ' 43' ' ' GLY . 8.2 p-90 -89.98 153.74 20.36 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.006 0.431 . . . . 75.43 109.891 178.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.8 m -82.43 155.24 69.11 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 114.823 -1.08 . . . . 72.22 109.316 -175.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.18 -16.53 13.03 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 122.884 2.389 . . . . 74.01 114.135 173.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.6 m -71.14 -36.42 72.08 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.073 0.949 . . . . 64.13 111.399 174.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.441 ' HA2' ' HE3' ' A' ' 39' ' ' TRP . . . 82.16 1.49 90.37 Favored Glycine 0 C--N 1.345 1.067 0 CA-C-N 115.744 -0.662 . . . . 72.42 114.66 176.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -103.08 -3.23 26.2 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.259 0.624 . . . . 54.4 111.09 -175.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.8 p -154.68 163.25 40.52 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.405 0.682 . . . . 51.11 110.599 -170.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -142.13 152.26 43.05 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.88 0.472 . . . . 74.54 110.446 174.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -109.16 148.68 30.52 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.776 0.83 . . . . 62.43 109.235 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 82.7 t -123.73 131.83 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 108.223 -1.029 . . . . 71.11 108.223 177.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 94.0 m-85 -115.41 147.19 40.84 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.864 0.866 . . . . 62.5 110.217 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.418 ' HB2' HD22 ' A' ' 36' ' ' LEU . 17.6 m-20 51.43 67.56 0.93 Allowed 'General case' 0 N--CA 1.481 1.113 0 O-C-N 124.647 1.217 . . . . 75.35 111.823 173.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -53.77 -31.34 48.32 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 114.516 1.302 . . . . 74.41 114.516 -172.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.4 -43.92 43.9 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 112.058 -0.417 . . . . 71.52 112.058 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.428 ' NE2' ' HD3' ' A' ' 56' ' ' LYS . 20.3 tp60 -72.29 -32.67 66.8 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.67 1.188 . . . . 61.45 110.968 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.462 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 53.6 t80 -69.71 -50.73 40.81 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.848 1.259 . . . . 75.34 109.762 178.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.496 ' HB1' ' O ' ' A' ' 66' ' ' ASN . . . -62.17 -32.14 72.73 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.628 -0.715 . . . . 74.5 112.135 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.428 ' HD3' ' NE2' ' A' ' 53' ' ' GLN . 31.5 tttm -62.38 -53.67 51.59 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.046 1.339 . . . . 71.22 113.45 -176.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -122.11 -22.11 5.74 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 114.033 1.123 . . . . 73.43 114.033 -170.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.542 ' CG1' HD11 ' A' ' 27' ' ' LEU . 85.7 t -86.44 -45.03 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.16 0.584 . . . . 72.25 110.824 -175.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 26.3 mt -62.88 -48.83 84.38 Favored Pre-proline 0 CA--C 1.559 1.305 0 CA-C-O 118.507 -0.759 . . . . 73.44 112.55 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.417 ' HG3' ' ND2' ' A' ' 66' ' ' ASN . 55.6 Cg_endo -67.56 -13.18 38.2 Favored 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 121.926 1.75 . . . . 64.11 113.239 175.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -73.28 -54.07 9.31 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.262 0.625 . . . . 73.41 110.675 176.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.5 ' CD1' HD13 ' A' ' 27' ' ' LEU . 35.5 m-85 -92.84 -43.71 8.85 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 112.194 0.442 . . . . 74.1 112.194 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -98.77 -176.99 3.51 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.488 0.715 . . . . 72.33 109.335 -178.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.55 39.68 2.58 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.312 0.577 . . . . 72.51 111.132 -174.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -161.23 162.12 31.06 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.881 0.873 . . . . 53.33 109.875 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.496 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 7.3 m120 -106.8 -26.22 11.37 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 108.618 -0.882 . . . . 53.13 108.618 173.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -61.03 115.31 3.64 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.114 0.965 . . . . 64.22 111.52 -177.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.476 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 24.9 ttt -83.13 -20.11 35.43 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 116.195 -0.457 . . . . 75.12 111.296 -177.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.93 -36.2 72.16 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.356 0.262 . . . . 72.45 110.525 172.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.492 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 37.2 t -63.32 -51.69 64.96 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.085 0.954 . . . . 45.11 110.727 172.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -58.08 -54.9 41.7 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.166 0.986 . . . . 71.24 111.342 -174.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.1 -37.75 80.65 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 CA-C-N 115.506 -0.77 . . . . 71.33 111.033 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 58.2 ttt-85 -59.44 -43.9 93.02 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 117.894 0.316 . . . . 75.44 111.396 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 70' ' ' SER . 10.0 mm100 -62.0 -44.26 97.1 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.535 0.522 . . . . 74.42 109.627 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.1 mt -59.32 -41.16 88.44 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 123.946 0.779 . . . . 73.53 111.567 176.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -61.25 -37.59 83.66 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.589 0.756 . . . . 73.42 111.181 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 41.9 mtm -68.83 -31.87 71.15 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 122.757 0.423 . . . . 75.12 110.565 173.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -81.78 -4.01 55.29 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.963 0.905 . . . . 71.54 111.137 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.65 15.09 74.23 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-O 119.527 -0.596 . . . . 71.23 114.353 175.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -72.91 131.91 42.81 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 117.683 0.741 . . . . 75.11 109.222 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -99.42 121.77 41.6 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 109.144 -0.687 . . . . 54.14 109.144 -174.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.554 ' HE2' HG22 ' A' ' 84' ' ' VAL . 1.2 tmtp? -79.21 127.66 32.33 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.802 1.241 . . . . 73.02 108.063 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 61.7 t -123.75 129.17 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.166 0.986 . . . . 74.14 108.631 178.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.554 HG22 ' HE2' ' A' ' 82' ' ' LYS . 30.6 t -92.25 134.0 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 108.279 -1.008 . . . . 73.04 108.279 178.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 46.6 m-70 . . . . . 0 N--CA 1.483 1.221 0 C-N-CA 122.774 0.43 . . . . 74.32 111.099 175.449 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 . . . . . 0 N--CA 1.471 0.6 0 CA-C-O 121.24 0.543 . . . . 71.15 110.735 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.534 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 3.6 m-20 -81.08 119.4 23.5 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.53 -0.915 . . . . 75.23 108.53 -175.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -115.87 107.34 14.88 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 108.349 -0.982 . . . . 53.32 108.349 170.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.456 HG23 ' HG2' ' A' ' 82' ' ' LYS . 46.7 m -124.23 114.76 20.04 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 114.538 -1.21 . . . . 75.32 109.382 -172.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.544 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 32.0 tt0 -101.18 114.34 28.2 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 109.008 -0.738 . . . . 71.33 109.008 -176.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -96.95 119.95 36.38 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.109 -1.071 . . . . 75.45 108.109 171.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -123.02 141.61 51.77 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.239 0.615 . . . . 73.51 110.093 -177.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -158.68 132.52 4.99 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 109.16 -0.681 . . . . 72.44 109.16 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -65.2 -22.48 60.99 Favored 'Trans proline' 0 C--N 1.384 2.433 0 C-N-CA 123.054 2.503 . . . . 65.24 114.131 -173.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.548 ' HB2' HG12 ' A' ' 117' ' ' ILE . 13.6 m -92.39 -1.52 56.96 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.695 0.398 . . . . 65.02 111.839 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -104.72 98.37 8.12 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 107.132 -1.432 . . . . 75.0 107.132 175.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 110' ' ' GLN . 67.1 mt -125.45 166.44 16.61 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 121.663 0.744 . . . . 64.03 111.918 -177.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -58.0 115.91 3.17 Favored 'General case' 0 CA--C 1.556 1.209 0 CA-C-N 113.883 -1.508 . . . . 71.12 111.673 170.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.518 ' H ' ' HZ2' ' A' ' 25' ' ' TRP . . . 70.21 7.0 59.17 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 115.041 0.776 . . . . 50.32 115.041 174.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.428 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 16.4 mm100 -100.67 65.41 1.15 Allowed 'General case' 0 C--O 1.242 0.67 0 CA-C-O 121.466 0.65 . . . . 54.33 110.296 -175.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -57.29 -36.07 70.6 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 114.895 -1.048 . . . . 71.0 111.482 173.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 19.2 pm0 -68.45 -16.59 63.96 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.204 0.601 . . . . 74.03 111.93 -176.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 79.9 mt -96.49 -19.68 18.95 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.335 0.654 . . . . 71.51 111.555 176.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.1 mt -67.03 -37.42 84.08 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.069 0.547 . . . . 73.24 110.682 178.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -69.23 -13.85 62.63 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.647 -0.706 . . . . 61.53 112.278 175.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -97.36 4.75 50.62 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.115 0.566 . . . . 71.42 110.369 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.548 HG12 ' HB2' ' A' ' 105' ' ' CYS . 44.9 mt -89.68 119.2 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 108.049 -1.093 . . . . 74.01 108.049 173.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -95.58 132.43 40.73 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.83 0.852 . . . . 62.52 111.411 -165.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 . . . . . 0 N--CA 1.486 1.366 0 C-N-CA 124.099 0.96 . . . . 73.5 111.386 173.92 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.443 HG13 ' HB2' ' A' ' 114' ' ' LEU . 54.9 t . . . . . 0 CA--C 1.556 1.197 0 CA-C-O 118.971 -0.538 . . . . 75.45 110.927 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -55.76 146.81 64.44 Favored 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 123.149 2.566 . . . . 61.1 112.733 176.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.56 -43.76 62.49 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 124.198 0.936 . . . . 71.12 111.674 177.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.418 ' HA ' ' HE1' ' A' ' 63' ' ' PHE . 86.9 t80 -50.05 -51.41 42.62 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.358 1.063 . . . . 73.22 112.307 174.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 98.1 mt -80.5 -34.43 35.74 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.474 0.484 . . . . 73.41 112.103 -169.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.6 t -69.89 -34.36 73.43 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 122.286 0.234 . . . . 64.34 110.992 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.411 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -68.11 -44.76 75.42 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 109.749 -0.463 . . . . 73.32 109.749 171.174 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.2 tp -60.01 -40.37 89.01 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.012 0.925 . . . . 72.54 111.686 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.473 ' HB2' HD11 ' A' ' 114' ' ' LEU . 91.0 t90 -54.9 -56.2 22.22 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.412 1.085 . . . . 74.02 111.56 177.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.6 m -60.66 -38.32 84.48 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.895 -1.048 . . . . 73.55 110.604 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.494 HD11 ' CG1' ' A' ' 58' ' ' VAL . 34.3 tp -64.9 -52.0 58.87 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.351 1.46 . . . . 74.41 113.057 -174.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.7 t -57.19 -33.43 43.16 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 C-N-CA 124.015 0.926 . . . . 71.4 112.047 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.5 t -96.92 -3.19 42.28 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.825 0.85 . . . . 60.12 112.125 -177.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.401 ' HB3' ' OG1' ' A' ' 33' ' ' THR . 37.2 t70 -76.93 128.97 80.12 Favored Pre-proline 0 N--CA 1.483 1.198 0 C-N-CA 123.419 0.688 . . . . 71.32 111.61 -170.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.37 -24.44 57.45 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 123.125 2.55 . . . . 75.04 113.5 -177.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -78.46 -29.34 46.82 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.618 0.367 . . . . 64.21 110.87 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.401 ' OG1' ' HB3' ' A' ' 30' ' ' ASP . 68.1 p -115.6 -5.35 12.19 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.369 0.877 . . . . 73.12 113.369 -172.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.492 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 2.8 p-10 -64.69 -21.4 66.73 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 118.664 0.666 . . . . 75.13 112.452 -172.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.29 -33.68 76.04 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.758 0.423 . . . . 72.44 111.337 174.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.591 HD22 ' HB2' ' A' ' 50' ' ' ASP . 43.3 mt -107.09 -12.92 15.3 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.565 0.746 . . . . 63.41 111.587 -175.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 34' ' ' ASP . 15.0 tt -156.77 108.81 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 CA-C-O 121.325 0.583 . . . . 74.23 110.495 175.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.437 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 23.5 p -133.62 145.96 50.48 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.678 0.391 . . . . 73.42 111.284 -172.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 18.4 p-90 -72.58 148.98 44.39 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.226 1.011 . . . . 74.03 111.194 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 25.3 p -70.94 153.1 94.89 Favored Pre-proline 0 CA--C 1.554 1.129 0 C-N-CA 123.19 0.596 . . . . 70.51 110.088 173.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -46.63 -31.9 10.96 Favored 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 123.333 2.688 . . . . 65.04 113.191 171.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.9 t -71.31 -60.47 2.21 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.514 -0.767 . . . . 70.54 109.517 170.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 103.53 19.45 12.26 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-N 115.513 -0.767 . . . . 65.53 113.706 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -101.64 6.6 42.07 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.58 0.752 . . . . 72.2 110.491 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.6 p -160.13 164.32 33.07 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 123.984 0.914 . . . . 53.2 109.431 -173.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 54.1 p90 -142.38 144.4 33.13 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.54 0.336 . . . . 74.43 111.176 178.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.47 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 59.3 m-70 -97.27 149.43 22.06 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.317 1.047 . . . . 74.33 108.813 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 98' ' ' ASP . 62.8 t -126.82 114.69 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.813 -0.81 . . . . 73.35 108.813 178.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -111.04 149.34 30.88 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.367 1.067 . . . . 73.14 110.227 -176.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.591 ' HB2' HD22 ' A' ' 36' ' ' LEU . 3.9 m-20 52.72 55.03 9.6 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 124.561 1.163 . . . . 71.44 110.061 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.534 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 78.3 mt-30 -55.3 -25.21 32.87 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 114.326 1.232 . . . . 52.21 114.326 -169.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.75 -44.56 56.33 Favored Glycine 0 CA--C 1.533 1.206 0 N-CA-C 111.923 -0.471 . . . . 65.34 111.923 173.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -70.5 -45.06 66.36 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.78 0.832 . . . . 74.31 109.853 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.434 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 69.2 t80 -48.44 -52.85 20.16 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.384 1.474 . . . . 74.32 111.689 173.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.488 ' HB2' ' HB2' ' A' ' 68' ' ' MET . . . -62.61 -33.3 74.73 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 116.336 -0.393 . . . . 44.33 111.693 178.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.1 tmtm? -73.38 -41.88 62.84 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 124.208 1.003 . . . . 54.53 113.244 -176.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.561 ' HG3' HG23 ' A' ' 58' ' ' VAL . 4.1 pt-20 -111.15 -39.63 4.69 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 113.583 0.957 . . . . 70.04 113.583 -172.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.561 HG23 ' HG3' ' A' ' 57' ' ' GLU . 66.3 t -80.28 -46.76 21.66 Favored 'Isoleucine or valine' 0 C--O 1.248 0.987 0 C-N-CA 123.725 0.81 . . . . 71.34 111.351 -168.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 54.9 mt -67.19 -41.7 35.73 Favored Pre-proline 0 CA--C 1.557 1.22 0 CA-C-O 118.326 -0.845 . . . . 74.32 112.757 -176.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.53 -17.58 53.34 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 121.941 1.761 . . . . 45.11 114.011 170.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -72.6 -57.88 3.79 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 117.858 0.299 . . . . 71.31 110.629 176.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.459 ' CD1' HD13 ' A' ' 27' ' ' LEU . 37.5 m-85 -86.26 -40.26 15.71 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 112.14 0.422 . . . . 74.14 112.14 -175.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.418 ' HE1' ' HA ' ' A' ' 20' ' ' PHE . 48.8 m-85 -106.98 -178.17 3.57 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.749 -0.834 . . . . 74.04 108.749 -178.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -119.17 54.58 0.97 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 122.436 1.113 . . . . 74.02 109.557 -176.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -170.7 171.7 6.1 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.673 1.589 . . . . 73.31 107.81 178.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -117.95 -24.48 7.07 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 122.29 -0.257 . . . . 65.22 111.071 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -63.53 125.93 25.84 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.345 0.658 . . . . 74.1 112.054 -173.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.534 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 25.3 ttt -86.68 -29.63 22.33 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.388 0.675 . . . . 70.13 111.646 -176.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.37 -34.45 70.7 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 122.799 0.439 . . . . 43.34 111.36 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.448 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 44.1 t -66.74 -45.31 79.05 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.275 1.03 . . . . 70.33 110.789 173.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -63.14 -46.86 85.25 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.442 1.097 . . . . 75.21 110.565 -176.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 80.5 t -60.99 -45.31 98.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.23 1.012 . . . . 63.22 110.947 174.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -62.52 -32.6 73.56 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.781 0.432 . . . . 73.34 111.318 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.461 ' HA ' ' HE2' ' A' ' 77' ' ' MET . 29.1 mm-40 -62.94 -51.71 65.84 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 109.903 -0.406 . . . . 74.3 109.903 172.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.9 mt -58.92 -38.0 77.95 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.859 0.864 . . . . 72.11 111.779 -177.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -59.13 -43.74 91.99 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.484 0.713 . . . . 73.12 111.075 175.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.461 ' HE2' ' HA ' ' A' ' 74' ' ' GLN . 43.6 mtm -67.29 -35.48 79.55 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.73 -0.668 . . . . 71.14 110.366 175.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -80.1 8.73 6.6 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 123.525 0.73 . . . . 63.15 110.917 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.29 4.82 87.8 Favored Glycine 0 C--N 1.351 1.41 0 N-CA-C 114.511 0.564 . . . . 51.51 114.511 169.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.55 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . 39.8 m-85 -74.09 141.27 45.67 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 108.939 -0.763 . . . . 74.12 108.939 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.499 ' HB3' ' HG2' ' A' ' 102' ' ' GLN . 32.7 ttm180 -101.6 129.07 47.63 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.774 0.43 . . . . 72.44 110.101 -173.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -71.92 111.54 7.26 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.897 1.279 . . . . 63.42 109.855 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.2 t -126.19 136.26 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 107.72 -1.215 . . . . 65.11 107.72 172.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 96.3 t -119.28 139.46 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.355 0.662 . . . . 74.14 109.322 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 71.9 m80 . . . . . 0 N--CA 1.48 1.06 0 C-N-CA 122.841 0.456 . . . . 74.54 110.704 -178.378 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.446 ' HB2' ' H ' ' A' ' 50' ' ' ASP . 5.3 ptp180 . . . . . 0 N--CA 1.471 0.597 0 N-CA-C 109.832 -0.432 . . . . 74.21 109.832 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -40.43 123.13 1.73 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.056 0.943 . . . . 74.11 111.118 171.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 22.0 t70 -112.3 134.88 53.59 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.386 -0.598 . . . . 73.13 109.386 178.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 73.9 m -133.9 128.53 34.75 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.049 -0.723 . . . . 64.02 109.049 166.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 46' ' ' PHE . 33.7 tt0 -104.46 117.09 33.32 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.02 -1.104 . . . . 74.43 108.02 170.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.55 ' HB3' ' HB3' ' A' ' 80' ' ' PHE . 97.7 m-85 -95.85 120.01 35.36 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.668 -1.234 . . . . 75.13 107.668 173.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.499 ' HG2' ' HB3' ' A' ' 81' ' ' ARG . 13.3 pt20 -115.74 136.45 53.05 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 123.182 0.593 . . . . 73.23 110.06 -174.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -156.43 128.73 4.07 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 123.021 0.529 . . . . 72.51 109.764 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.36 -39.74 44.68 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 123.089 2.526 . . . . 64.33 112.647 -174.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.516 ' HB2' HG12 ' A' ' 117' ' ' ILE . 3.4 m -81.66 -4.18 55.49 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.313 0.645 . . . . 73.14 110.754 -175.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -99.07 106.9 19.17 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 108.04 -1.096 . . . . 74.33 108.04 176.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.568 ' HB2' ' HB3' ' A' ' 110' ' ' GLN . 74.4 mt -117.1 141.59 48.07 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.733 -0.84 . . . . 71.51 108.733 169.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -60.32 -30.5 69.54 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 124.414 1.071 . . . . 54.42 112.69 -170.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -130.03 39.42 1.82 Allowed Glycine 0 C--N 1.345 1.032 0 N-CA-C 111.697 -0.561 . . . . 73.04 111.697 -178.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.568 ' HB3' ' HB2' ' A' ' 107' ' ' LEU . 3.0 tp-100 -141.58 74.09 1.44 Allowed 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.338 -0.986 . . . . 70.1 108.338 178.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -65.31 -22.78 66.87 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 114.895 -1.048 . . . . 74.21 112.795 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -71.45 -16.97 62.4 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.874 0.47 . . . . 75.24 112.258 -178.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.431 ' HA ' HD22 ' A' ' 116' ' ' ASN . 53.7 mt -93.49 -7.13 45.24 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 112.071 0.397 . . . . 73.41 112.071 178.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.473 HD11 ' HB2' ' A' ' 25' ' ' TRP . 66.4 mt -71.07 -27.63 63.76 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.612 0.365 . . . . 61.34 111.368 177.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -76.29 -3.69 38.0 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 112.097 0.406 . . . . 73.15 112.097 176.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.431 HD22 ' HA ' ' A' ' 113' ' ' LEU . 23.3 m-80 -101.43 -6.96 23.33 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.945 0.898 . . . . 61.24 109.893 174.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.516 HG12 ' HB2' ' A' ' 105' ' ' CYS . 54.4 mt -87.55 117.33 31.3 Favored 'Isoleucine or valine' 0 C--N 1.354 0.79 0 N-CA-C 107.684 -1.228 . . . . 62.23 107.684 173.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -106.58 140.26 39.74 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 109.347 -0.612 . . . . 63.33 109.347 -174.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 . . . . . 0 N--CA 1.482 1.172 0 CA-C-O 121.682 0.753 . . . . 55.42 111.286 174.611 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 57.2 t . . . . . 0 CA--C 1.548 0.897 0 CA-C-O 118.632 -0.699 . . . . 71.12 109.136 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -50.26 133.63 36.45 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.886 2.391 . . . . 61.41 111.868 168.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.42 -38.41 59.03 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.62 1.168 . . . . 45.15 112.031 -178.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -52.14 -49.22 64.16 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 124.166 0.916 . . . . 71.33 111.638 174.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.439 HD13 ' HB ' ' A' ' 117' ' ' ILE . 95.2 mt -77.41 -43.14 33.62 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.259 0.624 . . . . 73.32 112.026 -170.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.0 t -64.35 -41.33 96.81 Favored 'General case' 0 CA--C 1.551 1.017 0 O-C-N 123.22 0.325 . . . . 74.25 110.71 -178.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -77.38 -27.1 52.41 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.9 0.48 . . . . 75.11 111.114 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.485 ' O ' HG23 ' A' ' 28' ' ' VAL . 60.7 tp -59.16 -50.35 74.39 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.566 0.541 . . . . 75.33 111.078 172.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.424 ' HH2' ' HG3' ' A' ' 108' ' ' ARG . 34.7 t-105 -63.52 -40.7 97.73 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-N 117.777 0.262 . . . . 74.31 111.405 177.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.6 m -57.34 -37.08 72.01 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-O 121.579 0.704 . . . . 60.54 110.402 176.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.518 HD11 HG13 ' A' ' 58' ' ' VAL . 35.3 tp -70.58 -45.46 65.35 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.358 1.463 . . . . 65.21 112.31 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 24' ' ' LEU . 91.8 t -62.02 -35.34 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 123.437 0.695 . . . . 72.4 111.066 177.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.6 t -90.22 -0.09 57.45 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.944 0.898 . . . . 64.35 111.809 -177.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -84.36 127.11 67.49 Favored Pre-proline 0 N--CA 1.483 1.191 0 C-N-CA 123.036 0.534 . . . . 43.24 110.47 -178.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.67 -20.62 17.5 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.743 2.295 . . . . 41.44 113.306 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -81.54 -22.82 37.61 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.128 0.571 . . . . 64.05 111.42 -176.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.7 p -111.88 6.73 19.73 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.353 0.661 . . . . 62.51 112.258 177.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.423 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 0.6 OUTLIER -59.51 -29.75 68.09 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.041 0.537 . . . . 61.02 111.914 -174.357 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.69 -28.66 70.09 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.825 0.85 . . . . 72.32 112.181 -177.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.462 HD22 ' HB2' ' A' ' 50' ' ' ASP . 87.9 mt -116.21 -9.96 11.53 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.245 0.618 . . . . 75.12 111.702 -177.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 34' ' ' ASP . 17.3 tt -160.43 118.91 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 121.312 0.577 . . . . 74.42 110.837 171.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.4 p -148.69 151.78 35.51 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.568 0.747 . . . . 72.0 109.502 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 7.7 p-90 -70.13 152.46 44.28 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.29 0.636 . . . . 73.33 110.213 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.5 m -71.71 154.3 93.05 Favored Pre-proline 0 CA--C 1.561 1.389 0 C-N-CA 123.818 0.847 . . . . 74.13 110.097 173.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -40.08 -46.67 4.03 Favored 'Trans proline' 0 C--N 1.389 2.663 0 C-N-CA 124.403 3.402 . . . . 75.52 114.994 -175.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 30.5 t -80.21 -41.27 25.52 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 122.697 0.399 . . . . 72.54 110.331 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.82 28.21 7.96 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-N 116.04 -0.527 . . . . 71.23 113.186 176.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -82.54 -10.69 58.88 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.582 0.753 . . . . 73.31 110.776 174.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.457 ' HB3' ' HB3' ' A' ' 102' ' ' GLN . 68.2 p -155.72 -176.79 6.13 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 123.741 0.816 . . . . 74.31 110.135 -177.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -141.95 145.97 35.11 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.376 0.671 . . . . 72.11 110.191 175.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 54.1 m-70 -97.64 147.66 24.09 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.059 0.944 . . . . 63.11 108.844 176.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 95.1 t -125.08 123.11 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.689 1.196 . . . . 72.43 108.095 175.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.459 ' HB2' ' HA ' ' A' ' 36' ' ' LEU . 97.0 m-85 -110.35 147.34 34.13 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.675 0.79 . . . . 54.13 110.867 -177.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.462 ' HB2' HD22 ' A' ' 36' ' ' LEU . 6.4 m-20 50.52 68.32 0.79 Allowed 'General case' 0 CA--C 1.541 0.62 0 O-C-N 124.922 1.389 . . . . 71.23 111.812 174.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -47.81 -32.81 6.48 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.729 1.211 . . . . 75.22 114.036 -173.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.4 -44.86 50.23 Favored Glycine 0 CA--C 1.531 1.07 0 O-C-N 123.397 0.435 . . . . 65.31 112.706 176.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -74.04 -44.92 52.61 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.554 0.741 . . . . 72.22 110.182 -176.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.404 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 69.1 t80 -49.56 -50.93 40.26 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.482 1.513 . . . . 74.22 111.209 169.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.498 ' HB2' ' HB2' ' A' ' 68' ' ' MET . . . -62.09 -35.52 78.92 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 116.196 -0.456 . . . . 53.34 111.872 178.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -68.33 -46.82 69.15 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.27 1.028 . . . . 64.32 112.642 -175.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.452 ' HG3' HG23 ' A' ' 58' ' ' VAL . 11.9 pt-20 -115.16 -34.84 4.88 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 114.175 1.176 . . . . 72.3 114.175 -171.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.518 HG13 HD11 ' A' ' 27' ' ' LEU . 92.2 t -82.23 -42.27 18.62 Favored 'Isoleucine or valine' 0 C--O 1.247 0.929 0 C-N-CA 123.24 0.616 . . . . 70.4 110.987 -169.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 43.4 mt -66.02 -48.77 59.74 Favored Pre-proline 0 CA--C 1.558 1.272 0 CA-C-O 117.915 -1.041 . . . . 65.4 112.363 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -67.63 -13.95 40.49 Favored 'Trans proline' 0 C--N 1.384 2.432 0 CA-C-N 121.934 1.726 . . . . 45.31 113.046 175.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -72.64 -59.03 2.92 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.102 0.561 . . . . 74.2 110.119 176.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.475 ' CD1' HD13 ' A' ' 27' ' ' LEU . 37.2 m-85 -89.73 -47.99 7.56 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 112.405 0.521 . . . . 74.41 112.405 -179.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -93.82 -177.92 4.51 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 108.498 -0.927 . . . . 73.35 108.498 -178.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -116.93 43.79 2.2 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.778 -0.576 . . . . 74.11 110.159 -173.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 26.9 p80 -165.3 164.0 19.94 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.384 1.074 . . . . 73.41 108.832 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.477 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 1.5 m-20 -117.38 -12.71 10.42 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.007 0.523 . . . . 62.41 110.39 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -71.13 122.03 19.38 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.524 0.729 . . . . 72.13 109.738 178.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.498 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 22.8 ttt -90.92 -18.66 24.36 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.665 0.386 . . . . 75.02 111.472 -175.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.06 -37.61 72.07 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.848 0.459 . . . . 55.11 110.705 173.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.7 t -65.02 -44.04 90.48 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.446 1.098 . . . . 61.51 110.863 174.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -64.49 -53.24 51.26 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.351 1.06 . . . . 52.3 111.005 -175.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 66.7 t -63.05 -40.78 90.36 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 123.639 0.776 . . . . 75.12 111.317 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 -57.96 -38.64 76.37 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.13 0.572 . . . . 75.35 111.563 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -60.9 -49.67 76.51 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 123.789 0.681 . . . . 74.41 110.574 175.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 78.3 mt -61.22 -40.5 94.22 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.794 0.838 . . . . 75.34 111.618 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -57.75 -42.43 83.97 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.954 0.902 . . . . 74.23 111.454 175.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 70.8 mtm -74.59 -31.02 61.91 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.569 -0.741 . . . . 73.22 110.96 177.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -82.54 7.02 15.64 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.764 0.825 . . . . 62.25 110.857 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.1 10.37 82.8 Favored Glycine 0 C--N 1.347 1.181 0 N-CA-C 115.026 0.77 . . . . 61.34 115.026 168.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -71.98 138.49 48.03 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 117.638 0.719 . . . . 72.35 110.763 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 35.4 ttm-85 -100.45 122.53 43.33 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.927 -0.768 . . . . 74.12 108.927 -177.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.523 ' HE3' HG23 ' A' ' 99' ' ' THR . 1.3 tmtp? -78.92 123.24 27.07 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.777 1.231 . . . . 71.51 108.898 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 89.7 t -133.4 117.06 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.639 1.176 . . . . 74.24 108.058 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.6 p -102.92 126.21 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 109.118 -0.697 . . . . 54.15 109.118 -176.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 . . . . . 0 N--CA 1.488 1.454 0 C-N-CA 123.254 0.622 . . . . 74.03 110.626 -174.697 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 . . . . . 0 C--O 1.246 0.88 0 N-CA-C 107.849 -1.167 . . . . 74.14 107.849 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 5.1 m-20 -80.82 142.99 33.14 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.798 -0.815 . . . . 73.23 108.798 -179.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -135.67 122.67 21.39 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.343 -0.984 . . . . 75.45 108.343 167.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.523 HG23 ' HE3' ' A' ' 82' ' ' LYS . 24.1 m -136.9 114.08 10.72 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 109.236 -0.653 . . . . 51.44 109.236 177.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -103.91 111.88 24.61 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.857 -0.794 . . . . 65.41 108.857 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -97.26 129.29 44.59 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 109.072 -0.714 . . . . 63.23 109.072 175.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.457 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 19.3 pt20 -123.71 150.06 44.78 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.907 0.883 . . . . 72.12 109.533 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -156.68 135.55 7.8 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 108.357 -0.979 . . . . 71.32 108.357 175.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -59.82 -31.16 93.52 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.744 2.296 . . . . 75.03 112.823 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.503 ' HB2' HG12 ' A' ' 117' ' ' ILE . 5.2 m -92.1 7.75 40.98 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 122.953 0.501 . . . . 44.31 111.415 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -123.79 101.45 7.28 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 108.297 -1.001 . . . . 75.42 108.297 174.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 52.8 mt -126.27 174.17 8.75 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.49 0.716 . . . . 72.11 109.359 173.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.424 ' HG3' ' HH2' ' A' ' 25' ' ' TRP . 71.5 ttt180 -76.35 109.27 9.92 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.696 1.198 . . . . 72.52 110.84 -177.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.18 35.44 30.22 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 111.578 -0.609 . . . . 63.24 111.578 -177.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -132.88 42.67 3.05 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.205 -1.035 . . . . 64.33 108.205 -171.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.622 ' HA ' ' HG ' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -67.51 -21.18 65.5 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 114.134 -1.393 . . . . 72.55 112.531 -176.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.6 pm0 -72.16 -13.3 61.52 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.943 0.497 . . . . 65.42 111.713 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.463 ' HA ' HD22 ' A' ' 116' ' ' ASN . 31.9 mt -94.34 -7.4 41.86 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 112.236 0.458 . . . . 72.04 112.236 173.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.622 ' HG ' ' HA ' ' A' ' 111' ' ' GLU . 44.7 mt -72.12 -27.8 62.86 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 118.006 0.367 . . . . 74.14 111.63 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -65.34 -19.25 65.87 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.16 0.584 . . . . 73.02 111.466 173.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.463 HD22 ' HA ' ' A' ' 113' ' ' LEU . 36.3 m-80 -93.77 -10.85 32.81 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.327 0.651 . . . . 75.21 110.209 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.503 HG12 ' HB2' ' A' ' 105' ' ' CYS . 43.2 mt -84.86 124.83 40.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 108.051 -1.092 . . . . 73.41 108.051 177.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -126.75 145.98 50.4 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.429 0.691 . . . . 74.4 109.711 -173.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 . . . . . 0 N--CA 1.474 0.742 0 CA-C-N 115.395 -0.82 . . . . 73.3 109.236 169.626 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 70.7 t . . . . . 0 CA--C 1.554 1.131 0 CA-C-O 119.28 -0.391 . . . . 71.14 111.246 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -59.15 139.4 90.25 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 122.937 2.425 . . . . 72.13 112.039 173.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.7 -39.76 71.47 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.22 1.008 . . . . 52.44 112.294 -178.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -53.79 -45.86 70.85 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.109 0.564 . . . . 73.53 111.293 174.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 79.9 mt -76.32 -34.75 59.01 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 119.051 -0.5 . . . . 74.21 112.31 -172.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.6 t -71.13 -35.25 71.66 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 118.069 0.395 . . . . 73.12 110.369 177.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.551 ' HE2' ' HA ' ' A' ' 23' ' ' LYS . 8.3 mmpt? -70.63 -42.35 71.02 Favored 'General case' 0 C--N 1.353 0.751 0 C-N-CA 122.813 0.445 . . . . 71.43 110.678 176.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 28' ' ' VAL . 67.4 tp -59.94 -49.2 78.61 Favored 'General case' 0 N--CA 1.478 0.962 0 O-C-N 124.183 0.927 . . . . 71.22 111.172 175.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 90.8 t90 -53.99 -51.04 65.19 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.806 1.243 . . . . 75.4 111.182 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 64.2 m -64.92 -36.45 84.4 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.144 0.978 . . . . 72.21 111.512 177.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.408 ' HG ' HD13 ' A' ' 37' ' ' ILE . 32.2 tp -62.97 -51.04 68.4 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.673 1.189 . . . . 72.13 111.646 -178.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 24' ' ' LEU . 87.6 t -58.85 -35.69 57.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 124.609 1.164 . . . . 45.02 111.198 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 83.2 p -92.36 1.94 56.94 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.308 -0.86 . . . . 73.21 112.534 -174.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -89.98 134.2 32.27 Favored Pre-proline 0 CA--C 1.557 1.245 0 C-N-CA 123.035 0.534 . . . . 74.1 111.581 -174.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.78 -33.86 26.07 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 123.228 2.618 . . . . 73.13 114.236 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -70.54 -35.95 73.4 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.114 0.566 . . . . 52.44 110.916 -176.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.0 p -98.98 -0.02 42.96 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.776 -0.647 . . . . 71.11 111.208 -177.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -55.42 -32.4 62.67 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.54 1.136 . . . . 41.21 112.337 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.9 -36.52 83.65 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.455 0.702 . . . . 64.32 112.15 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.425 HD22 ' HB2' ' A' ' 50' ' ' ASP . 85.0 mt -109.07 -8.24 15.21 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.204 0.602 . . . . 74.25 111.48 -175.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.408 HD13 ' HG ' ' A' ' 27' ' ' LEU . 18.6 tt -160.56 118.3 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.037 0.535 . . . . 75.33 110.457 174.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 12.7 p -137.41 146.74 44.78 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.525 0.73 . . . . 33.43 109.75 -176.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 25.2 p-90 -71.24 147.37 48.29 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.013 0.525 . . . . 74.52 110.888 177.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.1 m -79.74 151.21 73.75 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 108.902 -0.777 . . . . 53.32 108.902 173.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.83 -19.59 55.17 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.674 2.249 . . . . 65.51 113.618 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 64.0 m -66.61 -35.64 80.67 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.146 0.578 . . . . 42.25 111.112 172.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.04 -2.69 74.3 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 115.784 -0.643 . . . . 25.24 113.877 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.458 HD22 ' N ' ' A' ' 44' ' ' ASN . 0.7 OUTLIER -97.55 3.26 50.63 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.116 0.966 . . . . 54.24 110.022 -179.617 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.3 p -158.03 169.56 24.28 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 123.806 0.842 . . . . 74.21 110.397 -170.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -150.33 153.38 35.98 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.909 0.884 . . . . 65.53 110.233 176.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -101.8 144.46 30.44 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.945 0.898 . . . . 71.25 109.277 176.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 97.8 t -122.75 120.86 61.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 124.928 1.291 . . . . 74.44 107.612 177.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 91.1 m-85 -106.01 146.84 29.57 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 123.905 0.882 . . . . 75.3 109.854 -176.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.425 ' HB2' HD22 ' A' ' 36' ' ' LEU . 15.4 m-20 52.36 65.24 1.56 Allowed 'General case' 0 C--N 1.353 0.73 0 O-C-N 124.911 1.382 . . . . 45.1 111.613 171.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.404 ' HB3' ' HG2' ' A' ' 68' ' ' MET . 85.2 mt-30 -52.72 -28.54 22.47 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 113.096 0.776 . . . . 73.3 113.096 -173.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -67.84 -48.34 55.61 Favored Glycine 0 C--N 1.344 0.997 0 O-C-N 123.343 0.402 . . . . 61.34 112.155 176.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -73.18 -45.53 55.93 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.31 0.644 . . . . 63.1 110.278 -178.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -54.04 -51.17 64.9 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.638 1.575 . . . . 71.44 111.574 176.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.532 ' HB2' ' HB2' ' A' ' 68' ' ' MET . . . -67.41 -29.73 69.3 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.307 0.484 . . . . 63.14 112.307 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -72.06 -43.21 65.25 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.971 0.909 . . . . 70.44 111.97 -177.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.553 ' HG3' HG23 ' A' ' 58' ' ' VAL . 7.0 pt-20 -109.02 -45.73 3.73 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 113.182 0.808 . . . . 75.21 113.182 -176.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.553 HG23 ' HG3' ' A' ' 57' ' ' GLU . 95.8 t -77.03 -42.3 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.42 0.688 . . . . 72.23 111.674 -167.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.2 mt -64.75 -49.49 69.16 Favored Pre-proline 0 CA--C 1.557 1.219 0 CA-C-O 117.946 -1.026 . . . . 61.45 112.384 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.93 -7.27 21.03 Favored 'Trans proline' 0 C--N 1.388 2.619 0 CA-C-N 121.743 1.658 . . . . 70.2 112.846 174.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -79.95 -66.63 0.85 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.112 0.565 . . . . 73.03 110.81 174.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -79.0 -40.15 32.26 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.257 0.623 . . . . 74.34 111.53 -176.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -105.06 -169.89 1.67 Allowed 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 108.138 -1.06 . . . . 61.11 108.138 178.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -126.32 45.26 2.69 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.513 0.673 . . . . 74.53 110.337 -174.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -159.16 161.78 36.29 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 115.109 -0.951 . . . . 74.22 108.973 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.502 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 1.6 m-20 -114.16 -19.8 11.19 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.568 0.347 . . . . 63.32 111.598 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -71.31 114.15 9.09 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.414 0.286 . . . . 74.13 111.062 -173.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.532 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 13.9 tpt -65.82 -37.55 86.54 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.255 1.022 . . . . 75.42 111.353 -177.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.17 -35.03 72.84 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.148 0.579 . . . . 62.21 111.168 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.482 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 45.1 t -68.44 -38.73 81.42 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.588 0.755 . . . . 73.03 111.004 176.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -65.29 -50.91 63.92 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.117 0.967 . . . . 71.11 110.627 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.5 t -63.41 -36.36 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.444 0.698 . . . . 63.0 110.059 177.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.9 ttp180 -57.46 -41.54 80.77 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.987 0.915 . . . . 75.34 110.605 175.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.545 ' HA ' ' HE2' ' A' ' 77' ' ' MET . 26.3 mm-40 -61.89 -47.34 85.44 Favored 'General case' 0 C--N 1.357 0.912 0 N-CA-C 109.644 -0.502 . . . . 73.04 109.644 177.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.422 ' HB3' ' HB2' ' A' ' 80' ' ' PHE . 89.6 mt -61.91 -38.26 87.73 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.618 0.767 . . . . 75.1 111.106 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -58.55 -39.87 81.46 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.95 0.9 . . . . 75.5 110.537 174.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.545 ' HE2' ' HA ' ' A' ' 74' ' ' GLN . 48.6 mtm -66.21 -41.7 89.77 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.715 0.406 . . . . 51.43 110.351 174.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -80.97 2.84 25.16 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.61 0.764 . . . . 74.14 111.614 -174.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.62 19.76 61.25 Favored Glycine 0 C--N 1.346 1.094 0 N-CA-C 114.761 0.664 . . . . 62.13 114.761 171.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.422 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 42.0 m-85 -78.15 145.4 35.69 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.123 -0.695 . . . . 74.51 109.123 176.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -99.46 123.43 43.73 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.682 0.793 . . . . 70.44 109.035 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -75.62 110.7 10.24 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.031 1.332 . . . . 70.55 109.278 177.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.6 t -123.19 132.65 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 108.407 -0.96 . . . . 50.42 108.407 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 85.6 t -125.83 121.37 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.121 0.968 . . . . 74.0 108.57 175.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 . . . . . 0 N--CA 1.481 1.087 0 C-N-CA 123.122 0.569 . . . . 75.35 111.343 -177.476 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 . . . . . 0 N--CA 1.469 0.484 0 N-CA-C 108.513 -0.921 . . . . 64.34 108.513 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 4.1 m-20 -84.31 141.41 30.94 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.612 -0.514 . . . . 71.54 109.612 175.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -140.9 106.87 5.16 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.957 -1.127 . . . . 74.15 107.957 169.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 77.4 m -122.57 117.25 25.43 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.377 0.671 . . . . 53.04 110.486 -178.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -99.46 106.27 18.29 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.842 -0.799 . . . . 72.51 108.842 -177.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -95.14 122.09 37.45 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.919 -0.771 . . . . 73.45 108.919 176.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -122.63 144.35 49.18 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.939 0.896 . . . . 54.13 110.803 -174.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -159.06 131.24 4.25 Favored Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 123.741 0.816 . . . . 74.2 109.757 176.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.35 -31.49 62.41 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 123.156 2.57 . . . . 54.22 114.118 -174.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 82.0 m -94.0 8.42 41.46 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 122.384 0.274 . . . . 72.44 111.438 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -109.02 100.38 9.58 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.823 -1.177 . . . . 65.21 107.823 173.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.408 ' HB2' ' HB2' ' A' ' 110' ' ' GLN . 80.0 mt -118.35 132.41 56.27 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.306 0.642 . . . . 62.51 109.501 175.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -66.97 114.26 5.63 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 107.895 -1.15 . . . . 73.12 107.895 174.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 106.89 -12.86 41.64 Favored Glycine 0 N--CA 1.472 1.04 0 CA-C-O 119.944 -0.365 . . . . 64.45 113.083 -177.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.408 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 15.6 mm-40 -107.98 79.44 1.27 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 117.374 0.587 . . . . 73.41 110.305 176.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -59.44 -32.96 70.7 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.307 1.043 . . . . 73.2 112.563 175.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.9 pm0 -67.32 -26.12 66.35 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.433 0.693 . . . . 72.14 112.255 -177.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 76.8 mt -86.39 -6.76 58.86 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 122.122 -0.362 . . . . 72.42 111.571 -175.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 75.8 mt -65.37 -33.84 76.92 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.087 0.555 . . . . 71.24 111.135 175.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -82.44 -1.54 50.49 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.509 0.324 . . . . 74.24 111.78 176.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.485 HD22 ' N ' ' A' ' 116' ' ' ASN . 0.7 OUTLIER -92.4 -15.22 27.52 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.457 0.703 . . . . 73.1 109.407 172.451 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 55.2 mt -82.0 114.27 22.64 Favored 'Isoleucine or valine' 0 C--N 1.355 0.812 0 N-CA-C 108.269 -1.011 . . . . 72.53 108.269 176.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -103.48 137.43 41.57 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.1 -0.704 . . . . 75.21 109.1 -176.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 14.3 ptt-85 . . . . . 0 N--CA 1.474 0.751 0 C-N-CA 122.626 0.37 . . . . 65.5 110.911 176.119 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 66.2 t . . . . . 0 CA--C 1.537 0.455 0 N-CA-C 107.894 -1.15 . . . . 71.04 107.894 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.535 ' HD2' HD12 ' A' ' 21' ' ' LEU . 50.8 Cg_exo -55.88 142.3 84.44 Favored 'Trans proline' 0 C--N 1.368 1.588 0 C-N-CA 122.346 2.031 . . . . 53.01 111.856 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.92 -36.93 40.98 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.185 0.928 . . . . 45.43 111.081 175.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -55.41 -47.36 76.02 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.901 0.88 . . . . 74.13 112.028 174.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.535 HD12 ' HD2' ' A' ' 18' ' ' PRO . 55.7 mt -77.88 -35.31 50.97 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.682 0.393 . . . . 72.2 111.932 -172.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.4 t -72.11 -36.03 69.34 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 117.48 0.127 . . . . 75.43 110.962 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.573 ' HB3' ' HB3' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -69.01 -42.49 76.37 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 122.733 0.413 . . . . 72.42 109.964 173.672 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.46 ' O ' HG23 ' A' ' 28' ' ' VAL . 63.6 tp -59.46 -40.12 85.84 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.976 0.911 . . . . 63.02 111.251 176.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 70.6 t-105 -60.97 -53.37 58.14 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 123.275 0.63 . . . . 70.43 111.452 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.4 m -60.89 -28.85 69.2 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 115.01 -0.995 . . . . 50.4 110.638 178.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.553 HD11 HG13 ' A' ' 58' ' ' VAL . 30.0 tp -72.78 -50.04 26.89 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.291 1.436 . . . . 71.13 112.445 -178.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 24' ' ' LEU . 99.3 t -60.18 -29.87 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 123.672 0.789 . . . . 75.11 111.482 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.6 t -100.56 3.19 42.54 Favored 'General case' 0 CA--C 1.563 1.477 0 C-N-CA 124.062 0.945 . . . . 63.0 112.313 -176.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -85.38 134.01 41.26 Favored Pre-proline 0 N--CA 1.498 1.969 0 C-N-CA 123.942 0.897 . . . . 44.32 112.09 -176.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -77.92 -10.41 16.76 Favored 'Trans proline' 0 C--N 1.384 2.425 0 C-N-CA 123.233 2.622 . . . . 62.51 114.362 -175.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -87.67 -26.02 23.21 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 118.122 0.419 . . . . 63.0 110.446 174.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.6 p -117.07 -1.94 11.8 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.32 0.859 . . . . 74.43 113.32 -173.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.423 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 9.3 p-10 -62.06 -28.37 69.55 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 118.261 0.482 . . . . 73.55 111.904 -177.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.7 -25.77 67.46 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.597 0.759 . . . . 65.14 113.011 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.8 mt -116.0 -5.57 11.98 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.076 0.551 . . . . 75.21 112.045 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 34' ' ' ASP . 17.7 tt -160.19 115.25 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-O 121.381 0.61 . . . . 74.34 110.924 173.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 29.7 p -150.45 156.82 42.2 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.982 -0.747 . . . . 64.11 108.982 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 32.5 p-90 -74.96 152.41 38.79 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.711 0.804 . . . . 74.11 109.896 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.0 m -76.85 148.47 79.15 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 123.589 0.755 . . . . 61.52 110.401 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.82 -33.36 13.92 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 123.625 2.883 . . . . 74.42 116.102 178.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.1 m -76.83 -32.05 57.32 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.825 0.45 . . . . 64.34 110.511 175.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.17 -0.31 66.3 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-O 119.593 -0.559 . . . . 71.34 114.257 171.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -87.91 -1.69 58.14 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.129 0.571 . . . . 70.52 111.251 -174.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 54.1 p -153.8 177.6 10.82 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.893 0.877 . . . . 71.51 110.434 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -141.64 149.64 40.92 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.245 0.618 . . . . 72.24 109.73 170.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -101.43 157.54 16.73 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.273 0.629 . . . . 73.21 109.371 177.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 98' ' ' ASP . 95.1 t -128.49 124.18 61.28 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 C-N-CA 124.8 1.24 . . . . 74.04 107.781 173.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -107.84 149.75 27.87 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.54 0.736 . . . . 74.34 109.891 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.0 t0 44.34 65.69 1.0 Allowed 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 125.486 1.514 . . . . 73.32 110.878 177.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.627 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 29.4 mt-30 -58.42 -21.04 49.46 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.364 0.876 . . . . 64.33 113.364 -172.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.54 -46.45 47.7 Favored Glycine 0 C--N 1.346 1.091 0 N-CA-C 112.275 -0.33 . . . . 44.2 112.275 173.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.405 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 58.2 tp60 -69.81 -44.51 69.87 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.523 -0.547 . . . . 72.44 109.523 177.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.526 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 54.6 t80 -52.54 -50.96 61.85 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.265 1.426 . . . . 71.12 111.297 175.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.445 ' HB1' ' O ' ' A' ' 66' ' ' ASN . . . -59.64 -37.35 78.43 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 121.106 0.479 . . . . 74.35 111.584 177.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -71.01 -49.26 47.07 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.594 1.158 . . . . 71.2 113.173 -175.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.503 ' HG3' HG23 ' A' ' 58' ' ' VAL . 6.5 pt-20 -105.81 -36.41 7.04 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 113.429 0.9 . . . . 64.34 113.429 -172.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.553 HG13 HD11 ' A' ' 27' ' ' LEU . 55.2 t -81.67 -43.82 20.05 Favored 'Isoleucine or valine' 0 C--O 1.251 1.161 0 C-N-CA 123.728 0.811 . . . . 62.35 111.611 -168.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 55.3 mt -67.2 -44.01 46.9 Favored Pre-proline 0 CA--C 1.553 1.072 0 CA-C-O 118.158 -0.925 . . . . 70.31 112.639 -178.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -70.6 -10.16 27.31 Favored 'Trans proline' 0 C--N 1.377 2.051 0 CA-C-N 121.833 1.69 . . . . 74.32 113.527 171.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -75.86 -49.41 18.03 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.275 0.63 . . . . 74.21 110.693 176.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.573 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 64.9 m-85 -102.34 -34.87 9.03 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 113.752 1.019 . . . . 74.15 113.752 -178.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -109.84 -177.58 3.31 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 108.904 -0.776 . . . . 63.22 108.904 -175.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -111.5 38.07 2.71 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.004 0.522 . . . . 70.25 110.951 -175.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -158.15 167.29 30.23 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.312 0.645 . . . . 75.44 109.684 -177.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.445 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 1.9 m-20 -121.33 -7.45 9.27 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.284 0.634 . . . . 74.52 110.768 176.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -78.7 120.19 23.01 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.119 0.568 . . . . 54.42 109.995 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.627 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 25.5 ttt -84.3 -18.72 35.39 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 116.79 -0.186 . . . . 71.21 111.267 -176.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -54.76 -38.74 67.57 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 122.971 0.508 . . . . 70.54 110.956 174.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.456 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 48.2 t -68.19 -44.67 75.32 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.034 -0.985 . . . . 53.33 111.188 174.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -59.44 -50.13 75.14 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.218 1.007 . . . . 64.13 110.46 -175.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.2 t -62.12 -45.91 97.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 114.932 -1.031 . . . . 63.34 111.119 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 54.2 ttt85 -58.33 -36.67 73.76 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 122.973 0.509 . . . . 71.42 111.516 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 70' ' ' SER . 31.3 mm-40 -61.67 -50.62 71.77 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 123.552 0.532 . . . . 71.23 109.701 176.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 98.1 mt -62.24 -33.55 74.8 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.628 0.771 . . . . 65.25 112.015 -177.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -56.9 -45.98 82.26 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 122.981 0.512 . . . . 71.21 110.866 170.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.455 ' HB3' ' O ' ' A' ' 119' ' ' ARG . 45.0 mtm -69.11 -28.84 66.84 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.294 0.638 . . . . 53.03 111.138 178.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -82.39 2.37 32.8 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.4 0.68 . . . . 71.24 110.975 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.71 1.86 79.73 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-O 119.201 -0.777 . . . . 73.35 114.405 171.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -72.04 142.45 49.28 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 117.752 0.776 . . . . 72.32 109.079 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -100.44 131.31 46.43 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.579 -0.526 . . . . 75.0 109.579 -176.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.573 ' HE3' HG22 ' A' ' 84' ' ' VAL . 50.2 tptt -69.59 108.2 3.74 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.417 1.487 . . . . 74.23 109.328 173.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.49 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 42.5 t -112.98 111.26 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 108.008 -1.108 . . . . 71.43 108.008 178.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.573 HG22 ' HE3' ' A' ' 82' ' ' LYS . 11.1 t -93.01 101.22 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.854 0.862 . . . . 63.11 109.004 -172.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 109.324 -0.621 . . . . 72.33 109.324 178.1 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 . . . . . 0 CA--C 1.554 1.11 0 CA-C-O 121.214 0.53 . . . . 75.1 110.417 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.571 ' HB2' ' H ' ' A' ' 51' ' ' GLN . 5.8 m-20 -41.41 109.56 0.13 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.007 1.323 . . . . 71.2 112.142 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.536 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 25.7 t70 -120.74 115.83 24.06 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.307 0.643 . . . . 63.51 109.882 -178.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.405 HG23 ' HD2' ' A' ' 82' ' ' LYS . 58.4 m -118.43 131.41 56.28 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 123.673 0.789 . . . . 74.42 109.209 172.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.49 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 42.0 tt0 -105.26 113.52 27.16 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.536 -1.283 . . . . 71.15 107.536 172.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -96.41 118.86 33.8 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.098 -1.075 . . . . 71.43 108.098 174.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -115.48 140.54 49.06 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.561 0.744 . . . . 43.13 110.539 -175.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -158.55 134.07 5.9 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 123.264 0.626 . . . . 62.45 109.346 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -65.07 -28.42 57.06 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.826 2.351 . . . . 75.43 112.953 -176.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 33.5 m -96.1 20.37 10.31 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.896 0.479 . . . . 74.21 110.579 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -127.07 101.13 6.4 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 107.598 -1.26 . . . . 74.34 107.598 169.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 110' ' ' GLN . 68.8 mt -108.31 170.41 8.03 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 109.323 -0.621 . . . . 71.43 109.323 174.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.77 -31.48 72.67 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 113.972 1.101 . . . . 73.12 113.972 -168.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -139.51 18.9 3.02 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-O 120.342 -0.143 . . . . 60.12 113.289 -175.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 17.4 mp0 -107.79 79.16 1.25 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.363 0.665 . . . . 62.33 110.041 -176.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -67.98 -27.7 66.8 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.364 1.066 . . . . 73.5 113.437 -177.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -71.28 -5.87 35.52 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.343 0.657 . . . . 53.52 111.866 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 72.7 mt -89.33 -6.65 56.51 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 122.972 0.509 . . . . 62.44 111.748 175.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 94.5 mt -68.23 -32.57 72.86 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 122.825 0.45 . . . . 51.43 111.231 176.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -74.12 -16.53 61.01 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.1 0.56 . . . . 72.13 111.109 175.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.49 HD22 ' N ' ' A' ' 116' ' ' ASN . 0.7 OUTLIER -79.95 -18.67 49.82 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.12 -0.696 . . . . 71.33 109.12 177.567 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 27.5 mt -98.51 122.27 50.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.667 0 C-N-CA 124.196 0.999 . . . . 74.41 108.677 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -113.07 153.47 28.11 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 108.98 -0.748 . . . . 70.43 108.98 176.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.455 ' O ' ' HB3' ' A' ' 77' ' ' MET . 13.3 ptp180 . . . . . 0 N--CA 1.483 1.209 0 CA-C-O 121.038 0.446 . . . . 64.42 110.029 175.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 74.0 t . . . . . 0 CA--C 1.554 1.101 0 CA-C-O 119.361 -0.352 . . . . 65.42 110.906 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.499 ' HD2' HD12 ' A' ' 21' ' ' LEU . 87.7 Cg_exo -52.77 143.46 47.55 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 123.537 2.825 . . . . 71.54 113.328 172.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.36 -40.29 64.84 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.373 1.069 . . . . 73.44 111.944 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -54.64 -48.94 71.66 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.177 0.591 . . . . 73.21 111.425 173.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.499 HD12 ' HD2' ' A' ' 18' ' ' PRO . 85.1 mt -75.36 -34.28 61.14 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 111.876 0.324 . . . . 70.34 111.876 -170.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.0 t -68.59 -38.83 80.96 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 117.579 0.172 . . . . 65.32 110.935 175.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.491 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -67.22 -42.09 84.64 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 122.412 0.285 . . . . 70.02 110.659 175.291 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.9 tp -58.32 -52.41 65.7 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.018 0.927 . . . . 75.31 111.822 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 84.3 t90 -56.62 -47.87 78.74 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.777 0.831 . . . . 71.53 111.107 -178.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 36.2 m -61.23 -37.03 81.6 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.998 -1.001 . . . . 73.11 111.159 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.2 tp -68.49 -44.75 74.06 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.414 1.085 . . . . 70.13 111.757 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.5 t -63.53 -42.26 95.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.1 0.96 . . . . 50.33 110.67 177.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.1 t -80.74 0.12 36.0 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-N 115.254 -0.884 . . . . 54.44 111.639 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -86.41 125.62 67.06 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.707 0.803 . . . . 63.13 110.639 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -82.84 -10.29 10.58 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.919 2.413 . . . . 60.31 114.177 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -82.49 -30.42 29.89 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.136 0.575 . . . . 64.1 111.455 -178.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 50.7 p -100.4 7.8 44.03 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.837 0.455 . . . . 61.23 110.659 -177.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.425 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 7.0 p-10 -58.3 -22.94 54.77 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.934 1.294 . . . . 74.22 112.897 -175.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.21 -38.22 82.65 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.803 0.841 . . . . 72.21 112.264 177.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 57.0 mt -117.66 -10.38 10.57 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.94 0.496 . . . . 74.55 111.954 -178.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 34' ' ' ASP . 17.1 tt -158.64 122.42 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-O 121.365 0.602 . . . . 74.22 111.913 175.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 53.8 t -152.39 158.95 43.41 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.666 0.786 . . . . 43.22 109.761 176.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 13.2 p-90 -70.82 153.23 42.93 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.669 0.788 . . . . 74.42 110.877 176.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.8 m -73.2 154.61 90.37 Favored Pre-proline 0 CA--C 1.553 1.077 0 CA-C-O 118.058 -0.972 . . . . 54.44 109.182 170.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -42.92 -31.34 2.18 Favored 'Trans proline' 0 C--N 1.388 2.617 0 C-N-CA 124.091 3.194 . . . . 64.21 115.821 -175.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 79.6 p -76.25 -49.51 16.87 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.972 0.509 . . . . 54.32 110.923 175.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.8 13.49 23.66 Favored Glycine 0 C--N 1.352 1.443 0 CA-C-N 115.606 -0.724 . . . . 52.34 113.557 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -94.5 -11.08 30.33 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.046 0.538 . . . . 64.02 111.137 -175.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.6 p -147.2 170.15 17.85 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.24 1.016 . . . . 71.24 109.146 -176.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -144.15 155.43 43.92 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.86 0.464 . . . . 70.43 110.798 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.402 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 52.6 m-70 -112.11 150.04 31.29 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.202 1.001 . . . . 62.44 109.32 -176.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.463 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 84.5 t -126.42 139.01 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 108.452 -0.944 . . . . 64.11 108.452 176.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -125.48 146.3 49.7 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.552 0.741 . . . . 73.02 109.061 176.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.4 t70 45.34 76.69 0.09 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.709 1.603 . . . . 70.22 112.019 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.606 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 53.3 mt-30 -51.05 -29.64 13.39 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.306 1.042 . . . . 64.31 113.023 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.99 -49.53 40.69 Favored Glycine 0 C--N 1.348 1.234 0 O-C-N 123.308 0.38 . . . . 64.51 112.835 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -75.16 -40.97 59.09 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.396 0.679 . . . . 61.02 110.222 -176.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -56.81 -48.84 77.05 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.282 1.433 . . . . 74.12 110.779 175.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' A' ' 66' ' ' ASN . . . -65.97 -28.84 69.2 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.19 0.441 . . . . 62.34 112.19 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -72.38 -46.35 55.71 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.797 0.839 . . . . 72.21 112.107 -177.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.523 ' HG3' HG23 ' A' ' 58' ' ' VAL . 7.1 pt-20 -110.11 -40.4 4.73 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 113.542 0.941 . . . . 75.1 113.542 -173.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.523 HG23 ' HG3' ' A' ' 57' ' ' GLU . 73.9 t -80.05 -43.24 22.39 Favored 'Isoleucine or valine' 0 C--O 1.252 1.189 0 C-N-CA 123.064 0.545 . . . . 71.45 111.51 -168.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.408 ' HG ' ' HA ' ' A' ' 55' ' ' ALA . 35.1 mt -63.06 -50.9 74.13 Favored Pre-proline 0 CA--C 1.558 1.28 0 CA-C-O 117.993 -1.003 . . . . 60.24 112.445 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.86 -12.91 36.92 Favored 'Trans proline' 0 C--N 1.389 2.695 0 C-N-CA 121.884 1.723 . . . . 75.14 113.138 177.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -74.43 -60.64 2.18 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 122.941 0.497 . . . . 71.35 110.306 177.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -85.34 -55.9 3.79 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 116.312 -0.403 . . . . 74.21 110.852 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -86.37 179.75 6.82 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 109.32 -0.622 . . . . 74.42 109.32 -176.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -113.07 38.97 2.67 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 121.526 0.679 . . . . 65.43 110.044 -171.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -162.6 163.95 26.95 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.936 -1.029 . . . . 74.42 109.301 -176.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.425 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 1.6 m120 -114.06 -7.89 13.06 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.173 0.589 . . . . 73.31 110.015 175.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -68.79 109.06 3.67 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.598 0.759 . . . . 72.2 111.0 -177.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.606 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 1.1 tpt -56.32 -39.76 73.29 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.498 1.119 . . . . 73.23 110.362 170.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.55 -41.54 66.56 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 124.548 1.155 . . . . 74.13 112.077 176.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.4 t -67.69 -41.39 83.71 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.631 0.772 . . . . 75.02 111.662 177.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -65.83 -52.37 51.1 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.465 0.706 . . . . 74.34 110.665 -176.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 95.4 t -61.11 -42.11 91.95 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-N 115.19 -0.914 . . . . 72.55 110.93 176.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -55.8 -46.9 77.92 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.564 0.746 . . . . 74.21 111.175 176.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -55.99 -55.57 31.13 Favored 'General case' 0 C--N 1.349 0.573 0 O-C-N 124.254 0.971 . . . . 72.44 110.417 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.4 mt -61.21 -42.41 98.54 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 124.15 0.906 . . . . 63.33 112.018 -175.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -59.19 -39.98 84.27 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.312 0.645 . . . . 71.24 111.368 175.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 57.2 mtm -73.86 -31.22 63.06 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.385 0.274 . . . . 72.41 110.795 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -79.38 3.51 18.12 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.71 0.804 . . . . 74.43 111.668 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.08 14.06 79.92 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-O 119.428 -0.651 . . . . 73.32 113.921 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -74.26 138.85 43.89 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 109.275 -0.639 . . . . 74.13 109.275 175.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -100.81 124.14 46.02 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.337 -0.616 . . . . 74.23 109.337 178.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.58 ' HE2' ' HB ' ' A' ' 84' ' ' VAL . 1.3 tmtp? -78.64 131.04 36.53 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.268 1.027 . . . . 74.53 108.934 177.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.2 t -129.97 122.66 54.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 107.472 -1.307 . . . . 74.43 107.472 175.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.58 ' HB ' ' HE2' ' A' ' 82' ' ' LYS . 6.5 p -99.14 124.87 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 109.226 -0.657 . . . . 71.44 109.226 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 . . . . . 0 N--CA 1.478 0.96 0 C-N-CA 123.069 0.548 . . . . 72.33 109.994 -177.703 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 . . . . . 0 CA--C 1.54 0.574 0 CA-C-O 122.182 0.992 . . . . 64.01 108.584 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -44.26 128.64 6.17 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 113.73 -1.577 . . . . 40.43 111.16 175.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -96.65 108.0 20.54 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.764 -0.828 . . . . 75.33 108.764 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.463 ' HB ' ' HB ' ' A' ' 48' ' ' VAL . 3.8 m -100.26 95.14 6.59 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 108.206 -1.035 . . . . 51.51 108.206 174.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -91.35 141.52 28.68 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.153 -1.054 . . . . 72.25 108.153 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -124.75 125.5 44.16 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.24 -1.022 . . . . 65.42 108.24 173.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -116.87 149.43 40.09 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.317 0.647 . . . . 73.34 110.083 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -162.96 127.92 2.07 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 108.936 -0.764 . . . . 64.43 108.936 174.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.3 -31.14 81.86 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 122.726 2.284 . . . . 62.42 113.355 -174.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 36.2 m -88.84 3.07 52.45 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 122.735 0.414 . . . . 73.21 111.466 -178.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -101.02 99.63 10.11 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.216 -1.401 . . . . 65.34 107.216 172.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 110' ' ' GLN . 87.5 mt -119.92 129.67 54.45 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.244 0.618 . . . . 63.13 109.349 176.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -72.05 93.18 1.37 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 107.641 -1.244 . . . . 74.25 107.641 174.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 145.45 -55.55 0.54 Allowed Glycine 0 C--N 1.33 0.213 0 N-CA-C 109.193 -1.563 . . . . 52.21 109.193 -173.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.539 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 2.6 mp0 -88.46 76.07 8.31 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.602 0.761 . . . . 72.12 110.181 176.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.68 -17.48 60.67 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.231 0.612 . . . . 43.23 112.036 175.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 19.3 pm0 -69.55 -21.72 63.61 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 111.494 0.183 . . . . 72.51 111.494 175.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.0 mt -80.04 -5.93 56.71 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.775 0.43 . . . . 73.22 112.125 -177.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 68.8 mt -69.97 -23.16 63.13 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.246 0.618 . . . . 71.2 111.944 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -81.13 -2.11 47.1 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 112.378 0.511 . . . . 72.12 112.378 176.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -90.32 -12.99 36.13 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 109.066 -0.716 . . . . 75.34 109.066 170.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 18.7 mt -93.19 121.3 43.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 107.79 -1.189 . . . . 72.12 107.79 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.81 168.57 18.49 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.067 0.46 . . . . 75.4 111.062 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 28.1 ptt180 . . . . . 0 N--CA 1.468 0.471 0 C-N-CA 123.999 0.919 . . . . 72.11 109.668 -172.526 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 70.8 t . . . . . 0 CA--C 1.544 0.748 0 CA-C-O 118.804 -0.617 . . . . 72.51 110.37 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.36 145.74 34.97 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.897 2.398 . . . . 64.14 111.863 174.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.99 -40.73 67.2 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.751 0.82 . . . . 75.21 111.968 -176.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.425 ' HA ' ' HE1' ' A' ' 63' ' ' PHE . 54.1 t80 -53.25 -49.43 66.89 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.74 0.816 . . . . 55.43 111.851 173.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 92.5 mt -77.72 -31.07 52.06 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.007 0.523 . . . . 60.34 112.303 -170.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.5 t -76.02 -34.23 59.69 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 117.586 0.176 . . . . 75.42 110.973 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.15 -39.66 71.81 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.611 0.364 . . . . 71.33 110.035 174.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.49 ' O ' HG23 ' A' ' 28' ' ' VAL . 53.4 tp -61.85 -43.41 98.9 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 124.152 0.908 . . . . 71.41 110.801 174.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.514 ' CE3' HD11 ' A' ' 114' ' ' LEU . 70.9 t-105 -56.66 -47.7 79.21 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.234 1.013 . . . . 71.2 110.947 177.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.3 m -63.36 -42.66 98.9 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.03 -0.987 . . . . 71.01 110.949 174.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.8 tp -62.21 -53.24 58.07 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.386 1.474 . . . . 71.41 112.528 -172.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 24' ' ' LEU . 24.8 t -58.76 -33.85 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 C-N-CA 123.095 0.558 . . . . 74.03 111.41 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.0 t -87.11 -16.08 36.56 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.087 0.955 . . . . 65.41 111.647 -176.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -76.12 127.05 85.91 Favored Pre-proline 0 N--CA 1.481 1.089 0 C-N-CA 122.76 0.424 . . . . 64.25 111.115 -172.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.13 -30.64 46.56 Favored 'Trans proline' 0 C--N 1.385 2.467 0 C-N-CA 123.195 2.597 . . . . 55.1 114.543 -175.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -65.06 -38.32 90.44 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.438 0.637 . . . . 71.5 110.594 178.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.4 p -101.34 -2.02 32.01 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.922 -1.035 . . . . 71.44 111.542 -175.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -57.9 -35.97 71.78 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.513 1.125 . . . . 71.24 111.391 -178.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.43 -38.78 66.69 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.368 -0.833 . . . . 62.24 111.783 178.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.419 ' HA ' ' HB2' ' A' ' 49' ' ' PHE . 79.4 mt -98.24 -25.6 14.82 Favored 'General case' 0 C--O 1.213 -0.819 0 C-N-CA 123.08 0.552 . . . . 63.51 111.072 -178.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 47' ' ' HIS . 19.8 tt -149.48 116.04 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 O-C-N 121.251 -0.905 . . . . 72.12 111.231 -176.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 9.0 p -142.86 150.38 39.79 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.611 0.764 . . . . 61.42 110.62 -171.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -70.12 150.21 46.78 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.537 0.735 . . . . 72.35 110.307 176.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 56.3 p -71.66 155.93 91.83 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 122.995 0.518 . . . . 70.12 109.616 167.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -52.93 -29.47 43.95 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.612 2.208 . . . . 75.25 112.763 173.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.7 m -76.11 -38.02 57.39 Favored 'General case' 0 C--N 1.352 0.709 0 C-N-CA 123.088 0.555 . . . . 73.31 110.906 175.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.606 ' HA3' ' HD2' ' A' ' 108' ' ' ARG . . . 78.95 20.83 69.55 Favored Glycine 0 C--N 1.344 1.009 0 O-C-N 123.358 0.411 . . . . 60.41 113.24 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -95.24 -17.43 21.71 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.823 0.849 . . . . 75.3 109.988 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.401 ' HB3' ' HB3' ' A' ' 102' ' ' GLN . 66.6 p -142.48 168.84 18.79 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 123.806 0.842 . . . . 72.15 109.72 -174.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.403 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 46.3 p90 -143.05 147.22 34.7 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.79 0.436 . . . . 64.21 110.404 175.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.417 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 13.9 m-70 -104.15 142.55 34.29 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.154 0.982 . . . . 25.22 109.343 -178.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.2 t -124.18 125.78 71.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 108.06 -1.089 . . . . 62.45 108.06 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 79.9 m-85 -108.8 145.16 35.65 Favored 'General case' 0 C--O 1.247 0.941 0 C-N-CA 124.662 1.185 . . . . 72.23 109.067 -174.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 47.78 76.42 0.11 Allowed 'General case' 0 CA--C 1.542 0.669 0 O-C-N 124.561 1.163 . . . . 73.34 112.365 173.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.542 ' HG2' ' HB2' ' A' ' 97' ' ' ASP . 5.2 mm-40 -52.78 -29.49 27.72 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.735 -0.666 . . . . 75.51 112.173 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.99 -50.95 49.16 Favored Glycine 0 C--N 1.345 1.049 0 O-C-N 123.492 0.495 . . . . 61.34 112.894 174.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.407 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 62.7 tp60 -70.14 -46.51 64.58 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.647 0.379 . . . . 60.35 110.62 -177.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.44 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 61.1 t80 -53.68 -50.88 64.87 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.169 1.388 . . . . 74.04 111.132 176.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.59 ' HB2' ' HB2' ' A' ' 68' ' ' MET . . . -59.48 -35.27 73.8 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.849 0.685 . . . . 74.31 112.849 177.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.56 -47.07 51.14 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.069 0.948 . . . . 61.2 112.406 -176.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.503 ' HG3' HG23 ' A' ' 58' ' ' VAL . 6.5 pt-20 -102.36 -43.03 5.8 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 112.664 0.616 . . . . 74.25 112.664 -173.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.503 HG23 ' HG3' ' A' ' 57' ' ' GLU . 55.8 t -79.33 -47.2 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.386 0.674 . . . . 54.42 111.418 -168.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.2 mt -65.36 -46.65 70.76 Favored Pre-proline 0 CA--C 1.561 1.39 0 N-CA-C 113.239 0.829 . . . . 63.52 113.239 -174.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.37 -16.0 49.93 Favored 'Trans proline' 0 C--N 1.387 2.584 0 CA-C-N 121.901 1.715 . . . . 74.11 113.031 173.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -79.67 -62.32 1.72 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 123.999 0.92 . . . . 72.44 111.584 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -84.97 -24.33 28.35 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 122.974 0.509 . . . . 74.52 111.642 -176.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.425 ' HE1' ' HA ' ' A' ' 20' ' ' PHE . 41.0 m-85 -122.65 -169.24 1.87 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.223 -1.028 . . . . 71.31 108.223 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -127.64 45.14 2.79 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.867 0.842 . . . . 71.11 110.334 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -154.51 156.12 36.1 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.649 1.18 . . . . 63.21 107.965 176.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.524 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 1.6 m-20 -108.43 -16.08 14.31 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 109.723 -0.473 . . . . 54.24 109.723 176.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -66.52 115.3 6.25 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.346 0.658 . . . . 52.31 110.994 -176.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.59 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 12.1 tpt -73.26 -33.78 65.46 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.781 0.832 . . . . 64.12 111.29 -177.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.3 -35.64 65.31 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.097 0.559 . . . . 74.4 111.282 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.529 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 44.1 t -66.13 -46.59 77.0 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.171 0.988 . . . . 72.02 110.944 176.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -62.26 -53.26 57.78 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.011 0.924 . . . . 70.42 110.682 -176.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.5 t -62.78 -37.63 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 115.449 -0.796 . . . . 71.24 111.087 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -59.88 -38.02 81.02 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.312 0.645 . . . . 74.34 111.347 177.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 70' ' ' SER . 81.1 mm-40 -60.19 -48.28 82.4 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 109.346 -0.612 . . . . 71.25 109.346 176.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.438 ' HA ' ' HB2' ' A' ' 78' ' ' TYR . 93.6 mt -63.77 -36.36 83.61 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.063 0.945 . . . . 74.1 111.498 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -60.29 -42.46 95.54 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.388 0.675 . . . . 62.11 110.972 173.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 72.1 mtm -76.14 -21.32 56.71 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.723 -0.671 . . . . 74.34 110.677 176.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.438 ' HB2' ' HA ' ' A' ' 75' ' ' LEU . 26.6 m-85 -83.04 -4.09 57.97 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.572 0.749 . . . . 71.33 111.414 173.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.62 17.7 77.04 Favored Glycine 0 C--N 1.347 1.17 0 N-CA-C 114.433 0.533 . . . . 24.01 114.433 174.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -66.59 154.36 40.66 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.427 0.691 . . . . 72.43 110.436 177.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -99.73 122.55 42.89 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.564 0.746 . . . . 73.3 109.199 -178.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.582 ' HE2' ' HB ' ' A' ' 84' ' ' VAL . 21.0 tptm -77.08 123.76 26.84 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.841 1.256 . . . . 73.41 109.557 177.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.463 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 47.5 t -126.21 109.29 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 N-CA-C 108.103 -1.073 . . . . 71.14 108.103 170.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.582 ' HB ' ' HE2' ' A' ' 82' ' ' LYS . 5.1 p -90.45 123.9 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.445 0.698 . . . . 74.22 109.599 -179.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 . . . . . 0 N--CA 1.481 1.101 0 C-N-CA 123.063 0.545 . . . . 74.22 111.713 -176.201 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 . . . . . 0 N--CA 1.47 0.526 0 N-CA-C 109.467 -0.568 . . . . 74.01 109.467 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.542 ' HB2' ' HG2' ' A' ' 51' ' ' GLN . 5.9 m-20 -103.53 145.02 30.64 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.77 -0.826 . . . . 64.43 108.77 165.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -129.64 112.54 13.78 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.466 -1.309 . . . . 75.32 107.466 168.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 41.2 m -123.32 118.71 28.15 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.167 0.987 . . . . 73.13 109.623 -175.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.463 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 41.2 tt0 -102.18 110.85 22.92 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.155 0.982 . . . . 74.41 108.628 -179.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -97.67 132.76 43.02 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.801 -0.815 . . . . 73.35 108.801 173.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.401 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 27.0 pt20 -139.02 145.99 40.32 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.772 0.829 . . . . 42.55 109.305 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -149.3 136.88 11.29 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 109.025 -0.731 . . . . 75.45 109.025 -177.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -59.02 -34.82 99.23 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 122.692 2.261 . . . . 73.41 112.725 -177.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.403 ' HB2' HG12 ' A' ' 117' ' ' ILE . 15.7 m -89.63 14.32 11.93 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.223 0.609 . . . . 45.53 111.007 179.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -122.67 98.82 6.09 Favored 'General case' 0 C--O 1.245 0.838 0 N-CA-C 107.799 -1.185 . . . . 74.13 107.799 174.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 91.5 mt -131.4 151.78 51.23 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.386 1.075 . . . . 71.0 109.426 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.606 ' HD2' ' HA3' ' A' ' 43' ' ' GLY . 16.1 ptm180 -63.17 112.39 2.64 Favored 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 124.194 0.998 . . . . 71.15 111.484 -178.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.96 -8.22 63.12 Favored Glycine 0 N--CA 1.472 1.08 0 CA-C-N 116.388 -0.369 . . . . 64.22 113.585 -178.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.523 HE21 ' N ' ' A' ' 110' ' ' GLN . 0.0 OUTLIER -102.75 71.73 1.18 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 117.641 0.721 . . . . 64.22 111.034 -177.662 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.473 ' HA ' ' HG ' ' A' ' 114' ' ' LEU . 9.4 pt-20 -70.29 -26.06 63.63 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.658 -0.701 . . . . 73.54 111.679 170.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.4 pm0 -65.05 -15.15 62.03 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.708 0.803 . . . . 72.02 112.193 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 79.9 mt -95.14 -17.88 21.42 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.147 0.579 . . . . 54.22 111.764 176.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.514 HD11 ' CE3' ' A' ' 25' ' ' TRP . 80.4 mt -67.87 -37.72 82.16 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.246 0.619 . . . . 63.53 110.992 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -64.12 -14.51 55.35 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.246 -0.888 . . . . 71.34 112.429 174.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -101.2 -2.4 31.39 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.6 0.76 . . . . 73.51 110.682 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.403 HG12 ' HB2' ' A' ' 105' ' ' CYS . 37.0 mt -92.81 113.33 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 106.995 -1.483 . . . . 74.3 106.995 173.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.446 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 9.8 mmpt? -115.77 145.05 43.14 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.04 0.536 . . . . 62.2 111.254 -169.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 30.6 ptt85 . . . . . 0 N--CA 1.478 0.959 0 N-CA-C 108.247 -1.02 . . . . 71.33 108.247 168.608 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 91.4 t . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 119.386 -0.34 . . . . 54.44 110.677 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.28 141.84 94.23 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.618 2.212 . . . . 71.54 111.123 174.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.47 -40.5 62.39 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.814 0.845 . . . . 74.21 111.36 176.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -50.45 -47.78 56.71 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 124.248 0.967 . . . . 75.55 112.961 173.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 90.3 mt -83.68 -26.19 30.05 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.816 0.447 . . . . 72.1 110.402 -170.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.7 m -66.11 -45.22 81.93 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 124.154 0.982 . . . . 60.24 110.983 171.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.464 ' HE2' ' HA ' ' A' ' 23' ' ' LYS . 10.6 mmpt? -67.18 -44.72 78.95 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.726 0.41 . . . . 72.3 110.153 176.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.5 tp -56.11 -53.23 59.59 Favored 'General case' 0 C--N 1.356 0.876 0 O-C-N 124.483 1.114 . . . . 72.15 111.47 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.528 ' HH2' ' HG3' ' A' ' 108' ' ' ARG . 8.3 t-105 -59.37 -49.26 78.52 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 122.942 0.497 . . . . 74.43 111.832 -178.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.5 m -62.1 -28.05 69.35 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 122.805 0.442 . . . . 70.44 111.291 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.474 HD13 ' CD1' ' A' ' 62' ' ' TYR . 24.0 tp -74.37 -44.45 52.15 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.203 1.001 . . . . 64.23 111.793 176.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.2 t -61.87 -36.74 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.881 0.872 . . . . 62.24 110.401 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 88.4 p -90.34 10.8 23.51 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.842 0.857 . . . . 73.41 111.736 -177.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -90.86 116.42 66.38 Favored Pre-proline 0 CA--C 1.56 1.36 0 C-N-CA 123.052 0.541 . . . . 44.32 110.675 175.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.69 -7.81 16.76 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 123.256 2.637 . . . . 72.55 113.156 177.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -85.55 -25.72 26.59 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.689 0.795 . . . . 75.02 111.509 177.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 40.9 p -106.32 9.34 31.97 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.84 0.456 . . . . 75.12 111.122 178.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -57.85 -30.39 65.75 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 113.381 0.882 . . . . 64.52 113.381 -170.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -69.06 -24.08 64.12 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.574 0.583 . . . . 65.43 112.574 -176.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.474 HD22 ' HB2' ' A' ' 50' ' ' ASP . 77.4 mt -115.13 -18.17 11.23 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.2 0.6 . . . . 64.11 111.056 -178.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.463 HD13 ' HG ' ' A' ' 27' ' ' LEU . 14.9 tt -160.94 123.86 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.234 0.613 . . . . 64.01 110.231 171.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 23.2 p -150.55 161.69 42.07 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.159 0.584 . . . . 40.41 110.433 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 38.4 p-90 -73.33 147.27 44.58 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 124.048 0.842 . . . . 75.03 109.47 172.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.2 m -75.64 149.62 83.69 Favored Pre-proline 0 CA--C 1.548 0.9 0 N-CA-C 108.348 -0.982 . . . . 71.22 108.348 171.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.77 -28.43 23.05 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 123.101 2.534 . . . . 75.15 114.25 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.0 m -73.71 -24.8 59.97 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.309 0.644 . . . . 50.54 111.946 177.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.24 0.84 90.13 Favored Glycine 0 C--N 1.342 0.889 0 C-N-CA 123.129 0.395 . . . . 34.22 113.649 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -82.27 -25.4 34.07 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.727 0.811 . . . . 72.3 111.036 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.9 p -146.96 178.99 7.91 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.358 0.663 . . . . 74.12 110.311 -169.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 42.1 p90 -146.63 143.85 29.09 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.711 0.404 . . . . 70.34 110.985 178.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -103.33 151.71 22.41 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.23 0.612 . . . . 74.1 109.464 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 98' ' ' ASP . 95.5 t -124.23 132.13 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.363 1.065 . . . . 71.33 108.349 176.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -116.07 148.77 39.89 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.835 0.854 . . . . 71.22 109.604 178.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.474 ' HB2' HD22 ' A' ' 36' ' ' LEU . 20.8 m-20 53.16 63.44 2.23 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 124.692 1.245 . . . . 70.43 111.259 170.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -50.12 -33.35 18.48 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.181 0.993 . . . . 73.13 113.33 -172.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.64 -43.99 90.76 Favored Glycine 0 CA--C 1.533 1.196 0 O-C-N 123.412 0.445 . . . . 65.41 112.441 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -74.11 -45.48 48.78 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.392 0.677 . . . . 71.34 110.059 -178.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.436 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 39.1 t80 -50.51 -52.27 39.93 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.28 1.432 . . . . 75.21 111.494 174.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.463 ' HB2' ' HB2' ' A' ' 68' ' ' MET . . . -62.2 -36.32 81.57 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.657 -0.701 . . . . 60.04 111.577 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -66.81 -46.92 73.65 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.85 0.86 . . . . 63.33 112.85 -175.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.488 ' HG3' HG23 ' A' ' 58' ' ' VAL . 11.1 pt-20 -113.07 -33.9 5.88 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 114.292 1.219 . . . . 74.42 114.292 -171.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.488 HG23 ' HG3' ' A' ' 57' ' ' GLU . 91.9 t -82.83 -45.03 19.24 Favored 'Isoleucine or valine' 0 C--O 1.253 1.286 0 C-N-CA 123.71 0.804 . . . . 50.43 111.938 -170.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.6 mt -64.59 -46.55 77.03 Favored Pre-proline 0 CA--C 1.557 1.231 0 CA-C-O 118.095 -0.955 . . . . 63.34 112.766 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.418 ' HG3' ' ND2' ' A' ' 66' ' ' ASN . 41.7 Cg_endo -67.2 -15.21 45.64 Favored 'Trans proline' 0 C--N 1.381 2.262 0 CA-C-N 121.954 1.733 . . . . 73.11 113.105 174.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -73.14 -50.6 21.8 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.58 0.752 . . . . 75.01 110.489 176.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.474 ' CD1' HD13 ' A' ' 27' ' ' LEU . 37.0 m-85 -92.76 -51.88 4.88 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 112.594 0.59 . . . . 74.3 112.594 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -90.87 -172.03 3.22 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.885 -0.783 . . . . 65.14 108.885 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -118.47 40.66 3.16 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 121.313 0.578 . . . . 65.42 110.397 -174.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -162.25 164.66 27.53 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.193 -0.912 . . . . 72.11 109.246 -177.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.418 ' ND2' ' HG3' ' A' ' 60' ' ' PRO . 13.1 m120 -106.24 -33.98 7.63 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.356 0.663 . . . . 72.25 109.864 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -62.97 127.09 29.62 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.31 0.644 . . . . 72.14 112.522 -173.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.463 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 25.7 ttt -88.16 -23.69 23.55 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.97 0.508 . . . . 75.34 111.365 -176.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.42 -38.37 77.28 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 121.424 0.63 . . . . 74.04 111.211 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.415 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 22.8 t -68.89 -40.39 79.21 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.593 1.157 . . . . 62.42 111.087 176.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -62.39 -48.32 80.25 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.456 1.103 . . . . 74.23 110.899 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 83.4 t -65.24 -39.46 85.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 123.786 0.834 . . . . 73.34 111.102 177.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 70.0 ttt-85 -54.24 -43.71 71.14 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.195 0.598 . . . . 71.11 110.952 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.519 ' HA ' ' HE2' ' A' ' 77' ' ' MET . 10.2 mm100 -62.15 -45.77 91.96 Favored 'General case' 0 C--N 1.349 0.549 0 O-C-N 123.959 0.787 . . . . 55.25 110.352 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 43.1 mt -59.77 -36.92 77.66 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.662 0.785 . . . . 75.42 111.439 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -61.0 -40.68 94.48 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.839 0.456 . . . . 64.12 111.182 173.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.519 ' HE2' ' HA ' ' A' ' 74' ' ' GLN . 31.9 mtm -69.71 -35.6 75.19 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.563 0.345 . . . . 60.41 110.597 178.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -81.57 4.44 21.41 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.695 0.798 . . . . 74.14 111.019 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.89 24.96 75.87 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-O 119.459 -0.634 . . . . 74.22 114.538 170.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -73.03 148.89 43.7 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 117.271 0.535 . . . . 72.34 109.805 173.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.85 121.01 40.66 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.566 -0.901 . . . . 62.4 108.566 177.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.678 ' HE2' ' HB ' ' A' ' 84' ' ' VAL . 1.2 tmtp? -82.73 126.27 32.19 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.756 -1.202 . . . . 61.13 107.756 176.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 88.2 t -129.37 111.18 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 107.698 -1.223 . . . . 73.11 107.698 177.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.678 ' HB ' ' HE2' ' A' ' 82' ' ' LYS . 10.2 p -98.99 125.86 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 108.717 -0.846 . . . . 74.55 108.717 -177.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 . . . . . 0 N--CA 1.478 0.973 0 C-N-CA 122.839 0.455 . . . . 72.5 110.755 -176.897 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 . . . . . 0 CA--C 1.55 0.968 0 N-CA-C 109.519 -0.548 . . . . 61.32 109.519 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -39.95 107.21 0.07 Allowed 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.036 0.934 . . . . 72.35 112.796 175.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.434 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 12.8 t70 -97.21 113.3 24.89 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 107.718 -1.216 . . . . 54.2 107.718 174.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.534 HG23 ' HE3' ' A' ' 82' ' ' LYS . 87.1 m -122.49 112.08 17.6 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.89 0.876 . . . . 61.03 109.483 -176.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 46' ' ' PHE . 41.4 tt0 -105.0 114.17 28.21 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.898 0.879 . . . . 74.34 108.853 -178.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -95.97 121.4 37.68 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.023 -1.103 . . . . 74.21 108.023 174.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -125.75 143.7 50.94 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.531 0.733 . . . . 70.23 109.685 -176.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.2 t-80 -158.92 133.31 5.3 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 108.568 -0.901 . . . . 73.14 108.568 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -64.19 -21.39 67.54 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.617 2.211 . . . . 74.43 113.556 -175.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.427 ' HB2' HG12 ' A' ' 117' ' ' ILE . 12.0 m -96.36 6.24 49.19 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.969 0.507 . . . . 72.01 111.128 178.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -114.32 100.03 8.03 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 106.974 -1.491 . . . . 74.34 106.974 171.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 110' ' ' GLN . 49.4 mt -129.38 158.95 37.71 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.707 -0.849 . . . . 74.42 108.707 175.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.528 ' HG3' ' HH2' ' A' ' 25' ' ' TRP . 35.8 ttp180 -73.62 126.38 30.15 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 123.394 0.677 . . . . 74.02 110.71 -178.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.57 28.86 72.92 Favored Glycine 0 C--N 1.346 1.134 0 O-C-N 123.872 0.732 . . . . 62.5 112.198 -177.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.403 ' HB3' ' HB2' ' A' ' 107' ' ' LEU . 6.3 tp60 -136.96 37.94 2.57 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 122.633 1.206 . . . . 75.32 108.122 -175.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.92 -10.61 58.13 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 113.533 -1.667 . . . . 71.24 113.393 -173.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 21.0 pm0 -64.85 -18.31 65.03 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.719 0.408 . . . . 71.42 111.437 172.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.451 ' HA ' HD22 ' A' ' 116' ' ' ASN . 67.3 mt -90.52 -6.88 54.23 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.272 0.629 . . . . 42.31 111.837 -178.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 96.6 mt -66.76 -33.71 76.23 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 118.041 0.382 . . . . 72.25 111.003 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -73.72 -12.78 60.83 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 120.882 0.372 . . . . 70.45 111.49 174.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.451 HD22 ' HA ' ' A' ' 113' ' ' LEU . 35.1 m-80 -94.97 -14.45 24.39 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.569 0.747 . . . . 74.24 109.355 177.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.427 HG12 ' HB2' ' A' ' 105' ' ' CYS . 45.2 mt -83.93 75.46 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.069 0 N-CA-C 107.344 -1.354 . . . . 73.33 107.344 169.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.13 147.28 51.63 Favored 'General case' 0 CA--C 1.558 1.284 0 CA-C-N 115.322 -0.853 . . . . 62.44 113.296 173.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 . . . . . 0 N--CA 1.486 1.338 0 CA-C-N 114.712 -1.131 . . . . 75.41 109.536 174.881 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.4 t . . . . . 0 CA--C 1.557 1.215 0 CA-C-O 119.001 -0.523 . . . . 63.41 110.815 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.48 ' HD2' HD12 ' A' ' 21' ' ' LEU . 53.0 Cg_exo -56.61 155.93 24.46 Favored 'Trans proline' 0 C--N 1.382 2.299 0 C-N-CA 123.253 2.635 . . . . 74.45 112.495 178.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.82 -43.74 66.2 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.638 0.775 . . . . 74.11 111.283 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -53.37 -47.01 69.82 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.531 0.733 . . . . 73.52 112.151 175.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.48 HD12 ' HD2' ' A' ' 18' ' ' PRO . 72.9 mt -81.76 -27.64 33.68 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.31 0.485 . . . . 73.43 112.31 -171.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.1 t -76.07 -32.17 59.15 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 118.285 0.493 . . . . 71.13 111.045 174.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.488 ' HE2' ' HA ' ' A' ' 23' ' ' LYS . 10.2 mmpt? -71.33 -38.92 71.65 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.502 -0.555 . . . . 52.13 109.502 173.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.5 tp -61.44 -44.49 97.03 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 123.919 0.762 . . . . 75.02 110.797 172.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -53.51 -56.08 20.02 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.071 0.948 . . . . 72.14 111.233 177.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.1 m -56.5 -47.39 79.38 Favored 'General case' 0 C--O 1.214 -0.786 0 O-C-N 124.574 1.171 . . . . 40.44 110.402 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.426 ' HG ' HG21 ' A' ' 37' ' ' ILE . 28.7 tp -54.79 -53.11 59.45 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.605 1.562 . . . . 73.34 113.133 -174.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 65.6 t -66.82 -28.14 42.11 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 C-N-CA 123.821 0.848 . . . . 74.44 111.104 178.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.3 t -94.05 -7.21 43.28 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.314 1.046 . . . . 71.24 112.263 -177.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -89.68 128.73 49.41 Favored Pre-proline 0 N--CA 1.484 1.234 0 C-N-CA 123.515 0.726 . . . . 74.15 111.614 -171.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -77.5 -11.05 17.31 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 122.859 2.373 . . . . 75.44 114.232 -178.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -81.3 -28.75 34.49 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 118.422 0.555 . . . . 73.21 110.862 175.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.422 HG21 ' HE1' ' A' ' 62' ' ' TYR . 40.0 p -114.51 4.0 15.08 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 112.435 0.532 . . . . 71.04 112.435 -177.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 1.5 p-10 -65.44 -24.82 67.28 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 112.3 0.481 . . . . 65.31 112.3 -174.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -68.05 -26.57 65.93 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.265 0.626 . . . . 61.44 112.448 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.455 HD22 ' HB2' ' A' ' 50' ' ' ASP . 66.4 mt -106.57 -13.89 15.19 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.02 0.528 . . . . 73.13 111.517 178.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.509 ' O ' ' HA ' ' A' ' 34' ' ' ASP . 16.4 tt -161.25 124.67 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-O 120.844 0.354 . . . . 64.14 111.26 174.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 28.0 p -148.92 161.12 42.52 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.933 -0.766 . . . . 62.54 108.933 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 38.7 p-90 -82.47 148.54 28.09 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 108.965 -0.754 . . . . 60.13 108.965 176.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.9 m -75.54 151.31 85.04 Favored Pre-proline 0 CA--C 1.546 0.793 0 CA-C-N 115.176 -0.92 . . . . 52.24 110.084 -176.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -46.67 -39.64 23.51 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 123.468 2.779 . . . . 72.33 115.451 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 26.3 p -80.88 -9.8 59.79 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 112.086 0.402 . . . . 61.35 112.086 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.92 -0.08 83.76 Favored Glycine 0 C--N 1.351 1.403 0 N-CA-C 115.962 1.145 . . . . 64.41 115.962 163.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -94.44 -2.15 52.37 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.962 0.905 . . . . 71.21 111.705 -175.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.409 ' HB3' ' HB3' ' A' ' 102' ' ' GLN . 80.9 p -148.59 174.8 11.76 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.908 0.883 . . . . 43.14 110.163 -179.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -145.66 153.97 41.6 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.226 0.61 . . . . 72.42 110.084 170.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -112.92 149.32 33.36 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.114 0.966 . . . . 63.35 110.065 -178.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 98' ' ' ASP . 76.3 t -123.35 105.84 16.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 124.787 1.235 . . . . 62.15 107.987 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -91.18 145.18 24.88 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 124.041 0.936 . . . . 55.14 110.669 -177.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.455 ' HB2' HD22 ' A' ' 36' ' ' LEU . 3.2 m-20 53.0 57.46 6.31 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 124.579 1.175 . . . . 71.34 111.61 173.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -55.33 -26.31 40.03 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 114.332 1.234 . . . . 72.15 114.332 -169.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.38 -47.88 40.77 Favored Glycine 0 CA--C 1.531 1.093 0 N-CA-C 111.838 -0.505 . . . . 60.31 111.838 174.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -69.17 -44.3 72.51 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.394 0.678 . . . . 71.31 109.477 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -52.74 -51.37 60.79 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.318 1.447 . . . . 74.45 111.331 175.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.414 ' HB2' ' HB2' ' A' ' 68' ' ' MET . . . -64.57 -34.88 79.28 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.51 -0.314 . . . . 61.43 111.778 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -66.1 -46.77 76.47 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.457 1.103 . . . . 74.03 112.377 -176.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.546 ' HG3' HG23 ' A' ' 58' ' ' VAL . 6.9 pt-20 -109.76 -39.26 5.16 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 113.766 1.024 . . . . 55.32 113.766 -173.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.546 HG23 ' HG3' ' A' ' 57' ' ' GLU . 84.9 t -82.5 -38.23 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.253 0.621 . . . . 62.14 111.615 -168.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 51.1 mt -69.97 -43.47 19.88 Favored Pre-proline 0 CA--C 1.565 1.519 0 CA-C-O 118.073 -0.965 . . . . 73.55 112.94 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -71.06 -10.57 27.72 Favored 'Trans proline' 0 C--N 1.385 2.497 0 CA-C-N 122.058 1.771 . . . . 42.32 113.155 171.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -78.91 -52.68 7.95 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.151 0.981 . . . . 74.33 110.964 176.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.436 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 49.3 m-85 -87.43 -24.45 24.17 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 122.892 0.477 . . . . 63.44 112.155 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -126.29 -150.09 0.43 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 107.35 -1.352 . . . . 74.24 107.35 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -142.88 55.54 1.39 Allowed 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.99 0.9 . . . . 73.23 109.615 172.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 32.7 p80 -154.51 148.3 25.48 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 114.845 -1.071 . . . . 65.1 108.825 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -110.98 0.18 16.92 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.263 0.625 . . . . 62.31 109.685 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -74.73 117.24 16.34 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.112 0.965 . . . . 74.53 110.088 176.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.414 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 13.6 tpt -75.56 -35.83 60.56 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.085 0.554 . . . . 73.21 110.77 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.89 -32.6 67.88 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.228 0.611 . . . . 63.43 111.61 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.46 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 44.7 t -59.25 -52.07 67.26 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.991 0.917 . . . . 71.32 111.068 173.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -64.96 -51.59 60.95 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.119 0.967 . . . . 74.42 110.894 -174.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.0 t -58.18 -46.46 88.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 124.024 0.93 . . . . 74.22 111.629 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.9 ttt85 -57.63 -41.2 80.89 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 123.671 0.607 . . . . 73.02 111.784 -178.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 70' ' ' SER . 13.3 mm100 -60.93 -48.12 83.28 Favored 'General case' 0 C--N 1.351 0.666 0 O-C-N 123.706 0.629 . . . . 74.22 109.829 -178.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.4 mt -64.98 -42.62 94.39 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.842 0.714 . . . . 60.4 111.129 -178.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.77 -37.91 80.36 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.243 0.617 . . . . 74.22 111.329 177.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 59.9 mtm -71.01 -32.55 69.37 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.627 0.371 . . . . 54.54 110.428 174.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -73.15 -2.2 20.59 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.476 0.71 . . . . 74.01 111.426 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.13 12.94 64.87 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-O 119.633 -0.537 . . . . 72.12 113.62 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -74.93 147.55 40.83 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.178 -1.045 . . . . 73.54 108.178 174.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.465 ' HB3' ' HG3' ' A' ' 102' ' ' GLN . 34.9 ttm-85 -98.88 122.03 41.6 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.723 -0.843 . . . . 74.53 108.723 -174.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -79.95 113.65 18.27 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.096 1.358 . . . . 63.14 108.846 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 39.4 t -123.86 125.56 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 108.905 -0.776 . . . . 52.21 108.905 178.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 68.9 t -106.21 110.08 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 108.127 -1.064 . . . . 75.21 108.127 178.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 . . . . . 0 N--CA 1.478 0.944 0 C-N-CA 122.826 0.45 . . . . 71.25 111.652 -173.71 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 . . . . . 0 N--CA 1.479 1.004 0 CA-C-O 120.886 0.374 . . . . 64.14 110.426 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -103.38 118.7 37.36 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.802 -0.814 . . . . 73.11 108.802 169.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.404 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 22.5 t70 -122.94 122.95 39.81 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.979 0.912 . . . . 64.13 109.773 177.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 50.1 m -120.06 127.55 52.68 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.741 0.816 . . . . 72.52 109.834 175.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.403 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 39.0 tt0 -100.52 117.54 34.88 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.407 -0.96 . . . . 75.53 108.407 173.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -98.19 118.93 35.92 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.357 -0.979 . . . . 73.21 108.357 169.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.465 ' HG3' ' HB3' ' A' ' 81' ' ' ARG . 16.6 pt20 -121.5 137.58 54.66 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.618 0.767 . . . . 73.33 109.292 178.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.574 ' HB3' ' HB3' ' A' ' 106' ' ' PHE . 65.0 t-80 -148.33 129.24 7.0 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-O 118.95 -0.548 . . . . 74.51 110.353 -171.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -65.16 -38.86 25.72 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 123.14 2.56 . . . . 61.33 113.437 -173.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.46 ' HB2' ' HE1' ' A' ' 103' ' ' HIS . 35.4 m -93.54 28.93 2.12 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.926 0.49 . . . . 61.23 110.458 178.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.574 ' HB3' ' HB3' ' A' ' 103' ' ' HIS . 67.4 t80 -133.57 113.28 12.26 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.862 -0.792 . . . . 64.23 108.862 174.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.63 ' HB2' ' HB2' ' A' ' 110' ' ' GLN . 50.0 mt -117.51 157.48 26.23 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 108.706 -0.85 . . . . 63.12 108.706 173.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.38 -26.95 65.54 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.459 1.103 . . . . 74.53 112.974 -171.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.19 37.83 2.02 Favored Glycine 0 N--CA 1.471 0.973 0 N-CA-C 112.252 -0.339 . . . . 62.42 112.252 -177.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.63 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -131.24 71.8 1.48 Allowed 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 121.515 0.674 . . . . 74.32 109.673 -178.35 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -63.27 -30.36 71.51 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.345 1.058 . . . . 61.34 113.145 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 19.8 pm0 -66.28 -15.77 63.49 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.748 0.419 . . . . 73.54 111.639 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.525 ' O ' HG13 ' A' ' 117' ' ' ILE . 49.3 mt -87.03 -21.45 26.09 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 118.953 -0.546 . . . . 75.35 111.374 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 96.8 mt -57.4 -41.1 79.64 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 123.395 0.678 . . . . 63.25 111.33 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -76.93 -7.83 56.27 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 115.448 -0.796 . . . . 71.21 112.581 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -101.15 -9.19 21.56 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.705 0.802 . . . . 74.43 109.857 172.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 113' ' ' LEU . 72.7 mt -81.13 108.96 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 107.265 -1.383 . . . . 72.53 107.265 173.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.478 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 11.2 mmpt? -108.67 144.09 36.88 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.997 -0.742 . . . . 74.4 108.997 -172.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 31.0 ptt-85 . . . . . 0 N--CA 1.471 0.581 0 O-C-N 123.655 0.597 . . . . 63.32 110.788 179.349 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.6 t . . . . . 0 CA--C 1.553 1.083 0 N-CA-C 107.75 -1.204 . . . . 71.03 107.75 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -52.9 135.78 58.72 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 123.013 2.475 . . . . 74.24 112.621 177.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.96 -42.42 68.9 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.31 1.044 . . . . 74.34 112.335 -178.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -57.66 -40.75 80.05 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.252 0.621 . . . . 73.22 111.653 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 66.0 mt -78.04 -34.06 50.69 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 112.25 0.463 . . . . 73.21 112.25 -174.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.1 t -74.45 -37.22 63.32 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 119.688 -0.196 . . . . 73.25 110.885 178.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.501 ' HE2' ' HA ' ' A' ' 23' ' ' LYS . 8.5 mmpt? -70.79 -37.06 73.29 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 122.793 0.437 . . . . 63.45 110.102 175.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.436 ' O ' HG23 ' A' ' 28' ' ' VAL . 59.9 tp -58.5 -53.59 56.63 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 123.808 0.843 . . . . 75.34 111.453 173.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 24.1 t-105 -61.68 -41.74 97.98 Favored 'General case' 0 CA--C 1.549 0.921 0 O-C-N 123.027 0.204 . . . . 75.34 111.182 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.453 ' O ' ' HB2' ' A' ' 30' ' ' ASP . 90.7 m -59.38 -36.52 75.95 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 122.897 0.479 . . . . 74.42 110.762 174.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.48 ' HG ' HG21 ' A' ' 37' ' ' ILE . 50.5 tp -70.78 -51.02 29.64 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.633 1.173 . . . . 65.41 111.939 -178.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 24' ' ' LEU . 96.4 t -60.58 -33.86 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.69 1.196 . . . . 65.43 111.2 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.6 t -86.91 -24.44 24.82 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.855 0.862 . . . . 73.42 111.684 -176.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 26' ' ' THR . 8.7 t70 -69.3 128.62 92.34 Favored Pre-proline 0 N--CA 1.488 1.467 0 C-N-CA 122.856 0.462 . . . . 74.14 111.828 -168.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.32 -1.89 11.29 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 123.175 2.583 . . . . 75.22 114.507 -176.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -87.15 -34.28 19.12 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 118.305 0.502 . . . . 61.54 111.0 172.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.0 p -112.27 1.57 16.19 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.742 0.817 . . . . 74.23 112.398 -171.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.432 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 8.9 p-10 -61.18 -25.15 66.83 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.951 0.901 . . . . 54.42 111.923 -178.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.26 -33.64 75.94 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.957 0.903 . . . . 75.11 112.496 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.438 HD22 ' HB2' ' A' ' 50' ' ' ASP . 69.3 mt -108.14 -13.35 14.94 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.221 0.608 . . . . 62.2 112.001 -178.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.48 HG21 ' HG ' ' A' ' 27' ' ' LEU . 19.8 tt -157.39 117.67 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-O 121.266 0.555 . . . . 64.21 110.507 177.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 29.0 p -144.73 153.01 41.24 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.212 0.605 . . . . 74.13 109.803 -178.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 35.5 p-90 -82.21 153.15 26.09 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.922 -0.581 . . . . 73.41 109.738 178.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.6 m -82.49 156.91 68.21 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 108.726 -0.842 . . . . 65.41 108.726 -178.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -61.23 -12.29 22.8 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.449 2.1 . . . . 35.04 113.297 178.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 77.2 p -74.44 -36.87 63.41 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.824 0.85 . . . . 74.43 110.656 171.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.93 -8.12 77.46 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 115.504 -0.771 . . . . 63.32 113.415 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.572 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 0.4 OUTLIER -101.2 12.59 37.27 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.181 0.992 . . . . 50.03 111.37 -172.246 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.4 p -163.77 151.86 13.12 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.888 0.875 . . . . 63.05 109.538 -175.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -138.99 147.25 41.92 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.946 0.498 . . . . 71.44 109.871 177.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -101.99 144.69 30.28 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.478 0.711 . . . . 61.43 109.556 -176.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.408 HG12 ' HG2' ' A' ' 51' ' ' GLN . 95.8 t -121.66 115.61 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 107.504 -1.295 . . . . 71.1 107.504 177.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.483 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 25.4 m-85 -114.51 149.14 36.85 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.661 1.185 . . . . 71.31 110.743 -172.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.438 ' HB2' HD22 ' A' ' 36' ' ' LEU . 5.4 m-20 52.36 53.2 12.75 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 125.021 1.45 . . . . 50.12 110.51 176.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.706 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 55.5 mt-30 -53.39 -25.85 17.2 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 114.853 -1.067 . . . . 71.21 113.576 -170.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.45 -50.42 55.47 Favored Glycine 0 CA--C 1.534 1.266 0 N-CA-C 112.205 -0.358 . . . . 71.11 112.205 174.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -73.72 -33.49 64.38 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.143 0.977 . . . . 74.41 110.608 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.43 ' HB3' ' HA ' ' A' ' 51' ' ' GLN . 83.3 t80 -66.03 -54.54 24.59 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.345 1.058 . . . . 74.42 110.582 -178.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.6 -26.04 67.66 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 116.108 -0.496 . . . . 43.31 111.724 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.1 tttm -64.01 -55.58 21.3 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.816 1.246 . . . . 72.14 113.064 178.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.491 ' HG3' HG23 ' A' ' 58' ' ' VAL . 2.1 pt-20 -112.02 -33.65 6.2 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 113.259 0.836 . . . . 73.41 113.259 -170.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.491 HG23 ' HG3' ' A' ' 57' ' ' GLU . 61.8 t -85.22 -43.23 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.305 0.642 . . . . 75.3 111.328 -168.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 17.6 mt -62.57 -51.64 71.13 Favored Pre-proline 0 CA--C 1.558 1.272 0 CA-C-O 118.312 -0.851 . . . . 41.0 112.429 178.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.3 -7.48 21.32 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 121.726 1.617 . . . . 45.02 112.783 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -80.11 -60.97 2.13 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.09 0.956 . . . . 71.13 110.771 175.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -83.73 -32.17 25.64 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 122.755 0.422 . . . . 64.23 112.052 -176.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -112.11 -175.95 2.81 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.82 -0.807 . . . . 71.23 108.82 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.95 28.8 8.1 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.392 0.677 . . . . 73.12 111.295 -174.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 26.1 p80 -157.42 155.95 31.37 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.155 0.582 . . . . 65.41 109.82 -172.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 38.8 p30 -117.74 -7.5 10.99 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.394 0.677 . . . . 71.53 111.668 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -72.94 121.55 20.25 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.861 -0.422 . . . . 61.41 109.861 -178.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.706 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 2.4 tpt -59.48 -45.52 91.44 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.186 0.994 . . . . 74.21 111.227 178.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.73 -34.68 74.77 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.574 -0.739 . . . . 65.44 112.087 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.4 t -63.2 -40.92 98.86 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.252 0.621 . . . . 71.03 111.35 175.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -64.13 -53.08 55.24 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.134 0.974 . . . . 72.04 110.861 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.4 HG22 ' HZ ' ' A' ' 101' ' ' PHE . 58.1 t -61.16 -39.49 82.63 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 CA-C-N 115.079 -0.964 . . . . 75.34 111.394 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -57.78 -48.91 78.35 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.617 0.767 . . . . 74.3 111.235 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -58.13 -43.16 87.14 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 124.437 1.086 . . . . 72.41 110.641 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.7 mt -65.18 -41.53 94.52 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.219 0.608 . . . . 64.2 111.672 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -60.34 -35.88 76.69 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 122.584 0.354 . . . . 63.55 111.185 172.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.47 ' O ' ' HA ' ' A' ' 119' ' ' ARG . 48.2 mtp -65.63 -39.68 91.71 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.149 0.58 . . . . 64.33 110.126 175.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -81.53 -1.33 45.8 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.081 0.552 . . . . 64.03 111.518 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.03 22.15 57.95 Favored Glycine 0 C--N 1.35 1.331 0 N-CA-C 114.399 0.52 . . . . 60.2 114.399 174.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.553 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . 34.2 m-85 -78.82 130.56 35.84 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.343 -0.984 . . . . 51.23 108.343 173.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -100.93 129.61 46.81 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.208 0.603 . . . . 73.43 109.649 -171.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -71.54 122.55 20.67 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.514 1.126 . . . . 71.44 110.905 -178.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 90.6 t -132.3 127.4 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 107.488 -1.301 . . . . 71.42 107.488 172.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.59 131.97 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 109.122 -0.696 . . . . 55.15 109.122 177.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 29.6 m-70 . . . . . 0 N--CA 1.479 0.979 0 C-N-CA 123.054 0.542 . . . . 65.35 110.207 -178.054 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 . . . . . 0 C--O 1.244 0.811 0 CA-C-O 120.865 0.364 . . . . 71.24 110.184 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.483 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 2.5 m-20 -80.73 147.22 30.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.614 -0.721 . . . . 61.35 109.765 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -134.78 117.93 16.5 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.864 0.866 . . . . 55.14 109.345 172.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 86.3 m -135.06 109.0 8.12 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.595 0.758 . . . . 72.21 109.125 178.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -99.15 119.7 38.28 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.786 -0.82 . . . . 64.42 108.786 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.553 ' HB3' ' HB3' ' A' ' 80' ' ' PHE . 92.9 m-85 -99.62 120.31 39.47 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.556 -0.905 . . . . 72.11 108.556 173.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -109.99 144.59 38.31 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.368 0.667 . . . . 64.25 110.027 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -153.34 127.06 4.33 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 109.149 -0.686 . . . . 75.34 109.149 177.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.8 -34.86 59.8 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 123.021 2.481 . . . . 73.44 112.957 -177.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 36.1 m -93.19 26.29 2.94 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 121.234 0.54 . . . . 75.33 110.833 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.572 ' O ' ' HA ' ' A' ' 44' ' ' ASN . 85.8 t80 -124.9 110.36 14.16 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 107.092 -1.448 . . . . 73.3 107.092 172.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.647 ' HB2' ' HB3' ' A' ' 110' ' ' GLN . 85.2 mt -131.48 174.49 10.04 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 108.849 -0.797 . . . . 65.23 108.849 170.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -63.09 -75.7 0.07 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.527 0.731 . . . . 72.33 111.513 -178.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -80.25 -10.9 84.9 Favored Glycine 0 C--N 1.349 1.271 0 O-C-N 123.195 0.31 . . . . 74.33 113.157 -177.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.647 ' HB3' ' HB2' ' A' ' 107' ' ' LEU . 5.3 tp-100 -90.99 40.55 1.03 Allowed 'General case' 0 CA--C 1.556 1.178 0 CA-C-O 121.531 0.682 . . . . 70.43 109.323 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -69.63 -12.53 61.72 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.088 0.955 . . . . 65.42 112.687 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.3 pm0 -64.45 -10.11 23.03 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.197 0.599 . . . . 75.24 112.174 169.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.474 ' O ' HG13 ' A' ' 117' ' ' ILE . 53.0 mt -91.18 -4.58 55.96 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.172 0.589 . . . . 75.41 111.961 175.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 90.2 mt -66.03 -34.56 78.36 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 118.536 0.607 . . . . 62.31 111.162 176.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -75.25 -17.25 60.36 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.515 0.726 . . . . 52.31 111.415 172.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.432 HD22 ' HA ' ' A' ' 113' ' ' LEU . 28.1 m-80 -90.86 -9.86 44.78 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.413 0.685 . . . . 71.23 110.034 176.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 113' ' ' LEU . 59.3 mt -84.26 121.7 36.95 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 N-CA-C 107.294 -1.373 . . . . 73.1 107.294 170.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.521 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 10.8 mmpt? -111.14 151.79 27.74 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.225 0.61 . . . . 64.11 109.837 -178.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 77' ' ' MET . 43.3 ptt85 . . . . . 0 N--CA 1.475 0.799 0 CA-C-N 115.053 -0.976 . . . . 75.25 109.563 170.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.8 t . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 118.989 -0.529 . . . . 43.3 110.25 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -52.28 148.48 25.22 Favored 'Trans proline' 0 C--N 1.386 2.526 0 C-N-CA 123.718 2.945 . . . . 75.22 113.172 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.77 -42.42 64.98 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.833 0.853 . . . . 75.31 111.771 176.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -52.71 -49.9 64.44 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.617 0.767 . . . . 73.1 112.081 174.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 82.5 mt -80.61 -30.81 36.78 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.187 0.44 . . . . 72.13 112.187 -169.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.8 t -72.15 -36.54 69.36 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 118.009 0.368 . . . . 61.32 111.026 175.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.498 ' HE2' ' HA ' ' A' ' 23' ' ' LYS . 9.0 mmpt? -73.52 -36.49 65.72 Favored 'General case' 0 C--N 1.359 0.981 0 C-N-CA 122.869 0.468 . . . . 33.23 110.324 176.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.0 tp -62.76 -49.34 75.38 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 124.049 0.843 . . . . 74.02 110.99 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.478 ' HH2' ' HG2' ' A' ' 108' ' ' ARG . 12.0 t-105 -60.47 -43.62 96.73 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 122.36 0.264 . . . . 61.13 111.209 178.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.4 m -54.42 -51.19 65.7 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 122.631 0.373 . . . . 74.0 110.436 172.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.45 ' HG ' HD13 ' A' ' 37' ' ' ILE . 37.1 tp -57.19 -53.39 58.68 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.116 1.767 . . . . 44.12 113.201 -175.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.7 t -61.47 -35.45 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.659 1.184 . . . . 63.05 111.785 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.2 t -93.32 -6.52 47.2 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.778 -0.646 . . . . 44.52 111.351 -176.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -83.42 129.83 58.79 Favored Pre-proline 0 CA--C 1.552 1.055 0 C-N-CA 123.004 0.521 . . . . 74.33 111.18 -172.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -80.88 -9.63 13.06 Favored 'Trans proline' 0 C--N 1.382 2.328 0 C-N-CA 122.863 2.375 . . . . 42.34 114.027 -176.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -80.53 -27.42 37.63 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 118.49 0.586 . . . . 74.24 110.589 175.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.8 p -105.59 10.02 33.15 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.537 0.735 . . . . 74.41 112.486 -179.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -56.83 -32.27 65.59 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.151 0.981 . . . . 61.04 112.476 -175.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.08 -38.24 90.39 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.835 0.854 . . . . 75.31 112.968 -176.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.446 ' HA ' ' HB2' ' A' ' 49' ' ' PHE . 77.9 mt -110.97 -8.5 14.47 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 122.687 0.395 . . . . 61.01 111.837 -175.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.45 HD13 ' HG ' ' A' ' 27' ' ' LEU . 18.6 tt -162.42 134.36 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 122.62 0.368 . . . . 74.42 111.163 173.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.3 p -161.96 156.6 22.55 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.15 0.58 . . . . 75.04 109.879 173.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 14.8 p-90 -77.03 150.31 35.8 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.335 0.654 . . . . 71.41 110.504 -177.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.2 m -75.54 147.11 81.57 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 108.579 -0.897 . . . . 75.22 108.579 176.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.49 -12.89 12.01 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.615 2.21 . . . . 62.44 113.639 176.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.0 m -65.76 -43.95 87.31 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.664 1.186 . . . . 55.15 110.728 169.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.46 -10.98 69.07 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 114.934 -1.03 . . . . 71.42 114.147 177.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -101.84 6.43 41.53 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.456 1.102 . . . . 74.34 111.605 -171.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.2 p -157.36 161.75 39.05 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.121 0.969 . . . . 65.42 109.657 -171.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.431 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 45.9 p90 -146.61 146.52 30.45 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.66 0.384 . . . . 72.13 110.731 177.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -103.28 143.55 32.51 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.575 0.75 . . . . 63.33 109.632 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.0 t -123.14 121.98 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 107.569 -1.271 . . . . 71.13 107.569 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.552 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 90.6 m-85 -105.14 144.71 31.55 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 123.572 0.749 . . . . 71.23 109.759 -177.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 42.98 73.02 0.15 Allowed 'General case' 0 N--CA 1.476 0.851 0 O-C-N 125.254 1.596 . . . . 64.34 112.608 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -53.72 -26.9 25.2 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.499 1.119 . . . . 71.13 113.498 -175.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.31 -48.12 47.51 Favored Glycine 0 C--N 1.35 1.35 0 O-C-N 123.014 0.196 . . . . 61.43 112.69 173.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.423 ' HG3' HD11 ' A' ' 36' ' ' LEU . 56.1 tp60 -71.62 -37.13 70.95 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.018 0.927 . . . . 74.24 110.663 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.468 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 59.8 t80 -61.96 -48.93 78.17 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.224 1.41 . . . . 75.1 110.135 176.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.466 ' HB2' ' HB2' ' A' ' 68' ' ' MET . . . -62.45 -33.0 73.96 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 116.06 -0.518 . . . . 73.45 111.6 178.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.1 tttm -67.74 -55.52 12.82 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.611 1.165 . . . . 71.44 113.398 -177.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -106.78 -33.38 7.6 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 113.138 0.792 . . . . 70.1 113.138 -170.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.468 ' HB ' ' O ' ' A' ' 54' ' ' PHE . 94.4 t -82.78 -49.94 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 122.923 0.489 . . . . 73.44 111.605 -171.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.2 mt -61.48 -47.76 92.42 Favored Pre-proline 0 CA--C 1.561 1.369 0 CA-C-O 118.048 -0.977 . . . . 61.05 113.042 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -66.62 -16.62 51.2 Favored 'Trans proline' 0 C--N 1.391 2.783 0 CA-C-N 121.964 1.737 . . . . 74.41 113.073 177.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -77.03 -53.97 7.14 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.384 0.674 . . . . 54.25 111.253 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -87.29 -46.71 9.45 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.241 0.617 . . . . 73.42 111.686 -177.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -100.33 -179.9 4.26 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.383 -0.826 . . . . 64.42 108.785 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -112.64 40.03 2.36 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 121.634 0.73 . . . . 64.45 109.654 -174.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 32.2 p80 -157.66 161.5 38.6 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 114.949 -1.023 . . . . 75.34 109.01 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.413 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 31.7 p30 -112.95 -11.01 13.47 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.217 0.607 . . . . 43.25 110.128 177.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -73.39 120.53 19.13 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.439 0.696 . . . . 73.04 111.262 -176.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.466 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 12.2 tpt -69.9 -36.63 75.55 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.702 0.801 . . . . 74.22 111.303 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.65 -30.92 67.68 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 123.724 0.64 . . . . 73.5 111.962 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.1 t -65.54 -47.35 76.16 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.39 1.076 . . . . 71.45 110.841 174.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -63.74 -52.92 58.28 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.511 1.125 . . . . 75.42 110.471 -176.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.7 t -62.94 -40.89 90.67 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 CA-C-N 115.25 -0.886 . . . . 62.23 111.055 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -57.7 -40.97 80.74 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 123.272 0.629 . . . . 73.33 111.407 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -57.57 -51.0 71.25 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 124.187 0.929 . . . . 73.44 110.07 176.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 68.2 mt -63.56 -38.14 89.98 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.923 0.889 . . . . 73.25 111.714 -177.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 -57.27 -44.6 84.11 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 122.803 0.441 . . . . 71.22 110.851 172.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 71.0 mtm -73.79 -25.17 59.99 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.905 -0.589 . . . . 54.11 111.499 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -86.54 1.58 51.13 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.35 0.66 . . . . 62.52 111.065 173.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.63 13.39 81.6 Favored Glycine 0 C--N 1.344 1.017 0 N-CA-C 115.068 0.787 . . . . 53.25 115.068 171.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -69.3 144.87 53.44 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 117.877 0.838 . . . . 73.12 109.248 177.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -101.18 122.54 43.82 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.414 -0.587 . . . . 75.31 109.414 -177.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.502 ' HE2' ' HB ' ' A' ' 84' ' ' VAL . 22.9 tptm -68.32 113.22 5.73 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.018 1.327 . . . . 74.11 109.743 172.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 90.3 t -125.58 106.61 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 107.711 -1.218 . . . . 73.55 107.711 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.502 ' HB ' ' HE2' ' A' ' 82' ' ' LYS . 3.5 p -107.7 123.11 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 108.442 -0.947 . . . . 73.02 108.442 -172.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 . . . . . 0 N--CA 1.482 1.137 0 C-N-CA 123.164 0.586 . . . . 75.35 111.725 -169.766 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 . . . . . 0 CA--C 1.542 0.645 0 CA-C-O 121.789 0.804 . . . . 75.13 111.917 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.552 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 52.4 m-20 -86.58 124.51 32.96 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.24 -1.022 . . . . 64.53 108.24 171.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -123.2 107.52 11.8 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 107.897 -1.149 . . . . 74.01 107.897 167.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 55.0 m -122.11 108.73 13.68 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.589 1.156 . . . . 42.11 109.579 -173.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 46' ' ' PHE . 38.7 tt0 -101.49 115.36 30.34 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.82 -0.807 . . . . 71.05 108.82 -179.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -96.63 120.03 36.2 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.181 -1.044 . . . . 63.52 108.181 171.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -118.3 145.48 45.04 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.714 -0.847 . . . . 64.33 108.714 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.467 ' HB3' ' HB3' ' A' ' 106' ' ' PHE . 42.6 t-80 -155.78 133.17 6.53 Favored Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 109.318 -0.623 . . . . 74.25 109.318 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -63.96 -35.53 54.46 Favored 'Trans proline' 0 C--N 1.384 2.447 0 C-N-CA 122.855 2.37 . . . . 54.21 112.268 -175.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 3.4 m -87.0 3.88 44.12 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.435 0.694 . . . . 73.4 111.002 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.467 ' HB3' ' HB3' ' A' ' 103' ' ' HIS . 88.9 t80 -111.84 103.28 11.53 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 107.911 -1.144 . . . . 74.2 107.911 175.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.413 HD12 ' HG2' ' A' ' 110' ' ' GLN . 28.3 mt -119.43 167.97 11.42 Favored 'General case' 0 C--O 1.246 0.881 0 N-CA-C 107.236 -1.394 . . . . 71.22 107.236 170.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . 0.478 ' HG2' ' HH2' ' A' ' 25' ' ' TRP . 30.3 ttp85 -60.63 -79.86 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.154 0.582 . . . . 75.31 110.903 -173.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -85.46 60.17 4.74 Favored Glycine 0 C--N 1.347 1.14 0 N-CA-C 111.624 -0.59 . . . . 63.42 111.624 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.413 ' HG2' HD12 ' A' ' 107' ' ' LEU . 2.8 tp-100 -150.93 35.44 0.6 Allowed 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 108.872 -0.788 . . . . 72.22 108.872 -170.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -64.16 -20.19 65.83 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.607 1.163 . . . . 61.21 113.154 -175.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.07 -8.18 53.13 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 112.022 0.379 . . . . 73.31 112.022 177.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.435 ' O ' HG13 ' A' ' 117' ' ' ILE . 17.7 mt -88.3 -16.61 32.64 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.368 0.667 . . . . 71.52 111.494 173.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 96.8 mt -61.61 -36.41 80.66 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.274 0.559 . . . . 64.42 111.212 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -72.77 -15.78 61.65 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 115.57 -0.741 . . . . 74.03 112.342 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -97.14 -7.68 31.95 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.706 0.802 . . . . 64.13 110.257 178.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 113' ' ' LEU . 64.2 mt -88.65 130.52 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 107.573 -1.269 . . . . 71.11 107.573 173.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -105.71 141.1 37.72 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.25 0.62 . . . . 61.54 109.992 -171.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 . . . . . 0 N--CA 1.48 1.031 0 O-C-N 124.209 0.943 . . . . 74.14 110.327 170.213 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.9 mmt . . . . . 0 N--CA 1.476 0.871 0 N-CA-C 109.549 -0.538 . . . . 71.34 109.549 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.26 96.01 0.98 Allowed Glycine 0 C--N 1.348 1.244 0 CA-C-N 115.263 -0.88 . . . . 61.0 112.399 -177.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 25.7 m-70 -91.75 -36.07 13.78 Favored 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 108.617 -0.883 . . . . 74.12 108.617 168.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -70.35 103.23 2.35 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.859 0.864 . . . . 74.12 109.213 174.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.1 m-70 -116.68 154.25 30.9 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 124.003 0.921 . . . . 71.4 109.732 177.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -71.83 147.51 47.13 Favored 'General case' 0 C--O 1.241 0.627 0 O-C-N 124.054 0.846 . . . . 74.52 111.311 -177.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 11.2 t60 65.29 70.83 0.45 Allowed 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.707 1.203 . . . . 71.53 110.793 175.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -86.24 97.06 10.16 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 108.079 -1.082 . . . . 74.4 108.079 172.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 52.4 p -69.3 -69.68 0.32 Allowed 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 115.479 -0.782 . . . . 74.5 111.077 -172.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -133.7 28.47 3.92 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 124.344 1.058 . . . . 72.21 108.409 175.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 77.8 mtp -78.47 165.63 23.54 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 114.494 -1.23 . . . . 73.01 111.646 -175.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.12 137.36 14.82 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 114.904 -1.043 . . . . 55.02 108.396 171.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 171.99 -78.57 0.09 OUTLIER Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.217 -0.753 . . . . 64.03 111.217 -177.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -83.63 79.26 2.83 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 123.047 2.498 . . . . 74.33 112.254 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 96.9 p 47.8 55.22 8.81 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.701 1.2 . . . . 45.41 112.896 173.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.41 ' N ' HD22 ' A' ' 16' ' ' ASN . 0.9 OUTLIER -79.73 17.88 0.85 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.509 0.724 . . . . 74.42 111.281 178.184 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.2 t -69.57 129.09 91.76 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 123.879 0.872 . . . . 71.43 109.805 175.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.84 147.37 85.21 Favored 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 122.418 2.078 . . . . 72.55 110.894 171.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.29 -33.24 41.23 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.441 1.096 . . . . 73.35 113.36 -172.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -54.75 -52.76 61.55 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.681 0.792 . . . . 72.15 112.272 174.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 95.7 mt -77.26 -29.48 53.93 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 120.992 0.425 . . . . 74.43 109.912 -171.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.4 m -58.76 -48.4 81.34 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-N 114.351 -1.295 . . . . 74.33 111.395 173.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.475 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -69.28 -47.4 64.67 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.951 -0.568 . . . . 73.23 110.731 176.13 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.5 ' O ' HG23 ' A' ' 28' ' ' VAL . 58.9 tp -56.77 -54.76 42.6 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.597 1.159 . . . . 74.43 113.485 -174.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 89.5 t90 -56.34 -45.84 80.23 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.374 0.67 . . . . 74.41 111.13 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 16.1 m -69.26 -28.46 66.33 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.616 0.766 . . . . 75.22 111.663 177.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.506 ' HG ' HG21 ' A' ' 37' ' ' ILE . 49.6 tp -67.21 -46.2 74.58 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.932 1.293 . . . . 74.01 110.931 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 24' ' ' LEU . 23.6 t -63.53 -37.98 81.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-N 115.129 -0.941 . . . . 73.44 110.732 175.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.2 m -74.5 -19.97 60.16 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.841 0.856 . . . . 74.15 111.565 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -74.87 132.54 77.33 Favored Pre-proline 0 CA--C 1.556 1.173 0 C-N-CA 123.773 0.829 . . . . 64.21 110.988 -172.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.32 -28.19 12.66 Favored 'Trans proline' 0 C--N 1.384 2.44 0 C-N-CA 123.036 2.491 . . . . 74.21 114.235 -176.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -69.48 -43.39 73.29 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.244 0.618 . . . . 63.24 110.061 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.0 p -96.01 -1.25 49.31 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.733 -0.667 . . . . 70.33 111.325 -175.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -56.02 -30.83 62.45 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.645 1.178 . . . . 62.41 111.657 177.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.75 -36.31 78.61 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.237 -0.892 . . . . 74.24 112.152 178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.8 mt -111.06 -6.0 14.7 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.166 0.587 . . . . 64.42 111.899 -176.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.506 HG21 ' HG ' ' A' ' 27' ' ' LEU . 18.8 tt -159.42 112.75 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 121.564 0.697 . . . . 74.11 110.504 175.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.527 ' SG ' ' HE2' ' A' ' 49' ' ' PHE . 24.5 p -139.9 145.41 37.95 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.174 0.59 . . . . 75.23 110.524 -174.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 18.8 p-90 -75.83 149.6 37.84 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.835 0.854 . . . . 71.12 111.513 -176.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.1 m -72.21 154.24 92.19 Favored Pre-proline 0 CA--C 1.556 1.192 0 C-N-CA 123.848 0.859 . . . . 62.22 109.262 174.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -43.21 -42.83 10.11 Favored 'Trans proline' 0 C--N 1.386 2.531 0 C-N-CA 124.432 3.421 . . . . 63.32 114.677 -176.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.2 m -67.52 -40.19 85.1 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.192 0.597 . . . . 71.21 111.37 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.11 11.82 55.8 Favored Glycine 0 C--N 1.347 1.193 0 CA-C-N 115.901 -0.591 . . . . 44.41 112.793 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.409 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 28.0 p-10 -91.63 -4.76 54.87 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.26 1.024 . . . . 62.35 111.276 -175.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.6 p -155.31 170.93 20.73 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 123.937 0.895 . . . . 52.32 109.744 -174.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 50.7 p90 -142.12 149.23 39.55 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.07 0.548 . . . . 72.33 110.299 178.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -107.84 147.16 31.28 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.225 1.01 . . . . 65.45 108.398 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.624 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 60.2 t -123.3 131.31 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 108.018 -1.104 . . . . 72.41 108.018 176.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.527 ' HE2' ' SG ' ' A' ' 38' ' ' CYS . 79.3 m-85 -118.73 146.71 44.54 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 124.148 0.979 . . . . 72.14 109.4 -177.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 52.68 70.98 0.51 Allowed 'General case' 0 CA--C 1.548 0.898 0 O-C-N 124.693 1.246 . . . . 74.41 111.088 -178.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -46.79 -41.45 15.42 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 124.391 1.076 . . . . 73.11 112.955 -177.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.48 -46.58 76.18 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 115.646 -0.706 . . . . 75.41 112.822 179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -72.69 -45.82 56.86 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.009 0.524 . . . . 74.32 110.822 -176.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.4 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 65.7 t80 -53.66 -49.15 68.57 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.778 1.231 . . . . 74.51 110.729 173.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.496 ' HB1' ' O ' ' A' ' 66' ' ' ASN . . . -64.44 -33.79 76.69 Favored 'General case' 0 CA--C 1.551 1.015 0 N-CA-C 112.409 0.522 . . . . 71.23 112.409 178.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -69.41 -50.4 46.26 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.455 1.102 . . . . 71.34 112.167 -177.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.509 ' HG3' HG23 ' A' ' 58' ' ' VAL . 3.3 pt-20 -105.69 -43.97 4.78 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 113.098 0.777 . . . . 74.21 113.098 -174.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.509 HG23 ' HG3' ' A' ' 57' ' ' GLU . 94.5 t -76.78 -45.48 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 122.751 0.421 . . . . 74.13 111.017 -166.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 32.3 mt -61.8 -51.14 78.06 Favored Pre-proline 0 CA--C 1.557 1.225 0 CA-C-O 117.764 -1.113 . . . . 55.31 112.073 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.5 ' HG3' ' ND2' ' A' ' 66' ' ' ASN . 60.2 Cg_endo -70.21 -9.58 26.27 Favored 'Trans proline' 0 C--N 1.384 2.406 0 CA-C-N 122.291 1.854 . . . . 62.13 113.719 176.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -79.35 -53.49 6.87 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.284 0.633 . . . . 72.3 110.965 176.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -91.69 -46.82 7.71 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 123.075 0.55 . . . . 73.44 111.176 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -99.12 -177.29 3.57 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 108.254 -1.017 . . . . 65.13 108.254 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -113.16 37.52 3.13 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 119.112 0.869 . . . . 72.41 111.721 -172.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 21.7 p80 -157.05 158.33 36.28 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 122.91 0.484 . . . . 74.22 110.271 -174.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.5 ' ND2' ' HG3' ' A' ' 60' ' ' PRO . 10.4 m120 -105.31 -16.21 14.82 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 122.515 0.326 . . . . 63.31 110.671 177.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -75.86 124.72 27.78 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.842 0.457 . . . . 40.1 110.995 -175.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 12.7 tpt -75.1 -33.97 61.69 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.82 0.848 . . . . 75.11 111.779 -176.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.07 -33.52 70.89 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.26 0.624 . . . . 60.15 111.68 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.44 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 48.2 t -64.7 -44.92 88.71 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.459 1.104 . . . . 73.45 111.223 175.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -60.64 -51.77 67.99 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.197 0.999 . . . . 73.51 110.709 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.6 t -61.32 -39.64 83.37 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.042 0 CA-C-N 115.0 -1.0 . . . . 40.34 111.342 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -60.69 -41.34 94.95 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.766 0.826 . . . . 71.44 112.096 -178.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.44 ' HG2' ' O ' ' A' ' 70' ' ' SER . 13.8 mm100 -58.98 -47.41 85.24 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 123.943 0.777 . . . . 54.2 109.616 176.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 80' ' ' PHE . 77.5 mt -61.65 -38.47 87.85 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.274 1.03 . . . . 72.5 112.172 -178.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -60.55 -35.65 76.55 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 122.557 0.343 . . . . 60.12 111.864 173.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 63.7 mtm -76.57 -23.56 53.54 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.039 0.536 . . . . 73.0 111.3 175.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -85.9 -7.0 58.98 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.405 0.682 . . . . 64.21 111.602 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.93 10.2 66.96 Favored Glycine 0 C--N 1.346 1.088 0 CA-C-O 119.569 -0.573 . . . . 62.45 114.27 175.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.429 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 24.0 m-85 -73.25 144.41 46.71 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 117.723 0.761 . . . . 71.33 109.506 178.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 57.5 ttt-85 -110.8 131.72 54.81 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.693 -0.484 . . . . 54.53 109.693 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.574 ' HE3' ' HA ' ' A' ' 99' ' ' THR . 18.6 tptm -74.48 127.43 33.04 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.735 0.814 . . . . 45.01 109.721 173.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 95.5 t -132.37 118.38 35.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 107.034 -1.469 . . . . 63.52 107.034 176.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.483 ' HB ' ' HE2' ' A' ' 82' ' ' LYS . 6.5 p -104.93 116.16 48.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 108.845 -0.798 . . . . 75.12 108.845 -177.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -91.02 -10.88 40.6 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 122.212 -0.305 . . . . 63.14 111.761 -177.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 35.0 mm -89.54 116.17 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 108.594 -0.891 . . . . 73.3 108.594 168.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -75.97 88.69 2.94 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 109.102 -0.703 . . . . 71.2 109.102 176.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -72.27 110.94 7.05 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 114.843 -1.071 . . . . 65.23 111.213 -169.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -177.6 -141.34 4.08 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-N 115.87 -0.604 . . . . 44.22 112.208 177.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -86.56 59.18 4.63 Favored Glycine 0 C--N 1.344 1.001 0 N-CA-C 112.0 -0.44 . . . . 43.24 112.0 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 85.2 mt -123.69 157.57 33.59 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.185 0.994 . . . . 73.13 110.242 -177.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.9 p -83.22 7.57 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.564 1.489 0 C-N-CA 123.932 0.893 . . . . 71.43 110.867 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -57.53 156.91 15.01 Favored Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 125.44 1.496 . . . . 74.12 112.302 175.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -56.67 153.84 34.16 Favored 'Trans proline' 0 C--N 1.394 2.924 0 C-N-CA 122.985 2.457 . . . . 63.14 113.301 -174.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -82.45 27.44 0.51 Allowed 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.238 1.015 . . . . 74.03 112.629 -169.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -125.93 162.25 25.64 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.05 0.94 . . . . 75.44 110.253 -176.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.87 142.02 28.13 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.028 -1.101 . . . . 72.11 108.028 170.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.421 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 20.3 t70 -106.7 105.13 15.02 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 106.891 -1.522 . . . . 54.21 106.891 166.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.624 ' HB ' ' HB ' ' A' ' 48' ' ' VAL . 31.6 m -112.79 91.24 3.58 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.118 0.567 . . . . 62.25 110.376 -171.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 46' ' ' PHE . 39.6 tt0 -98.32 114.68 27.07 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.9 0.48 . . . . 65.13 109.73 -175.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -98.68 120.24 38.78 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 109.199 -0.667 . . . . 74.21 109.199 171.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -108.22 144.24 35.93 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.171 0.988 . . . . 71.42 110.382 -175.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -160.08 132.27 4.29 Favored Pre-proline 0 N--CA 1.479 0.992 0 CA-C-O 119.193 -0.432 . . . . 74.41 110.206 177.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.41 -24.83 42.46 Favored 'Trans proline' 0 C--N 1.384 2.406 0 C-N-CA 122.94 2.427 . . . . 72.41 113.616 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.513 ' HB2' HG12 ' A' ' 117' ' ' ILE . 13.2 m -95.1 8.49 42.81 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.738 0.415 . . . . 72.01 111.015 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 44' ' ' ASN . 74.5 t80 -111.43 100.43 9.02 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 107.816 -1.179 . . . . 73.43 107.816 175.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 110' ' ' GLN . 96.3 mt -120.58 154.09 35.87 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.196 0.598 . . . . 61.23 109.658 173.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -71.21 -22.56 62.0 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.111 0.964 . . . . 75.13 112.575 -170.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -120.61 27.19 6.65 Favored Glycine 0 N--CA 1.468 0.831 0 N-CA-C 112.268 -0.333 . . . . 53.22 112.268 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.525 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 14.5 mm100 -135.17 78.2 1.72 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.339 0.656 . . . . 65.02 110.182 -175.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.31 -29.38 69.58 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.148 -0.933 . . . . 72.15 112.034 174.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 6.8 pm0 -76.28 -11.09 59.85 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.161 0.584 . . . . 62.14 111.693 -177.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.445 ' HA ' HD22 ' A' ' 116' ' ' ASN . 53.0 mt -91.19 -12.78 34.36 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.658 0.383 . . . . 70.31 110.981 176.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 64.8 mt -69.1 -27.69 65.82 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.047 0.539 . . . . 64.13 110.631 175.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -89.72 0.9 56.69 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.612 0.765 . . . . 71.54 112.132 173.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.445 HD22 ' HA ' ' A' ' 113' ' ' LEU . 20.3 m-80 -90.86 -17.36 26.65 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.282 -0.636 . . . . 43.23 109.282 161.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.513 HG12 ' HB2' ' A' ' 105' ' ' CYS . 32.7 mt -87.22 104.89 14.62 Favored 'Isoleucine or valine' 0 C--N 1.357 0.9 0 N-CA-C 106.64 -1.615 . . . . 65.31 106.64 173.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.481 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 11.0 mmpt? -112.47 155.81 23.63 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.953 -0.388 . . . . 51.31 109.953 -174.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -107.14 -53.29 2.64 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.792 0.837 . . . . 71.31 109.152 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt 179.87 149.11 0.31 Allowed 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.904 0.881 . . . . 64.42 110.867 177.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.0 p -85.96 -16.26 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.093 0 C-N-CA 123.466 0.706 . . . . 75.2 110.498 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 33.7 p -76.21 -8.49 57.16 Favored 'General case' 0 CA--C 1.557 1.239 0 C-N-CA 123.736 0.814 . . . . 64.14 112.25 177.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 33.1 t -131.62 -152.87 0.52 Allowed 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 106.939 -1.504 . . . . 73.54 106.939 169.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.5 p -59.24 131.98 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 N-CA-C 109.068 -0.715 . . . . 72.42 109.068 165.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 31.8 p . . . . . 0 C--O 1.254 1.316 0 CA-C-O 118.68 -0.676 . . . . 44.23 111.236 -174.828 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.312 0 N-CA-C 110.019 -0.363 . . . . 63.31 110.019 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 130.26 45.6 0.16 Allowed Glycine 0 C--N 1.343 0.96 0 CA-C-N 116.317 -0.401 . . . . 72.44 112.253 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -72.18 140.32 48.7 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.53 0.732 . . . . 75.44 110.298 176.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 67.59 73.85 0.31 Allowed 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 124.983 1.313 . . . . 72.32 111.783 173.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -145.46 -172.83 3.96 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.427 1.491 . . . . 72.53 108.52 175.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -113.65 82.62 1.71 Allowed 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 122.1 0.953 . . . . 73.12 110.614 174.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 33.3 t-80 -100.37 129.0 46.3 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 106.902 -1.518 . . . . 73.41 106.902 168.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 34.0 p-80 -61.18 143.44 55.54 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 123.249 0.343 . . . . 60.44 110.736 -175.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.8 t -75.26 162.66 28.25 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 122.795 0.438 . . . . 71.12 110.58 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -75.25 161.5 29.27 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.904 -0.589 . . . . 72.14 111.157 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 35.2 mmt -80.57 -161.0 0.34 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.897 0.879 . . . . 74.33 111.562 -173.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.22 81.44 0.35 Allowed 'General case' 0 C--N 1.355 0.831 0 C-N-CA 123.563 0.745 . . . . 72.35 110.162 173.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -152.15 -67.06 0.01 OUTLIER Glycine 0 N--CA 1.466 0.664 0 N-CA-C 109.325 -1.51 . . . . 41.44 109.325 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -68.96 134.54 29.94 Favored 'Trans proline' 0 C--N 1.363 1.326 0 C-N-CA 122.559 2.172 . . . . 45.13 108.333 156.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.482 ' HB3' HG23 ' A' ' 17' ' ' VAL . 73.5 m -61.73 130.69 47.01 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.234 0.54 . . . . 64.23 112.35 -172.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.496 HD22 ' N ' ' A' ' 16' ' ' ASN . 0.8 OUTLIER -88.23 24.63 1.82 Allowed 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.599 1.16 . . . . 63.43 110.276 -176.376 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.482 HG23 ' HB3' ' A' ' 15' ' ' SER . 84.1 t -61.27 129.83 91.13 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 124.267 1.027 . . . . 74.03 110.212 178.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -53.0 140.35 59.46 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 123.44 2.76 . . . . 70.14 111.593 175.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.49 -40.4 65.33 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.635 0.774 . . . . 64.43 112.235 -178.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -52.33 -49.84 63.46 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.05 0.94 . . . . 61.35 112.307 171.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 90.4 mt -81.65 -25.1 35.88 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.887 0.475 . . . . 72.04 110.684 -170.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.5 m -64.74 -53.36 48.38 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 124.183 0.993 . . . . 51.12 110.657 174.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.525 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -69.34 -39.94 77.86 Favored 'General case' 0 C--N 1.345 0.396 0 CA-C-N 115.457 -0.792 . . . . 74.14 110.848 -179.395 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.443 ' O ' HG23 ' A' ' 28' ' ' VAL . 54.4 tp -60.49 -48.44 81.77 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.594 0.758 . . . . 72.04 111.733 176.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.606 ' HE1' ' HA ' ' A' ' 108' ' ' ARG . 56.3 t90 -59.04 -47.72 84.21 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.99 0.516 . . . . 73.01 111.13 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 86.9 m -59.4 -40.79 87.78 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.044 0.938 . . . . 74.23 110.886 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 22.1 tp -62.92 -52.92 61.17 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.752 1.621 . . . . 54.43 112.355 -178.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 24' ' ' LEU . 93.6 t -60.84 -32.2 51.55 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 C-N-CA 124.227 1.011 . . . . 71.1 111.053 179.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 67.2 m -90.16 -5.84 56.02 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.271 1.028 . . . . 64.44 112.292 -176.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.409 ' HB3' ' OG1' ' A' ' 33' ' ' THR . 14.9 t70 -86.42 127.16 62.06 Favored Pre-proline 0 CA--C 1.556 1.208 0 C-N-CA 123.095 0.558 . . . . 72.21 111.192 -174.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -62.8 -32.39 77.81 Favored 'Trans proline' 0 C--N 1.384 2.446 0 C-N-CA 123.782 2.988 . . . . 74.32 114.526 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -72.11 -39.94 68.51 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 122.901 0.481 . . . . 75.03 110.262 -178.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.409 ' OG1' ' HB3' ' A' ' 30' ' ' ASP . 29.8 p -98.14 0.46 46.03 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.736 -0.666 . . . . 61.43 111.445 -176.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -55.04 -31.21 60.92 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.603 1.161 . . . . 73.13 111.074 173.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -59.84 -39.94 86.85 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.065 0.946 . . . . 72.11 112.801 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 48.4 mt -103.54 -13.49 16.55 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.863 0.465 . . . . 75.24 111.96 -178.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 16.6 tt -159.81 122.27 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-O 121.061 0.458 . . . . 71.15 110.042 177.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 26.6 p -139.52 148.7 42.99 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 122.86 0.464 . . . . 71.13 111.245 -173.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.42 ' HB3' HG12 ' A' ' 28' ' ' VAL . 20.5 p-90 -77.85 148.99 34.41 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.418 0.687 . . . . 73.12 109.977 175.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.9 m -81.87 144.51 51.87 Favored Pre-proline 0 CA--C 1.551 1.008 0 N-CA-C 108.618 -0.882 . . . . 71.21 108.618 174.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -52.35 -22.15 15.27 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 123.883 3.055 . . . . 74.45 115.219 -173.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.3 m -78.06 -37.79 45.91 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 123.01 0.524 . . . . 45.55 111.073 176.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.9 4.14 51.62 Favored Glycine 0 C--N 1.351 1.416 0 N-CA-C 114.875 0.71 . . . . 62.33 114.875 167.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 6.6 p30 -106.5 2.08 25.95 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 123.804 0.842 . . . . 74.32 111.672 -175.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 81.0 p -148.01 158.09 43.87 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 109.016 -0.735 . . . . 53.42 109.016 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -142.57 152.67 42.81 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 122.8 0.44 . . . . 74.31 110.139 176.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -108.53 141.89 39.77 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.762 0.825 . . . . 75.52 109.336 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.0 t -118.48 134.11 63.15 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 107.499 -1.297 . . . . 64.15 107.499 177.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.452 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 93.3 m-85 -123.45 147.21 47.38 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 123.853 0.861 . . . . 72.12 110.088 -172.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 48.11 63.32 2.09 Favored 'General case' 0 C--N 1.352 0.714 0 O-C-N 125.33 1.644 . . . . 74.35 111.356 175.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.521 ' HG2' ' HE2' ' A' ' 68' ' ' MET . 99.2 mt-30 -54.56 -29.14 50.29 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.309 1.044 . . . . 65.15 113.3 -171.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -63.42 -45.51 94.77 Favored Glycine 0 CA--C 1.531 1.069 0 O-C-N 123.36 0.413 . . . . 24.41 112.322 172.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -74.04 -45.71 47.89 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.81 0.844 . . . . 73.02 110.574 -178.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.408 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 80.1 t80 -55.28 -52.6 62.91 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.752 1.621 . . . . 71.31 111.2 179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.503 ' HB2' ' HB2' ' A' ' 68' ' ' MET . . . -66.92 -25.95 66.62 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.159 0.429 . . . . 73.25 112.159 -179.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.8 -49.99 18.79 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.756 0.822 . . . . 75.21 112.25 -177.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.524 ' HG3' HG23 ' A' ' 58' ' ' VAL . 6.1 pt-20 -105.19 -42.63 5.23 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 112.746 0.647 . . . . 72.25 112.746 -175.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.524 HG23 ' HG3' ' A' ' 57' ' ' GLU . 74.2 t -76.77 -43.98 33.33 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.9 0 C-N-CA 123.109 0.564 . . . . 61.3 111.877 -167.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.468 ' HG ' ' HA ' ' A' ' 55' ' ' ALA . 38.8 mt -60.85 -54.76 51.33 Favored Pre-proline 0 CA--C 1.564 1.481 0 CA-C-O 118.272 -0.871 . . . . 71.05 112.082 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.481 ' HG3' ' ND2' ' A' ' 66' ' ' ASN . 30.9 Cg_endo -65.87 -12.23 34.37 Favored 'Trans proline' 0 C--N 1.386 2.516 0 C-N-CA 121.925 1.75 . . . . 74.12 113.621 178.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -77.96 -62.53 1.64 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.113 0.965 . . . . 71.13 111.259 177.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.493 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 43.0 m-85 -78.77 -51.02 10.36 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.304 0.573 . . . . 72.24 110.676 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -89.36 -166.61 1.64 Allowed 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 107.53 -1.285 . . . . 74.1 107.53 175.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.59 43.57 3.11 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 119.531 1.059 . . . . 74.0 110.465 -178.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -163.61 162.64 24.4 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 115.06 -0.973 . . . . 71.44 108.854 -175.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.481 ' ND2' ' HG3' ' A' ' 60' ' ' PRO . 10.2 m120 -105.9 -148.95 0.42 Allowed 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 106.713 -1.588 . . . . 71.2 106.713 174.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 68.88 105.36 0.05 Allowed 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.734 0.813 . . . . 73.41 111.644 169.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.521 ' HE2' ' HG2' ' A' ' 51' ' ' GLN . 13.8 tpt -70.39 -28.2 64.91 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.604 -0.725 . . . . 64.24 110.869 -175.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.15 -39.4 75.16 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.197 0.599 . . . . 62.31 111.32 176.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.8 t -65.88 -43.66 87.65 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.304 1.041 . . . . 75.43 111.388 177.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -65.13 -52.95 52.17 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.123 0.969 . . . . 71.43 111.161 -177.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.42 HG12 HD21 ' A' ' 76' ' ' ASN . 59.6 t -63.33 -34.4 66.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 CA-C-N 115.58 -0.736 . . . . 74.11 110.884 178.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -55.84 -42.31 75.59 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.26 0.624 . . . . 71.05 111.113 177.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -62.94 -47.31 83.76 Favored 'General case' 0 C--N 1.347 0.462 0 O-C-N 124.018 0.823 . . . . 62.14 110.105 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 72' ' ' VAL . 77.3 mt -60.54 -44.62 95.91 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.222 1.009 . . . . 74.31 111.968 -177.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.42 HD21 HG12 ' A' ' 72' ' ' VAL . 66.9 m-80 -55.61 -41.04 72.88 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.979 0.512 . . . . 75.12 111.432 175.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 67.2 mtm -72.12 -36.9 69.55 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 116.221 -0.445 . . . . 74.12 110.708 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -77.34 -7.71 56.48 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.181 0.592 . . . . 61.04 111.251 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 91.91 14.4 56.47 Favored Glycine 0 C--N 1.347 1.16 0 CA-C-O 119.631 -0.538 . . . . 74.01 114.419 174.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -76.39 134.91 39.5 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 109.117 -0.698 . . . . 72.35 109.117 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.431 ' HD2' HE21 ' A' ' 102' ' ' GLN . 29.7 ttm180 -99.28 123.26 43.41 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 108.881 -0.785 . . . . 52.1 108.881 -175.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.525 ' HE3' HG23 ' A' ' 99' ' ' THR . 1.3 tmtp? -72.16 116.83 13.05 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.277 -1.009 . . . . 52.54 108.277 174.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.561 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 61.7 t -107.24 122.09 60.96 Favored 'Isoleucine or valine' 0 C--O 1.246 0.911 0 N-CA-C 108.276 -1.009 . . . . 64.04 108.276 177.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 57.5 t -82.06 119.77 32.26 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 124.336 1.054 . . . . 62.43 109.669 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -112.58 -49.66 2.94 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.782 -0.821 . . . . 74.04 108.782 174.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.447 HG12 ' HB3' ' A' ' 98' ' ' ASP . 50.2 mm -78.19 94.59 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 108.366 -0.976 . . . . 75.21 108.366 172.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.425 ' HB2' HD12 ' A' ' 91' ' ' LEU . 41.1 mt-10 -88.27 112.96 23.4 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 114.356 -1.293 . . . . 60.12 109.455 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -76.18 152.66 36.59 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 123.544 0.738 . . . . 72.41 110.513 177.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 148.57 -120.8 1.24 Allowed Glycine 0 C--N 1.338 0.69 0 N-CA-C 110.346 -1.102 . . . . 54.02 110.346 -177.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -98.01 -0.62 58.64 Favored Glycine 0 C--N 1.343 0.917 0 CA-C-O 119.987 -0.341 . . . . 74.22 112.873 176.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.425 HD12 ' HB2' ' A' ' 87' ' ' GLU . 59.2 mt -75.56 143.03 42.63 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.236 0.614 . . . . 72.21 111.417 -175.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 28.0 m -100.21 16.22 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 124.165 0.986 . . . . 75.24 111.023 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -62.19 142.34 95.76 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 109.516 -0.55 . . . . 74.33 109.516 172.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -49.82 144.88 19.55 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 124.071 3.18 . . . . 72.13 113.964 -163.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -79.7 10.41 4.06 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 114.534 -1.212 . . . . 75.21 112.231 -169.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -73.3 170.44 15.02 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.67 -0.695 . . . . 73.42 110.39 171.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.452 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 22.0 m-20 -90.43 133.25 35.15 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.799 -0.815 . . . . 72.21 108.799 164.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.447 ' HB3' HG12 ' A' ' 86' ' ' ILE . 9.1 t70 -131.37 104.23 6.89 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 106.057 -1.831 . . . . 71.43 106.057 165.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.525 HG23 ' HE3' ' A' ' 82' ' ' LYS . 32.6 m -126.99 111.38 14.01 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.675 -0.693 . . . . 53.22 109.281 -173.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.561 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 41.5 tt0 -100.55 112.02 24.34 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 110.1 -0.333 . . . . 72.45 110.1 -173.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -97.45 122.53 40.6 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 109.032 -0.729 . . . . 71.13 109.032 174.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.431 HE21 ' HD2' ' A' ' 81' ' ' ARG . 29.2 pt20 -120.98 145.56 47.61 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.552 0.741 . . . . 63.42 110.382 -176.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 -156.8 131.98 5.46 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 108.354 -0.98 . . . . 75.41 108.354 174.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -64.45 -20.81 66.38 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.986 2.457 . . . . 62.14 113.651 -175.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.495 ' HB2' HG12 ' A' ' 117' ' ' ILE . 18.5 m -98.4 7.12 46.62 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.324 0.65 . . . . 64.05 111.496 -179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 44' ' ' ASN . 62.3 t80 -108.09 100.87 10.16 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 107.721 -1.215 . . . . 70.23 107.721 175.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.594 ' HB2' ' HB3' ' A' ' 110' ' ' GLN . 96.0 mt -125.17 146.21 49.6 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.351 0.66 . . . . 71.11 109.321 173.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.606 ' HA ' ' HE1' ' A' ' 25' ' ' TRP . 31.4 ttt180 -83.11 102.11 11.61 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 109.397 -0.594 . . . . 63.13 109.397 176.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 123.99 -38.84 2.31 Favored Glycine 0 C--N 1.337 0.624 0 N-CA-C 110.349 -1.1 . . . . 72.45 110.349 -177.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.594 ' HB3' ' HB2' ' A' ' 107' ' ' LEU . 2.6 tp-100 -88.87 56.39 3.71 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 123.741 0.816 . . . . 70.23 109.012 176.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -62.87 -18.28 62.74 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.346 1.059 . . . . 73.33 112.514 -178.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -65.28 -20.91 66.63 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.558 0.743 . . . . 75.44 112.942 177.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.9 mt -91.89 -10.32 40.03 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.159 0.583 . . . . 71.43 111.693 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 74.5 mt -67.28 -35.41 79.42 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-O 121.394 0.616 . . . . 63.41 110.764 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -77.93 -4.93 49.36 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.498 -0.774 . . . . 64.45 111.99 176.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -103.17 -2.02 28.03 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.568 0.747 . . . . 64.33 110.014 173.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.495 HG12 ' HB2' ' A' ' 105' ' ' CYS . 60.0 mt -81.48 115.53 24.21 Favored 'Isoleucine or valine' 0 C--N 1.357 0.91 0 N-CA-C 107.053 -1.462 . . . . 72.51 107.053 168.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.8 mmpt? -105.68 136.55 45.07 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 109.756 -0.461 . . . . 74.04 109.756 -171.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -90.15 -21.74 22.07 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.115 0.566 . . . . 74.43 110.402 172.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -129.71 151.79 49.92 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.098 0.959 . . . . 71.23 108.864 176.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.1 p -70.73 -23.11 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 123.431 0.692 . . . . 72.2 110.648 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 48.9 p -82.69 178.55 8.14 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.554 0.742 . . . . 71.04 110.858 173.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 27.4 t -69.86 116.32 10.11 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.566 0.746 . . . . 62.1 110.446 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.7 p -156.33 155.48 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.118 0 C-N-CA 123.131 0.573 . . . . 70.22 110.614 -173.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 21.7 m . . . . . 0 C--O 1.251 1.132 0 N-CA-C 107.457 -1.312 . . . . 72.31 107.457 170.51 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.2 mtt . . . . . 0 N--CA 1.486 1.367 0 N-CA-C 110.108 -0.33 . . . . 63.44 110.108 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 146.79 113.42 0.78 Allowed Glycine 0 C--N 1.348 1.247 0 N-CA-C 111.481 -0.648 . . . . 71.34 111.481 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -120.82 5.42 10.48 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.322 0.649 . . . . 63.54 110.07 177.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 52.3 m-70 -123.82 169.11 11.89 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.275 1.03 . . . . 74.24 110.076 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -152.1 120.24 6.28 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 109.131 -0.692 . . . . 75.32 109.131 171.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -83.29 142.96 30.72 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 109.27 -0.641 . . . . 74.14 109.27 175.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -153.62 154.26 33.87 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.012 -0.54 . . . . 73.44 110.008 -169.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 47.7 m80 -73.19 92.84 1.78 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.671 -0.695 . . . . 72.21 109.43 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.1 t -96.24 113.44 25.04 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.544 0.738 . . . . 62.04 110.61 -177.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 17.5 p-80 -156.17 134.05 11.16 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.21 1.004 . . . . 75.12 108.733 173.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.0 ppp? -83.3 171.85 13.15 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.931 0.492 . . . . 74.43 109.771 173.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.59 61.46 5.72 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.159 0.584 . . . . 74.22 112.358 -174.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -86.45 -97.1 0.81 Allowed Glycine 0 C--N 1.344 1.009 0 N-CA-C 109.777 -1.329 . . . . 44.54 109.777 168.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -91.97 101.91 0.21 Allowed 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 122.581 2.187 . . . . 63.13 109.842 166.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 58.7 m -59.77 144.61 47.86 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.134 -0.484 . . . . 45.23 111.656 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.492 ' HB2' ' HB2' ' A' ' 115' ' ' GLU . 20.0 m-80 -84.34 21.75 1.37 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.171 0.989 . . . . 64.13 111.875 -170.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.1 t -67.77 118.18 55.25 Favored Pre-proline 0 CA--C 1.548 0.866 0 N-CA-C 108.81 -0.811 . . . . 65.25 108.81 173.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.529 ' HD2' HD12 ' A' ' 21' ' ' LEU . 32.4 Cg_exo -60.3 147.86 92.22 Favored 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.509 2.139 . . . . 74.25 111.682 173.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.63 -40.3 62.63 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.715 0.806 . . . . 44.31 111.508 176.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -53.72 -46.92 70.94 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.208 1.003 . . . . 52.43 111.705 174.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.529 HD12 ' HD2' ' A' ' 18' ' ' PRO . 28.9 mt -76.72 -37.35 56.21 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 112.468 0.544 . . . . 73.45 112.468 -173.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.8 t -69.87 -36.89 75.85 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 117.83 0.286 . . . . 75.54 110.699 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -75.73 -36.42 59.95 Favored 'General case' 0 C--N 1.358 0.964 0 C-N-CA 123.039 0.536 . . . . 34.23 110.392 176.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.2 tp -60.32 -44.6 95.31 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.307 0.643 . . . . 71.11 111.027 172.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 87.0 t90 -61.04 -44.85 96.78 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.714 0.806 . . . . 71.45 110.807 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 87.3 m -60.01 -38.99 84.25 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 124.213 1.005 . . . . 71.24 110.755 175.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.453 HD13 ' CD1' ' A' ' 62' ' ' TYR . 29.2 tp -67.41 -46.15 74.05 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.162 1.385 . . . . 55.04 111.726 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.5 t -62.4 -34.34 63.98 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 C-N-CA 125.259 1.424 . . . . 72.34 111.343 175.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.8 t -90.01 -5.09 57.01 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.007 0.923 . . . . 71.34 111.871 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -82.15 119.73 75.66 Favored Pre-proline 0 N--CA 1.48 1.07 0 C-N-CA 123.361 0.664 . . . . 64.43 111.004 -174.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.42 ' HA ' ' HB2' ' A' ' 34' ' ' ASP . 68.2 Cg_endo -71.28 -20.52 27.89 Favored 'Trans proline' 0 C--N 1.379 2.161 0 C-N-CA 122.428 2.085 . . . . 74.52 113.075 176.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -66.44 -40.82 89.69 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 122.61 0.364 . . . . 53.45 110.198 176.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.8 p -99.64 4.36 45.63 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 123.321 0.648 . . . . 64.22 111.276 -175.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.42 ' HB2' ' HA ' ' A' ' 31' ' ' PRO . 24.1 t70 -53.49 -29.0 33.89 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 125.365 1.466 . . . . 54.55 112.791 -178.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.32 -37.01 85.6 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 123.74 0.816 . . . . 42.31 112.542 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 89.7 mt -114.6 -11.58 12.36 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 112.512 0.56 . . . . 72.15 112.512 -176.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.429 HD13 ' HG ' ' A' ' 27' ' ' LEU . 14.8 tt -160.96 130.12 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-O 121.108 0.48 . . . . 73.34 110.207 175.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.3 p -153.68 164.19 38.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.483 -0.78 . . . . 72.51 109.908 178.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 30.6 p-90 -66.12 148.07 52.38 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 123.942 0.776 . . . . 71.14 110.579 172.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 42.8 m -75.13 153.46 86.42 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 123.354 0.662 . . . . 65.11 110.835 171.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -60.83 -27.54 84.96 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.278 1.985 . . . . 40.22 111.375 170.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 23.6 m -59.25 -32.07 69.66 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.852 1.261 . . . . 64.34 111.956 172.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.42 -14.58 11.68 Favored Glycine 0 C--N 1.348 1.196 0 N-CA-C 115.122 0.809 . . . . 43.44 115.122 177.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 7.5 p30 -103.51 20.66 17.48 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.142 0.977 . . . . 72.32 110.64 -176.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.2 p -166.3 173.37 10.13 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.779 0.831 . . . . 64.35 109.833 -172.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 49.1 p90 -147.16 144.03 28.67 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.754 0.422 . . . . 62.42 110.607 176.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -100.52 148.46 24.76 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.812 0.845 . . . . 72.2 109.882 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.643 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 96.7 t -129.81 141.12 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.702 1.201 . . . . 75.11 107.959 176.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -124.03 147.5 47.78 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.697 0.799 . . . . 73.41 109.21 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 48.14 69.73 0.51 Allowed 'General case' 0 C--N 1.353 0.724 0 O-C-N 124.936 1.397 . . . . 63.42 111.293 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.445 ' HB3' ' HG2' ' A' ' 68' ' ' MET . 52.0 mt-30 -51.26 -30.93 19.28 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.637 1.175 . . . . 73.53 113.12 -174.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.86 -45.81 49.41 Favored Glycine 0 CA--C 1.534 1.233 0 O-C-N 123.382 0.426 . . . . 60.44 112.658 176.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 59.2 tp60 -70.19 -42.26 72.64 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.591 0.757 . . . . 71.44 110.249 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -54.67 -48.35 72.48 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.5 1.52 . . . . 73.31 110.756 172.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.545 ' HB2' ' HB2' ' A' ' 68' ' ' MET . . . -64.8 -33.87 77.02 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 116.08 -0.509 . . . . 53.22 111.814 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -67.22 -47.4 70.95 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 124.497 1.119 . . . . 61.52 112.741 -178.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.449 ' HG3' HG23 ' A' ' 58' ' ' VAL . 9.7 pt-20 -112.32 -36.92 5.15 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 114.533 1.308 . . . . 72.11 114.533 -173.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.449 HG23 ' HG3' ' A' ' 57' ' ' GLU . 71.2 t -81.91 -42.91 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.467 0.707 . . . . 65.45 111.552 -169.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 47.9 mt -66.66 -44.52 54.51 Favored Pre-proline 0 CA--C 1.555 1.171 0 CA-C-O 117.928 -1.034 . . . . 75.4 112.718 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -65.49 -15.3 49.03 Favored 'Trans proline' 0 C--N 1.383 2.343 0 CA-C-N 121.813 1.683 . . . . 64.1 113.647 171.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -74.16 -59.7 2.61 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.482 0.313 . . . . 61.21 110.843 176.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.453 ' CD1' HD13 ' A' ' 27' ' ' LEU . 47.7 m-85 -91.19 -14.91 30.19 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 113.107 0.78 . . . . 74.44 113.107 -175.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -133.11 -174.36 3.46 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 108.878 -0.786 . . . . 72.12 108.878 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -119.67 46.56 1.9 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.207 0.603 . . . . 74.12 109.533 -176.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 18.7 p80 -158.74 161.68 37.05 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.724 0.809 . . . . 75.34 109.603 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.488 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 9.4 m120 -118.1 2.25 12.02 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.613 0.765 . . . . 75.35 110.161 176.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -83.16 115.23 21.83 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.225 0.61 . . . . 72.1 110.669 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.545 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 12.1 tpt -66.81 -40.02 87.91 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.686 0.794 . . . . 62.04 110.556 177.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.63 -34.83 74.85 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.45 0.7 . . . . 72.35 112.03 -177.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.2 t -66.26 -42.85 87.94 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.81 0.844 . . . . 64.42 111.499 176.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -60.33 -49.6 76.96 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.4 1.08 . . . . 73.51 110.364 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 69.1 t -64.21 -36.56 77.4 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 124.225 1.01 . . . . 70.21 110.845 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -60.07 -41.54 92.62 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.609 0.763 . . . . 73.34 111.073 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -63.25 -45.7 90.34 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.929 -0.578 . . . . 70.03 110.767 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 80' ' ' PHE . 94.1 mt -62.82 -38.31 90.25 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.814 0.846 . . . . 70.24 111.708 -177.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -62.75 -32.69 73.88 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.806 0.442 . . . . 73.43 111.954 173.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 47.0 mtm -69.26 -35.15 75.8 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 110.436 -0.209 . . . . 73.42 110.436 173.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -75.85 -18.59 59.38 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.252 0.621 . . . . 74.24 111.593 178.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.82 26.67 23.92 Favored Glycine 0 C--N 1.345 1.077 0 CA-C-O 119.709 -0.495 . . . . 61.13 113.997 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.44 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . 64.5 m-85 -78.72 133.01 37.18 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.856 -0.794 . . . . 74.21 108.856 171.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -102.12 127.61 48.96 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.267 0.627 . . . . 55.31 109.318 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.693 ' HE2' ' HB ' ' A' ' 84' ' ' VAL . 1.3 tmtp? -76.18 124.81 28.04 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.057 -1.09 . . . . 74.42 108.057 176.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 91.0 t -128.63 115.5 37.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.518 0 N-CA-C 106.644 -1.613 . . . . 73.2 106.644 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.693 ' HB ' ' HE2' ' A' ' 82' ' ' LYS . 9.2 p -102.86 114.79 43.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 CA-C-O 121.487 0.661 . . . . 71.2 109.502 -174.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 20.4 m-70 -87.37 3.99 44.79 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.868 -0.605 . . . . 75.25 110.858 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 48.9 mm -109.43 153.16 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 124.733 1.213 . . . . 74.45 108.734 169.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.434 ' HB3' HD12 ' A' ' 91' ' ' LEU . 28.7 tt0 -134.52 131.86 38.48 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 109.809 -0.441 . . . . 64.12 109.809 171.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 15.6 mm-40 -86.03 16.95 3.8 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.72 1.208 . . . . 75.23 111.472 -175.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -76.8 -2.33 76.13 Favored Glycine 0 C--N 1.358 1.763 0 C-N-CA 123.066 0.365 . . . . 55.02 113.843 175.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 91.48 57.88 1.5 Allowed Glycine 0 C--N 1.35 1.359 0 N-CA-C 111.624 -0.59 . . . . 64.04 111.624 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.434 HD12 ' HB3' ' A' ' 87' ' ' GLU . 81.3 mt -107.94 -175.55 2.81 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.685 0.794 . . . . 71.22 110.392 -177.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.4 p -64.79 -17.1 20.97 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.309 0 C-N-CA 124.268 1.027 . . . . 74.51 110.991 171.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -65.11 130.89 94.98 Favored Pre-proline 0 CA--C 1.553 1.071 0 C-N-CA 124.032 0.933 . . . . 74.33 110.41 174.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -63.85 162.89 26.92 Favored 'Trans proline' 0 C--N 1.378 2.117 0 C-N-CA 123.505 2.804 . . . . 63.02 112.989 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -69.05 -20.64 64.12 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.686 0.795 . . . . 62.4 112.544 -173.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -63.68 156.2 27.64 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.15 0.58 . . . . 71.43 110.232 174.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -104.52 124.31 49.05 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 108.973 -0.751 . . . . 73.2 108.973 -178.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.47 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 15.9 t70 -88.88 107.58 19.07 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 107.639 -1.245 . . . . 73.13 107.639 173.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.643 ' HB ' ' HB ' ' A' ' 48' ' ' VAL . 11.6 m -102.99 98.02 8.04 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 123.527 0.731 . . . . 75.41 110.017 -177.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 46' ' ' PHE . 38.6 tt0 -100.37 113.64 26.54 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 108.781 -0.822 . . . . 70.52 108.781 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.44 ' HB3' ' HB3' ' A' ' 80' ' ' PHE . 73.4 m-85 -96.33 120.32 36.41 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.549 -0.908 . . . . 62.2 108.549 173.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -110.13 146.71 35.0 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.8 0.84 . . . . 72.0 110.548 -174.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 23.9 t-80 -163.35 130.06 2.42 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 123.659 0.783 . . . . 74.42 108.901 172.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -64.89 -23.43 62.04 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.844 2.363 . . . . 55.3 112.957 -176.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 56.9 m -95.12 3.87 54.28 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.269 0.628 . . . . 61.33 111.328 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.439 ' O ' ' HA ' ' A' ' 44' ' ' ASN . 62.8 t80 -103.46 100.45 10.31 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 106.862 -1.533 . . . . 74.43 106.862 173.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.602 ' HB2' ' HB2' ' A' ' 110' ' ' GLN . 70.2 mt -113.48 134.66 54.55 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 109.354 -0.61 . . . . 71.14 109.354 173.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.0 ppt_? -62.96 -17.77 62.41 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.424 1.09 . . . . 72.33 112.636 -176.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -101.16 -42.6 2.37 Favored Glycine 0 C--N 1.346 1.096 0 N-CA-C 111.768 -0.533 . . . . 73.2 111.768 173.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.602 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 2.5 mp0 -91.36 84.06 5.54 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.451 0.7 . . . . 73.53 111.2 -172.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.9 -18.89 62.0 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 124.331 1.052 . . . . 63.35 112.827 177.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.488 ' O ' ' HG2' ' A' ' 115' ' ' GLU . 4.8 pm0 -73.71 -14.52 61.16 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 111.637 0.236 . . . . 74.31 111.637 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.426 ' HA ' HD22 ' A' ' 116' ' ' ASN . 70.8 mt -84.16 -7.54 59.33 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.656 0.382 . . . . 74.24 111.792 178.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 51.0 mt -71.05 -21.62 62.23 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.055 0.542 . . . . 65.44 112.008 178.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.492 ' HB2' ' HB2' ' A' ' 16' ' ' ASN . 16.9 pt-20 -80.18 -5.74 56.59 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 111.878 0.325 . . . . 75.24 111.878 174.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.426 HD22 ' HA ' ' A' ' 113' ' ' LEU . 28.3 m-80 -90.9 -16.75 27.62 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.777 -0.823 . . . . 72.03 108.777 169.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 13.6 mt -90.87 73.46 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.886 0 N-CA-C 107.704 -1.221 . . . . 72.32 107.704 175.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.18 161.29 31.09 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-O 121.56 0.695 . . . . 73.11 110.945 169.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -109.75 -55.85 2.39 Favored 'General case' 0 C--O 1.239 0.514 0 N-CA-C 108.273 -1.01 . . . . 72.44 108.273 173.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.599 ' HD3' HG21 ' A' ' 124' ' ' VAL . 49.1 mtpt -146.12 164.1 33.24 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.248 1.019 . . . . 75.33 108.983 -177.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 28.0 m -88.66 -19.53 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 CA-C-N 116.026 -0.534 . . . . 72.1 110.137 174.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 29.9 p -79.25 166.18 22.44 Favored 'General case' 0 C--O 1.245 0.847 0 C-N-CA 124.407 1.083 . . . . 64.4 110.728 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.2 m -74.11 93.87 2.34 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.731 0.812 . . . . 72.32 111.072 -173.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.599 HG21 ' HD3' ' A' ' 120' ' ' LYS . 41.1 t -119.77 135.13 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 108.267 -1.012 . . . . 71.5 108.267 176.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 27.8 p . . . . . 0 CA--C 1.551 0.984 0 C-N-CA 123.905 0.882 . . . . 65.12 109.163 -176.323 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 108.96 -0.756 . . . . 74.13 108.96 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -171.16 133.21 2.68 Favored Glycine 0 C--N 1.34 0.771 0 N-CA-C 111.991 -0.443 . . . . 72.43 111.991 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 40.8 t-80 -101.91 15.63 28.42 Favored 'General case' 0 CA--C 1.556 1.203 0 N-CA-C 108.857 -0.794 . . . . 70.54 108.857 171.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -65.16 129.4 39.59 Favored 'General case' 0 C--N 1.352 0.707 0 C-N-CA 124.822 1.249 . . . . 74.33 110.683 -176.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -119.98 150.96 39.69 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.118 0.567 . . . . 70.51 109.51 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -152.38 105.06 2.99 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.381 -0.97 . . . . 75.55 108.381 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 25.7 m80 -136.5 145.2 44.84 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.023 0.929 . . . . 75.21 109.185 175.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -140.29 82.53 1.86 Allowed 'General case' 0 C--O 1.24 0.555 0 N-CA-C 107.876 -1.157 . . . . 74.41 107.876 173.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.0 m -65.04 116.39 6.41 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.361 -0.836 . . . . 75.15 110.494 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -148.16 141.26 24.97 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.324 -0.991 . . . . 75.41 108.324 176.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 9.9 tpt -157.09 98.92 1.77 Allowed 'General case' 0 C--O 1.239 0.527 0 N-CA-C 109.0 -0.741 . . . . 42.31 109.0 -178.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.34 87.91 0.12 Allowed 'General case' 0 C--O 1.238 0.479 0 C-N-CA 123.576 0.75 . . . . 72.41 109.215 174.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -76.35 123.53 6.86 Favored Glycine 0 C--N 1.343 0.963 0 CA-C-O 118.867 -0.963 . . . . 71.43 112.085 -175.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -72.48 75.62 2.45 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.433 2.089 . . . . 54.23 109.915 173.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.0 m -63.77 161.39 15.34 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.014 -0.994 . . . . 73.44 112.051 -172.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -87.02 29.3 0.83 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.914 0.885 . . . . 74.54 110.945 -172.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 47.1 t -70.05 130.2 90.03 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.278 1.031 . . . . 61.22 110.09 -174.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.404 ' HD2' HD12 ' A' ' 21' ' ' LEU . 49.9 Cg_exo -56.72 141.49 91.86 Favored 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.775 2.317 . . . . 71.45 111.148 173.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.92 -36.63 65.44 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.072 0.949 . . . . 55.21 113.022 -173.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -51.85 -43.94 63.42 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.035 0.534 . . . . 75.51 112.084 173.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.404 HD12 ' HD2' ' A' ' 18' ' ' PRO . 98.2 mt -84.29 -29.81 26.11 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.409 0.684 . . . . 71.3 110.4 -173.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.6 m -61.17 -39.64 90.9 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.273 1.029 . . . . 51.23 110.607 173.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.558 ' HE2' ' HA ' ' A' ' 23' ' ' LYS . 10.7 mmpt? -79.97 -47.79 14.41 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.715 -0.675 . . . . 64.14 110.473 177.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.5 ' O ' HG23 ' A' ' 28' ' ' VAL . 55.3 tp -56.47 -50.28 72.19 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.107 0.963 . . . . 73.53 112.502 -176.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.467 ' HZ2' ' H ' ' A' ' 109' ' ' GLY . 84.7 t90 -58.35 -47.78 82.69 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 122.791 0.436 . . . . 75.2 111.014 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.8 m -68.8 -22.6 64.25 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 115.684 -0.689 . . . . 71.43 111.42 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.489 HD11 HG13 ' A' ' 58' ' ' VAL . 31.0 tp -74.4 -44.31 52.56 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.393 1.077 . . . . 74.55 110.723 175.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 24' ' ' LEU . 60.0 t -61.92 -32.68 54.94 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 CA-C-O 121.685 0.755 . . . . 65.22 110.258 173.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.4 t -88.72 0.18 56.71 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 114.636 -1.165 . . . . 73.22 112.023 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -81.61 122.72 80.85 Favored Pre-proline 0 N--CA 1.479 1.02 0 O-C-N 121.919 -0.488 . . . . 71.53 111.448 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -73.62 -6.21 18.35 Favored 'Trans proline' 0 C--N 1.38 2.219 0 C-N-CA 123.159 2.573 . . . . 64.41 113.822 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -86.35 -37.65 18.24 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 122.85 0.46 . . . . 72.51 110.987 174.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 41.6 p -104.34 8.61 35.94 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 122.772 0.429 . . . . 70.41 110.824 -175.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -59.51 -32.39 70.25 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.459 1.104 . . . . 61.45 111.896 -175.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.34 -32.35 73.24 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.637 0.775 . . . . 73.1 111.958 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 64.4 mt -102.82 -12.14 17.8 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.457 0.303 . . . . 73.43 111.219 -177.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 18.5 tt -159.89 122.83 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 123.053 0.541 . . . . 60.2 110.454 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 28.2 p -142.1 149.55 40.01 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.601 0.36 . . . . 63.43 110.567 -178.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 22.7 p-90 -72.6 154.23 40.87 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.611 0.765 . . . . 73.52 111.148 177.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.6 m -81.41 141.0 48.71 Favored Pre-proline 0 CA--C 1.547 0.829 0 N-CA-C 109.121 -0.696 . . . . 61.05 109.121 169.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -50.36 -22.91 9.34 Favored 'Trans proline' 0 C--N 1.368 1.602 0 C-N-CA 123.373 2.715 . . . . 73.02 115.05 176.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 64.0 m -70.65 -30.27 66.85 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.999 0.52 . . . . 71.15 111.618 175.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.99 65.87 2.18 Favored Glycine 0 C--N 1.342 0.88 0 CA-C-N 116.308 -0.406 . . . . 50.15 112.474 177.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.413 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 26.8 p30 -168.52 -17.06 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.981 0.913 . . . . 54.24 111.725 -171.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.2 p -141.51 162.27 35.89 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 123.927 0.891 . . . . 71.43 108.701 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 43.6 p90 -140.19 146.38 38.65 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.572 0.225 . . . . 75.31 110.535 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 67.6 m-70 -103.32 141.32 36.13 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.234 1.014 . . . . 63.14 109.536 -176.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 53.1 t -123.54 132.99 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.693 0.797 . . . . 75.44 108.983 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -122.75 151.96 41.09 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.549 1.14 . . . . 73.21 110.5 -174.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 53.62 60.82 3.43 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 124.584 1.178 . . . . 64.42 110.77 174.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -46.0 -37.31 6.44 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.006 1.322 . . . . 54.13 114.2 -170.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.51 -44.92 49.08 Favored Glycine 0 C--N 1.342 0.868 0 O-C-N 123.559 0.537 . . . . 44.23 112.844 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -72.83 -42.91 63.31 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.112 0.565 . . . . 73.43 110.111 -177.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -55.32 -52.62 62.89 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.188 1.395 . . . . 64.24 110.899 175.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.36 -31.82 71.71 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 116.298 -0.41 . . . . 52.24 111.676 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -70.49 -50.92 32.91 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.252 1.021 . . . . 74.02 112.421 -177.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.541 ' HG3' HG23 ' A' ' 58' ' ' VAL . 9.7 pt-20 -104.43 -39.24 6.5 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 112.855 0.687 . . . . 72.11 112.855 -173.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.541 HG23 ' HG3' ' A' ' 57' ' ' GLU . 96.5 t -80.94 -41.78 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.362 0.665 . . . . 62.11 112.016 -167.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 53.2 mt -64.15 -48.95 75.93 Favored Pre-proline 0 CA--C 1.565 1.528 0 CA-C-O 118.209 -0.9 . . . . 52.22 112.324 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.3 -8.49 23.52 Favored 'Trans proline' 0 C--N 1.387 2.598 0 CA-C-N 121.981 1.743 . . . . 74.25 113.281 175.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -73.63 -61.77 1.72 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.297 1.039 . . . . 72.32 110.391 174.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.541 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 25.5 m-85 -89.03 -38.59 14.29 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 112.005 0.372 . . . . 74.14 112.005 -177.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -102.81 -164.61 1.1 Allowed 'General case' 0 C--O 1.243 0.729 0 N-CA-C 107.566 -1.272 . . . . 75.33 107.566 176.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.443 ' HD3' ' HA ' ' A' ' 64' ' ' LYS . 31.5 mmtm -135.54 68.05 1.47 Allowed 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 121.856 0.836 . . . . 54.15 109.903 175.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -169.77 160.62 8.77 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 113.781 -1.554 . . . . 72.13 107.786 173.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -118.01 -5.79 10.97 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.74 0.416 . . . . 72.31 110.503 175.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -71.84 117.54 13.56 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 123.82 0.848 . . . . 73.32 110.47 176.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 11.7 ttm -70.89 -30.57 66.97 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.656 0.383 . . . . 71.25 111.034 176.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.67 -36.39 71.84 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 122.607 0.363 . . . . 64.13 111.241 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.429 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 40.2 t -63.94 -46.91 82.62 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 123.982 0.913 . . . . 73.04 111.633 172.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -63.18 -52.91 60.46 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.612 0.765 . . . . 75.44 111.052 -176.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.41 ' HA ' HD12 ' A' ' 75' ' ' LEU . 84.4 t -59.14 -40.66 81.51 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 C-N-CA 124.088 0.955 . . . . 64.34 111.254 177.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.3 ttt-85 -56.82 -43.9 81.46 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.147 0.579 . . . . 73.35 111.559 177.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 70' ' ' SER . 16.7 mm100 -58.9 -49.83 76.32 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 124.024 0.828 . . . . 73.41 109.937 177.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.433 ' HB3' ' HB2' ' A' ' 80' ' ' PHE . 65.2 mt -58.35 -44.27 88.7 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.305 1.042 . . . . 73.2 112.086 -177.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 42.1 m-80 -56.9 -39.55 74.63 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.504 0.722 . . . . 73.5 111.924 175.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 73.9 mtm -72.94 -35.03 66.9 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.051 0.54 . . . . 73.31 111.06 176.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.425 ' HA ' ' O ' ' A' ' 118' ' ' LYS . 55.3 m-85 -85.26 2.92 41.84 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.093 0.557 . . . . 72.41 111.22 179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.42 15.91 79.03 Favored Glycine 0 C--N 1.342 0.916 0 N-CA-C 114.652 0.621 . . . . 63.42 114.652 170.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.433 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 73.3 m-85 -73.74 129.42 37.9 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.273 0.559 . . . . 73.24 110.096 176.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 61.3 ttt180 -99.52 121.78 41.66 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.013 -0.994 . . . . 71.01 109.021 -175.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.424 ' HE3' HG23 ' A' ' 99' ' ' THR . 1.6 tmtp? -81.45 126.75 32.03 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.588 1.155 . . . . 53.41 109.723 -175.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 85.8 t -128.97 119.72 50.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 108.17 -1.048 . . . . 72.11 108.17 175.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.421 ' HB ' ' HE2' ' A' ' 82' ' ' LYS . 7.5 p -99.68 126.0 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 108.415 -0.957 . . . . 71.1 108.415 -178.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 59.1 m-70 -101.36 -23.52 14.36 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.573 0.349 . . . . 73.03 110.62 -177.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.566 HG12 ' HB3' ' A' ' 98' ' ' ASP . 29.4 mm -95.26 103.46 14.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 CA-C-O 121.04 0.448 . . . . 74.04 109.976 176.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -69.6 118.79 12.92 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 107.58 -1.267 . . . . 72.11 107.58 168.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -58.27 107.2 0.46 Allowed 'General case' 0 N--CA 1.477 0.924 0 O-C-N 124.529 1.143 . . . . 74.03 111.476 -168.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.61 172.12 29.66 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 114.193 -1.367 . . . . 33.52 111.747 178.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -83.12 57.29 5.07 Favored Glycine 0 N--CA 1.47 0.909 0 C-N-CA 123.401 0.524 . . . . 71.04 112.751 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 77.5 mt -84.02 -170.93 3.33 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.811 0.844 . . . . 62.42 110.88 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.5 p -81.08 42.91 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 123.255 1.502 . . . . 72.21 110.207 174.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.525 ' HB3' HD12 ' A' ' 86' ' ' ILE . 68.1 mttm -134.63 162.34 58.29 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 126.734 2.014 . . . . 70.43 106.959 -175.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.414 ' HB2' ' HG2' ' A' ' 96' ' ' ARG . 73.6 Cg_endo -70.33 137.39 33.69 Favored 'Trans proline' 0 C--N 1.372 1.775 0 CA-C-N 120.47 1.204 . . . . 74.52 109.615 167.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -74.73 -16.52 60.73 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 122.859 0.464 . . . . 75.14 111.11 -176.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.414 ' HG2' ' HB2' ' A' ' 94' ' ' PRO . 10.4 ptp180 -72.31 106.39 4.45 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 108.906 -0.776 . . . . 63.11 108.906 175.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -45.18 107.98 0.11 Allowed 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.636 1.174 . . . . 62.43 112.958 -178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.566 ' HB3' HG12 ' A' ' 86' ' ' ILE . 15.5 t70 -91.37 122.2 33.77 Favored 'General case' 0 C--O 1.249 1.045 0 CA-C-N 114.867 -1.06 . . . . 41.31 108.191 177.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.424 HG23 ' HE3' ' A' ' 82' ' ' LYS . 57.8 m -129.27 117.23 20.36 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.894 -0.78 . . . . 75.42 108.894 -178.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -104.73 112.17 25.17 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.322 -0.992 . . . . 75.43 108.322 -175.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -96.93 123.88 40.76 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.824 -1.176 . . . . 71.2 107.824 175.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -122.65 145.75 48.08 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 122.985 0.514 . . . . 70.23 110.697 -173.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -156.53 132.31 5.74 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 108.66 -0.867 . . . . 73.41 108.66 176.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -62.74 -29.95 77.73 Favored 'Trans proline' 0 C--N 1.378 2.104 0 C-N-CA 122.669 2.246 . . . . 73.33 113.195 -174.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 59.1 m -89.4 -2.78 58.53 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.641 0.376 . . . . 73.32 111.421 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.413 ' O ' ' HA ' ' A' ' 44' ' ' ASN . 64.8 t80 -102.19 99.45 9.57 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 106.881 -1.525 . . . . 75.3 106.881 175.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.421 HD12 ' HG2' ' A' ' 110' ' ' GLN . 76.6 mt -120.79 164.7 16.2 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.95 0.405 . . . . 73.25 110.673 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -81.58 122.74 27.97 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.593 -0.73 . . . . 73.31 109.489 177.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.467 ' H ' ' HZ2' ' A' ' 25' ' ' TRP . . . 63.56 57.65 14.0 Favored Glycine 0 C--N 1.344 0.985 0 O-C-N 124.15 0.906 . . . . 64.13 111.974 -176.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.421 ' HG2' HD12 ' A' ' 107' ' ' LEU . 5.9 tp60 -156.18 63.64 0.56 Allowed 'General case' 0 CA--C 1.548 0.897 0 CA-C-O 121.919 0.866 . . . . 74.51 109.535 -172.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -52.35 -46.24 66.02 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 113.746 -1.57 . . . . 65.1 111.446 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 14.1 pm0 -65.74 -19.55 65.94 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.579 -1.191 . . . . 72.34 112.839 -174.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.41 ' HA ' HD22 ' A' ' 116' ' ' ASN . 27.9 mt -96.41 -20.11 18.69 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 119.181 0.901 . . . . 74.33 111.712 177.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 80.9 mt -63.95 -32.6 74.19 Favored 'General case' 0 N--CA 1.483 1.193 0 CA-C-O 121.156 0.503 . . . . 63.41 110.376 175.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -79.35 -5.42 54.52 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 115.547 -0.751 . . . . 64.52 112.594 175.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.41 HD22 ' HA ' ' A' ' 113' ' ' LEU . 26.0 m-80 -90.25 2.78 55.09 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 110.096 -0.335 . . . . 74.11 110.096 172.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 45.1 mt -96.98 128.01 48.61 Favored 'Isoleucine or valine' 0 C--O 1.245 0.852 0 N-CA-C 109.009 -0.737 . . . . 71.33 109.009 174.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.456 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -112.1 150.73 30.33 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.425 0.69 . . . . 65.45 110.031 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -82.92 33.63 0.44 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.151 0.98 . . . . 73.35 110.374 170.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -129.45 159.32 36.63 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.516 1.127 . . . . 64.11 109.156 -175.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.6 m -70.54 0.06 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 N-CA-C 113.539 0.94 . . . . 73.45 113.539 -173.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.9 t -64.2 -32.49 74.08 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 109.797 -0.446 . . . . 75.34 109.797 167.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 32.2 t -97.51 97.39 9.04 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 107.518 -1.29 . . . . 73.12 107.518 169.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 30.8 m -85.31 160.29 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.445 0.698 . . . . 70.35 111.996 -172.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 CA--C 1.553 1.085 0 C-N-CA 124.451 1.101 . . . . 51.21 109.034 172.996 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 N--CA 1.486 1.374 0 N-CA-C 108.957 -0.757 . . . . 73.51 108.957 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -99.22 74.98 0.51 Allowed Glycine 0 C--N 1.346 1.084 0 O-C-N 123.291 0.37 . . . . 72.1 113.586 -173.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 27.7 p80 -125.92 9.64 7.55 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 117.296 0.548 . . . . 72.11 111.506 176.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 57.6 t60 -98.07 88.03 4.11 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 108.319 -0.993 . . . . 74.11 108.319 172.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -137.57 152.57 49.55 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.878 0.871 . . . . 72.52 109.573 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 48.1 p-80 -149.54 144.48 26.28 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.589 0.756 . . . . 61.45 109.339 172.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -113.16 146.38 39.34 Favored 'General case' 0 C--O 1.242 0.698 0 C-N-CA 124.474 1.11 . . . . 75.23 108.284 175.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 65.4 m-70 -67.05 90.63 0.19 Allowed 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 109.774 -0.454 . . . . 60.4 109.774 173.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.8 m -85.85 61.79 7.06 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.96 0.904 . . . . 74.31 109.356 175.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -88.1 114.39 24.67 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.253 -0.431 . . . . 75.23 111.369 -172.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 93.4 mmm -84.99 151.28 24.31 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 115.745 -0.661 . . . . 71.33 109.489 169.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -161.36 178.43 9.19 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 124.197 0.999 . . . . 72.42 109.83 -175.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -135.83 68.92 0.52 Allowed Glycine 0 CA--C 1.53 1.009 0 N-CA-C 111.415 -0.674 . . . . 74.21 111.415 175.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -87.46 137.3 4.18 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.312 2.008 . . . . 65.43 112.378 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.483 ' HB3' HG23 ' A' ' 17' ' ' VAL . 42.8 m -79.06 147.34 32.84 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.785 -0.643 . . . . 74.03 110.264 170.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -93.91 22.72 5.42 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.032 -0.986 . . . . 65.12 110.381 -175.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.483 HG23 ' HB3' ' A' ' 15' ' ' SER . 22.9 t -70.52 125.61 92.04 Favored Pre-proline 0 C--N 1.352 0.693 0 N-CA-C 108.982 -0.747 . . . . 74.42 108.982 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 21' ' ' LEU . 21.4 Cg_exo -65.69 145.24 80.89 Favored 'Trans proline' 0 C--N 1.365 1.439 0 C-N-CA 122.417 2.078 . . . . 75.03 110.341 170.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.41 -39.82 23.82 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.149 1.38 . . . . 64.41 112.499 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -54.1 -45.43 71.84 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.96 0.904 . . . . 73.14 112.833 177.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.514 HD12 ' HD2' ' A' ' 18' ' ' PRO . 98.4 mt -83.36 -29.23 28.4 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.056 0.543 . . . . 74.24 109.948 -171.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 87.7 m -59.72 -50.59 73.23 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 124.548 1.155 . . . . 61.24 111.023 170.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.486 ' HE2' ' HA ' ' A' ' 23' ' ' LYS . 11.2 mmpt? -68.49 -43.25 77.28 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.876 -0.602 . . . . 61.12 110.045 178.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.468 ' O ' HG23 ' A' ' 28' ' ' VAL . 55.5 tp -55.26 -54.03 48.56 Favored 'General case' 0 C--N 1.358 0.95 0 C-N-CA 124.601 1.161 . . . . 70.32 112.214 -178.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 14.1 t-105 -64.07 -46.08 85.92 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 122.629 0.372 . . . . 72.3 111.722 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 28.6 m -60.61 -25.01 65.93 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 121.306 0.574 . . . . 74.13 110.775 177.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.48 HD11 ' CG1' ' A' ' 58' ' ' VAL . 29.9 tp -80.47 -45.57 17.33 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 124.87 1.268 . . . . 62.04 111.94 177.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 24' ' ' LEU . 76.6 t -56.61 -39.97 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 C-N-CA 124.089 0.956 . . . . 42.32 111.513 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.5 t -89.36 -5.54 57.4 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-N 114.453 -1.249 . . . . 74.0 112.132 -175.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -74.35 122.28 87.17 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 122.68 0.392 . . . . 74.22 111.307 -175.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.4 -23.11 44.53 Favored 'Trans proline' 0 C--N 1.386 2.509 0 C-N-CA 122.851 2.367 . . . . 73.11 112.944 176.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -73.8 -34.41 64.61 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.185 0.594 . . . . 73.01 111.514 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 53.5 p -110.99 11.82 22.14 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.043 0.537 . . . . 75.02 110.533 -177.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -54.95 -38.23 67.46 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 124.924 1.289 . . . . 72.13 111.788 -177.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.82 -29.47 69.95 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.692 -0.686 . . . . 63.4 112.178 -177.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.533 ' HA ' ' HB2' ' A' ' 49' ' ' PHE . 68.9 mt -106.41 -9.88 16.54 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.628 0.371 . . . . 72.55 111.657 -179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.474 HD13 ' HG ' ' A' ' 27' ' ' LEU . 16.7 tt -161.45 125.86 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.327 0.651 . . . . 74.53 110.501 172.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 22.1 p -149.02 157.41 43.39 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.934 0.397 . . . . 74.01 110.566 177.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 14.7 p-90 -71.38 152.85 42.78 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.731 1.212 . . . . 74.44 110.409 177.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.2 p -74.28 153.39 88.19 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 123.271 0.628 . . . . 75.13 110.346 172.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.8 -26.34 60.11 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.7 2.267 . . . . 65.04 111.925 176.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 66.9 p -75.05 -26.96 59.81 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.303 1.041 . . . . 72.03 110.15 172.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.97 3.3 84.34 Favored Glycine 0 C--N 1.356 1.692 0 CA-C-N 115.658 -0.701 . . . . 64.42 113.468 176.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -86.19 -5.91 59.1 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.689 0.796 . . . . 65.14 112.022 -173.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 65.1 p -159.3 179.09 9.29 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.793 0.837 . . . . 64.53 110.046 -174.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -140.18 148.21 41.26 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 109.781 -0.451 . . . . 64.21 109.781 172.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -110.84 143.49 41.34 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.009 0.924 . . . . 74.44 109.018 -177.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 67.3 t -123.48 120.96 61.48 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 C-N-CA 124.385 1.074 . . . . 62.32 108.631 -178.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.533 ' HB2' ' HA ' ' A' ' 36' ' ' LEU . 90.1 m-85 -100.58 146.38 27.2 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 124.058 0.943 . . . . 72.43 109.87 -178.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.428 ' H ' ' HB2' ' A' ' 96' ' ' ARG . 6.9 m-20 49.95 67.94 0.83 Allowed 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.799 1.312 . . . . 73.55 111.674 176.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.474 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 14.7 mm-40 -49.52 -34.86 18.42 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.002 0.921 . . . . 71.13 113.377 -175.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.09 -49.83 44.34 Favored Glycine 0 CA--C 1.536 1.365 0 CA-C-O 119.818 -0.434 . . . . 74.12 112.441 175.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -69.5 -45.64 68.44 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 123.299 0.639 . . . . 75.4 110.542 -176.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.479 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 65.1 t80 -52.24 -51.59 57.47 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.553 1.541 . . . . 72.25 111.05 173.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.507 ' HA ' ' HG ' ' A' ' 59' ' ' LEU . . . -61.36 -36.56 80.53 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.916 0.389 . . . . 74.44 111.537 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.87 -52.89 31.35 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.513 1.125 . . . . 72.34 113.154 -174.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.518 ' HG3' HG23 ' A' ' 58' ' ' VAL . 6.7 pt-20 -106.62 -33.85 7.52 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 113.602 0.964 . . . . 73.2 113.602 -173.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.518 HG23 ' HG3' ' A' ' 57' ' ' GLU . 90.4 t -83.03 -40.29 16.21 Favored 'Isoleucine or valine' 0 C--O 1.251 1.169 0 C-N-CA 123.404 0.681 . . . . 55.24 111.488 -169.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.507 ' HG ' ' HA ' ' A' ' 55' ' ' ALA . 54.0 mt -64.0 -50.46 69.36 Favored Pre-proline 0 CA--C 1.556 1.202 0 CA-C-O 118.242 -0.885 . . . . 75.25 111.81 177.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -67.42 -13.34 38.91 Favored 'Trans proline' 0 C--N 1.381 2.288 0 CA-C-N 121.975 1.741 . . . . 74.54 113.001 176.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -70.68 -54.69 10.9 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.01 0.524 . . . . 72.24 110.536 172.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.414 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 31.5 m-85 -89.87 -52.68 4.86 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.137 0.494 . . . . 74.02 111.984 -178.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -87.71 -171.79 3.59 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.274 -0.875 . . . . 53.44 108.828 -179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -123.05 45.15 2.48 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-O 121.668 0.746 . . . . 74.32 109.749 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -161.16 165.5 29.39 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.636 1.174 . . . . 64.43 108.377 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -122.3 -8.15 8.69 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.52 0.328 . . . . 73.1 110.579 174.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -61.1 115.88 4.11 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.152 0.981 . . . . 74.41 110.605 -177.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.474 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 3.2 tpt -61.71 -49.87 74.73 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.203 1.401 . . . . 71.23 111.725 179.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.17 -35.31 71.39 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.866 0.867 . . . . 72.3 111.843 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.431 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 34.7 t -64.99 -42.98 94.02 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.731 0.813 . . . . 64.42 111.489 177.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -64.58 -50.25 67.96 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.827 0.851 . . . . 53.23 110.65 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.497 ' HA ' HD12 ' A' ' 75' ' ' LEU . 59.1 t -62.9 -38.45 81.94 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 CA-C-N 115.417 -0.81 . . . . 64.21 111.128 178.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.411 ' O ' ' HG3' ' A' ' 77' ' ' MET . 39.4 ttm180 -58.67 -43.33 89.86 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.023 0.529 . . . . 71.41 110.858 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.491 ' HA ' ' HE2' ' A' ' 77' ' ' MET . 34.3 mm-40 -59.34 -50.01 75.6 Favored 'General case' 0 C--N 1.358 0.963 0 O-C-N 124.034 0.834 . . . . 75.02 109.872 177.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.501 ' HB3' ' HB2' ' A' ' 80' ' ' PHE . 30.6 mt -56.47 -48.32 77.35 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.109 0.964 . . . . 75.31 111.921 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -62.58 -30.09 71.07 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 122.754 0.422 . . . . 71.22 112.049 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.491 ' HE2' ' HA ' ' A' ' 74' ' ' GLN . 47.9 mtm -69.47 -40.42 77.11 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 109.931 -0.396 . . . . 75.5 109.931 173.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -81.74 -2.65 51.4 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.997 0.519 . . . . 70.52 111.214 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 89.66 20.28 44.77 Favored Glycine 0 C--N 1.349 1.279 0 N-CA-C 114.882 0.713 . . . . 71.24 114.882 172.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.501 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 83.9 m-85 -82.3 134.85 35.28 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.069 0.935 . . . . 74.22 109.506 177.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 101' ' ' PHE . 38.3 ttm180 -101.44 126.74 48.27 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.086 0.554 . . . . 71.03 109.802 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.517 ' HE3' HG22 ' A' ' 84' ' ' VAL . 2.7 tmtm? -68.95 114.93 7.7 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 106.879 -1.526 . . . . 64.12 106.879 171.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.522 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 89.3 t -114.2 125.41 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 107.884 -1.154 . . . . 73.11 107.884 176.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.517 HG22 ' HE3' ' A' ' 82' ' ' LYS . 40.8 t -88.94 131.56 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.638 0.775 . . . . 73.42 109.315 -177.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 54.7 m-70 -125.4 -45.95 1.79 Allowed 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 108.214 -1.032 . . . . 71.32 108.214 169.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.419 HG21 ' HG2' ' A' ' 94' ' ' PRO . 36.6 mm -97.19 131.88 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 N-CA-C 108.823 -0.806 . . . . 73.24 108.823 167.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -108.17 150.82 26.74 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 125.12 1.368 . . . . 74.42 109.482 -171.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -127.42 91.67 3.35 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.288 0.635 . . . . 73.2 109.693 173.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -145.79 23.33 1.8 Allowed Glycine 0 N--CA 1.47 0.961 0 CA-C-N 115.946 -0.57 . . . . 72.42 112.246 177.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 83.0 20.02 61.87 Favored Glycine 0 C--N 1.343 0.934 0 O-C-N 123.044 -0.092 . . . . 73.53 112.884 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 78.5 mt -82.65 -177.42 6.71 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.588 1.155 . . . . 74.33 111.141 -177.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.0 p -88.19 74.49 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 CA-C-O 123.161 1.458 . . . . 70.22 108.578 168.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -133.28 165.79 34.08 Favored Pre-proline 0 N--CA 1.477 0.92 0 CA-C-N 113.593 -1.64 . . . . 73.11 108.349 176.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.419 ' HG2' HG21 ' A' ' 86' ' ' ILE . 35.2 Cg_endo -65.99 156.43 64.55 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 121.552 1.501 . . . . 72.14 111.283 164.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -76.29 -4.49 42.34 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.829 0.851 . . . . 73.23 112.139 -173.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.428 ' HB2' ' H ' ' A' ' 50' ' ' ASP . 17.7 ptt180 -82.64 168.49 17.24 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.226 1.01 . . . . 51.32 110.976 174.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -91.27 148.4 22.37 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.463 -0.939 . . . . 61.43 108.463 156.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -113.4 106.1 14.18 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 105.355 -2.091 . . . . 72.31 105.355 156.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 32.3 m -115.05 107.36 15.25 Favored 'General case' 0 N--CA 1.447 -0.588 0 O-C-N 123.823 0.702 . . . . 75.0 109.793 -170.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.522 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 41.7 tt0 -96.99 111.17 23.51 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.376 -1.342 . . . . 73.55 107.376 -177.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.419 ' HB3' ' HB3' ' A' ' 80' ' ' PHE . 71.4 m-85 -96.0 119.93 35.37 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 108.066 -1.087 . . . . 71.14 108.066 175.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -117.3 139.16 51.18 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.863 0.865 . . . . 75.22 109.287 -174.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 106' ' ' PHE . 55.9 t-80 -152.66 135.08 9.0 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 123.466 0.706 . . . . 75.33 109.423 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -59.64 -42.85 43.33 Favored 'Trans proline' 0 C--N 1.383 2.387 0 C-N-CA 122.863 2.376 . . . . 74.23 112.476 -174.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 37.0 m -92.19 16.66 10.96 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.996 0.518 . . . . 60.33 111.084 -177.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.491 ' HB3' ' HB3' ' A' ' 103' ' ' HIS . 35.9 t80 -124.33 104.18 8.64 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.167 -1.049 . . . . 74.53 108.167 171.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.493 HD12 ' HG3' ' A' ' 110' ' ' GLN . 38.3 mt -120.46 173.65 7.03 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 107.128 -1.434 . . . . 60.2 107.128 167.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -63.28 -68.91 0.3 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.39 0.676 . . . . 73.02 110.942 -172.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -87.71 37.55 3.23 Favored Glycine 0 C--N 1.351 1.365 0 C-N-CA 122.77 0.224 . . . . 72.23 112.98 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.493 ' HG3' HD12 ' A' ' 107' ' ' LEU . 15.8 mm100 -126.43 53.08 1.67 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.92 0.888 . . . . 75.11 108.944 -177.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.418 ' HA ' ' HG ' ' A' ' 114' ' ' LEU . 10.6 pt-20 -60.14 -30.65 69.44 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 114.942 -1.026 . . . . 73.14 111.815 175.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.4 pm0 -63.39 -22.55 66.95 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.363 0.665 . . . . 54.52 111.838 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.443 ' O ' HG13 ' A' ' 117' ' ' ILE . 80.7 mt -90.82 -9.19 47.35 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.253 0.621 . . . . 72.2 112.152 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.418 ' HG ' ' HA ' ' A' ' 111' ' ' GLU . 91.5 mt -61.06 -38.57 86.65 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.202 0.525 . . . . 74.22 110.818 175.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -79.94 -11.11 59.82 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.365 -0.834 . . . . 52.25 112.051 179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.417 HD22 ' HA ' ' A' ' 113' ' ' LEU . 23.3 m-80 -87.55 -10.68 50.95 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.54 0.736 . . . . 71.23 109.682 173.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 113' ' ' LEU . 58.9 mt -86.23 135.18 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 108.845 -0.798 . . . . 55.12 108.845 175.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -122.92 150.33 43.08 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.728 0.811 . . . . 74.1 109.748 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -85.15 -41.65 15.48 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 108.483 -0.932 . . . . 73.12 108.483 172.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -155.83 -170.09 3.3 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 126.153 1.781 . . . . 75.01 108.012 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.1 p -66.85 -33.66 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 N-CA-C 108.827 -0.805 . . . . 74.41 108.827 167.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 5.9 m -91.77 102.21 14.81 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.986 0.914 . . . . 63.51 109.104 171.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.8 m -130.89 95.74 3.9 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.67 0.788 . . . . 74.52 109.225 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 59.0 t -75.11 98.89 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 109.34 -0.615 . . . . 55.11 109.34 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 C--O 1.254 1.295 0 N-CA-C 108.494 -0.928 . . . . 52.32 108.494 176.983 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 N--CA 1.475 0.783 0 N-CA-C 109.532 -0.544 . . . . 72.22 109.532 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -136.78 94.65 0.23 Allowed Glycine 0 C--N 1.35 1.341 0 N-CA-C 110.793 -0.923 . . . . 62.02 110.793 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -121.37 128.85 52.65 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.477 0.711 . . . . 72.1 110.329 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 34.3 m-70 -127.11 128.7 46.63 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.053 0.941 . . . . 73.02 109.066 175.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -140.54 116.88 10.67 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.748 0.819 . . . . 64.41 109.981 -175.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.3 p-80 -72.28 113.38 9.24 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-O 121.0 0.428 . . . . 70.25 110.129 174.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -129.66 144.76 51.43 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.66 0.784 . . . . 74.32 109.645 176.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 51.5 t60 -138.29 96.32 3.16 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.203 -0.665 . . . . 75.55 109.203 176.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 15.2 p -75.94 100.35 4.82 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.206 0.602 . . . . 70.13 110.553 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 38.0 t60 -66.56 103.63 1.1 Allowed 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.688 0.795 . . . . 73.24 110.536 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 55.0 ttm -78.5 118.42 20.62 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.46 0.704 . . . . 62.4 109.889 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.57 97.69 0.81 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.591 0.756 . . . . 51.11 110.326 177.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -97.39 -131.47 7.06 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 119.382 -0.677 . . . . 71.25 113.388 -172.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -99.41 175.6 0.37 Allowed 'Trans proline' 0 C--N 1.371 1.744 0 C-N-CA 123.311 2.674 . . . . 63.5 114.962 -175.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.4 t -85.35 131.2 34.44 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 107.284 -1.376 . . . . 51.34 107.284 166.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -90.78 18.42 6.53 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 123.001 0.52 . . . . 74.44 112.367 -167.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 97.3 t -71.69 116.52 48.72 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 124.065 0.946 . . . . 73.41 109.805 177.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.89 163.2 39.99 Favored 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 122.65 2.233 . . . . 61.42 112.19 -177.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.64 -49.12 57.65 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.08 0.952 . . . . 51.41 112.636 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -52.33 -47.51 66.0 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.444 0.698 . . . . 71.11 112.612 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 89.2 mt -79.64 -35.32 39.55 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.374 0.27 . . . . 41.03 110.955 -172.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.5 t -71.95 -18.76 61.98 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 111.72 0.267 . . . . 72.52 111.72 177.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.6 mmpt? -83.74 -40.99 18.14 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.767 -0.457 . . . . 73.13 109.767 168.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 54.8 tp -61.0 -50.61 72.66 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.003 0.921 . . . . 74.54 113.352 -176.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.469 ' HB3' HD11 ' A' ' 114' ' ' LEU . 5.1 p-90 -62.37 -37.43 85.69 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 118.628 0.649 . . . . 73.33 110.842 -177.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 41.3 m -63.83 -43.44 96.17 Favored 'General case' 0 C--N 1.35 0.61 0 C-N-CA 124.268 1.027 . . . . 55.32 110.898 175.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.409 HD11 ' CG1' ' A' ' 58' ' ' VAL . 27.4 tp -61.6 -49.56 76.1 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.624 1.57 . . . . 74.52 111.711 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.7 t -59.81 -33.62 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 C-N-CA 124.634 1.174 . . . . 74.11 111.536 176.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.9 t -94.85 -6.95 41.62 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.423 0.689 . . . . 55.33 112.09 -175.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -83.01 132.43 50.84 Favored Pre-proline 0 N--CA 1.486 1.355 0 CA-C-N 118.079 0.4 . . . . 61.43 111.837 -173.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -70.13 -23.82 28.67 Favored 'Trans proline' 0 C--N 1.388 2.652 0 C-N-CA 123.154 2.569 . . . . 72.31 114.209 -176.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -76.4 -32.33 58.47 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 123.008 0.523 . . . . 71.14 111.079 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 31.7 p -105.88 1.35 26.69 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.122 0.569 . . . . 74.23 111.61 -176.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -57.31 -33.23 67.48 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.099 1.36 . . . . 72.44 112.56 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.97 -35.55 81.05 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.631 0.772 . . . . 65.32 113.027 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.528 HD22 ' HB2' ' A' ' 50' ' ' ASP . 80.9 mt -106.91 -11.05 15.8 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.063 0.545 . . . . 73.35 111.464 -175.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.2 tt -160.66 127.0 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 122.659 0.384 . . . . 74.13 110.631 174.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.1 p -158.92 161.29 36.75 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.032 0.533 . . . . 63.15 110.136 177.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 25.8 p-90 -71.12 147.3 48.55 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.028 -0.987 . . . . 73.54 110.455 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.4 m -70.96 153.54 94.66 Favored Pre-proline 0 CA--C 1.556 1.193 0 C-N-CA 124.016 0.926 . . . . 74.2 109.743 175.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -45.81 -44.63 17.96 Favored 'Trans proline' 0 C--N 1.384 2.401 0 C-N-CA 123.613 2.875 . . . . 74.22 114.899 -175.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 20.7 m -75.22 -27.22 59.46 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.31 0.644 . . . . 60.14 111.584 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.82 18.44 61.48 Favored Glycine 0 C--N 1.35 1.306 0 CA-C-N 116.562 -0.29 . . . . 55.12 113.606 175.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -80.85 -17.71 49.8 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.701 0.8 . . . . 71.32 111.326 175.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 19.0 p -158.28 -173.91 4.55 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 122.783 0.433 . . . . 71.45 110.806 -170.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 30.8 p90 -141.02 151.9 44.45 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.103 0.561 . . . . 73.54 110.179 176.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 55.5 m-70 -108.86 156.29 19.83 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.826 0.851 . . . . 72.01 109.647 176.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 84.7 t -130.51 123.16 54.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 124.442 1.097 . . . . 75.32 108.151 176.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -106.93 148.17 28.94 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.805 0.842 . . . . 64.33 109.686 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.528 ' HB2' HD22 ' A' ' 36' ' ' LEU . 7.9 m-20 54.23 55.54 8.05 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 124.714 1.258 . . . . 73.24 110.826 171.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.458 ' HA ' ' HB3' ' A' ' 54' ' ' PHE . 45.8 mt-30 -57.35 -22.77 44.59 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 114.759 -1.11 . . . . 70.33 113.158 -169.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.11 -47.83 56.95 Favored Glycine 0 C--N 1.348 1.23 0 N-CA-C 111.816 -0.513 . . . . 73.33 111.816 172.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.407 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 56.3 tp60 -71.17 -45.39 63.55 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.836 0.855 . . . . 75.2 110.044 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.458 ' HB3' ' HA ' ' A' ' 51' ' ' GLN . 57.0 t80 -49.16 -50.8 36.03 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.591 1.556 . . . . 72.54 111.403 171.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -62.65 -36.89 84.29 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.357 -0.383 . . . . 60.1 111.69 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.0 tmtt? -69.06 -45.01 71.44 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.994 0.918 . . . . 73.55 112.896 -175.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 53' ' ' GLN . 11.1 pt-20 -114.78 -33.02 5.62 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 114.43 1.27 . . . . 73.34 114.43 -172.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.447 ' HB ' ' O ' ' A' ' 54' ' ' PHE . 77.2 t -81.95 -44.46 19.98 Favored 'Isoleucine or valine' 0 C--O 1.25 1.117 0 C-N-CA 122.787 0.435 . . . . 75.02 111.29 -172.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 46.1 mt -64.07 -46.83 80.45 Favored Pre-proline 0 CA--C 1.564 1.511 0 CA-C-O 118.081 -0.961 . . . . 72.32 112.77 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -66.58 -15.38 47.48 Favored 'Trans proline' 0 C--N 1.388 2.653 0 CA-C-N 121.999 1.75 . . . . 71.35 113.454 174.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -75.49 -54.52 6.89 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.177 0.591 . . . . 71.52 110.646 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -90.19 -40.07 12.42 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 112.112 0.412 . . . . 72.14 112.112 -177.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -106.4 -176.28 3.03 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.758 0.823 . . . . 61.04 108.808 -177.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -119.42 48.83 1.44 Allowed 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 108.522 -0.918 . . . . 72.45 108.522 -176.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -164.12 159.9 20.89 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.73 1.212 . . . . 62.03 108.265 176.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -112.32 -21.08 11.59 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.395 0.678 . . . . 55.33 109.253 176.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -61.02 119.55 8.52 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.198 0.999 . . . . 50.11 111.09 -176.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 12.9 tpt -73.46 -32.93 64.62 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.649 0.78 . . . . 73.44 111.25 -176.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.88 -34.26 69.59 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.05 0.54 . . . . 72.52 111.577 177.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 40.1 t -64.85 -42.35 94.98 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.334 1.054 . . . . 74.02 111.672 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -68.47 -51.16 46.53 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.948 0.899 . . . . 74.44 110.995 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 65.0 t -62.12 -37.15 77.74 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 C-N-CA 123.734 0.814 . . . . 74.4 111.194 178.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -53.94 -50.13 67.15 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 123.925 0.89 . . . . 62.44 111.117 175.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -56.97 -51.5 68.94 Favored 'General case' 0 C--N 1.35 0.614 0 O-C-N 124.556 1.16 . . . . 62.34 110.547 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.1 mt -62.23 -44.36 96.73 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.912 0.885 . . . . 70.0 112.03 -176.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -59.11 -38.61 79.98 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.293 0.637 . . . . 72.41 111.437 176.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 50.7 mtm -69.61 -33.21 72.36 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.842 0.457 . . . . 73.51 110.676 175.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -82.1 7.2 14.05 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 122.95 0.5 . . . . 72.31 111.299 178.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 79.96 20.44 67.82 Favored Glycine 0 C--N 1.35 1.31 0 CA-C-O 119.948 -0.362 . . . . 72.23 113.447 172.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.523 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . 44.8 m-85 -82.82 137.89 34.15 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.978 -0.749 . . . . 72.45 108.978 175.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -101.46 125.24 48.07 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.022 -0.732 . . . . 75.04 109.022 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.59 115.58 8.13 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 107.965 -1.124 . . . . 74.12 107.965 173.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 61.7 t -131.27 113.86 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.219 -1.03 . . . . 73.42 108.219 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.5 p -96.11 126.45 48.72 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 N-CA-C 108.443 -0.947 . . . . 63.34 108.443 -176.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 69.1 m-70 -105.13 -42.56 5.26 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.396 0.279 . . . . 64.21 110.767 -175.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.428 HG22 ' NE2' ' A' ' 88' ' ' GLN . 34.0 mm -74.54 109.88 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 108.25 -1.019 . . . . 72.23 108.25 169.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -55.66 133.75 50.81 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 124.753 1.221 . . . . 73.34 110.869 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.428 ' NE2' HG22 ' A' ' 86' ' ' ILE . 35.5 mm-40 -116.83 6.17 13.12 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.188 0.995 . . . . 62.14 112.257 -171.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -70.5 -58.57 5.84 Favored Glycine 0 C--N 1.347 1.151 0 O-C-N 123.092 0.245 . . . . 43.04 112.813 -177.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 162.93 74.64 0.02 OUTLIER Glycine 0 C--N 1.347 1.172 0 C-N-CA 121.533 -0.365 . . . . 61.23 113.415 178.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 75.7 mt -112.34 174.39 5.91 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.156 0.582 . . . . 70.4 110.019 169.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.4 p -59.14 -33.78 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 124.565 1.146 . . . . 74.3 112.903 -174.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -63.28 152.45 84.74 Favored Pre-proline 0 N--CA 1.479 1.025 0 C-N-CA 123.733 0.813 . . . . 65.21 111.16 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.36 140.22 69.12 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.031 1.821 . . . . 73.1 110.358 172.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -86.93 51.47 2.25 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.286 0.634 . . . . 51.44 110.461 -176.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -72.6 86.22 1.19 Allowed 'General case' 0 C--N 1.354 0.776 0 CA-C-O 122.506 1.146 . . . . 63.33 108.302 175.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -35.26 101.17 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 111.888 -2.414 . . . . 43.24 113.877 178.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -99.14 115.83 29.96 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.332 -1.359 . . . . 71.52 107.332 175.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 91.2 m -125.77 119.8 28.9 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.265 -0.643 . . . . 52.12 109.265 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -104.13 117.45 34.3 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.375 -1.343 . . . . 54.21 107.375 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.523 ' HB3' ' HB3' ' A' ' 80' ' ' PHE . 97.6 m-85 -97.35 119.57 36.12 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 107.514 -1.291 . . . . 73.51 107.514 173.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 80' ' ' PHE . 10.2 pt20 -109.36 148.28 31.34 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.527 0.731 . . . . 72.11 110.151 -173.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -158.93 131.43 4.38 Favored Pre-proline 0 CA--C 1.547 0.846 0 CA-C-O 118.835 -0.603 . . . . 51.32 109.643 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -62.85 -26.55 74.67 Favored 'Trans proline' 0 C--N 1.383 2.37 0 C-N-CA 123.152 2.568 . . . . 75.31 113.707 -176.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 84.4 m -102.33 22.26 13.67 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.119 0.567 . . . . 75.14 111.109 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -119.74 108.27 14.21 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.02 -1.104 . . . . 73.44 108.02 170.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 91.4 mt -116.82 111.13 19.29 Favored 'General case' 0 C--O 1.212 -0.875 0 CA-C-O 118.32 -0.847 . . . . 72.52 108.889 170.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 40.7 -80.96 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 126.0 1.72 . . . . 73.1 115.263 165.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.23 30.03 2.66 Favored Glycine 0 C--N 1.356 1.649 0 C-N-CA 123.351 0.501 . . . . 63.13 112.887 -176.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.55 ' N ' HE21 ' A' ' 110' ' ' GLN . 0.0 OUTLIER -89.33 87.07 6.97 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 107.79 -1.189 . . . . 75.24 107.79 176.281 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.35 -25.79 67.75 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.122 -0.944 . . . . 61.4 112.335 -176.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 16.5 pm0 -69.12 -21.51 64.03 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.716 0.406 . . . . 74.21 111.536 177.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 82.2 mt -89.63 -13.09 37.85 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.234 0.614 . . . . 54.12 111.2 -178.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.469 HD11 ' HB3' ' A' ' 25' ' ' TRP . 91.9 mt -64.61 -35.61 81.56 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 122.943 0.497 . . . . 63.55 111.065 175.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -80.9 -1.67 44.38 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 111.719 0.266 . . . . 54.1 111.719 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.503 HD22 ' N ' ' A' ' 116' ' ' ASN . 0.6 OUTLIER -88.14 -24.75 23.27 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 108.95 -0.759 . . . . 73.54 108.95 170.504 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 57.9 mt -79.77 105.05 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 123.918 0.887 . . . . 74.3 108.868 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.556 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 10.8 mmpt? -107.39 139.53 41.74 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-O 120.86 0.362 . . . . 75.13 110.175 -170.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.43 ' HG3' ' HG3' ' A' ' 120' ' ' LYS . 16.1 ptm180 -79.43 -32.74 42.85 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.307 -0.861 . . . . 74.33 110.821 -178.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.43 ' HG3' ' HG3' ' A' ' 119' ' ' ARG . 54.8 mtpt -132.27 -176.36 4.05 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.902 0.881 . . . . 74.43 110.42 -175.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 57.5 t -77.9 -53.62 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 107.967 -1.123 . . . . 71.42 107.967 167.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 20.1 p -74.3 90.33 2.11 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 108.976 -0.75 . . . . 73.22 108.976 169.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 66.2 m -146.73 49.06 1.15 Allowed 'General case' 0 C--O 1.245 0.839 0 C-N-CA 123.986 0.915 . . . . 60.35 109.045 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 28.8 m -59.21 134.25 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 CA-C-N 115.709 -0.678 . . . . 61.31 109.263 173.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 68.5 m . . . . . 0 C--O 1.253 1.252 0 O-C-N 124.491 1.119 . . . . 61.32 109.058 -159.758 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 111.131 0.049 . . . . 74.01 111.131 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 110.15 134.34 6.77 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 111.946 -0.461 . . . . 73.33 111.946 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.0 m170 -96.85 149.05 22.29 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.429 0.692 . . . . 74.04 110.085 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -78.97 121.43 24.9 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 108.144 -1.058 . . . . 64.15 108.144 167.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 -71.05 -3.37 19.32 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.239 1.015 . . . . 74.31 112.492 -169.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 68.91 11.36 8.32 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.756 1.222 . . . . 75.2 112.631 171.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -89.89 111.57 22.66 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.43 0.633 . . . . 72.43 111.405 -173.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 15.3 p-80 -134.87 153.09 52.19 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 124.701 1.2 . . . . 73.23 107.926 167.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.0 t -65.6 117.91 8.74 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 122.735 0.414 . . . . 72.24 111.103 -174.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -116.93 140.17 49.78 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 108.439 -0.948 . . . . 73.13 108.439 175.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.1 ptm -151.47 -179.88 7.77 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 120.804 0.335 . . . . 75.31 111.713 -169.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.43 99.55 2.64 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.591 1.157 . . . . 75.15 107.974 176.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -167.95 -131.96 1.35 Allowed Glycine 0 C--N 1.347 1.18 0 CA-C-O 118.478 -1.179 . . . . 71.2 113.027 -173.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.2 115.12 2.22 Favored 'Trans proline' 0 C--N 1.388 2.637 0 C-N-CA 123.495 2.797 . . . . 71.43 112.583 -174.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 71.8 p 57.56 -82.17 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.876 1.671 . . . . 61.54 112.335 -173.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 61.98 68.39 0.69 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.704 1.202 . . . . 71.13 110.908 -175.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.5 t -81.17 115.71 58.0 Favored Pre-proline 0 C--O 1.242 0.688 0 N-CA-C 107.026 -1.472 . . . . 72.13 107.026 163.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.459 ' HD2' HD12 ' A' ' 21' ' ' LEU . 33.5 Cg_exo -58.15 146.32 88.75 Favored 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 122.479 2.12 . . . . 71.04 110.669 178.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.28 -34.29 45.91 Favored 'General case' 0 N--CA 1.476 0.832 0 O-C-N 123.711 0.632 . . . . 62.3 110.62 176.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -51.36 -52.39 46.08 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.911 0.885 . . . . 72.14 112.234 171.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.459 HD12 ' HD2' ' A' ' 18' ' ' PRO . 83.1 mt -80.86 -30.34 35.64 Favored 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.005 0.431 . . . . 71.23 110.065 -171.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 90.1 m -59.88 -51.66 68.75 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.856 1.262 . . . . 62.3 110.631 173.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.539 ' HB3' ' HB3' ' A' ' 62' ' ' TYR . 9.6 mmpt? -65.98 -45.38 81.88 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-N 115.548 -0.751 . . . . 75.33 110.144 177.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.459 ' O ' HG23 ' A' ' 28' ' ' VAL . 57.4 tp -56.29 -48.14 77.24 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.038 0.935 . . . . 74.53 111.595 -178.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 41.8 t90 -55.85 -46.3 78.25 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.05 0.94 . . . . 72.44 111.353 178.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 35.0 m -71.18 -25.48 62.56 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.469 1.108 . . . . 74.11 112.118 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.538 HD11 HG13 ' A' ' 58' ' ' VAL . 30.3 tp -78.01 -43.98 27.91 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.162 0.985 . . . . 73.53 110.793 -176.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 24' ' ' LEU . 74.3 t -57.96 -26.83 29.65 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.352 0 C-N-CA 125.042 1.337 . . . . 74.33 111.612 173.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 78.6 p -101.4 0.91 37.78 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.531 0.732 . . . . 75.23 112.631 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -81.45 120.15 77.42 Favored Pre-proline 0 N--CA 1.483 1.193 0 C-N-CA 122.946 0.498 . . . . 74.03 110.993 -172.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -71.77 -11.05 27.37 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 122.845 2.363 . . . . 71.42 113.165 178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -74.16 -36.2 64.07 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 122.591 0.356 . . . . 75.14 110.225 173.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 70.5 p -117.79 13.18 14.07 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.6 0.76 . . . . 72.23 111.631 -173.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -62.19 -30.22 70.92 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.175 0.59 . . . . 60.12 112.123 -171.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.67 -20.19 58.62 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 112.847 0.684 . . . . 73.23 112.847 178.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 59.4 mt -105.67 -16.77 14.6 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.007 0.523 . . . . 75.41 110.718 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.513 HD13 ' HG ' ' A' ' 27' ' ' LEU . 17.5 tt -160.28 121.7 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 123.21 0.604 . . . . 73.44 110.715 175.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 48.6 t -154.93 154.93 33.38 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.287 0.635 . . . . 75.21 109.67 177.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 29.2 p-90 -74.45 152.82 39.39 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.643 0.777 . . . . 71.35 111.007 -174.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.3 m -79.31 142.11 58.29 Favored Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 108.487 -0.931 . . . . 64.13 108.487 172.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.99 -26.52 49.9 Favored 'Trans proline' 0 C--N 1.377 2.032 0 C-N-CA 123.212 2.608 . . . . 71.02 114.152 -176.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.6 m -74.71 -27.45 60.39 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.914 0.486 . . . . 54.41 111.42 176.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 107' ' ' LEU . . . 94.48 -5.55 70.62 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-O 119.391 -0.671 . . . . 73.51 114.018 175.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.468 ' HA ' HD23 ' A' ' 107' ' ' LEU . 2.8 m-20 -78.94 -16.21 57.27 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.816 0.846 . . . . 61.43 111.955 -170.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 43.5 p -156.57 179.97 8.75 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.347 0.594 . . . . 71.04 110.965 -173.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -138.81 151.98 47.49 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.044 -0.98 . . . . 53.52 109.344 171.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 46.3 m-70 -107.37 139.22 42.19 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.738 0.815 . . . . 75.11 109.136 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.517 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 71.2 t -118.2 127.5 75.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 107.324 -1.361 . . . . 74.34 107.324 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -113.64 146.29 39.99 Favored 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 109.177 -0.675 . . . . 75.31 109.177 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 53.64 68.76 0.79 Allowed 'General case' 0 N--CA 1.476 0.859 0 O-C-N 124.851 1.344 . . . . 71.11 110.8 176.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.578 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 47.0 mt-30 -53.28 -26.92 20.13 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.491 0.717 . . . . 71.1 112.63 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -64.82 -53.06 36.77 Favored Glycine 0 C--N 1.349 1.281 0 O-C-N 123.252 0.345 . . . . 61.21 112.289 172.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 58.7 tp60 -69.8 -42.12 74.16 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.192 0.597 . . . . 71.24 110.754 -176.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.437 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 60.2 t80 -56.65 -50.16 72.89 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.49 1.516 . . . . 75.13 110.806 176.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.445 ' HB1' ' O ' ' A' ' 66' ' ' ASN . . . -62.4 -31.99 72.75 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 112.213 0.449 . . . . 51.51 112.213 177.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -70.6 -49.28 49.39 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.073 0.949 . . . . 64.45 112.778 -177.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.573 ' HG3' HG23 ' A' ' 58' ' ' VAL . 4.4 pt-20 -108.48 -37.48 5.95 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 113.569 0.952 . . . . 62.12 113.569 -172.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.573 HG23 ' HG3' ' A' ' 57' ' ' GLU . 98.6 t -81.99 -45.86 19.91 Favored 'Isoleucine or valine' 0 C--O 1.249 1.07 0 C-N-CA 123.315 0.646 . . . . 75.24 111.565 -166.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.1 mt -62.08 -48.97 87.03 Favored Pre-proline 0 CA--C 1.558 1.257 0 CA-C-O 117.79 -1.1 . . . . 72.14 112.705 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.521 ' HG3' ' ND2' ' A' ' 66' ' ' ASN . 52.6 Cg_endo -67.69 -15.23 44.06 Favored 'Trans proline' 0 C--N 1.388 2.611 0 C-N-CA 122.134 1.889 . . . . 73.14 113.186 176.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -74.05 -64.99 0.9 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.176 0.59 . . . . 63.34 110.824 178.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.539 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 29.8 m-85 -81.61 -46.51 14.29 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.209 0.528 . . . . 74.12 111.474 -176.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -98.57 -171.22 2.08 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 106.608 -1.627 . . . . 74.44 106.608 177.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -129.47 64.99 1.48 Allowed 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 119.428 1.013 . . . . 72.13 109.859 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -166.09 162.86 18.04 Favored 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 114.295 -1.32 . . . . 75.51 108.813 174.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.521 ' ND2' ' HG3' ' A' ' 60' ' ' PRO . 11.1 m120 -114.2 -5.85 13.02 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 122.682 0.393 . . . . 72.33 110.304 175.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -75.29 112.5 11.65 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 122.963 0.505 . . . . 74.32 110.66 -175.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.578 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 3.5 tpt -56.49 -48.64 76.72 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 125.281 1.432 . . . . 44.25 111.631 178.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.96 -30.07 67.64 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.414 -0.812 . . . . 75.12 112.597 -177.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.3 t -68.52 -41.35 80.07 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.643 0.777 . . . . 75.03 111.271 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -61.95 -49.24 76.89 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.832 0.853 . . . . 65.24 109.93 177.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 52.7 t -65.15 -35.4 75.32 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 CA-C-N 114.688 -1.142 . . . . 72.15 111.508 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -60.86 -42.49 97.98 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.67 0.788 . . . . 73.52 110.971 178.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.507 ' HA ' ' HE2' ' A' ' 77' ' ' MET . 32.1 mm-40 -64.85 -45.29 86.72 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.82 -0.627 . . . . 63.31 110.426 178.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.442 ' HB3' ' HB2' ' A' ' 80' ' ' PHE . 83.1 mt -63.59 -34.19 77.27 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.271 0.629 . . . . 71.31 111.847 -178.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -56.15 -40.03 73.21 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.212 0.605 . . . . 71.43 111.184 171.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.507 ' HE2' ' HA ' ' A' ' 74' ' ' GLN . 39.9 mtm -76.91 -23.91 52.49 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.278 0.631 . . . . 63.22 111.28 178.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -86.1 -8.61 57.76 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.06 0.544 . . . . 72.22 111.006 174.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.05 21.04 54.02 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 114.406 0.522 . . . . 40.01 114.406 173.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.442 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 17.7 m-85 -82.31 144.97 30.22 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 108.954 -0.758 . . . . 61.31 108.954 176.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 20.7 ttm180 -102.29 129.6 48.76 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 122.868 0.467 . . . . 75.5 110.24 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.631 ' HE3' HG22 ' A' ' 84' ' ' VAL . 52.8 tptt -68.71 118.65 11.97 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.426 1.09 . . . . 74.22 108.779 169.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.548 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 58.8 t -123.4 116.82 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 108.667 -0.864 . . . . 73.24 108.667 176.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.631 HG22 ' HE3' ' A' ' 82' ' ' LYS . 34.4 t -97.98 101.88 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.746 0.818 . . . . 74.03 109.318 -174.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 83.9 m-70 -86.03 -36.76 19.53 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 122.341 -0.224 . . . . 70.31 110.656 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 47.2 mm -78.77 82.04 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 107.629 -1.248 . . . . 74.22 107.629 166.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -64.54 126.84 29.14 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 113.976 -1.466 . . . . 73.03 108.815 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 33.3 mm-40 -60.62 113.13 2.29 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.601 0.761 . . . . 64.43 111.743 -168.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.01 167.11 21.96 Favored Glycine 0 C--O 1.244 0.742 0 CA-C-N 114.009 -1.45 . . . . 63.4 110.688 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -73.73 78.04 0.91 Allowed Glycine 0 CA--C 1.526 0.771 0 C-N-CA 122.932 0.301 . . . . 74.42 112.829 177.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 80.3 mt -93.07 164.02 13.42 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.053 0.941 . . . . 72.01 110.166 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 13.5 p -75.73 -21.82 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 CA-C-O 121.356 0.598 . . . . 71.44 109.446 171.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -61.63 137.62 94.99 Favored Pre-proline 0 CA--C 1.552 1.028 0 CA-C-N 115.029 -0.987 . . . . 74.13 109.759 169.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -68.2 155.67 68.57 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 122.825 2.35 . . . . 73.02 113.14 -172.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -78.42 0.53 25.39 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.582 1.153 . . . . 51.13 112.849 -170.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -64.81 86.95 0.05 Allowed 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.13 0.572 . . . . 74.4 110.087 173.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -36.76 105.38 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 125.413 1.485 . . . . 54.11 112.56 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -90.33 112.77 24.47 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 107.608 -1.256 . . . . 65.32 107.608 -177.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.53 HG23 ' HD2' ' A' ' 82' ' ' LYS . 76.6 m -118.06 107.12 13.62 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 114.894 -1.048 . . . . 70.41 109.256 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.548 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 41.9 tt0 -96.23 109.63 22.07 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.596 -1.261 . . . . 65.41 107.596 177.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -95.03 118.68 32.26 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 107.125 -1.435 . . . . 74.2 107.125 172.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -123.37 149.29 45.13 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.861 0.864 . . . . 63.55 109.87 -174.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -156.74 133.14 6.13 Favored Pre-proline 0 CA--C 1.547 0.842 0 N-CA-C 109.276 -0.638 . . . . 73.15 109.276 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -65.21 -27.2 56.48 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 122.928 2.419 . . . . 74.52 113.044 -174.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 113' ' ' LEU . 59.2 m -105.86 37.38 2.26 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.644 0.778 . . . . 62.32 109.511 175.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -133.9 106.9 7.52 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.055 -1.091 . . . . 70.31 108.055 170.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.596 ' HB2' ' HB3' ' A' ' 110' ' ' GLN . 68.0 mt -128.2 149.63 50.37 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 108.514 -0.921 . . . . 63.12 108.514 172.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -63.02 -59.14 5.21 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.486 0.714 . . . . 74.35 111.659 -175.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -88.95 50.57 3.71 Favored Glycine 0 C--N 1.342 0.877 0 N-CA-C 111.87 -0.492 . . . . 53.04 111.87 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.596 ' HB3' ' HB2' ' A' ' 107' ' ' LEU . 4.1 tp60 -165.19 53.0 0.11 Allowed 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 108.691 -0.855 . . . . 73.52 108.691 -172.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -62.64 -18.4 62.22 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.024 0.93 . . . . 44.2 112.966 -176.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.0 pm0 -68.26 -6.58 24.55 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 122.957 0.503 . . . . 72.03 112.145 176.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.414 ' HB3' ' O ' ' A' ' 105' ' ' CYS . 63.4 mt -86.28 -23.7 26.22 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 122.751 0.42 . . . . 70.3 111.473 174.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.19 -37.98 89.35 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.274 0.63 . . . . 64.1 111.35 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -72.21 -13.49 61.55 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 114.895 -1.048 . . . . 72.43 112.267 177.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -93.9 -11.62 30.64 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.327 0.651 . . . . 75.23 110.865 173.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 35.8 mt -87.41 91.99 3.67 Favored 'Isoleucine or valine' 0 C--N 1.353 0.745 0 N-CA-C 107.134 -1.432 . . . . 72.01 107.134 176.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.443 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 11.1 mmpt? -87.48 144.48 26.7 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 109.219 -0.66 . . . . 72.32 109.219 -178.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 8.6 ptm85 -86.24 -69.7 0.65 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 109.572 -0.529 . . . . 73.44 109.572 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -149.77 -166.41 2.54 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.464 1.106 . . . . 74.44 108.871 178.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.0 p -50.71 -41.76 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.043 0 C-N-CA 124.186 0.995 . . . . 75.51 112.13 -177.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 5.6 t -105.43 134.13 49.05 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 123.971 0.909 . . . . 62.31 109.661 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 41.9 t -96.33 101.51 13.16 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.649 -0.871 . . . . 63.24 108.649 173.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.1 p -153.44 97.72 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 124.136 0.974 . . . . 75.23 109.284 -178.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 31.1 t . . . . . 0 C--O 1.247 0.951 0 N-CA-C 107.01 -1.478 . . . . 75.54 107.01 178.094 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 mmt . . . . . 0 N--CA 1.48 1.036 0 N-CA-C 108.409 -0.96 . . . . 72.42 108.409 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -172.67 -127.46 0.97 Allowed Glycine 0 C--N 1.337 0.634 0 CA-C-N 115.3 -0.864 . . . . 41.22 111.601 -175.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.2 p80 43.54 43.32 4.53 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 125.787 1.635 . . . . 74.41 111.647 -174.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -132.25 114.1 14.04 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.713 1.205 . . . . 73.04 108.736 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 26.1 t-80 -79.86 141.49 36.11 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 108.646 -0.872 . . . . 61.25 108.646 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -64.0 100.86 0.34 Allowed 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.089 0.555 . . . . 73.41 111.239 -177.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -103.57 110.92 23.16 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.389 0.676 . . . . 73.25 110.951 177.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 -95.41 26.81 3.64 Favored 'General case' 0 CA--C 1.553 1.086 0 N-CA-C 108.922 -0.77 . . . . 72.43 108.922 164.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.0 m -62.76 151.72 37.84 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 125.154 1.381 . . . . 74.25 111.482 179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -146.62 135.14 22.02 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.41 0.684 . . . . 73.22 110.03 178.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.1 mmt -83.85 -178.69 7.08 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.857 0.863 . . . . 73.3 110.352 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -123.04 108.12 12.55 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.346 0.658 . . . . 63.11 109.462 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 130.21 173.23 13.33 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-N 116.181 -0.463 . . . . 64.13 112.547 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -89.0 171.28 4.77 Favored 'Trans proline' 0 C--N 1.367 1.522 0 C-N-CA 123.181 2.588 . . . . 74.31 112.511 173.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 95.3 p 53.21 43.8 31.06 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 125.279 1.432 . . . . 75.13 112.908 172.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -91.41 28.12 1.78 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.877 -0.601 . . . . 62.02 110.155 176.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 61.5 t -73.84 123.49 89.36 Favored Pre-proline 0 CA--C 1.55 0.952 0 C-N-CA 123.893 0.877 . . . . 64.33 110.649 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -61.81 139.0 77.79 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 122.734 2.289 . . . . 74.55 111.8 170.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.453 ' HA ' HG22 ' A' ' 22' ' ' THR . . . -56.58 -38.47 72.02 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.592 0.757 . . . . 73.31 112.392 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -51.33 -46.85 62.78 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.587 0.755 . . . . 75.13 111.626 173.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.449 ' HB3' HD22 ' A' ' 114' ' ' LEU . 77.8 mt -79.69 -34.73 39.99 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.122 0.569 . . . . 71.05 112.498 -172.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.453 HG22 ' HA ' ' A' ' 19' ' ' ALA . 14.3 t -71.38 -34.89 70.81 Favored 'General case' 0 N--CA 1.481 1.105 0 CA-C-N 118.041 0.382 . . . . 73.31 111.146 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.2 mtpt -81.06 -32.7 33.91 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 119.532 -0.271 . . . . 63.24 110.875 177.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.426 ' O ' HG23 ' A' ' 28' ' ' VAL . 57.4 tp -63.55 -39.58 94.77 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.091 0.556 . . . . 75.13 110.497 170.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 64.7 t-105 -57.44 -52.67 64.44 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.871 0.868 . . . . 65.42 110.666 174.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 38.6 m -59.84 -40.74 89.56 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 124.238 0.961 . . . . 72.22 110.721 177.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.483 ' HG ' HD13 ' A' ' 37' ' ' ILE . 26.9 tp -59.64 -52.26 66.28 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.196 1.398 . . . . 72.44 112.304 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 24' ' ' LEU . 96.9 t -62.01 -33.14 56.8 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 C-N-CA 123.855 0.862 . . . . 75.15 111.164 177.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.9 t -94.04 -1.71 54.05 Favored 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 123.911 0.884 . . . . 51.34 112.069 -174.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -89.0 130.54 44.21 Favored Pre-proline 0 N--CA 1.49 1.555 0 C-N-CA 123.29 0.636 . . . . 75.41 111.467 -174.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -73.32 -21.82 19.54 Favored 'Trans proline' 0 C--N 1.39 2.716 0 C-N-CA 123.271 2.647 . . . . 71.33 114.369 -174.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -78.45 -36.33 45.57 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.316 0.646 . . . . 74.41 110.455 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 21.5 p -92.01 -0.96 57.48 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.227 0.611 . . . . 61.34 111.28 -176.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.69 -29.17 58.92 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.88 1.272 . . . . 73.21 112.107 -179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.26 -36.98 79.03 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.934 0.894 . . . . 64.5 113.22 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.6 mt -114.16 -6.38 13.05 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.918 0.487 . . . . 63.12 112.134 -176.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.483 HD13 ' HG ' ' A' ' 27' ' ' LEU . 16.6 tt -160.11 125.71 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-O 120.943 0.401 . . . . 74.44 110.878 175.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 21.5 p -146.2 145.3 30.39 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.218 0.607 . . . . 63.45 110.255 -176.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 10.2 p-90 -69.25 152.19 45.36 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 118.028 0.376 . . . . 71.11 110.844 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 61.2 p -71.98 150.0 92.53 Favored Pre-proline 0 CA--C 1.552 1.048 0 N-CA-C 109.446 -0.575 . . . . 55.43 109.446 172.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -51.59 -24.27 16.82 Favored 'Trans proline' 0 C--N 1.377 2.078 0 C-N-CA 122.564 2.176 . . . . 73.34 113.67 171.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 59.8 m -69.99 -52.26 25.74 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.241 0.616 . . . . 64.02 109.765 169.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 92.16 5.58 65.63 Favored Glycine 0 C--N 1.347 1.186 0 CA-C-N 115.277 -0.874 . . . . 32.32 112.969 -177.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -87.92 -2.25 58.49 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.861 0.864 . . . . 72.04 110.022 -178.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.7 p -163.59 170.57 17.0 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.375 1.07 . . . . 71.24 109.494 -169.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -142.07 143.46 33.1 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 122.465 0.306 . . . . 50.3 111.075 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 28.1 m-70 -97.77 140.27 32.4 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.173 0.989 . . . . 64.42 109.487 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.5 t -123.95 132.7 70.95 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 C-N-CA 124.387 1.075 . . . . 61.23 108.308 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.416 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 79.3 m-85 -115.82 146.86 41.61 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.39 1.076 . . . . 72.45 109.756 -177.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 49.77 72.59 0.31 Allowed 'General case' 0 N--CA 1.479 1.007 0 O-C-N 124.727 1.267 . . . . 63.1 111.378 -179.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.416 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 16.3 mm-40 -51.09 -35.96 37.83 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.808 0.843 . . . . 72.31 112.717 -176.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.37 -47.38 71.16 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-N 115.809 -0.632 . . . . 52.12 112.885 177.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.1 tp60 -69.54 -44.33 71.19 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.187 0.595 . . . . 62.01 110.63 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -55.34 -49.26 72.68 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.376 1.47 . . . . 74.04 110.975 176.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.29 -35.93 78.68 Favored 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 116.432 -0.349 . . . . 71.34 111.932 177.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -70.11 -47.08 63.31 Favored 'General case' 0 CA--C 1.555 1.16 0 C-N-CA 124.263 1.025 . . . . 72.24 113.078 -175.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.487 ' HG3' HG23 ' A' ' 58' ' ' VAL . 7.1 pt-20 -107.01 -37.38 6.34 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 113.912 1.079 . . . . 74.25 113.912 -174.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.487 HG23 ' HG3' ' A' ' 57' ' ' GLU . 98.4 t -81.0 -43.7 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 122.754 0.421 . . . . 75.54 111.512 -168.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.5 mt -67.03 -43.86 48.17 Favored Pre-proline 0 CA--C 1.556 1.21 0 CA-C-O 117.979 -1.01 . . . . 71.33 112.833 -178.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.98 -14.36 43.37 Favored 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 121.894 1.729 . . . . 73.43 113.625 173.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -79.01 -57.76 3.58 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.384 0.674 . . . . 70.33 111.04 177.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.437 ' CE1' HD13 ' A' ' 27' ' ' LEU . 57.3 m-85 -86.57 -26.8 24.3 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 112.258 0.466 . . . . 74.43 112.258 -176.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -124.38 -178.45 4.11 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.063 0.945 . . . . 50.52 108.747 -176.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.66 37.67 2.85 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 122.917 0.487 . . . . 72.4 109.994 -172.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -160.84 160.7 31.41 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.92 0.888 . . . . 73.54 108.902 -176.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -109.69 -25.45 10.39 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 108.996 -0.742 . . . . 73.21 108.996 176.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -57.68 118.37 5.19 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.334 1.054 . . . . 55.42 111.655 -176.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.416 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 11.6 ttm -72.15 -31.57 66.08 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.1 -0.955 . . . . 73.44 111.709 -178.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.29 -37.36 69.74 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.076 0.55 . . . . 44.33 111.644 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.404 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 37.2 t -66.41 -44.96 81.52 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.214 1.005 . . . . 64.31 111.323 176.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -64.19 -52.91 56.62 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.531 1.132 . . . . 64.03 111.196 -176.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 68.0 t -65.8 -31.35 53.35 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 CA-C-N 115.515 -0.766 . . . . 64.15 111.251 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -60.28 -39.77 88.03 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 122.785 0.434 . . . . 73.44 111.227 173.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 70' ' ' SER . 21.7 mm-40 -65.09 -46.25 81.86 Favored 'General case' 0 C--N 1.355 0.809 0 O-C-N 123.646 0.591 . . . . 75.05 109.905 177.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.502 ' HB3' ' HB2' ' A' ' 80' ' ' PHE . 96.9 mt -57.4 -45.25 84.75 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 123.81 0.844 . . . . 61.15 111.285 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -55.57 -42.5 74.82 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.595 0.758 . . . . 74.51 111.933 176.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 59.3 mtm -73.6 -27.61 61.38 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 116.041 -0.527 . . . . 71.13 111.491 178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -85.28 -6.97 59.22 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.569 0.348 . . . . 71.04 111.207 177.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 86.65 17.71 59.62 Favored Glycine 0 C--N 1.352 1.469 0 CA-C-O 119.794 -0.448 . . . . 32.31 113.927 175.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.502 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 38.7 m-85 -78.2 137.34 38.09 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 108.332 -0.988 . . . . 73.02 108.332 173.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 13.6 ttm180 -107.93 130.79 55.01 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.306 0.642 . . . . 73.43 109.545 -175.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -65.78 125.45 25.36 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.038 0.935 . . . . 73.12 109.369 174.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 51.7 t -116.0 113.54 43.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 107.835 -1.172 . . . . 73.22 107.835 176.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 71.1 t -86.46 140.15 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 123.762 0.825 . . . . 73.23 110.898 -177.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -131.01 -61.28 0.94 Allowed 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 108.066 -1.087 . . . . 74.52 108.066 172.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.673 HG23 ' HB3' ' A' ' 93' ' ' LYS . 41.3 mm -120.49 123.33 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-N 115.307 -0.86 . . . . 74.2 110.047 -177.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -124.98 119.88 29.99 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.39 1.076 . . . . 74.25 108.336 170.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -87.42 10.72 16.6 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.233 0.613 . . . . 71.21 112.554 -174.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -75.49 78.68 1.13 Allowed Glycine 0 C--N 1.352 1.446 0 N-CA-C 113.591 0.196 . . . . 63.42 113.591 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 80.1 5.26 89.7 Favored Glycine 0 C--N 1.351 1.395 0 C-N-CA 123.018 0.342 . . . . 74.14 113.597 177.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 55.5 mt -103.12 158.75 16.09 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.89 0.876 . . . . 72.12 110.481 -174.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 4.5 p -81.95 75.77 0.96 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 CA-C-O 123.203 1.478 . . . . 72.33 109.252 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.673 ' HB3' HG23 ' A' ' 86' ' ' ILE . 73.1 mmtt -132.26 161.69 61.41 Favored Pre-proline 0 N--CA 1.482 1.137 0 CA-C-N 113.617 -1.628 . . . . 74.31 109.925 -173.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.82 172.96 6.28 Favored 'Trans proline' 0 C--N 1.386 2.519 0 C-N-CA 122.422 2.081 . . . . 71.33 113.319 174.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -34.85 79.22 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.108 -0.951 . . . . 74.42 111.291 -178.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -86.21 152.59 22.69 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.516 0.674 . . . . 72.43 111.381 -172.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.416 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 18.0 m-20 -80.84 134.15 35.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 114.337 -1.302 . . . . 74.21 108.554 170.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -115.1 105.27 12.74 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 107.644 -1.243 . . . . 71.24 107.644 169.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 93.3 m -124.7 153.23 42.65 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.478 1.111 . . . . 64.41 109.637 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.546 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 37.8 tt0 -130.9 153.55 49.02 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.548 -0.908 . . . . 72.04 108.548 162.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -124.46 120.31 31.66 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 107.277 -1.379 . . . . 74.33 107.277 169.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -110.32 144.56 38.87 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.552 0.741 . . . . 74.41 110.242 -174.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.463 ' HB3' ' HB3' ' A' ' 106' ' ' PHE . 64.8 t-80 -149.46 130.81 7.3 Favored Pre-proline 0 CA--C 1.55 0.969 0 CA-C-O 119.351 -0.357 . . . . 64.0 110.423 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.25 -40.83 30.28 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 123.299 2.666 . . . . 74.41 113.667 -175.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.416 ' HB2' ' HE1' ' A' ' 103' ' ' HIS . 34.2 m -97.13 22.96 7.85 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.275 0.63 . . . . 73.3 111.096 -177.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.463 ' HB3' ' HB3' ' A' ' 103' ' ' HIS . 89.1 t80 -117.37 99.05 6.75 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 106.706 -1.59 . . . . 72.44 106.706 173.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 63.1 mt -119.31 139.36 52.07 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.137 -1.06 . . . . 63.34 108.137 177.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -68.89 132.27 46.47 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.508 0.723 . . . . 73.31 110.125 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.48 1.6 90.49 Favored Glycine 0 C--N 1.344 0.983 0 O-C-N 123.555 0.534 . . . . 43.14 113.052 -173.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -122.84 53.46 1.28 Allowed 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 108.144 -1.058 . . . . 62.53 108.144 -175.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.55 -26.1 65.09 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 125.236 1.414 . . . . 73.32 114.102 -177.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 7.9 pm0 -71.01 -8.19 51.6 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 112.204 0.446 . . . . 65.32 112.204 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.491 ' O ' HG13 ' A' ' 117' ' ' ILE . 24.6 mt -83.1 -14.22 54.11 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 118.771 -0.633 . . . . 73.23 111.485 173.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.449 HD22 ' HB3' ' A' ' 21' ' ' LEU . 96.4 mt -63.17 -35.3 79.86 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 118.295 0.498 . . . . 72.15 110.857 175.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -80.15 -1.59 40.96 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.962 -0.563 . . . . 60.51 112.148 175.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -103.61 -13.71 16.43 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.586 0.754 . . . . 75.21 110.528 168.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.491 HG13 ' O ' ' A' ' 113' ' ' LEU . 63.9 mt -85.74 109.74 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 N-CA-C 106.879 -1.526 . . . . 72.1 106.879 173.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.3 mmpt? -109.21 170.39 8.08 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.807 -0.812 . . . . 70.4 108.807 -177.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 24.6 ptt85 -119.86 -40.65 2.72 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.155 -1.054 . . . . 55.51 108.155 168.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -137.15 179.23 6.51 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.519 1.128 . . . . 71.23 109.476 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 86.5 t -80.59 -37.23 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 N-CA-C 109.055 -0.72 . . . . 74.44 109.055 166.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 10.0 t -94.34 52.91 1.63 Allowed 'General case' 0 CA--C 1.559 1.308 0 CA-C-O 122.49 1.138 . . . . 70.25 110.64 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 36.7 m -86.39 92.99 9.0 Favored 'General case' 0 CA--C 1.552 1.039 0 CA-C-N 115.196 -0.911 . . . . 75.44 108.969 175.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 34.9 m -109.15 16.63 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 124.096 0.958 . . . . 62.33 112.258 -173.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.479 1.015 0 C-N-CA 123.716 0.807 . . . . 44.13 109.018 176.026 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ptt? . . . . . 0 N--CA 1.484 1.228 0 CA-C-O 120.893 0.378 . . . . 74.15 110.74 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -149.31 30.88 1.17 Allowed Glycine 0 N--CA 1.469 0.879 0 CA-C-N 115.669 -0.696 . . . . 74.54 111.467 175.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -97.6 138.02 35.64 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.23 1.012 . . . . 71.13 109.52 -174.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -62.98 112.72 2.71 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.79 0.836 . . . . 52.33 111.324 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -97.86 -87.37 0.33 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 123.482 0.713 . . . . 72.53 109.868 175.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -166.41 164.58 17.36 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.434 0.693 . . . . 75.14 110.011 -176.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -89.36 171.47 9.73 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 121.419 0.628 . . . . 73.15 111.905 -177.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -123.25 52.09 1.41 Allowed 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.825 1.25 . . . . 62.21 107.764 170.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.3 t -64.96 110.64 2.52 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 114.495 -1.23 . . . . 74.04 112.844 -167.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 29.5 p80 -152.15 131.45 12.83 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.87 0.868 . . . . 65.41 108.878 167.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -83.4 143.71 30.12 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.045 0.538 . . . . 53.23 110.881 -174.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -119.86 105.97 11.62 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.623 0.769 . . . . 62.04 109.505 178.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -154.98 109.11 0.39 Allowed Glycine 0 C--N 1.346 1.134 0 CA-C-O 118.929 -0.928 . . . . 61.52 112.024 -177.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -77.65 153.35 30.06 Favored 'Trans proline' 0 C--N 1.375 1.967 0 C-N-CA 122.906 2.404 . . . . 75.22 112.112 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.1 t -82.32 131.84 35.22 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 108.814 -0.81 . . . . 74.44 108.814 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -81.27 18.1 1.18 Allowed 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.329 1.052 . . . . 74.02 112.702 -172.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.4 t -57.83 130.67 82.53 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 124.356 1.062 . . . . 73.51 111.802 -178.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -58.94 152.37 58.6 Favored 'Trans proline' 0 C--N 1.382 2.313 0 C-N-CA 123.155 2.57 . . . . 74.42 112.314 174.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.72 -45.78 70.59 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.971 0.908 . . . . 71.41 112.1 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.6 t80 -54.85 -44.44 73.99 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 122.981 0.512 . . . . 73.31 112.009 176.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 61.2 mt -80.52 -31.09 37.16 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 112.393 0.516 . . . . 61.55 112.393 -171.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.1 t -70.99 -33.39 70.37 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.656 -0.498 . . . . 72.2 109.656 175.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -69.87 -42.41 73.52 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 122.915 0.486 . . . . 65.23 110.536 172.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.61 -43.67 93.68 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.8 0.84 . . . . 54.23 111.419 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 13.5 t-105 -64.58 -51.9 60.37 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-O 119.611 -0.233 . . . . 74.42 110.81 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 32.1 m -61.3 -20.69 63.2 Favored 'General case' 0 CA--C 1.554 1.133 0 CA-C-O 121.299 0.571 . . . . 73.1 110.883 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.0 tp -76.77 -54.77 6.18 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.597 1.159 . . . . 75.41 111.408 174.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 82.5 t -62.16 -36.22 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 123.749 0.819 . . . . 72.13 111.389 -177.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.5 p -78.15 -25.4 47.3 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.538 0.735 . . . . 74.14 112.305 -176.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -70.84 123.12 88.69 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 123.24 0.616 . . . . 63.34 111.563 -171.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.28 -13.51 33.45 Favored 'Trans proline' 0 C--N 1.379 2.136 0 C-N-CA 122.975 2.45 . . . . 61.13 113.479 -177.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -87.12 -22.39 25.4 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.723 0.809 . . . . 74.25 110.987 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.451 HG21 ' HE1' ' A' ' 62' ' ' TYR . 24.7 p -110.6 1.25 17.95 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.158 0.583 . . . . 74.43 111.685 175.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -54.12 -36.95 63.81 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.486 1.114 . . . . 70.42 112.271 -177.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.1 -33.17 75.39 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.526 -0.761 . . . . 72.12 112.256 -176.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.462 HD22 ' HB2' ' A' ' 50' ' ' ASP . 59.7 mt -103.48 -11.0 18.09 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.548 0.339 . . . . 55.43 111.36 -177.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 17.5 tt -162.15 128.43 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 122.971 0.508 . . . . 70.03 110.326 172.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 17.3 p -153.92 157.6 39.46 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.23 0.612 . . . . 71.21 110.057 -179.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 41.4 p-90 -73.63 149.22 42.18 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 122.993 0.517 . . . . 74.23 110.097 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.5 m -70.24 143.51 91.1 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 123.879 0.872 . . . . 75.51 110.098 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -55.59 -32.49 83.36 Favored 'Trans proline' 0 C--N 1.373 1.839 0 C-N-CA 122.813 2.342 . . . . 75.0 113.517 175.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 45.9 m -69.61 -19.68 63.64 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.217 0.607 . . . . 73.31 111.698 173.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.69 6.4 71.71 Favored Glycine 0 C--N 1.344 0.996 0 N-CA-C 115.617 1.007 . . . . 41.24 115.617 171.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -88.07 -5.66 58.36 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 118.109 0.955 . . . . 74.21 112.265 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.2 p -163.44 -171.66 2.65 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.162 0.585 . . . . 64.42 110.736 -170.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -145.03 148.81 34.13 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.404 0.682 . . . . 73.51 110.973 175.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 21.6 m-70 -99.52 150.79 21.86 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.588 1.155 . . . . 71.4 110.173 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.0 t -123.67 123.03 66.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 107.939 -1.134 . . . . 61.33 107.939 172.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -105.68 147.41 28.54 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.273 1.029 . . . . 64.42 110.034 -178.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.462 ' HB2' HD22 ' A' ' 36' ' ' LEU . 8.6 m-20 48.79 59.83 4.13 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 124.925 1.39 . . . . 63.22 111.196 172.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.496 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 75.7 mt-30 -54.65 -26.16 31.41 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 113.78 1.03 . . . . 71.25 113.78 -169.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.94 -50.08 37.33 Favored Glycine 0 C--N 1.35 1.348 0 O-C-N 123.198 0.311 . . . . 75.21 112.654 173.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -68.06 -40.13 82.84 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.452 0.701 . . . . 70.43 110.249 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.476 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 44.4 t80 -57.99 -48.14 80.91 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.113 1.365 . . . . 73.44 110.534 176.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.435 ' HB2' ' HB2' ' A' ' 68' ' ' MET . . . -61.27 -36.67 80.66 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.196 -0.456 . . . . 71.21 111.486 177.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -68.47 -53.99 19.83 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.252 1.021 . . . . 73.13 112.985 -176.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.559 ' HG3' HG23 ' A' ' 58' ' ' VAL . 6.3 pt-20 -100.45 -38.07 8.56 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 112.893 0.701 . . . . 61.42 112.893 -173.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.559 HG23 ' HG3' ' A' ' 57' ' ' GLU . 77.6 t -81.92 -44.46 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 123.045 0.538 . . . . 71.24 112.144 -167.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 49.3 mt -63.52 -45.17 83.24 Favored Pre-proline 0 CA--C 1.56 1.36 0 CA-C-O 117.797 -1.097 . . . . 73.21 112.684 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.09 -16.52 44.89 Favored 'Trans proline' 0 C--N 1.386 2.538 0 CA-C-N 122.037 1.763 . . . . 75.51 113.312 173.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -73.13 -47.62 42.57 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.453 0.701 . . . . 73.2 111.073 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.451 ' HE1' HG21 ' A' ' 33' ' ' THR . 53.8 m-85 -96.12 -48.1 5.8 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 122.853 0.461 . . . . 65.13 111.903 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -99.08 -171.27 2.06 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.85 0.86 . . . . 75.05 109.117 -178.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -118.89 44.72 2.24 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 121.361 0.601 . . . . 72.23 110.551 -176.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -164.04 164.51 22.99 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.333 -0.849 . . . . 74.3 109.557 -177.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.3 p30 -121.91 -11.8 8.48 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.588 0.755 . . . . 75.31 110.278 177.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -66.93 117.39 8.95 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.035 0.934 . . . . 74.3 109.75 174.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.496 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 24.0 ttt -87.72 -18.68 28.94 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.558 0.343 . . . . 73.35 110.917 -176.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.5 -37.49 67.92 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.862 0.465 . . . . 74.51 110.22 172.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.485 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 44.0 t -66.44 -46.22 77.21 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.911 1.284 . . . . 63.02 111.343 175.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -61.75 -51.28 68.98 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 123.889 0.876 . . . . 74.01 110.478 -175.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.6 t -63.35 -40.85 90.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 123.914 0.885 . . . . 61.43 110.772 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 71.3 ttt180 -56.58 -39.91 74.33 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.257 1.023 . . . . 73.32 111.073 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 70' ' ' SER . 25.8 mm-40 -63.38 -45.91 88.92 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 123.653 0.596 . . . . 72.24 109.822 176.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 80' ' ' PHE . 64.4 mt -61.16 -37.43 82.87 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.729 0.811 . . . . 71.34 111.5 -178.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -58.55 -38.54 78.03 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 123.509 0.724 . . . . 52.42 111.371 172.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 34.1 mtm -70.86 -34.07 71.26 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.189 -0.459 . . . . 72.42 110.493 177.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.454 ' CZ ' ' HB3' ' A' ' 119' ' ' ARG . 44.4 m-85 -81.21 -9.62 59.75 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.595 0.758 . . . . 71.43 111.59 -178.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.96 22.69 59.01 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 114.268 0.467 . . . . 61.0 114.268 178.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.4 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 72.1 m-85 -79.49 137.17 37.11 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 108.443 -0.947 . . . . 61.31 108.443 171.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -102.81 127.14 50.1 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.153 0.581 . . . . 74.5 110.595 -170.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.402 ' HD2' HG23 ' A' ' 99' ' ' THR . 41.3 tptt -65.05 115.88 5.89 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.865 1.266 . . . . 74.51 109.707 173.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 59.5 t -123.29 120.28 59.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 108.731 -0.84 . . . . 71.13 108.731 175.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 37.5 t -90.77 121.47 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.069 0.948 . . . . 65.11 109.384 -176.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 -107.84 -46.78 3.72 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 122.619 0.368 . . . . 62.23 110.696 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 33.7 mm -69.48 115.57 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 108.274 -1.01 . . . . 75.34 108.274 168.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -67.47 117.91 10.07 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.692 0.797 . . . . 72.52 110.014 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 32.8 mm-40 -69.75 94.53 0.81 Allowed 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.924 0.89 . . . . 74.01 110.749 -174.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.84 163.57 30.21 Favored Glycine 0 C--O 1.242 0.6 0 CA-C-N 114.539 -1.21 . . . . 62.55 111.358 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.54 83.85 0.36 Allowed Glycine 0 C--N 1.339 0.73 0 O-C-N 123.79 0.347 . . . . 72.05 112.293 176.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.428 ' HB2' ' HG2' ' A' ' 93' ' ' LYS . 88.7 mt -117.01 170.39 8.68 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.338 1.055 . . . . 71.53 109.802 -178.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.6 p -70.25 -23.4 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 123.234 0.613 . . . . 75.43 111.094 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.428 ' HG2' ' HB2' ' A' ' 91' ' ' LEU . 16.4 ptmt -70.61 158.06 88.71 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 124.042 0.937 . . . . 60.1 110.19 178.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -58.5 141.59 97.4 Favored 'Trans proline' 0 C--N 1.385 2.454 0 C-N-CA 122.566 2.177 . . . . 74.24 112.639 -174.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -81.86 2.45 30.31 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.296 1.038 . . . . 74.32 111.371 -177.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.6 ptt180 -59.06 153.37 17.98 Favored 'General case' 0 C--N 1.36 1.026 0 C-N-CA 123.556 0.742 . . . . 61.31 110.205 173.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -97.52 113.39 25.08 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 107.166 -1.42 . . . . 61.24 107.166 175.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -100.65 122.13 42.79 Favored 'General case' 0 C--O 1.247 0.943 0 N-CA-C 107.262 -1.384 . . . . 72.15 107.262 174.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.402 HG23 ' HD2' ' A' ' 82' ' ' LYS . 77.3 m -123.34 128.49 49.98 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.13 -0.693 . . . . 50.5 109.13 176.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.476 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 35.2 tt0 -101.55 111.0 23.1 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 106.799 -1.556 . . . . 75.43 106.799 172.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -94.05 119.88 33.53 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.445 -1.317 . . . . 65.12 107.445 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -121.69 142.12 50.48 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.788 -0.642 . . . . 75.42 110.796 -174.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 45.5 t-80 -147.26 130.28 8.0 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 107.665 -1.235 . . . . 74.24 107.665 175.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -63.01 -20.9 72.69 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.816 2.344 . . . . 62.51 113.846 -172.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.472 ' SG ' ' HB3' ' A' ' 113' ' ' LEU . 36.7 t -101.64 35.36 2.33 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 123.306 0.642 . . . . 70.15 110.099 175.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -137.48 109.01 6.94 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.931 0.892 . . . . 74.34 108.848 172.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 85.0 mt -118.14 104.86 11.23 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 118.969 -0.539 . . . . 62.31 109.933 174.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 45.6 ttt180 52.14 -79.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 125.669 1.588 . . . . 75.11 112.688 176.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -141.57 42.13 1.18 Allowed Glycine 0 C--N 1.348 1.243 0 CA-C-N 115.827 -0.624 . . . . 32.43 111.923 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -82.1 74.19 9.09 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 106.677 -1.601 . . . . 70.52 106.677 173.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -62.0 -31.14 71.49 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.143 -1.39 . . . . 75.13 112.695 -171.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 17.5 pm0 -69.2 -16.89 63.72 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 122.502 0.321 . . . . 72.12 111.586 177.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.472 ' HB3' ' SG ' ' A' ' 105' ' ' CYS . 40.7 mt -87.24 -14.6 40.58 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.329 0.252 . . . . 73.43 111.462 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.407 HD23 HD12 ' A' ' 117' ' ' ILE . 96.5 mt -63.86 -33.82 76.56 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 122.976 0.51 . . . . 73.23 111.661 177.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -73.74 -5.88 43.47 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 112.2 0.444 . . . . 54.34 112.2 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.434 HD22 ' HA ' ' A' ' 113' ' ' LEU . 23.2 m-80 -101.56 -6.68 23.56 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.8 0.84 . . . . 71.54 109.594 175.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.407 HD12 HD23 ' A' ' 114' ' ' LEU . 44.2 mt -90.77 111.95 24.35 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 N-CA-C 107.226 -1.398 . . . . 73.02 107.226 174.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.421 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 11.4 mmpt? -101.25 136.69 40.68 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.347 0.659 . . . . 75.52 111.115 -167.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.454 ' HB3' ' CZ ' ' A' ' 78' ' ' TYR . 15.7 ptt180 -83.07 19.64 1.38 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 123.546 0.738 . . . . 73.14 112.867 178.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -103.68 132.61 49.78 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.55 -1.278 . . . . 74.32 107.55 164.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.1 p -80.6 78.27 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 CA-C-O 123.074 1.416 . . . . 61.24 109.579 -172.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 10.1 t -77.67 57.24 1.59 Allowed 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 113.299 -1.773 . . . . 53.54 110.816 177.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.4 t -162.69 142.8 9.48 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-N 115.374 -0.83 . . . . 74.11 108.995 -177.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 16.4 m -70.9 96.69 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.015 0 CA-C-O 121.561 0.696 . . . . 71.55 110.366 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 C--O 1.248 0.994 0 C-N-CA 123.807 0.843 . . . . 52.15 109.492 -175.105 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.6 mmm . . . . . 0 N--CA 1.476 0.873 0 N-CA-C 109.396 -0.594 . . . . 74.04 109.396 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 173.92 126.3 0.91 Allowed Glycine 0 C--N 1.333 0.372 0 N-CA-C 110.048 -1.221 . . . . 65.23 110.048 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 -144.73 106.34 4.26 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-N 117.496 0.648 . . . . 75.02 109.87 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 47.5 t60 -64.93 125.14 23.93 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 123.926 0.89 . . . . 75.01 109.141 174.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -64.31 104.49 0.77 Allowed 'General case' 0 N--CA 1.475 0.791 0 O-C-N 124.258 0.974 . . . . 64.0 109.569 176.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -92.8 145.18 24.6 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.041 -0.981 . . . . 52.24 110.209 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -118.24 127.16 53.46 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.824 -0.806 . . . . 73.13 108.824 175.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -85.65 101.78 13.03 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.052 -1.092 . . . . 74.53 108.052 171.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.0 p -79.95 65.05 4.98 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.904 0.859 . . . . 54.01 109.531 175.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -76.92 137.23 38.97 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.496 -1.229 . . . . 74.24 109.977 -175.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 21.6 ptm -145.9 171.27 15.07 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 124.513 1.125 . . . . 75.02 109.22 -178.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -146.15 172.62 13.16 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.003 0.921 . . . . 74.03 108.553 172.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -121.32 72.93 0.36 Allowed Glycine 0 N--CA 1.468 0.811 0 CA-C-O 119.528 -0.596 . . . . 72.24 112.352 176.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -88.46 12.15 2.88 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 122.475 2.117 . . . . 62.44 110.871 172.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.433 ' OG ' HG23 ' A' ' 17' ' ' VAL . 20.3 t -86.66 162.53 17.87 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 124.743 1.217 . . . . 74.53 109.676 -179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -85.78 7.06 25.19 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.171 0.588 . . . . 72.42 111.366 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.433 HG23 ' OG ' ' A' ' 15' ' ' SER . 52.6 t -57.49 119.63 34.06 Favored Pre-proline 0 N--CA 1.48 1.065 0 C-N-CA 124.434 1.094 . . . . 54.24 110.606 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -64.43 155.91 63.35 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 122.702 2.268 . . . . 74.31 111.44 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.24 -44.81 61.81 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.057 0.943 . . . . 64.53 112.232 -175.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -53.19 -46.33 68.94 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 123.17 0.588 . . . . 62.53 112.338 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 68.9 mt -80.26 -33.6 37.73 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 112.452 0.538 . . . . 63.14 112.452 -173.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.9 t -71.67 -34.83 70.04 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 117.723 0.238 . . . . 64.41 110.415 176.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.512 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -70.44 -43.87 69.01 Favored 'General case' 0 C--N 1.356 0.85 0 C-N-CA 122.817 0.447 . . . . 74.31 110.078 174.018 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.474 ' O ' HG23 ' A' ' 28' ' ' VAL . 68.6 tp -54.28 -56.51 17.74 Favored 'General case' 0 C--O 1.214 -0.784 0 O-C-N 124.312 1.007 . . . . 73.44 111.546 177.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.518 ' HZ2' ' H ' ' A' ' 109' ' ' GLY . 23.0 t90 -58.11 -45.46 87.24 Favored 'General case' 0 CA--C 1.552 1.026 0 O-C-N 123.52 0.512 . . . . 74.12 110.908 -176.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 33.6 m -64.82 -30.75 71.77 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.704 0.802 . . . . 73.03 111.536 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.542 HD11 ' CG1' ' A' ' 58' ' ' VAL . 37.3 tp -74.05 -45.15 51.3 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.45 1.1 . . . . 72.44 111.26 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 24' ' ' LEU . 71.4 t -61.76 -32.04 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.083 0 C-N-CA 124.092 0.957 . . . . 62.22 110.321 173.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.6 t -93.64 5.15 52.56 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 124.359 1.064 . . . . 73.31 111.988 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.7 t0 -85.83 121.5 73.1 Favored Pre-proline 0 N--CA 1.482 1.141 0 C-N-CA 123.056 0.542 . . . . 61.13 110.436 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.46 -14.05 27.78 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.765 2.31 . . . . 74.44 113.54 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -78.96 -33.47 45.17 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.368 0.667 . . . . 73.33 111.23 177.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 67.4 p -111.62 9.53 21.09 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.812 -0.631 . . . . 74.42 110.683 -176.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -56.79 -34.62 67.82 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.338 1.455 . . . . 61.22 112.305 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.33 -34.01 76.76 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.503 -0.771 . . . . 74.14 111.71 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.418 HD22 ' HB2' ' A' ' 50' ' ' ASP . 87.9 mt -104.75 -13.57 15.85 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.227 0.611 . . . . 74.44 111.397 -174.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.48 HG21 ' HG ' ' A' ' 27' ' ' LEU . 20.1 tt -161.2 119.69 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.966 0 C-N-CA 123.005 0.522 . . . . 74.34 110.246 175.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 16.7 p -150.04 150.23 31.46 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.367 0.667 . . . . 75.25 109.768 -179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.441 ' HE3' ' HA2' ' A' ' 43' ' ' GLY . 8.2 p-90 -89.98 153.74 20.36 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-O 121.006 0.431 . . . . 75.43 109.891 178.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.8 m -82.43 155.24 69.11 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 114.823 -1.08 . . . . 72.22 109.316 -175.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.18 -16.53 13.03 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 122.884 2.389 . . . . 74.01 114.135 173.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 21.6 m -71.14 -36.42 72.08 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.073 0.949 . . . . 64.13 111.399 174.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.441 ' HA2' ' HE3' ' A' ' 39' ' ' TRP . . . 82.16 1.49 90.37 Favored Glycine 0 C--N 1.345 1.067 0 CA-C-N 115.744 -0.662 . . . . 72.42 114.66 176.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -103.08 -3.23 26.2 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.259 0.624 . . . . 54.4 111.09 -175.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.8 p -154.68 163.25 40.52 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.405 0.682 . . . . 51.11 110.599 -170.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -142.13 152.26 43.05 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.88 0.472 . . . . 74.54 110.446 174.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -109.16 148.68 30.52 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.776 0.83 . . . . 62.43 109.235 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 82.7 t -123.73 131.83 72.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 108.223 -1.029 . . . . 71.11 108.223 177.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 94.0 m-85 -115.41 147.19 40.84 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.864 0.866 . . . . 62.5 110.217 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.418 ' HB2' HD22 ' A' ' 36' ' ' LEU . 17.6 m-20 51.43 67.56 0.93 Allowed 'General case' 0 N--CA 1.481 1.113 0 O-C-N 124.647 1.217 . . . . 75.35 111.823 173.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -53.77 -31.34 48.32 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 114.516 1.302 . . . . 74.41 114.516 -172.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.4 -43.92 43.9 Favored Glycine 0 CA--C 1.532 1.146 0 N-CA-C 112.058 -0.417 . . . . 71.52 112.058 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.428 ' NE2' ' HD3' ' A' ' 56' ' ' LYS . 20.3 tp60 -72.29 -32.67 66.8 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.67 1.188 . . . . 61.45 110.968 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.462 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 53.6 t80 -69.71 -50.73 40.81 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.848 1.259 . . . . 75.34 109.762 178.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.496 ' HB1' ' O ' ' A' ' 66' ' ' ASN . . . -62.17 -32.14 72.73 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.628 -0.715 . . . . 74.5 112.135 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.428 ' HD3' ' NE2' ' A' ' 53' ' ' GLN . 31.5 tttm -62.38 -53.67 51.59 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.046 1.339 . . . . 71.22 113.45 -176.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -122.11 -22.11 5.74 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 114.033 1.123 . . . . 73.43 114.033 -170.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.542 ' CG1' HD11 ' A' ' 27' ' ' LEU . 85.7 t -86.44 -45.03 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.16 0.584 . . . . 72.25 110.824 -175.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 26.3 mt -62.88 -48.83 84.38 Favored Pre-proline 0 CA--C 1.559 1.305 0 CA-C-O 118.507 -0.759 . . . . 73.44 112.55 177.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.417 ' HG3' ' ND2' ' A' ' 66' ' ' ASN . 55.6 Cg_endo -67.56 -13.18 38.2 Favored 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 121.926 1.75 . . . . 64.11 113.239 175.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -73.28 -54.07 9.31 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.262 0.625 . . . . 73.41 110.675 176.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.5 ' CD1' HD13 ' A' ' 27' ' ' LEU . 35.5 m-85 -92.84 -43.71 8.85 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 112.194 0.442 . . . . 74.1 112.194 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -98.77 -176.99 3.51 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.488 0.715 . . . . 72.33 109.335 -178.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.55 39.68 2.58 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.312 0.577 . . . . 72.51 111.132 -174.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -161.23 162.12 31.06 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.881 0.873 . . . . 53.33 109.875 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.496 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 7.3 m120 -106.8 -26.22 11.37 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 108.618 -0.882 . . . . 53.13 108.618 173.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -61.03 115.31 3.64 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.114 0.965 . . . . 64.22 111.52 -177.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.476 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 24.9 ttt -83.13 -20.11 35.43 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 116.195 -0.457 . . . . 75.12 111.296 -177.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.93 -36.2 72.16 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 122.356 0.262 . . . . 72.45 110.525 172.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.492 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 37.2 t -63.32 -51.69 64.96 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.085 0.954 . . . . 45.11 110.727 172.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -58.08 -54.9 41.7 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.166 0.986 . . . . 71.24 111.342 -174.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.7 t -64.1 -37.75 80.65 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.03 0 CA-C-N 115.506 -0.77 . . . . 71.33 111.033 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 58.2 ttt-85 -59.44 -43.9 93.02 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 117.894 0.316 . . . . 75.44 111.396 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 70' ' ' SER . 10.0 mm100 -62.0 -44.26 97.1 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 123.535 0.522 . . . . 74.42 109.627 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.1 mt -59.32 -41.16 88.44 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 123.946 0.779 . . . . 73.53 111.567 176.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -61.25 -37.59 83.66 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.589 0.756 . . . . 73.42 111.181 175.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 41.9 mtm -68.83 -31.87 71.15 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 122.757 0.423 . . . . 75.12 110.565 173.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -81.78 -4.01 55.29 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 123.963 0.905 . . . . 71.54 111.137 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.65 15.09 74.23 Favored Glycine 0 C--N 1.345 1.079 0 CA-C-O 119.527 -0.596 . . . . 71.23 114.353 175.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -72.91 131.91 42.81 Favored 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 117.683 0.741 . . . . 75.11 109.222 178.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -99.42 121.77 41.6 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 109.144 -0.687 . . . . 54.14 109.144 -174.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.554 ' HE2' HG22 ' A' ' 84' ' ' VAL . 1.2 tmtp? -79.21 127.66 32.33 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.802 1.241 . . . . 73.02 108.063 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.544 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 61.7 t -123.75 129.17 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.166 0.986 . . . . 74.14 108.631 178.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.554 HG22 ' HE2' ' A' ' 82' ' ' LYS . 30.6 t -92.25 134.0 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 108.279 -1.008 . . . . 73.04 108.279 178.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 46.6 m-70 -118.21 -0.26 11.59 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 122.774 0.43 . . . . 74.32 111.099 175.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 48.1 mm -108.98 100.23 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.73 0.812 . . . . 74.0 109.294 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -82.1 168.02 18.17 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.231 0.612 . . . . 73.22 110.707 175.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 31.0 mm-40 -107.39 123.42 48.35 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.845 0.858 . . . . 71.34 109.02 177.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 170.96 -69.97 0.12 Allowed Glycine 0 C--N 1.341 0.846 0 N-CA-C 111.658 -0.577 . . . . 61.32 111.658 179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 173.71 76.39 0.05 OUTLIER Glycine 0 C--N 1.337 0.605 0 N-CA-C 110.719 -0.952 . . . . 71.03 110.719 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.524 HD13 ' HD3' ' A' ' 93' ' ' LYS . 71.0 mt -87.1 156.1 19.86 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.614 0.765 . . . . 70.45 110.929 -177.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.5 p -87.32 -14.6 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 123.98 0.912 . . . . 63.52 108.953 165.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.524 ' HD3' HD13 ' A' ' 91' ' ' LEU . 24.8 mtpp -65.78 158.83 73.13 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 125.578 1.551 . . . . 73.34 110.619 177.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -69.48 141.22 45.76 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 121.612 1.541 . . . . 70.42 110.76 171.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -80.8 3.66 21.7 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.497 0.719 . . . . 73.31 112.126 -174.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -63.79 169.69 3.93 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.653 0.781 . . . . 71.15 110.735 173.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.534 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 3.6 m-20 -81.08 119.4 23.5 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.53 -0.915 . . . . 75.23 108.53 -175.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -115.87 107.34 14.88 Favored 'General case' 0 C--O 1.243 0.757 0 N-CA-C 108.349 -0.982 . . . . 53.32 108.349 170.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.456 HG23 ' HG2' ' A' ' 82' ' ' LYS . 46.7 m -124.23 114.76 20.04 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 114.538 -1.21 . . . . 75.32 109.382 -172.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.544 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 32.0 tt0 -101.18 114.34 28.2 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 109.008 -0.738 . . . . 71.33 109.008 -176.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -96.95 119.95 36.38 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.109 -1.071 . . . . 75.45 108.109 171.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -123.02 141.61 51.77 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.239 0.615 . . . . 73.51 110.093 -177.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -158.68 132.52 4.99 Favored Pre-proline 0 CA--C 1.547 0.834 0 N-CA-C 109.16 -0.681 . . . . 72.44 109.16 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -65.2 -22.48 60.99 Favored 'Trans proline' 0 C--N 1.384 2.433 0 C-N-CA 123.054 2.503 . . . . 65.24 114.131 -173.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.548 ' HB2' HG12 ' A' ' 117' ' ' ILE . 13.6 m -92.39 -1.52 56.96 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 122.695 0.398 . . . . 65.02 111.839 -179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -104.72 98.37 8.12 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 107.132 -1.432 . . . . 75.0 107.132 175.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 110' ' ' GLN . 67.1 mt -125.45 166.44 16.61 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 121.663 0.744 . . . . 64.03 111.918 -177.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -58.0 115.91 3.17 Favored 'General case' 0 CA--C 1.556 1.209 0 CA-C-N 113.883 -1.508 . . . . 71.12 111.673 170.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.518 ' H ' ' HZ2' ' A' ' 25' ' ' TRP . . . 70.21 7.0 59.17 Favored Glycine 0 CA--C 1.532 1.155 0 N-CA-C 115.041 0.776 . . . . 50.32 115.041 174.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.428 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 16.4 mm100 -100.67 65.41 1.15 Allowed 'General case' 0 C--O 1.242 0.67 0 CA-C-O 121.466 0.65 . . . . 54.33 110.296 -175.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -57.29 -36.07 70.6 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 114.895 -1.048 . . . . 71.0 111.482 173.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 19.2 pm0 -68.45 -16.59 63.96 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.204 0.601 . . . . 74.03 111.93 -176.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 79.9 mt -96.49 -19.68 18.95 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.335 0.654 . . . . 71.51 111.555 176.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 82.1 mt -67.03 -37.42 84.08 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.069 0.547 . . . . 73.24 110.682 178.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -69.23 -13.85 62.63 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.647 -0.706 . . . . 61.53 112.278 175.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -97.36 4.75 50.62 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.115 0.566 . . . . 71.42 110.369 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.548 HG12 ' HB2' ' A' ' 105' ' ' CYS . 44.9 mt -89.68 119.2 36.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 108.049 -1.093 . . . . 74.01 108.049 173.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.6 mmmm -95.58 132.43 40.73 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.83 0.852 . . . . 62.52 111.411 -165.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -109.03 -8.63 15.16 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 124.099 0.96 . . . . 73.5 111.386 173.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -98.8 167.97 10.42 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.241 0.616 . . . . 73.43 110.578 175.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . 0.27 9.2 p 39.79 69.4 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 126.24 1.816 . . . . 71.13 112.46 -172.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 15.3 t -166.42 -158.64 0.33 Allowed 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 113.742 -1.572 . . . . 72.02 107.858 -172.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 78.4 p -72.56 73.24 1.03 Allowed 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 123.206 0.603 . . . . 61.31 111.22 176.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 17.5 t -89.28 67.24 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 107.808 -1.182 . . . . 63.14 107.808 177.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 72.0 m . . . . . 0 C--O 1.247 0.956 0 N-CA-C 107.354 -1.35 . . . . 62.34 107.354 178.8 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.485 1.287 0 N-CA-C 109.713 -0.477 . . . . 64.02 109.713 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 69.33 -103.48 1.1 Allowed Glycine 0 C--N 1.353 1.494 0 O-C-N 123.428 0.455 . . . . 74.15 112.115 -177.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.1 p80 -162.06 141.1 9.49 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.559 0.744 . . . . 60.4 109.847 173.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -155.3 81.15 1.05 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 109.388 -0.597 . . . . 74.13 109.388 176.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -130.23 83.91 2.16 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 107.431 -1.322 . . . . 73.21 107.431 177.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -107.99 128.87 55.03 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.585 0.754 . . . . 74.12 110.754 -178.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -146.97 162.32 38.99 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 124.741 1.216 . . . . 75.02 109.353 173.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -169.44 146.26 3.39 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.823 0.849 . . . . 52.24 109.667 174.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.8 m -77.31 96.75 4.67 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 123.659 0.6 . . . . 74.42 110.705 -173.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -74.11 123.25 24.07 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.289 -0.869 . . . . 71.55 109.805 -178.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -135.05 158.19 44.99 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.124 0.57 . . . . 72.13 110.922 -173.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.75 97.67 2.64 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.059 0.944 . . . . 62.32 108.835 178.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.99 148.57 44.77 Favored Glycine 0 C--N 1.353 1.5 0 CA-C-O 119.283 -0.732 . . . . 51.14 113.239 -175.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -79.62 175.85 10.18 Favored 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 122.969 2.446 . . . . 71.21 112.58 177.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 8.1 t -113.83 179.69 3.89 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.431 0.692 . . . . 53.21 109.491 177.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.3 m-80 -66.09 -14.66 62.14 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 122.796 0.438 . . . . 73.2 111.541 178.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.443 HG13 ' HB2' ' A' ' 114' ' ' LEU . 54.9 t -57.12 117.69 19.55 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 124.846 1.258 . . . . 75.45 110.927 176.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -55.76 146.81 64.44 Favored 'Trans proline' 0 C--N 1.383 2.353 0 C-N-CA 123.149 2.566 . . . . 61.1 112.733 176.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.56 -43.76 62.49 Favored 'General case' 0 N--CA 1.475 0.791 0 O-C-N 124.198 0.936 . . . . 71.12 111.674 177.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.418 ' HA ' ' HE1' ' A' ' 63' ' ' PHE . 86.9 t80 -50.05 -51.41 42.62 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.358 1.063 . . . . 73.22 112.307 174.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 98.1 mt -80.5 -34.43 35.74 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 123.474 0.484 . . . . 73.41 112.103 -169.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.6 t -69.89 -34.36 73.43 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 122.286 0.234 . . . . 64.34 110.992 178.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.411 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -68.11 -44.76 75.42 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 109.749 -0.463 . . . . 73.32 109.749 171.174 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.2 tp -60.01 -40.37 89.01 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.012 0.925 . . . . 72.54 111.686 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.473 ' HB2' HD11 ' A' ' 114' ' ' LEU . 91.0 t90 -54.9 -56.2 22.22 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.412 1.085 . . . . 74.02 111.56 177.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.6 m -60.66 -38.32 84.48 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.895 -1.048 . . . . 73.55 110.604 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.494 HD11 ' CG1' ' A' ' 58' ' ' VAL . 34.3 tp -64.9 -52.0 58.87 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.351 1.46 . . . . 74.41 113.057 -174.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.7 t -57.19 -33.43 43.16 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 C-N-CA 124.015 0.926 . . . . 71.4 112.047 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.5 t -96.92 -3.19 42.28 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.825 0.85 . . . . 60.12 112.125 -177.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.401 ' HB3' ' OG1' ' A' ' 33' ' ' THR . 37.2 t70 -76.93 128.97 80.12 Favored Pre-proline 0 N--CA 1.483 1.198 0 C-N-CA 123.419 0.688 . . . . 71.32 111.61 -170.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -65.37 -24.44 57.45 Favored 'Trans proline' 0 C--N 1.376 2.009 0 C-N-CA 123.125 2.55 . . . . 75.04 113.5 -177.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -78.46 -29.34 46.82 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 122.618 0.367 . . . . 64.21 110.87 -179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.401 ' OG1' ' HB3' ' A' ' 30' ' ' ASP . 68.1 p -115.6 -5.35 12.19 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 113.369 0.877 . . . . 73.12 113.369 -172.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.492 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 2.8 p-10 -64.69 -21.4 66.73 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 118.664 0.666 . . . . 75.13 112.452 -172.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.29 -33.68 76.04 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.758 0.423 . . . . 72.44 111.337 174.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.591 HD22 ' HB2' ' A' ' 50' ' ' ASP . 43.3 mt -107.09 -12.92 15.3 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.565 0.746 . . . . 63.41 111.587 -175.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 34' ' ' ASP . 15.0 tt -156.77 108.81 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 CA-C-O 121.325 0.583 . . . . 74.23 110.495 175.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.437 ' HB3' ' O ' ' A' ' 34' ' ' ASP . 23.5 p -133.62 145.96 50.48 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.678 0.391 . . . . 73.42 111.284 -172.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 18.4 p-90 -72.58 148.98 44.39 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.226 1.011 . . . . 74.03 111.194 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 25.3 p -70.94 153.1 94.89 Favored Pre-proline 0 CA--C 1.554 1.129 0 C-N-CA 123.19 0.596 . . . . 70.51 110.088 173.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -46.63 -31.9 10.96 Favored 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 123.333 2.688 . . . . 65.04 113.191 171.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 34.9 t -71.31 -60.47 2.21 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.514 -0.767 . . . . 70.54 109.517 170.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 103.53 19.45 12.26 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-N 115.513 -0.767 . . . . 65.53 113.706 178.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -101.64 6.6 42.07 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 123.58 0.752 . . . . 72.2 110.491 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.6 p -160.13 164.32 33.07 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 123.984 0.914 . . . . 53.2 109.431 -173.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 54.1 p90 -142.38 144.4 33.13 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.54 0.336 . . . . 74.43 111.176 178.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.47 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 59.3 m-70 -97.27 149.43 22.06 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.317 1.047 . . . . 74.33 108.813 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 98' ' ' ASP . 62.8 t -126.82 114.69 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.813 -0.81 . . . . 73.35 108.813 178.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -111.04 149.34 30.88 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.367 1.067 . . . . 73.14 110.227 -176.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.591 ' HB2' HD22 ' A' ' 36' ' ' LEU . 3.9 m-20 52.72 55.03 9.6 Favored 'General case' 0 N--CA 1.484 1.25 0 O-C-N 124.561 1.163 . . . . 71.44 110.061 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.534 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 78.3 mt-30 -55.3 -25.21 32.87 Favored 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 114.326 1.232 . . . . 52.21 114.326 -169.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.75 -44.56 56.33 Favored Glycine 0 CA--C 1.533 1.206 0 N-CA-C 111.923 -0.471 . . . . 65.34 111.923 173.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -70.5 -45.06 66.36 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.78 0.832 . . . . 74.31 109.853 179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.434 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 69.2 t80 -48.44 -52.85 20.16 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.384 1.474 . . . . 74.32 111.689 173.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.488 ' HB2' ' HB2' ' A' ' 68' ' ' MET . . . -62.61 -33.3 74.73 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 116.336 -0.393 . . . . 44.33 111.693 178.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.1 tmtm? -73.38 -41.88 62.84 Favored 'General case' 0 CA--C 1.556 1.199 0 C-N-CA 124.208 1.003 . . . . 54.53 113.244 -176.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.561 ' HG3' HG23 ' A' ' 58' ' ' VAL . 4.1 pt-20 -111.15 -39.63 4.69 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 113.583 0.957 . . . . 70.04 113.583 -172.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.561 HG23 ' HG3' ' A' ' 57' ' ' GLU . 66.3 t -80.28 -46.76 21.66 Favored 'Isoleucine or valine' 0 C--O 1.248 0.987 0 C-N-CA 123.725 0.81 . . . . 71.34 111.351 -168.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 54.9 mt -67.19 -41.7 35.73 Favored Pre-proline 0 CA--C 1.557 1.22 0 CA-C-O 118.326 -0.845 . . . . 74.32 112.757 -176.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.53 -17.58 53.34 Favored 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 121.941 1.761 . . . . 45.11 114.011 170.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -72.6 -57.88 3.79 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 117.858 0.299 . . . . 71.31 110.629 176.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.459 ' CD1' HD13 ' A' ' 27' ' ' LEU . 37.5 m-85 -86.26 -40.26 15.71 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 112.14 0.422 . . . . 74.14 112.14 -175.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.418 ' HE1' ' HA ' ' A' ' 20' ' ' PHE . 48.8 m-85 -106.98 -178.17 3.57 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.749 -0.834 . . . . 74.04 108.749 -178.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -119.17 54.58 0.97 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 122.436 1.113 . . . . 74.02 109.557 -176.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -170.7 171.7 6.1 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.673 1.589 . . . . 73.31 107.81 178.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -117.95 -24.48 7.07 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 122.29 -0.257 . . . . 65.22 111.071 -179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -63.53 125.93 25.84 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.345 0.658 . . . . 74.1 112.054 -173.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.534 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 25.3 ttt -86.68 -29.63 22.33 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.388 0.675 . . . . 70.13 111.646 -176.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.37 -34.45 70.7 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 122.799 0.439 . . . . 43.34 111.36 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.448 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 44.1 t -66.74 -45.31 79.05 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.275 1.03 . . . . 70.33 110.789 173.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -63.14 -46.86 85.25 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.442 1.097 . . . . 75.21 110.565 -176.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 80.5 t -60.99 -45.31 98.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 124.23 1.012 . . . . 63.22 110.947 174.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 56.3 ttp180 -62.52 -32.6 73.56 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.781 0.432 . . . . 73.34 111.318 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.461 ' HA ' ' HE2' ' A' ' 77' ' ' MET . 29.1 mm-40 -62.94 -51.71 65.84 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 109.903 -0.406 . . . . 74.3 109.903 172.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.9 mt -58.92 -38.0 77.95 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.859 0.864 . . . . 72.11 111.779 -177.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -59.13 -43.74 91.99 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.484 0.713 . . . . 73.12 111.075 175.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.461 ' HE2' ' HA ' ' A' ' 74' ' ' GLN . 43.6 mtm -67.29 -35.48 79.55 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.73 -0.668 . . . . 71.14 110.366 175.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -80.1 8.73 6.6 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 123.525 0.73 . . . . 63.15 110.917 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 84.29 4.82 87.8 Favored Glycine 0 C--N 1.351 1.41 0 N-CA-C 114.511 0.564 . . . . 51.51 114.511 169.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.55 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . 39.8 m-85 -74.09 141.27 45.67 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 108.939 -0.763 . . . . 74.12 108.939 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.499 ' HB3' ' HG2' ' A' ' 102' ' ' GLN . 32.7 ttm180 -101.6 129.07 47.63 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 122.774 0.43 . . . . 72.44 110.101 -173.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -71.92 111.54 7.26 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.897 1.279 . . . . 63.42 109.855 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 42.2 t -126.19 136.26 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 107.72 -1.215 . . . . 65.11 107.72 172.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 96.3 t -119.28 139.46 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.355 0.662 . . . . 74.14 109.322 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -117.01 -44.53 2.8 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.841 0.456 . . . . 74.54 110.704 -178.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.563 ' HA ' ' HE2' ' A' ' 93' ' ' LYS . 23.1 mm -67.35 132.94 32.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 N-CA-C 110.168 -0.308 . . . . 62.52 110.168 173.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -114.09 130.8 56.56 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.285 1.034 . . . . 72.51 108.676 -177.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -96.34 141.12 30.04 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.642 0.377 . . . . 63.32 111.168 -174.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 139.77 -151.0 21.79 Favored Glycine 0 C--N 1.337 0.625 0 N-CA-C 110.455 -1.058 . . . . 72.53 110.455 -177.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -94.73 62.26 1.64 Allowed Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.6 -0.6 . . . . 41.34 111.6 175.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 96.5 mt -119.47 150.8 39.63 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.779 0.832 . . . . 62.0 109.913 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.5 p -82.37 71.67 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.105 0 CA-C-O 122.863 1.316 . . . . 44.54 110.912 -172.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.563 ' HE2' ' HA ' ' A' ' 86' ' ' ILE . 17.9 ptmt -166.22 156.98 11.38 Favored Pre-proline 0 CA--C 1.553 1.088 0 CA-C-N 114.168 -1.378 . . . . 73.11 108.13 179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.569 ' HB2' ' HG2' ' A' ' 96' ' ' ARG . 35.1 Cg_endo -61.29 158.89 33.28 Favored 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 122.457 2.105 . . . . 60.22 113.209 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -95.62 4.06 53.44 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 115.093 -0.958 . . . . 73.24 111.647 -174.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.569 ' HG2' ' HB2' ' A' ' 94' ' ' PRO . 5.3 ptp180 -71.76 100.58 2.39 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.198 0.599 . . . . 74.21 109.832 174.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -40.43 123.13 1.73 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.056 0.943 . . . . 74.11 111.118 171.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.429 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 22.0 t70 -112.3 134.88 53.59 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 109.386 -0.598 . . . . 73.13 109.386 178.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 73.9 m -133.9 128.53 34.75 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.049 -0.723 . . . . 64.02 109.049 166.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 46' ' ' PHE . 33.7 tt0 -104.46 117.09 33.32 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 108.02 -1.104 . . . . 74.43 108.02 170.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.55 ' HB3' ' HB3' ' A' ' 80' ' ' PHE . 97.7 m-85 -95.85 120.01 35.36 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 107.668 -1.234 . . . . 75.13 107.668 173.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.499 ' HG2' ' HB3' ' A' ' 81' ' ' ARG . 13.3 pt20 -115.74 136.45 53.05 Favored 'General case' 0 C--O 1.243 0.73 0 C-N-CA 123.182 0.593 . . . . 73.23 110.06 -174.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -156.43 128.73 4.07 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 123.021 0.529 . . . . 72.51 109.764 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.36 -39.74 44.68 Favored 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 123.089 2.526 . . . . 64.33 112.647 -174.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.516 ' HB2' HG12 ' A' ' 117' ' ' ILE . 3.4 m -81.66 -4.18 55.49 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.313 0.645 . . . . 73.14 110.754 -175.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -99.07 106.9 19.17 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 108.04 -1.096 . . . . 74.33 108.04 176.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.568 ' HB2' ' HB3' ' A' ' 110' ' ' GLN . 74.4 mt -117.1 141.59 48.07 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 108.733 -0.84 . . . . 71.51 108.733 169.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -60.32 -30.5 69.54 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 124.414 1.071 . . . . 54.42 112.69 -170.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -130.03 39.42 1.82 Allowed Glycine 0 C--N 1.345 1.032 0 N-CA-C 111.697 -0.561 . . . . 73.04 111.697 -178.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.568 ' HB3' ' HB2' ' A' ' 107' ' ' LEU . 3.0 tp-100 -141.58 74.09 1.44 Allowed 'General case' 0 C--O 1.241 0.627 0 N-CA-C 108.338 -0.986 . . . . 70.1 108.338 178.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -65.31 -22.78 66.87 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 114.895 -1.048 . . . . 74.21 112.795 -176.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -71.45 -16.97 62.4 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.874 0.47 . . . . 75.24 112.258 -178.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.431 ' HA ' HD22 ' A' ' 116' ' ' ASN . 53.7 mt -93.49 -7.13 45.24 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 112.071 0.397 . . . . 73.41 112.071 178.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.473 HD11 ' HB2' ' A' ' 25' ' ' TRP . 66.4 mt -71.07 -27.63 63.76 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.612 0.365 . . . . 61.34 111.368 177.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -76.29 -3.69 38.0 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 112.097 0.406 . . . . 73.15 112.097 176.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.431 HD22 ' HA ' ' A' ' 113' ' ' LEU . 23.3 m-80 -101.43 -6.96 23.33 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.945 0.898 . . . . 61.24 109.893 174.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.516 HG12 ' HB2' ' A' ' 105' ' ' CYS . 54.4 mt -87.55 117.33 31.3 Favored 'Isoleucine or valine' 0 C--N 1.354 0.79 0 N-CA-C 107.684 -1.228 . . . . 62.23 107.684 173.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -106.58 140.26 39.74 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 109.347 -0.612 . . . . 63.33 109.347 -174.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -85.86 36.92 0.68 Allowed 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 121.682 0.753 . . . . 55.42 111.286 174.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -132.65 138.88 47.48 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 107.216 -1.401 . . . . 74.43 107.216 175.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.2 p -149.94 92.39 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 122.097 0.951 . . . . 74.31 109.269 -170.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.2 t -62.48 91.96 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 114.24 -1.345 . . . . 51.11 110.432 176.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 67.5 m -72.98 91.7 1.58 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.353 -0.839 . . . . 61.05 110.581 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.7 p -64.37 109.21 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.087 0 C-N-CA 124.234 1.014 . . . . 73.32 110.329 177.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.6 m . . . . . 0 C--O 1.254 1.32 0 C-N-CA 123.983 0.913 . . . . 64.51 109.813 -170.941 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptm . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 110.135 -0.321 . . . . 75.33 110.135 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.5 -28.68 3.03 Favored Glycine 0 CA--C 1.535 1.336 0 N-CA-C 115.823 1.089 . . . . 74.3 115.823 169.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -72.89 -22.14 60.8 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 117.426 0.613 . . . . 74.41 111.939 -172.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -86.18 31.69 0.64 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 123.468 0.707 . . . . 43.54 111.083 176.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -52.31 -35.73 51.4 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.746 1.618 . . . . 73.25 112.035 -173.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -128.27 80.44 1.96 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.498 1.119 . . . . 70.1 109.012 168.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 53.4 t60 -126.97 101.46 6.57 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 124.262 1.025 . . . . 61.45 108.444 171.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 68.4 t60 -74.51 92.29 2.35 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 109.233 -0.654 . . . . 63.51 109.233 173.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.3 t -88.05 -89.69 0.13 Allowed 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 106.421 -1.696 . . . . 75.51 106.421 167.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 27.0 m80 -157.07 143.41 18.07 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.545 1.138 . . . . 75.34 108.863 170.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 81.2 mtp -84.09 151.47 24.91 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 108.948 -0.76 . . . . 74.2 108.948 171.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.68 108.37 0.83 Allowed 'General case' 0 CA--C 1.545 0.751 0 O-C-N 124.173 0.92 . . . . 72.0 111.482 -177.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -164.75 63.77 0.23 Allowed Glycine 0 CA--C 1.533 1.211 0 N-CA-C 111.038 -0.825 . . . . 32.14 111.038 177.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -81.9 -1.0 10.65 Favored 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 123.04 2.494 . . . . 54.03 113.556 -173.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 68.4 p 53.25 -86.66 0.01 OUTLIER 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 125.697 1.599 . . . . 64.34 112.172 -173.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.23 39.41 7.45 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.202 1.001 . . . . 61.35 110.248 -177.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 57.2 t -65.94 126.42 91.78 Favored Pre-proline 0 CA--C 1.548 0.897 0 CA-C-N 114.665 -1.152 . . . . 71.12 109.136 170.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -50.26 133.63 36.45 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.886 2.391 . . . . 61.41 111.868 168.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.42 -38.41 59.03 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.62 1.168 . . . . 45.15 112.031 -178.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -52.14 -49.22 64.16 Favored 'General case' 0 CA--C 1.547 0.845 0 O-C-N 124.166 0.916 . . . . 71.33 111.638 174.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.439 HD13 ' HB ' ' A' ' 117' ' ' ILE . 95.2 mt -77.41 -43.14 33.62 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.259 0.624 . . . . 73.32 112.026 -170.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.0 t -64.35 -41.33 96.81 Favored 'General case' 0 CA--C 1.551 1.017 0 O-C-N 123.22 0.325 . . . . 74.25 110.71 -178.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -77.38 -27.1 52.41 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.9 0.48 . . . . 75.11 111.114 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.485 ' O ' HG23 ' A' ' 28' ' ' VAL . 60.7 tp -59.16 -50.35 74.39 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 123.566 0.541 . . . . 75.33 111.078 172.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.424 ' HH2' ' HG3' ' A' ' 108' ' ' ARG . 34.7 t-105 -63.52 -40.7 97.73 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-N 117.777 0.262 . . . . 74.31 111.405 177.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.6 m -57.34 -37.08 72.01 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-O 121.579 0.704 . . . . 60.54 110.402 176.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.518 HD11 HG13 ' A' ' 58' ' ' VAL . 35.3 tp -70.58 -45.46 65.35 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 125.358 1.463 . . . . 65.21 112.31 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 24' ' ' LEU . 91.8 t -62.02 -35.34 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 123.437 0.695 . . . . 72.4 111.066 177.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.6 t -90.22 -0.09 57.45 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.944 0.898 . . . . 64.35 111.809 -177.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -84.36 127.11 67.49 Favored Pre-proline 0 N--CA 1.483 1.191 0 C-N-CA 123.036 0.534 . . . . 43.24 110.47 -178.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -74.67 -20.62 17.5 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.743 2.295 . . . . 41.44 113.306 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -81.54 -22.82 37.61 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.128 0.571 . . . . 64.05 111.42 -176.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 25.7 p -111.88 6.73 19.73 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.353 0.661 . . . . 62.51 112.258 177.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.423 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 0.6 OUTLIER -59.51 -29.75 68.09 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.041 0.537 . . . . 61.02 111.914 -174.357 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.69 -28.66 70.09 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.825 0.85 . . . . 72.32 112.181 -177.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.462 HD22 ' HB2' ' A' ' 50' ' ' ASP . 87.9 mt -116.21 -9.96 11.53 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.245 0.618 . . . . 75.12 111.702 -177.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 34' ' ' ASP . 17.3 tt -160.43 118.91 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 121.312 0.577 . . . . 74.42 110.837 171.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 8.4 p -148.69 151.78 35.51 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.568 0.747 . . . . 72.0 109.502 -178.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 7.7 p-90 -70.13 152.46 44.28 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.29 0.636 . . . . 73.33 110.213 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 50.5 m -71.71 154.3 93.05 Favored Pre-proline 0 CA--C 1.561 1.389 0 C-N-CA 123.818 0.847 . . . . 74.13 110.097 173.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -40.08 -46.67 4.03 Favored 'Trans proline' 0 C--N 1.389 2.663 0 C-N-CA 124.403 3.402 . . . . 75.52 114.994 -175.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 30.5 t -80.21 -41.27 25.52 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 122.697 0.399 . . . . 72.54 110.331 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.82 28.21 7.96 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-N 116.04 -0.527 . . . . 71.23 113.186 176.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -82.54 -10.69 58.88 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.582 0.753 . . . . 73.31 110.776 174.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.457 ' HB3' ' HB3' ' A' ' 102' ' ' GLN . 68.2 p -155.72 -176.79 6.13 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 123.741 0.816 . . . . 74.31 110.135 -177.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 37.4 p90 -141.95 145.97 35.11 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.376 0.671 . . . . 72.11 110.191 175.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 54.1 m-70 -97.64 147.66 24.09 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.059 0.944 . . . . 63.11 108.844 176.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 95.1 t -125.08 123.11 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.689 1.196 . . . . 72.43 108.095 175.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.459 ' HB2' ' HA ' ' A' ' 36' ' ' LEU . 97.0 m-85 -110.35 147.34 34.13 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.675 0.79 . . . . 54.13 110.867 -177.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.462 ' HB2' HD22 ' A' ' 36' ' ' LEU . 6.4 m-20 50.52 68.32 0.79 Allowed 'General case' 0 CA--C 1.541 0.62 0 O-C-N 124.922 1.389 . . . . 71.23 111.812 174.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -47.81 -32.81 6.48 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.729 1.211 . . . . 75.22 114.036 -173.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.4 -44.86 50.23 Favored Glycine 0 CA--C 1.531 1.07 0 O-C-N 123.397 0.435 . . . . 65.31 112.706 176.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -74.04 -44.92 52.61 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.554 0.741 . . . . 72.22 110.182 -176.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.404 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 69.1 t80 -49.56 -50.93 40.26 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.482 1.513 . . . . 74.22 111.209 169.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.498 ' HB2' ' HB2' ' A' ' 68' ' ' MET . . . -62.09 -35.52 78.92 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 116.196 -0.456 . . . . 53.34 111.872 178.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -68.33 -46.82 69.15 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 124.27 1.028 . . . . 64.32 112.642 -175.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.452 ' HG3' HG23 ' A' ' 58' ' ' VAL . 11.9 pt-20 -115.16 -34.84 4.88 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 114.175 1.176 . . . . 72.3 114.175 -171.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.518 HG13 HD11 ' A' ' 27' ' ' LEU . 92.2 t -82.23 -42.27 18.62 Favored 'Isoleucine or valine' 0 C--O 1.247 0.929 0 C-N-CA 123.24 0.616 . . . . 70.4 110.987 -169.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 43.4 mt -66.02 -48.77 59.74 Favored Pre-proline 0 CA--C 1.558 1.272 0 CA-C-O 117.915 -1.041 . . . . 65.4 112.363 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -67.63 -13.95 40.49 Favored 'Trans proline' 0 C--N 1.384 2.432 0 CA-C-N 121.934 1.726 . . . . 45.31 113.046 175.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -72.64 -59.03 2.92 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.102 0.561 . . . . 74.2 110.119 176.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.475 ' CD1' HD13 ' A' ' 27' ' ' LEU . 37.2 m-85 -89.73 -47.99 7.56 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 112.405 0.521 . . . . 74.41 112.405 -179.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -93.82 -177.92 4.51 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 108.498 -0.927 . . . . 73.35 108.498 -178.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -116.93 43.79 2.2 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.778 -0.576 . . . . 74.11 110.159 -173.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 26.9 p80 -165.3 164.0 19.94 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.384 1.074 . . . . 73.41 108.832 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.477 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 1.5 m-20 -117.38 -12.71 10.42 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.007 0.523 . . . . 62.41 110.39 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -71.13 122.03 19.38 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.524 0.729 . . . . 72.13 109.738 178.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.498 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 22.8 ttt -90.92 -18.66 24.36 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 122.665 0.386 . . . . 75.02 111.472 -175.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.06 -37.61 72.07 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 122.848 0.459 . . . . 55.11 110.705 173.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.7 t -65.02 -44.04 90.48 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.446 1.098 . . . . 61.51 110.863 174.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -64.49 -53.24 51.26 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.351 1.06 . . . . 52.3 111.005 -175.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 66.7 t -63.05 -40.78 90.36 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 123.639 0.776 . . . . 75.12 111.317 178.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 32.7 ttm180 -57.96 -38.64 76.37 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.13 0.572 . . . . 75.35 111.563 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -60.9 -49.67 76.51 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 123.789 0.681 . . . . 74.41 110.574 175.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 78.3 mt -61.22 -40.5 94.22 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.794 0.838 . . . . 75.34 111.618 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -57.75 -42.43 83.97 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.954 0.902 . . . . 74.23 111.454 175.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 70.8 mtm -74.59 -31.02 61.91 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.569 -0.741 . . . . 73.22 110.96 177.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -82.54 7.02 15.64 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.764 0.825 . . . . 62.25 110.857 178.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.1 10.37 82.8 Favored Glycine 0 C--N 1.347 1.181 0 N-CA-C 115.026 0.77 . . . . 61.34 115.026 168.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -71.98 138.49 48.03 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 117.638 0.719 . . . . 72.35 110.763 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 35.4 ttm-85 -100.45 122.53 43.33 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.927 -0.768 . . . . 74.12 108.927 -177.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.523 ' HE3' HG23 ' A' ' 99' ' ' THR . 1.3 tmtp? -78.92 123.24 27.07 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.777 1.231 . . . . 71.51 108.898 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 89.7 t -133.4 117.06 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.639 1.176 . . . . 74.24 108.058 178.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.6 p -102.92 126.21 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 109.118 -0.697 . . . . 54.15 109.118 -176.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -100.63 -37.25 8.84 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.254 0.622 . . . . 74.03 110.626 -174.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.577 HG23 ' HB3' ' A' ' 93' ' ' LYS . 45.6 mm -74.81 86.86 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 107.327 -1.36 . . . . 73.12 107.327 166.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.558 ' HB2' ' HE3' ' A' ' 93' ' ' LYS . 32.4 mt-10 -61.68 101.33 0.18 Allowed 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 115.026 -0.988 . . . . 74.34 110.653 -174.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -66.41 128.87 37.84 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 114.579 -1.191 . . . . 51.22 112.145 -169.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.36 -148.0 13.73 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-N 115.207 -0.906 . . . . 44.41 111.416 -179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -99.03 25.12 29.48 Favored Glycine 0 C--N 1.341 0.841 0 N-CA-C 112.008 -0.437 . . . . 72.32 112.008 175.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 81.2 mt -77.69 173.95 11.5 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.99 0.916 . . . . 74.41 110.761 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 8.7 p -76.82 9.0 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.569 0 C-N-CA 123.849 0.86 . . . . 63.22 112.058 -178.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.577 ' HB3' HG23 ' A' ' 86' ' ' ILE . 74.4 mmtt -58.02 150.74 48.94 Favored Pre-proline 0 N--CA 1.483 1.193 0 C-N-CA 124.301 1.041 . . . . 72.43 110.923 173.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.419 ' HD2' HD12 ' A' ' 86' ' ' ILE . 73.5 Cg_endo -72.13 146.87 47.23 Favored 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 122.293 1.995 . . . . 54.41 110.003 169.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -84.64 68.58 10.42 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 122.584 1.183 . . . . 62.51 110.677 -177.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 12.1 ptp180 -134.85 157.13 47.59 Favored 'General case' 0 C--O 1.246 0.88 0 CA-C-N 114.187 -1.369 . . . . 74.14 107.849 167.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 5.1 m-20 -80.82 142.99 33.14 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.798 -0.815 . . . . 73.23 108.798 -179.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -135.67 122.67 21.39 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 108.343 -0.984 . . . . 75.45 108.343 167.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.523 HG23 ' HE3' ' A' ' 82' ' ' LYS . 24.1 m -136.9 114.08 10.72 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 109.236 -0.653 . . . . 51.44 109.236 177.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -103.91 111.88 24.61 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.857 -0.794 . . . . 65.41 108.857 -178.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -97.26 129.29 44.59 Favored 'General case' 0 C--O 1.244 0.765 0 N-CA-C 109.072 -0.714 . . . . 63.23 109.072 175.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.457 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 19.3 pt20 -123.71 150.06 44.78 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.907 0.883 . . . . 72.12 109.533 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -156.68 135.55 7.8 Favored Pre-proline 0 CA--C 1.55 0.97 0 N-CA-C 108.357 -0.979 . . . . 71.32 108.357 175.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -59.82 -31.16 93.52 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.744 2.296 . . . . 75.03 112.823 -177.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.503 ' HB2' HG12 ' A' ' 117' ' ' ILE . 5.2 m -92.1 7.75 40.98 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 122.953 0.501 . . . . 44.31 111.415 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -123.79 101.45 7.28 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 108.297 -1.001 . . . . 75.42 108.297 174.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 52.8 mt -126.27 174.17 8.75 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 123.49 0.716 . . . . 72.11 109.359 173.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.424 ' HG3' ' HH2' ' A' ' 25' ' ' TRP . 71.5 ttt180 -76.35 109.27 9.92 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.696 1.198 . . . . 72.52 110.84 -177.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.18 35.44 30.22 Favored Glycine 0 C--N 1.344 0.975 0 N-CA-C 111.578 -0.609 . . . . 63.24 111.578 -177.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -132.88 42.67 3.05 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.205 -1.035 . . . . 64.33 108.205 -171.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.622 ' HA ' ' HG ' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -67.51 -21.18 65.5 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 114.134 -1.393 . . . . 72.55 112.531 -176.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 9.6 pm0 -72.16 -13.3 61.52 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.943 0.497 . . . . 65.42 111.713 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.463 ' HA ' HD22 ' A' ' 116' ' ' ASN . 31.9 mt -94.34 -7.4 41.86 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 112.236 0.458 . . . . 72.04 112.236 173.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.622 ' HG ' ' HA ' ' A' ' 111' ' ' GLU . 44.7 mt -72.12 -27.8 62.86 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 118.006 0.367 . . . . 74.14 111.63 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -65.34 -19.25 65.87 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.16 0.584 . . . . 73.02 111.466 173.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.463 HD22 ' HA ' ' A' ' 113' ' ' LEU . 36.3 m-80 -93.77 -10.85 32.81 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.327 0.651 . . . . 75.21 110.209 -178.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.503 HG12 ' HB2' ' A' ' 105' ' ' CYS . 43.2 mt -84.86 124.83 40.22 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 N-CA-C 108.051 -1.092 . . . . 73.41 108.051 177.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.452 ' HD2' ' HB2' ' A' ' 123' ' ' SER . 74.4 mmtt -126.75 145.98 50.4 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.429 0.691 . . . . 74.4 109.711 -173.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -92.68 -16.49 25.46 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.395 -0.82 . . . . 73.3 109.236 169.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.422 ' HB3' ' HE2' ' A' ' 120' ' ' LYS . 11.2 ptpt -179.22 -171.31 0.2 Allowed 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 127.218 2.207 . . . . 73.31 108.078 170.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.0 t -56.76 -47.95 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-N 118.466 0.575 . . . . 74.4 110.327 178.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.5 t -79.46 96.23 6.02 Favored 'General case' 0 CA--C 1.557 1.218 0 CA-C-O 121.443 0.64 . . . . 54.34 109.714 172.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.452 ' HB2' ' HD2' ' A' ' 118' ' ' LYS . 54.7 m -144.24 77.91 1.56 Allowed 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.683 0.793 . . . . 75.54 109.956 176.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 40.4 t -125.3 153.15 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 125.329 1.452 . . . . 72.12 107.447 176.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 CA--C 1.556 1.181 0 C-N-CA 123.353 0.661 . . . . 52.33 110.54 177.72 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.9 ptp . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 121.356 0.598 . . . . 74.54 110.375 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.78 49.16 44.55 Favored Glycine 0 C--N 1.345 1.061 0 CA-C-N 115.914 -0.584 . . . . 71.24 112.062 -176.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 38.2 t60 -80.87 98.78 8.0 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.544 0.737 . . . . 75.11 109.012 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -73.23 129.17 37.45 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.142 -0.688 . . . . 62.0 109.142 176.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 35.2 m-70 -92.49 144.2 25.59 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.814 0.846 . . . . 61.51 109.5 -178.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -69.94 117.81 12.0 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.755 0.822 . . . . 53.42 109.675 178.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -76.59 87.68 3.28 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-O 121.915 0.864 . . . . 55.13 111.277 -175.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -96.41 2.72 52.89 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.786 0.834 . . . . 74.14 110.163 174.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.6 p -77.7 85.27 4.02 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.659 1.184 . . . . 71.23 111.033 -177.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -82.54 -34.89 27.69 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 115.635 -0.711 . . . . 71.54 109.82 175.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 65.0 mtm 69.8 -67.13 0.24 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 125.889 1.676 . . . . 65.34 111.38 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.02 159.3 1.83 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.529 1.132 . . . . 50.32 112.295 176.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -155.48 -171.76 22.37 Favored Glycine 0 C--O 1.242 0.654 0 CA-C-N 115.981 -0.554 . . . . 43.14 113.134 -177.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.01 178.43 5.35 Favored 'Trans proline' 0 C--N 1.371 1.722 0 C-N-CA 123.454 2.77 . . . . 73.14 112.361 176.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 44.3 t -60.43 154.97 19.26 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.618 0.767 . . . . 72.54 110.609 176.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.428 ' HB2' ' HB2' ' A' ' 115' ' ' GLU . 36.3 m-80 -93.62 -1.1 55.78 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 122.745 0.418 . . . . 74.41 111.446 -176.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 70.7 t -57.05 117.03 15.33 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 124.204 1.002 . . . . 71.14 111.246 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -59.15 139.4 90.25 Favored 'Trans proline' 0 C--N 1.381 2.281 0 C-N-CA 122.937 2.425 . . . . 72.13 112.039 173.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.7 -39.76 71.47 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.22 1.008 . . . . 52.44 112.294 -178.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -53.79 -45.86 70.85 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 123.109 0.564 . . . . 73.53 111.293 174.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 79.9 mt -76.32 -34.75 59.01 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 119.051 -0.5 . . . . 74.21 112.31 -172.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.6 t -71.13 -35.25 71.66 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 118.069 0.395 . . . . 73.12 110.369 177.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.551 ' HE2' ' HA ' ' A' ' 23' ' ' LYS . 8.3 mmpt? -70.63 -42.35 71.02 Favored 'General case' 0 C--N 1.353 0.751 0 C-N-CA 122.813 0.445 . . . . 71.43 110.678 176.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 28' ' ' VAL . 67.4 tp -59.94 -49.2 78.61 Favored 'General case' 0 N--CA 1.478 0.962 0 O-C-N 124.183 0.927 . . . . 71.22 111.172 175.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 90.8 t90 -53.99 -51.04 65.19 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.806 1.243 . . . . 75.4 111.182 179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 64.2 m -64.92 -36.45 84.4 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.144 0.978 . . . . 72.21 111.512 177.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.408 ' HG ' HD13 ' A' ' 37' ' ' ILE . 32.2 tp -62.97 -51.04 68.4 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.673 1.189 . . . . 72.13 111.646 -178.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 24' ' ' LEU . 87.6 t -58.85 -35.69 57.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 C-N-CA 124.609 1.164 . . . . 45.02 111.198 178.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 83.2 p -92.36 1.94 56.94 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.308 -0.86 . . . . 73.21 112.534 -174.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -89.98 134.2 32.27 Favored Pre-proline 0 CA--C 1.557 1.245 0 C-N-CA 123.035 0.534 . . . . 74.1 111.581 -174.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.78 -33.86 26.07 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 123.228 2.618 . . . . 73.13 114.236 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -70.54 -35.95 73.4 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.114 0.566 . . . . 52.44 110.916 -176.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 23.0 p -98.98 -0.02 42.96 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 115.776 -0.647 . . . . 71.11 111.208 -177.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -55.42 -32.4 62.67 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.54 1.136 . . . . 41.21 112.337 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.9 -36.52 83.65 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.455 0.702 . . . . 64.32 112.15 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.425 HD22 ' HB2' ' A' ' 50' ' ' ASP . 85.0 mt -109.07 -8.24 15.21 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.204 0.602 . . . . 74.25 111.48 -175.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.408 HD13 ' HG ' ' A' ' 27' ' ' LEU . 18.6 tt -160.56 118.3 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 123.037 0.535 . . . . 75.33 110.457 174.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 12.7 p -137.41 146.74 44.78 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.525 0.73 . . . . 33.43 109.75 -176.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 25.2 p-90 -71.24 147.37 48.29 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.013 0.525 . . . . 74.52 110.888 177.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.1 m -79.74 151.21 73.75 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 108.902 -0.777 . . . . 53.32 108.902 173.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.83 -19.59 55.17 Favored 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.674 2.249 . . . . 65.51 113.618 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 64.0 m -66.61 -35.64 80.67 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.146 0.578 . . . . 42.25 111.112 172.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.04 -2.69 74.3 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-N 115.784 -0.643 . . . . 25.24 113.877 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.458 HD22 ' N ' ' A' ' 44' ' ' ASN . 0.7 OUTLIER -97.55 3.26 50.63 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.116 0.966 . . . . 54.24 110.022 -179.617 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.3 p -158.03 169.56 24.28 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 123.806 0.842 . . . . 74.21 110.397 -170.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -150.33 153.38 35.98 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.909 0.884 . . . . 65.53 110.233 176.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 43.0 m-70 -101.8 144.46 30.44 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.945 0.898 . . . . 71.25 109.277 176.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 97.8 t -122.75 120.86 61.94 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 C-N-CA 124.928 1.291 . . . . 74.44 107.612 177.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.4 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 91.1 m-85 -106.01 146.84 29.57 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 123.905 0.882 . . . . 75.3 109.854 -176.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.425 ' HB2' HD22 ' A' ' 36' ' ' LEU . 15.4 m-20 52.36 65.24 1.56 Allowed 'General case' 0 C--N 1.353 0.73 0 O-C-N 124.911 1.382 . . . . 45.1 111.613 171.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.404 ' HB3' ' HG2' ' A' ' 68' ' ' MET . 85.2 mt-30 -52.72 -28.54 22.47 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 113.096 0.776 . . . . 73.3 113.096 -173.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -67.84 -48.34 55.61 Favored Glycine 0 C--N 1.344 0.997 0 O-C-N 123.343 0.402 . . . . 61.34 112.155 176.142 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -73.18 -45.53 55.93 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.31 0.644 . . . . 63.1 110.278 -178.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -54.04 -51.17 64.9 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.638 1.575 . . . . 71.44 111.574 176.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.532 ' HB2' ' HB2' ' A' ' 68' ' ' MET . . . -67.41 -29.73 69.3 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 112.307 0.484 . . . . 63.14 112.307 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -72.06 -43.21 65.25 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.971 0.909 . . . . 70.44 111.97 -177.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.553 ' HG3' HG23 ' A' ' 58' ' ' VAL . 7.0 pt-20 -109.02 -45.73 3.73 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 113.182 0.808 . . . . 75.21 113.182 -176.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.553 HG23 ' HG3' ' A' ' 57' ' ' GLU . 95.8 t -77.03 -42.3 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 123.42 0.688 . . . . 72.23 111.674 -167.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 42.2 mt -64.75 -49.49 69.16 Favored Pre-proline 0 CA--C 1.557 1.219 0 CA-C-O 117.946 -1.026 . . . . 61.45 112.384 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.93 -7.27 21.03 Favored 'Trans proline' 0 C--N 1.388 2.619 0 CA-C-N 121.743 1.658 . . . . 70.2 112.846 174.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -79.95 -66.63 0.85 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.112 0.565 . . . . 73.03 110.81 174.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -79.0 -40.15 32.26 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.257 0.623 . . . . 74.34 111.53 -176.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -105.06 -169.89 1.67 Allowed 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 108.138 -1.06 . . . . 61.11 108.138 178.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -126.32 45.26 2.69 Favored 'General case' 0 N--CA 1.485 1.298 0 CA-C-O 121.513 0.673 . . . . 74.53 110.337 -174.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -159.16 161.78 36.29 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 115.109 -0.951 . . . . 74.22 108.973 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.502 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 1.6 m-20 -114.16 -19.8 11.19 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.568 0.347 . . . . 63.32 111.598 179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -71.31 114.15 9.09 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 122.414 0.286 . . . . 74.13 111.062 -173.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.532 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 13.9 tpt -65.82 -37.55 86.54 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.255 1.022 . . . . 75.42 111.353 -177.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.17 -35.03 72.84 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.148 0.579 . . . . 62.21 111.168 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.482 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 45.1 t -68.44 -38.73 81.42 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.588 0.755 . . . . 73.03 111.004 176.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -65.29 -50.91 63.92 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.117 0.967 . . . . 71.11 110.627 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 48.5 t -63.41 -36.36 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 123.444 0.698 . . . . 63.0 110.059 177.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 16.9 ttp180 -57.46 -41.54 80.77 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.987 0.915 . . . . 75.34 110.605 175.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.545 ' HA ' ' HE2' ' A' ' 77' ' ' MET . 26.3 mm-40 -61.89 -47.34 85.44 Favored 'General case' 0 C--N 1.357 0.912 0 N-CA-C 109.644 -0.502 . . . . 73.04 109.644 177.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.422 ' HB3' ' HB2' ' A' ' 80' ' ' PHE . 89.6 mt -61.91 -38.26 87.73 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.618 0.767 . . . . 75.1 111.106 -179.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -58.55 -39.87 81.46 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.95 0.9 . . . . 75.5 110.537 174.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.545 ' HE2' ' HA ' ' A' ' 74' ' ' GLN . 48.6 mtm -66.21 -41.7 89.77 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 122.715 0.406 . . . . 51.43 110.351 174.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -80.97 2.84 25.16 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.61 0.764 . . . . 74.14 111.614 -174.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.62 19.76 61.25 Favored Glycine 0 C--N 1.346 1.094 0 N-CA-C 114.761 0.664 . . . . 62.13 114.761 171.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.422 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . 42.0 m-85 -78.15 145.4 35.69 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.123 -0.695 . . . . 74.51 109.123 176.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -99.46 123.43 43.73 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.682 0.793 . . . . 70.44 109.035 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -75.62 110.7 10.24 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.031 1.332 . . . . 70.55 109.278 177.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 98.6 t -123.19 132.65 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 108.407 -0.96 . . . . 50.42 108.407 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 85.6 t -125.83 121.37 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.121 0.968 . . . . 74.0 108.57 175.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -94.97 -15.88 23.2 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.122 0.569 . . . . 75.35 111.343 -177.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.462 HG12 ' HB3' ' A' ' 98' ' ' ASP . 41.7 mm -69.84 109.71 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 122.918 0.487 . . . . 74.04 110.231 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -125.28 99.15 5.94 Favored 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.175 0.99 . . . . 74.53 108.56 172.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -80.82 93.6 6.28 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.891 0.876 . . . . 72.54 109.379 -177.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -153.38 -25.14 0.04 OUTLIER Glycine 0 C--N 1.346 1.136 0 CA-C-N 115.623 -0.717 . . . . 74.41 113.282 -175.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 162.89 20.53 0.02 OUTLIER Glycine 0 N--CA 1.475 1.247 0 CA-C-N 117.074 0.437 . . . . 71.54 113.712 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 76.1 mt -99.87 153.12 19.41 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.995 0.918 . . . . 75.3 110.189 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.3 p -85.82 69.38 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.172 0 CA-C-O 122.93 1.348 . . . . 73.31 109.672 176.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.457 ' HE3' HD13 ' A' ' 86' ' ' ILE . 25.1 mtpp -124.87 144.06 45.69 Favored Pre-proline 0 C--O 1.244 0.768 0 CA-C-N 114.378 -1.283 . . . . 72.02 108.466 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -68.74 148.28 71.18 Favored 'Trans proline' 0 C--N 1.372 1.798 0 C-N-CA 122.629 2.219 . . . . 62.35 111.504 177.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -83.17 65.98 8.49 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-O 122.411 1.101 . . . . 73.52 110.503 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.3 ptp180 -135.07 -178.47 5.11 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.474 -1.239 . . . . 64.34 108.513 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 4.1 m-20 -84.31 141.41 30.94 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 109.612 -0.514 . . . . 71.54 109.612 175.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.462 ' HB3' HG12 ' A' ' 86' ' ' ILE . 22.5 t70 -140.9 106.87 5.16 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.957 -1.127 . . . . 74.15 107.957 169.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 77.4 m -122.57 117.25 25.43 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.377 0.671 . . . . 53.04 110.486 -178.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -99.46 106.27 18.29 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.842 -0.799 . . . . 72.51 108.842 -177.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -95.14 122.09 37.45 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.919 -0.771 . . . . 73.45 108.919 176.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -122.63 144.35 49.18 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.939 0.896 . . . . 54.13 110.803 -174.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -159.06 131.24 4.25 Favored Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 123.741 0.816 . . . . 74.2 109.757 176.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -64.35 -31.49 62.41 Favored 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 123.156 2.57 . . . . 54.22 114.118 -174.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 82.0 m -94.0 8.42 41.46 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 122.384 0.274 . . . . 72.44 111.438 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -109.02 100.38 9.58 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.823 -1.177 . . . . 65.21 107.823 173.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.408 ' HB2' ' HB2' ' A' ' 110' ' ' GLN . 80.0 mt -118.35 132.41 56.27 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.306 0.642 . . . . 62.51 109.501 175.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -66.97 114.26 5.63 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 107.895 -1.15 . . . . 73.12 107.895 174.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 106.89 -12.86 41.64 Favored Glycine 0 N--CA 1.472 1.04 0 CA-C-O 119.944 -0.365 . . . . 64.45 113.083 -177.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.408 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 15.6 mm-40 -107.98 79.44 1.27 Allowed 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 117.374 0.587 . . . . 73.41 110.305 176.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -59.44 -32.96 70.7 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.307 1.043 . . . . 73.2 112.563 175.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.9 pm0 -67.32 -26.12 66.35 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.433 0.693 . . . . 72.14 112.255 -177.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 76.8 mt -86.39 -6.76 58.86 Favored 'General case' 0 N--CA 1.48 1.04 0 O-C-N 122.122 -0.362 . . . . 72.42 111.571 -175.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 75.8 mt -65.37 -33.84 76.92 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.087 0.555 . . . . 71.24 111.135 175.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 16' ' ' ASN . 12.0 pt-20 -82.44 -1.54 50.49 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.509 0.324 . . . . 74.24 111.78 176.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.485 HD22 ' N ' ' A' ' 116' ' ' ASN . 0.7 OUTLIER -92.4 -15.22 27.52 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.457 0.703 . . . . 73.1 109.407 172.451 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 55.2 mt -82.0 114.27 22.64 Favored 'Isoleucine or valine' 0 C--N 1.355 0.812 0 N-CA-C 108.269 -1.011 . . . . 72.53 108.269 176.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -103.48 137.43 41.57 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.1 -0.704 . . . . 75.21 109.1 -176.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 14.3 ptt-85 -99.16 -61.55 1.35 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.626 0.37 . . . . 65.5 110.911 176.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -157.17 178.08 10.75 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.253 1.421 . . . . 73.52 109.045 -169.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.9 p -64.04 -30.68 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 122.745 0.418 . . . . 70.21 110.106 172.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 28.4 p -72.76 79.78 1.12 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.074 0.95 . . . . 75.51 110.029 175.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.5 t -173.44 -176.7 1.35 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.719 1.208 . . . . 51.25 108.459 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 2.5 p -64.4 104.17 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.342 0 C-N-CA 123.35 0.66 . . . . 64.14 110.363 174.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 14.9 t . . . . . 0 C--O 1.253 1.272 0 N-CA-C 108.496 -0.928 . . . . 72.41 108.496 -175.736 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.3 mtp . . . . . 0 N--CA 1.486 1.373 0 N-CA-C 109.892 -0.41 . . . . 74.13 109.892 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.87 -147.18 47.73 Favored Glycine 0 C--N 1.352 1.46 0 O-C-N 123.739 0.649 . . . . 73.31 112.123 -176.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.3 m80 -131.08 128.57 40.48 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 107.882 -1.155 . . . . 72.02 107.882 173.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -63.14 114.16 3.58 Favored 'General case' 0 N--CA 1.477 0.875 0 O-C-N 123.651 0.594 . . . . 74.21 110.13 -178.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 51.4 m170 -76.61 131.22 38.77 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 115.631 -0.713 . . . . 75.43 111.016 -173.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -148.52 138.78 22.52 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.025 0.93 . . . . 71.02 109.716 -175.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 63.47 83.59 0.16 Allowed 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.463 1.105 . . . . 75.23 111.442 171.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -91.42 104.58 17.08 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.469 0.708 . . . . 61.44 109.095 173.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.6 t -83.32 90.28 7.12 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.126 0.489 . . . . 73.52 110.326 -177.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -105.16 -7.65 18.91 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.697 0.799 . . . . 72.13 110.107 172.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 27.6 ttt -68.78 94.7 0.62 Allowed 'General case' 0 C--N 1.354 0.804 0 CA-C-O 121.193 0.521 . . . . 63.43 109.611 175.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -88.31 40.37 0.95 Allowed 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.355 -0.839 . . . . 71.05 110.677 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.37 -66.96 2.11 Favored Glycine 0 C--N 1.353 1.477 0 N-CA-C 110.292 -1.123 . . . . 61.22 110.292 172.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.39 112.67 2.78 Favored 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 122.183 1.922 . . . . 64.44 109.167 160.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 55.5 p -58.17 -57.46 12.77 Favored 'General case' 0 C--O 1.246 0.875 0 C-N-CA 123.344 0.658 . . . . 71.32 111.048 -175.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.43 HD22 ' N ' ' A' ' 16' ' ' ASN . 0.8 OUTLIER 59.52 50.78 7.09 Favored 'General case' 0 C--N 1.354 0.788 0 CA-C-N 114.297 -1.32 . . . . 65.34 109.674 178.196 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 66.2 t -67.38 110.17 4.83 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 114.491 -1.231 . . . . 71.04 107.894 169.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.535 ' HD2' HD12 ' A' ' 21' ' ' LEU . 50.8 Cg_exo -55.88 142.3 84.44 Favored 'Trans proline' 0 C--N 1.368 1.588 0 C-N-CA 122.346 2.031 . . . . 53.01 111.856 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.92 -36.93 40.98 Favored 'General case' 0 N--CA 1.474 0.731 0 O-C-N 124.185 0.928 . . . . 45.43 111.081 175.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -55.41 -47.36 76.02 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.901 0.88 . . . . 74.13 112.028 174.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.535 HD12 ' HD2' ' A' ' 18' ' ' PRO . 55.7 mt -77.88 -35.31 50.97 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 122.682 0.393 . . . . 72.2 111.932 -172.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.4 t -72.11 -36.03 69.34 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 117.48 0.127 . . . . 75.43 110.962 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.573 ' HB3' ' HB3' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -69.01 -42.49 76.37 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 122.733 0.413 . . . . 72.42 109.964 173.672 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.46 ' O ' HG23 ' A' ' 28' ' ' VAL . 63.6 tp -59.46 -40.12 85.84 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.976 0.911 . . . . 63.02 111.251 176.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 70.6 t-105 -60.97 -53.37 58.14 Favored 'General case' 0 C--O 1.242 0.695 0 C-N-CA 123.275 0.63 . . . . 70.43 111.452 178.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 24.4 m -60.89 -28.85 69.2 Favored 'General case' 0 CA--C 1.55 0.978 0 CA-C-N 115.01 -0.995 . . . . 50.4 110.638 178.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.553 HD11 HG13 ' A' ' 58' ' ' VAL . 30.0 tp -72.78 -50.04 26.89 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.291 1.436 . . . . 71.13 112.445 -178.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 24' ' ' LEU . 99.3 t -60.18 -29.87 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 123.672 0.789 . . . . 75.11 111.482 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.6 t -100.56 3.19 42.54 Favored 'General case' 0 CA--C 1.563 1.477 0 C-N-CA 124.062 0.945 . . . . 63.0 112.313 -176.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -85.38 134.01 41.26 Favored Pre-proline 0 N--CA 1.498 1.969 0 C-N-CA 123.942 0.897 . . . . 44.32 112.09 -176.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -77.92 -10.41 16.76 Favored 'Trans proline' 0 C--N 1.384 2.425 0 C-N-CA 123.233 2.622 . . . . 62.51 114.362 -175.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -87.67 -26.02 23.21 Favored 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 118.122 0.419 . . . . 63.0 110.446 174.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.6 p -117.07 -1.94 11.8 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.32 0.859 . . . . 74.43 113.32 -173.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.423 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 9.3 p-10 -62.06 -28.37 69.55 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 118.261 0.482 . . . . 73.55 111.904 -177.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -65.7 -25.77 67.46 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.597 0.759 . . . . 65.14 113.011 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.8 mt -116.0 -5.57 11.98 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.076 0.551 . . . . 75.21 112.045 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 34' ' ' ASP . 17.7 tt -160.19 115.25 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 CA-C-O 121.381 0.61 . . . . 74.34 110.924 173.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 29.7 p -150.45 156.82 42.2 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.982 -0.747 . . . . 64.11 108.982 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 32.5 p-90 -74.96 152.41 38.79 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.711 0.804 . . . . 74.11 109.896 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.0 m -76.85 148.47 79.15 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 123.589 0.755 . . . . 61.52 110.401 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.82 -33.36 13.92 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 123.625 2.883 . . . . 74.42 116.102 178.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.1 m -76.83 -32.05 57.32 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 122.825 0.45 . . . . 64.34 110.511 175.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 94.17 -0.31 66.3 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-O 119.593 -0.559 . . . . 71.34 114.257 171.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -87.91 -1.69 58.14 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.129 0.571 . . . . 70.52 111.251 -174.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 54.1 p -153.8 177.6 10.82 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.893 0.877 . . . . 71.51 110.434 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -141.64 149.64 40.92 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.245 0.618 . . . . 72.24 109.73 170.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -101.43 157.54 16.73 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.273 0.629 . . . . 73.21 109.371 177.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 98' ' ' ASP . 95.1 t -128.49 124.18 61.28 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.441 0 C-N-CA 124.8 1.24 . . . . 74.04 107.781 173.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -107.84 149.75 27.87 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.54 0.736 . . . . 74.34 109.891 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.0 t0 44.34 65.69 1.0 Allowed 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 125.486 1.514 . . . . 73.32 110.878 177.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.627 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 29.4 mt-30 -58.42 -21.04 49.46 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 113.364 0.876 . . . . 64.33 113.364 -172.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.54 -46.45 47.7 Favored Glycine 0 C--N 1.346 1.091 0 N-CA-C 112.275 -0.33 . . . . 44.2 112.275 173.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.405 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 58.2 tp60 -69.81 -44.51 69.87 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.523 -0.547 . . . . 72.44 109.523 177.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.526 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 54.6 t80 -52.54 -50.96 61.85 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 125.265 1.426 . . . . 71.12 111.297 175.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.445 ' HB1' ' O ' ' A' ' 66' ' ' ASN . . . -59.64 -37.35 78.43 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-O 121.106 0.479 . . . . 74.35 111.584 177.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -71.01 -49.26 47.07 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.594 1.158 . . . . 71.2 113.173 -175.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.503 ' HG3' HG23 ' A' ' 58' ' ' VAL . 6.5 pt-20 -105.81 -36.41 7.04 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 113.429 0.9 . . . . 64.34 113.429 -172.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.553 HG13 HD11 ' A' ' 27' ' ' LEU . 55.2 t -81.67 -43.82 20.05 Favored 'Isoleucine or valine' 0 C--O 1.251 1.161 0 C-N-CA 123.728 0.811 . . . . 62.35 111.611 -168.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 55.3 mt -67.2 -44.01 46.9 Favored Pre-proline 0 CA--C 1.553 1.072 0 CA-C-O 118.158 -0.925 . . . . 70.31 112.639 -178.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -70.6 -10.16 27.31 Favored 'Trans proline' 0 C--N 1.377 2.051 0 CA-C-N 121.833 1.69 . . . . 74.32 113.527 171.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -75.86 -49.41 18.03 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.275 0.63 . . . . 74.21 110.693 176.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.573 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 64.9 m-85 -102.34 -34.87 9.03 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 113.752 1.019 . . . . 74.15 113.752 -178.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -109.84 -177.58 3.31 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 108.904 -0.776 . . . . 63.22 108.904 -175.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.3 mmmp? -111.5 38.07 2.71 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.004 0.522 . . . . 70.25 110.951 -175.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -158.15 167.29 30.23 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.312 0.645 . . . . 75.44 109.684 -177.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.445 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 1.9 m-20 -121.33 -7.45 9.27 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.284 0.634 . . . . 74.52 110.768 176.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -78.7 120.19 23.01 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.119 0.568 . . . . 54.42 109.995 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.627 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 25.5 ttt -84.3 -18.72 35.39 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 116.79 -0.186 . . . . 71.21 111.267 -176.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -54.76 -38.74 67.57 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 122.971 0.508 . . . . 70.54 110.956 174.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.456 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 48.2 t -68.19 -44.67 75.32 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 115.034 -0.985 . . . . 53.33 111.188 174.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -59.44 -50.13 75.14 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.218 1.007 . . . . 64.13 110.46 -175.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.2 t -62.12 -45.91 97.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 114.932 -1.031 . . . . 63.34 111.119 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 54.2 ttt85 -58.33 -36.67 73.76 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 122.973 0.509 . . . . 71.42 111.516 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 70' ' ' SER . 31.3 mm-40 -61.67 -50.62 71.77 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 123.552 0.532 . . . . 71.23 109.701 176.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 98.1 mt -62.24 -33.55 74.8 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.628 0.771 . . . . 65.25 112.015 -177.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -56.9 -45.98 82.26 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 122.981 0.512 . . . . 71.21 110.866 170.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.455 ' HB3' ' O ' ' A' ' 119' ' ' ARG . 45.0 mtm -69.11 -28.84 66.84 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.294 0.638 . . . . 53.03 111.138 178.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -82.39 2.37 32.8 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.4 0.68 . . . . 71.24 110.975 175.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.71 1.86 79.73 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-O 119.201 -0.777 . . . . 73.35 114.405 171.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -72.04 142.45 49.28 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 117.752 0.776 . . . . 72.32 109.079 -178.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -100.44 131.31 46.43 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 109.579 -0.526 . . . . 75.0 109.579 -176.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.573 ' HE3' HG22 ' A' ' 84' ' ' VAL . 50.2 tptt -69.59 108.2 3.74 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.417 1.487 . . . . 74.23 109.328 173.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.49 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 42.5 t -112.98 111.26 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 108.008 -1.108 . . . . 71.43 108.008 178.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.573 HG22 ' HE3' ' A' ' 82' ' ' LYS . 11.1 t -93.01 101.22 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.854 0.862 . . . . 63.11 109.004 -172.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -90.88 -62.93 1.34 Allowed 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 109.324 -0.621 . . . . 72.33 109.324 178.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 28.4 mm -75.67 101.46 2.36 Favored 'Isoleucine or valine' 0 C--O 1.241 0.639 0 N-CA-C 107.422 -1.325 . . . . 61.4 107.422 166.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -86.63 127.02 34.9 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 114.833 -1.076 . . . . 73.11 108.225 175.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -79.96 117.66 21.0 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.022 0.439 . . . . 64.14 111.616 -177.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.18 -163.85 32.22 Favored Glycine 0 C--N 1.337 0.585 0 CA-C-N 114.857 -1.065 . . . . 65.11 111.523 175.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -84.6 57.41 5.02 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.003 -0.839 . . . . 64.13 111.003 174.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 47.5 mt -104.28 -179.17 3.87 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.072 0.949 . . . . 74.2 110.707 -173.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 11.1 p -79.1 -28.93 13.74 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.961 0 C-N-CA 123.639 0.776 . . . . 75.41 109.794 173.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -63.23 132.17 95.01 Favored Pre-proline 0 N--CA 1.48 1.065 0 C-N-CA 124.011 0.924 . . . . 41.21 110.422 178.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.53 153.42 70.0 Favored 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.724 2.283 . . . . 72.34 110.781 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -74.61 8.38 2.38 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.556 0.947 . . . . 71.12 113.556 -168.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -65.29 87.21 0.07 Allowed 'General case' 0 CA--C 1.554 1.11 0 CA-C-O 121.214 0.53 . . . . 75.1 110.417 176.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.571 ' HB2' ' H ' ' A' ' 51' ' ' GLN . 5.8 m-20 -41.41 109.56 0.13 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 125.007 1.323 . . . . 71.2 112.142 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.536 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 25.7 t70 -120.74 115.83 24.06 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.307 0.643 . . . . 63.51 109.882 -178.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.405 HG23 ' HD2' ' A' ' 82' ' ' LYS . 58.4 m -118.43 131.41 56.28 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 123.673 0.789 . . . . 74.42 109.209 172.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.49 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 42.0 tt0 -105.26 113.52 27.16 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.536 -1.283 . . . . 71.15 107.536 172.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -96.41 118.86 33.8 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 108.098 -1.075 . . . . 71.43 108.098 174.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -115.48 140.54 49.06 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.561 0.744 . . . . 43.13 110.539 -175.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -158.55 134.07 5.9 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 123.264 0.626 . . . . 62.45 109.346 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -65.07 -28.42 57.06 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.826 2.351 . . . . 75.43 112.953 -176.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 33.5 m -96.1 20.37 10.31 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 122.896 0.479 . . . . 74.21 110.579 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -127.07 101.13 6.4 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 107.598 -1.26 . . . . 74.34 107.598 169.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.437 ' HB2' ' HB2' ' A' ' 110' ' ' GLN . 68.8 mt -108.31 170.41 8.03 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 109.323 -0.621 . . . . 71.43 109.323 174.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.77 -31.48 72.67 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 113.972 1.101 . . . . 73.12 113.972 -168.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -139.51 18.9 3.02 Favored Glycine 0 C--N 1.347 1.165 0 CA-C-O 120.342 -0.143 . . . . 60.12 113.289 -175.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.437 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 17.4 mp0 -107.79 79.16 1.25 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.363 0.665 . . . . 62.33 110.041 -176.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -67.98 -27.7 66.8 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.364 1.066 . . . . 73.5 113.437 -177.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -71.28 -5.87 35.52 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.343 0.657 . . . . 53.52 111.866 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 72.7 mt -89.33 -6.65 56.51 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 122.972 0.509 . . . . 62.44 111.748 175.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 94.5 mt -68.23 -32.57 72.86 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 122.825 0.45 . . . . 51.43 111.231 176.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -74.12 -16.53 61.01 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.1 0.56 . . . . 72.13 111.109 175.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.49 HD22 ' N ' ' A' ' 116' ' ' ASN . 0.7 OUTLIER -79.95 -18.67 49.82 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.12 -0.696 . . . . 71.33 109.12 177.567 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 27.5 mt -98.51 122.27 50.0 Favored 'Isoleucine or valine' 0 C--N 1.351 0.667 0 C-N-CA 124.196 0.999 . . . . 74.41 108.677 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.9 mmpt? -113.07 153.47 28.11 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 108.98 -0.748 . . . . 70.43 108.98 176.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.455 ' O ' ' HB3' ' A' ' 77' ' ' MET . 13.3 ptp180 -76.99 -35.37 57.21 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-O 121.038 0.446 . . . . 64.42 110.029 175.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -174.35 140.55 0.66 Allowed 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.583 1.153 . . . . 74.54 108.796 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.6 p -98.58 -27.99 3.61 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 CA-C-N 115.204 -0.907 . . . . 75.11 109.635 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 13.5 t -95.08 156.9 16.12 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.41 -0.959 . . . . 62.51 108.41 167.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 32.9 t 61.68 24.12 14.29 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.875 0.87 . . . . 65.54 110.918 -176.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 5.1 p -75.43 105.65 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 123.467 0.707 . . . . 75.02 110.516 -176.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 30.8 p . . . . . 0 CA--C 1.558 1.282 0 CA-C-N 115.548 -0.751 . . . . 73.12 109.916 177.872 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 120.737 0.304 . . . . 74.31 110.897 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 91.47 29.18 12.61 Favored Glycine 0 C--N 1.344 0.972 0 CA-C-N 115.936 -0.575 . . . . 73.25 112.893 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -76.06 79.06 2.91 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 108.386 -0.968 . . . . 75.2 108.386 171.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 56.0 m80 -148.39 161.14 42.18 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.9 1.68 . . . . 64.13 107.23 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -74.58 83.98 2.05 Favored 'General case' 0 CA--C 1.558 1.27 0 CA-C-O 122.518 1.151 . . . . 73.13 111.396 -174.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -129.25 20.01 5.81 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 114.703 -1.135 . . . . 55.42 109.225 173.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 60.0 t60 -73.12 81.36 1.27 Allowed 'General case' 0 C--N 1.356 0.871 0 CA-C-O 122.104 0.954 . . . . 73.45 109.544 178.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 47.7 m80 -135.59 83.86 2.05 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 105.447 -2.057 . . . . 61.45 105.447 175.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.7 m -62.35 96.98 0.08 Allowed 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 114.88 -1.055 . . . . 54.21 111.577 -169.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 38.7 m170 -114.39 -47.34 2.93 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.113 0.965 . . . . 72.21 110.215 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 52.0 mtm -105.01 148.73 26.43 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.41 1.084 . . . . 74.54 109.55 -177.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.09 128.8 37.19 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.944 0.898 . . . . 31.32 111.814 -175.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 146.28 -82.03 0.2 Allowed Glycine 0 C--N 1.341 0.853 0 N-CA-C 110.83 -0.908 . . . . 73.1 110.83 -174.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -71.49 113.78 3.73 Favored 'Trans proline' 0 C--N 1.38 2.2 0 C-N-CA 122.519 2.146 . . . . 42.51 111.441 176.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 34.9 t -71.75 158.4 36.19 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.89 0.476 . . . . 72.5 109.765 174.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -81.67 -1.54 47.16 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.089 0.555 . . . . 75.45 110.989 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 74.0 t -58.15 120.06 40.17 Favored Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 124.599 1.16 . . . . 65.42 110.906 175.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.499 ' HD2' HD12 ' A' ' 21' ' ' LEU . 87.7 Cg_exo -52.77 143.46 47.55 Favored 'Trans proline' 0 C--N 1.378 2.089 0 C-N-CA 123.537 2.825 . . . . 71.54 113.328 172.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.36 -40.29 64.84 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.373 1.069 . . . . 73.44 111.944 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 81.6 t80 -54.64 -48.94 71.66 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.177 0.591 . . . . 73.21 111.425 173.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.499 HD12 ' HD2' ' A' ' 18' ' ' PRO . 85.1 mt -75.36 -34.28 61.14 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 111.876 0.324 . . . . 70.34 111.876 -170.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.0 t -68.59 -38.83 80.96 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 117.579 0.172 . . . . 65.32 110.935 175.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.491 ' HA ' ' HE3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -67.22 -42.09 84.64 Favored 'General case' 0 C--N 1.358 0.94 0 C-N-CA 122.412 0.285 . . . . 70.02 110.659 175.291 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.9 tp -58.32 -52.41 65.7 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.018 0.927 . . . . 75.31 111.822 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 84.3 t90 -56.62 -47.87 78.74 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.777 0.831 . . . . 71.53 111.107 -178.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 36.2 m -61.23 -37.03 81.6 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 114.998 -1.001 . . . . 73.11 111.159 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.2 tp -68.49 -44.75 74.06 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.414 1.085 . . . . 70.13 111.757 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.5 t -63.53 -42.26 95.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.1 0.96 . . . . 50.33 110.67 177.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.1 t -80.74 0.12 36.0 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-N 115.254 -0.884 . . . . 54.44 111.639 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -86.41 125.62 67.06 Favored Pre-proline 0 CA--C 1.55 0.95 0 C-N-CA 123.707 0.803 . . . . 63.13 110.639 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -82.84 -10.29 10.58 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.919 2.413 . . . . 60.31 114.177 -179.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -82.49 -30.42 29.89 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 123.136 0.575 . . . . 64.1 111.455 -178.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 50.7 p -100.4 7.8 44.03 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 122.837 0.455 . . . . 61.23 110.659 -177.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.425 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 7.0 p-10 -58.3 -22.94 54.77 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.934 1.294 . . . . 74.22 112.897 -175.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -60.21 -38.22 82.65 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.803 0.841 . . . . 72.21 112.264 177.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 57.0 mt -117.66 -10.38 10.57 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.94 0.496 . . . . 74.55 111.954 -178.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 34' ' ' ASP . 17.1 tt -158.64 122.42 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-O 121.365 0.602 . . . . 74.22 111.913 175.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 53.8 t -152.39 158.95 43.41 Favored 'General case' 0 C--O 1.243 0.733 0 C-N-CA 123.666 0.786 . . . . 43.22 109.761 176.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 13.2 p-90 -70.82 153.23 42.93 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.669 0.788 . . . . 74.42 110.877 176.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 45.8 m -73.2 154.61 90.37 Favored Pre-proline 0 CA--C 1.553 1.077 0 CA-C-O 118.058 -0.972 . . . . 54.44 109.182 170.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_exo -42.92 -31.34 2.18 Favored 'Trans proline' 0 C--N 1.388 2.617 0 C-N-CA 124.091 3.194 . . . . 64.21 115.821 -175.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 79.6 p -76.25 -49.51 16.87 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 122.972 0.509 . . . . 54.32 110.923 175.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.8 13.49 23.66 Favored Glycine 0 C--N 1.352 1.443 0 CA-C-N 115.606 -0.724 . . . . 52.34 113.557 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -94.5 -11.08 30.33 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.046 0.538 . . . . 64.02 111.137 -175.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.6 p -147.2 170.15 17.85 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 124.24 1.016 . . . . 71.24 109.146 -176.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -144.15 155.43 43.92 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.86 0.464 . . . . 70.43 110.798 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.402 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 52.6 m-70 -112.11 150.04 31.29 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.202 1.001 . . . . 62.44 109.32 -176.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.463 ' HB ' ' HB ' ' A' ' 99' ' ' THR . 84.5 t -126.42 139.01 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 N-CA-C 108.452 -0.944 . . . . 64.11 108.452 176.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -125.48 146.3 49.7 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.552 0.741 . . . . 73.02 109.061 176.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.4 t70 45.34 76.69 0.09 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.709 1.603 . . . . 70.22 112.019 -178.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.606 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 53.3 mt-30 -51.05 -29.64 13.39 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 124.306 1.042 . . . . 64.31 113.023 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -68.99 -49.53 40.69 Favored Glycine 0 C--N 1.348 1.234 0 O-C-N 123.308 0.38 . . . . 64.51 112.835 177.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 60.3 tp60 -75.16 -40.97 59.09 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.396 0.679 . . . . 61.02 110.222 -176.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -56.81 -48.84 77.05 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.282 1.433 . . . . 74.12 110.779 175.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' A' ' 66' ' ' ASN . . . -65.97 -28.84 69.2 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 112.19 0.441 . . . . 62.34 112.19 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -72.38 -46.35 55.71 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.797 0.839 . . . . 72.21 112.107 -177.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.523 ' HG3' HG23 ' A' ' 58' ' ' VAL . 7.1 pt-20 -110.11 -40.4 4.73 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 113.542 0.941 . . . . 75.1 113.542 -173.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.523 HG23 ' HG3' ' A' ' 57' ' ' GLU . 73.9 t -80.05 -43.24 22.39 Favored 'Isoleucine or valine' 0 C--O 1.252 1.189 0 C-N-CA 123.064 0.545 . . . . 71.45 111.51 -168.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.408 ' HG ' ' HA ' ' A' ' 55' ' ' ALA . 35.1 mt -63.06 -50.9 74.13 Favored Pre-proline 0 CA--C 1.558 1.28 0 CA-C-O 117.993 -1.003 . . . . 60.24 112.445 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.86 -12.91 36.92 Favored 'Trans proline' 0 C--N 1.389 2.695 0 C-N-CA 121.884 1.723 . . . . 75.14 113.138 177.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -74.43 -60.64 2.18 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 122.941 0.497 . . . . 71.35 110.306 177.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -85.34 -55.9 3.79 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 116.312 -0.403 . . . . 74.21 110.852 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.8 m-85 -86.37 179.75 6.82 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 109.32 -0.622 . . . . 74.42 109.32 -176.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -113.07 38.97 2.67 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 121.526 0.679 . . . . 65.43 110.044 -171.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -162.6 163.95 26.95 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 114.936 -1.029 . . . . 74.42 109.301 -176.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.425 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 1.6 m120 -114.06 -7.89 13.06 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.173 0.589 . . . . 73.31 110.015 175.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -68.79 109.06 3.67 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.598 0.759 . . . . 72.2 111.0 -177.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.606 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 1.1 tpt -56.32 -39.76 73.29 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.498 1.119 . . . . 73.23 110.362 170.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.55 -41.54 66.56 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 124.548 1.155 . . . . 74.13 112.077 176.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.4 t -67.69 -41.39 83.71 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.631 0.772 . . . . 75.02 111.662 177.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -65.83 -52.37 51.1 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.465 0.706 . . . . 74.34 110.665 -176.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 95.4 t -61.11 -42.11 91.95 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-N 115.19 -0.914 . . . . 72.55 110.93 176.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -55.8 -46.9 77.92 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 123.564 0.746 . . . . 74.21 111.175 176.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -55.99 -55.57 31.13 Favored 'General case' 0 C--N 1.349 0.573 0 O-C-N 124.254 0.971 . . . . 72.44 110.417 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.4 mt -61.21 -42.41 98.54 Favored 'General case' 0 N--CA 1.478 0.963 0 O-C-N 124.15 0.906 . . . . 63.33 112.018 -175.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -59.19 -39.98 84.27 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.312 0.645 . . . . 71.24 111.368 175.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 57.2 mtm -73.86 -31.22 63.06 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.385 0.274 . . . . 72.41 110.795 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -79.38 3.51 18.12 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.71 0.804 . . . . 74.43 111.668 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 81.08 14.06 79.92 Favored Glycine 0 C--N 1.345 1.049 0 CA-C-O 119.428 -0.651 . . . . 73.32 113.921 173.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -74.26 138.85 43.89 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 109.275 -0.639 . . . . 74.13 109.275 175.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 19.1 ttp180 -100.81 124.14 46.02 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 109.337 -0.616 . . . . 74.23 109.337 178.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.58 ' HE2' ' HB ' ' A' ' 84' ' ' VAL . 1.3 tmtp? -78.64 131.04 36.53 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.268 1.027 . . . . 74.53 108.934 177.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.2 t -129.97 122.66 54.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 107.472 -1.307 . . . . 74.43 107.472 175.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.58 ' HB ' ' HE2' ' A' ' 82' ' ' LYS . 6.5 p -99.14 124.87 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 109.226 -0.657 . . . . 71.44 109.226 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -99.24 -48.35 4.85 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.069 0.548 . . . . 72.33 109.994 -177.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.584 HG23 ' HB3' ' A' ' 93' ' ' LYS . 47.3 mm -89.04 98.96 8.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 109.693 -0.484 . . . . 74.3 109.693 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -79.57 123.67 27.81 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 115.294 -0.866 . . . . 54.45 109.737 177.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.578 HE22 ' HA ' ' A' ' 95' ' ' GLU . 16.9 mm100 -101.33 160.33 14.51 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 124.222 1.009 . . . . 73.21 111.706 -173.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 141.57 -80.37 0.26 Allowed Glycine 0 C--N 1.349 1.264 0 CA-C-N 115.201 -0.908 . . . . 63.31 111.378 176.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -147.66 22.78 1.49 Allowed Glycine 0 C--N 1.343 0.921 0 C-N-CA 122.879 0.275 . . . . 45.4 112.709 -177.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 78.2 mt -89.75 170.95 9.99 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.743 0.817 . . . . 74.44 110.636 178.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.9 p -82.98 -3.2 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.457 0 C-N-CA 122.864 0.466 . . . . 71.15 111.549 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.584 ' HB3' HG23 ' A' ' 86' ' ' ILE . 45.7 mmtm -54.86 146.76 35.66 Favored Pre-proline 0 N--CA 1.491 1.607 0 C-N-CA 123.898 0.879 . . . . 74.42 110.929 171.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -62.77 158.18 43.79 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 122.928 2.418 . . . . 75.03 111.629 178.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.578 ' HA ' HE22 ' A' ' 88' ' ' GLN . 11.4 pt-20 -85.75 58.87 5.29 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 122.403 1.097 . . . . 64.11 111.428 -177.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -155.83 83.49 1.02 Allowed 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 114.261 -1.336 . . . . 64.01 108.584 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -44.26 128.64 6.17 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 113.73 -1.577 . . . . 40.43 111.16 175.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -96.65 108.0 20.54 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.764 -0.828 . . . . 75.33 108.764 178.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.463 ' HB ' ' HB ' ' A' ' 48' ' ' VAL . 3.8 m -100.26 95.14 6.59 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 108.206 -1.035 . . . . 51.51 108.206 174.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -91.35 141.52 28.68 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 108.153 -1.054 . . . . 72.25 108.153 178.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -124.75 125.5 44.16 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.24 -1.022 . . . . 65.42 108.24 173.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -116.87 149.43 40.09 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.317 0.647 . . . . 73.34 110.083 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 44.4 t-80 -162.96 127.92 2.07 Favored Pre-proline 0 CA--C 1.544 0.734 0 N-CA-C 108.936 -0.764 . . . . 64.43 108.936 174.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -62.3 -31.14 81.86 Favored 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 122.726 2.284 . . . . 62.42 113.355 -174.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 36.2 m -88.84 3.07 52.45 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 122.735 0.414 . . . . 73.21 111.466 -178.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -101.02 99.63 10.11 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 107.216 -1.401 . . . . 65.34 107.216 172.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.539 ' HB2' ' HB2' ' A' ' 110' ' ' GLN . 87.5 mt -119.92 129.67 54.45 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.244 0.618 . . . . 63.13 109.349 176.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -72.05 93.18 1.37 Allowed 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 107.641 -1.244 . . . . 74.25 107.641 174.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 145.45 -55.55 0.54 Allowed Glycine 0 C--N 1.33 0.213 0 N-CA-C 109.193 -1.563 . . . . 52.21 109.193 -173.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.539 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 2.6 mp0 -88.46 76.07 8.31 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 123.602 0.761 . . . . 72.12 110.181 176.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.68 -17.48 60.67 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.231 0.612 . . . . 43.23 112.036 175.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 19.3 pm0 -69.55 -21.72 63.61 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 111.494 0.183 . . . . 72.51 111.494 175.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 64.0 mt -80.04 -5.93 56.71 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 122.775 0.43 . . . . 73.22 112.125 -177.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 68.8 mt -69.97 -23.16 63.13 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.246 0.618 . . . . 71.2 111.944 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -81.13 -2.11 47.1 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 112.378 0.511 . . . . 72.12 112.378 176.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -90.32 -12.99 36.13 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 109.066 -0.716 . . . . 75.34 109.066 170.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 18.7 mt -93.19 121.3 43.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 107.79 -1.189 . . . . 72.12 107.79 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.81 168.57 18.49 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.067 0.46 . . . . 75.4 111.062 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.508 HH21 ' HA ' ' A' ' 123' ' ' SER . 28.1 ptt180 -133.72 -46.68 0.8 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.999 0.919 . . . . 72.11 109.668 -172.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.471 ' N ' ' HG3' ' A' ' 119' ' ' ARG . 31.2 mmmt -140.65 -156.3 0.66 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.879 1.672 . . . . 71.53 106.902 -172.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.6 m -107.89 7.02 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 122.144 -0.347 . . . . 72.32 110.565 167.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.6 t -116.2 146.52 42.25 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.644 0.778 . . . . 53.43 111.084 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.508 ' HA ' HH21 ' A' ' 119' ' ' ARG . 35.7 t -162.38 68.37 0.25 Allowed 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 107.501 -1.296 . . . . 33.42 107.501 175.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 30.5 m -108.86 -164.9 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 124.385 1.074 . . . . 75.34 110.882 -172.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.1 p . . . . . 0 CA--C 1.557 1.235 0 C-N-CA 123.725 0.81 . . . . 73.33 111.124 177.242 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.9 ttm . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 109.003 -0.739 . . . . 71.13 109.003 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.07 124.49 9.1 Favored Glycine 0 C--N 1.347 1.183 0 N-CA-C 111.307 -0.717 . . . . 61.03 111.307 175.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -76.8 -28.06 55.47 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.144 0.578 . . . . 74.14 110.255 173.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 40.1 m-70 71.66 119.35 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 125.161 1.384 . . . . 63.51 111.864 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 12.1 m170 -98.38 43.41 1.06 Allowed 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 107.657 -1.238 . . . . 71.52 107.657 163.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -64.55 104.75 0.84 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.43 0.692 . . . . 62.2 109.39 -176.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -130.31 124.63 32.79 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.366 1.066 . . . . 64.23 109.439 -176.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -71.91 -38.53 69.9 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.494 0.718 . . . . 73.44 109.986 173.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.8 m 62.21 17.46 9.27 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.316 1.046 . . . . 70.52 113.126 176.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -89.81 -17.08 28.83 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.025 0.53 . . . . 74.5 111.716 -177.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 56.7 mtt -74.8 153.96 38.52 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 122.855 0.462 . . . . 73.11 110.368 175.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.5 14.86 1.13 Allowed 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.317 0.647 . . . . 61.31 112.441 -177.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -109.01 84.22 0.36 Allowed Glycine 0 C--N 1.343 0.953 0 CA-C-O 119.053 -0.859 . . . . 72.22 111.083 168.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -88.72 -158.01 0.07 OUTLIER 'Trans proline' 0 C--N 1.376 2.018 0 C-N-CA 123.012 2.475 . . . . 72.31 111.793 -178.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 73.5 m -67.19 160.21 27.38 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 122.872 0.469 . . . . 63.11 110.356 170.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.2 m-80 -84.57 40.55 0.8 Allowed 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.528 1.131 . . . . 72.21 110.771 -174.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 70.8 t -68.19 122.58 84.71 Favored Pre-proline 0 CA--C 1.544 0.748 0 C-N-CA 123.982 0.913 . . . . 72.51 110.37 -174.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.36 145.74 34.97 Favored 'Trans proline' 0 C--N 1.381 2.264 0 C-N-CA 122.897 2.398 . . . . 64.14 111.863 174.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.99 -40.73 67.2 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.751 0.82 . . . . 75.21 111.968 -176.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.425 ' HA ' ' HE1' ' A' ' 63' ' ' PHE . 54.1 t80 -53.25 -49.43 66.89 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.74 0.816 . . . . 55.43 111.851 173.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 92.5 mt -77.72 -31.07 52.06 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.007 0.523 . . . . 60.34 112.303 -170.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.5 t -76.02 -34.23 59.69 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 117.586 0.176 . . . . 75.42 110.973 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.15 -39.66 71.81 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 122.611 0.364 . . . . 71.33 110.035 174.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.49 ' O ' HG23 ' A' ' 28' ' ' VAL . 53.4 tp -61.85 -43.41 98.9 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 124.152 0.908 . . . . 71.41 110.801 174.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.514 ' CE3' HD11 ' A' ' 114' ' ' LEU . 70.9 t-105 -56.66 -47.7 79.21 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.234 1.013 . . . . 71.2 110.947 177.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 43.3 m -63.36 -42.66 98.9 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 115.03 -0.987 . . . . 71.01 110.949 174.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.8 tp -62.21 -53.24 58.07 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.386 1.474 . . . . 71.41 112.528 -172.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 24' ' ' LEU . 24.8 t -58.76 -33.85 50.36 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.074 0 C-N-CA 123.095 0.558 . . . . 74.03 111.41 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.0 t -87.11 -16.08 36.56 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.087 0.955 . . . . 65.41 111.647 -176.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -76.12 127.05 85.91 Favored Pre-proline 0 N--CA 1.481 1.089 0 C-N-CA 122.76 0.424 . . . . 64.25 111.115 -172.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -66.13 -30.64 46.56 Favored 'Trans proline' 0 C--N 1.385 2.467 0 C-N-CA 123.195 2.597 . . . . 55.1 114.543 -175.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -65.06 -38.32 90.44 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.438 0.637 . . . . 71.5 110.594 178.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 39.4 p -101.34 -2.02 32.01 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.922 -1.035 . . . . 71.44 111.542 -175.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -57.9 -35.97 71.78 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.513 1.125 . . . . 71.24 111.391 -178.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -54.43 -38.78 66.69 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.368 -0.833 . . . . 62.24 111.783 178.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.419 ' HA ' ' HB2' ' A' ' 49' ' ' PHE . 79.4 mt -98.24 -25.6 14.82 Favored 'General case' 0 C--O 1.213 -0.819 0 C-N-CA 123.08 0.552 . . . . 63.51 111.072 -178.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 47' ' ' HIS . 19.8 tt -149.48 116.04 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 O-C-N 121.251 -0.905 . . . . 72.12 111.231 -176.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 9.0 p -142.86 150.38 39.79 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.611 0.764 . . . . 61.42 110.62 -171.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -70.12 150.21 46.78 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.537 0.735 . . . . 72.35 110.307 176.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 56.3 p -71.66 155.93 91.83 Favored Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 122.995 0.518 . . . . 70.12 109.616 167.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -52.93 -29.47 43.95 Favored 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.612 2.208 . . . . 75.25 112.763 173.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.7 m -76.11 -38.02 57.39 Favored 'General case' 0 C--N 1.352 0.709 0 C-N-CA 123.088 0.555 . . . . 73.31 110.906 175.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.606 ' HA3' ' HD2' ' A' ' 108' ' ' ARG . . . 78.95 20.83 69.55 Favored Glycine 0 C--N 1.344 1.009 0 O-C-N 123.358 0.411 . . . . 60.41 113.24 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -95.24 -17.43 21.71 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.823 0.849 . . . . 75.3 109.988 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.401 ' HB3' ' HB3' ' A' ' 102' ' ' GLN . 66.6 p -142.48 168.84 18.79 Favored 'General case' 0 C--O 1.245 0.855 0 C-N-CA 123.806 0.842 . . . . 72.15 109.72 -174.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.403 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 46.3 p90 -143.05 147.22 34.7 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 122.79 0.436 . . . . 64.21 110.404 175.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.417 ' O ' ' HA ' ' A' ' 37' ' ' ILE . 13.9 m-70 -104.15 142.55 34.29 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.154 0.982 . . . . 25.22 109.343 -178.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.2 t -124.18 125.78 71.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 108.06 -1.089 . . . . 62.45 108.06 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 79.9 m-85 -108.8 145.16 35.65 Favored 'General case' 0 C--O 1.247 0.941 0 C-N-CA 124.662 1.185 . . . . 72.23 109.067 -174.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 47.78 76.42 0.11 Allowed 'General case' 0 CA--C 1.542 0.669 0 O-C-N 124.561 1.163 . . . . 73.34 112.365 173.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.542 ' HG2' ' HB2' ' A' ' 97' ' ' ASP . 5.2 mm-40 -52.78 -29.49 27.72 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 115.735 -0.666 . . . . 75.51 112.173 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.99 -50.95 49.16 Favored Glycine 0 C--N 1.345 1.049 0 O-C-N 123.492 0.495 . . . . 61.34 112.894 174.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.407 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 62.7 tp60 -70.14 -46.51 64.58 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 122.647 0.379 . . . . 60.35 110.62 -177.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.44 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 61.1 t80 -53.68 -50.88 64.87 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.169 1.388 . . . . 74.04 111.132 176.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.59 ' HB2' ' HB2' ' A' ' 68' ' ' MET . . . -59.48 -35.27 73.8 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 112.849 0.685 . . . . 74.31 112.849 177.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.56 -47.07 51.14 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.069 0.948 . . . . 61.2 112.406 -176.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.503 ' HG3' HG23 ' A' ' 58' ' ' VAL . 6.5 pt-20 -102.36 -43.03 5.8 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 112.664 0.616 . . . . 74.25 112.664 -173.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.503 HG23 ' HG3' ' A' ' 57' ' ' GLU . 55.8 t -79.33 -47.2 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 123.386 0.674 . . . . 54.42 111.418 -168.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.2 mt -65.36 -46.65 70.76 Favored Pre-proline 0 CA--C 1.561 1.39 0 N-CA-C 113.239 0.829 . . . . 63.52 113.239 -174.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.37 -16.0 49.93 Favored 'Trans proline' 0 C--N 1.387 2.584 0 CA-C-N 121.901 1.715 . . . . 74.11 113.031 173.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -79.67 -62.32 1.72 Allowed 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 123.999 0.92 . . . . 72.44 111.584 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -84.97 -24.33 28.35 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 122.974 0.509 . . . . 74.52 111.642 -176.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.425 ' HE1' ' HA ' ' A' ' 20' ' ' PHE . 41.0 m-85 -122.65 -169.24 1.87 Allowed 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 108.223 -1.028 . . . . 71.31 108.223 -179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -127.64 45.14 2.79 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 121.867 0.842 . . . . 71.11 110.334 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -154.51 156.12 36.1 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.649 1.18 . . . . 63.21 107.965 176.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.524 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 1.6 m-20 -108.43 -16.08 14.31 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 109.723 -0.473 . . . . 54.24 109.723 176.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -66.52 115.3 6.25 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.346 0.658 . . . . 52.31 110.994 -176.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.59 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 12.1 tpt -73.26 -33.78 65.46 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.781 0.832 . . . . 64.12 111.29 -177.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.3 -35.64 65.31 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.097 0.559 . . . . 74.4 111.282 176.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.529 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 44.1 t -66.13 -46.59 77.0 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.171 0.988 . . . . 72.02 110.944 176.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -62.26 -53.26 57.78 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.011 0.924 . . . . 70.42 110.682 -176.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.5 t -62.78 -37.63 79.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 115.449 -0.796 . . . . 71.24 111.087 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 -59.88 -38.02 81.02 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.312 0.645 . . . . 74.34 111.347 177.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 70' ' ' SER . 81.1 mm-40 -60.19 -48.28 82.4 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 109.346 -0.612 . . . . 71.25 109.346 176.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.438 ' HA ' ' HB2' ' A' ' 78' ' ' TYR . 93.6 mt -63.77 -36.36 83.61 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.063 0.945 . . . . 74.1 111.498 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -60.29 -42.46 95.54 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.388 0.675 . . . . 62.11 110.972 173.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 72.1 mtm -76.14 -21.32 56.71 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.723 -0.671 . . . . 74.34 110.677 176.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.438 ' HB2' ' HA ' ' A' ' 75' ' ' LEU . 26.6 m-85 -83.04 -4.09 57.97 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.572 0.749 . . . . 71.33 111.414 173.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.62 17.7 77.04 Favored Glycine 0 C--N 1.347 1.17 0 N-CA-C 114.433 0.533 . . . . 24.01 114.433 174.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -66.59 154.36 40.66 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.427 0.691 . . . . 72.43 110.436 177.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -99.73 122.55 42.89 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.564 0.746 . . . . 73.3 109.199 -178.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.582 ' HE2' ' HB ' ' A' ' 84' ' ' VAL . 21.0 tptm -77.08 123.76 26.84 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.841 1.256 . . . . 73.41 109.557 177.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.463 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 47.5 t -126.21 109.29 20.95 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.901 0 N-CA-C 108.103 -1.073 . . . . 71.14 108.103 170.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.582 ' HB ' ' HE2' ' A' ' 82' ' ' LYS . 5.1 p -90.45 123.9 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 123.445 0.698 . . . . 74.22 109.599 -179.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -108.45 -23.25 11.95 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.063 0.545 . . . . 74.22 111.713 -176.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 21.3 mm -121.24 101.13 9.95 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 N-CA-C 109.686 -0.487 . . . . 71.44 109.686 175.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -79.03 124.83 28.65 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 109.306 -0.627 . . . . 65.44 109.306 171.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -70.88 126.08 28.6 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.435 0.694 . . . . 73.1 111.9 -174.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 153.51 -163.81 30.86 Favored Glycine 0 C--N 1.341 0.815 0 CA-C-N 115.378 -0.828 . . . . 72.02 112.713 177.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -81.93 71.78 2.9 Favored Glycine 0 N--CA 1.468 0.794 0 CA-C-N 114.979 -0.611 . . . . 72.13 112.531 -174.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 96.1 mt -124.35 -176.16 3.44 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.317 1.047 . . . . 71.35 110.026 -176.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.0 p -83.4 30.15 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 CA-C-O 122.17 0.986 . . . . 72.1 110.934 -178.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.432 ' HB2' ' NZ ' ' A' ' 93' ' ' LYS . 9.1 mtmp? -134.08 146.26 59.08 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 124.715 1.206 . . . . 70.02 108.98 -174.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.447 ' HG2' ' HG2' ' A' ' 96' ' ' ARG . 58.0 Cg_endo -70.16 175.83 7.91 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 122.199 1.933 . . . . 74.44 111.523 170.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -80.66 13.41 2.58 Favored 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 112.688 0.625 . . . . 63.34 112.688 -177.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.447 ' HG2' ' HG2' ' A' ' 94' ' ' PRO . 21.4 ptt180 -64.92 154.24 38.02 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.258 0.623 . . . . 74.01 109.467 169.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.542 ' HB2' ' HG2' ' A' ' 51' ' ' GLN . 5.9 m-20 -103.53 145.02 30.64 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.77 -0.826 . . . . 64.43 108.77 165.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -129.64 112.54 13.78 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.466 -1.309 . . . . 75.32 107.466 168.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 41.2 m -123.32 118.71 28.15 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.167 0.987 . . . . 73.13 109.623 -175.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.463 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 41.2 tt0 -102.18 110.85 22.92 Favored 'General case' 0 C--O 1.241 0.607 0 C-N-CA 124.155 0.982 . . . . 74.41 108.628 -179.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -97.67 132.76 43.02 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 108.801 -0.815 . . . . 73.35 108.801 173.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.401 ' HB3' ' HB3' ' A' ' 45' ' ' SER . 27.0 pt20 -139.02 145.99 40.32 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.772 0.829 . . . . 42.55 109.305 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -149.3 136.88 11.29 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 109.025 -0.731 . . . . 75.45 109.025 -177.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -59.02 -34.82 99.23 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 122.692 2.261 . . . . 73.41 112.725 -177.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.403 ' HB2' HG12 ' A' ' 117' ' ' ILE . 15.7 m -89.63 14.32 11.93 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.223 0.609 . . . . 45.53 111.007 179.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -122.67 98.82 6.09 Favored 'General case' 0 C--O 1.245 0.838 0 N-CA-C 107.799 -1.185 . . . . 74.13 107.799 174.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 91.5 mt -131.4 151.78 51.23 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.386 1.075 . . . . 71.0 109.426 178.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.606 ' HD2' ' HA3' ' A' ' 43' ' ' GLY . 16.1 ptm180 -63.17 112.39 2.64 Favored 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 124.194 0.998 . . . . 71.15 111.484 -178.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.96 -8.22 63.12 Favored Glycine 0 N--CA 1.472 1.08 0 CA-C-N 116.388 -0.369 . . . . 64.22 113.585 -178.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.523 HE21 ' N ' ' A' ' 110' ' ' GLN . 0.0 OUTLIER -102.75 71.73 1.18 Allowed 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 117.641 0.721 . . . . 64.22 111.034 -177.662 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.473 ' HA ' ' HG ' ' A' ' 114' ' ' LEU . 9.4 pt-20 -70.29 -26.06 63.63 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.658 -0.701 . . . . 73.54 111.679 170.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.4 pm0 -65.05 -15.15 62.03 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.708 0.803 . . . . 72.02 112.193 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 79.9 mt -95.14 -17.88 21.42 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.147 0.579 . . . . 54.22 111.764 176.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.514 HD11 ' CE3' ' A' ' 25' ' ' TRP . 80.4 mt -67.87 -37.72 82.16 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.246 0.619 . . . . 63.53 110.992 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -64.12 -14.51 55.35 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.246 -0.888 . . . . 71.34 112.429 174.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -101.2 -2.4 31.39 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.6 0.76 . . . . 73.51 110.682 179.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.403 HG12 ' HB2' ' A' ' 105' ' ' CYS . 37.0 mt -92.81 113.33 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 106.995 -1.483 . . . . 74.3 106.995 173.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.446 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 9.8 mmpt? -115.77 145.05 43.14 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.04 0.536 . . . . 62.2 111.254 -169.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 30.6 ptt85 -110.95 11.5 22.22 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 108.247 -1.02 . . . . 71.33 108.247 168.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.9 mmmp? -107.97 155.09 20.72 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.389 1.476 . . . . 72.4 109.017 177.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 6.5 m 51.79 24.52 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 C-N-CA 126.35 1.86 . . . . 74.33 113.767 173.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.1 t -125.87 -33.54 2.7 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 112.509 0.559 . . . . 75.23 112.509 -171.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 48.2 p -163.57 -169.71 2.01 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.976 0.51 . . . . 73.12 111.062 -173.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 99.7 t -79.32 133.0 30.83 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 123.038 0.535 . . . . 71.11 110.491 178.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 24.1 m . . . . . 0 C--O 1.249 1.059 0 C-N-CA 124.443 1.097 . . . . 74.12 108.342 175.258 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.3 mmm . . . . . 0 N--CA 1.474 0.758 0 N-CA-C 110.243 -0.28 . . . . 74.01 110.243 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -102.5 51.48 0.87 Allowed Glycine 0 C--N 1.352 1.453 0 N-CA-C 114.317 0.487 . . . . 61.12 114.317 -169.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -157.59 86.58 0.93 Allowed 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 121.602 0.715 . . . . 75.24 110.129 172.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -118.05 91.33 3.54 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.391 1.076 . . . . 45.02 108.916 178.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 46.4 m-70 -91.92 101.84 14.41 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.491 -0.777 . . . . 71.31 109.181 -178.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -67.24 97.42 0.54 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.659 -0.7 . . . . 72.44 109.139 173.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -70.06 92.52 0.74 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.859 -0.61 . . . . 61.43 109.384 175.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -81.21 85.04 6.43 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 107.653 -1.24 . . . . 73.31 107.653 168.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.3 m -89.01 164.01 15.27 Favored 'General case' 0 C--O 1.243 0.756 0 CA-C-N 114.562 -1.199 . . . . 65.24 109.959 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 -73.49 91.31 1.79 Allowed 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 108.463 -0.94 . . . . 62.32 108.463 170.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 63.8 mtm -80.94 61.12 4.42 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.414 1.085 . . . . 71.14 110.323 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -168.33 154.57 7.21 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 125.761 1.624 . . . . 72.31 108.023 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.28 -86.13 0.48 Allowed Glycine 0 N--CA 1.469 0.884 0 N-CA-C 110.954 -0.858 . . . . 63.12 110.954 -176.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -76.77 38.4 0.63 Allowed 'Trans proline' 0 C--N 1.372 1.775 0 C-N-CA 123.141 2.561 . . . . 73.44 111.707 166.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.435 ' OG ' HG23 ' A' ' 17' ' ' VAL . 40.0 t -76.38 152.66 36.22 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.645 0.778 . . . . 73.04 111.348 -172.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -108.5 15.69 23.64 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.65 -0.704 . . . . 75.14 111.22 -174.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.435 HG23 ' OG ' ' A' ' 15' ' ' SER . 91.4 t -60.93 129.12 90.02 Favored Pre-proline 0 N--CA 1.482 1.14 0 CA-C-O 119.386 -0.34 . . . . 54.44 110.677 -177.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -61.28 141.84 94.23 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 122.618 2.212 . . . . 71.54 111.123 174.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.47 -40.5 62.39 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.814 0.845 . . . . 74.21 111.36 176.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -50.45 -47.78 56.71 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 124.248 0.967 . . . . 75.55 112.961 173.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 90.3 mt -83.68 -26.19 30.05 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.816 0.447 . . . . 72.1 110.402 -170.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.7 m -66.11 -45.22 81.93 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 124.154 0.982 . . . . 60.24 110.983 171.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.464 ' HE2' ' HA ' ' A' ' 23' ' ' LYS . 10.6 mmpt? -67.18 -44.72 78.95 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.726 0.41 . . . . 72.3 110.153 176.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 60.5 tp -56.11 -53.23 59.59 Favored 'General case' 0 C--N 1.356 0.876 0 O-C-N 124.483 1.114 . . . . 72.15 111.47 178.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.528 ' HH2' ' HG3' ' A' ' 108' ' ' ARG . 8.3 t-105 -59.37 -49.26 78.52 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 122.942 0.497 . . . . 74.43 111.832 -178.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 23.5 m -62.1 -28.05 69.35 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 122.805 0.442 . . . . 70.44 111.291 178.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.474 HD13 ' CD1' ' A' ' 62' ' ' TYR . 24.0 tp -74.37 -44.45 52.15 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.203 1.001 . . . . 64.23 111.793 176.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.2 t -61.87 -36.74 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.881 0.872 . . . . 62.24 110.401 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 88.4 p -90.34 10.8 23.51 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.842 0.857 . . . . 73.41 111.736 -177.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 54.3 t0 -90.86 116.42 66.38 Favored Pre-proline 0 CA--C 1.56 1.36 0 C-N-CA 123.052 0.541 . . . . 44.32 110.675 175.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -77.69 -7.81 16.76 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 123.256 2.637 . . . . 72.55 113.156 177.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -85.55 -25.72 26.59 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.689 0.795 . . . . 75.02 111.509 177.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 40.9 p -106.32 9.34 31.97 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 122.84 0.456 . . . . 75.12 111.122 178.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -57.85 -30.39 65.75 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 113.381 0.882 . . . . 64.52 113.381 -170.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -69.06 -24.08 64.12 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 112.574 0.583 . . . . 65.43 112.574 -176.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.474 HD22 ' HB2' ' A' ' 50' ' ' ASP . 77.4 mt -115.13 -18.17 11.23 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.2 0.6 . . . . 64.11 111.056 -178.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.463 HD13 ' HG ' ' A' ' 27' ' ' LEU . 14.9 tt -160.94 123.86 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.234 0.613 . . . . 64.01 110.231 171.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 23.2 p -150.55 161.69 42.07 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.159 0.584 . . . . 40.41 110.433 178.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 38.4 p-90 -73.33 147.27 44.58 Favored 'General case' 0 N--CA 1.475 0.801 0 O-C-N 124.048 0.842 . . . . 75.03 109.47 172.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.2 m -75.64 149.62 83.69 Favored Pre-proline 0 CA--C 1.548 0.9 0 N-CA-C 108.348 -0.982 . . . . 71.22 108.348 171.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.77 -28.43 23.05 Favored 'Trans proline' 0 C--N 1.378 2.094 0 C-N-CA 123.101 2.534 . . . . 75.15 114.25 -178.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.0 m -73.71 -24.8 59.97 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.309 0.644 . . . . 50.54 111.946 177.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.24 0.84 90.13 Favored Glycine 0 C--N 1.342 0.889 0 C-N-CA 123.129 0.395 . . . . 34.22 113.649 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -82.27 -25.4 34.07 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.727 0.811 . . . . 72.3 111.036 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.9 p -146.96 178.99 7.91 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.358 0.663 . . . . 74.12 110.311 -169.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 42.1 p90 -146.63 143.85 29.09 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 122.711 0.404 . . . . 70.34 110.985 178.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -103.33 151.71 22.41 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.23 0.612 . . . . 74.1 109.464 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 98' ' ' ASP . 95.5 t -124.23 132.13 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.363 1.065 . . . . 71.33 108.349 176.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -116.07 148.77 39.89 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.835 0.854 . . . . 71.22 109.604 178.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.474 ' HB2' HD22 ' A' ' 36' ' ' LEU . 20.8 m-20 53.16 63.44 2.23 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 124.692 1.245 . . . . 70.43 111.259 170.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -50.12 -33.35 18.48 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.181 0.993 . . . . 73.13 113.33 -172.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -66.64 -43.99 90.76 Favored Glycine 0 CA--C 1.533 1.196 0 O-C-N 123.412 0.445 . . . . 65.41 112.441 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -74.11 -45.48 48.78 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.392 0.677 . . . . 71.34 110.059 -178.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.436 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 39.1 t80 -50.51 -52.27 39.93 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.28 1.432 . . . . 75.21 111.494 174.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.463 ' HB2' ' HB2' ' A' ' 68' ' ' MET . . . -62.2 -36.32 81.57 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 115.657 -0.701 . . . . 60.04 111.577 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.9 tmtt? -66.81 -46.92 73.65 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.85 0.86 . . . . 63.33 112.85 -175.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.488 ' HG3' HG23 ' A' ' 58' ' ' VAL . 11.1 pt-20 -113.07 -33.9 5.88 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 114.292 1.219 . . . . 74.42 114.292 -171.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.488 HG23 ' HG3' ' A' ' 57' ' ' GLU . 91.9 t -82.83 -45.03 19.24 Favored 'Isoleucine or valine' 0 C--O 1.253 1.286 0 C-N-CA 123.71 0.804 . . . . 50.43 111.938 -170.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 50.6 mt -64.59 -46.55 77.03 Favored Pre-proline 0 CA--C 1.557 1.231 0 CA-C-O 118.095 -0.955 . . . . 63.34 112.766 179.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.418 ' HG3' ' ND2' ' A' ' 66' ' ' ASN . 41.7 Cg_endo -67.2 -15.21 45.64 Favored 'Trans proline' 0 C--N 1.381 2.262 0 CA-C-N 121.954 1.733 . . . . 73.11 113.105 174.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -73.14 -50.6 21.8 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.58 0.752 . . . . 75.01 110.489 176.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.474 ' CD1' HD13 ' A' ' 27' ' ' LEU . 37.0 m-85 -92.76 -51.88 4.88 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 112.594 0.59 . . . . 74.3 112.594 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -90.87 -172.03 3.22 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.885 -0.783 . . . . 65.14 108.885 -179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -118.47 40.66 3.16 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 121.313 0.578 . . . . 65.42 110.397 -174.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -162.25 164.66 27.53 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.193 -0.912 . . . . 72.11 109.246 -177.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.418 ' ND2' ' HG3' ' A' ' 60' ' ' PRO . 13.1 m120 -106.24 -33.98 7.63 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.356 0.663 . . . . 72.25 109.864 179.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -62.97 127.09 29.62 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.31 0.644 . . . . 72.14 112.522 -173.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.463 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 25.7 ttt -88.16 -23.69 23.55 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 122.97 0.508 . . . . 75.34 111.365 -176.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.42 -38.37 77.28 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 121.424 0.63 . . . . 74.04 111.211 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.415 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 22.8 t -68.89 -40.39 79.21 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.593 1.157 . . . . 62.42 111.087 176.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -62.39 -48.32 80.25 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.456 1.103 . . . . 74.23 110.899 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 83.4 t -65.24 -39.46 85.49 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.865 0 C-N-CA 123.786 0.834 . . . . 73.34 111.102 177.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 70.0 ttt-85 -54.24 -43.71 71.14 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.195 0.598 . . . . 71.11 110.952 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.519 ' HA ' ' HE2' ' A' ' 77' ' ' MET . 10.2 mm100 -62.15 -45.77 91.96 Favored 'General case' 0 C--N 1.349 0.549 0 O-C-N 123.959 0.787 . . . . 55.25 110.352 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 43.1 mt -59.77 -36.92 77.66 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.662 0.785 . . . . 75.42 111.439 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 -61.0 -40.68 94.48 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 122.839 0.456 . . . . 64.12 111.182 173.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.519 ' HE2' ' HA ' ' A' ' 74' ' ' GLN . 31.9 mtm -69.71 -35.6 75.19 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.563 0.345 . . . . 60.41 110.597 178.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -81.57 4.44 21.41 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.695 0.798 . . . . 74.14 111.019 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.89 24.96 75.87 Favored Glycine 0 C--N 1.351 1.375 0 CA-C-O 119.459 -0.634 . . . . 74.22 114.538 170.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -73.03 148.89 43.7 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 117.271 0.535 . . . . 72.34 109.805 173.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.85 121.01 40.66 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.566 -0.901 . . . . 62.4 108.566 177.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.678 ' HE2' ' HB ' ' A' ' 84' ' ' VAL . 1.2 tmtp? -82.73 126.27 32.19 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.756 -1.202 . . . . 61.13 107.756 176.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 88.2 t -129.37 111.18 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 107.698 -1.223 . . . . 73.11 107.698 177.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.678 ' HB ' ' HE2' ' A' ' 82' ' ' LYS . 10.2 p -98.99 125.86 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 108.717 -0.846 . . . . 74.55 108.717 -177.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 -97.72 -25.67 15.0 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 122.839 0.455 . . . . 72.5 110.755 -176.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.416 HD13 ' HD2' ' A' ' 93' ' ' LYS . 45.4 mm -94.04 98.54 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 N-CA-C 108.927 -0.768 . . . . 73.41 108.927 174.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -79.35 132.12 36.33 Favored 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 114.944 -1.026 . . . . 63.42 110.582 -178.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -64.58 96.86 0.18 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.629 0.772 . . . . 74.25 110.867 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.01 174.18 46.75 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.066 -0.97 . . . . 65.31 112.736 -179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -83.37 61.32 4.78 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 114.639 -0.78 . . . . 71.11 111.851 175.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 76.4 mt -106.45 176.77 5.06 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.412 1.085 . . . . 71.5 110.134 -174.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.8 p -76.64 -3.15 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.516 0 CA-C-O 121.433 0.635 . . . . 75.33 110.509 174.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.416 ' HD2' HD13 ' A' ' 86' ' ' ILE . 47.3 mmtm -68.13 127.89 93.27 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 123.673 0.789 . . . . 71.12 110.202 170.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -75.18 136.84 20.57 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.35 2.033 . . . . 55.33 110.446 173.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -71.75 6.67 1.85 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 114.277 1.214 . . . . 75.3 114.277 -163.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 34.2 ptt180 -67.11 96.66 0.47 Allowed 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 109.519 -0.548 . . . . 61.32 109.519 168.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -39.95 107.21 0.07 Allowed 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 124.036 0.934 . . . . 72.35 112.796 175.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.434 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 12.8 t70 -97.21 113.3 24.89 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 107.718 -1.216 . . . . 54.2 107.718 174.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.534 HG23 ' HE3' ' A' ' 82' ' ' LYS . 87.1 m -122.49 112.08 17.6 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.89 0.876 . . . . 61.03 109.483 -176.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 46' ' ' PHE . 41.4 tt0 -105.0 114.17 28.21 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 123.898 0.879 . . . . 74.34 108.853 -178.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -95.97 121.4 37.68 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 108.023 -1.103 . . . . 74.21 108.023 174.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -125.75 143.7 50.94 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.531 0.733 . . . . 70.23 109.685 -176.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.2 t-80 -158.92 133.31 5.3 Favored Pre-proline 0 CA--C 1.546 0.797 0 N-CA-C 108.568 -0.901 . . . . 73.14 108.568 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -64.19 -21.39 67.54 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.617 2.211 . . . . 74.43 113.556 -175.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.427 ' HB2' HG12 ' A' ' 117' ' ' ILE . 12.0 m -96.36 6.24 49.19 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 122.969 0.507 . . . . 72.01 111.128 178.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -114.32 100.03 8.03 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 106.974 -1.491 . . . . 74.34 106.974 171.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 110' ' ' GLN . 49.4 mt -129.38 158.95 37.71 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.707 -0.849 . . . . 74.42 108.707 175.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.528 ' HG3' ' HH2' ' A' ' 25' ' ' TRP . 35.8 ttp180 -73.62 126.38 30.15 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 123.394 0.677 . . . . 74.02 110.71 -178.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 68.57 28.86 72.92 Favored Glycine 0 C--N 1.346 1.134 0 O-C-N 123.872 0.732 . . . . 62.5 112.198 -177.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.403 ' HB3' ' HB2' ' A' ' 107' ' ' LEU . 6.3 tp60 -136.96 37.94 2.57 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 122.633 1.206 . . . . 75.32 108.122 -175.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.92 -10.61 58.13 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 113.533 -1.667 . . . . 71.24 113.393 -173.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 21.0 pm0 -64.85 -18.31 65.03 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 122.719 0.408 . . . . 71.42 111.437 172.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.451 ' HA ' HD22 ' A' ' 116' ' ' ASN . 67.3 mt -90.52 -6.88 54.23 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.272 0.629 . . . . 42.31 111.837 -178.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 96.6 mt -66.76 -33.71 76.23 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 118.041 0.382 . . . . 72.25 111.003 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -73.72 -12.78 60.83 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 120.882 0.372 . . . . 70.45 111.49 174.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.451 HD22 ' HA ' ' A' ' 113' ' ' LEU . 35.1 m-80 -94.97 -14.45 24.39 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.569 0.747 . . . . 74.24 109.355 177.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.427 HG12 ' HB2' ' A' ' 105' ' ' CYS . 45.2 mt -83.93 75.46 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.069 0 N-CA-C 107.344 -1.354 . . . . 73.33 107.344 169.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.435 ' HD2' ' O ' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -69.13 147.28 51.63 Favored 'General case' 0 CA--C 1.558 1.284 0 CA-C-N 115.322 -0.853 . . . . 62.44 113.296 173.644 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 16.7 ptm180 -86.01 -27.66 24.68 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-N 114.712 -1.131 . . . . 75.41 109.536 174.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.435 ' O ' ' HD2' ' A' ' 118' ' ' LYS . 31.5 mmmt -103.48 171.84 7.14 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.204 1.402 . . . . 63.22 109.69 175.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.5 p -95.27 33.26 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-O 122.627 1.203 . . . . 65.54 109.633 175.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 4.7 t -62.33 101.8 0.26 Allowed 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 114.279 -1.328 . . . . 75.53 110.904 -179.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 22.2 p -174.88 153.0 1.62 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.972 1.309 . . . . 72.01 108.488 -174.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 27.6 m -63.97 137.28 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 122.785 0.434 . . . . 72.42 111.81 -177.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 26.7 m . . . . . 0 CA--C 1.554 1.12 0 C-N-CA 123.301 0.64 . . . . 72.55 109.98 -177.895 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.1 ttm . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 120.763 0.316 . . . . 64.2 110.279 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -99.44 153.5 19.65 Favored Glycine 0 C--N 1.349 1.273 0 N-CA-C 111.047 -0.821 . . . . 55.14 111.047 173.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -70.41 86.23 0.61 Allowed 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.103 -0.702 . . . . 65.42 109.103 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -74.38 121.66 21.74 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.155 0.582 . . . . 63.34 111.22 -175.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 64.5 t60 -157.2 112.05 2.75 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.421 0.688 . . . . 62.31 109.589 177.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 46.6 p-80 -146.54 155.34 42.43 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.642 0.777 . . . . 73.32 110.13 176.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -133.77 148.43 51.38 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.105 0.962 . . . . 71.22 109.025 172.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 24.1 p80 -132.56 116.6 16.92 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.288 -1.004 . . . . 74.52 108.288 171.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.0 t -118.98 125.17 48.77 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.164 0.985 . . . . 63.33 110.579 -170.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -81.74 90.11 6.34 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 109.182 -0.673 . . . . 64.04 109.182 170.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 38.7 mtt -99.43 123.38 43.65 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.145 0.578 . . . . 62.23 109.481 173.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -108.78 113.73 26.92 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 124.053 0.941 . . . . 51.51 108.897 179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.6 132.63 38.01 Favored Glycine 0 C--N 1.348 1.202 0 CA-C-O 118.11 -1.383 . . . . 72.3 111.491 175.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -56.82 92.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.381 2.263 0 C-N-CA 123.185 2.59 . . . . 65.43 112.181 -177.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 77.5 p -71.7 128.42 35.73 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.694 0.798 . . . . 74.22 109.061 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.552 HD22 ' N ' ' A' ' 16' ' ' ASN . 0.7 OUTLIER -83.45 -6.71 59.54 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.278 0.631 . . . . 72.21 111.423 -171.297 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 93.4 t -50.37 114.8 4.82 Favored Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 124.348 1.059 . . . . 63.41 110.815 176.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.48 ' HD2' HD12 ' A' ' 21' ' ' LEU . 53.0 Cg_exo -56.61 155.93 24.46 Favored 'Trans proline' 0 C--N 1.382 2.299 0 C-N-CA 123.253 2.635 . . . . 74.45 112.495 178.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.82 -43.74 66.2 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.638 0.775 . . . . 74.11 111.283 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -53.37 -47.01 69.82 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 123.531 0.733 . . . . 73.52 112.151 175.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.48 HD12 ' HD2' ' A' ' 18' ' ' PRO . 72.9 mt -81.76 -27.64 33.68 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 112.31 0.485 . . . . 73.43 112.31 -171.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.1 t -76.07 -32.17 59.15 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 118.285 0.493 . . . . 71.13 111.045 174.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.488 ' HE2' ' HA ' ' A' ' 23' ' ' LYS . 10.2 mmpt? -71.33 -38.92 71.65 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 109.502 -0.555 . . . . 52.13 109.502 173.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.5 tp -61.44 -44.49 97.03 Favored 'General case' 0 N--CA 1.479 1.01 0 O-C-N 123.919 0.762 . . . . 75.02 110.797 172.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 74.7 t-105 -53.51 -56.08 20.02 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.071 0.948 . . . . 72.14 111.233 177.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.1 m -56.5 -47.39 79.38 Favored 'General case' 0 C--O 1.214 -0.786 0 O-C-N 124.574 1.171 . . . . 40.44 110.402 176.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.426 ' HG ' HG21 ' A' ' 37' ' ' ILE . 28.7 tp -54.79 -53.11 59.45 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 125.605 1.562 . . . . 73.34 113.133 -174.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 65.6 t -66.82 -28.14 42.11 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.306 0 C-N-CA 123.821 0.848 . . . . 74.44 111.104 178.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.3 t -94.05 -7.21 43.28 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.314 1.046 . . . . 71.24 112.263 -177.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -89.68 128.73 49.41 Favored Pre-proline 0 N--CA 1.484 1.234 0 C-N-CA 123.515 0.726 . . . . 74.15 111.614 -171.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -77.5 -11.05 17.31 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 122.859 2.373 . . . . 75.44 114.232 -178.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -81.3 -28.75 34.49 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 118.422 0.555 . . . . 73.21 110.862 175.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.422 HG21 ' HE1' ' A' ' 62' ' ' TYR . 40.0 p -114.51 4.0 15.08 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 112.435 0.532 . . . . 71.04 112.435 -177.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 1.5 p-10 -65.44 -24.82 67.28 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 112.3 0.481 . . . . 65.31 112.3 -174.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -68.05 -26.57 65.93 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.265 0.626 . . . . 61.44 112.448 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.455 HD22 ' HB2' ' A' ' 50' ' ' ASP . 66.4 mt -106.57 -13.89 15.19 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.02 0.528 . . . . 73.13 111.517 178.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.509 ' O ' ' HA ' ' A' ' 34' ' ' ASP . 16.4 tt -161.25 124.67 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 CA-C-O 120.844 0.354 . . . . 64.14 111.26 174.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 28.0 p -148.92 161.12 42.52 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.933 -0.766 . . . . 62.54 108.933 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 38.7 p-90 -82.47 148.54 28.09 Favored 'General case' 0 C--O 1.244 0.779 0 N-CA-C 108.965 -0.754 . . . . 60.13 108.965 176.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.9 m -75.54 151.31 85.04 Favored Pre-proline 0 CA--C 1.546 0.793 0 CA-C-N 115.176 -0.92 . . . . 52.24 110.084 -176.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -46.67 -39.64 23.51 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 123.468 2.779 . . . . 72.33 115.451 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 26.3 p -80.88 -9.8 59.79 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 112.086 0.402 . . . . 61.35 112.086 178.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 79.92 -0.08 83.76 Favored Glycine 0 C--N 1.351 1.403 0 N-CA-C 115.962 1.145 . . . . 64.41 115.962 163.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -94.44 -2.15 52.37 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.962 0.905 . . . . 71.21 111.705 -175.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.409 ' HB3' ' HB3' ' A' ' 102' ' ' GLN . 80.9 p -148.59 174.8 11.76 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.908 0.883 . . . . 43.14 110.163 -179.136 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -145.66 153.97 41.6 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.226 0.61 . . . . 72.42 110.084 170.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -112.92 149.32 33.36 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.114 0.966 . . . . 63.35 110.065 -178.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 98' ' ' ASP . 76.3 t -123.35 105.84 16.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 124.787 1.235 . . . . 62.15 107.987 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -91.18 145.18 24.88 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 124.041 0.936 . . . . 55.14 110.669 -177.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.455 ' HB2' HD22 ' A' ' 36' ' ' LEU . 3.2 m-20 53.0 57.46 6.31 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 124.579 1.175 . . . . 71.34 111.61 173.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.1 mt-30 -55.33 -26.31 40.03 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 114.332 1.234 . . . . 72.15 114.332 -169.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -70.38 -47.88 40.77 Favored Glycine 0 CA--C 1.531 1.093 0 N-CA-C 111.838 -0.505 . . . . 60.31 111.838 174.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -69.17 -44.3 72.51 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.394 0.678 . . . . 71.31 109.477 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -52.74 -51.37 60.79 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.318 1.447 . . . . 74.45 111.331 175.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.414 ' HB2' ' HB2' ' A' ' 68' ' ' MET . . . -64.57 -34.88 79.28 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.51 -0.314 . . . . 61.43 111.778 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -66.1 -46.77 76.47 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 124.457 1.103 . . . . 74.03 112.377 -176.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.546 ' HG3' HG23 ' A' ' 58' ' ' VAL . 6.9 pt-20 -109.76 -39.26 5.16 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 113.766 1.024 . . . . 55.32 113.766 -173.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.546 HG23 ' HG3' ' A' ' 57' ' ' GLU . 84.9 t -82.5 -38.23 15.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 C-N-CA 123.253 0.621 . . . . 62.14 111.615 -168.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 51.1 mt -69.97 -43.47 19.88 Favored Pre-proline 0 CA--C 1.565 1.519 0 CA-C-O 118.073 -0.965 . . . . 73.55 112.94 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -71.06 -10.57 27.72 Favored 'Trans proline' 0 C--N 1.385 2.497 0 CA-C-N 122.058 1.771 . . . . 42.32 113.155 171.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -78.91 -52.68 7.95 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.151 0.981 . . . . 74.33 110.964 176.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.436 ' HB3' ' HB3' ' A' ' 23' ' ' LYS . 49.3 m-85 -87.43 -24.45 24.17 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 122.892 0.477 . . . . 63.44 112.155 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -126.29 -150.09 0.43 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 107.35 -1.352 . . . . 74.24 107.35 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 20.0 pttm -142.88 55.54 1.39 Allowed 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 121.99 0.9 . . . . 73.23 109.615 172.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 32.7 p80 -154.51 148.3 25.48 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 114.845 -1.071 . . . . 65.1 108.825 177.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -110.98 0.18 16.92 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.263 0.625 . . . . 62.31 109.685 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -74.73 117.24 16.34 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.112 0.965 . . . . 74.53 110.088 176.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.414 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 13.6 tpt -75.56 -35.83 60.56 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.085 0.554 . . . . 73.21 110.77 178.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.89 -32.6 67.88 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.228 0.611 . . . . 63.43 111.61 178.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.46 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 44.7 t -59.25 -52.07 67.26 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.991 0.917 . . . . 71.32 111.068 173.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -64.96 -51.59 60.95 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.119 0.967 . . . . 74.42 110.894 -174.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.0 t -58.18 -46.46 88.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 124.024 0.93 . . . . 74.22 111.629 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 48.9 ttt85 -57.63 -41.2 80.89 Favored 'General case' 0 N--CA 1.483 1.213 0 O-C-N 123.671 0.607 . . . . 73.02 111.784 -178.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 70' ' ' SER . 13.3 mm100 -60.93 -48.12 83.28 Favored 'General case' 0 C--N 1.351 0.666 0 O-C-N 123.706 0.629 . . . . 74.22 109.829 -178.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 96.4 mt -64.98 -42.62 94.39 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.842 0.714 . . . . 60.4 111.129 -178.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.77 -37.91 80.36 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.243 0.617 . . . . 74.22 111.329 177.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 59.9 mtm -71.01 -32.55 69.37 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.627 0.371 . . . . 54.54 110.428 174.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -73.15 -2.2 20.59 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.476 0.71 . . . . 74.01 111.426 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 88.13 12.94 64.87 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-O 119.633 -0.537 . . . . 72.12 113.62 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -74.93 147.55 40.83 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.178 -1.045 . . . . 73.54 108.178 174.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.465 ' HB3' ' HG3' ' A' ' 102' ' ' GLN . 34.9 ttm-85 -98.88 122.03 41.6 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.723 -0.843 . . . . 74.53 108.723 -174.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.5 tptm -79.95 113.65 18.27 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.096 1.358 . . . . 63.14 108.846 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 100' ' ' GLU . 39.4 t -123.86 125.56 71.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 108.905 -0.776 . . . . 52.21 108.905 178.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 68.9 t -106.21 110.08 30.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 108.127 -1.064 . . . . 75.21 108.127 178.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -88.33 -46.88 8.83 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.826 0.45 . . . . 71.25 111.652 -173.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.532 ' HA ' ' HD3' ' A' ' 93' ' ' LYS . 33.0 mm -80.1 90.51 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 121.604 0.716 . . . . 74.33 109.855 -175.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -67.04 87.96 0.15 Allowed 'General case' 0 C--O 1.245 0.839 0 CA-C-N 114.274 -1.33 . . . . 71.15 109.844 171.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -80.22 93.23 5.83 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.465 -0.789 . . . . 74.33 109.476 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -155.9 17.71 0.47 Allowed Glycine 0 C--N 1.34 0.799 0 CA-C-N 115.297 -0.865 . . . . 64.22 112.238 178.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.24 26.96 16.92 Favored Glycine 0 C--N 1.347 1.16 0 C-N-CA 122.91 0.29 . . . . 63.43 113.031 -178.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 59.5 mt -93.56 172.03 8.52 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.556 0.742 . . . . 71.51 110.204 172.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.8 p -77.73 72.41 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-O 122.744 1.259 . . . . 75.12 110.394 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.532 ' HD3' ' HA ' ' A' ' 86' ' ' ILE . 62.2 mttp -143.9 151.2 52.19 Favored Pre-proline 0 CA--C 1.557 1.235 0 C-N-CA 125.29 1.436 . . . . 72.52 109.783 -178.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -66.76 156.7 64.73 Favored 'Trans proline' 0 C--N 1.383 2.377 0 C-N-CA 123.157 2.571 . . . . 60.11 112.749 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -82.59 61.9 5.95 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.316 0.646 . . . . 72.45 111.112 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -137.46 165.87 25.21 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.091 0.557 . . . . 64.14 110.426 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -103.38 118.7 37.36 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.802 -0.814 . . . . 73.11 108.802 169.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.504 ' HB3' HG12 ' A' ' 86' ' ' ILE . 22.5 t70 -122.94 122.95 39.81 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.979 0.912 . . . . 64.13 109.773 177.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 50.1 m -120.06 127.55 52.68 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.741 0.816 . . . . 72.52 109.834 175.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.403 ' HB3' ' HB ' ' A' ' 83' ' ' VAL . 39.0 tt0 -100.52 117.54 34.88 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.407 -0.96 . . . . 75.53 108.407 173.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -98.19 118.93 35.92 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.357 -0.979 . . . . 73.21 108.357 169.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.465 ' HG3' ' HB3' ' A' ' 81' ' ' ARG . 16.6 pt20 -121.5 137.58 54.66 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.618 0.767 . . . . 73.33 109.292 178.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.574 ' HB3' ' HB3' ' A' ' 106' ' ' PHE . 65.0 t-80 -148.33 129.24 7.0 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-O 118.95 -0.548 . . . . 74.51 110.353 -171.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -65.16 -38.86 25.72 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 123.14 2.56 . . . . 61.33 113.437 -173.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.46 ' HB2' ' HE1' ' A' ' 103' ' ' HIS . 35.4 m -93.54 28.93 2.12 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.926 0.49 . . . . 61.23 110.458 178.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.574 ' HB3' ' HB3' ' A' ' 103' ' ' HIS . 67.4 t80 -133.57 113.28 12.26 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.862 -0.792 . . . . 64.23 108.862 174.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.63 ' HB2' ' HB2' ' A' ' 110' ' ' GLN . 50.0 mt -117.51 157.48 26.23 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 108.706 -0.85 . . . . 63.12 108.706 173.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.38 -26.95 65.54 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.459 1.103 . . . . 74.53 112.974 -171.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.19 37.83 2.02 Favored Glycine 0 N--CA 1.471 0.973 0 N-CA-C 112.252 -0.339 . . . . 62.42 112.252 -177.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.63 ' HB2' ' HB2' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -131.24 71.8 1.48 Allowed 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 121.515 0.674 . . . . 74.32 109.673 -178.35 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -63.27 -30.36 71.51 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.345 1.058 . . . . 61.34 113.145 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 19.8 pm0 -66.28 -15.77 63.49 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.748 0.419 . . . . 73.54 111.639 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.525 ' O ' HG13 ' A' ' 117' ' ' ILE . 49.3 mt -87.03 -21.45 26.09 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 118.953 -0.546 . . . . 75.35 111.374 178.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 96.8 mt -57.4 -41.1 79.64 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 123.395 0.678 . . . . 63.25 111.33 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -76.93 -7.83 56.27 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 115.448 -0.796 . . . . 71.21 112.581 179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -101.15 -9.19 21.56 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.705 0.802 . . . . 74.43 109.857 172.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 113' ' ' LEU . 72.7 mt -81.13 108.96 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 107.265 -1.383 . . . . 72.53 107.265 173.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.478 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 11.2 mmpt? -108.67 144.09 36.88 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.997 -0.742 . . . . 74.4 108.997 -172.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 31.0 ptt-85 -96.94 2.38 51.55 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.655 0.597 . . . . 63.32 110.788 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -100.98 176.34 5.3 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.692 0.797 . . . . 71.35 110.442 177.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 29.6 m -87.5 68.95 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-O 123.18 1.467 . . . . 64.12 111.09 -174.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.0 t -77.38 -168.88 1.24 Allowed 'General case' 0 CA--C 1.559 1.318 0 CA-C-N 113.806 -1.543 . . . . 64.31 109.782 171.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 17.4 p -74.75 73.07 2.05 Favored 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 121.726 0.774 . . . . 74.44 111.275 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 16.5 m -139.48 157.4 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 125.308 1.443 . . . . 72.25 108.704 179.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 62.2 m . . . . . 0 C--O 1.254 1.296 0 N-CA-C 108.759 -0.83 . . . . 72.31 108.759 175.736 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 121.041 0.448 . . . . 55.32 110.786 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 155.11 128.66 1.17 Allowed Glycine 0 C--N 1.344 0.98 0 N-CA-C 110.284 -1.127 . . . . 74.43 110.284 178.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -92.73 165.36 12.99 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 122.974 0.51 . . . . 75.12 109.765 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -61.48 95.1 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.003 0.921 . . . . 73.44 111.106 -173.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.2 m170 -104.79 153.82 20.82 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.783 0.833 . . . . 74.35 109.32 173.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.2 m80 68.38 10.96 8.17 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 125.106 1.363 . . . . 71.54 112.283 175.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -75.1 119.55 19.4 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 109.785 -0.45 . . . . 54.31 109.785 -177.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -145.96 176.11 9.94 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.531 0.732 . . . . 61.45 109.803 -178.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.9 m -137.13 126.81 25.39 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.79 0.836 . . . . 74.03 108.86 175.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -59.24 -63.98 1.11 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.285 0.634 . . . . 72.54 110.315 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.499 ' HG3' ' O ' ' A' ' 14' ' ' PRO . 0.0 OUTLIER 177.61 149.86 0.18 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.085 1.354 . . . . 72.42 108.998 174.116 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -129.73 40.42 3.58 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.012 0.925 . . . . 31.05 108.543 177.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 176.29 -71.55 0.08 OUTLIER Glycine 0 C--N 1.348 1.219 0 CA-C-N 115.055 -0.975 . . . . 74.13 112.351 -177.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.499 ' O ' ' HG3' ' A' ' 11' ' ' MET . 34.3 Cg_exo -61.56 88.4 0.1 OUTLIER 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 123.413 2.742 . . . . 74.24 112.875 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 42.6 t -68.57 131.92 46.05 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.519 0.728 . . . . 71.21 111.189 -177.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -82.92 -3.7 57.32 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.433 0.693 . . . . 54.53 111.92 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.6 t -70.17 118.95 68.71 Favored Pre-proline 0 CA--C 1.553 1.083 0 N-CA-C 107.75 -1.204 . . . . 71.03 107.75 166.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -52.9 135.78 58.72 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 123.013 2.475 . . . . 74.24 112.621 177.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.96 -42.42 68.9 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.31 1.044 . . . . 74.34 112.335 -178.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -57.66 -40.75 80.05 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.252 0.621 . . . . 73.22 111.653 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 66.0 mt -78.04 -34.06 50.69 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 112.25 0.463 . . . . 73.21 112.25 -174.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.1 t -74.45 -37.22 63.32 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 119.688 -0.196 . . . . 73.25 110.885 178.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.501 ' HE2' ' HA ' ' A' ' 23' ' ' LYS . 8.5 mmpt? -70.79 -37.06 73.29 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 122.793 0.437 . . . . 63.45 110.102 175.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.436 ' O ' HG23 ' A' ' 28' ' ' VAL . 59.9 tp -58.5 -53.59 56.63 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 123.808 0.843 . . . . 75.34 111.453 173.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 24.1 t-105 -61.68 -41.74 97.98 Favored 'General case' 0 CA--C 1.549 0.921 0 O-C-N 123.027 0.204 . . . . 75.34 111.182 -178.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.453 ' O ' ' HB2' ' A' ' 30' ' ' ASP . 90.7 m -59.38 -36.52 75.95 Favored 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 122.897 0.479 . . . . 74.42 110.762 174.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.48 ' HG ' HG21 ' A' ' 37' ' ' ILE . 50.5 tp -70.78 -51.02 29.64 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.633 1.173 . . . . 65.41 111.939 -178.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 24' ' ' LEU . 96.4 t -60.58 -33.86 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 124.69 1.196 . . . . 65.43 111.2 -179.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.6 t -86.91 -24.44 24.82 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.855 0.862 . . . . 73.42 111.684 -176.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 26' ' ' THR . 8.7 t70 -69.3 128.62 92.34 Favored Pre-proline 0 N--CA 1.488 1.467 0 C-N-CA 122.856 0.462 . . . . 74.14 111.828 -168.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.32 -1.89 11.29 Favored 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 123.175 2.583 . . . . 75.22 114.507 -176.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -87.15 -34.28 19.12 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 118.305 0.502 . . . . 61.54 111.0 172.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 24.0 p -112.27 1.57 16.19 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.742 0.817 . . . . 74.23 112.398 -171.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.432 ' HA ' ' O ' ' A' ' 37' ' ' ILE . 8.9 p-10 -61.18 -25.15 66.83 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.951 0.901 . . . . 54.42 111.923 -178.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.26 -33.64 75.94 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.957 0.903 . . . . 75.11 112.496 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.438 HD22 ' HB2' ' A' ' 50' ' ' ASP . 69.3 mt -108.14 -13.35 14.94 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.221 0.608 . . . . 62.2 112.001 -178.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.48 HG21 ' HG ' ' A' ' 27' ' ' LEU . 19.8 tt -157.39 117.67 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 CA-C-O 121.266 0.555 . . . . 64.21 110.507 177.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 29.0 p -144.73 153.01 41.24 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.212 0.605 . . . . 74.13 109.803 -178.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 35.5 p-90 -82.21 153.15 26.09 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.922 -0.581 . . . . 73.41 109.738 178.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.6 m -82.49 156.91 68.21 Favored Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 108.726 -0.842 . . . . 65.41 108.726 -178.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -61.23 -12.29 22.8 Favored 'Trans proline' 0 C--N 1.377 2.044 0 C-N-CA 122.449 2.1 . . . . 35.04 113.297 178.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 77.2 p -74.44 -36.87 63.41 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.824 0.85 . . . . 74.43 110.656 171.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.93 -8.12 77.46 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 115.504 -0.771 . . . . 63.32 113.415 178.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.572 ' HA ' ' O ' ' A' ' 106' ' ' PHE . 0.4 OUTLIER -101.2 12.59 37.27 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.181 0.992 . . . . 50.03 111.37 -172.246 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.4 p -163.77 151.86 13.12 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.888 0.875 . . . . 63.05 109.538 -175.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -138.99 147.25 41.92 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.946 0.498 . . . . 71.44 109.871 177.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 25.0 m-70 -101.99 144.69 30.28 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.478 0.711 . . . . 61.43 109.556 -176.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.408 HG12 ' HG2' ' A' ' 51' ' ' GLN . 95.8 t -121.66 115.61 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 N-CA-C 107.504 -1.295 . . . . 71.1 107.504 177.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.483 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 25.4 m-85 -114.51 149.14 36.85 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.661 1.185 . . . . 71.31 110.743 -172.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.438 ' HB2' HD22 ' A' ' 36' ' ' LEU . 5.4 m-20 52.36 53.2 12.75 Favored 'General case' 0 N--CA 1.481 1.101 0 O-C-N 125.021 1.45 . . . . 50.12 110.51 176.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.706 ' HB3' ' SD ' ' A' ' 68' ' ' MET . 55.5 mt-30 -53.39 -25.85 17.2 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 114.853 -1.067 . . . . 71.21 113.576 -170.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -65.45 -50.42 55.47 Favored Glycine 0 CA--C 1.534 1.266 0 N-CA-C 112.205 -0.358 . . . . 71.11 112.205 174.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -73.72 -33.49 64.38 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 124.143 0.977 . . . . 74.41 110.608 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.43 ' HB3' ' HA ' ' A' ' 51' ' ' GLN . 83.3 t80 -66.03 -54.54 24.59 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 124.345 1.058 . . . . 74.42 110.582 -178.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.6 -26.04 67.66 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 116.108 -0.496 . . . . 43.31 111.724 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.1 tttm -64.01 -55.58 21.3 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 124.816 1.246 . . . . 72.14 113.064 178.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.491 ' HG3' HG23 ' A' ' 58' ' ' VAL . 2.1 pt-20 -112.02 -33.65 6.2 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 113.259 0.836 . . . . 73.41 113.259 -170.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.491 HG23 ' HG3' ' A' ' 57' ' ' GLU . 61.8 t -85.22 -43.23 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 C-N-CA 123.305 0.642 . . . . 75.3 111.328 -168.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 17.6 mt -62.57 -51.64 71.13 Favored Pre-proline 0 CA--C 1.558 1.272 0 CA-C-O 118.312 -0.851 . . . . 41.0 112.429 178.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.3 -7.48 21.32 Favored 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 121.726 1.617 . . . . 45.02 112.783 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -80.11 -60.97 2.13 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.09 0.956 . . . . 71.13 110.771 175.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -83.73 -32.17 25.64 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 122.755 0.422 . . . . 64.23 112.052 -176.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -112.11 -175.95 2.81 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.82 -0.807 . . . . 71.23 108.82 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.95 28.8 8.1 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.392 0.677 . . . . 73.12 111.295 -174.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 26.1 p80 -157.42 155.95 31.37 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.155 0.582 . . . . 65.41 109.82 -172.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 38.8 p30 -117.74 -7.5 10.99 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.394 0.677 . . . . 71.53 111.668 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -72.94 121.55 20.25 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.861 -0.422 . . . . 61.41 109.861 -178.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.706 ' SD ' ' HB3' ' A' ' 51' ' ' GLN . 2.4 tpt -59.48 -45.52 91.44 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.186 0.994 . . . . 74.21 111.227 178.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.73 -34.68 74.77 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 115.574 -0.739 . . . . 65.44 112.087 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 47.4 t -63.2 -40.92 98.86 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.252 0.621 . . . . 71.03 111.35 175.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -64.13 -53.08 55.24 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.134 0.974 . . . . 72.04 110.861 178.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.4 HG22 ' HZ ' ' A' ' 101' ' ' PHE . 58.1 t -61.16 -39.49 82.63 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 CA-C-N 115.079 -0.964 . . . . 75.34 111.394 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -57.78 -48.91 78.35 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.617 0.767 . . . . 74.3 111.235 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -58.13 -43.16 87.14 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 124.437 1.086 . . . . 72.41 110.641 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 83.7 mt -65.18 -41.53 94.52 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.219 0.608 . . . . 64.2 111.672 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -60.34 -35.88 76.69 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 122.584 0.354 . . . . 63.55 111.185 172.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.47 ' O ' ' HA ' ' A' ' 119' ' ' ARG . 48.2 mtp -65.63 -39.68 91.71 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.149 0.58 . . . . 64.33 110.126 175.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -81.53 -1.33 45.8 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.081 0.552 . . . . 64.03 111.518 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 83.03 22.15 57.95 Favored Glycine 0 C--N 1.35 1.331 0 N-CA-C 114.399 0.52 . . . . 60.2 114.399 174.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.553 ' HB3' ' HB3' ' A' ' 101' ' ' PHE . 34.2 m-85 -78.82 130.56 35.84 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.343 -0.984 . . . . 51.23 108.343 173.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -100.93 129.61 46.81 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.208 0.603 . . . . 73.43 109.649 -171.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -71.54 122.55 20.67 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.514 1.126 . . . . 71.44 110.905 -178.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 90.6 t -132.3 127.4 57.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 107.488 -1.301 . . . . 71.42 107.488 172.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.4 p -112.59 131.97 62.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 N-CA-C 109.122 -0.696 . . . . 55.15 109.122 177.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 29.6 m-70 -102.49 -33.29 9.57 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.054 0.542 . . . . 65.35 110.207 -178.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 30.8 mm -74.11 87.83 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 N-CA-C 108.736 -0.838 . . . . 64.02 108.736 169.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.417 ' H ' ' HE3' ' A' ' 93' ' ' LYS . 46.3 mt-10 -81.09 125.01 29.69 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 114.644 -1.162 . . . . 73.13 111.613 -175.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.72 HE22 ' HB2' ' A' ' 93' ' ' LYS . 80.9 mm-40 -117.49 75.6 1.0 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.344 0.657 . . . . 73.3 110.176 177.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -88.66 -69.03 1.27 Allowed Glycine 0 N--CA 1.47 0.902 0 N-CA-C 110.227 -1.149 . . . . 61.33 110.227 170.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -135.12 17.92 4.04 Favored Glycine 0 CA--C 1.525 0.66 0 C-N-CA 123.946 0.784 . . . . 71.02 111.241 171.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 68.9 mt -91.12 169.76 10.58 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.431 1.093 . . . . 73.0 110.643 -175.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.452 HG13 ' H ' ' A' ' 93' ' ' LYS . 6.5 p -101.68 -67.01 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.786 0 CA-C-O 118.985 -0.531 . . . . 63.12 109.796 175.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.72 ' HB2' HE22 ' A' ' 88' ' ' GLN . 64.0 mttm 58.98 165.83 0.08 OUTLIER Pre-proline 0 N--CA 1.492 1.671 0 C-N-CA 124.733 1.213 . . . . 61.42 113.224 -178.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -61.73 145.28 97.47 Favored 'Trans proline' 0 C--N 1.385 2.481 0 C-N-CA 122.153 1.902 . . . . 65.14 110.764 170.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.57 -14.78 61.7 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.326 0.65 . . . . 72.12 112.56 -170.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 8.4 ptm180 -59.96 142.82 53.1 Favored 'General case' 0 C--O 1.244 0.811 0 C-N-CA 123.525 0.73 . . . . 71.24 110.184 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.483 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 2.5 m-20 -80.73 147.22 30.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.614 -0.721 . . . . 61.35 109.765 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -134.78 117.93 16.5 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.864 0.866 . . . . 55.14 109.345 172.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 86.3 m -135.06 109.0 8.12 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.595 0.758 . . . . 72.21 109.125 178.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -99.15 119.7 38.28 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.786 -0.82 . . . . 64.42 108.786 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.553 ' HB3' ' HB3' ' A' ' 80' ' ' PHE . 92.9 m-85 -99.62 120.31 39.47 Favored 'General case' 0 C--O 1.24 0.602 0 N-CA-C 108.556 -0.905 . . . . 72.11 108.556 173.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -109.99 144.59 38.31 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.368 0.667 . . . . 64.25 110.027 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -153.34 127.06 4.33 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 109.149 -0.686 . . . . 75.34 109.149 177.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.8 -34.86 59.8 Favored 'Trans proline' 0 C--N 1.373 1.841 0 C-N-CA 123.021 2.481 . . . . 73.44 112.957 -177.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 36.1 m -93.19 26.29 2.94 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-O 121.234 0.54 . . . . 75.33 110.833 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.572 ' O ' ' HA ' ' A' ' 44' ' ' ASN . 85.8 t80 -124.9 110.36 14.16 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 107.092 -1.448 . . . . 73.3 107.092 172.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.647 ' HB2' ' HB3' ' A' ' 110' ' ' GLN . 85.2 mt -131.48 174.49 10.04 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 108.849 -0.797 . . . . 65.23 108.849 170.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 58.3 ttt180 -63.09 -75.7 0.07 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.527 0.731 . . . . 72.33 111.513 -178.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -80.25 -10.9 84.9 Favored Glycine 0 C--N 1.349 1.271 0 O-C-N 123.195 0.31 . . . . 74.33 113.157 -177.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.647 ' HB3' ' HB2' ' A' ' 107' ' ' LEU . 5.3 tp-100 -90.99 40.55 1.03 Allowed 'General case' 0 CA--C 1.556 1.178 0 CA-C-O 121.531 0.682 . . . . 70.43 109.323 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -69.63 -12.53 61.72 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.088 0.955 . . . . 65.42 112.687 -178.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.3 pm0 -64.45 -10.11 23.03 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.197 0.599 . . . . 75.24 112.174 169.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.474 ' O ' HG13 ' A' ' 117' ' ' ILE . 53.0 mt -91.18 -4.58 55.96 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.172 0.589 . . . . 75.41 111.961 175.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 90.2 mt -66.03 -34.56 78.36 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 118.536 0.607 . . . . 62.31 111.162 176.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -75.25 -17.25 60.36 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.515 0.726 . . . . 52.31 111.415 172.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.432 HD22 ' HA ' ' A' ' 113' ' ' LEU . 28.1 m-80 -90.86 -9.86 44.78 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.413 0.685 . . . . 71.23 110.034 176.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 113' ' ' LEU . 59.3 mt -84.26 121.7 36.95 Favored 'Isoleucine or valine' 0 C--N 1.351 0.659 0 N-CA-C 107.294 -1.373 . . . . 73.1 107.294 170.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.521 ' HA ' ' HE2' ' A' ' 118' ' ' LYS . 10.8 mmpt? -111.14 151.79 27.74 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.225 0.61 . . . . 64.11 109.837 -178.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 77' ' ' MET . 43.3 ptt85 -107.98 -179.46 3.9 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.053 -0.976 . . . . 75.25 109.563 170.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -73.66 165.53 24.92 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 116.051 -0.522 . . . . 75.45 109.985 169.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 22.3 t 63.44 65.52 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.242 1.017 . . . . 64.31 109.075 -171.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.3 t -156.5 148.78 23.32 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 114.815 -1.084 . . . . 75.13 108.981 178.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 66.2 p -168.09 144.02 3.85 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.046 0.539 . . . . 62.54 110.278 179.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 3.3 p -75.25 92.41 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 N-CA-C 108.84 -0.8 . . . . 70.23 108.84 170.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 39.3 m . . . . . 0 CA--C 1.557 1.246 0 C-N-CA 124.707 1.203 . . . . 63.43 109.989 -171.615 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 N--CA 1.482 1.133 0 N-CA-C 110.18 -0.304 . . . . 63.33 110.18 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -131.7 53.53 0.8 Allowed Glycine 0 C--N 1.355 1.588 0 N-CA-C 112.364 -0.294 . . . . 52.31 112.364 -170.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -131.65 42.88 3.13 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.685 0.794 . . . . 44.12 109.069 171.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 26.2 m170 -62.65 129.95 42.85 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.086 -0.961 . . . . 62.44 110.789 -178.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -106.05 46.09 0.94 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.354 0.662 . . . . 73.12 110.218 -177.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 33.1 m170 -78.62 80.85 4.97 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 107.99 -1.115 . . . . 65.24 107.99 168.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 17.3 t-80 -138.44 87.61 2.24 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.622 -1.172 . . . . 61.22 108.672 -169.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.1 p80 55.18 115.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 126.895 2.078 . . . . 74.32 113.692 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.7 p -143.6 159.11 43.03 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.138 0.975 . . . . 72.45 109.823 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 54.2 m80 59.45 30.77 20.49 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.384 1.073 . . . . 72.14 111.816 176.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 70.8 mtp -60.43 108.18 0.78 Allowed 'General case' 0 C--N 1.352 0.676 0 C-N-CA 123.975 0.91 . . . . 73.14 108.982 175.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.79 157.74 35.87 Favored 'General case' 0 C--O 1.24 0.553 0 O-C-N 123.51 0.506 . . . . 62.11 110.792 -177.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -105.26 95.07 1.06 Allowed Glycine 0 C--N 1.336 0.576 0 CA-C-O 119.183 -0.787 . . . . 64.14 111.441 175.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.03 113.91 3.41 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 121.847 1.698 . . . . 65.11 110.353 174.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.8 t -76.8 -176.78 4.01 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.346 0.659 . . . . 72.54 110.339 -176.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.434 ' HB2' ' HB2' ' A' ' 115' ' ' GLU . 25.0 m-80 -65.83 -10.62 39.56 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 123.306 0.642 . . . . 71.32 111.866 178.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 98.8 t -57.55 115.24 10.22 Favored Pre-proline 0 N--CA 1.482 1.168 0 C-N-CA 123.878 0.871 . . . . 43.3 110.25 176.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -52.28 148.48 25.22 Favored 'Trans proline' 0 C--N 1.386 2.526 0 C-N-CA 123.718 2.945 . . . . 75.22 113.172 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.77 -42.42 64.98 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.833 0.853 . . . . 75.31 111.771 176.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -52.71 -49.9 64.44 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.617 0.767 . . . . 73.1 112.081 174.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 82.5 mt -80.61 -30.81 36.78 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 112.187 0.44 . . . . 72.13 112.187 -169.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.8 t -72.15 -36.54 69.36 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-N 118.009 0.368 . . . . 61.32 111.026 175.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.498 ' HE2' ' HA ' ' A' ' 23' ' ' LYS . 9.0 mmpt? -73.52 -36.49 65.72 Favored 'General case' 0 C--N 1.359 0.981 0 C-N-CA 122.869 0.468 . . . . 33.23 110.324 176.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.0 tp -62.76 -49.34 75.38 Favored 'General case' 0 C--N 1.352 0.704 0 O-C-N 124.049 0.843 . . . . 74.02 110.99 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.478 ' HH2' ' HG2' ' A' ' 108' ' ' ARG . 12.0 t-105 -60.47 -43.62 96.73 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 122.36 0.264 . . . . 61.13 111.209 178.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 48.4 m -54.42 -51.19 65.7 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 122.631 0.373 . . . . 74.0 110.436 172.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.45 ' HG ' HD13 ' A' ' 37' ' ' ILE . 37.1 tp -57.19 -53.39 58.68 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 126.116 1.767 . . . . 44.12 113.201 -175.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.7 t -61.47 -35.45 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.659 1.184 . . . . 63.05 111.785 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.2 t -93.32 -6.52 47.2 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.778 -0.646 . . . . 44.52 111.351 -176.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -83.42 129.83 58.79 Favored Pre-proline 0 CA--C 1.552 1.055 0 C-N-CA 123.004 0.521 . . . . 74.33 111.18 -172.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -80.88 -9.63 13.06 Favored 'Trans proline' 0 C--N 1.382 2.328 0 C-N-CA 122.863 2.375 . . . . 42.34 114.027 -176.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -80.53 -27.42 37.63 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 118.49 0.586 . . . . 74.24 110.589 175.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 15.8 p -105.59 10.02 33.15 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.537 0.735 . . . . 74.41 112.486 -179.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -56.83 -32.27 65.59 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 124.151 0.981 . . . . 61.04 112.476 -175.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.08 -38.24 90.39 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.835 0.854 . . . . 75.31 112.968 -176.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.446 ' HA ' ' HB2' ' A' ' 49' ' ' PHE . 77.9 mt -110.97 -8.5 14.47 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 122.687 0.395 . . . . 61.01 111.837 -175.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.45 HD13 ' HG ' ' A' ' 27' ' ' LEU . 18.6 tt -162.42 134.36 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 122.62 0.368 . . . . 74.42 111.163 173.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 7.3 p -161.96 156.6 22.55 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.15 0.58 . . . . 75.04 109.879 173.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 14.8 p-90 -77.03 150.31 35.8 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.335 0.654 . . . . 71.41 110.504 -177.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.2 m -75.54 147.11 81.57 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 108.579 -0.897 . . . . 75.22 108.579 176.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.49 -12.89 12.01 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.615 2.21 . . . . 62.44 113.639 176.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.0 m -65.76 -43.95 87.31 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.664 1.186 . . . . 55.15 110.728 169.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.46 -10.98 69.07 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-N 114.934 -1.03 . . . . 71.42 114.147 177.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -101.84 6.43 41.53 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.456 1.102 . . . . 74.34 111.605 -171.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.2 p -157.36 161.75 39.05 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.121 0.969 . . . . 65.42 109.657 -171.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.431 ' O ' ' HA ' ' A' ' 100' ' ' GLU . 45.9 p90 -146.61 146.52 30.45 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.66 0.384 . . . . 72.13 110.731 177.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -103.28 143.55 32.51 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.575 0.75 . . . . 63.33 109.632 -178.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 79.0 t -123.14 121.98 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 107.569 -1.271 . . . . 71.13 107.569 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.552 ' HA ' ' O ' ' A' ' 97' ' ' ASP . 90.6 m-85 -105.14 144.71 31.55 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 123.572 0.749 . . . . 71.23 109.759 -177.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 42.98 73.02 0.15 Allowed 'General case' 0 N--CA 1.476 0.851 0 O-C-N 125.254 1.596 . . . . 64.34 112.608 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -53.72 -26.9 25.2 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 124.499 1.119 . . . . 71.13 113.498 -175.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -69.31 -48.12 47.51 Favored Glycine 0 C--N 1.35 1.35 0 O-C-N 123.014 0.196 . . . . 61.43 112.69 173.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.423 ' HG3' HD11 ' A' ' 36' ' ' LEU . 56.1 tp60 -71.62 -37.13 70.95 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 124.018 0.927 . . . . 74.24 110.663 -178.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.468 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 59.8 t80 -61.96 -48.93 78.17 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.224 1.41 . . . . 75.1 110.135 176.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.466 ' HB2' ' HB2' ' A' ' 68' ' ' MET . . . -62.45 -33.0 73.96 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-N 116.06 -0.518 . . . . 73.45 111.6 178.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.1 tttm -67.74 -55.52 12.82 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.611 1.165 . . . . 71.44 113.398 -177.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -106.78 -33.38 7.6 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 113.138 0.792 . . . . 70.1 113.138 -170.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.468 ' HB ' ' O ' ' A' ' 54' ' ' PHE . 94.4 t -82.78 -49.94 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 122.923 0.489 . . . . 73.44 111.605 -171.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 38.2 mt -61.48 -47.76 92.42 Favored Pre-proline 0 CA--C 1.561 1.369 0 CA-C-O 118.048 -0.977 . . . . 61.05 113.042 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -66.62 -16.62 51.2 Favored 'Trans proline' 0 C--N 1.391 2.783 0 CA-C-N 121.964 1.737 . . . . 74.41 113.073 177.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -77.03 -53.97 7.14 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.384 0.674 . . . . 54.25 111.253 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 42.2 m-85 -87.29 -46.71 9.45 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.241 0.617 . . . . 73.42 111.686 -177.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -100.33 -179.9 4.26 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 115.383 -0.826 . . . . 64.42 108.785 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -112.64 40.03 2.36 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 121.634 0.73 . . . . 64.45 109.654 -174.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 32.2 p80 -157.66 161.5 38.6 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 114.949 -1.023 . . . . 75.34 109.01 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.413 ' O ' ' HB1' ' A' ' 55' ' ' ALA . 31.7 p30 -112.95 -11.01 13.47 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.217 0.607 . . . . 43.25 110.128 177.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.2 t-20 -73.39 120.53 19.13 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 123.439 0.696 . . . . 73.04 111.262 -176.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.466 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 12.2 tpt -69.9 -36.63 75.55 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.702 0.801 . . . . 74.22 111.303 -178.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.65 -30.92 67.68 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 123.724 0.64 . . . . 73.5 111.962 -179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.1 t -65.54 -47.35 76.16 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.39 1.076 . . . . 71.45 110.841 174.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -63.74 -52.92 58.28 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.511 1.125 . . . . 75.42 110.471 -176.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.7 t -62.94 -40.89 90.67 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 CA-C-N 115.25 -0.886 . . . . 62.23 111.055 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -57.7 -40.97 80.74 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 123.272 0.629 . . . . 73.33 111.407 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -57.57 -51.0 71.25 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 124.187 0.929 . . . . 73.44 110.07 176.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 68.2 mt -63.56 -38.14 89.98 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.923 0.889 . . . . 73.25 111.714 -177.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 -57.27 -44.6 84.11 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 122.803 0.441 . . . . 71.22 110.851 172.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 71.0 mtm -73.79 -25.17 59.99 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.905 -0.589 . . . . 54.11 111.499 -179.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -86.54 1.58 51.13 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 123.35 0.66 . . . . 62.52 111.065 173.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.63 13.39 81.6 Favored Glycine 0 C--N 1.344 1.017 0 N-CA-C 115.068 0.787 . . . . 53.25 115.068 171.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -69.3 144.87 53.44 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 117.877 0.838 . . . . 73.12 109.248 177.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -101.18 122.54 43.82 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.414 -0.587 . . . . 75.31 109.414 -177.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.502 ' HE2' ' HB ' ' A' ' 84' ' ' VAL . 22.9 tptm -68.32 113.22 5.73 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.018 1.327 . . . . 74.11 109.743 172.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 90.3 t -125.58 106.61 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 107.711 -1.218 . . . . 73.55 107.711 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.502 ' HB ' ' HE2' ' A' ' 82' ' ' LYS . 3.5 p -107.7 123.11 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 N-CA-C 108.442 -0.947 . . . . 73.02 108.442 -172.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 19.9 m-70 -95.7 -26.05 15.86 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.164 0.586 . . . . 75.35 111.725 -169.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.412 HG12 ' HB3' ' A' ' 98' ' ' ASP . 47.1 mm -90.47 107.85 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 123.134 0.574 . . . . 63.21 110.242 -178.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -90.02 100.89 13.62 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.836 0.854 . . . . 73.23 109.476 169.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -71.99 94.88 1.52 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 123.521 0.728 . . . . 73.21 109.121 176.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -160.23 -127.87 0.93 Allowed Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.106 -0.798 . . . . 62.24 111.106 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -98.24 51.61 1.26 Allowed Glycine 0 C--N 1.343 0.97 0 CA-C-N 116.893 0.347 . . . . 63.35 112.503 178.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 89.2 mt -120.86 168.44 11.45 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.963 0.905 . . . . 61.34 110.949 -179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.3 p -112.06 79.64 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.075 0 CA-C-O 122.97 1.366 . . . . 72.13 109.263 175.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -140.2 161.24 56.48 Favored Pre-proline 0 N--CA 1.48 1.054 0 CA-C-N 113.817 -1.538 . . . . 72.42 107.756 175.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -66.21 133.52 33.23 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 121.358 1.372 . . . . 71.22 109.707 174.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -81.12 4.95 18.24 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.933 0.893 . . . . 64.11 112.257 -170.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -57.54 171.15 0.47 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.214 1.006 . . . . 75.13 111.917 171.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.552 ' O ' ' HA ' ' A' ' 49' ' ' PHE . 52.4 m-20 -86.58 124.51 32.96 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.24 -1.022 . . . . 64.53 108.24 171.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.412 ' HB3' HG12 ' A' ' 86' ' ' ILE . 29.6 t70 -123.2 107.52 11.8 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 107.897 -1.149 . . . . 74.01 107.897 167.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 55.0 m -122.11 108.73 13.68 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.589 1.156 . . . . 42.11 109.579 -173.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 46' ' ' PHE . 38.7 tt0 -101.49 115.36 30.34 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.82 -0.807 . . . . 71.05 108.82 -179.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -96.63 120.03 36.2 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.181 -1.044 . . . . 63.52 108.181 171.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -118.3 145.48 45.04 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.714 -0.847 . . . . 64.33 108.714 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.467 ' HB3' ' HB3' ' A' ' 106' ' ' PHE . 42.6 t-80 -155.78 133.17 6.53 Favored Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 109.318 -0.623 . . . . 74.25 109.318 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -63.96 -35.53 54.46 Favored 'Trans proline' 0 C--N 1.384 2.447 0 C-N-CA 122.855 2.37 . . . . 54.21 112.268 -175.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 3.4 m -87.0 3.88 44.12 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.435 0.694 . . . . 73.4 111.002 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.467 ' HB3' ' HB3' ' A' ' 103' ' ' HIS . 88.9 t80 -111.84 103.28 11.53 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 107.911 -1.144 . . . . 74.2 107.911 175.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.413 HD12 ' HG2' ' A' ' 110' ' ' GLN . 28.3 mt -119.43 167.97 11.42 Favored 'General case' 0 C--O 1.246 0.881 0 N-CA-C 107.236 -1.394 . . . . 71.22 107.236 170.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.478 ' HG2' ' HH2' ' A' ' 25' ' ' TRP . 30.3 ttp85 -60.63 -79.86 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.154 0.582 . . . . 75.31 110.903 -173.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -85.46 60.17 4.74 Favored Glycine 0 C--N 1.347 1.14 0 N-CA-C 111.624 -0.59 . . . . 63.42 111.624 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.413 ' HG2' HD12 ' A' ' 107' ' ' LEU . 2.8 tp-100 -150.93 35.44 0.6 Allowed 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 108.872 -0.788 . . . . 72.22 108.872 -170.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -64.16 -20.19 65.83 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.607 1.163 . . . . 61.21 113.154 -175.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.07 -8.18 53.13 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 112.022 0.379 . . . . 73.31 112.022 177.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.435 ' O ' HG13 ' A' ' 117' ' ' ILE . 17.7 mt -88.3 -16.61 32.64 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.368 0.667 . . . . 71.52 111.494 173.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 96.8 mt -61.61 -36.41 80.66 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.274 0.559 . . . . 64.42 111.212 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.434 ' HB2' ' HB2' ' A' ' 16' ' ' ASN . 12.6 pt-20 -72.77 -15.78 61.65 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 115.57 -0.741 . . . . 74.03 112.342 177.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 36.3 m-80 -97.14 -7.68 31.95 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.706 0.802 . . . . 64.13 110.257 178.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 113' ' ' LEU . 64.2 mt -88.65 130.52 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 107.573 -1.269 . . . . 71.11 107.573 173.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -105.71 141.1 37.72 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.25 0.62 . . . . 61.54 109.992 -171.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -92.2 7.04 44.39 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 124.209 0.943 . . . . 74.14 110.327 170.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -102.58 -168.75 1.57 Allowed 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.078 0.951 . . . . 72.13 110.695 -173.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.2 p -60.55 -22.89 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.373 0 C-N-CA 124.417 1.087 . . . . 63.12 113.775 -168.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 38.6 p -82.13 73.23 9.17 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-O 121.515 0.674 . . . . 73.01 110.27 174.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 34.0 t -170.45 172.71 5.91 Favored 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 114.606 -1.179 . . . . 75.43 109.228 -174.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 7.4 p -165.53 134.13 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 C-N-CA 124.056 0.942 . . . . 74.54 109.749 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 CA--C 1.556 1.178 0 N-CA-C 108.443 -0.947 . . . . 72.43 108.443 177.199 . . . . . . . . 0 0 . 1 stop_ save_